1	orlistat	hsa04916	Melanogenesis	5579_5578_5566_81029_1387_107	6	+	0.037090956947261	0.245318725577717
2	orlistat	hsa04120	Ubiquitin mediated proteolysis	9063_4281_8945_23759_330_22888_326_8651	8	+	0.0103215320093284	0.187851882569777
3	orlistat	hsa05010	Alzheimer's disease	775_2902_779_6390_317_3709_4035_487_517	9	+	0.00129953453817571	0.0394192143246632
4	orlistat	hsa04310	Wnt signaling pathway	6425_8945_5579_5578_4088_5566_81029_3725_1387_5516	10	+	0.0199457917764641	0.243201055166699
5	orlistat	hsa05016	Huntington's disease	5432_2902_4899_6648_7052_1639_6390_317_246721_10540_9001_1387_10126_517	14	+	0.0278200736560103	0.243201055166699
6	orlistat	hsa03420	Nucleotide excision repair	5111	1	+	0.0377413423965719	0.245318725577717
7	orlistat	hsa04740	Olfactory transduction	26211_7932_5566_135948_2979_5592	6	+	5.61566142238143e-15	5.1102518943671e-13
8	orlistat	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8329_8294_8342_8341_3123_3126_3127_3125_8969_8370_718_8332_8359_8330_8331_8336_554313_6738_121504_3018_85235_3119_3111_1511	34	+	0.00497712755624379	0.113229651904546
9	orlistat	hsa04110	Cell cycle	995_1647_5111_4088_7040_1870_1387	7	+	0.0259622605718311	0.243201055166699
10	orlistat	hsa05221	Acute myeloid leukemia	861_6655	2	+	0.0293979297454252	0.243201055166699
11	orlistat	hsa04530	Tight junction	29895_5579_5578_998_6709_2036_88_3996_5516	9	+	0.0283739001602148	0.243201055166699
12	orlistat	hsa04150	mTOR signaling pathway	6794	1	+	0.0177103855262332	0.243201055166699
13	orlistat	hsa05012	Parkinson's disease	9627_6390_317_517	4	+	0.000195730215626766	0.00890572481101785
14	orlistat	hsa04620	Toll-like receptor signaling pathway	3592_1432_3576_3441_7099_3725	6	+	0.0365378432550878	0.245318725577717
15	orlistat	hsa04120	Ubiquitin mediated proteolysis	23327_10277_996_4281_10075_7328_11060_23759_5371_4193_672_26091_83737_8454_26272_9820_7329_27338_23221_7327_9040	21	-	0.0226543724123308	0.191532421304251
16	orlistat	hsa05010	Alzheimer's disease	55851_2597_3710_2904_5663_51806_5664_6622_348_4842_4843_776_5533_5532_3709_489_23236_5594_4713_642502_6391_4137_1537_808_823_805_801_517	28	-	0.0142836433570177	0.166047354025331
17	orlistat	hsa04080	Neuroactive ligand-receptor interaction	623_151_2901_152_2904_2908_5724_134_5644_6870_2488_1813_624_3360_799_3953_3972_4986_5646_7068_1909_2911_2918_5025_148_6915_146_7067_5733_3269_3358_9170_1812_5734_2558_4160_6755_2740_8811_10800_680	41	-	0.0034976005355354	0.0650553699609584
18	orlistat	hsa04742	Taste transduction	2785_346562_5566_3710_6340	5	-	0.0221988816835997	0.191532421304251
19	orlistat	hsa05016	Huntington's disease	246721_2904_5432_1537_6648_5434_7157_1639_6667_10488_64446_7416_23236_1175_581_548644_163_4713_642502_6391_3092_5978_1387_293_517	25	-	0.00106029065179554	0.0328690102056617
20	orlistat	hsa03420	Nucleotide excision repair	5983_6117_5111_5985	4	-	0.046003418294576	0.285221193426371
21	orlistat	hsa04740	Olfactory transduction	51806_5592_56656_26211_5566_135948_2978_808_805_801_816	11	-	5.91466509381143e-26	5.50063853724463e-24
22	orlistat	hsa04340	Hedgehog signaling pathway	7479_5566_7472_7480_6469	5	-	0.0164639321770689	0.170127299163045
23	orlistat	hsa04630	Jak-STAT signaling pathway	3581_3561_3566_2057_3953_1271_6654_10379_3440_5293_50615_3451_50616_3977_3976_8835_3597_1489_1387_3569	20	-	0.00236367630627485	0.0549554741208903
24	orlistat	hsa04062	Chemokine signaling pathway	113_156_5580_5293_7852_5880_10235_2309_3579_2783_5829_5566_7410_1398_6362_4793_6367_2785_108_2185_23236_115_6352_5594_5579_6654_6464_6358_6359_3845_7409_5970_8976	33	-	0.0300274554070249	0.228914570415456
25	orlistat	hsa05012	Parkinson's disease	4713_7327_5413_7314_6391_7054_1537_7416_65018_6531_6622_293_517_642502	14	-	0.00032900349918696	0.0152986627121936
26	orlistat	hsa04260	Cardiac muscle contraction	776_781_782_783_1537_4624_481_4635_7171_7137_10368	11	-	0.0388963171821295	0.258382678424146
27	orlistat	hsa04060	Cytokine-cytokine receptor interaction	3597_5155_8742_8741_7852_7850_1489_1896_959_1271_3554_3579_2057_3451_4049_3953_4982_3977_3976_8718_6362_6367_3581_23495_8743_3624_8200_4254_1956_7040_91_6352_268_8794_8795_3561_3566_944_3569_3440_6358_6359_50615_50616_7423_7422_1435_51330	48	-	0.0319988109182896	0.228914570415456
28	orlistat	hsa03010	Ribosome	440589_6192_6233_6187_6142_6141_6234_9045_439992_6160_6159_6129_6189	13	-	0.0141422015450258	0.166047354025331
29	orlistat	hsa03050	Proteasome	9491_5689_5702	3	-	0.00794931659272342	0.123214407187213
30	fluorocurarine	hsa04740	Olfactory transduction	8387_81697_26212_56656_8388	5	+	0.0198881161878468	0.725916240856408
31	fluorocurarine	hsa05322	Systemic lupus erythematosus	2903_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	+	0.00569684942698343	0.41587000816979
32	fluorocurarine	hsa04512	ECM-receptor interaction	1278_1284_7059_1302_3690_3371_1292	7	+	0.0312123357426658	0.759500169738201
33	fluorocurarine	hsa04740	Olfactory transduction	4991	1	-	0.000575084618898805	0.0408310079418152
34	moxonidine	hsa05214	Glioma	5154_5578	2	+	0.0180406635724886	0.0691614321521407
35	moxonidine	hsa04070	Phosphatidylinositol signaling system	8526_5578	2	+	0.0239945355414357	0.0691614321521407
36	moxonidine	hsa04080	Neuroactive ligand-receptor interaction	2688_1442_2689	3	+	0.0449450463632359	0.0837150037631633
37	moxonidine	hsa05200	Pathways in cancer	2260_5578_5154_7042	4	+	0.0190590611292972	0.0691614321521407
38	moxonidine	hsa05131	Shigellosis	7430_5578	2	+	0.0137214813830822	0.0691614321521407
39	moxonidine	hsa05130	Pathogenic Escherichia coli infection	7430_5578	2	+	0.0137214813830822	0.0691614321521407
40	moxonidine	hsa05212	Pancreatic cancer	2260_5154	2	+	0.0319206609932957	0.0691614321521407
41	moxonidine	hsa05215	Prostate cancer	2260_5154	2	+	0.031278481526646	0.0691614321521407
42	moxonidine	hsa04530	Tight junction	4619_5578_5516	3	+	0.00898821413993621	0.0691614321521407
43	moxonidine	hsa04664	Fc epsilon RI signaling pathway	8398_5578	2	+	0.025740769003202	0.0691614321521407
44	moxonidine	hsa04370	VEGF signaling pathway	8398_5578	2	+	0.0245709374949867	0.0691614321521407
45	moxonidine	hsa05218	Melanoma	2260_5154	2	+	0.0211992044533351	0.0691614321521407
46	moxonidine	hsa04350	TGF-beta signaling pathway	5516_7042	2	+	0.0306415794091915	0.0691614321521407
47	moxonidine	hsa04630	Jak-STAT signaling pathway	2688_1442_2689	3	+	0.0124769352890242	0.0691614321521407
48	moxonidine	hsa04810	Regulation of actin cytoskeleton	2260_7430_5154	3	+	0.0304856616668224	0.0691614321521407
49	moxonidine	hsa04010	MAPK signaling pathway	8398_782_5578_5154_8912_4763_7042_2260	8	+	1.54619862641083e-06	6.03017464300224e-05
50	moxonidine	hsa04540	Gap junction	5154_5578	2	+	0.0345414267547491	0.0709008233386955
51	moxonidine	hsa04260	Cardiac muscle contraction	782_4635	2	+	0.0281474781446568	0.0691614321521407
52	moxonidine	hsa04060	Cytokine-cytokine receptor interaction	2689_2688_5154_7042	4	+	0.00865830466038985	0.0691614321521407
53	moxonidine	hsa04912	GnRH signaling pathway	8398_5578	2	+	0.0450773097186264	0.0837150037631633
54	moxonidine	hsa04730	Long-term depression	5578_8398_5516	3	+	0.00149353607434549	0.0291239534497371
55	moxonidine	hsa05322	Systemic lupus erythematosus	8343_8339_8347_8346_8344	5	-	0.0083764419676824	0.309928352804249
56	terazosin	hsa04070	Phosphatidylinositol signaling system	23533_3710_5579_51806_5578_3631_3708_23236	8	+	0.0245825925906723	0.352408865302675
57	terazosin	hsa04740	Olfactory transduction	51806_26212	2	+	1.37497806115624e-05	0.00107248288770187
58	terazosin	hsa04664	Fc epsilon RI signaling pathway	23533_10000_5579_5581_5599_5578_5600_5603	8	+	0.029588801453865	0.352408865302675
59	terazosin	hsa04720	Long-term potentiation	51806_3710_5579_2904_5578_6196_3708_27330_23236	9	+	0.00853987754473327	0.218964036429169
60	terazosin	hsa04540	Gap junction	3710_5579_5578_2983_5598_1813_5155_115_3708_23236	10	+	0.0112289249450856	0.218964036429169
61	terazosin	hsa05012	Parkinson's disease	1339	1	+	0.0316264366297272	0.352408865302675
62	terazosin	hsa04912	GnRH signaling pathway	4214_3710_5579_5578_5599_5598_5603_2002_115_3708_51806_5600_2185_2796_23236	15	+	0.000194126398284924	0.00757092953311204
63	terazosin	hsa04730	Long-term depression	3710_5579_5578_2983_3708_23236_5516	7	+	0.04524492550796	0.44113802370261
64	terazosin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3111	22	-	1.05309584585865e-12	5.79202715222258e-11
65	terazosin	hsa04330	Notch signaling pathway	196403_1488_4854_5664	4	-	0.0174879846986542	0.48091957921299
66	cefalonium	hsa04670	Leukocyte transendothelial migration	5829_7430	2	+	0.0435427579761828	0.389830318292949
67	alsterpaullone	hsa05214	Glioma	818_1026_4193_5578	4	+	0.0147092160620159	0.389405613532079
68	alsterpaullone	hsa05131	Shigellosis	7278_113457_5578	3	+	0.0469972292193889	0.389405613532079
69	alsterpaullone	hsa05130	Pathogenic Escherichia coli infection	7278_113457_5578	3	+	0.0469972292193889	0.389405613532079
70	alsterpaullone	hsa05322	Systemic lupus erythematosus	8358_85235_8968_3013_3113_8969_8332_8330_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357	19	+	6.48385143471485e-13	3.76063383213461e-11
71	alsterpaullone	hsa04012	ErbB signaling pathway	818_1026_56924_5578	4	+	0.0361931085644046	0.389405613532079
72	alsterpaullone	hsa04540	Gap junction	7278_5578_113457_112	4	+	0.0441072027722856	0.389405613532079
73	alsterpaullone	hsa04270	Vascular smooth muscle contraction	9138_5578_3778_59_112	5	+	0.0268953261857075	0.389405613532079
74	alsterpaullone	hsa04916	Melanogenesis	2033_4286_4157_2535_5613_7855_5616_5894_3845_6934_112_8324_1385_1387_8321_107_8323_8322	18	-	0.0303482819757461	0.0806397206784111
75	alsterpaullone	hsa05332	Graft-versus-host disease	355	1	-	0.000365990874415824	0.00179142901687745
76	alsterpaullone	hsa04650	Natural killer cell mediated cytotoxicity	8503_6850_5295_5290_5291_10451_836_3459_3845_4277_4276_10725_673_5533_5532_5894_5534_8795_3460_6655_6654_355_7409_4772	24	-	0.0110815491912035	0.0332446475736105
77	alsterpaullone	hsa04120	Ubiquitin mediated proteolysis	10277_9817_8554_7328_23759_331_996_11059_22954_55958_7324_7326_4281_51366_7321_7322_22888_51343_6477_51433_26091_83737_8925_55236_26232_8065_329_23291_10401_997_64750_10054_672_8454_8453_8452_8451_8945_8697_7320_7337_868_25898_4734_55120_6502_7323_11065_3093_51588_10393_27338_11060_7189_51465_57154_63893	57	-	0.0499622937413237	0.127126839197402
78	alsterpaullone	hsa04640	Hematopoietic cell lineage	3589_3554_960_1604_2057	5	-	8.71505604086266e-06	6.75416843166856e-05
79	alsterpaullone	hsa03320	PPAR signaling pathway	7316_1962_6256_2181_8310_5467_1376_6257_28965	9	-	0.0107200361480109	0.0332321120588338
80	alsterpaullone	hsa05010	Alzheimer's disease	5533_836_1327_841_8772_5534_317_9451_5663_5532_3708_3709_509_7132_355	15	-	3.27382709297393e-08	6.08931839293151e-07
81	alsterpaullone	hsa04080	Neuroactive ligand-receptor interaction	5029_4889_5618_4157_7068_2908_5025_4886_5031_2150_136_9568_2690_9170	14	-	6.66844917599916e-16	3.10082886683961e-14
82	alsterpaullone	hsa04742	Taste transduction	5613_5616_112	3	-	0.000437167209199499	0.00203282752277767
83	alsterpaullone	hsa05320	Autoimmune thyroid disease	355	1	-	1.53340358655209e-05	0.000101861809678103
84	alsterpaullone	hsa04612	Antigen processing and presentation	4800_4801_4802_3306_1385_3304_3312_3303	8	-	0.000231801261096187	0.00134734483012159
85	alsterpaullone	hsa04670	Leukocyte transendothelial migration	24146_1364_8503_1432_5829_5295_6387_5290_9475_10451_1365_7430_4636_394_7409_6093_9080_5908_5291_643752	20	-	0.00904260640694063	0.0300343712801957
86	alsterpaullone	hsa05016	Huntington's disease	4899_1327_317_246721_23186_7019_6874_6908_5433_5430_836_6667_2033_509_7419_3708_548644_51164_841_1385_1387_9519	22	-	3.04404693539965e-06	2.83096364992167e-05
87	alsterpaullone	hsa04740	Olfactory transduction	5613_5616	2	-	8.62688651864611e-42	8.02300446234088e-40
88	alsterpaullone	hsa04514	Cell adhesion molecules (CAMs)	24146_965_214_4685_4897_9080_1364_1365_5792_6693_25945_5817	12	-	2.67679767772373e-06	2.76602426698119e-05
89	alsterpaullone	hsa04510	Focal adhesion	8503_595_1302_5295_331_5154_5290_9475_10451_4636_394_4659_5501_5728_2324_5829_7057_23396_1399_1398_5908_329_5063_1793_3480_673_5894_6093_5291_4233_1729_6655_6654_2002_7424_7409_7422_643752	38	-	0.0044476666829623	0.0165453200606198
90	alsterpaullone	hsa05322	Systemic lupus erythematosus	6738_3014	2	-	2.26270689199004e-14	7.01439136516912e-13
91	alsterpaullone	hsa05340	Primary immunodeficiency	64421	1	-	0.00128481115187103	0.00519510596191329
92	alsterpaullone	hsa04530	Tight junction	5520_64398_4636_9223_24146_5728_5583_5581_93643_51776_55844_8777_9080_5519_22800_9218_5515_5516_7082_1364_1457_3845_1365	23	-	0.00798440495017224	0.0275018392728155
93	alsterpaullone	hsa05110	Vibrio cholerae infection	7082_30001_5613_5616_526_528_23545	7	-	0.0126155803410688	0.0366640303662312
94	alsterpaullone	hsa04512	ECM-receptor interaction	960_1605_7057_1302_3161	5	-	1.24603375146437e-05	8.91393376047588e-05
95	alsterpaullone	hsa04062	Chemokine signaling pathway	3717_1147_5295_8503_5290_9475_6387_112_2309_3551_5829_1399_1398_7409_5908_408_673_5894_6093_5291_107_5613_6655_6654_5616_10451_6772_7074_3845_5970_8976_643752	32	-	0.00102555897001247	0.00433531746414362
96	alsterpaullone	hsa04810	Regulation of actin cytoskeleton	8503_10672_5295_5154_5290_9475_10451_4636_23396_10458_4659_5501_3985_5829_8394_7430_1399_1398_2263_5962_2261_2264_324_5063_1793_673_22800_5894_2245_6093_5291_200576_8874_1729_6655_6654_5305_7074_3845_54434_7409_8976	42	-	0.00595604806668005	0.0213043257769709
97	alsterpaullone	hsa05012	Parkinson's disease	2861_7326_836_1327_7314_317_51465_509_27429_7419	10	-	1.86457992730968e-07	2.47722761771143e-06
98	alsterpaullone	hsa04260	Cardiac muscle contraction	10479_1327_481	3	-	9.4489093032586e-07	1.09843570650381e-05
99	alsterpaullone	hsa04060	Cytokine-cytokine receptor interaction	55540_5154_6387_9180_90_7132_657_27242_3554_2057_2324_3459_3572_3588_4982_23529_3589_3625_4055_91_655_92_4233_7048_5618_3460_355_7424_7422_8795_51330_2690	32	-	7.90665777570645e-08	1.2255319552345e-06
100	alsterpaullone	hsa03010	Ribosome	6139_51187_6125_6168_6141_9349_6233	7	-	5.59983049591234e-06	4.73440214654407e-05
101	alsterpaullone	hsa04020	Calcium signaling pathway	8912_8877_5613_56848_5616_3707_5533_5532_3708_3709_136_5534_5025_7419_490_107	16	-	2.35262889778075e-08	5.46986218734024e-07
102	alsterpaullone	hsa03050	Proteasome	5706_23198	2	-	0.000339227561191021	0.00175267573282028
103	alsterpaullone	hsa04912	GnRH signaling pathway	4215_4216_1432_468_5613_6655_6654_5616_3709_2002_3708_5606_3845_6416_112_5894_107	17	-	0.0102029715932796	0.0327198744198277
104	alsterpaullone	hsa05330	Allograft rejection	355	1	-	0.000851230132754479	0.00376973344505555
105	alsterpaullone	hsa04730	Long-term depression	10672_673_5519_3708_3709_5894_3480_3845_5515_5516	10	-	0.0236745105705196	0.0647567495017154
106	alsterpaullone	hsa04270	Vascular smooth muscle contraction	5583_5581_5613_5616_3709_673_10672_3708_9826_5894_136_112_6093_9475_4659_107_5501	17	-	0.00275930204500222	0.0106922954243836
107	alsterpaullone	hsa04940	Type I diabetes mellitus	355	1	-	0.000142041344807458	0.00088065633780624
108	alsterpaullone	hsa02010	ABC transporters	23461_5826_23457_9619	4	-	0.0149728586123995	0.0421962379076713
109	alsterpaullone	hsa04610	Complement and coagulation cascades	1604_2152_7035_5104_5329	5	-	0.000270692549053188	0.00148084747423215
110	ketorolac	hsa05332	Graft-versus-host disease	3824_3119_3123_3126_3127_941_355_3125	8	+	0.000116310286521302	0.00284089811546206
111	ketorolac	hsa05320	Autoimmune thyroid disease	3119_3123_3126_3127_941_355_3125	7	+	0.00215561947819726	0.0221720860614575
112	ketorolac	hsa04740	Olfactory transduction	26211	1	+	0.000118370754810919	0.00284089811546206
113	ketorolac	hsa05322	Systemic lupus erythematosus	3119_3123_941_3126_3127_3125_8358_8968_3013_8350_8351_8352_8353_8354_8355_8356_8357	17	+	7.49531366985214e-06	0.000539662584229354
114	ketorolac	hsa05310	Asthma	2205_3119_3123_3126_3127_3125	6	+	0.00067245303811065	0.00968332374879336
115	ketorolac	hsa04010	MAPK signaling pathway	2261_10000_5598_9254_4763_8817_355_5607_10912_2249_5058_2260_2247_5971_4149	15	+	0.0359860376551232	0.323874338896109
116	ketorolac	hsa05330	Allograft rejection	3119_3123_3126_3127_941_355_3125	7	+	0.000373303022626405	0.00671945440727529
117	ketorolac	hsa04940	Type I diabetes mellitus	3119_3123_3126_3127_941_355_3125	7	+	0.000815264306983154	0.00978317168379785
118	ketorolac	hsa04070	Phosphatidylinositol signaling system	5296_8394_3707_3633_51763	5	-	0.0449966426598141	0.448408008816638
119	ketorolac	hsa05131	Shigellosis	347733_7280_9181_7430_9475	5	-	0.0152933469790407	0.282926919112253
120	ketorolac	hsa05130	Pathogenic Escherichia coli infection	347733_7280_9181_7430_9475	5	-	0.0152933469790407	0.282926919112253
121	ketorolac	hsa04360	Axon guidance	6405_4233_2049_219699_9475_22885_10507	7	-	0.0484765414936906	0.448408008816638
122	ketorolac	hsa04370	VEGF signaling pathway	5829_5296_8681_100137049_5600	5	-	0.0470209782429307	0.448408008816638
123	ketorolac	hsa05218	Melanoma	4286_5296_1029_8074_1956_4233	6	-	0.0103262837527968	0.282926919112253
124	ketorolac	hsa04810	Regulation of actin cytoskeleton	5829_10672_2909_3693_8394_8074_54961_9475_5296_1956_7430_324_3655	13	-	0.00393343729042938	0.282926919112253
125	ketorolac	hsa04730	Long-term depression	10672_8681_100137049_5518_2911	5	-	0.0356700118956331	0.448408008816638
126	0316684-0000	hsa04740	Olfactory transduction	818	1	+	0.000815804059158409	0.0489482435495045
127	0316684-0000	hsa04912	GnRH signaling pathway	5598_2767_818_8681_5600_3725_100137049	7	+	0.0292391418259061	0.877174254777183
128	0316684-0000	hsa05332	Graft-versus-host disease	3119_3105_3106_3126_3127_3125_3135_3123_649853	9	-	0.000944432649419904	0.0207775182872379
129	0316684-0000	hsa04080	Neuroactive ligand-receptor interaction	9568_5618_7068	3	-	0.00136666728757501	0.0240533442613202
130	0316684-0000	hsa05320	Autoimmune thyroid disease	3119_3105_3106_3126_3127_3125_3135_3123_649853	9	-	0.00384093459331957	0.048286034887446
131	0316684-0000	hsa04612	Antigen processing and presentation	4802_3119_3123_3106_3126_3127_3125_3135_6890_3308_3105_821_649853	13	-	0.0019013631899899	0.0278866601198519
132	0316684-0000	hsa05131	Shigellosis	7280_5578_347733_999_60_7430_7534	7	-	0.0397031434635914	0.332132861928492
133	0316684-0000	hsa05130	Pathogenic Escherichia coli infection	7280_5578_347733_999_60_7430_7534	7	-	0.0397031434635914	0.332132861928492
134	0316684-0000	hsa04740	Olfactory transduction	219464	1	-	4.60076359724408e-08	4.04867196557479e-06
135	0316684-0000	hsa05322	Systemic lupus erythematosus	85235_3119_3123_3126_3127_3014_3125_8332_8969_8331_8336_8329_9555_8330	14	-	0.0415166077410615	0.332132861928492
136	0316684-0000	hsa05310	Asthma	3123_3126_3127_3119_3125	5	-	0.0305198306182683	0.332132861928492
137	0316684-0000	hsa05012	Parkinson's disease	7419_7327	2	-	0.0490424813998452	0.359644863598865
138	0316684-0000	hsa05330	Allograft rejection	3119_3105_3106_3126_3127_3125_3135_3123_649853	9	-	0.000506744340938562	0.0148645006675312
139	0316684-0000	hsa04940	Type I diabetes mellitus	3382_3119_3105_3106_3126_3127_3125_3135_3123_649853	10	-	0.000332142257392727	0.01461425932528
140	Prestwick-972	hsa05322	Systemic lupus erythematosus	717_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	+	1.39128202657333e-07	7.23466653818132e-06
141	Prestwick-972	hsa04070	Phosphatidylinositol signaling system	8394_8821_3710_5298_3631	5	-	0.00343281510501482	0.138818343247432
142	Prestwick-972	hsa04810	Regulation of actin cytoskeleton	8394_5155_5881_1956_7430_324_3675	7	-	0.0235229532690784	0.324866244718629
143	Prestwick-972	hsa05213	Endometrial cancer	2309_1956_6934_324	4	-	0.00523842804707291	0.138818343247432
144	Prestwick-972	hsa05210	Colorectal cancer	5881_1956_324_6934	4	-	0.0245182071485758	0.324866244718629
145	lincomycin	hsa04740	Olfactory transduction	81797_4991	2	+	0.00333877318652638	0.240391669429899
146	lincomycin	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	-	0.00741265012561229	0.101618009922728
147	lincomycin	hsa04070	Phosphatidylinositol signaling system	3636_8394_3633_3707	4	-	0.0463516218406881	0.27347456886006
148	lincomycin	hsa04640	Hematopoietic cell lineage	1436_2057_3123_3126_3570_3127_3125	7	-	0.00104100262838038	0.0614191550744424
149	lincomycin	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	-	0.0155560009529606	0.152967342704113
150	lincomycin	hsa05014	Amyotrophic lateral sclerosis (ALS)	11261_5606_5600_5603	4	-	0.0184732959629547	0.155703494544904
151	lincomycin	hsa04514	Cell adhesion molecules (CAMs)	2734_3123_3126_3127_3125_26047	6	-	0.0314058378988712	0.228711212752631
152	lincomycin	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.00246417042161937	0.0726930274377714
153	lincomycin	hsa04620	Toll-like receptor signaling pathway	3665_5606_5600_5603_7187	5	-	0.0348881510978589	0.228711212752631
154	lincomycin	hsa05330	Allograft rejection	3123_3126_3127_3125	4	-	0.00535653461421439	0.101618009922728
155	lincomycin	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	-	0.00861169575616341	0.101618009922728
156	griseofulvin	hsa04740	Olfactory transduction	5593	1	+	0.0156721489551127	0.376131574922705
157	griseofulvin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_6737_8359_8294_8367_554313_121504	15	+	1.10055005997771e-07	5.28264028789301e-06
158	griseofulvin	hsa04080	Neuroactive ligand-receptor interaction	2911_5618_4889_2917	4	-	0.00151578479092905	0.0314525344117778
159	griseofulvin	hsa04740	Olfactory transduction	219464	1	-	6.21879700698028e-09	3.86591361926565e-07
160	griseofulvin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8345_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	31	-	9.31545450425458e-09	3.86591361926565e-07
161	griseofulvin	hsa04060	Cytokine-cytokine receptor interaction	7852_5618_7422_2057	4	-	0.00108677656044586	0.0300674848390021
162	dilazep	hsa04740	Olfactory transduction	8387_8388	2	+	0.0132402210736511	0.397206632209533
163	dilazep	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8349_8329_8294_121504_8343_8347_8346_8344_8339_8969_8968_8370_8358_8359_8330_8331_8336_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_720_721	41	+	1.21969929882644e-29	7.31819579295864e-28
164	dilazep	hsa04080	Neuroactive ligand-receptor interaction	2911_5618_2917_4886_136_1909	6	-	0.0323086656343934	0.523400383277173
165	dilazep	hsa04740	Olfactory transduction	157_409_816	3	-	4.78153811584526e-06	0.000387304587383466
166	dilazep	hsa05322	Systemic lupus erythematosus	6738	1	-	0.00717591527285474	0.280254334720124
167	dilazep	hsa04210	Apoptosis	3556_8503_651610_841_596_5575_5295_472_51135_8837_1677	11	-	0.0176766411751555	0.357951983796899
168	dilazep	hsa05012	Parkinson's disease	7419	1	-	0.0103797901748194	0.280254334720124
169	riluzole	hsa05214	Glioma	7039_2475_10000_816	4	+	0.0476184665372907	0.422018066597533
170	riluzole	hsa04660	T cell receptor signaling pathway	10000_5588_915_4775_7535_925	6	+	0.0275627834465927	0.420841864546784
171	riluzole	hsa04740	Olfactory transduction	3000_816	2	+	0.0375022123370983	0.420841864546784
172	riluzole	hsa05322	Systemic lupus erythematosus	3119_3013_8358_6738_8968_8350_8351_8352_8353_8354_8355_8356_8357	13	+	1.36011873498381e-05	0.000884077177739476
173	riluzole	hsa05340	Primary immunodeficiency	7535_915_925	3	+	0.0388469413427801	0.420841864546784
174	riluzole	hsa05221	Acute myeloid leukemia	861_5371_2475_10000	4	+	0.0359045873180303	0.420841864546784
175	riluzole	hsa04012	ErbB signaling pathway	7039_2475_10000_1399_816	5	+	0.0356604300277015	0.420841864546784
176	riluzole	hsa05332	Graft-versus-host disease	3105_3106_3107_3135_3133_649853	6	-	0.0244318548716292	0.289691993477889
177	riluzole	hsa04080	Neuroactive ligand-receptor interaction	3953_64106_2901_7067	4	-	0.0108006846213062	0.224114205892104
178	riluzole	hsa04740	Olfactory transduction	109_5568	2	-	2.06035693711423e-06	8.55048128902406e-05
179	riluzole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	30	-	5.25728459627542e-10	4.3635462149086e-08
180	riluzole	hsa04210	Apoptosis	8503_5568_841_581_598_5575_331_51135_208	9	-	0.049911265486357	0.441268073092175
181	riluzole	hsa04540	Gap junction	7280_5568_347733_6655_113457_2776_3708_5607_109_112_7278	11	-	0.00975628556815573	0.224114205892104
182	riluzole	hsa05012	Parkinson's disease	509	1	-	0.0226303440101511	0.289691993477889
183	riluzole	hsa05330	Allograft rejection	3105_3106_3107_3135_3133_649853	6	-	0.0164432270320524	0.27295756873207
184	riluzole	hsa04940	Type I diabetes mellitus	3105_3106_3107_3135_3133_649853	6	-	0.029257040746971	0.303541797749824
185	sulfamethoxazole	hsa05332	Graft-versus-host disease	3123_3126_3127_3119_3125	5	+	0.000298904639389937	0.00292926546602138
186	sulfamethoxazole	hsa04640	Hematopoietic cell lineage	3123_3126_3127_3125	4	+	0.0279993801920438	0.191968613999501
187	sulfamethoxazole	hsa05320	Autoimmune thyroid disease	3119_7253_3123_3126_3127_3125	6	+	9.43473242905578e-05	0.00154100629674578
188	sulfamethoxazole	hsa04612	Antigen processing and presentation	3123_3126_3127_3119_3125	5	+	0.00667807621446487	0.0545376224181298
189	sulfamethoxazole	hsa04514	Cell adhesion molecules (CAMs)	3123_3126_3127_3119_3125	5	+	0.0313418145305308	0.191968613999501
190	sulfamethoxazole	hsa05322	Systemic lupus erythematosus	3123_3126_3127_3119_3125	5	+	0.0404141486245161	0.220032586955699
191	sulfamethoxazole	hsa05310	Asthma	3123_3126_3127_3119_3125	5	+	7.1406348520931e-05	0.00154100629674578
192	sulfamethoxazole	hsa05330	Allograft rejection	3123_3126_3127_3119_3125	5	+	0.000195295930086096	0.00239237514355468
193	sulfamethoxazole	hsa04940	Type I diabetes mellitus	3382_3119_3123_3126_3127_3125	6	+	3.65103012508858e-05	0.00154100629674578
194	sulfamethoxazole	hsa04080	Neuroactive ligand-receptor interaction	2740_5618_2908_7068	4	-	0.000771660839321402	0.0320239248318382
195	sulfamethoxazole	hsa05200	Pathways in cancer	8030_598_5295_331_5154_332_5899_1488_4149_6789_9134_1613_2263_1398_367_2260_1017_4842_324_581_3480_999_998_7042_91_3725_2271_841_6655_208_7184	31	-	0.040162728973524	0.332716540548888
196	sulfamethoxazole	hsa05131	Shigellosis	7280_347733_999_998_9475_60_7430_7534_2017	9	-	0.0135332390672737	0.208883760959051
197	sulfamethoxazole	hsa05130	Pathogenic Escherichia coli infection	7280_347733_999_998_9475_60_7430_7534_2017	9	-	0.0135332390672737	0.208883760959051
198	sulfamethoxazole	hsa04740	Olfactory transduction	818_157_409	3	-	2.35324309289451e-07	1.95319176710244e-05
199	sulfamethoxazole	hsa05322	Systemic lupus erythematosus	8337	1	-	0.00228192981698678	0.0631333916033009
200	sulfamethoxazole	hsa05212	Pancreatic cancer	9134_3480_6655_5295_5154_208_2263_367_1385_2260_1017_7184	12	-	0.0176167027314862	0.208883760959051
201	sulfamethoxazole	hsa04110	Cell cycle	995_472_5001_1017_51343_5934_4173_699_9134_996_7042_7534_651610_4616	14	-	0.0380622014047742	0.332716540548888
202	sulfamethoxazole	hsa05215	Prostate cancer	9134_3480_6655_5295_5154_208_2263_367_1385_2260_1017_7184	12	-	0.0166489849456511	0.208883760959051
203	sulfamethoxazole	hsa04210	Apoptosis	5534_3552_841_581_598_5295_331_472_51135_208_651610	11	-	0.049497788870748	0.332716540548888
204	sulfamethoxazole	hsa03010	Ribosome	6181	1	-	0.0318064831927735	0.329992263125025
205	cloxacillin	hsa05332	Graft-versus-host disease	3123_3107_3126_3127_3125	5	+	0.00525109651029279	0.0865917693549523
206	cloxacillin	hsa04640	Hematopoietic cell lineage	3590_2812_3123_3126_3127_3125_3684	7	+	0.00750427241438381	0.0865917693549523
207	cloxacillin	hsa05320	Autoimmune thyroid disease	3449_3123_3107_3126_3127_3125	6	+	0.00285778548477827	0.0865917693549523
208	cloxacillin	hsa04612	Antigen processing and presentation	3449_3123_3107_3126_3127_3125	6	+	0.027048742857688	0.210379111115351
209	cloxacillin	hsa04740	Olfactory transduction	26212_9635	2	+	0.00653144968216864	0.0865917693549523
210	cloxacillin	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.00865917693549523	0.0865917693549523
211	cloxacillin	hsa04010	MAPK signaling pathway	208	1	+	0.0156296547830204	0.136759479351428
212	cloxacillin	hsa05330	Allograft rejection	3123_3107_3126_3127_3125	5	+	0.00356194447501522	0.0865917693549523
213	cloxacillin	hsa04940	Type I diabetes mellitus	3123_3107_3126_3127_3125	5	+	0.00627910058541217	0.0865917693549523
214	cloxacillin	hsa05322	Systemic lupus erythematosus	85235_8348_8969_8332_8330_8331_8329_8336	8	-	0.000275274133623172	0.0112862394785501
215	pentoxifylline	hsa05332	Graft-versus-host disease	3123_3107_3126_3127_3125_356_355	7	+	0.00234568439378044	0.0347161290279505
216	pentoxifylline	hsa04070	Phosphatidylinositol signaling system	8871_5728_5578_3709_3631_8821_23236	7	+	0.0380443567181328	0.286839338204987
217	pentoxifylline	hsa05320	Autoimmune thyroid disease	1081_3123_3107_3126_3127_3125_356_355	8	+	0.00204253972002419	0.0347161290279505
218	pentoxifylline	hsa05131	Shigellosis	9076_5578_7278_113457_10382_2017	6	+	0.0297470888115859	0.27516057150717
219	pentoxifylline	hsa05130	Pathogenic Escherichia coli infection	9076_5578_7278_113457_10382_2017	6	+	0.0297470888115859	0.27516057150717
220	pentoxifylline	hsa04740	Olfactory transduction	5568_26692	2	+	6.14593217902631e-05	0.00227399490623973
221	pentoxifylline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_55766_8294_8367_554313_8368_121504_8342	20	+	3.86629491307741e-06	0.000286105823567728
222	pentoxifylline	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0387620727304037	0.286839338204987
223	pentoxifylline	hsa04912	GnRH signaling pathway	5568_1081_5578_5599_2002_2798_3709_2796_23236	9	+	0.0444098271933092	0.298757019300444
224	pentoxifylline	hsa05330	Allograft rejection	3123_3107_3126_3127_3125_356_355	7	+	0.00141140223633384	0.0347161290279505
225	pentoxifylline	hsa04940	Type I diabetes mellitus	3123_3107_3126_3127_3125_356_355	7	+	0.00296267104339252	0.0365396095351744
226	pentoxifylline	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00613493913449081	0.331286713262504
227	meclofenamic acid	hsa04740	Olfactory transduction	26212_26692_26664_818_5132_816	6	+	5.11551452295401e-05	0.00212293852702591
228	meclofenamic acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2213_3119_2215_3013_3014	29	+	1.4808718564845e-07	1.22912364088214e-05
229	meclofenamic acid	hsa03440	Homologous recombination	8940_10111	2	-	0.0340014567433217	0.663028406494773
230	meclofenamic acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8359_8370_8294_554313_121504	14	-	3.10261712352789e-10	1.21002067817588e-08
231	tiapride	hsa05010	Alzheimer's disease	489_5534	2	-	0.0130634031477195	0.523086367239375
232	tiapride	hsa04080	Neuroactive ligand-receptor interaction	2911_2901_2908_1081_2917	5	-	0.0193735691570139	0.523086367239375
233	tiapride	hsa04740	Olfactory transduction	5568_816	2	-	9.53601306217582e-07	7.72417058036241e-05
234	tiapride	hsa04940	Type I diabetes mellitus	3382_3105_3106_3107_3135_649853	6	-	0.0348434022687093	0.617979006311251
235	tinidazole	hsa05320	Autoimmune thyroid disease	3586_3105_3106_3107_3135_649853	6	+	0.0427469624878685	0.454186476433603
236	tinidazole	hsa04660	T cell receptor signaling pathway	10298_3586_208_29851_56924_5293_4776_27040_4772_5534_2534	11	+	0.02085013673773	0.303272720757995
237	tinidazole	hsa04740	Olfactory transduction	81697_5593_157_1179_4991	5	+	0.000892493816895862	0.0379309872180741
238	tinidazole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8370_3586_718_8368_8366_8290_3014_8359_8294_8367_554313_121504_8354_8364	19	+	8.61599215349047e-05	0.0073235933304669
239	tinidazole	hsa04370	VEGF signaling pathway	9261_208_5293_4776_8681_4772_5534_100137049	8	+	0.0315801065070613	0.383472721871459
240	tinidazole	hsa05330	Allograft rejection	3586_3105_3106_3107_3135_649853	6	+	0.0115135940195913	0.303272720757995
241	tinidazole	hsa04730	Long-term depression	5593_2775_5519_5330_3709_8681_100137049_23236	8	+	0.0214074861711526	0.303272720757995
242	tinidazole	hsa04940	Type I diabetes mellitus	3105_3106_3107_2571_3135_649853	6	+	0.0208458731368503	0.303272720757995
243	tinidazole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	6.7856424645374e-06	0.000393567262943169
244	guaifenesin	hsa05332	Graft-versus-host disease	3553_3126_3127_3123_3125	5	+	0.0208214318569247	0.372936023008617
245	guaifenesin	hsa04640	Hematopoietic cell lineage	3553_3123_3126_3127_3125_1378_3674	7	+	0.0402207625234111	0.442428387757522
246	guaifenesin	hsa05320	Autoimmune thyroid disease	3123_3451_3126_3127_3125	5	+	0.0461615069788049	0.444304504670997
247	guaifenesin	hsa04740	Olfactory transduction	1179_26476_9635_816	4	+	0.00597419745216453	0.16876198439578
248	guaifenesin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_3123_3126_3127_3125_8370_718_717_8359_554313_121504_720_721	22	+	4.03557625527596e-08	3.10739371656249e-06
249	guaifenesin	hsa04360	Axon guidance	2044_10298_10154_1943_1946_998_8482_5534_10505_3897	10	+	0.0290599498448273	0.372936023008617
250	guaifenesin	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0270390784559717	0.372936023008617
251	guaifenesin	hsa04940	Type I diabetes mellitus	3553_3126_2572_3127_3125_3123	6	+	0.00657514224918625	0.16876198439578
252	guaifenesin	hsa05016	Huntington's disease	246721_7419_4695_7052_5439_27113_5468_548644_23236	9	-	0.0446752398702981	0.661193550080412
253	guaifenesin	hsa05322	Systemic lupus erythematosus	85235_3013_6737_8330_8969_8332_88_8331_8329_8351_8336	11	-	0.000737483392153488	0.0545737710193581
254	guaifenesin	hsa04360	Axon guidance	5362_1969_56924_64221_4772_6092_27289_10507_3983	9	-	0.00429844715672861	0.159042544798959
255	guaifenesin	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0344598907057705	0.637507978056754
256	guaifenesin	hsa04912	GnRH signaling pathway	50487_6655_1839_107_5338_4323_23236	7	-	0.0149483819557824	0.368726754909299
257	thiamazole	hsa05332	Graft-versus-host disease	3126_3108_3127_3123_3125	5	+	0.0157625034079357	0.191033188498459
258	thiamazole	hsa05320	Autoimmune thyroid disease	3126_3108_3127_3123_3125	5	+	0.0356550006484153	0.305048338880886
259	thiamazole	hsa04520	Adherens junction	4008_998_10580_91_2260_1387_2064	7	+	0.0198476039998399	0.191033188498459
260	thiamazole	hsa04740	Olfactory transduction	7932	1	+	8.1067281429372e-05	0.00312109033503082
261	thiamazole	hsa04514	Cell adhesion molecules (CAMs)	214_3108_3123_3126_3127_3696_3125_23308_1462	9	+	0.0470998010257898	0.362668467898581
262	thiamazole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504_3108	19	+	8.66531214942352e-07	6.67229035505611e-05
263	thiamazole	hsa04370	VEGF signaling pathway	5293_998_8681_4772_5600_5534_100137049	7	+	0.0166541622530609	0.191033188498459
264	thiamazole	hsa05310	Asthma	3123_3125_3108_3127_3126	5	+	0.00453248401242614	0.116333756318938
265	thiamazole	hsa05330	Allograft rejection	3126_3108_3127_3123_3125	5	+	0.0109517096810688	0.191033188498459
266	thiamazole	hsa04940	Type I diabetes mellitus	3126_3108_3127_3123_3125	5	+	0.0186247996069907	0.191033188498459
267	thiamazole	hsa04740	Olfactory transduction	393046	1	-	0.00247112864017181	0.0852539380859274
268	thiamazole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8370_94239_8366_8364_8368_8359_8294_8367_554313_121504_8337	16	-	6.15707379785781e-07	4.24838092052189e-05
269	lithocholic acid	hsa05320	Autoimmune thyroid disease	3451_3448_3126_3113_3127_3125_3123	7	+	0.0199440882697908	0.408853809530711
270	lithocholic acid	hsa04740	Olfactory transduction	2978_23538_1179_816	4	+	0.000106087837101151	0.00434960132114719
271	lithocholic acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113_720_721	32	+	1.85096968940301e-11	1.51779514531047e-09
272	lithocholic acid	hsa05310	Asthma	3123_3113_3127_3126_3125_8288	6	+	0.0056138495286691	0.153445220450289
273	lithocholic acid	hsa04512	ECM-receptor interaction	1278_948_3690_3371_1277_5649_3679_51206_3674	9	+	0.0395644519596694	0.51297113100887
274	lithocholic acid	hsa05330	Allograft rejection	3126_3113_3127_3123_3125	5	+	0.0467355213163969	0.51297113100887
275	lithocholic acid	hsa04940	Type I diabetes mellitus	3123_2572_3127_3126_3125_3113	6	+	0.0266948999795363	0.437796359664395
276	lithocholic acid	hsa03440	Homologous recombination	5890_7516_8438_6742	4	-	0.023926836899826	0.466573319546607
277	lithocholic acid	hsa04080	Neuroactive ligand-receptor interaction	64106_2561_1909	3	-	0.0372764425420693	0.500942228836044
278	lithocholic acid	hsa05200	Pathways in cancer	5914_405_6655_3551	4	-	0.0146720174367302	0.381472453354985
279	lithocholic acid	hsa04740	Olfactory transduction	51806	1	-	2.57093396381897e-05	0.0010026642458894
280	lithocholic acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_81_8969_8370_8332_8359_8330_8331_8336_554313_8351_85235_3013	24	-	3.40003788675548e-09	2.65202955166927e-07
281	lithocholic acid	hsa04060	Cytokine-cytokine receptor interaction	3589_1271_3594	3	-	0.0385340176027726	0.500942228836044
282	nalidixic acid	hsa05214	Glioma	23533_5578_4193_818_1956_3845	6	+	0.0116477025159056	0.100549420053376
283	nalidixic acid	hsa05332	Graft-versus-host disease	3804_3126_3127_941_3123_3125	6	+	0.00166117143738494	0.0323928430290063
284	nalidixic acid	hsa05320	Autoimmune thyroid disease	3451_3449_3123_3126_3127_941_3125	7	+	0.00104654860947367	0.0315739808540705
285	nalidixic acid	hsa04612	Antigen processing and presentation	3451_3449_3123_3126_3127_3125_6891_6892_3804	9	+	0.00121438387900271	0.0315739808540705
286	nalidixic acid	hsa04740	Olfactory transduction	818_9635	2	+	0.00331297633894781	0.0516824308875858
287	nalidixic acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_9103_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504_941	20	+	1.36709043368569e-08	1.06633053827484e-06
288	nalidixic acid	hsa04012	ErbB signaling pathway	23533_10298_5578_2549_818_1956_3845	7	+	0.0128909512888943	0.100549420053376
289	nalidixic acid	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0123817687678885	0.100549420053376
290	nalidixic acid	hsa05223	Non-small cell lung cancer	23533_6257_1956_3845_5578	5	+	0.0204576735988595	0.145063503701004
291	nalidixic acid	hsa04912	GnRH signaling pathway	5578_5598_818_108_1956_3845_5320	7	+	0.0345813961068836	0.224779074694743
292	nalidixic acid	hsa05330	Allograft rejection	3123_941_3126_3127_3125	5	+	0.00554927536458604	0.0721405797396185
293	nalidixic acid	hsa04940	Type I diabetes mellitus	3123_941_3126_3127_3125	5	+	0.00965744097227326	0.100549420053376
294	nalidixic acid	hsa04070	Phosphatidylinositol signaling system	8871_8503_8394_8396_5290_3631_3708_23236	8	-	0.00517918203404108	0.147067527047561
295	nalidixic acid	hsa05211	Renal cell carcinoma	8503_208_5155_5290_3725_4233	6	-	0.0377219643567555	0.381934889112149
296	nalidixic acid	hsa04662	B cell receptor signaling pathway	8503_6850_208_5290_7410_3725	6	-	0.0440940191529154	0.396846172376239
297	nalidixic acid	hsa04740	Olfactory transduction	5568	1	-	8.27565837499917e-05	0.00670328328374933
298	nalidixic acid	hsa04510	Focal adhesion	8503_596_208_2909_3693_5155_6464_5290_1277_2002_7410_3725_4638_4233_3675	15	-	0.00544694544620595	0.147067527047561
299	nalidixic acid	hsa04810	Regulation of actin cytoskeleton	8503_8394_2909_3693_5155_54961_7410_7430_5290_2263_4638_8396_8976_3675	14	-	0.0213242411010602	0.36702870876976
300	nalidixic acid	hsa04912	GnRH signaling pathway	5568_1081_5598_2002_3708_113_3725_23236	8	-	0.0317185303875101	0.36702870876976
301	nalidixic acid	hsa05210	Colorectal cancer	8503_596_208_1856_5290_3725_4233	7	-	0.0258088133184902	0.36702870876976
302	nalidixic acid	hsa05222	Small cell lung cancer	8503_4149_596_208_5290_8554_3675	7	-	0.0286453913043484	0.36702870876976
303	metaraminol	hsa04742	Taste transduction	51764_3745_50835_773	4	+	0.0421685828872511	0.857427852040772
304	metaraminol	hsa04740	Olfactory transduction	81696_81797	2	+	0.0133326779101021	0.813293352516228
305	metaraminol	hsa04730	Long-term depression	3708_8681_100137049_773_6261	5	+	0.0288718918391558	0.857427852040772
306	metaraminol	hsa04070	Phosphatidylinositol signaling system	8394_3633_5290_3631_3708_5335_23236	7	-	0.0495916490033412	0.652956711877326
307	metaraminol	hsa04740	Olfactory transduction	5568	1	-	3.90680950319789e-06	0.000154318975376317
308	metaraminol	hsa04514	Cell adhesion molecules (CAMs)	5817	1	-	0.0455625490193181	0.652956711877326
309	metaraminol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	30	-	1.08780669863316e-11	8.59367291920196e-10
310	metaraminol	hsa04060	Cytokine-cytokine receptor interaction	8792_8744_3552_7042	4	-	0.0268556394602305	0.652956711877326
311	metaraminol	hsa04270	Vascular smooth muscle contraction	5568_5583_5581_10672_2776_9475_3708_6093_4638_23236	10	-	0.0388551667802783	0.652956711877326
312	cefamandole	hsa04060	Cytokine-cytokine receptor interaction	1435_3568_5155_4254_3572_7852_7042_6372	8	+	0.0288560424996396	0.894537317488828
313	cefamandole	hsa05220	Chronic myeloid leukemia	5605_861_1488_7042	4	+	0.0214818039951352	0.894537317488828
314	terbutaline	hsa04740	Olfactory transduction	219464_26212_7932_157_26707_393046	6	+	9.18106976508588e-06	0.000381014395251064
315	terbutaline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013	34	+	3.29216213655704e-09	2.73249457334234e-07
316	terbutaline	hsa04530	Tight junction	5010_3996_998	3	+	0.0497095910071516	1
317	terbutaline	hsa03440	Homologous recombination	8940_5425_7156_5424_675_5888_10111	7	-	0.000890099334232675	0.0347138740350743
318	terbutaline	hsa04080	Neuroactive ligand-receptor interaction	2846_7434_7068_1909	4	-	0.014910345237924	0.214995244736829
319	terbutaline	hsa04740	Olfactory transduction	818_5567_157_409	4	-	0.000104382544850428	0.00814183849833338
320	terbutaline	hsa04514	Cell adhesion molecules (CAMs)	5817	1	-	0.0218404174424233	0.214995244736829
321	terbutaline	hsa04530	Tight junction	7525	1	-	0.0220507943319825	0.214995244736829
322	terbutaline	hsa04630	Jak-STAT signaling pathway	3460	1	-	0.0106554982458209	0.207782215793508
323	terbutaline	hsa05012	Parkinson's disease	836	1	-	0.021934576259444	0.214995244736829
324	terbutaline	hsa04060	Cytokine-cytokine receptor interaction	3579_4233_3460	3	-	0.00269065874381101	0.0699571273390863
325	nortriptyline	hsa04740	Olfactory transduction	26211	1	+	8.72043599175699e-05	0.00680194007357045
326	nortriptyline	hsa05322	Systemic lupus erythematosus	3013_3111_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	+	0.00455028872699296	0.177461260352725
327	nortriptyline	hsa03450	Non-homologous end-joining	27343_27434_2547	3	+	0.0161237564160506	0.419217666817316
328	nortriptyline	hsa04080	Neuroactive ligand-receptor interaction	1131	1	-	0.00521555775400963	0.118219309090885
329	nortriptyline	hsa04740	Olfactory transduction	219464	1	-	0.000120191673883656	0.0040865169120443
330	nortriptyline	hsa04510	Focal adhesion	9475	1	-	0.0227720119959706	0.3871242039315
331	nortriptyline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3012_3013	34	-	4.77140472311029e-18	3.244555211715e-16
332	piromidic acid	hsa04910	Insulin signaling pathway	2475_5568_208_5140_6009_23265	6	+	0.0424483179232323	0.454803406320346
333	piromidic acid	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_4741_5879_317	4	+	0.0213836878414693	0.31723376859563
334	piromidic acid	hsa04740	Olfactory transduction	5568	1	+	0.0159373867586351	0.31723376859563
335	piromidic acid	hsa04210	Apoptosis	317_5568_3553_843_208	5	+	0.0253787014876504	0.31723376859563
336	piromidic acid	hsa05221	Acute myeloid leukemia	861_208_2475_5914	4	+	0.02508538015623	0.31723376859563
337	piromidic acid	hsa04620	Toll-like receptor signaling pathway	3593_3553_3448_3663_208_3576_5879	7	+	0.00315041193287855	0.236280894965891
338	piromidic acid	hsa04940	Type I diabetes mellitus	3593_3553_3119_2571	4	+	0.0100391671482187	0.31723376859563
339	piromidic acid	hsa04080	Neuroactive ligand-receptor interaction	5618_7067_2908_3354_135_9568_5644	7	-	0.0131221937278755	0.209955099646008
340	piromidic acid	hsa04740	Olfactory transduction	219464_5613_393046	3	-	7.29370368515553e-08	5.83496294812442e-06
341	piromidic acid	hsa04710	Circadian rhythm - mammal	8553_1408_5187_9572	4	-	0.0181421685213375	0.2418955802845
342	piromidic acid	hsa04210	Apoptosis	651610_581_7157_5613_5575_5295_331_23052_472_5534_8837_1677_8794	13	-	0.011454753053223	0.209955099646008
343	piromidic acid	hsa05012	Parkinson's disease	7419	1	-	0.003445640046597	0.13782560186388
344	piromidic acid	hsa04060	Cytokine-cytokine receptor interaction	5618_2057_3594_3601_3572_7042_8794	7	-	0.00986888816511254	0.209955099646008
345	theobromine	hsa04512	ECM-receptor interaction	3690_7057_1277	3	+	0.0498215804023981	0.468858236681595
346	theobromine	hsa04062	Chemokine signaling pathway	6349_6348_728830_414062_10235_6093	6	+	0.0116266042429829	0.468858236681595
347	theobromine	hsa04060	Cytokine-cytokine receptor interaction	1436_6348_8742_8741_10913_1950	6	+	0.0422249472569448	0.468858236681595
348	theobromine	hsa05211	Renal cell carcinoma	5296_6655_2271_5781_7422	5	-	0.0358306567618607	0.508795326018422
349	theobromine	hsa04662	B cell receptor signaling pathway	3551_5296_10892_6655_8519_7410	6	-	0.0123718957039507	0.292801531660167
350	theobromine	hsa04080	Neuroactive ligand-receptor interaction	7067	1	-	0.0338230844910151	0.508795326018422
351	theobromine	hsa04740	Olfactory transduction	157	1	-	0.0017188876247026	0.122041021353885
352	theobromine	hsa04370	VEGF signaling pathway	5296_9261_8398_6714_7422	5	-	0.0450610299397069	0.533222187619865
353	theobromine	hsa05220	Chronic myeloid leukemia	3551_5296_6655_4193_867_5781	6	-	0.0123718957039507	0.292801531660167
354	Prestwick-864	hsa05332	Graft-versus-host disease	3107_3553_3112_3119	4	+	0.00529572061547169	0.111210132924906
355	Prestwick-864	hsa05320	Autoimmune thyroid disease	3107_3446_3112_3119	4	+	0.011259927600338	0.177343859705323
356	Prestwick-864	hsa04612	Antigen processing and presentation	3107_3119_3805_3446_3112_3310	6	+	0.00336961316942114	0.106142814836766
357	Prestwick-864	hsa04740	Olfactory transduction	8392	1	+	0.0322369934570227	0.290132941113204
358	Prestwick-864	hsa04710	Circadian rhythm - mammal	1408_5187	2	+	0.0215917486311949	0.259884269679823
359	Prestwick-864	hsa05330	Allograft rejection	3107_3112_3119	3	+	0.0247508828266498	0.259884269679823
360	Prestwick-864	hsa04940	Type I diabetes mellitus	3553_3107_3382_3112_3119	5	+	0.00088671628773087	0.0558631261270448
361	Prestwick-864	hsa05332	Graft-versus-host disease	3108_3119_3105_3106_3135_355_649853	7	-	0.0177267359735208	0.318334767778124
362	Prestwick-864	hsa04080	Neuroactive ligand-receptor interaction	1812_7067_5025_135_2149_9170	6	-	0.0189484980820312	0.318334767778124
363	Prestwick-864	hsa05320	Autoimmune thyroid disease	3108_3119_3105_3106_3135_355_649853	7	-	0.0474811873312593	0.569774247975112
364	Prestwick-864	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3012_8368_8335_8359_8294_8367_554313_121504_3119_3108	18	-	0.00475093585995396	0.312975517877571
365	Prestwick-864	hsa03010	Ribosome	6234	1	-	0.0466395914997293	0.569774247975112
366	Prestwick-864	hsa05330	Allograft rejection	3108_3119_3105_3106_3135_355_649853	7	-	0.0113241600682666	0.317076481911465
367	Prestwick-864	hsa04940	Type I diabetes mellitus	3108_3119_3105_3106_2571_3135_355_649853	8	-	0.00745179804470407	0.312975517877571
368	roxithromycin	hsa04740	Olfactory transduction	1179_5568_9635_442194	4	+	0.0372355284342816	0.92934310848794
369	roxithromycin	hsa04080	Neuroactive ligand-receptor interaction	5029_5618_2908_152_2149	5	-	0.000604691712580176	0.0183423152815987
370	roxithromycin	hsa04740	Olfactory transduction	801_808_805	3	-	1.03218025522512e-08	9.39284032254859e-07
371	roxithromycin	hsa05322	Systemic lupus erythematosus	55506_8329_8343_8347_8346_8344_8339_3123_3126_3127_3125_8969_8968_8358_8330_8331_8336_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3014_9555	30	-	1.36706924469918e-06	6.22016506338127e-05
372	roxithromycin	hsa04260	Cardiac muscle contraction	776	1	-	0.0443279098544826	0.806767959351583
373	roxithromycin	hsa03010	Ribosome	9349	1	-	0.015003644920909	0.34133292195068
374	procyclidine	hsa04310	Wnt signaling pathway	4088_5880_4772_23236	4	+	0.0366644628963505	0.702825612338271
375	procyclidine	hsa04360	Axon guidance	5880_4772_1944_5365	4	+	0.0231598663398557	0.702825612338271
376	procyclidine	hsa04080	Neuroactive ligand-receptor interaction	1909_7433	2	-	0.000791952602120473	0.0328660329879996
377	procyclidine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	19	-	0.000205538914525041	0.0170597299055784
378	benzthiazide	hsa05332	Graft-versus-host disease	5551_3126_3127_3123_3125	5	+	5.4646138468963e-05	0.000870963754040639
379	benzthiazide	hsa04640	Hematopoietic cell lineage	3690_3123_3126_3570_3127_3125	6	+	0.000163869198613295	0.0012781797491837
380	benzthiazide	hsa05320	Autoimmune thyroid disease	5551_3126_3127_3123_3125	5	+	0.000151263129896548	0.0012781797491837
381	benzthiazide	hsa04612	Antigen processing and presentation	3123_3126_3127_3125	4	+	0.00910098408305991	0.0443672974049171
382	benzthiazide	hsa04514	Cell adhesion molecules (CAMs)	23308_3123_3126_3127_3125	5	+	0.00760276256508722	0.0423582485769145
383	benzthiazide	hsa05322	Systemic lupus erythematosus	3123_3126_3127_3125	4	+	0.0416483805792317	0.162428684259004
384	benzthiazide	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.000214370891768348	0.00139341079649426
385	benzthiazide	hsa04512	ECM-receptor interaction	3690_961_1302	3	+	0.0413842575572347	0.162428684259004
386	benzthiazide	hsa05330	Allograft rejection	5551_3126_3127_3123_3125	5	+	3.52564784652195e-05	0.000870963754040639
387	benzthiazide	hsa04940	Type I diabetes mellitus	5551_3126_3127_3123_3125	5	+	6.69972118492799e-05	0.000870963754040639
388	benzthiazide	hsa05332	Graft-versus-host disease	3135_3105_3106_649853_3123	5	-	0.0255426544464699	0.319283180580874
389	benzthiazide	hsa04080	Neuroactive ligand-receptor interaction	1081	1	-	0.00173399389603568	0.065024771101338
390	benzthiazide	hsa05320	Autoimmune thyroid disease	1081_3105_3106_3135_3123_649853	6	-	0.0183853279667698	0.319283180580874
391	benzthiazide	hsa04612	Antigen processing and presentation	4800_3123_3106_3135_3105_811_3305_649853	8	-	0.0226536408002395	0.319283180580874
392	benzthiazide	hsa04740	Olfactory transduction	409	1	-	1.74630222583385e-05	0.00130972666937539
393	benzthiazide	hsa04630	Jak-STAT signaling pathway	9180	1	-	0.0466766731678079	0.437593810948199
394	benzthiazide	hsa05330	Allograft rejection	3135_3105_3106_649853_3123	5	-	0.0179852033512085	0.319283180580874
395	benzthiazide	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853_3123	5	-	0.0299817768583351	0.321233323482162
396	cefsulodin	hsa04640	Hematopoietic cell lineage	2814_3575_3123_3126_3127_3125_924	7	+	0.0327015519913155	0.469841241071084
397	cefsulodin	hsa05010	Alzheimer's disease	5533	1	+	0.0321129216193618	0.469841241071084
398	cefsulodin	hsa05320	Autoimmune thyroid disease	3123_3446_3126_3127_3125	5	+	0.039251024326608	0.469841241071084
399	cefsulodin	hsa04740	Olfactory transduction	81696_8390_81797	3	+	0.00194163061733938	0.0698987022242177
400	cefsulodin	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8366_8368_9103_8360_8362_8294_3123_3126_3127_3125_8370_8359_554313_121504_83740_729	23	+	3.95879266086562e-09	2.85033071582325e-07
401	cefsulodin	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0233739382505593	0.469841241071084
402	cefsulodin	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.0461975897644554	0.469841241071084
403	cefsulodin	hsa03440	Homologous recombination	5890_7156_10111_25788_8940	5	-	0.0223034999576025	0.370238099296202
404	cefsulodin	hsa04080	Neuroactive ligand-receptor interaction	3953_5618_4158_1081	4	-	0.00562627462386441	0.233490396890373
405	cefsulodin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3014_720_721	36	-	4.41514593586954e-13	3.66457112677172e-11
406	cefsulodin	hsa04210	Apoptosis	651610_581_5576_5575_5534_472_598_8737_8837_1677_8794	11	-	0.0165979770197365	0.370238099296202
407	cefsulodin	hsa03022	Basal transcription factors	2969_10629_6875_51616_6872_728198	6	-	0.0186833600637029	0.370238099296202
408	spectinomycin	hsa04740	Olfactory transduction	157	1	+	0.0159373867586351	0.796869337931755
409	spectinomycin	hsa05211	Renal cell carcinoma	5228_6655_5295_998_5290_5291_5605_405_5781_1398_3725_7042_673_7422	14	-	0.0404332775857071	0.365320437629299
410	spectinomycin	hsa04080	Neuroactive ligand-receptor interaction	5029_5618_4157_7068_64106_5025_136_7433_9170	9	-	0.000179535623834294	0.00798933526062608
411	spectinomycin	hsa04740	Olfactory transduction	810_219464_5567_409	4	-	1.69882630500614e-12	1.51195541145546e-10
412	spectinomycin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8347_8346_8344_3123_3126_3127_3125_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235_9555	31	-	0.000609579281787574	0.018084185359698
413	spectinomycin	hsa05221	Acute myeloid leukemia	6932_5970_6655_5295_5290_673_5605_6934_11040_5914_5291_6198	12	-	0.0410472401830673	0.365320437629299
414	spectinomycin	hsa04530	Tight junction	5519_8531_60_998_50855	5	-	0.013165357415249	0.29292920248929
415	spectinomycin	hsa05216	Thyroid cancer	6932_8030_7157_673_5605_7175_6934_6257	8	-	0.0205694189388416	0.305113047592817
416	spectinomycin	hsa04060	Cytokine-cytokine receptor interaction	5618_3566_3459_5154_6358_3572_657_4982_7422_7042_91_3597_8792_6359_51330_659	16	-	0.0292348300361539	0.365320437629299
417	spectinomycin	hsa03010	Ribosome	6187_9349_6234	3	-	0.017506894688377	0.305113047592817
418	spectinomycin	hsa05210	Colorectal cancer	324_581_7157_6655_5295_7042_5290_673_6932_5601_6934_3725_91_8324_2956_5291	16	-	0.0373115360744024	0.365320437629299
419	theophylline	hsa04514	Cell adhesion molecules (CAMs)	933_4099_923_25945_5817	5	+	0.0153342586073427	0.255570976789045
420	theophylline	hsa05322	Systemic lupus erythematosus	9103_720_721_8343_8339_8347_8346_8344	8	+	0.000189093382995268	0.0094546691497634
421	theophylline	hsa04530	Tight junction	5584_9223_5519_84612_208_93643	6	+	0.00386954023226521	0.0967385058066303
422	theophylline	hsa04730	Long-term depression	5519_2775_1392	3	+	0.0425401049070785	0.425401049070785
423	theophylline	hsa04610	Complement and coagulation cascades	721_720_2153	3	+	0.0397235417961322	0.425401049070785
424	theophylline	hsa04310	Wnt signaling pathway	6477_6932_5881_79718_6934_5602_3725_6093_23236	9	-	0.0475461861512328	0.758837440995594
425	theophylline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3013_554313_8359_8294_8367_121504_8368_8351_6738	17	-	2.64967169217538e-06	0.000182827346760101
426	theophylline	hsa05221	Acute myeloid leukemia	6932_6654_5371_6934_11040	5	-	0.0335058527460626	0.758837440995594
427	theophylline	hsa05210	Colorectal cancer	6654_6932_5881_6934_5602_3725	6	-	0.0407788728609465	0.758837440995594
428	etidronic acid	hsa05332	Graft-versus-host disease	3553_3107_5551_3811_3802	5	+	0.000818292253426197	0.0374977215445502
429	etidronic acid	hsa04650	Natural killer cell mediated cytotoxicity	3811_3448_3107_3802_5880_5551	6	+	0.0261749746805303	0.28055473973181
430	etidronic acid	hsa04080	Neuroactive ligand-receptor interaction	151_2911_1269_3360_3062_2688_2689_3269_1442	9	+	0.038294549416664	0.28055473973181
431	etidronic acid	hsa05320	Autoimmune thyroid disease	959_958_3107_5551_3448	5	+	0.00212769668996456	0.0411354693393148
432	etidronic acid	hsa04062	Chemokine signaling pathway	1237_3579_5880_998_6368_2829_6363	7	+	0.0386972054802496	0.28055473973181
433	etidronic acid	hsa04060	Cytokine-cytokine receptor interaction	959_958_1237_3553_3448_6368_2688_2829_6363_3579_83729_2689	12	+	0.00129302488084656	0.0374977215445502
434	etidronic acid	hsa05330	Allograft rejection	959_958_3107_5551	4	+	0.00416275701221173	0.0603599766770701
435	etidronic acid	hsa04940	Type I diabetes mellitus	3553_3107_5551	3	+	0.0375198516827131	0.28055473973181
436	etidronic acid	hsa04740	Olfactory transduction	109	1	-	8.72043599175699e-05	0.00654032699381774
437	etidronic acid	hsa04210	Apoptosis	651610_581_208_5575_472_5534_8837_1677	8	-	0.012864661484593	0.482424805672237
438	etidronic acid	hsa04530	Tight junction	9076_24146_5581_208_998_4619_2036_84612_55870_9223	10	-	0.0282789122441525	0.503647001628479
439	etidronic acid	hsa04115	p53 signaling pathway	5366_581_7057_472_10912_651610	6	-	0.0335764667752319	0.503647001628479
440	etidronic acid	hsa03020	RNA polymerase	246721_5439_548644_10622	4	-	0.0207512615611589	0.503647001628479
441	ciprofibrate	hsa05131	Shigellosis	7278_6093_7430_113457	4	+	0.0284449811948861	0.457136840457445
442	ciprofibrate	hsa05130	Pathogenic Escherichia coli infection	7278_6093_7430_113457	4	+	0.0284449811948861	0.457136840457445
443	ciprofibrate	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_718_8332_8359_8330_8331_8336_554313_121504_85235	22	+	7.76760259238036e-13	4.2721814258092e-11
444	ciprofibrate	hsa05221	Acute myeloid leukemia	5914_862_5467_11040	4	+	0.0332463156696324	0.457136840457445
445	ciprofibrate	hsa04080	Neuroactive ligand-receptor interaction	5618_152_1081_7068_64106_7067_2150	7	-	0.00981492303504582	0.366868244208175
446	ciprofibrate	hsa04740	Olfactory transduction	801_109_805_808	4	-	3.30407194758729e-07	2.74237971649745e-05
447	ciprofibrate	hsa05012	Parkinson's disease	7314_842_4712	3	-	0.0497570090706287	0.766437446654449
448	ciprofibrate	hsa04060	Cytokine-cytokine receptor interaction	5618_3566_2057_2324_3572_4982_7422_8795	8	-	0.0212357646826966	0.440642117165954
449	ciprofibrate	hsa05213	Endometrial cancer	2309_5594_999_5290_673_6934_324_2064_842	9	-	0.013260297983428	0.366868244208175
450	AR-A014418	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	1.29498820353344e-07	3.75546579024698e-06
451	AR-A014418	hsa04740	Olfactory transduction	818	1	-	0.0226573265175533	0.58324224893747
452	AR-A014418	hsa04140	Regulation of autophagy	8408_9706_23710	3	-	0.024488495607471	0.58324224893747
453	AR-A014418	hsa04010	MAPK signaling pathway	784_8517_4217_6654_2005_3306_3304_3727_3303_8569	10	-	0.0273394804189439	0.58324224893747
454	methanthelinium bromide	hsa05016	Huntington's disease	4899_6390_5439_246721_7416_548644_23236	7	+	0.0177362585771087	0.325164740580326
455	methanthelinium bromide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8367_8370_8366_8368_8359_8294_554313_121504_8364	14	+	3.052764428942e-08	1.6790204359181e-06
456	methanthelinium bromide	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.00935317502841688	0.257212313281464
457	methanthelinium bromide	hsa05211	Renal cell carcinoma	5605_7039_2271_4233_3725	5	-	0.025810415034544	0.453716798650127
458	methanthelinium bromide	hsa04080	Neuroactive ligand-receptor interaction	1909	1	-	0.0471367785257881	0.453716798650127
459	methanthelinium bromide	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_834_5603_581	4	-	0.0410424189093408	0.453716798650127
460	methanthelinium bromide	hsa04740	Olfactory transduction	157	1	-	0.0036347581295683	0.265337343458486
461	methanthelinium bromide	hsa05210	Colorectal cancer	4233_3725_836_6934_581	5	-	0.0441445892186706	0.453716798650127
462	nicardipine	hsa04740	Olfactory transduction	818_5137_1258_1179	4	+	0.000411370502502468	0.0312641581901876
463	nicardipine	hsa04740	Olfactory transduction	157	1	-	0.000801931692988083	0.0553332868161777
464	nicardipine	hsa04912	GnRH signaling pathway	8398_5599_50487_113_3725_6714_23236	7	-	0.0282412966091268	0.974324733014875
465	chloramphenicol	hsa05332	Graft-versus-host disease	3135_3117_3553_3119	4	+	0.00801659228640122	0.256530953164839
466	chloramphenicol	hsa04740	Olfactory transduction	816	1	+	0.0154966916135747	0.33059608775626
467	chloramphenicol	hsa04720	Long-term potentiation	816_814_3710_2776	4	+	0.0477717735187001	0.436770500742401
468	chloramphenicol	hsa03450	Non-homologous end-joining	3981_10111	2	+	0.0304459463276677	0.429380963681862
469	chloramphenicol	hsa04912	GnRH signaling pathway	5338_2776_5609_3710_816	5	+	0.0461252704362909	0.436770500742401
470	chloramphenicol	hsa05330	Allograft rejection	3135_3117_3119	3	+	0.0335453877876455	0.429380963681862
471	chloramphenicol	hsa04940	Type I diabetes mellitus	3135_3117_2572_3119_3553	5	+	0.00150630313038677	0.0964034003447533
472	chloramphenicol	hsa05322	Systemic lupus erythematosus	85235_8330_8969_3014_8332_88_8331_8329_8336	9	-	0.000547286486090064	0.0311953297071337
473	chloramphenicol	hsa05219	Bladder cancer	1956_3845_4193	3	-	0.0310195261798149	0.453965120500418
474	chloramphenicol	hsa04540	Gap junction	2697_1956_3845_107_7082	5	-	0.0169395655670362	0.453965120500418
475	CAY-10397	hsa05219	Bladder cancer	4318_1956	2	+	0.0402966914964459	0.745296183554575
476	CAY-10397	hsa04710	Circadian rhythm - mammal	9572_8863	2	-	0.0309631804174427	1
477	estriol	hsa04740	Olfactory transduction	1179	1	+	2.54266473218401e-05	0.00104249254019544
478	estriol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3109_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	26	+	1.18720662171136e-10	9.73509429803315e-09
479	estriol	hsa04210	Apoptosis	10000_581_596_5293_472_5532_651610	7	+	0.046487730236847	0.762398775884291
480	estriol	hsa04630	Jak-STAT signaling pathway	53832_3449_2057_3953_3589_3568_894_5293_1270_200734_5781_9180_3976_10000	14	+	0.00200234946281018	0.0547308853168116
481	estriol	hsa05210	Colorectal cancer	10000_581_5599_596_5293_5880_11211	7	+	0.0364007578003422	0.746215534907015
482	estriol	hsa04080	Neuroactive ligand-receptor interaction	5031_9170	2	-	0.00161011558012229	0.0652096809949527
483	estriol	hsa04740	Olfactory transduction	5613_5616	2	-	9.548595867783e-06	0.000773436265290423
484	estriol	hsa05012	Parkinson's disease	517	1	-	0.0318777574805456	0.645524588981048
485	estriol	hsa04020	Calcium signaling pathway	5613_5616	2	-	0.0263852081742524	0.645524588981048
486	lidoflazine	hsa05010	Alzheimer's disease	3709_1339	2	+	0.000490822915260173	0.014070256904125
487	lidoflazine	hsa04612	Antigen processing and presentation	6891	1	+	0.0206311562857426	0.354855888114773
488	lidoflazine	hsa05016	Huntington's disease	9586_1339	2	+	0.000236503158681759	0.0101696358233156
489	lidoflazine	hsa04740	Olfactory transduction	8387_219464_5616_8388	4	+	5.26617185135605e-08	4.5289077921662e-06
490	lidoflazine	hsa05012	Parkinson's disease	1339_7318	2	+	0.00601899372106216	0.129408365002836
491	lidoflazine	hsa04740	Olfactory transduction	109	1	-	0.00740105119142981	0.451464122677218
492	propantheline bromide	hsa04740	Olfactory transduction	816	1	+	0.000575084618898805	0.0402559233229164
493	propantheline bromide	hsa04080	Neuroactive ligand-receptor interaction	4889_5618_1081_7068_5025_5031_2150_9170	8	-	0.0278246154254869	0.468801924369701
494	propantheline bromide	hsa05200	Pathways in cancer	4088_598_5295_9618_1613_5605_5335_5336_3673_3675_4149_6789_405_5900_324_1398_1017_7475_9134_613_999_4233_842_2271_5594_6655_5602_6772_7157_355_7423_5914_5970	33	-	0.0361233747266731	0.468801924369701
495	propantheline bromide	hsa04210	Apoptosis	651610_3552_7157_598_11261_5295_8795_472_355_8837_5970_9020_842	13	-	0.0126082222736601	0.290864025037957
496	propantheline bromide	hsa04370	VEGF signaling pathway	7867_9261_1432_5594_5829_11261_5295_5605_4775_5335_5336_842	12	-	0.0125592895111086	0.290864025037957
497	propantheline bromide	hsa05110	Vibrio cholerae infection	60_11015_5336_10945_115_528_5335_523_375	9	-	0.0377196950642288	0.468801924369701
498	propantheline bromide	hsa05223	Non-small cell lung cancer	2309_842_6789_6655_5295_5605_7157_5335_5336_5594	10	-	0.00625113901770294	0.290864025037957
499	propantheline bromide	hsa05213	Endometrial cancer	2309_5594_7157_6655_5295_999_5605_324_842	9	-	0.0133730586224348	0.290864025037957
500	cycloserine	hsa04510	Focal adhesion	1278_10319_5578_3690_3371_4633_1284_23396_4638_3674_3082	11	+	0.0236906219022247	0.78720068015391
501	cycloserine	hsa04512	ECM-receptor interaction	1278_10319_1284_3690_3371_3674	6	+	0.0244571581878988	0.78720068015391
502	cycloserine	hsa04730	Long-term depression	2911_10842_5578_5320_23236	5	+	0.0405128053141744	0.78720068015391
503	cycloserine	hsa04640	Hematopoietic cell lineage	3554	1	-	0.0311015103947807	0.32267817034585
504	cycloserine	hsa05010	Alzheimer's disease	355_5534_6868_2776_509	5	-	0.0254530131056178	0.32267817034585
505	cycloserine	hsa04080	Neuroactive ligand-receptor interaction	5618_4157_7068	3	-	1.78216762335012e-05	0.0014791991273806
506	cycloserine	hsa04514	Cell adhesion molecules (CAMs)	999_9019	2	-	0.00599524452989631	0.124401323995348
507	cycloserine	hsa04530	Tight junction	5519_5583_998	3	-	0.0183526251927378	0.304653578199447
508	cycloserine	hsa04260	Cardiac muscle contraction	7171	1	-	0.0297403331343677	0.32267817034585
509	cycloserine	hsa04060	Cytokine-cytokine receptor interaction	5618_3554_3601_657_355_659	6	-	0.000880103762762788	0.0365243061546557
510	cycloserine	hsa04020	Calcium signaling pathway	56848_490_2776_5534	4	-	0.00535013697719679	0.124401323995348
511	nadide	hsa04740	Olfactory transduction	26539_4993_816	3	+	0.00739817378736089	0.389243271878784
512	nadide	hsa04920	Adipocytokine signaling pathway	5599_8471_1375_5781_9021_4793	6	+	0.016218469661616	0.389243271878784
513	nadide	hsa04512	ECM-receptor interaction	22798_2812_1605_3908_3679_3691	6	+	0.0402215696075937	0.449526141088794
514	nadide	hsa04630	Jak-STAT signaling pathway	6778_3594_3589_200734_50616_5781_8554_8651_81848_9021	10	+	0.0264519112198803	0.421104487617429
515	nadide	hsa04930	Type II diabetes mellitus	8651_8471_5599_9021	4	+	0.0476383562059503	0.449526141088794
516	nadide	hsa05330	Allograft rejection	3117_958_3107_3111	4	+	0.0292433671956548	0.421104487617429
517	nadide	hsa05222	Small cell lung cancer	22798_596_6502_3908_330_331_8554	7	+	0.0153029188846087	0.389243271878784
518	nadide	hsa04070	Phosphatidylinositol signaling system	3628_8394_3633_5290_23396_3705	6	-	0.0259884939067378	0.222346003424312
519	nadide	hsa05211	Renal cell carcinoma	2271_208_6655_5155_5290_201163_7423_7042	8	-	0.0016221191857608	0.0624515886517908
520	nadide	hsa04740	Olfactory transduction	5613_5566_5616	3	-	0.0105543185168637	0.162536505159701
521	nadide	hsa05212	Pancreatic cancer	208_6655_5155_5290_6934_2263	6	-	0.0481307060725716	0.296277578927069
522	nadide	hsa05215	Prostate cancer	208_6655_5155_5290_6934_2263	6	-	0.0461137249635828	0.296277578927069
523	nadide	hsa04210	Apoptosis	5613_5566_5534_5616_5290_208_8837_7186	8	-	0.00540513550496691	0.138731811294151
524	nadide	hsa05221	Acute myeloid leukemia	861_208_6655_6934_5290	5	-	0.0318711429255057	0.245407800526394
525	nadide	hsa04664	Fc epsilon RI signaling pathway	208_6655_5290_8681_5606_9846_100137049	7	-	0.00970241119274542	0.162536505159701
526	nadide	hsa04150	mTOR signaling pathway	208_9470_7423_6196_5290	5	-	0.0204299555840231	0.222346003424312
527	nadide	hsa04010	MAPK signaling pathway	5155_1326_100137049_5613_6655_5534_5616_4763_5598_208_6196_23162_5606_7042_8681_2263_3164_9344_5566_7186	20	-	0.000185354388463096	0.0142722879116584
528	nadide	hsa04912	GnRH signaling pathway	5598_6655_5616_5606_8681_5613_100137049_5566	8	-	0.0151916100215395	0.194958995276424
529	nadide	hsa05220	Chronic myeloid leukemia	861_208_6655_5290_9846_7042	6	-	0.0246381796729976	0.222346003424312
530	phenoxybenzamine	hsa04120	Ubiquitin mediated proteolysis	23759_4193_8452	3	+	0.0354182930099873	0.425019516119848
531	phenoxybenzamine	hsa05010	Alzheimer's disease	355_2081_4695_9451	4	+	0.0192444220665103	0.404132863396716
532	phenoxybenzamine	hsa05016	Huntington's disease	1639_1211_4695_10126_27113	5	+	0.0342836937482114	0.425019516119848
533	phenoxybenzamine	hsa04740	Olfactory transduction	2979_2774_8392	3	+	4.92830971680446e-08	4.13978016211575e-06
534	phenoxybenzamine	hsa04360	Axon guidance	1949_27289_1969	3	+	0.048312320081743	0.434160243168852
535	phenoxybenzamine	hsa05219	Bladder cancer	1026_11186_1029_3576_1612_4193_5228_1950_7422	9	+	0.00409445913708062	0.171967283757386
536	phenoxybenzamine	hsa04115	p53 signaling pathway	1647_27113_5366_1029_4193_63970_355_1026_10912_8795	10	+	0.0314923507617527	0.425019516119848
537	phenoxybenzamine	hsa04062	Chemokine signaling pathway	3576_5293_113_10850	4	+	0.0106623570694838	0.298545997945546
538	phenoxybenzamine	hsa05012	Parkinson's disease	2861_4695_5413	3	+	0.0498605457196859	0.434160243168852
539	phenoxybenzamine	hsa04070	Phosphatidylinositol signaling system	8867_8503_8760_5578_8394_5305_5295_3633_5287_3631_5331_5332_51763_5728_8821_1606_3707_23236	18	-	0.0346906462791953	0.301808622628999
540	phenoxybenzamine	hsa05010	Alzheimer's disease	4714_5331_5594_841_2776_5530_5533_5532_5332_489_5664_102_23236	13	-	0.0308643705476505	0.298355581960622
541	phenoxybenzamine	hsa04080	Neuroactive ligand-receptor interaction	5029_5028_1269_1812_4889_3953_1131_7068_5618_4886_5031_3354_56288_2692_2690	15	-	0.000753078969537306	0.0193170631228228
542	phenoxybenzamine	hsa04742	Taste transduction	2778	1	-	0.0182980352475077	0.198991133316646
543	phenoxybenzamine	hsa05016	Huntington's disease	4714_841_7052_2776_5331_5978_7416_55567_5332_1385_6874_23236	12	-	0.0102451135047949	0.127332124988165
544	phenoxybenzamine	hsa04740	Olfactory transduction	818_26212_409	3	-	1.32393231816885e-17	1.1518211168069e-15
545	phenoxybenzamine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	34	-	0.00444992789381945	0.0774287453524584
546	phenoxybenzamine	hsa04110	Cell cycle	890_51343_983_701_11200_699_51433_1017_1031_7531_7533_995_996_9134_8379_8556_7043_9700_8243_5347_4173_6502_5933_7027_7465	25	-	0.04905344261653	0.329094213502821
547	phenoxybenzamine	hsa05012	Parkinson's disease	4714_2861_7326_7327_7416	5	-	0.000888140833233231	0.0193170631228228
548	phenoxybenzamine	hsa04260	Cardiac muscle contraction	27092	1	-	0.000527498473164905	0.0193170631228228
549	phenoxybenzamine	hsa04060	Cytokine-cytokine receptor interaction	5618_3554_9180_2057_3455_3953_5155_8742_8741_4254_7852_657_6387_4982_7046_7043_7424_2690_659	19	-	0.00641232873183902	0.0929787666116658
550	phenoxybenzamine	hsa03010	Ribosome	140801_6125_6168_439992_6129_6189	6	-	0.0491749974199618	0.329094213502821
551	phenoxybenzamine	hsa04610	Complement and coagulation cascades	5265_5328_5329	3	-	0.0425994665649959	0.329094213502821
552	ronidazole	hsa04740	Olfactory transduction	810_81285	2	+	0.000185912623237151	0.0152448351054464
553	ronidazole	hsa04514	Cell adhesion molecules (CAMs)	9076_9074_3688_8174_4099_3107_3111_933_923_26047	10	+	0.0351484046960778	0.718546165200679
554	ronidazole	hsa04510	Focal adhesion	23533_3688_2335_2318_596_331_5155_1277_5649_1284_5880_5923_6714_1291_3082	15	+	0.0139602875304425	0.572371788748143
555	ronidazole	hsa04360	Axon guidance	2045_80031_5365_22854_5880_1944_219699_3688_27289_10507	10	+	0.0323036271913155	0.718546165200679
556	ronidazole	hsa05222	Small cell lung cancer	23533_3688_2335_1284_596_331_5915	7	+	0.043813790561017	0.718546165200679
557	ronidazole	hsa05211	Renal cell carcinoma	5228_5295_998_5290_5605_5781_3725_7422	8	-	0.0200056542828499	0.200056542828499
558	ronidazole	hsa04080	Neuroactive ligand-receptor interaction	64106_1909	2	-	0.00159064046941066	0.0636256187764264
559	ronidazole	hsa05131	Shigellosis	7278_999_113457_998_7100_7534_9475	7	-	0.0169952069960828	0.194230937098089
560	ronidazole	hsa05130	Pathogenic Escherichia coli infection	7278_999_113457_998_7100_7534_9475	7	-	0.0169952069960828	0.194230937098089
561	ronidazole	hsa04740	Olfactory transduction	109	1	-	1.11251726077966e-06	8.90013808623728e-05
562	ronidazole	hsa05219	Bladder cancer	5228_11186_999_7057_4193_5605_7422	7	-	0.00437778596810208	0.116740959149389
563	ronidazole	hsa03022	Basal transcription factors	2967_10629_6884_6875_51616_728198	6	-	0.00915585645497098	0.146493703279536
564	ronidazole	hsa04060	Cytokine-cytokine receptor interaction	91_7422_2057	3	-	0.00770518185602598	0.146493703279536
565	lorglumide	hsa05332	Graft-versus-host disease	57292_3123_3107_3126_3127_941_3125	7	+	0.00503103667532718	0.134160978008725
566	lorglumide	hsa04650	Natural killer cell mediated cytotoxicity	57292_3451_3449_962_2207_4068_3806_8743_3107_7410_80328_4772_2534	13	+	0.0237388279763101	0.211011804233868
567	lorglumide	hsa04120	Ubiquitin mediated proteolysis	22888	1	+	0.0331521195028717	0.265216956022974
568	lorglumide	hsa04640	Hematopoietic cell lineage	1436_2814_3815_3123_2812_3126_3127_3125_7066_933	10	+	0.00953268884639346	0.177150254143148
569	lorglumide	hsa05320	Autoimmune thyroid disease	3451_3449_3123_3107_3126_3127_3125_941	8	+	0.00475244778613895	0.134160978008725
570	lorglumide	hsa04612	Antigen processing and presentation	57292_3451_3449_3123_3806_3126_3127_3125_3107	9	+	0.0393083452766486	0.285878874739263
571	lorglumide	hsa04740	Olfactory transduction	26539	1	+	7.4969624475374e-07	5.99756995802992e-05
572	lorglumide	hsa04514	Cell adhesion molecules (CAMs)	3123_4099_3107_3126_3127_3125_6693_10666_57863_941_933_5817_1462	13	+	0.0132862690607361	0.177150254143148
573	lorglumide	hsa05310	Asthma	3123_3125_3126_3127_2207	5	+	0.0170053001095268	0.194346286966021
574	lorglumide	hsa05330	Allograft rejection	3123_3107_3126_3127_941_3125	6	+	0.0115135940195913	0.177150254143148
575	lorglumide	hsa04940	Type I diabetes mellitus	3123_3107_3126_3127_941_3125	6	+	0.0208458731368503	0.208458731368503
576	lorglumide	hsa04130	SNARE interactions in vesicular transport	8773_6804_9570_8675_8417_6844	6	-	0.0402220058169029	0.874828626517638
577	lorglumide	hsa04080	Neuroactive ligand-receptor interaction	5028_1081_3953_1131_2908_2925_2149	7	-	0.0227633230104164	0.660136367302076
578	lorglumide	hsa04740	Olfactory transduction	818_5613_5616_157	4	-	1.43320970144091e-06	0.000124689244025359
579	lorglumide	hsa04912	GnRH signaling pathway	2778_5331_1432_1081_5613_1839_5616_5602_818_3709_5603_3725_10746_8398_23236	15	-	0.00557158971618542	0.242364152654066
580	enoxacin	hsa04640	Hematopoietic cell lineage	3590_916_3552_1435	4	+	0.0166897990510792	0.458969473904678
581	enoxacin	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_3725_3579	3	+	0.0455532533225359	0.501085786547895
582	enoxacin	hsa04920	Adipocytokine signaling pathway	5599_6794_8471_4793	4	+	0.00714266711133993	0.392846691123696
583	enoxacin	hsa04912	GnRH signaling pathway	5599_3725_5568_5320	4	+	0.0327181107841322	0.501085786547895
584	enoxacin	hsa04270	Vascular smooth muscle contraction	800_5568_5320_1909	4	+	0.0426898940329679	0.501085786547895
585	enoxacin	hsa04740	Olfactory transduction	26212_157_4991	3	-	8.4087506598431e-05	0.00630656299488232
586	enoxacin	hsa04514	Cell adhesion molecules (CAMs)	24146	1	-	0.0471003354120219	0.67997374607064
587	enoxacin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	0.00768285325429644	0.288106997036116
588	enoxacin	hsa05212	Pancreatic cancer	2308_842_3551_5296_5155_4193_1956_3845_6934	9	-	0.0216276791697469	0.405518984432754
589	enoxacin	hsa05215	Prostate cancer	2308_842_3551_5296_5155_4193_1956_3845_6934	9	-	0.0203670840037158	0.405518984432754
590	bephenium hydroxynaphthoate	hsa05332	Graft-versus-host disease	3824_3123_3107_3126_3127_3125	6	+	0.0232285657325744	0.445450744366222
591	bephenium hydroxynaphthoate	hsa04664	Fc epsilon RI signaling pathway	23533_2207_5599_3937_5605_7410_8681_5600_100137049	9	+	0.0210966316989417	0.445450744366222
592	bephenium hydroxynaphthoate	hsa05310	Asthma	3123_3125_3126_3127_2207	5	+	0.0220477637556522	0.445450744366222
593	bephenium hydroxynaphthoate	hsa05012	Parkinson's disease	7345	1	+	0.0222605715450198	0.445450744366222
594	bephenium hydroxynaphthoate	hsa05330	Allograft rejection	3123_3107_3126_3127_3125	5	+	0.0483985801917107	0.645314402556143
595	bephenium hydroxynaphthoate	hsa04940	Type I diabetes mellitus	3126_3107_2572_3127_3125_3123	6	+	0.0278406715228889	0.445450744366222
596	bephenium hydroxynaphthoate	hsa03440	Homologous recombination	5890_7516_5893_8940_6742	5	-	0.0408204333882527	0.489845200659032
597	bephenium hydroxynaphthoate	hsa04080	Neuroactive ligand-receptor interaction	7067_7433	2	-	3.94778412568049e-05	0.00165806933278581
598	bephenium hydroxynaphthoate	hsa04740	Olfactory transduction	5613_26212_5616	3	-	2.24148422669653e-07	1.88284675042509e-05
599	bephenium hydroxynaphthoate	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3013_554313_8368_8359_8294_8367_8351_8970_121504_9555	18	-	0.00977128801657871	0.164157638678522
600	bephenium hydroxynaphthoate	hsa04210	Apoptosis	3556_3553_472_596_5296_5613_5616_5533_5534_8737_8837_651610	12	-	0.0166212387678688	0.232697342750163
601	bephenium hydroxynaphthoate	hsa05012	Parkinson's disease	7416	1	-	0.00494850196349657	0.138558054977904
602	bephenium hydroxynaphthoate	hsa04060	Cytokine-cytokine receptor interaction	3556_3553_3594_5155_3572_7422	6	-	0.00773587139995242	0.162453299399001
603	clioquinol	hsa05131	Shigellosis	7278_113457_7430_10382_9181_6093	6	+	0.0234814172329369	0.324043557814529
604	clioquinol	hsa05130	Pathogenic Escherichia coli infection	7278_113457_7430_10382_9181_6093	6	+	0.0234814172329369	0.324043557814529
605	clioquinol	hsa04740	Olfactory transduction	8383	1	+	1.77773088306882e-05	0.00122663430931749
606	clioquinol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_8294_720_721_121504_8367	16	+	0.000204027518807024	0.00703894939884233
607	clioquinol	hsa04540	Gap junction	7082_1813_7278_6654_5155_113457_1956_10382_23236	9	+	0.0110274423154187	0.25363117325463
608	clioquinol	hsa04640	Hematopoietic cell lineage	2057	1	-	0.0438935406364502	0.433794739908313
609	clioquinol	hsa05010	Alzheimer's disease	5331_4137_23236	3	-	0.00733532323205827	0.217614589217729
610	clioquinol	hsa04080	Neuroactive ligand-receptor interaction	4889_4157_1813_5021_2925_3354	6	-	0.00419205217009937	0.186546321569422
611	clioquinol	hsa05016	Huntington's disease	5331_1385_246721_161_23236	5	-	0.0340706743399889	0.410109088846717
612	clioquinol	hsa04740	Olfactory transduction	5613_26212_5616	3	-	4.84334736903734e-08	4.31057915844323e-06
613	clioquinol	hsa04514	Cell adhesion molecules (CAMs)	3135_3113_25945	3	-	0.04874098201217	0.433794739908313
614	clioquinol	hsa05322	Systemic lupus erythematosus	6738_3113_9555	3	-	0.0368637383233004	0.410109088846717
615	clioquinol	hsa04540	Gap junction	2778_5331_5155_1813_5613_6655_5616_113457_115_5607_3845_7278_23236	13	-	0.023160961130259	0.347682339630175
616	clioquinol	hsa04060	Cytokine-cytokine receptor interaction	7046_2057_3594_23529_5155_7852_6387_655	8	-	0.021162072473533	0.347682339630175
617	clioquinol	hsa04912	GnRH signaling pathway	2778_4214_1432_2002_5613_6655_1839_5616_115_3845_5600_3725_5331_23236	14	-	0.0234392588514725	0.347682339630175
618	brinzolamide	hsa04740	Olfactory transduction	7932_1179_4991	3	+	0.000978771100104198	0.0376826873540116
619	brinzolamide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3117_8368_3014_8359_8294_8367_554313_121504	16	+	0.000121639494254064	0.00936624105756293
620	brinzolamide	hsa04210	Apoptosis	3556_3554_3553_581_5575_330_9941_5534	8	+	0.0183183117150455	0.470170000686168
621	brinzolamide	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8336	7	-	0.00567022073231764	0.21546838782807
622	verteporfin	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	3.21761503477008e-05	0.00151227906634194
623	verteporfin	hsa04940	Type I diabetes mellitus	3558_3382_2571	3	+	0.0375198516827131	0.881716514543758
624	verteporfin	hsa04120	Ubiquitin mediated proteolysis	8651_23221_8945	3	-	0.000388203973659206	0.00695222313717934
625	verteporfin	hsa04080	Neuroactive ligand-receptor interaction	146_4889_5618_7442_1131_4886_5031_2150_1909_2690	10	-	0.000130950928018493	0.0037102762938573
626	verteporfin	hsa05016	Huntington's disease	5331_246721_27113_5439_6667_3092_548644	7	-	0.000773871703785742	0.00939701354596972
627	verteporfin	hsa04740	Olfactory transduction	818_801_109_805_808	5	-	5.31066211574131e-13	4.51406279838011e-11
628	verteporfin	hsa04514	Cell adhesion molecules (CAMs)	9076_2734_214_4897_6382_3655_9019_24146_3123_3106_3107_50848_3897_999_3135_3688_23705_4685_3685_1364_5792_3105_4950_1001_5817	25	-	0.0338983196112382	0.192090477797016
629	verteporfin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8348_8329_8294_8343_8347_8346_8344_3123_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235_3014	29	-	0.00763665374144828	0.0649115568023104
630	verteporfin	hsa04360	Axon guidance	23654_6387_10512_2050_1948_1969_1946_1945_10507_8829_3897_54910_5361_55558_10725_219699_4775_6091_10500_6092_4233_7869_3688_2042_2043_5364_2041_6405_5881_2049_3985	31	-	0.000595238653791543	0.00843254759538019
631	verteporfin	hsa04110	Cell cycle	7040_7042	2	-	0.00040895430218702	0.00695222313717934
632	verteporfin	hsa04530	Tight junction	9076_24146_9223_1364_2017_50848_4950	7	-	0.0268645625276971	0.175652908834943
633	verteporfin	hsa04350	TGF-beta signaling pathway	659_4091_7059_4052_9372_3625_7057_6667_657_1874_652_7040_7042_91_90_92_7048_653	18	-	0.0335371407958481	0.192090477797016
634	verteporfin	hsa04512	ECM-receptor interaction	3913_3915_7059_960_3912_3911_961_3691_3688_1605_3909_3914_7057_375790_3685_6382_3673_3655_3339_1289_2335	21	-	0.00299488362918743	0.0282850120534368
635	verteporfin	hsa05012	Parkinson's disease	2861	1	-	1.18257267394408e-05	0.000502593386426234
636	verteporfin	hsa03010	Ribosome	6125_284393_389342	3	-	0.00871952996996435	0.0673781861315427
637	verteporfin	hsa05210	Colorectal cancer	6934_5295_5881_7855_8324_7976_8321_8323_8322_324_3480_6932_1956_7040_8312_7042_91_3725_4233_7048_5602_2535	22	-	0.00111612138923341	0.011858789760605
638	verteporfin	hsa05217	Basal cell carcinoma	6934_324_2535_5727_6932_652_7477_8312_7855_8324_7976_8321_8323_8322	14	-	0.0144378040121833	0.102267778419632
639	trifluridine	hsa05332	Graft-versus-host disease	3119_3123_3458_3126_3127_3125_355	7	+	0.0002508524302697	0.00371261596799156
640	trifluridine	hsa05320	Autoimmune thyroid disease	3119_3123_3126_3127_3125_355	6	+	0.0041534896993991	0.0384197797194417
641	trifluridine	hsa04740	Olfactory transduction	5137	1	+	0.000835389899918386	0.0103031420989934
642	trifluridine	hsa04514	Cell adhesion molecules (CAMs)	3383_3119_3123_3126_3127_3125_23308_26047	8	+	0.0318801579422382	0.196594307310469
643	trifluridine	hsa05322	Systemic lupus erythematosus	3119_3123_3458_3126_3127_3125_8348_8337_8343_8339_8347_8346_8344	13	+	0.00022438095236069	0.00371261596799156
644	trifluridine	hsa04360	Axon guidance	9353_1949_2048_5880_7869_3985_10505_27289_64218	9	+	0.0107894445887405	0.0887132110629774
645	trifluridine	hsa04110	Cell cycle	995_1647_1026_9134_4088_4193_472_8556	8	+	0.0176837808982392	0.125675374350825
646	trifluridine	hsa04210	Apoptosis	10000_598_317_472_355_8794	6	+	0.0371900347676985	0.211697120985361
647	trifluridine	hsa04115	p53 signaling pathway	1647_1026_5366_9134_317_4193_5268_472_355_9540	10	+	3.54399667874778e-05	0.0019445257201425
648	trifluridine	hsa05310	Asthma	3123_3126_3127_3119_3125	5	+	0.00196303589292388	0.0207520937251953
649	trifluridine	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0495514670803739	0.261914897424833
650	trifluridine	hsa05330	Allograft rejection	3119_3123_3458_3126_3127_3125_355	7	+	0.000144797504496153	0.00357167177757177
651	trifluridine	hsa04940	Type I diabetes mellitus	3119_3123_3458_3126_3127_2571_355_3125	8	+	5.25547491930406e-05	0.0019445257201425
652	trifluridine	hsa05220	Chronic myeloid leukemia	1026_10000_4088_598_4193_861	6	+	0.0186814745656632	0.125675374350825
653	trifluridine	hsa04080	Neuroactive ligand-receptor interaction	5029	1	-	0.000791935447598857	0.0269258052183611
654	trifluridine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8343_8347_8346_8344_8339_3123_3126_3127_3125_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3014	42	-	2.03611689795759e-21	1.38455949061116e-19
655	trifluridine	hsa04110	Cell cycle	995_890_5347_991_891_699_701_9184_996_1869_1031_7465	12	-	0.0042084474404754	0.0953914753174424
656	trifluridine	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.0390566424955683	0.379407384242663
657	trifluridine	hsa04630	Jak-STAT signaling pathway	9655	1	-	0.0322573084680917	0.365582829305039
658	trifluridine	hsa04062	Chemokine signaling pathway	7409	1	-	0.00740860606552904	0.125946303113994
659	trifluridine	hsa04020	Calcium signaling pathway	2064	1	-	0.0107189449162534	0.145777650861046
660	tetracycline	hsa04210	Apoptosis	3556_208_5616_5290_472_5613_651610	7	+	0.0039597863307453	0.13463273524534
661	tetracycline	hsa04062	Chemokine signaling pathway	1234_157_5829_5613_3576_5616_6358_2931_5290_208_6359	11	+	0.00375903066830018	0.13463273524534
662	tetracycline	hsa05211	Renal cell carcinoma	3725_405_5293_7422	4	-	0.00413101891530836	0.168522978964054
663	tetracycline	hsa04662	B cell receptor signaling pathway	3725_5293_4793	3	-	0.0296556290092785	0.396066707686347
664	tetracycline	hsa05200	Pathways in cancer	4088_5293_405_7422_6934_3725_2247_4842	8	-	0.00886963047179233	0.168522978964054
665	tetracycline	hsa04520	Adherens junction	4088_8976_6934	3	-	0.0347426936566971	0.396066707686347
666	tetracycline	hsa04350	TGF-beta signaling pathway	4088_655_6667	3	-	0.0425732867802632	0.4044462244125
667	tetracycline	hsa05210	Colorectal cancer	4088_3725_5293_6934	4	-	0.00694520188597614	0.168522978964054
668	dihydroergotamine	hsa05332	Graft-versus-host disease	3119_3123_3126_3127_3125_5551	6	+	0.0098680602776065	0.13682362952657
669	dihydroergotamine	hsa05320	Autoimmune thyroid disease	1081_3119_3123_3126_3127_3125_5551	7	+	0.00797332347862502	0.13682362952657
670	dihydroergotamine	hsa04740	Olfactory transduction	5137_51806_23538_4991	4	+	0.0011280508650593	0.060611438515404
671	dihydroergotamine	hsa04514	Cell adhesion molecules (CAMs)	3383_3119_3123_3126_3127_3696_3125_23308_57863_947_26285_5817	12	+	0.0138345889209777	0.156133217822463
672	dihydroergotamine	hsa05310	Asthma	3123_3126_3127_3119_3125	5	+	0.0103916680653091	0.13682362952657
673	dihydroergotamine	hsa04912	GnRH signaling pathway	4214_1432_5579_1081_51806_5598_6655_1956_4323	9	+	0.0464989055048697	0.459176691860588
674	dihydroergotamine	hsa05330	Allograft rejection	3593_3119_3123_3126_3127_3125_5551	7	+	0.00153446679785833	0.060611438515404
675	dihydroergotamine	hsa04940	Type I diabetes mellitus	3593_3119_3123_3126_3127_3125_5551	7	+	0.00321178676313015	0.084577051429094
676	dihydroergotamine	hsa04740	Olfactory transduction	219464	1	-	0.00512843229948771	0.369247125563115
677	dihydroergotamine	hsa04710	Circadian rhythm - mammal	9572_1408	2	-	0.0361333110108867	1
678	acenocoumarol	hsa05010	Alzheimer's disease	5330_4698	2	+	0.0497880748635736	1
679	acenocoumarol	hsa04740	Olfactory transduction	26476_8390_81797_23538	4	+	0.00113192641778871	0.0510353164757604
680	acenocoumarol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_88_8294_8367_554313_121504	15	+	0.00124476381648196	0.0510353164757604
681	acenocoumarol	hsa04210	Apoptosis	472_5576_8837_651610_5534	5	-	0.0420674025199269	0.869392985411823
682	acenocoumarol	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0264751420612323	0.869392985411823
683	acenocoumarol	hsa05210	Colorectal cancer	91_3725_8321_8312_6934	5	-	0.0344509413194465	0.869392985411823
684	triamcinolone	hsa05211	Renal cell carcinoma	2271_405_3082_10000_7039	5	+	0.0424838366483386	0.585429380822016
685	triamcinolone	hsa05200	Pathways in cancer	51176_836_10319_861_10000_3576_5371_405_51384_5900_2271_5467_7039_2260_2950_3674_3082	17	+	0.00763832703530031	0.290256427341412
686	triamcinolone	hsa04740	Olfactory transduction	26529	1	+	0.0011974113001081	0.0910032588082156
687	triamcinolone	hsa04510	Focal adhesion	10000_10319_7148_3690_2909_1277_29780_824_55742_3674_3082	11	+	0.0236906219022247	0.450121816142269
688	triamcinolone	hsa05221	Acute myeloid leukemia	861_5371_10000_5467_51176	5	+	0.0211857463228968	0.450121816142269
689	triamcinolone	hsa04060	Cytokine-cytokine receptor interaction	655	1	-	0.0325585142740777	1
690	dihydrostreptomycin	hsa04912	GnRH signaling pathway	5598_8681_1839_100137049_816	5	+	0.0173894290933509	0.817303167387492
691	dihydrostreptomycin	hsa04540	Gap junction	7280_3710_347733_7278_2767_113457	6	-	0.0366996275458333	1
692	pindolol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	1.08305301233164e-06	6.71492867645617e-05
693	pindolol	hsa04710	Circadian rhythm - mammal	4862_8863	2	+	0.0297918576794478	0.615698392041921
694	pindolol	hsa04010	MAPK signaling pathway	786_9344_782_8823_5566_4763_5156_356_4208_8913_7042_2260_2261	13	+	0.00224088913603774	0.0694675632171699
695	pindolol	hsa04740	Olfactory transduction	5566	1	-	0.0228488206154537	1
696	cefotaxime	hsa05332	Graft-versus-host disease	3109_3119_3123_3107_3126_3127_940_3125_5551	9	+	0.00029410855576389	0.00471998771313776
697	cefotaxime	hsa05320	Autoimmune thyroid disease	3109_3119_3123_3107_3126_3127_940_3125_5551_7038	10	+	0.00033714197950984	0.00471998771313776
698	cefotaxime	hsa04612	Antigen processing and presentation	4261_3109_3119_3123_3107_3126_3127_3125_6891_811	10	+	0.0103476726988679	0.0965782785227671
699	cefotaxime	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_4741_5630_5533_10452_5600_4842	7	+	0.0184961457757052	0.144255344439536
700	cefotaxime	hsa04740	Olfactory transduction	5568	1	+	1.18028827655497e-06	4.95721076153087e-05
701	cefotaxime	hsa04514	Cell adhesion molecules (CAMs)	3109_3119_3683_3123_29851_3107_3126_3127_940_3125_5797_6383_6693_26285	14	+	0.00619852609898901	0.0650845240393846
702	cefotaxime	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8347_8346_8344_3109_3123_3126_3127_3125_8370_8359_554313_121504_8339_3119_940	26	+	1.67959398126713e-08	1.41085894426439e-06
703	cefotaxime	hsa05310	Asthma	3596_3119_3123_3126_3127_3125_3109	7	+	0.000899544251093808	0.0107945310131257
704	cefotaxime	hsa05012	Parkinson's disease	836	1	+	0.0318777574805456	0.223144302363819
705	cefotaxime	hsa04912	GnRH signaling pathway	5319_5568_6655_1839_3709_3708_3972_5600_112_4323_23236	11	+	0.0188905808194631	0.144255344439536
706	cefotaxime	hsa05330	Allograft rejection	3109_3119_3123_3107_3126_3127_940_3125_5551	9	+	0.000153571075883438	0.0032249925935522
707	cefotaxime	hsa04940	Type I diabetes mellitus	3109_3119_2572_3107_3126_3127_940_3125_5551_3123	10	+	8.94041831450747e-05	0.00250331712806209
708	cefotaxime	hsa04740	Olfactory transduction	109	1	-	0.0318206650307395	1
709	thioproperazine	hsa04210	Apoptosis	842_5296_5613_331_5616_208_8837	7	+	0.00967266562070605	0.254713528011926
710	thioproperazine	hsa04664	Fc epsilon RI signaling pathway	5609_5581_5296_208_50487_8681_100137049_2534	8	+	0.00137130324944217	0.108332956705931
711	thioproperazine	hsa04370	VEGF signaling pathway	842_5296_208_50487_8681_100137049	6	+	0.0168006878480494	0.331813584998976
712	thioproperazine	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0439410874161466	0.459415411627845
713	thioproperazine	hsa04912	GnRH signaling pathway	2778_100137049_5613_50487_5616_8681_5609_816	8	+	0.00808925642101914	0.254713528011926
714	thioproperazine	hsa04270	Vascular smooth muscle contraction	2778_5581_5613_50487_5616_8681_100137049	7	+	0.0356424595328557	0.459415411627845
715	thioproperazine	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	-	0.0101973353280545	0.144166916718291
716	thioproperazine	hsa04640	Hematopoietic cell lineage	3123_3675_3126_3127_3125	5	-	0.0280129832711864	0.213598997442796
717	thioproperazine	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	-	0.0211067960121662	0.213598997442796
718	thioproperazine	hsa05322	Systemic lupus erythematosus	85235_3123_3126_3127_3125_8332_8969_8331_8336_8329_8330	11	-	0.000141928926192817	0.00865766449776184
719	thioproperazine	hsa04115	p53 signaling pathway	55367_51512_10912_8795	4	-	0.0464113521161884	0.314565831009721
720	thioproperazine	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.00344211597480815	0.104984537231649
721	thioproperazine	hsa05330	Allograft rejection	3123_3126_3127_3125	4	-	0.00740625581252465	0.144166916718291
722	thioproperazine	hsa05222	Small cell lung cancer	598_3912_5293_8554_3675	5	-	0.0268805634458654	0.213598997442796
723	thioproperazine	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	-	0.0118169603867452	0.144166916718291
724	picotamide	hsa04514	Cell adhesion molecules (CAMs)	5010_965_958_3113_3133_6693_5817	7	+	0.0111739680313502	0.466572247210115
725	picotamide	hsa05322	Systemic lupus erythematosus	958_718_3113_720_721_8341_8340	7	+	0.0158160083800039	0.466572247210115
726	picotamide	hsa05340	Primary immunodeficiency	958_3561_3718	3	+	0.027557032747388	0.494794469867771
727	picotamide	hsa05330	Allograft rejection	958_3113_3133	3	+	0.0335453877876455	0.494794469867771
728	picotamide	hsa05220	Chronic myeloid leukemia	861_6777_4193_9846	4	+	0.0477717735187001	0.514138368020413
729	picotamide	hsa05131	Shigellosis	7278_6093_7430_113457	4	-	0.0221521422634581	0.398738560742246
730	picotamide	hsa05130	Pathogenic Escherichia coli infection	7278_6093_7430_113457	4	-	0.0221521422634581	0.398738560742246
731	picotamide	hsa04270	Vascular smooth muscle contraction	5581_4660_8681_4637_1909_6093_100137049	7	-	0.00706290067342133	0.381396636364752
732	pirenzepine	hsa04740	Olfactory transduction	1179	1	+	0.00167624308094183	0.127394474151579
733	pirenzepine	hsa04514	Cell adhesion molecules (CAMs)	214_9672_3683_3107_23308_57863_6383	7	+	0.0462339940349503	0.348879696784099
734	pirenzepine	hsa05322	Systemic lupus erythematosus	85235_717_8330_8332_8969_8331_8329_8336_8354	9	+	0.00938086064520765	0.214217537260697
735	pirenzepine	hsa04360	Axon guidance	9901_1944_9475_5880_3985_6092_27289	7	+	0.0419745009017241	0.348879696784099
736	pirenzepine	hsa04664	Fc epsilon RI signaling pathway	6655_8681_100137049_2205_5880	5	+	0.0457073281457915	0.348879696784099
737	pirenzepine	hsa04912	GnRH signaling pathway	2778_3710_100137049_6655_1839_8681_5337_2796	8	+	0.00558463916183177	0.212216288149607
738	pirenzepine	hsa04730	Long-term depression	2778_8681_100137049_3710_2775	5	+	0.0316767459086199	0.348879696784099
739	pirenzepine	hsa04270	Vascular smooth muscle contraction	2778_3710_3778_9475_8681_800_100137049	7	+	0.0264969083790568	0.348879696784099
740	pirenzepine	hsa05220	Chronic myeloid leukemia	2122_861_6655_5925_7042_1488	6	+	0.0112746072242472	0.214217537260697
741	pirenzepine	hsa04520	Adherens junction	51701_4088_117178_5792_6934_2260	6	-	0.0292171430180212	0.761294585799982
742	pirenzepine	hsa04740	Olfactory transduction	818	1	-	0.000583676048585479	0.0402736473523981
743	chlortalidone	hsa05010	Alzheimer's disease	51806_3708_776	3	+	0.00257575529548825	0.109181607407925
744	chlortalidone	hsa05016	Huntington's disease	7052_3092_246721_3708	4	+	0.00385346849675029	0.109181607407925
745	chlortalidone	hsa04740	Olfactory transduction	51806_8390_8383_26664_5137_4991_26539_1258	8	+	1.6130213265381e-05	0.00137106812755739
746	chlortalidone	hsa04110	Cell cycle	995_1029	2	+	0.0173330802893729	0.368327956149174
747	chlortalidone	hsa04512	ECM-receptor interaction	1278_10319_3688_1281_22798_948_3690_1289_3908_7057_3371_7060_1277	13	+	0.0234139440147153	0.39803704825016
748	chlortalidone	hsa05210	Colorectal cancer	10000	1	+	0.0298537328030145	0.422927881376039
749	chlortalidone	hsa03440	Homologous recombination	5425_5892_10111	3	-	0.0405401272607534	0.699317195247996
750	chlortalidone	hsa04520	Adherens junction	117178_5795_6934_91_2260_8976	6	-	0.0196944790008547	0.553302223322302
751	chlortalidone	hsa04740	Olfactory transduction	810_157	2	-	0.00670492565086955	0.462639869909999
752	chlortalidone	hsa04512	ECM-receptor interaction	8515_3691_1289_5649_3688_3675	6	-	0.0240566184053175	0.553302223322302
753	furosemide	hsa04640	Hematopoietic cell lineage	1436_3563_2811_3690_3126_1438_926_3655_931_3674	10	+	0.0358213507756513	0.565977342255291
754	furosemide	hsa04740	Olfactory transduction	26211_5593_7932_5137_9635_816	6	+	0.000187513879944791	0.0148135965156385
755	furosemide	hsa05322	Systemic lupus erythematosus	717_3113_3126_8358_6738_8968_3013_8350_8351_8352_8353_8354_8355_8356_8357	15	+	0.0286712043400928	0.565977342255291
756	furosemide	hsa04512	ECM-receptor interaction	1278_2811_22798_3690_3694_3371_3918_5649_6383_3655_3339_1291_3674	13	+	0.00160896362637166	0.0635540632416806
757	furosemide	hsa03010	Ribosome	6192	1	+	0.044473573892531	0.585568722918325
758	furosemide	hsa04020	Calcium signaling pathway	2911_6262_773_2905_2902_3709_3360_6261_5724_5330_1956_487_135_488_5137_814_816_6870	18	+	0.0249056623340904	0.565977342255291
759	furosemide	hsa05211	Renal cell carcinoma	8503_2549_5290_201163_3845_3725	6	-	0.0300463923178324	0.570881454038816
760	furosemide	hsa04740	Olfactory transduction	818	1	-	0.000186170689714814	0.0141489724183259
761	furosemide	hsa05322	Systemic lupus erythematosus	474382_474381_85235_83740_8330_8332_8969_8331_8329_8336	10	-	0.0267712347473879	0.570881454038816
762	furosemide	hsa04060	Cytokine-cytokine receptor interaction	2324	1	-	0.00524508628662485	0.199313278891744
763	furosemide	hsa04020	Calcium signaling pathway	818	1	-	0.0469806607755803	0.714106043788821
764	ketotifen	hsa05332	Graft-versus-host disease	57292_3553_3119_3126_3113_3127_3111_3125_3134_355_3123	11	+	0.000708860162630118	0.0196117978327666
765	ketotifen	hsa05320	Autoimmune thyroid disease	1081_3119_3126_3113_3127_3111_3125_3134_355_3123	10	+	0.00931185286132138	0.110411969641382
766	ketotifen	hsa04910	Insulin signaling pathway	23433_9021_5139	3	+	0.0261838967433558	0.238006414488396
767	ketotifen	hsa04740	Olfactory transduction	818	1	+	4.36952240028361e-11	3.6267035922354e-09
768	ketotifen	hsa04514	Cell adhesion molecules (CAMs)	9076_965_3383_3119_3123_3126_3127_3111_3125_5818_3134_57502_5817_6383_923_25945_3113_26047_1462	19	+	0.00898113716396041	0.110411969641382
769	ketotifen	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_9103_8294_8343_8347_8346_8344_3123_3126_3127_3125_8370_8359_554313_121504_8339_3119_2215_3113_3111	28	+	1.73598294694127e-05	0.000720432922980627
770	ketotifen	hsa04012	ErbB signaling pathway	818	1	+	0.0303275141445367	0.238006414488396
771	ketotifen	hsa05310	Asthma	3119_3123_3113_3127_3111_3126_3125	7	+	0.0109953771135122	0.114077037552689
772	ketotifen	hsa04062	Chemokine signaling pathway	1230_6772_6773_108_2931_23236	6	+	0.0315430187876188	0.238006414488396
773	ketotifen	hsa04260	Cardiac muscle contraction	782	1	+	0.0450779626626652	0.303907634732133
774	ketotifen	hsa03010	Ribosome	6189_439992	2	+	0.0475999909821413	0.303907634732133
775	ketotifen	hsa05330	Allograft rejection	3119_3113_3126_3127_3111_3125_3134_355_3123	9	+	0.00380369166875095	0.0631412817012658
776	ketotifen	hsa04940	Type I diabetes mellitus	3553_3119_3113_3126_3127_3111_3125_3134_355_3123	10	+	0.00301626268173389	0.0625874506459782
777	bambuterol	hsa05332	Graft-versus-host disease	3113_3107_3126_3127_940_3125_356_355_5551_3123_3558	11	+	0.00390665520043518	0.0585998280065277
778	bambuterol	hsa05010	Alzheimer's disease	775_355_3709_4023_776	5	+	0.00278959737177066	0.0502127526918719
779	bambuterol	hsa05320	Autoimmune thyroid disease	3113_3107_3126_3127_940_3125_356_355_5551_3123_7038_3558	12	+	0.0104258889277932	0.117291250437673
780	bambuterol	hsa05016	Huntington's disease	246721_1211_1639_9001_5468_161	6	+	0.00547338107143974	0.0703720423470824
781	bambuterol	hsa04740	Olfactory transduction	390892_8390_1179_26531_4991_816	6	+	4.5047196018737e-09	4.05424764168633e-07
782	bambuterol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113_940	31	+	7.86956013495933e-05	0.0035413020607317
783	bambuterol	hsa04530	Tight junction	5519_5865_6714_23136_4626	5	+	0.032024274662509	0.32024274662509
784	bambuterol	hsa05330	Allograft rejection	3113_3107_3126_3127_940_3558_356_355_5551_3123_3125	11	+	0.00203170668198756	0.0457134003447201
785	bambuterol	hsa04940	Type I diabetes mellitus	3382_2572_3107_3126_3127_940_3558_356_355_5551_3123_3125_3113	13	+	0.000700486857073183	0.0210146057121955
786	bambuterol	hsa04740	Olfactory transduction	818_810	2	-	0.00080646418441803	0.0500007794339179
787	naloxone	hsa04740	Olfactory transduction	51806_7932	2	+	0.0371654414393294	0.87511518698492
788	naloxone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_2215_8370_2214_8368_8366_942_8359_8294_8367_554313_121504_8364	17	+	1.64766440704878e-08	1.00507528829976e-06
789	naloxone	hsa05332	Graft-versus-host disease	3135_3105_3106_3107_649853	5	-	0.0485407761531934	0.451007866020838
790	naloxone	hsa04080	Neuroactive ligand-receptor interaction	9568_1269	2	-	0.00158991380498484	0.0635965521993936
791	naloxone	hsa05016	Huntington's disease	5331_23236	2	-	0.0267560191454203	0.399063665681338
792	naloxone	hsa04740	Olfactory transduction	818_26212_5566	3	-	5.85357452030186e-05	0.00468285961624149
793	naloxone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	0.00847994790637562	0.169598958127512
794	naloxone	hsa04060	Cytokine-cytokine receptor interaction	1956_6358_6359	3	-	0.00528909104798404	0.141042427946241
795	naloxone	hsa04912	GnRH signaling pathway	5331_3710_5599_5566_818_1956_3845_5600_5606_23236	10	-	0.0345941440775965	0.399063665681338
796	naloxone	hsa05330	Allograft rejection	3135_3105_3106_3107_649853	5	-	0.0349180707471171	0.399063665681338
797	apomorphine	hsa03450	Non-homologous end-joining	27343_7518	2	+	0.010640026982633	0.42560107930532
798	apomorphine	hsa04740	Olfactory transduction	818	1	-	0.0113627622120339	0.346564247467034
799	apomorphine	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8336	7	-	0.0246198678538507	0.500603979694964
800	apomorphine	hsa03020	RNA polymerase	246721_5439_548644_661	4	-	0.00331769473706251	0.202379378960813
801	practolol	hsa04640	Hematopoietic cell lineage	2323_3581_3554_2812_4254_7850_920_1378_931	9	+	0.0430802111460512	0.73236358948287
802	practolol	hsa04520	Adherens junction	4089_998_5797_1956_5787_88_3643_2241_2534_25945	10	+	0.00824959305749939	0.350607704943724
803	practolol	hsa04740	Olfactory transduction	56656_1258_390892	3	+	1.97959226772412e-05	0.0016826534275655
804	practolol	hsa04062	Chemokine signaling pathway	998_6347_23236	3	+	0.0369045954269357	0.73236358948287
805	practolol	hsa05012	Parkinson's disease	5413	1	+	0.0220127284880991	0.623693973829475
806	practolol	hsa04080	Neuroactive ligand-receptor interaction	7434_1812_1909	3	-	0.0075776773456705	0.299318255153985
807	practolol	hsa04740	Olfactory transduction	810	1	-	1.18028827655497e-06	9.32427738478426e-05
808	practolol	hsa04514	Cell adhesion molecules (CAMs)	3119	1	-	0.0316064560646451	0.832303343035654
809	alfuzosin	hsa05332	Graft-versus-host disease	3123_355_3126_3127_3125	5	+	0.0467058362214471	0.540453247705316
810	alfuzosin	hsa05016	Huntington's disease	4695_6648	2	+	0.026224911353101	0.354036303266863
811	alfuzosin	hsa04740	Olfactory transduction	26659_23538_7932_5568_1179	5	+	0.00122026774127741	0.0494208435217351
812	alfuzosin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3123_3126_3127_3125_8969_8370_717_8332_8359_8330_8331_8336_554313_121504_85235	26	+	9.87391267411336e-09	7.99786926603182e-07
813	alfuzosin	hsa05310	Asthma	3123_3126_3127_8288_3125	5	+	0.0148578506386133	0.290333664989428
814	alfuzosin	hsa05330	Allograft rejection	3593_3123_3126_3127_3125_355	6	+	0.00982739457770144	0.265339653597939
815	alfuzosin	hsa04940	Type I diabetes mellitus	3593_3123_3126_3127_3125_355	6	+	0.0179218311721869	0.290333664989428
816	alfuzosin	hsa04740	Olfactory transduction	157	1	-	2.08110988442571e-08	1.78975450060611e-06
817	alfuzosin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8329_8294_8969_8370_8332_8359_8330_8331_8336_6737_121504_85235_3119	23	-	2.33913167700386e-05	0.00100582662111166
818	alfuzosin	hsa05012	Parkinson's disease	4714_836	2	-	0.0348796945942801	0.999884578369363
819	trimethobenzamide	hsa05332	Graft-versus-host disease	3824_3126_3113_3127_3125_3123	6	+	0.0216858982228861	0.327353464861848
820	trimethobenzamide	hsa05010	Alzheimer's disease	5532_5664	2	+	0.0180787293570809	0.327353464861848
821	trimethobenzamide	hsa04612	Antigen processing and presentation	3824_3440_3123_3806_3126_3127_3125_8302_920_3113	10	+	0.0245515098646386	0.327353464861848
822	trimethobenzamide	hsa04740	Olfactory transduction	5593_8390_1179	3	+	1.97235727878532e-05	0.000788942911514128
823	trimethobenzamide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_9103_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113_8970	32	+	1.58286041578222e-11	1.26628833262578e-09
824	trimethobenzamide	hsa05310	Asthma	3123_3126_3127_3113_3125	5	+	0.0207477693342463	0.327353464861848
825	trimethobenzamide	hsa05330	Allograft rejection	3126_3113_3127_3123_3125	5	+	0.045753858480635	0.522901239778686
826	trimethobenzamide	hsa04070	Phosphatidylinositol signaling system	8394_5333_3707	3	-	0.024729149190664	0.49458298381328
827	trimethobenzamide	hsa05211	Renal cell carcinoma	3725_8453_7042	3	-	0.0215951021958999	0.49458298381328
828	tolnaftate	hsa04080	Neuroactive ligand-receptor interaction	623_2901_1131_5030_2150_134_2696_2357_2149	9	+	0.0150429626327057	0.327184437261349
829	tolnaftate	hsa04740	Olfactory transduction	5568	1	+	1.30488914272695e-11	1.13525355417245e-09
830	tolnaftate	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_94239_8366_8368_8294_121504_8367_8968_8370_8358_8359_8330_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	27	+	0.000118897079640419	0.00517202296435823
831	tolnaftate	hsa04115	p53 signaling pathway	5366_9134_983_4194_581_7057_4193_472_355_1017_8795	11	+	0.0293683077906961	0.511008555558112
832	tolnaftate	hsa04020	Calcium signaling pathway	623_1131_5568_2149	4	+	0.00386589498569559	0.112110954585172
833	tolnaftate	hsa04510	Focal adhesion	5829_5155_3909_55742_1291_3675	6	-	0.019397965116772	0.38795930233544
834	tolnaftate	hsa05322	Systemic lupus erythematosus	8343_8339_8347_8346_8344	5	-	0.0166831315642104	0.38795930233544
835	khellin	hsa04740	Olfactory transduction	26212_3000	2	+	0.0032529999698632	0.214697998010971
836	khellin	hsa04810	Regulation of actin cytoskeleton	2335	1	+	0.0322948502485783	1
837	metronidazole	hsa04080	Neuroactive ligand-receptor interaction	23566_799_4142	3	+	0.0272514801648266	0.7176223110071
838	metronidazole	hsa04740	Olfactory transduction	2979	1	+	1.16842750029456e-05	0.000461528862616351
839	metronidazole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_9103_88_8329_8294_8969_8370_8332_8359_8330_8331_8336_8337_554313_121504_85235_3014	25	+	1.99487606889027e-09	1.57595209442331e-07
840	metronidazole	hsa05016	Huntington's disease	1213_246721_6648_4698_5439_548644	6	-	0.0240306559027284	0.540689757811389
841	metronidazole	hsa04115	p53 signaling pathway	472_651610_3732	3	-	0.0495373109155703	0.743059663733554
842	metronidazole	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00571995866419287	0.257398139888679
843	niclosamide	hsa04740	Olfactory transduction	26211_393046	2	+	4.38915246910069e-06	0.000168982370060377
844	niclosamide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8349_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_8970	27	+	8.8992787480595e-09	6.85244463600581e-07
845	niclosamide	hsa04710	Circadian rhythm - mammal	8553_5187_9572	3	+	0.0322097000767904	0.496029381182572
846	niclosamide	hsa04115	p53 signaling pathway	1647_1026_5366_581_1029_6477_472_651610_8795	9	+	0.00778589306300581	0.182026882075884
847	niclosamide	hsa04010	MAPK signaling pathway	2872_50487_3164_10125_51776_11221_2260_4214_468_5971_5532_4609_3727_4791_1647_1848_1843_2317_1649_1846_5598_2353_7042	23	+	0.00945594192601993	0.182026882075884
848	niclosamide	hsa04080	Neuroactive ligand-receptor interaction	2690_5031_1813	3	-	0.0382034584416199	1
849	niclosamide	hsa05200	Pathways in cancer	6934_5154_5336_5888_1050_4824_5371_355_652_2261_112399_9134_898_4254_6932_8453_8554_91_3725_2956_2122_6502_5979_7186	24	-	0.00296347162615299	0.237077730092239
850	niclosamide	hsa04010	MAPK signaling pathway	784_91_2261_9064_5154_4137_4776_7786_355_2122_5600_3306_3725_3304_3305_3303_7186	17	-	0.0359060887042608	1
851	4-hydroxyphenazone	hsa04740	Olfactory transduction	26211	1	+	7.92319515438566e-06	0.000554623660806996
852	4-hydroxyphenazone	hsa04740	Olfactory transduction	157	1	-	0.0318206650307395	0.697743753957983
853	4-hydroxyphenazone	hsa04210	Apoptosis	5296_3556_5575_5534	4	-	0.0497118044851575	0.697743753957983
854	4-hydroxyphenazone	hsa04062	Chemokine signaling pathway	7454_2786_157_5296_6358_6359_23236	7	-	0.0297171063208284	0.697743753957983
855	4-hydroxyphenazone	hsa05210	Colorectal cancer	4088_5296_4437_8312_3725	5	-	0.0104010777140959	0.697743753957983
856	tolazoline	hsa04740	Olfactory transduction	8390	1	+	0.000118370754810919	0.004379717928004
857	tolazoline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3113	22	+	5.36355919898885e-09	3.96903380725175e-07
858	tolazoline	hsa04062	Chemokine signaling pathway	107	1	+	0.0323705031324765	0.598854307950815
859	tolazoline	hsa04940	Type I diabetes mellitus	3113_3107_3382_356_2571	5	+	0.0159649633358731	0.393802428951536
860	tolazoline	hsa05211	Renal cell carcinoma	2271_5291_5605_8453_5781_1398_3725	7	-	0.0220622968272129	0.506228791864065
861	tolazoline	hsa04080	Neuroactive ligand-receptor interaction	5021_7068_1909	3	-	0.0269988688994168	0.506228791864065
862	tolazoline	hsa04310	Wnt signaling pathway	5663_4041_51701_10725_11261_818_5528_4775_5519_3725_6885	11	-	0.0495559802824667	0.568395877336465
863	tolazoline	hsa04740	Olfactory transduction	818	1	-	1.72827151558826e-05	0.000661336467947321
864	tolazoline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_8294_720_721_6738_121504_9555_8367	18	-	1.76356391452619e-05	0.000661336467947321
865	lidocaine	hsa03320	PPAR signaling pathway	5170_51703_5465_5467_23305_8309	6	+	0.0399548649403558	0.353794761312079
866	lidocaine	hsa05200	Pathways in cancer	652671_356_5599_208_6655_6789_5371_4193_1438_2252_8817_5925_51384_7170_5467_2263_836_2260_7475_861	20	+	0.0213012705899455	0.33229982120315
867	lidocaine	hsa04740	Olfactory transduction	5566_8390_9635	3	+	0.00203733576237952	0.0595963818799801
868	lidocaine	hsa05212	Pancreatic cancer	5170_208_6655_4193_5925_2263_2260	7	+	0.0400409879784477	0.353794761312079
869	lidocaine	hsa05215	Prostate cancer	5170_208_6655_4193_5925_2263_2260	7	+	0.0381582221493438	0.353794761312079
870	lidocaine	hsa05221	Acute myeloid leukemia	861_208_6655_5371_5467_652671	6	+	0.0203549573467708	0.33229982120315
871	lidocaine	hsa05218	Melanoma	208_4193_8817_5925_2260_2252	6	+	0.0421753916107872	0.353794761312079
872	lidocaine	hsa04920	Adipocytokine signaling pathway	3717_51703_3953_208_5599_5465_32_23305_4852	9	+	0.000877635280488945	0.0595963818799801
873	lidocaine	hsa05223	Non-small cell lung cancer	6789_208_6655_5170_5925	5	+	0.0453583027323178	0.353794761312079
874	lidocaine	hsa04010	MAPK signaling pathway	836_51701_57551_9479_3553_1852_5599_208_6655_6789_786_8817_356_4763_776_1432_5566_2263_2260_2252	20	+	0.00229216853384539	0.0595963818799801
875	lidocaine	hsa05016	Huntington's disease	5432_246721_5439_6667_9001_55567_548644	7	-	0.0153635007599264	0.330315266338418
876	lidocaine	hsa03020	RNA polymerase	5432_246721_5439_548644	4	-	0.000912998187375775	0.0392589220571583
877	ivermectin	hsa04740	Olfactory transduction	9635	1	+	5.64421303468359e-05	0.00208835882283293
878	ivermectin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8348_8294_121504_8352_8968_8370_717_8358_8359_554313_8350_8351_7124_8353_8354_8355_8356_8357_3013_3113	29	+	3.11498007383902e-13	2.30508525464087e-11
879	ivermectin	hsa04650	Natural killer cell mediated cytotoxicity	8794	1	-	0.0316606306145226	0.497147596000787
880	ivermectin	hsa04080	Neuroactive ligand-receptor interaction	3953_3354	2	-	0.00232304054464138	0.0596247073124621
881	ivermectin	hsa04740	Olfactory transduction	818_5613_5616	3	-	8.38325555265798e-05	0.00322755338777332
882	ivermectin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3021_3020_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	21	-	5.11387889431861e-06	0.000393768674862533
883	ivermectin	hsa04340	Hedgehog signaling pathway	5613_5616_1454_652_653_4036	6	-	0.0475071172829188	0.523299186945347
884	ivermectin	hsa05216	Thyroid cancer	10342_5979_6256_6934	4	-	0.0475726533586679	0.523299186945347
885	ivermectin	hsa04912	GnRH signaling pathway	2002_5613_5616_2776_5608_818_5600_113_5338_107	10	-	0.0322823114286225	0.497147596000787
886	diazoxide	hsa05332	Graft-versus-host disease	3804_3126_3127_3123_3125	5	+	0.00134138552291637	0.047919369675679
887	diazoxide	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	+	0.0177156314930497	0.149373307719817
888	diazoxide	hsa04612	Antigen processing and presentation	3123_3126_3127_3125_6892_3804	6	+	0.00649561889851091	0.0831439219009397
889	diazoxide	hsa05131	Shigellosis	7100_7278_7430_113457	4	+	0.0210056213980993	0.149373307719817
890	diazoxide	hsa05130	Pathogenic Escherichia coli infection	7100_7278_7430_113457	4	+	0.0210056213980993	0.149373307719817
891	diazoxide	hsa04514	Cell adhesion molecules (CAMs)	965_3123_3126_3127_3125_23308	6	+	0.036977232469467	0.236654287804589
892	diazoxide	hsa05322	Systemic lupus erythematosus	3123_3126_3127_3125_8343_8339_8347_8346_8344	9	+	0.00149748030236497	0.047919369675679
893	diazoxide	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1839_6868_5600_5781	4	+	0.0428496241930544	0.249306904395953
894	diazoxide	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.00284015748837922	0.0605900264187567
895	diazoxide	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.00614785732182475	0.0831439219009397
896	diazoxide	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	+	0.00985297810004026	0.105098433067096
897	diazoxide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_8359_8294_8367_554313_121504	15	-	6.28855453994955e-07	3.01850617917578e-05
898	disulfiram	hsa04612	Antigen processing and presentation	972_3105_3106_3135_3310_3304_3303_649853	8	+	0.0229659391750879	0.787455968092389
899	disulfiram	hsa05200	Pathways in cancer	4286_2271_596_6789_6502_5295_5979_7188_405_1956_367_2247	12	-	0.00444824398649546	0.289135859122205
900	disulfiram	hsa04740	Olfactory transduction	409	1	-	0.0471055774427457	0.362813072651127
901	disulfiram	hsa04360	Axon guidance	3984_2050_1949_10507_3985	5	-	0.0486611823873638	0.362813072651127
902	disulfiram	hsa05212	Pancreatic cancer	367_1956_5295_596	4	-	0.0468236178681976	0.362813072651127
903	disulfiram	hsa05215	Prostate cancer	367_1956_5295_596	4	-	0.0453034047526261	0.362813072651127
904	disulfiram	hsa05218	Melanoma	2247_1956_5295_4286	4	-	0.0237635213943009	0.362813072651127
905	disulfiram	hsa03022	Basal transcription factors	51616_2969_728198	3	-	0.0202574864896167	0.362813072651127
906	disulfiram	hsa05222	Small cell lung cancer	7188_6502_5295_596	4	-	0.0423476204459379	0.362813072651127
907	atropine oxide	hsa04514	Cell adhesion molecules (CAMs)	5010_23308_26285_923_5817	5	+	0.0360292182557465	0.882715847265789
908	atropine oxide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8359_8370_8294_554313_121504	14	+	1.74093388169057e-08	8.53057602028379e-07
909	chlorphenamine	hsa04920	Adipocytokine signaling pathway	3953_32_8660_1375_5781_4793	6	+	0.000533954826439806	0.0261637864955505
910	chlorphenamine	hsa05332	Graft-versus-host disease	3106_3107_3552	3	-	0.0461022528096869	0.885819602600191
911	chlorphenamine	hsa04810	Regulation of actin cytoskeleton	5296_8396_3693_5154_7074_324_3984_2909_3675	9	-	0.0212062003200876	0.885819602600191
912	isoconazole	hsa04662	B cell receptor signaling pathway	11025_208_6655_2353_3725	5	+	0.0338998598838338	0.290907832202217
913	isoconazole	hsa04660	T cell receptor signaling pathway	1326_5063_208_6655_3725_2353_2534	7	+	0.0163011482006964	0.273106113864525
914	isoconazole	hsa04510	Focal adhesion	29895_5063_1311_208_6655_1277_29780_3725_3676_2909_2534	11	+	0.00990342353551083	0.273106113864525
915	isoconazole	hsa05322	Systemic lupus erythematosus	3013_3111_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	+	0.000202922213183696	0.0152191659887772
916	isoconazole	hsa04710	Circadian rhythm - mammal	9572_1408	2	+	0.043596172223849	0.290907832202217
917	isoconazole	hsa04340	Hedgehog signaling pathway	656_7474_5568_353500	4	+	0.0480096267840612	0.290907832202217
918	isoconazole	hsa04012	ErbB signaling pathway	5063_208_6655_1839_818_3725	6	+	0.018207074257635	0.273106113864525
919	isoconazole	hsa04010	MAPK signaling pathway	1326_782_1843_208_6655_1649_1846_2353_4763_5568_3725_3310_3164	13	+	0.0139039559051335	0.273106113864525
920	isoconazole	hsa04060	Cytokine-cytokine receptor interaction	83729	1	+	0.0325585142740777	0.290907832202217
921	isoconazole	hsa04912	GnRH signaling pathway	5568_1081_6655_1839_818_3725	6	+	0.0434517686853339	0.290907832202217
922	isoconazole	hsa05210	Colorectal cancer	2353_208_6655_8326_3725	5	+	0.0499099767851536	0.290907832202217
923	isoconazole	hsa04080	Neuroactive ligand-receptor interaction	2561_5618_2925	3	-	0.036981655837768	0.899886958719021
924	isoconazole	hsa04740	Olfactory transduction	157	1	-	3.93862979777865e-05	0.00287519975237841
925	isoconazole	hsa03020	RNA polymerase	5433_246721_5439_548644_84172	5	-	0.0055215352225216	0.201536035622038
926	clindamycin	hsa04740	Olfactory transduction	816	1	+	0.000808163090172309	0.0307101974265477
927	clindamycin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3113_8359_8294_8367_554313_121504	15	+	1.41840753764046e-05	0.00107798972860675
928	clindamycin	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0482277937016223	0.79460669418943
929	clindamycin	hsa04740	Olfactory transduction	5613_5616	2	-	0.0135634843951604	0.393341047459652
930	clindamycin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	1.49661093418476e-05	0.000868034341827161
931	nicergoline	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.0243687324274519	0.231294027296852
932	nicergoline	hsa04070	Phosphatidylinositol signaling system	8867_8396_27124_5290_3707	5	+	0.0456355950734548	0.358484252577455
933	nicergoline	hsa04640	Hematopoietic cell lineage	1435_3123_3126_3127_3125_920	6	+	0.0246713629116642	0.231294027296852
934	nicergoline	hsa05320	Autoimmune thyroid disease	958_3126_3127_3123_3125	5	+	0.0126763780713322	0.190145671069983
935	nicergoline	hsa04740	Olfactory transduction	157	1	+	0.00180505677094514	0.0451264192736285
936	nicergoline	hsa04514	Cell adhesion molecules (CAMs)	958_214_3123_3126_3127_3125_920_26285	8	+	0.021496017579804	0.231294027296852
937	nicergoline	hsa05310	Asthma	958_3125_3126_3127_3123	5	+	0.00140436381159848	0.0451264192736285
938	nicergoline	hsa05330	Allograft rejection	958_3126_3127_3123_3125	5	+	0.00356194447501522	0.0667864589065354
939	nicergoline	hsa04940	Type I diabetes mellitus	3382_3126_2572_3127_3125_3123	6	+	0.00120656476064509	0.0451264192736285
940	nicergoline	hsa04080	Neuroactive ligand-receptor interaction	5618_2908	2	-	0.026406033544296	0.326922373720963
941	nicergoline	hsa05016	Huntington's disease	1213	1	-	0.032231783324602	0.326922373720963
942	nicergoline	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_834_1616_5533_5606_4842	6	-	0.0119701889984213	0.26445574444476
943	nicergoline	hsa04740	Olfactory transduction	109	1	-	0.000122422770861356	0.00869201673115627
944	nicergoline	hsa04210	Apoptosis	3556_1147_3551_5296_5533_8717_8795	7	-	0.0289482860935362	0.326922373720963
945	nicergoline	hsa05221	Acute myeloid leukemia	1147_3551_5296_5371_6934_6198	6	-	0.0148989151799865	0.26445574444476
946	nicergoline	hsa05222	Small cell lung cancer	5728_4149_1147_3551_5296_3912_4842_3675	8	-	0.00849221372973574	0.26445574444476
947	gallamine triethiodide	hsa04080	Neuroactive ligand-receptor interaction	64106_2925	2	-	0.0378255183296843	0.868738387566432
948	gallamine triethiodide	hsa04740	Olfactory transduction	818	1	-	0.000177274446048212	0.0111682901010374
949	aminophenazone	hsa05332	Graft-versus-host disease	3123_3107_3126_3127_3125	5	+	0.00144217712522106	0.0257818722076932
950	aminophenazone	hsa04640	Hematopoietic cell lineage	933_3123_3126_3127_3125	5	+	0.0243632921813132	0.176074284397676
951	aminophenazone	hsa05320	Autoimmune thyroid disease	3451_3123_3107_3126_3127_3125	6	+	0.000616738161506409	0.0257818722076932
952	aminophenazone	hsa04612	Antigen processing and presentation	3451_3123_3107_3126_3127_3125_3305	7	+	0.00162411662206741	0.0257818722076932
953	aminophenazone	hsa04514	Cell adhesion molecules (CAMs)	3123_4099_3107_3126_3127_3125_4359_933	8	+	0.00392033878030771	0.0414435813918244
954	aminophenazone	hsa04510	Focal adhesion	10000_2335_3381_858_1277_1293_55742_1291_3082	9	+	0.0150493411887946	0.13920640599635
955	aminophenazone	hsa05218	Melanoma	8817_1021_10000_3082	4	+	0.0450423964438452	0.277761444737045
956	aminophenazone	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.00301256711510248	0.0371549944195973
957	aminophenazone	hsa04512	ECM-receptor interaction	1293_1277_1291_2335_3381	5	+	0.0214521771267811	0.176074284397676
958	aminophenazone	hsa04630	Jak-STAT signaling pathway	3451_10000_1271_6773_10253_10252_4352	7	+	0.0261732044374923	0.176074284397676
959	aminophenazone	hsa05330	Allograft rejection	3123_3107_3126_3127_3125	5	+	0.000958627578074284	0.0257818722076932
960	aminophenazone	hsa04940	Type I diabetes mellitus	3123_3107_3126_3127_3125	5	+	0.0017420183924117	0.0257818722076932
961	aminophenazone	hsa04650	Natural killer cell mediated cytotoxicity	3133	1	-	0.0457041628589215	0.667280777740254
962	aminophenazone	hsa04080	Neuroactive ligand-receptor interaction	2561_2149	2	-	0.0048930280774295	0.0892977624130884
963	aminophenazone	hsa04740	Olfactory transduction	818_5613_5566_5616	4	-	0.000805547200223186	0.0294024728081463
964	aminophenazone	hsa04340	Hedgehog signaling pathway	5613_5566_5616_1454_655_652_653_7477	8	-	0.00376461540835229	0.0892977624130884
965	aminophenazone	hsa04060	Cytokine-cytokine receptor interaction	655	1	-	0.000551590922967909	0.0294024728081463
966	levobunolol	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.0299963009279617	0.342814867748134
967	levobunolol	hsa04640	Hematopoietic cell lineage	1435_3123_3126_3127_3125_3590_925	7	+	0.0105227836662301	0.296910713943784
968	levobunolol	hsa05320	Autoimmune thyroid disease	7038_3123_3126_3127_3125	5	+	0.0163849815392718	0.296910713943784
969	levobunolol	hsa04612	Antigen processing and presentation	3123_3806_3126_3127_3125_6891_925	7	+	0.0117377080555342	0.296910713943784
970	levobunolol	hsa04740	Olfactory transduction	810_51806_1179	3	+	0.0203202685316042	0.296910713943784
971	levobunolol	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0108179213384683	0.296910713943784
972	levobunolol	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.0222683035457838	0.296910713943784
973	levobunolol	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	+	0.0343843377017923	0.343843377017923
974	levobunolol	hsa05131	Shigellosis	7278_7430_113457	3	-	0.0268418898586403	0.420522941118698
975	levobunolol	hsa05130	Pathogenic Escherichia coli infection	7278_7430_113457	3	-	0.0268418898586403	0.420522941118698
976	levobunolol	hsa05322	Systemic lupus erythematosus	85235_8969_8332_8330_8331_8336_8329	7	-	0.00133963375773045	0.0629627866133312
977	timolol	hsa05332	Graft-versus-host disease	3811_3113_3458_3107_3126_3127_3125_356_3123_3802	10	+	0.00102469934273249	0.0283500151489322
978	timolol	hsa04740	Olfactory transduction	8387_9635_8388	3	+	1.09068526857435e-07	9.0526877291671e-06
979	timolol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_2904_8368_554313_8294_3123_3458_8366_3126_3127_3125_8370_8359_8335_121504_3113_720_721	24	+	0.000104874631946294	0.0043522972257712
980	timolol	hsa05212	Pancreatic cancer	6716	1	+	0.0439545824375125	0.447837816488277
981	timolol	hsa04530	Tight junction	5588_5581	2	+	0.0182292116004203	0.243101488127234
982	timolol	hsa05310	Asthma	2207_3123_3126_3127_3125_3113	6	+	0.0205025351432607	0.243101488127234
983	timolol	hsa05012	Parkinson's disease	6392_7416_651820	3	+	0.0485607270890903	0.447837816488277
984	timolol	hsa05330	Allograft rejection	3113_3458_3107_3126_3127_3125_356_3123	8	+	0.00611119391272796	0.101445818951284
985	timolol	hsa04940	Type I diabetes mellitus	3382_3113_3458_3107_3126_3127_3125_356_3123	9	+	0.00438863564213431	0.0910641895742869
986	timolol	hsa04070	Phosphatidylinositol signaling system	8394_8871_8396_23236	4	-	0.0455501891839163	0.555712308043779
987	timolol	hsa04740	Olfactory transduction	816	1	-	0.0233250572769127	0.474276164630558
988	timolol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	3.96608786363022e-07	2.41931359681443e-05
989	timolol	hsa04115	p53 signaling pathway	472_651610_3732_27113	4	-	0.0342640910639839	0.522527388725754
990	timolol	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0162007840488729	0.474276164630558
991	molsidomine	hsa04740	Olfactory transduction	26212	1	+	0.0154966916135747	0.441655710986879
992	molsidomine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	5.61003223575876e-07	3.19771837438249e-05
993	molsidomine	hsa04930	Type II diabetes mellitus	775_776_773	3	+	0.0499055424293142	0.94820530615697
994	molsidomine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	25	-	3.91566054985411e-11	2.66264917390079e-09
995	molsidomine	hsa04710	Circadian rhythm - mammal	1454_9572_1408	3	-	0.0114644117119601	0.389789998206643
996	dirithromycin	hsa04740	Olfactory transduction	5593	1	+	0.0228488206154537	0.61691815661725
997	dirithromycin	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0157101398278764	0.61691815661725
998	dirithromycin	hsa04130	SNARE interactions in vesicular transport	9570_8417_6844_10652	4	-	0.0151076392405634	0.626129527415462
999	dirithromycin	hsa05222	Small cell lung cancer	208_3909_9618_5925_6502_3655	6	-	0.0186904336541929	0.626129527415462
1000	dosulepin	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	0.00015548878302664	0.00948481576462504
1001	dosulepin	hsa04710	Circadian rhythm - mammal	8553_1408	2	+	0.0312587547138942	0.953392018773773
1002	dosulepin	hsa04740	Olfactory transduction	157	1	-	3.93862979777865e-05	0.00307213124226735
1003	dosulepin	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	-	0.0213972573950465	0.834493038406813
1004	budesonide	hsa05200	Pathways in cancer	6513_10000_5599_5155_54205_5371_998_867_83439_3576_1029_5602_5915_4791	14	+	0.0487180568868304	0.853026663566937
1005	budesonide	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_534_3576_998_5602	5	+	0.0356700118956331	0.853026663566937
1006	budesonide	hsa04920	Adipocytokine signaling pathway	5599_6513_10000_5563_5602	5	+	0.0291483785109738	0.853026663566937
1007	budesonide	hsa05214	Glioma	5154_5594_208_6655_5295_6464_4193_5291_5925_3845_3480_1869	12	-	0.0161753242449503	0.159955984200064
1008	budesonide	hsa04662	B cell receptor signaling pathway	5594_6850_3551_10725_208_6655_5295_5291_5533_5881_3845_3725_8519_4793	14	-	0.0085382334058403	0.159955984200064
1009	budesonide	hsa05010	Alzheimer's disease	5594_642502_6391_5533_22926_5664_23236	7	-	0.0492681518085804	0.228013709938569
1010	budesonide	hsa04080	Neuroactive ligand-receptor interaction	2901_1909_7068_1131_9170	5	-	8.00814667629893e-05	0.00712725054190605
1011	budesonide	hsa04910	Insulin signaling pathway	2872_5594_3551_5599_5576_6655_5295_6464_5140_5291_2002_5564_208_23265_3845_51763_5509_8651_5792	19	-	0.048017807726807	0.228013709938569
1012	budesonide	hsa05016	Huntington's disease	5432_642502_6391_3092_1385_23236_163	7	-	0.0289275356513975	0.174224468157257
1013	budesonide	hsa05212	Pancreatic cancer	5594_3551_596_3480_6655_5295_5154_4193_5925_3845_208_1869_1385_2260_5291	15	-	0.015374934005461	0.159955984200064
1014	budesonide	hsa05215	Prostate cancer	5594_3551_596_3480_6655_5295_5154_4193_5925_3845_208_1869_1385_2260_5291	15	-	0.0144798214880882	0.159955984200064
1015	budesonide	hsa04664	Fc epsilon RI signaling pathway	1432_6850_5581_5599_208_6655_5295_5291_5881_3845_5603_5608_5594	13	-	0.0287695239087257	0.174224468157257
1016	budesonide	hsa04370	VEGF signaling pathway	9261_1432_5594_10725_208_5295_998_5291_5533_5881_3845_5603	12	-	0.0461333535918779	0.228013709938569
1017	budesonide	hsa05218	Melanoma	5594_3480_5295_4193_5154_5925_3845_2257_208_1869_2260_5291_4233	13	-	0.0126967550160072	0.159955984200064
1018	budesonide	hsa05223	Non-small cell lung cancer	11186_5594_6789_208_6655_5295_5291_5925_3845_1869	10	-	0.0293636744085264	0.174224468157257
1019	budesonide	hsa04010	MAPK signaling pathway	9261_9344_2872_5154_5881_5058_5603_3164_5608_3552_3551_6789_10746_2260_408_4214_208_2005_998_5533_5536_3725_4791_784_1432_5594_5599_6655_2002_1843_3845_27092_2257	33	-	0.0492043941328673	0.228013709938569
1020	budesonide	hsa05012	Parkinson's disease	642502_6391	2	-	0.00199988203134101	0.0604356962221695
1021	budesonide	hsa04060	Cytokine-cytokine receptor interaction	3552_2057_23529_8742_8741_5154_9180_4254_4233_8795	10	-	0.0106249813061324	0.159955984200064
1022	budesonide	hsa03010	Ribosome	6187_440589	2	-	0.0241557790718324	0.174224468157257
1023	budesonide	hsa04020	Calcium signaling pathway	5533_1131_23236_1909	4	-	0.00203715829962369	0.0604356962221695
1024	budesonide	hsa05210	Colorectal cancer	5594_596_5599_3480_6655_5295_1856_5291_4233_5881_3845_208_3725_8321	14	-	0.0210026732045999	0.174224468157257
1025	budesonide	hsa05220	Chronic myeloid leukemia	5594_3551_613_6655_5295_6464_4193_5291_5925_3845_208_1869_598	13	-	0.0237734615509516	0.174224468157257
1026	mycophenolic acid	hsa04740	Olfactory transduction	26212	1	+	0.000797092999981516	0.0178017436662539
1027	mycophenolic acid	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8370_83740_8368_8366_8360_8359_8362_8294_8367_554313_121504	17	+	7.09063295779481e-07	4.75072408172252e-05
1028	mycophenolic acid	hsa04110	Cell cycle	995_1647_1026_5111_4193_472_651610	7	+	0.0424093719083953	0.528796916527569
1029	mycophenolic acid	hsa04210	Apoptosis	331_472_355_651610_8794_8795	6	+	0.0344592318774405	0.528796916527569
1030	mycophenolic acid	hsa04115	p53 signaling pathway	55367_1647_1026_5366_4193_5268_472_355_651610_8795_9540	11	+	5.36593841080896e-06	0.0001797589367621
1031	mycophenolic acid	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0473549477487375	0.528796916527569
1032	mycophenolic acid	hsa04070	Phosphatidylinositol signaling system	5578_8394_5331_3708_3709_3707_23236	7	-	0.0442714749951332	0.6136648912269
1033	mycophenolic acid	hsa04120	Ubiquitin mediated proteolysis	7329	1	-	0.0458818062700101	0.6136648912269
1034	mycophenolic acid	hsa04080	Neuroactive ligand-receptor interaction	7067_3354_1131_56288	4	-	0.0497566128021811	0.6136648912269
1035	mycophenolic acid	hsa04740	Olfactory transduction	157	1	-	5.77576347188257e-06	0.000213703248459655
1036	mycophenolic acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8347_8346_8344_3021_3020_55766_8370_8359_554313_6738_121504_8339_727	24	-	3.72738706854097e-08	2.75826643072032e-06
1037	mycophenolic acid	hsa04060	Cytokine-cytokine receptor interaction	5155_3566_7422	3	-	0.0147240731682602	0.363193804817085
1038	vancomycin	hsa04080	Neuroactive ligand-receptor interaction	2902_2901_2925_2862_5724_134_1812_1813_799_2740_2688_2689_4986_1394_1442_147_2918_5027_6915_148_2550_4158_4829	23	+	0.0267786835270543	0.711567339894825
1039	vancomycin	hsa04740	Olfactory transduction	81697	1	+	3.07149906318027e-08	2.58005921307143e-06
1040	vancomycin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_3014_8359_8294_720_721_121504_3119_3109_8367	19	+	0.000890864479017941	0.0374163081187535
1041	vancomycin	hsa05012	Parkinson's disease	6571_5413	2	+	0.0495921992089202	0.711567339894825
1042	vancomycin	hsa04940	Type I diabetes mellitus	3553_3109_3119_3107_3135_3382	6	+	0.0425617749684689	0.711567339894825
1043	vancomycin	hsa05322	Systemic lupus erythematosus	85235_8969_8332_8330_8331_8329_8336	7	-	0.00127148763121284	0.0686603320854934
1044	tenoxicam	hsa04120	Ubiquitin mediated proteolysis	8651_6502_7320_5371_4193	5	+	0.0439317544129077	0.666298275262433
1045	tenoxicam	hsa05016	Huntington's disease	4899_4695_246721_7350_3708_10540	6	+	0.00737307238035317	0.167737396653035
1046	tenoxicam	hsa04740	Olfactory transduction	23538_5616_26476_808_390892_801_805	7	+	5.26563128488448e-08	4.79172446924488e-06
1047	tenoxicam	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8342_3109_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3119_2215_3113_3112_720_721_942_729	31	+	3.33905019858337e-05	0.00151926784035543
1048	tenoxicam	hsa05012	Parkinson's disease	4695_6622	2	+	0.00139846282962215	0.0424200391652052
1049	tenoxicam	hsa03010	Ribosome	6234_6181	2	+	0.0170911356140585	0.311058668175865
1050	piracetam	hsa04740	Olfactory transduction	8390_442194	2	+	0.00922881517078771	0.627559431613564
1051	piracetam	hsa04370	VEGF signaling pathway	5335_8398_10000_7422_5534	5	+	0.0412884542916034	1
1052	piracetam	hsa04080	Neuroactive ligand-receptor interaction	4886	1	-	0.0001757571674212	0.0065030151945844
1053	piracetam	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8294_121504_8968_8370_8358_8359_8335_8350_8351_8352_8353_8354_8355_8356_8357_3012_3013	27	-	1.01353623923027e-08	7.500168170304e-07
1054	piracetam	hsa04060	Cytokine-cytokine receptor interaction	7852_4233_8795_3572	4	-	0.0150988621822857	0.341197832598137
1055	piracetam	hsa04020	Calcium signaling pathway	3708_5257	2	-	0.0184431260863858	0.341197832598137
1056	etamsylate	hsa04740	Olfactory transduction	5137_5566	2	+	0.00954612436265917	0.34843353923706
1057	etamsylate	hsa05322	Systemic lupus erythematosus	3013_8358_88_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	+	0.000345048395331959	0.025188532859233
1058	etamsylate	hsa05200	Pathways in cancer	3688_842_581_6655_6777_5371_998_4254_6932_405_2257_3725_5888	13	-	0.0252800411473471	0.395196105440753
1059	etamsylate	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8336	7	-	0.0277390102233382	0.395196105440753
1060	etamsylate	hsa04210	Apoptosis	8737_8837_5534_842_581	5	-	0.0359269186764321	0.395196105440753
1061	etamsylate	hsa05221	Acute myeloid leukemia	6932_6655_6777_5371	4	-	0.0337685531898677	0.395196105440753
1062	etamsylate	hsa04115	p53 signaling pathway	27113_10912_3732_842_581	5	-	0.0143310758423341	0.395196105440753
1063	etamsylate	hsa05210	Colorectal cancer	6932_3725_6655_842_581	5	-	0.029324808633708	0.395196105440753
1064	beclometasone	hsa03320	PPAR signaling pathway	2172_2710_5170_2170	4	+	0.0344938642201251	0.586395691742127
1065	beclometasone	hsa04740	Olfactory transduction	2978	1	+	0.0228488206154537	0.582644925694069
1066	beclometasone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	3.44010701225683e-07	1.75445457625098e-05
1067	dobutamine	hsa05016	Huntington's disease	5331_7802	2	+	0.0183501486356713	0.688130573837674
1068	dobutamine	hsa04740	Olfactory transduction	818_26476_816	3	+	4.07532462991363e-05	0.00305649347243522
1069	dobutamine	hsa05322	Systemic lupus erythematosus	85235_3013_8330_8332_8969_8331_8329_8351_8336	9	-	0.0212751605210759	1
1070	alcuronium chloride	hsa04740	Olfactory transduction	23538	1	+	0.0230713779443961	1
1071	alcuronium chloride	hsa04740	Olfactory transduction	818	1	-	0.00167914135823883	0.107465046927285
1072	alcuronium chloride	hsa04710	Circadian rhythm - mammal	79365_9572	2	-	0.046653887934764	0.746462206956224
1073	alcuronium chloride	hsa04912	GnRH signaling pathway	4214_1081_6655_818_8681_100137049_23236	7	-	0.0180080875193733	0.538890668948601
1074	alcuronium chloride	hsa02010	ABC transporters	5826_1244_23457_9619	4	-	0.0252605001069657	0.538890668948601
1075	triflusal	hsa04210	Apoptosis	824_10000_317_843	4	+	0.0179386842471671	0.713871745155337
1076	triflusal	hsa05221	Acute myeloid leukemia	5371_10000_5914	3	+	0.0291319505264371	0.713871745155337
1077	triflusal	hsa04920	Adipocytokine signaling pathway	8471_10000_1375	3	+	0.0396595413975187	0.713871745155337
1078	triflusal	hsa04662	B cell receptor signaling pathway	10725_208_8519_7409_5534_3725_4793	7	-	0.0363628443231264	0.552715233711521
1079	triflusal	hsa04080	Neuroactive ligand-receptor interaction	3354	1	-	0.000791935447598857	0.0300935470087566
1080	triflusal	hsa04740	Olfactory transduction	818	1	-	8.27878022493393e-06	0.000629187297094979
1081	triflusal	hsa04664	Fc epsilon RI signaling pathway	5578_208_8681_5335_9846_7409_81579_100137049	8	-	0.017548933448163	0.333429735515097
1082	triflusal	hsa04370	VEGF signaling pathway	5578_10725_208_8681_5335_5534_81579_100137049	8	-	0.0154250744776034	0.333429735515097
1083	phenindione	hsa05200	Pathways in cancer	5879_3910_3576_5371_4254_5156_5925_1956_1495_5337_91_2261_3082	13	+	0.00930001163771821	0.229518447911177
1084	phenindione	hsa04740	Olfactory transduction	442194	1	+	0.0155732280236746	0.229518447911177
1085	phenindione	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_5879_1432_3576	4	+	0.0414216723977497	0.396464578664176
1086	phenindione	hsa05219	Bladder cancer	5925_1956_3576_2261	4	+	0.00817241812118006	0.229518447911177
1087	phenindione	hsa05218	Melanoma	5925_1956_3082_5156	4	+	0.0414216723977497	0.396464578664176
1088	phenindione	hsa04010	MAPK signaling pathway	5879_1432_5156_1956_5871_91_8398_5971_2261_27330_3164	11	+	0.0171282423814311	0.229518447911177
1089	phenindione	hsa04912	GnRH signaling pathway	8398_1081_1956_5337_1432_23236	6	+	0.014457765718517	0.229518447911177
1090	phenindione	hsa05010	Alzheimer's disease	5534	1	-	0.0154721696558335	0.59567853174959
1091	phenindione	hsa04660	T cell receptor signaling pathway	5163_1432_10725_6655_5600_5603_5534_9020_4793	9	-	0.0444209056893234	0.649405010329818
1092	phenindione	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_85235_8364_8370_8366_8368_8365_8330_8332_8359_8969_8331_8329_8336_8367_554313_121504_8294	21	-	8.28857992869301e-07	6.38220654509362e-05
1093	phenindione	hsa04020	Calcium signaling pathway	5333_5534	2	-	0.0498996914454082	0.649405010329818
1094	phenindione	hsa04940	Type I diabetes mellitus	3135_3106_3107_3552_2571	5	-	0.03517983682555	0.649405010329818
1095	CP-690334-01	hsa05332	Graft-versus-host disease	3812_57292_3811_3553_3804_3106_3803_3802_3135_356_3105_649853	12	+	0.0047636853911549	0.0819353887278643
1096	CP-690334-01	hsa04650	Natural killer cell mediated cytotoxicity	23533_57292_3809_3808_3805_3804_3806_5293_3803_3802_27040_5880_5336_3451_3105_3106_3812_3810_3811_4277_4276_3135_4772_5534_356_5879_2534	27	+	0.00729565896137785	0.104571111779749
1097	CP-690334-01	hsa04120	Ubiquitin mediated proteolysis	23327_7337_331_330_8916_9021_63893	7	+	0.0471944435585006	0.368974740548277
1098	CP-690334-01	hsa04612	Antigen processing and presentation	3812_57292_3811_3809_3808_3805_3804_3106_3806_3810_3803_3802_3135_3306_3451_3105_920_115653_649853	19	+	0.00865942644644191	0.106387239199143
1099	CP-690334-01	hsa05016	Huntington's disease	2902_4899_317_246721_3708_56901	6	+	0.000801598973507601	0.0172343779304134
1100	CP-690334-01	hsa04740	Olfactory transduction	26212_8388_8387_1179_2979_816_4995	7	+	2.91055923258025e-10	1.25154047000951e-08
1101	CP-690334-01	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_9103_8349_8348_8329_8294_121504_8343_8347_8346_8345_8344_8339_8969_8968_55766_8370_8358_8359_8330_8331_8336_8334_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_85236_3012_3013_3017_720_721_8970	50	+	5.92967717253926e-11	5.09952236838376e-09
1102	CP-690334-01	hsa04110	Cell cycle	995_1032_699_5925	4	+	0.0129686297196012	0.123922461765078
1103	CP-690334-01	hsa04350	TGF-beta signaling pathway	91_7044_5516	3	+	0.046137316976651	0.368974740548277
1104	CP-690334-01	hsa05012	Parkinson's disease	317_56901_6531	3	+	0.00077216594690703	0.0172343779304134
1105	CP-690334-01	hsa03010	Ribosome	6187_440589_6123	3	+	0.0121410491334413	0.123922461765078
1106	CP-690334-01	hsa05214	Glioma	51806_595_208_6655_5295_5154_4193_818_5335_3480_3845	11	-	0.0454901515286484	0.238823295525404
1107	CP-690334-01	hsa05211	Renal cell carcinoma	208_6655_5295_998_56924_405_5058_5781_1399_7042_3845_4233	12	-	0.0345974390561543	0.238823295525404
1108	CP-690334-01	hsa03320	PPAR signaling pathway	9415	1	-	0.0422060140052377	0.238823295525404
1109	CP-690334-01	hsa05010	Alzheimer's disease	51806_4695_348_489_23236	5	-	0.0102112339647833	0.142957275506966
1110	CP-690334-01	hsa04080	Neuroactive ligand-receptor interaction	5618_1813_64106_2901_5031_1241_7067_56288	8	-	0.00298626936445424	0.0836155422047187
1111	CP-690334-01	hsa05200	Pathways in cancer	595_596_598_7042_5154_9618_7175_5881_1487_3655_4254_3675_1050_6789_5914_1613_405_652_1399_208_2263_2260_5295_3480_998_4193_6934_4609_91_2956_3918_4233_4791_1436_2122_6655_3845_5335_7186	39	-	0.0360946014615872	0.238823295525404
1112	CP-690334-01	hsa04520	Adherens junction	3480_117178_998_5881_8826_5792_6934_91_56288_2260_4233_6714_8976	13	-	0.0286365464148434	0.238823295525404
1113	CP-690334-01	hsa05016	Huntington's disease	4899_4695_7052_3092_5978_9001_23236	7	-	0.0287439561745551	0.238823295525404
1114	CP-690334-01	hsa04740	Olfactory transduction	818_51806	2	-	3.02066406663007e-11	2.53735781596926e-09
1115	CP-690334-01	hsa05322	Systemic lupus erythematosus	8330	1	-	0.0002136706385537	0.0089741668192554
1116	CP-690334-01	hsa04360	Axon guidance	9353_5362_2043_2041_10725_998_1944_56924_7852_5881_3845_54910_10512_5058_4233_27289_7869_3983	18	-	0.0431215816984563	0.238823295525404
1117	CP-690334-01	hsa04370	VEGF signaling pathway	1432_5829_208_5295_998_10725_5881_3845_5603_5335_6714_8398	12	-	0.0436371717491851	0.238823295525404
1118	CP-690334-01	hsa05012	Parkinson's disease	7327_4695_7054	3	-	0.00934431499278721	0.142957275506966
1119	CP-690334-01	hsa03010	Ribosome	6168_6205	2	-	0.0238059197305522	0.238823295525404
1120	CP-690334-01	hsa05210	Colorectal cancer	595_596_3480_6655_5295_7042_5881_4609_3845_6934_208_91_2956_4233	14	-	0.0197017865192941	0.236421438231529
1121	CP-690334-01	hsa05220	Chronic myeloid leukemia	2122_595_208_6655_5295_4193_1487_5781_1399_4609_91_3845_7042_598	14	-	0.00784017854266065	0.142957275506966
1122	pancuronium bromide	hsa05332	Graft-versus-host disease	3123_3126_3127_3119_3125	5	+	0.000381140608877311	0.00498617103530955
1123	pancuronium bromide	hsa04640	Hematopoietic cell lineage	3123_3684_3126_3127_3125	5	+	0.00759127876518063	0.0466321409861096
1124	pancuronium bromide	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3119_3125	5	+	0.00101290620329867	0.00871099334836856
1125	pancuronium bromide	hsa04612	Antigen processing and presentation	3119_3123_3126_3127_3125_3310	6	+	0.00164668781460035	0.0118012626713025
1126	pancuronium bromide	hsa04514	Cell adhesion molecules (CAMs)	3119_3123_3126_3127_3684_3125	6	+	0.0109538009321869	0.0588766800105046
1127	pancuronium bromide	hsa05322	Systemic lupus erythematosus	3123_3126_3127_3119_3125	5	+	0.0487682045689929	0.233003644051855
1128	pancuronium bromide	hsa05310	Asthma	3123_3126_3127_3119_3125	5	+	9.16696073046177e-05	0.00394179311409856
1129	pancuronium bromide	hsa05330	Allograft rejection	3123_3126_3127_3119_3125	5	+	0.000249587025968882	0.00498617103530955
1130	pancuronium bromide	hsa04940	Type I diabetes mellitus	3123_3126_3127_3119_3125	5	+	0.000463829863749726	0.00498617103530955
1131	pancuronium bromide	hsa04662	B cell receptor signaling pathway	4067_3551_8519_4775_5534_3725_27071_4793	8	-	0.00802611752741849	0.208679055712881
1132	pancuronium bromide	hsa04080	Neuroactive ligand-receptor interaction	9568_64106_7433	3	-	0.0372764425420693	0.587310575484678
1133	pancuronium bromide	hsa04740	Olfactory transduction	5566_393046_4991	3	-	0.000987209167996471	0.0385011575518624
1134	pancuronium bromide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3013_554313_8359_8294_8367_121504_8368_8351_3108	17	-	4.30499780779332e-05	0.00335789829007879
1135	pancuronium bromide	hsa04810	Regulation of actin cytoskeleton	7430_998	2	-	0.0376481138131204	0.587310575484678
1136	diperodon	hsa04514	Cell adhesion molecules (CAMs)	3695_942_3109_1462	4	+	0.0289966654210745	0.396189540643174
1137	diperodon	hsa04530	Tight junction	93408_79784_5588_208	4	+	0.031043152536804	0.396189540643174
1138	diperodon	hsa04920	Adipocytokine signaling pathway	208_5588_2182	3	+	0.0210949713319225	0.396189540643174
1139	diperodon	hsa05330	Allograft rejection	942_3109	2	+	0.044537468937765	0.396189540643174
1140	diperodon	hsa05220	Chronic myeloid leukemia	861_5925_208	3	+	0.0279509654954838	0.396189540643174
1141	diperodon	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00423032713108944	0.131140141063773
1142	PNU-0251126	hsa04115	p53 signaling pathway	55367_8795_4193_3486	4	-	0.0342640910639839	1
1143	PNU-0251126	hsa05220	Chronic myeloid leukemia	598_208_5781_4193	4	-	0.043825122349189	1
1144	folic acid	hsa05014	Amyotrophic lateral sclerosis (ALS)	598_842_836_5600_581	5	+	0.0175441218668651	0.570183960673116
1145	folic acid	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8343_8336_8339_8347_8346_8344	12	+	0.000508720864977072	0.0330668562235097
1146	folic acid	hsa05322	Systemic lupus erythematosus	85235_8969_8332_8330_8331_8329_8336	7	-	0.000772214248885672	0.0362940696976266
1147	folic acid	hsa04210	Apoptosis	5533_472_7186_596	4	-	0.0139490244403679	0.327802074348646
1148	quipazine	hsa05010	Alzheimer's disease	317	1	+	0.0051604529670075	0.1376120791202
1149	quipazine	hsa04740	Olfactory transduction	818_81696_81797	3	+	2.83826832660142e-05	0.00113530733064057
1150	quipazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8342_8341_8347_8346_8344_8969_8370_8332_8359_8330_8331_8336_8337_554313_121504_8339_85235_3119_729	31	+	3.78924479161861e-11	3.03139583329489e-09
1151	quipazine	hsa05213	Endometrial cancer	23533_6655_5290_1956_1495_324	6	+	0.0447886908439988	0.650045343860815
1152	quipazine	hsa05210	Colorectal cancer	23533_6655_5880_5290_1956_7040_324_3725_8326	9	+	0.0371495848920029	0.650045343860815
1153	quipazine	hsa03010	Ribosome	439992_9349_6137_6181_6189_6171	6	-	0.00315084221961705	0.173296322078938
1154	PHA-00665752	hsa05214	Glioma	5728_5594_7157_6654_5155_5290_5605_808_805_801_816	11	-	0.00901067156871765	0.162192088236918
1155	PHA-00665752	hsa05211	Renal cell carcinoma	2271_5594_5062_6654_5155_5290_5605_2033_5781_1398_7423	11	-	0.0208556068174038	0.234625576695793
1156	PHA-00665752	hsa04080	Neuroactive ligand-receptor interaction	7068_5025_1081_9170	4	-	0.00027701194783481	0.0124655376525665
1157	PHA-00665752	hsa04740	Olfactory transduction	219464_808_109_816_801_805	6	-	4.58828787245588e-06	0.000412945908521029
1158	PHA-00665752	hsa05212	Pancreatic cancer	6934_5728_5970_5594_9134_7157_6654_5155_5290_5605_2033_3326_1385_1017	14	-	0.00712417258576978	0.16029388317982
1159	PHA-00665752	hsa04110	Cell cycle	5591_9134_4173_7157_983_699_4176_472_11200_7027_7534_1017_7531_2033_7465_4616	16	-	0.019394262479685	0.234625576695793
1160	PHA-00665752	hsa05215	Prostate cancer	6934_5728_5970_5594_9134_7157_6654_5155_5290_5605_2033_3326_1385_1017	14	-	0.00668626186458333	0.16029388317982
1161	PHA-00665752	hsa05219	Bladder cancer	4313_5594_7157_999_7057_5605_7423	7	-	0.0360906235184831	0.249858162820268
1162	PHA-00665752	hsa04115	p53 signaling pathway	472_5728_9134_7157_983_7057_64065_11200_1017_4616	10	-	0.0347023033219707	0.249858162820268
1163	PHA-00665752	hsa03450	Non-homologous end-joining	5591_7520_27343_7518	4	-	0.0252428265150195	0.249858162820268
1164	PHA-00665752	hsa03430	Mismatch repair	4436_5983_2956_6117_5985	5	-	0.0311462015749799	0.249858162820268
1165	PHA-00665752	hsa04060	Cytokine-cytokine receptor interaction	3597_2057_3459_5155_3572_4982_7423_655_51330	9	-	0.0323261413153783	0.249858162820268
1166	PHA-00665752	hsa04912	GnRH signaling pathway	4313_3710_1081_6654_5580_808_5605_109_5601_5600_805_801_6416_816_5594	15	-	0.0149283490640688	0.223925235961032
1167	AG-028671	hsa04080	Neuroactive ligand-receptor interaction	5618_7068_1909	3	+	0.0275146749906946	0.277575350351944
1168	AG-028671	hsa05200	Pathways in cancer	1026_4149_1613_4088_598_999_998_5899_1857_6772_4193_5900_3655_2271_331_1398_9618_10342_1017_355_7423	21	+	0.0292184579317836	0.277575350351944
1169	AG-028671	hsa05131	Shigellosis	7280_347733_999_998_60_7430_7534	7	+	0.00801137280539437	0.202954777736657
1170	AG-028671	hsa05130	Pathogenic Escherichia coli infection	7280_347733_999_998_60_7430_7534	7	+	0.00801137280539437	0.202954777736657
1171	AG-028671	hsa04110	Cell cycle	1026_4173_4088_699_4193_51433_10912_7534_1017_7531	10	+	0.0280084895143427	0.277575350351944
1172	AG-028671	hsa05219	Bladder cancer	7423_1026_999_1613_4193	5	+	0.0281358782532307	0.277575350351944
1173	AG-028671	hsa04115	p53 signaling pathway	1026_5366_6477_4193_355_10912_1017_8795	8	+	0.00706443640177231	0.202954777736657
1174	AG-028671	hsa03022	Basal transcription factors	10629_51616_2969_6872_728198	5	+	0.0180865086209032	0.277575350351944
1175	6-bromoindirubin-3'-oxime	hsa05010	Alzheimer's disease	776_5534	2	+	0.0360850276806788	0.71432036218072
1176	6-bromoindirubin-3'-oxime	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	0.00768285325429644	0.553165434309344
1177	6-bromoindirubin-3'-oxime	hsa04080	Neuroactive ligand-receptor interaction	4889_5618_64106_4158_5025_799_2150_2149	8	-	0.0361732547050368	0.621163917571648
1178	6-bromoindirubin-3'-oxime	hsa04740	Olfactory transduction	5137	1	-	8.10544761235695e-10	6.97068494662698e-08
1179	6-bromoindirubin-3'-oxime	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_89_8329_8294_8343_8347_8346_8344_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235_3017_3014_727	30	-	2.1342843982251e-07	9.17742291236793e-06
1180	6-bromoindirubin-3'-oxime	hsa03010	Ribosome	6233	1	-	0.0211991796780819	0.455782363078761
1181	6-bromoindirubin-3'-oxime	hsa05220	Chronic myeloid leukemia	5970_2122_5594_4088_572_1398_5605_9846_6777_369_1488	11	-	0.0198174194310223	0.455782363078761
1182	16,16-dimethylprostaglandin E2	hsa05213	Endometrial cancer	2002_6934_324_842	4	-	0.0152194765967258	0.515560326035195
1183	16,16-dimethylprostaglandin E2	hsa05210	Colorectal cancer	3725_842_324_6934_581	5	-	0.0180898360012349	0.515560326035195
1184	aconitine	hsa05322	Systemic lupus erythematosus	85235_3119_8969_8332_8330_8331_8329_8336	8	-	0.00124870442706325	0.084911901040301
1185	aconitine	hsa04540	Gap junction	7278_6714_113457_6655_23236	5	-	0.0117048722686549	0.397965657134267
1186	epivincamine	hsa04080	Neuroactive ligand-receptor interaction	64106	1	-	0.0156754121871989	0.215536917573985
1187	epivincamine	hsa04740	Olfactory transduction	818	1	-	0.000824873011382486	0.0226840078130184
1188	epivincamine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	5.9751788456701e-05	0.00328634836511855
1189	epivincamine	hsa04710	Circadian rhythm - mammal	1454_8553_1408	3	-	0.00750078650725706	0.137514419299713
1190	epivincamine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0491083275387865	0.540191602926651
1191	racecadotril	hsa05014	Amyotrophic lateral sclerosis (ALS)	4217_5534_581	3	+	0.0445656291556509	0.915328491401148
1192	racecadotril	hsa05322	Systemic lupus erythematosus	85235_8969_9103_8332_8330_8331_8329_8336	8	+	0.000991611146598919	0.0466057238901492
1193	demecarium bromide	hsa04740	Olfactory transduction	5566	1	+	0.00177904229185186	0.0587083956311114
1194	demecarium bromide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	2.58770100503729e-05	0.00170788266332461
1195	demecarium bromide	hsa04340	Hedgehog signaling pathway	51384_1454_5566_652_7477	5	+	0.0163189105087803	0.359016031193167
1196	demecarium bromide	hsa04012	ErbB signaling pathway	2002_3725_5335	3	-	0.0390284894864283	0.691129785178069
1197	vinburnine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_3014	32	-	1.75402136769688e-25	7.89309615463596e-24
1198	isocorydine	hsa05131	Shigellosis	7278_5578_113457_2534_347733	5	+	0.014357525445389	0.125628347647154
1199	isocorydine	hsa05130	Pathogenic Escherichia coli infection	7278_5578_113457_2534_347733	5	+	0.014357525445389	0.125628347647154
1200	isocorydine	hsa05014	Amyotrophic lateral sclerosis (ALS)	2903_2902_596_581_5533_10452_5534	7	+	0.000675832226546402	0.012970589734107
1201	isocorydine	hsa04740	Olfactory transduction	5593	1	+	0.0017046777088385	0.023865487923739
1202	isocorydine	hsa05322	Systemic lupus erythematosus	2903_8361_8363_8362_8365_8364_8370_8360_8368_8366_3111_8359_8294_8367_554313_121504	16	+	1.12977348973019e-06	7.90841442811133e-05
1203	isocorydine	hsa04370	VEGF signaling pathway	5578_56848_5533_7422_5534_6714	6	+	0.0135908501004096	0.125628347647154
1204	isocorydine	hsa04720	Long-term potentiation	2903_2902_2911_5578_5533_6196_5534_27330	8	+	0.000741176556234686	0.012970589734107
1205	isocorydine	hsa04150	mTOR signaling pathway	6196_27330_7422_7249	4	+	0.0429149834900709	0.273095349482269
1206	isocorydine	hsa04010	MAPK signaling pathway	785_9344_5578_5598_27330_8817_6196_8911_5533_5534_2257_3164_5609	13	+	0.0261488260821028	0.18304178257472
1207	isocorydine	hsa04540	Gap junction	2911_5593_347733_5598_7278_5578_113457_6714_1902	9	+	0.000670485677628635	0.012970589734107
1208	isocorydine	hsa04020	Calcium signaling pathway	2903_2911_2902_56848_5578_3360_6261_5533_8911_5534	10	+	0.0260559789555028	0.18304178257472
1209	isocorydine	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8336	7	-	0.0149520846291104	0.702747977568189
1210	isocorydine	hsa04610	Complement and coagulation cascades	5627_5265_2149_5328	4	-	0.0361442183531338	0.849389131298644
1211	(+)-chelidonine	hsa04740	Olfactory transduction	1179_816	2	+	0.00327440214364139	0.164491123308135
1212	(+)-chelidonine	hsa04510	Focal adhesion	5170_22798_2316_7057_3685_5154_88_3696_7414_3725_6093_10627	12	+	0.0161992129528401	0.367182160264376
1213	(+)-chelidonine	hsa04010	MAPK signaling pathway	3164_2316_1852_27092_8074_5154_1846_1843_4208_8911_10912_7042_3725_3304_3303_4763	16	+	0.00483797421494514	0.164491123308135
1214	(+)-chelidonine	hsa04540	Gap junction	2911_7278_113457_5154_112_23236	6	+	0.0480804216349211	0.649565885358056
1215	(+)-chelidonine	hsa04640	Hematopoietic cell lineage	3655_966_4254_7037	4	-	0.00269448258569801	0.0490395830597038
1216	(+)-chelidonine	hsa04080	Neuroactive ligand-receptor interaction	7068_64106_1131_5025_4886_2149	6	-	7.63441375621469e-12	3.47365825907768e-10
1217	(+)-chelidonine	hsa04742	Taste transduction	5613_5616_3710	3	-	0.0391769412886121	0.22566706734661
1218	(+)-chelidonine	hsa04670	Leukocyte transendothelial migration	5295_5290_7410_7430_5781_5335_5747_1499_50848	9	-	0.00883092453192771	0.0886685939133696
1219	(+)-chelidonine	hsa05016	Huntington's disease	5432_246721_5439_836_1327_4701_6392_642502_6391_317_4712_841_5978_2033_509_7419_6875_548644_23236	19	-	0.0178985333297934	0.116340466643657
1220	(+)-chelidonine	hsa04740	Olfactory transduction	5613_5616_808_109_801_805	6	-	4.19695836277858e-20	3.81923211012851e-18
1221	(+)-chelidonine	hsa04514	Cell adhesion molecules (CAMs)	965_4685_3105_3106_999_3135_3134_5792_3655_50848_9019	11	-	0.0129033421168631	0.106745830239504
1222	(+)-chelidonine	hsa04510	Focal adhesion	2002_5728_5170_5594_5295_5062_4659_6655_5747_331_7057_5290_3915_7410_6654_1499_3655_4233_2335	19	-	0.00575447929102674	0.0748082307833476
1223	(+)-chelidonine	hsa05322	Systemic lupus erythematosus	55506_8361_8363_8362_8365_8364_94239_8360_8368_8349_8329_8294_8343_8347_8346_8345_8344_6632_723790_8367_8366_8969_55766_8370_8332_8359_8330_8331_8336_8337_8334_554313_6738_121504_8339_8357_85235_85236_3014	39	-	0.0158562671291008	0.110993869903706
1224	(+)-chelidonine	hsa04512	ECM-receptor interaction	3655_3915_7057_2335	4	-	0.00379097687137672	0.0574964825492136
1225	(+)-chelidonine	hsa04630	Jak-STAT signaling pathway	5295_3597_8554_3454_6774_598_6655_6654_5290_6772_50616_2033_5781_9180_9655_10254	16	-	0.0396777261268765	0.22566706734661
1226	(+)-chelidonine	hsa04062	Chemokine signaling pathway	2309_23236_5295_5594_5580_6774_5613_6655_6654_5616_6772_7410_109_5290_113_5747_10681_8976_408	19	-	0.0143816498826659	0.10906084494355
1227	(+)-chelidonine	hsa04260	Cardiac muscle contraction	7168_1327	2	-	0.000305487490245938	0.00694984040309509
1228	(+)-chelidonine	hsa04060	Cytokine-cytokine receptor interaction	27242_3597_9180_3454_4254_4982_355_50616_7043_7042_655_4233_90	13	-	1.08778213785811e-07	3.2996058181696e-06
1229	(+)-chelidonine	hsa03010	Ribosome	6187_440589_6139_6137_6125_6168_6160	7	-	0.00974380152894171	0.0886685939133696
1230	(+)-chelidonine	hsa03050	Proteasome	5683	1	-	0.00737957689289367	0.0839426871566655
1231	(+)-chelidonine	hsa04610	Complement and coagulation cascades	966_2149_4179_2152_7035	5	-	0.0487585914694913	0.261001871983748
1232	alpha-yohimbine	hsa05332	Graft-versus-host disease	3553_3126_3113_3127_3125_3123	6	+	0.00774272446651515	0.141307117030362
1233	alpha-yohimbine	hsa05320	Autoimmune thyroid disease	1081_3123_3113_3127_3126_3125	6	+	0.0203572593079482	0.244287111695378
1234	alpha-yohimbine	hsa05016	Huntington's disease	64446_5978	2	+	0.0499576944785816	0.419644633620085
1235	alpha-yohimbine	hsa04740	Olfactory transduction	26476_5566	2	+	8.79207006818856e-05	0.0036926694286392
1236	alpha-yohimbine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2212_3013_3113_8970	32	+	3.32575212052621e-14	2.79363178124202e-12
1237	alpha-yohimbine	hsa05310	Asthma	3123_3126_3127_3113_3125	5	+	0.00841113791847392	0.141307117030362
1238	alpha-yohimbine	hsa04010	MAPK signaling pathway	3554_3553_3925_5599_5566_50487_5155_998_6196_23162_1950_7042_5494_2263_9344_9693_4763_5578	18	+	0.0260973576800029	0.27402225564003
1239	alpha-yohimbine	hsa04540	Gap junction	2911_5578_5566_5155_113457_1950_6714_7278	8	+	0.0315827753039655	0.294772569503678
1240	alpha-yohimbine	hsa05330	Allograft rejection	3126_3113_3127_3123_3125	5	+	0.0196754167997638	0.244287111695378
1241	alpha-yohimbine	hsa04940	Type I diabetes mellitus	3553_3126_3113_3127_3125_1363_3123	7	+	0.00240387050891695	0.0673083742496746
1242	alpha-yohimbine	hsa05332	Graft-versus-host disease	3135_3123_3126_3127_3125	5	-	0.00124585593264641	0.0237242743035916
1243	alpha-yohimbine	hsa04640	Hematopoietic cell lineage	3655_3125_3126_3127_3123	5	-	0.0214888569876109	0.135379799021949
1244	alpha-yohimbine	hsa05320	Autoimmune thyroid disease	3135_3123_3126_3127_3125	5	-	0.00319484292170798	0.0287535862953718
1245	alpha-yohimbine	hsa04612	Antigen processing and presentation	3123_3126_3127_3125_3135_811	6	-	0.00600059062202408	0.0472546511484396
1246	alpha-yohimbine	hsa04740	Olfactory transduction	219464	1	-	0.0154966916135747	0.108476841295023
1247	alpha-yohimbine	hsa04514	Cell adhesion molecules (CAMs)	3123_3126_3127_3125_3135_3655	6	-	0.0345180646844054	0.196506157156227
1248	alpha-yohimbine	hsa05322	Systemic lupus erythematosus	85235_3123_3126_3127_3125_8332_8969_8331_8336_8329_8330	11	-	7.59051732330278e-05	0.00478202591368075
1249	alpha-yohimbine	hsa04115	p53 signaling pathway	472_581_7057_4616	4	-	0.0374297442202337	0.196506157156227
1250	alpha-yohimbine	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.00267456990071884	0.0280829839575478
1251	alpha-yohimbine	hsa03020	RNA polymerase	246721_5439_548644_84172	4	-	0.00239178415036037	0.0280829839575478
1252	alpha-yohimbine	hsa05330	Allograft rejection	3135_3123_3126_3127_3125	5	-	0.000826562949743296	0.0237242743035916
1253	alpha-yohimbine	hsa04940	Type I diabetes mellitus	3135_3123_3126_3127_3125	5	-	0.00150630313038677	0.0237242743035916
1254	5279552	hsa04340	Hedgehog signaling pathway	656_353500	2	+	0.0412137851461406	0.224400589990146
1255	5279552	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_8517_1839_3725	4	+	0.000730272179334482	0.0211778932007
1256	5279552	hsa04012	ErbB signaling pathway	5599_3725_1839	3	+	0.0130106174194792	0.164393010375502
1257	5279552	hsa04620	Toll-like receptor signaling pathway	5599_8517_3725	3	+	0.019605771175515	0.164393010375502
1258	5279552	hsa04912	GnRH signaling pathway	5599_3725_1839	3	+	0.0226748979828279	0.164393010375502
1259	5279552	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	-	0.000535489421863816	0.00606888011445658
1260	5279552	hsa05320	Autoimmune thyroid disease	3135_3105_3106_649853	4	-	0.00121031822804947	0.0102877049384205
1261	5279552	hsa04612	Antigen processing and presentation	3135_3105_3106_649853	4	-	0.00715582494472536	0.0486596096241324
1262	5279552	hsa04514	Cell adhesion molecules (CAMs)	3135_3105_3106_649853	4	-	0.0268829407475609	0.152336664236178
1263	5279552	hsa04540	Gap junction	7278_2767_113457	3	-	0.044500761082149	0.216146553827581
1264	5279552	hsa05330	Allograft rejection	3135_3105_3106_649853	4	-	0.000376584499305291	0.00606888011445658
1265	5279552	hsa04940	Type I diabetes mellitus	3135_3105_3106_1363_649853	5	-	4.80323693299374e-05	0.00163310055721787
1266	5253409	hsa04612	Antigen processing and presentation	3310_3304_3305_3303	4	+	0.0219529820629648	0.439059641259296
1267	5253409	hsa04310	Wnt signaling pathway	3725_5532_6477_27101_8061	5	+	0.0342875040036491	0.457166720048655
1268	5253409	hsa04010	MAPK signaling pathway	1843_1649_2353_5532_3725_7786_3310_3304_3305_3303	10	+	0.00149962031387139	0.0599848125548556
1269	dioxybenzone	hsa04120	Ubiquitin mediated proteolysis	26232_5371_9820	3	+	0.0255928634159233	0.537450131734389
1270	dioxybenzone	hsa04740	Olfactory transduction	8390_135948_26664_8392_81797_390892_3000	7	+	1.45246575235536e-05	0.000996888503796389
1271	dioxybenzone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8341_8340_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3119_2215_2214_3111	27	+	2.37354405665807e-05	0.000996888503796389
1272	dioxybenzone	hsa03010	Ribosome	9045	1	+	0.0144736095891313	0.405261068495676
1273	dioxybenzone	hsa04670	Leukocyte transendothelial migration	7430_5600	2	-	0.0347680363578209	0.503427499068058
1274	dioxybenzone	hsa04740	Olfactory transduction	810	1	-	1.26316290867729e-09	1.0736884723757e-07
1275	dioxybenzone	hsa04514	Cell adhesion molecules (CAMs)	3119	1	-	0.00329933840406597	0.140221882172804
1276	dioxybenzone	hsa05322	Systemic lupus erythematosus	6738_9555_3119	3	-	0.0355360587577453	0.503427499068058
1277	dioxybenzone	hsa05012	Parkinson's disease	836_4694	2	-	0.0177257243835288	0.502228857533316
1278	dioxybenzone	hsa04060	Cytokine-cytokine receptor interaction	5618_3554_3552_2057_3953_3624_1956_2690	8	-	0.0274526740500635	0.503427499068058
1279	5255229	hsa04662	B cell receptor signaling pathway	3725_4792_2353	3	+	0.0188514009661668	0.174375458937043
1280	5255229	hsa05200	Pathways in cancer	2308_3576_3725_2353_4791_4792	6	+	0.0354242004046467	0.256670196758042
1281	5255229	hsa04660	T cell receptor signaling pathway	3725_4792_2353	3	+	0.0485592264136836	0.256670196758042
1282	5255229	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_3576_4792	3	+	0.016395372390337	0.174375458937043
1283	5255229	hsa04010	MAPK signaling pathway	1647_1843_1649_2353_3725_3164_4791	7	+	0.00404895448504909	0.133784819345769
1284	5255229	hsa04620	Toll-like receptor signaling pathway	3725_3576_4792_2353	4	+	0.00723161185652804	0.133784819345769
1285	5255229	hsa04060	Cytokine-cytokine receptor interaction	23529_83729_3576_8743_3976	5	+	0.044018987339379	0.256670196758042
1286	5255229	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	-	0.000280350535906333	0.00275675425113812
1287	5255229	hsa05320	Autoimmune thyroid disease	3135_3105_3106_649853	4	-	0.000640731687048658	0.00400457304405411
1288	5255229	hsa04612	Antigen processing and presentation	3135_3105_3106_649853	4	-	0.00392692076232262	0.0196346038116131
1289	5255229	hsa04514	Cell adhesion molecules (CAMs)	3135_3105_3106_649853	4	-	0.0154160600556352	0.0642335835651467
1290	5255229	hsa04330	Notch signaling pathway	8850_5664	2	-	0.0454241850019869	0.162229232149953
1291	5255229	hsa05330	Allograft rejection	3135_3105_3106_649853	4	-	0.00019635949432751	0.00275675425113812
1292	5255229	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853	4	-	0.000330810510136574	0.00275675425113812
1293	5211181	hsa05131	Shigellosis	7278_113457	2	+	0.0254394944374782	0.13991721940613
1294	5211181	hsa05130	Pathogenic Escherichia coli infection	7278_113457	2	+	0.0254394944374782	0.13991721940613
1295	5211181	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	-	0.00099600288425102	0.0167725089380379
1296	5211181	hsa04650	Natural killer cell mediated cytotoxicity	10725_3135_3106_3105	4	-	0.0491569748835859	0.301964274284885
1297	5211181	hsa05320	Autoimmune thyroid disease	3135_3105_3106_649853	4	-	0.00222268436361683	0.0238938569088809
1298	5211181	hsa04612	Antigen processing and presentation	3135_3105_3106_649853	4	-	0.0126122872698834	0.108465670520997
1299	5211181	hsa04514	Cell adhesion molecules (CAMs)	3135_3105_3106_649853	4	-	0.045072582620695	0.301964274284885
1300	5211181	hsa05330	Allograft rejection	3135_3105_3106_649853	4	-	0.000703707754775024	0.0167725089380379
1301	5211181	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853	4	-	0.00117017504218869	0.0167725089380379
1302	5252917	hsa04350	TGF-beta signaling pathway	4088_1311_7042	3	+	0.0313684295786096	0.55413737444579
1303	5252917	hsa04120	Ubiquitin mediated proteolysis	51619_8453_8554_55294_57154	5	-	0.0420673116939888	0.311298106535517
1304	5252917	hsa05131	Shigellosis	7277_7280_203068_347733	4	-	0.00804684085464569	0.0883734217797743
1305	5252917	hsa05130	Pathogenic Escherichia coli infection	7277_7280_203068_347733	4	-	0.00804684085464569	0.0883734217797743
1306	5252917	hsa04350	TGF-beta signaling pathway	3398_655_652_4090_57154	5	-	0.00736477912617587	0.0883734217797743
1307	5252917	hsa04540	Gap junction	203068_5607_7280_7277_347733	5	-	0.00955388343565128	0.0883734217797743
1308	Y-27632	hsa04540	Gap junction	7278_2767_113457_2776	4	-	0.0218541735471449	0.808604421244361
1309	5248896	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	+	9.53684682404243e-05	0.00086506084683883
1310	5248896	hsa04650	Natural killer cell mediated cytotoxicity	3135_3105_3106	3	+	0.0380259825737369	0.12494251417085
1311	5248896	hsa05320	Autoimmune thyroid disease	3135_3105_3106_649853	4	+	0.000221174649368319	0.00127175423386783
1312	5248896	hsa04612	Antigen processing and presentation	3135_3105_3106_649853	4	+	0.00142147600804209	0.00653878963699361
1313	5248896	hsa04514	Cell adhesion molecules (CAMs)	3135_3105_3106_649853	4	+	0.00591628367559919	0.0226790874231302
1314	5248896	hsa05330	Allograft rejection	3135_3105_3106_649853	4	+	6.64413223642681e-05	0.00086506084683883
1315	5248896	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853	4	+	0.000112834023500717	0.00086506084683883
1316	5224221	hsa04080	Neuroactive ligand-receptor interaction	2908	1	+	0.0331976976654081	0.448168918483009
1317	5224221	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_8970	26	+	1.785084084208e-14	9.6394540547232e-13
1318	5224221	hsa04115	p53 signaling pathway	5366_1647_6477_8795_581	5	+	0.0295429138893837	0.448168918483009
1319	5224221	hsa04010	MAPK signaling pathway	1647_5534_5599_7042_1649_1845_1843_3725_3310_3304_3305_3303_11221	13	+	0.0254799508390233	0.448168918483009
1320	5224221	hsa04080	Neuroactive ligand-receptor interaction	4886	1	-	0.04883644616263	0.501486805969775
1321	5224221	hsa04740	Olfactory transduction	5613_5616	2	-	0.0130540623212433	0.291540725174434
1322	5224221	hsa04110	Cell cycle	5111_993_9134_898_6502_5933_1031	7	-	0.0225265104151498	0.377319049453759
1323	5224221	hsa04540	Gap junction	5613_7278_5616_113457_115_203068_107	7	-	0.00691170000343213	0.231541950114976
1324	5224221	hsa04912	GnRH signaling pathway	5608_5580_5613_5616_107_115_5606_6300	8	-	0.00434998967285318	0.231541950114976
1325	carbamazepine	hsa05332	Graft-versus-host disease	3553_3123_3126_3127_3111_3125	6	+	0.0254652623222251	0.411374245469583
1326	carbamazepine	hsa04080	Neuroactive ligand-receptor interaction	7434_3363_8484_7433	4	+	0.011034070697912	0.411374245469583
1327	carbamazepine	hsa04740	Olfactory transduction	5613_5593_4991	3	+	1.43045393815656e-05	0.00115866768990681
1328	carbamazepine	hsa05310	Asthma	3123_3126_3127_3111_3125	5	+	0.0239180297999799	0.411374245469583
1329	carbamazepine	hsa04010	MAPK signaling pathway	9261_9344_22808_4763_10454_3305_3553_775_776_2258_5536_7786_3725_9175_785_1843_5613_1649_6196_23162_2005_2353_3310	23	+	0.0183058686723285	0.411374245469583
1330	carbamazepine	hsa04940	Type I diabetes mellitus	3553_3123_3126_3127_3111_3125	6	+	0.0304721663310802	0.411374245469583
1331	carbamazepine	hsa05010	Alzheimer's disease	11261_2776	2	-	0.0255826805175086	0.547832047389262
1332	carbamazepine	hsa04080	Neuroactive ligand-receptor interaction	2561_4889_152_7067_4886	5	-	0.0458915276090948	0.547832047389262
1333	carbamazepine	hsa04740	Olfactory transduction	157	1	-	7.658562861984e-07	6.35660717544672e-05
1334	carbamazepine	hsa04510	Focal adhesion	8515_10298_1302_596_3911_2317_2909_3678_3914_3909_5881_1956_5747_7791_3655_3725	16	-	0.0462027027918655	0.547832047389262
1335	carbamazepine	hsa05012	Parkinson's disease	291	1	-	0.0324288996984188	0.547832047389262
1336	carbamazepine	hsa04060	Cytokine-cytokine receptor interaction	27242_1956_2057	3	-	0.00549595205295328	0.228082010197561
1337	carbamazepine	hsa05222	Small cell lung cancer	3914_3911_9134_7157_596_3909_5747_3655_5970	9	-	0.0372764461319974	0.547832047389262
1338	blebbistatin	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	-	0.00196612264175145	0.0314723684976152
1339	blebbistatin	hsa05320	Autoimmune thyroid disease	3135_3105_3106_649853	4	-	0.00431434697054704	0.0442220564481072
1340	blebbistatin	hsa04612	Antigen processing and presentation	3135_3105_3106_649853	4	-	0.0231918290356787	0.190172998092565
1341	blebbistatin	hsa05322	Systemic lupus erythematosus	8343_8339_8347_8346_8344	5	-	0.0300860821590016	0.205588228086511
1342	blebbistatin	hsa05330	Allograft rejection	3135_3105_3106_649853	4	-	0.00139770712818843	0.0314723684976152
1343	blebbistatin	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853	4	-	0.00230285623153282	0.0314723684976152
1344	natamycin	hsa04740	Olfactory transduction	1258	1	+	0.0224968487047365	0.551172793266044
1345	natamycin	hsa04360	Axon guidance	57556_2041_1944_64221_27289_10507_80031	7	+	0.00763585694888391	0.374156990495312
1346	natamycin	hsa04080	Neuroactive ligand-receptor interaction	5618_1081_1909	3	-	0.0102428486838247	0.218261575147664
1347	natamycin	hsa05131	Shigellosis	7280_347733_7278_113457_7430_2017_2534	7	-	0.0133086326309551	0.218261575147664
1348	natamycin	hsa05130	Pathogenic Escherichia coli infection	7280_347733_7278_113457_7430_2017_2534	7	-	0.0133086326309551	0.218261575147664
1349	natamycin	hsa04740	Olfactory transduction	409	1	-	2.44566445481421e-06	0.000200544485294765
1350	natamycin	hsa04060	Cytokine-cytokine receptor interaction	5618_3566_7042	3	-	0.0104386045897132	0.218261575147664
1351	natamycin	hsa04020	Calcium signaling pathway	11261_1909	2	-	0.0362729673190216	0.495730553359962
1352	natamycin	hsa04940	Type I diabetes mellitus	3135_3123_3106_3382_3119	5	-	0.0471205320998755	0.551983376027113
1353	saquinavir	hsa04070	Phosphatidylinositol signaling system	3633_3631_5331_5330_3708_3709_3707_27124_9162	9	+	0.0207539917217915	0.348667060926097
1354	saquinavir	hsa04910	Insulin signaling pathway	5256	1	+	0.0151734020647976	0.348667060926097
1355	saquinavir	hsa04740	Olfactory transduction	26212_5593	2	+	1.40249863367009e-06	0.000117809885228288
1356	saquinavir	hsa04514	Cell adhesion molecules (CAMs)	6402_3688_3119_3122_4099_3113_6383_6614_933_26285_25945_26047_5817	13	+	0.030700052203848	0.429800730853872
1357	saquinavir	hsa04540	Gap junction	2911_5593_7278_5155_113457_3709_5331_5330_3708_1956_153	11	+	0.0170443396032299	0.348667060926097
1358	saquinavir	hsa05012	Parkinson's disease	7416	1	+	0.0150806834482645	0.348667060926097
1359	saquinavir	hsa04130	SNARE interactions in vesicular transport	6809_8773_662_9570_10228_6843_9554	7	-	0.0225154484218523	0.283051351589
1360	saquinavir	hsa05010	Alzheimer's disease	4698_11261_5594_7385	4	-	0.0196480610346809	0.283051351589
1361	saquinavir	hsa04080	Neuroactive ligand-receptor interaction	5618_7442_7068_7067_2908_5026	6	-	0.004338048463098	0.0763496529505248
1362	saquinavir	hsa04740	Olfactory transduction	157	1	-	3.75766079805385e-10	3.30674150228739e-08
1363	saquinavir	hsa05322	Systemic lupus erythematosus	55766	1	-	0.00159068032315949	0.0466599561460117
1364	saquinavir	hsa04062	Chemokine signaling pathway	2309_6655_5594_157_9475	5	-	0.0258528621714856	0.284381483886342
1365	saquinavir	hsa04060	Cytokine-cytokine receptor interaction	5618_2057_3455_4982_7422_8795	6	-	0.00318276514266995	0.0700208331387389
1366	saquinavir	hsa04020	Calcium signaling pathway	11261_5026	2	-	0.000721660446963426	0.0317530596663907
1367	quercetin	hsa05332	Graft-versus-host disease	3119_3126_942_3127_3125_3135_355_3123_941	9	+	0.0380121030920112	0.288258448447752
1368	quercetin	hsa04120	Ubiquitin mediated proteolysis	26232_4214_4281_326_7337	5	+	0.0237944460728283	0.240588288069708
1369	quercetin	hsa04080	Neuroactive ligand-receptor interaction	5618_11255_1081_7068_7067_2908_2925_3363_5733_2696_23566_5645	12	+	0.0144466260406447	0.219107161616445
1370	quercetin	hsa05320	Autoimmune thyroid disease	3439_3449_1081_3119_942_3447_3126_3127_3125_3135_355_3123_941	13	+	0.00352997036993261	0.0642454607327735
1371	quercetin	hsa05016	Huntington's disease	5439_246721_548644_6648_23236	5	+	0.0010554691436988	0.0320158973588636
1372	quercetin	hsa04740	Olfactory transduction	4991_808_81797_390892_81696_801_393046_805	8	+	6.34568593612756e-08	5.77457420187608e-06
1373	quercetin	hsa05322	Systemic lupus erythematosus	8348_8329_3123_3126_3127_3125_8969_8968_8358_8330_8331_8336_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013_942_941_727	27	+	0.00208771572572693	0.0474955327602877
1374	quercetin	hsa05219	Bladder cancer	23604_4313_3576_1613_5925_7422_1869_2261_2064	9	+	0.0380121030920112	0.288258448447752
1375	quercetin	hsa05012	Parkinson's disease	6622	1	+	0.000147995171978534	0.0067337803250233
1376	quercetin	hsa04260	Cardiac muscle contraction	4635_6548	2	+	0.0322948469285634	0.288258448447752
1377	quercetin	hsa05330	Allograft rejection	3119_3126_942_3127_3125_3135_355_3123_941	9	+	0.0168933927814731	0.21961410615915
1378	quercetin	hsa04940	Type I diabetes mellitus	3382_3119_942_3126_3127_3125_3135_355_3123_941	10	+	0.0230368650364086	0.240588288069708
1379	quercetin	hsa04080	Neuroactive ligand-receptor interaction	2859_1813_2561_7068_6754_3362_4887_7067_799_2692_2690	11	-	0.0203469823154401	0.382580008858813
1380	quercetin	hsa04740	Olfactory transduction	818_5593_409	3	-	1.29115954696447e-10	1.12330880585909e-08
1381	quercetin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3017_940_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	21	-	0.0263848281971595	0.382580008858813
1382	quercetin	hsa04710	Circadian rhythm - mammal	406_8864_8863_9575	4	-	0.0383121291722489	0.476165033997951
1383	quercetin	hsa05012	Parkinson's disease	4714_51465_836_6622	4	-	0.0250158509362229	0.382580008858813
1384	quercetin	hsa04060	Cytokine-cytokine receptor interaction	3581_3553_1438_939_7422_7042_8795_2690	8	-	0.00119514545921394	0.0519888274758064
1385	quercetin	hsa04020	Calcium signaling pathway	5331_5257_3362_818_3709_490	6	-	0.0131528983886056	0.381434053269562
1386	fludrocortisone	hsa04916	Melanogenesis	7299_11211_8321_816	4	+	0.00212170373423183	0.0636511120269549
1387	fludrocortisone	hsa05332	Graft-versus-host disease	3812_3824_3119_3105_3106_3126_3127_3125_3135_3811_5551_3123_649853	13	+	0.0245576251191993	0.26268141775496
1388	fludrocortisone	hsa05010	Alzheimer's disease	2902_1339_3710_6392_317_6390_651820_3709_22926_4023_6622_517	12	+	0.00578260484521111	0.13010860901725
1389	fludrocortisone	hsa04310	Wnt signaling pathway	56998_8945_324_5599_4775_8312_4776_11211_5467_5602_8321_816	12	+	0.0336061445372512	0.274959364395692
1390	fludrocortisone	hsa05016	Huntington's disease	2902_6648_6392_317_6390_1339_651820_5468_517	9	+	0.000143963448025201	0.00647835516113404
1391	fludrocortisone	hsa04740	Olfactory transduction	219464_26211_5593_8390_26664_9635_4991_393046_816	9	+	5.37535367252022e-14	4.8378183052682e-12
1392	fludrocortisone	hsa05322	Systemic lupus erythematosus	3119_94239_3123_721_3126_3127_3125_727_720_8335_81	11	+	0.0291868241949955	0.26268141775496
1393	fludrocortisone	hsa04530	Tight junction	9076_4301_10000_50848_5588_6709_51208_4626_3996_81_9223	11	+	0.0474980347727588	0.305344509253449
1394	fludrocortisone	hsa04350	TGF-beta signaling pathway	91_7057_353500_4052	4	+	0.0112409388718425	0.184927503483006
1395	fludrocortisone	hsa04062	Chemokine signaling pathway	1234_4283_3717_1230_1233_5829_6655_3576_7454_3718_7852_10000_5906_23533_2793_8503_6376	17	+	0.0370504726821603	0.277878545116202
1396	fludrocortisone	hsa05012	Parkinson's disease	1339_7318_6392_651820_6390_317_7054_6622_517	9	+	0.0123285002322004	0.184927503483006
1397	fludrocortisone	hsa03050	Proteasome	23198	1	+	0.0170805818047532	0.219607480346827
1398	fludrocortisone	hsa05222	Small cell lung cancer	23533_8503_10000_598_3908_330_3673_3674_4149_3912_317_3918_1869_1284_1027_2335_3685_7189_5915_6257_7186_7187	22	+	0.0287071655569884	0.26268141775496
1399	fludrocortisone	hsa04940	Type I diabetes mellitus	3382_3119_3105_3106_3126_3127_2571_3135_5551_1363_3123_3125_649853	13	+	0.0435154560500061	0.301260849576965
1400	fludrocortisone	hsa04740	Olfactory transduction	1179	1	-	1.02509507430669e-07	8.81581763903753e-06
1401	fludrocortisone	hsa05322	Systemic lupus erythematosus	8363_8362_3013_3017_940_8355_8358_8968_720_721_8350_8351_8352_8353_8354_87_8356_8357	18	-	0.00118569246206569	0.0509847758688247
1402	milrinone	hsa05332	Graft-versus-host disease	3113_3126_3127_3123_3125	5	+	0.00350197591135074	0.039022542547861
1403	milrinone	hsa04640	Hematopoietic cell lineage	1436_2812_3123_3126_3127_3125_931_925	8	+	0.00110842030957872	0.0360236600613084
1404	milrinone	hsa05320	Autoimmune thyroid disease	3113_3126_3127_3123_3125	5	+	0.00861928840918619	0.0700317183246378
1405	milrinone	hsa04612	Antigen processing and presentation	3123_3126_3127_3125_925_3113	6	+	0.0178586693508648	0.128979278645135
1406	milrinone	hsa04740	Olfactory transduction	5137	1	+	0.00371544187378938	0.039022542547861
1407	milrinone	hsa04514	Cell adhesion molecules (CAMs)	6403_3123_3126_3127_3125_57863_6614_925_3113	9	+	0.00417377796353587	0.039022542547861
1408	milrinone	hsa05310	Asthma	3123_3126_3127_3113_3125	5	+	0.000916675680738481	0.0360236600613084
1409	milrinone	hsa05330	Allograft rejection	3126_3113_3127_3123_3125	5	+	0.00235862041048418	0.039022542547861
1410	milrinone	hsa04940	Type I diabetes mellitus	3113_3126_3127_3123_3125	5	+	0.00420242765900042	0.039022542547861
1411	milrinone	hsa04080	Neuroactive ligand-receptor interaction	64106_1081_1909	3	-	0.0106068223309544	0.39775583741079
1412	milrinone	hsa04740	Olfactory transduction	157_409	2	-	1.36308996451629e-05	0.00102231747338722
1413	milrinone	hsa05322	Systemic lupus erythematosus	3013_8358_6738_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	-	0.0399144160688463	0.748395301290868
1414	milrinone	hsa04060	Cytokine-cytokine receptor interaction	3566_4233_9180_3572	4	-	0.0277378680555103	0.693446701387758
1415	dexpropranolol	hsa04662	B cell receptor signaling pathway	933_23533_10000_11025	4	+	0.0230379468778312	0.67961943289602
1416	dexpropranolol	hsa04350	TGF-beta signaling pathway	1875_653_4086_7042	4	+	0.0361931085644046	0.711797801766624
1417	dexpropranolol	hsa04150	mTOR signaling pathway	23533_6794_10000_6196	4	+	0.00715977182507418	0.422426537679377
1418	dexpropranolol	hsa04080	Neuroactive ligand-receptor interaction	64106	1	-	0.0228648010655793	1
1419	sertaconazole	hsa04740	Olfactory transduction	56656	1	+	0.000793631690036713	0.0571414816826433
1420	sertaconazole	hsa04130	SNARE interactions in vesicular transport	6804_9570_8417_2054_8675	5	-	0.0150564794204345	1
1421	sertaconazole	hsa05200	Pathways in cancer	5154_6777_2737_7475_369	5	-	0.0462487685628102	1
1422	piperidolate	hsa04740	Olfactory transduction	26211	1	+	0.00354340548427472	0.24803838389923
1423	piperidolate	hsa04080	Neuroactive ligand-receptor interaction	64106_5618_7442_56288	4	-	0.0201158033596974	0.54312669071183
1424	piperidolate	hsa04740	Olfactory transduction	157	1	-	7.658562861984e-07	6.20343591820704e-05
1425	piperidolate	hsa05322	Systemic lupus erythematosus	85235_3123_3013_3126_3127_3125_8332_8969_8331_8336_8337_8351_8343_8329_8339_8347_8346_8330_8344	19	-	9.62245159898984e-05	0.00389709289759089
1426	clofibrate	hsa05010	Alzheimer's disease	2903_2902_22926_489_6622_4842	6	+	0.0233123667834774	0.524528252628241
1427	clofibrate	hsa05016	Huntington's disease	2902_246721_27113_5441_5439_548644	6	+	0.013141756899926	0.39425270699778
1428	clofibrate	hsa04740	Olfactory transduction	5566_8390_26716_818_815_409_817	7	+	4.58023318048865e-07	4.12220986243979e-05
1429	clofibrate	hsa04530	Tight junction	5010_93408_208_8573	4	+	0.0348382771291959	0.627088988325526
1430	clofibrate	hsa05012	Parkinson's disease	6622	1	+	0.000468857790786056	0.0210986005853725
1431	clofibrate	hsa05010	Alzheimer's disease	2902_1327_1329_351_8851_4843	6	-	0.031187204873256	0.918264108579534
1432	clofibrate	hsa04080	Neuroactive ligand-receptor interaction	2911_7442_2902_3360_2568_4886_3062_3350_9568_4543_1901	11	-	0.042709958538583	0.918264108579534
1433	clofibrate	hsa04740	Olfactory transduction	7932_157_8388_8387_5566_26476_815	7	-	9.57074734941692e-07	8.23084272049855e-05
1434	clofibrate	hsa05012	Parkinson's disease	2861_1329_7416_1327	4	-	0.0340516685390701	0.918264108579534
1435	indometacin	hsa04080	Neuroactive ligand-receptor interaction	2913_624_1133_4158_4829_4142_7434_3351_5644	9	+	0.0249694681343689	0.981516520645134
1436	indometacin	hsa04740	Olfactory transduction	5566_26189_808_5137_801_393046_805	7	+	7.62146159541228e-06	0.000624959850823807
1437	indometacin	hsa04740	Olfactory transduction	10798_815_8590	3	-	3.28327175220373e-12	2.95494457698336e-10
1438	indometacin	hsa03010	Ribosome	6125_140801_9349	3	-	0.0343714070475982	1
1439	ciclosporin	hsa04740	Olfactory transduction	26333_8390_5593_5568_157	5	+	1.52882571797727e-08	1.34536663182e-06
1440	ciclosporin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_2215_8370_8366_8348_8368_8367_554313_8359_89_8294_720_721_6738_121504_8364	20	+	0.0357238156067062	0.740994548661971
1441	ciclosporin	hsa05212	Pancreatic cancer	64764_7184	2	+	0.0464021714605216	0.740994548661971
1442	ciclosporin	hsa05012	Parkinson's disease	51465_6390_6622	3	+	0.00934262826227471	0.411075643540087
1443	ciclosporin	hsa05010	Alzheimer's disease	4695_1327_5534_6263_1329_317_4137_487_3709_5664_810_4712_6622_517_842	15	-	0.0382224381270382	0.496891695651497
1444	ciclosporin	hsa05016	Huntington's disease	5430_1211_4695_1327_4712_581_1329_317_246721_64446_23186_9001_5468_517_842	15	-	0.0149899238582277	0.311172551218172
1445	ciclosporin	hsa04740	Olfactory transduction	26211_7932_8388_8387_5613_5566_5616_23538_81697_2978_26532_81797_810_815	14	-	8.77038273328274e-11	7.98104828728729e-09
1446	ciclosporin	hsa05322	Systemic lupus erythematosus	2215_717_3013_942_720_721_8351_81	8	-	0.0031532019680718	0.143470689547267
1447	ciclosporin	hsa04110	Cell cycle	995_9134_699_4193_5934_8556_8555_7042_8900	9	-	0.0461991741367595	0.525515605805639
1448	ciclosporin	hsa05012	Parkinson's disease	4695_1327_4712_1329_317_6622_517_842	8	-	0.00560019793791726	0.16987267078349
1449	ciclosporin	hsa04260	Cardiac muscle contraction	6546_1329_10369_1327_782	5	-	0.0381444387700191	0.496891695651497
1450	ciclosporin	hsa03050	Proteasome	5717	1	-	0.0170973929240754	0.311172551218172
1451	LY-294002	hsa04916	Melanogenesis	4286_5579_5578_2775_1856_1857_5331_2535_6934_112_810_8324_23236_816_7306	15	+	0.0300754617527789	0.230578540104638
1452	LY-294002	hsa05010	Alzheimer's disease	2903_2902_1329_3553_842_841_54205_317_4137_5331_5532_3708_3709_6868_488_810_22926_7124_6622_517_23236	21	+	0.00025483090562507	0.00503698083226896
1453	LY-294002	hsa05016	Huntington's disease	2902_4899_1329_317_246721_5331_6875_1639_5439_7419_54205_7350_3708_9001_548644_23236_842_841_5441_5978_55567_517	22	+	0.000136209036481067	0.00417707711875272
1454	LY-294002	hsa04740	Olfactory transduction	26212_56656_23538_8390_1179_26539_5137_8392_810_393046_816	11	+	2.21961069342963e-26	2.04204183795526e-24
1455	LY-294002	hsa05322	Systemic lupus erythematosus	2903_8361_8363_8362_8365_8364_8367_8360_8368_8335_9103_6738_8349_8348_8329_8294_121504_8343_8341_8347_7124_8345_8344_959_8339_723790_3109_8366_87_8969_8968_8346_55766_8370_2212_92815_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_85236_3012_3013_3113_3017_940_8970	62	+	0.00123947942118167	0.0190053511247856
1456	LY-294002	hsa04110	Cell cycle	995_699_1021_4173_4088_51343_4193_1028_5925_1869_898_10393_10912_1870_8555_1032_5111_8556	18	+	0.0330097702454503	0.233607604813956
1457	LY-294002	hsa03410	Base excision repair	10039_27343_5111	3	+	0.0466882570041432	0.306808546027227
1458	LY-294002	hsa04340	Hedgehog signaling pathway	6608_2737_8945_5727_353500	5	+	0.0112876439435825	0.148351891829941
1459	LY-294002	hsa03030	DNA replication	5111_4173	2	+	0.0149936643368854	0.160787738202013
1460	LY-294002	hsa05110	Vibrio cholerae infection	3784_5579_5578_8992_535_4583	6	+	0.0205611764020709	0.189162822899052
1461	LY-294002	hsa04062	Chemokine signaling pathway	23533_10000_156_3718_5290_7852_56288_112_6359_2309_7454_3579_3551_3576_25759_4793_998_2931_2185_3702_6093_23236_5331_6352_5579_6655_6358_6773_6372_5879_8976_10803	32	+	0.0157292352588926	0.160787738202013
1462	LY-294002	hsa05012	Parkinson's disease	1329_842_5413_6622_54205_317_65018_7419_9627_517	10	+	6.95391325783647e-06	0.000319880009860478
1463	LY-294002	hsa04260	Cardiac muscle contraction	7168_7169_782_783_9254_1329_786_10368_4635_488_7170	11	+	0.0295979278315443	0.230578540104638
1464	LY-294002	hsa03050	Proteasome	5717	1	+	0.000273748958275487	0.00503698083226896
1465	LY-294002	hsa05010	Alzheimer's disease	55851_2597_1327_2905_2902_1329_317_5663_5330_51806_5664_489_6622_3553_4698_11261_4712_322_509_810_348_776_5534_5532_3708_3709_4035_56901_488_836_8851_5331_1020_841_840_642502_6391_4137_1537_355_808_805_351_824_801_517	46	-	0.00466166231817907	0.0486884731009814
1466	LY-294002	hsa04080	Neuroactive ligand-receptor interaction	2902_1269_1268_155_886_1081_64106_2908_2901_5030_5031_152_56288_136_135_134_887_6870_3354_2905_4161_1813_2561_5540_3362_4142_5029_57105_2742_2151_4987_7433_9568_4988_5646_7068_1909_2912_2917_5021_1132_5025_6915_146_10203_5724_6865_8001_9170_2550_5618_4157_2557_7067_4158_6751_2893_1241_2798_8484_2897_2690	62	-	0.000101531582237934	0.00238599218259145
1467	LY-294002	hsa04742	Taste transduction	2785_6340_5568_5613_5566_5616_5330_51764_346562	9	-	0.00799579987328252	0.0738966680871318
1468	LY-294002	hsa05131	Shigellosis	7280_7277_347733_7278_113457_9475_60_3688_7430_9181_6093_81873	12	-	0.043670875107931	0.255582663038722
1469	LY-294002	hsa05016	Huntington's disease	2902_4899_1327_8218_1329_317_246721_5331_5330_3064_10126_5432_6648_5434_7052_4698_2033_509_56901_7419_1213_1211_3708_9001_836_161_5481_163_27113_4712_841_642502_6391_1537_55567_1387_517	37	-	1.51213807414807e-05	0.000473803263233062
1470	LY-294002	hsa05130	Pathogenic Escherichia coli infection	7280_7277_347733_7278_113457_9475_60_3688_7430_9181_6093_81873	12	-	0.043670875107931	0.255582663038722
1471	LY-294002	hsa04740	Olfactory transduction	51806_7932_157_8388_8387_219464_26211_5568_26333_5566_818_810_409_8392_2978_109_5613_5616_808_4992_816_4991_801_393046_805	25	-	3.69020519820307e-32	3.46879288631089e-30
1472	LY-294002	hsa04710	Circadian rhythm - mammal	8864_5187_8553_1454_406_1408_9575_9572_4862_79365_1407_8863	12	-	0.0462223965070029	0.255582663038722
1473	LY-294002	hsa04530	Tight junction	5010_4619_50855_6709_5521_56288_81_9223_87_5584_6714_5583_5581_93408_2036_84612_51776_5865_50848_55844_8777_60_9080_5519_3265_4628_26285_4620_8189_5728_1364_1457_4624_27134_1365	35	-	0.0110787437671815	0.0801078395473124
1474	LY-294002	hsa04062	Chemokine signaling pathway	3717_3576_1147_157_156_5296_6464_5294_8503_113_9475_115_5330_6387_56288_6358_10235_6359_2785_3055_5568_6349_6348_5566_5196_728830_643_25759_7410_5906_1398_6362_6366_409_673_109_3265_6093_10681_107_4793_6356_5331_5613_6777_5616_6772_6773_51764_414062_5291_2793_5970	53	-	0.00864748243572819	0.0738966680871318
1475	LY-294002	hsa04810	Regulation of actin cytoskeleton	8503_10298_5296_2909_5155_5154_9475_5605_5881_23365_23396_3655_10458_4659_87_9459_81_3985_3690_1730_3693_1445_56924_93408_7410_50649_7430_324_1398_2245_2260_2261_28964_5294_2264_10152_2768_1793_1132_8396_673_1956_3265_2263_4628_6093_10788_10093_60_3688_2335_1729_8394_3678_54961_6548_5291_3984_10787_81873_2251_2250	62	-	0.00949555101702442	0.0743818163000246
1476	LY-294002	hsa05012	Parkinson's disease	2861_1327_1329_317_9246_7345_6531_6622_7327_836_4698_509_7419_51465_56901_5481_7332_4712_642502_6391_1537_517	22	-	8.79732024704943e-06	0.000413474051611323
1477	LY-294002	hsa04260	Cardiac muscle contraction	784_7168_776_1327_27092_1329_6548_1537_4624_488_482_781	12	-	0.000237008521542812	0.00360129627417837
1478	LY-294002	hsa04060	Cytokine-cytokine receptor interaction	944_3576_29949_3594_3441_55540_8744_5155_5154_8764_3439_6387_9180_1896_3572_3455_27242_3554_3553_3556_2057_2324_3575_6348_5196_3446_355_3558_657_939_655_8718_6362_6366_3581_3601_3606_3815_23529_3589_3624_1956_7040_7043_91_8792_4233_8995_3467_1437_5618_1435_3566_3460_3568_970_7292_6358_6359_6356_643_7424_7422_51330_3447_2690	66	-	0.000268181637438815	0.00360129627417837
1479	LY-294002	hsa03010	Ribosome	6187_440589_285053_6181_6168_140801_9349_6205_6125_6142_284393_439992_6203_6165_389342_6189_6139	17	-	0.000226587325748716	0.00360129627417837
1480	LY-294002	hsa03050	Proteasome	5717_10197_23198_5718	4	-	0.000314518728646556	0.00369559506159703
1481	LY-294002	hsa04730	Long-term depression	5519_2768_2781_2982_50487_2767_2775_673_5331_5330_3708_3709_8681_5320_3265_5605_100137049	17	-	0.0451959836879079	0.255582663038722
1482	genistein	hsa04916	Melanogenesis	2778_7306_5578_51384_2775_1857_108_434_2535_7474_23236	11	+	0.0332738989580118	0.252181088604797
1483	genistein	hsa05010	Alzheimer's disease	4714_836_1020_4701_5532_4698_4713_355_4137_51107_3708_3709_6868_351_5534_22926_4712_6622_23236	19	+	0.00516451595297152	0.0686142833751931
1484	genistein	hsa04080	Neuroactive ligand-receptor interaction	623_151_886_624_5030_56288_135_1909_9038_2568_3360_799_2742_4987_9568_5023_4889_1132_1131_4886_4887_3355_6915_3351_10203_3269_4543_23566_8001_2550_7068_2570_2692	33	+	0.0108397258071379	0.112010500007092
1485	genistein	hsa05016	Huntington's disease	4714_6648_4712_4701_581_7052_1639_4713_293_7350_3708_3066_4698_836_55567_163_10126_23236	18	+	0.000965989528138001	0.029945675372278
1486	genistein	hsa04740	Olfactory transduction	7932_8390_26716_2978_26532_409_4991_5137_8590_1258	10	+	3.54274113367216e-20	3.29474925431511e-18
1487	genistein	hsa04510	Focal adhesion	5170_22798_394_5154_9475_5058_5602_3673_87_3693_7057_93408_1399_5293_1293_55742_1291_5295_208_3909_3725_1284_2335_5578_5599_6655_7422_6696	28	+	0.0425435005626491	0.252181088604797
1488	genistein	hsa04110	Cell cycle	995_5591_5001_5000_993_9134_699_4193_5934_10912_3066_1871_1869_4616	14	+	0.0479015029077483	0.252181088604797
1489	genistein	hsa05216	Thyroid cancer	5979	1	+	0.0488143971830937	0.252181088604797
1490	genistein	hsa04720	Long-term potentiation	5578_5532_3708_3709_5534_27330_23236	7	+	0.0388551639062543	0.252181088604797
1491	genistein	hsa04062	Chemokine signaling pathway	3717_5295_3551_108_208_6655_3576_3718_6772_9475_51764_5293_56288_8976_1399_10663_6370_5058_6387_409_23236	21	+	0.00416931164987711	0.0646243305730952
1492	genistein	hsa05012	Parkinson's disease	4714_836_4712_4701_5413_4698_4713_6622_293	9	+	0.000198466954120671	0.0092287133666112
1493	genistein	hsa04260	Cardiac muscle contraction	9254_27092_482_4635_4634	5	+	0.00252034694014968	0.0468784530867841
1494	genistein	hsa04060	Cytokine-cytokine receptor interaction	8744_5154_6387_3452_3556_53832_2057_3576_657_10663_8718_3587_658_3581_3601_3605_3604_3976_3624_8200_3626_8792_8794_4352_3566_3454_11009_355_7422_6370	30	+	0.00151864327238035	0.0353084560828431
1495	genistein	hsa03010	Ribosome	440589_6205_6187_6168_284393_6181_6144_6160_389342	9	+	0.0105377817340376	0.112010500007092
1496	genistein	hsa03020	RNA polymerase	661	1	+	0.0488143971830937	0.252181088604797
1497	genistein	hsa03050	Proteasome	5717_5689	2	+	0.0123262480942031	0.114634107276089
1498	genistein	hsa05010	Alzheimer's disease	2902_2905_317_5663_487_6622_3553_11261_779_3709_4035_489_102_7124_5595_5594_841_642502_6391_355_808_805_801_517	24	-	0.00846514265559277	0.123279205416217
1499	genistein	hsa05016	Huntington's disease	2902_5430_5439_627_841_581_7157_1639_8218_6391_317_6667_1213_27113_642502_1385_548644_7419_161_517_246721	21	-	0.000493345665425987	0.0154581641833476
1500	genistein	hsa04740	Olfactory transduction	808_26211_5593_4993_26333_5566_1179_393046_818_2979_10798_8590_23538_805_801_219464_815_816_817	19	-	8.36041335620929e-18	7.85878855483673e-16
1501	genistein	hsa03410	Base excision repair	3980_27301	2	-	0.0356055199977968	0.371879875532544
1502	genistein	hsa04062	Chemokine signaling pathway	8503_3576_10000_156_2771_9475_10235_7454_3055_4067_3551_5829_5566_5196_1398_408_1233_208_2931_6352_10681_4793_5595_5594_6772_673_8976	27	-	0.00918036636078209	0.123279205416217
1503	genistein	hsa05012	Parkinson's disease	2861_6570_7327_642502_6391_317_6531_7419_6622_517	10	-	4.51817123429794e-05	0.00212354048012003
1504	genistein	hsa04260	Cardiac muscle contraction	6546_782_779_6548_10369_7170_4635_27092_7171	9	-	0.0227648707288643	0.267487231064156
1505	genistein	hsa03010	Ribosome	6204_440589_6181_6205_6187_6168_284393_439992_6144_389342_6189	11	-	0.00809237619278545	0.123279205416217
1506	genistein	hsa03050	Proteasome	5690	1	-	0.000740982719436627	0.0174130939067607
1507	thalidomide	hsa05010	Alzheimer's disease	1020_2905_642502_6391_317_4137_322_5534	8	+	0.00630457686836589	0.178204454616361
1508	thalidomide	hsa05200	Pathways in cancer	8312_598_10297_7482_5155_3909_5605_5880_5747_26291_652671_2308_4286_3576_5371_1857_5925_5900_2249_675_2263_284217_3082_3910_3480_1612_998_5293_6932_1956_2322_5467_7042_1869_3918_1436_1284_3688_2271_5578_861_7184_4914_1282_867_8817_51588_5915_2254_6257_2250	51	+	0.0374607357721699	0.505404580531897
1509	thalidomide	hsa05320	Autoimmune thyroid disease	3107	1	+	0.0397509220643065	0.505404580531897
1510	thalidomide	hsa05016	Huntington's disease	5432_246721_1211_7052_642502_6391_317_55567_293	9	+	0.00800918897152186	0.178204454616361
1511	thalidomide	hsa04740	Olfactory transduction	7932_3000_5566_26716_26532_4992_409_4991_5137_5568_26529_23538_2979_817	14	+	1.02353666497075e-06	9.10947631823967e-05
1512	thalidomide	hsa04540	Gap junction	2911_7280_7082_5568_1813_347733_5598_5566_5578_5155_5605_5607_1956_2767_113_112_10746_1902	18	+	0.0380378649992668	0.505404580531897
1513	thalidomide	hsa05012	Parkinson's disease	642502_6391_317_293	4	+	0.00255068133448419	0.113505319384546
1514	thalidomide	hsa04120	Ubiquitin mediated proteolysis	7337_8945_23759_331_22888_8554_6921	7	-	0.00457177823575856	0.138677273151343
1515	thalidomide	hsa05010	Alzheimer's disease	2902_842_351_317_5530_56901_5664_810_824_7124_6622_1020	12	-	0.0129135921300953	0.293784220959668
1516	thalidomide	hsa05016	Huntington's disease	2902_246721_1211_6648_842_1639_5439_317_6667_1175_7350_10540_56901_548644	14	-	0.0218243732070668	0.397203592368616
1517	thalidomide	hsa04740	Olfactory transduction	219464_26211_1179_393046_10798_4993_810_815_816	9	-	9.26759710094454e-13	8.43351336185953e-11
1518	thalidomide	hsa05012	Parkinson's disease	6622_6570_317_842_56901	5	-	0.000626876669058752	0.0285228884421732
1519	prednisolone	hsa04080	Neuroactive ligand-receptor interaction	5618_4158_6915_10203_4987_9568_9038	7	+	0.00740978601999336	0.301089641973364
1520	prednisolone	hsa04740	Olfactory transduction	8387_815_8388	3	+	2.35731158277624e-08	1.95656861370428e-06
1521	prednisolone	hsa04810	Regulation of actin cytoskeleton	8396_3696_8817_10787_2263_6093	6	+	0.0135154772032832	0.301089641973364
1522	prednisolone	hsa03010	Ribosome	140801	1	+	0.0145103441914874	0.301089641973364
1523	prednisolone	hsa05214	Glioma	1021_208_4193_673_5925_1956_5335_1869_7039_801_808_805	12	-	0.0113622195988725	0.329504368367303
1524	prednisolone	hsa04070	Phosphatidylinositol signaling system	3710_3636_56623_8396_5305_3707_8394_808_5335_801_8526_805	12	-	0.0333937863311188	0.418007612198815
1525	prednisolone	hsa04740	Olfactory transduction	26211_5593_5613_5566_808_4993_801_805	8	-	5.75849887297571e-06	0.000500989401948887
1526	prednisolone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8347_8346_8344_8370_8359_554313_6738_121504_8339_942_720_721	23	-	0.00214838917864267	0.0934549292709562
1527	prednisolone	hsa05223	Non-small cell lung cancer	1021_842_208_5915_673_5925_1956_5335_1869_7039	10	-	0.0232938925087682	0.405313729652567
1528	prednisolone	hsa05012	Parkinson's disease	6570_842_56901	3	-	0.0186783942956424	0.405313729652567
1529	prednisolone	hsa03010	Ribosome	6204_6181	2	-	0.0336327963838127	0.418007612198815
1530	MK-886	hsa05332	Graft-versus-host disease	3811_3553_3122_3804_3126_3127_3125_3135_3123_942	10	+	0.000196081472070417	0.00843150329902793
1531	MK-886	hsa04640	Hematopoietic cell lineage	3553_3122_3123_3568_3126_3127_3125_3575_921_931	10	+	0.0285955075641561	0.351316235788204
1532	MK-886	hsa05010	Alzheimer's disease	3553_5594_4842	3	+	0.0363300517539503	0.390548056354966
1533	MK-886	hsa05320	Autoimmune thyroid disease	3122_3126_942_3127_3125_3135_3123	7	+	0.0279816600337329	0.351316235788204
1534	MK-886	hsa04740	Olfactory transduction	815	1	+	6.87015548837825e-08	5.90833372000529e-06
1535	MK-886	hsa05310	Asthma	3122_3123_3126_3127_3125	5	+	0.0277589522298356	0.351316235788204
1536	MK-886	hsa05330	Allograft rejection	3122_3126_942_3127_3125_3135_3123	7	+	0.00618952946528242	0.133074883503572
1537	MK-886	hsa05210	Colorectal cancer	1630_5594_581_5599_5900_1857_4437_91_5879	9	+	0.0490461872080459	0.468663566654661
1538	MK-886	hsa04940	Type I diabetes mellitus	3553_3122_942_3126_3127_3125_3135_1363_3123	9	+	0.00105291001351666	0.0301834203874776
1539	MK-886	hsa03320	PPAR signaling pathway	2710_51703_6257_1579_4023_1376_5468_284541	8	-	0.0250845816497114	1
1540	MK-886	hsa04740	Olfactory transduction	26211_8388_8387_810_815_409	6	-	0.00177978727694807	0.142382982155846
1541	SR-95531	hsa05332	Graft-versus-host disease	3804_3107_3126_3127_3111_3125_3123_942	8	+	0.00472235795547003	0.0640513462294758
1542	SR-95531	hsa04640	Hematopoietic cell lineage	2323_1435_2812_3123_2993_3126_3127_3125_3570_933_1378_931_926	13	+	0.00254070178320179	0.0470633945347187
1543	SR-95531	hsa05320	Autoimmune thyroid disease	3448_1081_942_3107_3126_3127_3111_3125_3123	9	+	0.00544468955020763	0.0640513462294758
1544	SR-95531	hsa04612	Antigen processing and presentation	3448_3123_3107_3126_3127_3111_3125_6891_3804_926	10	+	0.043077674519787	0.366160233418189
1545	SR-95531	hsa04740	Olfactory transduction	4992_26529_8383_816	4	+	9.0241707672673e-06	0.00076705451521772
1546	SR-95531	hsa05322	Systemic lupus erythematosus	942_3123_3013_3126_3127_3111_3125_8358_6738_8968_8341_8350_8351_8352_8353_8354_8355_8356_8357	19	+	0.00125163536899097	0.0417145074696403
1547	SR-95531	hsa05218	Melanoma	5159_8817_1021_2250_3479_5293_8822_4193_2246_2247_4233_3082	12	+	0.0014722767342226	0.0417145074696403
1548	SR-95531	hsa05310	Asthma	3123_3126_3127_3111_3125	5	+	0.0372130741247341	0.351456811178044
1549	SR-95531	hsa05330	Allograft rejection	3593_942_3107_3126_3127_3111_3125_3123	8	+	0.00276843497263051	0.0470633945347187
1550	SR-95531	hsa04940	Type I diabetes mellitus	3593_3126_3107_942_3127_3111_3125_3123	8	+	0.00602836199806831	0.0640513462294758
1551	SR-95531	hsa04080	Neuroactive ligand-receptor interaction	1131_7442_5025_136	4	-	7.36206020693446e-11	3.4601682972592e-09
1552	SR-95531	hsa04742	Taste transduction	5613_3710	2	-	0.0412518100717314	0.352515467885705
1553	SR-95531	hsa04740	Olfactory transduction	5613_818_808_409_801_805	6	-	6.80326215428348e-16	6.39506642502647e-14
1554	SR-95531	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8343_8347_8346_8344_8339_3123_3126_3127_3125_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_85236_3013_9555	44	-	3.08471562095641e-05	0.000724908170924756
1555	SR-95531	hsa04110	Cell cycle	699_4089_23595_651610_4616_51343_51433_7534_1017_7531_7533_9978_902_5001_996_4193_10393_7027_8555_5591_4176_4172_4173_6502_1022_472_8317_5933_8556	29	-	0.0122518295735627	0.164524568559271
1556	SR-95531	hsa04512	ECM-receptor interaction	3691_960_7057_3912	4	-	0.0220802725593394	0.259443202572238
1557	SR-95531	hsa04260	Cardiac muscle contraction	7168_7381_7385	3	-	0.00792157884238403	0.14892568223682
1558	SR-95531	hsa04060	Cytokine-cytokine receptor interaction	3597_2057_3588_3459_5154_8741_3572_1956_90_51330	10	-	6.10096974690914e-07	1.91163718736486e-05
1559	SR-95531	hsa04020	Calcium signaling pathway	115_3710_5613_1131_5025_3709_808_818_1956_7416_136_801_7419_805_5257	15	-	0.0303843268325538	0.317347413584451
1560	SR-95531	hsa02010	ABC transporters	20	1	-	0.0383999702033481	0.352515467885705
1561	SR-95531	hsa04610	Complement and coagulation cascades	966_5329	2	-	0.0102985163789599	0.161343423270372
1562	cyanocobalamin	hsa04740	Olfactory transduction	816	1	+	0.0076376264228825	0.21385353984071
1563	cyanocobalamin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	2.68236688012278e-06	0.000150212545286876
1564	cyanocobalamin	hsa04740	Olfactory transduction	818_157_816	3	-	0.00140018820391768	0.052507057646913
1565	cyanocobalamin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_6737_8359_8294_8367_554313_121504	15	-	0.000313208658448774	0.0234906493836581
1566	metrizamide	hsa04740	Olfactory transduction	26664	1	+	8.07186853320966e-05	0.00613462008523934
1567	metrizamide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	0.000428688058629446	0.0162901462279189
1568	metrizamide	hsa04070	Phosphatidylinositol signaling system	5331_5296_5333_8394_51763	5	-	0.0449966426598141	0.532899808525609
1569	metrizamide	hsa04740	Olfactory transduction	157	1	-	0.00177904229185186	0.135207214180741
1570	metrizamide	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_6738_8336	8	-	0.0300684557528225	0.532899808525609
1571	metrizamide	hsa04710	Circadian rhythm - mammal	79365_1408	2	-	0.0490828771010429	0.532899808525609
1572	metrizamide	hsa04210	Apoptosis	3553_5296_472_51135_8837_651610	6	-	0.0265955714006995	0.532899808525609
1573	metrizamide	hsa04150	mTOR signaling pathway	5296_6196_5170_7422	4	-	0.0450683359551042	0.532899808525609
1574	metrizamide	hsa03020	RNA polymerase	5432_246721_5439_548644	4	-	0.00767867536494328	0.291789663867845
1575	lumicolchicine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0363396115899527	1
1576	apigenin	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	1.1659364407439e-06	5.01352669519877e-05
1577	apigenin	hsa05219	Bladder cancer	1026_1612_4193	3	+	0.0137128735023958	0.196551186867673
1578	apigenin	hsa04115	p53 signaling pathway	64393_55367_1026_4193_7249	5	+	0.00139063415704228	0.029898634376409
1579	apigenin	hsa04640	Hematopoietic cell lineage	3554_3566_2057_4254_1604_3678	6	-	0.00246702633098743	0.020132603675824
1580	apigenin	hsa05010	Alzheimer's disease	5533_776_836_842_840_2932_5530_5663_102_5532_3709_351_5534_5332_8851_7132_23236	17	-	0.00058350652396539	0.00649151007911496
1581	apigenin	hsa04080	Neuroactive ligand-receptor interaction	5618_2561_2908_5025_4886_5031_3354_2150_136_7433_2690_2149_9170	13	-	2.50037277196114e-10	1.11266588352271e-08
1582	apigenin	hsa04742	Taste transduction	2778_5567	2	-	0.00248829933071982	0.020132603675824
1583	apigenin	hsa04612	Antigen processing and presentation	4801_2923_6891_3306_1385_3304_3305_3303	8	-	0.0109785762868044	0.0644454063227756
1584	apigenin	hsa05016	Huntington's disease	23236_1387_836_842_581_5439_5430_246721_5978_2033_5332_1385_548644_5481_291	15	-	3.67381110532894e-05	0.000653938376748551
1585	apigenin	hsa04740	Olfactory transduction	818_5567_157	3	-	5.83262506398221e-29	5.19103630694417e-27
1586	apigenin	hsa04514	Cell adhesion molecules (CAMs)	9076_965_214_4685_9080_57863_6383_6693_26047_5817	10	-	0.000255556756671533	0.00324922162053806
1587	apigenin	hsa04920	Adipocytokine signaling pathway	2181_7132_6257_1147	4	-	0.00460670523441338	0.0341663971552326
1588	apigenin	hsa04512	ECM-receptor interaction	3912_961_7057_3678_6383_3339_3161	7	-	0.00864086096840896	0.0549311875848855
1589	apigenin	hsa05012	Parkinson's disease	2861_7326_836_842_51465_5481_291	7	-	7.40177140848431e-06	0.000164689413838776
1590	apigenin	hsa04260	Cardiac muscle contraction	784_776_7171_481_6548	5	-	0.00174741303440365	0.0172799733402139
1591	apigenin	hsa04060	Cytokine-cytokine receptor interaction	5154_8741_6387_7132_3556_27242_3554_3454_3455_3572_657_4982_8718_3601_4254_8742_1956_7042_91_8792_92_4233_5618_3566_2057_7424_7422_51330_2690	29	-	0.000244045922287411	0.00324922162053806
1592	apigenin	hsa03010	Ribosome	6125	1	-	7.15474709262777e-08	2.12257497081291e-06
1593	apigenin	hsa03050	Proteasome	9491_23198	2	-	0.00808663623625701	0.0549311875848855
1594	apigenin	hsa05210	Colorectal cancer	8503_8312_4087_4088_4089_5295_5290_4437_4436_8324_7976_8321_8322_836_1856_324_581_3480_2932_673_1956_6934_7042_91_3725_2956_4233_842_6655_3845_2535	31	-	0.0133955391456522	0.0701295872919439
1595	apigenin	hsa04940	Type I diabetes mellitus	1363_2571	2	-	0.0115856910243192	0.0644454063227756
1596	dl-alpha tocopherol	hsa04210	Apoptosis	5613_5575_5616	3	+	0.0353843286380251	0.219415218080338
1597	dl-alpha tocopherol	hsa04340	Hedgehog signaling pathway	5613_5616_653	3	+	0.0115122906698037	0.157998911262238
1598	dl-alpha tocopherol	hsa04010	MAPK signaling pathway	9064_5598_5616_8912_4763_5613	6	+	0.0219701304920012	0.171367017837609
1599	dl-alpha tocopherol	hsa04540	Gap junction	5598_5616_5613	3	+	0.0393822186298043	0.219415218080338
1600	dl-alpha tocopherol	hsa04020	Calcium signaling pathway	8912_5613_4638_5616_489	5	+	0.0162050165397167	0.157998911262238
1601	dl-alpha tocopherol	hsa04912	GnRH signaling pathway	5598_5616_5613_5338	4	+	0.0114640438267695	0.157998911262238
1602	dl-alpha tocopherol	hsa04270	Vascular smooth muscle contraction	5613_4638_5616_5581	4	+	0.0152921759457662	0.157998911262238
1603	dl-alpha tocopherol	hsa04070	Phosphatidylinositol signaling system	8871_5728_5333_3709_3708_8821_4952_3707	8	-	0.0156292959704298	0.208390612939064
1604	dl-alpha tocopherol	hsa04080	Neuroactive ligand-receptor interaction	5618_4886	2	-	0.00469421518058584	0.125179071482289
1605	dl-alpha tocopherol	hsa05200	Pathways in cancer	5728_836_4149_841_581_898_5602_4193_6772_1613_355_1956_2271_8324_91_3655_4254_1017_4233_7475_7422	21	-	0.047767282823235	0.474486254462427
1606	dl-alpha tocopherol	hsa04740	Olfactory transduction	5566	1	-	5.37516544324812e-06	0.00043001323545985
1607	dl-alpha tocopherol	hsa04210	Apoptosis	836_3552_841_581_5566_472_355_651610_8795	9	-	0.0133353532053534	0.208390612939064
1608	dl-alpha tocopherol	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_28964_1956_5603_5602_102_1432_4233	8	-	0.0110369158881142	0.208390612939064
1609	dl-alpha tocopherol	hsa04115	p53 signaling pathway	55367_5728_1017_836_841_581_898_4194_4193_472_355_651610_8795	13	-	1.39244079037515e-05	0.00055697631615006
1610	dl-alpha tocopherol	hsa04912	GnRH signaling pathway	1432_5566_3709_2002_3708_1956_5603_5602_81579	9	-	0.0468660586451019	0.474486254462427
1611	convolamine	hsa05211	Renal cell carcinoma	112399_6655_998_7422_1399_5781	6	+	0.0135592358162024	0.298303187956453
1612	convolamine	hsa04740	Olfactory transduction	26212_9635	2	+	0.00461160868747326	0.152183086686618
1613	convolamine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3108_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013	27	+	1.40355634293858e-14	9.26347186339463e-13
1614	convolamine	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0456324494739526	0.752935416320218
1615	convolamine	hsa05014	Amyotrophic lateral sclerosis (ALS)	5606_5600_5534	3	-	0.0268418898586403	0.881506226985325
1616	cinchonidine	hsa05211	Renal cell carcinoma	405_7422_4233_5781_998	5	+	0.0385198480909035	0.953907779210348
1617	cinchonidine	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_998_5781_1432_4233_23545	6	+	0.0107096246069949	0.717544848668658
1618	cinchonidine	hsa04662	B cell receptor signaling pathway	5296_933_27071_8519	4	-	0.0331195891243053	0.640312056403236
1619	cinchonidine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_8359_8294_8367_554313_121504	15	-	1.92535735550526e-08	1.11670726619305e-06
1620	cinchonidine	hsa05218	Melanoma	1869_5296_2260_4286	4	-	0.028067817486794	0.640312056403236
1621	cinchonidine	hsa05222	Small cell lung cancer	1869_598_5296_2335	4	-	0.0495880093222256	0.719026135172271
1622	acepromazine	hsa04640	Hematopoietic cell lineage	915_1378_3568_2993_3589	5	+	0.0125294880803543	0.226471139940915
1623	acepromazine	hsa05014	Amyotrophic lateral sclerosis (ALS)	10452_5534_1432_581	4	+	0.0125817299967175	0.226471139940915
1624	acepromazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_718_8368_8366_8359_8294_8367_554313_121504	15	+	1.48294095956821e-08	8.00788118166833e-07
1625	acepromazine	hsa05332	Graft-versus-host disease	3135_3105_3106_3119_649853	5	-	0.0270797268022146	0.41285722560937
1626	acepromazine	hsa04080	Neuroactive ligand-receptor interaction	64106	1	-	0.0011580126140762	0.0451624919489718
1627	acepromazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8348_8294_8367_554313_121504_3119	16	-	0.000229269521454078	0.0178830226734181
1628	acepromazine	hsa03020	RNA polymerase	246721_5439_548644_84172	4	-	0.030558707271677	0.41285722560937
1629	acepromazine	hsa05330	Allograft rejection	3135_3105_3106_3119_649853	5	-	0.01910108263539	0.41285722560937
1630	acepromazine	hsa04940	Type I diabetes mellitus	3135_3105_3106_3119_649853	5	-	0.0317582481237977	0.41285722560937
1631	berberine	hsa04740	Olfactory transduction	2978	1	+	0.00517240453328015	0.170689349598245
1632	berberine	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	0.000335008455707316	0.0221105580766829
1633	berberine	hsa04916	Melanogenesis	5331_5578_2776_115_109_6934_7477	7	-	0.0484020940545352	0.552108717759592
1634	berberine	hsa04080	Neuroactive ligand-receptor interaction	64106	1	-	0.00785381073135467	0.270956470231736
1635	berberine	hsa04740	Olfactory transduction	109	1	-	0.000178996066782675	0.0123507286080046
1636	berberine	hsa04540	Gap junction	5331_5578_7278_113457_2776_115_109	7	-	0.0299514285951862	0.552108717759592
1637	hydroquinine	hsa05214	Glioma	5605_10000_4193_816	4	+	0.0209728852486814	0.250674271837379
1638	hydroquinine	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_842_836_5868_581	5	+	0.00232221331299478	0.0777941459853251
1639	hydroquinine	hsa04210	Apoptosis	836_5566_10000_842_581	5	+	0.0143668257884237	0.250674271837379
1640	hydroquinine	hsa04664	Fc epsilon RI signaling pathway	5605_1432_10000_2205	4	+	0.0379179655611649	0.250674271837379
1641	hydroquinine	hsa04370	VEGF signaling pathway	5605_1432_10000_842	4	+	0.035130517085606	0.250674271837379
1642	hydroquinine	hsa05219	Bladder cancer	5605_2261_4193	3	+	0.0310195261798149	0.250674271837379
1643	hydroquinine	hsa05218	Melanoma	5605_2247_10000_4193	4	+	0.0275063546816006	0.250674271837379
1644	hydroquinine	hsa04115	p53 signaling pathway	842_836_4193_581	4	+	0.0252087330056911	0.250674271837379
1645	hydroquinine	hsa04010	MAPK signaling pathway	3305_1432_836_5566_5605_4763_51776_2261_10000_2247_23162_5536	12	+	0.00138179061294302	0.0777941459853251
1646	hydroquinine	hsa04912	GnRH signaling pathway	5605_5566_1432_816_112	5	+	0.0292518349828937	0.250674271837379
1647	hydroquinine	hsa05210	Colorectal cancer	836_10000_842_581	4	+	0.045427923983365	0.250674271837379
1648	hydroquinine	hsa04740	Olfactory transduction	109	1	-	0.0221646098749858	0.354633757999773
1649	hydroquinine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_85235_8364_8370_8366_8368_8365_8330_8332_8359_8969_8331_8329_8336_8367_554313_121504_8294	21	-	1.47628370041054e-13	7.08616176197059e-12
1650	hydroquinine	hsa04540	Gap junction	7278_112_113457_109_5154	5	-	0.020528015567313	0.354633757999773
1651	physostigmine	hsa05322	Systemic lupus erythematosus	85235_8969_8332_8330_8331_8329_8336	7	+	0.00469434322987435	0.21593978857422
1652	physostigmine	hsa04350	TGF-beta signaling pathway	3400_4090_83729_3624	4	+	0.0361931085644046	0.832441496981306
1653	physostigmine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_3020_8359_3021_8367_554313_121504_9555_8294	18	-	3.01533128150827e-08	1.92981202016529e-06
1654	hydrocotarnine	hsa04640	Hematopoietic cell lineage	3690_3581_924	3	+	0.0488228911898949	0.866197651252266
1655	hydrocotarnine	hsa04662	B cell receptor signaling pathway	8503_4067_6655_7409_5534_3725	6	-	0.0430515721877322	0.828742764613845
1656	hydrocotarnine	hsa04740	Olfactory transduction	818	1	-	8.14787051303021e-05	0.00627386029503326
1657	hydrocotarnine	hsa04060	Cytokine-cytokine receptor interaction	9180_3455	2	-	0.0187635844533333	0.502713967579963
1658	hydrocotarnine	hsa03020	RNA polymerase	246721_5439_548644_10622	4	-	0.0195862584771414	0.502713967579963
1659	pseudopelletierine	hsa05332	Graft-versus-host disease	3126_3108_3127_3123_3125	5	+	0.000435174684811538	0.00793872053694156
1660	pseudopelletierine	hsa04640	Hematopoietic cell lineage	3123_3126_3127_3125	4	+	0.0361931085644046	0.241287390429364
1661	pseudopelletierine	hsa05320	Autoimmune thyroid disease	3126_3108_3127_3123_3125	5	+	0.00115245538660453	0.0138294646392544
1662	pseudopelletierine	hsa04612	Antigen processing and presentation	3123_3108_3126_3127_3125	5	+	0.00933430562124095	0.080008333896351
1663	pseudopelletierine	hsa04514	Cell adhesion molecules (CAMs)	24146_965_3108_3123_3126_3127_3125	7	+	0.00321923647305307	0.0321923647305307
1664	pseudopelletierine	hsa04115	p53 signaling pathway	8795_54205_27113_3486	4	+	0.0177631921026057	0.133223940769543
1665	pseudopelletierine	hsa05310	Asthma	3123_3125_3108_3127_3126	5	+	0.000105069964695379	0.00630419788172274
1666	pseudopelletierine	hsa05330	Allograft rejection	3126_3108_3127_3123_3125	5	+	0.000285336429790278	0.00793872053694156
1667	pseudopelletierine	hsa04940	Type I diabetes mellitus	3126_3108_3127_3123_3125	5	+	0.000529248035796104	0.00793872053694156
1668	pseudopelletierine	hsa04070	Phosphatidylinositol signaling system	64768_5578_8394_5295_3633_3709_51763_5336_23236	9	-	0.0386953804740182	0.336953265308008
1669	pseudopelletierine	hsa04080	Neuroactive ligand-receptor interaction	64106_5618_2150_7068	4	-	0.00569246647978722	0.144209150821276
1670	pseudopelletierine	hsa05131	Shigellosis	9076_5578_999_998_9475_60_2534	7	-	0.0378031671985338	0.336953265308008
1671	pseudopelletierine	hsa05130	Pathogenic Escherichia coli infection	9076_5578_999_998_9475_60_2534	7	-	0.0378031671985338	0.336953265308008
1672	pseudopelletierine	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_842_596_598_11261_5606_5868	7	-	0.0378031671985338	0.336953265308008
1673	pseudopelletierine	hsa04740	Olfactory transduction	219464	1	-	7.17201105417139e-08	5.45072840117026e-06
1674	pseudopelletierine	hsa05322	Systemic lupus erythematosus	3014	1	-	0.0108925729633938	0.206958886304482
1675	pseudopelletierine	hsa04210	Apoptosis	842_3551_596_598_11261_5295_331_8795_841_8717_8837_5576_5575	13	-	0.00172879829462365	0.0656943351956987
1676	pseudopelletierine	hsa04370	VEGF signaling pathway	9261_1432_842_5578_11261_5295_998_7422_5336	9	-	0.039902360365422	0.336953265308008
1677	pseudopelletierine	hsa05110	Vibrio cholerae infection	5578_375_5336_60_523_528_55176	7	-	0.0468787460830077	0.356278470230858
1678	lobeline	hsa05332	Graft-versus-host disease	3812_3113_3119	3	+	0.0205997025835892	0.346917885610951
1679	lobeline	hsa04612	Antigen processing and presentation	3812_3305_3113_3119	4	+	0.0330331947788169	0.346917885610951
1680	lobeline	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_1432_842	3	+	0.0414230311177255	0.346917885610951
1681	lobeline	hsa04360	Axon guidance	2047_57715_4233_10505_9475	5	+	0.0323530434071602	0.346917885610951
1682	lobeline	hsa05218	Melanoma	5296_2247_4233_3479	4	+	0.0164179139287265	0.346917885610951
1683	lobeline	hsa04350	TGF-beta signaling pathway	654_6667_10468_9475	4	+	0.0308371345107995	0.346917885610951
1684	lobeline	hsa04540	Gap junction	2983_5607_1813_23236	4	+	0.0376938992552248	0.346917885610951
1685	lobeline	hsa05210	Colorectal cancer	5296_11211_4233_842	4	+	0.0277098256900189	0.346917885610951
1686	lobeline	hsa04080	Neuroactive ligand-receptor interaction	706_4886	2	-	1.48010593587561e-08	6.73448200823403e-07
1687	lobeline	hsa04520	Adherens junction	7454_10458_5595_5594_4088_4233_2064_1457_8936_7082_5819_1500_1387_6934_7525_2260_81_3643_2534	19	-	0.00130683400034158	0.0396406313436946
1688	lobeline	hsa04740	Olfactory transduction	818_5566_157	3	-	9.42854874400524e-13	8.57997935704477e-11
1689	lobeline	hsa05012	Parkinson's disease	27429_7327_7332_4701_4713	5	-	0.0174188641748769	0.2641861066523
1690	lobeline	hsa04260	Cardiac muscle contraction	481	1	-	0.00633532430024825	0.115302902264518
1691	lobeline	hsa04060	Cytokine-cytokine receptor interaction	3556_3601_3554_3566_3588_3459_7852_50616_9180_7042_655_4233	12	-	0.00517681746540142	0.115302902264518
1692	lobeline	hsa04020	Calcium signaling pathway	115_5578_5566_818_5532_3709_489_2064_56848	9	-	0.0306067640856479	0.397887933113423
1693	calycanthine	hsa04330	Notch signaling pathway	2648_22938_1488	3	-	0.0138979945553778	0.542021787659734
1694	Prestwick-675	hsa04514	Cell adhesion molecules (CAMs)	8516_3119_5818_23308_920_26047_5817	7	+	0.0147172712732439	0.897753547667878
1695	Prestwick-675	hsa04740	Olfactory transduction	157	1	-	0.0233250572769127	0.322052892265194
1696	Prestwick-675	hsa05322	Systemic lupus erythematosus	85235_3113_8330_8332_8969_8331_8329_8336	8	-	0.00408881324140981	0.257595234208818
1697	Prestwick-675	hsa04360	Axon guidance	2050_10154_6405_7852_5881_6092_10505	7	-	0.00862894384811617	0.271811731215659
1698	Prestwick-675	hsa04710	Circadian rhythm - mammal	1408_8863	2	-	0.0255597533543805	0.322052892265194
1699	Prestwick-675	hsa04540	Gap junction	7278_1813_113457_113_23236	5	-	0.0245757921951691	0.322052892265194
1700	sulmazole	hsa05322	Systemic lupus erythematosus	2903_8361_8363_8362_8365_8364_8370_8360_8368_8366_3014_8359_8294_8367_554313_121504	16	+	6.58111054916484e-09	3.81704411851561e-07
1701	sulmazole	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	-	0.000118293119960969	0.00106317190732927
1702	sulmazole	hsa04640	Hematopoietic cell lineage	3123_3126_3127_3125	4	-	0.00160947502476726	0.008283338097648
1703	sulmazole	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	-	0.000273630670645293	0.00173299424742019
1704	sulmazole	hsa04612	Antigen processing and presentation	3123_3126_3127_3125	4	-	0.00174386065213642	0.008283338097648
1705	sulmazole	hsa04514	Cell adhesion molecules (CAMs)	3123_3126_3127_3125_6693_5817	6	-	0.00011983518988569	0.00106317190732927
1706	sulmazole	hsa05322	Systemic lupus erythematosus	3123_3126_3127_3125	4	-	0.0091493353737821	0.0386305271337467
1707	sulmazole	hsa05310	Asthma	3123_3126_3127_3125	4	-	3.53274892309583e-05	0.00106317190732927
1708	sulmazole	hsa05330	Allograft rejection	3123_3126_3127_3125	4	-	8.24903222129372e-05	0.00106317190732927
1709	sulmazole	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	-	0.000139891040438062	0.00106317190732927
1710	iproniazid	hsa05332	Graft-versus-host disease	3119_3821_3123_3458_3126_3127_3111_3125_356_3558	10	+	0.000415964214934694	0.00873524851362857
1711	iproniazid	hsa05211	Renal cell carcinoma	10000_5063_208_2889_5155_7042_1387_4233_3082	9	+	0.0418083461581409	0.234126738485589
1712	iproniazid	hsa04640	Hematopoietic cell lineage	1436_3581_1435_960_948_2057_2812_3123_945_3126_3127_3125_3589_4254_3674	15	+	0.000383968964342867	0.00873524851362857
1713	iproniazid	hsa05200	Pathways in cancer	10000_596_4089_5155_330_8321_3674_5371_5727_8822_324_208_3082_23604_10319_3910_331_54205_4193_4254_5467_7042_91_5468_4233_1436_3688_1021_861_862_356_1387	32	+	0.00656298765456734	0.0612545514426285
1714	iproniazid	hsa05320	Autoimmune thyroid disease	3448_3119_3123_3126_3127_3111_3558_356_3125	9	+	0.00599441939971229	0.0612545514426285
1715	iproniazid	hsa04740	Olfactory transduction	8388_8387_26333_2979_810_816	6	+	9.69595689928199e-05	0.00407230189769844
1716	iproniazid	hsa04510	Focal adhesion	29780_3910_3688_10000_1280_5063_596_331_2889_5155_330_3696_1277_208_3691_10319_1281_55742_4233_3674_3082	21	+	0.0167119639013219	0.127618633428276
1717	iproniazid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8294_3123_3458_3126_3127_3125_8370_8359_6737_121504_3119_3014_3111	23	+	3.46860072096673e-05	0.00291362460561205
1718	iproniazid	hsa04210	Apoptosis	10000_596_208_5575_54205_331_330_5532_356_8837_8794	11	+	0.02327102771194	0.150366640600228
1719	iproniazid	hsa05310	Asthma	3119_3123_3126_3127_3111_3125	6	+	0.0121585718862806	0.102132003844757
1720	iproniazid	hsa04512	ECM-receptor interaction	10319_3688_1281_1280_948_3910_3691_2812_3696_1277_960_51206_3674	13	+	0.00219915126957225	0.026389815234867
1721	iproniazid	hsa05330	Allograft rejection	3119_3123_3458_3126_3127_3111_3558_356_3125	9	+	0.000829787108715314	0.0139404234264173
1722	iproniazid	hsa05210	Colorectal cancer	10000_596_4089_54205_4233_324_208_91_7042_8321	10	+	0.0362841001088176	0.217704600652906
1723	iproniazid	hsa05222	Small cell lung cancer	10319_3688_1021_3910_596_208_54205_331_330_10000_3674	11	+	0.0202468814313405	0.141728170019383
1724	iproniazid	hsa04940	Type I diabetes mellitus	3119_3123_3458_3126_3127_3111_3558_356_3125	9	+	0.00201904272609053	0.026389815234867
1725	iproniazid	hsa05211	Renal cell carcinoma	4233_3725_405_5155_6655	5	-	0.0454581576046267	1
1726	iproniazid	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0464898223041555	1
1727	mafenide	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8370_83740_3123_8366_8360_8359_8362_8294_8367_554313_8368_121504_8341_8340	20	+	0.000146799928779933	0.0117439943023946
1728	mafenide	hsa04062	Chemokine signaling pathway	3576_10235	2	+	0.00648240458504209	0.259296183401684
1729	mafenide	hsa04070	Phosphatidylinositol signaling system	8394_5290_3631_8821_51763_8526	6	-	0.0121606821496224	0.667277893346343
1730	mafenide	hsa04650	Natural killer cell mediated cytotoxicity	4276_11261_5290_673_6452_5058_8795_3106	8	-	0.0210200505718104	0.667277893346343
1731	mafenide	hsa04115	p53 signaling pathway	11200_8795_5366_3732_4616	5	-	0.0290972337207536	0.667277893346343
1732	mafenide	hsa05220	Chronic myeloid leukemia	861_7040_867_5290_673	5	-	0.0388712448616835	0.667277893346343
1733	SC-560	hsa05010	Alzheimer's disease	5533	1	+	0.0160992362161158	0.301860679052171
1734	SC-560	hsa05016	Huntington's disease	246721	1	+	0.0112727844107636	0.28181961026909
1735	SC-560	hsa04740	Olfactory transduction	157	1	+	5.37516544324812e-06	0.000403137408243609
1736	SC-560	hsa05322	Systemic lupus erythematosus	55506_8361_8363_8362_8365_8364_8370_8360_8368_8366_8359_8294_8367_554313_121504_3108	16	+	0.000456635248357697	0.0171238218134136
1737	SC-560	hsa04710	Circadian rhythm - mammal	1408_5187_8863	3	+	0.0220544529534704	0.330816794302056
1738	SC-560	hsa04080	Neuroactive ligand-receptor interaction	6915_4157_9170	3	-	0.000231612710895687	0.0104225719903059
1739	SC-560	hsa05200	Pathways in cancer	23533_4088_598_331_9618_5605_3326_5747_10342_2308_613_4286_6789_1613_1857_405_369_2263_1017_7477_23604_208_1398_999_4193_673_1495_91_5599_6502_861_7422_5914_5970_7184	35	-	0.00419189591925739	0.0679024882559593
1740	SC-560	hsa04910	Insulin signaling pathway	2308_5170_2002_23533_5599_5576_9470_369_6464_7249_673_5605_5564_208_51806_51763_1398_6009	18	-	0.00502302356124942	0.0679024882559593
1741	SC-560	hsa04740	Olfactory transduction	51806_109	2	-	2.83629504684332e-08	2.55266554215899e-06
1742	SC-560	hsa05212	Pancreatic cancer	2308_5970_5170_23533_208_4193_673_5605_3326_369_2263_1017_7184	13	-	0.00823633494513361	0.0679024882559593
1743	SC-560	hsa05215	Prostate cancer	2308_5970_5170_23533_208_4193_673_5605_3326_369_2263_1017_7184	13	-	0.00788201205428176	0.0679024882559593
1744	SC-560	hsa05219	Bladder cancer	23604_999_4193_1613_5605_7422_369_673	8	-	0.00772024429599113	0.0679024882559593
1745	SC-560	hsa04150	mTOR signaling pathway	23533_5170_92335_208_9470_7249_673_7422_6009	9	-	0.00829919300906169	0.0679024882559593
1746	SC-560	hsa04060	Cytokine-cytokine receptor interaction	91_23765_7422_2057_51330	5	-	0.00316452483235134	0.0679024882559593
1747	SC-560	hsa05213	Endometrial cancer	23533_5170_2002_208_999_673_5605_1495_369	9	-	0.00829919300906169	0.0679024882559593
1748	SC-560	hsa05220	Chronic myeloid leukemia	23533_4088_613_1398_6464_4193_673_5605_861_208_369_91_5970_598	14	-	0.000583504931833173	0.0175051479549952
1749	mefexamide	hsa05200	Pathways in cancer	861_2260_862	3	+	0.0370491851293972	0.900205736385582
1750	mefexamide	hsa04740	Olfactory transduction	5566_56656_26212	3	+	0.0145136484917248	0.841791612520038
1751	mefexamide	hsa04510	Focal adhesion	3381	1	+	0.0465623656751163	0.900205736385582
1752	mefexamide	hsa04070	Phosphatidylinositol signaling system	8394_8871_5333_23236_3631	5	-	0.00127092047097068	0.0749843077872701
1753	hydrastinine	hsa04740	Olfactory transduction	8392_56656_1179	3	+	0.000243287922205837	0.0187331700098494
1754	hydrastinine	hsa04530	Tight junction	5865	1	+	0.0455903121898194	1
1755	hydrastinine	hsa04740	Olfactory transduction	409	1	-	0.000791382117527979	0.0601450409321264
1756	hydrastinine	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_1956_50848_5781_5603	5	-	0.0422101434363093	0.867016540005099
1757	hydrastinine	hsa04540	Gap junction	7280_347733_5154_5607_1956_23236	6	-	0.0384642181646017	0.867016540005099
1758	hydrastinine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0456324494739526	0.867016540005099
1759	metampicillin	hsa05010	Alzheimer's disease	4698_3553_842_517_5664	5	+	0.0334142017232678	0.590642747873403
1760	metampicillin	hsa04660	T cell receptor signaling pathway	29851_10298	2	+	0.0339449855099657	0.590642747873403
1761	metampicillin	hsa04740	Olfactory transduction	5566_26692_4991	3	+	1.50628597978312e-08	1.31046880241131e-06
1762	metampicillin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8341_3108_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3119_3014_720_721	27	+	2.51199540147402e-05	0.0010927179996412
1763	metampicillin	hsa04270	Vascular smooth muscle contraction	5566_5579	2	+	0.0243468244540521	0.590642747873403
1764	metampicillin	hsa05322	Systemic lupus erythematosus	3113_8343_8339_8347_8346_8344	6	-	0.0251109267217339	0.891790152298642
1765	metampicillin	hsa02010	ABC transporters	6891_23457_4363	3	-	0.0330292648999497	0.891790152298642
1766	nifenazone	hsa05332	Graft-versus-host disease	3812_57292_3811_3109_3119_3117_3804_3107_3113_3111_3802_3803	12	+	8.51522532893094e-05	0.00241264717653043
1767	nifenazone	hsa04612	Antigen processing and presentation	3812_57292_3811_3809_3808_3119_3117_3804_3806_3113_3810_3803_3802_115653_6892_3111_3109_3107_972	19	+	2.90270946587657e-05	0.00123365152299754
1768	nifenazone	hsa04740	Olfactory transduction	219464_8392	2	+	8.7883417483218e-09	7.47009048607353e-07
1769	nifenazone	hsa04210	Apoptosis	8837	1	+	0.044230026411576	0.564594893567383
1770	nifenazone	hsa05310	Asthma	958_3109_3119_3117_3113_3111	6	+	0.0214351272567363	0.364397163364517
1771	nifenazone	hsa05012	Parkinson's disease	4698_7419_4713	3	+	0.0487888985434819	0.564594893567383
1772	nifenazone	hsa05330	Allograft rejection	958_3109_3119_3117_3107_3113_3111	7	+	0.0192122930926932	0.364397163364517
1773	nifenazone	hsa04080	Neuroactive ligand-receptor interaction	56288_2555_1812	3	-	0.0274170195606435	0.507214861871905
1774	nifenazone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_8337_554313_121504_85235_3119	23	-	3.92609671412987e-08	2.9053115684561e-06
1775	nifenazone	hsa04060	Cytokine-cytokine receptor interaction	5155_7040_3455	3	-	0.0196306499881991	0.484222699708911
1776	nifenazone	hsa05220	Chronic myeloid leukemia	4088_208_6777_1029_867_5296_7040_598	8	-	0.0108069899200332	0.399858627041228
1777	ethosuximide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3111_9103_3014_8359_8294_8367_554313_121504_3119	18	+	2.66281935034209e-10	1.59769161020525e-08
1778	ethosuximide	hsa04512	ECM-receptor interaction	2812_51206_1311_3674_7060	5	+	0.0180898360012349	0.361796720024698
1779	ethosuximide	hsa04540	Gap junction	7082_7278_113457_5330_80310_57369_6714	7	+	0.00159711118981364	0.0479133356944092
1780	ethosuximide	hsa04330	Notch signaling pathway	8650_6868_5664	3	-	0.0212713078239005	0.42542615647801
1781	ethosuximide	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00627712214662827	0.251084885865131
1782	chlorphenesin	hsa05320	Autoimmune thyroid disease	3439_3447_3565_3558	4	+	0.0464543224612795	0.715189661644771
1783	chlorphenesin	hsa04740	Olfactory transduction	26212	1	+	0.0017359954844314	0.137143643270081
1784	chlorphenesin	hsa05221	Acute myeloid leukemia	861_6777_5371_652671_5467	5	+	0.0179411019896219	0.708673528590065
1785	chlorphenesin	hsa04610	Complement and coagulation cascades	2155_721_7035_720_1378	5	+	0.031368065969223	0.715189661644771
1786	chlorphenesin	hsa04070	Phosphatidylinositol signaling system	5333_5578_8396_23236	4	-	0.0234537600020798	0.445621440039516
1787	chlorphenesin	hsa04540	Gap junction	115_6714_23236_1813_5578	5	-	0.0107466446798519	0.445621440039516
1788	chlorphenesin	hsa04912	GnRH signaling pathway	115_3725_6714_23236_5578	5	-	0.0189203303379765	0.445621440039516
1789	aztreonam	hsa05010	Alzheimer's disease	348	1	+	0.015459886261876	0.587475677951288
1790	aztreonam	hsa04740	Olfactory transduction	26659_7932_81797_5613	4	+	0.00156357994192492	0.118832075586294
1791	aztreonam	hsa05322	Systemic lupus erythematosus	717	1	+	0.0457000031220386	1
1792	aztreonam	hsa04070	Phosphatidylinositol signaling system	8394_3707_5333_51763_3708	5	-	0.0456355950734548	0.83284961009055
1793	aztreonam	hsa04912	GnRH signaling pathway	776_8399_3708_8681_5606_3725_100137049	7	-	0.0210727666881657	0.769155984118048
1794	aztreonam	hsa04730	Long-term depression	3708_8681_100137049_8399_673	5	-	0.036189707874405	0.83284961009055
1795	aztreonam	hsa04270	Vascular smooth muscle contraction	776_8399_100137049_4882_673_3708_9826_8681_4659	9	-	0.00356172110700453	0.260005640811331
1796	aceclofenac	hsa04540	Gap junction	7082_2983_7278_5155_113457_3708	6	+	0.00966566237012026	0.483283118506013
1797	aceclofenac	hsa04730	Long-term depression	2983_3708_8681_100137049	4	+	0.0488322342968738	1
1798	aceclofenac	hsa04070	Phosphatidylinositol signaling system	8394_56623_3633_23236	4	-	0.0463516218406881	0.785424307309382
1799	aceclofenac	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	19	-	2.88887938348168e-11	1.70443883625419e-09
1800	telenzepine	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	0.000177876566778717	0.0103168408731656
1801	telenzepine	hsa05214	Glioma	5578_5154_5290_1956_808_5335_1869_801_805	9	-	0.000188617821484163	0.00688455048417195
1802	telenzepine	hsa04070	Phosphatidylinositol signaling system	5578_5290_8526_808_5335_51763_801_3707_805	9	-	0.000539400578665701	0.0131254140808654
1803	telenzepine	hsa04910	Insulin signaling pathway	5575_5290_808_23265_51763_9322_801_805_5792	9	-	0.020627072993189	0.210486484403397
1804	telenzepine	hsa04740	Olfactory transduction	801_808_805	3	-	0.0104820571556017	0.153038034471785
1805	telenzepine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_727_8368_8366_6738_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	21	-	4.70913793051365e-09	3.43767068927496e-07
1806	telenzepine	hsa05212	Pancreatic cancer	5154_5290_1956_1869_2260_4790	6	-	0.0474767872053427	0.286833492825896
1807	telenzepine	hsa05215	Prostate cancer	5154_5290_1956_1869_2260_4790	6	-	0.0454838606874425	0.286833492825896
1808	telenzepine	hsa04664	Fc epsilon RI signaling pathway	5578_5290_8681_7409_5335_100137049	6	-	0.0298976489279751	0.242503152415798
1809	telenzepine	hsa04370	VEGF signaling pathway	8877_5578_5290_8681_5335_7422_5534_100137049	8	-	0.00234123066475504	0.0427274596317795
1810	telenzepine	hsa05218	Melanoma	4286_5154_5290_1956_1869_2260	6	-	0.0194137494573003	0.210486484403397
1811	telenzepine	hsa05223	Non-small cell lung cancer	1869_1956_5335_5290_5578	5	-	0.0230670119894134	0.210486484403397
1812	telenzepine	hsa04912	GnRH signaling pathway	5578_808_1956_8681_801_100137049_805	7	-	0.039904987716165	0.286833492825896
1813	lasalocid	hsa04740	Olfactory transduction	26211_26212_5566_1179	4	+	2.58072485679973e-05	0.00113551893699188
1814	lasalocid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013	30	+	2.26839576069024e-09	1.99618826940741e-07
1815	lasalocid	hsa05310	Asthma	3123_3126_3127_3119_3125	5	+	0.0291191989906682	0.854163170392934
1816	lasalocid	hsa04010	MAPK signaling pathway	8912_5607_3554_4137_3925	5	-	0.0175815351992465	0.457119915180409
1817	cefotetan	hsa04740	Olfactory transduction	23538_5568	2	+	6.41172981239079e-06	0.000525761844616045
1818	cefotetan	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_2215_8370_2214_3117_8368_8366_8359_88_8294_8367_554313_121504_8364	18	+	0.000248019344417785	0.0101687931211292
1819	cefotetan	hsa05131	Shigellosis	7100_7278_6093_113457	4	-	0.0271111211223254	0.406666816834881
1820	cefotetan	hsa05130	Pathogenic Escherichia coli infection	7100_7278_6093_113457	4	-	0.0271111211223254	0.406666816834881
1821	cefotetan	hsa04740	Olfactory transduction	157	1	-	0.00740148004105896	0.222044401231769
1822	cefotetan	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_6738_121504	15	-	3.33138325703391e-07	1.99882995422035e-05
1823	iocetamic acid	hsa04740	Olfactory transduction	26211_26212_5566_816	4	+	0.0363362451398112	1
1824	iocetamic acid	hsa04020	Calcium signaling pathway	146_887_886_5330_5566_2925_6915_8911_2185_3269_816	11	+	0.0205305349720939	1
1825	iocetamic acid	hsa04070	Phosphatidylinositol signaling system	1609_5333_51763_23236	4	-	0.0311521743989069	0.778804359972672
1826	iocetamic acid	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	10392_7082_5600_998	4	-	0.0253275523521581	0.778804359972672
1827	cefoxitin	hsa05220	Chronic myeloid leukemia	7042_1488_6655_6777	4	+	0.0324664590984663	1
1828	cefoxitin	hsa05131	Shigellosis	7278_7430_113457	3	-	0.00921493921890054	0.142831557892958
1829	cefoxitin	hsa05130	Pathogenic Escherichia coli infection	7278_7430_113457	3	-	0.00921493921890054	0.142831557892958
1830	cefoxitin	hsa04540	Gap junction	7278_2767_113457	3	-	0.033430288072879	0.345446310086416
1831	iopromide	hsa05214	Glioma	5296_208_1956_1021	4	+	0.0318854344011399	0.157149640977047
1832	iopromide	hsa05211	Renal cell carcinoma	5296_208_7428_1399_3725	5	+	0.0108417659090912	0.0831202053030325
1833	iopromide	hsa05200	Pathways in cancer	11186_23604_1021_1282_861_208_5296_1956_1399_2258_91_3725_2247_7428	14	+	0.00284289639167702	0.0405463411812295
1834	iopromide	hsa04510	Focal adhesion	8515_1282_5829_208_5296_1956_1399_3725_6714	9	+	0.0127715850686966	0.0881239369740066
1835	iopromide	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_6714_1956_1432	4	+	0.0414216723977497	0.185795741288512
1836	iopromide	hsa04664	Fc epsilon RI signaling pathway	5296_208_5319_1432_5581	5	+	0.015381973132698	0.0964869223778329
1837	iopromide	hsa04370	VEGF signaling pathway	5319_1432_5829_208_5296_6714	6	+	0.00317355237942815	0.0405463411812295
1838	iopromide	hsa05219	Bladder cancer	23604_1956_11186	3	+	0.0430830704437129	0.185795741288512
1839	iopromide	hsa05218	Melanoma	1021_5296_208_1956_2258_2247	6	+	0.00217128991066748	0.0405463411812295
1840	iopromide	hsa04012	ErbB signaling pathway	5296_208_1956_1399_3725_6714	6	+	0.00556019866397136	0.0548076725448606
1841	iopromide	hsa05223	Non-small cell lung cancer	5296_208_1956_11186_1021	5	+	0.00352576879836778	0.0405463411812295
1842	iopromide	hsa04810	Regulation of actin cytoskeleton	10152_8515_5829_5296_1956_8394_1399_2258_2245_2247	10	+	0.00666832384286384	0.0575142931447006
1843	iopromide	hsa04010	MAPK signaling pathway	5319_9479_1432_773_208_1956_27091_1399_2258_91_3725_2247_23162	13	+	0.0014497212693503	0.0405463411812295
1844	iopromide	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0177233074560524	0.101909017872301
1845	iopromide	hsa04912	GnRH signaling pathway	3725_6714_1956_1432_5319	5	+	0.0470458374339006	0.190950751937597
1846	iopromide	hsa05210	Colorectal cancer	5296_208_1956_91_3725	5	+	0.0193071442225378	0.10247638087347
1847	iopromide	hsa05220	Chronic myeloid leukemia	1021_5296_208_861_1399_91	6	+	0.00280750086763194	0.0405463411812295
1848	iopromide	hsa04710	Circadian rhythm - mammal	1454_1408	2	-	0.00640609671867943	0.204995094997742
1849	pyrithyldione	hsa04070	Phosphatidylinositol signaling system	8394_5333_27124_5293_3631	5	+	0.0200771531629412	0.475159291522942
1850	pyrithyldione	hsa04740	Olfactory transduction	390892	1	+	0.00743417234709774	0.26391311832197
1851	pyrithyldione	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_958_8359_8294_8367_554313_121504	15	+	4.04821076421931e-07	2.87422964259571e-05
1852	pyrithyldione	hsa04360	Axon guidance	3688_2041_4772_23365_5534_4233	6	+	0.0495861360064879	0.704123131292128
1853	pyrithyldione	hsa05330	Allograft rejection	958_3107_3133	3	+	0.0442670963237931	0.704123131292128
1854	pyrithyldione	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	-	0.000887536408065912	0.0106408842963508
1855	pyrithyldione	hsa04640	Hematopoietic cell lineage	3123_960_3126_3127_3125	5	-	0.00171254232223561	0.0128821116147813
1856	pyrithyldione	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	-	0.00198566723813071	0.0128821116147813
1857	pyrithyldione	hsa04612	Antigen processing and presentation	3123_3126_3127_3125	4	-	0.0113599459281832	0.0643730269263715
1858	pyrithyldione	hsa05131	Shigellosis	7278_6093_113457	3	-	0.0179521670758961	0.0832327746246092
1859	pyrithyldione	hsa05130	Pathogenic Escherichia coli infection	7278_6093_113457	3	-	0.0179521670758961	0.0832327746246092
1860	pyrithyldione	hsa04514	Cell adhesion molecules (CAMs)	3123_3126_3127_3125_6383_6693	6	-	0.00202072339055393	0.0128821116147813
1861	pyrithyldione	hsa04510	Focal adhesion	6093_3693_7422_1399_5602	5	-	0.0486387701971139	0.190813636927139
1862	pyrithyldione	hsa05322	Systemic lupus erythematosus	85235_8969_3123_3126_3127_3125_8332_8330_8331_8336_8329	11	-	2.01905597411085e-07	1.02971854679653e-05
1863	pyrithyldione	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.000274930664913469	0.00701073195529346
1864	pyrithyldione	hsa04512	ECM-receptor interaction	3693_960_6383	3	-	0.0485690761066715	0.190813636927139
1865	pyrithyldione	hsa05330	Allograft rejection	3123_3126_3127_3125	4	-	0.000626491079127088	0.0106408842963508
1866	pyrithyldione	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	-	0.00104322395062263	0.0106408842963508
1867	iopamidol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3013_554313_8359_8294_8367_121504_8368_8351	16	+	1.90291324477177e-06	0.000127495187399709
1868	iopamidol	hsa05212	Pancreatic cancer	6655_5155_6934_7039_2260_1017_7184	7	+	0.00929358036481263	0.170419432332434
1869	iopamidol	hsa05215	Prostate cancer	6655_5155_6934_7039_2260_1017_7184	7	+	0.00879475906314941	0.170419432332434
1870	iopamidol	hsa04115	p53 signaling pathway	1017_4194_6477_472_651610_8795	6	+	0.010174294467608	0.170419432332434
1871	iopamidol	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0431071596976787	0.577635939948895
1872	iopamidol	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	-	8.84995855588517e-05	0.0006981577898313
1873	iopamidol	hsa04650	Natural killer cell mediated cytotoxicity	3135_3105_3106	3	-	0.0362437110478001	0.0906092776195003
1874	iopamidol	hsa05320	Autoimmune thyroid disease	3135_3105_3106_649853	4	-	0.000205422120227089	0.00102711060113544
1875	iopamidol	hsa04612	Antigen processing and presentation	3135_3105_3106_649853	4	-	0.00132395142857487	0.00529580571429948
1876	iopamidol	hsa04514	Cell adhesion molecules (CAMs)	3135_3105_3106_649853	4	-	0.00552953919018456	0.0184317973006152
1877	iopamidol	hsa04360	Axon guidance	3985_22885_9475	3	-	0.0318612882951281	0.0906092776195003
1878	iopamidol	hsa05330	Allograft rejection	3135_3105_3106_649853	4	-	6.1636490476133e-05	0.0006981577898313
1879	iopamidol	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853	4	-	0.000104723668474695	0.0006981577898313
1880	methazolamide	hsa04012	ErbB signaling pathway	5599_6714_1956_867	4	+	0.0234196739564208	0.786368330358592
1881	methazolamide	hsa05220	Chronic myeloid leukemia	1869_4088_6777_3551	4	-	0.043058425978199	1
1882	cromoglicic acid	hsa03440	Homologous recombination	7156_7516	2	+	0.0100285963238814	0.371058063983612
1883	cromoglicic acid	hsa05221	Acute myeloid leukemia	3551_11040	2	+	0.0381953932793042	0.505172312613563
1884	cromoglicic acid	hsa05131	Shigellosis	7278_113457	2	-	0.0105195160837215	0.0946756447534935
1885	cromoglicic acid	hsa05130	Pathogenic Escherichia coli infection	7278_113457	2	-	0.0105195160837215	0.0946756447534935
1886	cromoglicic acid	hsa04540	Gap junction	7278_113457	2	-	0.0267350719948195	0.142199358622267
1887	cromoglicic acid	hsa04620	Toll-like receptor signaling pathway	3663_5602	2	-	0.0315998574716148	0.142199358622267
1888	levomepromazine	hsa05332	Graft-versus-host disease	3553_3123_3126_3127_3125_3135_355_3108	8	+	6.45363686444832e-05	0.00219423653391243
1889	levomepromazine	hsa04640	Hematopoietic cell lineage	1435_3553_2057_3123_3568_3126_3127_3125_3589	9	+	0.0014009542086136	0.019052977237145
1890	levomepromazine	hsa05320	Autoimmune thyroid disease	3108_3123_3126_3127_3125_3135_355	7	+	0.00133197867890679	0.019052977237145
1891	levomepromazine	hsa04612	Antigen processing and presentation	3108_3123_3126_3127_3125_3135_6892	7	+	0.0176527717785624	0.133376497882471
1892	levomepromazine	hsa04740	Olfactory transduction	26212_157	2	+	0.00234802350074119	0.0226714938949405
1893	levomepromazine	hsa04514	Cell adhesion molecules (CAMs)	8516_965_3108_3383_3683_3123_3680_3126_3127_3125_3135	11	+	0.00243012703549051	0.0226714938949405
1894	levomepromazine	hsa05310	Asthma	3123_3125_3108_3127_3126	5	+	0.00266723457587535	0.0226714938949405
1895	levomepromazine	hsa05330	Allograft rejection	3108_3123_3126_3127_3125_3135_355	7	+	0.000223467214248014	0.00506525685628832
1896	levomepromazine	hsa04940	Type I diabetes mellitus	3108_2572_3126_3127_3125_3135_355_3123_3553	9	+	1.36239892386859e-05	0.000926431268230641
1897	sulfamonomethoxine	hsa05330	Allograft rejection	3123_355_3126_3127_3125	5	+	0.037464071240783	0.744995631538791
1898	sulfamonomethoxine	hsa05131	Shigellosis	7278_113457	2	-	0.043967757296479	0.373725937020071
1899	sulfamonomethoxine	hsa05130	Pathogenic Escherichia coli infection	7278_113457	2	-	0.043967757296479	0.373725937020071
1900	ifosfamide	hsa04080	Neuroactive ligand-receptor interaction	2561	1	+	0.0338230844910151	0.394602652395176
1901	ifosfamide	hsa05200	Pathways in cancer	23604_4313_3551_3815_861_675_7186_7482_3914_652_3688_3845_3576_2263_10342_8324_7184_3725	18	+	0.00188426668500152	0.0439662226500355
1902	ifosfamide	hsa04740	Olfactory transduction	219464	1	+	0.0017188876247026	0.0439662226500355
1903	ifosfamide	hsa05322	Systemic lupus erythematosus	3013_3014_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	+	0.000332679148295651	0.0232875403806956
1904	ifosfamide	hsa05219	Bladder cancer	23604_3576_3845_4313	4	+	0.0231445299149731	0.324023418809623
1905	ifosfamide	hsa03010	Ribosome	6204_6205_6169_6168_6181_6157_9045	7	+	0.0149243083778805	0.261175396612909
1906	pralidoxime	hsa04740	Olfactory transduction	818	1	+	2.53984994896457e-05	0.0017778949642752
1907	pralidoxime	hsa04350	TGF-beta signaling pathway	9372_3624_91_1874_7046_653_10637	7	+	0.0433042222119241	0.690034398204924
1908	pralidoxime	hsa04512	ECM-receptor interaction	2335_1302_22987_3690_3381_1290_961	7	+	0.0373167417400439	0.690034398204924
1909	pralidoxime	hsa04912	GnRH signaling pathway	2778_5331_8398_4323_998_818_3708_5320_2796_23236	10	+	0.00750471012095506	0.262664854233427
1910	pralidoxime	hsa04730	Long-term depression	2778_8398_5331_3708_5320_23236	6	+	0.0492881713003517	0.690034398204924
1911	pralidoxime	hsa04070	Phosphatidylinositol signaling system	5298_8394_808_3709_8760_801_3631_805	8	-	0.00712666993375226	0.270813457482586
1912	pralidoxime	hsa04740	Olfactory transduction	5613_801_808_157_805	5	-	0.0145204673208023	0.367851838793658
1913	pralidoxime	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_6738_121504	15	-	0.000295201632361917	0.0224353240595057
1914	pralidoxime	hsa04360	Axon guidance	9353_3688_10298_1944_64218_6091_4233_5998_7869_57556	10	-	0.0282986263620654	0.506321023720584
1915	pralidoxime	hsa04210	Apoptosis	3552_581_5613_23052_472_8837_651610	7	-	0.0426526805846747	0.54026728740588
1916	pralidoxime	hsa04512	ECM-receptor interaction	7059_1289_3914_3918_3688_3655_3339	7	-	0.0333105936658279	0.506321023720584
1917	paracetamol	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.0371073952357455	0.338175660779744
1918	paracetamol	hsa04640	Hematopoietic cell lineage	3123_3126_3127_3125_947_3674	6	+	0.0429429410513961	0.338175660779744
1919	paracetamol	hsa05320	Autoimmune thyroid disease	3123_3126_3127_1081_3125	5	+	0.021300846625875	0.335488334357531
1920	paracetamol	hsa04740	Olfactory transduction	818	1	+	0.000373324290726209	0.0117597151578756
1921	paracetamol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504_8341	19	+	1.03658536610841e-07	6.53048780648298e-06
1922	paracetamol	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.013604064056576	0.285685345188096
1923	paracetamol	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.0276971024912213	0.338175660779744
1924	paracetamol	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	+	0.0424214069398716	0.338175660779744
1925	paracetamol	hsa05211	Renal cell carcinoma	405_2271_7422_5290_7042	5	-	0.0209841094520892	0.378083958346741
1926	paracetamol	hsa05221	Acute myeloid leukemia	6932_5371_6934_5290	4	-	0.0404028066011905	0.457898474813492
1927	paracetamol	hsa04330	Notch signaling pathway	182_1488_6868_5664	4	-	0.0204638982793302	0.378083958346741
1928	paracetamol	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.027454375328787	0.378083958346741
1929	paracetamol	hsa05213	Endometrial cancer	6932_2002_6934_5290	4	-	0.0278002910549074	0.378083958346741
1930	paracetamol	hsa05210	Colorectal cancer	581_596_5290_6932_6934_7042	6	-	0.0104837901053337	0.378083958346741
1931	alpha-estradiol	hsa05322	Systemic lupus erythematosus	2215_2214_3013_8358_8968_8341_8350_8351_8352_8353_8354_8355_8356_8357	14	+	0.000921949936997463	0.075599894833792
1932	alpha-estradiol	hsa04650	Natural killer cell mediated cytotoxicity	5881_6654_8795_5534_3455	5	-	0.0432645739444531	0.405592866600123
1933	alpha-estradiol	hsa04640	Hematopoietic cell lineage	3554	1	-	0.0094869173452123	0.206340452258368
1934	alpha-estradiol	hsa05010	Alzheimer's disease	842_4712_6868_351_5534_810_513	7	-	0.0284636615199899	0.405592866600123
1935	alpha-estradiol	hsa04080	Neuroactive ligand-receptor interaction	9568_3354_2925_1241_64106	5	-	2.70654382563516e-05	0.00117734656415129
1936	alpha-estradiol	hsa04612	Antigen processing and presentation	5641_6890	2	-	0.0327082528684854	0.405592866600123
1937	alpha-estradiol	hsa04740	Olfactory transduction	818_810_2979_5616_5613	5	-	2.26040235853609e-09	1.9665500519264e-07
1938	alpha-estradiol	hsa05012	Parkinson's disease	2861_513_293_4712_842	5	-	0.042943677245779	0.405592866600123
1939	alpha-estradiol	hsa04620	Toll-like receptor signaling pathway	3725_5606_3455	3	-	0.0466198697241521	0.405592866600123
1940	alpha-estradiol	hsa04260	Cardiac muscle contraction	27092	1	-	0.0139964147990271	0.243537617503072
1941	alpha-estradiol	hsa04060	Cytokine-cytokine receptor interaction	3601_3554_3455_23529_7422_91_8795	7	-	0.000248538488752069	0.00720761617381
1942	gliquidone	hsa05211	Renal cell carcinoma	2549_7428_8453_405_5781	5	+	0.0479235942612793	1
1943	gliquidone	hsa04540	Gap junction	7278_5155_113457_5331_1956_3845_6714	7	-	0.0119591286317565	0.837139004222955
1944	Prestwick-1084	hsa04360	Axon guidance	9353_2047_57556_6585_56924_2048_5534	7	+	0.0206995932252714	0.455391050955971
1945	Prestwick-1084	hsa04512	ECM-receptor interaction	960_2335_3910_3690_3691_1277	6	+	0.00919074741312083	0.455391050955971
1946	Prestwick-1084	hsa04020	Calcium signaling pathway	5159_6261_5333_108_8911_7416_5534_1910_4638	9	+	0.0154201658461363	0.455391050955971
1947	Prestwick-1084	hsa04080	Neuroactive ligand-receptor interaction	4889_706_5026_2150_5031_1131	6	-	2.15262616757102e-05	0.000936392382893394
1948	Prestwick-1084	hsa04740	Olfactory transduction	5613_109	2	-	3.21204259985283e-13	2.79447706187196e-11
1949	Prestwick-1084	hsa04370	VEGF signaling pathway	1432_8399_5829_572_11261_5605_5296_5881_8681_3265_7422_5603_5534_6714_100137049_842	16	-	0.00851236336693538	0.185143903230845
1950	Prestwick-1084	hsa04630	Jak-STAT signaling pathway	3597_5296_1154_6655_6777_6772_3572	7	-	0.0484457423644207	0.591753725650513
1951	Prestwick-1084	hsa04260	Cardiac muscle contraction	6262_6548	2	-	0.0323428873361021	0.562766239648177
1952	Prestwick-1084	hsa04060	Cytokine-cytokine receptor interaction	27242_3597_2324_55540_3572_657_4982_7422_655_8792_51330_7040	12	-	0.0066301380494955	0.185143903230845
1953	15(S)-15-methylprostaglandin E2	hsa04080	Neuroactive ligand-receptor interaction	2911_2555_4829_2908_5030_3274_2150_2570_1909_886	10	+	0.0474727442492449	0.968407678496731
1954	15(S)-15-methylprostaglandin E2	hsa05016	Huntington's disease	4899_841_6667_10540_5468_161	6	+	0.0420037733869493	0.968407678496731
1955	15(S)-15-methylprostaglandin E2	hsa04740	Olfactory transduction	5568_816	2	+	8.0357848359679e-10	6.83041711057272e-08
1956	15(S)-15-methylprostaglandin E2	hsa04110	Cell cycle	4193	1	+	0.00501538066684252	0.213153678340807
1957	15(S)-15-methylprostaglandin E2	hsa04080	Neuroactive ligand-receptor interaction	5618_2740_4158_5732_2570_6915_56288_5030_135_134_2696	11	-	0.0161332191592912	0.228553938089959
1958	15(S)-15-methylprostaglandin E2	hsa05016	Huntington's disease	64446_246721_317_161_1213	5	-	0.00294216965506367	0.0833614735601373
1959	15(S)-15-methylprostaglandin E2	hsa04740	Olfactory transduction	810_4991_157_26716	4	-	4.96091455817957e-10	4.21677737445263e-08
1960	15(S)-15-methylprostaglandin E2	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8294_121504_3122_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_720_721_8970_729	31	-	2.98531447245616e-05	0.00126875865079387
1961	15(S)-15-methylprostaglandin E2	hsa05012	Parkinson's disease	7345_317_7054	3	-	0.00679884674025259	0.144475493230368
1962	15(S)-15-methylprostaglandin E2	hsa04260	Cardiac muscle contraction	488	1	-	0.0139460797660349	0.228553938089959
1963	15(S)-15-methylprostaglandin E2	hsa03010	Ribosome	140801_6234_6144	3	-	0.0465881289124342	0.565712993936701
1964	cefapirin	hsa04630	Jak-STAT signaling pathway	3717_3448_3953_3589_5293_200734_5781	7	+	0.00521029632281888	0.291776594077857
1965	cefapirin	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0138316628568472	0.746909794269749
1966	prazosin	hsa04740	Olfactory transduction	818	1	+	7.39179968537634e-08	6.13519373886236e-06
1967	prazosin	hsa04510	Focal adhesion	2321_7059_7148_1302_1311_1729_5599_208_3910_7057_1277_25759_7410_1399_10000_55742_3918_29895	18	+	0.0444288303584191	0.564815058604352
1968	prazosin	hsa05322	Systemic lupus erythematosus	3013_3113_8358_6738_8968_8341_8350_8351_8352_8353_8354_8355_8356_8357	14	+	0.0405393765318489	0.564815058604352
1969	prazosin	hsa05221	Acute myeloid leukemia	10000_3815_861_208_862_5292_5371	7	+	0.0476350049425357	0.564815058604352
1970	prazosin	hsa04920	Adipocytokine signaling pathway	51703_10000_3953_208_6513_5563_5599_1375_8471	9	+	0.0138453651615803	0.383055102803722
1971	prazosin	hsa04512	ECM-receptor interaction	7059_7148_1302_1311_3910_2812_7057_1277_3918_51206_961	11	+	0.00811841599632862	0.336914263847638
1972	prazosin	hsa04940	Type I diabetes mellitus	3382_3105_2572_3558_2571_3113	6	+	0.0387254850534462	0.564815058604352
1973	prazosin	hsa04080	Neuroactive ligand-receptor interaction	1131	1	-	0.0051843013226196	0.165897642323827
1974	prazosin	hsa05322	Systemic lupus erythematosus	85235_8330_3014_8332_8969_8331_8329_8343_8336_8339_8347_8346_8344	13	-	0.0010000368195797	0.0640023564531008
1975	prazosin	hsa04360	Axon guidance	10298_10505_11261_4775_5534_3985_4233_5998_64218	9	-	0.0399381766718031	0.71955520347752
1976	rottlerin	hsa05010	Alzheimer's disease	348_23236	2	+	0.00149473822470562	0.0317631872749944
1977	rottlerin	hsa05016	Huntington's disease	5978_23236	2	+	0.0011027165724047	0.0312436362181332
1978	rottlerin	hsa04740	Olfactory transduction	219464_816	2	+	8.86643907618339e-09	3.76823660737794e-07
1979	rottlerin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8349_8348_8329_8294_121504_8343_8347_8346_8344_8339_723790_3126_8969_8968_8370_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_8970	44	+	6.15195036801452e-15	5.22915781281234e-13
1980	rottlerin	hsa04710	Circadian rhythm - mammal	406_9572_5187_8553	4	+	0.0179698335427683	0.254572641855884
1981	rottlerin	hsa04062	Chemokine signaling pathway	2309_7410_3576_4792_23236	5	+	0.0251859344953918	0.267600554013538
1982	rottlerin	hsa04810	Regulation of actin cytoskeleton	3688_1729_7410_2263_2260_3675	6	+	0.0241320495252482	0.267600554013538
1983	rottlerin	hsa05012	Parkinson's disease	7054	1	+	0.00342120684469676	0.0581605163598449
1984	rottlerin	hsa04080	Neuroactive ligand-receptor interaction	4886_2690	2	-	0.0184191105813749	0.298389591418273
1985	rottlerin	hsa05200	Pathways in cancer	1050_9134_112399_1147_26060_596_6789_6502_581_998_1856_1857_898_5979_5295_8453_3725_652_2956_2261_8321	21	-	0.00482124385651826	0.0976301880944948
1986	rottlerin	hsa05014	Amyotrophic lateral sclerosis (ALS)	11261_581_4217_5534_596	5	-	0.0429334323935318	0.445880584444352
1987	rottlerin	hsa04740	Olfactory transduction	5613_5616	2	-	0.000547079401824291	0.0221567157738838
1988	rottlerin	hsa04360	Axon guidance	5361_11261_998_2049_7852_6387_5534_10512_3985	9	-	0.0440375885870965	0.445880584444352
1989	rottlerin	hsa04210	Apoptosis	5295_1147_596_5613_11261_581_5616_23052_472_5534_651610	11	-	0.000302639839080058	0.0221567157738838
1990	rottlerin	hsa04115	p53 signaling pathway	9134_64393_581_472_898_651610	6	-	0.030801123144775	0.415815162454462
1991	rottlerin	hsa05210	Colorectal cancer	26060_581_5295_1856_1857_596_3725_2956_8321	9	-	0.00261281625691187	0.0705460389366205
1992	bergenin	hsa03440	Homologous recombination	7156_8940_7516	3	+	0.0160267162628886	0.408681264703659
1993	bergenin	hsa04740	Olfactory transduction	157	1	+	0.0154966916135747	0.408681264703659
1994	bergenin	hsa03450	Non-homologous end-joining	27343_2547	2	+	0.0304459463276677	0.517581087570351
1995	bergenin	hsa05213	Endometrial cancer	5170_8312_6934_842	4	-	0.0173099193238014	0.852571389572379
1996	vigabatrin	hsa04070	Phosphatidylinositol signaling system	5331_5295_3707_3709	4	+	0.0488022775981728	0.781638164503108
1997	vigabatrin	hsa05211	Renal cell carcinoma	405_5295_7042_10298_6513	5	+	0.0103639051594346	0.540487283724756
1998	vigabatrin	hsa04740	Olfactory transduction	818	1	+	0.0154424938207073	0.540487283724756
1999	vigabatrin	hsa05220	Chronic myeloid leukemia	7046_5295_4193_7042	4	+	0.0469673778283038	0.781638164503108
2000	vigabatrin	hsa04070	Phosphatidylinositol signaling system	8394_3709_23236	3	-	0.0216554742863634	0.347029134873064
2001	vigabatrin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8359_8370_8294_554313_121504	14	-	9.0409047220227e-12	2.98349855826749e-10
2002	vigabatrin	hsa04540	Gap junction	6714_3709_23236	3	-	0.0357509587759586	0.347029134873064
2003	nocodazole	hsa04510	Focal adhesion	5829_2317_80310_5155_998_859_2002_1292_3918_7409_7422_7414_3725_7791_3673_6093_1291_3675	18	+	0.0227158738267335	0.620900551264049
2004	nocodazole	hsa04710	Circadian rhythm - mammal	1454_8553_9572_4862	4	+	0.00669836484004892	0.274632958442006
2005	nocodazole	hsa04010	MAPK signaling pathway	5155_6722_4763_8681_5495_3164_1616_2260_100137049_57551_786_998_6885_5534_3725_1647_782_1843_2317_1649_1846_1845_2002_6196_23162_27092	26	+	0.00187684602862982	0.153901374347645
2006	nocodazole	hsa04640	Hematopoietic cell lineage	1436_3655	2	-	0.0162472283076447	0.208892935384003
2007	nocodazole	hsa04080	Neuroactive ligand-receptor interaction	3354_5618_56288_2149_4886	5	-	1.00890045064978e-06	4.54005202792401e-05
2008	nocodazole	hsa04740	Olfactory transduction	157	1	-	6.31427634268426e-16	5.68284870841583e-14
2009	nocodazole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8347_8346_8344_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235_3017_727	28	-	0.0052905938245519	0.111186687663837
2010	nocodazole	hsa05212	Pancreatic cancer	5728_1017_5594_9134_5296_6655_1871_5155_4193_5290_673_5605_6934_2263_1385_2260_1387_7184_842	19	-	0.00741244584425579	0.111186687663837
2011	nocodazole	hsa04110	Cell cycle	995_472_9134_651610_990_993_4173_6502_699_4193_51433_1111_8317_7027_1017_1871_7534_1031_1387_7531_5933	21	-	0.0401242629049728	0.451397957680944
2012	nocodazole	hsa05215	Prostate cancer	5728_1017_5594_9134_5296_6655_1871_5155_4193_5290_673_5605_6934_2263_1385_2260_1387_7184_842	19	-	0.00697351642177579	0.111186687663837
2013	nocodazole	hsa04060	Cytokine-cytokine receptor interaction	1436_5618_3597_55540_5155_8742_8741_3572_355_4982_9180_91	12	-	0.002274189447849	0.06822568343547
2014	nocodazole	hsa05213	Endometrial cancer	5728_6934_5296_6655_999_5290_673_5605_842_324_5594	11	-	0.0472970244047107	0.472970244047107
2015	5666823	hsa05212	Pancreatic cancer	1869_898_8503_1387	4	-	0.0449510333837329	0.601865992928071
2016	5666823	hsa05215	Prostate cancer	1869_898_8503_1387	4	-	0.0434854142787252	0.601865992928071
2017	5666823	hsa05223	Non-small cell lung cancer	1869_8503_6258	3	-	0.0486117226097312	0.601865992928071
2018	5666823	hsa04620	Toll-like receptor signaling pathway	3665_8737_8503_9641_7187	5	-	0.018984037755852	0.597997189309338
2019	5666823	hsa05222	Small cell lung cancer	8503_2335_898_6258_1869_7187	6	-	0.00206901116343769	0.130347703296574
2020	pentamidine	hsa04740	Olfactory transduction	8390_26476_26532_10798_8590_810_2979	7	+	0.0398562762945638	1
2021	pentamidine	hsa05219	Bladder cancer	23604_7422_1612_7057_4193	5	+	0.029217338099969	1
2022	pentamidine	hsa04080	Neuroactive ligand-receptor interaction	7434_2908_1081_4886	4	-	0.0486693733828107	0.685356610650898
2023	pentamidine	hsa04510	Focal adhesion	55742_998	2	-	0.0259943164413191	0.589204506003233
2024	pentamidine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_8970	22	-	3.10755769471548e-07	2.11313923240653e-05
2025	pentamidine	hsa04062	Chemokine signaling pathway	998	1	-	0.00740860606552904	0.251892606227987
2026	4,5-dianilinophthalimide	hsa04916	Melanogenesis	2771_1857	2	+	0.0168630929290407	0.252946393935611
2027	4,5-dianilinophthalimide	hsa05214	Glioma	801_6654_805_808	4	-	0.0389926905949929	0.754306152450491
2028	4,5-dianilinophthalimide	hsa04270	Vascular smooth muscle contraction	2778_808_6093_4659_801_805	6	-	0.0277680681708071	0.754306152450491
2029	benserazide	hsa05010	Alzheimer's disease	4698_4842	2	+	0.0030978255341389	0.130108672433834
2030	benserazide	hsa05016	Huntington's disease	3092_4698_90993	3	+	0.00711013803344682	0.149312898702383
2031	benserazide	hsa04740	Olfactory transduction	219464_8390_26189_26707	4	+	2.06546068184649e-06	0.000173498697275105
2032	benserazide	hsa05012	Parkinson's disease	4698	1	+	0.00485705607837149	0.135997570194402
2033	benserazide	hsa04610	Complement and coagulation cascades	2161_5328_7035_2153_2244_5329_2266_5104_2243	9	+	0.043572513856936	0.732018232796525
2034	benserazide	hsa04910	Insulin signaling pathway	8660_5565_2872_5613_5567_5616_5140_5605_23265_1398_8651	11	-	0.0310525204342281	0.694182276080371
2035	benserazide	hsa04740	Olfactory transduction	5613_5567_5616	3	-	0.000363104499888687	0.0143426277456031
2036	benserazide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_727_8368_8366_3113_8359_8294_8367_554313_6738_121504	17	-	0.000145680990815295	0.0115087982744083
2037	benserazide	hsa04720	Long-term potentiation	5613_5567_5616_5605_5534_4659_23236	7	-	0.0375932634998817	0.694182276080371
2038	paclitaxel	hsa05010	Alzheimer's disease	836	1	+	0.0326237338205431	0.750345877872491
2039	paclitaxel	hsa04740	Olfactory transduction	26532_816	2	+	0.000264383540719461	0.0182424643096428
2040	paclitaxel	hsa04510	Focal adhesion	7408	1	+	0.0165663604976794	0.571539437169939
2041	paclitaxel	hsa04740	Olfactory transduction	5567	1	-	8.08046843619865e-05	0.00606035132714899
2042	paclitaxel	hsa05212	Pancreatic cancer	2308_898_5155_1956_2033_1869_2260	7	-	0.0315017774445311	0.787544436113278
2043	paclitaxel	hsa05215	Prostate cancer	2308_898_5155_1956_2033_1869_2260	7	-	0.0299798799814195	0.787544436113278
2044	colchicine	hsa05010	Alzheimer's disease	3708_5534	2	+	0.0182712809628199	0.473725060799487
2045	colchicine	hsa05016	Huntington's disease	3708	1	+	0.00244841218241002	0.100384899478811
2046	colchicine	hsa04740	Olfactory transduction	81696_26476_7932_26212_81797	5	+	0.000331474033045444	0.0271808707097264
2047	colchicine	hsa04510	Focal adhesion	1284_7059_22798_1311_2316_2889_5880_998_330_93408_3918_1956_7414_7791_3725_3082_2534_3675	18	+	0.0231085395511945	0.473725060799487
2048	colchicine	hsa04080	Neuroactive ligand-receptor interaction	9568_7434_2901	3	-	7.9625240637193e-05	0.00233567372535766
2049	colchicine	hsa04740	Olfactory transduction	5566	1	-	3.6386650447569e-10	3.20202523938607e-08
2050	colchicine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8342_8347_8346_8344_8370_8359_8330_8336_8334_554313_6738_121504_8339_8357_3119_3017	27	-	9.48142715788378e-06	0.000417182794946886
2051	colchicine	hsa05012	Parkinson's disease	842_7054	2	-	0.0124766617254363	0.219589246367679
2052	colchicine	hsa04020	Calcium signaling pathway	5566_2776	2	-	0.000721848517634687	0.0158806673879631
2053	colchicine	hsa05210	Colorectal cancer	5595_842_581_4088_6655_5290_5599_5881_5602_91_5879_8321	12	-	0.0198838172630469	0.291629319858021
2054	tioguanine	hsa04670	Leukocyte transendothelial migration	2771_103910_7852_7408_399_5879	6	-	0.0458393941249869	0.806231723988553
2055	tioguanine	hsa04360	Axon guidance	5595_5365_2771_7852_5879_10505_64218	7	-	0.022186133488115	0.806231723988553
2056	hexestrol	hsa05010	Alzheimer's disease	3709	1	+	0.015463422538762	0.274475750063025
2057	hexestrol	hsa04310	Wnt signaling pathway	3725	1	+	0.0470782642215276	0.668511351945692
2058	hexestrol	hsa05016	Huntington's disease	64446	1	+	0.010728384072195	0.253905089708615
2059	hexestrol	hsa04740	Olfactory transduction	8387_442194_8388	3	+	0.000492767491624049	0.0349864919053075
2060	hexestrol	hsa05322	Systemic lupus erythematosus	3013_9103_8358_8968_8341_8350_8351_8352_8353_8354_8355_8356_8357	13	+	0.00787673151705127	0.253905089708615
2061	hexestrol	hsa05332	Graft-versus-host disease	3552_3105_3106_3126_3127_3125_3123	7	-	0.0202501244210035	0.267928756014294
2062	hexestrol	hsa05010	Alzheimer's disease	22926_6622	2	-	0.00309380538188461	0.0845640137715127
2063	hexestrol	hsa04080	Neuroactive ligand-receptor interaction	9568_1131_2690	3	-	0.000334673491881409	0.0274432263342755
2064	hexestrol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_6737_3126_3127_3014_3125_8359_8294_8367_554313_8368_121504	20	-	0.00171533039286195	0.0703285461073399
2065	hexestrol	hsa04062	Chemokine signaling pathway	5829_5290_4067_3551	4	-	0.0192961467247107	0.267928756014294
2066	hexestrol	hsa04020	Calcium signaling pathway	7416_1131_490_5336	4	-	0.0261393908306628	0.267928756014294
2067	hexestrol	hsa05330	Allograft rejection	3105_3106_3126_3127_3125_3123	6	-	0.0374859335882113	0.341538506025925
2068	hexestrol	hsa04270	Vascular smooth muscle contraction	27094	1	-	0.0150436528121429	0.267928756014294
2069	hexestrol	hsa04940	Type I diabetes mellitus	3552_3105_3106_3126_3127_3125_3123	7	-	0.0247646128934013	0.267928756014294
2070	halofantrine	hsa04740	Olfactory transduction	818_1179	2	+	0.00242273596001322	0.169591517200925
2071	halofantrine	hsa04340	Hedgehog signaling pathway	7479_3549_8643_5727_653	5	+	0.0301103274153708	1
2072	halofantrine	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8336	7	-	0.00546393689848668	0.224021412837954
2073	alpha-ergocryptine	hsa05016	Huntington's disease	64446_7802_627	3	+	0.0139962509497035	0.349906273742587
2074	alpha-ergocryptine	hsa04740	Olfactory transduction	8392_7932_5568_442194_816	5	+	3.10028792733095e-05	0.00232521594549821
2075	alpha-ergocryptine	hsa05012	Parkinson's disease	6531	1	+	0.00710813961017673	0.266555235381627
2076	alpha-ergocryptine	hsa04912	GnRH signaling pathway	776_5568_3710_1081_5599_1839_998_3709_8681_2185_100137049_816	12	+	0.0378330720384464	0.70937010072087
2077	alpha-ergocryptine	hsa05010	Alzheimer's disease	51806_841_4713_5331_351_348	6	-	0.0315725679440839	0.428469115561807
2078	alpha-ergocryptine	hsa04080	Neuroactive ligand-receptor interaction	1241_3354_2901_56288_7433	5	-	0.000110049817507222	0.00484219197031777
2079	alpha-ergocryptine	hsa04740	Olfactory transduction	219464_51806_5613	3	-	6.77621708516927e-10	5.96307103494896e-08
2080	alpha-ergocryptine	hsa04514	Cell adhesion molecules (CAMs)	3135_23308_5792	3	-	0.0131043357565838	0.239181069132011
2081	alpha-ergocryptine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_6738_121504_85235_3014	23	-	0.00414902591309541	0.121704760117465
2082	alpha-ergocryptine	hsa04530	Tight junction	208_56288_8777	3	-	0.0135898334734097	0.239181069132011
2083	alpha-ergocryptine	hsa05012	Parkinson's disease	2861_4713_7419_65018	4	-	0.0340827705560528	0.428469115561807
2084	meptazinol	hsa04740	Olfactory transduction	5613	1	-	0.0017359954844314	0.118047692941335
2085	meptazinol	hsa04370	VEGF signaling pathway	3845_5881_5335_842_5603	5	-	0.0457088839642967	1
2086	meptazinol	hsa05223	Non-small cell lung cancer	11186_3845_5335_842	4	-	0.0490000947447557	1
2087	CP-319743	hsa04612	Antigen processing and presentation	3444	1	+	0.0141845188012262	0.406622872301818
2088	CP-319743	hsa04660	T cell receptor signaling pathway	3725_940_208	3	+	0.0472186330843114	1
2089	CP-319743	hsa04740	Olfactory transduction	26692_26333_81285_1179_26539_816	6	+	1.34388997215777e-07	1.15574537605568e-05
2090	CP-319743	hsa05012	Parkinson's disease	6390_6622_4713	3	+	0.0136689624961811	0.406622872301818
2091	CP-319743	hsa05010	Alzheimer's disease	56901_317_2776_5332_3710_4695_810_348_776_779_5533_3708_3709_6868_489_23236_5594_4713_4137_355_351_22926	22	-	0.000390840183815854	0.00793930292577488
2092	CP-319743	hsa04080	Neuroactive ligand-receptor interaction	1269_155_147_2925_2901_5030_552_56288_5745_135_1909_5645_5644_5646_1812_5724_7434_2740_4988_5028_2642_2911_2916_3953_1131_4886_5026_3354_3350_5733_3269_1910_8001_2550_5618_5340_7068_7067_4159_2570_1241_8484_1511_2149	44	-	0.00758909881182527	0.0891719110389469
2093	CP-319743	hsa04742	Taste transduction	5613_5566_5616_3710_112	5	-	0.0156946590121089	0.147529794713824
2094	CP-319743	hsa05320	Autoimmune thyroid disease	3113_7038_3452_3439_3451_3122_3105_3106_3126_3127_3125_959_3135_3448_3119_3447_3446_3441_3111_356_355_3123_649853	23	-	0.046627024353637	0.313067163517277
2095	CP-319743	hsa05016	Huntington's disease	8218_4899_56901_317_246721_2776_5332_23186_7019_6874_5430_6648_7052_7419_1213_581_3708_9001_4695_548644_23236_27113_4713_1387	24	-	0.000422303347115685	0.00793930292577488
2096	CP-319743	hsa04740	Olfactory transduction	219464_5593_157_5137_5613_5566_8383_8392_818_5616_109_4992_390892_810_9635_816	16	-	1.45609307658508e-22	1.36872749198998e-20
2097	CP-319743	hsa04110	Cell cycle	995_472_1031_993_9134_4088_699_1029_8881_1111_10393_10912_1870_7042_1869_8556_1387_4616	18	-	0.0259259031697878	0.203086241496671
2098	CP-319743	hsa03410	Base excision repair	3980_4968	2	-	0.0149584625309807	0.147529794713824
2099	CP-319743	hsa04530	Tight junction	5584_7082_56288_5581_10207_5578_998_8777_6709_22800_79784_51776_3845_4636_8573_8531_6714_9223_55870	19	-	0.0070370621533072	0.0891719110389469
2100	CP-319743	hsa04062	Chemokine signaling pathway	3717_157_5296_3718_5290_7852_5332_56288_112_8503_7454_2786_5829_5566_3576_7410_998_109_729230_6093_3055_4790_23236_115_6355_5594_5613_6777_5616_6358_6359_7074_3845	33	-	0.0203566208747178	0.173956578383952
2101	CP-319743	hsa05012	Parkinson's disease	2861_6570_4695_4713_317_7345_51465_56901_7419	9	-	1.50484708532101e-06	7.07278130100875e-05
2102	CP-319743	hsa04260	Cardiac muscle contraction	786_776_782_9254_779_481_70_478_10479_7137_7170	11	-	0.0294896254485837	0.213232676320528
2103	CP-319743	hsa03010	Ribosome	6181_6141_284393_439992_6203_6160_389342_6189	8	-	0.000201895151531365	0.0063260480813161
2104	CP-319743	hsa03050	Proteasome	23198_5683	2	-	0.00138551902486598	0.0217064647229004
2105	atractyloside	hsa05219	Bladder cancer	7422_1613_7057	3	+	0.0178812267415814	0.623441310129461
2106	atractyloside	hsa04350	TGF-beta signaling pathway	91_3400_7057_7044	4	+	0.0259767212553942	0.623441310129461
2107	atractyloside	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00423032713108944	0.190364720899025
2108	flurbiprofen	hsa04740	Olfactory transduction	7932_815_9635	3	+	6.06620836591199e-05	0.00467098044175223
2109	flurbiprofen	hsa04514	Cell adhesion molecules (CAMs)	6403_3384_3383_23308_947_29851_958_965_920_9672_933_4099_23562	13	+	0.0129435631956611	0.249163591516476
2110	flurbiprofen	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_958_9103_8359_8294_8367_554313_121504_8341	17	+	0.000617168123806171	0.0237609727665376
2111	flurbiprofen	hsa04920	Adipocytokine signaling pathway	2475_51703_5599_208_57818_8660_5602_6257_4852_4793	10	+	0.00174191907721253	0.0447092563151216
2112	flurbiprofen	hsa05010	Alzheimer's disease	3553	1	-	0.00735367773262529	0.551525829946897
2113	flurbiprofen	hsa04350	TGF-beta signaling pathway	3399_4089_3624_7057_9475_656_353500_7042_6093	9	-	0.0179701535791451	0.673880759217941
2114	flurbiprofen	hsa03020	RNA polymerase	5432_246721_5439_548644	4	-	0.0463078272464349	1
2115	paromomycin	hsa05332	Graft-versus-host disease	3812_3811_3552_3119_3804_3113_3802_3002	8	+	0.000657819443776673	0.0519677360583572
2116	paromomycin	hsa04910	Insulin signaling pathway	208	1	+	0.0456665842431597	0.601276692534936
2117	paromomycin	hsa05016	Huntington's disease	1742_23236	2	+	0.0359643292743892	0.601276692534936
2118	paromomycin	hsa04740	Olfactory transduction	5137_26476_26212_442194_3000	5	+	0.00317123676532053	0.125263852230161
2119	paromomycin	hsa05218	Melanoma	208_1029_2250_2249_1870_2247_4233_3082	8	+	0.0119561108430819	0.314844252201157
2120	paromomycin	hsa05012	Parkinson's disease	6622	1	+	0.0455433170812947	0.601276692534936
2121	paromomycin	hsa04070	Phosphatidylinositol signaling system	1609_8503_8394_8396_3633_5333_23236	7	-	0.0163835934829738	0.430658501660583
2122	paromomycin	hsa04662	B cell receptor signaling pathway	8503_6655_3845_5534_3725_4793	6	-	0.0440940191529154	0.77164533517602
2123	paromomycin	hsa04080	Neuroactive ligand-receptor interaction	1131_2908	2	-	0.0184567929283107	0.430658501660583
2124	paromomycin	hsa04060	Cytokine-cytokine receptor interaction	3454	1	-	0.00364972647981679	0.255480853587175
2125	scopolamine	hsa04740	Olfactory transduction	9635	1	+	0.000791533991799135	0.0656973213193282
2126	scopolamine	hsa04540	Gap junction	2911_5594_1813_7278_113457_5605_3710	7	+	0.0134229060544106	0.55705060125804
2127	scopolamine	hsa04080	Neuroactive ligand-receptor interaction	3953_5618_2908	3	-	0.00273739115359918	0.110864341720767
2128	scopolamine	hsa04740	Olfactory transduction	810_26211_5566	3	-	9.50033795222655e-06	0.000769527374130351
2129	furazolidone	hsa05010	Alzheimer's disease	3553_3710	2	+	0.0183143334303477	0.421281700217377
2130	furazolidone	hsa04740	Olfactory transduction	26211_8390_5566_8383_1179_9635	6	+	0.00130701501023582	0.109789260859809
2131	furazolidone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3112_8359_8294_8367_554313_121504_3119	16	+	0.00367470108777157	0.154337445686406
2132	furazolidone	hsa04270	Vascular smooth muscle contraction	9138_3710_10266_4881_4882_3778_2977_108_8681_5322_100137049_5566	12	+	0.0200610333436846	0.421281700217377
2133	furazolidone	hsa04650	Natural killer cell mediated cytotoxicity	6655_3107_5781_5534	4	-	0.023161739017216	0.637676553527139
2134	nadolol	hsa04650	Natural killer cell mediated cytotoxicity	23533_8503_3107_6850_5293_3460_10451_6452_836_3455_4772_3106_3459_5781_4276_10725_3135_5532_4775_5894_3133_5534_5291_5777_5594_5578_6655_6654_6464_5881_355_3845_3265_2534	34	+	0.00669071835277573	0.0491211923659303
2135	nadolol	hsa05010	Alzheimer's disease	55851_3710_51806_572_5534_317_9451_3416_5332_5664_7381_6622_1327_4705_836_3553_4702_4712_808_509_810_348_8772_5532_3709_374291_489_488_4695_801_23236_5594_841_4713_642502_6391_4137_4728_355_842_23385_351_513_8851_805	45	+	0.00285687779564735	0.0244133193446228
2136	nadolol	hsa04080	Neuroactive ligand-receptor interaction	155_886_2908_2925_552_56288_5644_4161_799_8001_2688_2689_7433_1442_5029_4889_2914_2916_3953_5025_4886_3355_6915_3356_3352_3269_3358_9170_2550_5618_4157_7068_7067_2897_2570_1241_8484_1511_2357	39	+	8.64014963006774e-11	4.06087032613184e-09
2137	nadolol	hsa04742	Taste transduction	2914_3710_5613_5566_5567_50834_112	7	+	0.00164284552440026	0.0171586088104027
2138	nadolol	hsa05131	Shigellosis	4950_347733_5578_998_7099_7430_9181_8440_2017_9475_6093_2534	12	+	0.0437330357763693	0.183017071234722
2139	nadolol	hsa04670	Leukocyte transendothelial migration	5010_23533_8503_2773_5293_9475_10451_4636_5603_5747_81_3676_5829_1500_7430_5781_50848_6300_4318_998_1495_6093_5291_1432_5578_27035_4689_1365_7408_4950	30	+	0.00920471383962397	0.0618030786374752
2140	nadolol	hsa04614	Renin-angiotensin system	1511	1	+	0.0339577540609234	0.173991912544915
2141	nadolol	hsa05016	Huntington's disease	4899_5440_1327_3064_317_55081_5332_23186_7019_6875_7381_5432_5433_4705_6874_6648_4702_5434_7157_6667_64446_836_2033_509_1212_5430_374291_10540_4712_4695_161_5481_23236_842_841_4713_642502_5441_6391_246721_3092_4728_9586_1385_513_1387_293_291	48	+	0.00235321885468479	0.022120257234037
2142	nadolol	hsa05130	Pathogenic Escherichia coli infection	4950_347733_5578_998_7099_7430_9181_8440_2017_9475_6093_2534	12	+	0.0437330357763693	0.183017071234722
2143	nadolol	hsa04740	Olfactory transduction	808_51806_157_26211_5613_5566_5567_442194_393046_818_109_805_390892_810_801_9635_816	17	+	1.49368377156923e-38	1.40406274527508e-36
2144	nadolol	hsa04514	Cell adhesion molecules (CAMs)	5010_9672_3695_6385_23308_3111_6383_6382_3655_3676_9019_958_3123_3106_3107_3126_3127_3125_933_25945_29851_4099_3135_3133_23705_6402_965_4685_50848_3680_3685_1365_5792_4950_1002_926_5817	37	+	0.0338800452089114	0.173991912544915
2145	nadolol	hsa04140	Regulation of autophagy	5289_115201_9474_9140_8678_23192	6	+	0.039571195729187	0.183017071234722
2146	nadolol	hsa04530	Tight junction	5010_2773_4619_6709_64398_56288_4636_81_9223_5584_5581_84612_1365_5865_3996_2017_50848_79784_55844_207_208_998_8777_5519_22800_3265_1495_4628_5590_5520_7082_8189_5578_10207_5728_1457_3845_7525_4950	39	+	0.0447807727489214	0.183017071234722
2147	nadolol	hsa04630	Jak-STAT signaling pathway	23533_3717_598_8503_5291_6772_9655_3558_30837_10254_1442_2057_3455_3459_3572_3588_2688_5781_3589_2033_81848_2689_10401_9063_207_3953_1271_3976_208_5293_5777_200734_8554_9021_8027_4352_5618_3460_6655_6654_867_51588_8835_1387	44	+	0.0277906259996709	0.163269927748067
2148	nadolol	hsa04062	Chemokine signaling pathway	23533_3717_3576_1147_157_2773_8503_9475_10451_5332_56288_10235_112_2309_3551_5829_5566_5567_1399_6362_4793_408_1236_207_6357_5747_208_998_5293_109_3265_6093_5291_23236_5590_5594_5613_6655_6654_6464_6772_7074_3845_5894_5970	45	+	0.000310488288514256	0.00416941416004858
2149	nadolol	hsa04810	Regulation of actin cytoskeleton	23533_8503_3680_10298_56034_10297_5154_9475_7074_5881_3679_10552_4636_23365_5747_3655_10458_3676_23396_81_5829_4638_3693_3695_1445_8826_7430_80310_1399_55740_2263_200576_2261_2264_79784_2768_324_5062_8394_2934_9138_998_2335_5293_22800_3265_3985_4628_6093_5291_23191_8874_10093_5594_1729_6655_6654_10451_3685_5894_3690_54961_3845_54434_2257_10787_6548	67	+	0.0351685780675892	0.173991912544915
2150	nadolol	hsa05012	Parkinson's disease	2861_1327_7332_317_27429_7381_6622_4705_836_4702_5413_509_374291_4695_5481_4728_842_4712_4713_642502_6391_65018_51465_513_293_291	26	+	0.00012053450012741	0.00188837383532942
2151	nadolol	hsa04260	Cardiac muscle contraction	784_7168_1327_9254_70_6548_4635_488_7381_10479_781	11	+	8.5649699415481e-05	0.00161021434901104
2152	nadolol	hsa04060	Cytokine-cytokine receptor interaction	3459_56034_55540_5154_1896_3572_657_2322_27242_3554_3553_2057_2324_3455_3576_3953_958_3558_3588_4982_2688_2689_3976_8718_6362_3082_1236_3606_3556_23495_3589_23765_8771_3625_4055_4254_7042_91_90_8792_4233_7048_4352_1436_6357_5618_3460_970_7292_1271_8764_355_7422_83729_51330	55	+	1.27396565880672e-06	3.99175906426106e-05
2153	nadolol	hsa03010	Ribosome	283412_284064_6137_6204_6125_6168_6192_6160_6158_6159_6129_9045_6171	13	+	6.82786826380686e-06	0.000160454904199461
2154	nadolol	hsa04020	Calcium signaling pathway	51806_155_3710_5534_2925_3709_552_7220_5532_5332_4638_490_886_5256_5257_5566_5567_818_8911_810_816_5025_56848_2767_3356_6915_109_489_488_3269_3358_5481_23236_8877_5578_5613_8912_808_801_2064_293_805_291	43	+	0.000510063946130759	0.00599325136703642
2155	nadolol	hsa03050	Proteasome	10197_5719_5717_5707_5689_9491_5683	7	+	0.00679335639103292	0.0491211923659303
2156	nadolol	hsa04610	Complement and coagulation cascades	3827_966_5265_5327_5627_727_4179_1604_717_722_7035_2152_2153_1675_5329	15	+	0.0219003892658159	0.137242439399113
2157	harmol	hsa04740	Olfactory transduction	51806_2979_4991	3	+	0.000171186927158491	0.00701866401349813
2158	harmol	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_8348_8294_121504_3109_8366_8968_8370_8362_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2215_83740_3013_3111	32	+	3.50962072265735e-13	2.87788899257903e-11
2159	harmol	hsa04115	p53 signaling pathway	55367_1647_1026_64393_7249_355_8795	7	+	0.0313264462554903	0.856256197650068
2160	harmol	hsa04916	Melanogenesis	4157_5578_1855_3845_6934_107_2535	7	-	0.0138867575009082	0.168955549594383
2161	harmol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	1.56870994526924e-05	0.00114515826004655
2162	harmol	hsa04530	Tight junction	8189_5578_8777_9080_3845_4636_27134	7	-	0.0480625034543895	0.350856275217043
2163	harmol	hsa04664	Fc epsilon RI signaling pathway	5578_5336_7410_3845_5600_5602_2534	7	-	0.00354793286506912	0.118119629735008
2164	harmol	hsa04370	VEGF signaling pathway	5578_842_3845_5600_5336	5	-	0.04007448389596	0.325048591600564
2165	harmol	hsa05216	Thyroid cancer	3845_6934_673	3	-	0.0363396115899527	0.325048591600564
2166	harmol	hsa05223	Non-small cell lung cancer	5578_673_3845_842_5336	5	-	0.0111858312249561	0.163313135884359
2167	harmol	hsa04010	MAPK signaling pathway	4217_3554_4149_3925_5578_1649_673_7189_5607_3845_5600_5602_5495_3164	14	-	0.00758727789843505	0.13846782164644
2168	harmol	hsa05213	Endometrial cancer	3845_842_6934_673	4	-	0.0392876154765905	0.325048591600564
2169	harmol	hsa05210	Colorectal cancer	842_1855_673_3845_6934_5602_2535	7	-	0.00485423135897293	0.118119629735008
2170	ajmaline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_3109	15	+	1.68767076999665e-05	0.00119824624669762
2171	ajmaline	hsa04115	p53 signaling pathway	472_4194_651610_7057_3486	5	+	0.0437669684546513	1
2172	ajmaline	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.049996516130574	1
2173	ajmaline	hsa04916	Melanogenesis	801_808_805_7477	4	-	0.00542309243092516	0.111173394833966
2174	ajmaline	hsa05214	Glioma	801_808_4193_805	4	-	0.00105842013860854	0.0433952256829501
2175	ajmaline	hsa04070	Phosphatidylinositol signaling system	801_808_805	3	-	0.0149399938249783	0.153134936706028
2176	ajmaline	hsa04720	Long-term potentiation	801_808_805	3	-	0.0144391705123542	0.153134936706028
2177	ajmaline	hsa04912	GnRH signaling pathway	801_808_805	3	-	0.036174764620607	0.296633069888977
2178	ajmaline	hsa04270	Vascular smooth muscle contraction	801_808_805	3	-	0.0448680221386449	0.30659815128074
2179	iodixanol	hsa05332	Graft-versus-host disease	3553_3123_3126_3127_3125_355	6	+	0.00160213151100226	0.0357276304014228
2180	iodixanol	hsa04640	Hematopoietic cell lineage	3553_3123_3126_3127_3125_947_915_914_3675	9	+	0.000996864799968949	0.0357276304014228
2181	iodixanol	hsa05320	Autoimmune thyroid disease	1081_3123_3126_3127_3125_355	6	+	0.00461475942774704	0.064635884393764
2182	iodixanol	hsa04612	Antigen processing and presentation	3123_3806_3126_3127_3125_6890	6	+	0.0406426660490277	0.325141328392222
2183	iodixanol	hsa04740	Olfactory transduction	157	1	+	0.000547267868566916	0.0357276304014228
2184	iodixanol	hsa05322	Systemic lupus erythematosus	474382_474381_83740_3123_3126_3127_3125_720_721	9	+	0.0208447193696945	0.18760247432725
2185	iodixanol	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0120874509072427	0.124328066474496
2186	iodixanol	hsa05330	Allograft rejection	3123_355_3126_3127_3125	5	+	0.00538632369948033	0.064635884393764
2187	iodixanol	hsa04940	Type I diabetes mellitus	3553_3123_3126_3127_3125_355	6	+	0.0019848683556346	0.0357276304014228
2188	iodixanol	hsa04070	Phosphatidylinositol signaling system	5333_51763_23236	3	-	0.0488703198646367	0.675895543838852
2189	iodixanol	hsa05320	Autoimmune thyroid disease	355_3107_1081	3	-	0.0202977125809576	0.675895543838852
2190	doxazosin	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	1.77596841612272e-05	0.00106558104967363
2191	doxazosin	hsa04664	Fc epsilon RI signaling pathway	100137049_8681_10000_5320	4	+	0.0342855777198645	0.304618419683199
2192	doxazosin	hsa04370	VEGF signaling pathway	100137049_8681_10000_5320	4	+	0.0317422989760171	0.304618419683199
2193	doxazosin	hsa04350	TGF-beta signaling pathway	5519_4088_1634_3624_8200	5	+	0.0115877662036875	0.23175532407375
2194	doxazosin	hsa04912	GnRH signaling pathway	5566_8681_5320_810_100137049_2797	6	+	0.00679672286452918	0.203901685935875
2195	doxazosin	hsa04730	Long-term depression	5519_8681_100137049_5320	4	+	0.0247995566228356	0.304618419683199
2196	doxazosin	hsa04270	Vascular smooth muscle contraction	810_5566_8681_100137049_5320	5	+	0.0355388156297066	0.304618419683199
2197	doxazosin	hsa05332	Graft-versus-host disease	3552_3123_3106_3107_3126_3127_3125_3135	8	-	0.000969160527282951	0.0314696797253501
2198	doxazosin	hsa05320	Autoimmune thyroid disease	3123_3106_3107_3126_3127_3125_3135	7	-	0.0118251592805122	0.155697930526744
2199	doxazosin	hsa04740	Olfactory transduction	5566	1	-	1.65156179288403e-06	0.000130473381637838
2200	doxazosin	hsa04060	Cytokine-cytokine receptor interaction	3552_7042	2	-	0.00159340150508102	0.0314696797253501
2201	doxazosin	hsa05330	Allograft rejection	3123_3106_3107_3126_3127_3125_3135	7	-	0.00236586897603594	0.0373807298213679
2202	doxazosin	hsa04940	Type I diabetes mellitus	3552_3123_3106_3107_3126_3127_3125_3135	8	-	0.00126341443125889	0.0314696797253501
2203	mometasone	hsa05332	Graft-versus-host disease	3811_3553_941_3135_355_3133_3802	7	+	0.00773576733486777	0.197158642257167
2204	mometasone	hsa04740	Olfactory transduction	56656_5132	2	+	2.07266346197528e-06	0.000169958403881973
2205	mometasone	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8370_83740_8368_8366_941_8360_8359_8362_8294_8367_554313_8970_121504	19	+	0.000244300247229892	0.0100163101364256
2206	mometasone	hsa04710	Circadian rhythm - mammal	4862_8553_5187	3	+	0.0371132274123804	0.380410580976899
2207	mometasone	hsa04115	p53 signaling pathway	1647_27113_5366_581_4193_355_1026_8795	8	+	0.0284348136313589	0.333093531110204
2208	mometasone	hsa04010	MAPK signaling pathway	9479_9344_3925_22808_4763_5603_3310_3164_11221_5319_3553_27006_2260_4217_8398_23542_3727_1647_1843_1649_1846_355_8911	23	+	0.0174936920263942	0.286896549232865
2209	mometasone	hsa05012	Parkinson's disease	6390	1	+	0.0227038266456732	0.3102856308242
2210	mometasone	hsa04940	Type I diabetes mellitus	3382_2572_941_3135_355_3133_3553	7	+	0.00961749474425203	0.197158642257167
2211	mometasone	hsa04115	p53 signaling pathway	27113_9134_4194_7057_1017_4616	6	-	0.00912256182505348	0.62945676592869
2212	mometasone	hsa04060	Cytokine-cytokine receptor interaction	5155	1	-	0.0226824009229175	0.782542831840654
2213	dihydroergocristine	hsa05214	Glioma	23533_5578_1029_51806_5335_816	6	+	0.0207454668511525	0.266233491256457
2214	dihydroergocristine	hsa04070	Phosphatidylinositol signaling system	23533_5578_51806_3708_5335_3707	6	+	0.0385739542368635	0.371274309529811
2215	dihydroergocristine	hsa04740	Olfactory transduction	51806_816	2	+	0.000783410305594005	0.0190079881686181
2216	dihydroergocristine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	19	+	4.98337373255461e-07	3.83719777406705e-05
2217	dihydroergocristine	hsa04664	Fc epsilon RI signaling pathway	23533_5578_50487_8681_5335_5603_100137049_6300	8	+	0.00489707009958715	0.0754148795336421
2218	dihydroergocristine	hsa04370	VEGF signaling pathway	23533_5578_50487_8681_5335_7422_5603_5534_100137049_6300	10	+	0.000297095684673991	0.0114381838599487
2219	dihydroergocristine	hsa04010	MAPK signaling pathway	9479_9344_5534_5578_50487_1846_5607_8681_5603_7042_7786_4149_100137049_6300_2264	15	+	0.0365450499312421	0.371274309529811
2220	dihydroergocristine	hsa04912	GnRH signaling pathway	51806_1081_5578_50487_3708_8681_5603_5338_100137049_6300_816	11	+	0.000987427956811331	0.0190079881686181
2221	dihydroergocristine	hsa05322	Systemic lupus erythematosus	85235_8969_8332_8330_8331_8329_8336	7	-	0.000314747229802896	0.00849817520467819
2222	raubasine	hsa04740	Olfactory transduction	5137_26212	2	+	0.00653144968216864	0.215537839511565
2223	raubasine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	2.70412768791808e-05	0.00178472427402593
2224	raubasine	hsa04070	Phosphatidylinositol signaling system	3628_3707_3708_3631_8526_23236	6	-	0.00499702576378896	0.146205389492922
2225	raubasine	hsa04740	Olfactory transduction	157	1	-	0.00743417234709774	0.146205389492922
2226	raubasine	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8337_8350_8351_8352_8353_8354_8355_8356_8357	12	-	4.7796082021648e-05	0.00281996883927723
2227	raubasine	hsa04360	Axon guidance	55558_57556_10725_2048_5998_7869_3983	7	-	0.017501600446111	0.258148606580137
2228	lobelanidine	hsa04640	Hematopoietic cell lineage	1436_2812_3122_2209_2993_3690_915_931_3675	9	+	0.0498809666563509	1
2229	lobelanidine	hsa04740	Olfactory transduction	8390_5568_442194_816	4	+	5.24956377447726e-05	0.00215232114753568
2230	lobelanidine	hsa05322	Systemic lupus erythematosus	8329_8343_8347_8346_8344_8339_3122_2209_8969_8968_8358_8330_8331_8336_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3111	26	+	1.4680829580045e-07	1.20382802556369e-05
2231	lobelanidine	hsa04120	Ubiquitin mediated proteolysis	11060_6477_4193_389898_22888_51619_6502	7	-	0.029702012223109	0.524105168806557
2232	lobelanidine	hsa05014	Amyotrophic lateral sclerosis (ALS)	4217_5630_5608_834	4	-	0.0336610318143406	0.524105168806557
2233	lobelanidine	hsa04740	Olfactory transduction	109_157	2	-	0.0259077107607063	0.524105168806557
2234	lobelanidine	hsa04540	Gap junction	23236_7278_109_113457_5154	5	-	0.0496574494513312	0.524105168806557
2235	harmalol	hsa04740	Olfactory transduction	26212_3000_816_5566	4	+	0.00220535824195511	0.172017942872499
2236	harmalol	hsa04912	GnRH signaling pathway	775_8398_3710_5566_2776_5337_5603_6714_5609_816	10	+	0.0113839199224793	0.443972876976693
2237	harmalol	hsa04916	Melanogenesis	7306_801_808_4286_805	5	-	0.0447270364629308	0.485201618930553
2238	harmalol	hsa05131	Shigellosis	7278_7280_113457_347733	4	-	0.0217658585922602	0.326487878883903
2239	harmalol	hsa05130	Pathogenic Escherichia coli infection	7278_7280_113457_347733	4	-	0.0217658585922602	0.326487878883903
2240	harmalol	hsa05322	Systemic lupus erythematosus	718_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	-	2.10099626968242e-05	0.000945448321357089
2241	scoulerine	hsa05332	Graft-versus-host disease	3553_3126_3127_3123_3125	5	+	0.0120441828477494	0.12445655609341
2242	scoulerine	hsa04640	Hematopoietic cell lineage	3553_3690_3123_3126_3127_3125_931_3684	8	+	0.00689796273101951	0.10308271299276
2243	scoulerine	hsa05320	Autoimmune thyroid disease	3439_3123_3447_3126_3127_3125	6	+	0.00761106928170358	0.10308271299276
2244	scoulerine	hsa04612	Antigen processing and presentation	4800_3439_3123_3447_3126_3127_3125_6892	8	+	0.00779893860104637	0.10308271299276
2245	scoulerine	hsa05016	Huntington's disease	161	1	+	0.0469760257858231	0.364064199840129
2246	scoulerine	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0171627013954873	0.152012498074316
2247	scoulerine	hsa05330	Allograft rejection	3592_3126_3127_3123_3125	5	+	0.00831312201554518	0.10308271299276
2248	scoulerine	hsa04940	Type I diabetes mellitus	3592_3553_3123_3126_3127_3125	6	+	0.00334611638509011	0.10308271299276
2249	scoulerine	hsa04080	Neuroactive ligand-receptor interaction	7067_4886_1909	3	-	0.0270776568069054	0.713044962581842
2250	scoulerine	hsa05322	Systemic lupus erythematosus	85235_3113_8330_8332_8969_8331_8329_8343_8336_8339_8347_8346_8344	13	-	0.0045025991217674	0.355705330619625
2251	scoulerine	hsa04350	TGF-beta signaling pathway	5308_4088_3398_6667_7057_655_652_9475	8	-	0.0213943571771843	0.713044962581842
2252	scoulerine	hsa05210	Colorectal cancer	4088_6655_5290_5599_1956_324_3725	7	-	0.0462347723326336	0.714574040518004
2253	thiamine	hsa03440	Homologous recombination	7516_10111	2	-	0.0411910633528485	0.463399462719546
2254	thiamine	hsa04662	B cell receptor signaling pathway	10725_3725_6654_4793	4	-	0.0103460419896608	0.463399462719546
2255	thiamine	hsa04660	T cell receptor signaling pathway	10725_3725_6654_4793	4	-	0.0345896873886639	0.463399462719546
2256	thiamine	hsa04912	GnRH signaling pathway	5338_6714_6654_3725	4	-	0.0327181107841322	0.463399462719546
2257	10-methoxyharmalan	hsa04740	Olfactory transduction	810	1	+	0.000555425521773311	0.0194398932620659
2258	10-methoxyharmalan	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	8.47028425116568e-05	0.00592919897581598
2259	10-methoxyharmalan	hsa04740	Olfactory transduction	157	1	-	0.00115197843420076	0.0783345335256517
2260	10-methoxyharmalan	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8337_8336	8	-	0.0313058530244275	1
2261	metrifonate	hsa04950	Maturity onset diabetes of the young	4760_3375_2494	3	+	0.00568353791008271	0.358062888335211
2262	metrifonate	hsa04070	Phosphatidylinositol signaling system	8871_3631_808_51763_801_805	6	-	0.00704899032544712	0.422939419526827
2263	metrifonate	hsa04210	Apoptosis	472_8837_651610_5534_8717	5	-	0.0457326426926645	0.72355515066693
2264	metrifonate	hsa04060	Cytokine-cytokine receptor interaction	7042	1	-	0.0463884722135705	0.72355515066693
2265	morantel	hsa04540	Gap junction	5598_7278_113457	3	+	0.023048389948331	0.524119915760964
2266	morantel	hsa04740	Olfactory transduction	219464	1	-	0.000583676048585479	0.0420246754981545
2267	8-azaguanine	hsa04070	Phosphatidylinositol signaling system	5728_1040_5578_1606_51763_5336_200576_8527_8760	9	-	0.0486680218219975	0.563158538225971
2268	8-azaguanine	hsa04120	Ubiquitin mediated proteolysis	10277_868_51366_7322_4734_6502_7329_672_26091_51588_9820_8450_7320_11060	14	-	0.0471169221711689	0.563158538225971
2269	8-azaguanine	hsa04080	Neuroactive ligand-receptor interaction	64106_7068	2	-	0.000123938684169286	0.0100390334177122
2270	8-azaguanine	hsa04310	Wnt signaling pathway	5578_9475	2	-	0.0180039538942716	0.364580066359
2271	8-azaguanine	hsa05012	Parkinson's disease	27429	1	-	0.00710405601876678	0.191809512506703
2272	8-azaguanine	hsa04060	Cytokine-cytokine receptor interaction	91_5155_8795	3	-	0.000479138894038974	0.0194051252085784
2273	8-azaguanine	hsa03010	Ribosome	6125	1	-	0.045197027462149	0.563158538225971
2274	meticrane	hsa05322	Systemic lupus erythematosus	3013_3113_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	+	0.000166058866734449	0.0106277674710047
2275	meticrane	hsa05010	Alzheimer's disease	11261_489	2	-	0.0499755701898441	0.427568767179777
2276	meticrane	hsa04080	Neuroactive ligand-receptor interaction	7434_1131_4157	3	-	0.0142147657152755	0.279534814031895
2277	meticrane	hsa04740	Olfactory transduction	5613_5616	2	-	4.30022173254872e-05	0.00165558536703126
2278	meticrane	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	19	-	2.02091676957883e-05	0.0015561059125757
2279	meticrane	hsa04210	Apoptosis	8503_5613_11261_5616_472_8737_8837_651610_8795	9	-	0.0145212890406179	0.279534814031895
2280	meticrane	hsa05221	Acute myeloid leukemia	8503_6655_6777_673_6932_5914	6	-	0.0413736167364884	0.427568767179777
2281	meticrane	hsa05110	Vibrio cholerae infection	30001_8992_5613_5616_523_528	6	-	0.0413736167364884	0.427568767179777
2282	meticrane	hsa05012	Parkinson's disease	7419	1	-	0.0455433170812947	0.427568767179777
2283	meticrane	hsa03020	RNA polymerase	246721_5439_548644_10622	4	-	0.0388238623856151	0.427568767179777
2284	sulfaphenazole	hsa04130	SNARE interactions in vesicular transport	8773_9570_8417	3	+	0.0415790152418491	1
2285	sulfaphenazole	hsa04740	Olfactory transduction	23538_816	2	+	0.0357622234054987	1
2286	sulfaphenazole	hsa05211	Renal cell carcinoma	2271_5295_998_3845_5781_3725	6	-	0.0405302490056971	0.381093451090991
2287	sulfaphenazole	hsa05010	Alzheimer's disease	4714	1	-	0.0321129216193618	0.381093451090991
2288	sulfaphenazole	hsa04080	Neuroactive ligand-receptor interaction	64106_2561	2	-	0.0187658322903353	0.381093451090991
2289	sulfaphenazole	hsa05131	Shigellosis	7278_2017_113457_8976_998	5	-	0.0471716382637231	0.381093451090991
2290	sulfaphenazole	hsa05130	Pathogenic Escherichia coli infection	7278_2017_113457_8976_998	5	-	0.0471716382637231	0.381093451090991
2291	sulfaphenazole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8370_8332_8359_8330_8331_8336_554313_8351_85235_3013_3014	24	-	8.4209227795861e-10	6.14727362909785e-08
2292	sulfaphenazole	hsa04060	Cytokine-cytokine receptor interaction	4982_8795	2	-	0.0130985700724591	0.381093451090991
2293	sulfaphenazole	hsa04020	Calcium signaling pathway	3707	1	-	0.0328385267700159	0.381093451090991
2294	sulfaphenazole	hsa05213	Endometrial cancer	2002_3845_5170_5295_324	5	-	0.0368051052897718	0.381093451090991
2295	procaine	hsa04360	Axon guidance	2047_10154_2048_5058_4772_6093_10505	7	+	0.0197476887539301	0.795627016163491
2296	procaine	hsa04740	Olfactory transduction	5566	1	-	0.000560974963402418	0.0179511988288774
2297	procaine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013	32	-	4.00596757640021e-18	2.56381924889613e-16
2298	chlortetracycline	hsa04916	Melanogenesis	5331_801_808_805_23236	5	-	0.0389112936633165	0.278559729249942
2299	chlortetracycline	hsa04070	Phosphatidylinositol signaling system	8871_56623_5331_808_51763_801_805_23236	8	-	8.9862902349252e-05	0.00395396770336709
2300	chlortetracycline	hsa04910	Insulin signaling pathway	2308_2319_808_51763_801_805	6	-	0.0370352785966159	0.278559729249942
2301	chlortetracycline	hsa05322	Systemic lupus erythematosus	81_92815_8343_8339_8347_8346_8344	7	-	0.0149520846291104	0.219297241226953
2302	chlortetracycline	hsa04720	Long-term potentiation	5331_801_808_805_23236	5	-	0.011834317070567	0.219297241226953
2303	chlortetracycline	hsa04062	Chemokine signaling pathway	157_156_6358_6359_5331_408_10681_23236	8	-	0.0220682380809696	0.242750618890666
2304	chlortetracycline	hsa04912	GnRH signaling pathway	5331_801_808_805_23236	5	-	0.0443163205624908	0.278559729249942
2305	aciclovir	hsa05332	Graft-versus-host disease	3105_3106_3126_3127_3125_3135_3123_649853	8	+	0.0057465335783056	0.07952872565974
2306	aciclovir	hsa05010	Alzheimer's disease	6622_348	2	+	0.00445694916311101	0.0775509154381316
2307	aciclovir	hsa05320	Autoimmune thyroid disease	3448_3105_3106_3126_3127_3125_3135_3123_649853	9	+	0.00672248916909407	0.07952872565974
2308	aciclovir	hsa04612	Antigen processing and presentation	4261_3448_3123_3106_3126_3127_3125_3135_6892_3105_3305_925_649853	13	+	0.00401291159801296	0.0775509154381316
2309	aciclovir	hsa05016	Huntington's disease	7416	1	+	0.000540178359499606	0.0234977586382329
2310	aciclovir	hsa04740	Olfactory transduction	8387_26212_7932_1179_8388	5	+	2.23644211913969e-05	0.00194570464365153
2311	aciclovir	hsa04514	Cell adhesion molecules (CAMs)	5010_6402_3688_965_3123_3106_3126_3127_3685_3125_3135_4359_9672_3105_925_649853	16	+	0.0106062259483432	0.102526850833984
2312	aciclovir	hsa05310	Asthma	2207_3123_3126_3127_3125_8288	6	+	0.0132018703517719	0.114856272060416
2313	aciclovir	hsa05012	Parkinson's disease	6622_7416	2	+	0.0360533357939741	0.285149110370522
2314	aciclovir	hsa05330	Allograft rejection	3105_3106_3126_3127_3125_3135_3123_649853	8	+	0.00339002163424139	0.0775509154381316
2315	aciclovir	hsa04940	Type I diabetes mellitus	3105_3106_3126_3127_3125_3135_3123_649853	8	+	0.0073129862675623	0.07952872565974
2316	aciclovir	hsa05131	Shigellosis	7454_7846_7430_9181	4	-	0.0383105848570311	0.969749901033229
2317	aciclovir	hsa05130	Pathogenic Escherichia coli infection	7454_7846_7430_9181	4	-	0.0383105848570311	0.969749901033229
2318	aciclovir	hsa04710	Circadian rhythm - mammal	8553_79365	2	-	0.0393141851770228	0.969749901033229
2319	guanabenz	hsa05332	Graft-versus-host disease	3811_3553_3109_3105_3106_3126_3127_3802_3135_3123_941_3125_649853	13	+	1.36927914676281e-05	0.00107568581148931
2320	guanabenz	hsa04640	Hematopoietic cell lineage	1435_3553_2812_3690_3123_3568_952_3126_3127_3125_3589_1378_931	13	+	0.00803620885820599	0.112506924014884
2321	guanabenz	hsa04080	Neuroactive ligand-receptor interaction	2904_2846_2570_1909_4142_1902_7433_1813_2561_5540_5724_2566_185_3953_4986_148_3356_3269_4544_2555_7253_8001_2893_8484_2357	25	+	0.0391658388973625	0.426864044993437
2322	guanabenz	hsa05320	Autoimmune thyroid disease	3109_7253_3105_3106_3126_3127_3125_3135_3123_941_649853	11	+	0.00118622708468368	0.0199286150226858
2323	guanabenz	hsa04612	Antigen processing and presentation	3811_3109_3123_3106_3126_3127_3125_3135_3105_3802_649853	11	+	0.0496793859090032	0.426864044993437
2324	guanabenz	hsa04740	Olfactory transduction	26212_26664_818_390892_5137_816	6	+	2.56115669402216e-05	0.00107568581148931
2325	guanabenz	hsa04920	Adipocytokine signaling pathway	3953_208_6513_8660_5599_1375_5781_5602_6257	9	+	0.0440670189639925	0.426864044993437
2326	guanabenz	hsa05330	Allograft rejection	3109_3105_3106_3126_3127_3125_3135_3123_941_649853	10	+	0.000408716538330336	0.00858304730493705
2327	guanabenz	hsa04940	Type I diabetes mellitus	3382_3109_3105_3106_3126_3127_3125_3135_3123_3553_941_649853	12	+	8.25178896941141e-05	0.00231050091143519
2328	guanabenz	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8343_8336_8339_8347_8346_8344	12	-	8.37590461228413e-05	0.00569561513635321
2329	guanabenz	hsa04370	VEGF signaling pathway	8681_4775_100137049_842_7422	5	-	0.0262472142050331	0.892405282971125
2330	lisuride	hsa04740	Olfactory transduction	26212	1	+	1.25721808933887e-05	0.000477742873948771
2331	lisuride	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013	33	+	1.00947382256744e-14	7.67200105151254e-13
2332	lisuride	hsa04920	Adipocytokine signaling pathway	1375_4793	2	-	0.0239574459975162	0.431234027955292
2333	daunorubicin	hsa04080	Neuroactive ligand-receptor interaction	2905_1813_9127_6754_1241_6915_8811_1909_1511_5644	10	+	0.00467586569537709	0.102869045298296
2334	daunorubicin	hsa04670	Leukocyte transendothelial migration	5010_93408_8503_5335	4	+	0.0336163944073307	0.493040451307517
2335	daunorubicin	hsa05016	Huntington's disease	5430_6648_642502_6391_317_9001_1339_6875	8	+	0.0261788976754271	0.460748599087517
2336	daunorubicin	hsa04740	Olfactory transduction	818_5613_5616_816	4	+	1.46795890820131e-10	1.29180383921715e-08
2337	daunorubicin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_1511_9555	28	+	0.000677155422441182	0.0198632257249413
2338	daunorubicin	hsa04115	p53 signaling pathway	55367_1647_1026_5366_55240_64393_317_4193_7249_3486_8493_898_355_10912_8795_5268_3732_9540_2810	19	+	9.53297553797211e-05	0.00419450923670773
2339	daunorubicin	hsa04062	Chemokine signaling pathway	8503_156_5613_6655_6777_5616_7454_8976_4793	9	+	0.0399049699823133	0.501662479777653
2340	daunorubicin	hsa04260	Cardiac muscle contraction	786_1339	2	+	0.0462747374004689	0.509022111405158
2341	daunorubicin	hsa04916	Melanogenesis	23236_5567_6934_2535_5578_2773_2776_7475_7855_5332_2033_7477_113_8324_1385_1387_8321_107_8322	19	-	0.0154830794096102	0.0519789094465485
2342	daunorubicin	hsa05332	Graft-versus-host disease	3123_355_3126_3127_3125	5	-	0.0263291118400188	0.0798366617084441
2343	daunorubicin	hsa04650	Natural killer cell mediated cytotoxicity	8503_5295_5290_10451_3383_3455_3459_7410_5781_7535_10725_673_5533_5532_5530_5534_8795_5777_5578_6655_6654_6464_355_4775_7409	25	-	0.00447197609654688	0.0161679135798233
2344	daunorubicin	hsa04640	Hematopoietic cell lineage	3581_3554_960_2057_3690_3123_3126_3127_3125_933_290	11	-	0.00134524228728326	0.00632263875023132
2345	daunorubicin	hsa03320	PPAR signaling pathway	79966_5360_7316_6256_1375_9415_5467_6319_28965	9	-	0.00391552518047153	0.014722374678573
2346	daunorubicin	hsa05010	Alzheimer's disease	2903_488_317_9451_2776_5332_7132_509_8772_5533_5532_3708_5530_5534_102_23236_842_841_4137_355_351_8851	22	-	1.81181834202029e-06	2.43301320214153e-05
2347	daunorubicin	hsa04080	Neuroactive ligand-receptor interaction	2903_64106_2908_56288_136_134_1813_5540_3953_2150_5021_1131_4886_6915_5732_23566_9170_5618_7068_7067_4158_2740_2690	23	-	9.92247774807977e-13	4.66356454159749e-11
2348	daunorubicin	hsa04742	Taste transduction	5567	1	-	5.05594319011958e-06	5.94073324839051e-05
2349	daunorubicin	hsa05320	Autoimmune thyroid disease	3123_355_3126_3127_3125	5	-	0.00326890436288195	0.0133598700048219
2350	daunorubicin	hsa04612	Antigen processing and presentation	4800_4801_4802_3123_3126_3127_3125_6890_1385_3304_3305_3303	12	-	0.0016759282099631	0.00750177389221578
2351	daunorubicin	hsa05131	Shigellosis	4690_5578_7278_113457_9475_7430_25_9181_2017	9	-	0.0431588357080002	0.1014232639138
2352	daunorubicin	hsa04670	Leukocyte transendothelial migration	8503_5295_1432_3383_5781_5578_5290_2773_6387_27035_9475_7852_10451_7430_4636_7410_5747_7409_23562	19	-	0.00115820533883937	0.00573006851846846
2353	daunorubicin	hsa05016	Huntington's disease	4899_317_246721_2776_5332_23186_6874_5430_5439_2033_509_1213_3708_548644_23236_27113_842_841_5978_1385_1387_9519	22	-	2.68052481451156e-07	4.19948887606811e-06
2354	daunorubicin	hsa05130	Pathogenic Escherichia coli infection	4690_5578_7278_113457_9475_7430_25_9181_2017	9	-	0.0431588357080002	0.1014232639138
2355	daunorubicin	hsa04740	Olfactory transduction	4991_26529_5567_157_26716	5	-	4.24645400107485e-41	3.99166676101036e-39
2356	daunorubicin	hsa04514	Cell adhesion molecules (CAMs)	965_214_4685_3383_5819_3123_4099_6693_3126_3127_3685_3125_23705_3897_6383_933_5792_9019_4897_23562	20	-	0.000459843058271953	0.00254266161632727
2357	daunorubicin	hsa04510	Focal adhesion	8503_10298_596_6464_5295_331_5154_5290_9475_10451_4636_5747_4659_3690_3693_7057_7410_1399_1398_55742_329_3082_5062_1793_3480_673_1956_3725_6714_4233_5578_5228_3371_1729_2317_6655_6654_1289_3685_7409_7422_83660	42	-	0.00366499203746743	0.0143545521467474
2358	daunorubicin	hsa05340	Primary immunodeficiency	7535_6890_64421	3	-	0.013443283034474	0.0468025409348354
2359	daunorubicin	hsa04140	Regulation of autophagy	8408_5289_9474_5562	4	-	0.0393691327249643	0.1014232639138
2360	daunorubicin	hsa04530	Tight junction	55844_10207_5578_2773_8777_50855_6709_51776_84612_1457_56288_4636_64398_7525_2017_2036_9223_6714_27134_23562	20	-	0.000256729710956941	0.00180780170139117
2361	daunorubicin	hsa04664	Fc epsilon RI signaling pathway	8503_50487_1432_4067_5295_5578_6655_6416_10451_5290_7410_6654_7409_5609	14	-	0.0296327780735221	0.0819259158503258
2362	daunorubicin	hsa05218	Melanoma	8503_3480_5295_5154_5290_4193_1956_1871_2260_673_4233_3082	12	-	0.0296065713463565	0.0819259158503258
2363	daunorubicin	hsa05110	Vibrio cholerae infection	5567_3784_5578	3	-	4.87107730630679e-05	0.000416255697084398
2364	daunorubicin	hsa04512	ECM-receptor interaction	960_3690_3693_1289_7057_3371_3685_6383_3161	9	-	0.00039293413637204	0.00246238725459812
2365	daunorubicin	hsa04630	Jak-STAT signaling pathway	3717_6777_598_5295_5292_8503_5290_6772_9655_10253_10254_2057_3455_3459_3572_2033_5781_3581_3953_1154_200734_8554_4609_8027_5777_868_5618_6655_6654_867_51588_10379_8835_1387_2690	35	-	0.0421116654336978	0.1014232639138
2366	daunorubicin	hsa04062	Chemokine signaling pathway	3717_6777_157_156_2773_8503_5290_9475_7852_6387_5332_56288_113_5747_2309_2786_4067_3551_5567_7410_1399_1398_6361_4793_5295_673_107_4792_23236_6655_6654_6464_10451_6772_7409_5970	36	-	0.00112287148226148	0.00573006851846846
2367	daunorubicin	hsa04810	Regulation of actin cytoskeleton	8503_10298_10672_5295_5154_5290_9475_10451_4636_5747_10458_4659_3690_1730_3693_23191_8394_7410_50649_7430_1399_1398_2245_5962_8396_200576_324_5062_1793_1131_9138_673_1956_2260_8874_1729_6655_6654_5305_3685_8936_7409_54434_3985	44	-	0.00186776841352292	0.00798046503959793
2368	daunorubicin	hsa05012	Parkinson's disease	2861_7326_842_7314_317_51465_509	7	-	2.85625119782829e-10	8.94958708652864e-09
2369	daunorubicin	hsa04620	Toll-like receptor signaling pathway	8503_6416_1326_841_3551_3455_8772_5295_6772_148022_7189_1432_5290_3725_8737_29110_5970_5609_4792	19	-	0.0196612941234011	0.0616053882533234
2370	daunorubicin	hsa04260	Cardiac muscle contraction	27092_481_488	3	-	2.04444207967944e-07	3.84355110979735e-06
2371	daunorubicin	hsa04060	Cytokine-cytokine receptor interaction	8744_5154_8741_7852_6387_90_7132_27242_3554_2057_3455_3459_3572_657_4982_6361_3082_3581_3604_3953_23765_8742_1956_91_655_8792_92_4233_8795_5618_355_7422_2690	33	-	4.64024951761952e-09	1.09045863664059e-07
2372	daunorubicin	hsa03010	Ribosome	6139_6181_9349_6137_6125_6168_6233_439992_6144_6234_6129_6189_6171	13	-	0.000453491681917588	0.00254266161632727
2373	daunorubicin	hsa04020	Calcium signaling pathway	2903_5534_2776_7220_5333_5332_136_113_493_5532_5256_5567_3707_814_56848_5021_1131_5533_6915_3708_5530_488_107_23236_5578_1956_683	27	-	1.81764985784983e-05	0.000187847124931414
2374	daunorubicin	hsa03050	Proteasome	23198	1	-	1.99837366948313e-05	0.000187847124931414
2375	daunorubicin	hsa04912	GnRH signaling pathway	6416_113_50487_2776_5332_5337_5609_5567_4214_4216_468_3708_1956_3725_6714_107_23236_1432_5578_5598_6655_6654	22	-	0.0406311525620852	0.1014232639138
2376	daunorubicin	hsa04730	Long-term depression	50487_2781_4067_5578_10672_2773_2776_673_3708_5332_3480_23236	12	-	0.0296065713463565	0.0819259158503258
2377	daunorubicin	hsa04270	Vascular smooth muscle contraction	5567_5578_10672_50487_2776_673_27094_3708_5332_136_113_9138_9475_4659_107_23236	16	-	0.000269247061909323	0.00180780170139117
2378	daunorubicin	hsa04940	Type I diabetes mellitus	3382_3123_3126_3127_3125_355	6	-	0.0333949406756477	0.0896892692431681
2379	daunorubicin	hsa02010	ABC transporters	6890_215_8714_23457_22	5	-	0.0189110117976432	0.0612977623785676
2380	daunorubicin	hsa04610	Complement and coagulation cascades	727_7056_7035_2152_5329	5	-	0.000111782091386297	0.000875626382525993
2381	methyldopate	hsa04740	Olfactory transduction	393046	1	+	1.16979404802778e-05	0.000853949655060279
2382	methyldopate	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8341_8350_8351_8352_8353_8354_8355_8356_8357	12	+	0.0143464355809098	0.523644898703208
2383	methyldopate	hsa05210	Colorectal cancer	11211_581_1856_7046_8312_5602_91	7	+	0.0473015402564626	0.921512001401661
2384	estrone	hsa04740	Olfactory transduction	26212	1	+	0.010723060181307	0.64338361087842
2385	estrone	hsa04730	Long-term depression	30814_3708_1394_23236	4	+	0.0480607763437941	1
2386	estrone	hsa05332	Graft-versus-host disease	3105_3106_3126_3127_3125_3133_3123_3113	8	-	0.0112902324942281	0.119958720251174
2387	estrone	hsa04080	Neuroactive ligand-receptor interaction	3953_1269_706_2692	4	-	0.000389027547495404	0.0165336707685547
2388	estrone	hsa05016	Huntington's disease	4714_1350_4728	3	-	0.0036164373335614	0.102465724450906
2389	estrone	hsa04740	Olfactory transduction	5566	1	-	5.2965888823509e-10	4.50210054999827e-08
2390	estrone	hsa05221	Acute myeloid leukemia	1050_6932_6654_5295_5293_5605_3265_6934_6777_5914	10	-	0.00983450557083332	0.119958720251174
2391	estrone	hsa05012	Parkinson's disease	4714_1350_4728	3	-	0.0491482511071127	0.379781940373144
2392	estrone	hsa04060	Cytokine-cytokine receptor interaction	3454_23529_5155_8742_8741_3953_7042	7	-	0.00991605828810202	0.119958720251174
2393	estrone	hsa04020	Calcium signaling pathway	5566_5335_489	3	-	0.00519828958771937	0.110463653739037
2394	estrone	hsa05330	Allograft rejection	3105_3106_3126_3127_3125_3133_3123_3113	8	-	0.0068208750038613	0.115954875065642
2395	estrone	hsa04940	Type I diabetes mellitus	3105_3106_3126_3127_3125_3133_3123_3113	8	-	0.0141990815697969	0.134102437048082
2396	estrone	hsa05220	Chronic myeloid leukemia	1026_598_6654_5293_5605_2122_3265_6777_7042_5295	10	-	0.0416741240571288	0.354230054485595
2397	(-)-MK-801	hsa04740	Olfactory transduction	810_8390_1258	3	+	0.00765842933140497	0.275703455930579
2398	(-)-MK-801	hsa04630	Jak-STAT signaling pathway	3593_3451_10000_3454_23529_6654_200734_2688_2689_9180_10253_1442	12	+	0.00324730993904718	0.233806315611397
2399	(-)-MK-801	hsa04080	Neuroactive ligand-receptor interaction	3953_5028_5618_2925_1131	5	-	0.0260700042137355	0.52950670229379
2400	(-)-MK-801	hsa04910	Insulin signaling pathway	5584_5170_3551_5575_5293_7249_2002_6720_10211_51763_5602_8651_3845_5792	14	-	0.0186749627231066	0.52950670229379
2401	(-)-MK-801	hsa05322	Systemic lupus erythematosus	8330_3113	2	-	0.0491794487732384	0.629280197600058
2402	(-)-MK-801	hsa04210	Apoptosis	3552_3551_598_5575_5293_472_51135_651610_8795_7186	10	-	0.02715418986122	0.52950670229379
2403	(-)-MK-801	hsa04060	Cytokine-cytokine receptor interaction	3953_5618_3552_8795	4	-	0.00790361779685636	0.52950670229379
2404	(-)-MK-801	hsa04020	Calcium signaling pathway	1131_2925_5578	3	-	0.0364574685296592	0.568736509062683
2405	fluspirilene	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_8349_8362_8294_121504_8366_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_83740_3013_3111_8970	31	+	2.0116997179259e-11	1.48865779126517e-09
2406	fluspirilene	hsa05219	Bladder cancer	2277_1026_3576_1029_1613_7422	6	+	0.0176338129588275	0.469416304285415
2407	fluspirilene	hsa04115	p53 signaling pathway	55367_1647_27113_5366_1029_1026_8795_4616	8	+	0.0190303907142736	0.469416304285415
2408	fluspirilene	hsa05012	Parkinson's disease	7318	1	+	0.0322629605731282	0.596864770602872
2409	fluspirilene	hsa04080	Neuroactive ligand-receptor interaction	3354_1269_4889	3	-	0.0375966244088989	1
2410	fluspirilene	hsa04060	Cytokine-cytokine receptor interaction	91_4982_2324	3	-	0.0270071214859322	1
2411	megestrol	hsa04740	Olfactory transduction	393046	1	+	0.000264270578457621	0.019556022805864
2412	megestrol	hsa05219	Bladder cancer	5925_2277_1612_7057	4	+	0.0433364546473922	1
2413	megestrol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3013_554313_3113_8359_8330_8294_8367_121504_8368_8351	18	-	1.44392234452774e-07	1.0251848646147e-05
2414	megestrol	hsa04010	MAPK signaling pathway	3554_3925_6789_6655_1649_4137_4763_10912_5534_10746_2260_5971_3725	13	-	0.0359533499606474	0.987633594723948
2415	benzbromarone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_8294_8367_8342_121504_3119	16	+	4.10209864171793e-07	3.11759496770563e-05
2416	benzbromarone	hsa04710	Circadian rhythm - mammal	8553_1408_5187	3	+	0.0047057761533757	0.178819493828277
2417	benzbromarone	hsa04916	Melanogenesis	6934_1856	2	-	0.0498179773724322	0.236635392519053
2418	benzbromarone	hsa05200	Pathways in cancer	405_3914_6934_1856	4	-	0.0259605035405503	0.216064570689521
2419	benzbromarone	hsa05210	Colorectal cancer	6934_1856	2	-	0.0341154585299244	0.216064570689521
2420	benzbromarone	hsa05217	Basal cell carcinoma	6934_1856	2	-	0.0158321651825013	0.216064570689521
2421	prasterone	hsa04080	Neuroactive ligand-receptor interaction	2908_2359_728	3	+	0.0270396014602359	0.576491214956812
2422	prasterone	hsa04310	Wnt signaling pathway	11261	1	+	0.0461897422766118	0.729797927970466
2423	prasterone	hsa04740	Olfactory transduction	56656_4991	2	+	0.000129664304405291	0.010243480048018
2424	prasterone	hsa05221	Acute myeloid leukemia	6654_862_5371_5605_3845_5914	6	+	0.0291894286054082	0.576491214956812
2425	prasterone	hsa04620	Toll-like receptor signaling pathway	7097_3451_6352_7100_6772_5605_3627_3553_6373	9	+	0.0186784374552049	0.576491214956812
2426	prasterone	hsa04740	Olfactory transduction	219464_26211	2	-	0.00461160868747326	0.285919738623342
2427	etynodiol	hsa05131	Shigellosis	7278_113457_929_7430_6093_81027	6	+	0.0267790539097316	0.401685808645974
2428	etynodiol	hsa05130	Pathogenic Escherichia coli infection	7278_113457_929_7430_6093_81027	6	+	0.0267790539097316	0.401685808645974
2429	etynodiol	hsa04740	Olfactory transduction	51806_8390	2	+	8.96488152500427e-05	0.0067236611437532
2430	etynodiol	hsa04710	Circadian rhythm - mammal	4862_8553_8863	3	+	0.0197643348366958	0.401685808645974
2431	etynodiol	hsa04920	Adipocytokine signaling pathway	3717_3551_5602_2182_1375_5781_8717	7	+	0.019469832652075	0.401685808645974
2432	etynodiol	hsa04070	Phosphatidylinositol signaling system	8394_8396_5578_3631	4	-	0.0262613664072924	0.748448942607833
2433	etynodiol	hsa04310	Wnt signaling pathway	4040_5578_1855_9475_6934_5534	6	-	0.0242367077432905	0.748448942607833
2434	etynodiol	hsa04210	Apoptosis	472_3554_651610_5534	4	-	0.042221706252878	0.802212418804682
2435	podophyllotoxin	hsa05010	Alzheimer's disease	836_5663_3708_3709_6868_102_6622	7	+	0.0162352015805893	0.198708438533873
2436	podophyllotoxin	hsa04080	Neuroactive ligand-receptor interaction	2917_64106_2893_6755_59340_56288_5733_5732_2150_5644	10	+	0.00260556939764433	0.0960877520901619
2437	podophyllotoxin	hsa05016	Huntington's disease	246721_836_3708_2033_9001_3064_1385	7	+	0.0092783450378333	0.161443203658299
2438	podophyllotoxin	hsa04740	Olfactory transduction	26212	1	+	3.26736221896154e-14	2.84260513049654e-12
2439	podophyllotoxin	hsa04510	Focal adhesion	10000_1302_596_858_2909_5154_7057_4636_5602_7791_3655_81_3676_857_3381_3694_3695_7414_29780_1290_10627_1399_3918_3725_4233_1281_2335_5599_2317_1289_7422	31	+	0.0182720403249538	0.198708438533873
2440	podophyllotoxin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8341_81_8347_8346_8344_8370_718_8359_554313_121504_8339_3118_3117_3111	25	+	0.00773817652812672	0.161443203658299
2441	podophyllotoxin	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3579_836_5599_50848_3576_5602_6868_5600_5336_102_3725_4233_9020	13	+	0.0308204328754556	0.262979077538939
2442	podophyllotoxin	hsa04512	ECM-receptor interaction	1289_2811_2335_1302_3381_960_3694_3695_7057_1281_3655_1290_3918_3676_3339	15	+	0.0284066369612204	0.262979077538939
2443	podophyllotoxin	hsa05012	Parkinson's disease	6622_836_9627	3	+	0.00331337076172972	0.0960877520901619
2444	podophyllotoxin	hsa03010	Ribosome	6181_6171	2	+	0.0120743282451723	0.175077759554998
2445	podophyllotoxin	hsa04270	Vascular smooth muscle contraction	108_3709_3708_72	4	+	0.0332502281945785	0.262979077538939
2446	podophyllotoxin	hsa05332	Graft-versus-host disease	3135_3105_3106_3111_649853	5	-	0.00077377510518561	0.0152457721040936
2447	podophyllotoxin	hsa05320	Autoimmune thyroid disease	3135_3105_3106_3111_649853	5	-	0.002015446161421	0.0218340000820608
2448	podophyllotoxin	hsa04612	Antigen processing and presentation	6891_3105_3106_3806_3111_3135_5994_649853	8	-	0.000128424702444046	0.00834760565886299
2449	podophyllotoxin	hsa04514	Cell adhesion molecules (CAMs)	3688_3105_3106_3111_3135_57863_649853_5817	8	-	0.00165535131583628	0.0215195671058716
2450	podophyllotoxin	hsa05322	Systemic lupus erythematosus	85235_8330_3111_8332_8969_8331_8329_8336	8	-	0.00253876320122376	0.0235742297256492
2451	podophyllotoxin	hsa05330	Allograft rejection	3135_3105_3106_3111_649853	5	-	0.000510437857396215	0.0152457721040936
2452	podophyllotoxin	hsa04940	Type I diabetes mellitus	3135_3105_3106_3111_649853	5	-	0.000938201360251912	0.0152457721040936
2453	paroxetine	hsa04740	Olfactory transduction	26212_8388_8387_1179_2978_5137	6	+	0.00180439027317614	0.144351221854091
2454	paroxetine	hsa04270	Vascular smooth muscle contraction	112	1	+	0.0451298228928404	1
2455	paroxetine	hsa04912	GnRH signaling pathway	2778_1956_50487_1081_816	5	-	0.0168978368076828	0.861789677191823
2456	pheneticillin	hsa05332	Graft-versus-host disease	3553_3123_3107_3126_3127_3125	6	+	0.0160438799399614	0.223812110037963
2457	pheneticillin	hsa04640	Hematopoietic cell lineage	1437_960_3553_2814_3123_3126_3127_3125_1378_3684	10	+	0.00851505891435274	0.210038119887368
2458	pheneticillin	hsa05016	Huntington's disease	7052_6648	2	+	0.0181469278409159	0.223812110037963
2459	pheneticillin	hsa04740	Olfactory transduction	51806_5593_23538_26476_26532_1258	6	+	0.00321631449441225	0.210038119887368
2460	pheneticillin	hsa05322	Systemic lupus erythematosus	85235_3123_3126_3127_3125_8332_8969_8331_8336_8342_8329_8330	12	+	0.0441477647131329	0.408366823596479
2461	pheneticillin	hsa04512	ECM-receptor interaction	2814_7059_1281_22798_1311_7057_3371_960_1291	9	+	0.0180012479409633	0.223812110037963
2462	pheneticillin	hsa05330	Allograft rejection	3123_3107_3126_3127_3125	5	+	0.0357547259438636	0.377978531406558
2463	pheneticillin	hsa04940	Type I diabetes mellitus	3553_3123_3107_3126_3127_2571_3125	7	+	0.0057466947292528	0.210038119887368
2464	pheneticillin	hsa05200	Pathways in cancer	5970_4149_581_572_998_5290_3918_7423_6934_5914_2247_3675	12	-	0.011324542149981	0.185791293034008
2465	pheneticillin	hsa04210	Apoptosis	581_572_5290_472_8837_5970	6	-	0.00347587772387229	0.12165572033553
2466	pheneticillin	hsa05221	Acute myeloid leukemia	572_5970_6934_5290_5914	5	-	0.00303011628039182	0.12165572033553
2467	pheneticillin	hsa04370	VEGF signaling pathway	10725_572_998_5290	4	-	0.036541624905913	0.354913163199633
2468	pheneticillin	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.012942722770936	0.185791293034008
2469	pheneticillin	hsa04912	GnRH signaling pathway	2778_5331_1839_998_23236	5	-	0.0306590743863604	0.354913163199633
2470	pheneticillin	hsa05210	Colorectal cancer	572_5290_6934_581	4	-	0.0472053769081881	0.354913163199633
2471	pheneticillin	hsa05222	Small cell lung cancer	3918_5970_4149_5290_3675	5	-	0.0132708066452863	0.185791293034008
2472	propidium iodide	hsa05200	Pathways in cancer	91_861_1956_6257_3910	5	+	0.014520422880897	0.392051417784219
2473	propidium iodide	hsa04910	Insulin signaling pathway	5770	1	+	0.0456116806113896	0.827768642268633
2474	propidium iodide	hsa04740	Olfactory transduction	3000	1	+	5.53817030050105e-06	0.000448591794340585
2475	propidium iodide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_8294_720_721_121504_6737_8367	17	+	0.000177976160654142	0.00720803450649275
2476	propidium iodide	hsa04080	Neuroactive ligand-receptor interaction	3953	1	-	0.00750306024646205	0.169610528650885
2477	propidium iodide	hsa04350	TGF-beta signaling pathway	4090_4088_7057_5519_1874_5934_5933_57154	8	-	0.00581402813932293	0.169610528650885
2478	propidium iodide	hsa04062	Chemokine signaling pathway	6655	1	-	0.0468723862078483	0.785112468981459
2479	propidium iodide	hsa04060	Cytokine-cytokine receptor interaction	3953	1	-	0.00759450128287545	0.169610528650885
2480	PF-01378883-00	hsa04120	Ubiquitin mediated proteolysis	23327_23759_5371_867_8651_5071_9021	7	+	0.020524631718119	0.294186387959706
2481	PF-01378883-00	hsa05016	Huntington's disease	1213_4899_1339_7052_54205_651820_246721_6392_56901_55567	10	+	0.00722003049738694	0.155230655693819
2482	PF-01378883-00	hsa04740	Olfactory transduction	8388_8387_2978_1179_81697_26476_81797_810_81696_393046_816	11	+	3.6606569518813e-09	3.14816497861792e-07
2483	PF-01378883-00	hsa04514	Cell adhesion molecules (CAMs)	23308_22871_9672_5133_5797_3384_3383_3123_3126_3127_3125_7412_914_1272_3689_4684_3688_3119_947_3113_3685_3684_5818_6693_26047_1000	26	+	0.0272666843814946	0.334990693829791
2484	PF-01378883-00	hsa05322	Systemic lupus erythematosus	2903_474382_8363_474381_8365_8364_8367_8360_8368_88_8362_8294_121504_8341_3123_3458_8366_3126_3127_3125_8968_8370_717_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2213_3119_83740_3013_3113_8361	40	+	9.36018220475616e-06	0.000402487834804515
2485	PF-01378883-00	hsa04512	ECM-receptor interaction	1278_1291_375790_2811_1280_3910_3691_960_7057_3685_1277_5649_63923_3688_9672_1288_1281_51206_9899	19	+	0.0151498252926782	0.260576995034065
2486	PF-01378883-00	hsa03010	Ribosome	6141_6165_6171	3	+	0.00606938257775683	0.155230655693819
2487	PF-01378883-00	hsa04120	Ubiquitin mediated proteolysis	51343_7318_7189_331_23759_5371_4193_26232_26272_8916_8651_326_9021	13	-	0.0132412454526832	0.145812732488835
2488	PF-01378883-00	hsa05010	Alzheimer's disease	775_5331_4713_3553_3710_2904_2081_2776_4137_5533_5532_3708_3709_5534_810_801_6622_808_805_23236	20	-	0.0296938328692378	0.245648981009149
2489	PF-01378883-00	hsa05016	Huntington's disease	4899_1211_6648_2904_1639_4713_5430_2776_5331_64446_3708_7416_9001_9586_1742_23236	16	-	0.000933551866088106	0.0283177399380059
2490	PF-01378883-00	hsa03420	Nucleotide excision repair	2068	1	-	0.00686551122586931	0.104126920259018
2491	PF-01378883-00	hsa04740	Olfactory transduction	26211_26212_56656_8388_8387_23538_808_805_810_801_9635_816_81797	13	-	4.03203057419135e-16	3.66914782251413e-14
2492	PF-01378883-00	hsa04110	Cell cycle	5001_699_4088_51343_4193_1028_5000_8555_7042_8243	10	-	0.0102721292820967	0.133537680667257
2493	PF-01378883-00	hsa05340	Primary immunodeficiency	4261_3561_695_29851_925_6891_920_326_5897_915_5788_29760_926	13	-	0.0446494458294872	0.338591630873611
2494	PF-01378883-00	hsa04115	p53 signaling pathway	55367_3732_7249_4193	4	-	0.0144210394769177	0.145812732488835
2495	PF-01378883-00	hsa05110	Vibrio cholerae infection	525_5579	2	-	0.0041212796833776	0.0750072902374723
2496	PF-01378883-00	hsa03022	Basal transcription factors	6872	1	-	0.0232269552568319	0.21136529283717
2497	PF-01378883-00	hsa05012	Parkinson's disease	6622_4713_7416_7318_5413	5	-	6.63910016784746e-06	0.000302079057637059
2498	PF-01378883-00	hsa03010	Ribosome	284393_439992_6234_6165_389342_6189	6	-	0.00202129827415339	0.0459845357369896
2499	metoprolol	hsa05332	Graft-versus-host disease	3553_3119_3123_3107_3126_3127_3111_3125_3135	9	+	0.00656066407972263	0.108907023723396
2500	metoprolol	hsa04640	Hematopoietic cell lineage	2814_1435_3553_2812_3123_3568_960_3126_3127_3125_3674_1378_931_290	14	+	0.00862630490111463	0.114884901342716
2501	metoprolol	hsa05010	Alzheimer's disease	348_3708_3709_3553_51806	5	+	0.0248684458023287	0.229342333510365
2502	metoprolol	hsa05320	Autoimmune thyroid disease	3448_3119_3123_3107_3126_3127_3111_3125_3135	9	+	0.0355358002675075	0.268133765654829
2503	metoprolol	hsa04612	Antigen processing and presentation	4800_6891_3448_3119_3123_3107_3126_3127_3111_3125_3135_6892	12	+	0.0462531333581556	0.319917505727243
2504	metoprolol	hsa05016	Huntington's disease	5432_5468_3708_1211	4	+	0.00536745719371499	0.108907023723396
2505	metoprolol	hsa04740	Olfactory transduction	51806_26212_5568_157_9635_3000_815	7	+	5.21150709944847e-06	0.000432555089254223
2506	metoprolol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8342_8341_8340_3123_3126_3127_3125_8370_8359_554313_121504_2213_3119_3111	24	+	0.000476887357750909	0.0197908253466627
2507	metoprolol	hsa05310	Asthma	3119_3123_3126_3127_3111_3125	6	+	0.0319670281990092	0.265326334051776
2508	metoprolol	hsa03010	Ribosome	9045	1	+	0.00985814137190907	0.114884901342716
2509	metoprolol	hsa05330	Allograft rejection	3119_3123_3107_3126_3127_3111_3125_3135	8	+	0.0110732435029124	0.114884901342716
2510	metoprolol	hsa04940	Type I diabetes mellitus	3553_3119_3123_3107_3126_3127_3111_2571_3135_3125	10	+	0.00296053573058521	0.0819081552128575
2511	metoprolol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3111_8359_8294_8367_554313_121504	15	-	7.30853890665181e-10	3.36192789705983e-08
2512	metformin	hsa05332	Graft-versus-host disease	57292_3824_3553_3123_3107_3126_3127_3111_3125_3135_3133	11	+	0.0437604406035268	0.433545324694507
2513	metformin	hsa04120	Ubiquitin mediated proteolysis	7337_23759_11060_51343_7329_22888_996_8651_6923	9	+	0.0481717027438341	0.433545324694507
2514	metformin	hsa04612	Antigen processing and presentation	4800_4261_57292_3824_3448_5994_3123_3107_3126_3127_5641_3125_3135_6890_6891_3111_3133_4802_920_811	20	+	0.021147389900029	0.272275553231343
2515	metformin	hsa05016	Huntington's disease	8218_7052_6390_1329_317_5331_7350_3708_5332_55567_23236	11	+	0.00859551882520892	0.154719338853761
2516	metformin	hsa04740	Olfactory transduction	219464_5566_2979_8392_393046_5137_26476_26532_810_26529_815_816	12	+	2.81787987853335e-09	2.53609189068002e-07
2517	metformin	hsa04110	Cell cycle	4174_996_993_51343_7042_8318	6	+	0.0211769874735489	0.272275553231343
2518	metformin	hsa05012	Parkinson's disease	6390_1329_317	3	+	0.000116549526620441	0.00524472869791984
2519	metformin	hsa04260	Cardiac muscle contraction	1329_779	2	+	0.00506056452932156	0.151816935879647
2520	metformin	hsa04912	GnRH signaling pathway	112_5331_5332_5337_5602_5609_5566_810_100137049_6300_816_779_998_108_3725_23236_5605_100133953_6655_3708_815_2002_2798_8681_2797	25	+	0.00783326744943698	0.154719338853761
2521	metformin	hsa04940	Type I diabetes mellitus	3382_3126_3107_2572_3127_3111_3125_3135_3133_3123_3553_5798	12	+	0.0290944732449275	0.327312824005434
2522	metformin	hsa04080	Neuroactive ligand-receptor interaction	2902_7068_64106_5617_2893_4142_1241_2561_6752_56288_135_5645_5644_5646	14	-	0.000193085596613985	0.00585692976395755
2523	metformin	hsa04742	Taste transduction	3710	1	-	0.0119189655057359	0.154946551574567
2524	metformin	hsa04740	Olfactory transduction	26333_26476_5593_56656_817	5	-	6.39889467674063e-16	5.82299415583397e-14
2525	metformin	hsa04514	Cell adhesion molecules (CAMs)	2734_1272_3685_3897_6383_6693_3655_925	8	-	0.0183560125833699	0.208799643135833
2526	metformin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_88_6741_8294_121504_8343_8347_87_8344_8339_8346_8968_8370_717_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_720_721	36	-	0.00170457729644091	0.0387791334940307
2527	metformin	hsa04340	Hedgehog signaling pathway	7473_653	2	-	0.0421275324063615	0.27939339680942
2528	metformin	hsa04062	Chemokine signaling pathway	2786_5595_56288_156_6774_208_2773_5290_6773_5332_5906_2793_6093_5291_2790	15	-	0.0308284027722918	0.27939339680942
2529	metformin	hsa05012	Parkinson's disease	2861_4717_836_4701_4713_4698_7345_509_7385	9	-	0.0282892931581751	0.27939339680942
2530	metformin	hsa04260	Cardiac muscle contraction	6548_4635_7385	3	-	0.0113250683006499	0.154946551574567
2531	metformin	hsa04060	Cytokine-cytokine receptor interaction	27242_29949_3552_2057_3589_55540_5617_3572_3570_7422_8718_659	12	-	1.83890188424551e-05	0.000836700357331707
2532	metformin	hsa03010	Ribosome	440589_51187_6187_284393_389342_9045	6	-	0.0365303022260517	0.27939339680942
2533	metformin	hsa04020	Calcium signaling pathway	2902_3710_5578_11261_489_5530_5335_135_5336_5332_490_817	12	-	0.00765775392495784	0.139371121434233
2534	metformin	hsa04940	Type I diabetes mellitus	3552	1	-	0.0376970227988163	0.27939339680942
2535	metformin	hsa04610	Complement and coagulation cascades	717_720_721	3	-	0.0429835995091416	0.27939339680942
2536	kanamycin	hsa05016	Huntington's disease	1213_317_9001	3	+	0.0100684049078542	0.417838803675949
2537	kanamycin	hsa04740	Olfactory transduction	5592_135948_390892	3	+	4.79877482425156e-07	3.9829831041288e-05
2538	kanamycin	hsa05012	Parkinson's disease	6622_317	2	+	0.0247541468218956	0.684864728739112
2539	kanamycin	hsa04080	Neuroactive ligand-receptor interaction	9568_2918_5618_1081_3354	5	-	0.0261297925832536	0.597608252924213
2540	kanamycin	hsa05016	Huntington's disease	3092_4698_836	3	-	0.0373505158077633	0.597608252924213
2541	kanamycin	hsa04740	Olfactory transduction	157	1	-	1.53469045410092e-07	1.22775236328074e-05
2542	kanamycin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8330_8294_8367_554313_8970_121504	16	-	0.00448056168812053	0.179222467524821
2543	kanamycin	hsa04020	Calcium signaling pathway	115_6262_3707	3	-	0.0364893051660468	0.597608252924213
2544	3-hydroxy-DL-kynurenine	hsa05332	Graft-versus-host disease	3123_3113_3127_940_3126_3125	6	+	0.0325090450937999	0.325090450937999
2545	3-hydroxy-DL-kynurenine	hsa04740	Olfactory transduction	51806_816_26211	3	+	4.60323510233393e-06	0.000368258808186714
2546	3-hydroxy-DL-kynurenine	hsa04510	Focal adhesion	8516_4638_6696_2909_5295_7057_5154_5649_93408_3918_5880_7422_1277_3725_55742_1291_87_3675	18	+	0.0444288303584191	0.355430642867353
2547	3-hydroxy-DL-kynurenine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8294_87_3123_3126_3127_3125_8370_8359_8335_121504_3113_940	22	+	2.97493064003092e-05	0.00118997225601237
2548	3-hydroxy-DL-kynurenine	hsa04370	VEGF signaling pathway	5319_56848_5295_5880_5533_8681_4772_7422_100137049	9	+	0.0402836974526889	0.355430642867353
2549	3-hydroxy-DL-kynurenine	hsa05310	Asthma	3123_3126_3127_3113_3125	5	+	0.0297145115849815	0.325090450937999
2550	3-hydroxy-DL-kynurenine	hsa04512	ECM-receptor interaction	8516_1291_961_7057_1277_5649_6383_9672_3918_6696_3675	11	+	0.00811841599632862	0.21649109323543
2551	3-hydroxy-DL-kynurenine	hsa05012	Parkinson's disease	317	1	+	0.0158138942199357	0.253022307518971
2552	3-hydroxy-DL-kynurenine	hsa05330	Allograft rejection	3123_3126_3127_940_3125_3113	6	+	0.0221126858030619	0.294835810707492
2553	3-hydroxy-DL-kynurenine	hsa04940	Type I diabetes mellitus	3126_2572_3127_940_3125_3123_3113	7	+	0.0134293121814908	0.253022307518971
2554	3-hydroxy-DL-kynurenine	hsa04080	Neuroactive ligand-receptor interaction	4889_1812	2	-	0.00231244660475544	0.0539570874442936
2555	3-hydroxy-DL-kynurenine	hsa04740	Olfactory transduction	818_26212	2	-	1.36308996451629e-05	0.000954162975161403
2556	3-hydroxy-DL-kynurenine	hsa05322	Systemic lupus erythematosus	8358_85235_8968_3013_8330_8332_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357	18	-	0.000142028046668385	0.00497098163339348
2557	3-hydroxy-DL-kynurenine	hsa04530	Tight junction	24146	1	-	0.0316409456430316	0.553716548753053
2558	doxycycline	hsa05332	Graft-versus-host disease	3123_3125_3126_3127_3558	5	+	0.00230943242778938	0.0648764331675178
2559	doxycycline	hsa04640	Hematopoietic cell lineage	3123_960_3126_3127_3125	5	+	0.0362963210740992	0.317592809398368
2560	doxycycline	hsa05320	Autoimmune thyroid disease	3123_3558_3126_3127_3125	5	+	0.00578651989210031	0.0810112784894043
2561	doxycycline	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6868_5336_1432_3579_5602	5	+	0.0175352608645901	0.204578043420218
2562	doxycycline	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.00442120789133818	0.0773711380984182
2563	doxycycline	hsa04810	Regulation of actin cytoskeleton	7454_3694_8394_1730_5155_7430_1399_2263_2264	9	+	0.0482095575453031	0.374963225352357
2564	doxycycline	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0251987902392515	0.251987902392515
2565	doxycycline	hsa05330	Allograft rejection	3123_3558_3126_3127_3125	5	+	0.00154526902120166	0.0648764331675178
2566	doxycycline	hsa04940	Type I diabetes mellitus	3123_3558_3126_3127_3125	5	+	0.00278041856432219	0.0648764331675178
2567	doxycycline	hsa05131	Shigellosis	7278_113457	2	-	0.0495375820369308	0.445838238332377
2568	doxycycline	hsa05130	Pathogenic Escherichia coli infection	7278_113457	2	-	0.0495375820369308	0.445838238332377
2569	doxycycline	hsa05322	Systemic lupus erythematosus	85235_8330_8332_727_8969_8331_8336_8329	8	-	3.82237493307575e-06	0.000172006871988409
2570	doxycycline	hsa04540	Gap junction	2778_7278_113457	3	-	0.0212187241895041	0.445838238332377
2571	doxycycline	hsa05217	Basal cell carcinoma	6932_2737	2	-	0.0480156907680054	0.445838238332377
2572	monensin	hsa05332	Graft-versus-host disease	3126_3108_3127_3123_3125	5	+	0.0332034923250004	0.531255877200006
2573	monensin	hsa04640	Hematopoietic cell lineage	2814_3123_3126_3127_3125_920_3655_4254	8	+	0.029231712979455	0.531255877200006
2574	monensin	hsa05310	Asthma	3123_3125_3108_3127_3126	5	+	0.0101907182617144	0.468911411192428
2575	monensin	hsa05330	Allograft rejection	3126_3108_3127_3123_3125	5	+	0.0235713251699894	0.531255877200006
2576	monensin	hsa04940	Type I diabetes mellitus	3108_3123_3126_3127_3125_1363	6	+	0.0117227852798107	0.468911411192428
2577	12,13-EODE	hsa05211	Renal cell carcinoma	2034	1	+	0.0288746740572694	0.0577493481145388
2578	12,13-EODE	hsa04360	Axon guidance	10512	1	-	0.0131986801319868	0.0131986801319868
2579	(-)-catechin	hsa03022	Basal transcription factors	27097	1	+	0.0037996200379962	0.0037996200379962
2580	demecolcine	hsa05214	Glioma	5336	1	+	0.0452774847892847	0.0932929618042716
2581	demecolcine	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5336	1	+	0.0493050348981896	0.0932929618042716
2582	demecolcine	hsa05110	Vibrio cholerae infection	5336	1	+	0.0412353185884104	0.0932929618042716
2583	demecolcine	hsa05223	Non-small cell lung cancer	5336	1	+	0.0378556498171266	0.0932929618042716
2584	demecolcine	hsa04540	Gap junction	2697_203068	2	-	0.040898875866603	0.42116704871409
2585	troglitazone	hsa04660	T cell receptor signaling pathway	10298_6655_5290_4772_2353_920_3725_925_2534	9	+	0.0375498793821644	0.587141161939188
2586	troglitazone	hsa04510	Focal adhesion	10627_3914_10298_3691_6655_5290_22798_1950_2335_3725_6093_1291_2534_1301	14	+	0.025606663359423	0.587141161939188
2587	troglitazone	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	0.0238050188390939	0.587141161939188
2588	troglitazone	hsa05223	Non-small cell lung cancer	842_6655_1029_5290_1950_6257	6	+	0.0178621791768703	0.587141161939188
2589	troglitazone	hsa04512	ECM-receptor interaction	3914_2335_961_3691_1301_1291_22798	7	+	0.0396717001310262	0.587141161939188
2590	troglitazone	hsa04080	Neuroactive ligand-receptor interaction	7067	1	-	0.0163205264530361	1
2591	rosiglitazone	hsa04910	Insulin signaling pathway	6009	1	+	0.0223692761988106	0.353434563941207
2592	rosiglitazone	hsa04740	Olfactory transduction	5137	1	+	3.4912265065923e-07	2.75806894020792e-05
2593	rosiglitazone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_85235_8364_8370_8366_8368_8365_8330_8332_8359_8969_8331_8329_8336_8367_554313_121504_8294	21	+	2.19854535442154e-05	0.000868425414996508
2594	rosiglitazone	hsa04530	Tight junction	5578	1	+	0.0221676184414647	0.353434563941207
2595	rosiglitazone	hsa05012	Parkinson's disease	317	1	+	0.0220127284880991	0.353434563941207
2596	rosiglitazone	hsa04080	Neuroactive ligand-receptor interaction	64106_3354_5031	3	-	0.0274170195606435	0.324434731467615
2597	rosiglitazone	hsa04740	Olfactory transduction	5613_5567_5616_157	4	-	0.00219405643475017	0.137470135129446
2598	rosiglitazone	hsa05322	Systemic lupus erythematosus	8348_3013_8358_8968_8337_8350_8351_8352_8353_8354_8355_8356_8357	13	-	0.00774479634532092	0.137470135129446
2599	rosiglitazone	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	50848_5335_5600_3725_6714_4233_5781	7	-	0.0237587919133454	0.324434731467615
2600	rosiglitazone	hsa04370	VEGF signaling pathway	9261_8398_5829_3845_5600_5335_6714	7	-	0.0338937415097862	0.343779378170689
2601	rosiglitazone	hsa04010	MAPK signaling pathway	784_4908_9261_3554_8398_3925_5613_6655_5567_5616_91_8986_3845_5600_7042_7786_3725_2260_23162_3164	20	-	0.00669891163599396	0.137470135129446
2602	rosiglitazone	hsa04912	GnRH signaling pathway	8398_5613_6655_5567_5616_3845_5600_3725_6714	9	-	0.040043053534032	0.355382100114534
2603	rosiglitazone	hsa05210	Colorectal cancer	6655_1857_5900_3845_6934_7042_91_3725_4233	9	-	0.00686938147802149	0.137470135129446
2604	metergoline	hsa04130	SNARE interactions in vesicular transport	8773_9527_8417_662_8675	5	-	0.0447843249258166	0.624014171416654
2605	metergoline	hsa04080	Neuroactive ligand-receptor interaction	2918_4889_7442	3	-	0.00377445525211322	0.156639892962699
2606	metergoline	hsa04350	TGF-beta signaling pathway	4090_5594_3397_3398_7057_5519_1874_7042_91	9	-	0.0418474278586037	0.624014171416654
2607	metergoline	hsa04060	Cytokine-cytokine receptor interaction	91_3597_5155_7042	4	-	0.0106748966634868	0.295338807689801
2608	metergoline	hsa04020	Calcium signaling pathway	11261	1	-	0.00360350710692177	0.156639892962699
2609	metergoline	hsa04270	Vascular smooth muscle contraction	5594	1	-	0.0451094581746979	0.624014171416654
2610	methylergometrine	hsa04060	Cytokine-cytokine receptor interaction	3593_3581_5155_8742_8741_355_10663_1896_8794	9	+	0.0102131859935683	0.510659299678415
2611	methylergometrine	hsa03440	Homologous recombination	5425_7156_5893_8940	4	-	0.0111387880252624	0.205900083588672
2612	methylergometrine	hsa04740	Olfactory transduction	5566	1	-	0.000375299642527819	0.0136984369522654
2613	methylergometrine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	0.000118222733183788	0.00863025952241652
2614	methylergometrine	hsa04060	Cytokine-cytokine receptor interaction	4254	1	-	0.0112821963610231	0.205900083588672
2615	clorgiline	hsa05010	Alzheimer's disease	1339	1	+	0.0461264446045339	0.807212780579343
2616	clorgiline	hsa04740	Olfactory transduction	26212_7932_1179	3	+	0.00382384006747114	0.13383440236149
2617	clorgiline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	0.000325082265498534	0.0227557585848974
2618	clorgiline	hsa04350	TGF-beta signaling pathway	1634_6667_3624_5519_3400_652_7042_83729	8	+	0.0082726447664395	0.193028377883588
2619	clorgiline	hsa04120	Ubiquitin mediated proteolysis	23759	1	-	0.0456130317587229	0.667179195857159
2620	clorgiline	hsa04080	Neuroactive ligand-receptor interaction	64106_5618_2555_1909	4	-	0.0486856721120812	0.667179195857159
2621	clorgiline	hsa04740	Olfactory transduction	219464_801_808_805_409	5	-	0.00435128771359997	0.22156663009907
2622	clorgiline	hsa03020	RNA polymerase	5432_246721_5439_548644	4	-	0.0360346596979046	0.667179195857159
2623	clorgiline	hsa04912	GnRH signaling pathway	776_5580_5599_6655_5331_808_3845_3725_801_805_23236	11	-	0.0058307007920808	0.22156663009907
2624	clopamide	hsa04740	Olfactory transduction	818_5566	2	+	0.000546374896778923	0.0224013707679358
2625	clopamide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_718_8368_8366_3113_8359_8294_8367_554313_121504	16	+	4.28983095020991e-05	0.00351766137917213
2626	clopamide	hsa04540	Gap junction	5566_7278_1813_113457_5331_5607_6655	7	+	0.0381050201929247	0.861502589086119
2627	clopamide	hsa05220	Chronic myeloid leukemia	4088_4089_6655_861_7046_5781	6	+	0.0420245165407863	0.861502589086119
2628	clopamide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_8359_8294_8367_554313_8343_121504_3119_8339_8347_8346_8344	21	-	1.98125472171988e-11	1.24819047468352e-09
2629	zaprinast	hsa04740	Olfactory transduction	5137	1	+	0.00512843229948771	0.241036318075922
2630	zaprinast	hsa05219	Bladder cancer	23604_1869_7423	3	-	0.0205997025835892	0.741589293009211
2631	clenbuterol	hsa05332	Graft-versus-host disease	3804_355_3811_942_3802	5	+	0.0255426544464699	1
2632	clenbuterol	hsa04630	Jak-STAT signaling pathway	23533	1	+	0.0466766731678079	1
2633	clenbuterol	hsa04912	GnRH signaling pathway	776_8398_1839_5331_5606_5600_5603_23236	8	-	0.0263624758388903	0.906415040735192
2634	tyrphostin AG-825	hsa04115	p53 signaling pathway	1647_5366	2	+	0.00557558780037866	0.0223023512015146
2635	tyrphostin AG-825	hsa05010	Alzheimer's disease	5663_8772_7132_9451	4	-	0.00756557785781164	0.145637373762874
2636	tyrphostin AG-825	hsa04080	Neuroactive ligand-receptor interaction	4886	1	-	1.96142138054455e-07	1.5102944630193e-05
2637	tyrphostin AG-825	hsa04310	Wnt signaling pathway	23002_81839_57680_324_10725_5663_22943_6477_9475_5519_1457_1387_6934_4609_6885_7976_59343_4088_23291_7855	20	-	0.0240038145061402	0.231036714621599
2638	tyrphostin AG-825	hsa05016	Huntington's disease	246721_1387_3092_1385_6874_9519	6	-	0.0235725660844522	0.231036714621599
2639	tyrphostin AG-825	hsa04514	Cell adhesion molecules (CAMs)	965_1364_4897	3	-	0.018278703669731	0.231036714621599
2640	tyrphostin AG-825	hsa04350	TGF-beta signaling pathway	4092_57154_4086_9765_4088_64750_7057_9475_5519_657_655_4609_90_1387_659	15	-	0.00569208587966799	0.145637373762874
2641	tyrphostin AG-825	hsa04512	ECM-receptor interaction	7057	1	-	0.0303423939113077	0.234782575659682
2642	tyrphostin AG-825	hsa03022	Basal transcription factors	2967_2960_2959_6880_6877_6874_9519	7	-	0.0331201547997211	0.234782575659682
2643	tyrphostin AG-825	hsa05012	Parkinson's disease	7326	1	-	0.00106942361652475	0.0411728092362029
2644	tyrphostin AG-825	hsa04060	Cytokine-cytokine receptor interaction	5154_657_6387_4982_90_655_7132_8795_659	9	-	0.0113149890732151	0.174250831727513
2645	tyrphostin AG-825	hsa03010	Ribosome	6125_6168	2	-	0.0335403679513831	0.234782575659682
2646	tyrphostin AG-825	hsa04270	Vascular smooth muscle contraction	10672_4659_9475	3	-	0.047820944772852	0.306851062292467
2647	phenanthridinone	hsa03440	Homologous recombination	4683	1	-	0.0144118453463398	0.0288236906926796
2648	metacycline	hsa04670	Leukocyte transendothelial migration	9076_6494_4301_7294_93408_5880_7430_26285_5879	9	+	0.0465357994976641	0.985437469870031
2649	metacycline	hsa04080	Neuroactive ligand-receptor interaction	146_5618_1081_3953_3354_56288	6	-	0.0425353314199935	0.414666550971553
2650	metacycline	hsa04740	Olfactory transduction	51806_157	2	-	9.50494385515503e-07	7.31880676846937e-05
2651	metacycline	hsa05322	Systemic lupus erythematosus	8353_8344_8347_8346_8358_8343_8968_3013_8350_8351_8352_8339_8354_8355_8356_8357	16	-	0.0080910469016988	0.149687124173296
2652	metacycline	hsa04210	Apoptosis	3556_5534_581_5296_598_596_5290_5291_51135_208_7186	11	-	0.0097199431281361	0.149687124173296
2653	metacycline	hsa04370	VEGF signaling pathway	9261_5829_208_50487_5290_5291_5296_5881_5335_5534_4772	11	-	0.00371434731526862	0.143002371637842
2654	metacycline	hsa04060	Cytokine-cytokine receptor interaction	3556_5618_2057_3953_8771_7046	6	-	0.043133966975732	0.414666550971553
2655	metacycline	hsa05210	Colorectal cancer	581_4088_208_596_5290_673_5296_5881_7046_5291	10	-	0.0252712313815682	0.324314136063459
2656	metacycline	hsa05220	Chronic myeloid leukemia	2122_4088_208_5290_673_5296_7046_867_598_5291	10	-	0.00849413922033139	0.149687124173296
2657	repaglinide	hsa05332	Graft-versus-host disease	3553_3126_3107_3113_3127_3125_3123	7	+	0.000116172914720499	0.00542131449272885
2658	repaglinide	hsa04640	Hematopoietic cell lineage	3553_3123_3126_3127_3125_931	6	+	0.0199727153898521	0.15794858009018
2659	repaglinide	hsa05320	Autoimmune thyroid disease	3126_3107_3113_3127_3125_3123	6	+	0.00224119540956852	0.0268943449148222
2660	repaglinide	hsa04612	Antigen processing and presentation	3123_3107_3126_3127_3125_3305_3113	7	+	0.00649374146504705	0.0667927693547697
2661	repaglinide	hsa04740	Olfactory transduction	810_1179	2	+	0.0137019527000038	0.123317574300034
2662	repaglinide	hsa04514	Cell adhesion molecules (CAMs)	6403_965_3123_3107_3126_3127_3125_9672_3113_26047	10	+	0.0017580575668271	0.0253160289623102
2663	repaglinide	hsa04360	Axon guidance	2044_57556_6405_2048_1944_5879_2534	7	+	0.0396887401840959	0.259780844841355
2664	repaglinide	hsa04210	Apoptosis	3553_841_5575_472_9941_651610	6	+	0.0219373027903028	0.15794858009018
2665	repaglinide	hsa05310	Asthma	3123_3126_3127_3113_3125	5	+	0.00113094447088521	0.0203570004759338
2666	repaglinide	hsa05330	Allograft rejection	3113_3107_3126_3127_3125_3123	6	+	0.000467315815145111	0.0112155795634827
2667	repaglinide	hsa04940	Type I diabetes mellitus	3553_3126_3107_3113_3127_3125_3123	7	+	0.000150592069242468	0.00542131449272885
2668	repaglinide	hsa04080	Neuroactive ligand-receptor interaction	7442_1081	2	-	0.00655332628910822	0.138059293625054
2669	repaglinide	hsa04740	Olfactory transduction	109	1	-	1.16979404802778e-05	0.000853949655060279
2670	repaglinide	hsa05322	Systemic lupus erythematosus	8353_3123_8358_8968_3013_8350_8351_8352_81_8354_8355_8356_8357	13	-	0.00756489280137283	0.138059293625054
2671	repaglinide	hsa04060	Cytokine-cytokine receptor interaction	7852	1	-	0.00118119303489489	0.0431135457736635
2672	PF-00562151-00	hsa04650	Natural killer cell mediated cytotoxicity	3107_6850_5578_3459_5293_5881_5880_8794_2534	9	+	0.00385164194091735	0.175249708311739
2673	PF-00562151-00	hsa05010	Alzheimer's disease	2902_2081_4694_4712_840_6392_4698_6390_6391_51806_5330_3708_3709_489_824_6622	16	+	0.0163645824462652	0.2198616750976
2674	PF-00562151-00	hsa04080	Neuroactive ligand-receptor interaction	2902_624_2908_5030_5724_134_9038_4161_799_2740_2150_2689_7433_2688_1442_2911_2913_2916_1131_4886_5732_7442_5340_1812_6755_1241_10800_728	28	+	0.0379985535207286	0.34578683703863
2675	PF-00562151-00	hsa04742	Taste transduction	5330_5567	2	+	0.019337297505388	0.219961759123788
2676	PF-00562151-00	hsa05016	Huntington's disease	2902_246721_6648_4694_4712_5330_7052_4698_6390_6391_6392_3708_5978_23186_1385_6874_161_291	18	+	0.0257333810894103	0.260193075459593
2677	PF-00562151-00	hsa04740	Olfactory transduction	51806_26529_7932_5567	4	+	8.02745739734722e-21	7.30498623158597e-19
2678	PF-00562151-00	hsa05012	Parkinson's disease	2861_4694_4712_6392_7314_6390_6391_51465_4698_6622_291	11	+	0.0169124365459692	0.2198616750976
2679	PF-00562151-00	hsa04260	Cardiac muscle contraction	782_9254_781_4635	4	+	0.00777564778004187	0.176895986995953
2680	PF-00562151-00	hsa04060	Cytokine-cytokine receptor interaction	55540_5155_7852_60401_1896_3556_27242_3579_3459_3570_655_2688_2689_3976_8718_3581_23529_1271_23765_1956_268_8794_7048_1436_3560_7423_7422	27	+	0.0164675661235413	0.2198616750976
2681	PF-00562151-00	hsa03010	Ribosome	285053_140801_6142_6181_6129_6233	6	+	0.00774204385574642	0.176895986995953
2682	PF-00562151-00	hsa04080	Neuroactive ligand-receptor interaction	151_2902_4159_154_64106_2908_1909_23566_4161_5724_2150_9568_1395_5028_2912_5025_3354_3352_2488_9170_5618_4157_6915_7067_7068_1241_728	27	-	0.0243869602133849	0.369868896569671
2683	PF-00562151-00	hsa05016	Huntington's disease	2902_1175_5439_51164_5434_7157_1639_6391_317_6667_161_1537_5978_642502_1385_7419_293_517_163	19	-	0.0431068047476657	0.415123836985568
2684	PF-00562151-00	hsa04740	Olfactory transduction	818_51806_5566_26529_4991	5	-	1.54313976179382e-19	1.40425718323238e-17
2685	PF-00562151-00	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_8348_8329_8294_6628_121504_8343_8347_87_8344_723790_3123_3126_3127_3125_8969_8346_8370_8332_8359_8330_8331_8336_8337_554313_6738_8351_8339_85235_85236_3117_3013_942_3014_8970	44	-	0.000625986239606218	0.0284823739020829
2686	PF-00562151-00	hsa04512	ECM-receptor interaction	1284_960_7057_3912	4	-	0.0079527632030735	0.144740290295938
2687	PF-00562151-00	hsa04630	Jak-STAT signaling pathway	23533_3581_5618_2057_3594_598_3570_6772_3572_5781_208_8835_8503_10252_10254	15	-	0.0456180040643481	0.415123836985568
2688	PF-00562151-00	hsa05012	Parkinson's disease	2861_7318_642502_6391_317_7054_1537_7345_65018_7419_293_517	12	-	0.0323579171103138	0.415123836985568
2689	PF-00562151-00	hsa04260	Cardiac muscle contraction	1537_776_6262	3	-	0.00259853440349225	0.0788222102392649
2690	PF-00562151-00	hsa04060	Cytokine-cytokine receptor interaction	3594_5155_8742_8741_8995_3553_2057_3570_3572_4982_8718_6367_3581_7040_7042_93_268_8795_5618_1435_6358_6359_355_6372_51330	25	-	0.0074580104857792	0.144740290295938
2691	PF-00562151-00	hsa03010	Ribosome	440589_140801_6187_6142_439992_6159_6165_6189	8	-	0.0382377225652811	0.415123836985568
2692	benzathine benzylpenicillin	hsa04080	Neuroactive ligand-receptor interaction	1241_3269_4158	3	+	0.000231907063218352	0.00664800247892609
2693	benzathine benzylpenicillin	hsa04740	Olfactory transduction	818_5566_56656	3	+	2.23959301665213e-07	1.92604999432083e-05
2694	benzathine benzylpenicillin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8329_8294_87_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3014_720_721_3111	27	+	1.92014190593559e-06	8.25661019552304e-05
2695	benzathine benzylpenicillin	hsa05220	Chronic myeloid leukemia	8517_861_208_6464_867_5605_91_7042_1869_7157	10	+	0.0315062482262643	0.677384336864682
2696	benzathine benzylpenicillin	hsa04115	p53 signaling pathway	472_651610_3732	3	-	0.00456559318243911	0.114139829560978
2697	cefuroxime	hsa04740	Olfactory transduction	5137_8392	2	+	0.000784445395025358	0.0572645138368511
2698	cefuroxime	hsa04512	ECM-receptor interaction	7059_22798_3690_1289_3680_1605_1290	7	+	0.0210753368129616	0.769249793673098
2699	cefuroxime	hsa05016	Huntington's disease	836_841	2	-	0.04992420570191	0.798237375347239
2700	cefuroxime	hsa04740	Olfactory transduction	219464_5566_109_157_4991	5	-	0.00811096226780376	0.567767358746263
2701	cefuroxime	hsa04510	Focal adhesion	83660_3918	2	-	0.0366226431267056	0.798237375347239
2702	cefuroxime	hsa04920	Adipocytokine signaling pathway	3953_32_2182_1375_1374_7186	6	-	0.0489980116566018	0.798237375347239
2703	finasteride	hsa04120	Ubiquitin mediated proteolysis	7320_5371_652671_55236_7329	5	+	0.0243060020647659	0.261289522196233
2704	finasteride	hsa05010	Alzheimer's disease	775_3708_6622_517_2905	5	+	0.00204164022735999	0.0438952648882398
2705	finasteride	hsa04910	Insulin signaling pathway	5599_8471_10211_5290_3991	5	+	0.0239970878608684	0.261289522196233
2706	finasteride	hsa05016	Huntington's disease	1211_7052_64446_3708_1387_517	6	+	0.00286201616615258	0.0492266780578244
2707	finasteride	hsa04740	Olfactory transduction	818_5593_9635_393046	4	+	2.90881952123998e-11	2.50158478826638e-09
2708	finasteride	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_6738_8362_8294_121504_3586_8366_8968_8370_718_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_83740_3013_3113_3111_720_721_729	37	+	8.08367359203905e-07	3.47597964457679e-05
2709	finasteride	hsa04110	Cell cycle	5925_1387_993	3	+	0.00904851552904813	0.12969538924969
2710	finasteride	hsa04115	p53 signaling pathway	3732	1	+	0.0299286134157274	0.285984528194728
2711	finasteride	hsa05012	Parkinson's disease	6622_517	2	+	0.000656629852550881	0.0188233891064586
2712	finasteride	hsa03010	Ribosome	6125_6234_6181	3	+	0.0345892332220589	0.297467405709707
2713	finasteride	hsa05320	Autoimmune thyroid disease	5551_3451_3113	3	-	0.0329821643556083	0.897863239353522
2714	memantine	hsa04740	Olfactory transduction	26211_8390_2979_7932	4	+	0.0200417094282572	1
2715	memantine	hsa04130	SNARE interactions in vesicular transport	8773_8417_6844	3	-	0.0194358206581049	0.583074619743147
2716	memantine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00990516326968448	0.583074619743147
2717	irinotecan	hsa04916	Melanogenesis	112_1857_3265_7855_810_816	6	+	0.0273761240358027	0.180230295250012
2718	irinotecan	hsa04120	Ubiquitin mediated proteolysis	23327_51343_7318_55294_22888_23759_4193_7329_26232_8651	10	+	0.0423924921469194	0.235808237567239
2719	irinotecan	hsa05200	Pathways in cancer	572_10297_5154_9618_7855_10342_4149_4824_1857_5900_1017_1399_2261_3082_4313_998_4193_1026_3265_3725_3918_4791_4792_1436_5228_2335_8817_355_7422_2353	30	+	0.0264154840518333	0.180230295250012
2720	irinotecan	hsa04742	Taste transduction	112	1	+	0.0118863769185171	0.151126792249717
2721	irinotecan	hsa04310	Wnt signaling pathway	10297_8061_5519_5532_7855_5528_3725_64840_1857_816	10	+	0.0201426783236605	0.179269837080578
2722	irinotecan	hsa05016	Huntington's disease	1213_5430_4712_642502_6391_246721_7416_9001_509_55567_7381	11	+	0.00282392739003876	0.0837765125711499
2723	irinotecan	hsa04740	Olfactory transduction	393046_26539_2979_810_9635_816	6	+	3.67557335936689e-15	3.27126028983653e-13
2724	irinotecan	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_9103_8349_8329_8294_121504_8343_8347_8346_8344_8339_6737_3021_3020_8969_8968_55766_8370_718_8358_8359_8330_8331_8336_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3012_3013_3115_720_721	51	+	5.08966023492559e-08	2.26489880454189e-06
2725	irinotecan	hsa04115	p53 signaling pathway	55367_1647_1026_5366_55240_64393_5268_4193_7249_3486_355_10912_2810_5054_1017_3732_9540_4616	18	+	0.0196015618482092	0.179269837080578
2726	irinotecan	hsa05110	Vibrio cholerae infection	11015	1	+	0.0082900843730535	0.147563501840352
2727	irinotecan	hsa04062	Chemokine signaling pathway	7454_2786_1399_156_5829_998_2788_7852_3265_10235_112_4792	12	+	0.00459382514643245	0.102212609508122
2728	irinotecan	hsa05012	Parkinson's disease	7318_4712_642502_6391_7054_7345_7416_509_7381	9	+	0.0283508329606761	0.180230295250012
2729	irinotecan	hsa04260	Cardiac muscle contraction	7139_7381_4635	3	+	0.0114202030806882	0.151126792249717
2730	irinotecan	hsa04020	Calcium signaling pathway	2905_5532_487_3362_57105_5333_8911_7416_5724_489_1909_810_816	13	+	0.0148836805915456	0.165580946580945
2731	irinotecan	hsa04930	Type II diabetes mellitus	8651	1	+	0.0381716561874646	0.226485160045623
2732	irinotecan	hsa03050	Proteasome	5717	1	+	0.0258596653667492	0.180230295250012
2733	irinotecan	hsa05332	Graft-versus-host disease	356_3107	2	-	0.00023920482586162	0.00187377113591602
2734	irinotecan	hsa04640	Hematopoietic cell lineage	3554_3566_2057_4254_1604_3673_3655_3674_912	9	-	2.51176851474969e-05	0.00033729462912353
2735	irinotecan	hsa03320	PPAR signaling pathway	11001_9370_7316_5360_10580_2181_2180_8310_1374_5467_6256	11	-	0.00541230077498117	0.0308525916143208
2736	irinotecan	hsa05010	Alzheimer's disease	51806_3710_317_9451_2776_5663_5332_5664_7132_6622_4695_8883_808_776_2932_5530_5533_5532_3708_3709_6868_488_102_23236_3416_5594_841_840_4713_51107_842_22926_801_805	34	-	0.000169683413939961	0.00159502409103563
2737	irinotecan	hsa04080	Neuroactive ligand-receptor interaction	155_4889_147_2908_2925_5030_5031_3062_56288_1909_5645_2488_1813_799_2740_4987_4988_5029_2911_2916_1131_4886_3354_3350_5733_3269_1910_8001_2550_5618_5340_1812_7068_7067_4159_2570_8484_1511_2690	39	-	8.80725842375761e-09	4.13941145916608e-07
2738	irinotecan	hsa04742	Taste transduction	2785_3710_5613_5567_5616_6337	6	-	0.00193515094139387	0.0139926298839249
2739	irinotecan	hsa05320	Autoimmune thyroid disease	3452_3439_3451_3447_3446_3441_3107_356_959_7038	10	-	0.0464566229303483	0.155436515256271
2740	irinotecan	hsa04612	Antigen processing and presentation	4800_4801_4802_3312_3326_3439_3805_3441_3447_3446_5993_3107_3452_3451_3308_1385_3305_821	18	-	0.0159523178158698	0.06815990339508
2741	irinotecan	hsa05016	Huntington's disease	8218_4899_64764_317_2776_5332_23186_3064_6875_6874_5431_4695_5434_7157_7416_2033_7419_1211_3708_5481_23236_842_841_4713_3092_55567_1385_1387	28	-	6.08702506201317e-07	1.14436071165848e-05
2742	irinotecan	hsa04740	Olfactory transduction	51806_5593_157_5613_5567_8383_8392_808_5616_109_4992_801_9635_805	14	-	8.22169387096905e-37	7.72839223871091e-35
2743	irinotecan	hsa04514	Cell adhesion molecules (CAMs)	2734_214_4897_3655_9019_959_3107_25945_1013_9378_999_3688_23705_23562_965_4685_3685_5819_1365_5792_4950_5817	22	-	0.00012659365251088	0.00148747541700284
2744	irinotecan	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_94239_8366_8368_6738_8294_121504_8343_8347_8346_8344_959_8339_8367_8968_8370_717_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_1511	35	-	0.0221203436083115	0.0904048825730992
2745	irinotecan	hsa04110	Cell cycle	4089_9133_8243_4085_4087_4088_983_8555_701_51433_9184_996_23595_1871_651610_25_64682_7157_699_8881_8317_1111_5925_5934_2033_545_7534_1017_7531_995_902_5001_5000_991_990_993_9134_2932_8379_891_8454_7027_7042_9700_1031_8318_5591_1027_5347_4172_4173_890_6502_1022_1029_472_10393_5933_1387_7465_4999	61	-	0.0427811805144406	0.148941887716941
2746	irinotecan	hsa05340	Primary immunodeficiency	959_23495_64421_3718_5993	5	-	0.0479538185365091	0.155436515256271
2747	irinotecan	hsa05310	Asthma	959_3596	2	-	0.00485568816274572	0.0304289791532065
2748	irinotecan	hsa04512	ECM-receptor interaction	3688_1281_22798_3910_3691_3693_1605_7057_3685_1277_961_1293_3673_3655_1290_1291_3674_3161	18	-	0.0331343577145408	0.129776234381951
2749	irinotecan	hsa04630	Jak-STAT signaling pathway	3717_3446_3597_3596_3595_5295_3718_5290_5291_6772_3447_9655_8503_10254_3452_3439_3451_2057_2885_3572_2033_5781_3977_6777_9063_200734_8554_8027_868_5618_3566_3460_6774_6655_6654_3441_867_1387_11009_2690	40	-	0.0421218783621952	0.148941887716941
2750	irinotecan	hsa05012	Parkinson's disease	6570_4695_842_4713_7314_317_7326_7416_51465_7419_6622_5481_7332	13	-	2.64118938304345e-08	8.27572673353614e-07
2751	irinotecan	hsa04260	Cardiac muscle contraction	784_7168_776_27092_481_4635_488_10479_7137_7170	10	-	0.000153211961271785	0.00159502409103563
2752	irinotecan	hsa04060	Cytokine-cytokine receptor interaction	3597_3596_3595_8742_8741_6387_1896_7132_3452_3439_2321_3554_2057_3451_4254_3572_657_4982_3977_6363_27242_659_959_7293_3604_23495_3624_608_1956_7042_90_4233_7048_5618_6355_3566_3460_11009_3446_3441_51330_356_3447_2690	44	-	1.07433711090018e-07	2.52469221061542e-06
2753	irinotecan	hsa03010	Ribosome	6204_51187_6125_6168_284393_6123_389342_6233_6171	9	-	8.38684197647086e-07	1.31393857631377e-05
2754	irinotecan	hsa04020	Calcium signaling pathway	51806_155_3710_147_5336_2925_2776_115_7220_1956_5332_5335_1909_490_493_1812_5567_3707_7416_7419_2911_776_1131_5530_5533_5532_3708_109_5733_488_3269_1910_107_5481_23236_5579_5578_5613_3709_5616_808_801_2065_805	44	-	0.00675850654018359	0.033436821830382
2755	irinotecan	hsa03050	Proteasome	5718_5717_5706_5707_5690_23198_9491	7	-	0.0145536835206862	0.06815990339508
2756	irinotecan	hsa05330	Allograft rejection	959_356_3107	3	-	0.00244333330891492	0.0164052379312859
2757	irinotecan	hsa04950	Maturity onset diabetes of the young	3087	1	-	0.00590794307508271	0.0308525916143208
2758	irinotecan	hsa04940	Type I diabetes mellitus	3329_3107_3382_5799_356	5	-	0.00575200847740741	0.0308525916143208
2759	irinotecan	hsa05217	Basal cell carcinoma	6934_2737_324_7157_2932_1856_1857_8312_1499_7976	10	-	0.0352074485200484	0.132380006435382
2760	irinotecan	hsa02010	ABC transporters	26154_5825_4363_19_9619_8714	6	-	0.0158541070704716	0.06815990339508
2761	irinotecan	hsa04610	Complement and coagulation cascades	5340_717_629_4179_1604_7035_2152	7	-	0.000224588124325271	0.00187377113591602
2762	CP-944629	hsa04740	Olfactory transduction	157_1179_816	3	+	4.54084182664204e-06	0.000354185662478079
2763	CP-944629	hsa05322	Systemic lupus erythematosus	2903_8361_8363_8362_8365_8364_8367_8360_8368_8329_8294_8366_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235	22	+	2.52231811001113e-05	0.000983704062904341
2764	CP-944629	hsa04270	Vascular smooth muscle contraction	23236	1	+	0.0314987596378631	0.81896775058444
2765	CP-944629	hsa04740	Olfactory transduction	51806_157	2	-	2.10099101983866e-05	0.00174382254646609
2766	CP-944629	hsa04010	MAPK signaling pathway	57551_776_1432_2318_5578_100137049_6655_27092_5155_5154_355_4763_1956_5606_2005_8681_3725_5609_9693_11221	20	-	0.0254368277200018	0.703752233586716
2767	CP-944629	hsa04912	GnRH signaling pathway	51806_8681_776_1432_5578_100137049_6655_2776_1956_5606_3725_5609_23236	13	-	0.00150173639305846	0.0623220603119261
2768	CP-944629	hsa04270	Vascular smooth muscle contraction	51806_776_5578_3779_2776_9475_27094_8681_100137049_23236	10	-	0.0443386242664803	0.920026453529466
2769	16-phenyltetranorprostaglandin E2	hsa05332	Graft-versus-host disease	3119_3123_3126_3127_3125_3134	6	+	0.0421083403640012	0.447401116367513
2770	16-phenyltetranorprostaglandin E2	hsa04080	Neuroactive ligand-receptor interaction	7434_3269_4157	3	+	0.000674261267674012	0.0286561038761455
2771	16-phenyltetranorprostaglandin E2	hsa04740	Olfactory transduction	157_56656_816	3	+	1.52333189459986e-06	0.000129483211040988
2772	16-phenyltetranorprostaglandin E2	hsa05322	Systemic lupus erythematosus	6738_3119_718_3123_3126_3127_3125_8358_727_8968_3013_8350_8351_8352_8353_8354_8355_8356_8357	19	+	0.00127230202250106	0.0360485573041967
2773	16-phenyltetranorprostaglandin E2	hsa05310	Asthma	3123_3126_3127_3119_3125	5	+	0.0374424028625888	0.447401116367513
2774	16-phenyltetranorprostaglandin E2	hsa05330	Allograft rejection	3119_3123_3126_3127_3125_3134	6	+	0.0289435188639775	0.410033183906348
2775	16-phenyltetranorprostaglandin E2	hsa04270	Vascular smooth muscle contraction	27094	1	+	0.0218839080728113	0.372026437237792
2776	16-phenyltetranorprostaglandin E2	hsa04940	Type I diabetes mellitus	3119_3123_3126_3127_2571_3134_3125	7	+	0.0183510132883417	0.372026437237792
2777	16-phenyltetranorprostaglandin E2	hsa04070	Phosphatidylinositol signaling system	51806_5333_3631_3708_3709_3706_27124_23236	8	-	0.0333552975088288	0.439178083866246
2778	16-phenyltetranorprostaglandin E2	hsa04080	Neuroactive ligand-receptor interaction	3953_7067_1131_23566_3360	5	-	0.0464111186887846	0.523782625201998
2779	16-phenyltetranorprostaglandin E2	hsa04740	Olfactory transduction	51806_157	2	-	6.82853937847639e-06	0.000539454610899635
2780	16-phenyltetranorprostaglandin E2	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3113_8359_8294_8367_554313_8970_121504	16	-	0.00271512040960925	0.107247256179565
2781	16-phenyltetranorprostaglandin E2	hsa05221	Acute myeloid leukemia	861_572_6777_3845_6934_11040_5970	7	-	0.0270978288446313	0.428145695745175
2782	16-phenyltetranorprostaglandin E2	hsa05213	Endometrial cancer	6934_572_1956_3845_1495_8312_842	7	-	0.0154567653188896	0.407028153397426
2783	16-phenyltetranorprostaglandin E2	hsa04912	GnRH signaling pathway	51806_5598_8681_3709_3708_1956_3845_112_6714_100137049_23236	11	-	0.0213562273872372	0.421785490897935
2784	trihexyphenidyl	hsa04662	B cell receptor signaling pathway	2353_5532_6655_5880_3725	5	+	0.0382983817972308	0.64679973748102
2785	trihexyphenidyl	hsa04740	Olfactory transduction	26333_442194	2	+	0.009240709890108	0.34652662087905
2786	trihexyphenidyl	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_8359_88_8294_8367_554313_121504_3119	17	+	1.87283814485197e-07	1.40462860863898e-05
2787	trihexyphenidyl	hsa04350	TGF-beta signaling pathway	9372_5519_353500_7042_83729_10468	6	+	0.0210855961855305	0.527139904638262
2788	trihexyphenidyl	hsa04010	MAPK signaling pathway	1848_782_6788_6655_7042_1649_1846_5532_4763_5880_2353_3725	12	+	0.0431199824987347	0.64679973748102
2789	trihexyphenidyl	hsa05332	Graft-versus-host disease	3105_3111	2	-	0.0412958312524653	0.393898423524292
2790	trihexyphenidyl	hsa04310	Wnt signaling pathway	5599_4088_64840_1856	4	-	0.0275833754292423	0.393898423524292
2791	trihexyphenidyl	hsa05330	Allograft rejection	3105_3111	2	-	0.0346921513753222	0.393898423524292
2792	trihexyphenidyl	hsa05210	Colorectal cancer	5599_4088_1856	3	-	0.0259793758759666	0.393898423524292
2793	trihexyphenidyl	hsa04940	Type I diabetes mellitus	3105_3111	2	-	0.0447611844913968	0.393898423524292
2794	BCB000040	hsa04080	Neuroactive ligand-receptor interaction	4889_5618_2488_1813_2846_5025_2908_3360_1241_3953_2150_7067_1909_2740_4543_1394_7068_2690	18	+	6.60624932449225e-06	0.00030719059358889
2795	BCB000040	hsa04660	T cell receptor signaling pathway	1739_4690_1432_1147_5063_6655_6654_4776_3725_3551_5594	11	+	0.0443335186905362	0.458113026468874
2796	BCB000040	hsa04670	Leukocyte transendothelial migration	9076_24146_1432_5579_7070_9475_7430_4636_5747_5781	10	+	0.00777121942872637	0.120453901145259
2797	BCB000040	hsa05016	Huntington's disease	246721_1327_2776_9167_5436_7157_1639_10488_509_1175_9001_161_5481_23236_4714_4712_841_4713_642502_6390_6391_1385	22	+	0.0432484503673668	0.458113026468874
2798	BCB000040	hsa04740	Olfactory transduction	5613_5566_5567_5616_808_109_81797_81696_801_805	10	+	6.9241868239023e-18	6.43949374622914e-16
2799	BCB000040	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8329_8294_121504_6632_3021_3020_8969_8968_8370_8358_8359_8330_8331_8336_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3012_3013_942_3017_727_9555	41	+	0.0183111388925387	0.2432765595723
2800	BCB000040	hsa04260	Cardiac muscle contraction	27092_9167_1327_4635_488	5	+	0.00734377839387322	0.120453901145259
2801	BCB000040	hsa04060	Cytokine-cytokine receptor interaction	5154_7850_1489_3556_8794_3459_6354_3572_657_6363_3953_3589_4055_4254_8718_91_8792_4233_8795_5618_3449_3460_3568_355_7422_6370_11009_2690	28	+	0.00398950309172361	0.0927559468825739
2802	BCB000040	hsa03010	Ribosome	6125_9349_6192	3	+	3.75521411312812e-05	0.00116411637506972
2803	BCB000040	hsa05010	Alzheimer's disease	810_836_6622_2776_23236	5	-	0.0136941993032989	0.200848256448384
2804	BCB000040	hsa04080	Neuroactive ligand-receptor interaction	2901_7067_2925_4886_7434_6915_5732	7	-	0.00164815782120696	0.0725189441331062
2805	BCB000040	hsa05016	Huntington's disease	5978_836_2776_23236	4	-	0.0028503102699748	0.0824112713203289
2806	BCB000040	hsa04740	Olfactory transduction	219464_157_818_810_26529_816	6	-	2.73536393122254e-07	2.40712025947584e-05
2807	BCB000040	hsa05322	Systemic lupus erythematosus	8329_8343_8347_8346_8344_3123_3126_3127_3125_8969_8332_8330_8331_8336_8337_6737_8351_8339_85235_3013_720_721_8970	23	-	0.00374596687819677	0.0824112713203289
2808	BCB000040	hsa04010	MAPK signaling pathway	784_4217_9479_836_9064_5598_6655_23162_5603_5602_2257	11	-	0.0205525384224805	0.258374768739755
2809	BCB000040	hsa05012	Parkinson's disease	836_7345_6622_5413	4	-	0.0472102791398838	0.461611618256642
2810	BCB000040	hsa04260	Cardiac muscle contraction	784	1	-	0.0312727793988346	0.344000573387181
2811	BCB000040	hsa04060	Cytokine-cytokine receptor interaction	1435_3815_3624_6358_6359_7852_8718_1896_8794	9	-	0.0087322509360555	0.153687616474577
2812	semustine	hsa05016	Huntington's disease	7052_2902_4899_1387_841	5	+	0.0101281683223515	0.258604440807829
2813	semustine	hsa04740	Olfactory transduction	5593_8392_808_109_5137_801_805	7	+	2.6160964491308e-06	0.00022760039107438
2814	semustine	hsa04530	Tight junction	7525_9223_5516	3	+	0.0184159682801101	0.258604440807829
2815	semustine	hsa04920	Adipocytokine signaling pathway	5564_5106_57818_8660_3953_2180_32_5599_5105_9021_4793	11	+	0.0228218020200765	0.258604440807829
2816	semustine	hsa05310	Asthma	3109_3119_3123_3126_3127_3125_5553	7	+	0.0130228527774113	0.258604440807829
2817	semustine	hsa04062	Chemokine signaling pathway	2919_2788_6773_109_6376_4793	6	+	0.0237797186949728	0.258604440807829
2818	semustine	hsa04810	Regulation of actin cytoskeleton	9087_3691_1131_8817_929_1956_3984	7	+	0.016965434679458	0.258604440807829
2819	semustine	hsa05012	Parkinson's disease	7314	1	+	0.0010460176849155	0.0455017692938242
2820	semustine	hsa03010	Ribosome	6233_6192	2	+	0.0335985482448837	0.324785966367209
2821	semustine	hsa04662	B cell receptor signaling pathway	8503_6850_3551_10892_11261_8519_7410_3845_4794_4793_6655_4067	12	-	0.0433645161869122	0.433645161869122
2822	semustine	hsa04080	Neuroactive ligand-receptor interaction	5028_3354_3953_5030_6915_3351_7067_5732	8	-	0.00222885352288075	0.0501492042648169
2823	semustine	hsa05016	Huntington's disease	5432_7052_5441_5331_3708_55567_23236	7	-	0.0293680801976002	0.339394182213688
2824	semustine	hsa04740	Olfactory transduction	810_51806_157_816	4	-	1.04747240716673e-09	4.71362583225029e-08
2825	semustine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8342_3122_3123_3126_3127_3125_8969_8968_55766_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3113_720_721_729	43	-	6.01423220562405e-11	5.41280898506164e-09
2826	semustine	hsa04664	Fc epsilon RI signaling pathway	5320_8503_6850_5581_6655_6300_7410_3845_5600_5603_5602_5608_4067	13	-	0.0301683717523278	0.339394182213688
2827	semustine	hsa05012	Parkinson's disease	27429_9246	2	-	0.00200730476300497	0.0501492042648169
2828	semustine	hsa04260	Cardiac muscle contraction	9254	1	-	0.0212961324647614	0.339394182213688
2829	semustine	hsa04912	GnRH signaling pathway	5608_51806_5603_6655_5602_107_5331_3708_3709_3845_5600_5320_112_810_6300_816_23236	17	-	0.0265601367443824	0.339394182213688
2830	karakoline	hsa05016	Huntington's disease	64446_4899_6667_4713	4	+	0.00140317766612796	0.0603366396435023
2831	karakoline	hsa04740	Olfactory transduction	26212_7932_26692_5566_1179_810_393046_816	8	+	1.48797972089867e-06	0.000127966255997286
2832	karakoline	hsa04514	Cell adhesion molecules (CAMs)	23308_57863_22871_6383_3384_3383_3107_3126_933_8516_4099_6402_3688_3119_3113_3685_941_5797_1001_6693_3111_26047_5817	23	+	0.00212176357038948	0.0608238890178318
2833	karakoline	hsa05322	Systemic lupus erythematosus	3018_3119_2215_3113_3013_3126_9103_3111_941_8358_8968_720_721_8350_8351_8352_8353_8354_8355_8356_8357	21	+	0.0174706906093514	0.300495878480844
2834	karakoline	hsa04630	Jak-STAT signaling pathway	23529_6773_9021_3448_1439	5	+	0.0335548473993564	0.412245268049236
2835	karakoline	hsa05012	Parkinson's disease	4713_6531	2	+	0.00300764072266891	0.0646642755373816
2836	karakoline	hsa03010	Ribosome	140801_6181	2	+	0.0238302430283483	0.341566816739659
2837	karakoline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_720_721_9555	24	-	1.04844801109227e-08	8.28273928762893e-07
2838	etiocholanolone	hsa05332	Graft-versus-host disease	3812_3824_3119_3117_3804_3569_3126_3127_3125_356_3123_941_3558	13	+	0.000952377589969407	0.0202380237868499
2839	etiocholanolone	hsa04640	Hematopoietic cell lineage	3581_3590_960_2057_3815_2208_3123_3569_3126_3127_3559_3125_920_933_3690_290	16	+	0.0351202622941971	0.298522229500675
2840	etiocholanolone	hsa05010	Alzheimer's disease	810_3709	2	+	1.55140606099984e-05	0.000659347575924932
2841	etiocholanolone	hsa04080	Neuroactive ligand-receptor interaction	2862_1268_886_134_2846_2908_59340_5745_1909_9038_1902_2488_1813_3360_3361_5724_2566_7434_2740_185_1395_719_2917_2918_6915_9002_5733_3352_3269_4161_9294_6752_2897_4829_6754_1241_2358_2359_10800	39	+	0.0131895418814729	0.194818726606368
2842	etiocholanolone	hsa05016	Huntington's disease	7052_1213_1387	3	+	3.19375462135497e-05	0.000904897142717241
2843	etiocholanolone	hsa04740	Olfactory transduction	26211_7932_5568_157_818_81697_3000_810_393046_816	10	+	2.28922625442235e-07	1.945842316259e-05
2844	etiocholanolone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8294_3123_3126_3127_3125_8370_717_8359_554313_6738_121504_8354_3119_3117_941	25	+	0.0137519101133907	0.194818726606368
2845	etiocholanolone	hsa05310	Asthma	3119_3117_3123_3126_3127_3125_8288	7	+	0.0442586131163831	0.338781103338399
2846	etiocholanolone	hsa03010	Ribosome	140801_284393_389342	3	+	0.0242446374723261	0.284831563522277
2847	etiocholanolone	hsa05330	Allograft rejection	3119_3117_3123_3126_3127_3558_356_941_3125	9	+	0.0342455049905194	0.298522229500675
2848	etiocholanolone	hsa04940	Type I diabetes mellitus	3119_3117_3126_2572_3127_3558_356_3123_941_3125	10	+	0.0268076765668025	0.284831563522277
2849	etiocholanolone	hsa04070	Phosphatidylinositol signaling system	3708_8821_27124_3709_23236	5	-	0.038899154102893	1
2850	etiocholanolone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	1.64384544462594e-05	0.00106849953900686
2851	foliosidine	hsa05016	Huntington's disease	1213_5330_3708_7416_55567_23236	6	+	0.0316874785275863	0.526012143557933
2852	foliosidine	hsa04740	Olfactory transduction	5593_7932_26707_8392_4991_9635	6	+	8.157496776254e-07	6.77072232429082e-05
2853	foliosidine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_2215_8370_2214_3123_8366_3126_3127_3125_8359_8294_8367_554313_8368_121504_8341_8364	21	+	0.00793169171815395	0.208091720091903
2854	foliosidine	hsa05012	Parkinson's disease	6622_7416	2	+	0.00620215097226254	0.208091720091903
2855	foliosidine	hsa03010	Ribosome	6144	1	+	0.0100285166309351	0.208091720091903
2856	foliosidine	hsa04730	Long-term depression	5593_5579_5519_5330_3708_8681_3845_5516_100137049_1392_23236	11	+	0.0455347562251668	0.629897461114807
2857	foliosidine	hsa04740	Olfactory transduction	4991	1	-	0.000583676048585479	0.0227633658948337
2858	foliosidine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3113	23	-	1.20486704844586e-10	9.39796297787771e-09
2859	foliosidine	hsa04920	Adipocytokine signaling pathway	6794_10000_5599_6513_5563_8660_4793	7	-	0.00383770454324603	0.0997803181243968
2860	gossypol	hsa04120	Ubiquitin mediated proteolysis	23327_7337_4281_331_51343_6477_330_7329_25898_55236_9021	11	+	0.0291880457786246	0.265611216585484
2861	gossypol	hsa05010	Alzheimer's disease	836_2904_4698_54205_779_4137_3708_824_6622	9	+	0.000192631464888852	0.00584315443496184
2862	gossypol	hsa04742	Taste transduction	2914_5568	2	+	0.0285619002359873	0.265611216585484
2863	gossypol	hsa05016	Huntington's disease	246721_54205_627_2904_7052_4698_5439_3708_1211_836_548644	11	+	0.000476684747583842	0.00867566240602592
2864	gossypol	hsa04740	Olfactory transduction	7932_5568_26692_26333_2774_23538_135948_393046_818_5137_81797_26539_81696_9635	14	+	1.38868739164784e-11	1.26370552639953e-09
2865	gossypol	hsa04514	Cell adhesion molecules (CAMs)	214_5175_9369_942_23308_57863_3111_941_3384_3383_3123_8506_3126_3127_3696_3125_1462_6693_4359_10686_6402_4684_3113_3685_925_5797_5792_920_923_1002_26047_1000	32	+	0.0381827914994205	0.289552835537272
2866	gossypol	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_2904_8368_554313_8360_8362_8294_121504_8343_8341_8347_8346_8344_8339_3123_8366_3126_3127_3125_8968_8370_8358_8359_8330_8335_8350_8351_8352_8353_8354_8355_8356_8357_83740_3013_3113_3111_941_720_721_8970_942	48	+	1.48916510675485e-05	0.000677570123573457
2867	gossypol	hsa04110	Cell cycle	1647_1021_8243_51343_1028_8556_7042_894_4616	9	+	0.0359001328261242	0.289552835537272
2868	gossypol	hsa04664	Fc epsilon RI signaling pathway	23533_10000_6850_50487_5293_5290_27040_8681_5600_5608_2206_2207_100137049_5163_8398_1432_5579_5578_5599_6655_5581_2534	22	+	0.0186940675291247	0.243022877878621
2869	gossypol	hsa04810	Regulation of actin cytoskeleton	23533_29895_10095_5063_5290_6655_5155_998_3685_56924_3679_2248_3696_1399_5293_6093_2247_57144_26230_8976_3675	21	+	0.0279597158308017	0.265611216585484
2870	gossypol	hsa05012	Parkinson's disease	2861_836_5413_4698_54205_6622	6	+	0.000446033727200842	0.00867566240602592
2871	gossypol	hsa03010	Ribosome	6141_6139_6129_6224_6144	5	+	0.00420536868660043	0.0637814250801065
2872	gossypol	hsa04080	Neuroactive ligand-receptor interaction	2901_1081_7068_4886_9568_2149	6	-	0.000172391501168735	0.00758522605142434
2873	gossypol	hsa04740	Olfactory transduction	818_5613_219464_5616	4	-	7.12117897199071e-10	6.26663749535182e-08
2874	gossypol	hsa04510	Focal adhesion	857_596_858_1289_998_1277_208_1398_9475	9	-	0.0404406934973916	0.777362325330835
2875	gossypol	hsa05218	Melanoma	208	1	-	0.044168313939252	0.777362325330835
2876	gossypol	hsa05012	Parkinson's disease	7419_7381_5413	3	-	0.00663690084115014	0.194682424673737
2877	myosmine	hsa05016	Huntington's disease	7052_1212_6390_1387	4	+	0.00535451375420023	0.155280898871807
2878	myosmine	hsa04740	Olfactory transduction	5568_26692_442194_818_810_9635	6	+	1.58185888473876e-06	0.000137621722972272
2879	myosmine	hsa04514	Cell adhesion molecules (CAMs)	8516_965_3384_8174_3383_3119_3123_4099_3107_3126_3127_3125_3676_3695_923_25945_26047_5817	18	+	0.0201385959875761	0.309586070247002
2880	myosmine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_3123_3126_3127_3125_8370_8359_554313_6738_121504_8354_3119_729	22	+	0.00238755083529706	0.103858461335422
2881	myosmine	hsa04512	ECM-receptor interaction	1278_8516_1291_7148_948_1289_3694_3695_7057_3679_3673_1277_3676	13	+	0.0135640568152167	0.295018235730963
2882	myosmine	hsa03010	Ribosome	6192_6144	2	+	0.0473869271982337	0.531196332823086
2883	myosmine	hsa04940	Type I diabetes mellitus	3382_3119_3126_3107_2572_3127_3125_3123	8	+	0.0213507634653105	0.309586070247002
2884	myosmine	hsa04070	Phosphatidylinositol signaling system	8394_8396_5333_51763_27124_23236	6	-	0.0308105356018296	1
2885	myosmine	hsa05200	Pathways in cancer	3551_3675	2	-	0.0067800547295784	0.440703557422596
2886	myosmine	hsa05016	Huntington's disease	23236	1	-	0.0462786923541475	1
2887	benzamil	hsa04120	Ubiquitin mediated proteolysis	8651_868_4281_330_26091	5	+	0.0431000795379022	0.421422999926155
2888	benzamil	hsa05010	Alzheimer's disease	6622_836_3553	3	+	0.000421299308441025	0.0123581130476034
2889	benzamil	hsa05016	Huntington's disease	836_64446_1387_7416	4	+	0.00102062518866232	0.022453754150571
2890	benzamil	hsa04740	Olfactory transduction	81697_26333_23538_393046	4	+	7.12117897199071e-10	6.26663749535182e-08
2891	benzamil	hsa04510	Focal adhesion	10000_10298_330_5290_3679_3673_6714_3675_3694_7057_22798_7414_29780_55742_1291_1399_5063_3910_3918_1281_6093_1284_3688_7148_5579_3685_7422	27	+	0.048538710571209	0.427140653026639
2892	benzamil	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_6738_8362_8294_121504_8366_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2215_83740_3013_941	31	+	2.47126273666576e-05	0.00108735560413293
2893	benzamil	hsa04512	ECM-receptor interaction	1284_3688_1281_22798_1291_3910_2812_3694_7057_3685_3918_3679_3673_7148_51206_3675	16	+	0.00760395068906817	0.111524610106333
2894	benzamil	hsa05012	Parkinson's disease	6622_836_7416	3	+	0.00663690084115014	0.111524610106333
2895	benzamil	hsa03010	Ribosome	6139_6171	2	+	0.016579058580917	0.208422450731528
2896	benzamil	hsa05222	Small cell lung cancer	1284_3688_10000_22798_3551_3910_330_5290_3918_5925_3685_3673_6257_3675	14	+	0.0376362283619049	0.413998511980954
2897	benzamil	hsa04120	Ubiquitin mediated proteolysis	57154_8945_6502_23759_5371_867_22888_8651_23221	9	-	0.0178961143139266	0.644260115301358
2898	benzamil	hsa04740	Olfactory transduction	810	1	-	0.000555425521773311	0.0399906375676784
2899	PNU-0230031	hsa04120	Ubiquitin mediated proteolysis	6502_5371_7318	3	+	0.0189434011433876	0.329615179894944
2900	PNU-0230031	hsa04740	Olfactory transduction	5593_4992_56656_816	4	+	2.42912630645304e-08	2.11333988661414e-06
2901	PNU-0230031	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3018_3119_3013_3113_941	29	+	1.27719572118015e-05	0.000555580138713365
2902	PNU-0230031	hsa04110	Cell cycle	6502	1	+	0.00328651376640975	0.0953088992258827
2903	PNU-0230031	hsa04512	ECM-receptor interaction	1286_960_1301_948_2812_3694_3695_3685_1277_3679_1290_1291_3674_22798	14	+	0.0091891575390112	0.199864176473494
2904	PNU-0230031	hsa04670	Leukocyte transendothelial migration	7852	1	-	0.0451957452086435	1
2905	PNU-0230031	hsa04740	Olfactory transduction	51806	1	-	7.54805681527077e-07	2.9437421579556e-05
2906	PNU-0230031	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013	33	-	1.00600902295255e-12	7.84687037902989e-11
2907	0179445-0000	hsa05332	Graft-versus-host disease	3812_3824_3122_3113_3107_3126_3111_3558_356_355_941	11	+	0.00496374643994486	0.150566975344994
2908	0179445-0000	hsa05010	Alzheimer's disease	776_1339_6390_54205_779_355_509_810	8	+	0.0338714036501506	0.281713625168471
2909	0179445-0000	hsa05320	Autoimmune thyroid disease	3448_7253_3122_3126_3107_3113_3111_3558_356_355_941	11	+	0.0233362191996241	0.281713625168471
2910	0179445-0000	hsa05016	Huntington's disease	246721_1339_7052_6390_54205_509_1387	7	+	0.0094164840456742	0.214225012039088
2911	0179445-0000	hsa04740	Olfactory transduction	26212_5568_8388_8387_8390_442194_2979_810_816	9	+	2.11335583584085e-07	1.92315381061517e-05
2912	0179445-0000	hsa05322	Systemic lupus erythematosus	9103_8349_8348_8329_8341_3122_3126_8969_8968_8358_8330_8331_8336_8334_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3113_3111_941_720_721	30	+	0.000308560008045015	0.0140394803660482
2913	0179445-0000	hsa04115	p53 signaling pathway	5728_1026_894_64393_1647_54205_4193_7249_5268_355_575_5054_5366_8795	14	+	0.0160039080457206	0.26993466026096
2914	0179445-0000	hsa04512	ECM-receptor interaction	375790_960_22798_1311_3910_3688_3694_3695_7060_3679_961_7148_1277_3676_2335	15	+	0.0293742417674434	0.281713625168471
2915	0179445-0000	hsa05012	Parkinson's disease	6390_54205_1339_7054_509	5	+	0.0328320027200487	0.281713625168471
2916	0179445-0000	hsa03010	Ribosome	140801_6224_6144	3	+	0.034053295350035	0.281713625168471
2917	0179445-0000	hsa05330	Allograft rejection	3122_3113_3107_3126_3111_3558_356_355_941	9	+	0.0177978896875358	0.26993466026096
2918	0179445-0000	hsa04940	Type I diabetes mellitus	3122_3126_3107_3113_3111_3558_356_355_941	9	+	0.0446628917541949	0.338693595802645
2919	0179445-0000	hsa05332	Graft-versus-host disease	3135_3105_3106_3553_649853	5	-	0.0182725215230142	0.0636154453023457
2920	0179445-0000	hsa04650	Natural killer cell mediated cytotoxicity	8503_6850_5295_10451_6452_5335_5336_3451_836_3454_3455_3105_3106_7410_80328_4277_673_3135_5532_4775_4772_5534_5578_6655_6654_6464_7409_2534	28	-	0.0116634373595447	0.0456817963248834
2921	0179445-0000	hsa03440	Homologous recombination	5890_8940_5888_6118_675_7156_80198_641_5424_7517_7516_5892_5893_10714_8438_5889_25788_10111	18	-	0.0396412518605222	0.116446177340284
2922	0179445-0000	hsa04640	Hematopoietic cell lineage	3554_3553_2057_960_1604_3566_3655	7	-	1.30844315420948e-05	0.000153742070619614
2923	0179445-0000	hsa05010	Alzheimer's disease	51806_1327_5534_317_2776_5663_5332_5664_7132_3710_3553_23236_776_1339_8772_5532_3708_3709_488_102_836_8851_23621_4714_842_841_840_808_23385_801_805	31	-	0.000371952208849528	0.00291362563598797
2924	0179445-0000	hsa04080	Neuroactive ligand-receptor interaction	1081_64106_2908_5030_5031_56288_136_1909_1813_5021_7433_9568_5029_4889_3953_1131_4886_3354_9170_5618_7442_4157_7068_2740_2149_2690	26	-	8.46037155252409e-12	3.97637462968632e-10
2925	0179445-0000	hsa04742	Taste transduction	5613_5567_5616_3710_112	5	-	0.00224030401515347	0.0110836093381277
2926	0179445-0000	hsa05320	Autoimmune thyroid disease	958_3451_1081_3105_3106_3135_649853	7	-	0.0160887515388828	0.0581670247944224
2927	0179445-0000	hsa04612	Antigen processing and presentation	4801_3451_3105_3106_3135_5993_3306_1385_3304_3305_3303_649853	12	-	0.00119286837331412	0.00659586041714866
2928	0179445-0000	hsa05131	Shigellosis	25_5578_9475_7100_7430_9181_2017_2534	8	-	0.0199578435014803	0.0646909410047982
2929	0179445-0000	hsa04670	Leukocyte transendothelial migration	24146_1366_8503_5295_1432_5578_5336_7409_6387_7410_9475_7852_10451_7430_27035_5603_5747_5335_1500	19	-	0.000847758558967824	0.00531262030286503
2930	0179445-0000	hsa05016	Huntington's disease	246721_1327_64764_317_2776_5332_23186_3064_6874_10126_5430_836_7052_5439_2033_1339_581_3708_548644_161_23236_4714_842_841_3092_1385	26	-	3.29620488774928e-06	6.19686518896865e-05
2931	0179445-0000	hsa05130	Pathogenic Escherichia coli infection	25_5578_9475_7100_7430_9181_2017_2534	8	-	0.0199578435014803	0.0646909410047982
2932	0179445-0000	hsa04740	Olfactory transduction	51806_157_5613_5567_5616_808_801_393046_805	9	-	1.49518075664952e-37	1.40546991125055e-35
2933	0179445-0000	hsa04514	Cell adhesion molecules (CAMs)	24146_965_1366_958_3105_3106_4897_3135_23308_5792_9672_23705_3655_5817_25945_9019_649853	17	-	2.7466342501956e-05	0.000258183619518386
2934	0179445-0000	hsa04510	Focal adhesion	8503_5170_595_1302_596_5295_331_3909_9475_10451_5747_3655_5728_3911_2324_3693_7057_7410_23396_1398_1291_3912_896_1793_3480_1277_1956_3725_3918_4233_5578_2335_1729_2317_6655_6654_6464_7409_673_2534	40	-	0.000819696633000537	0.00531262030286503
2935	0179445-0000	hsa05340	Primary immunodeficiency	958_100_5993	3	-	0.0134697176625196	0.0506461384110737
2936	0179445-0000	hsa04530	Tight junction	50855_6709_56288_93643_24146_5584_5580_51776_2017_55844_10207_8777_5519_22800_4628_5590_5520_8189_5578_5728_1366_1457_1459_27134	24	-	0.00182939887324673	0.00955352744917737
2937	0179445-0000	hsa05218	Melanoma	8503_595_3480_5295_5728_673_5925_1956_2257_1869_2260_4233	12	-	0.0222550026302264	0.0697323415747094
2938	0179445-0000	hsa05310	Asthma	958	1	-	0.00280660691429399	0.0131910524971818
2939	0179445-0000	hsa04512	ECM-receptor interaction	1291_960_3912_1302_3911_9672_3693_1605_3909_2335_7057_3918_3655_3339_1277_3161	16	-	0.0367512603217344	0.111439305491711
2940	0179445-0000	hsa04630	Jak-STAT signaling pathway	3717_6777_595_5295_5292_8503_9180_10254_3451_2057_3455_3572_2033_8651_10401_896_3953_1271_8554_4609_868_5618_3566_3454_6655_6654_867_51588_50616_10379_2690	31	-	0.00633979796557398	0.0270882276710888
2941	0179445-0000	hsa04062	Chemokine signaling pathway	3717_6777_1147_157_6464_112_8503_9475_115_6387_5332_56288_5747_4067_3551_7074_5567_2788_7410_1398_4793_408_5295_673_10681_107_23236_5590_5580_5613_6655_6654_5616_10451_7409_5970_7852	37	-	0.000954829690457373	0.00560962443143707
2942	0179445-0000	hsa04810	Regulation of actin cytoskeleton	8503_5295_8826_9475_10451_23365_5747_3655_10458_23396_7074_3693_8394_7410_50649_7430_324_1398_2263_2260_2261_8396_2264_2768_1793_1131_673_22800_1956_10787_4628_23191_2335_1729_6655_6654_54961_8936_7409_54434_2257_26999_2149	43	-	0.000700644908864711	0.00506620164871406
2943	0179445-0000	hsa05012	Parkinson's disease	4714_836_1339_842_317_51465_65018_27429_1327	9	-	3.32625943833306e-09	7.81670968008269e-08
2944	0179445-0000	hsa04260	Cardiac muscle contraction	776_1339_1327_488_4635_27092	6	-	1.16761055505022e-05	0.000153742070619614
2945	0179445-0000	hsa04060	Cytokine-cytokine receptor interaction	8742_8741_7852_6387_9180_7132_3556_3554_3553_1956_2057_2324_3572_4982_8718_958_3953_1271_8771_4055_3451_7042_655_8792_4233_5618_3566_3454_3455_8764_50616_51330_2690	33	-	1.63449594474384e-09	5.12142062686403e-08
2946	0179445-0000	hsa03010	Ribosome	6168_6125_6205_6234_6181_6203_6158_6160_6129	9	-	7.61475855135939e-06	0.000119297883971297
2947	0179445-0000	hsa04020	Calcium signaling pathway	51806_3710_5336_2776_115_7220_5332_5335_136_1909_9630_493_5256_5567_3707_814_56848_776_5534_5021_1131_5532_3708_1956_488_107_23236_8877_5578_5613_3709_5616_8912_808_805_801_2065_2149	38	-	0.00487082195062438	0.0218027268266044
2948	0179445-0000	hsa03050	Proteasome	23198	1	-	1.87488407040578e-05	0.00019582122513127
2949	0179445-0000	hsa04950	Maturity onset diabetes of the young	3087	1	-	0.0102008111011608	0.0416902714569181
2950	0179445-0000	hsa04610	Complement and coagulation cascades	2157_7056_7035_2149_1604	5	-	7.05756130257116e-05	0.000603100693128808
2951	sulfamerazine	hsa04650	Natural killer cell mediated cytotoxicity	3812_3824_3383_3805_3806_5880_5293_3802_4776_9436_7410_3811_5781_2185_3448_51744_259197	17	+	0.0079851588526989	0.331384092387004
2952	sulfamerazine	hsa04080	Neuroactive ligand-receptor interaction	1268_9127_2846_3062_2568_1812_1813_3360_799_2918_2688_1442_4987_2914_2917_3953_5023_5733_3352_8001_5340_2892_2740_2696	24	+	0.0478496331904705	0.79430391096181
2953	sulfamerazine	hsa04740	Olfactory transduction	26532_26664_26692	3	+	4.9355013254041e-07	4.0964661000854e-05
2954	sulfamerazine	hsa04020	Calcium signaling pathway	2778_775_2769_51196_3710_1812_5260_5023_9127_3360_5156_5333_776_7416_2185_488_5733_8911_2065	19	+	0.0305251070977322	0.633395972277943
2955	sulfamerazine	hsa04930	Type II diabetes mellitus	775_2475_776_5313_5293_3630_9021	7	+	0.0266573288334132	0.633395972277943
2956	sulfamerazine	hsa05010	Alzheimer's disease	836_4712_841_572_3708_5534_823_23236	8	-	0.000727466355866777	0.0223089682465812
2957	sulfamerazine	hsa04080	Neuroactive ligand-receptor interaction	1909_1269_1081_1813_3953_1131_2908_5618_4886_3354_56288_7067_134_9568_2690_7068_7433_2561	18	-	0.00723017872976587	0.110862740523077
2958	sulfamerazine	hsa05016	Huntington's disease	246721_1387_836_4712_841_581_7052_6667_3708_5468_548644_161_23236	13	-	0.0192696580091114	0.221601067104781
2959	sulfamerazine	hsa04740	Olfactory transduction	818_5613_5616_393046	4	-	3.76783041597252e-16	3.46640398269472e-14
2960	sulfamerazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_94239_8366_8368_6737_8329_8294_8343_8347_8346_8344_8367_3123_3126_3127_3125_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235_3113_727_9555	35	-	0.0020036473362288	0.0368671109866099
2961	sulfamerazine	hsa05012	Parkinson's disease	27429_836_7332_4712_5413	5	-	0.00128277929111537	0.0295039236956535
2962	sulfamerazine	hsa04260	Cardiac muscle contraction	481_4635_27092	3	-	0.016389431316279	0.215403954442524
2963	sulfamerazine	hsa04060	Cytokine-cytokine receptor interaction	1436_5618_8771_3594_3953_8744_4254_3572_3976_7422_7042_8718_2690	13	-	8.49200202986554e-05	0.00390632093373815
2964	sulfamerazine	hsa03050	Proteasome	23198	1	-	0.0399862888524678	0.408748730491893
2965	bromopride	hsa04070	Phosphatidylinositol signaling system	3633	1	+	0.0199130031704552	0.305332715280313
2966	bromopride	hsa04120	Ubiquitin mediated proteolysis	7337_5371_330_55236	4	+	0.0186795320214144	0.305332715280313
2967	bromopride	hsa05010	Alzheimer's disease	1339_2904_6392_651820_317_824	6	+	0.0129835604460179	0.298621890258412
2968	bromopride	hsa04310	Wnt signaling pathway	5599_51384_894_7480_5516	5	+	0.0248944834637077	0.32718463980873
2969	bromopride	hsa04660	T cell receptor signaling pathway	920_29851_10000	3	+	0.034575821568567	0.353441731589796
2970	bromopride	hsa04910	Insulin signaling pathway	5599_8660_10000_10211_5105	5	+	0.0430877417308537	0.357087792287755
2971	bromopride	hsa04740	Olfactory transduction	7932_8383_442194_5132_26539_393046	6	+	2.09460497276726e-08	1.92703657494588e-06
2972	bromopride	hsa04514	Cell adhesion molecules (CAMs)	8516_8506_23308_3384_3383_3123_3126_3127_3125_51208_9379_29851_26285_965_3688_3683_3685_5797_3117_920_923_26047_1000	23	+	0.00447871161047819	0.137347156054665
2973	bromopride	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_2904_8368_8360_88_8362_8294_3123_8366_3126_3127_3125_8370_8359_554313_121504_83740_3117_720_721	26	+	0.00145692948602953	0.0670187563573584
2974	bromopride	hsa04110	Cell cycle	5925_894_699_1029	4	+	0.0452905347887516	0.357087792287755
2975	bromopride	hsa04720	Long-term potentiation	2904	1	+	0.0304030707283834	0.349635313376409
2976	bromopride	hsa03010	Ribosome	6129_6192_6123	3	+	0.0465766685592724	0.357087792287755
2977	bromopride	hsa05332	Graft-versus-host disease	3105_3106_3107_3113_3135_649853	6	-	0.0360579022973426	0.447083317900652
2978	bromopride	hsa05211	Renal cell carcinoma	2271_2549_405_3845_7422_7042_10000_6655_7423	9	-	0.0368186261800537	0.447083317900652
2979	bromopride	hsa05320	Autoimmune thyroid disease	1081_3105_3106_3107_3113_3135_649853	7	-	0.0342085742949445	0.447083317900652
2980	bromopride	hsa04740	Olfactory transduction	810_51806_393046	3	-	3.24484532917465e-06	0.000227998436758947
2981	bromopride	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8347_8346_8344_8370_8359_8337_554313_121504_8339_3113_720_721_9555	24	-	5.36466910021051e-06	0.000227998436758947
2982	bromopride	hsa05219	Bladder cancer	11186_4318_1613_1956_3845_7422_7423	7	-	0.0123312553596948	0.349385568524686
2983	bromopride	hsa05330	Allograft rejection	3105_3106_3107_3113_3135_649853	6	-	0.0246270766146704	0.447083317900652
2984	bromopride	hsa04940	Type I diabetes mellitus	3105_3106_3107_3113_3135_649853	6	-	0.04286617395233	0.455453098243506
2985	sulfapyridine	hsa05332	Graft-versus-host disease	3553_3804_3126_3127_3125_3123_3113	7	+	0.0317145310909868	0.507432497455789
2986	sulfapyridine	hsa05016	Huntington's disease	6392_3708_651820	3	+	0.00365412438623594	0.0974433169662917
2987	sulfapyridine	hsa04740	Olfactory transduction	26212_5568_157_5566_8392_810_9635	7	+	2.81325323902185e-05	0.00112530129560874
2988	sulfapyridine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113_3014	31	+	1.14453341720212e-07	9.15626733761696e-06
2989	sulfapyridine	hsa05012	Parkinson's disease	6392_651820	2	+	0.0123225247602426	0.246450495204852
2990	sulfapyridine	hsa04070	Phosphatidylinositol signaling system	8394_3633_5291_5331_8821_23236_3705	7	-	0.0485960900722183	0.826133531227711
2991	sulfapyridine	hsa04080	Neuroactive ligand-receptor interaction	9568	1	-	0.000547995010373429	0.0232897879408707
2992	sulfapyridine	hsa05322	Systemic lupus erythematosus	8353_8344_8347_3013_8346_8358_8343_8968_720_721_8350_8351_8352_8339_8354_8355_8356_8357	18	-	8.51630073975869e-05	0.00723885562879489
2993	sulfapyridine	hsa04530	Tight junction	84612	1	-	0.0460386141921171	0.826133531227711
2994	sulfapyridine	hsa05213	Endometrial cancer	5170_6655_999_5291_6932_324	6	-	0.0280669015818164	0.795228878151465
2995	(+)-isoprenaline	hsa05322	Systemic lupus erythematosus	85235_8969_8332_8330_8331_8329_8336	7	-	0.0011433199765097	0.0663125586375626
2996	amphotericin B	hsa05332	Graft-versus-host disease	3123_3126_3127_3119_3125	5	+	0.0176765907633437	0.177271981179675
2997	amphotericin B	hsa05320	Autoimmune thyroid disease	1081_3119_3123_3126_3127_3125	6	+	0.0119461813264957	0.177271981179675
2998	amphotericin B	hsa04740	Olfactory transduction	8387_26211_5568_816_8388	5	+	0.0194894575002048	0.177271981179675
2999	amphotericin B	hsa05310	Asthma	3123_3126_3127_3119_3125	5	+	0.00512899710399521	0.177271981179675
3000	amphotericin B	hsa04912	GnRH signaling pathway	5568_1081_1839_5331_3708_8681_100137049_107_816	9	+	0.0138963065447919	0.177271981179675
3001	amphotericin B	hsa05330	Allograft rejection	3123_3126_3127_3119_3125	5	+	0.0123183216201574	0.177271981179675
3002	amphotericin B	hsa04730	Long-term depression	2781_6261_2892_5331_3708_8681_100137049	7	+	0.0132165148391284	0.177271981179675
3003	amphotericin B	hsa04940	Type I diabetes mellitus	3123_3126_3127_3119_3125	5	+	0.0208555271976088	0.177271981179675
3004	amphotericin B	hsa04740	Olfactory transduction	219464	1	-	0.0106899485444737	0.652086861212896
3005	methoxsalen	hsa05222	Small cell lung cancer	6502_6257_1288_5925	4	+	0.0477186071565786	0.826570303053229
3006	methoxsalen	hsa05219	Bladder cancer	1956_2261_1613	3	-	0.0492215265334523	1
3007	methoxsalen	hsa04540	Gap junction	115_5331_5607_1956_5154	5	-	0.0341114664560538	1
3008	phenazopyridine	hsa05332	Graft-versus-host disease	3553_3119_3105_3106_3107_3126_3135_649853	8	+	0.00619975009073197	0.106379578904936
3009	phenazopyridine	hsa05016	Huntington's disease	7052_3708	2	+	0.00218228529104491	0.0589217028582126
3010	phenazopyridine	hsa04740	Olfactory transduction	26212_8390_8590_816	4	+	2.97026891905134e-06	0.000240591782443159
3011	phenazopyridine	hsa04514	Cell adhesion molecules (CAMs)	9378_3119_9071_3105_29851_3107_3126_3685_3135_6693_920_3106_26047_649853	14	+	0.0471323545772006	0.405473268371565
3012	phenazopyridine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3126_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3119	23	+	5.5856719725883e-05	0.00226219714889826
3013	phenazopyridine	hsa04630	Jak-STAT signaling pathway	1437_3560_3590_23533_3589_5618_5290_6773_50615_200734_51561_3952_81848_10252_9021_4352	16	+	0.042132506088818	0.405473268371565
3014	phenazopyridine	hsa05012	Parkinson's disease	6622	1	+	0.0073968748351328	0.106379578904936
3015	phenazopyridine	hsa05330	Allograft rejection	3119_3105_3106_3107_3126_3135_649853	7	+	0.0118977584603058	0.137674062183539
3016	phenazopyridine	hsa04940	Type I diabetes mellitus	3553_3119_3105_3106_3107_3126_3135_649853	8	+	0.00787996880777304	0.106379578904936
3017	phenazopyridine	hsa05200	Pathways in cancer	1436_2737_4286_581_6789_5154_867_3918_4088_7046_6934_7042_5914_2260_2261_3725_4149	17	-	0.00693020363140974	0.114348359918261
3018	phenazopyridine	hsa04740	Olfactory transduction	157_4991	2	-	0.00658168907350965	0.114348359918261
3019	phenazopyridine	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	-	0.00147658045113538	0.0885343917433556
3020	phenazopyridine	hsa04010	MAPK signaling pathway	4217_9479_1432_4216_9448_6789_6416_5154_5607_7046_5606_7042_3725_2260_2261_4149	16	-	0.00268286035585926	0.0885343917433556
3021	phenazopyridine	hsa05210	Colorectal cancer	581_4088_7046_6934_7042_3725	6	-	0.0228811460117648	0.302031127355295
3022	carbimazole	hsa05214	Glioma	1021_6655_5155_4193_5578	5	+	0.0246567332966368	0.524577488744497
3023	carbimazole	hsa04740	Olfactory transduction	4991	1	+	0.0017046777088385	0.0554020255372513
3024	carbimazole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_81	15	+	5.09677477804422e-06	0.000331290360572874
3025	carbimazole	hsa04664	Fc epsilon RI signaling pathway	6655_81579_8398_6850_5578	5	+	0.048422537422569	0.524577488744497
3026	carbimazole	hsa04730	Long-term depression	3708_81579_8398_4842_5578	5	+	0.0336369593013069	0.524577488744497
3027	carbimazole	hsa05220	Chronic myeloid leukemia	861_6655_1021_4193_7042	5	+	0.0406207085080856	0.524577488744497
3028	carbimazole	hsa04740	Olfactory transduction	109	1	-	0.0162930012040895	0.54292833244476
3029	carbimazole	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0190501169278863	0.54292833244476
3030	colecalciferol	hsa05211	Renal cell carcinoma	4233_5781_1399	3	+	0.0292284170745252	0.676424328149331
3031	colecalciferol	hsa04210	Apoptosis	472_8837_651610	3	+	0.0488465146610594	0.676424328149331
3032	colecalciferol	hsa04115	p53 signaling pathway	472_651610_7249	3	+	0.026309141743502	0.676424328149331
3033	niridazole	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	+	0.0437709823557887	0.556353364270733
3034	niridazole	hsa04062	Chemokine signaling pathway	4793	1	+	0.047527455646003	0.556353364270733
3035	niridazole	hsa05330	Allograft rejection	3135_3105_3106_649853	4	+	0.032819019248853	0.556353364270733
3036	niridazole	hsa04940	Type I diabetes mellitus	3105_3106_2572_2571_3135_649853	6	+	0.00309001532247077	0.173040858058363
3037	niridazole	hsa04080	Neuroactive ligand-receptor interaction	3953_1812	2	-	0.001138472723761	0.048954327121723
3038	niridazole	hsa04740	Olfactory transduction	219464_157	2	-	4.40769928341948e-06	0.000379062138374075
3039	niridazole	hsa05322	Systemic lupus erythematosus	85235_3119_3013_8330_8332_8969_8331_8329_8351_8343_8336_8339_8347_8346_8344	15	-	0.00601030341131544	0.172295364457709
3040	niridazole	hsa04062	Chemokine signaling pathway	23236_157_112	3	-	0.0365196996235061	0.785173541905381
3041	pilocarpine	hsa04540	Gap junction	7278_113457_5154	3	-	0.0357509587759586	0.453137048119794
3042	pilocarpine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00174779567373024	0.0559294615593677
3043	neostigmine bromide	hsa04662	B cell receptor signaling pathway	4776_5881_8519	3	+	0.0379824525031227	0.688037528979874
3044	neostigmine bromide	hsa04370	VEGF signaling pathway	4776_5881_56848	3	+	0.0404727958223455	0.688037528979874
3045	neostigmine bromide	hsa05016	Huntington's disease	5432_1213_246721_6648_5439_548644	6	-	0.0113711846818208	0.198660606016033
3046	neostigmine bromide	hsa04540	Gap junction	7278_5607_5155_113457	4	-	0.0145361419036122	0.198660606016033
3047	neostigmine bromide	hsa03020	RNA polymerase	5432_246721_5439_548644	4	-	0.000275028044252327	0.0112761498143454
3048	melatonin	hsa05200	Pathways in cancer	5925	1	+	0.0107841588980198	0.612199263552571
3049	melatonin	hsa04740	Olfactory transduction	5566_4991	2	+	0.0182746048821663	0.612199263552571
3050	melatonin	hsa04710	Circadian rhythm - mammal	8553_9572	2	+	0.0383493942832031	0.856469805658203
3051	melatonin	hsa03020	RNA polymerase	5432_246721_5439_548644	4	-	0.00177602362365207	0.106561417419124
3052	bisacodyl	hsa04916	Melanogenesis	1906_1385	2	+	0.0481595202980174	0.376519885966318
3053	bisacodyl	hsa05010	Alzheimer's disease	4311_6390_6622_4023	4	+	0.0101661672754142	0.174858077137124
3054	bisacodyl	hsa04310	Wnt signaling pathway	10725_5599_324_3725	4	+	0.0347883924223354	0.332422416480094
3055	bisacodyl	hsa05016	Huntington's disease	1385_6390_7802_161	4	+	0.0053537074813392	0.15347294779839
3056	bisacodyl	hsa04740	Olfactory transduction	2774	1	+	6.67087334534737e-11	2.86847553849937e-09
3057	bisacodyl	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_8335_9103_88_8362_8294_121504_8342_8341_723790_3123_8366_3126_3127_3125_8968_8370_8358_8359_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_83740_3012_3013_8349_941	42	+	1.72885235686949e-12	1.48681302690776e-10
3058	bisacodyl	hsa05212	Pancreatic cancer	1385	1	+	0.030964878407629	0.332422416480094
3059	bisacodyl	hsa05215	Prostate cancer	1385	1	+	0.0304902802604053	0.332422416480094
3060	bisacodyl	hsa04062	Chemokine signaling pathway	5829_6464_998_7852_6368_56288	6	+	0.031409996790029	0.332422416480094
3061	bisacodyl	hsa05012	Parkinson's disease	6390_6622	2	+	0.00893882088953797	0.174858077137124
3062	bisacodyl	hsa03010	Ribosome	6139_6144	2	+	0.0474331394182444	0.376519885966318
3063	bisacodyl	hsa05332	Graft-versus-host disease	355_3119	2	-	0.0258720761538244	0.0962441232922268
3064	bisacodyl	hsa04650	Natural killer cell mediated cytotoxicity	8503_836_5296_4775_5295_355_673_10451_6452_5335_5058_2534	12	-	0.0015303354084977	0.00889507456189288
3065	bisacodyl	hsa04640	Hematopoietic cell lineage	3554_4254_2057	3	-	6.8123639155427e-05	0.000703944271272746
3066	bisacodyl	hsa05010	Alzheimer's disease	836_842_841_8772_4698_5664_317_8883_355_3709_23621_489_488_810_7132_23236	16	-	0.000365212658324492	0.0030877070203798
3067	bisacodyl	hsa04080	Neuroactive ligand-receptor interaction	5618_7442_4157_3953_5031_7434_64106_2150_136_56288_2690_9170	12	-	1.6003097032894e-10	7.44144012029571e-09
3068	bisacodyl	hsa04742	Taste transduction	5613_5616_112	3	-	0.012977175291832	0.0574703477209703
3069	bisacodyl	hsa05320	Autoimmune thyroid disease	355_3119	2	-	0.00374304214856944	0.020476642342174
3070	bisacodyl	hsa04612	Antigen processing and presentation	4801_5993_3119_1508_3308_811_3304_3305_3303	9	-	0.0315346541809378	0.110562181050407
3071	bisacodyl	hsa04670	Leukocyte transendothelial migration	8503_5295_5296_2773_1500_9080_10451_4313_5335_5600_5603_9475_1365	13	-	0.0159979000455997	0.0676274865563987
3072	bisacodyl	hsa05016	Huntington's disease	5432_3092_836_842_841_581_7157_1639_317_10488_4698_5481_23236	13	-	8.06485372126656e-06	0.000150006279215558
3073	bisacodyl	hsa04740	Olfactory transduction	810_5613_5616_157	4	-	2.85143627179205e-27	2.65183573276661e-25
3074	bisacodyl	hsa04514	Cell adhesion molecules (CAMs)	214_3385_3119_9080_1365_9672_9019	7	-	1.58663320645127e-05	0.000245928146999947
3075	bisacodyl	hsa04510	Focal adhesion	8503_857_7094_5295_2324_5296_3691_596_5155_5154_9475_10451_1956_5058_207_6714_673_4233_2534_3912	20	-	0.00026910232431732	0.00250265161615108
3076	bisacodyl	hsa05322	Systemic lupus erythematosus	55506_85235_3119_94239_8330_3021_3020_8332_8969_8331_8336_3014_8334_6738_8329_9555_55766	17	-	0.0208876446660077	0.0809396230807798
3077	bisacodyl	hsa04530	Tight junction	5584_5583_5580_2773_9080_4619_1457_56288_207_6714_9223_1365	12	-	0.00149532093953015	0.00889507456189288
3078	bisacodyl	hsa04720	Long-term potentiation	5613_5616_673_3709_810_23236	6	-	0.0175382081875412	0.0709153635409275
3079	bisacodyl	hsa05110	Vibrio cholerae infection	11015_5335_5616_23545_5613	5	-	0.0458753308272921	0.147117440239247
3080	bisacodyl	hsa05310	Asthma	3119	1	-	0.0320986977243116	0.110562181050407
3081	bisacodyl	hsa04512	ECM-receptor interaction	3691_3912_9672_3161	4	-	0.000567310321684338	0.00439665499305362
3082	bisacodyl	hsa04630	Jak-STAT signaling pathway	868_3717_6778_207_2057_3953_598_5295_5618_6772_5296_23529_9063_10379_8835_8503_2690	17	-	0.00814140203888283	0.042063910534228
3083	bisacodyl	hsa04062	Chemokine signaling pathway	3717_157_5296_2773_8503_9475_10451_56288_113_112_7454_4067_5580_7074_408_5295_207_673_23236_5613_5616_6772_5058_5970	24	-	0.0112512567532149	0.0523183439024493
3084	bisacodyl	hsa04810	Regulation of actin cytoskeleton	8503_5296_5295_5155_5154_9475_10451_5058_23365_7454_7074_3691_1445_2263_200576_2264_8394_8396_673_1956_6548_54434_3984_3985	24	-	0.00111482583503899	0.00797529251220201
3085	bisacodyl	hsa05012	Parkinson's disease	836_842_7314_317_4698_5481	6	-	3.2363868113864e-06	7.52459933647338e-05
3086	bisacodyl	hsa04260	Cardiac muscle contraction	6548_488	2	-	2.14523414676188e-05	0.000285009679498364
3087	bisacodyl	hsa04060	Cytokine-cytokine receptor interaction	8792_3953_5618_3554_7132_2057_2324_23529_5155_5154_8741_8742_657_355_1956_90_4254_27242_4233_7048_2690	21	-	1.07632791253321e-06	3.33661652885295e-05
3088	bisacodyl	hsa04020	Calcium signaling pathway	489_5613_5616_3709_7220_1956_5335_136_113_488_810_3707_5481_23236	14	-	2.75442380520602e-05	0.0003202017673552
3089	bisacodyl	hsa05330	Allograft rejection	355_3119	2	-	0.0357195086584391	0.11863979661553
3090	bisacodyl	hsa04730	Long-term depression	673_2773_4067_3709_23236	5	-	0.00934294963159699	0.0457312797757116
3091	bisacodyl	hsa04610	Complement and coagulation cascades	7056_2152_5329	3	-	0.00148671078840099	0.00889507456189288
3092	amiodarone	hsa03440	Homologous recombination	5890_8940_25788_5888	4	-	0.0389208648860616	1
3093	amiodarone	hsa04740	Olfactory transduction	5566_26529_157	3	-	0.000180604205254886	0.0137259195993713
3094	amiodarone	hsa04530	Tight junction	6714	1	-	0.0464091675189432	1
3095	methyldopa	hsa05010	Alzheimer's disease	3709_4713	2	+	0.025423652078257	1
3096	methyldopa	hsa04740	Olfactory transduction	816	1	+	1.16379246684923e-06	9.31033973479384e-05
3097	methyldopa	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_6738_121504	15	-	0.0150493682334963	1
3098	leflunomide	hsa05010	Alzheimer's disease	5532_1339	2	+	0.00225804397296786	0.10048295679707
3099	leflunomide	hsa05016	Huntington's disease	7052_7416_1339_7350	4	+	0.0140902124008252	0.418009634557814
3100	leflunomide	hsa04740	Olfactory transduction	2978_5568_9635_8392	4	+	7.17449198704671e-07	6.38529786847157e-05
3101	leflunomide	hsa04512	ECM-receptor interaction	2814_8515_960_1302_1311_3381_9900_3918_1284_7059_1291	11	+	0.0473338901559148	0.864380942185807
3102	leflunomide	hsa05012	Parkinson's disease	7416_1339_7054	3	+	0.0485607270890903	0.864380942185807
3103	leflunomide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	1.19388696957879e-07	6.44698963572547e-06
3104	leflunomide	hsa04370	VEGF signaling pathway	572_6714_50487_5603	4	-	0.035130517085606	0.859665731773711
3105	amikacin	hsa04520	Adherens junction	4088_91_2260_1956_2241	5	+	0.0333049621967622	0.694214421826377
3106	amikacin	hsa04740	Olfactory transduction	26212_1179	2	+	0.0182776174228042	0.618155294013757
3107	amikacin	hsa04930	Type II diabetes mellitus	8651_775_776_773	4	+	0.0193173529379299	0.618155294013757
3108	carmustine	hsa05010	Alzheimer's disease	355_22926	2	+	0.00149416932170313	0.0408406281265522
3109	carmustine	hsa04080	Neuroactive ligand-receptor interaction	5618_7442_2150	3	+	0.000112977681860735	0.00926416991258027
3110	carmustine	hsa05016	Huntington's disease	1385_7416_161_7019	4	+	0.0142177677025087	0.145732118950714
3111	carmustine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_720_721	23	+	0.000248623267268929	0.0101935539580261
3112	carmustine	hsa04062	Chemokine signaling pathway	6093_6655_156	3	+	0.00375406413691183	0.057901634516544
3113	carmustine	hsa04540	Gap junction	6655	1	+	0.0302988364802058	0.248450459137688
3114	carmustine	hsa05012	Parkinson's disease	7416	1	+	0.00339914833744717	0.057901634516544
3115	carmustine	hsa04060	Cytokine-cytokine receptor interaction	5618_2057_55540_657_355_8795	6	+	0.00423670496462517	0.057901634516544
3116	carmustine	hsa03010	Ribosome	51187	1	+	0.0212673322343301	0.193769027023896
3117	carmustine	hsa04020	Calcium signaling pathway	8912_7220_7416	3	+	0.00509716989379582	0.0597097044701796
3118	carmustine	hsa04080	Neuroactive ligand-receptor interaction	5025_4157_4886_9170	4	-	0.00211099208445422	0.0886616675470772
3119	carmustine	hsa04740	Olfactory transduction	818	1	-	1.42743508055367e-08	1.19904546766508e-06
3120	carmustine	hsa05322	Systemic lupus erythematosus	8346_85235_3123_8330_3126_3127_3014_3125_8332_8969_8331_8336_8343_8329_8339_8347_87_8344	18	-	0.00413973590261896	0.115912605273331
3121	carmustine	hsa04360	Axon guidance	1949	1	-	0.0104459253655587	0.219364432676733
3122	carmustine	hsa05215	Prostate cancer	10488_5728_596_7157_572_5605_3326_367_2263_2260	10	-	0.0436653500562289	0.543233678405339
3123	carmustine	hsa03010	Ribosome	9349	1	-	0.0452694732004449	0.543233678405339
3124	carmustine	hsa05213	Endometrial cancer	5728_7157_572_999_5605_1495_324	7	-	0.0396285050489749	0.543233678405339
3125	dinoprostone	hsa04740	Olfactory transduction	5137	1	+	5.0761942602293e-07	4.3655270637972e-05
3126	dinoprostone	hsa04514	Cell adhesion molecules (CAMs)	3134	1	+	0.0325563462770413	0.478834313618663
3127	dinoprostone	hsa05212	Pancreatic cancer	2308_842_6932_4193_5605_1956_2033_367_2263_2260	10	+	0.0130287644966834	0.280118436678693
3128	dinoprostone	hsa05215	Prostate cancer	2308_842_6932_4193_5605_1956_2033_367_2263_2260	10	+	0.0121827648926792	0.280118436678693
3129	dinoprostone	hsa05012	Parkinson's disease	842	1	+	0.0334070451361858	0.478834313618663
3130	dinoprostone	hsa04270	Vascular smooth muscle contraction	8398_5583_10267_5581_9138_4660_2776_5605_108_3709_113_1909_81579	13	+	0.00818740912585714	0.280118436678693
3131	dinoprostone	hsa05332	Graft-versus-host disease	3105_3106_3126_3127_3125_3135_3123_649853	8	-	0.000424912813308151	0.00892316907947117
3132	dinoprostone	hsa05320	Autoimmune thyroid disease	3105_3106_3126_3127_3125_3135_3123_649853	8	-	0.00164116665137076	0.0229763331191906
3133	dinoprostone	hsa04612	Antigen processing and presentation	4800_4801_3123_3106_3126_3127_3125_3135_3105_811_649853	11	-	0.00106428508337112	0.0178799894006348
3134	dinoprostone	hsa04740	Olfactory transduction	5613_5616	2	-	8.79938194105053e-05	0.00488582554714233
3135	dinoprostone	hsa05322	Systemic lupus erythematosus	3017_85235_3123_3126_3127_3125_8332_8969_8331_8336_8329_8330	12	-	0.0150520271862041	0.180624326234449
3136	dinoprostone	hsa04210	Apoptosis	581_5613_5616_472_9941_51135_8837_651610	8	-	0.0259122929837366	0.272079076329234
3137	dinoprostone	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.0347694152830644	0.324514542641934
3138	dinoprostone	hsa05330	Allograft rejection	3105_3106_3126_3127_3125_3135_3123_649853	8	-	0.00023471212244459	0.00657193942844852
3139	dinoprostone	hsa05210	Colorectal cancer	581_1856_7040_6934_91_3725_2956	7	-	0.0494811327240081	0.415641514881668
3140	dinoprostone	hsa04940	Type I diabetes mellitus	3382_3105_3106_3126_3127_3125_3135_3123_649853	9	-	0.000116329179693865	0.00488582554714233
3141	5140203	hsa04350	TGF-beta signaling pathway	91_7059	2	+	0.018952807917658	0.227433695011896
3142	clotrimazole	hsa05332	Graft-versus-host disease	57292_3811_3119_3113_3111_3802_940	7	+	0.00520507853817141	0.0975952225907139
3143	clotrimazole	hsa05320	Autoimmune thyroid disease	3439_1081_3119_3447_3113_3111_940	7	+	0.0155149663953492	0.232724495930238
3144	clotrimazole	hsa04612	Antigen processing and presentation	4261_57292_3811_3119_3439_3447_3113_3111_3802_6890_925	11	+	0.00430793529126881	0.0975952225907139
3145	clotrimazole	hsa05016	Huntington's disease	64446_3708_161	3	+	0.0499071007034309	0.623838758792886
3146	clotrimazole	hsa04740	Olfactory transduction	26211_26212_135948_81797_81696	5	+	0.000907872991677754	0.0680904743758315
3147	clotrimazole	hsa05322	Systemic lupus erythematosus	2212_3119_3013_3113_3111_8358_8968_940_8350_8351_8352_8353_8354_8355_8356_8357	16	+	0.00247737333231654	0.0929014999618702
3148	clotrimazole	hsa04080	Neuroactive ligand-receptor interaction	2911_5618_4157_1131_7434_2149	6	-	0.00769478909613907	0.323181142037841
3149	clotrimazole	hsa04740	Olfactory transduction	818_801_808_805	4	-	1.00103082609808e-06	8.40865893922387e-05
3150	clotrimazole	hsa04010	MAPK signaling pathway	9479_5155_57551_5607_776_10454_3306_5608_3554_3552_6789_2249_2261_6300_4217_4216_8399_998_5534_3725_4791_5578_4763_4137_5606_9693	26	-	0.0473626863599345	0.74508702824461
3151	clotrimazole	hsa05012	Parkinson's disease	7419_1327	2	-	0.0175139451020334	0.385491070565238
3152	clotrimazole	hsa04912	GnRH signaling pathway	808_4216_8399_5578_998_2776_5608_818_5606_805_3725_801_6300_776	14	-	0.0183567176459637	0.385491070565238
3153	5109870	hsa05211	Renal cell carcinoma	3725_54583_6513_2034_7422	5	+	0.0155165283153216	0.173785117131602
3154	5109870	hsa04740	Olfactory transduction	157	1	+	0.00740148004105896	0.138160960766434
3155	5109870	hsa04710	Circadian rhythm - mammal	8553_5187_79365	3	+	0.00316552455143601	0.0886346874402083
3156	5109870	hsa05219	Bladder cancer	1956_1026_4193_7422	4	+	0.0111276831422784	0.155787563991898
3157	5109870	hsa04115	p53 signaling pathway	1647_1026_5366_1643_4193_3486_355_5054_5268_8795_9540	11	+	2.97879272112865e-07	1.66812392383204e-05
3158	5109870	hsa04740	Olfactory transduction	5567	1	-	0.00740105119142981	0.125817870254307
3159	5109870	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	30	-	1.23138191787011e-20	6.28004778113756e-19
3160	5109870	hsa04110	Cell cycle	995_890_5347_991_993_891_898_983_699_701_996_9700_1031	13	-	1.35023925099047e-06	3.4431100900257e-05
3161	5151277	hsa03450	Non-homologous end-joining	5591	1	+	0.0367857526230995	0.367857526230995
3162	decitabine	hsa04740	Olfactory transduction	26211	1	+	0.0333351393004055	0.84267117337574
3163	decitabine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6738_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	26	+	8.19624014282895e-19	5.08166888855395e-17
3164	topiramate	hsa05200	Pathways in cancer	355_8321_324	3	+	0.0241269078112142	0.176930657282237
3165	topiramate	hsa04310	Wnt signaling pathway	8321_324	2	+	0.0338275161200467	0.186051338660257
3166	topiramate	hsa05210	Colorectal cancer	8321_324	2	+	0.0113273378929259	0.124600716822185
3167	topiramate	hsa05217	Basal cell carcinoma	8321_324	2	+	0.00511049406771198	0.112430869489664
3168	colforsin	hsa05200	Pathways in cancer	2353_868_2271_842_596_898_3480_3576_3909_6772_4254_2034_2263_5914_2335_3725_3675	17	+	0.0318331705112837	0.512809440106611
3169	colforsin	hsa04740	Olfactory transduction	818	1	+	0.000257068222455344	0.0195371849066061
3170	colforsin	hsa04512	ECM-receptor interaction	2335_3693_3909_1277_3339_7057_3675	7	+	0.0154028353886968	0.512809440106611
3171	colforsin	hsa05222	Small cell lung cancer	842_596_898_3909_2335_3675	6	+	0.0483497976878624	0.512809440106611
3172	colforsin	hsa05014	Amyotrophic lateral sclerosis (ALS)	5606_836_5608_5603_5868	5	-	0.0258921469575653	0.578257948718958
3173	colforsin	hsa04740	Olfactory transduction	109	1	-	0.000373324290726209	0.025012727478656
3174	colforsin	hsa03020	RNA polymerase	5433_246721_5439_548644	4	-	0.0122628175809303	0.410804388961165
3175	HC toxin	hsa04070	Phosphatidylinositol signaling system	8503_5578_8394_5293_5291_3708_23396	7	+	0.0335709017158505	0.579933877215852
3176	HC toxin	hsa04080	Neuroactive ligand-receptor interaction	6915_2150_7433	3	+	0.0278671668967993	0.579933877215852
3177	HC toxin	hsa04664	Fc epsilon RI signaling pathway	8503_8399_5578_5293_5291_5606_2534	7	+	0.0396050590997726	0.579933877215852
3178	HC toxin	hsa04740	Olfactory transduction	5613	1	-	2.53984994896457e-05	0.00193028596121307
3179	HC toxin	hsa05212	Pancreatic cancer	595_596_3480_5155_5154_2033_1871_1387	8	-	0.0185874281440306	0.353161134736581
3180	HC toxin	hsa05215	Prostate cancer	595_596_3480_5155_5154_2033_1871_1387	8	-	0.0175620912660064	0.353161134736581
3181	HC toxin	hsa05216	Thyroid cancer	6257_5979_595_6256_4609	5	-	0.00577955700507689	0.219623166192922
3182	cetirizine	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.00629570446095401	0.0730301717470665
3183	cetirizine	hsa04640	Hematopoietic cell lineage	1436_2057_3123_3126_3127_3125	6	+	0.00386315936465716	0.0658083257824255
3184	cetirizine	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	+	0.013298598035491	0.120311434928514
3185	cetirizine	hsa04612	Antigen processing and presentation	6891_3123_3126_3127_3125	5	+	0.0178664845997757	0.129532013348374
3186	cetirizine	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.00207778214889328	0.0602556823179051
3187	cetirizine	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0145203455948206	0.120311434928514
3188	cetirizine	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.00453850522637417	0.0658083257824255
3189	cetirizine	hsa04940	Type I diabetes mellitus	3382_3126_3127_3123_3125	5	+	0.00110594297968685	0.0602556823179051
3190	cetirizine	hsa05332	Graft-versus-host disease	3552_3119_3123_3126_3127_3125_3135	7	-	0.0171662075324816	0.255935432410196
3191	cetirizine	hsa04080	Neuroactive ligand-receptor interaction	5025_56288_4889	3	-	0.000473280746413829	0.019404510602967
3192	cetirizine	hsa04612	Antigen processing and presentation	4800_4802_3308_3119_3123_3126_3127_3125_3135_3326_1385_567	12	-	0.0126403018905681	0.255935432410196
3193	cetirizine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_3123_3126_3127_3125_8370_8359_554313_8351_8339_3119_3013_3017	27	-	6.6371960778357e-07	5.44250078382527e-05
3194	cetirizine	hsa05212	Pancreatic cancer	6934_5296_369_5155_5605_3326_367_1385_5970_7184_842	11	-	0.0249693104790435	0.255935432410196
3195	cetirizine	hsa05215	Prostate cancer	6934_5296_369_5155_5605_3326_367_1385_5970_7184_842	11	-	0.023753030846168	0.255935432410196
3196	cetirizine	hsa05310	Asthma	3123_3126_3127_3119_3125	5	-	0.041470105709058	0.291850725397631
3197	cetirizine	hsa04060	Cytokine-cytokine receptor interaction	27242_3552_2324_5155_8742_8741_8795	7	-	0.0299377348554404	0.267257886363094
3198	cetirizine	hsa05330	Allograft rejection	3119_3123_3126_3127_3125_3135	6	-	0.032592425166231	0.267257886363094
3199	cetirizine	hsa04730	Long-term depression	5515_5605_3710_10672_2773_5331_8681_369_100137049_23236	10	-	0.0132877460528439	0.255935432410196
3200	cetirizine	hsa05222	Small cell lung cancer	3914_4149_842_5296_598_9618_51588_3673_5970_7187	10	-	0.0427098622533119	0.291850725397631
3201	cetirizine	hsa04940	Type I diabetes mellitus	3552_3119_3123_3126_3127_3125_3135	7	-	0.0210589388858193	0.255935432410196
3202	norcyclobenzaprine	hsa04010	MAPK signaling pathway	8817_1326_50487_1846_8912_4763_2258_3310_5971_3164	10	+	0.0416629310905803	1
3203	norcyclobenzaprine	hsa05332	Graft-versus-host disease	3119_3105_3126_3127_3125_3123	6	-	0.0202127463808413	0.289716031458725
3204	norcyclobenzaprine	hsa04080	Neuroactive ligand-receptor interaction	146_3354_9170	3	-	0.00377247222188363	0.108144203693997
3205	norcyclobenzaprine	hsa05320	Autoimmune thyroid disease	3119_3105_3126_3127_3125_3123	6	-	0.0492417222946572	0.41220672244267
3206	norcyclobenzaprine	hsa04740	Olfactory transduction	219464_26211_5613	3	-	2.8643425781844e-05	0.00123166730861929
3207	norcyclobenzaprine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8347_8346_8344_3123_3126_3127_3125_8370_8359_554313_121504_8339_3119_9555	25	-	1.44851376677132e-07	1.24572183942334e-05
3208	norcyclobenzaprine	hsa05310	Asthma	3123_3126_3127_3119_3125	5	-	0.0194978523009629	0.289716031458725
3209	norcyclobenzaprine	hsa05213	Endometrial cancer	324_7157_5295_5605_5296_6934	6	-	0.0459048081683028	0.41220672244267
3210	norcyclobenzaprine	hsa05330	Allograft rejection	3119_3105_3126_3127_3125_3123	6	-	0.0135148489121353	0.289716031458725
3211	norcyclobenzaprine	hsa05222	Small cell lung cancer	9134_7157_5295_9618_5296_8554_3673_1017_6256	9	-	0.0395768420104277	0.41220672244267
3212	norcyclobenzaprine	hsa04940	Type I diabetes mellitus	3119_3105_3126_3127_3125_3123	6	-	0.0242833872372692	0.29833875748645
3213	vorinostat	hsa05010	Alzheimer's disease	842_4713_6392_651820_317_778_4137_5331_3708_3709_22926_5664_23621	13	+	0.00513280287898857	0.0827042738590205
3214	vorinostat	hsa04080	Neuroactive ligand-receptor interaction	154_1081_1812_1132_2908_5724_4142_1241_6915_2358_2150_2689_7433_148_2688_728_1442	17	+	0.000149883743296128	0.00653923168652238
3215	vorinostat	hsa04742	Taste transduction	5566_51764	2	+	0.0287039765764917	0.234850717444023
3216	vorinostat	hsa04740	Olfactory transduction	26212_5566	2	+	3.64751995261694e-22	3.28276795735525e-20
3217	vorinostat	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_88_8329_8294_121504_8343_8341_8347_8346_8344_8339_3109_8969_8968_8370_92815_8358_8359_8330_8331_8336_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013	44	+	0.000217974389550746	0.00653923168652238
3218	vorinostat	hsa04062	Chemokine signaling pathway	5331_2185_2770_2771_5566_2788_6773_7852_6774_51764_729230_10235_208_5293_4793	15	+	0.00551361825726803	0.0827042738590205
3219	vorinostat	hsa05012	Parkinson's disease	842_5413_6392_7314_4713_317_9246_7345_7416_65018_651820	11	+	0.0286118161497251	0.234850717444023
3220	vorinostat	hsa04260	Cardiac muscle contraction	10479_778_7137_6548	4	+	0.0110019128247323	0.126371172066153
3221	vorinostat	hsa04060	Cytokine-cytokine receptor interaction	7852_3459_4804_3552_2057_3556_55540_8744_8743_8795_50615_1956_2688_2689_3977_7293_655_1896_8792_3587_729230	21	+	0.00147207054713383	0.0331215873105112
3222	vorinostat	hsa03010	Ribosome	6123_6129_6125_6224_6181_6165_6233	7	+	0.0244491988057434	0.234850717444023
3223	vorinostat	hsa03050	Proteasome	5698	1	+	0.0112329930725469	0.126371172066153
3224	vorinostat	hsa05332	Graft-versus-host disease	355	1	-	0.0104262986176712	0.0619384952975195
3225	vorinostat	hsa04650	Natural killer cell mediated cytotoxicity	6850_5534_3460_6464_5295_7409_355_5533_10451_5894_369_3845_8795	13	-	0.0170291379380636	0.0737929310649423
3226	vorinostat	hsa04640	Hematopoietic cell lineage	3554_3566_960_4254_3673_3675	6	-	0.0135417009564623	0.0643995770944726
3227	vorinostat	hsa05010	Alzheimer's disease	776_3710_4712_4700_8772_2776_5533_355_5332_23385_5534_4694_8851_7132_823_23236	16	-	0.00462777583748944	0.035309109510425
3228	vorinostat	hsa04080	Neuroactive ligand-receptor interaction	5029_4889_5618_152_4157_64106_5025_4886_5031_3354_56288_136_5026_9170	14	-	2.09755401425508e-07	9.54387076486061e-06
3229	vorinostat	hsa05320	Autoimmune thyroid disease	355	1	-	0.00208789357615023	0.0211109239366301
3230	vorinostat	hsa04612	Antigen processing and presentation	1385_4802_4801	3	-	0.000380341160108163	0.00692220911396857
3231	vorinostat	hsa05131	Shigellosis	25_2017_203068	3	-	0.0279876304889112	0.0979567067111892
3232	vorinostat	hsa04670	Leukocyte transendothelial migration	2909_5295_6387_9080_10451_1365_7409_5600_6300	9	-	0.00476970827215536	0.035309109510425
3233	vorinostat	hsa05016	Huntington's disease	4899_6874_51164_4694_4712_4700_7157_2776_5978_2033_5332_1385_1387_23236	14	-	0.000359561305189017	0.00692220911396857
3234	vorinostat	hsa05130	Pathogenic Escherichia coli infection	25_2017_203068	3	-	0.0279876304889112	0.0979567067111892
3235	vorinostat	hsa04740	Olfactory transduction	5613_109_5616_4991	4	-	2.92944150573694e-23	2.66579177022062e-21
3236	vorinostat	hsa04514	Cell adhesion molecules (CAMs)	965_4685_4897_9080_1365_5792_6693_5817	8	-	0.000589848913522522	0.00894604185509158
3237	vorinostat	hsa05340	Primary immunodeficiency	7374	1	-	0.0345947751355212	0.116597205086386
3238	vorinostat	hsa04210	Apoptosis	596_598_5295_331_7132_4615_3554_3551_7157_839_51135_8717_8772_5533_5534_4790_8795_5613_5575_5616_355_9941_2021_8837_5970_823	26	-	0.0372193327392908	0.120962831402695
3239	vorinostat	hsa04530	Tight junction	55844_8777_9080_4619_51776_1457_56288_3845_2017_6714_1365	11	-	0.0055706040049196	0.0362089260319774
3240	vorinostat	hsa05110	Vibrio cholerae infection	5613_109_5616	3	-	0.0200091867545736	0.0791667823767912
3241	vorinostat	hsa04810	Regulation of actin cytoskeleton	10298_2909_5295_5155_5154_10451_3673_3675_3691_3693_1445_1399_369_3845_5962_8396_8074_10787_10093_54961_7409_5894	22	-	0.00504415850148928	0.035309109510425
3242	vorinostat	hsa05012	Parkinson's disease	7327_7332_4712_4700_51465_4694	6	-	3.4261423310686e-05	0.00103926317375748
3243	vorinostat	hsa04260	Cardiac muscle contraction	784_776_27092	3	-	0.000784766100841157	0.010201959310935
3244	vorinostat	hsa04060	Cytokine-cytokine receptor interaction	5155_5154_8741_6387_9180_4254_7132_3554_657_3601_23529_3625_4055_8742_7043_7042_91_93_4233_8795_5618_3566_3460_355_7424_51330	26	-	0.00162797198200451	0.0185181812953013
3245	vorinostat	hsa03010	Ribosome	9349_6168_284393_6234_6129_389342	6	-	0.00285268489727878	0.0259594325652369
3246	vorinostat	hsa04020	Calcium signaling pathway	776_3710_8877_5025_5613_5616_2776_5026_5533_9630_109_136_113_5534_5332_3707_2064_107_23236	19	-	0.014026321510714	0.0643995770944726
3247	vorinostat	hsa03050	Proteasome	5717_5713	2	-	0.0183867258918128	0.0760541843706802
3248	vorinostat	hsa05330	Allograft rejection	355	1	-	0.0235370970230062	0.0892448262122318
3249	vorinostat	hsa04940	Type I diabetes mellitus	355	1	-	0.0109469577733591	0.0619384952975195
3250	vorinostat	hsa05220	Chronic myeloid leukemia	595_4088_4089_5295_1487_1871_1488_25_3551_7157_1399_369_598_5894_7043_4609_91_4790_1027_861_6777_6464_3845_7042_5970	25	-	0.0115709276929432	0.0619384952975195
3251	vorinostat	hsa04610	Complement and coagulation cascades	2161_7056_7035_5329	4	-	0.0141537532075764	0.0643995770944726
3252	alvespimycin	hsa05214	Glioma	208_6464_4193_5293_818_5925_1950_3480_810_7039	10	+	0.0255792820796346	0.373746412218047
3253	alvespimycin	hsa04612	Antigen processing and presentation	4800_3805_3105_3106_3107_3135_3308_3309_920_3310_3304_3305_3303_649853	14	+	0.00599012421474601	0.130285201670726
3254	alvespimycin	hsa04740	Olfactory transduction	818_810_5566_7932	4	+	3.25941110898852e-07	2.83568766482001e-05
3255	alvespimycin	hsa04510	Focal adhesion	5170_2909_5293_394_4638_3675_2321_5829_3693_3791_7057_7410_208_55742_10627_8516_3480_1277_1950_5228_5599_6464_83660	23	+	0.0257756146357274	0.373746412218047
3256	alvespimycin	hsa05212	Pancreatic cancer	367_5170_842_3551_3480_64764_4193_5293_5925_208_1950_7039_2263_7184	14	+	0.00599012421474601	0.130285201670726
3257	alvespimycin	hsa05215	Prostate cancer	367_5170_842_3551_3480_64764_4193_5293_5925_208_1950_7039_2263_7184	14	+	0.00567200493480483	0.130285201670726
3258	alvespimycin	hsa04270	Vascular smooth muscle contraction	146_5319_3778_3710_5581_5566_50487_553_72_113_1909_810_4638_800	14	+	0.0454851523540813	0.565315464972153
3259	alvespimycin	hsa04650	Natural killer cell mediated cytotoxicity	5295_5594_3460_6654_673_6850_5530_5335_5781_5291_8795_5578	12	-	0.0325094262414245	0.219235563414281
3260	alvespimycin	hsa04640	Hematopoietic cell lineage	3123_3126_3127_3125_7037_933	6	-	0.0346442477396408	0.219235563414281
3261	alvespimycin	hsa03320	PPAR signaling pathway	11001_1375_1374_28965	4	-	0.0405843071638493	0.235896285389874
3262	alvespimycin	hsa05010	Alzheimer's disease	5594_1327_23621_572_842_5530_4137_3709_22926_5664_7381_3710	12	-	0.00137481037645936	0.0255714730021441
3263	alvespimycin	hsa04080	Neuroactive ligand-receptor interaction	5029_4889_7442_1081_5025_4886_5026_152_2690	9	-	1.36147634313183e-08	6.33086499556301e-07
3264	alvespimycin	hsa04612	Antigen processing and presentation	3123_5721_3126_3127_3125_6890	6	-	0.0353605747442389	0.219235563414281
3265	alvespimycin	hsa05016	Huntington's disease	5433_5430_548644_6648_1327_7157_5439_246721_1175_842_3064_7419_55567_7381_10126_6908	16	-	0.0103083862281503	0.116511567848609
3266	alvespimycin	hsa04740	Olfactory transduction	5613_5566_5616_109_4991_409	6	-	2.35995277644309e-18	2.19475608209207e-16
3267	alvespimycin	hsa04630	Jak-STAT signaling pathway	6777_3460_1154_6654_6772_5291_200734_5781_4609_5295_2690	11	-	0.00448207762716543	0.0595476027609121
3268	alvespimycin	hsa05012	Parkinson's disease	7419_1327_7327_65018_27429_7381_842	7	-	0.000877691124174684	0.0204063186370614
3269	alvespimycin	hsa04260	Cardiac muscle contraction	784_7381_1327	3	-	0.00254816731669531	0.0394965934087773
3270	alvespimycin	hsa04060	Cytokine-cytokine receptor interaction	3460_5155_5154_8795_6387_655_7422_7042_93_51330_7040_2690	12	-	3.16279121597282e-07	9.80465276951574e-06
3271	alvespimycin	hsa03010	Ribosome	285053_9349_6142_6227_439992_6234_6189	7	-	0.0246981037868074	0.191410304347757
3272	alvespimycin	hsa04020	Calcium signaling pathway	3710_5261_5578_5613_5566_3709_5616_8877_5530_5026_115_109_5335_5025_7419_2064_3707	17	-	0.0232489308817801	0.191410304347757
3273	alvespimycin	hsa03050	Proteasome	5721	1	-	0.0112753130176073	0.116511567848609
3274	alvespimycin	hsa05210	Colorectal cancer	4088_572_5295_5291_4436_7855_8321_8322_7157_1855_5900_673_7040_8312_4609_3725_2956_842_5594_6654_7042_2535	22	-	0.0474710351767128	0.257538177678697
3275	alvespimycin	hsa04610	Complement and coagulation cascades	1675_2161_727	3	-	0.0151132380312389	0.140553113690522
3276	probenecid	hsa04740	Olfactory transduction	26539	1	+	0.0106850639503664	0.25109900283361
3277	probenecid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_88_8294_8367_554313_121504	15	+	1.69090966235892e-07	7.94727541308692e-06
3278	probenecid	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0195956239110533	0.306998107939835
3279	probenecid	hsa03320	PPAR signaling pathway	1962	1	-	0.0287679164680007	0.369873211731438
3280	probenecid	hsa04080	Neuroactive ligand-receptor interaction	5618_2908_2150	3	-	8.43395264297423e-07	3.33930496691508e-05
3281	probenecid	hsa04740	Olfactory transduction	5613_5616_157	3	-	3.9808813625665e-11	3.58279322630985e-09
3282	probenecid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6738_8294_121504_8343_8347_8346_8344_8339_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	35	-	1.11310165563836e-06	3.33930496691508e-05
3283	probenecid	hsa04060	Cytokine-cytokine receptor interaction	5618_3552_2057_3459_5154_3572_657_6387_4982_355_659	11	-	0.00954953406691186	0.143243011003678
3284	probenecid	hsa03010	Ribosome	51187	1	-	0.00309437100308944	0.0556986780556099
3285	probenecid	hsa04020	Calcium signaling pathway	5613_11261_3709_490_5616	5	-	0.0028519279888858	0.0556986780556099
3286	probenecid	hsa04940	Type I diabetes mellitus	3552_3123_3107_3126_3127_3125_355_1363_3133	9	-	0.0372046397644924	0.41855219735054
3287	probenecid	hsa04610	Complement and coagulation cascades	1675	1	-	0.043944444523063	0.43944444523063
3288	selegiline	hsa04330	Notch signaling pathway	113878_9612_1856	3	+	0.0465593705261004	1
3289	selegiline	hsa05016	Huntington's disease	6390	1	-	0.0164561612350442	0.457107022553511
3290	selegiline	hsa04740	Olfactory transduction	26212	1	-	1.1773820096551e-05	0.000871262687144774
3291	selegiline	hsa04920	Adipocytokine signaling pathway	3717_948_3953_5565_1374_5602_5781	7	-	0.0185313657791964	0.457107022553511
3292	selegiline	hsa04010	MAPK signaling pathway	4217_1432_5534_5578_4149_6788_7042_5155_5154_1846_2002_7189_6196_5602_91_3725_4763_408	18	-	0.0264626382861109	0.489558808293052
3293	6-azathymine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	2.95455540403034e-09	1.30000437777335e-07
3294	6-azathymine	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.00571995866419287	0.125839090612243
3295	6-azathymine	hsa05010	Alzheimer's disease	4713_6622_5664	3	-	0.0365233553726998	0.670400582366825
3296	6-azathymine	hsa04080	Neuroactive ligand-receptor interaction	3953_3354_5618_4886_1813	5	-	0.0198915364549626	0.670400582366825
3297	6-azathymine	hsa04740	Olfactory transduction	818_219464_157_409	4	-	2.56651750173347e-05	0.00218153987647345
3298	6-azathymine	hsa05322	Systemic lupus erythematosus	3119_3013_8358_8968_720_721_8350_8351_8352_8353_8354_8355_8356_8357	14	-	0.0394353283745191	0.670400582366825
3299	6-azathymine	hsa04060	Cytokine-cytokine receptor interaction	5618_3953_5155_27242_3572_7042	6	-	0.0323821720870219	0.670400582366825
3300	omeprazole	hsa05211	Renal cell carcinoma	6654_2271_5295_8453_5605_7424_3265_5781_1398_3725_7042_4233_7422	13	-	0.0110055231056263	0.19820662433457
3301	omeprazole	hsa03440	Homologous recombination	8940_6118_7156_5890_5892_8438	6	-	0.0371473520408784	0.338040903571993
3302	omeprazole	hsa04080	Neuroactive ligand-receptor interaction	3354_5618_1081_4886	4	-	3.37053305245551e-05	0.0010223950259115
3303	omeprazole	hsa04740	Olfactory transduction	5566_157	2	-	7.21411846987531e-11	6.56484780758653e-09
3304	omeprazole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_81_8347_8346_8344_3123_3126_3127_3125_87_8370_8359_554313_8351_8339_85236_3013_3017	29	-	2.8921044328365e-05	0.0010223950259115
3305	omeprazole	hsa05216	Thyroid cancer	6932_7157_999_5605_5979_3265_6934	7	-	0.0152466634103515	0.19820662433457
3306	omeprazole	hsa04060	Cytokine-cytokine receptor interaction	7424_5618_3552_4254_8795_655_7422_7042_4233_51330	10	-	0.0135326617093735	0.19820662433457
3307	omeprazole	hsa04020	Calcium signaling pathway	5566_488_5333_3709_5534_107	6	-	0.0241078388059229	0.274226666417373
3308	omeprazole	hsa05213	Endometrial cancer	2309_3611_5728_6654_842_7157_999_5295_6932_5605_3265_6934	12	-	0.0023591330160677	0.0536702761155402
3309	omeprazole	hsa05220	Chronic myeloid leukemia	613_5295_7157_4089_6654_4193_5605_3265_5781_1398_7042_9846	12	-	0.0362663738280552	0.338040903571993
3310	LM-1685	hsa05332	Graft-versus-host disease	3123_3126_3127_3111_3125_3134_355	7	+	0.0218437583497713	0.313093869680055
3311	LM-1685	hsa05320	Autoimmune thyroid disease	3439_3123_3447_3126_3127_3111_3125_3134_355	9	+	0.00896263092185254	0.256928753093106
3312	LM-1685	hsa04740	Olfactory transduction	219464_157_8388_8387_26333_10798_26539_26529_815	9	+	0.00129885348181119	0.0558506997178812
3313	LM-1685	hsa05322	Systemic lupus erythematosus	55506_8360_8363_8362_8365_8364_8367_8366_8368_8335_88_8294_3123_3126_3127_3125_8370_8359_554313_121504_8354_2213_3017_3111_8361	25	+	1.34010215986122e-05	0.00115248785748065
3314	LM-1685	hsa04110	Cell cycle	5934_7465	2	+	0.0483993861615545	0.520293401236711
3315	LM-1685	hsa05310	Asthma	3123_3126_3127_3111_3125_6037	6	+	0.0162428348670097	0.279376759712567
3316	LM-1685	hsa05330	Allograft rejection	3123_3126_3127_3111_3125_3134_355	7	+	0.0140676462076647	0.279376759712567
3317	LM-1685	hsa04940	Type I diabetes mellitus	3123_3126_3127_3111_3125_3134_355	7	+	0.0266739814638243	0.327708915126984
3318	LM-1685	hsa05010	Alzheimer's disease	3553_3710_317_5532_3709_22926_351_102_513_517	10	-	0.0160465258665891	0.162248205984401
3319	LM-1685	hsa04670	Leukocyte transendothelial migration	93408_5578_23562_7070_9475	5	-	0.0124806357855632	0.162248205984401
3320	LM-1685	hsa05016	Huntington's disease	246721_548644_27019_1211_5439_317_5978_513_1387_517	10	-	0.00963079668417773	0.146067083043362
3321	LM-1685	hsa04740	Olfactory transduction	5592_5567	2	-	2.07270771728515e-16	1.88616402272949e-14
3322	LM-1685	hsa04062	Chemokine signaling pathway	7454_5580_3551_6655_5567_9475_56288_10235_6360_107_8976	11	-	0.0149561738599329	0.162248205984401
3323	LM-1685	hsa05012	Parkinson's disease	2861_513_317_517	4	-	0.0012270365651424	0.0558301637139792
3324	LM-1685	hsa04260	Cardiac muscle contraction	6546_4635	2	-	0.00744100393027162	0.135426271530943
3325	LM-1685	hsa04060	Cytokine-cytokine receptor interaction	3581_3601_3561_3553_3552_3587_3589_3459_939_7424_8718_58985_6360_94	14	-	0.00192799672270376	0.0584825672553474
3326	LM-1685	hsa03010	Ribosome	6142_285053_6165	3	-	0.00600190744942394	0.135426271530943
3327	SC-58125	hsa04740	Olfactory transduction	26539_26212_2979_5592	4	+	0.00597419745216453	0.221045305730088
3328	SC-58125	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8335_554313_8359_8294_720_721_121504_8354_8367	18	+	9.14846851286092e-06	0.000676986669951708
3329	SC-58125	hsa05010	Alzheimer's disease	4714_3553_841_8883_22926_517_6622_4842	8	-	0.000272565855068679	0.00844954150712905
3330	SC-58125	hsa04742	Taste transduction	2784_6337	2	-	0.0412332896777199	0.348608721820723
3331	SC-58125	hsa05016	Huntington's disease	1212_4714_246721_1211_51164_841_5978_2033_55567_6648_161_517	12	-	0.0045557423832135	0.0847368083277711
3332	SC-58125	hsa04740	Olfactory transduction	5592_81697_2979_8390_815	5	-	1.13696917301755e-16	1.05738133090632e-14
3333	SC-58125	hsa05322	Systemic lupus erythematosus	2209_940_3020_55766_3021_729	6	-	0.000658316599577814	0.0153058609401842
3334	SC-58125	hsa04062	Chemokine signaling pathway	2784_6360_10000_1147_3551_6655_2773_673_5880_3845_10235_56288_6773_6375_6376	15	-	0.0192714272608111	0.224030341906929
3335	SC-58125	hsa05012	Parkinson's disease	4714_51465_6622_517	4	-	0.000137002220784541	0.00637060326648116
3336	SC-58125	hsa04260	Cardiac muscle contraction	6546_782_70	3	-	0.00783042664593063	0.105756500404627
3337	SC-58125	hsa04060	Cytokine-cytokine receptor interaction	2690_3439_1435_3553_3552_3575_3447_8771_8742_8741_94_939_7424_7422_650_3597_1896_6360_6375_6376_3596	21	-	0.00796016669712249	0.105756500404627
3338	SC-58125	hsa03010	Ribosome	440589_9349_6187_6168_6160_6165	6	-	0.027120194098628	0.280242005685823
3339	SC-58125	hsa04020	Calcium signaling pathway	623_6546_5578_5724_7220_8911_4842_5733_1909_3269_6865_490_815_57105_6870	15	-	0.0383925950681303	0.348608721820723
3340	tanespimycin	hsa05332	Graft-versus-host disease	3812_57292_3811_3553_3109_3119_3105_3106_3107_3126_3127_3125_3135_356_355_3133_3123_649853	18	+	0.0468478520765845	0.396077294829305
3341	tanespimycin	hsa04742	Taste transduction	2778_51764_50832_50834	4	+	0.0121654381554237	0.276334369553243
3342	tanespimycin	hsa04740	Olfactory transduction	26211_1179_818_2979_81797_4991_81697_409	8	+	1.87124863891982e-26	1.74026123419543e-24
3343	tanespimycin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_9103_88_8329_8294_121504_2212_958_3109_3123_3126_3127_3125_8969_8968_8370_718_8358_8359_8330_8331_8336_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_3018_85235_3119_3013_720_721_8970_729	50	+	0.0270435394755034	0.314381146402727
3344	tanespimycin	hsa03410	Base excision repair	27343	1	+	0.0058185754121693	0.180375837777248
3345	tanespimycin	hsa04340	Hedgehog signaling pathway	51384_8945_655_652_53944	5	+	0.0229910951676734	0.308366155998308
3346	tanespimycin	hsa03030	DNA replication	5983_6742	2	+	0.0232103558278296	0.308366155998308
3347	tanespimycin	hsa05012	Parkinson's disease	4714_2861_836_1339_1327_4712_4713_4698_6390_7345_51465_5481_509_4695_6622_517	16	+	0.00494790263382786	0.180375837777248
3348	tanespimycin	hsa04260	Cardiac muscle contraction	785_786_1339_1327_782_27092_4635_488_482_781	10	+	0.0347268393680194	0.32295960612258
3349	tanespimycin	hsa04060	Cytokine-cytokine receptor interaction	8744_608_7852_9180_2323_3556_3553_2057_3576_3570_3572_3953_655_2688_2689_6363_6362_3601_3606_958_23495_3589_3624_3627_4254_1435_1950_91_3626_4233_8795_1436_5618_3561_3448_50615_356_355_50616_3560_83729_10803	42	+	0.0148566865351206	0.276334369553243
3350	tanespimycin	hsa03050	Proteasome	5698_5689_5701_5719	4	+	0.0334131122453099	0.32295960612258
3351	tanespimycin	hsa05010	Alzheimer's disease	2903_2902_3710_2905_51806_1329_317_2776_5663_4023_5664_6622_3553_11261_8851_810_23621_348_22926_776_1339_5534_5533_3709_4712_489_1020_102_836_513_23236_5331_5595_5594_841_4713_642502_6391_4137_355_808_351_824_801_805	45	-	0.00286341279109692	0.0332871736965017
3352	tanespimycin	hsa04080	Neuroactive ligand-receptor interaction	151_2902_1269_4159_135_2905_4889_2846_2847_5031_59340_5724_5746_134_154_2488_1813_2561_3360_799_5029_64106_2150_7433_9568_186_1395_4161_2859_5028_1132_185_4886_5026_7067_5733_3352_3269_2903_23566_9170_5618_7442_4157_7068_6752_4160_5617_6754_1241_2740_2357_728_2690	54	-	1.87594590426205e-06	4.36157422740927e-05
3353	tanespimycin	hsa04612	Antigen processing and presentation	4800_3452_4802_3449_3133_3119_3117_3123_3446_3126_3127_3125_6891_6890_5993_1385_811_1508_3804_925_3113	21	-	0.02016306797387	0.156263776797492
3354	tanespimycin	hsa05016	Huntington's disease	2902_4899_627_1329_317_246721_2776_5331_3064_6875_5432_5433_5430_836_6648_1639_5439_6667_7419_1213_1339_581_163_9001_5468_548644_161_23236_4712_841_4713_642502_5441_6391_3092_1385_513_291	38	-	2.26627843138998e-05	0.000351273156865447
3355	tanespimycin	hsa04740	Olfactory transduction	51806_157_23538_26532_5137_219464_26333_5566_442194_818_810_815_409_1179_109_81797_5593_5613_5616_808_4992_816_801_393046_805	25	-	2.17930948387091e-32	2.02675781999995e-30
3356	tanespimycin	hsa04530	Tight junction	10000_50855_4619_5521_88_4636_81_9223_5584_5583_5580_5581_93408_5588_2037_2036_84612_51776_3996_207_998_9080_5519_22800_3265_8573_4628_6714_7082_8189_5578_10207_5728_1366_1364_1365_7525_4950_27134	39	-	0.0447733098398111	0.320301370392495
3357	tanespimycin	hsa04062	Chemokine signaling pathway	6777_10000_157_156_5296_112_5290_115_6387_6358_5747_6359_2309_2786_4067_3551_5829_5566_3576_7410_1399_6367_409_408_8517_5295_207_1233_5580_998_673_108_109_3265_2185_10681_107_4792_23236_7852_5595_5594_5331_5613_6655_6654_5616_6772_2783_51764_2793_2790_5970_8976_10803	55	-	0.0162968427605373	0.137782397884543
3358	tanespimycin	hsa05012	Parkinson's disease	2861_4713_1329_1339_4712_5413_836_642502_6391_317_7054_9246_7327_65018_27429_513_7419_6622_291	19	-	7.29562976512889e-07	3.39246784078493e-05
3359	tanespimycin	hsa04260	Cardiac muscle contraction	784_7169_1339_782_1329_6548_776_7170_4635	9	-	1.38684188075239e-05	0.000257952589819945
3360	tanespimycin	hsa04060	Cytokine-cytokine receptor interaction	3446_3594_8794_55540_5155_5154_8741_7852_6387_6358_4254_8995_3452_3455_27242_3554_3553_3586_3454_2324_4055_3576_3570_3559_3572_657_939_4982_7424_8718_6367_3604_3581_3605_1233_3588_3589_23765_3625_3624_958_1956_7040_7042_3449_93_268_4233_8795_3587_1436_5618_3566_2057_3460_3568_970_5617_1438_6359_50615_356_355_50616_7422_2690_51330_10803	68	-	0.000458245384187976	0.00608811724706882
3361	tanespimycin	hsa03010	Ribosome	285053_140801_9349_6125_6142_284393_6160_6165_6204_6129_6187_6205_6181_389342_440589_6157_6158_9045_6171_6169_6192_6234	22	-	0.00517417823058532	0.053466508382715
3362	tanespimycin	hsa03050	Proteasome	5690	1	-	1.68471705129449e-06	4.36157422740927e-05
3363	tanespimycin	hsa04610	Complement and coagulation cascades	5345_966_728_727_2158_7056_5648_2157_7035_1675_5329_2161_5328_2243	14	-	0.0147517573261074	0.137191343132799
3364	tomelukast	hsa04740	Olfactory transduction	135948_442194	2	-	4.38310999883985e-06	0.000359415019904868
3365	tomelukast	hsa05322	Systemic lupus erythematosus	727	1	-	0.0229720175397565	0.941852719130017
3366	raloxifene	hsa04070	Phosphatidylinositol signaling system	8871_8503_5578_8394_3707_23236	6	+	0.0295548070204522	0.688466403437988
3367	raloxifene	hsa04740	Olfactory transduction	26476_26212	2	+	0.00160817160968228	0.128653728774582
3368	raloxifene	hsa05322	Systemic lupus erythematosus	474382_474381_83740_3017_8343_8339_8347_8346_8344	9	+	0.0427466613391946	0.688466403437988
3369	raloxifene	hsa04740	Olfactory transduction	4992_56656	2	-	4.1993039965491e-05	0.00319147103737732
3370	raloxifene	hsa05322	Systemic lupus erythematosus	8369	1	-	0.0469471405818105	0.891995671054399
3371	raloxifene	hsa05216	Thyroid cancer	7849_10342_5979_595	4	-	0.0376941292863171	0.891995671054399
3372	raloxifene	hsa03020	RNA polymerase	246721_5439_548644_84172	4	-	0.0376941292863171	0.891995671054399
3373	nordihydroguaiaretic acid	hsa04740	Olfactory transduction	816	1	+	2.3190493105776e-07	1.94800142088518e-05
3374	nordihydroguaiaretic acid	hsa05322	Systemic lupus erythematosus	55506_8361_8363_8362_8365_8364_8370_8360_8368_8366_8359_8294_8367_554313_121504_3119_8354_6737	18	+	0.000590914324020092	0.0248184016088439
3375	nordihydroguaiaretic acid	hsa04080	Neuroactive ligand-receptor interaction	1081_7067_2908_6754_1241_3354_56288_23566	8	-	0.0160330234216669	0.344710003565838
3376	nordihydroguaiaretic acid	hsa04740	Olfactory transduction	818_5613_109_816	4	-	1.62907653093753e-07	1.40100581660628e-05
3377	nordihydroguaiaretic acid	hsa04010	MAPK signaling pathway	4915_5155_8074_776_3725_5495_3164_836_6789_51347_51776_2872_57551_4216_208_5154_5533_1956_5320_3310_4791_51701_782_5613_6654_1649_2002_6196_23162_2005_9693	31	-	0.0127908106114016	0.344710003565838
3378	nordihydroguaiaretic acid	hsa05012	Parkinson's disease	836_6622	2	-	0.00862136399240038	0.344710003565838
3379	sulfasalazine	hsa04740	Olfactory transduction	135948_9635_816	3	+	0.00143253742124115	0.0558689594284048
3380	sulfasalazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_8294_720_721_121504_8367	16	+	0.000110610688502099	0.00862763370316372
3381	sulfasalazine	hsa04650	Natural killer cell mediated cytotoxicity	5296_6655	2	-	0.0349308025184347	0.672417948479868
3382	sulfasalazine	hsa04740	Olfactory transduction	157	1	-	3.22953545733533e-08	2.4867423021482e-06
3383	sulfasalazine	hsa05322	Systemic lupus erythematosus	8369	1	-	0.00729517483644315	0.280864231203061
3384	sulfasalazine	hsa04020	Calcium signaling pathway	6915_5332_776	3	-	0.0192105922533342	0.493071867835578
3385	celecoxib	hsa04120	Ubiquitin mediated proteolysis	25898_23759_10075_7329_8916	5	+	0.0176048872267307	0.226348550057966
3386	celecoxib	hsa05010	Alzheimer's disease	2902_5595_1329_317_3708_3709_489_348	8	+	0.0260433748942138	0.260433748942138
3387	celecoxib	hsa04910	Insulin signaling pathway	5595_5599_5562_23265_10211_5568	6	+	0.0394068747058096	0.354661872352286
3388	celecoxib	hsa05016	Huntington's disease	2902_3708_1329_317_5978	5	+	0.000777753647382052	0.0174994570660962
3389	celecoxib	hsa04740	Olfactory transduction	219464_5568_157_26333_1179_26539_26529_815	8	+	1.4764310845825e-08	1.32878797612425e-06
3390	celecoxib	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8294_121504_3108_8968_8370_8358_8359_8330_8335_8350_8351_8352_8353_8354_8355_8356_8357_3012_3013_3113_3017_720_721	33	+	4.49114176741511e-05	0.0020210137953368
3391	celecoxib	hsa04530	Tight junction	5519_3996_55844_4633_93408	5	+	0.0174617556974026	0.226348550057966
3392	celecoxib	hsa04630	Jak-STAT signaling pathway	3581_5618_2057_6774_3568_3446	6	+	0.0170199383234632	0.226348550057966
3393	celecoxib	hsa04062	Chemokine signaling pathway	5595_6347_157_2921_9475_6774_5880_5568_8976	9	+	0.024017457492416	0.260433748942138
3394	celecoxib	hsa05012	Parkinson's disease	1329_317	2	+	0.000438468932684945	0.0131540679805483
3395	celecoxib	hsa04740	Olfactory transduction	26211_5592_157_8390_2979_10798_409_4991_8590	9	-	5.20746117583891e-08	4.84293889353019e-06
3396	celecoxib	hsa05322	Systemic lupus erythematosus	717_7124_942_3111_2215	5	-	0.00947353795041469	0.293679676462855
3397	celecoxib	hsa03010	Ribosome	9349	1	-	0.00144517676963416	0.0672007197879884
3398	NS-398	hsa04080	Neuroactive ligand-receptor interaction	1813	1	+	0.00116823258598373	0.0946268394646821
3399	NS-398	hsa03022	Basal transcription factors	51616_6884_2957_2969_728198	5	+	0.0186268079054103	0.754385720169117
3400	NS-398	hsa04650	Natural killer cell mediated cytotoxicity	5605_3106_369	3	-	0.0487096593419894	0.698171783901848
3401	NS-398	hsa04080	Neuroactive ligand-receptor interaction	1241_1269_5025_5724_7068	5	-	0.00223120900466313	0.0479709936002573
3402	NS-398	hsa04740	Olfactory transduction	157_816	2	-	1.28981626303095e-08	1.10924198620662e-06
3403	NS-398	hsa04630	Jak-STAT signaling pathway	3588	1	-	0.00106804924384046	0.0306174116567599
3404	NS-398	hsa05012	Parkinson's disease	7314_65018	2	-	0.0176948885315838	0.304352082743241
3405	NS-398	hsa04060	Cytokine-cytokine receptor interaction	3588_51330_7043_7040	4	-	0.000571325969815403	0.0245670167020623
3406	piperacetazine	hsa04740	Olfactory transduction	810	1	+	0.000375299642527819	0.0144495300529571
3407	piperacetazine	hsa05322	Systemic lupus erythematosus	85235_3119_8330_8332_8969_8331_8329_8343_8336_8339_8347_8346_8344	13	+	0.000401375834804363	0.0144495300529571
3408	piperacetazine	hsa05322	Systemic lupus erythematosus	3119_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	-	9.5730178948197e-05	0.00459504858951346
3409	TTNPB	hsa04740	Olfactory transduction	26539_2979_815_4991	4	+	0.0109398209038626	0.787667105078107
3410	TTNPB	hsa04740	Olfactory transduction	5593	1	-	0.000547267868566916	0.038856018668251
3411	tretinoin	hsa04742	Taste transduction	6337	1	+	0.0180163623883073	0.276250889954045
3412	tretinoin	hsa04740	Olfactory transduction	8387_3000_409_816_8388	5	+	2.02694753904494e-14	1.86479173592134e-12
3413	tretinoin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3586_2209_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2213_3119_3013_3113_3111_942	32	+	0.00531765581104022	0.163074778205233
3414	tretinoin	hsa04710	Circadian rhythm - mammal	4862_406_1408_5187_8553	5	+	0.0433953756256356	0.465027494725571
3415	tretinoin	hsa04110	Cell cycle	5000_5111_993_4088_4193_10912_8243	7	+	0.0454918201361972	0.465027494725571
3416	tretinoin	hsa04810	Regulation of actin cytoskeleton	623_10093_79784_3688_9459_624_9087_998_93408_8394_324_2258_4342_2335	14	+	0.0084883352899892	0.195231711669752
3417	tretinoin	hsa05012	Parkinson's disease	7318_4712_4698_6390_317_7416_842	7	+	0.0153486829516853	0.276250889954045
3418	tretinoin	hsa03010	Ribosome	6181	1	+	0.000113008294932057	0.00519838156687462
3419	tretinoin	hsa03050	Proteasome	23198	1	+	0.0387523623532283	0.465027494725571
3420	tretinoin	hsa03320	PPAR signaling pathway	10062_2710_51703_1375_5467_1376_28965	7	-	0.00740706190293151	0.0870329773594452
3421	tretinoin	hsa05010	Alzheimer's disease	2903_3710_2905_2776_5663_487_5332_5664_6622_1327_836_3553_509_810_4842_4843_5533_5534_102_4695_5331_5594_4712_642502_6391_4137_51107_351	28	-	0.00921381101559813	0.0962331372740249
3422	tretinoin	hsa04080	Neuroactive ligand-receptor interaction	151_2903_135_2905_64106_2908_2925_56288_5746_1909_1813_2561_799_7434_5021_2150_7433_2859_4889_2913_3953_185_5025_4886_3354_148_5733_3269_9170_2550_5618_4157_7068_6752_4160_5617_7067_8484_2692_2690	40	-	0.00110321735086227	0.0207404861962107
3423	tretinoin	hsa04742	Taste transduction	2778_3710_773_5567_50834_112	6	-	0.0377891381098207	0.296014915193595
3424	tretinoin	hsa05016	Huntington's disease	4899_627_1327_246721_2776_5331_5332_3064_10126_5432_4695_7052_1639_5439_6667_509_7419_2876_581_9001_836_548644_161_4712_642502_6391_5978_1385_1387_291	30	-	0.00713408995715438	0.0870329773594452
3425	tretinoin	hsa04740	Olfactory transduction	157_26333_23538_5567_393046_3000_810_815_409_81797	10	-	7.96185944933645e-28	7.48414788237626e-26
3426	tretinoin	hsa05322	Systemic lupus erythematosus	55506_2903_8363_474381_8365_8364_8367_8360_8368_8335_474382_6738_88_8362_8329_8294_8351_8343_8347_8346_8344_8353_3122_3123_8366_3126_3127_3125_8969_8968_55766_8370_8332_8359_8330_8331_8336_8334_554313_8350_121504_8352_8339_8354_8355_8356_8357_8358_85235_83740_3013_942_3014_727_8361	55	-	0.0225212481529085	0.206380391290264
3427	tretinoin	hsa04530	Tight junction	50855_6709_5521_88_56288_22800_24146_5728_5581_2037_4619_10627_8777_998_5519_10207_9080_60_7082_5578_1365_6237	22	-	0.024150896853116	0.206380391290264
3428	tretinoin	hsa04062	Chemokine signaling pathway	3717_3576_157_5747_9475_115_6387_5332_56288_112_7454_3579_4067_5567_2931_7410_1398_6366_409_8517_5295_1233_998_673_3702_10681_107_5331_4793_6356_7852_5594_6655_6777_10451_6772	36	-	0.049293284642924	0.356428365879604
3429	tretinoin	hsa05012	Parkinson's disease	2861_836_4695_1327_4712_642502_6391_51465_509_27429_7419_6622_291	13	-	9.91072316884108e-05	0.00465803988935531
3430	tretinoin	hsa04260	Cardiac muscle contraction	784_7168_1327_6548_27092_478	6	-	0.000353100247269054	0.00892614761989352
3431	tretinoin	hsa03010	Ribosome	6234_285053_6142_6141_284393_6144_6160_389342_6139	9	-	0.000379836068931639	0.00892614761989352
3432	tretinoin	hsa03050	Proteasome	5690_23198	2	-	0.00137629028015231	0.0215618810557195
3433	coralyne	hsa04740	Olfactory transduction	4991	1	+	1.11326742453151e-06	9.01746613870523e-05
3434	coralyne	hsa04060	Cytokine-cytokine receptor interaction	3581_5618_3446_3448_2057_1233_3953_970_5154_3624_91_1956_2688_1950_7042_6363_1896_6374_6366	19	+	0.0491903608018535	0.680413506039326
3435	coralyne	hsa04730	Long-term depression	50487_5331_3708_3709_5320_4842_23236	7	+	0.0479462111713006	0.680413506039326
3436	coralyne	hsa04080	Neuroactive ligand-receptor interaction	64106	1	-	0.0112185142222026	0.437522054665901
3437	coralyne	hsa04060	Cytokine-cytokine receptor interaction	7852	1	-	0.00750524147694089	0.437522054665901
3438	suloctidil	hsa05010	Alzheimer's disease	487_2081_842_9451	4	+	0.0353098574129801	0.403541227576915
3439	suloctidil	hsa04740	Olfactory transduction	56656	1	+	4.05539865619215e-09	1.62215946247686e-07
3440	suloctidil	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_554313_8349_8362_8294_121504_8343_8341_8347_8346_8344_8339_723790_3109_8366_8968_8370_8358_8359_8337_8334_8335_8350_8351_8352_8353_8354_8355_8356_8357_83740_3012_3013_941_8970	43	+	1.31587191378351e-15	1.05269753102681e-13
3441	suloctidil	hsa04530	Tight junction	6709_8189	2	+	0.024999479671795	0.39999167474872
3442	suloctidil	hsa04010	MAPK signaling pathway	1326_1649_50487_5606_3310_3164_11221_4616_8823_2260_2247_4214_468_1950_4609_3725_3727_4791_1647_1848_782_5599_1847_1846_8817_1843_2353_5971	28	+	0.0107731924370303	0.287285131654141
3443	suloctidil	hsa05012	Parkinson's disease	7416_842	2	+	0.0248391105463483	0.39999167474872
3444	suloctidil	hsa03010	Ribosome	6192	1	+	0.0307305996642044	0.403541227576915
3445	suloctidil	hsa04740	Olfactory transduction	109	1	-	0.00121196596094889	0.0702940257350356
3446	suloctidil	hsa04060	Cytokine-cytokine receptor interaction	3455	1	-	0.0156349486123104	0.453413509757002
3447	androsterone	hsa05332	Graft-versus-host disease	3119_3123_3107_3126_3127_3125	6	+	0.0342544307823136	0.382716499916253
3448	androsterone	hsa04640	Hematopoietic cell lineage	2811_948_3690_3123_3126_3127_3559_3125_929_1378_931	11	+	0.0168511901765593	0.382716499916253
3449	androsterone	hsa05320	Autoimmune thyroid disease	3119_3123_3107_3126_3127_3125_3442	7	+	0.0323070733389873	0.382716499916253
3450	androsterone	hsa04660	T cell receptor signaling pathway	4793	1	+	0.0463567233255046	0.40330349293189
3451	androsterone	hsa04740	Olfactory transduction	26211_135948_4992_816	4	+	1.80063409040719e-05	0.00156655165865426
3452	androsterone	hsa05310	Asthma	3123_3126_3127_3119_3125	5	+	0.0311325179115522	0.382716499916253
3453	androsterone	hsa04540	Gap junction	7082_1813_5598_7278_113457_5331_108_1956_2982_81027	10	+	0.0415859775643342	0.401997783121897
3454	androsterone	hsa04020	Calcium signaling pathway	2769_886_1131_2925_5724_5331_9630_108_1956_816_5733_4842_3269_1910_10800_2066_493	17	+	0.0351923218313796	0.382716499916253
3455	androsterone	hsa05330	Allograft rejection	3119_3123_3107_3126_3127_3125	6	+	0.0233476271617157	0.382716499916253
3456	androsterone	hsa04940	Type I diabetes mellitus	3119_3123_3107_3126_3127_3630_3125	7	+	0.0143033523871876	0.382716499916253
3457	androsterone	hsa04080	Neuroactive ligand-receptor interaction	7434_2150_1081	3	-	2.68279989522472e-05	0.00118043195389888
3458	androsterone	hsa04670	Leukocyte transendothelial migration	24146_5600_9475	3	-	0.0480843123133599	0.470157720397297
3459	androsterone	hsa04740	Olfactory transduction	219464	1	-	4.4881089717018e-11	3.94953589509758e-09
3460	androsterone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8348_8294_8343_8347_8346_8344_3123_8370_8359_8330_554313_121504_8339	22	-	0.00273738430737198	0.0802966063495781
3461	androsterone	hsa05012	Parkinson's disease	836_1339_517	3	-	0.0259529533981329	0.437011651487287
3462	androsterone	hsa04260	Cardiac muscle contraction	1339	1	-	0.0297962489650423	0.437011651487287
3463	androsterone	hsa04060	Cytokine-cytokine receptor interaction	2057_3624_4254_355_7422_9180_7042_4233_7040	9	-	0.0196501375860841	0.43230302689385
3464	androsterone	hsa03010	Ribosome	284393_389342	2	-	0.0479757682758115	0.470157720397297
3465	androsterone	hsa04020	Calcium signaling pathway	5256_3710_11261_2776_5534_5257	6	-	0.0413406214691224	0.470157720397297
3466	testosterone	hsa04640	Hematopoietic cell lineage	2811_3565_2812_915_933_921_910_3675	8	+	0.0299621810592695	0.389508353770504
3467	testosterone	hsa04662	B cell receptor signaling pathway	974_973_3551_5293_2353_4772_5534_933_3845	9	+	0.00491497803111355	0.191684143213428
3468	testosterone	hsa04660	T cell receptor signaling pathway	2353_3551_3565_4772_5293_3558_5335_5534_915_3845	10	+	0.0260932778093627	0.389508353770504
3469	testosterone	hsa04740	Olfactory transduction	26212_23538_816	3	+	0.000242850164036666	0.0189423127948599
3470	testosterone	hsa05322	Systemic lupus erythematosus	3108_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	+	0.0195222056859972	0.389508353770504
3471	testosterone	hsa05221	Acute myeloid leukemia	3551_5371_5293_3845_5914_652671	6	+	0.0386442366065029	0.430607207901032
3472	testosterone	hsa04512	ECM-receptor interaction	2811_22798_2812_7057_3918_9672_3339_3675	8	+	0.0253150695947602	0.389508353770504
3473	testosterone	hsa04740	Olfactory transduction	26212_5566_157	3	-	2.92692911013108e-05	0.00240008187030749
3474	testosterone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_6738_121504	15	-	0.00638113202727184	0.261626413118145
3475	testosterone	hsa04210	Apoptosis	8503_3554_3553_842_5296_5566_472_8837_651610_8795	10	-	0.0142709819592414	0.390073506885932
3476	hesperidin	hsa04740	Olfactory transduction	1179_816	2	+	0.000814310419506536	0.0627019023020033
3477	hesperidin	hsa04630	Jak-STAT signaling pathway	3581_3560_3953_598_5293_867_3572_2033_3558_9021_4352	11	+	0.01959622824668	0.75445478749718
3478	hesperidin	hsa04520	Adherens junction	5881_4233_117178_998	4	-	0.0417159347834235	0.501563128468101
3479	hesperidin	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5335_4233_9020_998	4	-	0.0292109289033992	0.501563128468101
3480	hesperidin	hsa04370	VEGF signaling pathway	5829_5881_5335_998_5534	5	-	0.00891681789113834	0.490424984012609
3481	fusidic acid	hsa04070	Phosphatidylinositol signaling system	8394_5298_5336	3	-	0.0231646405918976	0.641076864167068
3482	clebopride	hsa04660	T cell receptor signaling pathway	10000_6655_998_5588_5533_5600_5290_3725_5609	9	+	0.0413255370257008	0.47840674289843
3483	clebopride	hsa04740	Olfactory transduction	5593	1	+	1.16842750029456e-05	0.000817899250206192
3484	clebopride	hsa04510	Focal adhesion	1278_8515_10000_1302_3910_3690_6655_998_5290_5154_93408_29780_3725_55742	14	+	0.0421790360056681	0.47840674289843
3485	clebopride	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	0.00186551643950446	0.0652930753826561
3486	clebopride	hsa04512	ECM-receptor interaction	1278_8515_9672_1302_3910_3690_6383	7	+	0.047840674289843	0.47840674289843
3487	clebopride	hsa04540	Gap junction	5593_2982_6655_5154_3708_5331_5607_113	8	+	0.0307742089429726	0.47840674289843
3488	clebopride	hsa04730	Long-term depression	5519_5593_6261_2982_5331_3708_4842	7	+	0.0231844412760623	0.47840674289843
3489	droperidol	hsa04910	Insulin signaling pathway	3630	1	+	0.00731872962511326	0.3037272794422
3490	droperidol	hsa04740	Olfactory transduction	5137_135948_390892	3	+	1.07485658254293e-06	8.92130963510632e-05
3491	droperidol	hsa04514	Cell adhesion molecules (CAMs)	9076_24146_3383_5175_9369_3117_941_23308_51208_6383_6693_1000_25945_1462	14	+	0.0432312171550478	0.761470969037132
3492	droperidol	hsa04512	ECM-receptor interaction	1278_3690_3691_1277_3679_6383_1101_1292_1290_1291	10	+	0.0378771755767269	0.761470969037132
3493	droperidol	hsa03010	Ribosome	6165	1	+	0.0458717451227188	0.761470969037132
3494	droperidol	hsa04640	Hematopoietic cell lineage	2057	1	-	0.0303630665156237	0.455341877997836
3495	droperidol	hsa04080	Neuroactive ligand-receptor interaction	7434_64106_7067_4157_1812	5	-	0.000430427801820053	0.0187236093791723
3496	droperidol	hsa04612	Antigen processing and presentation	3119	1	-	0.0314028881377818	0.455341877997836
3497	droperidol	hsa04740	Olfactory transduction	810_5566_157	3	-	6.9432796822845e-09	6.04065332358751e-07
3498	droperidol	hsa04514	Cell adhesion molecules (CAMs)	9076_23705_3119	3	-	0.0254237116567693	0.455341877997836
3499	droperidol	hsa04350	TGF-beta signaling pathway	5308_4092_4091_4089_3624_656_652_653_353500_7042_91_5933	12	-	0.0429500972590377	0.53380835164804
3500	droperidol	hsa05210	Colorectal cancer	8503_836_324_5599_4089_6655_5900_6934_7042_91_8324_4233_2535	13	-	0.0223287874335507	0.455341877997836
3501	mephenytoin	hsa05332	Graft-versus-host disease	3126_3107_3113_3127_3125_3123	6	+	0.00151655576264493	0.0344867855732262
3502	mephenytoin	hsa04640	Hematopoietic cell lineage	2812_3123_3126_3127_3125_925	6	+	0.035596669442669	0.264997428073203
3503	mephenytoin	hsa05320	Autoimmune thyroid disease	3126_3107_3113_3127_3125_3123	6	+	0.00437968548227676	0.0446092702544428
3504	mephenytoin	hsa04612	Antigen processing and presentation	3123_3107_3126_3127_3125_925_3113	7	+	0.0131185636362545	0.109867970453631
3505	mephenytoin	hsa04514	Cell adhesion molecules (CAMs)	3113_3123_3107_3126_3127_3696_3125_6383_925_26047	10	+	0.00466067002658358	0.0446092702544428
3506	mephenytoin	hsa05310	Asthma	3123_3126_3127_3113_3125	5	+	0.00205891257153589	0.0344867855732262
3507	mephenytoin	hsa04512	ECM-receptor interaction	8515_2812_3381_3696_3918_1282_6383_1292	8	+	0.00284363551846434	0.0381047159474222
3508	mephenytoin	hsa05330	Allograft rejection	3113_3107_3126_3127_3125_3123	6	+	0.000952294303969139	0.0344867855732262
3509	mephenytoin	hsa04940	Type I diabetes mellitus	3126_3107_3113_3127_3125_3123	6	+	0.00187974625228664	0.0344867855732262
3510	mephenytoin	hsa05332	Graft-versus-host disease	3123_3126_3127_3119_3125	5	-	0.00127712493221666	0.0189123527154106
3511	mephenytoin	hsa04640	Hematopoietic cell lineage	3123_3126_3127_2057_3125	5	-	0.0219518993807399	0.129794745599467
3512	mephenytoin	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3119_3125	5	-	0.00327220221755053	0.0271076968111329
3513	mephenytoin	hsa04612	Antigen processing and presentation	3123_3126_3127_3119_3125	5	-	0.0238398512325551	0.129794745599467
3514	mephenytoin	hsa04514	Cell adhesion molecules (CAMs)	24146_214_3119_3123_3126_3127_3125_6693	8	-	0.00331930981360811	0.0271076968111329
3515	mephenytoin	hsa05322	Systemic lupus erythematosus	3119_3123_3126_3127_3125_3013_8351	7	-	0.0162609059772748	0.113826341840924
3516	mephenytoin	hsa05310	Asthma	3123_3126_3127_3119_3125	5	-	0.000319781808537569	0.0156693086183409
3517	mephenytoin	hsa05330	Allograft rejection	3123_3126_3127_3119_3125	5	-	0.000847576319559014	0.0189123527154106
3518	mephenytoin	hsa04940	Type I diabetes mellitus	3123_3126_3127_3119_3125	5	-	0.00154386552778862	0.0189123527154106
3519	kaempferol	hsa04740	Olfactory transduction	81697_26211_393046_816	4	+	5.18989795784544e-05	0.00404812040711944
3520	kaempferol	hsa05322	Systemic lupus erythematosus	85235_3119_717_8330_8969_8332_88_8331_8336_6737_8343_8329_8339_8347_8346_8344	16	+	0.00448056168812053	0.174741905836701
3521	kaempferol	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	-	0.0307038730807558	0.320729972620829
3522	kaempferol	hsa05322	Systemic lupus erythematosus	85235_3123_8330_3126_3127_3125_8332_8969_8331_8336_8343_8329_8339_8347_8346_8344	16	-	3.77776649712096e-06	0.000253110355307104
3523	kaempferol	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.011092332285671	0.185796565784989
3524	kaempferol	hsa04350	TGF-beta signaling pathway	4090_4088_3398_9475_7042_93	6	-	0.0335091016171015	0.320729972620829
3525	kaempferol	hsa05330	Allograft rejection	3123_3126_3127_3125	4	-	0.0228066485725353	0.305609090871973
3526	kaempferol	hsa05210	Colorectal cancer	8503_581_4088_596_6934_7042_2535	7	-	0.00922184111081994	0.185796565784989
3527	kaempferol	hsa04940	Type I diabetes mellitus	3382_3126_3127_3123_3125	5	-	0.0084619404305288	0.185796565784989
3528	oxedrine	hsa04740	Olfactory transduction	26539_26211_5593	3	+	0.027541973097492	0.801725749420098
3529	oxedrine	hsa04510	Focal adhesion	3688_10000_1301_1302_5578_3691_3908_3696_858_3725	10	+	0.0442272477750386	0.801725749420098
3530	oxedrine	hsa04512	ECM-receptor interaction	3688_1301_1302_2812_3691_3908_3696	7	+	0.00685205016240932	0.513903762180699
3531	oxedrine	hsa04070	Phosphatidylinositol signaling system	8871_8394_3631_5331_5335_8760_23236	7	-	0.00355996118810826	0.242077360791362
3532	oxedrine	hsa05211	Renal cell carcinoma	201163_5155_998_1399_673	5	-	0.036359050272449	0.541966734104616
3533	oxedrine	hsa04080	Neuroactive ligand-receptor interaction	64106	1	-	0.0340677484309554	0.541966734104616
3534	oxedrine	hsa04540	Gap junction	7278_5155_113457_5331_5607_23236	6	-	0.0306729157336743	0.541966734104616
3535	oxedrine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0398504951547512	0.541966734104616
3536	benzylpenicillin	hsa05320	Autoimmune thyroid disease	3108_3119_7253_3107_3111_356	6	+	0.0484485330698142	0.436036797628328
3537	benzylpenicillin	hsa04910	Insulin signaling pathway	5105	1	+	0.0219338909365014	0.296107527642769
3538	benzylpenicillin	hsa05016	Huntington's disease	2902_1387	2	+	0.0128544561389607	0.296107527642769
3539	benzylpenicillin	hsa04740	Olfactory transduction	26333_9635_8392	3	+	2.84297921723074e-05	0.0023028131659569
3540	benzylpenicillin	hsa05310	Asthma	3119_3111_3108_2205_8288	5	+	0.019193129187389	0.296107527642769
3541	benzylpenicillin	hsa04062	Chemokine signaling pathway	6375	1	+	0.00242515656619709	0.0982188409309821
3542	benzylpenicillin	hsa05012	Parkinson's disease	6622	1	+	0.0218837606255094	0.296107527642769
3543	benzylpenicillin	hsa05330	Allograft rejection	356_3107_3108_3119_3111	5	+	0.0425692339205554	0.436036797628328
3544	benzylpenicillin	hsa04270	Vascular smooth muscle contraction	776	1	+	0.0451021047493209	0.436036797628328
3545	benzylpenicillin	hsa05332	Graft-versus-host disease	3123_3126_3127_3125_3135_3134	6	-	0.00660341943662932	0.101692659324092
3546	benzylpenicillin	hsa04080	Neuroactive ligand-receptor interaction	1131_1909	2	-	0.00938898100382993	0.120491922882484
3547	benzylpenicillin	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125_3135_3134	6	-	0.0175518692400845	0.193070561640929
3548	benzylpenicillin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8347_8346_8344_3123_3126_3127_3125_8370_8359_554313_121504_8339	23	-	2.10366149111533e-08	1.6198193481588e-06
3549	benzylpenicillin	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.0310220331377667	0.298587068951004
3550	benzylpenicillin	hsa04060	Cytokine-cytokine receptor interaction	23765	1	-	0.00180281540847558	0.051025640911158
3551	benzylpenicillin	hsa05330	Allograft rejection	3123_3126_3127_3125_3135_3134	6	-	0.0042750417592729	0.0822945538660033
3552	benzylpenicillin	hsa04940	Type I diabetes mellitus	3382_3123_3126_3127_3125_3135_3134	7	-	0.00198801198355161	0.051025640911158
3553	Prestwick-664	hsa05016	Huntington's disease	1211	1	+	0.033774091187147	1
3554	Prestwick-664	hsa04740	Olfactory transduction	3000	1	+	5.49505155592137e-05	0.00395643712026339
3555	Prestwick-664	hsa04080	Neuroactive ligand-receptor interaction	146_2911_7067_1909	4	-	0.00412389806883351	0.112719880548116
3556	Prestwick-664	hsa04740	Olfactory transduction	810_26212_4991	3	-	3.3219266353207e-06	0.00023338875874469
3557	Prestwick-664	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3113_720_721	24	-	5.69240874987048e-06	0.00023338875874469
3558	Prestwick-664	hsa04710	Circadian rhythm - mammal	8553_8863_9572	3	-	0.046921780613705	0.769517202064762
3559	Prestwick-664	hsa05210	Colorectal cancer	581_4088_208_6655_7042_5599_324_3725_8324_8321	10	-	0.0300141495776227	0.615290066341265
3560	vanoxerine	hsa05010	Alzheimer's disease	1339_841_2081_5331_3708_4023_517	7	+	0.000196496919845383	0.00447030492648246
3561	vanoxerine	hsa05016	Huntington's disease	1212_4899_1339_841_7052_1639_246721_5331_7350_3708_9001_55567_517	13	+	0.0150232264345828	0.205585302610741
3562	vanoxerine	hsa03420	Nucleotide excision repair	5111	1	+	0.0378674513132597	0.265072159192818
3563	vanoxerine	hsa04740	Olfactory transduction	5593_56656	2	+	5.9653124071998e-19	5.42843429055182e-17
3564	vanoxerine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8349_89_8294_121504_8343_8342_8347_8346_8344_8339_723790_3123_3126_3127_3125_8968_3108_8370_8358_8359_8337_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113_941_8348_8970_942	46	+	2.06658258632575e-06	9.40295076778216e-05
3565	vanoxerine	hsa05212	Pancreatic cancer	51176_2260_5155_1950	4	+	0.0225917914956858	0.205585302610741
3566	vanoxerine	hsa05215	Prostate cancer	51176_2260_5155_1950	4	+	0.0222536840788475	0.205585302610741
3567	vanoxerine	hsa04210	Apoptosis	843_8743_331_841	4	+	0.0225917914956858	0.205585302610741
3568	vanoxerine	hsa04530	Tight junction	5010_9074_10207_5581_23136_93408_89_6714_26285	9	+	0.0283751581833867	0.234739944971654
3569	vanoxerine	hsa05110	Vibrio cholerae infection	115	1	+	0.00817513283274065	0.14878741755588
3570	vanoxerine	hsa05012	Parkinson's disease	1339_517	2	+	7.80934842648112e-06	0.000236883568936594
3571	vanoxerine	hsa03010	Ribosome	140801_6234_6129_6181_6171	5	+	0.0158920878818658	0.205585302610741
3572	vanoxerine	hsa04940	Type I diabetes mellitus	3593_4049_3108_3126_3107_942_3127_3125_3123_3382_941_3113	12	+	0.0362494329938447	0.265072159192818
3573	vanoxerine	hsa04080	Neuroactive ligand-receptor interaction	3953_1812	2	-	0.0130941969929277	0.865092431282356
3574	vanoxerine	hsa05016	Huntington's disease	842	1	-	0.0224699332800612	0.865092431282356
3575	ouabain	hsa04080	Neuroactive ligand-receptor interaction	2859_1081_2925_5030_1241_2740_186_9568	8	+	0.027383375637793	0.429151403854118
3576	ouabain	hsa04740	Olfactory transduction	26212_4991	2	+	8.86643907618339e-09	3.76823660737794e-07
3577	ouabain	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_8349_8329_8294_121504_8343_8342_8347_8346_8344_8339_723790_92815_8969_8968_8370_717_8358_8359_8330_8331_8336_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3012_3013_3017_3014_941	48	+	1.99048452327492e-17	1.69191184478368e-15
3578	ouabain	hsa04350	TGF-beta signaling pathway	4088_4090_1634_3397_3399_7057_6667_3400_7042_6093_92_57154	12	+	0.0203081128493232	0.429151403854118
3579	ouabain	hsa04810	Regulation of actin cytoskeleton	6093_7430_2909_7414_1398	5	+	0.0106206001701078	0.300917004819721
3580	ouabain	hsa04540	Gap junction	108	1	+	0.0302930402720554	0.429151403854118
3581	ouabain	hsa05012	Parkinson's disease	1339_7318_509	3	+	0.0488383278240244	0.593036837863153
3582	ouabain	hsa04650	Natural killer cell mediated cytotoxicity	6850_6655_5295_5881_3135_5532_10451_5335_3845_355	10	-	0.0110707448789919	0.0612797671257586
3583	ouabain	hsa03440	Homologous recombination	10714_5888_4683_5425_675_641_5892_5889_25788_10111	10	-	0.0314872638845677	0.1220131475527
3584	ouabain	hsa04640	Hematopoietic cell lineage	960_3554_3566_2057	4	-	0.00817371614810519	0.0542968286981273
3585	ouabain	hsa05010	Alzheimer's disease	3710_841_8772_317_5532_355_3709_351_488_7132_23236	11	-	0.000824367128778212	0.00766661429763737
3586	ouabain	hsa04080	Neuroactive ligand-receptor interaction	4157_5021_1131_7067_2150_136_2690	7	-	9.4956134124662e-10	4.41546023679678e-08
3587	ouabain	hsa05200	Pathways in cancer	5467_5295_5155_5154_5881_5335_5888_8321_8322_1050_4149_3551_5727_8772_5900_652_1019_613_367_9134_898_675_7043_4609_2956_4233_841_26060_6502_6655_6772_7188_355_3845_7187_2535	36	-	0.0303092651714099	0.1220131475527
3588	ouabain	hsa05320	Autoimmune thyroid disease	3135_355	2	-	0.0282431424878921	0.119391465971544
3589	ouabain	hsa04670	Leukocyte transendothelial migration	1432_5829_5295_1500_9080_7852_10451_5335_9475	9	-	0.0206750328570012	0.0961389027850556
3590	ouabain	hsa05016	Huntington's disease	5433_841_5438_317_7419_5481_23236	7	-	4.13886435061958e-06	0.000107890628391801
3591	ouabain	hsa04740	Olfactory transduction	5613_5616_409	3	-	3.7835379483583e-21	3.51869029197322e-19
3592	ouabain	hsa04514	Cell adhesion molecules (CAMs)	965_214_3385_4897_9080_3135_5792_9019	8	-	0.00298635474476546	0.0213639224048606
3593	ouabain	hsa04510	Focal adhesion	5154_5062_5829_6655_5295_5155_10451_9475_5881_6714_4233	11	-	5.42998727322141e-05	0.000721412594870845
3594	ouabain	hsa05322	Systemic lupus erythematosus	55506_55766_3021_3020	4	-	9.41119071633988e-06	0.000175048147323922
3595	ouabain	hsa04512	ECM-receptor interaction	960	1	-	9.28531348700365e-05	0.00107941769286417
3596	ouabain	hsa04630	Jak-STAT signaling pathway	3717_3566_2057_6655_5295_6772_10379_4609_8835_2690	10	-	0.00276100909052701	0.0213639224048606
3597	ouabain	hsa04150	mTOR signaling pathway	9470_5295	2	-	0.0279263922583517	0.119391465971544
3598	ouabain	hsa04062	Chemokine signaling pathway	3717_5580_3551_5829_5613_6655_5295_5616_6772_9475_7852_7074_10451_3845_23236_409_408	17	-	0.0190175923516154	0.0930861099315912
3599	ouabain	hsa04810	Regulation of actin cytoskeleton	5154_8394_5295_5062_5829_26999_6655_1131_5155_5881_54961_9475_8396_7074_10451_3845_3985_2934_1445	19	-	0.00961689010146467	0.059624718629081
3600	ouabain	hsa05012	Parkinson's disease	7419_317_5481	3	-	4.64045713513121e-06	0.000107890628391801
3601	ouabain	hsa04260	Cardiac muscle contraction	784_488	2	-	0.000689192092593755	0.0071216516234688
3602	ouabain	hsa04060	Cytokine-cytokine receptor interaction	27242_3554_3566_2057_23765_5155_5154_8741_8742_7852_657_355_7043_7132_4233_2690	16	-	2.7680741542045e-05	0.000429051493901697
3603	ouabain	hsa03010	Ribosome	6125_6168_3921_9349	4	-	0.00147745329166853	0.0124911960113794
3604	ouabain	hsa04020	Calcium signaling pathway	23236_5256_3710_5532_5021_5613_1131_5616_5257_3709_5335_136_488_7419_5481_493	16	-	0.0166070417759157	0.0858030491755644
3605	ouabain	hsa03050	Proteasome	23198	1	-	0.0112016778616978	0.0612797671257586
3606	ouabain	hsa04730	Long-term depression	3709_3845_3710_23236	4	-	0.0405095531049697	0.144899555337007
3607	ouabain	hsa04610	Complement and coagulation cascades	2161_7056_7035_5329	4	-	0.0394000038695739	0.144899555337007
3608	domperidone	hsa05332	Graft-versus-host disease	3811_3553_3552_3821_3804_3107_3126_3127_3802_3123_3125	11	+	0.021966301916431	0.279285838651766
3609	domperidone	hsa05211	Renal cell carcinoma	3725_5781	2	+	0.0216550725536305	0.279285838651766
3610	domperidone	hsa05016	Huntington's disease	4714_2902_246721_1213_317_1346_3708_9377_146754	9	+	0.00446765353284508	0.132540388141071
3611	domperidone	hsa04740	Olfactory transduction	5593_8390_135948_808_390892_801_805	7	+	1.93782862975167e-11	1.72466748047899e-09
3612	domperidone	hsa05322	Systemic lupus erythematosus	958_3123_3126_3127_3014_3125_8290_88	8	+	0.0322905488059783	0.319317649303563
3613	domperidone	hsa04110	Cell cycle	995_4088_10744_5111_4193	5	+	0.0169413061904335	0.279285838651766
3614	domperidone	hsa04530	Tight junction	6709_5865_88_56288_4626	5	+	0.00350729963648685	0.132540388141071
3615	domperidone	hsa04115	p53 signaling pathway	317_4193	2	+	0.0307706452859919	0.319317649303563
3616	domperidone	hsa04630	Jak-STAT signaling pathway	3467_3600_3596_64109_3589_3718_3443_5781_8651	9	+	0.0383771198298299	0.341556366485486
3617	domperidone	hsa05012	Parkinson's disease	4714_5413_317_1346_9377_6622	6	+	0.0121108922412098	0.269467352366918
3618	domperidone	hsa04640	Hematopoietic cell lineage	3655_966_960_3675	4	-	0.0307917767431479	0.367370955769804
3619	domperidone	hsa04080	Neuroactive ligand-receptor interaction	5025_5618_7068_2150_5031	5	-	1.45235972068198e-08	6.53561874306891e-07
3620	domperidone	hsa04740	Olfactory transduction	219464	1	-	3.24359967390181e-19	2.91923970651163e-17
3621	domperidone	hsa05322	Systemic lupus erythematosus	6632_85236_3113_6628_8343_8339_8347_8346_8344	9	-	0.0288275818153474	0.367370955769804
3622	domperidone	hsa04110	Cell cycle	4087_4088_983_651610_4616_699_51433_4089_7534_1017_7531_995_5001_996_9134_4193_7027_5591_1647_1031_4173_1022_472_5934_7529	25	-	0.032655196068427	0.367370955769804
3623	domperidone	hsa04720	Long-term potentiation	5605_5594_2776	3	-	0.0310903647062909	0.367370955769804
3624	domperidone	hsa04060	Cytokine-cytokine receptor interaction	5618_3597_3459_5154_3572_4982_268_4233_51330	9	-	2.36791675199769e-06	7.10375025599307e-05
3625	domperidone	hsa04020	Calcium signaling pathway	5256_5025_2776_115_7416_113_7419_293	8	-	0.00075141956494671	0.016906940211301
3626	domperidone	hsa03050	Proteasome	5702	1	-	0.0388994824037773	0.388994824037773
3627	flucytosine	hsa05214	Glioma	5605_818_1956_1029	4	+	0.0377511003917877	0.475663864936525
3628	flucytosine	hsa04740	Olfactory transduction	818	1	+	0.0107660088990159	0.402147112197559
3629	flucytosine	hsa05219	Bladder cancer	5605_1956_1029	3	+	0.0492215265334523	0.516826028601249
3630	flucytosine	hsa05218	Melanoma	5605_1956_1029_26281_2258	5	+	0.0127665749903987	0.402147112197559
3631	flucytosine	hsa05216	Thyroid cancer	5605_51176_7849	3	+	0.0204297237745126	0.429024199264765
3632	flucytosine	hsa04540	Gap junction	5605_7278_1956_113457_2977	5	+	0.0341114664560538	0.475663864936525
3633	flucytosine	hsa04740	Olfactory transduction	219464_5567_816	3	-	0.0269672830823965	1
3634	flucytosine	hsa04010	MAPK signaling pathway	4217_5534_3925_5567_4137_10912_27092_91_5971_3727_3164_2264	12	-	0.0494545215958468	1
3635	clofazimine	hsa05016	Huntington's disease	4899_6392_317_651820_64446_3708_90993_5468	8	+	0.0443755229824974	0.749948867800296
3636	clofazimine	hsa04740	Olfactory transduction	8392_4991_9635_26692_56656	5	+	4.8748216973004e-09	4.19234665967834e-07
3637	clofazimine	hsa03010	Ribosome	6165_6129	2	+	0.0165548324582652	0.711857795705404
3638	clofazimine	hsa04912	GnRH signaling pathway	6655_3708_1956_8681_3725_100137049	6	-	0.0496886160907359	0.859032728608926
3639	alexidine	hsa04740	Olfactory transduction	816	1	+	1.72827151558826e-05	0.00126163820637943
3640	alexidine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8330_8294_8367_554313_121504	15	+	0.000536608822928617	0.0195862220368945
3641	alexidine	hsa04640	Hematopoietic cell lineage	3675	1	-	0.0302615572409898	0.292528386662901
3642	alexidine	hsa04080	Neuroactive ligand-receptor interaction	5031_7442_2690_7433	4	-	0.000137808977952259	0.00599469054092327
3643	alexidine	hsa05016	Huntington's disease	5331_3064_161_539_581	5	-	0.0191864169728482	0.27649908886113
3644	alexidine	hsa04740	Olfactory transduction	5613_5566_109_5616_157	5	-	3.01558759253055e-07	2.62356120550158e-05
3645	alexidine	hsa04514	Cell adhesion molecules (CAMs)	23705_9672_6382	3	-	0.0254252035734372	0.27649908886113
3646	alexidine	hsa05322	Systemic lupus erythematosus	3014_94239	2	-	0.00425168197895157	0.0739792664337573
3647	alexidine	hsa04210	Apoptosis	207_581_5613_11261_5616_355_5291_208_8717_5575_5576_5566	12	-	0.0462531333581556	0.344617001633825
3648	alexidine	hsa05012	Parkinson's disease	539	1	-	0.00157575836284432	0.034272744391864
3649	alexidine	hsa04260	Cardiac muscle contraction	6262	1	-	0.0449110285279731	0.344617001633825
3650	alexidine	hsa04060	Cytokine-cytokine receptor interaction	355_23765_7423_6387_2690	5	-	0.000448775225130474	0.0130144815287837
3651	alexidine	hsa03010	Ribosome	6125_9045	2	-	0.0475333795357	0.344617001633825
3652	alexidine	hsa05222	Small cell lung cancer	4149_3912_207_9134_898_6502_208_5291_7188_51588_1871_1869_3675	13	-	0.0234208622709767	0.27649908886113
3653	aminophylline	hsa04740	Olfactory transduction	818_51806	2	+	0.009240709890108	0.16009942258431
3654	aminophylline	hsa04510	Focal adhesion	8515_3690_83660_998_3371_5156_93408_4636_5602_824_55742_1277_3676	13	+	0.00180146230929621	0.042634607986677
3655	aminophylline	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	0.000970631410380718	0.042634607986677
3656	aminophylline	hsa04720	Long-term potentiation	775_5533_51806_818_3708_3709	6	+	0.0112746072242472	0.16009942258431
3657	aminophylline	hsa04020	Calcium signaling pathway	146_51806_775_3360_3274_5156_818_3708_3709_5533	10	+	0.0151647862520512	0.179449970649273
3658	aminophylline	hsa04912	GnRH signaling pathway	775_51806_8398_1081_998_818_3708_3709_5602	9	+	0.00159264384636309	0.042634607986677
3659	aminophylline	hsa04270	Vascular smooth muscle contraction	146_51806_775_3779_3708_3709_8398	7	+	0.0264969083790568	0.268754356416148
3660	aminophylline	hsa04740	Olfactory transduction	157	1	-	0.00520657650434988	0.291568284243593
3661	esculetin	hsa04070	Phosphatidylinositol signaling system	5289_5333_3705_3708_3631	5	+	0.0241711680836563	1
3662	esculetin	hsa04670	Leukocyte transendothelial migration	3383_27035_7852_5781_6093_4636	6	+	0.0458393941249869	1
3663	esculetin	hsa04740	Olfactory transduction	109	1	-	0.0110987502387991	0.710320015283142
3664	esculetin	hsa04512	ECM-receptor interaction	3655_7059_960_3693_3675	5	-	0.0256881952074261	0.822022246637635
3665	STOCK1N-35696	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_5534_836_5868_581	5	+	0.0121864423983014	0.25997743783043
3666	STOCK1N-35696	hsa05219	Bladder cancer	1026_11186_4193_7422	4	+	0.0199718220547343	0.319549152875749
3667	STOCK1N-35696	hsa04115	p53 signaling pathway	55367_1647_1026_836_581_4193_355_5366_8795	9	+	6.3456947404484e-05	0.00406124463388698
3668	STOCK1N-35696	hsa04010	MAPK signaling pathway	1647_836_22800_5534_1649_1846_4791_91_355_1432_3310_7786_3725_3304_3303	15	+	0.00356637691778082	0.114124061368986
3669	STOCK1N-35696	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3013_554313_3017_3014_8359_8330_8336_8294_8367_8351_8368_121504_8357	21	-	2.79358835286972e-15	9.21884156447008e-14
3670	Gly-His-Lys	hsa04080	Neuroactive ligand-receptor interaction	3953_4157_4886	3	+	0.0269852090540785	0.971467525946826
3671	Gly-His-Lys	hsa04740	Olfactory transduction	818_109	2	+	0.00012753831781683	0.00918275888281176
3672	Gly-His-Lys	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	-	2.22977721887052e-08	5.79742076906335e-07
3673	etilefrine	hsa03320	PPAR signaling pathway	2710_1579_1375_284541_8309_5105	6	+	0.00835449978014248	0.186583828423182
3674	etilefrine	hsa04740	Olfactory transduction	5568	1	+	0.00167624308094183	0.0561541432115513
3675	etilefrine	hsa05322	Systemic lupus erythematosus	8361_8360_3018_8362_8365_8364_8370_8366_8368_8363_8359_8294_8367_554313_6738_121504	16	+	9.09841432531214e-07	6.09593759795913e-05
3676	etilefrine	hsa04540	Gap junction	5568_7278_113457_5330_5607_112	6	+	0.0276740203886831	0.370831873208354
3677	etilefrine	hsa04270	Vascular smooth muscle contraction	5568_4881_3778_5330_1579_112_284541	7	+	0.0264969083790568	0.370831873208354
3678	benfluorex	hsa05010	Alzheimer's disease	810_3708	2	+	0.0363506779247356	0.654312202645241
3679	benfluorex	hsa04740	Olfactory transduction	810	1	+	1.7519988391434e-06	6.30719582091624e-05
3680	benfluorex	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8294_121504_8968_55766_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_8970	28	+	6.41362943820397e-10	4.61781319550686e-08
3681	benfluorex	hsa05012	Parkinson's disease	5413	1	+	0.0316128154762042	0.654312202645241
3682	benfluorex	hsa04080	Neuroactive ligand-receptor interaction	706_9170	2	-	0.00946354225123319	0.302670355493329
3683	benfluorex	hsa04740	Olfactory transduction	109	1	-	1.72827151558826e-05	0.00139989992762649
3684	benfluorex	hsa04514	Cell adhesion molecules (CAMs)	2734_24146_1366_4267_999_9080_3135_1364_1365_5792_3655	11	-	0.0194044212829003	0.392939530978731
3685	benfluorex	hsa04530	Tight junction	24146_2037_1366_1364_9080_60_5518_84612_1365_3265_4627_1460	12	-	0.0112100131664196	0.302670355493329
3686	benfluorex	hsa04630	Jak-STAT signaling pathway	10379	1	-	0.0464571082736837	0.606824006234043
3687	benfluorex	hsa04060	Cytokine-cytokine receptor interaction	355_655_4233	3	-	0.0272605224235788	0.441620463261977
3688	amoxicillin	hsa05332	Graft-versus-host disease	3105_3106_3126_3127_3125_3135_3123_3113_649853	9	+	8.68753030808742e-05	0.0023421051838188
3689	amoxicillin	hsa04640	Hematopoietic cell lineage	1435_947_3123_3126_3127_3125_924_7850_3589_3676	10	+	0.00293951925991538	0.0293763845338135
3690	amoxicillin	hsa05320	Autoimmune thyroid disease	958_3105_3106_3126_3127_3125_3135_3123_3113_649853	10	+	9.03816535015953e-05	0.0023421051838188
3691	amoxicillin	hsa04612	Antigen processing and presentation	3123_3106_3126_3127_3125_3135_3105_3113_649853	9	+	0.00989260559871746	0.0868350935887422
3692	amoxicillin	hsa04740	Olfactory transduction	5566_8392_1179	3	+	0.000492767491624049	0.00778572636765998
3693	amoxicillin	hsa04514	Cell adhesion molecules (CAMs)	958_947_3683_3123_3106_3126_3127_3125_3135_3105_3676_3113_649853	13	+	0.0029748237502596	0.0293763845338135
3694	amoxicillin	hsa05310	Asthma	958_3113_3126_3127_3125_3123	6	+	0.00182142008720132	0.0239820311481507
3695	amoxicillin	hsa05330	Allograft rejection	958_3113_3106_3126_3127_3125_3135_3123_3105_649853	10	+	7.56576628949064e-06	0.000597695536869761
3696	amoxicillin	hsa04940	Type I diabetes mellitus	3105_3106_3126_3127_3125_3135_3123_3113_649853	9	+	0.00011858760424399	0.0023421051838188
3697	amoxicillin	hsa05214	Glioma	595_5578_3480_5295_5155_808_5336_801_805	9	-	0.0214146277515631	0.340025044438751
3698	amoxicillin	hsa04070	Phosphatidylinositol signaling system	5578_8394_8396_5295_808_5336_801_3705_805_23236	10	-	0.0280756364457068	0.340025044438751
3699	amoxicillin	hsa04080	Neuroactive ligand-receptor interaction	5618_2908_4886	3	-	0.000485037673578109	0.0191589881063353
3700	amoxicillin	hsa04740	Olfactory transduction	5613_5616_808_109_801_805	6	-	6.98925541104549e-05	0.00552151177472594
3701	amoxicillin	hsa04514	Cell adhesion molecules (CAMs)	3655_5792	2	-	0.0356356848274939	0.340025044438751
3702	amoxicillin	hsa05322	Systemic lupus erythematosus	55506_8358_85235_8968_3013_8330_8332_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357	19	-	0.00268406515759486	0.0706803824833313
3703	amoxicillin	hsa05110	Vibrio cholerae infection	5578_11015_5336_5616_115_109_5613_523	8	-	0.0321791084667405	0.340025044438751
3704	amoxicillin	hsa04540	Gap junction	5578_5613_7278_5155_113457_2776_115_5616_109_2697_23236	11	-	0.0479319078601194	0.340972197536508
3705	amoxicillin	hsa05012	Parkinson's disease	7332_4713	2	-	0.0247787113254396	0.340025044438751
3706	amoxicillin	hsa03020	RNA polymerase	246721_5439_9533_10622_548644	5	-	0.0387370303790982	0.340025044438751
3707	amoxicillin	hsa04912	GnRH signaling pathway	5578_5613_5616_2776_808_115_109_3725_801_81579_805_23236	12	-	0.0433745540984529	0.340972197536508
3708	isoetarine	hsa05016	Huntington's disease	1639_246721_548644_836_5439	5	+	0.0313755313965567	0.486320736646629
3709	isoetarine	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.00300319928097167	0.0930991777101218
3710	isoetarine	hsa05322	Systemic lupus erythematosus	3013_8358_727_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	-	3.92453855307116e-05	0.00231547774631198
3711	corbadrine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	1.30883300987175e-10	6.15151514639723e-09
3712	corbadrine	hsa05332	Graft-versus-host disease	3105_3106_3135_3134_355_649853	6	-	0.00456541486888761	0.0839645941989705
3713	corbadrine	hsa05320	Autoimmune thyroid disease	3105_3106_3135_3134_355_649853	6	-	0.012425141335532	0.15531426669415
3714	corbadrine	hsa04612	Antigen processing and presentation	3134_3105_3106_3135_6890_811_649853	7	-	0.0380274556049007	0.347193472807144
3715	corbadrine	hsa04310	Wnt signaling pathway	8312_5613_6477_1856_5881_4775_79718_6934_5534_8321	10	-	0.0448375884446203	0.347193472807144
3716	corbadrine	hsa04740	Olfactory transduction	5613	1	-	5.59348872511932e-05	0.00419511654383949
3717	corbadrine	hsa05322	Systemic lupus erythematosus	8353_3013_3014_8358_8968_8350_8351_8352_81_8354_8355_8356_8357	13	-	0.00194869075781682	0.0730759034181307
3718	corbadrine	hsa05330	Allograft rejection	3105_3106_3135_3134_355_649853	6	-	0.00292999141042652	0.073249785260663
3719	corbadrine	hsa05210	Colorectal cancer	836_6934_1856_5881_8312_7042_8321	7	-	0.029598197153705	0.317123540932554
3720	corbadrine	hsa04940	Type I diabetes mellitus	3105_3106_3135_3134_355_649853	6	-	0.0055976396132647	0.0839645941989705
3721	corbadrine	hsa05217	Basal cell carcinoma	6934_2737_8321_1856_8312	5	-	0.0462924630409525	0.347193472807144
3722	butyl hydroxybenzoate	hsa05332	Graft-versus-host disease	3123_3126_3127_3119_3125	5	+	0.0100139429599229	0.150209144398844
3723	butyl hydroxybenzoate	hsa04640	Hematopoietic cell lineage	960_3690_3123_2993_3126_3127_3125_3589_920	9	+	0.00150256630770224	0.0696654916438667
3724	butyl hydroxybenzoate	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3119_3125	5	+	0.0233264059235366	0.26540985904895
3725	butyl hydroxybenzoate	hsa05131	Shigellosis	9076_7278_7454_7430_113457	5	+	0.0283103849652213	0.26540985904895
3726	butyl hydroxybenzoate	hsa05130	Pathogenic Escherichia coli infection	9076_7278_7454_7430_113457	5	+	0.0283103849652213	0.26540985904895
3727	butyl hydroxybenzoate	hsa05310	Asthma	3123_3126_3127_3119_3125	5	+	0.00278661966575467	0.0696654916438667
3728	butyl hydroxybenzoate	hsa05330	Allograft rejection	3123_3126_3127_3119_3125	5	+	0.00688260399368625	0.129048824881617
3729	butyl hydroxybenzoate	hsa04940	Type I diabetes mellitus	3382_3119_3123_3126_3127_3125	6	+	0.00266595622290431	0.0696654916438667
3730	butyl hydroxybenzoate	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8294_8343_8347_8346_8344_8370_8359_8337_6737_121504_8339_9555	22	-	7.29108740458899e-06	0.00057599590496253
3731	butyl hydroxybenzoate	hsa04060	Cytokine-cytokine receptor interaction	3554_7040_7042	3	-	0.00269256258029824	0.10635622192178
3732	indapamide	hsa04080	Neuroactive ligand-receptor interaction	1269_886_64106_2908_3274_5724_134_2488_2740_3362_57105_2688_2689_1442_146_2914_2918_6915_9002_23566_2550_5618_4158_6755_1241_2696	26	+	0.00163404639285315	0.0452086168689372
3733	indapamide	hsa05200	Pathways in cancer	2475_22798_596_331_330_9618_3479_5881_7039_26291_652671_51176_3910_5371_1613_7471_2260_7475_3815_51384_208_4193_4254_1496_91_1284_2335_5599_1288_8817_861_6257	32	+	0.00105117340214435	0.0436236961889905
3734	indapamide	hsa05016	Huntington's disease	317_6667	2	+	0.00924541329301081	0.153473860663979
3735	indapamide	hsa04740	Olfactory transduction	7932_816	2	+	1.42030783582891e-06	0.0001178855503738
3736	indapamide	hsa04514	Cell adhesion molecules (CAMs)	9076_3117_947_1272_3107_3111_3684_23308_57863_6693_26285_925_5817	13	+	0.0312391109023673	0.351309237273261
3737	indapamide	hsa04510	Focal adhesion	1284_22798_3910_596_5599_858_2909_3693_331_7057_330_3479_5881_208_824_6093_1288_6696_2335	19	+	0.017143252855607	0.23714833116923
3738	indapamide	hsa05322	Systemic lupus erythematosus	3117_3111	2	+	0.0494774689690275	0.351309237273261
3739	indapamide	hsa05221	Acute myeloid leukemia	51176_2475_3815_861_208_5371_652671	7	+	0.0393917796494806	0.351309237273261
3740	indapamide	hsa04512	ECM-receptor interaction	1284_2335_9900_3910_3693_7057_1288_6696_22798	9	+	0.0452044902570014	0.351309237273261
3741	indapamide	hsa05222	Small cell lung cancer	1284_22798_596_331_3910_317_330_9618_1288_208_6257_2335	12	+	0.00262452991829641	0.0544589958046505
3742	indapamide	hsa05010	Alzheimer's disease	5534	1	-	0.0336308147028267	0.653749738351472
3743	indapamide	hsa04740	Olfactory transduction	5566_816	2	-	0.000278064652115934	0.00987129515011566
3744	indapamide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_6737_8359_8330_8294_8367_554313_121504	16	-	0.00011786151393602	0.00836816748945742
3745	indapamide	hsa04810	Regulation of actin cytoskeleton	8394_6655	2	-	0.0368309711747308	0.653749738351472
3746	camptothecin	hsa05010	Alzheimer's disease	779_348	2	+	0.0498757341385087	0.527257760892806
3747	camptothecin	hsa04740	Olfactory transduction	26476_2978_816	3	+	0.00024631082830821	0.00911350064740377
3748	camptothecin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_9103_8294_121504_8341_3021_3020_8968_55766_8370_8358_8359_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_1511	33	+	3.82637768790043e-14	2.83151948904632e-12
3749	camptothecin	hsa04110	Cell cycle	995_1647_1026_2810_4088_4193_1028_10912_8900_4616	10	+	0.0349856921320743	0.5177882435547
3750	camptothecin	hsa04530	Tight junction	5010	1	+	0.045559938950939	0.527257760892806
3751	camptothecin	hsa05219	Bladder cancer	1026_5228_1612_4193_1956_2261_1890	7	+	0.00272138112444121	0.0596777323519666
3752	camptothecin	hsa04115	p53 signaling pathway	1647_1026_5366_2810_4193_5268_10912_5054_4616	9	+	0.00322582337037657	0.0596777323519666
3753	camptothecin	hsa05332	Graft-versus-host disease	5551_355_3108	3	-	0.000679321594063684	0.0035098282359957
3754	camptothecin	hsa04650	Natural killer cell mediated cytotoxicity	8503_6850_5058_5295_5290_5291_10451_6452_5335_5336_836_3455_4772_3459_7410_3845_4277_10725_673_5533_5532_4775_5894_5534_8795_5777_5578_6655_6654_355_5530_7409_5551_2534	34	-	0.0203164743736369	0.0609494231209107
3755	camptothecin	hsa04640	Hematopoietic cell lineage	3554_3566_2057_960_4254_1604_3678_3673	8	-	4.77666638127169e-06	4.44229973458267e-05
3756	camptothecin	hsa03320	PPAR signaling pathway	11001_5170_1962_2182_2181_1375_1374_5467_5468_6257_6256	11	-	0.00384415805091869	0.0143002679494175
3757	camptothecin	hsa05010	Alzheimer's disease	51806_3710_5534_317_9451_2776_5663_5332_7132_836_509_776_8772_2932_5533_5532_3708_5530_6868_488_23236_4714_842_841_840_355_3709_351_22926	29	-	4.34342448534819e-06	4.44229973458267e-05
3758	camptothecin	hsa04080	Neuroactive ligand-receptor interaction	5029_4889_5618_7442_4157_7068_3953_1131_2908_2901_4886_5031_3354_2150_136_7433_56288_2690_2149_9170	20	-	9.68408612068614e-18	4.50310004611905e-16
3759	camptothecin	hsa04742	Taste transduction	3710_5613_5567_5616_6337_112	6	-	0.00127442118117412	0.00592605849245966
3760	camptothecin	hsa05320	Autoimmune thyroid disease	5551_355_3108	3	-	3.45829721096608e-05	0.000214414427079897
3761	camptothecin	hsa04612	Antigen processing and presentation	4800_4801_4802_3312_3108_5993_5994_3308_1385_3304_3305_3303	12	-	0.000192238821168221	0.00111738814804028
3762	camptothecin	hsa04670	Leukocyte transendothelial migration	9076_8503_2909_5295_5290_9475_6387_5335_394_5829_1500_5336_7410_7430_2773_5747_6093_5291_1432_5578_10451_27035_1366_1364_7409_4950	26	-	0.00538558855678707	0.0192638359915845
3763	camptothecin	hsa05016	Huntington's disease	4899_64764_317_246721_2776_5332_23186_3064_6875_6874_6908_5433_5430_5431_836_7052_5439_6667_2033_509_3708_5468_548644_23236_4714_51164_842_841_3092_5978_1385_1387_9519	33	-	9.31608178707701e-06	7.21996338498468e-05
3764	camptothecin	hsa04740	Olfactory transduction	51806_157_5613_5567_5616_818_109	7	-	4.92804754112711e-45	4.58308421324821e-43
3765	camptothecin	hsa04514	Cell adhesion molecules (CAMs)	9076_965_214_4685_3108_6383_5819_4897_1366_23308_1364_5792_9672_4950_25945_9019_5817	17	-	1.39616337510827e-06	1.8549027697867e-05
3766	camptothecin	hsa04510	Focal adhesion	8503_5170_595_10298_596_2909_5747_5155_5154_5290_9475_3678_5058_394_3673_4659_6093_5501_5728_5829_7057_7410_23396_331_1399_1398_329_5295_3911_1793_3480_2932_3909_5894_3725_6714_5291_4233_5578_1729_2317_6655_6654_10451_2002_7424_7409_673_2534	49	-	0.0018466696493733	0.00780637624507804
3767	camptothecin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_718_3108_8368_8366_6738_8359_8294_8367_554313_8970_121504_6632_6737	20	-	2.44184002223397e-06	2.83863902584699e-05
3768	camptothecin	hsa05340	Primary immunodeficiency	8517_64421_5993_5994	4	-	0.0118458144191656	0.0381085116310176
3769	camptothecin	hsa04530	Tight junction	9076_2773_50855_6709_64398_56288_55870_9223_5728_5583_5580_5581_51776_2017_55844_10207_8777_5519_22800_9218_8573_6714_5515_5590_5520_7082_5578_1366_1364_1457_3845_4950_1459_27134	34	-	0.0202946145191121	0.0609494231209107
3770	camptothecin	hsa05310	Asthma	3108	1	-	0.000917331946161061	0.00449009847331467
3771	camptothecin	hsa04512	ECM-receptor interaction	960_9672_3911_7057_3909_3678_6383_3673_3161	9	-	3.44221161836631e-05	0.000214414427079897
3772	camptothecin	hsa04630	Jak-STAT signaling pathway	3717_6777_595_598_5295_8503_5290_5291_9180_9655_10254_2057_3455_3459_3572_3588_2033_10401_9063_3953_1154_200734_8554_10379_6778_8027_5777_23529_868_5618_3566_6655_6654_51588_8835_1387_3601_2690	38	-	0.0118832993258012	0.0381085116310176
3773	camptothecin	hsa04062	Chemokine signaling pathway	3717_6777_1147_157_156_2773_8503_5290_9475_115_6387_5332_56288_5747_2309_4067_3551_5829_5567_112_7410_1399_1398_7409_4793_408_8517_5295_2932_673_109_5894_6093_5291_107_23236_5590_5580_5613_6655_6654_5616_10451_7074_3845_5058_5970_8976	48	-	0.00574017873149413	0.0197717267418131
3774	camptothecin	hsa04810	Regulation of actin cytoskeleton	8503_10298_10672_2909_5295_5155_5154_5290_9475_3678_5058_23396_5747_3673_10458_4659_5501_5829_1730_23191_8394_7410_50649_7430_1399_1398_2263_5962_8396_54434_324_1793_1131_673_22800_5894_3985_6093_5291_200576_10451_8874_1729_6655_6654_5305_6548_7074_8936_3845_8976_7409_26999_2149	54	-	0.00262280637947524	0.0101633747204666
3775	camptothecin	hsa05012	Parkinson's disease	4714_2861_7326_836_842_317_51465_509_27429	9	-	6.72362935215511e-11	1.8472876025277e-09
3776	camptothecin	hsa04260	Cardiac muscle contraction	776_6262_6548_488_10479_481	6	-	1.08104348202925e-06	1.67561739714534e-05
3777	camptothecin	hsa04060	Cytokine-cytokine receptor interaction	5155_5154_6387_9180_90_7132_657_27242_3554_2057_3455_3459_3953_3572_3588_4982_10913_659_3601_23529_3625_4254_7042_91_655_93_92_4233_7048_5618_3566_355_7424_8795_51330_2690	36	-	7.94532302162451e-11	1.8472876025277e-09
3778	camptothecin	hsa03010	Ribosome	6139_6205_51187_6137_6125_6168_6171	7	-	3.29232036523052e-08	6.12371587932877e-07
3779	camptothecin	hsa04020	Calcium signaling pathway	51806_3710_5534_2776_115_7220_5332_5335_136_5336_490_6262_5567_3707_818_56848_776_1131_5533_5532_3708_5530_488_107_23236_8877_5578_5613_3709_5616_109_2149	32	-	7.6637509001528e-06	6.47935303376555e-05
3780	camptothecin	hsa03050	Proteasome	5717_5706_23198_5718	4	-	0.000523600114629487	0.00286440062709072
3781	camptothecin	hsa05330	Allograft rejection	5551_355_3108	3	-	0.00240565032156279	0.00972719477849302
3782	camptothecin	hsa04940	Type I diabetes mellitus	5551_355_3382_3108	4	-	0.00175915126024504	0.00779052700965661
3783	camptothecin	hsa02010	ABC transporters	23461_4363_5826_10057_9619_8714_23457	7	-	0.0271632487530281	0.0789431916884879
3784	camptothecin	hsa04610	Complement and coagulation cascades	1604_5329_7035_2149_718	5	-	1.04955924439357e-05	7.50838536373862e-05
3785	ethisterone	hsa05010	Alzheimer's disease	776_4695_841	3	+	9.51198283056801e-06	0.000423283235960276
3786	ethisterone	hsa05016	Huntington's disease	8218_4899_1387_4695_841_7052_5439_246721_1211_5468_548644_10126	12	+	0.0450656741112452	0.60311926591995
3787	ethisterone	hsa04740	Olfactory transduction	157_8388_8387_23538_8383_1179_818_5137_816	9	+	9.38869403884232e-10	8.35593769456966e-08
3788	ethisterone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8294_8341_8340_3123_3126_3127_3125_8370_8359_554313_121504_3119_2215_3113_941_720_721	27	+	0.0213714088086308	0.475513845992035
3789	ethisterone	hsa05110	Vibrio cholerae infection	11015	1	+	0.0288776504875716	0.514022178678775
3790	ethisterone	hsa05012	Parkinson's disease	27429_4695_9627_7054	4	+	0.0017458385419235	0.0517932100770638
3791	ethisterone	hsa04080	Neuroactive ligand-receptor interaction	2901_1812_3953_1131_3355_3354	6	-	3.08501352278327e-05	0.00140368115286639
3792	ethisterone	hsa04740	Olfactory transduction	4991	1	-	2.18734789182875e-14	1.99048658156416e-12
3793	ethisterone	hsa04514	Cell adhesion molecules (CAMs)	999_3655_25945_3135	4	-	0.00947405882928943	0.287379784488446
3794	ethisterone	hsa05012	Parkinson's disease	642502_6391_842_4712_2861	5	-	0.0236636685353515	0.538348459179247
3795	ethisterone	hsa04260	Cardiac muscle contraction	784_776	2	-	0.0322457669116335	0.58687295779173
3796	mexiletine	hsa05320	Autoimmune thyroid disease	1081_3586_3444_3107_3126_3127_3125_5551_3123_3448	10	+	0.0100540765263036	0.427298252367903
3797	mexiletine	hsa05016	Huntington's disease	2902_246721_841_7052_6390_6667	6	+	0.0312978895166823	0.545827020457169
3798	mexiletine	hsa04740	Olfactory transduction	810_8392_9635_816	4	+	3.387035586426e-08	2.8789802484621e-06
3799	mexiletine	hsa05012	Parkinson's disease	6390_9627_5413	3	+	0.0260021540329818	0.545827020457169
3800	mexiletine	hsa05330	Allograft rejection	3586_3123_3107_3126_3127_3125_5551	7	+	0.0321074717915982	0.545827020457169
3801	mexiletine	hsa05016	Huntington's disease	1213	1	-	0.032509155562764	0.715201422380808
3802	mexiletine	hsa04740	Olfactory transduction	157	1	-	8.06890403763305e-05	0.00266273833241891
3803	mexiletine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_720_721	28	-	5.43184089426118e-13	3.58501499021238e-11
3804	dantrolene	hsa05332	Graft-versus-host disease	3811_3119_3113_3107_3126_3127_3125_3123_3802	9	+	0.000993008909336295	0.0284321800767445
3805	dantrolene	hsa05320	Autoimmune thyroid disease	3119_3126_3107_3113_3127_3125_3123	7	+	0.0325743710807838	0.325743710807838
3806	dantrolene	hsa04612	Antigen processing and presentation	3811_3809_972_3119_3123_3107_3126_3127_3125_3802_925_3113	12	+	0.00529558625366047	0.0847293800585675
3807	dantrolene	hsa04910	Insulin signaling pathway	5584_5105	2	+	0.0499583761953745	0.444074455069996
3808	dantrolene	hsa04514	Cell adhesion molecules (CAMs)	8174_3383_3119_3123_1272_3107_3126_3127_3125_23308_57863_51208_1000_26285_923_925_3113_4359	18	+	0.00106620675287792	0.0284321800767445
3809	dantrolene	hsa05322	Systemic lupus erythematosus	474382_474381_3123_3126_3127_3125_8968_8358_8330_8350_8351_8352_8353_8354_8355_8356_8357_2215_3119_2214_3013_83740_3113	23	+	1.30988079410359e-05	0.00104790463528287
3810	dantrolene	hsa05310	Asthma	3119_3123_3113_3127_3126_3125	6	+	0.00914357563062265	0.104498007207116
3811	dantrolene	hsa05330	Allograft rejection	3119_3113_3107_3126_3127_3125_3123	7	+	0.00735396364773898	0.0980528486365197
3812	dantrolene	hsa04940	Type I diabetes mellitus	3119_3126_3107_2572_3127_3125_3123_3113	8	+	0.00457198777943113	0.0847293800585675
3813	dantrolene	hsa05211	Renal cell carcinoma	2271_5291_405_5058_7422_1399_7042_3725_4233	9	-	0.00297166953726288	0.0594333907452576
3814	dantrolene	hsa04662	B cell receptor signaling pathway	5291_5533_4775_933_3725_29760_4793	7	-	0.0320766008764636	0.410524604064822
3815	dantrolene	hsa04080	Neuroactive ligand-receptor interaction	7434_7442_1909	3	-	0.0280045071021875	0.410524604064822
3816	dantrolene	hsa05200	Pathways in cancer	8312_4088_5291_8324_652671_4149_5371_1613_405_1399_2263_2260_2261_7477_324_3480_7046_6934_7042_91_3725_4233_1436_2271_2335_6502_7422_5914_10928_6256	30	-	4.43894524569651e-05	0.0017755780982786
3817	dantrolene	hsa04520	Adherens junction	4088_3480_7046_6934_91_2260_4233	7	-	0.0422386603879876	0.422386603879876
3818	dantrolene	hsa04740	Olfactory transduction	109	1	-	1.22103417781159e-05	0.000976827342249272
3819	dantrolene	hsa04370	VEGF signaling pathway	1432_5829_56848_5291_5533_4775_7422	7	-	0.0359209028556719	0.410524604064822
3820	dantrolene	hsa05210	Colorectal cancer	6934_4088_3480_7042_8312_5291_7046_324_3725_91_8324_4233	12	-	0.000212766097015791	0.00567376258708776
3821	vincamine	hsa05332	Graft-versus-host disease	57292_3824_3109_3113_3107_3126_3127_3111_3125_355_3123_941	12	+	0.0143702317755846	0.183782424100194
3822	vincamine	hsa05010	Alzheimer's disease	2904_6392_651820_4713_317_355_489_6622_23236	9	+	0.00434596743099819	0.15197631537854
3823	vincamine	hsa04080	Neuroactive ligand-receptor interaction	1269_886_2904_5732_5032_153_5030_59340_56288_2893_135_1909_2569_2488_1813_2561_5540_799_2741_57105_2688_2151_4987_7433_9568_680_1442_2692_2918_185_148_6869_3352_3269_23566_4161_7253_11255_2570_2892_2696_2563_728_5745	44	+	0.0484516578549364	0.392017959008122
3824	vincamine	hsa05320	Autoimmune thyroid disease	3446_3109_7253_3441_3107_3126_3127_3111_3125_355_3123_941_3113_3448	14	+	0.0164323360226249	0.183782424100194
3825	vincamine	hsa04740	Olfactory transduction	26211_7932_26333_5616_1179_26476_816_5137_8590_3000	10	+	2.43266916480272e-10	2.16507555667442e-08
3826	vincamine	hsa04514	Cell adhesion molecules (CAMs)	5010_8506_3695_23308_57863_6383_3384_3383_3123_3107_3126_3127_3125_10666_914_1272_1462_965_4099_4359_3109_6403_6404_3113_3111_941_5797_6693_923_5817	30	+	0.00512279714759123	0.15197631537854
3827	vincamine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_2904_8368_9103_8294_81_3109_3123_8366_3126_3127_3125_8370_717_8359_554313_121504_8354_2215_3113_3111_941	28	+	0.0353282607835159	0.314421520973292
3828	vincamine	hsa04110	Cell cycle	1029_5001_1387_1021_993	5	+	0.00884809154594558	0.183782424100194
3829	vincamine	hsa05012	Parkinson's disease	7318_4713_6392_651820_317_6622_291	7	+	0.0150355008092584	0.183782424100194
3830	vincamine	hsa05330	Allograft rejection	3592_3109_3126_3107_3113_3127_3111_3125_355_3123_941	11	+	0.01858473951575	0.183782424100194
3831	vincamine	hsa04940	Type I diabetes mellitus	3592_3382_3109_3113_3107_3126_3127_3111_3125_355_3123_941	12	+	0.0180868945619152	0.183782424100194
3832	vincamine	hsa05131	Shigellosis	7100_7278_7430_113457_998	5	-	0.0308651532974298	0.532423894380664
3833	vincamine	hsa05130	Pathogenic Escherichia coli infection	7100_7278_7430_113457_998	5	-	0.0308651532974298	0.532423894380664
3834	vincamine	hsa04010	MAPK signaling pathway	1326_3551_9344_998_5881_5154_2002_5607_23162_5536_10454_3553_2260_9693_4149	15	-	0.0291060045582524	0.532423894380664
3835	vincamine	hsa04540	Gap junction	7278_113457_5154_5331_5607_6714_23236	7	-	0.0253484117461748	0.532423894380664
3836	thioguanosine	hsa04740	Olfactory transduction	26211	1	+	0.000560974963402418	0.0171097363837737
3837	thioguanosine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8349_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	26	+	4.57381129713023e-13	2.79002489124944e-11
3838	thioguanosine	hsa04115	p53 signaling pathway	1647_1026_5366_4193_8795	5	+	0.0484586849974959	0.985326594949083
3839	thioguanosine	hsa04640	Hematopoietic cell lineage	3655_3554	2	-	0.000489360522763937	0.00550530588109429
3840	thioguanosine	hsa05010	Alzheimer's disease	841_840_5664_317_2776_4137_808_22926_489_488_102_801_805_23621	14	-	0.00773345331570176	0.0696010798413158
3841	thioguanosine	hsa04080	Neuroactive ligand-receptor interaction	5029_152_7068_5025_4886_5031_56288_136	8	-	5.69184980741641e-09	2.56133241333738e-07
3842	thioguanosine	hsa05320	Autoimmune thyroid disease	3135_3107	2	-	0.0283342922322976	0.196160484685137
3843	thioguanosine	hsa05016	Huntington's disease	1213_246721_841_317_2776_23186_3064_6874_161_6908	10	-	9.94730792186571e-05	0.00127893958995416
3844	thioguanosine	hsa04740	Olfactory transduction	157_5613_5616_818_808_805_801_409	8	-	2.69021148647826e-16	2.42119033783043e-14
3845	thioguanosine	hsa04514	Cell adhesion molecules (CAMs)	2734_965_4685_3107_9080_3135_1364_23705_3655_50848	10	-	0.0144475520202704	0.108356640152028
3846	thioguanosine	hsa04110	Cell cycle	51343_595_891_983_701_51433_23595_651610_4616_699_8881_5934_1031_890_994_5001_996_2810_9134_898_8454_7040_8555_9700_8697_5591_5347_4173_6502_472_8317_5933	32	-	0.011698880788246	0.0957181155401945
3847	thioguanosine	hsa04630	Jak-STAT signaling pathway	10401_3717_6777_595_3588_6655_6654_9063_867_5291_5290_8554_10379_10254	14	-	0.041700929735821	0.234567729763993
3848	thioguanosine	hsa05012	Parkinson's disease	7327_317	2	-	5.96691923295031e-07	1.34255682741382e-05
3849	thioguanosine	hsa04260	Cardiac muscle contraction	488	1	-	9.1900452341398e-05	0.00127893958995416
3850	thioguanosine	hsa04060	Cytokine-cytokine receptor interaction	3554_3588_23765_3625_5154_6358_6359_7852_6387_655_7040_4233	12	-	4.46633025877419e-07	1.33989907763226e-05
3851	thioguanosine	hsa03010	Ribosome	6125_6171	2	-	7.16165358979583e-05	0.00127893958995416
3852	thioguanosine	hsa04020	Calcium signaling pathway	115_5256_8877_5578_5613_5616_2776_818_808_5335_136_489_488_5025_801_107_805_493	18	-	0.0491770544183572	0.260349111626597
3853	thioguanosine	hsa03050	Proteasome	23198_5709	2	-	0.0398514856558441	0.234567729763993
3854	thioguanosine	hsa04730	Long-term depression	5519_5605_2776_5578	4	-	0.0407872961102172	0.234567729763993
3855	thioguanosine	hsa04610	Complement and coagulation cascades	5104	1	-	0.000695914638362391	0.00695914638362391
3856	procainamide	hsa05332	Graft-versus-host disease	3553_3126_3113_3127_3125_3123	6	+	0.0310588949787608	0.146159505782404
3857	procainamide	hsa04640	Hematopoietic cell lineage	2323_3553_948_3575_3123_2993_3126_3127_3125_933	10	+	0.0293210451186829	0.146159505782404
3858	procainamide	hsa05131	Shigellosis	347688_7454_7278_113457_7099_56604_3059_6093	8	+	0.0137502530524588	0.127654519582156
3859	procainamide	hsa04670	Leukocyte transendothelial migration	23533_4301_3689_3383_5829_7410_4688_5293_7852_93408_88_27035_5603_6093	14	+	0.00875716387460685	0.127654519582156
3860	procainamide	hsa05016	Huntington's disease	3708_10540_9001	3	+	0.0270925251999095	0.144493467732851
3861	procainamide	hsa05130	Pathogenic Escherichia coli infection	347688_7454_7278_113457_7099_56604_3059_6093	8	+	0.0137502530524588	0.127654519582156
3862	procainamide	hsa04740	Olfactory transduction	5592_5616_8392_4991_5137_816	6	+	0.000509573873324765	0.0203829549329906
3863	procainamide	hsa04510	Focal adhesion	23533_88_2318_2324_5829_6655_596_331_7057_3371_56924_93408_7410_1956_1950_1277_5293_3725_6093_1291	20	+	0.0123384138284133	0.127654519582156
3864	procainamide	hsa05322	Systemic lupus erythematosus	2212_958_9103_3123_3126_3127_3113_3125_8358_88_8968_3013_8350_8351_8352_8353_8354_8355_8356_8357	20	+	0.000187482875121027	0.0149986300096822
3865	procainamide	hsa05212	Pancreatic cancer	23533_596_83439_6655_4193_3630_5293_1956_1950_367_2260	11	+	0.0167590472311926	0.127654519582156
3866	procainamide	hsa05215	Prostate cancer	23533_596_83439_6655_4193_3630_5293_1956_1950_367_2260	11	+	0.0163094839477211	0.127654519582156
3867	procainamide	hsa05218	Melanoma	23533_4193_5293_8822_8823_1956_2249_2260_1950	9	+	0.0177434129160491	0.127654519582156
3868	procainamide	hsa05310	Asthma	958_3578_3123_3126_3127_3125_3113	7	+	0.00205861918649225	0.041172383729845
3869	procainamide	hsa04810	Regulation of actin cytoskeleton	23533_7454_8823_5829_6655_9138_93408_3689_3630_56924_8822_1133_7410_1956_1950_88_5293_6093_2260_2249	20	+	0.0227468977982347	0.12998227313277
3870	procainamide	hsa04540	Gap junction	347688_5592_3710_6655_5616_113457_3708_1956_56604_1950_7278	11	+	0.0191481779373234	0.127654519582156
3871	procainamide	hsa05330	Allograft rejection	958_3113_3126_3127_3125_3123	6	+	0.021089180355771	0.129779571420129
3872	procainamide	hsa04940	Type I diabetes mellitus	3382_3126_2572_3127_3630_3125_3123_3553_3113	9	+	0.00110832614645279	0.0295553639054077
3873	procainamide	hsa04080	Neuroactive ligand-receptor interaction	146_3354_4157	3	-	5.9162844284513e-06	0.000254400230423406
3874	procainamide	hsa04740	Olfactory transduction	810_5613_109_157	4	-	5.26136269283312e-09	4.52477191583648e-07
3875	procainamide	hsa04210	Apoptosis	472_8503_3554_842_596_5296_5613_5575_331_5290_23052_5533_355_5576_8837_651610	16	-	0.00734163880023056	0.210460312273276
3876	procainamide	hsa04010	MAPK signaling pathway	9261_9344_5154_5607_5603_5494_8399_1844_4616_3554_4149_6789_9448_51347_8491_2264_408_4214_57551_9064_5062_2005_5533_3727_5613_6655_1846_4137_355_23162_27092_1386_4763	33	-	0.0349166304040562	0.500471702458139
3877	procainamide	hsa05012	Parkinson's disease	51465_1339_842_7054	4	-	0.0340986791536527	0.500471702458139
3878	procainamide	hsa03010	Ribosome	6234_6141	2	-	0.0236224082921838	0.500471702458139
3879	procainamide	hsa04020	Calcium signaling pathway	146_5533_5613_115_109_810_490	7	-	0.0498921445904023	0.556208096268107
3880	ethionamide	hsa04740	Olfactory transduction	5566_1179	2	+	0.00973812372536636	0.592163994106454
3881	ethionamide	hsa05221	Acute myeloid leukemia	861_5914_862_5371_5467	5	+	0.0185051248158267	0.592163994106454
3882	ethionamide	hsa04010	MAPK signaling pathway	3164_5534_998_4763_5536	5	-	0.021646912699916	0.619577442679178
3883	nafcillin	hsa04070	Phosphatidylinositol signaling system	8394_3633_5333_8821_4952_27124_3705	7	-	0.0186409356117104	0.340197074913715
3884	nafcillin	hsa04740	Olfactory transduction	219464_157	2	-	0.000381890712786446	0.0139390110167053
3885	nafcillin	hsa05322	Systemic lupus erythematosus	8358_85235_8968_3119_3013_8351_8330_8332_8969_8331_8329_720_721_8350_8336_8352_8353_8354_8355_8356_8357	21	-	9.00822287219392e-08	6.57600269670156e-06
3886	nafcillin	hsa04210	Apoptosis	651610_581_598_5575_472_8837_1677_7186	8	-	0.0139343822897638	0.339069969050919
3887	liothyronine	hsa04540	Gap junction	347688_5598_56604_23236	4	+	0.0188210863342491	0.502566216037111
3888	liothyronine	hsa04080	Neuroactive ligand-receptor interaction	1131	1	-	0.00261134975992408	0.0900915667173808
3889	liothyronine	hsa04740	Olfactory transduction	818_157	2	-	0.00018365400327406	0.0126721262259101
3890	liothyronine	hsa04060	Cytokine-cytokine receptor interaction	1435_5155_9180	3	-	0.038337077919225	0.881752792142175
3891	napelline	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.0317832766173061	0.387755974731134
3892	napelline	hsa04640	Hematopoietic cell lineage	1435_3815_3575_3123_3126_3127_3125_3690_2209	9	+	0.000900615634658503	0.0549375537141687
3893	napelline	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0115121783786528	0.23408096036594
3894	napelline	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.0236287002903575	0.360337679427952
3895	napelline	hsa04940	Type I diabetes mellitus	3123_2571_3126_3127_3125	5	+	0.00884849337964686	0.23408096036594
3896	napelline	hsa05010	Alzheimer's disease	6868	1	-	0.0106717328857972	0.421533448988989
3897	napelline	hsa04080	Neuroactive ligand-receptor interaction	2692_2149	2	-	0.0048930280774295	0.38654921811693
3898	napelline	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.0429996127231619	0.679393881025958
3899	napelline	hsa04062	Chemokine signaling pathway	2786_1399	2	-	0.0372882559803965	0.679393881025958
3900	napelline	hsa04020	Calcium signaling pathway	2778_2149	2	-	0.0357361635094348	0.679393881025958
3901	cefotiam	hsa05200	Pathways in cancer	23533_405_7849_330_324	5	+	0.0472689519401	0.719555034909214
3902	cefotiam	hsa04740	Olfactory transduction	9635	1	+	2.59097952592214e-05	0.00106230160562808
3903	cefotiam	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3109_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2212_3013_3113	28	+	6.99467795024053e-12	5.73563591919723e-10
3904	cefotiam	hsa04610	Complement and coagulation cascades	623_5265_624_5327_2161_5328	6	+	0.0462423514144286	0.719555034909214
3905	cefotiam	hsa05219	Bladder cancer	4318_1869_1613	3	-	0.0121582562751758	0.285719022466631
3906	cefotiam	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00469701594463385	0.220759749397791
3907	nitrofural	hsa05010	Alzheimer's disease	517_4713	2	+	0.0131983061617145	0.990030596160587
3908	nitrofural	hsa05016	Huntington's disease	7416_517_4713	3	+	0.0267714137010555	0.990030596160587
3909	nitrofural	hsa05212	Pancreatic cancer	8503_5154_6934_596	4	-	0.014413654637358	0.208140605912926
3910	nitrofural	hsa05215	Prostate cancer	8503_5154_6934_596	4	-	0.0138990213565885	0.208140605912926
3911	nitrofural	hsa04010	MAPK signaling pathway	784_9261_2768_5154_2002_355_5606_91_408	9	-	0.00214677842851631	0.124513148853946
3912	nitrofural	hsa05213	Endometrial cancer	2002_8503_6934	3	-	0.0179431556821488	0.208140605912926
3913	nitrofural	hsa05210	Colorectal cancer	91_8503_6934_596	4	-	0.011958159748395	0.208140605912926
3914	biperiden	hsa05010	Alzheimer's disease	4695_3710_2904_6392_651820_4137_5532_3709_489	9	+	0.0136561720858039	0.251273566378792
3915	biperiden	hsa05016	Huntington's disease	5430_4695_2904_7052_5439_651820_246721_6392_7416_55567_548644	11	+	0.0319248062746114	0.419583168180607
3916	biperiden	hsa04740	Olfactory transduction	7932_56656_26333_5566_1179_81797_9635	7	+	4.03436953266876e-11	3.71161997005526e-09
3917	biperiden	hsa04062	Chemokine signaling pathway	5579_5829_5566_3576_7852_7074_5880_112_6363	9	+	0.00450608896040348	0.13818672811904
3918	biperiden	hsa05012	Parkinson's disease	6392_7416_4695_651820_51465	5	+	0.00692368970891621	0.159244863305073
3919	biperiden	hsa04620	Toll-like receptor signaling pathway	7097_3576_1326_2353	4	+	0.0232979170778222	0.357234728526607
3920	biperiden	hsa03010	Ribosome	6129_9045	2	+	0.00270858150248774	0.124594749114436
3921	biperiden	hsa04070	Phosphatidylinositol signaling system	8394_3628_3633_23236	4	-	0.0251154674033064	0.571064499245981
3922	biperiden	hsa05131	Shigellosis	7278_7430_113457	3	-	0.0486534736239775	0.571064499245981
3923	biperiden	hsa05130	Pathogenic Escherichia coli infection	7278_7430_113457	3	-	0.0486534736239775	0.571064499245981
3924	iohexol	hsa05010	Alzheimer's disease	810_775_489	3	+	0.00251870269622765	0.0713632430597834
3925	iohexol	hsa05016	Huntington's disease	7802_9001	2	+	0.000363910113584696	0.0154661798273496
3926	iohexol	hsa04740	Olfactory transduction	8388_8387_5566_8390_26539_816_810_5137	8	+	1.56798779322207e-05	0.00133278962423876
3927	iohexol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3111_8359_88_8294_8367_554313_6738_121504_3108	18	+	0.0392761604059692	0.667694726901476
3928	iohexol	hsa05012	Parkinson's disease	2861_9627	2	+	0.00601672337194239	0.127855371653776
3929	iohexol	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8336	7	-	0.0145328924954532	0.732507302334983
3930	iohexol	hsa04370	VEGF signaling pathway	8503_4775_5600_6300	4	-	0.0489787802383406	0.732507302334983
3931	glycocholic acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_6737_8359_8294_8367_554313_121504	15	+	5.7279877479735e-11	2.06207558927046e-09
3932	glycocholic acid	hsa04370	VEGF signaling pathway	6714_8681_100137049	3	+	0.0481040298570947	0.577248358285136
3933	glycocholic acid	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.00411823661471148	0.0741282590648066
3934	glycocholic acid	hsa05016	Huntington's disease	246721_5439_548644_23236_581	5	-	0.0233189474775376	0.559654739460902
3935	glycocholic acid	hsa03022	Basal transcription factors	51616_728198	2	-	0.0425385693516587	0.566123349784133
3936	glycocholic acid	hsa04540	Gap junction	10746_5155_23236	3	-	0.0471769458153444	0.566123349784133
3937	glycocholic acid	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00240249077732702	0.115319557311697
3938	hycanthone	hsa05016	Huntington's disease	5430_7802_581_6390_64446_27113	6	+	0.0100001486462789	0.293337693624181
3939	hycanthone	hsa04740	Olfactory transduction	26212_7932_5613_5616_390892_9635_8590	7	+	1.08689785506344e-07	9.56470112455827e-06
3940	hycanthone	hsa04210	Apoptosis	8503_4803_843_581_5613_5616_11213_355_9941_8743_5534_8837_8794_8795	14	+	0.0419359491237895	0.527194788984782
3941	hycanthone	hsa04340	Hedgehog signaling pathway	8945_5613_5616_5727_3549_656_7479_655_353500_7471_7475	11	+	0.0208177926640852	0.3663931508879
3942	hycanthone	hsa04115	p53 signaling pathway	55367_1647_27113_5366_581_64393_4193_3486_8493_898_355_1026_10912_8795_5268_3732_9540_4616	18	+	0.000131450372765801	0.00578381640169524
3943	hycanthone	hsa05012	Parkinson's disease	6390_6571_6622_7318	4	+	0.0256105032126112	0.375620713784964
3944	hycanthone	hsa04020	Calcium signaling pathway	154_624_5333_135_51196_3360_3363_814_2911_776_773_2767_148_6915_108_3709_5733_5534_3358_8877_5578_5613_5616_8913_107_8911	26	+	0.0200963769029547	0.3663931508879
3945	hycanthone	hsa04080	Neuroactive ligand-receptor interaction	3354_5618	2	-	5.79524753729768e-06	0.000463619802983814
3946	hycanthone	hsa04350	TGF-beta signaling pathway	4088_4089_3624_4609_6667_7057_1874_1875_652_653_7043_7042	12	-	0.0388799788097411	0.622079660955858
3947	hycanthone	hsa04062	Chemokine signaling pathway	10451_6777_5295_7410_5291	5	-	0.0138228670765069	0.552914683060276
3948	hycanthone	hsa05012	Parkinson's disease	836_842_517	3	-	0.0365636867310889	0.622079660955858
3949	hycanthone	hsa05210	Colorectal cancer	836_7043_4088_4089_5295_5291_1956_6934_4609_7042_4233_842	12	-	0.034869256217985	0.622079660955858
3950	ciclopirox	hsa05332	Graft-versus-host disease	3553_3119_3105_3107_3126_3127_3125_355_3123	9	+	0.0026739630138082	0.0727770495964093
3951	ciclopirox	hsa05211	Renal cell carcinoma	23533_112399_6513_5155_405_5228_7422_1399_7042_3725_54583	11	+	0.00925827702053173	0.128072832117356
3952	ciclopirox	hsa05200	Pathways in cancer	23533_9134_4088_5155_330_1488_5888_3551_27006_6513_405_8823_5900_1399_4842_23604_9063_112399_581_4193_4254_1956_7042_3725_54583_1026_861_6502_355_7422_2353_5228_6256	33	+	0.0127445835886142	0.151114348264997
3953	ciclopirox	hsa05320	Autoimmune thyroid disease	3119_3105_3107_3126_3127_3125_355_3123	8	+	0.0260852149368679	0.240563648862226
3954	ciclopirox	hsa04740	Olfactory transduction	810_23538_157	3	+	2.35324309289451e-07	1.95319176710244e-05
3955	ciclopirox	hsa04210	Apoptosis	23533_3553_3551_581_5575_317_330_355_8717_8837_8794_8795	12	+	0.0176167027314862	0.182773290839169
3956	ciclopirox	hsa04115	p53 signaling pathway	55367_1647_27113_5366_9134_581_317_4193_3486_355_1026_5054_8795_9540_4616	15	+	0.000102059805170717	0.00423548191458476
3957	ciclopirox	hsa05330	Allograft rejection	3119_3105_3107_3126_3127_3125_355_3123	8	+	0.00499270270647776	0.0828788649275308
3958	ciclopirox	hsa04940	Type I diabetes mellitus	3553_3119_3105_3107_3126_3127_3125_355_3123	9	+	0.00350732769139322	0.0727770495964093
3959	ciclopirox	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3014	31	-	2.39746871709944e-23	1.17475967137873e-21
3960	ciclopirox	hsa04110	Cell cycle	995_891_5347_991_699_701_996_9700_51343	9	-	0.000312094267778001	0.00764630956056103
3961	hexetidine	hsa05332	Graft-versus-host disease	3553_3105_3106_3113_3135_356_649853	7	+	0.0105615709593913	0.208591026447978
3962	hexetidine	hsa05320	Autoimmune thyroid disease	1081_3105_3106_3113_3135_356_649853	7	+	0.0297130189158643	0.335332642050469
3963	hexetidine	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_8348_8294_121504_87_8366_8968_8370_8362_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_83740_3013_3113_8970	32	+	1.59579229991702e-10	1.26067591693445e-08
3964	hexetidine	hsa04062	Chemokine signaling pathway	5331_208_10803	3	+	0.019382078676028	0.284359408883255
3965	hexetidine	hsa04010	MAPK signaling pathway	8074_4763_3310_3164_5609_11221_3553_775_8398_208_1956_7042_3725_3727_785_1647_1848_1843_1649_1846_356_23162_2353_5971_9693	25	+	0.0102455520612486	0.208591026447978
3966	hexetidine	hsa05012	Parkinson's disease	6392_651820	2	+	0.0489081747141402	0.482968225302134
3967	hexetidine	hsa05330	Allograft rejection	3105_3106_3113_3135_356_649853	6	+	0.0215969171303738	0.284359408883255
3968	hexetidine	hsa04940	Type I diabetes mellitus	3382_3105_3106_3113_3135_356_3553_649853	8	+	0.00406217091463316	0.16045575112801
3969	hexetidine	hsa04740	Olfactory transduction	5566	1	-	0.00740148004105896	0.362672522011889
3970	hexetidine	hsa04270	Vascular smooth muscle contraction	5581_4882_3709_4637_5566_23236	6	-	0.0309471186581671	0.758204407125094
3971	ritodrine	hsa05332	Graft-versus-host disease	3553_3123_3126_3127_3125_3558	6	+	0.0157380286687947	0.369554044686624
3972	ritodrine	hsa05200	Pathways in cancer	2735_652346_5880_7855_1630_4149_5371_8822_51384_7471_4842_4318_3918_1956_5467_7042_2950_3688_5579_5578_5599_4914_862_5915	24	+	0.0312641314917209	0.369554044686624
3973	ritodrine	hsa04514	Cell adhesion molecules (CAMs)	9378_3689_3688_965_3123_3126_3127_3125_5797_23308_923_1002	12	+	0.0347232300330472	0.369554044686624
3974	ritodrine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_718_3123_8366_3126_3127_3125_8359_89_8294_8367_554313_8368_121504	20	+	2.16595828320453e-05	0.00181940495789181
3975	ritodrine	hsa05310	Asthma	3123_3125_3126_3127_2207	5	+	0.0156409612150278	0.369554044686624
3976	ritodrine	hsa05012	Parkinson's disease	4698	1	+	0.0316621542107996	0.369554044686624
3977	ritodrine	hsa05330	Allograft rejection	3123_3558_3126_3127_3125	5	+	0.035195623303488	0.369554044686624
3978	ritodrine	hsa04940	Type I diabetes mellitus	3553_3123_3126_3127_3558_3125	6	+	0.0189837035139892	0.369554044686624
3979	ritodrine	hsa05010	Alzheimer's disease	6622_4137	2	-	0.00154839352682569	0.0321291656816331
3980	ritodrine	hsa04080	Neuroactive ligand-receptor interaction	2908_1081	2	-	1.25475175740538e-05	0.00104144395864647
3981	ritodrine	hsa04612	Antigen processing and presentation	3119	1	-	0.045321872081162	0.417968375859605
3982	ritodrine	hsa05016	Huntington's disease	7419_5978_3064_6667_10126	5	-	0.034448561689115	0.417968375859605
3983	ritodrine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8347_8346_8344_55766_8370_8359_554313_121504_8339_3119_8970	22	-	0.000957405430985653	0.0303102794487631
3984	ritodrine	hsa05221	Acute myeloid leukemia	1050_8503_861_6655_6777_5292_5291_6932_5914	9	-	0.037979992116548	0.417968375859605
3985	ritodrine	hsa05012	Parkinson's disease	7419_6622	2	-	0.0123800414503969	0.205508688076589
3986	ritodrine	hsa04060	Cytokine-cytokine receptor interaction	9180_2057_3455_5155_5154_3572_7043_91_8792	9	-	0.0416999589180895	0.417968375859605
3987	ritodrine	hsa04020	Calcium signaling pathway	7419_5257	2	-	0.0010955522692324	0.0303102794487631
3988	guanfacine	hsa05322	Systemic lupus erythematosus	85235_3113_8330_8332_8969_8331_8329_8336	8	+	0.031937316019146	1
3989	guanfacine	hsa05221	Acute myeloid leukemia	5914_5371_652671_5467_11040	5	+	0.0193726121294375	1
3990	guanfacine	hsa04650	Natural killer cell mediated cytotoxicity	10725_6655_5781	3	-	0.0486375449254527	0.459354590962609
3991	guanfacine	hsa05010	Alzheimer's disease	4698_3709_517_23236	4	-	0.0260831586373033	0.369511414028463
3992	guanfacine	hsa04080	Neuroactive ligand-receptor interaction	9568_2908_7433	3	-	0.000163091902269265	0.00462093723096251
3993	guanfacine	hsa04612	Antigen processing and presentation	6891	1	-	0.0437774088596001	0.459354590962609
3994	guanfacine	hsa04740	Olfactory transduction	818_5566_4991	3	-	1.63528636980909e-07	6.94996707168863e-06
3995	guanfacine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	30	-	1.41457633677996e-07	6.94996707168863e-06
3996	guanfacine	hsa04530	Tight junction	6714_5583_5581	3	-	0.0485650639084856	0.459354590962609
3997	guanfacine	hsa05012	Parkinson's disease	4698_517	2	-	0.0176152560086299	0.299459352146708
3998	guanfacine	hsa04060	Cytokine-cytokine receptor interaction	23529_7422_4233_3570_3572	5	-	0.00161695026512593	0.034360193133926
3999	resveratrol	hsa04740	Olfactory transduction	219464	1	+	1.00380201344982e-10	8.43193691297849e-09
4000	resveratrol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8349_8294_121504_8341_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	27	+	2.72294905139077e-05	0.00114363860158412
4001	resveratrol	hsa04115	p53 signaling pathway	55367_1647_27113_5366_842_1643_4193_355_1026_8795_9540_4616	12	+	0.0105031056954017	0.290378916698613
4002	resveratrol	hsa04512	ECM-receptor interaction	960	1	+	0.0444080915295653	0.532897098354784
4003	resveratrol	hsa04062	Chemokine signaling pathway	2309_6774_7410_3576_10000	5	+	0.0138275674618387	0.290378916698613
4004	resveratrol	hsa05012	Parkinson's disease	6622_842_4712	3	+	0.0364737354209542	0.532897098354784
4005	resveratrol	hsa04260	Cardiac muscle contraction	4635	1	+	0.0438347373224112	0.532897098354784
4006	resveratrol	hsa05332	Graft-versus-host disease	3135	1	-	0.0370778052097614	0.22741053861987
4007	resveratrol	hsa04640	Hematopoietic cell lineage	960_4254	2	-	0.00109521662427089	0.0201519858865844
4008	resveratrol	hsa05010	Alzheimer's disease	1327_5534_5664_317_2776_808_3708_5530_489_488_102_801_805	13	-	0.0113532775222296	0.0919478720226383
4009	resveratrol	hsa04080	Neuroactive ligand-receptor interaction	5029_5618_7068_7067_2908_5026_5031	7	-	1.02145074102384e-08	4.69867340870966e-07
4010	resveratrol	hsa04742	Taste transduction	5613_5616	2	-	0.0415567696248354	0.238951425342804
4011	resveratrol	hsa05320	Autoimmune thyroid disease	3135	1	-	0.011993200698605	0.0919478720226383
4012	resveratrol	hsa04740	Olfactory transduction	5613_5616_808_109_801_805	6	-	2.85713543518152e-16	2.628564600367e-14
4013	resveratrol	hsa04514	Cell adhesion molecules (CAMs)	965_3688_9019_3135_6693_9080_25945_3897	8	-	0.00753216861140241	0.0692959512249022
4014	resveratrol	hsa05322	Systemic lupus erythematosus	55506_8361_8363_8362_8365_8364_8367_8360_8368_8294_121504_8343_8347_87_6632_8344_8339_8366_3021_3020_8968_8346_55766_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3014	37	-	0.00318740867473572	0.0418916568679552
4015	resveratrol	hsa04110	Cell cycle	9133_983_8555_701_9184_4616_699_8881_1111_5925_890_545_1031_995_891_996_991_993_4193_8317_8556_7042_9700_8697_5347_4173_472_5934_10926_1387_7465	31	-	0.00612364714667597	0.0681100804935335
4016	resveratrol	hsa04330	Notch signaling pathway	2648_3714_3280_1387_8850_1855_1856_3516_8650_5664_22938_1488_4853_9541	14	-	0.030856204381374	0.202769343077601
4017	resveratrol	hsa04630	Jak-STAT signaling pathway	5618_6655_5295_3572_5291_5781_8554_9655_8835_1387	10	-	0.0066629426569761	0.0681100804935335
4018	resveratrol	hsa05012	Parkinson's disease	2861_7326_317_1327_5481	5	-	0.000304185142488443	0.00699625827723419
4019	resveratrol	hsa04060	Cytokine-cytokine receptor interaction	5618_2324_55540_3576_5154_3572_1956_7042_655_4254_27242_8795_659	13	-	1.30629251662291e-05	0.000400596371764359
4020	resveratrol	hsa03010	Ribosome	6125_6160_6129_6234	4	-	0.0030068545948766	0.0418916568679552
4021	resveratrol	hsa04610	Complement and coagulation cascades	5627_2161_7035	3	-	0.0308083714071066	0.202769343077601
4022	butein	hsa04740	Olfactory transduction	7932_26664_26532_4992_5137_409	6	+	0.00585708937628562	0.340353502422655
4023	butein	hsa04810	Regulation of actin cytoskeleton	93408_5155	2	+	0.00919874330872042	0.340353502422655
4024	butein	hsa05012	Parkinson's disease	4695	1	+	0.0461709073268393	1
4025	butein	hsa04080	Neuroactive ligand-receptor interaction	7067_10203	2	-	0.00931242552036944	0.605314825627153
4026	butein	hsa05016	Huntington's disease	90993	1	-	0.0155208929647988	0.605314825627153
4027	butein	hsa04020	Calcium signaling pathway	107	1	-	0.0233963143648621	0.608304173486415
4028	ketoconazole	hsa05332	Graft-versus-host disease	3824_3553_3105_3106_3126_3127_940_3125_3135_3123_3113_649853	12	+	7.41260991391157e-05	0.00326154836212109
4029	ketoconazole	hsa04120	Ubiquitin mediated proteolysis	11060_9820_4193	3	+	0.0491932946206311	0.360750827217961
4030	ketoconazole	hsa04640	Hematopoietic cell lineage	3581_1435_3553_2057_3123_2993_3126_3127_3125_3570_3673_921_931_917	14	+	0.00478944837382946	0.0702452428161654
4031	ketoconazole	hsa05320	Autoimmune thyroid disease	3448_3105_3106_3126_3127_940_3125_3135_3123_3113_649853	11	+	0.0014878227356844	0.0261856801480454
4032	ketoconazole	hsa04612	Antigen processing and presentation	4261_3824_3448_3123_3106_3126_3127_3125_3135_3105_3113_649853	12	+	0.0208822769638353	0.20418226364639
4033	ketoconazole	hsa05016	Huntington's disease	64446_6390_90993_3708_4698	5	+	0.0458199470712217	0.360750827217961
4034	ketoconazole	hsa04740	Olfactory transduction	8392_135948_9635_442194	4	+	6.97503174144954e-07	6.1380279324756e-05
4035	ketoconazole	hsa04514	Cell adhesion molecules (CAMs)	9076_24146_3688_3106_3123_29851_3126_3127_3696_3125_3135_4359_3105_940_3113_649853	16	+	0.0244016845776372	0.214734824283207
4036	ketoconazole	hsa05310	Asthma	6356_3123_3126_3127_3125_3113	6	+	0.0201112224951047	0.20418226364639
4037	ketoconazole	hsa05012	Parkinson's disease	4698_6390	2	+	0.017831108811382	0.20418226364639
4038	ketoconazole	hsa05330	Allograft rejection	3105_3106_3126_3127_940_3125_3135_3123_3113_649853	10	+	0.000510378343434986	0.0112283235555697
4039	ketoconazole	hsa04940	Type I diabetes mellitus	3553_3105_3106_3126_3127_940_3125_3135_3123_3113_649853	11	+	0.000393596942506251	0.0112283235555697
4040	ketoconazole	hsa04080	Neuroactive ligand-receptor interaction	3354_2908_136_1081_1812	5	-	0.00060089513022755	0.017826555530084
4041	ketoconazole	hsa04740	Olfactory transduction	810_157	2	-	1.16479485480459e-09	1.03666742077609e-07
4042	ketoconazole	hsa04210	Apoptosis	8503_3552_581_5296_5295_23052_472_5534_8737_8837_651610_842	12	-	0.0429359349053793	0.437466297515854
4043	ketoconazole	hsa05221	Acute myeloid leukemia	1050_8503_5296_6655_5295_5371_6932_6934_652671	9	-	0.0443455517573456	0.437466297515854
4044	ketoconazole	hsa04330	Notch signaling pathway	2648_3714_4854_1856_182_6868_22938_1488	8	-	0.0278512329398701	0.413126621941406
4045	ketoconazole	hsa05012	Parkinson's disease	2861_1339_842	3	-	0.0254973261147637	0.413126621941406
4046	ketoconazole	hsa04060	Cytokine-cytokine receptor interaction	4254_3455_4233_3552_3572	5	-	0.000433018421238777	0.017826555530084
4047	ketoconazole	hsa03010	Ribosome	6125_6234	2	-	0.0473694092357845	0.437466297515854
4048	ketoconazole	hsa05210	Colorectal cancer	8503_842_581_5296_3480_6655_5295_5602_1856_6932_6934_3725_8324_4233	14	-	0.00630785230330391	0.140349713748512
4049	mimosine	hsa04740	Olfactory transduction	5566	1	+	0.00115957261243775	0.0452233318850723
4050	mimosine	hsa05322	Systemic lupus erythematosus	8361_2212_8363_8362_8365_8364_8370_8360_8368_8366_8359_8294_8367_554313_121504_3108_9555	17	+	3.932078269003e-07	3.06702104982234e-05
4051	mimosine	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	-	0.00318624100038684	0.078168131041107
4052	mimosine	hsa04650	Natural killer cell mediated cytotoxicity	8503_3105_3106_3135_5881_7409	6	-	0.0124655872539925	0.130888666166921
4053	mimosine	hsa05320	Autoimmune thyroid disease	3135_3105_3106_649853	4	-	0.00689325190586788	0.104543927669549
4054	mimosine	hsa04612	Antigen processing and presentation	3135_4800_3106_3105_649853	5	-	0.00829713711663085	0.104543927669549
4055	mimosine	hsa04514	Cell adhesion molecules (CAMs)	3135_3105_3106_4756_649853	5	-	0.0380176472999414	0.299388972487038
4056	mimosine	hsa04664	Fc epsilon RI signaling pathway	8503_7409_5600_5881	4	-	0.0246427333937663	0.221784600543897
4057	mimosine	hsa05330	Allograft rejection	3135_3105_3106_649853	4	-	0.00227687423481183	0.078168131041107
4058	mimosine	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853	4	-	0.00372229195433843	0.078168131041107
4059	buspirone	hsa04662	B cell receptor signaling pathway	10725_7409_27071_3551_5336	5	-	0.0191282714845942	0.264660221107648
4060	buspirone	hsa04660	T cell receptor signaling pathway	5163_3551_10725_7409_5600_6300	6	-	0.024811895728842	0.264660221107648
4061	buspirone	hsa04670	Leukocyte transendothelial migration	5829_9475_7409_5600_5336_6300	6	-	0.0376220844289014	0.343973343349956
4062	buspirone	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	102_6300_5600_3551_5336	5	-	0.0156291963603083	0.264660221107648
4063	buspirone	hsa04664	Fc epsilon RI signaling pathway	6300_5163_7409_5600_5336	5	-	0.0231071848833635	0.264660221107648
4064	buspirone	hsa04370	VEGF signaling pathway	5829_6300_10725_5600_5336	5	-	0.0210563822148342	0.264660221107648
4065	buspirone	hsa03020	RNA polymerase	5432_246721_5439_548644	4	-	0.00356613842832798	0.228232859412991
4066	dextromethorphan	hsa04120	Ubiquitin mediated proteolysis	23759_5371	2	+	0.0357935785513216	0.587014688241674
4067	dextromethorphan	hsa05016	Huntington's disease	5331_1213_54205_7416	4	+	0.0354922634210706	0.587014688241674
4068	dextromethorphan	hsa04740	Olfactory transduction	8388_8387_1179_818_8392_4991_810_9635	8	+	0.00129907046017507	0.106523777734356
4069	dextromethorphan	hsa05322	Systemic lupus erythematosus	8330_3108	2	+	0.0250414913338113	0.587014688241674
4070	dextromethorphan	hsa05012	Parkinson's disease	54205_7416	2	+	0.0349855469064194	0.587014688241674
4071	dextromethorphan	hsa05214	Glioma	8503_5155_6655_6464_5290_808_1869_801_805	9	-	0.0451816835520126	1
4072	dextromethorphan	hsa04080	Neuroactive ligand-receptor interaction	5029_7442_7068	3	-	0.000112419533252506	0.00472162039660525
4073	dextromethorphan	hsa04740	Olfactory transduction	219464_801_808_5566_805	5	-	2.6456048456082e-06	0.000222230807031089
4074	fluphenazine	hsa04916	Melanogenesis	5579_2775_6932_7482_1906_434_23236	7	+	0.0245419559268497	0.181740111110121
4075	fluphenazine	hsa05214	Glioma	8503_1956_5579	3	+	0.0298819379532273	0.181740111110121
4076	fluphenazine	hsa05332	Graft-versus-host disease	3119_3804_3458_3126_3127_940_3125_3135_355_3133_3123_941_942	13	+	0.0433256026752838	0.20300219964993
4077	fluphenazine	hsa05010	Alzheimer's disease	2902_1339_4713_6622_6390_355_4137_3708_3709_6868_4023_348_23236	13	+	0.00680904652487309	0.102135697873096
4078	fluphenazine	hsa05200	Pathways in cancer	8503_2737_22798_596_4088_598_330_867_5602_3673_4149_5371_5900_405_2263_2260_4312_998_6932_1956_7849_1496_7482_91_3725_1436_1284_2271_5579_5599_862_3685_861_355_7422_6257	36	+	0.042593280752478	0.20300219964993
4079	fluphenazine	hsa04742	Taste transduction	50835_50834	2	+	0.02842551218698	0.181740111110121
4080	fluphenazine	hsa05320	Autoimmune thyroid disease	3439_3449_1081_3119_942_3447_3126_3127_940_3125_3135_355_3133_3123_941	15	+	0.0469743594003611	0.20300219964993
4081	fluphenazine	hsa04310	Wnt signaling pathway	8945_5579_5599_7482_6932_4088_5602_3725_6093_23236	10	+	0.00494019852186316	0.0889235733935369
4082	fluphenazine	hsa04910	Insulin signaling pathway	8660_8503_5599_5575_3635_867_23433_5602_8651_5105	10	+	0.0146322349040576	0.145794883815297
4083	fluphenazine	hsa05016	Huntington's disease	2902_246721_27113_6648_4713_1639_6390_5439_64446_3708_9001_1339_548644_23236	14	+	0.00470044743002981	0.0889235733935369
4084	fluphenazine	hsa04740	Olfactory transduction	26212_81285_4991_8390_442194_3000_390892_393046	8	+	9.62918796529653e-16	8.66626916876688e-14
4085	fluphenazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_6738_8294_121504_3123_3458_3126_3127_3125_8968_8370_718_8358_8359_8330_554313_8350_8351_8352_8353_8354_8355_8356_8357_2213_3119_3013_942_940_941_720_721_8970	42	+	0.000473678087449603	0.0213155139352321
4086	fluphenazine	hsa05212	Pancreatic cancer	8503_596_6932_1956_2263_2260	6	+	0.0473671799183171	0.20300219964993
4087	fluphenazine	hsa04110	Cell cycle	995_1647_4088_51343_5934_8556_8243_4616	8	+	0.017415445561138	0.145794883815297
4088	fluphenazine	hsa05215	Prostate cancer	8503_596_6932_1956_2263_2260	6	+	0.0468669917055992	0.20300219964993
4089	fluphenazine	hsa05218	Melanoma	8503_1956_2260	3	+	0.0151073169693196	0.145794883815297
4090	fluphenazine	hsa05110	Vibrio cholerae infection	8992_5579	2	+	0.013708165039528	0.145794883815297
4091	fluphenazine	hsa05012	Parkinson's disease	6570_1339_4713_6622_6390_6531_9627	7	+	0.00121530588949614	0.0364591766848842
4092	fluphenazine	hsa03050	Proteasome	3458	1	+	0.0178193746885363	0.145794883815297
4093	fluphenazine	hsa05330	Allograft rejection	3119_942_3458_3126_3127_940_3125_3135_355_3133_3123_941	12	+	0.035777937857464	0.201250900448235
4094	fluphenazine	hsa04940	Type I diabetes mellitus	3382_2572_3119_942_3458_3126_3127_940_3125_3135_355_3133_3123_941	14	+	0.0302900185183535	0.181740111110121
4095	fluphenazine	hsa04640	Hematopoietic cell lineage	921_3589_3675	3	-	0.045205301442739	0.45205301442739
4096	fluphenazine	hsa05010	Alzheimer's disease	488_5331_22926_489_5534_810_7381	7	-	0.00677277527328443	0.101591629099266
4097	fluphenazine	hsa04080	Neuroactive ligand-receptor interaction	4889_5618_2846_4158_2908_5031_7434_64106_8484_1909_9568_9170	12	-	0.00387427158899603	0.0697368886019285
4098	fluphenazine	hsa05016	Huntington's disease	5331_7381_2876_55567	4	-	8.21440924536894e-05	0.00246432277361068
4099	fluphenazine	hsa04740	Olfactory transduction	5613_5616_818_109_810_409	6	-	1.42068021470662e-10	1.27861219323596e-08
4100	fluphenazine	hsa05221	Acute myeloid leukemia	1050_8503_6934_3551_2885_5296_6777_5371_5605_861_5467_5914	12	-	0.0381037872654808	0.428667606736659
4101	fluphenazine	hsa05012	Parkinson's disease	7345_7381_7332	3	-	0.00111956052510256	0.0251901118148076
4102	fluphenazine	hsa04060	Cytokine-cytokine receptor interaction	3601_3579_3589_23765_5618_7043_7042_8718	8	-	7.06498656361596e-05	0.00246432277361068
4103	fluphenazine	hsa04610	Complement and coagulation cascades	5104	1	-	0.0202986880535607	0.260983132117209
4104	dopamine	hsa05322	Systemic lupus erythematosus	8353_3013_8358_8968_8350_8351_8352_81_8354_8355_8356_8357	12	-	0.000219500174824699	0.0120725096153584
4105	deferoxamine	hsa05332	Graft-versus-host disease	3553_3119_3123_3107_3126_3127_3125_3135_356_355	10	+	0.00350751676261309	0.0435934226210484
4106	deferoxamine	hsa04070	Phosphatidylinositol signaling system	5578	1	+	0.0431844582224559	0.336875320284395
4107	deferoxamine	hsa05320	Autoimmune thyroid disease	3439_3107_3119_3123_3447_3446_3126_3127_3125_3135_356_355	12	+	0.00207354626669385	0.0390604552341117
4108	deferoxamine	hsa05016	Huntington's disease	1212_4713_317_291	4	+	0.00276852627288502	0.0401436309568328
4109	deferoxamine	hsa04740	Olfactory transduction	219464_26211_157_135948_8392_26532_5137_26529	8	+	5.83245120319644e-06	0.00050742325467809
4110	deferoxamine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_8294_3123_3126_3127_3125_8370_717_8359_554313_121504_3119_720_721_729	24	+	0.00126280769293789	0.0390604552341117
4111	deferoxamine	hsa05219	Bladder cancer	1026_5595_3576_1029_1613_4193_1956_7422	8	+	0.0252757271941666	0.24433202954361
4112	deferoxamine	hsa04115	p53 signaling pathway	1647_1026_894_9134_1029_317_4193_7249_3486_355_5366_8795_9540_4616	14	+	0.00224485374908688	0.0390604552341117
4113	deferoxamine	hsa05012	Parkinson's disease	4713_317_7054_291	4	+	0.0464655614185373	0.336875320284395
4114	deferoxamine	hsa03010	Ribosome	6187_440589	2	+	0.0337866363076536	0.293943735876586
4115	deferoxamine	hsa05330	Allograft rejection	3119_3123_3107_3126_3127_3125_3135_356_355	9	+	0.00566877240668849	0.0616478999227373
4116	deferoxamine	hsa04940	Type I diabetes mellitus	3553_3119_3123_3107_3126_3127_3125_3135_356_355_5798	11	+	0.00161088898331493	0.0390604552341117
4117	deferoxamine	hsa05010	Alzheimer's disease	3553_351_841_5664_355_489_488_6622_517_23236	10	-	0.012416729309938	0.161417481029194
4118	deferoxamine	hsa04080	Neuroactive ligand-receptor interaction	152_1813_64106_1132_2908_3360_4886_2566_7434_3354_5026_2742_2150_4160_7433_3351_4142_5646	18	-	0.0182020008047843	0.184042452581708
4119	deferoxamine	hsa04910	Insulin signaling pathway	3667_5256_1977_6655_7249_23265_867_5602	8	-	0.0319443352394194	0.220653627568207
4120	deferoxamine	hsa05016	Huntington's disease	4899_1211_6648_841_581_5441_6667_163_161_517_23236	11	-	0.0112613287224897	0.161417481029194
4121	deferoxamine	hsa04740	Olfactory transduction	26333_10798_409	3	-	4.43010431157606e-16	4.03139492353421e-14
4122	deferoxamine	hsa04510	Focal adhesion	5063_1302_5578_6655_88_3918_5881_5602_7791_3655_55742_1291_4233	13	-	0.0155614281255085	0.177011244927659
4123	deferoxamine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_94239_8366_8368_88_8329_8294_8343_8347_8346_8345_8344_8367_8969_8370_717_8332_8359_8330_8331_8336_8334_554313_6738_121504_8339_8357_85235_3119_85236_720_721	37	-	0.000157988479896367	0.00518607392592632
4124	deferoxamine	hsa04710	Circadian rhythm - mammal	1454_406_1407_8863_8553	5	-	0.0395211272849949	0.220653627568207
4125	deferoxamine	hsa05212	Pancreatic cancer	1869_7039_6655_6934	4	-	0.0430653314231194	0.220653627568207
4126	deferoxamine	hsa05215	Prostate cancer	1869_7039_6655_6934	4	-	0.0425458837791378	0.220653627568207
4127	deferoxamine	hsa04530	Tight junction	55844_5580_5578_2771_5581_88	6	-	0.0065004849470024	0.147886032544305
4128	deferoxamine	hsa04720	Long-term potentiation	6196_5578_23236	3	-	0.0436457724860189	0.220653627568207
4129	deferoxamine	hsa04810	Regulation of actin cytoskeleton	10152_10093_7454_5063_8394_1132_6655_88_54961_5881_7430_2249_23365_3655_26999	15	-	0.0255120242167784	0.211054018520621
4130	deferoxamine	hsa05012	Parkinson's disease	2861_6622_517	3	-	0.000170969470085483	0.00518607392592632
4131	deferoxamine	hsa04260	Cardiac muscle contraction	27092_4635_488	3	-	0.0227646502475915	0.207158317253083
4132	deferoxamine	hsa03010	Ribosome	6168_6234_6181_9349	4	-	0.012060576764999	0.161417481029194
4133	deferoxamine	hsa04020	Calcium signaling pathway	5256_5578_56848_3360_5026_8912_7220_5333_489_488_9630_23236_493	13	-	0.0497507597039028	0.228210666855106
4134	deferoxamine	hsa03050	Proteasome	23198	1	-	0.0388057255486692	0.220653627568207
4135	deferoxamine	hsa04270	Vascular smooth muscle contraction	5580_5578_5581_27094_23365_23236	6	-	0.0286291314737333	0.217104247009144
4136	calmidazolium	hsa05010	Alzheimer's disease	6868_317_9451	3	+	9.56076168780071e-05	0.0027407516838362
4137	calmidazolium	hsa05016	Huntington's disease	8218_317_2033_55567_10126_291	6	+	0.00206670067688451	0.033045380074624
4138	calmidazolium	hsa04740	Olfactory transduction	26212_5593_818_26532_4991_816	6	+	9.83637871063502e-10	4.22964284557306e-08
4139	calmidazolium	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_8349_8348_8329_8294_121504_8343_8347_8346_8345_8344_8339_723790_8969_8968_8370_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_85236_3012_3013_3017_3111_8970	49	+	5.71371105114786e-12	4.91379150398716e-10
4140	calmidazolium	hsa04530	Tight junction	9223_998	2	+	0.000439756884630052	0.00945477301954612
4141	calmidazolium	hsa05012	Parkinson's disease	6531_317_291	3	+	0.0023054916331133	0.033045380074624
4142	calmidazolium	hsa04730	Long-term depression	5593	1	+	0.0197041601080309	0.242079681327237
4143	calmidazolium	hsa04270	Vascular smooth muscle contraction	27094_800_59_553	4	+	0.0241989532837374	0.260138747800177
4144	calmidazolium	hsa04080	Neuroactive ligand-receptor interaction	5029_2847_3360_5021	4	-	0.0490649428798482	1
4145	calmidazolium	hsa05322	Systemic lupus erythematosus	3014	1	-	0.0469471405818105	1
4146	probucol	hsa04740	Olfactory transduction	816	1	+	1.72322686492842e-05	0.00136134922329345
4147	probucol	hsa04940	Type I diabetes mellitus	3135_3106_3107_3382_3119	5	+	0.028832433408699	1
4148	probucol	hsa04610	Complement and coagulation cascades	624_2_720_721_5328_729	6	+	0.049288236034181	1
4149	probucol	hsa04080	Neuroactive ligand-receptor interaction	3354_7442_2925_3360_7433	5	-	0.00222205628072922	0.0599955195796889
4150	probucol	hsa04670	Leukocyte transendothelial migration	5829	1	-	0.00696611276686716	0.14106378352906
4151	probucol	hsa04740	Olfactory transduction	26476	1	-	1.19771570802309e-09	9.70149723498703e-08
4152	probucol	hsa05322	Systemic lupus erythematosus	55506_8361_8363_8362_8365_8364_8367_8360_8368_8294_8343_8347_8346_8344_8366_8370_8359_8337_554313_121504_8339_3017_3014	23	-	0.000187096776517707	0.00757741944896713
4153	probucol	hsa04062	Chemokine signaling pathway	5829_6655_23236_1230_408	5	-	0.0337394226680405	0.491312409682308
4154	probucol	hsa04060	Cytokine-cytokine receptor interaction	1230_2057_2324_3624_8995_7424_3553_8795	8	-	0.0363935118283191	0.491312409682308
4155	geldanamycin	hsa05010	Alzheimer's disease	842_841_840_9451_5332_23236	6	+	0.00380709647167059	0.110405797678447
4156	geldanamycin	hsa04080	Neuroactive ligand-receptor interaction	2859_5618_1133_1131_2908_3362_2692_6915_2743_8484_5733_1902_4158	13	+	0.0165911990205753	0.206204902112864
4157	geldanamycin	hsa04612	Antigen processing and presentation	4800_3135_3308_3119_3805_3105_3106_3107_3303_3320_3326_3309_811_3304_3305_925_3310_649853	18	+	0.00918861607633184	0.133234933106812
4158	geldanamycin	hsa05016	Huntington's disease	842_841_64764_5332_90993_5481_23236	7	+	0.00508149029484721	0.110522413912927
4159	geldanamycin	hsa04740	Olfactory transduction	157	1	+	5.68229888108641e-15	4.94360002654518e-13
4160	geldanamycin	hsa05322	Systemic lupus erythematosus	55506_3119	2	+	0.000208354365979375	0.00906341492010281
4161	geldanamycin	hsa04720	Long-term potentiation	5332_23236	2	+	0.0450012166921703	0.392103508107911
4162	geldanamycin	hsa05012	Parkinson's disease	51465_7054_5481_842	4	+	0.00682429466515402	0.11874272717368
4163	geldanamycin	hsa04260	Cardiac muscle contraction	782_4635	2	+	0.0328949061572424	0.357732104460011
4164	geldanamycin	hsa03320	PPAR signaling pathway	3611_11001_2171_8310	4	-	0.0395940887490792	0.26301787526174
4165	geldanamycin	hsa05010	Alzheimer's disease	1327_4712_351_8883_355_489_810_513_7381_8851_23621	11	-	0.00112403573145713	0.0261338307563783
4166	geldanamycin	hsa04080	Neuroactive ligand-receptor interaction	5029_4889_7442_7067_706_2925_4886_5026_1241_55879_4988_5646_9170	13	-	3.3519319050474e-06	0.000155864833584704
4167	geldanamycin	hsa05016	Huntington's disease	5432_548644_1387_55567_1327_4712_1639_5439_5430_246721_27113_7019_6875_7381_513	15	-	0.00916210210978907	0.104648259295755
4168	geldanamycin	hsa04740	Olfactory transduction	5613_5566_5616_109_4991_810	6	-	1.3926398383945e-17	1.29515504970689e-15
4169	geldanamycin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_6738_8294_121504_8343_8347_8346_8344_8339_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3014_727_9555	39	-	0.00307986481168513	0.0409182039266739
4170	geldanamycin	hsa04062	Chemokine signaling pathway	5295_5580_3551_156_5829_5613_5566_3576_5616_9475_5296_6387_109_1399_112_5970_4792	17	-	0.0187791890068136	0.134343429048743
4171	geldanamycin	hsa05012	Parkinson's disease	7327_1327_4712_7054_65018_27429_513_7381	8	-	0.00301172315603399	0.0409182039266739
4172	geldanamycin	hsa04260	Cardiac muscle contraction	784_7381_1327_6548	4	-	0.0109891899670721	0.104648259295755
4173	geldanamycin	hsa04060	Cytokine-cytokine receptor interaction	55540_5154_8741_6387_27242_3554_2057_3455_3576_3572_4982_659_3588_3589_3625_8742_7040_7042_655_8795_4055_3460_355_7422_51330	25	-	0.0141818795553026	0.114887407342966
4174	geldanamycin	hsa03010	Ribosome	6234_6189_439992	3	-	0.000440362392882142	0.0136512341793464
4175	geldanamycin	hsa04020	Calcium signaling pathway	2925_5578_5613_5566_5616_5026_109_5335_489_5336_810_3707_493	13	-	0.00302247205855531	0.0409182039266739
4176	geldanamycin	hsa03050	Proteasome	10197	1	-	0.0112525009995435	0.104648259295755
4177	geldanamycin	hsa04610	Complement and coagulation cascades	1675_2161_727	3	-	0.0148241815926408	0.114887407342966
4178	3-aminobenzamide	hsa04620	Toll-like receptor signaling pathway	3665_5595_9641	3	+	0.032645594830153	0.513184021690425
4179	3-aminobenzamide	hsa05220	Chronic myeloid leukemia	861_613_5595	3	+	0.0150292311168249	0.513184021690425
4180	3-aminobenzamide	hsa04310	Wnt signaling pathway	2535	1	-	0.045868874376683	0.996670932290273
4181	3-aminobenzamide	hsa04740	Olfactory transduction	4991	1	-	1.72414848472591e-05	0.00132759433323895
4182	3-aminobenzamide	hsa04115	p53 signaling pathway	581_317_3479_472_3732_9540	6	-	0.0498073921676779	0.996670932290273
4183	bucladesine	hsa04520	Adherens junction	4088_91_2260_5881_8976	5	+	0.0125591802964668	0.316945628816937
4184	bucladesine	hsa04010	MAPK signaling pathway	8398_9064_27006_208_4137_5881_5922_91_3725_3164_2260	11	+	0.00683701346401784	0.316945628816937
4185	bucladesine	hsa05210	Colorectal cancer	4088_208_5881_91_3725	5	+	0.0150926489912827	0.316945628816937
4186	bucladesine	hsa05220	Chronic myeloid leukemia	4088_613_91_208	4	+	0.0400672743400602	0.631059570855948
4187	bucladesine	hsa05214	Glioma	6655_3479_4193_808_801_805	6	-	0.0242943847111911	0.299742248206897
4188	bucladesine	hsa05332	Graft-versus-host disease	3553_3105_3106_3107_3111_3135_355_649853	8	-	0.000152798407967205	0.00719760230457058
4189	bucladesine	hsa05211	Renal cell carcinoma	5063_6655_998_3725_6923_3082	6	-	0.0363650653954758	0.322739955384848
4190	bucladesine	hsa05320	Autoimmune thyroid disease	3105_3106_3107_3111_3135_355_649853	7	-	0.00269122328939016	0.0477692133866753
4191	bucladesine	hsa05016	Huntington's disease	10126	1	-	0.0326865552328388	0.322739955384848
4192	bucladesine	hsa04514	Cell adhesion molecules (CAMs)	6402_3105_3106_3107_3111_3135_57863_5792_6693_649853	10	-	0.0253303308343857	0.299742248206897
4193	bucladesine	hsa05330	Allograft rejection	3105_3106_3107_3111_3135_355_649853	7	-	0.000473463201563967	0.0112052957703472
4194	bucladesine	hsa04940	Type I diabetes mellitus	3553_3105_3106_3107_3111_3135_355_649853	8	-	0.000202749360692129	0.00719760230457058
4195	bendroflumethiazide	hsa05332	Graft-versus-host disease	3123_3824_3126_3127_3125	5	+	0.00245849676326974	0.0719901236313455
4196	bendroflumethiazide	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	+	0.0277190432989178	0.252936270102625
4197	bendroflumethiazide	hsa04612	Antigen processing and presentation	3824_3123_3806_3126_3127_3125	6	+	0.0123525094115223	0.180346637408226
4198	bendroflumethiazide	hsa05322	Systemic lupus erythematosus	718_3123_3126_3127_3125_720_721	7	+	0.0332643368894535	0.26981073254779
4199	bendroflumethiazide	hsa04360	Axon guidance	57556_5365_1947_5534_3984_8829_57144	7	+	0.0216827232514991	0.226119828194205
4200	bendroflumethiazide	hsa05310	Asthma	3123_3125_3126_3127_2207	5	+	0.00063273616188057	0.0461897398172816
4201	bendroflumethiazide	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.00990999058489191	0.180346637408226
4202	bendroflumethiazide	hsa04940	Type I diabetes mellitus	3382_3126_3127_3123_3125	5	+	0.00295849823142516	0.0719901236313455
4203	bendroflumethiazide	hsa04610	Complement and coagulation cascades	721_2_728_720_718	5	+	0.016694684460332	0.203118660934039
4204	bendroflumethiazide	hsa04740	Olfactory transduction	51806_5566	2	-	4.39230065256548e-06	0.000175692026102619
4205	bendroflumethiazide	hsa05322	Systemic lupus erythematosus	8329_8343_8347_8346_8344_8339_8969_8968_8358_8330_8331_8336_6737_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_720_721	26	-	3.74711708347916e-08	2.99769366678333e-06
4206	fluocinonide	hsa04640	Hematopoietic cell lineage	3123_3126_3127_1438_3125_1378_3673	7	+	0.0314034075517237	0.412496027157858
4207	fluocinonide	hsa05010	Alzheimer's disease	5330	1	+	0.0484738904585509	0.448383486741596
4208	fluocinonide	hsa04080	Neuroactive ligand-receptor interaction	2741_1813	2	+	0.0185723587631897	0.412496027157858
4209	fluocinonide	hsa05016	Huntington's disease	5330	1	+	0.0334456238236101	0.412496027157858
4210	fluocinonide	hsa05322	Systemic lupus erythematosus	729_3123_3126_3127_3125_8358_8968_3013_8350_8351_8352_8353_8354_8355_8356_8357	16	+	5.49439500023222e-05	0.00406585230017184
4211	fluocinonide	hsa05310	Asthma	3123_3126_3127_8288_3125	5	+	0.00488417924096964	0.180714631915877
4212	fluocinonide	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.0449848356281538	0.448383486741596
4213	fluocinonide	hsa04610	Complement and coagulation cascades	5327_2_2153_1378_729_2243	6	+	0.0331705690996771	0.412496027157858
4214	fluocinonide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_3108_8969_8370_8332_8359_8330_8331_8336_554313_8351_85235_3119_3013_720_721	27	-	4.3645574701426e-07	3.75351942432264e-05
4215	fluocinonide	hsa04012	ErbB signaling pathway	6777_5599_1839_867_2002_1956_1399_3725_6714_2064	10	-	0.0406596477677605	0.874182427006851
4216	fluocinonide	hsa04010	MAPK signaling pathway	9479_50487_5154_5881_3725_3164_3554_4149_1852_836_1399_408_2768_1956_5536_7042_7786_23542_1432_5599_5607_2002_23162_2005_9693	25	-	0.0264740265199892	0.758922093573024
4217	fluocinonide	hsa05210	Colorectal cancer	836_6934_5599_1855_1857_5881_1956_324_7042_3725_4233	11	-	0.0181702240632858	0.758922093573024
4218	furaltadone	hsa02010	ABC transporters	19_64137_10347_1244	4	+	0.0309103031883806	1
4219	furaltadone	hsa05016	Huntington's disease	7052_6390_27113_23236	4	-	0.0356349339664411	0.9301997799163
4220	furaltadone	hsa04740	Olfactory transduction	810_26529	2	-	1.39984595272578e-07	1.20386751934417e-05
4221	furaltadone	hsa05322	Systemic lupus erythematosus	8358_85235_8968_3013_6737_8330_8332_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357	19	-	0.00150201823052572	0.064586783912606
4222	fenoprofen	hsa05010	Alzheimer's disease	3708_54205	2	+	0.0363506779247356	1
4223	fenoprofen	hsa04740	Olfactory transduction	5593	1	+	1.7519988391434e-06	0.000141911905970615
4224	fenoprofen	hsa04070	Phosphatidylinositol signaling system	8871_5728_8394_3631_808_5335_51763_801_5291_805	10	-	0.0388523425391673	0.812960155832828
4225	fenoprofen	hsa04080	Neuroactive ligand-receptor interaction	3953_7067	2	-	2.75126627670736e-05	0.00115553183621709
4226	fenoprofen	hsa04740	Olfactory transduction	219464_801_808_805	4	-	6.86439339134637e-07	5.76609044873095e-05
4227	flunixin	hsa05212	Pancreatic cancer	5925_2260_3845	3	+	0.0424579227294816	0.414142056183184
4228	flunixin	hsa05215	Prostate cancer	5925_2260_3845	3	+	0.0413174507847608	0.414142056183184
4229	flunixin	hsa05218	Melanoma	5925_2260_3845_2258	4	+	0.00362594398551882	0.170419367319385
4230	flunixin	hsa04810	Regulation of actin cytoskeleton	2245_2934_3845_2260_2258	5	+	0.0405098019973177	0.414142056183184
4231	flunixin	hsa04540	Gap junction	5598_3709_3845	3	+	0.0471769458153444	0.414142056183184
4232	flunixin	hsa05210	Colorectal cancer	6934_5295_8312_3725_8324_8321	6	-	0.0154155600418533	1
4233	flunixin	hsa05217	Basal cell carcinoma	8324_8321_6934_8312	4	-	0.042763754558798	1
4234	flumetasone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3013_554313_8359_8294_8367_121504_8368_8351_6738	17	-	7.73180614686699e-05	0.00579885461015024
4235	flumetasone	hsa04360	Axon guidance	9353_57556_5364_998_1944_2049_64221_3985_6092_10505_7869	11	-	0.019541462665895	0.732804849971063
4236	sulfamethoxypyridazine	hsa04120	Ubiquitin mediated proteolysis	7320_4281_5371	3	+	0.0486426240309054	0.474265584301328
4237	sulfamethoxypyridazine	hsa05010	Alzheimer's disease	3553_3710	2	+	0.00215386210842862	0.0560004148191441
4238	sulfamethoxypyridazine	hsa05200	Pathways in cancer	1284_596_208_5578_5371_4254_2034_652_2249_2247_2253_3674	12	+	0.0485520913863006	0.474265584301328
4239	sulfamethoxypyridazine	hsa05016	Huntington's disease	4899_1211_90993	3	+	0.00506767153278376	0.0805213291380911
4240	sulfamethoxypyridazine	hsa04740	Olfactory transduction	2979_5568_816	3	+	1.53089286430737e-07	5.97048217079874e-06
4241	sulfamethoxypyridazine	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_9103_8362_8294_121504_8366_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_2215_83740_3117_3013_940	33	+	3.33361136015003e-09	2.60021686091702e-07
4242	sulfamethoxypyridazine	hsa04512	ECM-receptor interaction	2814_1281_1301_1311_3381_2812_1277_1284_7148_960_3674	11	+	0.0278661592142213	0.362260069784877
4243	sulfamethoxypyridazine	hsa05012	Parkinson's disease	5413	1	+	0.00516162366269815	0.0805213291380911
4244	sulfamethoxypyridazine	hsa04080	Neuroactive ligand-receptor interaction	64106_2908_1081_2149_1909	5	-	0.00226123038092342	0.141713148762321
4245	sulfamethoxypyridazine	hsa04210	Apoptosis	841_581_598_5534_331_355_5291_208_5576_8837_23052_8795	12	-	0.0210623782208542	0.596767382924202
4246	sulfamethoxypyridazine	hsa05012	Parkinson's disease	7419	1	-	0.00333442702970168	0.141713148762321
4247	cloperastine	hsa04662	B cell receptor signaling pathway	973_6655_5533_2353_933_3725_4792	7	+	0.0410049963436798	0.474486386262581
4248	cloperastine	hsa05016	Huntington's disease	1211	1	+	0.00739318421873896	0.155948889378097
4249	cloperastine	hsa04740	Olfactory transduction	5566	1	+	5.60600127383518e-06	0.000227043051590325
4250	cloperastine	hsa04514	Cell adhesion molecules (CAMs)	9076_965_959_3383_3119_29851_3107_23308_933_923_25945_4099_26047	13	+	0.00770117972237514	0.155948889378097
4251	cloperastine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8294_121504_959_8968_8370_8358_8359_8335_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_729	29	+	2.37791076248414e-11	1.92610771761215e-09
4252	cloperastine	hsa05219	Bladder cancer	23604_2277_3576_1612_2261	5	+	0.0356229428104666	0.474486386262581
4253	cloperastine	hsa04010	MAPK signaling pathway	775_4214_3164_1848_783_1843_1647_6655_1649_1846_5533_776_5598_2353_3725_5971_2261_5566_11221	19	+	0.0301316978531953	0.474486386262581
4254	cloperastine	hsa04912	GnRH signaling pathway	775_4214_776_3710_5598_6655_1839_3725_5566	9	+	0.0487830298299236	0.493928177027976
4255	cloperastine	hsa04740	Olfactory transduction	51806_393046_816	3	-	0.000170762609413611	0.0136610087530889
4256	cloperastine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	0.0056923538908616	0.227694155634464
4257	trioxysalen	hsa04510	Focal adhesion	29895_91807_2335_5599_3480_6655_3371_824_6093	9	+	0.0160389617891934	1
4258	trioxysalen	hsa04662	B cell receptor signaling pathway	3551_10725_6655_5290_8519_5534_4794	7	-	0.0423337753578843	0.51397302588126
4259	trioxysalen	hsa04080	Neuroactive ligand-receptor interaction	146_4889_2692	3	-	0.0142545937656616	0.375370969162422
4260	trioxysalen	hsa04740	Olfactory transduction	157	1	-	3.6246258347933e-06	0.000286345440948671
4261	trioxysalen	hsa05322	Systemic lupus erythematosus	3123_8358_8350_8968_3013_8970_8351_8352_8353_8354_8355_8356_8357	13	-	0.0107892182965035	0.375370969162422
4262	trioxysalen	hsa04010	MAPK signaling pathway	9479_3551_5534_1850_5598_6655_6789_5155_1846_2002_6722_4763_8911_7040_27092_2263_3164_1852_4616	19	-	0.0309750069900018	0.51397302588126
4263	trioxysalen	hsa05012	Parkinson's disease	5413	1	-	0.0455419136856813	0.51397302588126
4264	trioxysalen	hsa04060	Cytokine-cytokine receptor interaction	5155_3566_8795_7040	4	-	0.0364124657962445	0.51397302588126
4265	flecainide	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_1432_834_596_598_6506_5533	7	+	0.0378031671985338	0.936736208321016
4266	flecainide	hsa04740	Olfactory transduction	219464_5568_26692_816_81797	5	+	0.00012521945645134	0.0103932148854612
4267	flecainide	hsa04920	Adipocytokine signaling pathway	10000_3953_10645_2182_1375_5781_8717_8471_4793	9	+	0.0135501907462872	0.562332915970919
4268	flecainide	hsa04080	Neuroactive ligand-receptor interaction	7434_56288_2925_6754	4	-	0.0488836650289631	0.562162147833076
4269	flecainide	hsa04740	Olfactory transduction	5137_51806	2	-	4.18881819303832e-05	0.00289028455319644
4270	flecainide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_8359_8294_8367_554313_121504	15	-	0.00124476381648196	0.0429443516686276
4271	flecainide	hsa04062	Chemokine signaling pathway	6777_56288	2	-	0.036393492941567	0.549869954600787
4272	flecainide	hsa04010	MAPK signaling pathway	1326_3925_5155_4763_9344_4137_3553_1852_2260_2261_57551_776_5536_5534_3725_3727_784_2122_5598_1844_7189_27092	22	-	0.00308031478317911	0.0708472400131195
4273	flecainide	hsa02010	ABC transporters	19_8714_10347_5243_5244	5	-	0.039845648884115	0.549869954600787
4274	eucatropine	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.0266023951081043	0.309577849094829
4275	eucatropine	hsa04640	Hematopoietic cell lineage	3123_2993_3126_3127_3125_924	6	+	0.0277233894711787	0.309577849094829
4276	eucatropine	hsa05322	Systemic lupus erythematosus	8361_2212_8363_8362_8365_8364_8370_8360_3123_8366_3126_3127_3125_8359_8294_8367_554313_8368_121504	19	+	1.91723196993574e-08	1.28454541985695e-06
4277	eucatropine	hsa05310	Asthma	3123_3125_3126_3127_2207	5	+	0.0015845620920559	0.0530828300838727
4278	eucatropine	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.0196921039716548	0.309577849094829
4279	eucatropine	hsa04940	Type I diabetes mellitus	3123_2571_3126_3127_3125	5	+	0.00703132074955166	0.15703283007332
4280	eucatropine	hsa04740	Olfactory transduction	801_808_805	3	-	1.10448251557087e-07	9.05675662768113e-06
4281	eucatropine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8329_8294_121504_8969_8370_8332_8359_8330_8331_8336_554313_6738_8351_85235_3013	25	-	5.45512454734861e-05	0.00223660106441293
4282	eucatropine	hsa05012	Parkinson's disease	513_517	2	-	0.0180016818891018	0.492045971635449
4283	difenidol	hsa05200	Pathways in cancer	6789_5371_4791_861_652671_4842	6	+	0.0334306904070756	0.451124390500625
4284	difenidol	hsa05221	Acute myeloid leukemia	861_5371_652671	3	+	0.00979978299938338	0.323392838979652
4285	difenidol	hsa04662	B cell receptor signaling pathway	10892_11261_5291_5881_3725_27071	6	-	0.0313052818385064	0.298233663751962
4286	difenidol	hsa04080	Neuroactive ligand-receptor interaction	2908_5031	2	-	0.0368649281035182	0.298233663751962
4287	difenidol	hsa05014	Amyotrophic lateral sclerosis (ALS)	4217_598_11261_5608_581	5	-	0.0327744560709963	0.298233663751962
4288	difenidol	hsa04740	Olfactory transduction	5613	1	-	0.000173466585528261	0.0121426609869783
4289	difenidol	hsa04210	Apoptosis	581_5613_11261_5291_598_8837_5575	7	-	0.0224751229959667	0.298233663751962
4290	difenidol	hsa04664	Fc epsilon RI signaling pathway	5291_5881_8681_5335_100137049_5608	6	-	0.0383443281966808	0.298233663751962
4291	difenidol	hsa04370	VEGF signaling pathway	5829_11261_5291_5881_8681_5335_100137049	7	-	0.0114617313422141	0.267440397984996
4292	difenidol	hsa04060	Cytokine-cytokine receptor interaction	91_4055	2	-	0.0258369400560081	0.298233663751962
4293	difenidol	hsa05210	Colorectal cancer	581_5881_5291_5900_6934_3725_91_8324	8	-	0.0054853385390329	0.191986848866151
4294	0198306-0000	hsa05010	Alzheimer's disease	776_22926_842	3	+	0.0497552506323472	0.547307756955819
4295	0198306-0000	hsa05131	Shigellosis	9076_7277_5578_7278_113457_7100_7430_2534	8	+	0.0100354246261005	0.25757589873658
4296	0198306-0000	hsa05016	Huntington's disease	1387_6648_842	3	+	0.0367485118681179	0.471605902307513
4297	0198306-0000	hsa05130	Pathogenic Escherichia coli infection	9076_7277_5578_7278_113457_7100_7430_2534	8	+	0.0100354246261005	0.25757589873658
4298	0198306-0000	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8370_83740_8368_8366_8360_8359_8362_8294_8367_554313_121504_3119_3108	19	+	0.000238400879718131	0.0183568677382961
4299	0198306-0000	hsa04062	Chemokine signaling pathway	6357_6655_4793	3	+	0.0265728262546214	0.471605902307513
4300	0198306-0000	hsa04020	Calcium signaling pathway	5333_776_5578	3	+	0.0364002380814932	0.471605902307513
4301	0198306-0000	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3013_554313_8359_8294_8367_121504_8368_8351	16	-	1.63209804833607e-06	0.000104454275093508
4302	dexamethasone	hsa04120	Ubiquitin mediated proteolysis	8651_867_55236	3	+	0.0185553291766875	0.525734326672813
4303	dexamethasone	hsa04740	Olfactory transduction	810_26476_7932_26664_393046	5	+	1.43944656494173e-07	1.22352958020047e-05
4304	dexamethasone	hsa05012	Parkinson's disease	6392_651820_842	3	+	0.0183433074846159	0.525734326672813
4305	dexamethasone	hsa04070	Phosphatidylinositol signaling system	8871_5293_3631_808_5336_801_1606_3707_805_23236	10	-	0.0396304645498831	0.918546391884827
4306	dexamethasone	hsa04740	Olfactory transduction	801_2978_808_393046_805	5	-	3.91949415284836e-06	0.000344915485450656
4307	dexamethasone	hsa04060	Cytokine-cytokine receptor interaction	3601_3594_23765_3559_657_643_6362	7	-	0.013236420695427	0.582402510598788
4308	betaxolol	hsa05016	Huntington's disease	1213_4695_317	3	+	0.0193435879468211	0.483589698670527
4309	betaxolol	hsa04740	Olfactory transduction	26212_26476_2979_81797_81696_815	6	+	0.000260180533625848	0.0195135400219386
4310	betaxolol	hsa05322	Systemic lupus erythematosus	8361_2212_8363_8362_8365_8364_8370_8360_8368_8366_8359_8294_8367_554313_121504_8341_6737	17	+	0.00568417353499154	0.213156507562183
4311	betaxolol	hsa05010	Alzheimer's disease	4698_11261_355_5664	4	-	0.0102712836095801	0.210561313996392
4312	betaxolol	hsa04080	Neuroactive ligand-receptor interaction	5618_3953_2908_7434_64106_9170	6	-	0.00166166681726004	0.0454188930051078
4313	betaxolol	hsa05012	Parkinson's disease	4698	1	-	0.00158738791176149	0.0454188930051078
4314	betaxolol	hsa04020	Calcium signaling pathway	11261_2767	2	-	0.00034193783326899	0.0280389023280572
4315	doxepin	hsa05322	Systemic lupus erythematosus	8343_8339_8347_8346_8344	5	+	0.00306908839470495	0.0767272098676237
4316	doxepin	hsa05131	Shigellosis	7278_113457	2	-	0.00977821566755428	0.0440019705039943
4317	doxepin	hsa05130	Pathogenic Escherichia coli infection	7278_113457	2	-	0.00977821566755428	0.0440019705039943
4318	doxepin	hsa04540	Gap junction	7278_113457	2	-	0.0249106811237921	0.0747320433713763
4319	hemicholinium	hsa04740	Olfactory transduction	818	1	+	0.00780899247073287	0.367022646124445
4320	hemicholinium	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8343_8336_8339_8347_8346_8344	12	-	4.72916650857004e-06	0.000264833324479922
4321	scriptaid	hsa04070	Phosphatidylinositol signaling system	8867_3612_5578_3632_5293_3631_3708_5333_808_23396_5336_4952_200576_5286_801_805	16	+	0.0175092406672949	0.152689572602116
4322	scriptaid	hsa04640	Hematopoietic cell lineage	3655_2057	2	+	0.01608127483119	0.152689572602116
4323	scriptaid	hsa05010	Alzheimer's disease	842_317_3708_808_351_801_805_23621	8	+	0.0150329004952554	0.152689572602116
4324	scriptaid	hsa04080	Neuroactive ligand-receptor interaction	2550_2908_1241_6915_2150_5732_7433_728	8	+	6.75431908512707e-05	0.00186869494688516
4325	scriptaid	hsa05016	Huntington's disease	55081_842_64764_5440_317_246721_3708_90993_9519	9	+	0.0183963340484477	0.152689572602116
4326	scriptaid	hsa04740	Olfactory transduction	818_801_808_5566_805	5	+	2.10451630162652e-11	1.74674853035001e-09
4327	scriptaid	hsa04530	Tight junction	6709_5865_5578_10627_5581	5	+	0.0129375297166465	0.152689572602116
4328	scriptaid	hsa04630	Jak-STAT signaling pathway	868_2057_3455_3587_5293_8554_10379	7	+	0.0208811047383074	0.157557426661774
4329	scriptaid	hsa04062	Chemokine signaling pathway	4067_5566_5293_7852_5604_5880_10235_4793	8	+	0.00483484959958406	0.0828836872450896
4330	scriptaid	hsa05012	Parkinson's disease	2861_317_842_65018	4	+	0.00499299320753552	0.0828836872450896
4331	scriptaid	hsa04260	Cardiac muscle contraction	10479_6548	2	+	0.0229553844215249	0.158774742248881
4332	scriptaid	hsa04060	Cytokine-cytokine receptor interaction	2057_3455_55540_8744_7852_655_8718_3587	8	+	4.92715964615922e-05	0.00186869494688516
4333	scriptaid	hsa03010	Ribosome	6189_439992_6123_6203	4	+	0.0439405998130941	0.280543829575909
4334	scriptaid	hsa04640	Hematopoietic cell lineage	3673_3566	2	-	0.046507548142608	0.244164627748692
4335	scriptaid	hsa05010	Alzheimer's disease	637_8772_4700_51107_355_489_7132	7	-	0.0377366868824893	0.21132544654194
4336	scriptaid	hsa04080	Neuroactive ligand-receptor interaction	5029_4889_1269_152_5025_5618_4886_5031_56288_5724_9170	11	-	0.0158094577161783	0.120726768014452
4337	scriptaid	hsa05016	Huntington's disease	4899_581_4700_2033_1387_163	6	-	0.0100564833971501	0.105916462035897
4338	scriptaid	hsa04740	Olfactory transduction	5613_5616_816	3	-	8.82347605676173e-11	7.41171988767985e-09
4339	scriptaid	hsa04514	Cell adhesion molecules (CAMs)	965_1365_5792	3	-	0.00661423808115756	0.105916462035897
4340	scriptaid	hsa05322	Systemic lupus erythematosus	55506	1	-	0.000143573885381776	0.00603010318603459
4341	scriptaid	hsa05212	Pancreatic cancer	1027_5295_595_596_3480_1871_5155_5154_5894_6934_369_2033_1387_4790_4792	15	-	0.0259437954962354	0.155662772977412
4342	scriptaid	hsa05215	Prostate cancer	1027_5295_595_596_3480_1871_5155_5154_5894_6934_369_2033_1387_4790_4792	15	-	0.0252009857979242	0.155662772977412
4343	scriptaid	hsa04210	Apoptosis	637_5295_596_8772_598_581_331_5616_355_9941_4615_5613_8837_7132_4790_4792	16	-	0.0100872820986569	0.105916462035897
4344	scriptaid	hsa04512	ECM-receptor interaction	3673	1	-	0.0139356813313039	0.117059723182953
4345	scriptaid	hsa05012	Parkinson's disease	51465_7332_7054_4700	4	-	0.0257191323503661	0.155662772977412
4346	scriptaid	hsa04260	Cardiac muscle contraction	27092	1	-	0.0137969488579486	0.117059723182953
4347	scriptaid	hsa03010	Ribosome	6234	1	-	0.00305142027632793	0.0640798258028865
4348	scriptaid	hsa05222	Small cell lung cancer	10401_9063_5295_595_596_598_4609_331_1027_7188_1871_3673_4790_6256_4792_7187	16	-	0.00844063131366868	0.105916462035897
4349	scriptaid	hsa05220	Chronic myeloid leukemia	1027_595_4088_598_5295_861_4609_1487_9846_7043_1871_5894_1488_4790_369_4792	16	-	0.00250845575198746	0.0640798258028865
4350	sulfinpyrazone	hsa05332	Graft-versus-host disease	57292_3811_3553_942_3112_3802_5551	7	+	0.0162150433763094	0.356730954278807
4351	sulfinpyrazone	hsa04080	Neuroactive ligand-receptor interaction	887_1081_2908_2925_59340_5644_5729_4160_2740_2688_1442_1394_2914_2917_3953_148_6915_5737_5027_57105_5618_2554_7067_3357_680	25	+	0.0156420724706723	0.356730954278807
4352	sulfinpyrazone	hsa04740	Olfactory transduction	9635	1	+	9.15639960365419e-09	8.05763165121569e-07
4353	sulfinpyrazone	hsa05221	Acute myeloid leukemia	23533_10000_83439_208_862_5371_861_652346_3845	9	+	0.0111498792415109	0.356730954278807
4354	sulfinpyrazone	hsa05012	Parkinson's disease	1339_56901	2	+	0.0353474313572283	0.622114791887218
4355	sulfinpyrazone	hsa04740	Olfactory transduction	818	1	-	3.74513311188125e-06	0.000295865515838619
4356	sulfinpyrazone	hsa04514	Cell adhesion molecules (CAMs)	3135	1	-	0.0455042240198137	0.868071506855025
4357	sulfinpyrazone	hsa05322	Systemic lupus erythematosus	55506_474382_474381_83740_3013_8343_8970_8351_8339_8347_8346_8344	12	-	0.0350399817584352	0.868071506855025
4358	sulfinpyrazone	hsa05012	Parkinson's disease	842	1	-	0.0457439033213505	0.868071506855025
4359	mebeverine	hsa05332	Graft-versus-host disease	3811_3108_3119_3821_3113_3126_3127_3111_3802_356_3123_941_3125	13	+	3.25282907893279e-05	0.000539969627102843
4360	mebeverine	hsa05320	Autoimmune thyroid disease	959_958_3108_1081_3119_3113_3126_3127_3111_3125_356_3123_941	13	+	0.00023851104967144	0.00282805958896136
4361	mebeverine	hsa04612	Antigen processing and presentation	3811_3108_3822_3821_3123_3126_3127_3111_3125_6892_3119_3802_3113	13	+	0.0142783077237487	0.118509954107114
4362	mebeverine	hsa05016	Huntington's disease	7350_2904_1339_23236	4	+	0.0104549570688934	0.096417937413128
4363	mebeverine	hsa04740	Olfactory transduction	26211_5593_4991_442194_81285	5	+	8.99658975361956e-07	3.73358474775212e-05
4364	mebeverine	hsa04514	Cell adhesion molecules (CAMs)	9073_5175_3111_6383_3676_959_958_3108_3383_3123_3126_3127_3125_10666_51208_1462_6403_923_3119_3113_3685_941_6693_5817_1000	25	+	2.55135543499907e-05	0.000529406252762307
4365	mebeverine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_2904_8368_554313_8348_8294_121504_8341_959_958_3108_3123_8366_3126_3127_3125_8968_8370_8358_8359_8335_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_3113_3111_941	40	+	4.69879746486273e-12	3.90000189583607e-10
4366	mebeverine	hsa05212	Pancreatic cancer	51176	1	+	0.0301115376749196	0.205511016173079
4367	mebeverine	hsa05215	Prostate cancer	51176	1	+	0.0456115893750773	0.252384127875428
4368	mebeverine	hsa05310	Asthma	959_958_3108_2205_3119_3123_3126_3127_3111_3125_3113_8288	12	+	8.12049073135749e-06	0.000224666910234224
4369	mebeverine	hsa04512	ECM-receptor interaction	10319_3910_3690_2812_3694_7057_3685_3918_1282_6383_1290_3676	12	+	0.0321884724126509	0.205511016173079
4370	mebeverine	hsa04062	Chemokine signaling pathway	6093_23236_6846_6375_6773	5	+	0.0186935452684117	0.141051296116197
4371	mebeverine	hsa05012	Parkinson's disease	1339_7318_5413	3	+	0.0352892859700431	0.209215052536684
4372	mebeverine	hsa05330	Allograft rejection	959_958_3108_3119_3126_3113_3127_3111_3125_356_3123_941	12	+	5.54845667550293e-05	0.000767536506777905
4373	mebeverine	hsa04940	Type I diabetes mellitus	3108_3119_3113_3126_3127_3111_3125_356_3123_941	10	+	0.00200606728104264	0.0208129480408174
4374	mebeverine	hsa04080	Neuroactive ligand-receptor interaction	7067_4157	2	-	0.00655973296462713	0.491979972347035
4375	mebeverine	hsa04630	Jak-STAT signaling pathway	5781	1	-	0.0478947097491633	1
4376	fendiline	hsa05010	Alzheimer's disease	2902_836_841_9451_355_6868_4035_23236	8	+	0.043939275316653	0.397634607340784
4377	fendiline	hsa05320	Autoimmune thyroid disease	1081_3119_3113_3126_3127_3125_355_3123_7038_3448	10	+	0.0388797235571777	0.397634607340784
4378	fendiline	hsa05016	Huntington's disease	2902_27113_836_841_1639_7802_23236	7	+	0.012390632502033	0.213118879034968
4379	fendiline	hsa04740	Olfactory transduction	26211_4995_4991	3	+	1.71882700820561e-11	7.39095613528412e-10
4380	fendiline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_88_8348_8329_8294_121504_8343_8347_8346_8345_8344_8353_723790_6737_3123_3126_3127_3125_8969_8968_55766_8370_92815_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_8352_8339_8354_8355_8356_8357_8332_85235_3119_3012_3013_3113_8349_8970_729	57	+	4.10009682848383e-17	3.52608327249609e-15
4381	fendiline	hsa05310	Asthma	2205_3119_3123_3126_3127_3125_3113	7	+	0.0311565229500819	0.382780139101006
4382	fendiline	hsa05012	Parkinson's disease	836_7318_7054	3	+	0.00477515790129401	0.136887859837095
4383	fendiline	hsa04260	Cardiac muscle contraction	782_783	2	+	0.0462365822489284	0.397634607340784
4384	fendiline	hsa03010	Ribosome	6165_6171	2	+	0.0115663618679391	0.213118879034968
4385	fendiline	hsa04020	Calcium signaling pathway	2902_155_5578_2925_5335_1910_23236	7	+	0.0165659936608281	0.237445909138536
4386	fendiline	hsa04080	Neuroactive ligand-receptor interaction	7434_5618	2	-	0.00942390272259794	0.381668060265217
4387	fendiline	hsa04740	Olfactory transduction	810_219464_157_409	4	-	0.00302943888392157	0.245384549597647
4388	fendiline	hsa04060	Cytokine-cytokine receptor interaction	3566_5618_3553	3	-	0.027192164952712	0.734188453723224
4389	quinidine	hsa04740	Olfactory transduction	5593_4991	2	+	6.41172981239079e-06	0.000519350114803654
4390	quinidine	hsa05322	Systemic lupus erythematosus	958_717_3013_942_3014_8358_3117_88_8968_8350_8351_8352_8353_8354_8355_8356_8357	17	+	0.000662508266513299	0.0268315847937886
4391	quinidine	hsa04080	Neuroactive ligand-receptor interaction	2911_5618_4157_1131_1909	5	-	0.0260173858318738	0.580474652410529
4392	quinidine	hsa04740	Olfactory transduction	5567_157	2	-	2.15792720635243e-06	0.000185581739746309
4393	quinidine	hsa05322	Systemic lupus erythematosus	9555	1	-	0.0159100978790098	0.580474652410529
4394	quinidine	hsa04210	Apoptosis	8503_3553_5575_5567_5290_472_836_8837_651610_8795	10	-	0.0269988210423502	0.580474652410529
4395	quinidine	hsa04330	Notch signaling pathway	2648_1856_1857_5664_22938_9541	6	-	0.0391207826202533	0.672877461068357
4396	alprenolol	hsa04740	Olfactory transduction	26211_5566_5616_816_5613	5	+	0.00168248123821402	0.132916017818908
4397	alprenolol	hsa04060	Cytokine-cytokine receptor interaction	958_8771_6367_8794	4	+	0.0271405801525545	1
4398	alprenolol	hsa04080	Neuroactive ligand-receptor interaction	5025	1	-	1.11669804890252e-05	0.000474596670783571
4399	alprenolol	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_8362_8329_8294_8366_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3119_83740	25	-	6.26163104858496e-06	0.000474596670783571
4400	alprenolol	hsa04530	Tight junction	55870_50848	2	-	0.0247955448656462	0.351270218929988
4401	alprenolol	hsa04062	Chemokine signaling pathway	6093_5594_6655	3	-	0.0104217998835088	0.17717059801965
4402	alprenolol	hsa05012	Parkinson's disease	842	1	-	0.00724025126466816	0.153855339374198
4403	alprenolol	hsa04060	Cytokine-cytokine receptor interaction	2324_8742_8741_3572_7423_10913_4254	7	-	0.02998944421317	0.364157536874207
4404	alprenolol	hsa04020	Calcium signaling pathway	5025_2776	2	-	0.00313400828996996	0.0887969015491489
4405	praziquantel	hsa05332	Graft-versus-host disease	57292_3811_3553_3109_3123_3126_3127_3111_3802_3125	10	+	0.00178579781485308	0.0517881366307393
4406	praziquantel	hsa04640	Hematopoietic cell lineage	3553_3690_3123_3126_3127_1438_3125_915_3674_933_931_925_290	13	+	0.0223445243291791	0.277710516662655
4407	praziquantel	hsa04310	Wnt signaling pathway	23236_11211_5526_9475	4	+	0.0480653237508967	0.460279750854906
4408	praziquantel	hsa04740	Olfactory transduction	26476_9635	2	+	1.76251980616697e-09	7.66696115682632e-08
4409	praziquantel	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_2904_8369_8368_8290_88_8294_121504_3109_3123_8366_3126_3127_3125_8968_8370_8358_8359_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3111	36	+	1.28999490157424e-09	7.66696115682632e-08
4410	praziquantel	hsa05310	Asthma	3109_3123_3126_3127_3111_3125_8288	7	+	0.00933275673945626	0.202987459083174
4411	praziquantel	hsa04062	Chemokine signaling pathway	115_23533_23236_2785_9475	5	+	0.0191343885739413	0.277710516662655
4412	praziquantel	hsa05012	Parkinson's disease	6390_54205_6531	3	+	0.0360718507240769	0.392281376624336
4413	praziquantel	hsa04940	Type I diabetes mellitus	3382_3109_3123_3126_3127_3111_3125_3553	8	+	0.0191950443449569	0.277710516662655
4414	praziquantel	hsa04080	Neuroactive ligand-receptor interaction	2911	1	-	0.00256848440579345	0.0988866496230478
4415	praziquantel	hsa04740	Olfactory transduction	810	1	-	2.53984994896457e-05	0.00195568446070272
4416	praziquantel	hsa05213	Endometrial cancer	8503_2064_8312_324_842	5	-	0.0459482992819594	1
4417	amodiaquine	hsa05332	Graft-versus-host disease	3119_3105_3106_3107_3126_3127_3125_3135_3123_3113_649853	11	+	0.000202880379146704	0.00348954252132331
4418	amodiaquine	hsa05320	Autoimmune thyroid disease	3119_3105_3106_3107_3126_3127_3125_3135_3123_3113_649853	11	+	0.00110208402946602	0.0157965377556796
4419	amodiaquine	hsa04612	Antigen processing and presentation	3119_3123_3106_3107_3126_3127_3125_3135_3105_3113_926_649853	12	+	0.0168980365906383	0.181653893349362
4420	amodiaquine	hsa04740	Olfactory transduction	5137	1	+	2.91033491953625e-09	2.50288803080118e-07
4421	amodiaquine	hsa04514	Cell adhesion molecules (CAMs)	3119_3123_3106_3107_3126_3127_3125_3135_26047_6383_3105_3684_3676_3113_926_649853	16	+	0.0205107262597745	0.195991384260067
4422	amodiaquine	hsa05322	Systemic lupus erythematosus	6737_9103_8348_8329_3123_3126_3127_3125_8969_8968_8358_8330_8331_8336_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013_3113	28	+	7.21403097575626e-07	3.10203331957519e-05
4423	amodiaquine	hsa05310	Asthma	6356_3119_3123_3126_3127_3125_3113	7	+	0.00504169040067654	0.0619407677797404
4424	amodiaquine	hsa03010	Ribosome	140801	1	+	0.0314651000226775	0.270599860195027
4425	amodiaquine	hsa05330	Allograft rejection	3119_3105_3106_3107_3126_3127_3125_3135_3123_3113_649853	11	+	9.60230040276305e-05	0.00206449458659406
4426	amodiaquine	hsa04270	Vascular smooth muscle contraction	23236_5578	2	+	0.0484067352988905	0.378452657791326
4427	amodiaquine	hsa04940	Type I diabetes mellitus	3119_3105_3106_3107_3126_3127_3630_2571_3135_3123_3125_3113_649853	13	+	1.88124777143318e-05	0.000539291027810845
4428	amodiaquine	hsa04740	Olfactory transduction	818_810_157	3	-	1.97612269567446e-05	0.000839852145661645
4429	amodiaquine	hsa04510	Focal adhesion	6654_7409_2324	3	-	0.0274218575540288	0.582714473023112
4430	amodiaquine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3123_3126_3127_3125_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235	25	-	1.82333414452726e-07	1.54983402284817e-05
4431	amodiaquine	hsa04060	Cytokine-cytokine receptor interaction	5618_3601_2324	3	-	0.00269266046792551	0.0762920465912228
4432	clofilium tosylate	hsa04740	Olfactory transduction	26211_7932_9635_393046	4	+	1.00103082609808e-06	4.15427792830703e-05
4433	clofilium tosylate	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8294_121504_8968_8370_716_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2215_2214_3013_3113_3111	31	+	3.75108936955929e-08	3.11340417673421e-06
4434	clofilium tosylate	hsa04630	Jak-STAT signaling pathway	3581_59067_3561_6778_2057_3953_11009_5293_6773_50615_3600_2688_2689_9180_3449_81848_1442	17	+	0.0345385405611304	0.716674716643456
4435	clofilium tosylate	hsa04060	Cytokine-cytokine receptor interaction	5156_9180_2322_59067_3553_2057_8794_3576_939_2688_2689_650_10663_3581_3600_1233_3953_7042_268_6846_8795_3561_3449_11009_8995_50615_7423_7422_83729_6375	30	+	0.0035622685119195	0.0985560954964395
4436	clofilium tosylate	hsa04080	Neuroactive ligand-receptor interaction	7434_2911_5618_7442_3354	5	-	0.0258671394311278	0.452613516258542
4437	clofilium tosylate	hsa05016	Huntington's disease	246721_5978_5441	3	-	0.0365501306883046	0.452613516258542
4438	clofilium tosylate	hsa04740	Olfactory transduction	818_810	2	-	2.04550179247412e-06	0.000147276129058137
4439	clofilium tosylate	hsa04514	Cell adhesion molecules (CAMs)	214	1	-	0.021994583692132	0.452613516258542
4440	clofilium tosylate	hsa04062	Chemokine signaling pathway	115_7852_8976	3	-	0.0377177930215452	0.452613516258542
4441	clofilium tosylate	hsa05012	Parkinson's disease	7054	1	-	0.0223702836765635	0.452613516258542
4442	N-acetyl-L-leucine	hsa04740	Olfactory transduction	56656_2774_26664_442194_818_390892_9635	7	+	0.000375650357240148	0.0155894898254661
4443	N-acetyl-L-leucine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_9103_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_942_729	29	+	4.41294244607382e-08	3.66274223024127e-06
4444	N-acetyl-L-leucine	hsa03010	Ribosome	6192	1	+	0.0451279921208915	0.693006536671903
4445	N-acetyl-L-leucine	hsa04730	Long-term depression	2911_8398_5579_5578_2890_2892_5331_3708_5519	9	+	0.0397638721266451	0.693006536671903
4446	N-acetyl-L-leucine	hsa04080	Neuroactive ligand-receptor interaction	5618_56288_1131_1081	4	-	1.58576034139888e-05	0.000673948145094524
4447	N-acetyl-L-leucine	hsa04740	Olfactory transduction	810_5613_5616_816	4	-	1.54207579255638e-09	1.31076442367292e-07
4448	N-acetyl-L-leucine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_85235_8364_8370_8366_8368_8365_8330_8332_8359_8969_8331_8329_8336_8367_554313_121504_8294	21	-	0.0254578980536339	0.309131619222697
4449	N-acetyl-L-leucine	hsa04062	Chemokine signaling pathway	7454_5613_6777_5616_9475_56288_5291	7	-	0.0219455765860301	0.309131619222697
4450	N-acetyl-L-leucine	hsa05012	Parkinson's disease	4698_836_517	3	-	0.0094166228871445	0.266804315135761
4451	N-acetyl-L-leucine	hsa04260	Cardiac muscle contraction	7168	1	-	0.0208845281154313	0.309131619222697
4452	N-acetyl-L-leucine	hsa04060	Cytokine-cytokine receptor interaction	5618_3554_2057_5155_3601_5154_7042_4254_268_4233_8792	11	-	0.0206008982253686	0.309131619222697
4453	tonzonium bromide	hsa04640	Hematopoietic cell lineage	1435_3123_3568_3126_3127_3125_947_1604_3676_3674	10	+	0.0302858919204704	0.605717838409408
4454	tonzonium bromide	hsa04740	Olfactory transduction	442194_2979_815_26692_1258	5	+	0.000126290891302217	0.00505163565208868
4455	tonzonium bromide	hsa04514	Cell adhesion molecules (CAMs)	24146_3676_3383_5175_3123_4099_3107_3126_3127_3125_10666_947_25945_26047	14	+	0.0210483254667401	0.561288679113069
4456	tonzonium bromide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	29	+	8.8914552641836e-09	7.11316421134688e-07
4457	tonzonium bromide	hsa04940	Type I diabetes mellitus	3382_3123_3107_3126_3127_3125	6	+	0.0384396525916161	0.615034441465858
4458	tonzonium bromide	hsa04080	Neuroactive ligand-receptor interaction	64106_2925_4157_1081	4	-	0.00413808404409266	0.167592403785753
4459	tonzonium bromide	hsa05016	Huntington's disease	7419_161_581	3	-	0.0195610257885037	0.249144879432665
4460	tonzonium bromide	hsa04740	Olfactory transduction	219464_26211	2	-	2.97548090156828e-07	2.41013953027031e-05
4461	tonzonium bromide	hsa04062	Chemokine signaling pathway	3717_6655_2931	3	-	0.0139133868761791	0.249144879432665
4462	tonzonium bromide	hsa05012	Parkinson's disease	7419	1	-	0.0104343053717622	0.249144879432665
4463	tonzonium bromide	hsa04020	Calcium signaling pathway	7419_2925_489	3	-	0.0191564894404037	0.249144879432665
4464	tonzonium bromide	hsa04270	Vascular smooth muscle contraction	5583	1	-	0.0215310389633167	0.249144879432665
4465	tyloxapol	hsa04310	Wnt signaling pathway	4088_51176	2	+	0.0352613803616647	0.402861377877713
4466	tyloxapol	hsa04740	Olfactory transduction	81697_81797_442194_390892	4	+	7.64261630611819e-05	0.00611409304489455
4467	tyloxapol	hsa04510	Focal adhesion	3082_3679_22798_1302_3381_3690_208_3908_5156_93408_1956_1950_29780_7148_55742_1277_4233_1301	18	+	0.0254163920327074	0.402861377877713
4468	tyloxapol	hsa04512	ECM-receptor interaction	7148_22798_1302_3381_3690_3908_1277_3679_1301	9	+	0.0426249465063344	0.402861377877713
4469	tyloxapol	hsa04010	MAPK signaling pathway	9479_3925_5156_4763_30814_4908_3553_2260_208_779_8550_1956_1950_91_4791_1432_782_5598_4208_4137_355_8911	22	+	0.0356136417030351	0.402861377877713
4470	tyloxapol	hsa04060	Cytokine-cytokine receptor interaction	64109_8743_5156_9180_3553_10850_3576_6368_2688_3082_7292_3953_2919_1956_1950_91_4233_3565_5617_8995_355_6374	22	+	0.0224898502842774	0.402861377877713
4471	tyloxapol	hsa04940	Type I diabetes mellitus	3382_942_2572_3111_355_3002_3553	7	+	0.00981136625246247	0.392454650098499
4472	tyloxapol	hsa04080	Neuroactive ligand-receptor interaction	5029_146_5618_4157_1081_3953_64106_7067_56288_136	10	-	0.00794971698375115	0.238491509512535
4473	tyloxapol	hsa04740	Olfactory transduction	157	1	-	4.31300182927649e-13	3.88170164634884e-11
4474	tyloxapol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3123_3126_3127_3125_8969_8370_8332_8359_8330_8331_8336_554313_6738_121504_8357_85235_3119_9555	29	-	0.000105377851022244	0.00474200329600098
4475	tyloxapol	hsa04060	Cytokine-cytokine receptor interaction	5618_3460_3953_3459_8742_8741_5154_7852_355_10913_91_4254_268	13	-	0.0421717471364133	0.759091448455439
4476	tyloxapol	hsa04020	Calcium signaling pathway	146_5257_490_136_489_7419_2064	7	-	0.0217055730890721	0.488375394504122
4477	metyrapone	hsa05332	Graft-versus-host disease	3553_3123_3126_3127_941_355_3125	7	+	0.00254534115973224	0.0670273172062823
4478	metyrapone	hsa04640	Hematopoietic cell lineage	2323_1435_3553_3690_3123_3126_3127_3125_915_2811	10	+	0.00409958411334349	0.0809667862385339
4479	metyrapone	hsa05320	Autoimmune thyroid disease	3123_3126_3127_941_355_3125	6	+	0.0254958297104945	0.251771318391133
4480	metyrapone	hsa04740	Olfactory transduction	8390_9635	2	+	4.19331777148339e-05	0.00331272103947188
4481	metyrapone	hsa04360	Axon guidance	5362_57715_10298_5365_7852_219699_4772_2534_3985_57144_7869	11	+	0.0249151136180536	0.251771318391133
4482	metyrapone	hsa04115	p53 signaling pathway	1647_1026_5366_581_4193_3479_355_3732	8	+	0.00938358404509309	0.123550523260392
4483	metyrapone	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0405482261223165	0.3203309863663
4484	metyrapone	hsa04062	Chemokine signaling pathway	7852_156	2	+	0.0362992542157734	0.318626787005122
4485	metyrapone	hsa05330	Allograft rejection	3123_3126_3127_941_355_3125	6	+	0.00645584869570818	0.102002409392189
4486	metyrapone	hsa04940	Type I diabetes mellitus	3553_3126_2572_3127_941_355_3123_3125	8	+	0.000772555187357999	0.030515929900641
4487	metyrapone	hsa04080	Neuroactive ligand-receptor interaction	5618_1081_7067_2150_9568_2149	6	-	0.0325476082632542	0.983101298451377
4488	metyrapone	hsa04740	Olfactory transduction	810_26211_109	3	-	3.2138242071424e-06	0.000273175057607104
4489	valinomycin	hsa05332	Graft-versus-host disease	3824_3109_3821_3113_3107_3126_3127_3125_355_3123_3119	11	+	0.00831016208758673	0.109418228550644
4490	valinomycin	hsa05010	Alzheimer's disease	1339_3710_317_355_2776_5532_3708_6622_4842	9	+	0.0399271039388322	0.32304656823237
4491	valinomycin	hsa05320	Autoimmune thyroid disease	3586_958_3109_3119_3113_3107_3126_3127_3125_355_3123	11	+	0.0466849472552093	0.335299290641216
4492	valinomycin	hsa05016	Huntington's disease	1339_7052_1639_317_2776_3092_3708_5468	8	+	0.00860592808825287	0.109418228550644
4493	valinomycin	hsa04740	Olfactory transduction	5566_4995_393046_816	4	+	3.83145778212412e-12	1.79665661031803e-10
4494	valinomycin	hsa04514	Cell adhesion molecules (CAMs)	9076_8506_23308_57863_3655_3676_958_3383_3123_3107_3126_3127_3125_933_5788_1462_4099_3109_3119_3113_6693_923_925_1000	24	+	0.0175936951040278	0.173982096028719
4495	valinomycin	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_8335_8348_8329_8294_3109_121504_8341_958_8370_3123_8366_3126_3127_3125_8969_8968_3586_717_8362_8358_8359_8330_8331_8336_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_83740_3013_3113_720_721	51	+	4.03743058498433e-12	1.79665661031803e-10
4496	valinomycin	hsa05219	Bladder cancer	1026_1029_7057_4193_5925_1956_7422_4609_2261	9	+	0.049795797975284	0.335299290641216
4497	valinomycin	hsa05310	Asthma	958_3109_3586_2207_3123_3126_3127_3125_3119_3113	10	+	0.00288042759117221	0.0854526852047756
4498	valinomycin	hsa04062	Chemokine signaling pathway	3717_5566_2773_7454_5290_7410_2829_10663_4793	9	+	0.013902383580441	0.154664017332406
4499	valinomycin	hsa05012	Parkinson's disease	1339_6622_317_7318	4	+	0.00488285414235126	0.0869148037338524
4500	valinomycin	hsa05330	Allograft rejection	958_3109_3586_3113_3107_3126_3127_3125_355_3123_3119	11	+	0.00446682132242353	0.0869148037338524
4501	valinomycin	hsa04940	Type I diabetes mellitus	3109_3119_3113_3107_3126_3127_2571_355_3123_3125	10	+	0.0301408950554447	0.268253965993458
4502	valinomycin	hsa05332	Graft-versus-host disease	3812_57292_3811_3804_3569_3126_3127_3803_3802_3123_3125_942	12	-	0.0149758221217602	0.188267478102128
4503	valinomycin	hsa04120	Ubiquitin mediated proteolysis	4214_996_7322_6502_5371_4281_9021	7	-	0.0112594823084325	0.16513907385701
4504	valinomycin	hsa05010	Alzheimer's disease	775_776_348_5533_3708_3709_488_6622_517_23236	10	-	0.00931729396163535	0.163984373724782
4505	valinomycin	hsa04612	Antigen processing and presentation	57292_3809_3808_3804_3806_3803_3802_6892_3306_3304_3305_3303_3123_3126_3127_3125_3812_3810_3811_3310_3449_3448_920_115653	24	-	0.00136216291810084	0.059935168396437
4506	valinomycin	hsa05016	Huntington's disease	8218_4899_7802_64446_3708_7416_9001_161_517_23236	10	-	0.00410562878606019	0.0903238332933242
4507	valinomycin	hsa04740	Olfactory transduction	8388_8387_1179_26531_26476_4991_26529_9635	8	-	7.4912288827906e-12	6.59228141685573e-10
4508	valinomycin	hsa05012	Parkinson's disease	7314_6622_7416_517_5413	5	-	0.00256143332628865	0.0751353775711337
4509	AG-013608	hsa05332	Graft-versus-host disease	57292_3824_3119_3821_3123_3122_3125_3107_3126_3127_3111_3558_3135_355_3811_5551_940_3133_941_3802_3113	21	+	0.0171953844928767	0.115454724452172
4510	AG-013608	hsa04120	Ubiquitin mediated proteolysis	23327_4214_51343_8945_5371_23759_6477_330_867_4193_7337_7329_996_8916_331_55236_10075_9246_9021_7428	20	+	0.012966650597336	0.101789327396635
4511	AG-013608	hsa05010	Alzheimer's disease	836_3710_2904_6392_642502_6622_6391_651820_3708_4137_5330_5532_4035_351_5534_810_824_102_355_6263	20	+	0.000161709591612894	0.00380017540290301
4512	AG-013608	hsa04910	Insulin signaling pathway	8660_2475_10000_867_5599_32_5140_6009_6194_25759_10211_51763_2002_810_5568_7249_5563_9021_5577_51422	20	+	0.0164805403455776	0.115454724452172
4513	AG-013608	hsa05016	Huntington's disease	4899_83447_6648_2904_7052_642502_6391_651820_246721_6392_3708_1211_90993_9001_55567_836_5330_161	18	+	7.11879093499307e-06	0.000334583173944674
4514	AG-013608	hsa03420	Nucleotide excision repair	5425_5111	2	+	0.00489990407196026	0.0575738728455331
4515	AG-013608	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_834_5532_2904_10452_5534	6	+	0.0386009014175008	0.182502993285037
4516	AG-013608	hsa04740	Olfactory transduction	26211_26212_5568_4991_135948_26664_8392_81697_390892_810_816	11	+	9.52636033130137e-26	8.95477871142329e-24
4517	AG-013608	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_2904_8368_8360_8362_8329_8294_8351_8342_8341_958_3122_3123_8366_3126_3127_3125_8969_8968_940_8370_718_717_8358_8359_8330_8331_8336_554313_8350_121504_8352_8353_8354_8355_8356_8357_8332_85235_3119_83740_3013_3113_3014_941_720_721_8970_3111_729	56	+	0.00989855970226284	0.0930464612012707
4518	AG-013608	hsa04110	Cell cycle	5591_51343_1021_9134_699_1029_4193_1028_996_8556_7040_8555_7042_5111_894_1017	16	+	0.012994382220847	0.101789327396635
4519	AG-013608	hsa04530	Tight junction	5521_6709_10000_9073_5581_7122_5578_998_5519_2036_84612_4625_1496_22808_5865_8531_26285_9223_5583	19	+	0.00911257169133148	0.0930464612012707
4520	AG-013608	hsa05110	Vibrio cholerae infection	5568_3784_5578_525_535_4583	6	+	0.0289796808471148	0.151338333312711
4521	AG-013608	hsa03022	Basal transcription factors	54457_2957_51616	3	+	0.047337954455875	0.202262169038739
4522	AG-013608	hsa04062	Chemokine signaling pathway	10000_7852_5330_5058_10235_112_7454_5568_3576_25759_6369_6367_6366_1237_1230_2919_998_2185_9844_10681_4793_6355_6358_6359_643_2792_6373_10803	28	+	0.00397292252500146	0.0533506739071625
4523	AG-013608	hsa05012	Parkinson's disease	83447_836_6392_642502_6622_6391_651820_7054_9246_7345_6531_9627	12	+	7.72272182915049e-05	0.00241978617313382
4524	AG-013608	hsa04620	Toll-like receptor signaling pathway	3593_3439_3451_10000_958_5599_3447_3576_3446_941_2353_3725_6373_5609	14	+	0.0270257490370056	0.149436494675207
4525	AG-013608	hsa04260	Cardiac muscle contraction	7169_6262_782_783_7170_9254_477_4635_23439_478_4625	11	+	0.0388304241031994	0.182502993285037
4526	AG-013608	hsa03010	Ribosome	6123_6192_6194_6205_6141_284393_439992_6234_6165_389342_6189	11	+	0.00322173933256368	0.0504739162101643
4527	AG-013608	hsa03020	RNA polymerase	246721	1	+	0.0201397670600941	0.119294231059028
4528	AG-013608	hsa03050	Proteasome	5689	1	+	0.000281140946721173	0.00528544979835805
4529	AG-013608	hsa05330	Allograft rejection	3593_958_3119_3123_3122_3126_3107_3113_3127_3111_3125_3135_355_5551_940_3133_941_3558	18	+	0.0436354879121562	0.195320755416318
4530	AG-013608	hsa04940	Type I diabetes mellitus	3593_3382_2572_3119_3123_3122_3558_3107_3126_3127_3111_2571_3135_355_5551_940_3133_941_3125_3113_5799	21	+	0.0203054010313239	0.119294231059028
4531	AG-013608	hsa05332	Graft-versus-host disease	3812_57292_3824_3119_3804_3107_3126_3127_3111_3802_3135_356_355_3811_5551_3803_3123_3125_3112_3569	20	-	0.014638299071644	0.224453919098541
4532	AG-013608	hsa04120	Ubiquitin mediated proteolysis	7337_4214_4281_652671_7332_6502_23759_5371_4193_330_22888_996_51465_8452_331_89910_51343_8065_26091_9021_55958	21	-	0.044078740381341	0.36865855591667
4533	AG-013608	hsa03320	PPAR signaling pathway	2710_33_9370_5360_5465_9415_5467_6257	8	-	0.0433047645079649	0.36865855591667
4534	AG-013608	hsa05010	Alzheimer's disease	2902_51806_317_5331_6622_4842_775_776_1339_5532_3708_3709_6868_488_801_23236_841_2081_4137_355_808_8851_805	23	-	0.00373073812292202	0.0686455814617652
4535	AG-013608	hsa05016	Huntington's disease	2902_4899_27113_1339_841_581_8218_317_3708_1213_5331_163_55567_1387_161_23236	16	-	6.21112241465003e-06	0.000190474420715934
4536	AG-013608	hsa03420	Nucleotide excision repair	5887_5111_2072	3	-	0.0244885827434367	0.279908700622498
4537	AG-013608	hsa04740	Olfactory transduction	51806_7932_26211_5613_23538_5616_1179_5132_26531_808_805_4991_801_9635_816	15	-	1.1961074270855e-20	1.10041883291866e-18
4538	AG-013608	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_6738_88_89_8329_8294_121504_81_958_3123_3126_3127_3125_8969_8968_55766_8370_717_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_2215_2214_3013_3112_3111_729	50	-	0.0273823728869835	0.279908700622498
4539	AG-013608	hsa03030	DNA replication	5111_4173	2	-	0.0231095679790742	0.279908700622498
4540	AG-013608	hsa05012	Parkinson's disease	2861_1339_7332_5413_317_51465_6622	7	-	9.8853815544762e-07	4.54727551505905e-05
4541	AG-013608	hsa03010	Ribosome	6187_440589_6224_6125_6192_6144_6234_6129	8	-	0.000599656831756579	0.0137921071304013
4542	streptomycin	hsa04910	Insulin signaling pathway	23433_9021_5602	3	+	0.0259304287382987	0.544539003504273
4543	streptomycin	hsa04740	Olfactory transduction	26539_7932_8390_9635_1179	5	+	3.00737150314173e-07	2.52619206263905e-05
4544	streptomycin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8347_8346_8344_8370_716_8359_8330_554313_6738_121504_8339_2215_3113_3111	25	+	0.00025050377458102	0.0105211585324028
4545	streptomycin	hsa04530	Tight junction	6709_84612_27134	3	+	0.0256947207788007	0.544539003504273
4546	streptomycin	hsa04260	Cardiac muscle contraction	6262	1	+	0.0446764681692909	0.750564665244087
4547	streptomycin	hsa04512	ECM-receptor interaction	3914_3691_1277_3678_9672_3675	6	-	0.0380401636605284	1
4548	tremorine	hsa05332	Graft-versus-host disease	3812_3824_3558_356_355_3811_3802	7	+	0.0204057969239467	0.723289774040129
4549	tremorine	hsa04740	Olfactory transduction	26211_26212_26707_5593	4	+	2.06180265195029e-06	0.000177315028067725
4550	tremorine	hsa04510	Focal adhesion	5599_858_1292_5058_1950	5	+	0.0343097048870476	0.723289774040129
4551	tremorine	hsa04810	Regulation of actin cytoskeleton	10095_2934_5058_1950_10552_2247	6	+	0.0420517310488447	0.723289774040129
4552	tremorine	hsa03010	Ribosome	6165	1	+	0.0307870357467574	0.723289774040129
4553	tremorine	hsa03440	Homologous recombination	5890_7156_25788_10111	4	-	0.049552034873741	0.51675693511187
4554	tremorine	hsa05010	Alzheimer's disease	5534_488	2	-	0.0255105297942681	0.442821382249741
4555	tremorine	hsa04080	Neuroactive ligand-receptor interaction	2846_146_2908	3	-	0.00527516188996067	0.192543408983564
4556	tremorine	hsa05200	Pathways in cancer	4149_4088_6502_51588_7423_8321_4791	7	-	0.0303302316609412	0.442821382249741
4557	tremorine	hsa04740	Olfactory transduction	818	1	-	7.54805681527077e-07	5.51008147514766e-05
4558	tremorine	hsa04630	Jak-STAT signaling pathway	8651_51588	2	-	0.0494315132939392	0.51675693511187
4559	tremorine	hsa04060	Cytokine-cytokine receptor interaction	8718_7423_3579_8741	4	-	0.0145470989196285	0.353979407044293
4560	moxisylyte	hsa04130	SNARE interactions in vesicular transport	8417_6844	2	+	0.0281430708517663	0.675433700442391
4561	moxisylyte	hsa04070	Phosphatidylinositol signaling system	8394_8396_23396_64768_5336	5	-	0.0400762617033482	0.512976149802857
4562	moxisylyte	hsa04080	Neuroactive ligand-receptor interaction	64106	1	-	0.0328713783888333	0.512976149802857
4563	moxisylyte	hsa04740	Olfactory transduction	5567	1	-	0.00167624308094183	0.0536397785901386
4564	moxisylyte	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8343_8336_8339_8347_8346_8344	12	-	0.000276293531118023	0.0176827859915535
4565	moxisylyte	hsa04060	Cytokine-cytokine receptor interaction	355	1	-	0.0339851411534415	0.512976149802857
4566	epirizole	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	+	0.00472771581811366	0.110195271730947
4567	epirizole	hsa05320	Autoimmune thyroid disease	3135_3105_3106_649853	4	+	0.0100936574255413	0.15140486138312
4568	epirizole	hsa04612	Antigen processing and presentation	3135_3105_3106_649853	4	+	0.0497118044851575	0.497118044851575
4569	epirizole	hsa04740	Olfactory transduction	81797	1	+	0.0318206650307395	0.381847980368874
4570	epirizole	hsa05330	Allograft rejection	3135_3105_3106_649853	4	+	0.00339483616283194	0.110195271730947
4571	epirizole	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853	4	+	0.00550976358654737	0.110195271730947
4572	epirizole	hsa05332	Graft-versus-host disease	3108_3105_3126_3127_3125_3123	6	-	0.00523144663604968	0.0728027747227827
4573	epirizole	hsa05320	Autoimmune thyroid disease	3108_3105_3126_3127_3125_3123	6	-	0.0141176887158016	0.147227325179074
4574	epirizole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3014_3125_8359_8294_8367_554313_8368_121504_3108	20	-	6.08231574783046e-07	4.44009049591624e-05
4575	epirizole	hsa05310	Asthma	3123_3125_3108_3127_3126	5	-	0.00598378970324241	0.0728027747227827
4576	epirizole	hsa04060	Cytokine-cytokine receptor interaction	1436	1	-	0.00257989451190809	0.0614648220320135
4577	epirizole	hsa05330	Allograft rejection	3108_3105_3126_3127_3125_3123	6	-	0.00336793545380896	0.0614648220320135
4578	epirizole	hsa04940	Type I diabetes mellitus	3108_3105_3126_3127_2571_3123_3125	7	-	0.00150599351821017	0.0549687634146712
4579	imipramine	hsa04740	Olfactory transduction	26211	1	+	0.00353478575855988	0.0989740012396766
4580	imipramine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_942	26	+	1.29134936247008e-15	7.23155642983245e-14
4581	imipramine	hsa05222	Small cell lung cancer	3688_3910_317_331_330_3685	6	+	0.0128975695984851	0.240754632505055
4582	imipramine	hsa04070	Phosphatidylinositol signaling system	8394_3633_808_801_805_23236	6	-	0.0148383807944823	0.361756071937309
4583	imipramine	hsa05200	Pathways in cancer	1869_5888	2	-	0.0183943765391852	0.361756071937309
4584	imipramine	hsa04740	Olfactory transduction	801_808_805	3	-	0.0273798740959356	0.391598407714103
4585	imipramine	hsa04720	Long-term potentiation	801_808_107_805_23236	5	-	0.0455131237678675	0.447545717050697
4586	imipramine	hsa03020	RNA polymerase	5432_246721_5439_548644	4	-	0.00810914792024726	0.361756071937309
4587	imipramine	hsa04270	Vascular smooth muscle contraction	5581_808_23365_801_107_805_23236	7	-	0.0331863057384833	0.391598407714103
4588	homatropine	hsa05332	Graft-versus-host disease	3812_57292_3811_3804_3803_3802_3135	7	+	0.000384602414933173	0.00910225715341843
4589	homatropine	hsa04650	Natural killer cell mediated cytotoxicity	3812_57292_3811_3809_3808_3440_3804_6655_3806_3810_3803_3802_3135_5532_3845_8794	16	+	5.92752091243061e-06	0.000210426992391287
4590	homatropine	hsa04612	Antigen processing and presentation	3812_57292_3811_3809_3808_3440_3804_3806_3810_3803_3802_3135_811_115653	14	+	9.34502203439851e-07	6.63496564442294e-05
4591	homatropine	hsa04912	GnRH signaling pathway	6655_2776_3708_3845_5603_5338_5609	7	+	0.0417904817188738	0.74178105051001
4592	homatropine	hsa05221	Acute myeloid leukemia	861_5914_11040_673	4	-	0.0205184094798966	1
4593	allantoin	hsa05131	Shigellosis	7278_7280_113457_347733	4	-	0.0221521422634581	0.556576796509571
4594	allantoin	hsa05130	Pathogenic Escherichia coli infection	7278_7280_113457_347733	4	-	0.0221521422634581	0.556576796509571
4595	allantoin	hsa04540	Gap junction	7278_5607_7280_113457_347733	5	-	0.0309209331394206	0.556576796509571
4596	todralazine	hsa04670	Leukocyte transendothelial migration	5579_88_26285_5603_5175	5	+	0.0380636540946127	1
4597	todralazine	hsa04740	Olfactory transduction	26333	1	+	0.0471055774427457	1
4598	todralazine	hsa04080	Neuroactive ligand-receptor interaction	2149	1	-	0.00750091973044751	0.182522380107556
4599	todralazine	hsa04740	Olfactory transduction	5613_5616	2	-	0.0016234761991335	0.0592568812683728
4600	todralazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3113_8359_8294_8367_554313_121504	15	-	5.19696067186177e-05	0.00379378129045909
4601	todralazine	hsa04370	VEGF signaling pathway	5595_5829_5881_5335_7422_5534	6	-	0.0319972623350774	0.46716003009213
4602	todralazine	hsa05219	Bladder cancer	1869_7422_5595_7057_369	5	-	0.0108531636446472	0.198070236514811
4603	todralazine	hsa04810	Regulation of actin cytoskeleton	5595_5829_2909_3678_54961_5154_8394_5881_7430_324_369_2149	12	-	0.0435232835610174	0.508129171281816
4604	dexpanthenol	hsa04916	Melanogenesis	107_816_1857	3	+	0.0317161251102666	0.61761440168519
4605	dexpanthenol	hsa04930	Type II diabetes mellitus	8660_5581	2	+	0.0368486730590384	0.61761440168519
4606	dexpanthenol	hsa05332	Graft-versus-host disease	3135_3123_3126_3127_3125	5	-	0.00151237887920548	0.0371335708881467
4607	dexpanthenol	hsa04640	Hematopoietic cell lineage	3123_3126_3127_2057_3125	5	-	0.0253732025355783	0.186568792673853
4608	dexpanthenol	hsa05320	Autoimmune thyroid disease	3135_3123_3126_3127_3125	5	-	0.00385165237434462	0.0425257217099336
4609	dexpanthenol	hsa04612	Antigen processing and presentation	3135_3123_3126_3127_3125	5	-	0.0275265431813881	0.186568792673853
4610	dexpanthenol	hsa04514	Cell adhesion molecules (CAMs)	2734_3123_3126_3127_3125_3135_5792_6693	8	-	0.00418285787310822	0.0425257217099336
4611	dexpanthenol	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.00313136133770117	0.0425257217099336
4612	dexpanthenol	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0195956239110533	0.170761865510607
4613	dexpanthenol	hsa05330	Allograft rejection	3135_3123_3126_3127_3125	5	-	0.00100592577482153	0.0371335708881467
4614	dexpanthenol	hsa04940	Type I diabetes mellitus	3135_3123_3126_3127_3125	5	-	0.00182624119122033	0.0371335708881467
4615	benzonatate	hsa05322	Systemic lupus erythematosus	474382_959_474381_83740_3111_88	6	+	0.0427770035406753	1
4616	benzonatate	hsa04080	Neuroactive ligand-receptor interaction	64106	1	-	0.0328713783888333	0.547856306480555
4617	benzonatate	hsa04740	Olfactory transduction	157	1	-	0.00167624308094183	0.0838121540470915
4618	benzonatate	hsa05322	Systemic lupus erythematosus	85235_8330_3014_8332_8969_8331_8329_8336	8	-	0.0254525875733712	0.547856306480555
4619	thapsigargin	hsa04916	Melanogenesis	64764_5578_4286_1857	4	+	0.0121205774647769	0.0868641384975678
4620	thapsigargin	hsa04130	SNARE interactions in vesicular transport	55850_6811_9527_10282_662_53407_9570_8675_9554_6844_6845	11	+	0.0173526937259693	0.099488777362224
4621	thapsigargin	hsa05010	Alzheimer's disease	22926_55851_836_11261_9451_5533_5663_3709_23385_5534_6868_6390	12	+	0.0444991524336152	0.201417216278469
4622	thapsigargin	hsa04080	Neuroactive ligand-receptor interaction	5618_7068_3953_2908_5025_64106_7067	7	+	9.57023579051699e-07	8.23040277984461e-05
4623	thapsigargin	hsa05320	Autoimmune thyroid disease	3135	1	+	0.0267014168234982	0.131910236997442
4624	thapsigargin	hsa04670	Leukocyte transendothelial migration	10451_7409_5600_5603_5578	5	+	0.00897121671714638	0.0754863366761926
4625	thapsigargin	hsa05016	Huntington's disease	246721_51164_5434_7052_1639_6390_6667_10126_836_64764_5481	11	+	0.0148284555625356	0.0910890841698616
4626	thapsigargin	hsa04514	Cell adhesion molecules (CAMs)	3135_3655_5817_999_23308	5	+	0.00348804710835167	0.0395354365114486
4627	thapsigargin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8349_8348_8329_8294_121504_723790_8969_8968_8370_92815_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_8970	39	+	3.11743168121875e-05	0.00134049562292406
4628	thapsigargin	hsa04710	Circadian rhythm - mammal	8864_5187_8553_406_9572_79365_1407	7	+	0.0036777150243208	0.0395354365114486
4629	thapsigargin	hsa04530	Tight junction	4619_5590_55870_5583_5578	5	+	0.00250564814735648	0.0359142901121095
4630	thapsigargin	hsa04062	Chemokine signaling pathway	2309_5590_7454_3551_6774_6464_10451_7409_1398_5058_4790_4793	12	+	0.0222729281563577	0.119716988840423
4631	thapsigargin	hsa04810	Regulation of actin cytoskeleton	7454_9138_2335_3985_8394_10672_5058_1398_6548_10451_7409_2263_3655_3675	14	+	0.0140048007414763	0.0910890841698616
4632	thapsigargin	hsa05012	Parkinson's disease	7327_836_6390_51465_27429_5481	6	+	0.00897926271854564	0.0754863366761926
4633	thapsigargin	hsa04260	Cardiac muscle contraction	6548	1	+	0.00122521768150875	0.0210737441219505
4634	thapsigargin	hsa04060	Cytokine-cytokine receptor interaction	5618_2057_3953_3459_3572_50615_7422_90_8795_83729_51330	11	+	6.7514717487622e-05	0.00193542190131183
4635	thapsigargin	hsa03010	Ribosome	6234_6137	2	+	0.00120797827574491	0.0210737441219505
4636	thapsigargin	hsa04020	Calcium signaling pathway	5578_11261_5025_5533_7220_5333_3709_5534_490_5481	10	+	0.00965522910974557	0.0754863366761926
4637	thapsigargin	hsa05217	Basal cell carcinoma	1857	1	+	0.0276091193715576	0.131910236997442
4638	thapsigargin	hsa05010	Alzheimer's disease	1340_5331_317	3	-	0.0498818765920741	0.428047029835232
4639	thapsigargin	hsa04080	Neuroactive ligand-receptor interaction	9568_7434_2908_1081_4886	5	-	0.0259336707201681	0.428047029835232
4640	thapsigargin	hsa05016	Huntington's disease	1340_5331_317	3	-	0.0369668878069196	0.428047029835232
4641	thapsigargin	hsa04740	Olfactory transduction	5613_5616	2	-	2.10795854420246e-06	0.000177068517713007
4642	thapsigargin	hsa05215	Prostate cancer	5295_9134_5296_6655_596_5155_898_367_1017	9	-	0.0490783624479566	0.428047029835232
4643	thapsigargin	hsa03030	DNA replication	10714_5427_5111_5558_4173	5	-	0.0432444512268716	0.428047029835232
4644	thapsigargin	hsa03022	Basal transcription factors	11037_6884_51616_2969_728198	5	-	0.0472541448001823	0.428047029835232
4645	thapsigargin	hsa05222	Small cell lung cancer	5295_3912_9134_5296_598_596_317_7188_898_6502_1017	11	-	0.00608817397232652	0.255703306837714
4646	ascorbic acid	hsa05016	Huntington's disease	5331_3708	2	+	0.0181520351867528	0.662549284316477
4647	ascorbic acid	hsa04740	Olfactory transduction	810_26211	2	+	9.42272387105964e-06	0.000687858842587354
4648	ascorbic acid	hsa05012	Parkinson's disease	6622	1	+	0.0317869971452826	0.773483597201877
4649	ascorbic acid	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8336	7	-	0.0252236104123388	1
4650	hydroflumethiazide	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	+	0.00107326168563954	0.022689996258202
4651	hydroflumethiazide	hsa05320	Autoimmune thyroid disease	3135_3105_3106_649853	4	+	0.0023910481410965	0.0322791499048028
4652	hydroflumethiazide	hsa04612	Antigen processing and presentation	3135_3105_3106_649853	4	+	0.013493960732424	0.121445646591816
4653	hydroflumethiazide	hsa04514	Cell adhesion molecules (CAMs)	3135_3105_3106_5817_649853	5	+	0.0121843158968029	0.121445646591816
4654	hydroflumethiazide	hsa05330	Allograft rejection	3135_3105_3106_649853	4	+	0.000758762343697103	0.022689996258202
4655	hydroflumethiazide	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853	4	+	0.00126055534767789	0.022689996258202
4656	hydroflumethiazide	hsa04210	Apoptosis	5533_598_5566_5567_8837	5	-	0.020485113435409	0.782418110448804
4657	acetazolamide	hsa04640	Hematopoietic cell lineage	3690_3581_925	3	+	0.0334688327153247	0.630356832370786
4658	acetazolamide	hsa05014	Amyotrophic lateral sclerosis (ALS)	598_4217_5606_834	4	-	0.0298167696480739	0.678192586246771
4659	acetazolamide	hsa04710	Circadian rhythm - mammal	406_8863	2	-	0.0339674474721561	0.678192586246771
4660	acetazolamide	hsa04540	Gap junction	7278_6714_5155_113457_5607	5	-	0.0433231492780001	0.678192586246771
4661	aminocaproic acid	hsa04510	Focal adhesion	4638_3910_3695_6714_1291_55742	6	+	0.0259229367531145	0.380203072379013
4662	aminocaproic acid	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	10392_6714_5781	3	+	0.0445374961712682	0.48991245788395
4663	aminocaproic acid	hsa03450	Non-homologous end-joining	27343_7518	2	+	0.0123101252866745	0.270822756306839
4664	aminocaproic acid	hsa04540	Gap junction	5598_6714_113457_7278_2977	5	+	0.00392264596287144	0.172596422366343
4665	aminocaproic acid	hsa05332	Graft-versus-host disease	3135_3123_3126_3127_3125	5	-	0.00412729836921924	0.0817529559399273
4666	aminocaproic acid	hsa05200	Pathways in cancer	3688_4149_861_675_5155_1613_1856_4088_405_3845_6934_6502_91_2271	14	-	0.0400428655845	0.390417939448875
4667	aminocaproic acid	hsa05320	Autoimmune thyroid disease	3135_3123_3126_3127_3125	5	-	0.0100814294582427	0.11233592824899
4668	aminocaproic acid	hsa05322	Systemic lupus erythematosus	85235_3123_3126_3127_3125_8332_8969_8331_8336_8329_8330	11	-	0.000818776735024822	0.0638645853319361
4669	aminocaproic acid	hsa04710	Circadian rhythm - mammal	1454_9572_8863	3	-	0.00524057409871329	0.0817529559399273
4670	aminocaproic acid	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.00710730540460966	0.0923949702599256
4671	aminocaproic acid	hsa05330	Allograft rejection	3135_3123_3126_3127_3125	5	-	0.0027875578129311	0.0817529559399273
4672	aminocaproic acid	hsa04940	Type I diabetes mellitus	3135_3123_3126_3127_3125	5	-	0.0049459398732897	0.0817529559399273
4673	(-)-isoprenaline	hsa04670	Leukocyte transendothelial migration	9076_29895_1432_5829_7852_88_5600	7	+	0.0268143892645187	0.483518541304042
4674	(-)-isoprenaline	hsa04740	Olfactory transduction	810	1	+	0.00247112864017181	0.091431759686357
4675	(-)-isoprenaline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_88_8294_8367_554313_121504_3109	16	+	6.15707379785781e-07	4.55623461041478e-05
4676	(-)-isoprenaline	hsa04710	Circadian rhythm - mammal	8864_5187	2	+	0.0439322194821785	0.541830706946868
4677	(-)-isoprenaline	hsa05218	Melanoma	8817_208_2247_4193_2258	5	+	0.0284201059263572	0.483518541304042
4678	(-)-isoprenaline	hsa04060	Cytokine-cytokine receptor interaction	7852	1	+	0.0326701717097326	0.483518541304042
4679	(-)-isoprenaline	hsa04080	Neuroactive ligand-receptor interaction	2908_4157	2	-	0.0361057824251333	0.7512639737077
4680	(-)-isoprenaline	hsa04740	Olfactory transduction	818	1	-	0.000253935638586774	0.0177754947010742
4681	(-)-isoprenaline	hsa05210	Colorectal cancer	6934_1956_324_5602_3725_4233	6	-	0.0419078758472061	0.7512639737077
4682	chlorambucil	hsa05332	Graft-versus-host disease	3812_3119_3123_3107_3126_3127_3125	7	+	0.00206886920759591	0.0382740803405243
4683	chlorambucil	hsa05010	Alzheimer's disease	348	1	+	0.015451931306315	0.16334898809533
4684	chlorambucil	hsa05320	Autoimmune thyroid disease	3119_3123_3107_3126_3127_3125	6	+	0.021747623099015	0.190674994558562
4685	chlorambucil	hsa04612	Antigen processing and presentation	3812_3119_3805_3123_3107_3126_3127_3125	8	+	0.0276567600834386	0.204660024617446
4686	chlorambucil	hsa04740	Olfactory transduction	7932	1	+	1.23788797164225e-05	0.000458018549507633
4687	chlorambucil	hsa04514	Cell adhesion molecules (CAMs)	3119_3123_1272_3107_3126_3127_3125_23308_6693_3684_1462	11	+	0.0231902020409062	0.190674994558562
4688	chlorambucil	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8341_8340_3123_3126_3127_3125_8370_8359_554313_121504_3119_720_721	23	+	5.18610804797918e-08	3.83771995550459e-06
4689	chlorambucil	hsa05310	Asthma	3119_2207_3123_3126_3127_3125	6	+	0.00191661871965266	0.0382740803405243
4690	chlorambucil	hsa05330	Allograft rejection	3119_3123_3107_3126_3127_3125	6	+	0.00541353898418081	0.080120376965876
4691	chlorambucil	hsa04940	Type I diabetes mellitus	3119_3123_3107_3126_3127_3125	6	+	0.010118961968049	0.124800530939271
4692	chlorambucil	hsa05214	Glioma	1021_208_6655_5335_816	5	-	0.0487911956674146	0.534036375871946
4693	chlorambucil	hsa04640	Hematopoietic cell lineage	960_3552_2057_3589_933_3675	6	-	0.049187560935574	0.534036375871946
4694	chlorambucil	hsa04740	Olfactory transduction	816	1	-	0.000254596725577247	0.00967467557193539
4695	chlorambucil	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_88_8294_8367_554313_121504	15	-	4.64007568002974e-05	0.0035264575168226
4696	chlorambucil	hsa05221	Acute myeloid leukemia	208_6655_5371_652671_11040	5	-	0.0351910250529954	0.534036375871946
4697	chlorambucil	hsa05223	Non-small cell lung cancer	6789_208_6655_5335_1021	5	-	0.0258795788712189	0.534036375871946
4698	chlorambucil	hsa02010	ABC transporters	6891_19_20_11194	4	-	0.0470338313643512	0.534036375871946
4699	ramipril	hsa04070	Phosphatidylinositol signaling system	8394_23533_5333_3709	4	+	0.0324521192217598	1
4700	ramipril	hsa04080	Neuroactive ligand-receptor interaction	1081_2149_1909	3	-	3.86214626655342e-05	0.0031669599385738
4701	ramipril	hsa04514	Cell adhesion molecules (CAMs)	24146_5792	2	-	0.00862614661736168	0.176836005655914
4702	ramipril	hsa04062	Chemokine signaling pathway	2309_6655_5290_115_5332_4793	6	-	0.0314119147286759	0.515155401550285
4703	ramipril	hsa05012	Parkinson's disease	4714	1	-	0.0015373327207857	0.0420204277014758
4704	ramipril	hsa04260	Cardiac muscle contraction	783	1	-	0.0442645730376372	0.604949164847708
4705	ramipril	hsa04060	Cytokine-cytokine receptor interaction	27242_8744_355_9180_3572	5	-	0.000434452124893446	0.0178125371206313
4706	pregnenolone	hsa05131	Shigellosis	7278_9181_113457_8976_10382	5	+	0.0429334323935318	1
4707	pregnenolone	hsa05130	Pathogenic Escherichia coli infection	7278_9181_113457_8976_10382	5	+	0.0429334323935318	1
4708	pregnenolone	hsa04740	Olfactory transduction	810	1	-	0.0457283284698548	0.983159062101878
4709	pregnenolone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8359_8370_8294_554313_121504	14	-	4.36818634118614e-08	1.87832012671004e-06
4710	R-atenolol	hsa04910	Insulin signaling pathway	8660	1	+	0.0470697077702323	0.759014107814753
4711	R-atenolol	hsa05016	Huntington's disease	6667	1	+	0.0077438567313224	0.302010412521574
4712	R-atenolol	hsa04740	Olfactory transduction	5137_26211	2	+	1.9847155207215e-05	0.00154807810616277
4713	R-atenolol	hsa05012	Parkinson's disease	6531	1	+	0.0462646797697766	0.759014107814753
4714	R-atenolol	hsa05010	Alzheimer's disease	7381	1	-	0.0154887810395437	0.254016009048517
4715	R-atenolol	hsa04080	Neuroactive ligand-receptor interaction	7442_7068	2	-	0.00679687887925378	0.185781356032937
4716	R-atenolol	hsa05016	Huntington's disease	7381	1	-	0.0107586433088101	0.220552187830607
4717	R-atenolol	hsa04740	Olfactory transduction	5566	1	-	7.91468369705668e-06	0.000649004063158648
4718	R-atenolol	hsa05322	Systemic lupus erythematosus	727	1	-	0.0457363354263737	0.584848186883167
4719	R-atenolol	hsa04060	Cytokine-cytokine receptor interaction	3455	1	-	0.000795867731949319	0.0326305770099221
4720	R-atenolol	hsa04020	Calcium signaling pathway	115_5566	2	-	0.0499260647339289	0.584848186883167
4721	azaperone	hsa04740	Olfactory transduction	157	1	+	8.02953981878795e-06	0.000698569964234552
4722	azaperone	hsa04740	Olfactory transduction	5613_157	2	-	0.00160167797179698	0.118524169912977
4723	azaperone	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	50617_6868_5603_3725_6714_5335	6	-	0.0218490753319069	0.808415787280555
4724	sotalol	hsa04070	Phosphatidylinositol signaling system	8394_3708_3633_5333_5335_23236	6	-	0.0151003232692566	0.327173670833893
4725	sotalol	hsa05322	Systemic lupus erythematosus	8358_85235_8968_3013_8330_8332_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357	18	-	8.10382501569756e-08	5.26748626020341e-06
4726	sotalol	hsa04540	Gap junction	1813_7278_113457_2776_115_3708_23236	7	-	0.0112718072307257	0.327173670833893
4727	sitosterol	hsa05332	Graft-versus-host disease	3113_3126_3127_3123_3125	5	+	0.00115541904000397	0.0234101631126769
4728	sitosterol	hsa04640	Hematopoietic cell lineage	3123_3126_3127_3125_7850_1378	6	+	0.00498951886008809	0.0529632037410561
4729	sitosterol	hsa05320	Autoimmune thyroid disease	3113_3126_3127_3123_3125	5	+	0.00297061878003074	0.0398062916524119
4730	sitosterol	hsa04612	Antigen processing and presentation	3123_3126_3127_3125_3310_3113	6	+	0.00553346904757303	0.0529632037410561
4731	sitosterol	hsa05322	Systemic lupus erythematosus	3123_3126_3127_3125_8341_3113	6	+	0.0427770035406753	0.318451026358361
4732	sitosterol	hsa05310	Asthma	3123_3126_3127_3113_3125	5	+	0.000288207436471272	0.0193098982435752
4733	sitosterol	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0166998559191926	0.139861293323238
4734	sitosterol	hsa05330	Allograft rejection	3126_3113_3127_3123_3125	5	+	0.000765835293985578	0.0234101631126769
4735	sitosterol	hsa04940	Type I diabetes mellitus	3113_3126_3127_3123_3125	5	+	0.00139762167836877	0.0234101631126769
4736	sitosterol	hsa04080	Neuroactive ligand-receptor interaction	3953_3354_4158_2925_56288	5	-	0.0463028217558367	0.359252366355953
4737	sitosterol	hsa04740	Olfactory transduction	26212_157_4991	3	-	4.26109001977813e-05	0.00332365021542694
4738	sitosterol	hsa04110	Cell cycle	1028	1	-	0.0451489085492641	0.359252366355953
4739	sitosterol	hsa05012	Parkinson's disease	6622	1	-	0.0330389792827607	0.359252366355953
4740	sitosterol	hsa04620	Toll-like receptor signaling pathway	7097_1326_51135_3455_5296_208_6772_5603_10454_7187	10	-	0.0333338839229477	0.359252366355953
4741	sitosterol	hsa05330	Allograft rejection	3123_3126_3127_3133_3125	5	-	0.0410274133713901	0.359252366355953
4742	methoxamine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_717_8368_8359_8294_8367_554313_121504	15	+	0.000143852355740275	0.00992581254607897
4743	methoxamine	hsa05131	Shigellosis	7278_7454_113457	3	-	0.00120054039443906	0.0114051337471711
4744	methoxamine	hsa05130	Pathogenic Escherichia coli infection	7278_7454_113457	3	-	0.00120054039443906	0.0114051337471711
4745	methoxamine	hsa04540	Gap junction	7278_113457	2	-	0.0453602851325868	0.287281805839716
4746	rifampicin	hsa04070	Phosphatidylinositol signaling system	8394_5333_3709_8526	4	+	0.0488022775981728	1
4747	rifampicin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_2215_8370_2214_3122_8368_8366_8359_8294_8367_554313_121504_8364	17	+	2.07599016436673e-09	1.47395301670038e-07
4748	rifampicin	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0172073619700195	0.610861349935692
4749	rifampicin	hsa04740	Olfactory transduction	818	1	-	0.0113627622120339	0.369289771891102
4750	rifampicin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3119_3113	23	-	6.3175321566227e-14	4.10639590180476e-12
4751	nifuroxazide	hsa05211	Renal cell carcinoma	5293_201163_405_3845_7422_3725	6	+	0.0173564239153649	0.316754736455409
4752	nifuroxazide	hsa04740	Olfactory transduction	26212	1	+	0.000547267868566916	0.0399505544053849
4753	nifuroxazide	hsa05219	Bladder cancer	3576_3845_4193_7422	4	+	0.0332562067373262	0.485540618364962
4754	nifuroxazide	hsa04115	p53 signaling pathway	1647_5366_4193_472_5054_651610	6	+	0.0145256651409798	0.316754736455409
4755	nifuroxazide	hsa03450	Non-homologous end-joining	5591_7518_10111	3	+	0.00957604737408777	0.316754736455409
4756	nifuroxazide	hsa05322	Systemic lupus erythematosus	3013_720_721_8343_8351_8339_8347_8346_8344	9	-	0.00335172447273208	0.187696570472996
4757	nifuroxazide	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0248849431528665	0.696778408280262
4758	tetramisole	hsa04740	Olfactory transduction	26476	1	+	0.00517240453328015	0.168103147331605
4759	tetramisole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_8359_8294_8367_554313_121504	15	+	8.51407771861203e-07	5.53415051709782e-05
4760	tetramisole	hsa05211	Renal cell carcinoma	3725_405_2271_6655_201163	5	-	0.0181156487225315	0.615932056566071
4761	tetramisole	hsa05322	Systemic lupus erythematosus	85235_3119_8330_8332_8969_8331_8329_8336	8	-	0.0106422130337086	0.615932056566071
4762	tiaprofenic acid	hsa05010	Alzheimer's disease	6263	1	+	0.00522165187769987	0.216698552924545
4763	tiaprofenic acid	hsa04740	Olfactory transduction	5568_5566_4992_26692_816	5	+	0.000669479909633289	0.055566832499563
4764	tiaprofenic acid	hsa05310	Asthma	3123_3126_3127_3113_3125	5	+	0.0194978523009629	0.403104228138669
4765	tiaprofenic acid	hsa05012	Parkinson's disease	7318	1	+	0.0218711894234331	0.403104228138669
4766	tiaprofenic acid	hsa05330	Allograft rejection	3126_3113_3127_3123_3125	5	+	0.0431953829613096	0.597536130964783
4767	tiaprofenic acid	hsa04940	Type I diabetes mellitus	3382_3123_3126_3127_3125_3113	6	+	0.0242833872372692	0.403104228138669
4768	tiaprofenic acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8367_8370_8366_8368_8359_8294_554313_121504_8364	14	-	3.10261712352789e-10	1.67541324670506e-08
4769	tiaprofenic acid	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_5781_51382_5602	4	-	0.00599033999586549	0.161739179888368
4770	colistin	hsa04740	Olfactory transduction	26211_7932_816	3	+	0.00759862840334894	0.202630090755972
4771	colistin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3109_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	26	+	2.226477695284e-12	1.7811821562272e-10
4772	colistin	hsa04210	Apoptosis	3553_5575_317_5290_472_355_8837_651610	8	+	0.00671048260390647	0.202630090755972
4773	lovastatin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_8970	33	+	1.66513018816113e-14	1.26549894300246e-12
4774	lovastatin	hsa04210	Apoptosis	843_581_5575_5290_472_5534_8837_651610_8794	9	+	0.0118666986819552	0.450934549914298
4775	lovastatin	hsa03020	RNA polymerase	5432_246721_5439_548644	4	+	0.0349517806731214	0.885445110385742
4776	lovastatin	hsa04540	Gap junction	7278_3708_113457	3	-	0.0345805547517935	0.622801113969115
4777	sisomicin	hsa04740	Olfactory transduction	5137_5593_26532	3	+	0.0147268604099909	0.4859863935297
4778	sisomicin	hsa05322	Systemic lupus erythematosus	958_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	+	0.000972831774062073	0.0642068970880968
4779	conessine	hsa04740	Olfactory transduction	5132	1	+	0.0161038528923037	0.934023467753615
4780	conessine	hsa04080	Neuroactive ligand-receptor interaction	7067_5031_9170	3	-	0.00381955379991998	0.101854767997866
4781	conessine	hsa04910	Insulin signaling pathway	10000_2319_5613_9470_5616_6464_5562_8835_23265_5792_5290_5565_810	13	-	0.0285031316759293	0.380041755679057
4782	conessine	hsa04740	Olfactory transduction	810_5613_5616	3	-	1.97959226772412e-05	0.000791836907089648
4783	conessine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8347_8346_8344_3123_3126_3127_3125_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235_3014_9555	32	-	1.75715474555533e-11	1.40572379644426e-09
4784	conessine	hsa04210	Apoptosis	10000_842_581_5613_11261_839_5616_5290_596	9	-	0.0460535899867562	0.460535899867562
4785	conessine	hsa05210	Colorectal cancer	10000_842_581_4089_596_5881_5290_4437_91_3725	10	-	0.0110839952002154	0.221679904004308
4786	conessine	hsa05222	Small cell lung cancer	4149_842_596_10000_5290_51588_9618_3673_1017	9	-	0.0417437303030478	0.460535899867562
4787	conessine	hsa04940	Type I diabetes mellitus	3123_3126_3127_2571_1363_3125	6	-	0.0264694891251076	0.380041755679057
4788	co-dergocrine mesilate	hsa05131	Shigellosis	7454_5578_7278_113457_7430_6093_8976	7	+	0.0289240745735362	0.819515446250192
4789	co-dergocrine mesilate	hsa05130	Pathogenic Escherichia coli infection	7454_5578_7278_113457_7430_6093_8976	7	+	0.0289240745735362	0.819515446250192
4790	co-dergocrine mesilate	hsa04740	Olfactory transduction	26211_5593_8390_5132_816	5	+	0.000237526985276061	0.0201897937484652
4791	co-dergocrine mesilate	hsa04512	ECM-receptor interaction	960_3693_1288_3685_3918_3679_1293_1290_6696	9	+	0.0426249465063344	0.83958705649711
4792	co-dergocrine mesilate	hsa04910	Insulin signaling pathway	51806_5575_10211_6655_5140	5	-	0.0478781715921736	0.883418660332225
4793	co-dergocrine mesilate	hsa05322	Systemic lupus erythematosus	85235_8969_8332_8330_8331_8329_8336	7	-	0.00487859975463617	0.278080186014262
4794	co-dergocrine mesilate	hsa04210	Apoptosis	3556_5575_3553_5534	4	-	0.0395880394946956	0.883418660332225
4795	mitoxantrone	hsa05332	Graft-versus-host disease	355_3107_3119_3133	4	+	0.0208090736186946	0.305482909563666
4796	mitoxantrone	hsa05320	Autoimmune thyroid disease	355_3107_3133_3119	4	+	0.0415202091031253	0.366373215094115
4797	mitoxantrone	hsa04740	Olfactory transduction	23538	1	+	0.00257268872524751	0.162616750525593
4798	mitoxantrone	hsa04514	Cell adhesion molecules (CAMs)	3119_3107_3696_5797_3133_3676_925	7	+	0.0437460555336257	0.366373215094115
4799	mitoxantrone	hsa04115	p53 signaling pathway	355_1647_1026_5366_8795	5	+	0.027356678468388	0.305482909563666
4800	mitoxantrone	hsa04512	ECM-receptor interaction	2335_3381_3693_1289_3696_1291_3676	7	+	0.00485423135897293	0.162616750525593
4801	mitoxantrone	hsa05330	Allograft rejection	355_3107_3119_3133	4	+	0.0153192003034885	0.305482909563666
4802	mitoxantrone	hsa04940	Type I diabetes mellitus	355_3107_3119_3133	4	+	0.0239525478020956	0.305482909563666
4803	mitoxantrone	hsa04650	Natural killer cell mediated cytotoxicity	3459_3460_10725_3105_11261_6654_355_5291_10451_4775_7409_4772_8795_5295_6655	15	-	0.0440597902016293	0.143602279175681
4804	mitoxantrone	hsa04640	Hematopoietic cell lineage	3566_3552_2057_4254_3673_3655	6	-	0.00976355567867418	0.0409139476058728
4805	mitoxantrone	hsa03320	PPAR signaling pathway	7316_2180_6256	3	-	0.00330293225806	0.0223515928310105
4806	mitoxantrone	hsa05010	Alzheimer's disease	1327_841_8772_642502_11261_6391_9451_355_351_509_7132_23236	12	-	0.000115245233633289	0.00229615482560059
4807	mitoxantrone	hsa04080	Neuroactive ligand-receptor interaction	5029_4889_5618_7068_4886_5031_3354_2150_9170	9	-	1.21024248383615e-10	1.06501338577581e-08
4808	mitoxantrone	hsa04742	Taste transduction	112	1	-	0.00135227793042947	0.0119000457877793
4809	mitoxantrone	hsa05320	Autoimmune thyroid disease	3105_355	2	-	0.00862028652622791	0.0379292607154028
4810	mitoxantrone	hsa04670	Leukocyte transendothelial migration	5295_1432_2773_1364_5291_10451_7409_394_7430	9	-	0.0035559352231153	0.0223515928310105
4811	mitoxantrone	hsa05016	Huntington's disease	1213_4899_6874_1327_841_642502_6391_246721_9519_23186_509_1385_548644_5439_23236	15	-	0.000438158210674792	0.00428421361548686
4812	mitoxantrone	hsa04514	Cell adhesion molecules (CAMs)	965_4685_3105_1364_5792_3655	6	-	3.37478956698213e-05	0.000989938272981425
4813	mitoxantrone	hsa04510	Focal adhesion	5295_1398_596_3480_6655_6654_7057_5154_2002_10451_5228_7409_7422_1399_394_3673_3655_1291_4659_3725_5291	21	-	0.00436246670568802	0.0239935668812841
4814	mitoxantrone	hsa04530	Tight junction	6709_5584_64398_8189_5581_2773_1364_5519_84612_7525_2017_9223_27134	13	-	0.0130173453509994	0.0520693814039976
4815	mitoxantrone	hsa04720	Long-term potentiation	11261_4659_468_23236	4	-	0.00504454374639254	0.0261129323342673
4816	mitoxantrone	hsa05110	Vibrio cholerae infection	526_23545	2	-	0.00414107178253155	0.0239935668812841
4817	mitoxantrone	hsa04512	ECM-receptor interaction	3655_1291_7057_3673	4	-	0.00180172623174843	0.0144138098539874
4818	mitoxantrone	hsa03022	Basal transcription factors	2967_2966_2960_9519_2969_27097_10629_6884_6879_6877_9569_6874_51616_728198	14	-	0.0326691780908656	0.110572602769084
4819	mitoxantrone	hsa04062	Chemokine signaling pathway	2309_3717_2773_4067_3551_6655_6654_1398_113_5291_10451_7409_4792_1399_112_5295_5970_6777_8976_23236	20	-	0.00780313137357274	0.0361408189933895
4820	mitoxantrone	hsa04810	Regulation of actin cytoskeleton	5295_5154_5291_10451_3655_3673_4659_7430_324_1398_2263_200576_1399_8396_10787_2260_8874_5962_6655_6654_7409_54434_3985_8976	24	-	0.00773986404551083	0.0361408189933895
4821	mitoxantrone	hsa05012	Parkinson's disease	2861_7326_1327_7314_6391_642502_509_7332	8	-	0.000209718352054983	0.00307586916347308
4822	mitoxantrone	hsa04260	Cardiac muscle contraction	1327_4635	2	-	0.00013046334236367	0.00229615482560059
4823	mitoxantrone	hsa04060	Cytokine-cytokine receptor interaction	55540_5154_7132_27242_3552_2057_3459_3572_657_4982_23529_3625_4254_7042_91_655_93_7048_5618_3566_3460_355_7422_8795_51330	25	-	0.000414915259529517	0.00428421361548686
4824	mitoxantrone	hsa03010	Ribosome	6139_9349_6137_6125_6168_6234_6160_6233_6171	9	-	0.0254772820509223	0.0956005533968382
4825	mitoxantrone	hsa04020	Calcium signaling pathway	3707_11261_56848_113_23236	5	-	4.66393979697042e-09	2.05213351066698e-07
4826	mitoxantrone	hsa04912	GnRH signaling pathway	4216_1432_468_6655_6654_2002_113_112_3725_23236	10	-	0.0302233726085912	0.106386271582241
4827	mitoxantrone	hsa04730	Long-term depression	5519_3480_2773_4067_23236	5	-	0.0260728781991377	0.0956005533968382
4828	mitoxantrone	hsa04270	Vascular smooth muscle contraction	5581_4660_113_112_4659_23236	6	-	0.000272402138131838	0.00342448402222882
4829	mitoxantrone	hsa04610	Complement and coagulation cascades	7056_7035_5329	3	-	0.00326181293624625	0.0223515928310105
4830	metitepine	hsa04740	Olfactory transduction	818_26476	2	+	8.7981177064175e-05	0.003519247082567
4831	metitepine	hsa04514	Cell adhesion molecules (CAMs)	6402_942_29851_3107_3113_925_3134_933_4099_1462	10	+	0.0425919864139347	0.586590031768083
4832	metitepine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3113_8359_8294_8367_554313_8970_121504_942	17	+	7.97793270053258e-05	0.003519247082567
4833	metitepine	hsa04710	Circadian rhythm - mammal	8553_5187_9572	3	+	0.0189882407850018	0.434087499203818
4834	metitepine	hsa05223	Non-small cell lung cancer	842_2272_5925_5335_5915_6257	6	+	0.0217043749601909	0.434087499203818
4835	metitepine	hsa05131	Shigellosis	7278_6093_7430_113457	4	-	0.0161381666116209	0.435730498513764
4836	metitepine	hsa05130	Pathogenic Escherichia coli infection	7278_6093_7430_113457	4	-	0.0161381666116209	0.435730498513764
4837	ambroxol	hsa04740	Olfactory transduction	8392	1	+	1.72546782310925e-05	0.00134586490202522
4838	ambroxol	hsa04512	ECM-receptor interaction	8516_1284_948_2812_3690_3691_3679_6383	8	+	0.0158214846957276	0.617037903133376
4839	ambroxol	hsa04810	Regulation of actin cytoskeleton	8516_79784_10787_3679_324_3690_3691_1131_1956_7430_1399_3985_2263_2260	14	+	0.0466942617205191	1
4840	ambroxol	hsa04662	B cell receptor signaling pathway	5533_27071_5534	3	-	0.0296556290092785	0.479298492545343
4841	ambroxol	hsa04910	Insulin signaling pathway	5599_5576_2002_8835	4	-	0.0341421949321313	0.479298492545343
4842	ambroxol	hsa04210	Apoptosis	5533_5576_5534	3	-	0.0449601810682269	0.479298492545343
4843	adenosine phosphate	hsa04740	Olfactory transduction	818_51806_109	3	+	5.92203562969166e-05	0.00491528957264408
4844	adenosine phosphate	hsa05012	Parkinson's disease	6390	1	+	0.0318300197901184	1
4845	adenosine phosphate	hsa04060	Cytokine-cytokine receptor interaction	3082_23765_3976_8794_3815	5	+	0.0460200439743997	1
4846	adenosine phosphate	hsa04120	Ubiquitin mediated proteolysis	331_51343_6477_4193_26091_83737_51619_51433_55958_23291	10	-	0.0284584962337992	1
4847	maprotiline	hsa04612	Antigen processing and presentation	926	1	+	0.0437923546213035	0.700677673940856
4848	maprotiline	hsa05016	Huntington's disease	7052_163_27113_581	4	+	0.014060995785719	0.35700190190532
4849	maprotiline	hsa04740	Olfactory transduction	8390	1	+	1.2292623616916e-09	9.8340988935328e-08
4850	maprotiline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_720_721_8970	24	+	9.4451930235596e-05	0.00377807720942384
4851	maprotiline	hsa04530	Tight junction	4619_50848	2	+	0.017850095095266	0.35700190190532
4852	maprotiline	hsa05322	Systemic lupus erythematosus	3014_6738_8343_8339_8347_8346_8344	7	-	0.000645792583261657	0.0238943255806813
4853	maprotiline	hsa05219	Bladder cancer	1869_2261_1613	3	-	0.00936613620110265	0.173273519720399
4854	chlormezanone	hsa05332	Graft-versus-host disease	3553_3126_3107_942_3127_3125_3123_941	8	+	0.0228036175166741	0.456072350333482
4855	chlormezanone	hsa04640	Hematopoietic cell lineage	3581_3553_948_3815_3690_3123_2993_3126_3127_3125_915_2812_7066_921_933_3566_2814	17	+	0.00139872492719066	0.0559489970876264
4856	chlormezanone	hsa04740	Olfactory transduction	51806_26212_26692_135948_5593_5137_9635	7	+	2.71288161586335e-06	0.000217030529269068
4857	chlormezanone	hsa04512	ECM-receptor interaction	2814_7059_2335_948_2812_3690_1277_1284_3679_6383_1101_3918	12	+	0.0445263528525757	0.593684704701009
4858	chlormezanone	hsa05330	Allograft rejection	3126_3107_942_3127_941_3123_3125	7	+	0.0369246680470195	0.590794688752312
4859	chlormezanone	hsa04940	Type I diabetes mellitus	3382_942_3107_3126_3127_3125_3123_3553_941	9	+	0.0111428026478663	0.297141403943101
4860	chlormezanone	hsa05010	Alzheimer's disease	5534	1	-	0.0223183649333304	0.362673430166619
4861	chlormezanone	hsa04080	Neuroactive ligand-receptor interaction	7067_5618	2	-	0.0138072116841897	0.362673430166619
4862	chlormezanone	hsa03450	Non-homologous end-joining	27343_3981_7518	3	-	0.0194191337186275	0.362673430166619
4863	chlormezanone	hsa04062	Chemokine signaling pathway	408	1	-	0.0156288283789566	0.362673430166619
4864	retrorsine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	2.53999337365774e-08	1.39699635551176e-06
4865	retrorsine	hsa04070	Phosphatidylinositol signaling system	8394_3633_3631_5333_808_801_27124_805	8	-	0.00425389618939566	0.103511473941961
4866	retrorsine	hsa04740	Olfactory transduction	801_808_805	3	-	0.00390401890718805	0.103511473941961
4867	retrorsine	hsa05322	Systemic lupus erythematosus	85235_3013_8330_8332_8969_8331_8329_8351_8343_8336_8339_8347_8346_8344	14	-	0.000368134018848984	0.0268737833759758
4868	retrorsine	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_3551_535_10392_5781_6714_528	7	-	0.0100623948265914	0.146910964468234
4869	retrorsine	hsa04912	GnRH signaling pathway	4214_1432_6655_50487_808_113_6714_801_805	9	-	0.0100595653556249	0.146910964468234
4870	rescinnamine	hsa04940	Type I diabetes mellitus	3382_3109_3119	3	+	0.0447994549245091	0.761758569717304
4871	rescinnamine	hsa04120	Ubiquitin mediated proteolysis	5371	1	-	0.0316814956581608	0.905825797461685
4872	rescinnamine	hsa04740	Olfactory transduction	818_5566_157	3	-	0.000121619987259411	0.00936473901897465
4873	rescinnamine	hsa05012	Parkinson's disease	2861	1	-	0.0468298222690974	0.905825797461685
4874	corynanthine	hsa05010	Alzheimer's disease	5331	1	-	0.000518265267972556	0.0145114275032316
4875	corynanthine	hsa04080	Neuroactive ligand-receptor interaction	146_5025_4157_7068	4	-	0.00109996442699656	0.0230992529669278
4876	corynanthine	hsa04740	Olfactory transduction	5613_5566_5616	3	-	2.23959301665213e-07	1.88125813398779e-05
4877	corynanthine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3108_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3014_720_721	25	-	1.48743338027696e-05	0.000624722019716323
4878	corynanthine	hsa04060	Cytokine-cytokine receptor interaction	7852_7424_659_7422_3572	5	-	0.00318015736869026	0.0534266437939964
4879	corynanthine	hsa03020	RNA polymerase	246721_5435_5439_661_548644_84172	6	-	0.014612564330565	0.20457590062791
4880	galantamine	hsa05131	Shigellosis	7278_113457_2534	3	+	0.0300166843560646	0.570317002765227
4881	galantamine	hsa05130	Pathogenic Escherichia coli infection	7278_113457_2534	3	+	0.0300166843560646	0.570317002765227
4882	galantamine	hsa04540	Gap junction	7278_1813_113457_23236	4	+	0.0251672722027301	0.570317002765227
4883	galantamine	hsa05010	Alzheimer's disease	5331_4700_6392_4698_11261_840_2776_8883_5663_5532_351_513_7381_7385	14	-	0.00594447909991382	0.0921394260486642
4884	galantamine	hsa04080	Neuroactive ligand-receptor interaction	5618_4157_3953_2908_4886_64106_2150_5030	8	-	2.51358694692851e-09	1.16881793032176e-07
4885	galantamine	hsa04742	Taste transduction	5613_5567	2	-	0.0193299136783218	0.187969551814917
4886	galantamine	hsa04740	Olfactory transduction	26211_109_5567_409_5613	5	-	2.32563764898521e-19	2.16284301355625e-17
4887	galantamine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_94239_8366_8368_6738_8329_8294_121504_8343_8347_8346_8344_8339_8367_3123_3126_3127_3125_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3017_3014_8970_9555	47	-	7.56429476710721e-05	0.00175869853335243
4888	galantamine	hsa05012	Parkinson's disease	2861_7327_4700_6392_4698_51465_27429_513_7381_7385	10	-	0.0109960381455099	0.131075513829685
4889	galantamine	hsa04260	Cardiac muscle contraction	7168_7381_7171_481_7385	5	-	0.0202117797650448	0.187969551814917
4890	galantamine	hsa04060	Cytokine-cytokine receptor interaction	5618_3554_3953_4055_55540_3459_5154_3572_657_1956_91_90_4233_8795_659	15	-	6.13857739967934e-06	0.00019029589939006
4891	galantamine	hsa04020	Calcium signaling pathway	5256_109_5613_11261_5567_2776_3707_5331_5532_1956_5335_490_107	13	-	0.001708992754268	0.0317872652293848
4892	galantamine	hsa03050	Proteasome	5718	1	-	0.0112753130176073	0.131075513829685
4893	galantamine	hsa04270	Vascular smooth muscle contraction	5567_5613_50487_2776_5331_109_23365_4659_107	9	-	0.0271850766474848	0.229837466201462
4894	xylazine	hsa05332	Graft-versus-host disease	3117_3804_3126_3127_3125_3123	6	+	0.0265268093033219	0.348736540406711
4895	xylazine	hsa05320	Autoimmune thyroid disease	3117_3441_3446_3126_3127_3125_3123_7038	8	+	0.00842723001248594	0.332875585493195
4896	xylazine	hsa04612	Antigen processing and presentation	4261_3441_3117_3123_3446_3126_3127_3125_6891_3804	10	+	0.0278023663623649	0.348736540406711
4897	xylazine	hsa04310	Wnt signaling pathway	5532_23500	2	+	0.0353150926994138	0.348736540406711
4898	xylazine	hsa04740	Olfactory transduction	26212_2774_442194_26716_26532_4992_4993_5132	8	+	0.00549412895065593	0.332875585493195
4899	xylazine	hsa04530	Tight junction	10000_9073_5581_93643_9071_998_4620_93408_88_51208_3059_7525_4629_9223	14	+	0.0187366216134315	0.348736540406711
4900	xylazine	hsa05310	Asthma	3117_3123_3126_3127_3125	5	+	0.0248001520444242	0.348736540406711
4901	xylazine	hsa04940	Type I diabetes mellitus	3117_3126_2572_3127_3125_3123	6	+	0.0317191858746506	0.348736540406711
4902	xylazine	hsa04080	Neuroactive ligand-receptor interaction	7068_3953_2908_7067_56288_134	6	-	0.00765809505467692	0.214426661530954
4903	xylazine	hsa05016	Huntington's disease	5331_7157_4714_6667_10126	5	-	0.0448522203579755	0.538226644295706
4904	xylazine	hsa04740	Olfactory transduction	51806	1	-	1.84142474854577e-09	1.54679678877845e-07
4905	xylazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8370_94239_727_8368_8366_3014_8359_8294_8367_554313_121504_8364	17	-	0.0178179532748221	0.249451345847509
4906	xylazine	hsa05012	Parkinson's disease	4714_7345	2	-	0.0174893798324476	0.249451345847509
4907	xylazine	hsa04020	Calcium signaling pathway	5331_51806_776	3	-	0.00714108781491408	0.214426661530954
4908	xylazine	hsa05210	Colorectal cancer	5595_7043_4088_208_8312_1857_7157_5881_7046_3845_324_4233	12	-	0.0137332240242405	0.249451345847509
4909	cinchonine	hsa04650	Natural killer cell mediated cytotoxicity	836_3383_5579_2214_7410_27040_6452_5551_2215_2185_5336_9436	12	+	0.00363618242255335	0.150901570535964
4910	cinchonine	hsa04740	Olfactory transduction	5593_9635	2	+	0.000380862575276841	0.0316115937479778
4911	cinchonine	hsa05223	Non-small cell lung cancer	5925_5170_1021_5579_5336	5	+	0.0426687298782336	0.791492259072354
4912	cinchonine	hsa04740	Olfactory transduction	157	1	-	0.00520657650434988	0.179626889400071
4913	cinchonine	hsa05322	Systemic lupus erythematosus	3119_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	-	8.75979205494013e-05	0.00604425651790869
4914	cinchonine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.027454375328787	0.631450632562101
4915	sparteine	hsa04080	Neuroactive ligand-receptor interaction	2912_3953_2563_2901_799_6755_2741_2688_1442_4987_5732_5644	12	+	0.0373563761629302	0.50710065176281
4916	sparteine	hsa04740	Olfactory transduction	8390	1	+	0.0017188876247026	0.0567232916151858
4917	sparteine	hsa04510	Focal adhesion	8516_10298_5599_998_3679_2335_1290_1291_2534_3675	10	+	0.0384167160426371	0.50710065176281
4918	sparteine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_717_8368_8359_8294_8367_554313_121504_8341	16	+	1.19173973068795e-06	7.86548222254047e-05
4919	sparteine	hsa04512	ECM-receptor interaction	8516_2335_3679_1290_1291_3675	6	+	0.0199352042939815	0.438574494467593
4920	sparteine	hsa05211	Renal cell carcinoma	2271_208_2549_5155_5291_1399_7042_3725_6655	9	-	0.00514885345358795	0.176348775326125
4921	sparteine	hsa04662	B cell receptor signaling pathway	10725_208_6655_8519_3725_5291_4793	7	-	0.0469596353512887	0.427854455422853
4922	sparteine	hsa03420	Nucleotide excision repair	2967_5425_2068_5887_8450_2072	6	-	0.0146733181736828	0.300803022560497
4923	sparteine	hsa04514	Cell adhesion molecules (CAMs)	3119	1	-	0.0455625490193181	0.427854455422853
4924	sparteine	hsa05322	Systemic lupus erythematosus	3119_3013_3017_8358_8968_8337_8342_8350_8351_8352_8353_8354_8355_8356_8357	15	-	0.00188473514450552	0.154548281849453
4925	sparteine	hsa04210	Apoptosis	841_581_7157_208_5291_472_9941_8837_651610_8795	10	-	0.00645178446315091	0.176348775326125
4926	sparteine	hsa05012	Parkinson's disease	509	1	-	0.0459282792363712	0.427854455422853
4927	sparteine	hsa04020	Calcium signaling pathway	2778_2149	2	-	0.0361064305028764	0.427854455422853
4928	sparteine	hsa05220	Chronic myeloid leukemia	7157_208_6655_867_5291_1399_7042	7	-	0.0469596353512887	0.427854455422853
4929	salsolinol	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.0175847908161456	0.180872134108926
4930	salsolinol	hsa04640	Hematopoietic cell lineage	3690_3123_2993_3126_3127_3125_947_925	8	+	0.00107761318997032	0.077588149677863
4931	salsolinol	hsa04080	Neuroactive ligand-receptor interaction	2918	1	+	0.0473588855919152	0.284153313551491
4932	salsolinol	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	+	0.035420935828681	0.248436303514449
4933	salsolinol	hsa04612	Antigen processing and presentation	3805_3123_3126_3127_3125_6892_925	7	+	0.00493234879252745	0.110126223269159
4934	salsolinol	hsa04520	Adherens junction	51176_3480_5879_1496_10580	5	+	0.0379555463702631	0.248436303514449
4935	salsolinol	hsa04740	Olfactory transduction	4991	1	+	0.0036721383782321	0.110126223269159
4936	salsolinol	hsa04514	Cell adhesion molecules (CAMs)	965_5175_3123_3126_3127_3125_947_925	8	+	0.0124878279187571	0.154804057554061
4937	salsolinol	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_5879_3576_23545_525	5	+	0.0249653587438241	0.199722869950593
4938	salsolinol	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.00611812351495329	0.110126223269159
4939	salsolinol	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.0129003381295051	0.154804057554061
4940	salsolinol	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	+	0.0202764273902911	0.18248784651262
4941	salsolinol	hsa04080	Neuroactive ligand-receptor interaction	2908_5025_1909	3	-	3.94794202977699e-06	0.000173709449310188
4942	salsolinol	hsa04740	Olfactory transduction	818_801_808_805	4	-	3.56346590682381e-09	3.13584999800495e-07
4943	salsolinol	hsa04510	Focal adhesion	3912_6654_858_60_5601_1398_6714	7	-	0.0125860933815907	0.158225173939997
4944	salsolinol	hsa04110	Cell cycle	5591_902_5001_5000_993_4173_7157_6502_996_51343_4193_51433_1022_7027_4089_7534_1031_1017_7531_7533_4616	21	-	0.00309783765796975	0.0908699046337793
4945	salsolinol	hsa04062	Chemokine signaling pathway	3717_6654_2773_7852_1398_10681	6	-	0.0098108697368367	0.143892756140272
4946	salsolinol	hsa04810	Regulation of actin cytoskeleton	60_8394_6654_5605_22800_10787_1398	7	-	0.00715005318598598	0.125840936073353
4947	salsolinol	hsa04060	Cytokine-cytokine receptor interaction	3556_27242_3597_2057_3459_7852_9180_90_8795	9	-	0.00494531782663859	0.108796992186049
4948	oxybenzone	hsa04662	B cell receptor signaling pathway	11025_23533_974_5579_8519_4772_4793	7	+	0.0418878402047447	0.4053193522628
4949	oxybenzone	hsa05016	Huntington's disease	1213_7416	2	+	0.0360237377689641	0.4053193522628
4950	oxybenzone	hsa04740	Olfactory transduction	1258_816	2	+	4.34262179630241e-05	0.00351752365500495
4951	oxybenzone	hsa04710	Circadian rhythm - mammal	8553_5187_79365	3	+	0.023036523938346	0.4053193522628
4952	oxybenzone	hsa04664	Fc epsilon RI signaling pathway	23533_8398_3596_5579_2207_5599_27040_5320_5609_2205	10	+	0.00249837516843532	0.10118419432163
4953	oxybenzone	hsa03450	Non-homologous end-joining	2547_3981_10111	3	+	0.0271758481859034	0.4053193522628
4954	oxybenzone	hsa05310	Asthma	2205_3596_3119_2207	4	+	0.0429996127231619	0.4053193522628
4955	oxybenzone	hsa05012	Parkinson's disease	7416	1	+	0.0455393144787829	0.4053193522628
4956	oxybenzone	hsa04912	GnRH signaling pathway	4313_8398_5579_5599_5598_4323_776_5320_5609_816	10	+	0.0262060428245463	0.4053193522628
4957	oxybenzone	hsa03440	Homologous recombination	5890_25788_5888	3	-	0.0341945217295925	1
4958	parbendazole	hsa04640	Hematopoietic cell lineage	3690_7066_960_3674_2812	5	+	0.0395790283253699	0.857545613716348
4959	parbendazole	hsa04740	Olfactory transduction	5568	1	+	0.00514637275561102	0.334514229114716
4960	parbendazole	hsa04512	ECM-receptor interaction	3690_1293_960_3674_2812	5	+	0.035052211170729	0.857545613716348
4961	parbendazole	hsa04080	Neuroactive ligand-receptor interaction	1241_2561_2908_2149	4	-	0.00027975565880761	0.0123092489875348
4962	parbendazole	hsa04740	Olfactory transduction	219464_157_5613_5616_818_109_393046_409	8	-	5.86531236725665e-05	0.00516147488318585
4963	parbendazole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8348_8294_8343_8347_8346_8344_8370_718_8359_8336_554313_121504_8339_3119	23	-	0.000619077700953465	0.0136197094209762
4964	parbendazole	hsa04210	Apoptosis	472_8503_836_5296_5613_5534_331_5290_5533_5616_5576_8737	12	-	0.0384114566210274	0.636229844937796
4965	parbendazole	hsa04260	Cardiac muscle contraction	4635	1	-	0.0433793076093952	0.636229844937796
4966	parbendazole	hsa04060	Cytokine-cytokine receptor interaction	8718_50616_23765_1435_3594	5	-	0.000605782776045234	0.0136197094209762
4967	isoxsuprine	hsa02010	ABC transporters	6891_5244_5243	3	+	0.0454350492513249	1
4968	isoxsuprine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	19	-	3.8041917468376e-13	1.40755094632991e-11
4969	oxetacaine	hsa04540	Gap junction	5159_3708_7082_5568	4	+	0.036824172503419	1
4970	oxetacaine	hsa04910	Insulin signaling pathway	5256_5257_3551_5613_6654_5616_7249_2997_2002_23265_10211_51763_369_5507	14	-	0.00839715295260321	0.23512028267289
4971	oxetacaine	hsa05016	Huntington's disease	246721_10126_5435	3	-	0.049897974756834	0.551933110452068
4972	oxetacaine	hsa04740	Olfactory transduction	5613_5616_409	3	-	4.14783465464367e-05	0.00348418110990068
4973	oxetacaine	hsa05012	Parkinson's disease	2861	1	-	0.0327129104651748	0.551933110452068
4974	oxetacaine	hsa04060	Cytokine-cytokine receptor interaction	5155_5154_8795	3	-	0.00377670868959973	0.158621764963189
4975	dicycloverine	hsa04740	Olfactory transduction	26333_8390	2	+	0.000405137868222432	0.0295750643802375
4976	dicycloverine	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	0.0196129019643251	0.477247281131911
4977	dicycloverine	hsa04010	MAPK signaling pathway	1647_1848_9344_1843_4791_9254_2005_1649_2353_8817_6196_1399_7042_3725_5971_2247_3164_11221	18	+	0.011583499642368	0.422797736946432
4978	dicycloverine	hsa04510	Focal adhesion	5296_5829_6464_5154_1793_6093_55742	7	-	0.035198300085149	0.847171266943613
4979	hexamethonium bromide	hsa05131	Shigellosis	7100_6093_7430_10382	4	+	0.00230922229316842	0.0577305573292105
4980	hexamethonium bromide	hsa05130	Pathogenic Escherichia coli infection	7100_6093_7430_10382	4	+	0.00230922229316842	0.0577305573292105
4981	hexamethonium bromide	hsa04350	TGF-beta signaling pathway	6093_7046_652_653	4	+	0.0101750699988169	0.169584499980282
4982	ethambutol	hsa04662	B cell receptor signaling pathway	11025_5532_6655_2353	4	+	0.049403103974803	1
4983	ethambutol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	6.42262348212653e-07	3.59666914999086e-05
4984	ethambutol	hsa04080	Neuroactive ligand-receptor interaction	7434_3354	2	-	0.0261980179881082	1
4985	ethambutol	hsa03022	Basal transcription factors	51616_6875_2969_728198	4	-	0.0363019436287728	1
4986	idoxuridine	hsa04740	Olfactory transduction	393046	1	+	0.000835389899918386	0.0593126828942054
4987	idoxuridine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8347_8346_8344_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235	26	-	1.73407261207524e-16	1.07512501948665e-14
4988	amprolium	hsa05131	Shigellosis	7278_9181_113457_8976_9475	5	+	0.00500762205346713	0.0984832337181869
4989	amprolium	hsa05130	Pathogenic Escherichia coli infection	7278_9181_113457_8976_9475	5	+	0.00500762205346713	0.0984832337181869
4990	amprolium	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_9103_8359_8294_8367_554313_121504_3109	16	+	3.27697424574409e-08	1.93341480498901e-06
4991	amprolium	hsa04070	Phosphatidylinositol signaling system	8871_5298_8394_8396_5290_3631_5335_5291_3707	9	-	0.0367445343722891	0.395003744502108
4992	amprolium	hsa05010	Alzheimer's disease	841_4137	2	-	0.0130241755353557	0.217759811753684
4993	amprolium	hsa04080	Neuroactive ligand-receptor interaction	146_706_5025	3	-	0.0019206823924426	0.0825893428750318
4994	amprolium	hsa05016	Huntington's disease	6667_841_161	3	-	0.0266058779163456	0.326872214400817
4995	amprolium	hsa04740	Olfactory transduction	157	1	-	1.04920644954525e-07	9.02317546608915e-06
4996	amprolium	hsa05322	Systemic lupus erythematosus	3108_3123_3013_8358_8968_720_721_8350_8351_8352_8353_8354_8355_8356_8357	15	-	0.0143220155808813	0.217759811753684
4997	amprolium	hsa05012	Parkinson's disease	51465	1	-	0.015192545006071	0.217759811753684
4998	amprolium	hsa04060	Cytokine-cytokine receptor interaction	9180_3601_7422_2057_8795	5	-	0.0143497273697583	0.217759811753684
4999	prednisone	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.0340071390869801	0.339340405625345
5000	prednisone	hsa05212	Pancreatic cancer	5170_6655_5293_2263_1387_7184	6	+	0.0418364883647686	0.339340405625345
5001	prednisone	hsa05215	Prostate cancer	5170_6655_5293_2263_1387_7184	6	+	0.0400536767922787	0.339340405625345
5002	prednisone	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0123817687678885	0.339340405625345
5003	prednisone	hsa05223	Non-small cell lung cancer	2309_6655_5170_1029_5293	5	+	0.0204576735988595	0.339340405625345
5004	prednisone	hsa04060	Cytokine-cytokine receptor interaction	6367	1	+	0.0108563414149734	0.339340405625345
5005	prednisone	hsa05213	Endometrial cancer	2309_6655_5170_5293_1495	5	+	0.0178579135163694	0.339340405625345
5006	prednisone	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.0253253423262972	0.339340405625345
5007	prednisone	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	+	0.0389211077816334	0.339340405625345
5008	prednisone	hsa04910	Insulin signaling pathway	5584_5576_5575_8660_23265_208	6	-	0.0453299893597705	0.936819780101924
5009	prednisone	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0193218143937172	0.678864258349532
5010	prednisone	hsa05210	Colorectal cancer	4088_208_4233_6934_7042	5	-	0.0218988470435333	0.678864258349532
5011	miconazole	hsa05332	Graft-versus-host disease	3108_3123_3126_3127_3125_3113	6	+	0.00327042812582992	0.0451319081364529
5012	miconazole	hsa04640	Hematopoietic cell lineage	1435_2057_3123_3126_3570_3127_1378_3125	8	+	0.0085703604920507	0.0739193592439373
5013	miconazole	hsa05320	Autoimmune thyroid disease	3108_1081_3113_3126_3127_3125_3123	7	+	0.00227125291652047	0.0391791128099781
5014	miconazole	hsa04612	Antigen processing and presentation	3108_3123_3126_3127_3125_5994_3310_3113	8	+	0.00967127302110405	0.074146426495131
5015	miconazole	hsa04514	Cell adhesion molecules (CAMs)	3108_3383_8506_3123_3126_3127_3125_9672_923_3113	10	+	0.0130204769222437	0.0898412907634815
5016	miconazole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_3108_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113_8970	37	+	1.14103894463732e-20	7.87316871799751e-19
5017	miconazole	hsa05310	Asthma	3126_3108_3123_3113_3127_3125	6	+	0.000705955579083137	0.0243554674783682
5018	miconazole	hsa04010	MAPK signaling pathway	4908_1647_8398_4214_5599_6655_1649_1846_2353_1843_5607_4791_3725_3310_5971_3164_11221_4616	18	+	0.00474117942891569	0.0467344829421689
5019	miconazole	hsa04020	Calcium signaling pathway	2149	1	+	0.0478542511732697	0.30017666645051
5020	miconazole	hsa05330	Allograft rejection	3108_3113_3126_3127_3125_3123	6	+	0.00208379848559925	0.0391791128099781
5021	miconazole	hsa04940	Type I diabetes mellitus	3108_3123_3126_3127_3125_3113	6	+	0.00402428989555311	0.0462793337988608
5022	miconazole	hsa05332	Graft-versus-host disease	3123_3126_3127_3125_3135_355	6	-	0.0209407047137389	0.209142343745949
5023	miconazole	hsa04080	Neuroactive ligand-receptor interaction	3953	1	-	0.000116369985205178	0.00500390936382265
5024	miconazole	hsa05016	Huntington's disease	5331_6648	2	-	0.0128909302661379	0.17759415177805
5025	miconazole	hsa04740	Olfactory transduction	5613_5566_157	3	-	2.95615086680781e-05	0.00254228974545472
5026	miconazole	hsa05322	Systemic lupus erythematosus	85235_3123_8330_3126_3127_3125_8332_8969_8331_8336_8343_8329_8339_8347_8346_8344	16	-	0.00309283876913936	0.0886613780486617
5027	miconazole	hsa04210	Apoptosis	3554_5296_5613_5566_5291_472_355_598_8837_7186	10	-	0.0144553379354227	0.17759415177805
5028	miconazole	hsa05012	Parkinson's disease	7327	1	-	0.0218869894617854	0.209142343745949
5029	miconazole	hsa04060	Cytokine-cytokine receptor interaction	3953_355_3554_5154	4	-	0.010660051973716	0.17759415177805
5030	miconazole	hsa05330	Allograft rejection	3123_3126_3127_3125_3135_355	6	-	0.0140183224050417	0.17759415177805
5031	miconazole	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125_3135_355	6	-	0.0251430514152364	0.216230242171033
5032	oxybuprocaine	hsa04662	B cell receptor signaling pathway	10725_933_5579_4793	4	+	0.00825242721913699	0.111407767458349
5033	oxybuprocaine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	5.33085045919504e-10	2.87865924796532e-08
5034	oxybuprocaine	hsa04664	Fc epsilon RI signaling pathway	8398_5608_5579	3	+	0.0499172200521906	0.373808175680877
5035	oxybuprocaine	hsa04370	VEGF signaling pathway	10725_8398_5579	3	+	0.0469739320381311	0.373808175680877
5036	oxybuprocaine	hsa04010	MAPK signaling pathway	8912_8398_5579_6789_8817_4763_3164_5608	8	+	0.00744595778738966	0.111407767458349
5037	oxybuprocaine	hsa04540	Gap junction	7278_5593_113457_5579	4	+	0.0165925097079472	0.17919910484583
5038	oxybuprocaine	hsa04730	Long-term depression	5593_8398_5579_6261	4	+	0.00688302657647992	0.111407767458349
5039	oxybuprocaine	hsa05211	Renal cell carcinoma	2271_5296_6655_405_8453_1399_3725_4233	8	-	0.0204714514501731	0.334190136541288
5040	oxybuprocaine	hsa04080	Neuroactive ligand-receptor interaction	146_3354_7067_4886	4	-	0.0276458544725297	0.35018082331871
5041	oxybuprocaine	hsa04740	Olfactory transduction	5613_5616_409_4991	4	-	0.000293163316972195	0.0222804120898868
5042	oxybuprocaine	hsa05322	Systemic lupus erythematosus	8336	1	-	0.0219861931935058	0.334190136541288
5043	oxybuprocaine	hsa04210	Apoptosis	581_5296_5613_11261_5616_472_355_5576_8837_651610	10	-	0.00950840782701803	0.334190136541288
5044	oxybuprocaine	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_4233_535_5600_523_3725_528	7	-	0.0484060094872951	0.459857090129303
5045	oxybuprocaine	hsa04010	MAPK signaling pathway	4214_4149_3925_5599_5613_11261_5616_5154_51347_2002_6789_355_6885_3725_5600_1399_2005_2263_6655_409	20	-	0.0383533724392711	0.416408043626372
5046	oxybuprocaine	hsa04912	GnRH signaling pathway	4214_5599_5613_6655_5616_2776_2002_5600_3725_4323_23236	11	-	0.0180842005481891	0.334190136541288
5047	homosalate	hsa04740	Olfactory transduction	26211_7932	2	+	0.00117767718657919	0.0895034661800184
5048	homosalate	hsa05200	Pathways in cancer	6655	1	-	0.00790661389478138	0.217431882106488
5049	homosalate	hsa05131	Shigellosis	7278_6093_7430_113457	4	-	0.0498733051130063	0.685757945303837
5050	homosalate	hsa05130	Pathogenic Escherichia coli infection	7278_6093_7430_113457	4	-	0.0498733051130063	0.685757945303837
5051	homosalate	hsa05322	Systemic lupus erythematosus	8358_85235_8968_3013_8330_8332_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357	18	-	3.42783346367185e-08	1.88530840501952e-06
5052	mebhydrolin	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.01658331664773	0.202316463102306
5053	mebhydrolin	hsa04640	Hematopoietic cell lineage	3123_947_3126_3127_3125	5	+	0.0474107779404671	0.346819797900513
5054	mebhydrolin	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	+	0.0335098461951773	0.292014373986545
5055	mebhydrolin	hsa04740	Olfactory transduction	8392	1	+	0.00355761273421362	0.116676690626228
5056	mebhydrolin	hsa04514	Cell adhesion molecules (CAMs)	3383_3123_3126_3127_3125_23308_947	7	+	0.0319303196085425	0.292014373986545
5057	mebhydrolin	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.00574931485827325	0.116902735451556
5058	mebhydrolin	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.0121514155252609	0.185309086760229
5059	mebhydrolin	hsa04940	Type I diabetes mellitus	3382_3126_3127_3123_3125	5	+	0.00382546526643372	0.116676690626228
5060	mebhydrolin	hsa05016	Huntington's disease	246721_1639_5439_10126_5978_548644_161	7	-	0.0325354921720786	0.397430958515651
5061	mebhydrolin	hsa04740	Olfactory transduction	5613	1	-	0.0327012806720513	0.397430958515651
5062	mebhydrolin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	19	-	6.4888921485525e-12	4.1528909750736e-10
5063	mebhydrolin	hsa04370	VEGF signaling pathway	5605_5747_5335_5578	4	-	0.0372591523608423	0.397430958515651
5064	mebhydrolin	hsa05110	Vibrio cholerae infection	5613_5578_5335_523	4	-	0.0164984685856936	0.35196732982813
5065	mebhydrolin	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0131618236293192	0.35196732982813
5066	santonin	hsa05211	Renal cell carcinoma	2271_5155_998_5290_405_5781_3725	7	-	0.028802138465907	0.57604276931814
5067	santonin	hsa04080	Neuroactive ligand-receptor interaction	1131_4157_1081	3	-	0.0196424203801176	0.523797876803136
5068	santonin	hsa04740	Olfactory transduction	4991	1	-	7.94191065063184e-06	0.000317676426025274
5069	santonin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8342_8968_8370_718_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_720_721	30	-	1.88194042026234e-12	1.50555233620987e-10
5070	santonin	hsa04010	MAPK signaling pathway	4214_57551_6789_6788_5155_998_8074_8912_6722_4763_5871_10912_5600_2258_91_3725_9693_5536	18	-	0.0398536051696814	0.637657682714902
5071	quinethazone	hsa04740	Olfactory transduction	26476	1	+	0.00542586424405386	0.261329915965432
5072	quinethazone	hsa04664	Fc epsilon RI signaling pathway	5581_8681_100137049_5293_5600	5	+	0.0313370074142915	0.544390287077264
5073	quinethazone	hsa04370	VEGF signaling pathway	5293_4776_8681_4772_5600_100137049	6	+	0.00780089301389348	0.261329915965432
5074	quinethazone	hsa04912	GnRH signaling pathway	776_8681_5600_5337_5338_100137049	6	+	0.0325009126613292	0.544390287077264
5075	quinethazone	hsa04270	Vascular smooth muscle contraction	776_5581_553_8681_6093_100137049	6	+	0.0459682714274368	0.582891350964783
5076	quinethazone	hsa04662	B cell receptor signaling pathway	208_6655_4772_5534_27071_4793	6	-	0.034808002596871	0.661352049340549
5077	quinethazone	hsa04660	T cell receptor signaling pathway	1432_208_6655_56924_867_4772_5534_4793	8	-	0.0257678432674675	0.652785362775843
5078	quinethazone	hsa04740	Olfactory transduction	157	1	-	0.000183438351176054	0.0139413146893801
5079	quinethazone	hsa05221	Acute myeloid leukemia	5292_6655_5371_208_5914_652671	6	-	0.0131422479943432	0.499405423785042
5080	rifabutin	hsa05332	Graft-versus-host disease	3811_3119_3821_3804_3126_3127_3125_3134_3123_3802	10	+	0.0334791189629222	0.293920578470657
5081	rifabutin	hsa05010	Alzheimer's disease	6392_651820_317_4137_3708_6868_824_348_4842_23621	10	+	0.0349905450560306	0.293920578470657
5082	rifabutin	hsa04080	Neuroactive ligand-receptor interaction	2550_2898_140_624_6752_5540_2908_552_1241_6915_2150_2689_3269_2688_3358_2149_1442	17	+	0.0396602349851303	0.302859976250086
5083	rifabutin	hsa05016	Huntington's disease	8218_246721_6392_651820_64764_317_3708_1387	8	+	0.00355445470464148	0.126157695683747
5084	rifabutin	hsa04740	Olfactory transduction	26211_26333_1179_816_5137_409	6	+	1.99966634704824e-11	1.67971973152052e-09
5085	rifabutin	hsa05322	Systemic lupus erythematosus	3123_3126_3127_3119_3125	5	+	0.00510872993624749	0.126157695683747
5086	rifabutin	hsa04530	Tight junction	4301_10000_29895_998_5865_9863	6	+	0.0163902405441536	0.22946336761815
5087	rifabutin	hsa04062	Chemokine signaling pathway	10000_998_5293_7852_51764_10235_112_6367_409	9	+	0.00600750931827368	0.126157695683747
5088	rifabutin	hsa04620	Toll-like receptor signaling pathway	7100_10000_1326_5293	4	+	0.0321627543383219	0.293920578470657
5089	rifabutin	hsa04260	Cardiac muscle contraction	785_478	2	+	0.0159094626292853	0.22946336761815
5090	rifabutin	hsa04060	Cytokine-cytokine receptor interaction	2323_50615_4804_3606_2057_56034_64806_8200_7852_655_2688_2689_3556_1896_6367_8792_51561	17	+	0.0322477885479667	0.293920578470657
5091	rifabutin	hsa05210	Colorectal cancer	4088_10000_5293	3	+	0.0450913715198661	0.315639600639063
5092	rifabutin	hsa04640	Hematopoietic cell lineage	3589_960_4254	3	-	0.0230405252192084	0.166277808690835
5093	rifabutin	hsa05010	Alzheimer's disease	355_5534_489_488	4	-	3.74604033353257e-05	0.00114878570228332
5094	rifabutin	hsa04080	Neuroactive ligand-receptor interaction	5029_146_5618_152_4157_1813_3953_706_5025_3354_56288_1909_1131_9170	14	-	0.00319242065837031	0.0489504500950114
5095	rifabutin	hsa04742	Taste transduction	112	1	-	0.0412168559102651	0.223055926102611
5096	rifabutin	hsa05320	Autoimmune thyroid disease	355	1	-	0.0401931263650536	0.223055926102611
5097	rifabutin	hsa04612	Antigen processing and presentation	4800_4802_3308	3	-	0.0234957773150093	0.166277808690835
5098	rifabutin	hsa05016	Huntington's disease	246721_548644_581_7052_5439_7157_2033_9001_1387_161	10	-	0.0126707325571783	0.11657073952604
5099	rifabutin	hsa04740	Olfactory transduction	818_219464	2	-	4.99077327092132e-16	4.59151140924761e-14
5100	rifabutin	hsa04514	Cell adhesion molecules (CAMs)	9076_23308_1365_5792_5817	5	-	0.00484535467268465	0.056214878094536
5101	rifabutin	hsa03410	Base excision repair	5424_5426_7374_7515_10039_10038_27343_4350_3980	9	-	0.0453286261710399	0.231679644874204
5102	rifabutin	hsa04530	Tight junction	9076_207_2036_1365_56288_3265_55870	7	-	0.0268518059944311	0.176454725106262
5103	rifabutin	hsa05110	Vibrio cholerae infection	10312	1	-	0.0185336051870162	0.155008334291408
5104	rifabutin	hsa05012	Parkinson's disease	7332	1	-	1.21291409011854e-05	0.000557940481454528
5105	rifabutin	hsa04260	Cardiac muscle contraction	488	1	-	0.00185541940631431	0.0341397170761833
5106	rifabutin	hsa04060	Cytokine-cytokine receptor interaction	5618_4055_3594_3953_3589_5155_5154_8741_8742_355_6387_4982_8718_4254_51330	15	-	0.00488825026909009	0.056214878094536
5107	rifabutin	hsa03010	Ribosome	140801_6129	2	-	0.00176860158260358	0.0341397170761833
5108	rifabutin	hsa05220	Chronic myeloid leukemia	595_207_3551_4088_613_4609_6464_5605_7157_1487_369_1869_3265_5970_4790_598	16	-	0.0353013865394314	0.216515170775179
5109	rifabutin	hsa04610	Complement and coagulation cascades	2161	1	-	0.00888530834913704	0.0908275964578453
5110	nialamide	hsa04740	Olfactory transduction	26539_8392	2	+	0.0137019527000038	0.493270297200137
5111	nialamide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_3119_8354	16	+	7.71056870767938e-07	5.55160946952915e-05
5112	nialamide	hsa04360	Axon guidance	2044_64221_4772_10501_6093_8829_2242	7	+	0.0396887401840959	0.952529764418302
5113	nialamide	hsa04740	Olfactory transduction	157	1	-	8.46575634697791e-05	0.00258205568582826
5114	nialamide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8329_8294_121504_8969_8370_718_8332_8359_8330_8331_8336_554313_8351_85235_3013	25	-	1.3462679119122e-10	8.21223426266442e-09
5115	levcycloserine	hsa04740	Olfactory transduction	7932	1	+	0.000808163090172309	0.054955090131717
5116	levcycloserine	hsa04512	ECM-receptor interaction	961_3381_1288_7057_5649_63923	6	+	0.0282612916284905	0.960883915368677
5117	levcycloserine	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	-	0.035926696819254	0.438282671421907
5118	levcycloserine	hsa04650	Natural killer cell mediated cytotoxicity	3383_3454_4772_3105_3106_3135_5881_4775_6452_5335	10	-	0.00719012486851364	0.230083995792436
5119	levcycloserine	hsa05320	Autoimmune thyroid disease	3135_3105_3106_1081_649853	5	-	0.0204686151292847	0.428687540035632
5120	levcycloserine	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	-	0.00339121308305717	0.217037637315659
5121	levcycloserine	hsa05330	Allograft rejection	3135_3105_3106_649853	4	-	0.026792971252227	0.428687540035632
5122	levcycloserine	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853	4	-	0.0410890004458038	0.438282671421907
5123	myricetin	hsa04740	Olfactory transduction	26476	1	+	2.68134386809313e-05	0.00225232884919823
5124	myricetin	hsa04660	T cell receptor signaling pathway	4793_4772_925_5600	4	-	0.0181027956622834	0.427703530609021
5125	myricetin	hsa04920	Adipocytokine signaling pathway	3717_5781_4793	3	-	0.0237613072560567	0.427703530609021
5126	nilutamide	hsa05332	Graft-versus-host disease	5551_3126_3127_3123_3125	5	+	0.0317437958481046	0.514249492739294
5127	nilutamide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8329_8294_121504_3123_3126_3127_3125_8969_8968_8370_2212_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013	38	+	2.73101205292635e-18	2.21211976287034e-16
5128	nilutamide	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0384687526893953	0.519328161306837
5129	nilutamide	hsa05330	Allograft rejection	3593_3123_3126_3127_3125_5551	6	+	0.00595299195718749	0.160730782844062
5130	nilutamide	hsa05210	Colorectal cancer	10000_4088_6654_1857_83439_5880_5602_91	8	+	0.023162738187171	0.469045448290213
5131	nilutamide	hsa04940	Type I diabetes mellitus	3593_3382_3123_3126_3127_3125_5551	7	+	0.00292261784857387	0.118366022867242
5132	nilutamide	hsa04120	Ubiquitin mediated proteolysis	7326_7334_51366_1161_7322_7328_8065_6477_4193_26091_3093_51588_10393_51465_51433_55236_8450_7320_9039	19	-	0.0170691571981729	0.209706788434696
5133	nilutamide	hsa04080	Neuroactive ligand-receptor interaction	7068_4886_2150_136_2692_2690	6	-	0.00121175754644808	0.0521055744972674
5134	nilutamide	hsa04110	Cell cycle	5591_472_5001_1017_7027_4085_4173_7157_983_9134_4193_51433_1111_10393_23594_4089_7534_1387_7531_7465	20	-	0.0019247163710737	0.0551752026374461
5135	nilutamide	hsa04115	p53 signaling pathway	1111_472_841_9134_7157_983_6477_4193_64065_355_8493_1017	12	-	0.0125541466264606	0.179942768312602
5136	nilutamide	hsa03430	Mismatch repair	5982_5983_5985_5425_4436_2956_4292	7	-	0.00375512855974366	0.0807352640344887
5137	nilutamide	hsa04060	Cytokine-cytokine receptor interaction	3556_3597_7852_355_4982_2690	6	-	0.000885353424517742	0.0521055744972674
5138	nilutamide	hsa03010	Ribosome	51187	1	-	0.00992190871879748	0.170656829963317
5139	ticarcillin	hsa05322	Systemic lupus erythematosus	9103_8343_8339_8347_8346_8344	6	+	0.000306897070731441	0.00920691212194323
5140	ticarcillin	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	-	0.00137661941454725	0.0110365907208365
5141	ticarcillin	hsa04640	Hematopoietic cell lineage	960_3123_3126_3127_3125_933	6	-	0.000442175504890779	0.00604306523350731
5142	ticarcillin	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	-	0.00304881772539611	0.0178573609630344
5143	ticarcillin	hsa04612	Antigen processing and presentation	3123_3126_3127_3125	4	-	0.0168823150612669	0.0769083241679936
5144	ticarcillin	hsa04514	Cell adhesion molecules (CAMs)	3123_4099_3126_3127_3125_933	6	-	0.0036501924381076	0.0187072362453015
5145	ticarcillin	hsa05322	Systemic lupus erythematosus	8329_3123_3126_3127_3125_8969_8968_8358_8330_8331_8336_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013	22	-	1.57521092428246e-18	6.45836478955809e-17
5146	ticarcillin	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.000431211841636473	0.00604306523350731
5147	ticarcillin	hsa05330	Allograft rejection	3123_3126_3127_3125	4	-	0.000975330179740702	0.0099971343423422
5148	ticarcillin	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	-	0.00161511083719558	0.0110365907208365
5149	Chicago Sky Blue 6B	hsa04340	Hedgehog signaling pathway	652_653_4036	3	+	0.014442581214635	0.707686479517115
5150	Chicago Sky Blue 6B	hsa04130	SNARE interactions in vesicular transport	6804_6844	2	-	0.036412217298797	0.600655072824528
5151	Chicago Sky Blue 6B	hsa04630	Jak-STAT signaling pathway	3566_5292_6778_2057	4	-	0.0318875613043585	0.600655072824528
5152	triflupromazine	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	1.38729761896932e-06	8.04632619002206e-05
5153	triflupromazine	hsa04920	Adipocytokine signaling pathway	8660_208_2182	3	+	0.0452448500643457	0.847742129115768
5154	triflupromazine	hsa04010	MAPK signaling pathway	208_50487_1846_91_355_2257_3164_11221	8	+	0.0146732648620007	0.42552468099802
5155	triflupromazine	hsa04662	B cell receptor signaling pathway	10892_11261_6850_5534	4	-	0.00217323325954588	0.0318740878066729
5156	triflupromazine	hsa04310	Wnt signaling pathway	5613_11261_5616_5534	4	-	0.0230677532685166	0.169163523969122
5157	triflupromazine	hsa04660	T cell receptor signaling pathway	10892_11261_5534	3	-	0.0438001925116376	0.196699369571722
5158	triflupromazine	hsa04210	Apoptosis	5613_11261_5616_7186_5534	5	-	0.000477512669176227	0.021010557443754
5159	triflupromazine	hsa04340	Hedgehog signaling pathway	5613_655_5616	3	-	0.00829509395695988	0.0729968268212469
5160	triflupromazine	hsa04720	Long-term potentiation	5613_11261_5616_5534	4	-	0.00217323325954588	0.0318740878066729
5161	triflupromazine	hsa04062	Chemokine signaling pathway	5613_3717_6777_5616	4	-	0.0479674283449789	0.196699369571722
5162	triflupromazine	hsa04010	MAPK signaling pathway	5155_11261_5534_5616_4137_5613_7186	7	-	0.00320141192295935	0.0352155311525528
5163	triflupromazine	hsa04540	Gap junction	5616_5155_5613	3	-	0.0290319441743307	0.18248650623865
5164	triflupromazine	hsa04020	Calcium signaling pathway	5613_11261_5616_5534	4	-	0.0415882277269646	0.196699369571722
5165	Prestwick-1100	hsa05014	Amyotrophic lateral sclerosis (ALS)	5533_5534_317_5879_581	5	+	0.0447880857323696	0.79498852174956
5166	Prestwick-1100	hsa04740	Olfactory transduction	816	1	+	8.36278484608592e-05	0.005937577240721
5167	Prestwick-1100	hsa04514	Cell adhesion molecules (CAMs)	5010_214_29851_3107_3113_3695_3685_5797_23308_1272	10	+	0.026030988703533	0.79498852174956
5168	Prestwick-1100	hsa04020	Calcium signaling pathway	623_5534_5333_5724_5533_108_3709_135_1909_4638_3706_816	12	+	0.0356719309023123	0.79498852174956
5169	phenazone	hsa04512	ECM-receptor interaction	3690_1289_7148	3	+	0.039116987897416	0.772741595128502
5170	diflunisal	hsa05214	Glioma	23533_5594_6655_4193_1956_3845	6	+	0.0185832734315519	0.198161501896307
5171	diflunisal	hsa04662	B cell receptor signaling pathway	23533_5594_6655_7409_3845_4793	6	+	0.0330269169827178	0.198161501896307
5172	diflunisal	hsa04660	T cell receptor signaling pathway	23533_1326_5594_6655_867_7409_3845_4793	8	+	0.0241272894850073	0.198161501896307
5173	diflunisal	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8370_94239_8366_8364_8368_8359_55766_8294_8367_554313_121504_3119_8337	18	+	1.41249465257991e-06	0.000110174582901233
5174	diflunisal	hsa05212	Pancreatic cancer	23533_5594_6655_4193_1956_3845_80310	7	+	0.0238992669051341	0.198161501896307
5175	diflunisal	hsa05215	Prostate cancer	23533_5594_6655_4193_1956_3845_80310	7	+	0.0227117673845967	0.198161501896307
5176	diflunisal	hsa05221	Acute myeloid leukemia	23533_6655_3845_5594_5914	5	+	0.0410190659644138	0.228534796087448
5177	diflunisal	hsa05219	Bladder cancer	1956_3845_4193_5594	4	+	0.0468798252766041	0.243775091438341
5178	diflunisal	hsa05218	Melanoma	23533_5594_4193_1956_3845_80310_2258_2246	8	+	0.00230727953998841	0.0599892680396987
5179	diflunisal	hsa05223	Non-small cell lung cancer	23533_5594_6789_6655_1956_3845	6	+	0.00850268173703074	0.165802293872099
5180	diflunisal	hsa04010	MAPK signaling pathway	4214_9479_1326_5594_6789_6655_1846_8912_355_4763_1956_3845_2258_10746_2246	15	+	0.0325009035347101	0.198161501896307
5181	diflunisal	hsa04540	Gap junction	7082_5594_6655_113457_3708_1956_3845_80310_112_10746_7278	11	+	0.000252248366196934	0.00983768628168043
5182	diflunisal	hsa05213	Endometrial cancer	23533_6655_1956_3845_5594	5	+	0.0265788088220521	0.198161501896307
5183	diflunisal	hsa04912	GnRH signaling pathway	4214_5594_6655_3708_1956_3845_112_10746	8	+	0.0220316037592724	0.198161501896307
5184	diflunisal	hsa05220	Chronic myeloid leukemia	23533_5594_6655_4193_867_3845	6	+	0.0330269169827178	0.198161501896307
5185	diflunisal	hsa05214	Glioma	5578_673_5155_5154_4193	5	-	0.00993307029745197	0.163895659907958
5186	diflunisal	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	1.48015288795689e-06	9.76900906051547e-05
5187	diflunisal	hsa04710	Circadian rhythm - mammal	1408_8863	2	-	0.0312587547138942	0.257884726389627
5188	diflunisal	hsa05212	Pancreatic cancer	2308_5155_4193_5154_2260_673	6	-	0.00877271150792296	0.163895659907958
5189	diflunisal	hsa05215	Prostate cancer	2308_5155_4193_5154_2260_673	6	-	0.00834518631875071	0.163895659907958
5190	diflunisal	hsa05218	Melanoma	2260_673_5155_5154_4193	5	-	0.01386545191711	0.183023965305852
5191	diflunisal	hsa04810	Regulation of actin cytoskeleton	3691_5155_5154_673_3678_3985_2245_2260_3675	9	-	0.0404875147941476	0.296908441823749
5192	diflunisal	hsa04010	MAPK signaling pathway	5578_11261_5155_5154_673_6722_6196_3725_2260_3727_11221	11	-	0.0222382627450653	0.209675048739187
5193	diflunisal	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0215714135987266	0.209675048739187
5194	hydrochlorothiazide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	4.20232581421347e-06	0.0002185209423391
5195	hydrochlorothiazide	hsa04020	Calcium signaling pathway	56848_5724_5331_3708_5335_1909_3269_1910_814	9	+	0.0177330731099683	0.461059900859176
5196	hydrochlorothiazide	hsa05211	Renal cell carcinoma	3725_405_2271_5290	4	-	0.0128750153739696	0.59910962425344
5197	hydrochlorothiazide	hsa04010	MAPK signaling pathway	4217_9252_355_4763_23162_2005_5494_3725	8	-	0.0193261169114013	0.59910962425344
5198	captopril	hsa04740	Olfactory transduction	26211_26212	2	+	0.000557837173830556	0.0209188940186458
5199	captopril	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_88_8294_720_721_121504_3119_8367	18	+	3.99668642127223e-06	0.000299751481595417
5200	captopril	hsa04060	Cytokine-cytokine receptor interaction	6367_4233	2	+	0.0190396233230149	0.475990583075373
5201	captopril	hsa04210	Apoptosis	472_8503_5534_841_581	5	-	0.0129703129484267	0.415050014349654
5202	captopril	hsa04010	MAPK signaling pathway	4149_9344_9252_5607_5534_7786_3725_2260_408	9	-	0.0386320420529095	0.824150230462069
5203	captopril	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0116718468232832	0.415050014349654
5204	acebutolol	hsa04520	Adherens junction	4088_2260_3643_998	4	+	0.0385893242140818	0.888356083871494
5205	acebutolol	hsa04350	TGF-beta signaling pathway	656_4088_268_652_353500	5	+	0.0128544834647941	0.78412349135244
5206	acebutolol	hsa05210	Colorectal cancer	4088_23533_324_581	4	+	0.0445533610938917	0.888356083871494
5207	acebutolol	hsa04664	Fc epsilon RI signaling pathway	5606_3845_5581	3	-	0.0263690020337931	0.665649436969556
5208	diphemanil metilsulfate	hsa04740	Olfactory transduction	5566_157	2	+	0.00461160868747326	0.163712108405301
5209	diphemanil metilsulfate	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_717_8368_8359_8294_8367_554313_121504	15	+	1.08549277824982e-05	0.000770699872557372
5210	diphemanil metilsulfate	hsa04210	Apoptosis	5575_8837_841_5534	4	-	0.0458820294467293	0.321174206127105
5211	diphemanil metilsulfate	hsa04664	Fc epsilon RI signaling pathway	100137049_8681_5606_8399	4	-	0.0322068488344349	0.269765046850816
5212	diphemanil metilsulfate	hsa04370	VEGF signaling pathway	8681_100137049_8399_5534	4	-	0.0298048484504091	0.269765046850816
5213	diphemanil metilsulfate	hsa04010	MAPK signaling pathway	8399_5534_1846_5154_5606_8681_2258_5494_100137049	9	-	0.0213808331291266	0.269765046850816
5214	diphemanil metilsulfate	hsa04912	GnRH signaling pathway	2778_8681_5606_100137049_8399	5	-	0.0240318158869602	0.269765046850816
5215	diphemanil metilsulfate	hsa04730	Long-term depression	2778_8681_100137049_8399	4	-	0.0232554536228689	0.269765046850816
5216	diphemanil metilsulfate	hsa04270	Vascular smooth muscle contraction	2778_27094_8681_100137049_8399	5	-	0.0330324547164265	0.269765046850816
5217	amylocaine	hsa05332	Graft-versus-host disease	3824_3119_3117_3126_3113_3127_3125_3123	8	+	0.0251160902672448	0.268246086940379
5218	amylocaine	hsa04070	Phosphatidylinositol signaling system	3710	1	+	0.0431481395609272	0.268246086940379
5219	amylocaine	hsa04120	Ubiquitin mediated proteolysis	4281_23759_5371_330	4	+	0.0478059761554476	0.268246086940379
5220	amylocaine	hsa05010	Alzheimer's disease	6390_4695_3710_841_4842	5	+	0.0136139216191346	0.268246086940379
5221	amylocaine	hsa04910	Insulin signaling pathway	10580_208_23265_25759	4	+	0.0472244807297245	0.268246086940379
5222	amylocaine	hsa05016	Huntington's disease	4695_841_6390_64446_7416_9586_6648	7	+	0.0493326136901847	0.268246086940379
5223	amylocaine	hsa04740	Olfactory transduction	5137_26476_8390_26692_816	5	+	6.91441679967904e-08	6.01554261572076e-06
5224	amylocaine	hsa05322	Systemic lupus erythematosus	8329_3123_3126_3127_3125_8969_8968_717_8358_8330_8331_8336_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_2215_3117_3013_3113	27	+	0.000122223053746257	0.00531670283796218
5225	amylocaine	hsa04530	Tight junction	4619_208_29895_3059	4	+	0.0467642487208966	0.268246086940379
5226	amylocaine	hsa05219	Bladder cancer	11186_1029_3576_1612_7057_5925_1950_7422	8	+	0.0251160902672448	0.268246086940379
5227	amylocaine	hsa05310	Asthma	3119_3117_3123_3126_3127_3125_3113	7	+	0.0149325278508403	0.268246086940379
5228	amylocaine	hsa05012	Parkinson's disease	2861_6390_4695_7416	4	+	0.0464255209784611	0.268246086940379
5229	amylocaine	hsa04912	GnRH signaling pathway	3710_816	2	+	0.0240867678206172	0.268246086940379
5230	amylocaine	hsa05330	Allograft rejection	3119_3117_3113_3126_3127_3125_3123	7	+	0.0401582800989625	0.268246086940379
5231	amylocaine	hsa04270	Vascular smooth muscle contraction	4881_3710_2977	3	+	0.0486394828746825	0.268246086940379
5232	amylocaine	hsa04940	Type I diabetes mellitus	3119_3117_3126_3113_3127_3125_1363_3123	8	+	0.0310638529158163	0.268246086940379
5233	pheniramine	hsa04650	Natural killer cell mediated cytotoxicity	23533_3448_3106_3107_27040_6452_80328_9436_259197_6850	10	+	0.0286340989538913	0.406921756520589
5234	pheniramine	hsa05320	Autoimmune thyroid disease	958_3448_3106_3107_3113_3134	6	+	0.0113277586164542	0.214596727583778
5235	pheniramine	hsa05016	Huntington's disease	4713	1	+	0.0334456238236101	0.406921756520589
5236	pheniramine	hsa04740	Olfactory transduction	56656	1	+	8.58486772527606e-05	0.00313347671972576
5237	pheniramine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8342_958_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3113_3014	36	+	4.22918568029719e-19	3.08730554661695e-17
5238	pheniramine	hsa05330	Allograft rejection	958_3106_3107_3113_3134	5	+	0.0117587247991111	0.214596727583778
5239	pheniramine	hsa04070	Phosphatidylinositol signaling system	8394_8871_23236	3	-	0.0231646405918976	0.386098187392693
5240	pheniramine	hsa05322	Systemic lupus erythematosus	6738_3113_720_721	4	-	0.0275784419566209	0.386098187392693
5241	pheniramine	hsa04115	p53 signaling pathway	472_651610_10912	3	-	0.0181523756695633	0.386098187392693
5242	cyclic adenosine monophosphate	hsa05332	Graft-versus-host disease	3553_3119_3123_3126_3127_3111_3125_3803	8	+	0.000305023138292865	0.010192461793775
5243	cyclic adenosine monophosphate	hsa04640	Hematopoietic cell lineage	1435_3553_2812_3690_3123_3126_3127_3125_7066_1378	10	+	0.00201635819959263	0.030648644633808
5244	cyclic adenosine monophosphate	hsa05320	Autoimmune thyroid disease	3119_3123_3126_3127_3111_3125	6	+	0.0165465260798046	0.157191997758144
5245	cyclic adenosine monophosphate	hsa04612	Antigen processing and presentation	4800_3119_3123_3126_3127_3803_3125_3111_3310	9	+	0.00716121093430761	0.0777502901439112
5246	cyclic adenosine monophosphate	hsa04740	Olfactory transduction	5613	1	+	2.61600081345331e-05	0.00198816061822452
5247	cyclic adenosine monophosphate	hsa05310	Asthma	3119_3123_3126_3127_3111_3125	6	+	0.00139753381666203	0.0265531425165786
5248	cyclic adenosine monophosphate	hsa04512	ECM-receptor interaction	961_2812_3690_3693_1277_63923_1290	7	+	0.0396717001310262	0.33500546777311
5249	cyclic adenosine monophosphate	hsa04630	Jak-STAT signaling pathway	6775	1	+	0.0459587951931624	0.349286843468034
5250	cyclic adenosine monophosphate	hsa05330	Allograft rejection	3119_3123_3126_3127_3111_3125	6	+	0.00400705360180902	0.0507560122895809
5251	cyclic adenosine monophosphate	hsa04940	Type I diabetes mellitus	3382_3119_3123_3126_3127_3111_3125_3553	8	+	0.000402334018175328	0.010192461793775
5252	cyclic adenosine monophosphate	hsa04740	Olfactory transduction	5566	1	-	0.000575084618898805	0.0316296540394343
5253	pepstatin	hsa04520	Adherens junction	51176_7082_8936_5797_5795_91_5770_6714_25945	9	+	0.00137704455602728	0.0271966299815388
5254	pepstatin	hsa04740	Olfactory transduction	5566	1	+	0.000183438351176054	0.00724581487145413
5255	pepstatin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_2215_8370_2214_8368_8366_8359_8294_8367_554313_121504_3119_8364	17	+	6.62165655473359e-06	0.000523110867823954
5256	pepstatin	hsa04540	Gap junction	153_7082_5598_5566_6654_113457_3708_5607_57369_6714_7278	11	+	0.000281158328590728	0.0074038359862225
5257	pepstatin	hsa05016	Huntington's disease	246721_7381_842_5439_161_27113_548644_10126	8	-	0.0243943548624139	0.292732258348967
5258	pepstatin	hsa04740	Olfactory transduction	810	1	-	0.0162930012040895	0.285751753918295
5259	pepstatin	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8336	7	-	0.0186179972499394	0.285751753918295
5260	pepstatin	hsa04115	p53 signaling pathway	472_651610_6477_842_27113	5	-	0.010295652017677	0.285751753918295
5261	pepstatin	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0190501169278863	0.285751753918295
5262	sulfaguanidine	hsa05211	Renal cell carcinoma	3725_201163_112399_5155_7042	5	-	0.024130557017842	0.512674840079675
5263	sulfaguanidine	hsa04740	Olfactory transduction	5566	1	-	0.00354340548427472	0.240951572930681
5264	sulfaguanidine	hsa04010	MAPK signaling pathway	4149_8399_2005_5566_7042_5155_7189_4763_5600_3725_2263_2264_408	13	-	0.0102251720044263	0.347655848150494
5265	sulfaguanidine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0301573435340985	0.512674840079675
5266	minoxidil	hsa05332	Graft-versus-host disease	3123_3107_3126_3127_3125_355	6	+	0.00128044150249544	0.0354958222875813
5267	minoxidil	hsa05320	Autoimmune thyroid disease	3123_3107_3126_3127_3125_355	6	+	0.00372694038514689	0.0624262514512104
5268	minoxidil	hsa04340	Hedgehog signaling pathway	53944_8945_8643_1452_7480	5	+	0.0204207442483245	0.22803164410629
5269	minoxidil	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.010414477929686	0.139554004257792
5270	minoxidil	hsa05330	Allograft rejection	3123_3107_3126_3127_3125_355	6	+	0.000801718478058394	0.0354958222875813
5271	minoxidil	hsa04940	Type I diabetes mellitus	3123_3107_3126_3127_3125_355	6	+	0.00158936517705588	0.0354958222875813
5272	minoxidil	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	-	0.00712216334574369	0.115873650147503
5273	minoxidil	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	-	0.0149707836137009	0.159544089408897
5274	minoxidil	hsa04612	Antigen processing and presentation	6890_3123_3126_3127_3125	5	-	0.020485113435409	0.179244742559829
5275	minoxidil	hsa05016	Huntington's disease	246721_842_841_5439_1175_548644_161	7	-	0.0451914743040692	0.316340320128484
5276	minoxidil	hsa05322	Systemic lupus erythematosus	3123_3126_3127_3125_8358_6738_8968_3013_8350_8351_8352_8353_8354_8355_8356_8357	16	-	9.24180050838477e-09	6.46926035586934e-07
5277	minoxidil	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.00236333203995391	0.0827166213983869
5278	minoxidil	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0159544089408897	0.159544089408897
5279	minoxidil	hsa05330	Allograft rejection	3123_3126_3127_3125	4	-	0.00514354113705703	0.115873650147503
5280	minoxidil	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	-	0.00827668929625024	0.115873650147503
5281	minoxidil	hsa02010	ABC transporters	6890_215_23457	3	-	0.0435415159121094	0.316340320128484
5282	dropropizine	hsa04010	MAPK signaling pathway	776_4149_9064_782_1649_998_1399_6196_5322_5536_5603_5534_7786_8398_3164_5609	16	+	0.00309329065381804	0.1886907298829
5283	dropropizine	hsa04912	GnRH signaling pathway	776_8398_998_108_5322_5603_5609	7	+	0.0253855710457802	0.542535458973139
5284	dropropizine	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_1956_28964_5781	4	-	0.0353321347005482	0.972894648606165
5285	dropropizine	hsa04940	Type I diabetes mellitus	3134_1363_2571	3	-	0.0423013235022654	0.972894648606165
5286	brompheniramine	hsa05332	Graft-versus-host disease	3107_3553_3119	3	+	0.022671183690745	0.27205420428894
5287	brompheniramine	hsa04514	Cell adhesion molecules (CAMs)	214_3119_3107_57863_1002_5817	6	+	0.0117102906138672	0.187364649821875
5288	brompheniramine	hsa04210	Apoptosis	8794_5566_3553_330	4	+	0.0370501584378202	0.355681521003074
5289	brompheniramine	hsa04270	Vascular smooth muscle contraction	5566_4881_4882_148_9826_3779	6	+	0.00663392561652256	0.159214214796541
5290	brompheniramine	hsa04940	Type I diabetes mellitus	3553_3107_3382_3119_2571	5	+	0.000495731620726132	0.0237951177948543
5291	brompheniramine	hsa04080	Neuroactive ligand-receptor interaction	3354	1	-	0.023221541309235	0.434333334264448
5292	brompheniramine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3111_8359_8294_8367_554313_6738_121504_81	17	-	5.4459170189337e-07	4.08443776420027e-05
5293	brompheniramine	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_3725_1956_3551_523	5	-	0.0416397341365514	0.434333334264448
5294	N-acetyl-L-aspartic acid	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.00152316435345407	0.0163740167996313
5295	N-acetyl-L-aspartic acid	hsa04640	Hematopoietic cell lineage	3123_3126_3127_3125	4	+	0.0171976785909439	0.11353126059679
5296	N-acetyl-L-aspartic acid	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	+	0.00336486536345938	0.0289378421257507
5297	N-acetyl-L-aspartic acid	hsa04612	Antigen processing and presentation	3123_3126_3127_3125	4	+	0.0184818331204077	0.11353126059679
5298	N-acetyl-L-aspartic acid	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.00047844275329595	0.0102865191958629
5299	N-acetyl-L-aspartic acid	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.00108015363533252	0.0154822021064328
5300	N-acetyl-L-aspartic acid	hsa04940	Type I diabetes mellitus	3382_3126_3127_3123_3125	5	+	0.000181285513235626	0.00779527706913192
5301	N-acetyl-L-aspartic acid	hsa04080	Neuroactive ligand-receptor interaction	2908_5030_1081_1813	4	-	0.0373935807034095	1
5302	N-acetyl-L-aspartic acid	hsa04740	Olfactory transduction	409_816	2	-	2.01637930877376e-05	0.00083679741314111
5303	N-acetyl-L-aspartic acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	25	-	2.34092897351276e-08	1.94297104801559e-06
5304	niflumic acid	hsa04740	Olfactory transduction	393046	1	+	0.00180505677094514	0.12274386042427
5305	niflumic acid	hsa05322	Systemic lupus erythematosus	85235_8330_3111_8332_8969_8331_8329_6737_8336	9	+	0.011711510454876	0.398191355465784
5306	rilmenidine	hsa04520	Adherens junction	4088_4089_3480_5770_2260_25945_6714	7	+	0.0446634592641868	1
5307	rilmenidine	hsa04740	Olfactory transduction	818_23538_1258	3	+	0.000345116116340051	0.0279544054235441
5308	rilmenidine	hsa05322	Systemic lupus erythematosus	85235_3119_8330_3111_8332_8969_8331_8329_8343_8336_8339_8347_8346_8344	14	+	0.00246250976286012	0.0997316453958349
5309	rilmenidine	hsa05322	Systemic lupus erythematosus	3123_3013_8343_8351_8339_8347_8346_8344	8	-	0.0249123614581388	1
5310	N-acetylmuramic acid	hsa05332	Graft-versus-host disease	3804_3811_3552_3119_3802	5	+	0.0365569836712732	0.681467905783428
5311	N-acetylmuramic acid	hsa04080	Neuroactive ligand-receptor interaction	6915_8001_5724_7433	4	+	0.0499356564900858	0.681467905783428
5312	N-acetylmuramic acid	hsa05016	Huntington's disease	5331_3708	2	+	0.0360911283330569	0.681467905783428
5313	N-acetylmuramic acid	hsa04740	Olfactory transduction	5566	1	+	3.6246258347933e-06	0.000143172720474335
5314	N-acetylmuramic acid	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_8362_8329_8294_8366_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3119_83740_720_721	27	+	5.61811181741582e-10	4.4383083357585e-08
5315	N-acetylmuramic acid	hsa05211	Renal cell carcinoma	6655_5295_8453_3845_7422_7042_3725	7	-	0.0215088384892117	0.446308398651143
5316	N-acetylmuramic acid	hsa04080	Neuroactive ligand-receptor interaction	2561_135	2	-	0.00938898100382993	0.389642711658942
5317	N-acetylmuramic acid	hsa05200	Pathways in cancer	5295_581_6502_6655_2258_5371_4254_8453_4437_1956_3845_7422_7184_7042_10342_1488_4313_6256_3725_3675	20	-	0.037966232484036	0.450171042310713
5318	N-acetylmuramic acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8347_8346_8344_3123_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235	27	-	5.04614036026745e-11	4.18829649902198e-09
5319	N-acetylmuramic acid	hsa04012	ErbB signaling pathway	27_6655_5295_2002_1956_3845_3725	7	-	0.0487695083086434	0.465763173735358
5320	N-acetylmuramic acid	hsa03020	RNA polymerase	246721_5439_548644_10622	4	-	0.0281325060612184	0.450171042310713
5321	N-acetylmuramic acid	hsa04912	GnRH signaling pathway	4214_4313_6655_2002_1956_3845_113_3725_23236	9	-	0.0372519214107314	0.450171042310713
5322	N-acetylmuramic acid	hsa05210	Colorectal cancer	581_6655_5295_4437_1956_3845_7042_3725	8	-	0.0160504556056122	0.444062605088604
5323	bupivacaine	hsa05332	Graft-versus-host disease	942_3126_3127_3123_3125	5	+	0.0153968066172923	0.28389042721904
5324	bupivacaine	hsa05320	Autoimmune thyroid disease	942_3126_3127_3123_3125	5	+	0.0348841776113888	0.453494308948054
5325	bupivacaine	hsa04514	Cell adhesion molecules (CAMs)	6404_5175_3123_3126_3127_3125_57863_4359_942	9	+	0.0462003785471777	0.514804218097123
5326	bupivacaine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504_8354_942	20	+	1.92209570504199e-07	1.49923464993275e-05
5327	bupivacaine	hsa05310	Asthma	3123_2205_3126_3127_3125	5	+	0.00441932030517448	0.172353491901805
5328	bupivacaine	hsa05330	Allograft rejection	942_3126_3127_3123_3125	5	+	0.0106912259147959	0.277971873784693
5329	bupivacaine	hsa04940	Type I diabetes mellitus	3126_942_3127_3123_3125	5	+	0.0181981043089128	0.28389042721904
5330	bupivacaine	hsa04080	Neuroactive ligand-receptor interaction	5026	1	-	0.00245861845319168	0.0885102643149005
5331	bupivacaine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	30	-	7.42146450804742e-14	5.34345444579414e-12
5332	bupivacaine	hsa05223	Non-small cell lung cancer	2064_6257_1956_5335_6654	5	-	0.0458160055250065	0.71403127158548
5333	bupivacaine	hsa05210	Colorectal cancer	581_6654_5881_1956_324_91_8321	7	-	0.031624790428609	0.71403127158548
5334	piperine	hsa04740	Olfactory transduction	5137_9635	2	+	0.00326156705840893	0.24461752938067
5335	piperine	hsa04510	Focal adhesion	3695_2324_6655_3908_56924_3685_1277_1292_88_5293_55742_3082	12	+	0.0159097782511441	0.397744456278603
5336	piperine	hsa04012	ErbB signaling pathway	6655_5293_867_56924_3084_7039	6	+	0.0366707220878275	0.52630419418576
5337	piperine	hsa04512	ECM-receptor interaction	2812_3908_3695_3685_1277_1292	6	+	0.0319499632373126	0.52630419418576
5338	piperine	hsa04630	Jak-STAT signaling pathway	3581_3589_6655_3446_5293_867_50616_3976_9021	9	+	0.0421043355348608	0.52630419418576
5339	piperine	hsa04810	Regulation of actin cytoskeleton	9459_6655_9138_3695_3685_56924_88_7430_8976_324_5293_26281_2250	13	+	0.0106232161758326	0.397744456278603
5340	piperine	hsa05214	Glioma	7157_5155_5290_5291_5605_5296_808_801_673_805	10	-	0.00973438471316213	0.128311217445731
5341	piperine	hsa04070	Phosphatidylinositol signaling system	3636_5290_5291_5331_5296_808_4952_200576_801_805	10	-	0.0302039525876869	0.19981076327239
5342	piperine	hsa05211	Renal cell carcinoma	5296_5155_5290_5291_5605_405_8453_7042_673	9	-	0.0486887055830183	0.254026523530042
5343	piperine	hsa04080	Neuroactive ligand-receptor interaction	4889	1	-	7.49911324532445e-06	0.000644923739097903
5344	piperine	hsa05131	Shigellosis	3688_347733_7278_999_113457_7280_7430_7534	8	-	0.0280792635797552	0.19981076327239
5345	piperine	hsa05130	Pathogenic Escherichia coli infection	3688_347733_7278_999_113457_7280_7430_7534	8	-	0.0280792635797552	0.19981076327239
5346	piperine	hsa04740	Olfactory transduction	219464_5613_5616_808_801_805	6	-	5.02456690035753e-05	0.00216056376715374
5347	piperine	hsa04514	Cell adhesion molecules (CAMs)	3688_999	2	-	0.0247047041286468	0.19981076327239
5348	piperine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	19	-	0.00301836249205877	0.0865263914390181
5349	piperine	hsa05212	Pancreatic cancer	5170_6934_9134_7157_5155_5290_673_5605_5296_3326_1385_5291	12	-	0.0146216063977395	0.139717572245066
5350	piperine	hsa05215	Prostate cancer	5170_6934_9134_7157_5155_5290_673_5605_5296_3326_1385_5291	12	-	0.0139086602169409	0.139717572245066
5351	piperine	hsa04210	Apoptosis	5296_836_7157_5613_5575_331_5290_5291_472_5616_8737_8837_651610	13	-	0.00754979501503082	0.128311217445731
5352	piperine	hsa05216	Thyroid cancer	5605_7157_999_6934_673	5	-	0.0417538225776831	0.239388582778716
5353	piperine	hsa04060	Cytokine-cytokine receptor interaction	27242_3459_5155_8742_8741_7042	6	-	0.0104439363037223	0.128311217445731
5354	piperine	hsa03020	RNA polymerase	5432_246721_5439_548644_5440	5	-	0.0417538225776831	0.239388582778716
5355	piperine	hsa05213	Endometrial cancer	5170_7157_999_5290_5291_5605_5296_6934_673	9	-	0.00724117171598011	0.128311217445731
5356	enilconazole	hsa04740	Olfactory transduction	4991_2979_135948_9635_81797	5	+	0.00017017978485692	0.0132740232188398
5357	enilconazole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_88_8294_8367_554313_121504_3119	16	+	0.00784407580322803	0.305918956325893
5358	enilconazole	hsa04110	Cell cycle	4088	1	+	0.0312562382363703	0.741919367572533
5359	enilconazole	hsa04062	Chemokine signaling pathway	7409	1	-	0.0322052370198929	1
5360	nipecotic acid	hsa05016	Huntington's disease	4899	1	+	0.0461965873576664	1
5361	nipecotic acid	hsa04510	Focal adhesion	1278_5170_10298_8515_596_3690_5880_1277_1956_5923_55742_2335	12	+	0.0355602413354333	1
5362	nipecotic acid	hsa04360	Axon guidance	2047_1949_57715_10298_57556_2048_8482_5880_6092_80031	10	+	0.0072802734080674	0.495058591748583
5363	nipecotic acid	hsa04740	Olfactory transduction	157	1	-	8.20410400770718e-05	0.0063992011260116
5364	nipecotic acid	hsa04370	VEGF signaling pathway	5829_5296_3845_5600_5534_6714	6	-	0.0481237499279745	0.956368418434057
5365	nipecotic acid	hsa04540	Gap junction	2911_7278_6654_5155_113457_5607_3845_6714_23236	9	-	0.00505308041184886	0.197070136062106
5366	meteneprost	hsa04640	Hematopoietic cell lineage	3655_1604_3673	3	+	0.0324026434855582	0.469838330540594
5367	meteneprost	hsa04080	Neuroactive ligand-receptor interaction	4889_5618_64106_4158_2908_2688_1442_2150_728	9	+	9.45856614905446e-05	0.00411447627483869
5368	meteneprost	hsa04670	Leukocyte transendothelial migration	2909_5747_7409_5175_9475	5	+	0.0231585970217581	0.402959588178591
5369	meteneprost	hsa04740	Olfactory transduction	818_5613_5567_5616_816	5	+	4.10646561699688e-12	3.57262508678729e-10
5370	meteneprost	hsa04260	Cardiac muscle contraction	9167_1327_4635	3	+	0.0446968764247962	0.554708833515973
5371	meteneprost	hsa04060	Cytokine-cytokine receptor interaction	91_3556_5618_8771_3449_3588_3459_5154_3572_23529_355_7424_2688_7422_8718_8795	16	+	0.018603541234541	0.402959588178591
5372	meteneprost	hsa03010	Ribosome	9349	1	+	0.000625118601885761	0.0181284394546871
5373	meteneprost	hsa04740	Olfactory transduction	219464	1	-	1.79862086217508e-05	0.00136695185525306
5374	meteneprost	hsa05219	Bladder cancer	7157_999_7057_1613_1871_1890	6	-	0.00720079328638052	0.251008260850346
5375	meteneprost	hsa05223	Non-small cell lung cancer	5170_5578_7157_6655_1871_5336	6	-	0.0205220310989245	0.389918590879565
5376	meteneprost	hsa05220	Chronic myeloid leukemia	3551_7157_6655_1871_867_861_1398_91	8	-	0.00990822082303998	0.251008260850346
5377	nabumetone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_717_8368_3126_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	21	+	4.4285623971438e-09	3.27713617388641e-07
5378	nabumetone	hsa04920	Adipocytokine signaling pathway	208_32_5781_5588_3952	5	+	0.0478911497182891	0.71159869356353
5379	nabumetone	hsa04020	Calcium signaling pathway	146_5533_1812_818_9630_7416_8912_5733_810_816	10	+	0.0461389898792003	0.71159869356353
5380	nabumetone	hsa04080	Neuroactive ligand-receptor interaction	5618	1	-	0.0160192294729924	0.608730719973711
5381	nabumetone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_3113_8359_8294_8367_554313_8368_121504_9555	17	-	1.17897671592696e-06	8.9602230410449e-05
5382	PHA-00846566E	hsa03440	Homologous recombination	5890_7156_10111	3	+	0.00355952018356934	0.16373792844419
5383	PHA-00846566E	hsa05221	Acute myeloid leukemia	5970_5292_3551	3	-	0.0402162510893904	0.482595013072685
5384	PHA-00846566E	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_5970_50848_3551	4	-	0.0133557786069969	0.439812979765137
5385	PHA-00846566E	hsa05222	Small cell lung cancer	51588_5970_331_3551	4	-	0.0244340544313965	0.439812979765137
5386	carbachol	hsa04640	Hematopoietic cell lineage	920_1378_2812_3690	4	+	0.0253225240557822	0.325301009408079
5387	carbachol	hsa05322	Systemic lupus erythematosus	3013_9103_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	+	4.22555359085047e-07	1.60571036452318e-05
5388	carbachol	hsa04360	Axon guidance	2047_6093_57144_80031_2534	5	+	0.0256816586374799	0.325301009408079
5389	carbachol	hsa05222	Small cell lung cancer	2335_598_3918_5747_1869_3675	6	-	0.0186904336541929	1
5390	flavoxate	hsa04740	Olfactory transduction	1179	1	+	0.0110987502387991	0.721418765521942
5391	flavoxate	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	19	-	0.000119497395984913	0.0092012994908383
5392	flavoxate	hsa05012	Parkinson's disease	4712	1	-	0.0332796934550896	0.733761899870331
5393	flavoxate	hsa05210	Colorectal cancer	595_581_3480_5295_5881_5900_324_4609_8324_8322	10	-	0.00908274535022182	0.34968569598354
5394	PNU-0293363	hsa05214	Glioma	5594_5578_7157_6654_6464_5154_5290_5605_5296_808_5335_801_805	13	+	0.0107108697602622	0.206136556928093
5395	PNU-0293363	hsa04070	Phosphatidylinositol signaling system	8867_3710_5298_5578_5296_5290_5333_808_5335_4952_801_3707_805	13	+	0.0311013179812248	0.270548771469781
5396	PNU-0293363	hsa04640	Hematopoietic cell lineage	3655_966	2	+	0.0474153867411097	0.328260369746144
5397	PNU-0293363	hsa04080	Neuroactive ligand-receptor interaction	4157_7068_5025_56288_2150_9170	6	+	0.000123171962509143	0.00554273831291143
5398	PNU-0293363	hsa05200	Pathways in cancer	6777_8554_5296_331_5154_5290_5605_4436_5335_3326_5747_3655_7976_25_4149_7157_1857_5900_2034_324_1398_367_1017_9134_613_999_1495_6934_2263_5899_2956_4791_2335_2271_5594_5578_6774_6654_6772_355_5970_7184	42	+	0.0330670720685288	0.270548771469781
5399	PNU-0293363	hsa04740	Olfactory transduction	801_808_805	3	+	3.82833852896898e-11	3.44550467607208e-09
5400	PNU-0293363	hsa05212	Pancreatic cancer	6934_367_5970_5594_9134_7157_6654_5154_5290_5605_5296_3326_1385_2263_1017_7184	16	+	0.0114520309404496	0.206136556928093
5401	PNU-0293363	hsa05215	Prostate cancer	6934_367_5970_5594_9134_7157_6654_5154_5290_5605_5296_3326_1385_2263_1017_7184	16	+	0.0106991445280812	0.206136556928093
5402	PNU-0293363	hsa03430	Mismatch repair	9156_5983_6117_5985_4436_2956	6	+	0.0262519482778256	0.270548771469781
5403	PNU-0293363	hsa04060	Cytokine-cytokine receptor interaction	3597_3460_3588_23765_3459_5154_8741_8742_355_4982_655_51330	12	+	0.0183642172163826	0.236111364210633
5404	PNU-0293363	hsa05213	Endometrial cancer	2309_6934_5296_6654_999_5290_5605_7157_1495_324_5594	11	+	0.0163441806023136	0.236111364210633
5405	PNU-0293363	hsa05220	Chronic myeloid leukemia	25_6777_5594_5296_613_6654_6464_5290_5605_7157_5781_1398_5970	13	+	0.0293412149732509	0.270548771469781
5406	PNU-0293363	hsa04610	Complement and coagulation cascades	966	1	+	0.0434153516858221	0.325615137643666
5407	PNU-0293363	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	1.43383891915227e-08	6.30889124426999e-07
5408	tamoxifen	hsa04640	Hematopoietic cell lineage	2815_3581_966_3554_2057_1437_3123_2812_3126_3127_3125_947_933	13	+	0.02248169721205	0.659463118220133
5409	tamoxifen	hsa04740	Olfactory transduction	8390_7932_10798	3	+	1.52370935931768e-08	6.70432118099779e-07
5410	tamoxifen	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8349_8348_8294_121504_8343_8347_8346_8344_8339_3123_3126_3127_3125_8968_8370_8358_8359_8335_8350_8351_8352_8353_8354_8355_8356_8357_3012_3013_3017_8970	40	+	1.0957888041329e-11	9.64294147636952e-10
5411	tamoxifen	hsa05010	Alzheimer's disease	5595_22926_351_102_4842_23236	6	-	0.0233054398630736	0.32627615808303
5412	tamoxifen	hsa04080	Neuroactive ligand-receptor interaction	2859_4889_2914_7068_4886_5027_135_7433_3269_5646	10	-	0.0177176178015766	0.32627615808303
5413	tamoxifen	hsa05016	Huntington's disease	581_23236	2	-	7.50674566518868e-05	0.00315283317937925
5414	tamoxifen	hsa04740	Olfactory transduction	219464_5566_157_409	4	-	3.4005859955384e-09	2.85649223625226e-07
5415	tamoxifen	hsa05322	Systemic lupus erythematosus	717_3111	2	-	0.00140793462169595	0.0394221694074866
5416	tamoxifen	hsa04260	Cardiac muscle contraction	782	1	-	0.0203867507549758	0.32627615808303
5417	tolbutamide	hsa04740	Olfactory transduction	8387_8392_1179_8388	4	+	4.50645747150294e-06	0.000187017985067372
5418	tolbutamide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_3017	27	+	8.53184720314838e-07	7.08143317861316e-05
5419	tolbutamide	hsa04530	Tight junction	26285_5584	2	+	0.0247773038631141	0.514129055159618
5420	tolbutamide	hsa04630	Jak-STAT signaling pathway	3560_2057	2	+	0.0127795022796688	0.353566229737504
5421	tolbutamide	hsa05010	Alzheimer's disease	3553_1329_3708_351_4695_6622	6	-	0.0410450593658884	0.435952429609474
5422	tolbutamide	hsa04080	Neuroactive ligand-receptor interaction	1269_2917_64106_2908_2901_5030_3354_3351	8	-	0.00698808960061512	0.197995872017428
5423	tolbutamide	hsa04660	T cell receptor signaling pathway	5163_1432_3551_208_5058_5295_56924_5588_998_4776_4775_5335_3725_1326_4793	15	-	0.0499147691875745	0.435952429609474
5424	tolbutamide	hsa04740	Olfactory transduction	219464	1	-	1.95471138953607e-11	1.66150468110566e-09
5425	tolbutamide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8294_121504_8968_8370_8358_8359_8330_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3014	29	-	1.31492686566397e-05	0.000558843917907187
5426	tolbutamide	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	7082_1432_3551_8992_5058_998_10392_1956_5335_3725_50848	11	-	0.0461502029834893	0.435952429609474
5427	tolbutamide	hsa04720	Long-term potentiation	3708	1	-	0.042743077696034	0.435952429609474
5428	tolbutamide	hsa04260	Cardiac muscle contraction	1329	1	-	0.0299281296276071	0.435952429609474
5429	dexverapamil	hsa03010	Ribosome	6204_6169_6205_284393_6181_6157_389342_9045	8	+	3.41487075288974e-05	0.00184403020656046
5430	dexverapamil	hsa04110	Cell cycle	4174_25_890_5111_990_10971_4088_983_9184_7027_10926_8243_8697_4999	14	-	0.038540491337109	0.761174703907903
5431	dexverapamil	hsa05216	Thyroid cancer	5595_8030_999_5979_3845_6256	6	-	0.0157551760730481	0.414886303256933
5432	dexverapamil	hsa04060	Cytokine-cytokine receptor interaction	657_27242_3597_3572	4	-	0.000551369490037194	0.0435581897129383
5433	dexverapamil	hsa04270	Vascular smooth muscle contraction	5595	1	-	0.0101394111122438	0.40050673893363
5434	verapamil	hsa04916	Melanogenesis	51176_7306_51384_2771_5566_2775_5331_2033_90993_113_112_1906_7475_816_23236	15	+	0.0271546353971208	0.258262139121874
5435	verapamil	hsa05332	Graft-versus-host disease	3804_3107_3113_941_3135_356_5551_942	8	+	0.0214888954151342	0.258262139121874
5436	verapamil	hsa04120	Ubiquitin mediated proteolysis	22888_5371_4193	3	+	0.0187026952583117	0.258262139121874
5437	verapamil	hsa04740	Olfactory transduction	26212_157_5566_5593_8392_4991_816	7	+	2.61349224888959e-06	0.000114993658951142
5438	verapamil	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3113_941_942	35	+	2.005500432823e-08	1.76484038088424e-06
5439	verapamil	hsa04540	Gap junction	2911_5593_2771_5598_5566_113457_3709_5331_5607_80310_10382_113_112_2982_7278_23236	16	+	0.00394842778637002	0.115820548400187
5440	verapamil	hsa05012	Parkinson's disease	1329_5413_65018	3	+	0.0183255119463029	0.258262139121874
5441	verapamil	hsa05330	Allograft rejection	942_3107_3113_941_3135_356_5551	7	+	0.0350671684086227	0.280537347268982
5442	verapamil	hsa04730	Long-term depression	2911_5593_3480_2771_2775_5331_3709_2982_30814_4842_23236	11	+	0.0293479703547584	0.258262139121874
5443	verapamil	hsa04270	Vascular smooth muscle contraction	147_135_2982_3779_1909_552_5331_185_3709_10203_113_112_4629_6093_30814_5566_23236	17	+	0.0161563241387462	0.258262139121874
5444	verapamil	hsa04940	Type I diabetes mellitus	942_3107_2572_941_3135_356_5551_3113	8	+	0.0266716870346853	0.258262139121874
5445	verapamil	hsa05010	Alzheimer's disease	572_5595_23236	3	-	0.0263835860212645	0.534267616930606
5446	verapamil	hsa05016	Huntington's disease	23236	1	-	0.000758614864678671	0.0307239020194862
5447	verapamil	hsa05322	Systemic lupus erythematosus	8363_8362_94239_8329_87_3123_3126_3127_3125_8969_8968_8358_8330_8331_8336_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3014	27	-	1.87107934983652e-07	1.51557427336758e-05
5448	verapamil	hsa05012	Parkinson's disease	51465_7332	2	-	0.0497714492355486	0.669476613795662
5449	verapamil	hsa04060	Cytokine-cytokine receptor interaction	8792_657_23765_4254_9180	5	-	0.0108533685187642	0.293040950006633
5450	rofecoxib	hsa04120	Ubiquitin mediated proteolysis	23759_51366_55284_8065_55236_8450_7320_9021_63893	9	+	0.0287637933103217	0.489010833863483
5451	rofecoxib	hsa05016	Huntington's disease	2902_1211_6648_1327_7052_1639_1329_27113_29796_4698_1385_55567_517_842	14	+	0.027671795675663	0.489010833863483
5452	rofecoxib	hsa04740	Olfactory transduction	219464_51806_5568_157_26333_8390_2978_26476_4995_10798_81797	11	+	4.33076205790049e-11	3.94099347268945e-09
5453	rofecoxib	hsa05322	Systemic lupus erythematosus	3126_3017_720_721_8341_8340	6	+	0.00131465064801093	0.0598166044844973
5454	rofecoxib	hsa04630	Jak-STAT signaling pathway	3581_3566_2057_3594_3589_64109_3441_1438_1439_9021_3592	11	+	0.0389460422424111	0.489010833863483
5455	rofecoxib	hsa04810	Regulation of actin cytoskeleton	5595_1133_26999_2909_3693_5155_998_3696_673_27006_4659_3690_6237_2260_28964_6093	16	+	0.0140815528607565	0.42714043677628
5456	rofecoxib	hsa05012	Parkinson's disease	2861_842_4698_1329_29796_65018_6622_517_1327	9	+	0.0375691753629587	0.489010833863483
5457	rofecoxib	hsa04740	Olfactory transduction	393046_5592_815_9635	4	-	2.54373268866698e-12	2.34023407357362e-10
5458	rofecoxib	hsa05322	Systemic lupus erythematosus	3122_2209	2	-	0.000142348531853141	0.00654803246524449
5459	rofecoxib	hsa05110	Vibrio cholerae infection	11015	1	-	0.041481675658419	0.683419464841416
5460	rofecoxib	hsa04260	Cardiac muscle contraction	6546_782	2	-	0.0227590565791817	0.523458301321179
5461	rofecoxib	hsa03010	Ribosome	6165	1	-	0.000926043905733005	0.0283986797758122
5462	exemestane	hsa04520	Adherens junction	4088_5595_56288	3	-	0.0478270596159521	0.954245032728618
5463	sulindac	hsa05010	Alzheimer's disease	6390_4713	2	+	0.00310433786077157	0.0690715174021674
5464	sulindac	hsa05320	Autoimmune thyroid disease	3439_3107_7252_3123_3447_3446_3126_3127_3111_3125	10	+	0.00295416205751804	0.0690715174021674
5465	sulindac	hsa04612	Antigen processing and presentation	4261_3107_3439_3123_3447_3446_3126_3127_3111_3125_6891_6890	12	+	0.0153272343068124	0.232701453451601
5466	sulindac	hsa04740	Olfactory transduction	26333	1	+	4.33547459965979e-09	3.85857239369721e-07
5467	sulindac	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_9103_8294_87_3123_3126_3127_3125_8370_8359_554313_121504_3017_3111	22	+	0.000254798533212157	0.011338534727941
5468	sulindac	hsa05310	Asthma	3123_3126_3127_3111_3125_8288	6	+	0.0156877384349394	0.232701453451601
5469	sulindac	hsa05012	Parkinson's disease	6390_4713	2	+	0.0250689219322907	0.285995168278667
5470	sulindac	hsa05330	Allograft rejection	3123_3107_3126_3127_3111_3125	6	+	0.0387147779666205	0.382846137669914
5471	sulindac	hsa04940	Type I diabetes mellitus	3382_3123_3107_3126_3127_3111_3125	7	+	0.0257074308565094	0.285995168278667
5472	sulindac	hsa05010	Alzheimer's disease	355_5534_5664	3	-	0.0100590168065878	0.175026892434628
5473	sulindac	hsa04080	Neuroactive ligand-receptor interaction	2859_2901_2908_3360_5733_1902	6	-	0.00772671417356551	0.16805603327505
5474	sulindac	hsa04612	Antigen processing and presentation	3306	1	-	0.0437784437316627	0.380872460465465
5475	sulindac	hsa05016	Huntington's disease	6648	1	-	0.000252107476160217	0.0109666752129694
5476	sulindac	hsa04740	Olfactory transduction	5566	1	-	1.18797793078161e-09	1.03354079978e-07
5477	sulindac	hsa04514	Cell adhesion molecules (CAMs)	6693_57863	2	-	0.0174584601863631	0.190737995738739
5478	sulindac	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3013_554313_721_3014_8359_8294_720_121504_8368_8351_8367	19	-	0.0065895300399518	0.16805603327505
5479	sulindac	hsa05012	Parkinson's disease	7345_9246	2	-	0.0175391260449415	0.190737995738739
5480	sulindac	hsa04060	Cytokine-cytokine receptor interaction	3561_3597_2057_3572_7852_355_7042	7	-	0.0130840292805042	0.189718424567311
5481	sulindac	hsa04270	Vascular smooth muscle contraction	5566_5581	2	-	0.049297281904896	0.389896684156905
5482	sulindac	hsa05220	Chronic myeloid leukemia	1027_2122_6776_1029_5290_5291_25759_9846_7042_1869	10	-	0.0349863071119416	0.338200968748769
5483	amitriptyline	hsa04120	Ubiquitin mediated proteolysis	6921_51343_331_4193_868	5	+	0.043139880814698	0.776517854664564
5484	amitriptyline	hsa04910	Insulin signaling pathway	8835_868_10000_5139	4	+	0.0182331544623851	0.410245975403665
5485	amitriptyline	hsa04740	Olfactory transduction	26212_7932_56656_157_26333_5593_3000_4991_26529_815_816	11	+	2.42988067013692e-05	0.00109344630156161
5486	amitriptyline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_2209_8969_8968_8370_718_717_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_942_3017_1511	38	+	2.09001595835887e-08	1.88101436252298e-06
5487	amitriptyline	hsa03010	Ribosome	6187_440589	2	+	0.0165515115132361	0.410245975403665
5488	amitriptyline	hsa04080	Neuroactive ligand-receptor interaction	2902_56288_2740	3	-	0.01974246077047	0.49356151926175
5489	amitriptyline	hsa04740	Olfactory transduction	5137_409	2	-	6.11338939106797e-05	0.00458504204330098
5490	amitriptyline	hsa04060	Cytokine-cytokine receptor interaction	8718_1271_2057	3	-	0.0142228227732093	0.49356151926175
5491	15-delta prostaglandin J2	hsa04080	Neuroactive ligand-receptor interaction	7068_2908_3362_5031_186_7433_8484	7	+	6.50544211085864e-05	0.00299250337099497
5492	15-delta prostaglandin J2	hsa05016	Huntington's disease	246721_51164_841_581_7052_7416_9001_161_23236	9	+	0.0308352662677911	0.567368899327356
5493	15-delta prostaglandin J2	hsa04740	Olfactory transduction	818_8390	2	+	1.28755723172303e-13	1.18455265318519e-11
5494	15-delta prostaglandin J2	hsa05322	Systemic lupus erythematosus	2213_8970_8348	3	+	0.00114667212812283	0.0351646119291001
5495	15-delta prostaglandin J2	hsa04810	Regulation of actin cytoskeleton	23533_26230_5063_8394_2909_5293_3678_10109_3984_6093_10458_2260	12	+	0.0463964828354503	0.665167850350028
5496	15-delta prostaglandin J2	hsa05012	Parkinson's disease	7314_7345_7416	3	+	0.00232367459940534	0.0534445157863228
5497	15-delta prostaglandin J2	hsa04650	Natural killer cell mediated cytotoxicity	10451_3460_5295_5578	4	-	0.00963162000734975	0.144474300110246
5498	15-delta prostaglandin J2	hsa04120	Ubiquitin mediated proteolysis	6502_867_23759_9820_672	5	-	0.0238552272475138	0.26837130653453
5499	15-delta prostaglandin J2	hsa05010	Alzheimer's disease	351_3709_489_5664_102_6622_823	7	-	0.0162872529396688	0.209407537795742
5500	15-delta prostaglandin J2	hsa04080	Neuroactive ligand-receptor interaction	5029_5618_7442_4886_1241_3354_6754_2690	8	-	0.000341505905955671	0.0153677657680052
5501	15-delta prostaglandin J2	hsa05016	Huntington's disease	5430_6648_7157_5439_246721_3064_1385_55567_548644	9	-	0.0397321654598719	0.325081353762588
5502	15-delta prostaglandin J2	hsa04740	Olfactory transduction	818_5613_5566_109_409	5	-	3.24576208349125e-10	2.92118587514212e-08
5503	15-delta prostaglandin J2	hsa05012	Parkinson's disease	2861_6622_7054	3	-	0.00333382737481461	0.100014821244438
5504	15-delta prostaglandin J2	hsa04620	Toll-like receptor signaling pathway	208_5295_5608	3	-	0.0339076706229827	0.305169035606844
5505	15-delta prostaglandin J2	hsa04260	Cardiac muscle contraction	27092	1	-	0.0095198231512492	0.144474300110246
5506	15-delta prostaglandin J2	hsa04060	Cytokine-cytokine receptor interaction	7424_5618_3597_3460_3575_5155_4254_6387_4982_7046_7042_2690	12	-	0.00860324695836732	0.144474300110246
5507	15-delta prostaglandin J2	hsa03010	Ribosome	9349_6189_439992	3	-	0.0339076706229827	0.305169035606844
5508	tacrolimus	hsa05010	Alzheimer's disease	5595_3710_808_489_102_801_805_23621	8	+	0.0439661110920196	0.660212635569548
5509	tacrolimus	hsa04080	Neuroactive ligand-receptor interaction	7068_1132_4158_6754_8484_4986_2692	7	+	0.000248551899802069	0.00729085572752736
5510	tacrolimus	hsa05016	Huntington's disease	7052_5441_27113_55567	4	+	0.000499827670561101	0.0109962087523442
5511	tacrolimus	hsa04740	Olfactory transduction	801_808_805	3	+	1.69253370382534e-11	1.4894296593663e-09
5512	tacrolimus	hsa05012	Parkinson's disease	7318	1	+	0.000138579654343025	0.0060975047910931
5513	tacrolimus	hsa04260	Cardiac muscle contraction	481_6548	2	+	0.0461008759193632	0.660212635569548
5514	tacrolimus	hsa04740	Olfactory transduction	5593_56656_8388_8387_5566_8590	6	-	7.0903604203133e-05	0.00588499914886004
5515	tacrolimus	hsa04514	Cell adhesion molecules (CAMs)	5010_3383_3111_3897_3134_5817_57863_940_3133_6614_23705_1013_925_1462	14	-	0.0471323545772006	0.900606203592502
5516	tacrolimus	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3111_8359_940_8294_8367_554313_8343_121504_8339_8347_8346_8344	21	-	0.000422473826291573	0.0175326637911003
5517	pivampicillin	hsa04740	Olfactory transduction	5137_26212_8390	3	+	0.0368312587018577	1
5518	pivampicillin	hsa04080	Neuroactive ligand-receptor interaction	64106_7067_9170	3	-	0.0200606868987033	0.367506229803516
5519	pivampicillin	hsa05131	Shigellosis	7280_347733_7278_113457_9475_7430	6	-	0.0309913252753445	0.367506229803516
5520	pivampicillin	hsa05130	Pathogenic Escherichia coli infection	7280_347733_7278_113457_9475_7430	6	-	0.0309913252753445	0.367506229803516
5521	pivampicillin	hsa04740	Olfactory transduction	818_219464_109	3	-	0.000363104499888687	0.0286852554912063
5522	pivampicillin	hsa05322	Systemic lupus erythematosus	3119	1	-	0.0463608405436187	0.444646171303597
5523	pivampicillin	hsa04210	Apoptosis	842_3551_5575_472_8837_651610_8795_7186	8	-	0.032563843147147	0.367506229803516
5524	pivampicillin	hsa03022	Basal transcription factors	11037_2967_2969_10629_6884_6872	6	-	0.00562645703547517	0.222245052901269
5525	pivampicillin	hsa03020	RNA polymerase	5432_246721_5439_548644_10622	5	-	0.00901177484336183	0.237310070875195
5526	proguanil	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	+	0.0213788851378137	0.235469878052175
5527	proguanil	hsa04650	Natural killer cell mediated cytotoxicity	3451_3105_6655_3135_27040_80328_80329_3106	8	+	0.0201211181872895	0.235469878052175
5528	proguanil	hsa05320	Autoimmune thyroid disease	3135_3105_3106_3451_649853	5	+	0.0107821721099832	0.235469878052175
5529	proguanil	hsa04514	Cell adhesion molecules (CAMs)	965_214_3105_3106_3135_6383_649853	7	+	0.0453949499380206	0.337940182871931
5530	proguanil	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	1.72212601254469e-05	0.00115382442840494
5531	proguanil	hsa04664	Fc epsilon RI signaling pathway	10000_5603_5581_6655_27040_5320	6	+	0.0138213005063993	0.235469878052175
5532	proguanil	hsa05330	Allograft rejection	3135_3105_3106_649853	4	+	0.015747833067242	0.235469878052175
5533	proguanil	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853	4	+	0.0246013305427646	0.235469878052175
5534	proguanil	hsa05220	Chronic myeloid leukemia	5925_6655_7046_10000_1399	5	+	0.0377306554406555	0.31599423931549
5535	proguanil	hsa05214	Glioma	5578_808_5605_1956_5335_1869_801_673_805	9	-	0.00104401479883599	0.0319191562499208
5536	proguanil	hsa04070	Phosphatidylinositol signaling system	5578_8396_808_5335_51763_801_805_3705	8	-	0.00887875934108212	0.0784051287189541
5537	proguanil	hsa04080	Neuroactive ligand-receptor interaction	2561_2149	2	-	0.00928481787461298	0.0784051287189541
5538	proguanil	hsa05200	Pathways in cancer	2308_2271_8312_5578_7042_3913_8074_5881_673_5605_405_1956_5335_6934_5747_1869_3725_5888_7186_3675	20	-	0.0365147720016338	0.163242510124951
5539	proguanil	hsa04910	Insulin signaling pathway	2308_5256_2002_5575_673_5605_808_51763_5509_801_5566_805	12	-	0.00627280791481664	0.0784051287189541
5540	proguanil	hsa04740	Olfactory transduction	801_808_5566_805	4	-	0.00432887062154051	0.0784051287189541
5541	proguanil	hsa04510	Focal adhesion	5578_3913_1302_1729_394_3678_7057_2002_93408_5881_1956_5747_3725_673_83660_3675	16	-	0.00802262971923534	0.0784051287189541
5542	proguanil	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	0.00125996669407582	0.0319191562499208
5543	proguanil	hsa04370	VEGF signaling pathway	8398_5578_5605_5881_5335_5600_5747	7	-	0.0272225962481114	0.129307332178529
5544	proguanil	hsa05219	Bladder cancer	5605_1869_1956_7057_673	5	-	0.0233421460887232	0.122740331040037
5545	proguanil	hsa04720	Long-term potentiation	5578_5566_673_5605_808_801_805	7	-	0.0242250653368494	0.122740331040037
5546	proguanil	hsa04012	ErbB signaling pathway	2002_5578_673_5605_1956_5335_5747_3725	8	-	0.0178295134844818	0.104425047495549
5547	proguanil	hsa05223	Non-small cell lung cancer	5578_673_5605_1956_5335_1869	6	-	0.0178621791768703	0.104425047495549
5548	proguanil	hsa04512	ECM-receptor interaction	960_961_1302_7057_3678_6383_3913_3675	8	-	0.0149289405140688	0.104425047495549
5549	proguanil	hsa05213	Endometrial cancer	2002_6934_673_5605_1956_8312	6	-	0.0152992726052204	0.104425047495549
5550	proguanil	hsa04912	GnRH signaling pathway	2002_8398_5578_5566_2767_808_5605_1956_5600_3725_801_805	12	-	0.000973770857094756	0.0319191562499208
5551	proguanil	hsa05210	Colorectal cancer	6934_673_5881_1956_8312_7042_3725	7	-	0.0396717001310262	0.167502733886555
5552	proguanil	hsa04270	Vascular smooth muscle contraction	8398_5578_4882_2767_673_5605_9826_805_801_5566_808	11	-	0.00544275936927545	0.0784051287189541
5553	risperidone	hsa04660	T cell receptor signaling pathway	10892_867_4772_5534_920_6300	6	+	0.0164303870563514	0.366945310925181
5554	risperidone	hsa04740	Olfactory transduction	26529	1	+	0.0157935121512961	0.366945310925181
5555	risperidone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	6.86713964860064e-07	4.60098356456243e-05
5556	risperidone	hsa04080	Neuroactive ligand-receptor interaction	2908	1	-	0.0325181116063122	0.693719714267994
5557	risperidone	hsa04740	Olfactory transduction	409	1	-	0.00257268872524751	0.0823260392079203
5558	risperidone	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8337_8343_8336_8339_8347_8346_8344	13	-	6.43634900485786e-05	0.00411926336310903
5559	tribenoside	hsa04650	Natural killer cell mediated cytotoxicity	3451_4775_3107_5880_356_27040_6452_3845_5781_5534_2534	11	+	0.021406483290175	0.661205451950336
5560	tribenoside	hsa04740	Olfactory transduction	4992	1	+	1.72414848472591e-05	0.00137931878778073
5561	tribenoside	hsa04360	Axon guidance	5362_57715_6585_2041_4775_5880_3845_5534_27289_2534	10	+	0.0343750905373956	0.687501810747912
5562	tribenoside	hsa05219	Bladder cancer	1029_9252_3845_4193_7422	5	+	0.0247952044481376	0.661205451950336
5563	tribenoside	hsa04080	Neuroactive ligand-receptor interaction	2901	1	-	0.0024569286691251	0.191640436191758
5564	tribenoside	hsa05200	Pathways in cancer	4088_4286_4149_5578_6789_6655_6777_8074_1856_2122_4318_51588_1956_5335_112399_652_3655_4254_5888_8321_3675	21	-	0.00955958923852102	0.37282398030232
5565	tribenoside	hsa04670	Leukocyte transendothelial migration	5578_4318_2909_1364_9475_1535_5335_5600_7430	9	-	0.0424526499707412	0.555470210318831
5566	tribenoside	hsa05223	Non-small cell lung cancer	6789_6655_1956_5335_5578	5	-	0.0462764071935147	0.555470210318831
5567	roxarsone	hsa05332	Graft-versus-host disease	3824_3108_3804_3107_3126_3127_3125_3135_3123	9	+	2.76072701959941e-05	0.000993861727055787
5568	roxarsone	hsa04640	Hematopoietic cell lineage	1436_960_948_3123_3126_3127_3125_3684	8	+	0.010526200881755	0.08420960705404
5569	roxarsone	hsa05320	Autoimmune thyroid disease	3108_3123_3107_3126_3127_3125_3135	7	+	0.00278186491928626	0.0333823790314351
5570	roxarsone	hsa04612	Antigen processing and presentation	3824_3108_3123_3107_3126_3127_3125_3135_3804	9	+	0.00387568371771405	0.0398641753822017
5571	roxarsone	hsa04740	Olfactory transduction	26212_816	2	+	0.000550856349552911	0.0099154142919524
5572	roxarsone	hsa04514	Cell adhesion molecules (CAMs)	3108_3123_3107_3126_3127_3125_3135_23308_4359_3684	10	+	0.0256686190187567	0.184814056935048
5573	roxarsone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504_3108_9555	20	+	2.3294855765518e-07	1.6772296151173e-05
5574	roxarsone	hsa05310	Asthma	3123_3125_3108_3127_3126	5	+	0.00464766940428165	0.0418290246385348
5575	roxarsone	hsa05330	Allograft rejection	3108_3123_3107_3126_3127_3125_3135	7	+	0.000490595536382789	0.0099154142919524
5576	roxarsone	hsa04940	Type I diabetes mellitus	3108_3123_3107_3126_3127_3125_3135	7	+	0.00106361456593691	0.0153160497494915
5577	levocabastine	hsa05322	Systemic lupus erythematosus	2904_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	+	9.5730178948197e-05	0.00536089002109903
5578	levocabastine	hsa04512	ECM-receptor interaction	7148_6383_2812_3690_3685_9672	6	+	0.0109418622616449	0.306372143326057
5579	levocabastine	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0281176343032377	0.52486250699377
5580	levocabastine	hsa04080	Neuroactive ligand-receptor interaction	9568	1	-	0.00258902635180791	0.100972027720508
5581	levocabastine	hsa04740	Olfactory transduction	818	1	-	2.54544194284767e-05	0.00198544471542118
5582	lansoprazole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_2904_8368_8366_9103_8359_8294_8367_554313_6738_121504	17	+	0.000163445057197367	0.0135659397473815
5583	lansoprazole	hsa04930	Type II diabetes mellitus	5313_5599_776_3551_5581	5	+	0.0432970507402539	1
5584	lansoprazole	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8336	7	-	0.0107888075475664	0.377608264164824
5585	triprolidine	hsa04540	Gap junction	6714_5154_23236	3	+	0.0147254395287222	0.201247673559203
5586	triprolidine	hsa04060	Cytokine-cytokine receptor interaction	3566_8742_5154_8741_3570	5	+	0.0139417953349538	0.201247673559203
5587	triprolidine	hsa04912	GnRH signaling pathway	5599_4214_6714_23236	4	+	0.00300713450751266	0.123292514808019
5588	triprolidine	hsa04662	B cell receptor signaling pathway	10725_10892_11261_5336_5534_27071	6	-	0.0183823850629042	0.275735775943563
5589	triprolidine	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_581_11261_5606_5534_5608	6	-	0.00521990724151232	0.130497681037808
5590	triprolidine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_85235_8364_8370_8366_8368_8365_8330_8332_8359_8969_8331_8329_8336_8367_554313_121504_8294	21	-	1.49054788274845e-09	1.11791091206134e-07
5591	triprolidine	hsa04060	Cytokine-cytokine receptor interaction	3460	1	-	0.0160528412440084	0.275735775943563
5592	triprolidine	hsa03020	RNA polymerase	5432_246721_5439_10622_548644_84172	6	-	0.000246712377633696	0.0092517141612636
5593	Prestwick-674	hsa05332	Graft-versus-host disease	3824_942_3126_3127_3111_3125_356_3123_7124	9	+	0.000267472178286134	0.00939233807350236
5594	Prestwick-674	hsa05320	Autoimmune thyroid disease	3126_942_3127_3111_3125_356_3123	7	+	0.0135080690110678	0.131703672857911
5595	Prestwick-674	hsa04740	Olfactory transduction	26212_26692_8388_8387_26476_5137_816	7	+	0.0102683783600602	0.130118848151769
5596	Prestwick-674	hsa04514	Cell adhesion molecules (CAMs)	965_4684_5175_3123_3126_3127_3111_3125_5818_6614_942_26047_5817	13	+	0.0116773325264408	0.130118848151769
5597	Prestwick-674	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8294_3123_3126_3127_3125_8370_8359_554313_121504_7124_942_3111	22	+	2.1230241402264e-06	0.000165595882937659
5598	Prestwick-674	hsa05310	Asthma	3123_3126_3127_3111_3125_7124	6	+	0.00383500340953482	0.0598260531887432
5599	Prestwick-674	hsa04010	MAPK signaling pathway	2353_776_627_782_8823_5599_1852_4915_8913_4137_1850_4208_356_5600_4791_2260_10000_2246_8398_7124	20	+	0.0383533724392711	0.332395894473683
5600	Prestwick-674	hsa05330	Allograft rejection	3126_942_3127_3111_3125_356_3123_7124	8	+	0.000647456476028801	0.0126254012825616
5601	Prestwick-674	hsa04940	Type I diabetes mellitus	942_3126_3127_3111_2571_356_3123_7124_3125	9	+	0.000361243772057783	0.00939233807350236
5602	Prestwick-674	hsa04070	Phosphatidylinositol signaling system	8394_3633_3631_5331_3709_23396_805_801_8526_808_23236	11	-	0.0162509154906073	0.427940774585992
5603	Prestwick-674	hsa04080	Neuroactive ligand-receptor interaction	7442_1081_1813_7067_1131_2908_1909	7	-	0.030132543763059	0.476094191456332
5604	Prestwick-674	hsa04740	Olfactory transduction	801_808_805	3	-	3.28111836907644e-07	2.59208351157039e-05
5605	Prestwick-674	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_85235_8364_8370_8366_8368_8365_8330_8332_8359_8969_8331_8329_8336_8367_554313_121504_8294	21	-	0.000511894291581981	0.0202198245174883
5606	Prestwick-674	hsa05012	Parkinson's disease	1339_517	2	-	0.0249201025451067	0.476094191456332
5607	SR-95639A	hsa04740	Olfactory transduction	26211_26664	2	+	0.0264175891289086	0.766110084738349
5608	SR-95639A	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	4.68521123511845e-06	0.00027174225163687
5609	SR-95639A	hsa04662	B cell receptor signaling pathway	3725_7410_8519	3	-	0.0441198653293717	0.782405300460519
5610	5194442	hsa05332	Graft-versus-host disease	3135_3134_355_3107_3108	5	+	0.0286734365250726	0.315407801775799
5611	5194442	hsa04080	Neuroactive ligand-receptor interaction	2550_5031	2	+	0.00661338472597906	0.206402234975138
5612	5194442	hsa04612	Antigen processing and presentation	4800_3108_3107_3135_3134_3310_3304_3305_3303	9	+	0.0100470417675026	0.206402234975138
5613	5194442	hsa05016	Huntington's disease	836	1	+	0.0107221940246825	0.206402234975138
5614	5194442	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_3108	15	+	0.000777344118684371	0.0598554971386966
5615	5194442	hsa04010	MAPK signaling pathway	1647_3554_1326_836_9252_6655_5155_355_9693_7189_4763_1848_1649_3725_3310_3304_3305_5609_3303	19	+	0.0166020831453031	0.255672080437668
5616	5194442	hsa05330	Allograft rejection	3135_3134_355_3107_3108	5	+	0.0202607698135175	0.260013212606808
5617	5194442	hsa04940	Type I diabetes mellitus	3135_3134_355_3107_3108	5	+	0.0335980395300168	0.323381130476412
5618	5194442	hsa04080	Neuroactive ligand-receptor interaction	1813_7068_7433	3	-	0.0199818827857794	0.388848740372132
5619	5194442	hsa05131	Shigellosis	7278_999_113457_60_7534_6093	6	-	0.0306771861955479	0.388848740372132
5620	5194442	hsa05130	Pathogenic Escherichia coli infection	7278_999_113457_60_7534_6093	6	-	0.0306771861955479	0.388848740372132
5621	5194442	hsa04740	Olfactory transduction	801_808_805	3	-	0.000359279589642466	0.0301794855299671
5622	5194442	hsa05322	Systemic lupus erythematosus	85235_8330_3014_8332_8969_8331_8329_8337_8343_8336_8339_8347_8346_8344	14	-	0.00294125554206251	0.123532732766625
5623	5194442	hsa04630	Jak-STAT signaling pathway	3572	1	-	0.0324040616976777	0.388848740372132
5624	5194442	hsa04060	Cytokine-cytokine receptor interaction	655_5155_51330_3572	4	-	0.0495566943965294	0.520345291163559
5625	5194442	hsa05213	Endometrial cancer	2309_842_999_2002_6934_369	6	-	0.0229135416210191	0.388848740372132
5626	ioxaglic acid	hsa04740	Olfactory transduction	26529_9635_81797	3	+	0.000242850164036666	0.00886403098733831
5627	ioxaglic acid	hsa04514	Cell adhesion molecules (CAMs)	965_3689_3122_29851_3107_3113_3135_5792_6693_923_5817	11	+	0.0276381461382543	0.672528222697521
5628	ioxaglic acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_3122_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3113	34	+	5.08858668839459e-15	3.71466828252805e-13
5629	ioxaglic acid	hsa05332	Graft-versus-host disease	3123_3126_3127_3133_3125	5	-	0.000613463423455204	0.0104267824050892
5630	ioxaglic acid	hsa04640	Hematopoietic cell lineage	1435_3123_3126_3127_3125_3678_3675	7	-	0.000468008336258701	0.0104267824050892
5631	ioxaglic acid	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3133_3125	5	-	0.00160905844253304	0.015017878796975
5632	ioxaglic acid	hsa04612	Antigen processing and presentation	3123_3126_3127_3133_3125	5	-	0.0126359974013138	0.10108797921051
5633	ioxaglic acid	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.00150522676071001	0.015017878796975
5634	ioxaglic acid	hsa05330	Allograft rejection	3123_3126_3127_3133_3125	5	-	0.000403654328986396	0.0104267824050892
5635	ioxaglic acid	hsa04940	Type I diabetes mellitus	3123_3126_3127_3133_3125	5	-	0.000744770171792084	0.0104267824050892
5636	ioxaglic acid	hsa02010	ABC transporters	5244_215_5243	3	-	0.0319526304154972	0.22366841290848
5637	rolitetracycline	hsa04080	Neuroactive ligand-receptor interaction	9170	1	-	0.00170772074701942	0.0623318072662088
5638	rolitetracycline	hsa05131	Shigellosis	7280_347733_999_7430_2017_8976	6	-	0.0221906375412961	0.323983308102923
5639	rolitetracycline	hsa05130	Pathogenic Escherichia coli infection	7280_347733_999_7430_2017_8976	6	-	0.0221906375412961	0.323983308102923
5640	rolitetracycline	hsa04740	Olfactory transduction	157_409	2	-	0.000127166757348859	0.00928317328646671
5641	rolitetracycline	hsa04115	p53 signaling pathway	25898_841_581_4193_472_51512_651610	7	-	0.0179658159798706	0.323983308102923
5642	rolitetracycline	hsa03020	RNA polymerase	246721_5439_548644_661	4	-	0.028369872934001	0.345166787363679
5643	tridihexethyl	hsa04740	Olfactory transduction	26333	1	+	0.00542586424405386	0.096309090331956
5644	tridihexethyl	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_3108_9555	16	+	2.23046028621081e-07	1.58362680320968e-05
5645	tridihexethyl	hsa04664	Fc epsilon RI signaling pathway	8503_8398_695_5881_5335_5603_1432_2534	8	+	0.000460139134839792	0.0163349392868126
5646	tridihexethyl	hsa04370	VEGF signaling pathway	8503_1432_5829_5881_5335_5603_8398	7	+	0.0018572390220602	0.0439546568554247
5647	tridihexethyl	hsa05211	Renal cell carcinoma	8503_5295_998_5291_405_3845_7422_1398_4233	9	-	0.0155503086870796	0.16582863811041
5648	tridihexethyl	hsa04080	Neuroactive ligand-receptor interaction	2561_4889_7442	3	-	0.00279456264904341	0.0776543231773072
5649	tridihexethyl	hsa05200	Pathways in cancer	8503_5295_1613_5899_4254_3675_4149_6789_5900_1856_405_1398_2263_1017_7475_581_999_998_4193_4286_5291_4233_4791_3688_842_5602_6772_7157_3845_7422_7184	31	-	0.00169683838733918	0.0776543231773072
5650	tridihexethyl	hsa05131	Shigellosis	7280_347733_7278_999_113457_998_3688_7430_8976	9	-	0.00374237702059312	0.0776543231773072
5651	tridihexethyl	hsa05130	Pathogenic Escherichia coli infection	7280_347733_7278_999_113457_998_3688_7430_8976	9	-	0.00374237702059312	0.0776543231773072
5652	tridihexethyl	hsa05212	Pancreatic cancer	8503_842_7157_5295_4193_5291_3845_2263_1017_7184	10	-	0.0279710955848884	0.16582863811041
5653	tridihexethyl	hsa05215	Prostate cancer	8503_842_7157_5295_4193_5291_3845_2263_1017_7184	10	-	0.0270658849439038	0.16582863811041
5654	tridihexethyl	hsa04210	Apoptosis	8503_842_581_7157_5576_5295_5291_472_8837_8795	10	-	0.0279710955848884	0.16582863811041
5655	tridihexethyl	hsa04370	VEGF signaling pathway	8503_5295_842_10725_50487_998_5291_3845_7422	9	-	0.0363131768129238	0.188374604717042
5656	tridihexethyl	hsa05219	Bladder cancer	7157_999_1613_4193_3845_7422	6	-	0.026742516163667	0.16582863811041
5657	tridihexethyl	hsa05218	Melanoma	8503_4286_7157_5295_999_4193_5291_3845_4233	9	-	0.014415113591443	0.16582863811041
5658	tridihexethyl	hsa05223	Non-small cell lung cancer	8503_842_6789_5295_5291_7157_3845	7	-	0.026572793218406	0.16582863811041
5659	tridihexethyl	hsa03022	Basal transcription factors	2967_2969_10629_6884_51616_728198	6	-	0.0162341151486592	0.16582863811041
5660	tridihexethyl	hsa04930	Type II diabetes mellitus	8503_5581_5295_5291_5602_8651	6	-	0.0348200926324001	0.188374604717042
5661	tridihexethyl	hsa05213	Endometrial cancer	8503_842_7157_5295_999_5291_3845	7	-	0.0225429977161168	0.16582863811041
5662	tridihexethyl	hsa05210	Colorectal cancer	8503_842_581_7157_5295_1856_5291_5900_3845_5602_4233	11	-	0.00581793127128607	0.0965776591033488
5663	tridihexethyl	hsa05222	Small cell lung cancer	8503_3688_4149_842_7157_5295_5291_1017_3675	9	-	0.0480316281991665	0.234507361207695
5664	mecamylamine	hsa04740	Olfactory transduction	5593	1	+	0.00512843229948771	0.369247125563115
5665	mecamylamine	hsa05214	Glioma	1869_801_1956_805_808	5	-	0.0194105375962432	0.379076933457682
5666	mecamylamine	hsa03440	Homologous recombination	7517_7516_5890	3	-	0.0307186083664589	0.379076933457682
5667	mecamylamine	hsa04080	Neuroactive ligand-receptor interaction	2908	1	-	0.0484921760566231	0.379076933457682
5668	mecamylamine	hsa05014	Amyotrophic lateral sclerosis (ALS)	5533_4217_5600_6300	4	-	0.0438803586412794	0.379076933457682
5669	mecamylamine	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	50617_1956_5600_3725_28964_6300	6	-	0.007153210572944	0.379076933457682
5670	mecamylamine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0333565244986777	0.379076933457682
5671	mecamylamine	hsa04912	GnRH signaling pathway	808_1956_5600_3725_801_6300_805	7	-	0.0140157539243805	0.379076933457682
5672	mecamylamine	hsa05210	Colorectal cancer	4088_6932_1956_1855_3725	5	-	0.0476992124943657	0.379076933457682
5673	loracarbef	hsa04740	Olfactory transduction	26211_390892	2	+	0.000385635411266152	0.0138828748055815
5674	loracarbef	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_959_8359_8294_8367_554313_6738_121504	16	+	7.22544780353125e-05	0.0052023224185425
5675	loracarbef	hsa04740	Olfactory transduction	157	1	-	0.000793631690036713	0.0595223767527535
5676	loracarbef	hsa04210	Apoptosis	8503_11261_5533_5575_8837_8795	6	-	0.0339289024056962	1
5677	sulfametoxydiazine	hsa04720	Long-term potentiation	5331_2911_3709	3	+	0.0409933631272488	0.509480867781907
5678	sulfametoxydiazine	hsa04020	Calcium signaling pathway	5331_2911_4638_3709_2149	5	+	0.0379869857270452	0.509480867781907
5679	sulfametoxydiazine	hsa04730	Long-term depression	5331_2911_3709	3	+	0.0359122374786516	0.509480867781907
5680	sulfametoxydiazine	hsa04662	B cell receptor signaling pathway	6654_5336_7409_8915_3725_5970	6	-	0.0435708695519306	0.580498611469617
5681	sulfametoxydiazine	hsa04080	Neuroactive ligand-receptor interaction	5021_56288	2	-	0.0184355760808882	0.424018249860429
5682	sulfametoxydiazine	hsa04740	Olfactory transduction	409	1	-	8.20410400770718e-05	0.00566083176531795
5683	sulfametoxydiazine	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_8992_5781_5336_3725_5970_50848	7	-	0.0117386305401834	0.404982753636327
5684	sulfametoxydiazine	hsa05210	Colorectal cancer	836_581_6654_6932_6934_3725_8322	7	-	0.025448886071419	0.438993284731978
5685	Prestwick-1082	hsa04740	Olfactory transduction	7932	1	+	0.0161038528923037	0.56363485123063
5686	Prestwick-1082	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_718_8368_8366_3111_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	21	+	1.15572341497433e-12	8.09006390482031e-11
5687	Prestwick-1082	hsa05014	Amyotrophic lateral sclerosis (ALS)	5534_842_581	3	-	0.0369254038661997	0.290128173234426
5688	Prestwick-1082	hsa05322	Systemic lupus erythematosus	85235_8969_8332_8330_8331_8329_8336	7	-	0.00274462709793502	0.150954490386426
5689	Prestwick-1082	hsa05212	Pancreatic cancer	2308_6655_842_1871	4	-	0.0285630295141301	0.290128173234426
5690	Prestwick-1082	hsa05215	Prostate cancer	2308_6655_842_1871	4	-	0.0275919206304634	0.290128173234426
5691	Prestwick-1082	hsa04210	Apoptosis	472_651610_842_5534_581	5	-	0.00625929699195455	0.17213066727875
5692	Prestwick-1082	hsa04115	p53 signaling pathway	472_651610_842_581	4	-	0.0128529444315414	0.235637314578259
5693	Prestwick-1082	hsa05223	Non-small cell lung cancer	6655_842_1871	3	-	0.0338296634596582	0.290128173234426
5694	ganciclovir	hsa04740	Olfactory transduction	26539	1	+	0.00175603490987794	0.0553150996611551
5695	ganciclovir	hsa05322	Systemic lupus erythematosus	3013_941_8358_8968_720_721_8350_8351_8352_8353_8354_8355_8356_8357	14	+	2.47568888924219e-05	0.00155968400022258
5696	ganciclovir	hsa03440	Homologous recombination	7156_5893_5888_7516	4	-	0.0201663090888024	0.194100724979723
5697	ganciclovir	hsa04662	B cell receptor signaling pathway	3551_10725_8519_7410_4775_3725_27071_4793	8	-	0.00591411006413046	0.151795491646015
5698	ganciclovir	hsa04080	Neuroactive ligand-receptor interaction	7067_5618	2	-	0.0193871813282217	0.194100724979723
5699	ganciclovir	hsa05131	Shigellosis	9076_7278_999_113457_9475_8976	6	-	0.0160329014656343	0.194100724979723
5700	ganciclovir	hsa05130	Pathogenic Escherichia coli infection	9076_7278_999_113457_9475_8976	6	-	0.0160329014656343	0.194100724979723
5701	ganciclovir	hsa04740	Olfactory transduction	219464	1	-	5.70566879535971e-05	0.00439336497242698
5702	ganciclovir	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	0.000721506058259534	0.0277779832429921
5703	ganciclovir	hsa04210	Apoptosis	3552_3551_581_5575_596_472_8837_651610	8	-	0.0146062205169713	0.194100724979723
5704	ondansetron	hsa04740	Olfactory transduction	815_409	2	+	0.00477873709700603	0.32495412259641
5705	ondansetron	hsa04940	Type I diabetes mellitus	3107_3553_3111_2571	4	+	0.0351854071227421	1
5706	ondansetron	hsa04740	Olfactory transduction	818	1	-	0.00780899247073287	0.413876600948842
5707	2-deoxy-D-glucose	hsa04130	SNARE interactions in vesicular transport	23673_10282_662_10228_9554_6844	6	+	0.0214267813093456	0.557096314042986
5708	2-deoxy-D-glucose	hsa05016	Huntington's disease	6648	1	+	0.00111793449379094	0.0435994452578467
5709	2-deoxy-D-glucose	hsa04740	Olfactory transduction	26532_109	2	+	6.45943425733958e-07	5.03835872072487e-05
5710	2-deoxy-D-glucose	hsa05322	Systemic lupus erythematosus	2903_3017	2	+	0.0350864084329086	0.684184964441718
5711	2-deoxy-D-glucose	hsa05332	Graft-versus-host disease	3123_57292_3126_3127_3125	5	-	0.00181834320054086	0.0459940418589765
5712	2-deoxy-D-glucose	hsa04640	Hematopoietic cell lineage	3123_3126_3127_3125_3678_3589	6	-	0.00812613292515402	0.0853243957141172
5713	2-deoxy-D-glucose	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	-	0.0221954969189903	0.174789538237049
5714	2-deoxy-D-glucose	hsa04612	Antigen processing and presentation	57292_3123_3126_3127_3125_3304_3303	7	-	0.00219019246947507	0.0459940418589765
5715	2-deoxy-D-glucose	hsa04740	Olfactory transduction	1179_816	2	-	0.0357622234054987	0.250335563838491
5716	2-deoxy-D-glucose	hsa05322	Systemic lupus erythematosus	85235_94239_3123_8330_3126_3127_3125_8332_8969_8331_8336_8343_8329_8339_8347_8346_8344	17	-	8.36832003010467e-09	5.27204161896594e-07
5717	2-deoxy-D-glucose	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.00363819883090631	0.0573016315867744
5718	2-deoxy-D-glucose	hsa05330	Allograft rejection	3123_3126_3127_3125	4	-	0.00781410430781572	0.0853243957141172
5719	2-deoxy-D-glucose	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	-	0.0124510803976396	0.112059723578756
5720	procarbazine	hsa05332	Graft-versus-host disease	3812_3119_3122_3804_3106_3126_3127_3125_3135_5551_3123_3105_3113_649853	14	+	2.82368779322898e-05	0.000847106337968694
5721	procarbazine	hsa05010	Alzheimer's disease	5331_5330_3710_9377	4	+	0.00528635060124138	0.0528635060124138
5722	procarbazine	hsa05320	Autoimmune thyroid disease	3119_3440_3122_3105_3106_3126_3127_3125_3135_5551_3123_3113_649853	13	+	0.000689359073235017	0.0103403860985253
5723	procarbazine	hsa04612	Antigen processing and presentation	3812_3119_3440_3122_3123_3106_3126_3127_3125_3135_3105_3804_3113_649853	14	+	0.0189023545397897	0.141767659048423
5724	procarbazine	hsa05016	Huntington's disease	9377_5331_5330_7416_6875_1387	6	+	0.0236084322359617	0.163442992402812
5725	procarbazine	hsa04740	Olfactory transduction	26212_26529_8390	3	+	1.42552219134962e-09	1.28296997221466e-07
5726	procarbazine	hsa04514	Cell adhesion molecules (CAMs)	5797_3383_9073_3119_965_3122_3123_3106_3126_3127_3105_3125_3135_23308_57863_4359_6383_5818_3676_3113_649853	21	+	0.00420021132318711	0.0528635060124138
5727	procarbazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8329_8294_8342_3122_3123_3126_3127_3125_8969_8370_718_8332_8359_8330_8331_8336_554313_121504_85235_3119_3113	31	+	2.10372013655418e-06	9.46674061449381e-05
5728	procarbazine	hsa05310	Asthma	3119_2207_3122_3123_3126_3127_3125_3113	8	+	0.00474064297295496	0.0528635060124138
5729	procarbazine	hsa04350	TGF-beta signaling pathway	4091_7059_1634_7044_3624_7060_5519_91_654_1875_10637_1387_83729_10468	14	+	0.0172732399308464	0.141767659048423
5730	procarbazine	hsa05012	Parkinson's disease	7416_7318_9377	3	+	0.0187153658440734	0.141767659048423
5731	procarbazine	hsa04620	Toll-like receptor signaling pathway	3576_3440	2	+	0.0336533292953544	0.201919975772126
5732	procarbazine	hsa03010	Ribosome	6165_6202	2	+	0.0336533292953544	0.201919975772126
5733	procarbazine	hsa05330	Allograft rejection	3119_3122_3105_3106_3126_3127_3125_3135_5551_3123_3113_649853	12	+	0.000159907195404782	0.00287832951728608
5734	procarbazine	hsa04940	Type I diabetes mellitus	3382_3119_3122_3105_3106_3126_3127_3125_3135_5551_3123_3113_649853	13	+	0.00015011390995832	0.00287832951728608
5735	procarbazine	hsa04080	Neuroactive ligand-receptor interaction	1131_2908_4157	3	-	0.0274170195606435	0.495996673014509
5736	procarbazine	hsa04740	Olfactory transduction	818_109	2	-	8.79207006818856e-05	0.00720949745591462
5737	procarbazine	hsa05322	Systemic lupus erythematosus	55506_85235_3119_8348_8330_8332_8969_8331_8336_8337_8970_8329	12	-	0.0148699290370446	0.495996673014509
5738	procarbazine	hsa05210	Colorectal cancer	4088_6655_7042_5296_5900_6934_3725_5599	8	-	0.0192460593934298	0.495996673014509
5739	procarbazine	hsa05220	Chronic myeloid leukemia	613_4088_598_6655_5296_5781_7042	7	-	0.0302436995740554	0.495996673014509
5740	alprostadil	hsa05010	Alzheimer's disease	2903_2597_4695_3710_642502_6391_4137_5533_488_810_348_517	12	+	0.0166035152093222	0.340199945222488
5741	alprostadil	hsa05320	Autoimmune thyroid disease	1081_3119_3117_3113_3106_3107_3126_3127_3125_3135_3123_941_7038_3442_3448	15	+	0.0138821103967785	0.340199945222488
5742	alprostadil	hsa05016	Huntington's disease	1211_6648_5434_642502_6391_27113_64446_5978_10540_55567_4695_7419_161_517	14	+	0.0275763022420253	0.36243140089519
5743	alprostadil	hsa03420	Nucleotide excision repair	5983	1	+	0.0379119800203857	0.379783925345676
5744	alprostadil	hsa04740	Olfactory transduction	26211_7932_157_26692_5566_442194_26189_818_26532_23538_810_9635_816	13	+	7.21877334127145e-10	6.64127147396973e-08
5745	alprostadil	hsa05322	Systemic lupus erythematosus	2903_474382_8363_474381_8365_8364_8367_8360_8368_554313_6738_8362_8294_121504_8341_6632_3123_8366_3126_3127_3125_8968_8370_8358_8359_8335_8350_8351_8352_8353_8354_8355_8356_8357_2212_3119_2215_2214_3117_3013_83740_3113_3014_941_8361	45	+	3.57501816311291e-06	0.000164450835503194
5746	alprostadil	hsa04110	Cell cycle	5591_990_51343_1029_8555_7042_1031	7	+	0.0257665854413551	0.36243140089519
5747	alprostadil	hsa05012	Parkinson's disease	2861_4695_7318_5413_642502_6391_7419_517	8	+	0.0184891274577439	0.340199945222488
5748	alprostadil	hsa05330	Allograft rejection	3119_3117_3113_3106_3107_3126_3127_3125_3135_3123_941	11	+	0.0413376034386278	0.379783925345676
5749	alprostadil	hsa04940	Type I diabetes mellitus	3119_3117_3126_3106_3107_2572_3127_3125_3135_3123_941_3113	12	+	0.0359495116175733	0.379783925345676
5750	alprostadil	hsa04514	Cell adhesion molecules (CAMs)	9076_24146_947_3685_23308_6693	6	-	0.0431386891239559	1
5751	alprostadil	hsa05322	Systemic lupus erythematosus	3013_8358_6738_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	-	2.74318005364866e-05	0.00170077163326217
5752	molindone	hsa04740	Olfactory transduction	5568_442194_390892	3	+	0.00286175825793737	0.237525935408802
5753	molindone	hsa04540	Gap junction	5568_5594_6655_6654_3708_10746_23236	7	+	0.0418420086333608	0.91804373523762
5754	molindone	hsa04210	Apoptosis	10000_3551_5575_7186_8737_8837_823	7	-	0.0110878356801005	0.734266475273464
5755	molindone	hsa04540	Gap junction	2771_7278_2767_113457_5605_112	6	-	0.0402813196791601	0.734266475273464
5756	BCB000038	hsa04120	Ubiquitin mediated proteolysis	26232_51343_9820	3	+	0.00479888049104238	0.0835005205441374
5757	BCB000038	hsa05010	Alzheimer's disease	51806_11261_1339_842	4	+	0.00139562104102993	0.030354757642401
5758	BCB000038	hsa04080	Neuroactive ligand-receptor interaction	1816_1812_1813_7068_6755_7434_2150_4987	8	+	0.000873523706617755	0.0253321874919149
5759	BCB000038	hsa05200	Pathways in cancer	7471_4313_1021_842_3551_51176_2950_862_9618_5881_5467_2263_3655_5888_4233	15	+	0.00678708029760538	0.0924163933062975
5760	BCB000038	hsa05016	Huntington's disease	246721_1339_842_7052_55567_6648	6	+	0.00743580176027681	0.0924163933062975
5761	BCB000038	hsa04740	Olfactory transduction	5137_51806_2979_816	4	+	3.29506957928669e-10	2.86671053397942e-08
5762	BCB000038	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8290_8348_8329_8294_8969_8370_8332_8359_8330_8331_8336_8337_554313_6738_121504_85235_3113_720_721	28	+	0.000368679261351463	0.0160375478687886
5763	BCB000038	hsa04810	Regulation of actin cytoskeleton	5063_3691_8396_9138_3684_5881_10787_2263_3655_8976	10	+	0.0368802427858884	0.320858112237229
5764	BCB000038	hsa05012	Parkinson's disease	7314_1339_842_5413	4	+	0.0184156479177209	0.200270171105215
5765	BCB000038	hsa04730	Long-term depression	8398	1	+	0.0288916171463763	0.279285632414971
5766	BCB000038	hsa04270	Vascular smooth muscle contraction	115_51806_9138_8398	4	+	0.0451924824963024	0.357431452470755
5767	BCB000038	hsa04080	Neuroactive ligand-receptor interaction	5618_624_3953_2908_5025_4886_6915_56288_7067_7068	10	-	0.00195634762113563	0.0851011215193999
5768	BCB000038	hsa05016	Huntington's disease	4899_836_4712_7052_1175_3708_2033_23236	8	-	0.0203240175608383	0.442047381948233
5769	BCB000038	hsa04740	Olfactory transduction	219464_51806	2	-	2.99774418634234e-13	2.60803744211784e-11
5770	BCB000038	hsa04370	VEGF signaling pathway	8503_4775_5578_5296_11261_9261_5605_10725_5530_4772_5600_6714_56848_5594	14	-	0.0367696922115953	0.458884836519502
5771	BCB000038	hsa05012	Parkinson's disease	7314_836_6622_4712	4	-	0.00955032242628506	0.276959350362267
5772	BCB000038	hsa04060	Cytokine-cytokine receptor interaction	5618_3597_2057_3953_83729_8742_8741_3572_7852_1956_91_27242_3601_8795	14	-	0.0298852487401816	0.458884836519502
5773	diphenylpyraline	hsa04120	Ubiquitin mediated proteolysis	7337_7318_6502_5371_7329_8651_5071_9021	8	+	0.0419670315608338	0.466883226114276
5774	diphenylpyraline	hsa03320	PPAR signaling pathway	2173_5465	2	+	0.0316702277096249	0.402664323736659
5775	diphenylpyraline	hsa05010	Alzheimer's disease	776_4695_3710_11261_779_3709_6868_56901_6622	9	+	0.00777081990723928	0.138320594348859
5776	diphenylpyraline	hsa05016	Huntington's disease	1639_4899_4695_56901_1213	5	+	4.53839490373807e-05	0.00201958573216344
5777	diphenylpyraline	hsa04740	Olfactory transduction	26211_56656_26692_8388_8387_23538_8390_1179_393046_4991_9635_816	12	+	1.66509179676494e-08	1.4819316991208e-06
5778	diphenylpyraline	hsa04110	Cell cycle	6502_8556_8555	3	+	0.00155529755970437	0.0461404942712296
5779	diphenylpyraline	hsa05110	Vibrio cholerae infection	525	1	+	0.0186115167104127	0.276070831204455
5780	diphenylpyraline	hsa03010	Ribosome	9045_6181_6123	3	+	0.00603080295840828	0.134185365824584
5781	diphenylpyraline	hsa04740	Olfactory transduction	816	1	-	0.0024378876118808	0.185279458502941
5782	diphenylpyraline	hsa04710	Circadian rhythm - mammal	9572_1408	2	-	0.0429268924297477	0.882125296966429
5783	diphenylpyraline	hsa05210	Colorectal cancer	4088_208_5602_91_3725_4233	6	-	0.0151225068346758	0.57465525971768
5784	capsaicin	hsa05332	Graft-versus-host disease	3811_3553_3109_3119_3123_3126_3127_3125_3112_941_3802	11	+	0.000165780953268484	0.00593603670926836
5785	capsaicin	hsa05320	Autoimmune thyroid disease	3109_3119_7253_3123_3126_3127_3112_941_3125	9	+	0.00829589565505113	0.117525188446558
5786	capsaicin	hsa04612	Antigen processing and presentation	3811_3109_3119_3123_3806_3126_3127_3125_3112_3310_3802	11	+	0.0300771581710203	0.365222634933818
5787	capsaicin	hsa04740	Olfactory transduction	26212_9635_815_442194_390892	5	+	1.0978429594428e-05	0.00093316651552638
5788	capsaicin	hsa05310	Asthma	3596_3119_3123_3126_3127_3125_3109_3112_2205	9	+	0.00027934290396557	0.00593603670926836
5789	capsaicin	hsa05330	Allograft rejection	3109_3119_3123_3126_3127_3112_941_3125	8	+	0.00415214687807792	0.0705864969273246
5790	capsaicin	hsa04940	Type I diabetes mellitus	3553_3109_3119_3126_2572_3127_3630_3125_3123_941_3112	11	+	0.00023448338762573	0.00593603670926836
5791	capsaicin	hsa04080	Neuroactive ligand-receptor interaction	7434_64106_2908_146	4	-	0.0486693733828107	0.455761599461812
5792	capsaicin	hsa05016	Huntington's disease	7419	1	-	0.0109610700914488	0.405559593383606
5793	capsaicin	hsa05322	Systemic lupus erythematosus	3013_8358_8350_8968_8970_8351_8352_8353_8354_8355_8356_8357	12	-	0.0182530657037292	0.450242287358654
5794	capsaicin	hsa05221	Acute myeloid leukemia	3551_5371_5290_6934_5914_652671	6	-	0.0367655070820237	0.453441254011626
5795	capsaicin	hsa04340	Hedgehog signaling pathway	1454_656_654_652_653_353500	6	-	0.0321947422144149	0.453441254011626
5796	capsaicin	hsa03450	Non-homologous end-joining	5591_3981_10111	3	-	0.0250676441018443	0.453441254011626
5797	capsaicin	hsa04350	TGF-beta signaling pathway	4089_654_656_1874_652_653_353500_7042_57154	9	-	0.010756834886247	0.405559593383606
5798	capsaicin	hsa04060	Cytokine-cytokine receptor interaction	10913_8794_7422_7042	4	-	0.0492715242661418	0.455761599461812
5799	thiethylperazine	hsa05332	Graft-versus-host disease	3123_3126_3127_3125_3135_356	6	+	0.000601949010271426	0.012239629875519
5800	thiethylperazine	hsa04080	Neuroactive ligand-receptor interaction	1910	1	+	0.0478766684936508	0.365059597264087
5801	thiethylperazine	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125_3135_356	6	+	0.00180839347961988	0.0275780005642032
5802	thiethylperazine	hsa04612	Antigen processing and presentation	3123_3126_3127_3125_3135_3310	6	+	0.0182062834686705	0.158654755941271
5803	thiethylperazine	hsa04740	Olfactory transduction	810	1	+	0.00376473012532381	0.0459297075289505
5804	thiethylperazine	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0063082227404273	0.0641335978610109
5805	thiethylperazine	hsa05330	Allograft rejection	3123_3126_3127_3125_3135_356	6	+	0.000372550482472251	0.0113627897154037
5806	thiethylperazine	hsa04940	Type I diabetes mellitus	3123_3126_3127_2571_3135_356_3125	7	+	0.000115590221423929	0.00705100350685967
5807	thiethylperazine	hsa04916	Melanogenesis	805_5566_808_801_6934	5	-	0.0168995236208734	0.358293277619997
5808	thiethylperazine	hsa04340	Hedgehog signaling pathway	1455_5566_4036	3	-	0.0489910117743183	0.449084274597918
5809	thiethylperazine	hsa04720	Long-term potentiation	801_808_5566_805	4	-	0.0230379468778312	0.358293277619997
5810	thiethylperazine	hsa04912	GnRH signaling pathway	3725_5566_808_801_805	5	-	0.0194495425203855	0.358293277619997
5811	thiethylperazine	hsa05210	Colorectal cancer	8312_3725_7040_6934	4	-	0.0325721161472725	0.358293277619997
5812	thiethylperazine	hsa04270	Vascular smooth muscle contraction	5566_9826_801_805_808	5	-	0.0268953261857075	0.358293277619997
5813	diethylstilbestrol	hsa04740	Olfactory transduction	7932_1179_2979_26529_9635_816	6	+	0.000699309291681939	0.0594412897929648
5814	diethylstilbestrol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_716_3113_3111_8359_8294_8367_554313_8368_121504	17	+	0.00249383895917311	0.105988155764857
5815	diethylstilbestrol	hsa04010	MAPK signaling pathway	627_7850_3725_3164_3305_5609_3304_4616_3554_355_3303_8823_5607_5534_91_3310_4791_26281_1848_1843_1649_1846_6196_2353_5971	25	+	0.00869830817139263	0.246452064856124
5816	diethylstilbestrol	hsa05012	Parkinson's disease	1339	1	+	0.0151336174133733	0.321589370034183
5817	diethylstilbestrol	hsa04060	Cytokine-cytokine receptor interaction	56034_7852_7850_3554_3576_3572_6368_10913_8718_6362_6366_1236_3606_1233_3953_51561_91_8794_3441_355_7422_83729	22	+	0.0344154875881934	0.585063288999288
5818	diethylstilbestrol	hsa04130	SNARE interactions in vesicular transport	8417_2054_6844_662	4	-	0.0130920057243964	0.283660124028589
5819	diethylstilbestrol	hsa04080	Neuroactive ligand-receptor interaction	7433	1	-	0.0476055344379078	0.442051391209144
5820	diethylstilbestrol	hsa05131	Shigellosis	7278_7430_113457_998	4	-	0.0421648747330504	0.442051391209144
5821	diethylstilbestrol	hsa05130	Pathogenic Escherichia coli infection	7278_7430_113457_998	4	-	0.0421648747330504	0.442051391209144
5822	diethylstilbestrol	hsa04740	Olfactory transduction	818	1	-	0.00371544187378938	0.120751860898155
5823	diethylstilbestrol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	9.20854725744041e-06	0.000598555571733627
5824	diethylstilbestrol	hsa04330	Notch signaling pathway	113878_22938_6868_5664	4	-	0.0251176559635493	0.408161909407676
5825	hyoscyamine	hsa04740	Olfactory transduction	8390	1	+	0.00122861187930656	0.0847742196721526
5826	hyoscyamine	hsa04510	Focal adhesion	2335_5599_6464_3479_3690_63923_5880_88_7791_55742_2534	11	+	0.0245359020102019	0.777931506090562
5827	hyoscyamine	hsa04930	Type II diabetes mellitus	5599_8660_5315_5581	4	+	0.0338231089604592	0.777931506090562
5828	hyoscyamine	hsa05214	Glioma	6655_5155_5154_5290_5335_3845	6	-	0.0183241832780245	0.271197912514763
5829	hyoscyamine	hsa04070	Phosphatidylinositol signaling system	8871_8394_5290_5333_5335_4952_3707	7	-	0.0113114280696261	0.271197912514763
5830	hyoscyamine	hsa05221	Acute myeloid leukemia	6655_6777_5371_5290_6932_3845	6	-	0.0122310306134333	0.271197912514763
5831	hyoscyamine	hsa04540	Gap junction	6655_5155_113457_5154_3845_10746_7278	7	-	0.0286447851703559	0.344532953914529
5832	hyoscyamine	hsa05213	Endometrial cancer	2002_6655_5290_6932_3845_8312	6	-	0.00711275437947541	0.271197912514763
5833	hyoscyamine	hsa05210	Colorectal cancer	4088_6655_1856_6932_3845_5290_8312	7	-	0.0180846769451188	0.271197912514763
5834	hyoscyamine	hsa05220	Chronic myeloid leukemia	4088_6655_6777_5290_3845_5781	6	-	0.032590955100023	0.344532953914529
5835	ornidazole	hsa05016	Huntington's disease	246721	1	+	0.0329018073829691	0.789643377191258
5836	ornidazole	hsa04740	Olfactory transduction	135948_10798	2	+	0.000550856349552911	0.0396616571678096
5837	ornidazole	hsa04012	ErbB signaling pathway	6654_5579_5599_208_2549_1839_3084	7	+	0.0297262939063489	0.789643377191258
5838	ornidazole	hsa04080	Neuroactive ligand-receptor interaction	2149_9170	2	-	0.0134748328536113	0.485093982730007
5839	ornidazole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	30	-	1.54531126477782e-13	1.11262411064003e-11
5840	fenspiride	hsa04120	Ubiquitin mediated proteolysis	5371	1	+	0.0458231044149514	0.425500255281692
5841	fenspiride	hsa05010	Alzheimer's disease	1339	1	+	0.0106735886422891	0.138756652349758
5842	fenspiride	hsa04740	Olfactory transduction	26539_81797_409_4991	4	+	0.00118063170230003	0.025580353549834
5843	fenspiride	hsa04514	Cell adhesion molecules (CAMs)	8516_965_4684_3383_1272_942_3696_57863_26047_9672_3109_3676_926_1462	14	+	0.00199248168771049	0.0323778274252955
5844	fenspiride	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_6737_942_8359_88_89_8294_8367_554313_121504_3109	19	+	2.02091676957883e-05	0.00131359590022624
5845	fenspiride	hsa04512	ECM-receptor interaction	8516_2814_1281_2335_3910_3381_3696_2812_1282_9672_1291_3676	12	+	0.000354852576752974	0.0115327087444717
5846	fenspiride	hsa05012	Parkinson's disease	1339	1	+	0.0455433170812947	0.425500255281692
5847	fenspiride	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	0.000146456077471123	0.010691293655392
5848	fenspiride	hsa04920	Adipocytokine signaling pathway	3717_5599_1375_5781_8717_4793	6	-	0.0167125082281534	0.3050032751638
5849	fenspiride	hsa04010	MAPK signaling pathway	9261_3725_10912_5599_27092_57551_4763_5607_3845_5600_5534_7042_2263_2260_3164_2264	16	-	0.00996576599458173	0.3050032751638
5850	fenspiride	hsa03020	RNA polymerase	5432_246721_5439_548644	4	-	0.0132875693626117	0.3050032751638
5851	xylometazoline	hsa04740	Olfactory transduction	5568_1179	2	+	0.0363716250021558	0.503606023156227
5852	xylometazoline	hsa05340	Primary immunodeficiency	23495_958_915	3	+	0.0369806621002928	0.503606023156227
5853	xylometazoline	hsa05218	Melanoma	23533_5155_2249_2251_80310	5	+	0.0159368787584597	0.503606023156227
5854	xylometazoline	hsa04920	Adipocytokine signaling pathway	32_5105_5588_4793	4	+	0.0489616966957443	0.503606023156227
5855	xylometazoline	hsa04810	Regulation of actin cytoskeleton	23533_3690_5155_5829_2249_3984_4342_2251_80310	9	+	0.0445984732531473	0.503606023156227
5856	xylometazoline	hsa04010	MAPK signaling pathway	5568_5578_5155_8913_4763_23162_2249_9344_3164_4342_2251	11	+	0.0261782373200097	0.503606023156227
5857	xylometazoline	hsa04540	Gap junction	5568_5155_80310_1812_5578	5	+	0.0418190848974923	0.503606023156227
5858	xylometazoline	hsa05211	Renal cell carcinoma	5296_5155_405_3845_7040_7039	6	-	0.0208710311144972	0.292194435602961
5859	xylometazoline	hsa04080	Neuroactive ligand-receptor interaction	2901	1	-	0.0109440795954649	0.191521392920636
5860	xylometazoline	hsa05200	Pathways in cancer	367_4149_4318_841_5599_5155_5296_405_3845_7040_2263_7039_91_5914_2260_7184	16	-	0.0442544026419859	0.442544026419859
5861	xylometazoline	hsa04740	Olfactory transduction	219464	1	-	0.000377942953289968	0.0264560067302978
5862	xylometazoline	hsa05212	Pancreatic cancer	7039_5155_5296_3845_367_2263_2260_7184	8	-	0.00540513550496691	0.126119828449228
5863	xylometazoline	hsa05215	Prostate cancer	7039_5155_5296_3845_367_2263_2260_7184	8	-	0.00507795257932506	0.126119828449228
5864	xylometazoline	hsa04664	Fc epsilon RI signaling pathway	5163_5581_5296_5599_3845_5603	6	-	0.0303319551158294	0.353872809684676
5865	nimesulide	hsa05010	Alzheimer's disease	3708_6622	2	+	0.0180578599715242	0.365671664423365
5866	nimesulide	hsa04740	Olfactory transduction	26212_5593	2	+	4.54372625797698e-06	0.000368041826896135
5867	nimesulide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_2215_8370_8366_8368_8367_554313_9103_8359_8330_8294_720_721_121504_8354_8364	20	+	5.24247160555671e-05	0.00212320100025047
5868	nimesulide	hsa04062	Chemokine signaling pathway	3579_2931	2	+	0.013358809056018	0.360687844512486
5869	nimesulide	hsa05214	Glioma	6655_5155_5154_816_4193	5	-	0.0160648728522906	0.433124885196986
5870	nimesulide	hsa04080	Neuroactive ligand-receptor interaction	2570	1	-	0.0463229704115086	0.494930879004887
5871	nimesulide	hsa04740	Olfactory transduction	5613_816	2	-	0.0183010514871966	0.433124885196986
5872	nimesulide	hsa05322	Systemic lupus erythematosus	55506_8361_8363_8362_8365_8364_8370_8360_8368_8366_8359_8294_8367_554313_121504	15	-	1.28153756932843e-06	9.09891674223185e-05
5873	nimesulide	hsa05212	Pancreatic cancer	367_6655_5155_5154_4193	5	-	0.0487960021554114	0.494930879004887
5874	nimesulide	hsa05215	Prostate cancer	367_6655_5155_5154_4193	5	-	0.0469730549889842	0.494930879004887
5875	nimesulide	hsa03450	Non-homologous end-joining	27343_79840	2	-	0.0439533986311432	0.494930879004887
5876	flumequine	hsa05332	Graft-versus-host disease	3811_3126_3113_3127_3125_3123_3802	7	+	0.00594614180962966	0.145530260605269
5877	flumequine	hsa04640	Hematopoietic cell lineage	3581_3690_3123_3126_3127_3125_915_1378_4254_290	10	+	0.0116850954980626	0.193972585267839
5878	flumequine	hsa05320	Autoimmune thyroid disease	3448_3126_3113_3127_3125_3123	6	+	0.0484485330698142	0.368892415681871
5879	flumequine	hsa04612	Antigen processing and presentation	3811_3448_3805_3123_3126_3127_3125_3802_3113	9	+	0.0427241579693594	0.368892415681871
5880	flumequine	hsa04520	Adherens junction	4301_4089_5880_5797_88_5787_91_25945_2241_2534	10	+	0.00701350653519367	0.145530260605269
5881	flumequine	hsa04740	Olfactory transduction	4991	1	+	5.14858282954276e-07	4.27332374852049e-05
5882	flumequine	hsa04514	Cell adhesion molecules (CAMs)	7412_3695_965_3123_3126_3127_3125_5797_22871_9672_25945_3113_26047	13	+	0.0239199294777263	0.283622020950183
5883	flumequine	hsa05322	Systemic lupus erythematosus	3123_3126_3127_3113_3125_8358_88_8968_3013_8350_8351_8352_8353_8354_8355_8356_8357	17	+	0.00148429459285522	0.0615982256034916
5884	flumequine	hsa05310	Asthma	3123_3126_3127_3113_3125	5	+	0.019193129187389	0.265504953758881
5885	flumequine	hsa05330	Allograft rejection	3126_3113_3127_3123_3125	5	+	0.0425692339205554	0.368892415681871
5886	flumequine	hsa04270	Vascular smooth muscle contraction	5319_5583_3779_2776_5330_553_112_148_6093_800_2977	11	+	0.0488893562951877	0.368892415681871
5887	flumequine	hsa04740	Olfactory transduction	816	1	-	0.000793631690036713	0.0265866616162299
5888	flumequine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_727_3013_554313_8366_3014_8359_8294_8367_121504_8368_8351	18	-	1.44392234452774e-07	9.67427970833586e-06
5889	alverine	hsa04920	Adipocytokine signaling pathway	5599_208_32	3	+	0.0370057766884508	0.875192047747896
5890	alverine	hsa04662	B cell receptor signaling pathway	3725_27071_5534	3	-	0.0495836077113667	0.607399194464242
5891	alverine	hsa05016	Huntington's disease	1213_246721_6648_5439_5331_548644	6	-	0.0168978166373607	0.413996507615337
5892	alverine	hsa04720	Long-term potentiation	5331_814_5534	3	-	0.0495836077113667	0.607399194464242
5893	alverine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00457757875989916	0.224301359235059
5894	methocarbamol	hsa04740	Olfactory transduction	810_5593	2	+	0.00114446908852178	0.0869796507276553
5895	methocarbamol	hsa05340	Primary immunodeficiency	920_4261_29760_5897	4	+	0.0282827051696428	0.716495197630951
5896	methocarbamol	hsa04115	p53 signaling pathway	55367_25898_4194_3479_3486_4616	6	+	0.0243582244894227	0.716495197630951
5897	methocarbamol	hsa04070	Phosphatidylinositol signaling system	8394_51806_5333_3707_3631	5	-	0.0127259124348639	0.254235568470876
5898	methocarbamol	hsa04740	Olfactory transduction	51806	1	-	0.0154424938207073	0.254235568470876
5899	methocarbamol	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8337_8336	8	-	0.00468782461531664	0.254235568470876
5900	methocarbamol	hsa05210	Colorectal cancer	3725_5900_6655_1856_581	5	-	0.0184898595251546	0.254235568470876
5901	methocarbamol	hsa02010	ABC transporters	6890_23457_4363	3	-	0.0467194256635237	0.513913682298761
5902	PHA-00767505E	hsa04662	B cell receptor signaling pathway	4067_3551_8519_3845_5534_3725_4793	7	+	0.019075914657386	0.364012919136991
5903	PHA-00767505E	hsa05320	Autoimmune thyroid disease	958_3106_3119_1081_3134	5	+	0.0430564074434268	0.577898302015703
5904	PHA-00767505E	hsa05016	Huntington's disease	581	1	+	0.0224699332800612	0.364012919136991
5905	PHA-00767505E	hsa04740	Olfactory transduction	816	1	+	5.95646130584261e-05	0.00334423507731987
5906	PHA-00767505E	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_958_8359_8294_8367_554313_121504_3119	16	+	8.25737056128362e-05	0.00334423507731987
5907	PHA-00767505E	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	7082_1432_4067_3551_998_10392_6868_3725	8	+	0.0046086162021713	0.124432637458625
5908	PHA-00767505E	hsa05330	Allograft rejection	958_3106_3119_3134	4	+	0.0499418285692583	0.577898302015703
5909	PHA-00767505E	hsa04662	B cell receptor signaling pathway	5295_10892_6654_5605_5881_3725_5970_27071_4793	9	-	0.0499839373638842	0.286574574219603
5910	PHA-00767505E	hsa04080	Neuroactive ligand-receptor interaction	5029_4889_1813_7068_9568_2149_9170	7	-	0.0392009830299794	0.259329580044479
5911	PHA-00767505E	hsa05200	Pathways in cancer	2475_5295_5605_5881_5335_3326_5747_3655_3725_3675_7157_1857_324_1398_367_1017_9134_613_999_6932_6934_5899_2956_4791_2271_842_6654_6772_7189_5970	30	-	0.0254361016303109	0.218750474020674
5912	PHA-00767505E	hsa04740	Olfactory transduction	219464_5613_5616	3	-	6.99326133085389e-07	6.01420474453435e-05
5913	PHA-00767505E	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8367_554313_8359_8337_720_721_121504_9555_8294	18	-	0.00460293570064749	0.0659754117092807
5914	PHA-00767505E	hsa05212	Pancreatic cancer	6932_2475_5970_6934_9134_7157_6654_5605_3326_367_1385_1017_5295_842	14	-	0.00153597473163477	0.026418765384118
5915	PHA-00767505E	hsa05215	Prostate cancer	6932_2475_5970_6934_9134_7157_6654_5605_3326_367_1385_1017_5295_842	14	-	0.00139616279607092	0.026418765384118
5916	PHA-00767505E	hsa05216	Thyroid cancer	5605_7157_6932_999_6934	5	-	0.037389716544412	0.259329580044479
5917	PHA-00767505E	hsa04115	p53 signaling pathway	1017_842_9134_7157_6477_7249_472_51512_651610_4616	10	-	0.0113575232910238	0.129781810749549
5918	PHA-00767505E	hsa05110	Vibrio cholerae infection	8992_11015_5616_10945_60_5335_5613_523_375	9	-	0.0120727265813534	0.129781810749549
5919	PHA-00767505E	hsa04010	MAPK signaling pathway	9261_3925_5605_4763_3164_4616_7157_51776_5922_1398_2264_776_5536_5607_3725_4791_5613_6654_5616_5881_2002_7189_8911_1386_5970	25	-	0.0382052339009974	0.259329580044479
5920	PHA-00767505E	hsa04060	Cytokine-cytokine receptor interaction	3597_51330_659	3	-	0.000332576653894951	0.0143007961174829
5921	PHA-00767505E	hsa05213	Endometrial cancer	2309_6932_6654_6934_7157_5295_999_2002_5605_324_842	11	-	0.000595596124762384	0.0170737555765217
5922	PHA-00767505E	hsa05210	Colorectal cancer	6654_6934_7157_5295_1857_6932_5881_324_3725_2956_842	11	-	0.0198128091564443	0.189322398606023
5923	PHA-00767505E	hsa05222	Small cell lung cancer	1017_842_9134_7157_5295_7189_5747_3655_5970_3675	10	-	0.0430322226368485	0.264340796197784
5924	gemfibrozil	hsa04660	T cell receptor signaling pathway	1437_3551_208_998_5533_915_27040_5600_920	9	+	0.011807541181327	0.436879023709099
5925	gemfibrozil	hsa04740	Olfactory transduction	5132_8392	2	+	0.000814310419506536	0.0602589710434837
5926	gemfibrozil	hsa04210	Apoptosis	4803_3553_3551_208_331_5533_5576	7	+	0.0297835199415654	0.734660158558613
5927	gemfibrozil	hsa04664	Fc epsilon RI signaling pathway	8398_7410_5335_5290_5602	5	-	0.0470534307384299	0.975836944032109
5928	gemfibrozil	hsa04010	MAPK signaling pathway	4217_8398_9064_3925_9254_27092_1844_23162_5602_3725_2260_5971	12	-	0.0445668217925434	0.975836944032109
5929	oxymetazoline	hsa03420	Nucleotide excision repair	2072_2967_2074	3	-	0.0240112469591337	0.424198696278029
5930	oxymetazoline	hsa05322	Systemic lupus erythematosus	85235_8969_8332_8330_8331_8329_8336	7	-	0.00385023797741216	0.204062612802844
5931	oxymetazoline	hsa04540	Gap junction	7278_1813_113457_23236	4	-	0.0394682101212528	0.5229537841066
5932	oxymetazoline	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00847379057363697	0.22455545020138
5933	ethaverine	hsa04540	Gap junction	5566_6714_3708	3	+	0.033430288072879	0.445737174305053
5934	ethaverine	hsa04912	GnRH signaling pathway	1432_5566_6714_3708_2185	5	+	0.00141441181743605	0.056576472697442
5935	ethaverine	hsa04270	Vascular smooth muscle contraction	3708_4882_3778_5566	4	+	0.0122812062462891	0.245624124925782
5936	ethaverine	hsa04080	Neuroactive ligand-receptor interaction	4157	1	-	0.0224963290339683	0.487420462402647
5937	ethaverine	hsa04740	Olfactory transduction	157	1	-	0.00177904229185186	0.115637748970371
5938	ethaverine	hsa03020	RNA polymerase	5432_246721_5439_548644	4	-	0.00767867536494328	0.249556949360657
5939	glipizide	hsa04740	Olfactory transduction	5566	1	+	0.0337156197226511	1
5940	glipizide	hsa04080	Neuroactive ligand-receptor interaction	2908	1	-	0.0108470440379936	0.639975598241622
5941	glipizide	hsa04115	p53 signaling pathway	472_651610_836_841_27113	5	-	0.0496755386085276	1
5942	bromocriptine	hsa05010	Alzheimer's disease	779	1	+	0.0107675004338887	0.279955011281106
5943	bromocriptine	hsa05016	Huntington's disease	10126_161	2	+	0.0367856403366142	0.542434498951155
5944	bromocriptine	hsa04740	Olfactory transduction	8387_26212_8388_390892	4	+	0.000828711084976945	0.0646394646282017
5945	bromocriptine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_3119	15	+	0.00176232390923428	0.0687306324601369
5946	bromocriptine	hsa04010	MAPK signaling pathway	10369_782_3725_5578_1649_9254_779_5607_5156_8912_356_4208_8911_27091_5602_23542_2260_27330_5971_11221	20	+	0.0215815149113951	0.420839540772204
5947	bromocriptine	hsa05012	Parkinson's disease	2861	1	+	0.0457439033213505	0.542434498951155
5948	bromocriptine	hsa04930	Type II diabetes mellitus	8660_5294_5581_8471_5602	5	+	0.0486800191366421	0.542434498951155
5949	bromocriptine	hsa05211	Renal cell carcinoma	6655_5290_405_5781_7042_3725_4233	7	-	0.0281388945474457	0.231364244056776
5950	bromocriptine	hsa04650	Natural killer cell mediated cytotoxicity	10725_6655_3107_5290_3135_6452_5781_3133_5534_8794_8795	11	-	0.0274095385733751	0.231364244056776
5951	bromocriptine	hsa04662	B cell receptor signaling pathway	10725_10892_6655_5290_5534_3725_27071	7	-	0.0335945648937371	0.248599780213655
5952	bromocriptine	hsa04080	Neuroactive ligand-receptor interaction	7434_4889	2	-	0.00679687887925378	0.146461617198649
5953	bromocriptine	hsa04910	Insulin signaling pathway	5599_5576_5575_5140_8660_5562_5290_5602_8835_5507_6655	11	-	0.0274095385733751	0.231364244056776
5954	bromocriptine	hsa04740	Olfactory transduction	818	1	-	7.91468369705668e-06	0.000292843296791097
5955	bromocriptine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_6738_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	20	-	3.09118420195148e-06	0.00022874763094441
5956	bromocriptine	hsa04210	Apoptosis	3554_581_5576_5575_5290_5534_8837_8794_8795	9	-	0.0110116908669164	0.162973024830363
5957	bromocriptine	hsa04350	TGF-beta signaling pathway	4090_4088_656_654_653_353500_7042_57154	8	-	0.0257608579545053	0.231364244056776
5958	bromocriptine	hsa04930	Type II diabetes mellitus	5599_8660_8835_5290_5602	5	-	0.0382822983322369	0.257535461507776
5959	bromocriptine	hsa05210	Colorectal cancer	581_4088_6655_7042_5290_5599_5602_3725_4233	9	-	0.00791684417289994	0.146461617198649
5960	cotinine	hsa05211	Renal cell carcinoma	5879_10298_7428_6655_998_56924_7042_7039_1387_3082	10	+	0.00148842227676484	0.0595368910705936
5961	cotinine	hsa04650	Natural killer cell mediated cytotoxicity	3824_3449_3804_6655_3107_5880_3440_3451_6452_7535_5879_8794_2534	13	+	0.00930968241181119	0.248258197648298
5962	cotinine	hsa04520	Adherens junction	4301_5879_998_5797_5880_91_1387_2534	8	+	0.0237470142255201	0.379952227608322
5963	cotinine	hsa04740	Olfactory transduction	5137_8383_390892	3	+	0.000171186927158491	0.0136949541726793
5964	cotinine	hsa04360	Axon guidance	2051_2047_10298_6585_56924_2048_998_5880_10154_2534_5879_7869	12	+	0.0146037398536839	0.292074797073678
5965	cotinine	hsa05012	Parkinson's disease	6622	1	+	0.045653492931148	0.608713239081973
5966	cotinine	hsa05332	Graft-versus-host disease	3108_3105_3106_3135_355_649853	6	-	0.032264420521798	0.49040645756563
5967	cotinine	hsa04080	Neuroactive ligand-receptor interaction	146_2555_64106_1131_2925_1909	6	-	0.0432465057697327	0.49040645756563
5968	cotinine	hsa04740	Olfactory transduction	818_393046	2	-	6.54470721019383e-07	5.23576576815506e-05
5969	cotinine	hsa05322	Systemic lupus erythematosus	3108_8336	2	-	0.0350800204085935	0.49040645756563
5970	cotinine	hsa04530	Tight junction	4619_84612	2	-	0.049040645756563	0.49040645756563
5971	cotinine	hsa05012	Parkinson's disease	4698_65018	2	-	0.0489201727035693	0.49040645756563
5972	cotinine	hsa05330	Allograft rejection	3108_3105_3106_3135_355_649853	6	-	0.0219398677385395	0.49040645756563
5973	cotinine	hsa04940	Type I diabetes mellitus	3108_3105_3106_3135_355_649853	6	-	0.0384396525916161	0.49040645756563
5974	erythromycin	hsa05131	Shigellosis	7278_113457_2534	3	-	0.0469972292193889	0.815891086749208
5975	erythromycin	hsa05130	Pathogenic Escherichia coli infection	7278_113457_2534	3	-	0.0469972292193889	0.815891086749208
5976	amoxapine	hsa05214	Glioma	23533_6655_5293_5290_4193	5	+	0.0107839193158983	0.0613853868751134
5977	amoxapine	hsa04070	Phosphatidylinositol signaling system	23533_8394_8396_5293_5290_23236	6	+	0.00476081575088212	0.0391444850628085
5978	amoxapine	hsa05211	Renal cell carcinoma	23533_6655_5293_5290_3725	5	+	0.0158270119333927	0.0836570630765043
5979	amoxapine	hsa04662	B cell receptor signaling pathway	23533_3551_6655_5293_5290_5534_3725	7	+	0.000952261326866715	0.0199454175053129
5980	amoxapine	hsa04660	T cell receptor signaling pathway	23533_1432_3551_6655_5293_5290_5534_3725	8	+	0.001886728682935	0.0199454175053129
5981	amoxapine	hsa04670	Leukocyte transendothelial migration	5010_23533_1432_5293_5290_27035	6	+	0.0360995601857365	0.121425793352023
5982	amoxapine	hsa04910	Insulin signaling pathway	23533_3551_6655_5293_5290_8660_10211	7	+	0.021250778809706	0.0914379743889125
5983	amoxapine	hsa05014	Amyotrophic lateral sclerosis (ALS)	2902_5534_1432_5630_581	5	+	0.00608139707618852	0.045002338363795
5984	amoxapine	hsa05212	Pancreatic cancer	23533_3551_6655_4193_5290_5293	6	+	0.00964394033086622	0.059470965373675
5985	amoxapine	hsa05215	Prostate cancer	23533_3551_6655_4193_5290_5293	6	+	0.00917683314042961	0.059470965373675
5986	amoxapine	hsa04210	Apoptosis	23533_3553_3551_581_5293_5290_355_5534	8	+	0.000523779818922925	0.0199454175053129
5987	amoxapine	hsa05221	Acute myeloid leukemia	23533_3551_6655_5371_5293_5290	6	+	0.00146684779838444	0.0199454175053129
5988	amoxapine	hsa04664	Fc epsilon RI signaling pathway	23533_6655_1432_5293_5290	5	+	0.0222416694459517	0.0914379743889125
5989	amoxapine	hsa04370	VEGF signaling pathway	23533_1432_5293_5290_5534	5	+	0.020261606224127	0.0914379743889125
5990	amoxapine	hsa04012	ErbB signaling pathway	3725_6655_5293_5290_23533	5	+	0.0314005112793662	0.110649420698719
5991	amoxapine	hsa05223	Non-small cell lung cancer	23533_6655_5293_5290	4	+	0.0246814488859084	0.0961277482924854
5992	amoxapine	hsa04620	Toll-like receptor signaling pathway	23533_1432_3551_5293_5290_7100_3725_3553	8	+	0.00120271505319107	0.0199454175053129
5993	amoxapine	hsa04020	Calcium signaling pathway	146_2902_135_8911_113_5534_493_23236	8	+	0.0311263006823815	0.110649420698719
5994	amoxapine	hsa04930	Type II diabetes mellitus	5290_23533_8660_5293_3551	5	+	0.00256390947020155	0.0237161625993643
5995	amoxapine	hsa05213	Endometrial cancer	23533_6655_5293_5290	4	+	0.0220005161094239	0.0914379743889125
5996	amoxapine	hsa05210	Colorectal cancer	23533_581_4088_6655_5293_5290_3725	7	+	0.00175536972403237	0.0199454175053129
5997	amoxapine	hsa05220	Chronic myeloid leukemia	23533_3551_4088_6655_5293_5290_4193	7	+	0.000952261326866715	0.0199454175053129
5998	amoxapine	hsa04740	Olfactory transduction	818	1	-	0.000542209766835862	0.0401235227458538
5999	zimeldine	hsa05214	Glioma	5159_3480_4193_818_1956_816	6	+	0.0246070609920452	0.147642365952271
6000	zimeldine	hsa05332	Graft-versus-host disease	3804_3126_3127_3111_3125_5551_3123_941	8	+	0.000155953970678472	0.00935186333549162
6001	zimeldine	hsa04640	Hematopoietic cell lineage	1436_960_3123_3126_3127_3125_3589_933_1378_3684_925	11	+	0.000259773981541434	0.00935186333549162
6002	zimeldine	hsa05320	Autoimmune thyroid disease	3449_3123_3126_3127_3111_941_5551_3125	8	+	0.000632461920714502	0.011384314572861
6003	zimeldine	hsa04612	Antigen processing and presentation	4261_3449_3123_3126_3127_3111_3125_6891_3804_925	10	+	0.00113198658141298	0.0135838389769558
6004	zimeldine	hsa05131	Shigellosis	7278_347733_7430_113457_9181	5	+	0.0433927497741373	0.208285198915859
6005	zimeldine	hsa05130	Pathogenic Escherichia coli infection	7278_347733_7430_113457_9181	5	+	0.0433927497741373	0.208285198915859
6006	zimeldine	hsa04740	Olfactory transduction	818_1258_816	3	+	0.00275268233646811	0.0283133040322434
6007	zimeldine	hsa04514	Cell adhesion molecules (CAMs)	3123_4099_3126_3127_3111_3125_23308_941_933_3684_925	11	+	0.00630767084937712	0.050461366795017
6008	zimeldine	hsa05218	Melanoma	5159_3480_4193_8817_1956_3082	6	+	0.0348714737445518	0.193134316123672
6009	zimeldine	hsa05310	Asthma	3123_3126_3127_3111_3125	5	+	0.00458982283884464	0.0413084055496018
6010	zimeldine	hsa04540	Gap junction	5159_347733_7278_1813_113457_1956_3358_23236	8	+	0.0146404045020379	0.0958281021951572
6011	zimeldine	hsa04020	Calcium signaling pathway	5159_8912_56848_818_9630_3274_1956_5733_3269_10800_3358_816_23236	13	+	0.0115212785412246	0.0829532054968171
6012	zimeldine	hsa05330	Allograft rejection	3123_3126_3127_3111_941_5551_3125	7	+	0.000481969170418311	0.011384314572861
6013	zimeldine	hsa04940	Type I diabetes mellitus	3123_3126_3127_3111_941_5551_3125	7	+	0.00104542116848358	0.0135838389769558
6014	zimeldine	hsa04080	Neuroactive ligand-receptor interaction	9568_3953_146_1081	4	-	0.0199440417968554	0.339048710546542
6015	zimeldine	hsa04740	Olfactory transduction	810_5613_5616	3	-	4.07769897027873e-05	0.00346604412473692
6016	zimeldine	hsa04514	Cell adhesion molecules (CAMs)	3113	1	-	0.0317490503010113	0.390842392790249
6017	zimeldine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3113_8359_8348_8294_8367_554313_121504	16	-	0.00242641480640106	0.103122629272045
6018	zimeldine	hsa05012	Parkinson's disease	4714	1	-	0.0321870205827264	0.390842392790249
6019	zimeldine	hsa04060	Cytokine-cytokine receptor interaction	3953_4233_2057_3455	4	-	0.014541627531815	0.309009585051069
6020	zimeldine	hsa04270	Vascular smooth muscle contraction	146_776_5581_5613_5616_673_8681_112_810_6093_9475_100137049	12	-	0.0142648712379222	0.309009585051069
6021	metanephrine	hsa04920	Adipocytokine signaling pathway	9021_181_5465	3	+	0.0462113018103781	0.865839906647906
6022	metanephrine	hsa04664	Fc epsilon RI signaling pathway	50487_8681_100137049_5581	4	-	0.034995261451836	0.361617701668972
6023	metanephrine	hsa04370	VEGF signaling pathway	5829_572_50487_4775_8681_100137049	6	-	0.00144352954391763	0.0894988317228931
6024	metanephrine	hsa04912	GnRH signaling pathway	5331_8681_50487_100137049_2776	5	-	0.0265606596888303	0.361617701668972
6025	metanephrine	hsa04730	Long-term depression	5331_8681_50487_100137049_2776	5	-	0.00539571357023182	0.167267120677186
6026	metanephrine	hsa04270	Vascular smooth muscle contraction	5581_50487_2776_5331_8681_100137049	6	-	0.0104095439495169	0.215130574956683
6027	metanephrine	hsa02010	ABC transporters	215_8714_23457	3	-	0.0324886344728408	0.361617701668972
6028	metolazone	hsa04740	Olfactory transduction	818_26211	2	+	0.0368647341977576	0.911828188609026
6029	metolazone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3113_8359_8294_8367_554313_121504	15	+	4.90099808601492e-07	3.33267869849015e-05
6030	metolazone	hsa04630	Jak-STAT signaling pathway	3454_5290_3572_50616_2688_1442_10252	7	+	0.0402277142033394	0.911828188609026
6031	metolazone	hsa04070	Phosphatidylinositol signaling system	5296_1606_5290_3631	4	-	0.0188752668423732	0.440948857826451
6032	metolazone	hsa04662	B cell receptor signaling pathway	5296_4793_5290_8519	4	-	0.0181053072493353	0.440948857826451
6033	metolazone	hsa04330	Notch signaling pathway	182_1856_5664	3	-	0.025611456878796	0.440948857826451
6034	metolazone	hsa04150	mTOR signaling pathway	5296_7422_5290	3	-	0.0327557100126648	0.440948857826451
6035	dipyridamole	hsa04740	Olfactory transduction	810_816	2	+	0.000187229404022681	0.012918828877565
6036	dipyridamole	hsa04270	Vascular smooth muscle contraction	113_4660_10242_3709_5320_185_810_6093_800	9	+	0.0447034574182091	1
6037	dipyridamole	hsa04070	Phosphatidylinositol signaling system	8867_8503_5578_3628_5295_3633_3631_8821_5335_8526_23236	11	-	0.00820212309783216	0.136155243424014
6038	dipyridamole	hsa05010	Alzheimer's disease	572_776_489_23236	4	-	0.047702193929529	0.51031945858739
6039	dipyridamole	hsa04080	Neuroactive ligand-receptor interaction	64106_56288_2925_2555	4	-	0.00216008776367245	0.0597624281282711
6040	dipyridamole	hsa04740	Olfactory transduction	818_26212	2	-	9.26024896494002e-08	7.68600664090022e-06
6041	dipyridamole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6738_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	26	-	2.04616923130675e-06	8.49160230992301e-05
6042	dipyridamole	hsa05012	Parkinson's disease	27429_2861	2	-	0.0359593441209476	0.497437593673109
6043	dipyridamole	hsa04060	Cytokine-cytokine receptor interaction	7852_7423_5155_3552_4254	5	-	0.00421162987861167	0.0873913199811922
6044	loxapine	hsa02010	ABC transporters	6890_23457	2	+	0.0458483483889308	0.73876754222843
6045	loxapine	hsa04330	Notch signaling pathway	2648_5986_1856	3	-	0.0368017695007498	0.985152031721386
6046	propranolol	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.0307038730807558	0.262291216733168
6047	propranolol	hsa04640	Hematopoietic cell lineage	3123_3126_3127_3125_933_925	6	+	0.0335091016171015	0.262291216733168
6048	propranolol	hsa05200	Pathways in cancer	3688_51384_841_83439_2950_3576_5371_1613_861_2122_7849_1950_324_3082_4233_7048_7422	17	+	0.0144017697371329	0.23618902368898
6049	propranolol	hsa04740	Olfactory transduction	810_5568	2	+	0.00477873709700603	0.0979641104886236
6050	propranolol	hsa04514	Cell adhesion molecules (CAMs)	8516_3688_8174_3123_3126_3127_3125_5797_933_925	10	+	0.00420927752803839	0.0979641104886236
6051	propranolol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504	18	+	1.90695425717573e-07	1.5637024908841e-05
6052	propranolol	hsa05219	Bladder cancer	3576_7422_1613_1950	4	+	0.0307038730807558	0.262291216733168
6053	propranolol	hsa05310	Asthma	6356_3123_3126_3127_3125	5	+	0.00193180784623251	0.0792041216955329
6054	propranolol	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.0228066485725353	0.262291216733168
6055	propranolol	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	+	0.0351854071227421	0.262291216733168
6056	propranolol	hsa02010	ABC transporters	5244_64137_5243_89845	4	+	0.0351854071227421	0.262291216733168
6057	bretylium tosilate	hsa05332	Graft-versus-host disease	3123_3126_3127_3119_3125	5	+	0.00300554529844356	0.047667576874964
6058	bretylium tosilate	hsa04640	Hematopoietic cell lineage	3123_3126_4254_3127_3125_3674	6	+	0.0138338544088556	0.101448265664941
6059	bretylium tosilate	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3119_3125	5	+	0.0074477881278281	0.0819256694061091
6060	bretylium tosilate	hsa04612	Antigen processing and presentation	3123_3126_3127_3119_3125	5	+	0.0487960021554114	0.292776012932468
6061	bretylium tosilate	hsa04514	Cell adhesion molecules (CAMs)	9076_3119_3123_1272_3126_3127_3125_26285	8	+	0.0104815340724208	0.0981735607121734
6062	bretylium tosilate	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504_3119	19	+	1.3870195927391e-09	9.15432931207806e-08
6063	bretylium tosilate	hsa04664	Fc epsilon RI signaling pathway	5599_208_5881_10000_6850	5	+	0.0324099653585933	0.213905771366716
6064	bretylium tosilate	hsa05310	Asthma	3123_3126_3127_3119_3125	5	+	0.000780844903483688	0.0257678818149617
6065	bretylium tosilate	hsa05330	Allograft rejection	3123_3126_3127_3119_3125	5	+	0.00201923333080066	0.0444231332776145
6066	bretylium tosilate	hsa05210	Colorectal cancer	10000_581_5599_208_5881_324	6	+	0.0118998255408695	0.0981735607121734
6067	bretylium tosilate	hsa04940	Type I diabetes mellitus	3123_3126_3127_3119_3125	5	+	0.00361118006628515	0.047667576874964
6068	bretylium tosilate	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00358485908465126	0.136224645216748
6069	penbutolol	hsa05010	Alzheimer's disease	489	1	+	0.0324550053483119	0.60041759894377
6070	penbutolol	hsa05016	Huntington's disease	163	1	+	0.0225111777028222	0.555275716669614
6071	penbutolol	hsa04740	Olfactory transduction	818_26529	2	+	0.000405137868222432	0.01499010112423
6072	penbutolol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_8341	15	+	0.00026985703855734	0.01499010112423
6073	penbutolol	hsa05131	Shigellosis	7278_7430_113457_8976_9475	5	-	0.0031107523095433	0.0855456885124408
6074	penbutolol	hsa05130	Pathogenic Escherichia coli infection	7278_7430_113457_8976_9475	5	-	0.0031107523095433	0.0855456885124408
6075	penbutolol	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8336	7	-	0.011828979498774	0.162648468108142
6076	penbutolol	hsa04360	Axon guidance	2050_1949_6405_2048_9475_5361_6092	7	-	0.00740130048222042	0.135690508840708
6077	oligomycin	hsa05010	Alzheimer's disease	22926_6622	2	+	0.00150048230859712	0.0420135046407194
6078	oligomycin	hsa04310	Wnt signaling pathway	818_23002_5467	3	+	0.0269314898025878	0.377040857236229
6079	oligomycin	hsa05016	Huntington's disease	246721_5441	2	+	0.00072648506342367	0.0305123726637941
6080	oligomycin	hsa04740	Olfactory transduction	8388_8387_442194_818_409_8590_3000	7	+	4.02240536665133e-05	0.00337882050798712
6081	oligomycin	hsa04062	Chemokine signaling pathway	2309_2771_3576_409_2931	5	+	0.0251689779157158	0.377040857236229
6082	oligomycin	hsa04810	Regulation of actin cytoskeleton	5605_3693_4659_2249_80310	5	+	0.0107711466840143	0.2261940803643
6083	oligomycin	hsa05012	Parkinson's disease	7345_6622_6531	3	+	0.0490779133225238	0.588934959870286
6084	oligomycin	hsa05322	Systemic lupus erythematosus	85235_8969_8332_8330_8331_8329_8336	7	-	0.00108314636560306	0.035743830064901
6085	arachidonic acid	hsa05332	Graft-versus-host disease	57292_3553_3552_3105_3106_941_3135_649853	8	+	0.00435391229099638	0.111299413736305
6086	arachidonic acid	hsa04130	SNARE interactions in vesicular transport	23673_2054_6809_10652_9570_10228_6616	7	+	0.00874826091328107	0.116643478843748
6087	arachidonic acid	hsa04910	Insulin signaling pathway	23265_5256	2	+	0.0349794531259059	0.310928472230275
6088	arachidonic acid	hsa05016	Huntington's disease	5441	1	+	0.000777383379494913	0.0310953351797965
6089	arachidonic acid	hsa04740	Olfactory transduction	157_442194_818_409_5137_8590	6	+	0.000190291363193725	0.015223309055498
6090	arachidonic acid	hsa04514	Cell adhesion molecules (CAMs)	9076_5010_3383_5818_3105_3106_1013_941_3135_5797_5817_923_5133_1272_926_649853	16	+	0.00832037138685099	0.116643478843748
6091	arachidonic acid	hsa04510	Focal adhesion	93408_55742_10298_859	4	+	0.0272060938149429	0.31092678645649
6092	arachidonic acid	hsa05322	Systemic lupus erythematosus	3013_941_8358_8968_720_721_8350_8351_8352_8353_8354_8355_8356_8357	14	+	0.0487567320863701	0.390053856690961
6093	arachidonic acid	hsa04810	Regulation of actin cytoskeleton	10093_93408_10298_8976_2249	5	+	0.0341394219540957	0.310928472230275
6094	arachidonic acid	hsa04940	Type I diabetes mellitus	3382_3552_3105_3106_941_3135_3553_649853	8	+	0.00556497068681525	0.111299413736305
6095	arachidonic acid	hsa05010	Alzheimer's disease	5530_351_4712	3	-	0.0366413862698618	0.575453098627929
6096	arachidonic acid	hsa04080	Neuroactive ligand-receptor interaction	2911_2901_7252_5031_1902_5646	6	-	0.0430307494992151	0.575453098627929
6097	arachidonic acid	hsa04670	Leukocyte transendothelial migration	5747	1	-	0.0216264559702292	0.555079036569216
6098	arachidonic acid	hsa04740	Olfactory transduction	26476	1	-	7.08490444881201e-08	5.45537642558525e-06
6099	arachidonic acid	hsa05322	Systemic lupus erythematosus	3017	1	-	0.0108517629378092	0.417792873105654
6100	arachidonic acid	hsa04912	GnRH signaling pathway	8398	1	-	0.0448405011917867	0.575453098627929
6101	W-13	hsa05016	Huntington's disease	2902_513_10126_4712_509	5	+	0.00294216965506367	0.0872843664335556
6102	W-13	hsa04740	Olfactory transduction	8387_26476_23538_8392_8388	5	+	3.50827377757318e-09	3.12236366204013e-07
6103	W-13	hsa04510	Focal adhesion	596_5296_2909_3678_5880_5602_87_7058_3911_5829_3691_93408_1398_55742_1291_1278_207_1956_5595_2318_5579_5578_2316_6655_1289_2002_5599_7423	28	+	0.0378497911570546	0.259125493305989
6104	W-13	hsa04664	Fc epsilon RI signaling pathway	5579_5595_3596_207_5578_5296_6655_5605_5599_5880_5335_9846_5602_5322_8399	15	+	0.0113046087977736	0.167685030500308
6105	W-13	hsa05219	Bladder cancer	23604_11186_1029_9252_1613_5605_1956_7423_369_5595	10	+	0.00781788557547052	0.167685030500308
6106	W-13	hsa04012	ErbB signaling pathway	2002_5595_207_5579_5578_5599_6655_5602_3084_5605_5296_1956_5335_1398_6776_369	16	+	0.00981795693421826	0.167685030500308
6107	W-13	hsa05223	Non-small cell lung cancer	2309_11186_5579_207_5578_5296_6655_1029_5605_1956_5335_369_5595_6256	14	+	0.000900462220817545	0.0400705688263807
6108	W-13	hsa04010	MAPK signaling pathway	9261_9344_5605_6722_5607_5880_5602_3553_773_7189_1850_8823_1398_2246_408_8399_207_27092_9252_1956_5322_1616_3727_1647_5595_2318_5579_5578_5599_6655_4915_4763_2002_2316_8911_2005_7186	37	+	0.014735094321433	0.187346199229648
6109	W-13	hsa04540	Gap junction	2911_7280_5595_3710_5579_347733_2771_6655_5578_3709_115_5607_1956_5605_1902_1813	16	+	0.0194261338951394	0.216115739583426
6110	W-13	hsa03010	Ribosome	6204_6139_6181	3	+	0.0465881289124342	0.276422898213776
6111	W-13	hsa05213	Endometrial cancer	2309_2002_5595_207_5296_6655_5605_1956_8312_369	10	+	0.0310532450830617	0.251248982944772
6112	W-13	hsa04912	GnRH signaling pathway	2185_5605_5595_3710_5579_5578_5599_6655_3709_2002_115_1956_5322_5337_5602_2797_8399	17	+	0.0304095634451811	0.251248982944772
6113	W-13	hsa04730	Long-term depression	2911_5595_8399_773_5578_2771_5579_5605_3709_5322_369_3710	12	+	0.041244873435534	0.262199552554466
6114	W-13	hsa05210	Colorectal cancer	5595_207_596_4088_6655_5602_5880_1857_5296_1956_8312_369_5599_7976	14	+	0.037114307858392	0.259125493305989
6115	W-13	hsa05220	Chronic myeloid leukemia	5595_207_4088_6776_369_1029_5605_5296_9846_861_1398_1488_6655	13	+	0.0289032365385975	0.251248982944772
6116	oxamic acid	hsa04650	Natural killer cell mediated cytotoxicity	4776_3451_5595_5578_5293_3135_5879	7	+	0.0187644708000249	0.223743591008811
6117	oxamic acid	hsa04662	B cell receptor signaling pathway	4776_5879_5595_5293_8519	5	+	0.0166616881583249	0.223743591008811
6118	oxamic acid	hsa04740	Olfactory transduction	26476	1	+	0.0109912837241042	0.223743591008811
6119	oxamic acid	hsa04664	Fc epsilon RI signaling pathway	5879_5578_5595_5293_9846	5	+	0.0201699450201208	0.223743591008811
6120	oxamic acid	hsa04370	VEGF signaling pathway	4776_5879_5595_5293_5578	5	+	0.0183605141140869	0.223743591008811
6121	oxamic acid	hsa04010	MAPK signaling pathway	3727_5595_5578_4763_4776_5607_8911_9344_3164_5879_7186	11	+	0.0217528491258566	0.223743591008811
6122	oxamic acid	hsa04620	Toll-like receptor signaling pathway	3451_3576_5595_5293_5879	5	+	0.0495776983169525	0.409124348458935
6123	oxamic acid	hsa04730	Long-term depression	5331_5519_5595_4842_5578	5	+	0.0135850333536182	0.223743591008811
6124	copper sulfate	hsa05200	Pathways in cancer	3576_5605_5880_7170_5602_3655_2308_6513_1613_324_7472_7476_3480_4193_7849_8312_1869_3725_4233_4791_5595_5578_6776_1029_7189_7422_5915_54361_7184_2251	30	+	0.0375760897582349	0.705909118139412
6125	copper sulfate	hsa04740	Olfactory transduction	26476_2979_3000_157_5566	5	+	1.09421521408383e-05	0.000951967236252932
6126	copper sulfate	hsa05219	Bladder cancer	5595_3576_1029_1613_4193_5605_7422_1869	8	+	0.00692900595486629	0.301411759036684
6127	copper sulfate	hsa04115	p53 signaling pathway	55367_1647_1029_317_4193_7249_472_51512_651610	9	+	0.0431478777701553	0.705909118139412
6128	copper sulfate	hsa05012	Parkinson's disease	317_4712	2	+	0.0249201025451067	0.705909118139412
6129	copper sulfate	hsa05010	Alzheimer's disease	22926	1	-	0.0480324688917819	1
6130	copper sulfate	hsa04740	Olfactory transduction	8387_5137_10798_409_8388	5	-	0.0264073402809232	1
6131	iloprost	hsa05010	Alzheimer's disease	489	1	+	0.0154490110176722	0.625684946215724
6132	iloprost	hsa04740	Olfactory transduction	409	1	+	1.20660385873684e-05	0.00097734912557684
6133	iloprost	hsa05332	Graft-versus-host disease	3812_3804_3106_3553_3135	5	-	0.023105363382718	0.639248386921865
6134	iloprost	hsa04650	Natural killer cell mediated cytotoxicity	3812_3383_3804_3106_3135_7410_6452_9436_8795_4276	10	-	0.0390903882323413	0.811125555821082
6135	iloprost	hsa04740	Olfactory transduction	5566_8392_1179	3	-	0.000992293251634676	0.0823603398856781
6136	iloprost	hsa04514	Cell adhesion molecules (CAMs)	1272_6403_3383_6404_4099_3106_3135_6693_933_3655_9019_1001	12	-	0.00496284364792504	0.205958011388889
6137	trifluoperazine	hsa04916	Melanogenesis	5568_4157_816_7855	4	+	0.0237499907035085	0.295178455886463
6138	trifluoperazine	hsa05010	Alzheimer's disease	6390_5532_3708_3709_6868_5534_22926	7	+	0.00196525905897416	0.0284962563551253
6139	trifluoperazine	hsa05016	Huntington's disease	6390_27113_3708	3	+	3.09657583399549e-06	0.000134701048778804
6140	trifluoperazine	hsa04740	Olfactory transduction	26539_26211_26212_5568_816	5	+	8.02570609516054e-13	6.98236430278967e-11
6141	trifluoperazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8348_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_3113_8970	34	+	0.000383734715311515	0.00834623005802545
6142	trifluoperazine	hsa04062	Chemokine signaling pathway	2309_1234_5568_6655_3576_5290_7852_1399_6362_6093_4793_408	12	+	0.0357454435843509	0.388731698979816
6143	trifluoperazine	hsa05012	Parkinson's disease	6390_6531	2	+	9.25927690333823e-05	0.00268519030196809
6144	trifluoperazine	hsa03010	Ribosome	6181_6144	2	+	0.00176855293042566	0.0284962563551253
6145	trifluoperazine	hsa05214	Glioma	5154	1	-	0.0416465662254318	0.456395387148677
6146	trifluoperazine	hsa04080	Neuroactive ligand-receptor interaction	5029_5618_1813_64106_4158_5030_5031_2740_2690	9	-	0.00208677965066479	0.0619077963030554
6147	trifluoperazine	hsa04740	Olfactory transduction	109	1	-	1.1712627831399e-13	1.04242387699451e-11
6148	trifluoperazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_3123_3126_3127_3125_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3014_727	38	-	6.92406821215533e-08	3.08121035440912e-06
6149	trifluoperazine	hsa04710	Circadian rhythm - mammal	406_1408_5187_8863	4	-	0.0461523425206527	0.456395387148677
6150	trifluoperazine	hsa04012	ErbB signaling pathway	5599	1	-	0.00972337068589578	0.173075998208945
6151	trifluoperazine	hsa03022	Basal transcription factors	2967_2969_10629_6875_2957_51616_6872_728198	8	-	0.0291936345417216	0.43303891236887
6152	trifluoperazine	hsa04260	Cardiac muscle contraction	27092_6548	2	-	0.0459287713963947	0.456395387148677
6153	trifluoperazine	hsa04020	Calcium signaling pathway	5533_5331_109_489_7419_3707	6	-	0.00723274633396178	0.16092860593065
6154	chlorpromazine	hsa05010	Alzheimer's disease	5331_351_3709_841_2776	5	+	0.0249500019538815	0.444110034779091
6155	chlorpromazine	hsa04740	Olfactory transduction	1179_816	2	+	8.24109034098234e-10	7.33457040347428e-08
6156	chlorpromazine	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_8362_8294_8366_8370_718_8359_554313_121504_2215_2214_83740_3111_720_721	23	+	0.00155940466614979	0.0478842408889932
6157	chlorpromazine	hsa04062	Chemokine signaling pathway	7852_5331_6366_6772_112	5	+	0.0101894838354513	0.226716015338791
6158	chlorpromazine	hsa05012	Parkinson's disease	6531	1	+	0.00161407553558404	0.0478842408889932
6159	chlorpromazine	hsa04912	GnRH signaling pathway	1432_3709_1081_5599_5602_2776_5331_2798_1956_5320_112_3725_6714_816	14	+	0.0464110696738389	0.68843086682861
6160	chlorpromazine	hsa04080	Neuroactive ligand-receptor interaction	2903_1269_4157_2557_6752_1132_2908_2570_7434_57105_3351_4160_5733_4988_8484	15	-	5.92574082240759e-06	0.000269621207419545
6161	chlorpromazine	hsa04742	Taste transduction	3710	1	-	0.00332888482922	0.0504880865765033
6162	chlorpromazine	hsa04740	Olfactory transduction	219464_5593_56656_26333_1179_808_818_109_4991_801_805	11	-	7.4195620721299e-15	6.75180148563821e-13
6163	chlorpromazine	hsa05322	Systemic lupus erythematosus	2903_8361_8363_8362_8365_8364_8367_8360_8368_6738_8348_8294_121504_8343_8347_8346_8344_8339_8366_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3017_720_721	36	-	0.0309711016106777	0.281837024657167
6164	chlorpromazine	hsa04630	Jak-STAT signaling pathway	3717_2057_3594_3588_1154_6654_3601_3559_5291_10379_5296_51561_9180_9655_10254	15	-	0.0456685424185406	0.346319780007266
6165	chlorpromazine	hsa04062	Chemokine signaling pathway	5590_3717_3551_5829_6654_7410_5291_5331_5296_10451_109_5058_1398_23236_8976_408	16	-	0.00488943164095551	0.0635626113324216
6166	chlorpromazine	hsa05012	Parkinson's disease	836_4698_6390_1347_51465_7381_517	7	-	0.00062869177964117	0.0143027379868366
6167	chlorpromazine	hsa04260	Cardiac muscle contraction	784_27092_7168_7381_1347	5	-	0.0202763517236016	0.205016445205305
6168	chlorpromazine	hsa04060	Cytokine-cytokine receptor interaction	3601_3554_3553_3552_2057_3594_3588_23765_5155_3624_3559_4254_355_655_51561_9180_91_90	18	-	5.83629152042492e-05	0.00177034176119556
6169	chlorpromazine	hsa03010	Ribosome	6187_6168_440589_6189_439992	5	-	0.0030516633824114	0.0504880865765033
6170	chlorpromazine	hsa03050	Proteasome	5717_5690	2	-	0.03981811423117	0.32940439954877
6171	chlorpromazine	hsa02010	ABC transporters	10257	1	-	0.0165020945769041	0.187711325812284
6172	cyclobenzaprine	hsa04740	Olfactory transduction	5613_5616	2	+	0.0190378111418069	0.393448096930676
6173	cyclobenzaprine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3111_3014_8359_8294_8367_554313_121504	16	+	3.86573200497309e-07	2.39675384308332e-05
6174	cyclobenzaprine	hsa04710	Circadian rhythm - mammal	8553_5187	2	+	0.0412702859214802	0.511751545426354
6175	cyclobenzaprine	hsa04340	Hedgehog signaling pathway	5613_5616_7480_650_4036	5	+	0.0111502239296139	0.345656941818031
6176	cyclobenzaprine	hsa04010	MAPK signaling pathway	783_6788_50487_5616_1846_8912_6722_5613_91_3310_3164_2250	12	+	0.0351542351039191	0.511751545426354
6177	cyclobenzaprine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_8294_720_721_121504_8367	16	-	2.32651574187088e-06	0.000116325787093544
6178	cyclobenzaprine	hsa04060	Cytokine-cytokine receptor interaction	659	1	-	0.0156349486123104	0.39087371530776
6179	cyclobenzaprine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0447828608337697	0.663765897388307
6180	quinpirole	hsa05214	Glioma	1021_207_5296_6464_5605_5925_1956_7039	8	+	0.0297264700203627	0.480495657395201
6181	quinpirole	hsa04120	Ubiquitin mediated proteolysis	23759_4281	2	+	0.0495402114157969	0.493930791692627
6182	quinpirole	hsa04080	Neuroactive ligand-receptor interaction	7434_7252	2	+	0.000257020555933582	0.00642551389833955
6183	quinpirole	hsa04740	Olfactory transduction	109_393046_409	3	+	4.57613299968353e-06	0.000343209974976265
6184	quinpirole	hsa05322	Systemic lupus erythematosus	8358_85235_8968_3013_8351_8330_8332_8969_8331_8329_720_721_8350_8336_8352_8353_8354_8355_8356_8357	20	+	0.000211291789001315	0.00642551389833955
6185	quinpirole	hsa05223	Non-small cell lung cancer	1021_207_5296_5605_5925_1956_7039	7	+	0.0327173491763504	0.480495657395201
6186	quinpirole	hsa04940	Type I diabetes mellitus	3593_3553_3105_3106_3135_649853	6	+	0.0384396525916161	0.480495657395201
6187	quinpirole	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_6714_3576_6868_3579	5	-	0.0293281446373135	0.595992198222594
6188	quinpirole	hsa04540	Gap junction	7278_113457_115_108_3709_6714_1902	7	-	0.00773053607296045	0.51794591688835
6189	quinpirole	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0355816237744832	0.595992198222594
6190	quinpirole	hsa04912	GnRH signaling pathway	50487_115_108_3709_3725_6714	6	-	0.0457304015851839	0.612787381241464
6191	quinpirole	hsa05210	Colorectal cancer	581_3480_5900_324_91_3725	6	-	0.0166267587944338	0.556996419613532
6192	prochlorperazine	hsa05332	Graft-versus-host disease	3569_3119_3105_3106_3107_3126_3127_3125_3135_3123_3113_649853	12	+	0.000494031330601938	0.0144915856976568
6193	prochlorperazine	hsa05010	Alzheimer's disease	6392_1329_651820_4137_3708_5534	6	+	0.0315127145947645	0.314701637921065
6194	prochlorperazine	hsa05320	Autoimmune thyroid disease	1081_3119_3105_3106_3107_3126_3127_3125_3135_3123_3113_649853	12	+	0.00272823098720566	0.0400140544790163
6195	prochlorperazine	hsa04612	Antigen processing and presentation	6891_3119_3123_3106_3107_3126_3127_3125_3135_6890_3105_3310_3113_649853	14	+	0.0231822275978476	0.291433718372941
6196	prochlorperazine	hsa04740	Olfactory transduction	5566_816	2	+	4.49613667897491e-11	3.95660027749792e-09
6197	prochlorperazine	hsa04514	Cell adhesion molecules (CAMs)	9076_214_3383_3119_3123_3106_3107_3126_3127_3685_3125_3135_23308_3105_649853_25945_3113_1462	18	+	0.0429138597165088	0.314701637921065
6198	prochlorperazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8348_8294_8343_8341_8347_8346_8344_3123_3126_3127_3125_92815_8370_718_717_8359_554313_121504_8339_3119_3113_8970	32	+	2.94895879010599e-06	0.000129754186764664
6199	prochlorperazine	hsa05310	Asthma	3119_3123_3113_3127_3126_3125	6	+	0.0477220410131971	0.323041508397027
6200	prochlorperazine	hsa05012	Parkinson's disease	6392_1329_651820_9246	4	+	0.034069527251966	0.314701637921065
6201	prochlorperazine	hsa04060	Cytokine-cytokine receptor interaction	8744_8743_8742_8741_7852_9180_2323_3556_27242_10850_3576_3570_3572_970_4982_3976_8718_6362_3604_3953_3589_3624_3626_1956_5618_3566_1271_3569_6358_6359_7422	31	+	0.0421551284372565	0.314701637921065
6202	prochlorperazine	hsa04912	GnRH signaling pathway	4214_1081_5578_5598_6655_1839_3708_108_1956_8681_5600_5603_3725_100137049_5566_816	16	+	0.0360978208164325	0.314701637921065
6203	prochlorperazine	hsa05330	Allograft rejection	3119_3105_3106_3107_3126_3127_3125_3135_3123_3113_649853	11	+	0.00076769774928237	0.0168893504842121
6204	prochlorperazine	hsa04940	Type I diabetes mellitus	3119_3105_3106_3107_3126_3127_3125_3135_3123_3113_649853	11	+	0.0020944221858189	0.0368618304704126
6205	prochlorperazine	hsa04640	Hematopoietic cell lineage	3123_3554_3126_3127_3125	5	-	0.0387946885051656	0.38451690402786
6206	prochlorperazine	hsa04080	Neuroactive ligand-receptor interaction	5029_4889_5618_152_64106_4886_5031_3351_9568_56288_2690_9170	12	-	9.37848485301536e-06	0.000436099545665214
6207	prochlorperazine	hsa04742	Taste transduction	5613_5566	2	-	0.0413459036589097	0.38451690402786
6208	prochlorperazine	hsa04740	Olfactory transduction	818_5613_5566_4991	4	-	4.5122010204958e-18	4.19634694906109e-16
6209	prochlorperazine	hsa05322	Systemic lupus erythematosus	3123_3126_3127_3021_3125_8336_3014_3013_8351_3020	10	-	0.019586396603927	0.227691860520651
6210	prochlorperazine	hsa05012	Parkinson's disease	7332_4712_7054_509_7419_539_291	7	-	0.00324140163277615	0.0502417253080303
6211	prochlorperazine	hsa04260	Cardiac muscle contraction	4635_27092	2	-	0.00155541478879681	0.0361633938395258
6212	prochlorperazine	hsa04060	Cytokine-cytokine receptor interaction	5618_3554_3597_3454_5155_8741_7852_657_355_7042_8792_4233_8795_2690	14	-	3.16661566390333e-05	0.000981650855810032
6213	prochlorperazine	hsa03010	Ribosome	6129_6189_439992_6203	4	-	0.00300057413788618	0.0502417253080303
6214	prochlorperazine	hsa04610	Complement and coagulation cascades	2161_7035	2	-	0.00683190180950414	0.0907666954691264
6215	phenformin	hsa05016	Huntington's disease	4899_4713_7052_1639_581_163	6	+	0.0415726892713244	0.791440901949376
6216	phenformin	hsa04740	Olfactory transduction	5566_1179_26476_8392_4991_810_816	7	+	7.49933508339158e-06	0.000622444811921501
6217	phenformin	hsa04512	ECM-receptor interaction	1284_960_1301_2812_3691_2335_3679_3685_6383_1292_1291_3674_1280	13	+	0.0140299984315305	0.582244934908516
6218	phenformin	hsa04010	MAPK signaling pathway	6722_4763_8681_3164_5609_11221_4908_5566_23162_2260_2247_100137049_776_2258_998_5532_7046_5534_7048_782_5599_1649_4137_7189_355_5871_27092_2257_7186	29	+	0.0476771627680347	0.791440901949376
6219	phenformin	hsa05012	Parkinson's disease	2861_4713_5413	3	+	0.0255358178906574	0.706490961641521
6220	phenformin	hsa04080	Neuroactive ligand-receptor interaction	151_2902_5618_64106_1241_7067_185_9568_5645	9	-	0.0420294603820271	0.73625945568804
6221	phenformin	hsa04740	Olfactory transduction	26333_26212_26716	3	-	2.27944763760764e-08	2.07429735022295e-06
6222	phenformin	hsa04062	Chemokine signaling pathway	5296_208_3576_6773_6363_4793	6	-	0.0414995287117465	0.73625945568804
6223	phenformin	hsa05012	Parkinson's disease	1329_6622_291	3	-	0.0355952736815024	0.73625945568804
6224	phenformin	hsa04260	Cardiac muscle contraction	1329	1	-	0.0434299839693696	0.73625945568804
6225	phenformin	hsa04912	GnRH signaling pathway	5599_3725	2	-	0.0485445794959147	0.73625945568804
6226	Prestwick-967	hsa04080	Neuroactive ligand-receptor interaction	1081	1	+	0.0469392719776771	0.844906895598188
6227	Prestwick-967	hsa04740	Olfactory transduction	135948_157	2	+	0.0187247833201441	0.674092199525188
6228	Prestwick-967	hsa03450	Non-homologous end-joining	5591_27434	2	+	0.0457685390914507	0.844906895598188
6229	Prestwick-967	hsa04010	MAPK signaling pathway	1326_9064_783_5599_2317_5154_4791_8912_1616_5607_8986_5600_3304_5871_3303_4763	16	+	0.000532348130935253	0.0383290654273382
6230	Prestwick-967	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00411823661471148	0.156492991359036
6231	letrozole	hsa05211	Renal cell carcinoma	2271_5594_6655_405_3845_7422_1398	7	+	0.0281388945474457	0.229767774616761
6232	letrozole	hsa05200	Pathways in cancer	4089_9618_3326_3655_8324_5888_5925_405_5468_598_1017_9134_1398_999_5899_2956_2271_5594_6774_6655_6772_355_3845_7422_7184	25	+	0.00251733992651708	0.100277495668896
6233	letrozole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_6737_8359_8294_8367_554313_121504	15	+	0.000905437934796014	0.0742459106532731
6234	letrozole	hsa05212	Pancreatic cancer	5594_9134_6655_5925_3845_3326_1017_7184	8	+	0.0287411112290508	0.229767774616761
6235	letrozole	hsa04110	Cell cycle	995_5591_9134_996_4173_4089_699_5925_7027_7534_1017_4616	12	+	0.00366868886593522	0.100277495668896
6236	letrozole	hsa05215	Prostate cancer	5594_9134_6655_5925_3845_3326_1017_7184	8	+	0.0272226801252821	0.229767774616761
6237	letrozole	hsa05219	Bladder cancer	5594_999_5925_3845_7422_1890	6	+	0.00860911029259299	0.176486760998156
6238	letrozole	hsa05216	Thyroid cancer	5468_3845_999_5594	4	+	0.0336245523829406	0.229767774616761
6239	letrozole	hsa04115	p53 signaling pathway	5366_9134_4194_355_1017_8795_4616	7	+	0.023317865869724	0.229767774616761
6240	letrozole	hsa04350	TGF-beta signaling pathway	5594_3397_4089_6667_9475_5519_7027_653	8	+	0.0257608579545053	0.229767774616761
6241	letrozole	hsa05213	Endometrial cancer	2309_5594_6655_999_2002_3845	6	+	0.0208147221117118	0.229767774616761
6242	letrozole	hsa05220	Chronic myeloid leukemia	5594_598_6655_1398_5925_3845_4089	7	+	0.0335945648937371	0.229767774616761
6243	letrozole	hsa03010	Ribosome	6205_9045_6181_6157	4	-	0.0390127390293282	1
6244	letrozole	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0065673094738596	0.354634711588418
6245	gibberellic acid	hsa05211	Renal cell carcinoma	405_6654_5594_7042	4	+	0.0304725656438334	0.427161868233444
6246	gibberellic acid	hsa04910	Insulin signaling pathway	5594_6654_867_8660_23265_5140	6	+	0.024819330152473	0.427161868233444
6247	gibberellic acid	hsa04062	Chemokine signaling pathway	7454_5594_156_5829_6654_2788_3718_2931	8	+	0.0131762916947962	0.408465042538682
6248	gibberellic acid	hsa04010	MAPK signaling pathway	1432_5594_2318_6654_4763_23162_2249_7042_3164_4791_5536	11	+	0.00477035197420553	0.295761822400743
6249	gibberellic acid	hsa05220	Chronic myeloid leukemia	6654_5594_867_7042	4	+	0.0344485377607616	0.427161868233444
6250	gibberellic acid	hsa03010	Ribosome	9045_6205_284393_389342_6181	5	-	0.0180076366756275	0.986530062436346
6251	apramycin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8359_8370_8294_554313_121504	14	+	2.77809829057715e-12	7.50086538455831e-11
6252	apramycin	hsa04540	Gap junction	7278_113457_2776_3708_115_5607_3845	7	-	0.00335821444194825	0.21156750984274
6253	tocainide	hsa04080	Neuroactive ligand-receptor interaction	1269_56288	2	+	0.0134748328536113	0.525518481290841
6254	tocainide	hsa04740	Olfactory transduction	51806_5616_5613	3	+	0.00144671931698494	0.112844106724825
6255	tocainide	hsa03010	Ribosome	140801_6205_9045	3	-	0.0246066096960815	0.393705755137304
6256	tocainide	hsa03020	RNA polymerase	246721_5439_548644_661	4	-	4.11109705304503e-05	0.00131555105697441
6257	Prestwick-984	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	6.92239688480881e-10	2.42283890968308e-08
6258	Prestwick-984	hsa04740	Olfactory transduction	109	1	-	0.0318185494865763	1
6259	zuclopenthixol	hsa05332	Graft-versus-host disease	3553_3105_3106_3126_3127_3125_3135_355_3123_649853	10	+	0.00159916211687571	0.0496981428140726
6260	zuclopenthixol	hsa04640	Hematopoietic cell lineage	966_960_3553_3815_3123_3126_3127_3125_3566_7066_3570_3589_915_3655	14	+	0.00649287019769573	0.0934652162045493
6261	zuclopenthixol	hsa04080	Neuroactive ligand-receptor interaction	2911_2555_1081_624_2150_9568_2149	7	+	0.00735446265755562	0.0934652162045493
6262	zuclopenthixol	hsa05320	Autoimmune thyroid disease	3448_1081_3105_3106_3126_3127_3125_3135_355_3123_649853	11	+	0.00245353990726023	0.0496981428140726
6263	zuclopenthixol	hsa04612	Antigen processing and presentation	4800_3448_3123_3106_3126_3127_3125_3135_6890_3326_3105_567_649853	13	+	0.0226923382045433	0.201961810020435
6264	zuclopenthixol	hsa05131	Shigellosis	7454_7280_347733_5578_999_9475_7430_9181_6093_2534	10	+	0.00945153871731397	0.0934652162045493
6265	zuclopenthixol	hsa04910	Insulin signaling pathway	8660_2308_5602	3	+	0.0361205896021923	0.292248406781374
6266	zuclopenthixol	hsa05130	Pathogenic Escherichia coli infection	7454_7280_347733_5578_999_9475_7430_9181_6093_2534	10	+	0.00945153871731397	0.0934652162045493
6267	zuclopenthixol	hsa05012	Parkinson's disease	6622	1	+	0.00233014197049141	0.0496981428140726
6268	zuclopenthixol	hsa04260	Cardiac muscle contraction	4635	1	+	0.0433886969743432	0.321799502559712
6269	zuclopenthixol	hsa05330	Allograft rejection	3105_3106_3126_3127_3125_3135_355_3123_649853	9	+	0.00279203049517262	0.0496981428140726
6270	zuclopenthixol	hsa04940	Type I diabetes mellitus	3382_3105_3106_3126_3127_3125_3135_355_3123_3553_649853	11	+	0.000670707514293372	0.0496981428140726
6271	zuclopenthixol	hsa05131	Shigellosis	7278_7430_113457	3	-	0.00761324880546874	0.0456794928328124
6272	zuclopenthixol	hsa05130	Pathogenic Escherichia coli infection	7278_7430_113457	3	-	0.00761324880546874	0.0456794928328124
6273	zuclopenthixol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8359_8370_8294_554313_121504	14	-	2.25560339090219e-12	5.41344813816526e-11
6274	zuclopenthixol	hsa03010	Ribosome	6181_6169_6205_9045_439992_6157_6189	7	-	8.91489605525038e-06	0.000106978752663005
6275	fursultiamine	hsa04062	Chemokine signaling pathway	2931	1	+	0.0466265287661826	1
6276	fursultiamine	hsa04740	Olfactory transduction	157	1	-	0.0155732280236746	0.451944340129336
6277	fursultiamine	hsa04010	MAPK signaling pathway	784_2122_4149_6655_50487_8681_7042_7786_2260_100137049	10	-	0.0324942944255668	0.53762905376263
6278	fursultiamine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0177233074560524	0.451944340129336
6279	tracazolate	hsa04740	Olfactory transduction	816	1	+	0.0110987502387991	0.732517515760741
6280	tracazolate	hsa04080	Neuroactive ligand-receptor interaction	4886	1	-	0.000116171157408057	0.00964220606486873
6281	tracazolate	hsa05012	Parkinson's disease	4712	1	-	0.021934576259444	0.874814788284091
6282	pinacidil	hsa04740	Olfactory transduction	810_219464_26529_135948_8392	5	+	0.000884886158753171	0.0654815757477347
6283	pinacidil	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_8359_8294_8367_554313_121504	15	+	0.00440750023694511	0.163077508766969
6284	pinacidil	hsa04080	Neuroactive ligand-receptor interaction	1241	1	-	0.0476055344379078	0.690280249349663
6285	pinacidil	hsa05200	Pathways in cancer	5599_6932	2	-	0.0359874682214292	0.690280249349663
6286	pinacidil	hsa04664	Fc epsilon RI signaling pathway	50487_5599_5163_5608_9846	5	-	0.0369267639576787	0.690280249349663
6287	pinacidil	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0322715987469276	0.690280249349663
6288	azapropazone	hsa04740	Olfactory transduction	5566_26212_409	3	+	0.0371610148554953	1
6289	azapropazone	hsa04270	Vascular smooth muscle contraction	2983_5566_9475_5605_3709_1909_800	7	+	0.0259843304251539	1
6290	azapropazone	hsa04110	Cell cycle	472_4089_9134_8556_4173	5	-	0.0315741160410999	0.655261661598294
6291	azapropazone	hsa04920	Adipocytokine signaling pathway	3953_8660_5105_8717	4	-	0.0181704834100123	0.655261661598294
6292	azapropazone	hsa04350	TGF-beta signaling pathway	4089_9372_7059_3624	4	-	0.040323794559895	0.655261661598294
6293	azapropazone	hsa04512	ECM-receptor interaction	3655_7059_1605_3675	4	-	0.0363287495699973	0.655261661598294
6294	isocarboxazid	hsa05322	Systemic lupus erythematosus	55506_85235_8969_8332_8330_8331_8336_8329	8	-	0.000243578195916204	0.0138839571672236
6295	dicoumarol	hsa05010	Alzheimer's disease	3553_3710_489	3	+	0.0192404026536677	0.399238355063605
6296	dicoumarol	hsa05016	Huntington's disease	6667	1	+	0.000523049791578421	0.0144710442336696
6297	dicoumarol	hsa04740	Olfactory transduction	26476_5616_5593	3	+	1.05116829532679e-06	4.36234842560618e-05
6298	dicoumarol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_88_8294_121504_8968_8370_8358_8359_8335_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113	28	+	1.81819577297085e-07	1.50910249156581e-05
6299	dicoumarol	hsa04070	Phosphatidylinositol signaling system	5331_810_5333_8394_5578	5	-	0.0495810977112577	0.343849897688237
6300	dicoumarol	hsa04740	Olfactory transduction	810	1	-	0.00117446506855832	0.0369956496595871
6301	dicoumarol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	3.50389406939767e-05	0.00220745326372053
6302	dicoumarol	hsa04210	Apoptosis	3556_581_472_5534_8837_823	6	-	0.0298740121609408	0.271505851204046
6303	dicoumarol	hsa04720	Long-term potentiation	5578_2776_5331_5534_810_814	6	-	0.0147853629423162	0.23286946634148
6304	dicoumarol	hsa04020	Calcium signaling pathway	5331_5578_56848_5534_2776_115_5333_1909_810_814	10	-	0.0295048353338982	0.271505851204046
6305	dicoumarol	hsa04912	GnRH signaling pathway	5331_2002_5578_5599_998_2776_115_810_10746	9	-	0.00239342956695644	0.0502620209060852
6306	dicoumarol	hsa02010	ABC transporters	8714_20_5243_5244	4	-	0.0301673168004496	0.271505851204046
6307	H-7	hsa04740	Olfactory transduction	8392_801_808_805_816	5	+	9.1947712520733e-07	7.63166013922084e-05
6308	H-7	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8290_8329_8294_8969_8370_8332_8359_8330_8331_8336_8335_121504_85235_3119_941	25	+	9.69064630142666e-05	0.00402161821509206
6309	H-7	hsa04360	Axon guidance	64221_9037_5063	3	+	0.0491960784493808	0.931385185356822
6310	H-7	hsa05219	Bladder cancer	23604_7157_3576_7057_4193_5605_1956	7	+	0.0372423374553499	0.931385185356822
6311	H-7	hsa04916	Melanogenesis	112_115_5330_7855_1906_8324_8321_8322_818_1856_1857_10488_2033_7475_816_7477_3815_51384_2932_11211_6934_107_5605_5594_3845_1385_1387_2535	28	-	0.0108086231779606	0.0483814561299189
6312	H-7	hsa04650	Natural killer cell mediated cytotoxicity	8503_2185_5296_5294_5295_5533_5290_5291_5605_10451_6452_5335_5336_836_3105_11261_3459_4776_7410_80328_4277_4276_10725_673_3135_4775_4772_3133_8795_5777_1437_5594_3460_6655_6654_6464_27040_5881_356_355_3845_7409_3106	43	-	0.0292220522277188	0.0915624303135189
6313	H-7	hsa04640	Hematopoietic cell lineage	3570_3655_3675_3554_3553_3552_2057_3690_3123_3126_3127_3125_3581_3815_3589_960_1437_1435_3566_1604_2209_925	22	-	0.0124841757584227	0.0510222835344232
6314	H-7	hsa03320	PPAR signaling pathway	79966_2710_5170_7316_11001_2182_2181_1375_9415_5467_6257_6256_8309	13	-	0.00129586903600975	0.00716539349323038
6315	H-7	hsa05010	Alzheimer's disease	55851_2597_3710_317_9451_5663_5330_7132_1327_3553_4728_4698_11261_509_776_8772_2932_5533_3708_3709_6868_489_836_4714_5594_841_4713_642502_6391_355_351_8851	32	-	1.07934646529904e-07	2.0291713547622e-06
6316	H-7	hsa04080	Neuroactive ligand-receptor interaction	5029_2901_152_2908_2925_5030_5031_56288_136_135_134_6870_1813_5724_7434_2150_2151_4987_7433_9568_4988_7068_1909_4889_2917_3953_1131_4886_6915_146_5732_8001_9170_5618_7442_3354_7067_2897_6751_2893_6755_1241_2798_728_2690	45	-	5.83610993089602e-11	2.74297166752113e-09
6317	H-7	hsa04742	Taste transduction	6340_3710_5330_51764_112_6338	6	-	0.00013178279883383	0.00112614391730727
6318	H-7	hsa04612	Antigen processing and presentation	3326_8625_6891_3308_3306_3304_3305_3303_4800_4801_4802_3123_3106_3126_3127_3125_811_3135_3133_3312_3119_3111_3105_1385_925_649853	26	-	0.0435161059633759	0.123954968501737
6319	H-7	hsa04670	Leukocyte transendothelial migration	8503_5296_2909_394_5290_9475_7852_6387_5335_5336_26285_24146_87_7410_7430_5294_5295_5747_9080_1495_2185_6093_5291_60_1432_10451_27035_1536_1364_1365_7409_88	32	-	0.00386220225654774	0.0201692784508604
6320	H-7	hsa04614	Renin-angiotensin system	1215	1	-	0.0192654685984751	0.0646769302948807
6321	H-7	hsa05016	Huntington's disease	4899_1327_317_246721_5330_23186_3064_6874_10126_6908_5432_5433_5430_836_4728_5434_7052_1639_5439_10488_2033_509_1213_581_55567_3708_548644_161_5481_163_4714_27113_841_4713_642502_6391_7157_5978_4698_1385_1387_9519	42	-	7.77272695752243e-06	8.11818148896787e-05
6322	H-7	hsa04740	Olfactory transduction	818_7932_157_816	4	-	1.07348904236821e-57	1.00907969982612e-55
6323	H-7	hsa04514	Cell adhesion molecules (CAMs)	2734_214_23308_3655_9019_24146_3123_3106_3126_3127_3696_3125_5817_25945_9080_3135_3133_26285_6402_965_4685_3119_3111_1364_1365_5792_3105_6693_923_925_26047_649853	32	-	0.000530527617947989	0.00383612277593161
6324	H-7	hsa04510	Focal adhesion	8503_5170_10000_10298_1302_596_5296_2909_394_5155_5154_5290_9475_60_5881_5747_7791_3655_4659_6714_22798_5728_7059_5063_3690_7057_3696_56924_7410_23396_331_1399_1398_1293_55742_3675_5294_87_5295_3912_896_3910_3480_29780_2932_329_3909_1956_3725_6093_5291_1290_5228_5594_1729_2316_2317_6655_6654_6464_10451_7409_7422_88_673_3911_83660	67	-	0.0146964438601639	0.0552586289142163
6325	H-7	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_6737_88_8362_8294_121504_87_8345_3123_8366_3126_3127_3125_8968_55766_8370_718_717_8358_8359_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_83740_3013_3014_2209_8970_3111_729	46	-	0.0334470673898322	0.101420139827233
6326	H-7	hsa05340	Primary immunodeficiency	64421_8625_925_6891_100_29760	6	-	0.0183902363896227	0.0640252674305383
6327	H-7	hsa04140	Regulation of autophagy	5289_64422_9474_8408_5562_23710	6	-	0.0183902363896227	0.0640252674305383
6328	H-7	hsa04530	Tight junction	10000_93643_6709_88_64398_56288_9223_87_24146_5728_5583_5580_5581_5515_2036_51776_5865_2017_55844_8777_9080_5518_4624_1495_4628_6714_26285_60_5520_7082_8189_10207_1364_1457_3845_7525_6237_1459_27134_1365	40	-	0.0113428638335432	0.0484649636524119
6329	H-7	hsa04720	Long-term potentiation	5533_3710_814_11261_673_818_5330_3708_3709_2033_5594_3845_5605_1387_4659_107_816_468	18	-	0.0131631962044074	0.0515558518005956
6330	H-7	hsa05110	Vibrio cholerae infection	60_7082_8992_5336_115_526_5335_523_23545	9	-	0.000897589148187905	0.00602666999497593
6331	H-7	hsa04512	ECM-receptor interaction	7059_960_22798_1302_3910_3690_3912_3911_3909_3696_7057_961_1293_3655_1290_3339_3675	17	-	0.0011545796111032	0.0067831552152313
6332	H-7	hsa04062	Chemokine signaling pathway	3717_6777_10000_157_156_5296_5294_5747_8503_5290_9475_115_5330_10451_56288_10235_112_2309_7454_3551_7410_1399_1398_5580_5295_2932_673_729230_2185_6093_5291_107_4792_4793_7852_5594_6655_6654_6464_6387_6772_2783_51764_3845_7409_5970_8976	47	-	4.34723209594352e-05	0.000408639817018691
6333	H-7	hsa04810	Regulation of actin cytoskeleton	8503_10298_5296_10672_2909_5295_5155_5154_5290_9475_5605_5881_23396_5747_3655_10458_4659_87_3675_7454_3985_3690_1445_3696_56924_8396_7410_8826_7430_1399_1398_2245_2260_28964_5294_2264_10152_200576_324_5063_8394_1131_673_3984_1956_23191_2263_4628_6093_5291_5962_8874_10093_60_10451_5594_1729_6655_6654_5305_8817_8936_3845_54434_88_2257_7409_6237_8976_2250	70	-	0.00853975671194651	0.0422493226801564
6334	H-7	hsa04540	Gap junction	7280_3710_983_5155_113457_5605_5330_5607_10381_112_347733_1813_2767_5154_3708_1956_6714_107_115_7082_5594_5598_7278_6654_3709_3845_1453_6655	28	-	0.0495197296650335	0.134587863743062
6335	H-7	hsa05012	Parkinson's disease	4714_2861_7326_4698_836_1327_4713_7314_6391_317_7054_4728_509_5481_642502	15	-	4.99868319724922e-10	1.56625406847142e-08
6336	H-7	hsa04260	Cardiac muscle contraction	776_1327_782_783_7139_4624_4635_7171_481	9	-	1.33051591767568e-06	2.0552770196598e-05
6337	H-7	hsa04060	Cytokine-cytokine receptor interaction	3594_8744_5155_5154_7852_6387_9180_1896_7132_3556_3554_3553_3552_2057_3459_3953_3570_3572_657_655_3977_7040_23529_3581_3601_3815_3588_3589_23765_8771_3625_4055_1956_729230_91_90_8792_92_7048_3467_1437_5618_1435_3566_3460_356_355_50616_7422_8795_83729_51330_2690	53	-	3.94160862526241e-09	9.26278026936666e-08
6338	H-7	hsa03010	Ribosome	6204_440589_6139_6165_6137_6187_6168_6141_6234_9349_6158_6160_6129_6233	14	-	1.60052137409896e-06	2.0552770196598e-05
6339	H-7	hsa04020	Calcium signaling pathway	3710_5336_2925_489_115_7220_5333_5335_136_135_1909_9630_490_491_6870_11261_5724_3707_818_493_814_56848_816_146_776_1131_2767_5533_6915_3708_1956_2185_107_5481_8877_5330_8912_3709	38	-	1.74917193162536e-06	2.0552770196598e-05
6340	H-7	hsa03050	Proteasome	23198_5719_5689_5709_5702	5	-	0.000276776287418959	0.00216808091811518
6341	H-7	hsa04730	Long-term depression	5515_5319_2781_3710_5518_10672_50487_2767_673_5605_5330_3708_3709_8681_3845_3480_8398_100137049_5594	19	-	0.0396687387960494	0.116526920213395
6342	H-7	hsa04270	Vascular smooth muscle contraction	3710_10672_50487_9475_115_5330_8681_4637_136_135_112_4659_5319_5583_5580_5581_100137049_146_776_8398_4882_2767_673_3708_9826_6093_107_5605_5594_27094_3709_800_1909	33	-	0.0104764970244287	0.0483814561299189
6343	H-7	hsa02010	ABC transporters	6833_23461_5826_19_5244_5243_9619_6891_10057	9	-	0.0253087547120401	0.0820352738941989
6344	H-7	hsa04610	Complement and coagulation cascades	718_717_629_7056_1604_2_7035_2152_2153_729_728_5329	12	-	0.00103742408080326	0.0065011909063671
6345	PF-00539745-00	hsa04740	Olfactory transduction	26212	1	+	1.11326742453151e-06	8.68348591134578e-05
6346	PF-00539745-00	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3579_535_525_10392_5781_102_3725	7	+	0.0479462111713006	1
6347	PF-00539745-00	hsa04740	Olfactory transduction	5568_442194_4991	3	-	0.000505802460267366	0.0197262959504273
6348	PF-00539745-00	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8370_83740_8368_8366_3111_8360_8359_88_8362_8294_8367_554313_121504_6737	20	-	2.75894016256874e-06	0.000215197332680362
6349	PF-00875133-00	hsa05211	Renal cell carcinoma	10000	1	+	0.0289850382990122	0.425113895052179
6350	PF-00875133-00	hsa05010	Alzheimer's disease	779_355_836_348_4698	5	+	0.00532822534009475	0.234441914964169
6351	PF-00875133-00	hsa04670	Leukocyte transendothelial migration	7412_1364_3688	3	+	0.0180807736444354	0.397777020177579
6352	PF-00875133-00	hsa05016	Huntington's disease	246721_1211_836_7052_4698_9001_1385_5468	8	+	0.0443657538687127	0.453109317370181
6353	PF-00875133-00	hsa04740	Olfactory transduction	5137_109_7932_816	4	+	7.03926335948907e-10	6.19455175635038e-08
6354	PF-00875133-00	hsa04350	TGF-beta signaling pathway	10637_4088	2	+	0.0463407256401321	0.453109317370181
6355	PF-00875133-00	hsa04062	Chemokine signaling pathway	2785_10000_156_3577_2931_51764_109_10235	8	+	0.0343053723195194	0.431267537731101
6356	PF-00875133-00	hsa05012	Parkinson's disease	4698_7327_836_5413	4	+	0.0254176405702272	0.425113895052179
6357	PF-00875133-00	hsa03010	Ribosome	6165_9045	2	+	0.0165515115132361	0.397777020177579
6358	PF-00875133-00	hsa04612	Antigen processing and presentation	3106	1	-	0.00200330577115526	0.0607669417250429
6359	PF-00875133-00	hsa04740	Olfactory transduction	51806_157_5616_818_2978_9635_816	7	-	8.82744078745099e-11	8.0329711165804e-09
6360	PF-00875133-00	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8342_81_8347_8346_8345_8344_8969_55766_8370_718_8332_8359_8330_8331_8336_554313_121504_8339_85235_3017_729	33	-	0.0003252445765157	0.0147986282314644
6361	PF-00875133-00	hsa04710	Circadian rhythm - mammal	8864_5187_406_1408_4862_8863	6	-	0.00820059952924672	0.186563639290363
6362	PF-00875133-00	hsa05012	Parkinson's disease	4714_2861_4713_4698_317_6622	6	-	0.022412264083952	0.339919338606605
6363	PF-00875133-00	hsa04260	Cardiac muscle contraction	7139_782_4635	3	-	0.044756742779055	0.577559620890942
6364	PF-00875133-00	hsa03010	Ribosome	6234_6141_6203	3	-	0.0124627279423336	0.226821648550472
6365	pioglitazone	hsa03320	PPAR signaling pathway	5465_1593	2	+	0.00685165453276205	0.127440774309374
6366	pioglitazone	hsa05010	Alzheimer's disease	836_842_11261_2081_317_2776_5533_3708_3709_351_4842	11	+	0.00362891137034239	0.0843721893604606
6367	pioglitazone	hsa04080	Neuroactive ligand-receptor interaction	1269_22953_1813_64106_3360_1131_5032_6915_56288_7067_135_7433	12	+	9.28710592877295e-06	0.000431850425687942
6368	pioglitazone	hsa05016	Huntington's disease	5432_7419_6648_842_836_317_6667_2776_3708_5978_55567_1385_1387_161	14	+	0.0132648792524788	0.205605628413421
6369	pioglitazone	hsa04740	Olfactory transduction	818_157_1258_816_390892	5	+	7.35910565190317e-17	6.84396825626995e-15
6370	pioglitazone	hsa05012	Parkinson's disease	836_7419_317_842	4	+	9.19033727561207e-05	0.00284900455543974
6371	pioglitazone	hsa04260	Cardiac muscle contraction	782_6262_781_4635	4	+	0.0217350170033492	0.288765225901639
6372	pioglitazone	hsa03010	Ribosome	440589_140801_6187_6181_6234_6165	6	+	0.0272060365873384	0.316270175327809
6373	pioglitazone	hsa05016	Huntington's disease	1175_7802_627_5434_581_6392_651820_6390_317_2776_5331_3708_7416_163	14	-	0.00359550704590305	0.0826966620557701
6374	pioglitazone	hsa03420	Nucleotide excision repair	5887	1	-	0.0260322394734321	0.399161005259292
6375	pioglitazone	hsa04740	Olfactory transduction	26211_5568_157_393046_442194_26716_2978_808_805_4991_801_26529_9635_816	14	-	6.437277891602e-12	5.92229566027384e-10
6376	pioglitazone	hsa05322	Systemic lupus erythematosus	2903_8361_8363_8362_8365_8364_8367_8360_8368_554313_88_8294_121504_958_6737_8366_8968_8370_8358_8359_8337_8335_8350_8351_8352_8353_8354_8355_8356_8357_3012_3013_3111_8970	34	-	0.0367246080579785	0.482666277333432
6377	pioglitazone	hsa05012	Parkinson's disease	6392_651820_6390_317_7416_6531_9627	7	-	0.000870485278732473	0.0400423228216938
6378	pioglitazone	hsa04260	Cardiac muscle contraction	784_6262_10368	3	-	0.00256680999008135	0.0787155063624947
6379	pioglitazone	hsa03050	Proteasome	5702	1	-	0.0112005746695179	0.206090573919129
6380	proxyphylline	hsa04740	Olfactory transduction	5137_81797	2	+	0.000184127996681809	0.0139937277478175
6381	proxyphylline	hsa04080	Neuroactive ligand-receptor interaction	7067_2901_2150	3	-	0.00273739115359918	0.110864341720767
6382	proxyphylline	hsa04740	Olfactory transduction	109	1	-	1.53469045410092e-07	1.24309926782175e-05
6383	proxyphylline	hsa05322	Systemic lupus erythematosus	8351_3013	2	-	0.0492041810367769	0.878717000571125
6384	proxyphylline	hsa04020	Calcium signaling pathway	109_6262_5534	3	-	0.0364893051660468	0.878717000571125
6385	homochlorcyclizine	hsa04740	Olfactory transduction	815_442194	2	+	0.0022865164297535	0.0846011079008795
6386	homochlorcyclizine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3113_8359_8294_8367_554313_8970_121504	16	+	7.81551209366443e-06	0.000578347894931168
6387	homochlorcyclizine	hsa04010	MAPK signaling pathway	785_2318_6655_4915_1846_4791_8912_8913_5322_5534_3310_5971_2247_9020	14	+	0.0400694168811504	0.988378949735043
6388	homochlorcyclizine	hsa04740	Olfactory transduction	818_5613	2	-	0.00112123119871375	0.0863348023009587
6389	homochlorcyclizine	hsa05322	Systemic lupus erythematosus	85235_3013_8330_8332_8969_8331_8329_8351_8336	9	-	0.0467033363632939	0.599359483328938
6390	homochlorcyclizine	hsa05221	Acute myeloid leukemia	1050_2475_6777_6199_6934	5	-	0.0396262494095866	0.599359483328938
6391	homochlorcyclizine	hsa04540	Gap junction	5613_7278_2767_113457_5331_2697_107	7	-	0.0277952105727837	0.535057803526086
6392	homochlorcyclizine	hsa04060	Cytokine-cytokine receptor interaction	3556	1	-	0.00800501143625471	0.308192940295806
6393	homochlorcyclizine	hsa04912	GnRH signaling pathway	5331_2002_5613_2767_5608_818_5603_107	8	-	0.0209426731134805	0.535057803526086
6394	chlorogenic acid	hsa04740	Olfactory transduction	157	1	-	0.0455978363991259	1
6395	betulinic acid	hsa04120	Ubiquitin mediated proteolysis	4193	1	+	0.00494730395816855	0.13687540950933
6396	betulinic acid	hsa05010	Alzheimer's disease	6868_4695_3708_6622	4	+	0.0352944525845467	0.585887912903475
6397	betulinic acid	hsa04740	Olfactory transduction	26211_5593_8390_5566_26692	5	+	1.09081826008282e-05	0.000905379155868741
6398	betulinic acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8341_3126_8370_8359_554313_121504_3119_2215_2214_3117_3113_8970	22	+	0.000234327314345428	0.00972458354533526
6399	betulinic acid	hsa05310	Asthma	3117_3113_3126_3119_3565	5	+	0.0465215815925046	0.64354854536298
6400	betulinic acid	hsa05012	Parkinson's disease	4695_6622	2	+	0.024863188378644	0.515911158856863
6401	betulinic acid	hsa05332	Graft-versus-host disease	3107_5551	2	-	0.0273294007171093	0.248594488189693
6402	betulinic acid	hsa05320	Autoimmune thyroid disease	3107_5551	2	-	0.0411842353236052	0.258872336319804
6403	betulinic acid	hsa04930	Type II diabetes mellitus	5581_5602	2	-	0.030883011872681	0.248594488189693
6404	betulinic acid	hsa04912	GnRH signaling pathway	3708_23236_5602	3	-	0.0271984077686005	0.248594488189693
6405	betulinic acid	hsa05330	Allograft rejection	3107_5551	2	-	0.0228719552036909	0.248594488189693
6406	betulinic acid	hsa04270	Vascular smooth muscle contraction	3708_23236_5581	3	-	0.0338992483895036	0.248594488189693
6407	betulinic acid	hsa04940	Type I diabetes mellitus	3107_5551	2	-	0.0296789557373416	0.248594488189693
6408	amantadine	hsa04740	Olfactory transduction	818_393046_1179_157	4	+	0.00118063170230003	0.0956311678863024
6409	amantadine	hsa05322	Systemic lupus erythematosus	3119_3013_940_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	13	+	0.0105118256658506	0.425728939466949
6410	amantadine	hsa03450	Non-homologous end-joining	27343_2547_3981	3	+	0.027010519777622	0.729284033995794
6411	amantadine	hsa04930	Type II diabetes mellitus	8651_8660	2	-	0.0487972948957775	1
6412	primaquine	hsa05332	Graft-versus-host disease	3123_355_3126_3127_3125	5	+	0.0281358782532307	0.317270914457963
6413	primaquine	hsa04640	Hematopoietic cell lineage	960_2812_3690_3123_3568_3126_3127_3125	8	+	0.0231969273203208	0.317270914457963
6414	primaquine	hsa05010	Alzheimer's disease	355	1	+	0.0236012620406186	0.317270914457963
6415	primaquine	hsa05016	Huntington's disease	1212_246721	2	+	0.0499901759588151	0.367502099870577
6416	primaquine	hsa04740	Olfactory transduction	23538_1179	2	+	8.79938194105053e-05	0.00321177440848344
6417	primaquine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_8335_3126_3127_3125_8359_8294_8367_554313_8368_121504_8354	20	+	2.27628347175736e-06	0.000166168693438287
6418	primaquine	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0347694152830644	0.317270914457963
6419	primaquine	hsa05330	Allograft rejection	3123_355_3126_3127_3125	5	+	0.0198693069303086	0.317270914457963
6420	primaquine	hsa04940	Type I diabetes mellitus	3123_355_3126_3127_3125	5	+	0.0329777162281873	0.317270914457963
6421	primaquine	hsa04640	Hematopoietic cell lineage	3673_960_3566_3552	4	-	0.000869637937004286	0.0114295271720563
6422	primaquine	hsa05010	Alzheimer's disease	776_5594_842_351_2776_4137_5663_3709_23385_489_509_5332_22926_801_23236_808_805_3710	18	-	0.00762720967266499	0.0701703289885179
6423	primaquine	hsa04080	Neuroactive ligand-receptor interaction	5029_5618_7442_4157_7068_7067_1131_5025_4886_3354_1909_2690_9170	13	-	1.69443985166631e-08	5.19628221177668e-07
6424	primaquine	hsa05016	Huntington's disease	4899_6874_842_5978_1639_64764_5439_246721_2776_3092_1387_2033_23186_509_5332_1385_548644_23236	18	-	0.00285121346098587	0.0327889548013375
6425	primaquine	hsa04740	Olfactory transduction	157_5613_5616_808_409_801_805	7	-	2.78982725892291e-21	2.56664107820908e-19
6426	primaquine	hsa04514	Cell adhesion molecules (CAMs)	2734_4685_3108_999_3106_3107_4897_4756_3135_5819_1365_5792_3105_9019_5817	15	-	0.0434125514871747	0.330692729252221
6427	primaquine	hsa05310	Asthma	3108	1	-	0.0497571377928726	0.330692729252221
6428	primaquine	hsa05012	Parkinson's disease	2861_7327_51465_842_509	5	-	4.38088867144119e-06	0.000100760439443147
6429	primaquine	hsa04260	Cardiac muscle contraction	476_7171_776_10479_27092	5	-	0.00516611397369862	0.0528091650644748
6430	primaquine	hsa04060	Cytokine-cytokine receptor interaction	5618_3566_3552_3460_3459_5154_3572_6387_4982_90_2690_659	12	-	1.79159500773087e-09	8.241337035562e-08
6431	primaquine	hsa03010	Ribosome	6187_6234_440589	3	-	2.44865270625133e-05	0.000450552097950245
6432	primaquine	hsa04020	Calcium signaling pathway	3709_776_3710_5025_5613_1131_5336_5616_2776_115_808_489_1909_5332_801_23236_490_3707_805_493	20	-	0.0122115847343869	0.102133254142145
6433	primaquine	hsa04610	Complement and coagulation cascades	7035	1	-	0.000113857849118892	0.00174582035315634
6434	naringenin	hsa05010	Alzheimer's disease	3708_776_355_489	4	+	0.00732478267754308	0.123056348982724
6435	naringenin	hsa04660	T cell receptor signaling pathway	5163_4772	2	+	0.0239928223502155	0.287913868202586
6436	naringenin	hsa05016	Huntington's disease	7052_246721_3708	3	+	0.00127435839950524	0.0356820351861467
6437	naringenin	hsa04740	Olfactory transduction	26211_7932_5613_5566_5616_4991_816	7	+	3.68956995328964e-06	0.00030992387607633
6438	naringenin	hsa04510	Focal adhesion	596_5829_2317_2324_3685_1277_3690	7	+	0.0387184099340358	0.325234643445901
6439	naringenin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3109_8969_8370_8332_8359_8330_8331_8336_554313_6738_121504_85235_3113	24	+	0.000571884188637661	0.0240191359227818
6440	naringenin	hsa05212	Pancreatic cancer	596	1	+	0.0205936799688781	0.287913868202586
6441	naringenin	hsa05215	Prostate cancer	596	1	+	0.031497061770906	0.293972576528456
6442	naringenin	hsa05012	Parkinson's disease	6570_9627	2	+	0.0060387952410377	0.123056348982724
6443	naringenin	hsa04620	Toll-like receptor signaling pathway	9641_7187	2	+	0.0482289063324061	0.368293466538374
6444	naringenin	hsa04260	Cardiac muscle contraction	776	1	+	0.0297557247883734	0.293972576528456
6445	naringenin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	1.8595933224075e-09	9.85584460875975e-08
6446	naringenin	hsa04210	Apoptosis	472_8837_651610_5534	4	-	0.0195982866465268	0.25967729806648
6447	naringenin	hsa04115	p53 signaling pathway	472_651610_3732_4193	4	-	0.00863813824129745	0.152607108929588
6448	naringenin	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00519340254704827	0.137625167496779
6449	meclocycline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8359_8370_8294_554313_121504	14	+	1.87013249748801e-11	6.91949024070564e-10
6450	carteolol	hsa04740	Olfactory transduction	26211_7932_23538_816_810_409	6	+	2.04684599984071e-08	1.82169293985823e-06
6451	carteolol	hsa04110	Cell cycle	472_8555	2	+	0.00601741927226086	0.198905773409263
6452	carteolol	hsa04370	VEGF signaling pathway	5880	1	+	0.0199618269947896	0.355320520507255
6453	carteolol	hsa05012	Parkinson's disease	6392_1339_651820	3	+	0.00670468899132346	0.198905773409263
6454	carteolol	hsa03010	Ribosome	140801_6165	2	+	0.016697471952337	0.355320520507255
6455	carteolol	hsa05211	Renal cell carcinoma	2271_5594_208_6655_405_5781_4233	7	-	0.00531009881532923	0.392947312334363
6456	carteolol	hsa04660	T cell receptor signaling pathway	5594_208_6655_867_5534_925_4793	7	-	0.0386734357973202	0.698911651056091
6457	carteolol	hsa04210	Apoptosis	3556_3553_841_208_5534_598	6	-	0.0430519042128922	0.698911651056091
6458	carteolol	hsa05220	Chronic myeloid leukemia	5594_598_6655_867_5781_208	6	-	0.0218547360500231	0.698911651056091
6459	digitoxigenin	hsa05211	Renal cell carcinoma	8503_6654_2271_5594_208_6655_7042_201163_405_2033_1398_10000_1387_3725_3082	15	+	0.00444453547139469	0.0782238242965465
6460	digitoxigenin	hsa04080	Neuroactive ligand-receptor interaction	1081_7068_2908_4886_2150_5644	6	+	0.000121455753919716	0.00356270211497834
6461	digitoxigenin	hsa05016	Huntington's disease	1213_4713_1639_3708_2033_23186_509_1387	8	+	0.034192976295469	0.334331323777919
6462	digitoxigenin	hsa04740	Olfactory transduction	26212_5568	2	+	3.74157373450308e-12	3.29258488636271e-10
6463	digitoxigenin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8349_8329_8294_121504_8343_8347_8346_8345_8344_8339_723790_8969_8968_8370_92815_8358_8359_8330_8331_8336_8337_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3012_3013	44	+	6.38946433179418e-11	2.81136430598944e-09
6464	digitoxigenin	hsa04350	TGF-beta signaling pathway	4092_4088_92_1634_5594_3397_3399_3398_7057_5519_3400_4090_2033_7042_6198_1387_5515	17	+	0.00536064709610478	0.0786228240762034
6465	digitoxigenin	hsa04010	MAPK signaling pathway	10000_8649_5534_6722_4763_5494_5495_3164_5609_11221_4616_5568_1850_6788_1398_10746_23118_4214_208_6789_7042_3725_3727_5594_1843_6655_6654_1649_1846_1845_8912_11072_2005_2353_1386	35	+	0.0426395898202947	0.375228390418593
6466	digitoxigenin	hsa04260	Cardiac muscle contraction	481	1	+	0.0139308202794596	0.153239023074056
6467	digitoxigenin	hsa03010	Ribosome	140801	1	+	0.0030507919090035	0.067117421998077
6468	digitoxigenin	hsa04020	Calcium signaling pathway	5568_8912_3708_5534_490_2065	6	+	0.00986057015143317	0.123961453332303
6469	digitoxigenin	hsa04650	Natural killer cell mediated cytotoxicity	10451_6452_5295_355_5336	5	-	0.00942333200265744	0.0559117698824341
6470	digitoxigenin	hsa04640	Hematopoietic cell lineage	960_3566_2057	3	-	0.045752854750619	0.197283147704903
6471	digitoxigenin	hsa05010	Alzheimer's disease	841_8772_317_355_3709_5664_810_7132	8	-	0.011295239748049	0.0628297710985226
6472	digitoxigenin	hsa04080	Neuroactive ligand-receptor interaction	56288_5618_7442_2150_4157	5	-	6.94539288097724e-07	3.09069983203487e-05
6473	digitoxigenin	hsa04670	Leukocyte transendothelial migration	10451_5295_7430_5336	4	-	0.0091918896839118	0.0559117698824341
6474	digitoxigenin	hsa05016	Huntington's disease	5432_246721_841_5439_317_5978_548644_5481	8	-	0.00479720272325074	0.0388137311244833
6475	digitoxigenin	hsa04740	Olfactory transduction	810_5613_5616_409	4	-	1.15414438718224e-12	1.02718850459219e-10
6476	digitoxigenin	hsa04514	Cell adhesion molecules (CAMs)	214	1	-	2.62575679748842e-05	0.000778974516588231
6477	digitoxigenin	hsa04510	Focal adhesion	10451_5295_4233_5154_2324	5	-	4.82744009996098e-05	0.00107410542224132
6478	digitoxigenin	hsa05322	Systemic lupus erythematosus	55766_3014	2	-	9.59088779404142e-05	0.00170717802733937
6479	digitoxigenin	hsa05212	Pancreatic cancer	5295_5154_3551	3	-	0.0325581937077759	0.168214856555812
6480	digitoxigenin	hsa05215	Prostate cancer	5295_5154_3551	3	-	0.0465499562000333	0.197283147704903
6481	digitoxigenin	hsa03410	Base excision repair	55247_143_4968_7515_27301_10038_4595_8930_23583	9	-	0.0359110367928137	0.168214856555812
6482	digitoxigenin	hsa04530	Tight junction	5519_2036_9223_51776_56288	5	-	0.0093322944864179	0.0559117698824341
6483	digitoxigenin	hsa04512	ECM-receptor interaction	960	1	-	0.00282744948443332	0.0251643004114565
6484	digitoxigenin	hsa04810	Regulation of actin cytoskeleton	7454_5295_10451_5154_1445_7430_3985_200576	8	-	0.000599318670748422	0.00598180747792784
6485	digitoxigenin	hsa05012	Parkinson's disease	317_5481	2	-	0.000204619557188602	0.0030351900982976
6486	digitoxigenin	hsa04060	Cytokine-cytokine receptor interaction	5618_7132_3566_2057_2324_5154_355_27242_4233_7048	10	-	0.000243560220591533	0.00309669423323521
6487	digitoxigenin	hsa03010	Ribosome	6137	1	-	0.000604901879790456	0.00598180747792784
6488	digitoxigenin	hsa03020	RNA polymerase	5432_64425_246721_548644_5439_55703_10621_10622_10623	9	-	0.00859176049443221	0.0559117698824341
6489	digitoxigenin	hsa04020	Calcium signaling pathway	5613_5616_7220_3709_113_5336_810_3707_5481_9630	10	-	0.0356339691199522	0.168214856555812
6490	buflomedil	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.012725668694589	0.194286022775918
6491	buflomedil	hsa04640	Hematopoietic cell lineage	3123_1378_3126_3127_3125	5	+	0.0356604300277015	0.336226911689757
6492	buflomedil	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	+	0.0260659432917528	0.286725376209281
6493	buflomedil	hsa05322	Systemic lupus erythematosus	8329_3123_3126_3127_3125_8969_8968_8358_8330_8331_8336_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013	22	+	1.28603656320112e-12	8.48784131712739e-11
6494	buflomedil	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.00434576915544892	0.143410382129814
6495	buflomedil	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.0092782205251874	0.194286022775918
6496	buflomedil	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	+	0.0147186380890847	0.194286022775918
6497	buflomedil	hsa05332	Graft-versus-host disease	3123_3107_3126_3127_3125	5	-	0.048912689389978	0.433744935291633
6498	buflomedil	hsa04662	B cell receptor signaling pathway	10725_10892_5605_4775_3845_3725_27071_4793	8	-	0.0249661265916887	0.39368389155192
6499	buflomedil	hsa05010	Alzheimer's disease	5663_517	2	-	0.036932652520056	0.39368389155192
6500	buflomedil	hsa04080	Neuroactive ligand-receptor interaction	1131_4886	2	-	0.00159008461492931	0.0445223692180207
6501	buflomedil	hsa04740	Olfactory transduction	219464_5567	2	-	9.35564050301184e-06	0.000392936901126497
6502	buflomedil	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3123_3126_3127_3125_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_8970_9555	27	-	3.30619784370139e-09	2.77720618870917e-07
6503	buflomedil	hsa04210	Apoptosis	3554_581_5567_331_472_51135_8737_8837_651610	9	-	0.0374937039573257	0.39368389155192
6504	buflomedil	hsa04060	Cytokine-cytokine receptor interaction	23765_3554_5154	3	-	0.00528554229321688	0.110996388157554
6505	buflomedil	hsa05330	Allograft rejection	3123_3107_3126_3127_3125	5	-	0.035195623303488	0.39368389155192
6506	bacampicillin	hsa05332	Graft-versus-host disease	3812_3122_3123_3126_3127_3125	6	+	0.0039065903612239	0.114642511972281
6507	bacampicillin	hsa05320	Autoimmune thyroid disease	3122_3123_3126_3127_3125	5	+	0.0364360914176381	0.449378460817537
6508	bacampicillin	hsa04740	Olfactory transduction	1179_816	2	+	0.000550856349552911	0.0407633698669154
6509	bacampicillin	hsa05310	Asthma	3122_3123_3126_3127_3125	5	+	0.00464766940428165	0.114642511972281
6510	bacampicillin	hsa05330	Allograft rejection	3122_3123_3126_3127_3125	5	+	0.0112164349644569	0.207504046842453
6511	bacampicillin	hsa04940	Type I diabetes mellitus	3122_3123_3126_3127_3125	5	+	0.0190579369846034	0.28205746737213
6512	bacampicillin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	5.1340886813644e-09	1.89961281210483e-07
6513	bacampicillin	hsa04115	p53 signaling pathway	472_651610_10912_581	4	-	0.0112240742890257	0.207645374346975
6514	Prestwick-983	hsa04740	Olfactory transduction	219464_442194	2	+	8.79207006818856e-05	0.00676989395250519
6515	Prestwick-983	hsa04070	Phosphatidylinositol signaling system	5331_51763_3631	3	-	0.0352700880837763	0.809353430388836
6516	Prestwick-983	hsa04512	ECM-receptor interaction	3914_1605_3675	3	-	0.0449054215733425	0.809353430388836
6517	nizatidine	hsa04740	Olfactory transduction	5593	1	+	0.000257068222455344	0.00925445600839239
6518	nizatidine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_717_8368_8359_8294_8367_554313_121504	15	+	5.00517140571459e-05	0.0036037234121145
6519	nizatidine	hsa05131	Shigellosis	7100_7278_113457	3	-	0.028724241178117	0.416501497082697
6520	nizatidine	hsa05130	Pathogenic Escherichia coli infection	7100_7278_113457	3	-	0.028724241178117	0.416501497082697
6521	spaglumic acid	hsa05219	Bladder cancer	7423_7422	2	+	0.0474795730227216	0.788495068707251
6522	epiandrosterone	hsa04740	Olfactory transduction	818_810_9635_8387_8388	5	+	0.000896750843914966	0.0717400675131973
6523	epiandrosterone	hsa03440	Homologous recombination	7517_5893_25788_10111	4	-	0.0464580411345532	0.702855830218344
6524	epiandrosterone	hsa04080	Neuroactive ligand-receptor interaction	3354_1812	2	-	0.00159312873685171	0.0387661325967249
6525	epiandrosterone	hsa04740	Olfactory transduction	810_109	2	-	9.35893006712594e-06	0.000683201894900194
6526	epiandrosterone	hsa05322	Systemic lupus erythematosus	8358_85235_8968_3013_8330_8332_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357	18	-	0.000196274459204755	0.00716401776097356
6527	dicloxacillin	hsa05211	Renal cell carcinoma	6655_405_7422_5781_1399_7042_3082	7	+	0.0151597318886909	0.128015513726723
6528	dicloxacillin	hsa05200	Pathways in cancer	6502_4088_1488_2335_3551_5599_331_6655_999_4193_4254_27006_405_7046_7422_1399_7042_2260_1017_7475_3082	21	+	0.00893728533686305	0.0970333836573703
6529	dicloxacillin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	0.000721506058259534	0.0182781534759082
6530	dicloxacillin	hsa04110	Cell cycle	1017_5111_4088_6502_699_4193_472_7027_7042_8556_651610	11	+	0.00374976248977137	0.047496991537104
6531	dicloxacillin	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_3551_5599_1839_6868_5781_5603_102_528	9	+	0.00122305534062777	0.0232380514719276
6532	dicloxacillin	hsa04115	p53 signaling pathway	1017_4194_7057_4193_472_651610	6	+	0.0369377855516225	0.255206518356665
6533	dicloxacillin	hsa04920	Adipocytokine signaling pathway	3551_948_5599_10645_5781_4793	6	+	0.032956614210076	0.250470267996578
6534	dicloxacillin	hsa04350	TGF-beta signaling pathway	656_4088_3624_6667_7057_5519_7046_7027_353500_7042_268	11	+	0.000367673658455171	0.0182781534759082
6535	dicloxacillin	hsa04912	GnRH signaling pathway	2778_4214_1432_5599_6655_1839_2776_8681_5603_5338_100137049_23236	12	+	0.000586746639053894	0.0182781534759082
6536	dicloxacillin	hsa04730	Long-term depression	2778_10672_2776_5519_8681_100137049_23236	7	+	0.014204614576691	0.128015513726723
6537	dicloxacillin	hsa05220	Chronic myeloid leukemia	3551_4088_6655_4193_7046_5781_1399_7042_1488	9	+	0.00173059681383803	0.0263050715703381
6538	ergocalciferol	hsa05016	Huntington's disease	5439_246721_548644_842_55567	5	-	0.0301314875036288	0.679590191576512
6539	ergocalciferol	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00291231818059744	0.163089818113457
6540	cisapride	hsa05214	Glioma	4193_5290	2	+	0.0421274226273044	0.300416213840127
6541	cisapride	hsa05200	Pathways in cancer	3576_1613_5290_4193_8817_7480_2950	7	+	0.00118470803526124	0.0334709230093548
6542	cisapride	hsa05212	Pancreatic cancer	2950_4193_5290	3	+	0.0100965432972462	0.100965432972462
6543	cisapride	hsa05215	Prostate cancer	2950_4193_5290	3	+	0.0098004869454681	0.100965432972462
6544	cisapride	hsa03410	Base excision repair	27343_5111	2	+	0.0146429725511733	0.122024771259778
6545	cisapride	hsa05219	Bladder cancer	3576_1613_4193	3	+	0.00133883692037419	0.0334709230093548
6546	cisapride	hsa05218	Melanoma	8817_4193_5290	3	+	0.00554034802296921	0.0923391337161535
6547	cisapride	hsa03022	Basal transcription factors	2967_51616_728198	3	-	0.0216992108754495	1
6548	puromycin	hsa05010	Alzheimer's disease	836_9451_5663_22926_56901_1339_7124	7	+	0.0374069963923949	0.364136200747305
6549	puromycin	hsa04080	Neuroactive ligand-receptor interaction	5618_2846_2908_2901_5030_2561_2798_7067_7433	9	+	0.00498742947159795	0.149622884147939
6550	puromycin	hsa04740	Olfactory transduction	816	1	+	6.47581800326093e-13	5.82823620293484e-11
6551	puromycin	hsa04710	Circadian rhythm - mammal	8864_5187_9572_406_79365_8553	6	+	0.00248025090829257	0.111611290873166
6552	puromycin	hsa04062	Chemokine signaling pathway	2309_8503_5579_3718_113_4792_4793	7	+	0.0224050813257459	0.364136200747305
6553	puromycin	hsa04010	MAPK signaling pathway	1326_7042_6722_5607_3725_3304_3305_3303_11221_4616_836_4791_8911_10912_10125_4214_468_773_1956_4609_3310_7124_9020_1647_1848_5579_1843_1649_1844_8817_23162_5971_9693_7186	34	+	0.0392502729551183	0.364136200747305
6554	puromycin	hsa04260	Cardiac muscle contraction	1339	1	+	0.01383507894741	0.311289276316725
6555	puromycin	hsa04270	Vascular smooth muscle contraction	4659_5579_113	3	+	0.0250294070349024	0.364136200747305
6556	puromycin	hsa05131	Shigellosis	10092_7280_347733_7278_113457_203068_10383_10381	8	-	0.00992587540972552	0.104221691802118
6557	puromycin	hsa05130	Pathogenic Escherichia coli infection	10092_7280_347733_7278_113457_203068_10383_10381	8	-	0.00992587540972552	0.104221691802118
6558	puromycin	hsa04740	Olfactory transduction	5613_5616	2	-	2.05153538598288e-06	0.000172328972422562
6559	puromycin	hsa04510	Focal adhesion	5295_3912_3911	3	-	0.0195175293401453	0.182163607174689
6560	puromycin	hsa04210	Apoptosis	5295_598_839_317_23052_5616_355_5613_8717	9	-	0.0495696666677013	0.346987666673909
6561	puromycin	hsa03410	Base excision repair	10357_5111_5425_5427_2237_7374_3146_4968_3978_100130561	10	-	4.30050341900479e-05	0.00180621143598201
6562	puromycin	hsa03030	DNA replication	5111_4172_5425_5427_6117_2237_1763_3978	8	-	0.000902310405300378	0.0252646913484106
6563	puromycin	hsa04540	Gap junction	7280_347733_5613_7278_5616_113457_203068_10383_10381_2697_23236	11	-	0.00962435351925341	0.104221691802118
6564	puromycin	hsa03430	Mismatch repair	5425_3978_2956_6117_5111	5	-	0.00906284914707943	0.104221691802118
6565	puromycin	hsa04060	Cytokine-cytokine receptor interaction	355_23765_6387_4254	4	-	0.00776864142218607	0.104221691802118
6566	puromycin	hsa04020	Calcium signaling pathway	5613_5616_23236	3	-	0.0364130804052255	0.305869875403894
6567	puromycin	hsa05222	Small cell lung cancer	3912_3911_9134_898_598_5295_317_8554_6502	9	-	0.0445247071046182	0.340006854253448
6568	serotonin	hsa05332	Graft-versus-host disease	3123_941_3126_3127_3125	5	+	0.0252919480590874	0.363478897599833
6569	serotonin	hsa04740	Olfactory transduction	81797	1	+	1.73563979496164e-05	0.000694255917984656
6570	serotonin	hsa04514	Cell adhesion molecules (CAMs)	965_3123_3126_3127_3125_5818_23308_4359_9672_941	10	+	0.0384223741193085	0.384223741193085
6571	serotonin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_941_2209	31	+	8.86140953465464e-14	7.08912762772371e-12
6572	serotonin	hsa04115	p53 signaling pathway	581_4194_317_4193_7057_472_651610	7	+	0.0184346801969661	0.363478897599833
6573	serotonin	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0318044035399854	0.363478897599833
6574	serotonin	hsa05330	Allograft rejection	3123_941_3126_3127_3125	5	+	0.0178034441164596	0.363478897599833
6575	serotonin	hsa04940	Type I diabetes mellitus	3123_941_3126_3127_3125	5	+	0.029691825466915	0.363478897599833
6576	serotonin	hsa04740	Olfactory transduction	26212	1	-	0.000175878773742148	0.0126632717094347
6577	serotonin	hsa04060	Cytokine-cytokine receptor interaction	5155_4233	2	-	0.0259445726634191	0.934004615883088
6578	dinoprost	hsa05016	Huntington's disease	23236	1	+	0.0465994222969066	0.827139745770092
6579	dinoprost	hsa04740	Olfactory transduction	818_26212	2	+	0.00170123695221489	0.0603939118036286
6580	dinoprost	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_3119	15	+	6.25545203109216e-05	0.00444137094207543
6581	dinoprost	hsa04060	Cytokine-cytokine receptor interaction	3589_3572	2	+	0.025840628751862	0.611561547127401
6582	dinoprost	hsa05322	Systemic lupus erythematosus	85235_8969_8332_8330_8331_8329_8336	7	-	0.00072808155509795	0.0218424466529385
6583	dinoprost	hsa04360	Axon guidance	55558_1949_2048_2049	4	-	0.0448087345870319	0.672131018805478
6584	vinblastine	hsa04640	Hematopoietic cell lineage	933_3673_925_1604	4	+	0.0423584724020781	0.532506510197553
6585	vinblastine	hsa04080	Neuroactive ligand-receptor interaction	1241_1269_5733_5618_7434_2150_2901_56288_9170	9	+	9.39590565480472e-06	0.000413419848811408
6586	vinblastine	hsa04740	Olfactory transduction	219464_5613_5566_5616_109_5137	6	+	2.35652272892799e-13	2.07374000145663e-11
6587	vinblastine	hsa04260	Cardiac muscle contraction	27092_9167_488	3	+	0.0229160004321343	0.403321607605564
6588	vinblastine	hsa04060	Cytokine-cytokine receptor interaction	5618_3459_3460_3576_5154_3627_3572_355_655_7422_8718_1896_268_51330_6376	15	+	0.00173964782331911	0.0510296694840272
6589	vinblastine	hsa03010	Ribosome	6125_9349_6141	3	+	0.00421858219685637	0.0928088083308401
6590	vinblastine	hsa04020	Calcium signaling pathway	5613_5566_5616_3709_5533_3708_109_5733_488_5137_23236_493	12	+	0.0279279883699087	0.409610496091994
6591	vinblastine	hsa05332	Graft-versus-host disease	3123_3107_3126_3127_3125_355	6	-	0.0435650565686503	0.340844888473793
6592	vinblastine	hsa04080	Neuroactive ligand-receptor interaction	4889_1081_3354_7067_6915_728	6	-	0.0183911447583801	0.22882297866584
6593	vinblastine	hsa05320	Autoimmune thyroid disease	1081_3123_3107_3126_3127_3125_355	7	-	0.0422183258780629	0.340844888473793
6594	vinblastine	hsa05131	Shigellosis	7280_7277_347733_7278_3688_113457_203068_10383_10381	9	-	0.00793068311026732	0.134821612874544
6595	vinblastine	hsa05130	Pathogenic Escherichia coli infection	7280_7277_347733_7278_3688_113457_203068_10383_10381	9	-	0.00793068311026732	0.134821612874544
6596	vinblastine	hsa04740	Olfactory transduction	818_219464_26212_157	4	-	6.13410410113315e-06	0.000260699424298159
6597	vinblastine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8294_121504_8343_8347_8346_8344_8339_3123_3126_3127_3125_8968_8370_8358_8359_8335_8350_8351_8352_8353_8354_8355_8356_8357_3012_3013	36	-	5.44536330628189e-12	4.62855881033961e-10
6598	vinblastine	hsa04540	Gap junction	7280_7277_347733_6655_113457_3709_203068_1956_10383_10381_6714_7278_23236	13	-	0.00728544669778411	0.134821612874544
6599	vinblastine	hsa04620	Toll-like receptor signaling pathway	6772	1	-	0.0451279921208915	0.340844888473793
6600	vinblastine	hsa04060	Cytokine-cytokine receptor interaction	2057_8771_3572_7852_355_1956	6	-	0.0188442453018927	0.22882297866584
6601	vinblastine	hsa05330	Allograft rejection	3123_3107_3126_3127_3125_355	6	-	0.0299880354954742	0.318622877139413
6602	metixene	hsa04740	Olfactory transduction	5137	1	+	6.08159613691952e-09	4.98690883227401e-07
6603	metixene	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_8970	26	+	2.37468267742335e-06	9.73619897743574e-05
6604	metixene	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8336_8329	7	-	0.000160050343960375	0.0083226178859395
6605	metixene	hsa04620	Toll-like receptor signaling pathway	148022_8503_5603	3	-	0.0476716223866124	0.67280321120142
6606	fluoxetine	hsa04710	Circadian rhythm - mammal	8553_9572	2	+	0.0280682538713914	0.661472220490438
6607	fluoxetine	hsa04920	Adipocytokine signaling pathway	32_6257_1375_4793	4	+	0.0367484566939132	0.661472220490438
6608	fluoxetine	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0185130580400191	0.661472220490438
6609	fluoxetine	hsa05214	Glioma	5296_5155_5154	3	-	0.00803560164851381	0.168850665460302
6610	fluoxetine	hsa05131	Shigellosis	7278_113457	2	-	0.048122416114372	0.24061208057186
6611	fluoxetine	hsa04670	Leukocyte transendothelial migration	5296_7409_50848	3	-	0.0400053984841733	0.24061208057186
6612	fluoxetine	hsa05130	Pathogenic Escherichia coli infection	7278_113457	2	-	0.048122416114372	0.24061208057186
6613	fluoxetine	hsa04510	Focal adhesion	5296_7409_5155_5154	4	-	0.0382206374247885	0.24061208057186
6614	fluoxetine	hsa05212	Pancreatic cancer	5296_5155_5154	3	-	0.0181787762293745	0.181787762293745
6615	fluoxetine	hsa05215	Prostate cancer	5296_5155_5154	3	-	0.0176608458842933	0.181787762293745
6616	fluoxetine	hsa05218	Melanoma	5296_5155_5154	3	-	0.0101310399276181	0.168850665460302
6617	fluoxetine	hsa04810	Regulation of actin cytoskeleton	5296_7409_5155_5154	4	-	0.0459677376710033	0.24061208057186
6618	fluoxetine	hsa04540	Gap junction	113457_7278_5155_5154_23236	5	-	0.000305768407661441	0.0152884203830721
6619	Trolox C	hsa04740	Olfactory transduction	26211	1	+	0.00371544187378938	0.115178698087471
6620	Trolox C	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_6737_9103_8359_8330_8294_8367_554313_121504	17	+	7.92965727290184e-08	4.91638750919914e-06
6621	Trolox C	hsa04810	Regulation of actin cytoskeleton	10298_624_2934_5155_5880_10552_8976_2335_2149_3675	10	+	0.0351628408128696	0.726698710132638
6622	Trolox C	hsa05010	Alzheimer's disease	3708_5534	2	-	0.00309572012438966	0.110938382516845
6623	Trolox C	hsa04080	Neuroactive ligand-receptor interaction	7434_56288_1812_4886_7068	5	-	0.00421284996899411	0.110938382516845
6624	Trolox C	hsa04910	Insulin signaling pathway	8660_2475_3551_2872_5599_5613_9470_8503_5140_6009_23433_5834_3845_51763_1399_5566	16	-	0.0208618323945795	0.247673031284863
6625	Trolox C	hsa05016	Huntington's disease	5432_3708_7419	3	-	0.00711013137160555	0.14042509458921
6626	Trolox C	hsa04740	Olfactory transduction	219464_5613_5566	3	-	3.27721492747913e-07	2.58899979270851e-05
6627	Trolox C	hsa04360	Axon guidance	2050_2042_5364_1808_10725_54910_9475_6387_3845_64218_5534_6092_4233_5998_7869_3983	16	-	0.0114876553998642	0.181504955317854
6628	Trolox C	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_4067_3551_5599_8992_5335_5781_5603_3725_4233	10	-	0.0250808132946697	0.247673031284863
6629	Trolox C	hsa04664	Fc epsilon RI signaling pathway	8503_1432_8399_5581_5599_3845_5603_5335_81579_4067	10	-	0.03550486551478	0.311653819518624
6630	Trolox C	hsa05012	Parkinson's disease	7419_5413	2	-	0.0249529356436522	0.247673031284863
6631	Trolox C	hsa04060	Cytokine-cytokine receptor interaction	2057_8742_8741_6387_9180_7042_93_4233	8	-	0.0460306518397504	0.363642149534028
6632	clorsulon	hsa04070	Phosphatidylinositol signaling system	23533_51806_3709_8821_5290_3707	6	+	0.00785059943958117	0.525990162451938
6633	clorsulon	hsa04012	ErbB signaling pathway	1839_27_56924_5290_23533	5	+	0.0459242098973917	0.713652767228801
6634	clorsulon	hsa04930	Type II diabetes mellitus	23533_776_5290_5581	4	+	0.0199000976944394	0.66665327276372
6635	clorsulon	hsa04912	GnRH signaling pathway	51806_776_4323_1839_3709_5566	6	+	0.0344019478255983	0.713652767228801
6636	etamivan	hsa05211	Renal cell carcinoma	7422_7423_5293_7042	4	+	0.0163229121956932	0.376226108153916
6637	etamivan	hsa05219	Bladder cancer	1956_7423_7422	3	+	0.019801374113364	0.376226108153916
6638	etamivan	hsa04150	mTOR signaling pathway	7423_5293_5562_7422	4	+	0.00568194214840451	0.323870702459057
6639	etamivan	hsa05332	Graft-versus-host disease	3123_3107_3126_3127_3125	5	-	0.00194391243542625	0.0410074527283694
6640	etamivan	hsa04640	Hematopoietic cell lineage	3123_4254_3126_3127_3125	5	-	0.0314005112793662	0.297585106519565
6641	etamivan	hsa05320	Autoimmune thyroid disease	3123_3107_3126_3127_3125	5	-	0.00490411634774659	0.0572146907237102
6642	etamivan	hsa04612	Antigen processing and presentation	3123_3107_3126_3127_3125	5	-	0.0340097264593788	0.297585106519565
6643	etamivan	hsa05322	Systemic lupus erythematosus	55506_85235_3012_3123_3126_3127_3125_8332_8969_8331_8336_8335_8329_8330	14	-	1.88634038882923e-06	0.000132043827218046
6644	etamivan	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.0038416575584957	0.0537832058189398
6645	etamivan	hsa05330	Allograft rejection	3123_3107_3126_3127_3125	5	-	0.00129743517150091	0.0410074527283694
6646	etamivan	hsa04940	Type I diabetes mellitus	3123_3107_3126_3127_3125	5	-	0.00234328301304968	0.0410074527283694
6647	cyclizine	hsa05332	Graft-versus-host disease	3105_3106_3126_3127_3125_3135_3123_649853	8	+	2.21208614902924e-05	0.000604896116792687
6648	cyclizine	hsa04640	Hematopoietic cell lineage	2057_3123_3126_3127_3125_920_931	7	+	0.00734919439228175	0.0651303868850586
6649	cyclizine	hsa05320	Autoimmune thyroid disease	3105_3106_3126_3127_3125_3135_3123_649853	8	+	9.66464586739156e-05	0.00147385849477721
6650	cyclizine	hsa04612	Antigen processing and presentation	3123_3106_3126_3127_3125_3135_3105_920_649853	9	+	0.000561232887182906	0.00684704122363145
6651	cyclizine	hsa04740	Olfactory transduction	26539_5613	2	+	0.00973812372536636	0.0660028385830387
6652	cyclizine	hsa04514	Cell adhesion molecules (CAMs)	3123_3106_3126_3127_3125_3135_3105_920_649853	9	+	0.0075085032619318	0.0651303868850586
6653	cyclizine	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.00854169008328638	0.0651303868850586
6654	cyclizine	hsa05330	Allograft rejection	3105_3106_3126_3127_3125_3135_3123_649853	8	+	1.16800086455718e-05	0.000604896116792687
6655	cyclizine	hsa04940	Type I diabetes mellitus	3105_3106_3126_3127_3125_3135_3123_649853	8	+	2.974898935046e-05	0.000604896116792687
6656	cyclizine	hsa05214	Glioma	5578_6464_5155_5154_5290_5925_1956_5335	8	-	0.000403258578349183	0.0130175884813326
6657	cyclizine	hsa04070	Phosphatidylinositol signaling system	8871_5578_8394_5290_5333_5335	6	-	0.0153654259934209	0.0710195277262971
6658	cyclizine	hsa05211	Renal cell carcinoma	2271_6513_5155_5290_3725	5	-	0.0407564574536343	0.124041392250191
6659	cyclizine	hsa04662	B cell receptor signaling pathway	6850_5290_8519_5533_5881_933_3725_27071_4793	9	-	0.000209482328153277	0.0130175884813326
6660	cyclizine	hsa04080	Neuroactive ligand-receptor interaction	7067	1	-	0.0226931992911724	0.0857265291526409
6661	cyclizine	hsa05200	Pathways in cancer	23604_2308_4149_2335_3911_5578_5599_6513_5155_5154_5290_5925_5881_1956_5335_2271_3725_898_8324_2260	20	-	0.000557896649199967	0.0130175884813326
6662	cyclizine	hsa04520	Adherens junction	7454_5881_1956_6714_25945_2260	6	-	0.019037784812114	0.0783908786381165
6663	cyclizine	hsa04740	Olfactory transduction	157	1	-	0.00116602335056337	0.0163243269078872
6664	cyclizine	hsa04510	Focal adhesion	2335_3911_5578_5599_6464_5155_5154_5290_5881_1956_394_3725_6714	13	-	0.00293657321971784	0.0228400139311388
6665	cyclizine	hsa04710	Circadian rhythm - mammal	1454_9572_5187	3	-	0.00648369134818733	0.0412598540339194
6666	cyclizine	hsa05212	Pancreatic cancer	2308_898_5155_5154_5290_5925_1956_2260	8	-	0.0026176320106339	0.0228400139311388
6667	cyclizine	hsa05215	Prostate cancer	2308_898_5155_5154_5290_5925_1956_2260	8	-	0.00245260251343141	0.0228400139311388
6668	cyclizine	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_1956_5335_3725_6714_50848	6	-	0.0115060794075121	0.0619558121942959
6669	cyclizine	hsa04664	Fc epsilon RI signaling pathway	6850_5578_5599_5290_5881_5606_5335	7	-	0.00514699674124729	0.036028977188731
6670	cyclizine	hsa04370	VEGF signaling pathway	5578_5290_5533_5881_5335_6714	6	-	0.0162330349088679	0.0710195277262971
6671	cyclizine	hsa05218	Melanoma	5155_5154_5290_5925_1956_2260	6	-	0.0115060794075121	0.0619558121942959
6672	cyclizine	hsa04920	Adipocytokine signaling pathway	5599_6794_6513_1375_4793	5	-	0.0318087004729006	0.106029001576335
6673	cyclizine	hsa04012	ErbB signaling pathway	5578_5599_6464_5290_1956_5335_3725_6714	8	-	0.00229584016933528	0.0228400139311388
6674	cyclizine	hsa05223	Non-small cell lung cancer	5925_1956_5335_5290_5578	5	-	0.0146791207465232	0.0710195277262971
6675	cyclizine	hsa04010	MAPK signaling pathway	57551_4149_5578_5599_1847_5155_5154_5881_4137_5533_5607_1956_5606_5536_3725_2260_4763	17	-	0.000807494063177503	0.0141311461056063
6676	cyclizine	hsa04540	Gap junction	5578_5155_5154_5607_1956_6714	6	-	0.0349872104915402	0.111322942473082
6677	cyclizine	hsa05210	Colorectal cancer	5599_5290_5881_1956_3725_8324	6	-	0.0232686293414311	0.0857265291526409
6678	cyclizine	hsa05222	Small cell lung cancer	4149_2335_3911_898_5290_5925	6	-	0.0256035376977765	0.0896123819422177
6679	tubocurarine chloride	hsa04740	Olfactory transduction	26212	1	+	0.000257068222455344	0.0185089120167848
6680	tubocurarine chloride	hsa05322	Systemic lupus erythematosus	3013_3014_8358_88_8968_8350_8351_8352_8353_8354_8355_8356_8357	13	+	0.00056981763197135	0.0205134347509686
6681	tubocurarine chloride	hsa04512	ECM-receptor interaction	7148_961_3910_5649_1290_1291	6	+	0.0442236640854262	0.787646927165741
6682	tubocurarine chloride	hsa04080	Neuroactive ligand-receptor interaction	56288	1	-	0.03359651606225	1
6683	tubocurarine chloride	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8970_121504	15	-	5.09677477804422e-06	0.000321096811016786
6684	tetracaine	hsa04740	Olfactory transduction	1179	1	+	0.00520657650434988	0.270741978226194
6685	tetracaine	hsa05014	Amyotrophic lateral sclerosis (ALS)	5600_834_5608	3	-	0.0232808720351943	0.504381682024688
6686	tetracaine	hsa04010	MAPK signaling pathway	57551_2122_3552_4763_5600_3164_5608	7	-	0.0264668530011274	0.504381682024688
6687	tetracaine	hsa04912	GnRH signaling pathway	3708_6714_5608_5600	4	-	0.029098943193732	0.504381682024688
6688	parthenolide	hsa04080	Neuroactive ligand-receptor interaction	2912_2908_2150_680_728	5	+	0.00223120900466313	0.045092316395035
6689	parthenolide	hsa04612	Antigen processing and presentation	3448_3117_3804_3106_3135_6892_3133_3310_1385_3304_3305_3303	12	+	0.0201781317539473	0.181603185785526
6690	parthenolide	hsa05016	Huntington's disease	1385_27113_4695_842_4728	5	+	0.045442178750042	0.357432177610098
6691	parthenolide	hsa04740	Olfactory transduction	810_26539_7932_8390	4	+	6.8466186693867e-07	5.54576112220323e-05
6692	parthenolide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_723790_8364_8370_8366_3117_3013_8365_554313_8368_8359_8348_8337_8367_8351_8970_121504_8294	21	+	0.00131053636647228	0.0417152451590847
6693	parthenolide	hsa04530	Tight junction	24146	1	+	0.00334017158481741	0.045092316395035
6694	parthenolide	hsa05219	Bladder cancer	2277_1026_1029_1613_4193_5228_1950_1890_7422	9	+	0.00313689469497909	0.045092316395035
6695	parthenolide	hsa04115	p53 signaling pathway	1647_27113_5366_2810_1029_4193_3732_842_1026_8795_4616	11	+	0.00836062770501792	0.0967444063009216
6696	parthenolide	hsa04062	Chemokine signaling pathway	6359_6358_10235_6773	4	+	0.0144444888400044	0.146250449505045
6697	parthenolide	hsa05012	Parkinson's disease	4695_842_4728	3	+	0.048540172268038	0.357432177610098
6698	parthenolide	hsa04020	Calcium signaling pathway	810_8877	2	+	0.0015450090799661	0.0417152451590847
6699	parthenolide	hsa03440	Homologous recombination	10714_5425_7156_6742_5890_7516_5424	7	-	0.0366378673785175	0.404385668468135
6700	parthenolide	hsa04080	Neuroactive ligand-receptor interaction	5029_1269_4157_4886_3354_136_2149	7	-	4.80862978517475e-05	0.00142656016960184
6701	parthenolide	hsa05016	Huntington's disease	5432_4714_6875_3708_509	5	-	0.000554825676356102	0.0123448712989233
6702	parthenolide	hsa04740	Olfactory transduction	801_109_805_808	4	-	5.74819463266329e-12	5.11589322307033e-10
6703	parthenolide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_6632_8344_8339_3123_3126_3127_3125_8968_55766_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113	37	-	2.77190600320763e-06	0.00012334981714274
6704	parthenolide	hsa05110	Vibrio cholerae infection	109	1	-	0.0408929327664406	0.404385668468135
6705	parthenolide	hsa04062	Chemokine signaling pathway	5295_4067_5580_6777_6387_7852_10451_109_107_8976	10	-	0.0357772028674162	0.404385668468135
6706	parthenolide	hsa05012	Parkinson's disease	4714_2861_509	3	-	0.0016124802176302	0.0287021478738176
6707	parthenolide	hsa04260	Cardiac muscle contraction	776_4635	2	-	0.0225196901491234	0.33404207054533
6708	prenylamine	hsa04070	Phosphatidylinositol signaling system	8871_1608_3710_5579_8394_8396_3631_5331_27124	9	+	0.0442010068806365	0.626278460047916
6709	prenylamine	hsa04080	Neuroactive ligand-receptor interaction	3269_2358_5030_1081_1812	5	+	0.0107165751144972	0.307208486615586
6710	prenylamine	hsa05200	Pathways in cancer	598_5602_330_3725_3673_652671_4149_5371_5900_650_7472_23604_11186_6469_51384_4609_836_4791_4792_1436_1284_1026_5579_861_8817_7189_7422_2353	28	+	0.0399841123039462	0.626278460047916
6711	prenylamine	hsa04740	Olfactory transduction	81697_26212_157_409	4	+	1.31059177140974e-05	0.000563554461706188
6712	prenylamine	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_8335_8349_8348_8329_8294_121504_8343_8347_8352_8345_8344_959_8339_723790_8366_8346_8969_8968_3108_8370_8362_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_7124_8353_8354_8355_8356_8357_8332_85235_83740_3012_3013_8970	52	+	3.38920925074447e-23	2.91471995564024e-21
6713	prenylamine	hsa04010	MAPK signaling pathway	4763_5602_3725_3164_11221_4616_836_4149_10912_409_5607_4609_3310_7124_4791_1647_1848_5579_1843_1649_1846_8817_7189_2353_5971	25	+	0.0239658422129397	0.515265607578204
6714	prenylamine	hsa04080	Neuroactive ligand-receptor interaction	2561_136_9170	3	-	0.019847019571494	0.387016881644133
6715	prenylamine	hsa04740	Olfactory transduction	219464_5613_157	3	-	0.000353028317690486	0.013768104389929
6716	prenylamine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_88_8294_720_721_121504_8367	17	-	0.000133484559324025	0.0104117956272739
6717	prenylamine	hsa04060	Cytokine-cytokine receptor interaction	3554	1	-	0.000823380570163293	0.0214078948242456
6718	mesalazine	hsa04740	Olfactory transduction	26211_817_390892	3	+	1.41562847492413e-05	0.000594563959468135
6719	mesalazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8342_8347_8346_8344_3109_8370_718_8359_8337_554313_121504_8339_3119	24	+	1.24560745303648e-06	0.000104631026055064
6720	mesalazine	hsa04540	Gap junction	2911_1813_6655_113457_3709_5607_1956_113_7278_23236	10	+	0.0307891597088373	0.862096471847444
6721	mesalazine	hsa04070	Phosphatidylinositol signaling system	8871_1040_8394_8396_3633_3631_808_801_5286_8527_805_23236	12	-	0.0418697855786664	0.253268084515637
6722	mesalazine	hsa04080	Neuroactive ligand-receptor interaction	2550_5029_152_4889_4158_2925_1909	7	-	0.000883750091335149	0.0397687541100817
6723	mesalazine	hsa04612	Antigen processing and presentation	3106	1	-	0.0144274049565604	0.162308305761305
6724	mesalazine	hsa05016	Huntington's disease	5435_7157_3064_513_9519_517_23236	7	-	0.0287481896459656	0.199025928318223
6725	mesalazine	hsa04740	Olfactory transduction	801_2979_805_808	4	-	2.30193591509887e-09	2.07174232358898e-07
6726	mesalazine	hsa05322	Systemic lupus erythematosus	3014_87_94239_6634	4	-	0.0184185495521414	0.163341792097465
6727	mesalazine	hsa04110	Cell cycle	5591_890_8243_5347_4085_4087_7157_699_472_1869_10926_7043_7042_7529_51343_651610_4999_9978	18	-	0.0217789056129954	0.163341792097465
6728	mesalazine	hsa03022	Basal transcription factors	2966_2961_9519_6880_6877_51616_6872_728198	8	-	0.0190205467934062	0.163341792097465
6729	mesalazine	hsa04630	Jak-STAT signaling pathway	3601_3459_3596_3572	4	-	0.00984703566128756	0.156339862311667
6730	mesalazine	hsa04010	MAPK signaling pathway	5595_5062_7157_2002_5532_3845_2249_7043_7042_5058_9693	11	-	0.0123858310943706	0.159246399784765
6731	mesalazine	hsa05012	Parkinson's disease	513_51465_517	3	-	0.0093507119973032	0.156339862311667
6732	mesalazine	hsa04620	Toll-like receptor signaling pathway	5595	1	-	0.00451816774996881	0.135545032499064
6733	mesalazine	hsa04260	Cardiac muscle contraction	6548	1	-	0.020633298658015	0.163341792097465
6734	mesalazine	hsa04060	Cytokine-cytokine receptor interaction	3601_3596_2324_3459_27242_3572_657_7043_7042_8795	10	-	0.0104226574874445	0.156339862311667
6735	mesalazine	hsa04610	Complement and coagulation cascades	5054	1	-	0.0422113474192729	0.253268084515637
6736	hydrastine hydrochloride	hsa05332	Graft-versus-host disease	3105_3106_3111_941_3135_649853	6	+	0.00289110834546155	0.0520052655236775
6737	hydrastine hydrochloride	hsa05320	Autoimmune thyroid disease	1081_3105_3106_3111_941_3135_649853	7	+	0.00197297999435057	0.0480091798625305
6738	hydrastine hydrochloride	hsa05016	Huntington's disease	4899	1	+	0.0476582300995481	0.386561199696335
6739	hydrastine hydrochloride	hsa04740	Olfactory transduction	51806_5566_816	3	+	0.00549729624427448	0.0668837709720062
6740	hydrastine hydrochloride	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_9103_3111_941_8359_8294_8367_554313_121504	17	+	6.09095711372556e-06	0.000444639869301966
6741	hydrastine hydrochloride	hsa04020	Calcium signaling pathway	51806_3710_5566_51196_2925_5724_8913_1956_113_5733_1910_816	12	+	0.0170880374121042	0.17820381872623
6742	hydrastine hydrochloride	hsa04912	GnRH signaling pathway	51806_3710_1081_5566_2002_1956_113_816	8	+	0.0227791773768317	0.207859993563589
6743	hydrastine hydrochloride	hsa05330	Allograft rejection	3105_3106_3111_941_3135_649853	6	+	0.00183746755892674	0.0480091798625305
6744	hydrastine hydrochloride	hsa04940	Type I diabetes mellitus	3105_3106_3111_941_3135_649853	6	+	0.00356200448792312	0.0520052655236775
6745	hydrastine hydrochloride	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_4067_5599_1432_102_3725_6714_5781	8	-	0.00430647465640221	0.163646036943284
6746	hydrastine hydrochloride	hsa04912	GnRH signaling pathway	1432_5599_5613_50487_5616_808_109_3725_6714_801_805	11	-	0.0018318383743929	0.13921971645386
6747	laudanosine	hsa04540	Gap junction	1813_7278_113457_5156_5331_2977	6	+	0.00330866710267579	0.211754694571251
6748	laudanosine	hsa04740	Olfactory transduction	818	1	-	2.72187150779305e-05	0.00209584106100065
6749	laudanosine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	0.00135893385658413	0.052318953478489
6750	laudanosine	hsa05212	Pancreatic cancer	5170_596_5296_208_4193_5154_2033_6934	8	-	0.020841770627682	0.320963267666303
6751	laudanosine	hsa05215	Prostate cancer	5170_596_5296_208_4193_5154_2033_6934	8	-	0.0197042947885533	0.320963267666303
6752	laudanosine	hsa04150	mTOR signaling pathway	6794_5170_5296_208_6009_9706	6	-	0.0158561406468576	0.320963267666303
6753	laudanosine	hsa04060	Cytokine-cytokine receptor interaction	355_5154_8795	3	-	0.0270497578212051	0.347138558705466
6754	thioridazine	hsa05332	Graft-versus-host disease	3811_3552_3821_3117_3123_3107_3126_3127_3111_3802_3135_3133_3125_3569	14	+	0.0330217783706319	0.295578507914529
6755	thioridazine	hsa04120	Ubiquitin mediated proteolysis	10277_4214_7318_7322_868_5371_330_4193_83737_9820_8651_23221	12	+	0.0254757552150918	0.292971184973556
6756	thioridazine	hsa04640	Hematopoietic cell lineage	3570_3676_3675_3554_3552_2057_3123_3126_3127_3125_931_3581_2812_960_1436_966_1435_3566_947_3569_1604_3684_920_924	24	+	0.0396612576343191	0.304069641863113
6757	thioridazine	hsa05010	Alzheimer's disease	6622_6390_317_9451_4137_5331_5532_3708_3709_489_348_23236	12	+	0.000756434415555256	0.0173979915577709
6758	thioridazine	hsa04740	Olfactory transduction	26211_26692_5566_8390_442194_818_5137_816	8	+	2.06480709476629e-17	1.89962252718499e-15
6759	thioridazine	hsa04514	Cell adhesion molecules (CAMs)	2734_214_6383_8506_3127_22871_9672_3676_24146_3383_3123_3107_3126_3695_3125_25945_8516_1272_3135_6693_4359_3133_6402_965_4684_3117_947_3111_3684_920_923_1003_26047_5817	34	+	0.034437978167466	0.295578507914529
6760	thioridazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_8349_8348_8329_8294_121504_8343_8342_8341_8347_8346_8345_8344_8353_723790_3123_3126_3127_3125_8969_8968_8370_92815_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_8352_8339_8354_8355_8356_8357_8332_85235_3012_3013_3111_3117_8970	55	+	1.00382045896987e-06	4.6175741112614e-05
6761	thioridazine	hsa04340	Hedgehog signaling pathway	5566_7472	2	+	0.0136818345941239	0.179818397522771
6762	thioridazine	hsa03022	Basal transcription factors	2967	1	+	0.035340908554998	0.295578507914529
6763	thioridazine	hsa04010	MAPK signaling pathway	9479_1326_2872_1649_50487_5881_6237_4763_10369_5602_9344_3304_3305_5609_3303_3725_4616_10000_4908_3554_4149_3552_1616_5566_4791_5871_2263_2247_408_4214_57551_8398_5598_9254_9252_998_5532_5536_3310_3727_81579_5971_3164_1848_1432_782_2318_5578_1843_1647_6655_1847_1846_4137_8817_6196_23162_2258_2353_1386_2251	61	+	0.0471239927346845	0.308505139412574
6764	thioridazine	hsa05012	Parkinson's disease	7318_5413_6390_317_7416_7419_6622	7	+	0.000436275334636691	0.0133791102621919
6765	thioridazine	hsa04260	Cardiac muscle contraction	6546_6262_782_9254_10369_4635	6	+	0.0464897549694856	0.308505139412574
6766	thioridazine	hsa03010	Ribosome	6187_140801_440589_6224_6144	5	+	0.00208214106324043	0.0383113955636239
6767	thioridazine	hsa03050	Proteasome	5689	1	+	0.00732843672418972	0.112369363104242
6768	thioridazine	hsa04080	Neuroactive ligand-receptor interaction	5029_151_5733_57105_64106_2925_3269_7434_3354_2798_10203_135_1909_9568_154_2690_2740_2561	18	-	0.000945332826782493	0.0289902066879965
6769	thioridazine	hsa05016	Huntington's disease	4899_842_841_6390_1329_317_5430_3092_55567_10126_517	11	-	0.000862768103155645	0.0289902066879965
6770	thioridazine	hsa04740	Olfactory transduction	219464_157_26532_5613_5616_2978_26333_5137_26476_109_816_810_409	13	-	2.63143365062522e-11	2.4209189585752e-09
6771	thioridazine	hsa04350	TGF-beta signaling pathway	4086_9475_1874_7057_656_655_652_653_353500_4091_9372_5519_3400_7042_91_6093_5308_3398_5934_5933_57154_83729	22	-	0.0298831163487098	0.392749529154472
6772	thioridazine	hsa05012	Parkinson's disease	7327_842_5413_6622_6390_1329_317_7345_9627_517_7332	11	-	0.0474664552183671	0.545864235011222
6773	thioridazine	hsa04260	Cardiac muscle contraction	27092_7168_1329_488	4	-	0.0155310920190436	0.285772093150402
6774	thioridazine	hsa04060	Cytokine-cytokine receptor interaction	5155_5154_9180_27242_3451_3553_3455_3570_655_8718_3601_3589_23765_4254_7042_91_4233_1435_8995_355_6372_83729_2690	23	-	0.0120209513659158	0.276481881416063
6775	thioridazine	hsa04610	Complement and coagulation cascades	1675_720_721	3	-	0.0212645569779698	0.32605654032887
6776	methapyrilene	hsa04080	Neuroactive ligand-receptor interaction	1131_2908_2555_9170	4	-	0.0147950656177875	0.272273103800116
6777	methapyrilene	hsa04740	Olfactory transduction	5566	1	-	3.39026298900368e-07	1.42391045538155e-05
6778	methapyrilene	hsa04510	Focal adhesion	5296_3655_5881	3	-	0.0273303092152777	0.382624329013888
6779	methapyrilene	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8342_3123_3126_3127_3125_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235	26	-	4.97951865159117e-08	4.18279566733658e-06
6780	methapyrilene	hsa04370	VEGF signaling pathway	5296_11261_5605_10725_5881_4775_3845_5336_6300	9	-	0.0162067323690545	0.272273103800116
6781	methapyrilene	hsa04060	Cytokine-cytokine receptor interaction	23529_3601_4254_2057	4	-	0.0106748966634868	0.272273103800116
6782	PHA-00745360	hsa04916	Melanogenesis	5568_7306_2776_816	4	+	0.0327281497805613	0.28557677090261
6783	PHA-00745360	hsa04120	Ubiquitin mediated proteolysis	7337_5371_26091_8453_8450_26272_5071	7	+	0.0356970963628262	0.28557677090261
6784	PHA-00745360	hsa04640	Hematopoietic cell lineage	1378_7850_3552	3	+	0.0323791931134402	0.28557677090261
6785	PHA-00745360	hsa05010	Alzheimer's disease	6392_651820_2081_317_2776_5533_3709_489_824_4842	10	+	0.034967540651308	0.28557677090261
6786	PHA-00745360	hsa05016	Huntington's disease	1213_1211_581_7052_651820_317_2776_6392_7416	9	+	0.010588041635813	0.270008245353286
6787	PHA-00745360	hsa04740	Olfactory transduction	26211_26212_7932_5568_56656_8388_8387_135948_1179_26476_2979_816	12	+	1.8394604015806e-07	1.61872515339093e-05
6788	PHA-00745360	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8294_121504_3586_8968_8370_8358_8359_8335_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_729	29	+	0.00419582181727967	0.184616159960305
6789	PHA-00745360	hsa04110	Cell cycle	995_1029_1021_1870_7042	5	+	0.0318022446856106	0.28557677090261
6790	PHA-00745360	hsa04630	Jak-STAT signaling pathway	3593_10000_3586_3953_3446_5293_5781_10379	8	+	0.0329584091442898	0.28557677090261
6791	PHA-00745360	hsa05012	Parkinson's disease	6392_651820_317_7345_7416_5071	6	+	0.0221150369931746	0.28557677090261
6792	PHA-00745360	hsa04260	Cardiac muscle contraction	7169_4635_783	3	+	0.0446873475754506	0.30249896820305
6793	PHA-00745360	hsa03010	Ribosome	6129_6181_6144	3	+	0.012273102061513	0.270008245353286
6794	PHA-00745360	hsa05217	Basal cell carcinoma	324	1	+	0.0402432222114454	0.295116962883933
6795	betulin	hsa04740	Olfactory transduction	26212_816	2	+	0.0375022123370983	0.937555308427457
6796	betulin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	2.84074347605072e-06	0.000142037173802536
6797	betulin	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	-	0.00670057072886694	0.086940863181653
6798	betulin	hsa04640	Hematopoietic cell lineage	3123_1435_3126_3127_3125	5	-	0.0176038000775757	0.107383180473212
6799	betulin	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	-	0.0141191326854297	0.0956963437568013
6800	betulin	hsa04520	Adherens junction	4088_6714_10458_4233	4	-	0.0492533172287345	0.231111719304062
6801	betulin	hsa04740	Olfactory transduction	818	1	-	0.0224968487047365	0.124755251908084
6802	betulin	hsa04514	Cell adhesion molecules (CAMs)	24146_3688_3123_3126_3127_3125_6693	7	-	0.00855156031294948	0.086940863181653
6803	betulin	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5335_6714_4233_5603	4	-	0.0346894989957138	0.176338286561545
6804	betulin	hsa04664	Fc epsilon RI signaling pathway	100137049_8681_5335_5608_5603	5	-	0.0122606524088222	0.0934874746172693
6805	betulin	hsa04370	VEGF signaling pathway	9261_8681_5335_7422_5603_6714_100137049	7	-	0.000445597428867331	0.0271814431609072
6806	betulin	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.00221741389317698	0.0676311237418979
6807	betulin	hsa04912	GnRH signaling pathway	818_8681_5603_6714_100137049_5608	6	-	0.0111435403662025	0.0934874746172693
6808	betulin	hsa05330	Allograft rejection	3123_3126_3127_3125	4	-	0.00483472143330129	0.086940863181653
6809	betulin	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	-	0.00779024418518547	0.086940863181653
6810	pronetalol	hsa04660	T cell receptor signaling pathway	5532_29851_5588_4793	4	+	0.033613339015157	0.789913466856189
6811	pronetalol	hsa04360	Axon guidance	5532_1949_5880_27289_1944	5	+	0.0151377843553523	0.711475864701558
6812	pronetalol	hsa05332	Graft-versus-host disease	3105_3106_3126_3127_3125_3135_3123_649853	8	-	0.00409221978122733	0.0827193534024514
6813	pronetalol	hsa04080	Neuroactive ligand-receptor interaction	3953_7067_5030_1081_135	5	-	0.0106285932996465	0.139943145112012
6814	pronetalol	hsa05320	Autoimmune thyroid disease	1081_3105_3106_3126_3127_3125_3135_3123_649853	9	-	0.00466710511409341	0.0827193534024514
6815	pronetalol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_3123_3126_3127_3125_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013	36	-	2.02553318879061e-12	1.60017121914458e-10
6816	pronetalol	hsa03010	Ribosome	140801	1	-	0.044470325155338	0.439144460908963
6817	pronetalol	hsa04020	Calcium signaling pathway	2778_2776_135	3	-	0.0192105922533342	0.216805255430486
6818	pronetalol	hsa05330	Allograft rejection	3105_3106_3126_3127_3125_3135_3123_649853	8	-	0.00238847698755796	0.0827193534024514
6819	pronetalol	hsa04940	Type I diabetes mellitus	3105_3106_3126_3127_3125_3135_3123_649853	8	-	0.0052354021140792	0.0827193534024514
6820	sulfachlorpyridazine	hsa05332	Graft-versus-host disease	3126_3107_3113_3127_3125_3123	6	+	0.026742516163667	0.213940129309336
6821	sulfachlorpyridazine	hsa04640	Hematopoietic cell lineage	3123_3568_2993_3126_3127_3559_3125_3589_921_3684_925_3674	12	+	0.00277267536484704	0.0520769325331436
6822	sulfachlorpyridazine	hsa05320	Autoimmune thyroid disease	958_7252_3126_3107_3113_3127_3125_3123	8	+	0.0085192743778851	0.0766734694009659
6823	sulfachlorpyridazine	hsa04310	Wnt signaling pathway	6093	1	+	0.00722922908188622	0.0743577848422583
6824	sulfachlorpyridazine	hsa04740	Olfactory transduction	8392_157	2	+	1.40249863367009e-06	0.000100979901624246
6825	sulfachlorpyridazine	hsa04514	Cell adhesion molecules (CAMs)	8516_958_3384_3688_3123_4099_3107_3126_3127_3125_5818_51208_3684_925_3113_5817	16	+	0.00289316291850798	0.0520769325331436
6826	sulfachlorpyridazine	hsa05322	Systemic lupus erythematosus	958_85235_718_3123_715_8330_3126_3127_3125_8332_8290_8969_8331_8336_8329_3113	16	+	0.00476853581054457	0.063932837245796
6827	sulfachlorpyridazine	hsa05310	Asthma	958_3123_3126_3127_3125_3113_8288	7	+	0.00168411536689211	0.0520769325331436
6828	sulfachlorpyridazine	hsa05330	Allograft rejection	958_3113_3107_3126_3127_3125_3123	7	+	0.00532773643714967	0.063932837245796
6829	sulfachlorpyridazine	hsa04940	Type I diabetes mellitus	3126_3107_3113_3127_3125_3123	6	+	0.0319724359728335	0.230201539004401
6830	sulfachlorpyridazine	hsa05214	Glioma	5578_208_6655_4193_5336_810	6	-	0.036853826423075	0.684658246374358
6831	sulfachlorpyridazine	hsa04740	Olfactory transduction	810_26212_4991	3	-	0.000992293251634676	0.0803757533824088
6832	sulfachlorpyridazine	hsa05220	Chronic myeloid leukemia	3551_4088_208_6655_4193_1399_91	7	-	0.023916682144829	0.684658246374358
6833	citalopram	hsa04740	Olfactory transduction	26212_8390_56656	3	+	8.44565771868327e-05	0.00658761302057295
6834	citalopram	hsa04514	Cell adhesion molecules (CAMs)	5797_3107_6404_965_29851_3680_940_23114_23308_57502_933_26285_4099	13	+	0.0107024510729394	0.278263727896424
6835	citalopram	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_940_8359_8294_8367_554313_121504	15	+	0.00385760278719285	0.150446508700521
6836	citalopram	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8329_8294_8969_8370_8332_8359_8330_8331_8336_6737_121504_85235	22	-	2.76030398271082e-11	1.65618238962649e-09
6837	citalopram	hsa04370	VEGF signaling pathway	10725_100137049_8681_5335_208	5	-	0.0406787517782198	0.996343808110715
6838	withaferin A	hsa05332	Graft-versus-host disease	3553_3123_3107_3126_3127_3111_3125	7	+	0.0078941344057182	0.105255125409576
6839	withaferin A	hsa04640	Hematopoietic cell lineage	3553_3690_3123_3126_3570_3125_3589_1604_3127	9	+	0.0473053804824483	0.270316459899705
6840	withaferin A	hsa04612	Antigen processing and presentation	3123_3107_3126_3127_3111_3125_6892_3310_3304_3305_3303	11	+	0.00763701728102048	0.105255125409576
6841	withaferin A	hsa05016	Huntington's disease	317	1	+	0.00163541300542244	0.0436110134779317
6842	withaferin A	hsa04740	Olfactory transduction	81697_26529_816	3	+	1.40289260875621e-05	0.00112231408700497
6843	withaferin A	hsa04514	Cell adhesion molecules (CAMs)	965_8506_3123_3107_3126_3127_3685_3125_23308_51208_3111_26285_923_5817	14	+	0.0166190881139396	0.143098835101821
6844	withaferin A	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_2215_8370_8366_3123_3126_3127_3111_3125_8359_8294_8367_554313_8368_121504_8341_8364	21	+	3.38501761705569e-05	0.00135400704682228
6845	withaferin A	hsa05219	Bladder cancer	23604_2277_3576_5925_1950_7422	6	+	0.0250485360254935	0.166990240169957
6846	withaferin A	hsa04115	p53 signaling pathway	1647_5366_317_3479_7249_5268_5054_8795	8	+	0.0290035544594278	0.178483412058017
6847	withaferin A	hsa05310	Asthma	3123_3126_3127_3111_3125	5	+	0.023570801103468	0.166990240169957
6848	withaferin A	hsa04150	mTOR signaling pathway	2277_5170_3479_7249_5293_6196_7422_5563	8	+	0.00706458721583423	0.105255125409576
6849	withaferin A	hsa04010	MAPK signaling pathway	9479_1326_1847_3310_3304_3305_3303_4908_3553_2263_7046_1950_5534_3725_1647_5579_1843_5598_1649_1846_1845_8912_6196	23	+	0.0178873543877276	0.143098835101821
6850	withaferin A	hsa05330	Allograft rejection	3123_3107_3126_3127_3111_3125	6	+	0.0168732659255152	0.143098835101821
6851	withaferin A	hsa04940	Type I diabetes mellitus	3553_3123_3107_3126_3127_3111_3125	7	+	0.00981136625246247	0.112129900028143
6852	withaferin A	hsa05332	Graft-versus-host disease	5551_3126_3127_3123_3125	5	-	0.0356229428104666	0.40500662005613
6853	withaferin A	hsa04740	Olfactory transduction	51806	1	-	5.60600127383518e-06	0.000448480101906814
6854	withaferin A	hsa05322	Systemic lupus erythematosus	85235_3123_3126_3127_3125_8332_8969_8331_8336_8329_8330_55766	12	-	0.0211840238394352	0.40500662005613
6855	withaferin A	hsa04360	Axon guidance	9353_1949_2042_2043_6405_1944_6387_2048_23365_5534_57556	11	-	0.026702102502854	0.40500662005613
6856	withaferin A	hsa04530	Tight junction	9076	1	-	0.0455632447563146	0.40500662005613
6857	withaferin A	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.0423792929046818	0.40500662005613
6858	withaferin A	hsa05012	Parkinson's disease	2861	1	-	0.0455539346708327	0.40500662005613
6859	withaferin A	hsa05330	Allograft rejection	5551_3126_3127_3123_3125	5	-	0.0253476072181581	0.40500662005613
6860	withaferin A	hsa04940	Type I diabetes mellitus	5551_3126_3127_3123_3125	5	-	0.0415969880542076	0.40500662005613
6861	CP-320650-01	hsa05200	Pathways in cancer	596_1612_330_1488_3674_4149_3576_5371_2033_2249_4842_581_998_4193_7046_8453_8312_91_3725_1284_5599_6502_1029_3685_1387_2251	26	+	0.0245892461916777	0.221303215725099
6862	CP-320650-01	hsa04910	Insulin signaling pathway	5599_32_57818_8660_10211_810	6	+	0.00651869423868515	0.0977804135802773
6863	CP-320650-01	hsa05016	Huntington's disease	1213_4899_581_6392_651820_246721_5331_7350_3708_2033_1387_163	12	+	0.0217996408271017	0.217996408271017
6864	CP-320650-01	hsa04740	Olfactory transduction	26211_7932_26476_3000_810_816	6	+	5.46950334370951e-13	4.92255300933856e-11
6865	CP-320650-01	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8341_8347_8346_8344_8339_8968_8370_718_717_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3018_2215_3013_720_721_729	38	+	6.01444033206534e-05	0.0027064981494294
6866	CP-320650-01	hsa05221	Acute myeloid leukemia	5371	1	+	0.0191969768468723	0.215965989527313
6867	CP-320650-01	hsa04340	Hedgehog signaling pathway	8945	1	+	0.0183000115413243	0.215965989527313
6868	CP-320650-01	hsa05012	Parkinson's disease	6392_7345_651820_6531	4	+	0.000861118834607709	0.0258335650382313
6869	CP-320650-01	hsa04260	Cardiac muscle contraction	4635	1	+	0.00122526787103464	0.0275685270982794
6870	CP-320650-01	hsa03010	Ribosome	140801_6224_6144	3	+	0.00417535169444791	0.0751563305000624
6871	CP-320650-01	hsa05217	Basal cell carcinoma	8312	1	+	0.0278049125821279	0.227494739308319
6872	CP-320650-01	hsa04640	Hematopoietic cell lineage	3589_2057	2	-	0.0228817355335266	0.503398181737585
6873	CP-320650-01	hsa04080	Neuroactive ligand-receptor interaction	2550_5618_64106_2908_4886_3354_7067_9170	8	-	0.000250579741123977	0.011025508609455
6874	CP-320650-01	hsa04740	Olfactory transduction	818_5613_5616_816	4	-	1.94449235671469e-11	1.71115327390893e-09
6875	CP-320650-01	hsa05322	Systemic lupus erythematosus	94239_718_3014_3020_3021_8342	6	-	0.0298905049485099	0.526072887093774
6876	CP-320650-01	hsa04062	Chemokine signaling pathway	5970_2782_5829_5613_6655_5616_7852_208_10681_8976	10	-	0.045589587670693	0.573126245002998
6877	CP-320650-01	hsa03010	Ribosome	6187_440589	2	-	0.00812606347116824	0.238364528487602
6878	CP-320650-01	hsa04912	GnRH signaling pathway	2002_776_1432_8399_5578_5599_5613_6655_1839_5616_3709_818_3708_1956_2767_3725_6714_816	18	-	0.0389944352684227	0.571918383936866
6879	piribedil	hsa04520	Adherens junction	4301_4088_998_5797_5770_6714_2241	7	+	0.0476872632304665	0.870292553956014
6880	piribedil	hsa04740	Olfactory transduction	26211_26212_7932_8392_818_26476	6	+	0.0144282608296728	0.526631520283057
6881	piribedil	hsa05322	Systemic lupus erythematosus	717_3013_8358_8968_8341_8350_8351_8352_8353_8354_8355_8356_8357	13	+	0.00907734998465825	0.526631520283057
6882	piribedil	hsa04630	Jak-STAT signaling pathway	6776	1	+	0.0322573084680917	0.784927839390231
6883	piribedil	hsa04080	Neuroactive ligand-receptor interaction	2561_5618	2	-	0.00655521094587426	0.179175765853896
6884	piribedil	hsa04740	Olfactory transduction	818_409	2	-	0.000132086858594735	0.00541556120238413
6885	piribedil	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3123_8969_8370_8332_8359_8330_8331_8336_554313_6738_121504_85235	23	-	3.25033716350147e-08	2.66527647407121e-06
6886	fluvoxamine	hsa04740	Olfactory transduction	818	1	+	0.0471055774427457	0.644042160248319
6887	fluvoxamine	hsa04360	Axon guidance	6091_5532_8829_57556_2048	5	+	0.0486611823873638	0.644042160248319
6888	fluvoxamine	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	528_50617_1956_1432	4	+	0.0237635213943009	0.644042160248319
6889	fluvoxamine	hsa04940	Type I diabetes mellitus	3135_3107_3382	3	+	0.0308945320225961	0.644042160248319
6890	fluvoxamine	hsa05322	Systemic lupus erythematosus	85235_8330_3111_8332_8969_8331_8329_720_721_8336	10	-	0.0293577358943377	0.391405833602597
6891	fluvoxamine	hsa05212	Pancreatic cancer	5728_595_6655_5155_6934_1869_2260	7	-	0.0297835199415654	0.391405833602597
6892	fluvoxamine	hsa05215	Prostate cancer	5728_595_6655_5155_6934_1869_2260	7	-	0.028336040039125	0.391405833602597
6893	fluvoxamine	hsa04350	TGF-beta signaling pathway	4090_4088_9475_655_653_7042_57154	7	-	0.0269370215990315	0.391405833602597
6894	fluvoxamine	hsa04020	Calcium signaling pathway	2776	1	-	0.0321703424878847	0.391405833602597
6895	fluvoxamine	hsa05213	Endometrial cancer	5728_6655_595_6934_324	5	-	0.0316120819275467	0.391405833602597
6896	fluvoxamine	hsa05220	Chronic myeloid leukemia	595_4088_6655_1399_7042_1869	6	-	0.0400164283672262	0.41731418154393
6897	etofenamate	hsa05211	Renal cell carcinoma	3725_2549_998	3	+	0.0481494507881519	0.927659059430928
6898	etofenamate	hsa04660	T cell receptor signaling pathway	3725_27040_998_2353	4	+	0.0355822481049909	0.927659059430928
6899	etofenamate	hsa04740	Olfactory transduction	4991	1	-	0.000401513531624439	0.0122461627145454
6900	etofenamate	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	0.000146456077471123	0.0089338207257385
6901	5186223	hsa03440	Homologous recombination	5890_5892_5888	3	+	0.0425094633198815	0.517198470391892
6902	5186223	hsa03320	PPAR signaling pathway	335_2710_5170_5360_6319	5	+	0.040775367375998	0.517198470391892
6903	5186223	hsa04510	Focal adhesion	5170_3691_3693_1289_3685_9475_7410_3679_208_1291_10627	11	+	0.0254257578193766	0.476385917243537
6904	5186223	hsa04512	ECM-receptor interaction	3691_3693_1289_3685_3679_1291	6	+	0.0261033379311527	0.476385917243537
6905	5186223	hsa04810	Regulation of actin cytoskeleton	9459_3691_8396_3693_3685_9475_7410_3679_2263_2246_2261_2264_10627	13	+	0.00845293632045904	0.476385917243537
6906	5186223	hsa04060	Cytokine-cytokine receptor interaction	3953	1	+	0.0156551408022481	0.476385917243537
6907	5186223	hsa04120	Ubiquitin mediated proteolysis	8453_8554_7322	3	-	0.0151634054902633	0.288104704315003
6908	5186223	hsa04350	TGF-beta signaling pathway	4091_4090	2	-	0.04237117991002	0.385229925867774
6909	celastrol	hsa04612	Antigen processing and presentation	3135_3308_3310_3304_3305_3303	6	+	0.0406426660490277	0.489996747899652
6910	celastrol	hsa04710	Circadian rhythm - mammal	406_9572_79365_8553	4	+	0.000883350748846814	0.0202875967475756
6911	celastrol	hsa05219	Bladder cancer	1026_5228_4193_7422	4	+	0.0332562067373262	0.489996747899652
6912	celastrol	hsa04115	p53 signaling pathway	1647_1026_5366_4193_355_10912_5054_8795	8	+	0.000966076035598838	0.0202875967475756
6913	celastrol	hsa04010	MAPK signaling pathway	2353_2872_3164_1848_1843_1647_1847_1846_1844_8913_355_10912_1649_2005_3310_3304_3305_3303_8074	19	+	0.000289326826239485	0.0182275900530876
6914	celastrol	hsa04610	Complement and coagulation cascades	5054_728_2161_1604_2152	5	+	0.046666356942824	0.489996747899652
6915	celastrol	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	-	0.0296461203912429	0.251509486213916
6916	celastrol	hsa04640	Hematopoietic cell lineage	966_3123_3126_3127_3125_3655	6	-	0.0319960182324512	0.251509486213916
6917	celastrol	hsa05322	Systemic lupus erythematosus	3123_3125_3126_3017_3014_3127_8343_8339_8347_8346_8345_8344	12	-	0.000664931285902532	0.0492049151567874
6918	celastrol	hsa05212	Pancreatic cancer	207_3551_9134_3480_5295_1869_596	7	-	0.0115181286964837	0.170468304707959
6919	celastrol	hsa05215	Prostate cancer	207_3551_9134_3480_5295_1869_596	7	-	0.0109093596382058	0.170468304707959
6920	celastrol	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.0106823533395766	0.170468304707959
6921	celastrol	hsa04060	Cytokine-cytokine receptor interaction	3455	1	-	0.0158221910627452	0.195140356440524
6922	celastrol	hsa05330	Allograft rejection	3123_3126_3127_3125	4	-	0.0220020307975412	0.232592897002578
6923	celastrol	hsa05222	Small cell lung cancer	5295_3551_207_9134_6502_596_1869_3655	8	-	0.00277945273298921	0.102839751120601
6924	celastrol	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	-	0.033987768407286	0.251509486213916
6925	5286656	hsa05131	Shigellosis	7278_113457	2	+	0.00836880576855953	0.0585816403799167
6926	5286656	hsa05130	Pathogenic Escherichia coli infection	7278_113457	2	+	0.00836880576855953	0.0585816403799167
6927	5286656	hsa04540	Gap junction	7278_113457	2	+	0.0214227309876145	0.0999727446088677
6928	5286656	hsa05200	Pathways in cancer	2260_673_6934_5602	4	-	0.011815678773352	0.0498884214874862
6929	5286656	hsa04910	Insulin signaling pathway	673_5602_5509	3	-	0.00621888157992256	0.0393862500061762
6930	5286656	hsa04520	Adherens junction	2260_6934	2	-	0.0203146998440744	0.0643298828395689
6931	5286656	hsa05212	Pancreatic cancer	2260_6934_673	3	-	0.0018641248381595	0.0236122479500203
6932	5286656	hsa05215	Prostate cancer	2260_6934_673	3	-	0.0018065696916214	0.0236122479500203
6933	5286656	hsa05221	Acute myeloid leukemia	6934_673	2	-	0.0115883897756267	0.0498884214874862
6934	5286656	hsa05218	Melanoma	2260_673	2	-	0.0163155965904636	0.0563629700397833
6935	5286656	hsa05216	Thyroid cancer	6934_673	2	-	0.00309438887668032	0.029396694328463
6936	5286656	hsa04920	Adipocytokine signaling pathway	3717_5602	2	-	0.0146611745767673	0.0557124633917157
6937	5286656	hsa04012	ErbB signaling pathway	673_5602	2	-	0.0236801371359345	0.069218862397347
6938	5286656	hsa04010	MAPK signaling pathway	673_2260_5602_3925	4	-	0.00605921900730022	0.0393862500061762
6939	5286656	hsa05213	Endometrial cancer	6934_673	2	-	0.00916709723470294	0.0497642421312445
6940	5286656	hsa05210	Colorectal cancer	673_6934_5602	3	-	0.00158755215351027	0.0236122479500203
6941	5149715	hsa05216	Thyroid cancer	7849	1	+	0.0382793544930585	0.153117417972234
6942	5149715	hsa04010	MAPK signaling pathway	6789_7786_4137	3	-	0.0370708007911794	0.259495605538256
6943	5162773	hsa05016	Huntington's disease	246721_5439_548644_27113	4	-	0.0245195248836238	0.116467743197213
6944	5162773	hsa04110	Cell cycle	472_651610_5933_2810	4	-	0.00543178222787902	0.0344012874432338
6945	5162773	hsa04115	p53 signaling pathway	472_651610_2810_27113	4	-	0.000805896669784584	0.00765601836295355
6946	5162773	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.000801561152603652	0.00765601836295355
6947	pararosaniline	hsa04115	p53 signaling pathway	5366_1647_6477	3	+	0.0131138508792154	0.580217138071817
6948	pararosaniline	hsa04350	TGF-beta signaling pathway	7059_83729_3397	3	+	0.0236823321661966	0.580217138071817
6949	pararosaniline	hsa05200	Pathways in cancer	112399_9134_6502_5295_1857_652_2261	7	-	0.0128442378531243	0.484400866420423
6950	pararosaniline	hsa05222	Small cell lung cancer	6502_5295_9134	3	-	0.0285101249395545	0.484400866420423
6951	5152487	hsa05131	Shigellosis	7278_113457_347733	3	+	4.1183418000021e-05	0.000102958545000052
6952	5152487	hsa05130	Pathogenic Escherichia coli infection	7278_113457_347733	3	+	4.1183418000021e-05	0.000102958545000052
6953	5152487	hsa04540	Gap junction	7278_113457_347733	3	+	0.000176531467367806	0.000294219112279677
6954	5213008	hsa04010	MAPK signaling pathway	4214_355_5606_5922	4	+	0.00456352164380047	0.077579867944608
6955	5213008	hsa04912	GnRH signaling pathway	4214_5606	2	+	0.0303717978679738	0.258160281877777
6956	5213008	hsa04330	Notch signaling pathway	182_1857	2	-	0.0264392232952279	0.511532546266598
6957	5213008	hsa04630	Jak-STAT signaling pathway	3717_3601_2057_10379	4	-	0.00905382353781382	0.371206765050367
6958	5186324	hsa04010	MAPK signaling pathway	57551_355_5922	3	+	0.040689395932479	0.345186098915542
6959	5186324	hsa04062	Chemokine signaling pathway	7074_7409	2	-	0.0219076161548075	0.179879655743178
6960	5186324	hsa04810	Regulation of actin cytoskeleton	7074_7409	2	-	0.0276737931912582	0.179879655743178
6961	5114445	hsa04360	Axon guidance	10725_3985_6092_6091_5534	5	-	0.0199584747393848	0.45904491900585
6962	5114445	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00571995866419287	0.263118098552872
6963	nicotinic acid	hsa05332	Graft-versus-host disease	3113_3119	2	+	0.0402966914964459	0.237140006736681
6964	nicotinic acid	hsa04514	Cell adhesion molecules (CAMs)	6402_923_3113_3119	4	+	0.017719976278563	0.212164737777162
6965	nicotinic acid	hsa05322	Systemic lupus erythematosus	474382_474381_3119_83740_3113_8342	6	+	0.000738892073278967	0.0280778987846007
6966	nicotinic acid	hsa04360	Axon guidance	64221_4233_998_9901	4	+	0.0164761108954453	0.212164737777162
6967	nicotinic acid	hsa05310	Asthma	3113_3119	2	+	0.0223331302923328	0.212164737777162
6968	nicotinic acid	hsa05330	Allograft rejection	3113_3119	2	+	0.0338442544261615	0.237140006736681
6969	nicotinic acid	hsa04940	Type I diabetes mellitus	3113_3119	2	+	0.0436836854514939	0.237140006736681
6970	nicotinic acid	hsa05211	Renal cell carcinoma	3725_405_5290	3	-	0.0344000434083385	0.37209965170932
6971	nicotinic acid	hsa05322	Systemic lupus erythematosus	85235_718_8969_8332_8330_8331_8329_8336	8	-	9.49976381547742e-05	0.00522487009851258
6972	nicotinic acid	hsa04620	Toll-like receptor signaling pathway	7100_3725_5290_5602	4	-	0.0182469272275819	0.334526999172335
6973	nicotinic acid	hsa04930	Type II diabetes mellitus	8660_5290_5602	3	-	0.0105782063332278	0.290900674163764
6974	nicotinic acid	hsa05210	Colorectal cancer	3725_5290_5602	3	-	0.0498215804023981	0.37209965170932
6975	nicotinic acid	hsa04610	Complement and coagulation cascades	5265_2152_718	3	-	0.0310029701959639	0.37209965170932
6976	proscillaridin	hsa04080	Neuroactive ligand-receptor interaction	2550_2912_1081_1813_2563_2908_3360_5030_2692	9	+	0.0328752827275644	0.441031095837449
6977	proscillaridin	hsa05016	Huntington's disease	1212_3708_1387_2033_509	5	+	0.0187918387997066	0.389930655093912
6978	proscillaridin	hsa04740	Olfactory transduction	26212_9635_8392_5566	4	+	7.29033137555902e-08	3.02548752085699e-06
6979	proscillaridin	hsa04514	Cell adhesion molecules (CAMs)	9076_4950_3107	3	+	0.0361441380693443	0.441031095837449
6980	proscillaridin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8349_8329_8294_121504_8343_8342_8347_8346_8344_8339_723790_8969_8968_8370_92815_8358_8359_8330_8331_8336_8337_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_2215_2214_3012_3013	46	+	7.28663896718922e-15	6.04791034276705e-13
6981	proscillaridin	hsa04664	Fc epsilon RI signaling pathway	27040	1	+	0.0431212049314491	0.441031095837449
6982	proscillaridin	hsa05012	Parkinson's disease	6622_509	2	+	0.00881875325100683	0.243985506611189
6983	proscillaridin	hsa04260	Cardiac muscle contraction	481	1	+	0.0442645730376372	0.441031095837449
6984	proscillaridin	hsa04060	Cytokine-cytokine receptor interaction	1436_3589_3569_8795_7046_3977_7042_1489_92_51330	10	+	0.0478226489462294	0.441031095837449
6985	proscillaridin	hsa04650	Natural killer cell mediated cytotoxicity	836_5295_355_5290_10451_6452_7409_5336_2534	9	-	0.0284364645531753	0.145341929938452
6986	proscillaridin	hsa05010	Alzheimer's disease	836_841_8772_317_8883_5331_355_351_7132_23236	10	-	0.00399505869596825	0.0334132181844617
6987	proscillaridin	hsa04080	Neuroactive ligand-receptor interaction	7442_136	2	-	6.59262206526058e-12	3.03260615001987e-10
6988	proscillaridin	hsa05320	Autoimmune thyroid disease	355	1	-	0.0179018282462908	0.109797879910584
6989	proscillaridin	hsa05016	Huntington's disease	836_841_317_5331_9001_5481_23236	7	-	7.31856883234949e-05	0.00168327083144038
6990	proscillaridin	hsa04740	Olfactory transduction	818_5613_5616_157	4	-	1.52543804008185e-16	1.4034029968753e-14
6991	proscillaridin	hsa04514	Cell adhesion molecules (CAMs)	933_214_1365_57863_4099	5	-	0.00127169301316905	0.0149489262439607
6992	proscillaridin	hsa04510	Focal adhesion	5295_7409_596_83660_2324_5155_5154_5290_9475_10451_23396_3673_55742_4233_2534	15	-	0.0198514125475087	0.114145622148175
6993	proscillaridin	hsa05322	Systemic lupus erythematosus	55506_721_3021_3020_720_6737	6	-	0.00129990662990963	0.0149489262439607
6994	proscillaridin	hsa03410	Base excision repair	55247_143_5425_5427_4968_4913_10714_7515_27301_10038_4595_8930_23583	13	-	0.00568151091935268	0.0400320930043888
6995	proscillaridin	hsa04530	Tight junction	93643_50855_51776_1019_9223_27134_1365	7	-	0.0060918402397983	0.0400320930043888
6996	proscillaridin	hsa04512	ECM-receptor interaction	3673_960	2	-	0.00357831261393597	0.0329204760482109
6997	proscillaridin	hsa04630	Jak-STAT signaling pathway	3717_5295_3566_2057_598_6777_5290_6772_10379_4609_8835	11	-	0.0384761048731829	0.186305349912254
6998	proscillaridin	hsa05012	Parkinson's disease	836_317_5481	3	-	5.29249380756442e-05	0.00162303143431976
6999	proscillaridin	hsa04260	Cardiac muscle contraction	784	1	-	0.000526225949962934	0.00968255747931798
7000	proscillaridin	hsa04060	Cytokine-cytokine receptor interaction	1436_27242_3566_2057_2324_5155_5154_8741_8742_657_355_8718_8792_7132_4233_7048	16	-	0.000907089232460396	0.0139087015643927
7001	proscillaridin	hsa03010	Ribosome	6168_6137_9349	3	-	0.00200945299132784	0.0205410750224624
7002	proscillaridin	hsa04020	Calcium signaling pathway	5331_5256_5613_5616_818_136_113_5336_3707_5481_23236	11	-	0.00490872021672055	0.0376335216615242
7003	proscillaridin	hsa03050	Proteasome	23198	1	-	0.0258991600841858	0.140160160455594
7004	isoflupredone	hsa03450	Non-homologous end-joining	7518_3981_10111	3	+	0.0094830380088921	0.635363546595771
7005	sanguinarine	hsa05010	Alzheimer's disease	5532_3708	2	+	0.0181143121787415	0.24528468886739
7006	sanguinarine	hsa04080	Neuroactive ligand-receptor interaction	886_64106_5644_2568_2742_2688_1442_9568_2689_2914_2918_4887_3357_3351_6869_5733_7442_2555_2897_2892_8484_680	22	+	0.0127762186438684	0.24528468886739
7007	sanguinarine	hsa05016	Huntington's disease	3708	1	+	0.00240987830979817	0.0626568360547524
7008	sanguinarine	hsa04740	Olfactory transduction	26211_81797_8590_81696	4	+	0.000105471384170974	0.00411338398266799
7009	sanguinarine	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_554313_8362_8329_8294_121504_8366_8969_8968_8370_717_8358_8359_8330_8331_8336_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_83740_3117_3013	38	+	1.9320513607816e-15	1.50700006140965e-13
7010	sanguinarine	hsa04110	Cell cycle	7042	1	+	0.0455133262630222	0.394448827612859
7011	sanguinarine	hsa05012	Parkinson's disease	5413	1	+	0.0220127284880991	0.24528468886739
7012	sanguinarine	hsa04060	Cytokine-cytokine receptor interaction	8743_7852_7850_2829_2323_3554_3579_3574_3576_3558_2688_2689_650_6362_6367_3082_8771_3624_7042_3456_6357_3448	22	+	0.0201695428198794	0.24528468886739
7013	sanguinarine	hsa04950	Maturity onset diabetes of the young	5313_3170_3375_5080	4	+	0.0379228418510527	0.369747708047764
7014	sanguinarine	hsa04640	Hematopoietic cell lineage	960_2057_2993_4254_1604_3655	6	-	0.00980801075268838	0.0900916784071918
7015	sanguinarine	hsa05010	Alzheimer's disease	776_5594_841_5534_6390_509_2776_808_5663_51107_355_3709_6868_489_488_102_801_23236_805_3710	20	-	0.023748933356441	0.167060463730097
7016	sanguinarine	hsa04080	Neuroactive ligand-receptor interaction	1241_5618_3355_4157_7068_134_2908_2925_7434_3953_56288_7433_2690	13	-	1.67361153121087e-08	7.61493246700946e-07
7017	sanguinarine	hsa04612	Antigen processing and presentation	4801_3451_5993_3119_6890_3133	6	-	0.00710094618817402	0.0900916784071918
7018	sanguinarine	hsa04670	Leukocyte transendothelial migration	9076_8503_5578_5296_394_998_9475_1500_5781_5747_6093_5600	12	-	0.023865780532871	0.167060463730097
7019	sanguinarine	hsa05016	Huntington's disease	4899_51164_841_6390_3064_2776_23186_509_6874_23236	10	-	3.07325693227138e-06	9.32221269455652e-05
7020	sanguinarine	hsa04740	Olfactory transduction	26212_157_5613_5567_5616_808_818_109_801_805	10	-	1.20292601816661e-18	1.09466267653162e-16
7021	sanguinarine	hsa04514	Cell adhesion molecules (CAMs)	9076_2734_214_3119_4897_3685_23308_5792_3133_3655_25945_9019_5817	13	-	0.0167951982078188	0.138942094264683
7022	sanguinarine	hsa05310	Asthma	3119	1	-	0.0498370628585881	0.323940908580823
7023	sanguinarine	hsa05012	Parkinson's disease	7327_7332_6390_7345_51465_509_9627	7	-	7.35043229184841e-05	0.00133777867711641
7024	sanguinarine	hsa04260	Cardiac muscle contraction	776_6548_481_488	4	-	0.00177651853885292	0.026943864505936
7025	sanguinarine	hsa04060	Cytokine-cytokine receptor interaction	8792_5618_3451_2057_3454_3953_27242_6358_3572_91_355_7422_7042_8718_90_4254_6359_4233_7048_2690	20	-	1.0767002389397e-05	0.000244949304358782
7026	sanguinarine	hsa03010	Ribosome	9349_6137_6125_6168_439992_6160_6189_6171	8	-	0.008797933843906	0.0900916784071918
7027	sanguinarine	hsa04610	Complement and coagulation cascades	727_1604_4179_7035	4	-	0.00990018444035075	0.0900916784071918
7028	sulfamethizole	hsa05332	Graft-versus-host disease	3812_3824_3113_3107_3119	5	+	0.0165109252605139	0.586137846748244
7029	sulfamethizole	hsa04080	Neuroactive ligand-receptor interaction	2911_2901_7442_5540_11255_2890_4142_3355_2740_1268_9002_7433_680_6755_5644	15	+	0.0343421336994133	0.609572873164586
7030	sulfamethizole	hsa04612	Antigen processing and presentation	3812_3824_3809_3119_3805_3107_3113	7	+	0.0337402213380085	0.609572873164586
7031	sulfamethizole	hsa04740	Olfactory transduction	810	1	+	8.36278484608592e-05	0.005937577240721
7032	sulfamethizole	hsa03440	Homologous recombination	5890_8940_5893_25788	4	-	0.0181643750751535	0.460164168570555
7033	sulfamethizole	hsa04080	Neuroactive ligand-receptor interaction	7068	1	-	0.00357193614612691	0.135733573552823
7034	sulfamethizole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_94239_8366_8368_8294_121504_8367_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	26	-	2.46173547383915e-11	1.87091896011775e-09
7035	decamethonium bromide	hsa04120	Ubiquitin mediated proteolysis	7320	1	+	0.0480915972365668	0.949809045422194
7036	decamethonium bromide	hsa04740	Olfactory transduction	7932	1	+	2.50334864603717e-06	9.88822715184682e-05
7037	decamethonium bromide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_3018_85235_3119_1511	24	+	8.16218405030965e-08	6.44812539974462e-06
7038	decamethonium bromide	hsa05012	Parkinson's disease	4695	1	+	0.0465845473413447	0.949809045422194
7039	decamethonium bromide	hsa03440	Homologous recombination	5890_5425	2	-	0.0405160119399457	0.641975820116637
7040	decamethonium bromide	hsa04640	Hematopoietic cell lineage	3589_2993_3553_925_3675	5	-	0.00298722445748239	0.128450651671743
7041	noscapine	hsa04660	T cell receptor signaling pathway	6655_1432_5293_4793	4	+	0.0441069738331619	0.50163626326602
7042	noscapine	hsa05223	Non-small cell lung cancer	6789_6655_5293	3	+	0.0286799937218934	0.50163626326602
7043	noscapine	hsa04010	MAPK signaling pathway	2872_1432_3552_6789_6655_1843_5536_408	8	+	0.0168850273166836	0.50163626326602
7044	noscapine	hsa04620	Toll-like receptor signaling pathway	7097_3929_1432_5293_958	5	+	0.00819515068050539	0.50163626326602
7045	noscapine	hsa04080	Neuroactive ligand-receptor interaction	2908	1	-	0.0323288297744208	1
7046	noscapine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0352056766874895	1
7047	tomatidine	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	3.11585392213201e-11	1.02823179430356e-09
7048	tomatidine	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1956_836	2	+	0.0388519094615818	0.523549210936163
7049	tomatidine	hsa05010	Alzheimer's disease	776_5594_4712_5664_5533_355_5534	7	-	0.0121738301505082	0.159998910549536
7050	tomatidine	hsa04080	Neuroactive ligand-receptor interaction	5618_4886	2	-	2.16437523956836e-08	9.95612610201445e-07
7051	tomatidine	hsa04740	Olfactory transduction	5566_157	2	-	1.97134732548433e-13	1.81363953944558e-11
7052	tomatidine	hsa05322	Systemic lupus erythematosus	55506_6738_8348_8329_8343_8347_8346_8344_8339_3123_8969_8968_8358_8330_8331_8336_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3017_3014	29	-	0.000644844889943161	0.015583744777559
7053	tomatidine	hsa04512	ECM-receptor interaction	7059_960	2	-	0.0329654629932592	0.303282259537985
7054	tomatidine	hsa04062	Chemokine signaling pathway	5594_157_6655_6772_9475_5747_5566	7	-	0.00518737822037321	0.0954477592548671
7055	tomatidine	hsa05012	Parkinson's disease	2861_4712	2	-	0.000677554120763435	0.015583744777559
7056	tomatidine	hsa04260	Cardiac muscle contraction	776_481	2	-	0.0324685104535887	0.303282259537985
7057	tomatidine	hsa04060	Cytokine-cytokine receptor interaction	5618_5154_8741_3572_657_355_50616_8742_7040_7042_4254_4233	12	-	0.00666364560477377	0.102175899273198
7058	tomatidine	hsa03010	Ribosome	6204_6234_6203	3	-	0.0240670574959803	0.276771161203773
7059	tomatidine	hsa04020	Calcium signaling pathway	776_5256_5578_5566_5534_2767_5533_5336_493	9	-	0.039637572551102	0.331514243154671
7060	papaverine	hsa04130	SNARE interactions in vesicular transport	8417_10228_6844	3	+	0.00590438961893103	0.171227298949
7061	papaverine	hsa04080	Neuroactive ligand-receptor interaction	5618	1	-	0.000541265217796184	0.0405948913347138
7062	papaverine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_8359_8294_8367_554313_121504	15	-	0.00160943298268781	0.0603537368507929
7063	papaverine	hsa03020	RNA polymerase	246721_5439_548644_5441	4	-	0.0402623499454073	0.754919061476387
7064	papaverine	hsa04020	Calcium signaling pathway	5331	1	-	0.0113794390033726	0.284485975084315
7065	tetrahydroalstonine	hsa05332	Graft-versus-host disease	3135_3105_3106_3119_649853	5	+	4.38701805965504e-05	0.000753489993083024
7066	tetrahydroalstonine	hsa04650	Natural killer cell mediated cytotoxicity	3135_3105_3106_5534	4	+	0.0317438454872526	0.190463072923516
7067	tetrahydroalstonine	hsa05320	Autoimmune thyroid disease	3135_3105_3106_3119_649853	5	+	0.000121869717954726	0.00127963203852462
7068	tetrahydroalstonine	hsa04612	Antigen processing and presentation	3135_3105_3106_3119_649853	5	+	0.00115197823131576	0.00967661714305238
7069	tetrahydroalstonine	hsa04514	Cell adhesion molecules (CAMs)	3135_3105_3106_3119_649853	5	+	0.00628581952778077	0.0440007366944654
7070	tetrahydroalstonine	hsa04210	Apoptosis	472_651610_5534	3	+	0.0424579227294816	0.222904094329778
7071	tetrahydroalstonine	hsa05330	Allograft rejection	3135_3105_3106_3119_649853	5	+	2.82671951068531e-05	0.000753489993083024
7072	tetrahydroalstonine	hsa04940	Type I diabetes mellitus	3135_3105_3106_3119_649853	5	+	5.38207137916446e-05	0.000753489993083024
7073	tetrahydroalstonine	hsa04070	Phosphatidylinositol signaling system	5331_8394_51763_3707	4	-	0.0331137236083492	0.858888714318034
7074	tetrahydroalstonine	hsa04210	Apoptosis	472_5575_1677_651610_8837	5	-	0.0140087273137687	0.798497456884816
7075	arecoline	hsa04740	Olfactory transduction	818_5137	2	+	8.90276280290637e-05	0.00685512735823791
7076	arecoline	hsa04912	GnRH signaling pathway	5331_8398_3710_6655_3709_818_108_5337_5320_3725	10	+	0.0119581587794511	0.460389113008867
7077	arecoline	hsa04730	Long-term depression	2911_8398_3710_3480_5331_3709_5320	7	+	0.0249363134385589	0.640032044923012
7078	arecoline	hsa05131	Shigellosis	7278_6093_7430_113457	4	-	0.0167854504753102	0.341304159664641
7079	arecoline	hsa05130	Pathogenic Escherichia coli infection	7278_6093_7430_113457	4	-	0.0167854504753102	0.341304159664641
7080	arecoline	hsa03450	Non-homologous end-joining	27343_7518	2	-	0.0276741250073019	0.422030406361354
7081	arecoline	hsa04540	Gap junction	7278_113457_2776_3709_10746_6714	6	-	0.00571874819434468	0.341304159664641
7082	anisomycin	hsa04916	Melanogenesis	23236_4286_1856_10488_5332_2033_6934_8324_1906_1499_1387_1385_8323_7306	14	+	0.0353464910035824	0.14138596401433
7083	anisomycin	hsa04640	Hematopoietic cell lineage	1435_2057_3589_3569_3570_3684_3678_915_7124_1604_3675	11	+	0.0398173758501511	0.152633274092246
7084	anisomycin	hsa03320	PPAR signaling pathway	51703_7316_51_2170_5465_1376_1375_6257	8	+	0.0433348376595286	0.159472202587065
7085	anisomycin	hsa05010	Alzheimer's disease	22926_5533_4698_836_6622_6390_2081_9451_5663_5532_3708_3709_23385_5534_5332_6868_7124_348_4842_23236	20	+	0.000521039849582576	0.00684795230879957
7086	anisomycin	hsa04080	Neuroactive ligand-receptor interaction	2550_1241_7442_3355_1081_2917_3953_1131_2908_5025_799_7434_5021_7067_2741_5030_7433_624_7068_1909_623	21	+	3.55179290462639e-08	1.20469544571068e-06
7087	anisomycin	hsa05016	Huntington's disease	4899_246721_5332_23186_6875_10126_6908_5430_836_1639_5439_6667_10488_2033_55567_3708_548644_23236_51164_6390_4698_1385_1387	23	+	0.00109519419171486	0.0111953184041963
7088	anisomycin	hsa04740	Olfactory transduction	26212_1179_4991	3	+	2.45399105777822e-32	2.25767177315596e-30
7089	anisomycin	hsa04514	Cell adhesion molecules (CAMs)	9076_6385_3688_3383_23308_3105_3106_3107_3685_9080_3135_3134_1364_5817_22871_3133_3684_50848_649853	19	+	0.0301493139377239	0.137733336386167
7090	anisomycin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_8349_8348_8329_8294_8351_8343_8342_8341_8347_87_8345_8344_8353_723790_3021_3020_92815_8969_8968_8346_55766_8370_8352_8358_8359_8330_8331_8336_8337_8334_554313_8350_121504_7124_8339_8354_8355_8356_8357_8332_85235_85236_3012_3013_3017_3014_720_721_8970	59	+	0.000866228684478739	0.0099616298715055
7091	anisomycin	hsa04710	Circadian rhythm - mammal	8864_5187_8553_406_1408_1453_79365_1407_9572_8863	10	+	0.00715311894568445	0.05062207253869
7092	anisomycin	hsa03410	Base excision repair	27343_4595	2	+	0.0230270751447816	0.12461711254823
7093	anisomycin	hsa03030	DNA replication	1763	1	+	0.00579396425813183	0.0444203926456774
7094	anisomycin	hsa05110	Vibrio cholerae infection	535_7082_9414_55176_51606	5	+	0.0165793451299545	0.101686650130388
7095	anisomycin	hsa05310	Asthma	7124	1	+	0.0204079031325745	0.117345443012303
7096	anisomycin	hsa04062	Chemokine signaling pathway	8503_1147_5293_5290_7852_5332_2309_7454_4067_3551_3576_6363_4793_6364_3627_673_6093_4790_4792_23236_6352_6347_6774_6655_6654_6464_6358_6359_7409_5970_8976	31	+	0.0329362326140835	0.137733336386167
7097	anisomycin	hsa04810	Regulation of actin cytoskeleton	623_8503_6548_624_5155_5293_5290_3678_4636_23365_10458_4659_87_3675_7454_93408_7430_2249_7414_2263_2260_8394_1131_673_22800_6093_10093_3688_6655_6654_3685_3684_8817_7409_3985_8976	36	+	0.0306099257834703	0.137733336386167
7098	anisomycin	hsa05012	Parkinson's disease	7314_6390_836_6622_4698	5	+	3.92835471427396e-08	1.20469544571068e-06
7099	anisomycin	hsa04260	Cardiac muscle contraction	7171_481_6548	3	+	2.5851196689478e-05	0.000475662019086395
7100	anisomycin	hsa04060	Cytokine-cytokine receptor interaction	3459_5155_7852_4050_53832_3456_2057_3576_3570_3572_3953_3976_6363_27242_6364_3604_23529_3589_3624_3627_51561_7042_7124_92_8795_1435_6352_6347_3460_3569_1271_6358_6359_7424_7422_51330_7040	37	+	0.0014046734486708	0.0129229957277714
7101	anisomycin	hsa03010	Ribosome	6233_6203	2	+	1.21549228669298e-07	2.79563225939385e-06
7102	anisomycin	hsa04020	Calcium signaling pathway	623_5532_5261_624_5021_814_1131_5534_5025_3709_8911_5533_7220_3708_5332_1909_490_4842_23236	19	+	0.000107436445160442	0.00164735882579344
7103	anisomycin	hsa03050	Proteasome	5713_23198	2	+	0.00341999853381562	0.0286036241010034
7104	anisomycin	hsa04270	Vascular smooth muscle contraction	8398_100137049_4660_3709_673_27094_3708_8681_23365_1909_5332_6093_4659_23236	14	+	0.00781738075422485	0.051371359242049
7105	anisomycin	hsa05217	Basal cell carcinoma	6934_8324_1856_8323_1499	5	+	0.0318349742182974	0.137733336386167
7106	anisomycin	hsa02010	ABC transporters	23461_1244_6890	3	+	0.0245974556563443	0.125720328910204
7107	anisomycin	hsa04080	Neuroactive ligand-receptor interaction	5026_136_5031	3	-	0.0145114134371145	0.422810506736867
7108	anisomycin	hsa04740	Olfactory transduction	5613_5616	2	-	2.90104206906813e-05	0.0023208336552545
7109	anisomycin	hsa05322	Systemic lupus erythematosus	3123	1	-	0.0317473817462515	0.422810506736867
7110	anisomycin	hsa04210	Apoptosis	3554_596_5613_5295_317_23052_5616_355_8717	9	-	0.0162199286430325	0.422810506736867
7111	anisomycin	hsa04630	Jak-STAT signaling pathway	5295	1	-	0.0221318476406353	0.422810506736867
7112	anisomycin	hsa04810	Regulation of actin cytoskeleton	5881_5295_5154	3	-	0.0367915323963346	0.422810506736867
7113	anisomycin	hsa04060	Cytokine-cytokine receptor interaction	355_3554_3625_5154	4	-	0.0369959193394759	0.422810506736867
7114	stachydrine	hsa04740	Olfactory transduction	818_109_816	3	+	0.00140928702008936	0.105696526506702
7115	stachydrine	hsa04520	Adherens junction	4233_7454_56288_2241	4	-	0.0216096754531006	0.497022535421314
7116	stachydrine	hsa05322	Systemic lupus erythematosus	85235_8969_8332_8330_8331_8329_6737_8336	8	-	0.000669538504712226	0.0307987712167624
7117	dipivefrine	hsa05332	Graft-versus-host disease	3135_3105_3106_3107_649853	5	-	0.00516443201882265	0.129521681268324
7118	dipivefrine	hsa04662	B cell receptor signaling pathway	933_3725_4793_3551_8519	5	-	0.0430255418211149	0.296876238565693
7119	dipivefrine	hsa04080	Neuroactive ligand-receptor interaction	1269	1	-	0.0224963290339683	0.229386803331033
7120	dipivefrine	hsa05320	Autoimmune thyroid disease	3135_3105_3106_3107_649853	5	-	0.0124776211363817	0.172191171682067
7121	dipivefrine	hsa04612	Antigen processing and presentation	3105_3106_3107_3135_811_649853	6	-	0.0265955714006995	0.229386803331033
7122	dipivefrine	hsa04514	Cell adhesion molecules (CAMs)	9076_24146_3105_4099_3107_3135_933_3106_649853	9	-	0.0075085032619318	0.129521681268324
7123	dipivefrine	hsa04210	Apoptosis	3551_598_472_5576_651610_8795	6	-	0.0265955714006995	0.229386803331033
7124	dipivefrine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0406527468892159	0.296876238565693
7125	dipivefrine	hsa05330	Allograft rejection	3135_3105_3106_3107_649853	5	-	0.00350207794987258	0.129521681268324
7126	dipivefrine	hsa04940	Type I diabetes mellitus	3135_3105_3106_3107_649853	5	-	0.00617641767397965	0.129521681268324
7127	piretanide	hsa04670	Leukocyte transendothelial migration	2909_3688_1432_5600_5880	5	+	0.0380636540946127	0.710597511051695
7128	piretanide	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0201495787732418	1
7129	betahistine	hsa04070	Phosphatidylinositol signaling system	8394_27124_23236	3	+	0.0297535454848283	0.404788254053682
7130	betahistine	hsa04512	ECM-receptor interaction	3693_1291_2335	3	+	0.038007615965987	0.404788254053682
7131	betahistine	hsa04540	Gap junction	7278_113457_23236	3	+	0.0485438960382854	0.404788254053682
7132	betahistine	hsa05330	Allograft rejection	5551_3119	2	+	0.0454776234979186	0.404788254053682
7133	betahistine	hsa04940	Type I diabetes mellitus	5551_3119_2571	3	+	0.00740673746504644	0.33330318592709
7134	betahistine	hsa05332	Graft-versus-host disease	3552_3123_3126_3127_3125_3135	6	-	0.0315375913812549	0.576145094313182
7135	betahistine	hsa04080	Neuroactive ligand-receptor interaction	4886	1	-	5.72704328339255e-05	0.00486798679088367
7136	betahistine	hsa04510	Focal adhesion	5296_3691_5595	3	-	0.0100655818156386	0.427787227164641
7137	betahistine	hsa05012	Parkinson's disease	7327_4728	2	-	0.0489101234118574	0.576145094313182
7138	betahistine	hsa05210	Colorectal cancer	5595_8312_4088_4089_1855_5296_5900_3845_7040_6934	10	-	0.0266928595516598	0.576145094313182
7139	betahistine	hsa04940	Type I diabetes mellitus	3552_3123_3126_3127_3125_3135	6	-	0.037590062779761	0.576145094313182
7140	tropine	hsa04612	Antigen processing and presentation	5994_3806_6892_3107_3111	5	+	0.00443712433257829	0.195233470633445
7141	chloropyrazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_2215_729	23	+	1.40859964463988e-14	6.76127829427142e-13
7142	chloropyrazine	hsa03020	RNA polymerase	246721_5439_548644_661	4	-	0.00144382112293826	0.0563090237945921
7143	monocrotaline	hsa04640	Hematopoietic cell lineage	3553_3570_3815	3	+	0.0367520252714041	0.822186175193801
7144	monocrotaline	hsa05014	Amyotrophic lateral sclerosis (ALS)	4217_581_11261_5868_5534_5608	6	-	0.00707806279686642	0.460074081796317
7145	monocrotaline	hsa04350	TGF-beta signaling pathway	4092_7059_6667_1874_655_6093	6	-	0.043544018814762	1
7146	harmine	hsa04740	Olfactory transduction	2979	1	+	0.015410601018595	0.24656961629752
7147	harmine	hsa05322	Systemic lupus erythematosus	8358_3108_85235_8968_958_3013_8330_8332_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357	20	+	4.45557992198528e-12	2.13867836255293e-10
7148	harmine	hsa04115	p53 signaling pathway	55367_1647_1026_5366_64393_4193_7249_355_8795	9	+	6.7404073361556e-06	0.000161769776067734
7149	harmine	hsa05330	Allograft rejection	958_355_3108	3	+	0.0326029858532293	0.391235830238752
7150	harmine	hsa05332	Graft-versus-host disease	3105_3106_3119_3133_3123	5	-	0.00544172184954697	0.0300895208151421
7151	harmine	hsa04650	Natural killer cell mediated cytotoxicity	8503_5296_5295_5290_5291_5604_10451_5058_5336_836_3455_3105_3106_3459_5781_3845_4277_4276_637_673_5533_5532_5530_4772_3133_5534_5578_6655_3460_6464_2885_80328_2534	33	-	0.00999926812244725	0.040589875240411
7152	harmine	hsa04640	Hematopoietic cell lineage	3554_960_2057_3123_4254_1604_3678_3655	8	-	3.03932442816148e-06	4.76160827078632e-05
7153	harmine	hsa03320	PPAR signaling pathway	79966_2710_51_11001_1962_34_2181_2171_1375_8310_2180_6257_6256	13	-	0.00991047309109185	0.040589875240411
7154	harmine	hsa05010	Alzheimer's disease	3710_1340_5534_2776_1020_5663_5332_5664_4694_1327_836_4728_4701_4698_808_776_637_8772_2932_5533_5532_3709_374291_489_488_102_8851_23236_3416_842_841_840_4719_4137_5530_805_801_823	38	-	0.000415634404501527	0.00279068814451025
7155	harmine	hsa04080	Neuroactive ligand-receptor interaction	5029_4889_1269_7068_64106_5025_5618_4886_5031_2150_136_56288_2690_2149_9170	15	-	1.66867866518787e-21	7.84278972638299e-20
7156	harmine	hsa04742	Taste transduction	2778_3710_2782_5613_5566_5567_5616_6337_112	9	-	0.0160216373580857	0.0529944243866172
7157	harmine	hsa05320	Autoimmune thyroid disease	3105_3106_3133_3119_3123	5	-	0.000377118673395647	0.00272685809993776
7158	harmine	hsa04612	Antigen processing and presentation	4800_10197_4802_5993_3119_4801_8625_2923_3309_3105_3106_5641_3133_3123_3306_1385_3304_3312_3303_1514	20	-	0.0242105655698279	0.0758597721187941
7159	harmine	hsa04670	Leukocyte transendothelial migration	9076_8503_5296_2771_2909_5747_5290_9475_7852_6387_5600_5336_87_5829_1500_7430_5781_50848_6300_5295_998_9080_1499_6093_5291_1432_5578_10451_1366_1364_1365	31	-	0.0298850836346043	0.0877874331766501
7160	harmine	hsa05016	Huntington's disease	4899_1327_1340_64764_246721_2776_5332_23186_6874_6908_5432_5433_5430_6648_4694_4701_5435_1639_5439_6667_2033_1213_1211_581_374291_836_548644_161_5481_23236_27113_842_841_5441_4719_3092_4728_4698_1385_1387_291	41	-	0.000358386723397879	0.00272685809993776
7161	harmine	hsa04740	Olfactory transduction	219464_157_5613_5566_5567_5616_818_808_805_801_409	11	-	8.11520966204155e-42	7.62829708231906e-40
7162	harmine	hsa04514	Cell adhesion molecules (CAMs)	9076_965_4685_3119_3123_3106_4897_1364_3685_9080_1366_2734_1365_5792_3133_3105_3655_50848_9019_1001_5817	21	-	2.01115578221261e-05	0.000236310804409982
7163	harmine	hsa04510	Focal adhesion	8503_595_10298_5296_2909_5295_5154_5290_9475_5604_3678_5601_5747_7791_3655_5063_6093_3725_5501_5728_857_207_2885_5829_3691_3693_858_7057_87_23396_3912_896_5062_3480_2932_998_673_4659_1499_6714_5291_4233_2335_1729_2317_6655_5578_6464_10451_3685_2002_7422_5058_2064_2534	55	-	0.0100462098898886	0.040589875240411
7164	harmine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_94239_8366_8368_8294_8343_8347_8346_8344_8339_8367_3123_3021_3020_87_8370_92815_8359_554313_6738_121504_6632_3119_3014	29	-	0.000619280213543645	0.00388082267154018
7165	harmine	hsa05340	Primary immunodeficiency	8625_100_64421_5993	4	-	0.0115968726607623	0.0419271550042945
7166	harmine	hsa04140	Regulation of autophagy	5289_9474_23192_5562_64422	5	-	0.0328159873086806	0.0907265531475287
7167	harmine	hsa05218	Melanoma	673_8503_595_207_5296_3480_5295_5154_5290_5728_5604_3845_2260_5291_4233	15	-	0.0296697920417119	0.0877874331766501
7168	harmine	hsa05310	Asthma	3123_3119	2	-	0.00475008748414446	0.0279067639693487
7169	harmine	hsa04512	ECM-receptor interaction	375790_960_3912_3691_3693_1605_7057_3685_3678_3655_2335_3161	12	-	0.000357953324164409	0.00272685809993776
7170	harmine	hsa04630	Jak-STAT signaling pathway	8503_6777_595_5296_5295_5292_5290_5291_6772_9655_3597_10254_896_2057_3455_3459_3572_2033_5781_10401_9063_207_7297_3588_8554_4609_8027_868_5618_6778_3460_6655_2885_867_50616_8835_1387_2690	38	-	0.0077504914353235	0.0383445365747584
7171	harmine	hsa04062	Chemokine signaling pathway	8503_6777_1147_157_5296_2771_112_5290_9475_115_5604_10451_5332_56288_113_5747_4067_3551_2782_5829_5566_5567_6464_5291_409_408_5295_207_2932_998_673_6093_10681_4790_107_23236_5590_5580_5613_6655_2885_5616_6387_6772_7074_55970_3845_5058_5970_7852	50	-	0.00766868186643152	0.0383445365747584
7172	harmine	hsa04810	Regulation of actin cytoskeleton	8503_10298_5296_2909_5295_5154_5290_9475_5604_10451_55970_10109_54961_23365_5747_3655_10458_4659_87_5501_23396_3678_5829_3691_3693_23191_1445_50649_7430_324_55740_2245_2260_2261_8396_2264_10152_79784_2768_5063_5062_2934_998_673_22800_10787_2263_4628_6093_5291_5962_2335_8874_1729_6655_5305_3685_7074_8936_3845_54434_5058_2149	63	-	0.0320147502192396	0.0907265531475287
7173	harmine	hsa05012	Parkinson's disease	2861_7326_7327_836_1327_4701_1340_4698_4694_4719_4728_842_374291_65018_27429_51465_5481_291	18	-	1.26343773680862e-06	2.37526294520021e-05
7174	harmine	hsa04260	Cardiac muscle contraction	784_776_1327_1340_27092_488_10479_481	8	-	9.93583735534457e-06	0.000133424101628913
7175	harmine	hsa04060	Cytokine-cytokine receptor interaction	3597_55540_5154_8741_7852_6387_90_3556_27242_3554_2057_3455_3459_3572_657_4982_659_3588_3625_4254_7042_91_655_92_4233_5618_3460_50616_7422_51330_2690	31	-	2.11858177028398e-13	6.63822288022314e-12
7176	harmine	hsa03010	Ribosome	6187_440589_9349_6137_6125_6168_439992_51187_6189	9	-	3.37875752460577e-07	7.94008018282356e-06
7177	harmine	hsa04020	Calcium signaling pathway	2778_3710_5534_2776_115_5332_136_113_5336_490_493_5256_5566_5567_818_776_5025_2767_5533_5532_5530_489_488_107_5481_23236_5578_5613_3709_5616_808_805_801_2064_2065_2149_291	37	-	8.21940753237528e-05	0.000772624308043276
7178	harmine	hsa03050	Proteasome	10197_5719_5706_5707_5690_23198_7979	7	-	0.00998540625527263	0.040589875240411
7179	harmine	hsa05330	Allograft rejection	3105_3106_3119_3133_3123	5	-	0.0162214495485023	0.0529944243866172
7180	harmine	hsa04950	Maturity onset diabetes of the young	3087_3280	2	-	0.0163493436937436	0.0529944243866172
7181	harmine	hsa04940	Type I diabetes mellitus	3382_3119_3105_3106_3133_3123	6	-	0.0107951795852157	0.040589875240411
7182	harmine	hsa02010	ABC transporters	23461_4363_10057_9619_368_10257	6	-	0.0107951795852157	0.040589875240411
7183	harmine	hsa04610	Complement and coagulation cascades	1604_7035_1675_2161_2149_5329	6	-	2.59610953498338e-05	0.000271149218098264
7184	thioperamide	hsa05332	Graft-versus-host disease	3105_3106_3107_3111_3135_649853	6	+	0.0111308316605608	0.151616116056534
7185	thioperamide	hsa04640	Hematopoietic cell lineage	948_3690_3589_2993_915_947_920_3674_3675	9	+	0.0135469661959707	0.151616116056534
7186	thioperamide	hsa05320	Autoimmune thyroid disease	3105_3106_3107_3111_3135_649853	6	+	0.028498077341354	0.204668009996997
7187	thioperamide	hsa04612	Antigen processing and presentation	3105_3106_3107_3111_3135_6892_1520_920_649853	9	+	0.0153535307399022	0.151616116056534
7188	thioperamide	hsa04910	Insulin signaling pathway	7249	1	+	0.0458572600340064	0.301893628557209
7189	thioperamide	hsa04740	Olfactory transduction	818_5593	2	+	2.8890336242459e-05	0.00228233656315426
7190	thioperamide	hsa04514	Cell adhesion molecules (CAMs)	1272_3105_29851_3107_3685_3135_6693_51208_9672_947_920_3111_26285_923_3106_649853	16	+	0.000285981833556329	0.0101724587042997
7191	thioperamide	hsa05340	Primary immunodeficiency	23495_915_29851_920_3718	5	+	0.0199341741285722	0.174977750684134
7192	thioperamide	hsa04512	ECM-receptor interaction	1280_948_3690_9672_1289_3685_1277_2335_1290_3918_3674_3675	12	+	0.000386295900163278	0.0101724587042997
7193	thioperamide	hsa04062	Chemokine signaling pathway	108_3718	2	+	0.025575629647788	0.202047474217525
7194	thioperamide	hsa05330	Allograft rejection	3105_3106_3107_3111_3135_649853	6	+	0.00730651422089587	0.144303655862693
7195	thioperamide	hsa04940	Type I diabetes mellitus	3105_3106_3107_3111_3135_649853	6	+	0.0134953108715839	0.151616116056534
7196	thioperamide	hsa04350	TGF-beta signaling pathway	4088_6093_3624_7042	4	-	0.0308371345107995	1
7197	benperidol	hsa05332	Graft-versus-host disease	3123_3107_3126_3127_3125	5	+	0.0297675984754834	0.286513135326528
7198	benperidol	hsa04640	Hematopoietic cell lineage	2323_3581_1435_3690_3123_3126_3127_3125_7850_4254	10	+	0.00321581386116963	0.123808833655031
7199	benperidol	hsa05320	Autoimmune thyroid disease	3449_3123_3107_3126_3127_3443_3125	7	+	0.00665327188385881	0.137096141364861
7200	benperidol	hsa04612	Antigen processing and presentation	4261_3449_3123_3107_3126_3127_3443_3125_6891	9	+	0.0106828162102489	0.137096141364861
7201	benperidol	hsa04740	Olfactory transduction	26211_135948_442194_1179	4	+	0.00156357994192492	0.120395655528219
7202	benperidol	hsa05310	Asthma	3123_3126_3127_8288_3125	5	+	0.00903989708635428	0.137096141364861
7203	benperidol	hsa05330	Allograft rejection	3123_3107_3126_3127_3125	5	+	0.0210584921206735	0.231643413327409
7204	benperidol	hsa04940	Type I diabetes mellitus	3126_3107_2572_3127_3125_3123	6	+	0.0102365264039756	0.137096141364861
7205	benperidol	hsa04080	Neuroactive ligand-receptor interaction	3953_5025_5618_2150_2690	5	-	2.89915493111351e-09	1.33361126831221e-07
7206	benperidol	hsa04742	Taste transduction	5567	1	-	0.0186102646072285	0.214018042983128
7207	benperidol	hsa04740	Olfactory transduction	801_808_5567_805	4	-	9.88023316151914e-17	9.08981450859761e-15
7208	benperidol	hsa04514	Cell adhesion molecules (CAMs)	3135_965_2734_4685_6383	5	-	0.000882458496085396	0.0202965454099641
7209	benperidol	hsa04110	Cell cycle	5111_4085_4087_4088_983_11200_9184_1022_7157_8881_4089_7534_1031_7531_7533_9133_902_5001_5000_10393_8556_8243_5591_1017_4173_6500_472_5934_7465	29	-	0.00661867436533362	0.101486340268449
7210	benperidol	hsa04530	Tight junction	2773_22800_7525_4627_60_51776_1457_387_5516	9	-	0.0283832580683301	0.290139971365152
7211	benperidol	hsa05218	Melanoma	7157_5154	2	-	0.010134760409985	0.133199708245517
7212	benperidol	hsa04060	Cytokine-cytokine receptor interaction	3556_5618_3566_2057_3460_3953_23765_5154_8741_355_6387_7424_91_3597_55540_2690	16	-	0.000688040976073725	0.0202965454099641
7213	benperidol	hsa03010	Ribosome	6168_6138_51187_6203	4	-	0.00607840073664296	0.101486340268449
7214	oxolinic acid	hsa05332	Graft-versus-host disease	3824_3119_3804_3107_3126_3127_3802_3811_3123_3125_3113	11	+	1.33969518929065e-07	9.51183584396361e-06
7215	oxolinic acid	hsa04640	Hematopoietic cell lineage	1435_3123_3126_3127_3125_1378	6	+	0.0405902840531518	0.288191016777378
7216	oxolinic acid	hsa05320	Autoimmune thyroid disease	3119_3126_3107_3113_3127_3125_3123	7	+	0.00113578976985717	0.0115201533799799
7217	oxolinic acid	hsa04612	Antigen processing and presentation	3824_3119_3123_3107_3126_3127_3125_3811_3804_6892_3802_3113	12	+	1.74817666897152e-05	0.00062060271748489
7218	oxolinic acid	hsa04740	Olfactory transduction	810_26692	2	+	0.00344261284437124	0.0305531889937948
7219	oxolinic acid	hsa04514	Cell adhesion molecules (CAMs)	965_3119_3683_3123_1272_3107_3126_3127_3125_5797_23308_3113	12	+	0.000611468267573307	0.0072357078329508
7220	oxolinic acid	hsa04360	Axon guidance	9353_2047_57715_57556_56920_56924_4776_8482_8829	9	+	0.0139720164007273	0.110223684939071
7221	oxolinic acid	hsa05310	Asthma	3119_3123_3113_3127_3126_3125	6	+	0.000371748398117197	0.00595015224218528
7222	oxolinic acid	hsa05330	Allograft rejection	3119_3113_3107_3126_3127_3125_3123	7	+	0.00018869297362064	0.00446573370902181
7223	oxolinic acid	hsa04940	Type I diabetes mellitus	3119_3126_3107_3113_3127_3125_3123	7	+	0.000419024805787696	0.00595015224218528
7224	oxolinic acid	hsa05010	Alzheimer's disease	5533_823_5664	3	-	0.0363050364497341	0.762405765444416
7225	oxolinic acid	hsa04740	Olfactory transduction	409	1	-	1.03302078968363e-07	4.33868731667125e-06
7226	oxolinic acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8329_8294_8343_81_8347_8346_8344_8969_8370_8332_8359_8330_8331_8336_8337_554313_121504_8339_85235_3113_3017	31	-	3.24442201148193e-10	2.72531448964482e-08
7227	oxolinic acid	hsa05012	Parkinson's disease	65018	1	-	0.0151508442612752	0.424223639315706
7228	oxolinic acid	hsa05210	Colorectal cancer	324_596_4088_6655_6932_5599_5881_8312_3725	9	-	0.046909106180769	0.788072983836919
7229	pargyline	hsa04740	Olfactory transduction	5593_9635	2	+	0.00922881517078771	0.627559431613564
7230	pargyline	hsa04080	Neuroactive ligand-receptor interaction	2570	1	-	0.0115627336376421	0.265942873665768
7231	pargyline	hsa04740	Olfactory transduction	409	1	-	0.000255603592996059	0.00881832395836404
7232	pargyline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3108_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235	22	-	1.72649690593557e-09	1.19128286509554e-07
7233	STOCK1N-28457	hsa05214	Glioma	23533_2475_6464_5154_808_810_801_805	8	+	0.0263024943722081	0.410318912206446
7234	STOCK1N-28457	hsa04080	Neuroactive ligand-receptor interaction	2488_1813_3953_56288_134_5644	6	+	0.0425239959495214	0.552811947343778
7235	STOCK1N-28457	hsa04740	Olfactory transduction	157_8392_808_810_801_805	6	+	0.000494031226020843	0.0385344356296258
7236	STOCK1N-28457	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_88_8294_8367_554313_121504	15	+	0.0144620359377112	0.410318912206446
7237	STOCK1N-28457	hsa04150	mTOR signaling pathway	23533_2475_5170_6794_7249_6196_7422	7	+	0.0248839356852834	0.410318912206446
7238	STOCK1N-28457	hsa04912	GnRH signaling pathway	801_4313_2488_3709_808_4216_5600_810_3725_6714_6300_805	12	+	0.0170884145179326	0.410318912206446
7239	STOCK1N-28457	hsa05214	Glioma	818_6654_5594_7157_208_6655_5295_6464_4193_5605_808_5335_3480_801_369_805	16	-	0.0218605034123408	0.198930581052301
7240	STOCK1N-28457	hsa04640	Hematopoietic cell lineage	3554_960_2057_1435	4	-	0.0307659686073377	0.248443163349045
7241	STOCK1N-28457	hsa04080	Neuroactive ligand-receptor interaction	1269_7068_5025_5618_6915_2150_3269_9170	8	-	1.06310566700336e-06	4.83713078486529e-05
7242	STOCK1N-28457	hsa04740	Olfactory transduction	818_5137_801_808_805	5	-	8.28636916130947e-15	7.54059593679162e-13
7243	STOCK1N-28457	hsa05212	Pancreatic cancer	6934_5970_5170_5594_5295_9134_7157_3480_6655_6654_4193_4790_5605_208_10488_3326_369_1385_1017_572_842	21	-	0.0147625004861266	0.16792344302969
7244	STOCK1N-28457	hsa04110	Cell cycle	983_4616_7157_699_51433_1017_7534_1031_995_4174_5001_9134_4193_8454_7027_7040_8243_5591_4176_5347_4173_6502_472_7529_7465	25	-	0.0327617358262477	0.248443163349045
7245	STOCK1N-28457	hsa05215	Prostate cancer	6934_5970_5170_5594_5295_9134_7157_3480_6655_6654_4193_4790_5605_208_10488_3326_369_1385_1017_572_842	21	-	0.0140170469594533	0.16792344302969
7246	STOCK1N-28457	hsa05223	Non-small cell lung cancer	2309_5170_11186_842_2272_6789_572_6655_5295_5605_7157_6654_5335_208_369_5594	16	-	0.00654332086957422	0.0992403665218757
7247	STOCK1N-28457	hsa04260	Cardiac muscle contraction	1537_776_7171_27092	4	-	0.0419161817263902	0.293413272084731
7248	STOCK1N-28457	hsa04060	Cytokine-cytokine receptor interaction	50616_5618_3554_3597_2057_2324_23765_53832_3572_7852_1435_7040_655_51330_659	15	-	0.00100604763404644	0.0228875836745565
7249	STOCK1N-28457	hsa05213	Endometrial cancer	2309_3611_5170_6934_7157_572_6655_5295_999_2002_5605_208_842_1495_324_369_6654_5594	18	-	0.000823987774304287	0.0228875836745565
7250	STOCK1N-28457	hsa05220	Chronic myeloid leukemia	5295_5594_7157_613_6655_6654_6464_4193_5605_208_572_5781_1398_598_5970_4790_369_7040	18	-	0.0203841484491185	0.198930581052301
7251	STOCK1N-28457	hsa04610	Complement and coagulation cascades	718	1	-	0.0038522038378049	0.0701101098480492
7252	pyrantel	hsa04130	SNARE interactions in vesicular transport	8773_6804_662_6616_8417_51272	6	+	0.00102574962919595	0.0263275738160294
7253	pyrantel	hsa04740	Olfactory transduction	5613	1	+	0.000550860749115784	0.0212081388409577
7254	pyrantel	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	8.15456665491719e-05	0.00627901632428624
7255	pyrantel	hsa04740	Olfactory transduction	818_51806	2	-	0.000269889886014316	0.0107955954405726
7256	pyrantel	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3113	22	-	4.23888619869e-08	3.391108958952e-06
7257	pyrantel	hsa05223	Non-small cell lung cancer	6789_1869_6654_6257_842	5	-	0.0495748086548794	0.755961339436086
7258	pyrantel	hsa04010	MAPK signaling pathway	8912_6654_4149_3552_6789_50487_1846_2002_5606_5536_5922_7042_3306_9020_776_27092	16	-	0.047952582937391	0.755961339436086
7259	pyrantel	hsa05222	Small cell lung cancer	4149_842_3909_1869_3655_1017_6257	7	-	0.0387723295493346	0.755961339436086
7260	tiratricol	hsa04740	Olfactory transduction	5593	1	+	0.00175603490987794	0.117654338961822
7261	tiratricol	hsa04360	Axon guidance	2047_1949_80031_6405_8482_5534_7869	7	+	0.0476311677288806	1
7262	tiratricol	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0402506240657491	1
7263	tiratricol	hsa05332	Graft-versus-host disease	3123_3126_3127_3111_3125	5	-	0.00811092001594831	0.120718012153416
7264	tiratricol	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3111_3125	5	-	0.0191287610406475	0.204951011149795
7265	tiratricol	hsa04612	Antigen processing and presentation	3123_3126_3127_3111_3125_6892	6	-	0.0418364883647686	0.392217078419706
7266	tiratricol	hsa04740	Olfactory transduction	818_109	2	-	0.00331297633894781	0.0828244084736953
7267	tiratricol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_3111_3126_3127_3014_3125_8359_8294_8367_554313_8368_121504	20	-	1.36709043368569e-08	1.02531782526427e-06
7268	tiratricol	hsa05310	Asthma	3123_3126_3127_3111_3125	5	-	0.00222616166608088	0.0828244084736953
7269	tiratricol	hsa05330	Allograft rejection	3123_3126_3127_3111_3125	5	-	0.00554927536458604	0.104048913085988
7270	tiratricol	hsa04940	Type I diabetes mellitus	3123_3126_3127_3111_3125	5	-	0.00965744097227326	0.120718012153416
7271	levamisole	hsa05332	Graft-versus-host disease	3109_3123_3126_3127_3111_3125	6	+	0.000989923211895551	0.0140569096089168
7272	levamisole	hsa04070	Phosphatidylinositol signaling system	8394_23533_3708_8821_5293	5	+	0.0462798684471036	0.273822554978696
7273	levamisole	hsa04640	Hematopoietic cell lineage	1436_3690_3123_3126_3127_3125_7173_915_1378	9	+	0.000510442990206659	0.0109559357744423
7274	levamisole	hsa05320	Autoimmune thyroid disease	3109_3123_3126_3127_3111_3125_7173	7	+	0.000577830616335367	0.0109559357744423
7275	levamisole	hsa04612	Antigen processing and presentation	3109_3123_3126_3127_3111_3125	6	+	0.0275069444853965	0.236156620791619
7276	levamisole	hsa04514	Cell adhesion molecules (CAMs)	3109_3123_3126_3127_3111_3125_6383_6693_26047	9	+	0.00789001060459135	0.080027250417998
7277	levamisole	hsa05322	Systemic lupus erythematosus	3109_3123_3126_3127_3111_3125_720_721	8	+	0.0313058530244275	0.236156620791619
7278	levamisole	hsa05310	Asthma	3109_3123_3126_3127_3111_3125	6	+	0.000200183764394304	0.0109559357744423
7279	levamisole	hsa05213	Endometrial cancer	23533_1956_5293_1495	4	+	0.0461669305401993	0.273822554978696
7280	levamisole	hsa05330	Allograft rejection	3109_3123_3126_3127_3111_3125	6	+	0.00061723581827844	0.0109559357744423
7281	levamisole	hsa04940	Type I diabetes mellitus	3109_3123_3126_3127_3111_3125	6	+	0.00123131366689396	0.0145705450582452
7282	levamisole	hsa04610	Complement and coagulation cascades	2155_721_720_2149_1378	5	+	0.0332614958861435	0.236156620791619
7283	levamisole	hsa04740	Olfactory transduction	818_816	2	-	0.00160167797179698	0.113719135997586
7284	levamisole	hsa05222	Small cell lung cancer	3551_6502_3909_7189_8554_3673	6	-	0.0464635238892765	1
7285	etofylline	hsa04520	Adherens junction	5770_2260_3643_5792_7414	5	+	0.0436338907021905	0.530879003543318
7286	etofylline	hsa04740	Olfactory transduction	1179	1	+	0.00249030857659602	0.181792526091509
7287	etofylline	hsa04370	VEGF signaling pathway	8398_4772_5293_5320_5534	5	+	0.0382942363953235	0.530879003543318
7288	etofylline	hsa05218	Melanoma	1029_2260_1021_5293_2249	5	+	0.0288718918391558	0.530879003543318
7289	etofylline	hsa04010	MAPK signaling pathway	786_3554_8398_782_5534_6722_6196_9479_2249_5320_7042_22808_2260	13	+	0.0146710803301016	0.530879003543318
7290	etofylline	hsa05220	Chronic myeloid leukemia	1021_7042_1029_5293_5781	5	+	0.0349688555685794	0.530879003543318
7291	etofylline	hsa04740	Olfactory transduction	818_157	2	-	0.000135340278320961	0.0108272222656769
7292	tranylcypromine	hsa05332	Graft-versus-host disease	3135_3105_3106_649853_3002	5	+	0.00474610739222106	0.0840711571014892
7293	tranylcypromine	hsa04650	Natural killer cell mediated cytotoxicity	3448_962_3105_6655_3135_3002_8794_3106_3383	9	+	0.00788119540652642	0.0972014100138259
7294	tranylcypromine	hsa04742	Taste transduction	5330_5568_50834_40	4	+	0.0472391881831362	0.317790902322916
7295	tranylcypromine	hsa05320	Autoimmune thyroid disease	3448_3105_3106_3135_3002_649853	6	+	0.00253554532439416	0.0792649186347865
7296	tranylcypromine	hsa04740	Olfactory transduction	26211_5568	2	+	0.00934304970867563	0.0987693826345709
7297	tranylcypromine	hsa04514	Cell adhesion molecules (CAMs)	5797_3383_9369_3105_3106_3135_4359_649853	8	+	0.0189121837677853	0.174937699852014
7298	tranylcypromine	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	0.00107236379763365	0.0792649186347865
7299	tranylcypromine	hsa05223	Non-small cell lung cancer	6655_5170_1950_2272	4	+	0.0472391881831362	0.317790902322916
7300	tranylcypromine	hsa04540	Gap junction	7082_5568_6655_5330_1950_10382	6	+	0.0291483847670262	0.239664496973327
7301	tranylcypromine	hsa05330	Allograft rejection	3135_3105_3106_649853_3002	5	+	0.00321344264735621	0.0792649186347865
7302	tranylcypromine	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853_3002	5	+	0.00568048358793846	0.0840711571014892
7303	tranylcypromine	hsa04740	Olfactory transduction	818	1	-	2.64608924139954e-05	0.00211687139311963
7304	tranylcypromine	hsa04510	Focal adhesion	7059_1302_5599_2909_3914_9475_5296_7410_5170_4636_5602_6714_1291_83660	14	-	0.0378992474045853	0.627904912919263
7305	tranylcypromine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_9555	15	-	0.000454784736308834	0.0181913894523534
7306	tranylcypromine	hsa04810	Regulation of actin cytoskeleton	3985_5296_2909_9138_8074_9475_7410_7430_2149_2263_2245_1131_2264_4636	14	-	0.0452155163256153	0.627904912919263
7307	chlorzoxazone	hsa05332	Graft-versus-host disease	3812_3123_3126_3127_3125	5	+	0.0157625034079357	0.239590051800623
7308	chlorzoxazone	hsa04640	Hematopoietic cell lineage	1436_3123_3126_3127_3125_3589_3684	7	+	0.0289105619699676	0.31388610138822
7309	chlorzoxazone	hsa05320	Autoimmune thyroid disease	3123_3451_3126_3127_3125	5	+	0.0356550006484153	0.338722506159945
7310	chlorzoxazone	hsa05131	Shigellosis	347688_7278_113457_7430_56604_8976	6	+	0.0131747313740816	0.239590051800623
7311	chlorzoxazone	hsa05130	Pathogenic Escherichia coli infection	347688_7278_113457_7430_56604_8976	6	+	0.0131747313740816	0.239590051800623
7312	chlorzoxazone	hsa04740	Olfactory transduction	8392_1179	2	+	0.000547079401824291	0.0415780345386461
7313	chlorzoxazone	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0214507143102493	0.271709047929824
7314	chlorzoxazone	hsa04540	Gap junction	347688_7082_1813_2982_7278_113457_56604_6714_6655	9	+	0.0048632212700278	0.184802408261056
7315	chlorzoxazone	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.04261252578828	0.359839106656587
7316	chlorzoxazone	hsa04080	Neuroactive ligand-receptor interaction	5031_7433	2	-	0.00663534409961168	0.204850251175663
7317	chlorzoxazone	hsa05014	Amyotrophic lateral sclerosis (ALS)	1432_834_1616_5606_9973_5534_5608	7	-	0.00833556184570955	0.204850251175663
7318	chlorzoxazone	hsa04740	Olfactory transduction	51806	1	-	1.20660385873684e-05	0.00090495289405263
7319	chlorzoxazone	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_5599_535_5335_3725_6714_28964	7	-	0.0249363134385589	0.374044701578383
7320	chlorzoxazone	hsa04062	Chemokine signaling pathway	7454	1	-	0.0109253467293687	0.204850251175663
7321	scopolamine N-oxide	hsa04740	Olfactory transduction	442194_390892	2	+	0.0359033542161109	0.748925818466511
7322	scopolamine N-oxide	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0227468549338936	0.748925818466511
7323	scopolamine N-oxide	hsa04070	Phosphatidylinositol signaling system	8871_8394_5333_23236_27124_3705	6	-	0.0447306438399565	1
7324	antimycin A	hsa05016	Huntington's disease	2776	1	+	0.0464130493831311	1
7325	antimycin A	hsa04740	Olfactory transduction	1179	1	+	0.00026763111453094	0.0190018091316967
7326	antimycin A	hsa04062	Chemokine signaling pathway	2793	1	+	0.047527455646003	1
7327	antimycin A	hsa04740	Olfactory transduction	5613	1	-	5.20027147614742e-07	4.00420903663351e-05
7328	antimycin A	hsa05322	Systemic lupus erythematosus	55506_3013_3014_8358_8968_55766_720_721_8350_8351_8352_8353_8354_8355_8356_8357	16	-	0.00289238922395576	0.111356985122297
7329	antimycin A	hsa04630	Jak-STAT signaling pathway	8835_3717	2	-	0.0498463908124451	0.726113172006677
7330	antimycin A	hsa04010	MAPK signaling pathway	9261_9344_3925_5155_3306_5494_3304_3305_3303_2002_4149_11261_2263_408_9064_6885_5534_5613_4137_8912_6195_5970_7186	23	-	0.00995216736932161	0.255438962479255
7331	antimycin A	hsa04060	Cytokine-cytokine receptor interaction	7852_5155_4254_6358_6359	5	-	0.034858865609244	0.671033162977947
7332	H-89	hsa05222	Small cell lung cancer	3673_51588_3688_5295_3675	5	+	0.0361119474530301	1
7333	H-89	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	4.25520187845174e-07	2.08504892044135e-05
7334	cefmetazole	hsa05332	Graft-versus-host disease	3123_3126_3127_3803_3125_3558	6	+	0.00148881235833602	0.0352352258139525
7335	cefmetazole	hsa04640	Hematopoietic cell lineage	1435_947_3123_3126_3127_1438_3125_7850_3589_914_4254	11	+	4.8357927596996e-05	0.00171670642969336
7336	cefmetazole	hsa05320	Autoimmune thyroid disease	3123_3558_3126_3127_3125	5	+	0.0175977869563404	0.156180359237521
7337	cefmetazole	hsa04612	Antigen processing and presentation	3123_3126_3127_3803_3125_3305	6	+	0.0383195173091815	0.302298414327987
7338	cefmetazole	hsa04740	Olfactory transduction	23538_1179_816	3	+	0.014251982382119	0.14455582130435
7339	cefmetazole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504_8341_8340	20	+	9.48318244519932e-09	6.73305953609152e-07
7340	cefmetazole	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0115121783786528	0.136227444147391
7341	cefmetazole	hsa05330	Allograft rejection	3123_3558_3126_3127_3125	5	+	0.00507051322523611	0.0900016097479409
7342	cefmetazole	hsa04940	Type I diabetes mellitus	3123_3558_3126_3127_3125	5	+	0.00884849337964686	0.125648605990985
7343	cefmetazole	hsa05014	Amyotrophic lateral sclerosis (ALS)	5630_5606_1432_834_5534	5	-	0.029388470385454	1
7344	cefmetazole	hsa04740	Olfactory transduction	109	1	-	0.000254596725577247	0.0193493511438708
7345	cefmetazole	hsa04010	MAPK signaling pathway	57551_9479_1432_9252_5534_5155_4763_4137_6196_5606_10454_8398_2247_2264	14	-	0.0455231386815794	1
7346	asiaticoside	hsa05322	Systemic lupus erythematosus	3013_8358_8968_720_721_8350_8351_8352_8353_8354_8355_8356_8357	13	+	1.98282470703499e-06	0.000126900781250239
7347	asiaticoside	hsa05220	Chronic myeloid leukemia	91_861_1021_3551	4	+	0.0422992885477458	0.998330529427862
7348	asiaticoside	hsa04080	Neuroactive ligand-receptor interaction	5618_2908	2	-	0.0266604424971321	1
7349	asiaticoside	hsa04740	Olfactory transduction	818_409	2	-	0.000814310419506536	0.0618875918824967
7350	oxprenolol	hsa05332	Graft-versus-host disease	3135_3105_3106_649853_941	5	+	0.0092198568036638	0.153480140621917
7351	oxprenolol	hsa04650	Natural killer cell mediated cytotoxicity	3105_6655_5880_7410_3135_27040_6452_5781_3106_2534	10	+	0.00789154219591178	0.153480140621917
7352	oxprenolol	hsa05320	Autoimmune thyroid disease	3135_3105_3106_649853_941	5	+	0.0215830150567362	0.251801842328589
7353	oxprenolol	hsa04520	Adherens junction	7454_5880_7525_91_5770_2534	6	+	0.0314250635282312	0.274969305872023
7354	oxprenolol	hsa04740	Olfactory transduction	818_810_3000_1179	4	+	0.0268806008011456	0.268806008011456
7355	oxprenolol	hsa04514	Cell adhesion molecules (CAMs)	8174_8506_3105_3106_941_3135_23308_6383_923_649853	10	+	0.006544757400624	0.153480140621917
7356	oxprenolol	hsa05330	Allograft rejection	3135_3105_3106_649853_941	5	+	0.00632529232637098	0.153480140621917
7357	oxprenolol	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853_941	5	+	0.0109628671872798	0.153480140621917
7358	oxprenolol	hsa04740	Olfactory transduction	5566	1	-	0.00012388037542307	0.00879550665503797
7359	oxprenolol	hsa04060	Cytokine-cytokine receptor interaction	5618	1	-	0.00357461228009228	0.126898735943276
7360	oxprenolol	hsa04020	Calcium signaling pathway	5566	1	-	0.048772510771545	1
7361	bumetanide	hsa04080	Neuroactive ligand-receptor interaction	7434_2563_56288_2570_4886	5	+	0.0459830892833617	0.790909135673821
7362	bumetanide	hsa04520	Adherens junction	51701_117178_7048_5797_5880_56288_6714_10458_2260	9	+	0.0164459618025859	0.390013641240004
7363	bumetanide	hsa04740	Olfactory transduction	8392_1179	2	+	6.48435075131569e-06	0.000557654164613149
7364	bumetanide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3017_3014_8359_8336_8294_8367_554313_121504_8341_8340	19	+	0.000101633712523223	0.00437024963849859
7365	bumetanide	hsa04020	Calcium signaling pathway	8911_23236	2	+	0.0181401693600002	0.390013641240004
7366	bumetanide	hsa05322	Systemic lupus erythematosus	3113_8343_8339_8347_8346_8344	6	-	0.0145116838830335	0.379042345998672
7367	bumetanide	hsa04664	Fc epsilon RI signaling pathway	100137049_8681_5335_1432	4	-	0.0240661806983284	0.379042345998672
7368	bumetanide	hsa04370	VEGF signaling pathway	100137049_8681_5335_1432	4	-	0.022229237650279	0.379042345998672
7369	bumetanide	hsa04912	GnRH signaling pathway	10746_8681_1432_776_100137049	5	-	0.0168978368076828	0.379042345998672
7370	sulfaquinoxaline	hsa04740	Olfactory transduction	51806	1	+	5.64421303468359e-05	0.00378162273323801
7371	sulfaquinoxaline	hsa05131	Shigellosis	7278_6093_7430_113457_9181	5	-	0.0113836474364523	0.205601481559582
7372	sulfaquinoxaline	hsa04910	Insulin signaling pathway	5613_5575_5616_5290_8660_23265_32_6655	8	-	0.0164099417892732	0.206765266544842
7373	sulfaquinoxaline	hsa05130	Pathogenic Escherichia coli infection	7278_6093_7430_113457_9181	5	-	0.0113836474364523	0.205601481559582
7374	sulfaquinoxaline	hsa04740	Olfactory transduction	5613_5616	2	-	0.0130540623212433	0.205601481559582
7375	sulfaquinoxaline	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_720_721_8336	9	-	0.00721980431827067	0.205601481559582
7376	sulfaquinoxaline	hsa04060	Cytokine-cytokine receptor interaction	8744	1	-	0.0323925514516584	0.340121790242413
7377	L-methionine sulfoximine	hsa04740	Olfactory transduction	26212_26532_7932_5566_816	5	+	7.2094084399485e-08	6.34427942715468e-06
7378	L-methionine sulfoximine	hsa05322	Systemic lupus erythematosus	8970_2215_720_721	4	+	0.0354723702574032	1
7379	L-methionine sulfoximine	hsa04350	TGF-beta signaling pathway	6093	1	+	0.0207246397640934	0.91188414962011
7380	L-methionine sulfoximine	hsa04070	Phosphatidylinositol signaling system	8394_8867_3633_1606	4	-	0.047160786627165	1
7381	L-methionine sulfoximine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	4.56306595078074e-07	2.05337967785133e-05
7382	altretamine	hsa05332	Graft-versus-host disease	3123_3107_3126_3127_3111_3125	6	+	0.00566333650478123	0.0764550428145466
7383	altretamine	hsa04640	Hematopoietic cell lineage	3581_3554_960_3123_3126_3127_3125_933	8	+	0.0160954637090117	0.162966570053743
7384	altretamine	hsa05320	Autoimmune thyroid disease	959_3123_3107_3126_3127_3111_3125	7	+	0.00424611974846734	0.0687871399251709
7385	altretamine	hsa04740	Olfactory transduction	26539_135948	2	+	0.000278064652115934	0.0112616184106953
7386	altretamine	hsa04514	Cell adhesion molecules (CAMs)	24146_959_3695_3683_3123_3107_3126_3127_3111_3125_5818_23308_57863_933_25945_1462	16	+	5.4293910459866e-05	0.00439780674724915
7387	altretamine	hsa05310	Asthma	959_3123_3126_3127_3111_3125	6	+	0.00126839246949719	0.0256849475073181
7388	altretamine	hsa05330	Allograft rejection	959_3123_3107_3126_3127_3111_3125	7	+	0.000773584129956548	0.0208867715088268
7389	altretamine	hsa04940	Type I diabetes mellitus	3123_3107_3126_3127_3111_3125	6	+	0.00692658361535989	0.0801504675491644
7390	altretamine	hsa05211	Renal cell carcinoma	7424_8503_5296_6655_5155_405_2034_8453_7040_7042_7039_4233	12	-	0.0136460250750968	0.303624057920904
7391	altretamine	hsa04080	Neuroactive ligand-receptor interaction	3354_5618_1081	3	-	2.61595426640793e-05	0.00116409964855153
7392	altretamine	hsa04740	Olfactory transduction	5566_157	2	-	8.13071778782178e-10	7.23633883116138e-08
7393	altretamine	hsa05322	Systemic lupus erythematosus	3113_8330_55766	3	-	0.0190978633636747	0.33994196787341
7394	altretamine	hsa04020	Calcium signaling pathway	115_11261_5256_5566	4	-	0.00763970299603615	0.226644522215739
7395	zomepirac	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_8341	15	+	2.48462194968094e-08	1.09323365785961e-06
7396	zomepirac	hsa04740	Olfactory transduction	157	1	-	0.0320685237337246	0.843132410054544
7397	zomepirac	hsa04370	VEGF signaling pathway	5829_6714_8681_100137049	4	-	0.035130517085606	0.843132410054544
7398	drofenine	hsa04070	Phosphatidylinositol signaling system	8394_8871_23396_5305_23236	5	-	0.0377431651459572	1
7399	drofenine	hsa04060	Cytokine-cytokine receptor interaction	4233	1	-	0.0331195685944744	1
7400	methacholine chloride	hsa05332	Graft-versus-host disease	5551_3113	2	+	0.0423041340631832	0.33626392641615
7401	methacholine chloride	hsa04514	Cell adhesion molecules (CAMs)	26285_923_3113_26047_5817	5	+	0.00370445805245139	0.118542657678444
7402	methacholine chloride	hsa05330	Allograft rejection	5551_3113	2	+	0.0355481655853266	0.33626392641615
7403	methacholine chloride	hsa04940	Type I diabetes mellitus	3113_5551	2	+	0.0458483483889308	0.33626392641615
7404	methacholine chloride	hsa04070	Phosphatidylinositol signaling system	5298_8394_8396_3632_200576_23236	6	-	0.04746395480207	0.508542372879321
7405	methacholine chloride	hsa04740	Olfactory transduction	818_109_409	3	-	0.00283358890735424	0.0923640035213425
7406	methacholine chloride	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504	18	-	4.16428116433598e-06	0.000312321087325199
7407	methacholine chloride	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.0225069366043516	0.422005061331593
7408	methacholine chloride	hsa04060	Cytokine-cytokine receptor interaction	8795	1	-	0.0036945601408537	0.0923640035213425
7409	methacholine chloride	hsa04912	GnRH signaling pathway	5595_6654_818_109_8681_3725_100137049_23236	8	-	0.032677568363995	0.490163525459925
7410	methacholine chloride	hsa05330	Allograft rejection	3123_3126_3127_3125	4	-	0.0445845210398521	0.508542372879321
7411	phenacetin	hsa04520	Adherens junction	4301_7046_2260_8976	4	+	0.0334492832821649	0.361252259447381
7412	phenacetin	hsa04710	Circadian rhythm - mammal	1408_5187	2	+	0.0193438907526448	0.349679225149522
7413	phenacetin	hsa04920	Adipocytokine signaling pathway	3953_8660_181_4793	4	+	0.0194266236194179	0.349679225149522
7414	phenacetin	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0108660628994169	0.349679225149522
7415	phenacetin	hsa05220	Chronic myeloid leukemia	5925_7046_1488_867	4	+	0.0275128203459517	0.361252259447381
7416	phenacetin	hsa04080	Neuroactive ligand-receptor interaction	146_1812	2	-	0.013714387034456	0.528003900826556
7417	phenacetin	hsa04740	Olfactory transduction	818_4991	2	-	0.000183529606098064	0.0141317796695509
7418	mevalolactone	hsa05131	Shigellosis	7278_113457	2	+	0.0112847988455147	0.0940399903792892
7419	mevalolactone	hsa05130	Pathogenic Escherichia coli infection	7278_113457	2	+	0.0112847988455147	0.0940399903792892
7420	mevalolactone	hsa04540	Gap junction	7278_1956_113457	3	+	0.00234157610639841	0.0585394026599603
7421	mevalolactone	hsa04360	Axon guidance	10725_6092_64218	3	-	0.0160272827235329	0.352600219917724
7422	pridinol	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.00971912832011388	0.660900725767744
7423	pridinol	hsa05332	Graft-versus-host disease	3135_3105_3106_3133_649853	5	-	0.00753622017210579	0.209532847405063
7424	pridinol	hsa04080	Neuroactive ligand-receptor interaction	5021	1	-	0.0158663822551475	0.249860591363046
7425	pridinol	hsa05320	Autoimmune thyroid disease	3135_3105_3106_3133_649853	5	-	0.0178471850973604	0.249860591363046
7426	pridinol	hsa04612	Antigen processing and presentation	3105_3106_3135_6890_3133_649853	6	-	0.0388922662562935	0.388922662562935
7427	pridinol	hsa04350	TGF-beta signaling pathway	4090_3399_6667_5933_7040_7042	6	-	0.035596669442669	0.388922662562935
7428	pridinol	hsa05330	Allograft rejection	3135_3105_3106_3133_649853	5	-	0.00514821546903359	0.209532847405063
7429	pridinol	hsa04940	Type I diabetes mellitus	3135_3105_3106_3133_649853	5	-	0.00897997917450272	0.209532847405063
7430	hecogenin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	4.20232581421347e-06	0.000252139548852808
7431	hecogenin	hsa03450	Non-homologous end-joining	5591_27343	2	+	0.0414573591909282	0.924743534940724
7432	hecogenin	hsa04060	Cytokine-cytokine receptor interaction	5618	1	+	0.0462371767470362	0.924743534940724
7433	hecogenin	hsa05332	Graft-versus-host disease	3123_3106_355	3	-	0.0498572679633788	0.567324904360877
7434	hecogenin	hsa04115	p53 signaling pathway	836_355_6477_841	4	-	0.045682035316687	0.567324904360877
7435	hecogenin	hsa05330	Allograft rejection	3123_3106_355	3	-	0.0394889224638975	0.567324904360877
7436	pipenzolate bromide	hsa04640	Hematopoietic cell lineage	3589_3553_2057_3684	4	+	0.0210209154267953	0.651648378230654
7437	pipenzolate bromide	hsa04664	Fc epsilon RI signaling pathway	208_27040_5880_5581	4	+	0.0154990244655421	0.651648378230654
7438	pipenzolate bromide	hsa04010	MAPK signaling pathway	3553_1850_208_5880_7042_5971_3164	7	+	0.0435662206884184	0.680964286778673
7439	pipenzolate bromide	hsa04916	Melanogenesis	5331_6932_808_112_801_805	6	-	0.00996637832778833	0.122325475673662
7440	pipenzolate bromide	hsa05214	Glioma	1869_801_808_805	4	-	0.0276024456715908	0.228705978421752
7441	pipenzolate bromide	hsa04070	Phosphatidylinositol signaling system	8394_3633_5331_808_801_805	6	-	0.00238016500456005	0.0582461393255833
7442	pipenzolate bromide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	3.44010701225683e-07	1.99526206710896e-05
7443	pipenzolate bromide	hsa04720	Long-term potentiation	5331_6196_808_801_805	5	-	0.0105452996270398	0.122325475673662
7444	pipenzolate bromide	hsa04912	GnRH signaling pathway	2002_5331_808_112_6714_801_805	7	-	0.00301273134442672	0.0582461393255833
7445	pipenzolate bromide	hsa04270	Vascular smooth muscle contraction	5331_808_112_801_27345_805	6	-	0.0172130763357337	0.166393071245426
7446	isopropamide iodide	hsa05214	Glioma	1869_6655_5154_5290	4	-	0.0251091352117856	0.263645919723749
7447	isopropamide iodide	hsa04662	B cell receptor signaling pathway	7410_6655_4067_5290_4793	5	-	0.00935512257029235	0.196457573976139
7448	isopropamide iodide	hsa04510	Focal adhesion	7059_6655_1289_5154_5290_7410_29780_83660	8	-	0.0225795359011535	0.263645919723749
7449	isopropamide iodide	hsa04664	Fc epsilon RI signaling pathway	7410_6655_4067_5290	4	-	0.0449852364044118	0.339759151722458
7450	isopropamide iodide	hsa05223	Non-small cell lung cancer	1869_6655_6256_5290	4	-	0.0141084432742851	0.22220798156999
7451	isopropamide iodide	hsa04062	Chemokine signaling pathway	4067_6655_6777_5290_7852_7410_4793_23236_408	9	-	0.00541478948068691	0.170565868641638
7452	isopropamide iodide	hsa04010	MAPK signaling pathway	9344_3925_6655_1649_5154_4137_5607_4616_408	9	-	0.0485370216746369	0.339759151722458
7453	isopropamide iodide	hsa04540	Gap junction	7278_113457_5154_5607_6655_23236	6	-	0.00524851732092394	0.170565868641638
7454	isopropamide iodide	hsa05220	Chronic myeloid leukemia	1869_6655_6777_5290	4	-	0.0386171289321214	0.339759151722458
7455	glycopyrronium bromide	hsa04670	Leukocyte transendothelial migration	5829_93408_399_1432_3383	5	+	0.0287453126394953	0.881682851489241
7456	glycopyrronium bromide	hsa04740	Olfactory transduction	157	1	-	0.0320685237337246	0.83378161707684
7457	glycopyrronium bromide	hsa04710	Circadian rhythm - mammal	79365_1408	2	-	0.0213369669767314	0.83378161707684
7458	aminohippuric acid	hsa05332	Graft-versus-host disease	3105_3106_3107_3113_3135_649853	6	+	0.00431713774568821	0.0673473488327361
7459	aminohippuric acid	hsa05320	Autoimmune thyroid disease	958_3105_3106_3107_3113_3135_649853	7	+	0.00311748153070094	0.0607908898486683
7460	aminohippuric acid	hsa05016	Huntington's disease	7052	1	+	0.0339524481776207	0.24075372344131
7461	aminohippuric acid	hsa04740	Olfactory transduction	818_23538	2	+	0.000380470720614807	0.0216236904139341
7462	aminohippuric acid	hsa04514	Cell adhesion molecules (CAMs)	2734_958_3107_3105_3106_3680_3113_3135_57863_947_923_649853	12	+	0.0027797335856582	0.0607908898486683
7463	aminohippuric acid	hsa04510	Focal adhesion	5599_858_3680_1289_5602_1277_3690_7410_5880_29780_1292_6093_4233_3674	14	+	0.0179822372383217	0.175326813073637
7464	aminohippuric acid	hsa04360	Axon guidance	1949_80031_22885_2048_5880_4772_6093_4233_57556	9	+	0.0478694434700986	0.311151382555641
7465	aminohippuric acid	hsa04512	ECM-receptor interaction	960_3690_3680_1289_1277_1292_3674	7	+	0.0280406364716359	0.21871696447876
7466	aminohippuric acid	hsa04020	Calcium signaling pathway	2769_776_8913_56848_5333_818_6915_108_8911_6869_489_9630_491	13	+	0.013255021213826	0.147698807811204
7467	aminohippuric acid	hsa04930	Type II diabetes mellitus	8651_5599_776_8913_5602	5	+	0.0223282726495717	0.193511696296288
7468	aminohippuric acid	hsa05330	Allograft rejection	958_3105_3106_3107_3113_3135_649853	7	+	0.000554453600357285	0.0216236904139341
7469	aminohippuric acid	hsa04940	Type I diabetes mellitus	3105_3106_3107_3113_3135_649853	6	+	0.0052965248277045	0.0688548227601585
7470	phenyl biguanide	hsa05332	Graft-versus-host disease	3135_3134_355_3107_3133	5	+	0.00987849043215533	0.205400113367505
7471	phenyl biguanide	hsa05320	Autoimmune thyroid disease	3135_3134_355_3107_3133	5	+	0.0230298139487884	0.322417395283038
7472	phenyl biguanide	hsa04740	Olfactory transduction	26476	1	+	0.00039538288714154	0.0276768020999078
7473	phenyl biguanide	hsa05330	Allograft rejection	3135_3134_355_3107_3133	5	+	0.0067874478346152	0.205400113367505
7474	phenyl biguanide	hsa04940	Type I diabetes mellitus	3135_3134_355_3107_3133	5	+	0.011737149335286	0.205400113367505
7475	phenyl biguanide	hsa04740	Olfactory transduction	5137_26716	2	-	0.0357622234054987	1
7476	reserpine	hsa04080	Neuroactive ligand-receptor interaction	3953_3351_9038_5645_624	5	+	0.0312545541732194	0.718854745984046
7477	reserpine	hsa04080	Neuroactive ligand-receptor interaction	4886	1	-	0.0326176796437991	0.569185518640934
7478	reserpine	hsa04740	Olfactory transduction	219464	1	-	0.00260858237279785	0.161732107113467
7479	reserpine	hsa05322	Systemic lupus erythematosus	85235_3119_8330_8332_8969_8331_8329_8337_8336	9	-	0.00891407914643825	0.276336453539586
7480	reserpine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0367216463639312	0.569185518640934
7481	lomustine	hsa05219	Bladder cancer	4193_1956_7422_1613_1871	5	+	0.0133197836252826	0.959024421020347
7482	lomustine	hsa05010	Alzheimer's disease	5331_4698_5594	3	-	0.0497552506323472	0.70230181149029
7483	lomustine	hsa04080	Neuroactive ligand-receptor interaction	1241_5029_2149_7433	4	-	0.0108006846213062	0.295218712982369
7484	lomustine	hsa04740	Olfactory transduction	5137_219464_157	3	-	1.37692007171045e-05	0.00112907445880257
7485	lomustine	hsa05322	Systemic lupus erythematosus	89_85235_942_3123_55766_8330_3126_3127_3125_8332_8969_8331_8336_8343_8329_8339_8347_8346_8344	19	-	0.000238400879718131	0.00977443606844337
7486	orphenadrine	hsa05211	Renal cell carcinoma	5879_2271_56924_2034_8453_3725_1387	7	+	0.0493386609213554	0.464728294460475
7487	orphenadrine	hsa04080	Neuroactive ligand-receptor interaction	7067_1395_3356_2917	4	+	0.0272393826270423	0.42493436898186
7488	orphenadrine	hsa05200	Pathways in cancer	5371_331_1387_5337_5888_51176_3576_1612_2034_7471_2247_3918_8453_5467_91_3725_4791_2261_2271_5599_8817_355_5879_2064	24	+	0.0222043521130685	0.42493436898186
7489	orphenadrine	hsa05016	Huntington's disease	1387	1	+	0.00520789360413845	0.2031078505614
7490	orphenadrine	hsa04510	Focal adhesion	1280_93408_5829_858_331_56924_3918_5649_5599_7060_29780_3725_55742_5879_2064_10627	16	+	0.0402136269289492	0.464728294460475
7491	orphenadrine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_9103_8359_8294_720_721_121504_8367	17	+	0.000461278937688395	0.0359797571396948
7492	orphenadrine	hsa05219	Bladder cancer	1612_2064_3576_1890_2261	5	+	0.0474348866172392	0.464728294460475
7493	orphenadrine	hsa04010	MAPK signaling pathway	9479_9344_5607_8681_3164_2261_100137049_4776_2247_91_3725_4791_1848_5599_5598_4915_4137_8817_355_8911_5971_5879	22	+	0.0114255792587852	0.297065060728415
7494	orphenadrine	hsa04070	Phosphatidylinositol signaling system	8394_3708_5333_808_801_805_23236	7	-	0.0367881197069919	0.472114202906396
7495	orphenadrine	hsa04080	Neuroactive ligand-receptor interaction	2911_1081_7433	3	-	0.0196681938038295	0.470410607512026
7496	orphenadrine	hsa04740	Olfactory transduction	801_808_157_805	4	-	0.00158548574592459	0.122082402436193
7497	orphenadrine	hsa04720	Long-term potentiation	2911_3708_808_5534_801_805_23236	7	-	0.0347634501785031	0.472114202906396
7498	orphenadrine	hsa03450	Non-homologous end-joining	5591_27343_27434	3	-	0.0244369146759494	0.470410607512026
7499	orphenadrine	hsa04912	GnRH signaling pathway	4313_1081_5598_998_3708_808_3725_801_805_23236	10	-	0.0135952839437304	0.470410607512026
7500	phenelzine	hsa04910	Insulin signaling pathway	25759	1	+	0.0219056681868703	0.799556888820766
7501	phenelzine	hsa05016	Huntington's disease	1387_317_9001	3	+	0.0499454351963792	1
7502	phenelzine	hsa04740	Olfactory transduction	26211_8383_3000_4991	4	+	0.000218683396056784	0.0159638879121452
7503	phenelzine	hsa03440	Homologous recombination	57804_8940_8438_5890_5892_5893_7156_5888	8	-	0.0198164058192415	0.363293478312658
7504	phenelzine	hsa04080	Neuroactive ligand-receptor interaction	5618_7442_1081_2561_706_5025_1241_152_2150_7433_56288_5644_9170	13	-	0.00461460334502627	0.143052703695814
7505	phenelzine	hsa04740	Olfactory transduction	818_219464_109	3	-	7.7613548787084e-14	7.21806003719881e-12
7506	phenelzine	hsa05012	Parkinson's disease	4712_7054_65018_27429_513_291	6	-	0.0219855198285768	0.363293478312658
7507	phenelzine	hsa04060	Cytokine-cytokine receptor interaction	1436_5618_8744_3597_50616_3589_3594_5154_8741_8742_4982_91_655_4254_51330_8795	16	-	0.0234382889233973	0.363293478312658
7508	phenelzine	hsa03010	Ribosome	140801	1	-	0.000610553242789629	0.0283907257897177
7509	ketoprofen	hsa05332	Graft-versus-host disease	3824_3109_3119_3117_3804_3107_3126_3127_3125_356_3123_941	12	+	0.00094661881375068	0.0125005526663875
7510	ketoprofen	hsa04120	Ubiquitin mediated proteolysis	23327_326_7329	3	+	0.00471012093755311	0.0318838955772826
7511	ketoprofen	hsa04640	Hematopoietic cell lineage	1435_948_3690_3123_4254_3126_3127_1438_3125_947_915_931_3676_925	14	+	0.0401824088426981	0.196447332119857
7512	ketoprofen	hsa04662	B cell receptor signaling pathway	10000	1	+	0.0301953391960643	0.166074365578354
7513	ketoprofen	hsa05010	Alzheimer's disease	2903_776_1339_317_487_3709_810	7	+	0.0381660009615226	0.196447332119857
7514	ketoprofen	hsa04080	Neuroactive ligand-receptor interaction	151_2903_2901_624_2908_2925_185_117_135_2488_3360_5724_7434_2740_4987_4986_1395_5028_719_2917_2642_7433_4887_3356_3351_3350_3352_3269_5340_2555_2558_5617_6752_2692	34	+	0.0273258349000154	0.160311564746757
7515	ketoprofen	hsa05320	Autoimmune thyroid disease	3439_3449_3109_3119_3117_3123_3447_3107_3126_3127_3125_356_941_3448	14	+	0.000709450397632979	0.0124863269983404
7516	ketoprofen	hsa04612	Antigen processing and presentation	3439_3824_3449_972_3119_3805_3123_3447_3107_3126_3127_3125_3117_8302_3804_3109_925_3448	18	+	0.00328359316210711	0.0288956198265426
7517	ketoprofen	hsa05016	Huntington's disease	1339_4899_317_246721	4	+	0.000703134258100367	0.0124863269983404
7518	ketoprofen	hsa04740	Olfactory transduction	5593_8390_1179_818_5137_810_26659_9635_816	9	+	1.64822736965771e-06	0.000145044008529878
7519	ketoprofen	hsa04514	Cell adhesion molecules (CAMs)	23308_57863_22871_3676_3383_3123_3107_3126_3127_3125_25945_1462_4099_4359_3109_965_4684_3688_3119_6404_3117_947_3685_941_5797_57502_6693_925_26047_1000	30	+	1.54787273211128e-05	0.000681064002128963
7520	ketoprofen	hsa05322	Systemic lupus erythematosus	2903_8361_8363_8362_8365_8364_8367_8360_8368_9103_8290_8294_3109_3123_8366_3126_3127_3125_8370_718_8359_8330_554313_121504_8354_3119_3117_941_720_721	30	+	5.39342679847717e-05	0.00158207186088664
7521	ketoprofen	hsa04110	Cell cycle	699	1	+	0.000994362143917184	0.0125005526663875
7522	ketoprofen	hsa05310	Asthma	3109_3119_3117_3123_3126_3127_3125_8288	8	+	0.00920016476563788	0.0578296070982952
7523	ketoprofen	hsa05012	Parkinson's disease	1339_317	2	+	0.00137507378834176	0.0151258116717594
7524	ketoprofen	hsa03010	Ribosome	6165	1	+	0.00304420960595099	0.0288956198265426
7525	ketoprofen	hsa05330	Allograft rejection	3109_3119_3117_3123_3107_3126_3127_3125_356_941	10	+	0.00407730894123574	0.0299002655690621
7526	ketoprofen	hsa04940	Type I diabetes mellitus	3109_3119_3117_2572_3107_3126_3127_3125_356_3123_941	11	+	0.00369905262351077	0.0295924209880862
7527	ketoprofen	hsa04080	Neuroactive ligand-receptor interaction	64106_7067_2901_2149	4	-	0.0277685587584446	0.873678070808026
7528	ketoprofen	hsa04514	Cell adhesion molecules (CAMs)	214	1	-	0.0315787254508925	0.873678070808026
7529	ketoprofen	hsa05322	Systemic lupus erythematosus	6738	1	-	0.0219866634645818	0.873678070808026
7530	nefopam	hsa05016	Huntington's disease	4899_54205	2	+	0.00934271235758522	0.383051206660994
7531	nefopam	hsa04740	Olfactory transduction	51806_8388_8387_5566_8390_3000_81797	7	+	0.00175321616375842	0.14376372542819
7532	nefopam	hsa05012	Parkinson's disease	54205	1	+	0.0151064105793025	0.412908555834268
7533	nefopam	hsa05322	Systemic lupus erythematosus	85235_8330_8969_8332_88_8331_8336_6737_8970_8329	10	-	0.044062789774344	1
7534	prilocaine	hsa05211	Renal cell carcinoma	10298_2549_5155_3845_7042_7039	6	+	0.0470513549039355	0.611667613751162
7535	prilocaine	hsa05016	Huntington's disease	4695	1	+	0.0226761715028004	0.58958045907281
7536	prilocaine	hsa04740	Olfactory transduction	26212_5566	2	+	0.00026469355062814	0.0206460969489949
7537	prilocaine	hsa04540	Gap junction	5578_5566_56034_5155_3709_3356_3845_1902	8	+	0.0202854515683381	0.58958045907281
7538	prilocaine	hsa04730	Long-term depression	5578_3480_3709_8681_3845_100137049	6	+	0.0446377178902309	0.611667613751162
7539	prilocaine	hsa04270	Vascular smooth muscle contraction	5578_4882_3778_3709_8681_6093_4638_100137049_5566	9	+	0.0399526043772686	0.611667613751162
7540	prilocaine	hsa04080	Neuroactive ligand-receptor interaction	146_1813_3953_3354_7433_2149	6	-	0.00227143896063194	0.0666288761785369
7541	prilocaine	hsa05200	Pathways in cancer	4088_598_331_9618_5291_5881_6772_652671_3675_4149_7157_5371_1613_1856_405_1398_1017_581_208_999_4193_4254_5467_91_4286_3918_4233_4791_1021_5594_841_5599_867_6789_2258_5914	36	-	0.0182012070621105	0.400426555366431
7542	prilocaine	hsa04740	Olfactory transduction	818_51806	2	-	1.86186637940208e-09	1.63844241387383e-07
7543	prilocaine	hsa04210	Apoptosis	841_581_7157_598_11261_331_5291_208_5576_8737_8794_5575	12	-	0.0419947626956735	0.583237037654616
7544	prilocaine	hsa04370	VEGF signaling pathway	9261_1432_5594_5829_208_11261_5291_7867_5881_8398_6714	11	-	0.0471837233180179	0.583237037654616
7545	prilocaine	hsa05012	Parkinson's disease	7327	1	-	0.00152194351539649	0.0666288761785369
7546	prilocaine	hsa05220	Chronic myeloid leukemia	1021_5594_4088_208_4193_867_5291_7157_1398_91_598	11	-	0.028455777215682	0.500821678996003
7547	metoclopramide	hsa04740	Olfactory transduction	442194_9635_816_1258	4	+	0.00217049980141495	0.160616985304706
7548	metoclopramide	hsa04514	Cell adhesion molecules (CAMs)	6402_965_3688_3119_3685_941_5818_57863_51208_6383	10	+	0.0406748810381988	0.888046127787246
7549	metoclopramide	hsa04920	Adipocytokine signaling pathway	51703_10000_10645_5465_5602_4852	6	+	0.0480024933939052	0.888046127787246
7550	metoclopramide	hsa02010	ABC transporters	11194_5244_64137_5243_8714_10347	6	+	0.00888763137452364	0.328842360857375
7551	metoclopramide	hsa04740	Olfactory transduction	51806_26212_26529	3	-	0.0143554376892119	0.976169762866409
7552	metoclopramide	hsa04115	p53 signaling pathway	355_25898_4193_841_4616	5	-	0.045493433403756	1
7553	hydralazine	hsa04662	B cell receptor signaling pathway	10000_6655_5532_7410_5880_933_4793	7	+	0.0209785192462521	0.440548904171294
7554	hydralazine	hsa04740	Olfactory transduction	810_26476_7932	3	+	0.00140928702008936	0.0591900548437531
7555	hydralazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_716_3113_8359_8294_8367_554313_8368_121504_8354	17	+	3.16096956042277e-05	0.00265521443075513
7556	hydralazine	hsa04062	Chemokine signaling pathway	2785_4283_10000_2185_6655_2788_3718_7852_7410_5880_10235_6363_6093_4793	14	+	0.0170550302216293	0.440548904171294
7557	hydralazine	hsa04080	Neuroactive ligand-receptor interaction	1909_1813_3953_2917_3354_7067_7433_64106	8	-	0.0361732547050368	0.799777666545456
7558	hydralazine	hsa04740	Olfactory transduction	26212_5566_157	3	-	7.10074021932403e-08	5.96462178423218e-06
7559	hydralazine	hsa05012	Parkinson's disease	2861_7419	2	-	0.0180998625507301	0.760194227130664
7560	6-benzylaminopurine	hsa05332	Graft-versus-host disease	3119_3126_3107_3113_3127_3125_3123_941	8	+	0.0129086279152258	0.138767750088677
7561	6-benzylaminopurine	hsa04120	Ubiquitin mediated proteolysis	7320_5371	2	+	0.00866044483794801	0.106399750866218
7562	6-benzylaminopurine	hsa04640	Hematopoietic cell lineage	1435_947_3690_3123_3126_3127_3125_7850_3589_1378_290_3675	12	+	0.0342163811913074	0.245217398537703
7563	6-benzylaminopurine	hsa05010	Alzheimer's disease	775_487_4695_4137	4	+	0.0196480610346809	0.168973324898256
7564	6-benzylaminopurine	hsa05320	Autoimmune thyroid disease	3119_3113_3107_3126_3127_3125_3123_7038_941	9	+	0.0159479415609006	0.152391441581939
7565	6-benzylaminopurine	hsa05016	Huntington's disease	7350_4695	2	+	0.000754109317335296	0.0216178004302785
7566	6-benzylaminopurine	hsa04740	Olfactory transduction	5593_56656	2	+	3.9449331099457e-09	3.3926424745533e-07
7567	6-benzylaminopurine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8294_3123_3126_3127_3125_8370_717_8359_554313_121504_3119_3113_941	23	+	0.000560914625241076	0.0216178004302785
7568	6-benzylaminopurine	hsa05310	Asthma	3119_3123_3113_3127_3126_3125	6	+	0.0246949002810761	0.193069220379322
7569	6-benzylaminopurine	hsa05012	Parkinson's disease	4695	1	+	0.00226004020119371	0.0429732105095585
7570	6-benzylaminopurine	hsa05330	Allograft rejection	3592_3119_3113_3107_3126_3127_3125_3123_941	9	+	0.00249844247148596	0.0429732105095585
7571	6-benzylaminopurine	hsa04940	Type I diabetes mellitus	3592_3119_3113_3107_3126_3127_3125_3123_941	9	+	0.0057829211235433	0.0828885361041206
7572	6-benzylaminopurine	hsa04916	Melanogenesis	107	1	-	0.045569594775994	0.663883832387624
7573	6-benzylaminopurine	hsa05010	Alzheimer's disease	3708	1	-	0.00111194045285329	0.0461455287934115
7574	6-benzylaminopurine	hsa04080	Neuroactive ligand-receptor interaction	7067_3354	2	-	0.00012215651263267	0.0101389905485116
7575	6-benzylaminopurine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_6737_8359_8294_8367_554313_6738_121504	16	-	0.0189864149132808	0.393968109450577
7576	6-benzylaminopurine	hsa05012	Parkinson's disease	7419	1	-	0.0109419188088315	0.302726420377672
7577	6-benzylaminopurine	hsa04020	Calcium signaling pathway	3708_7419_814_107	4	-	0.047991602341274	0.663883832387624
7578	tropicamide	hsa04120	Ubiquitin mediated proteolysis	4214	1	+	0.0219157694854773	0.560463851052929
7579	tropicamide	hsa05016	Huntington's disease	1213_7802_7350	3	+	0.049897974756834	0.560463851052929
7580	tropicamide	hsa04740	Olfactory transduction	51806_5566_8383_5132	4	+	0.000214530906783734	0.016947941635915
7581	tropicamide	hsa05012	Parkinson's disease	9627	1	+	0.0327129104651748	0.560463851052929
7582	tropicamide	hsa04740	Olfactory transduction	26212_157_816	3	-	6.68333019860111e-06	0.000561399736682493
7583	tropicamide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_88_8294_8367_554313_121504	15	-	0.0148984269339157	0.31286696561223
7584	tropicamide	hsa05221	Acute myeloid leukemia	8503_6934_3551_208_6655_5371_3845_5467_652671	9	-	0.00600638612682333	0.25226821732658
7585	tropicamide	hsa04664	Fc epsilon RI signaling pathway	8503_208_6655_8681_5335_5603_3845_100137049_5606	9	-	0.0407212547546559	0.423108936152728
7586	tropicamide	hsa04370	VEGF signaling pathway	8503_5829_208_9261_8681_3845_5603_5335_6714_100137049	10	-	0.0104534550088365	0.292696740247422
7587	tropicamide	hsa05223	Non-small cell lung cancer	8503_5170_208_6655_5335_3845_6257	7	-	0.0300541835089082	0.423108936152728
7588	lomefloxacin	hsa04120	Ubiquitin mediated proteolysis	6502_9063_867	3	+	0.0494223208638813	0.849198870067477
7589	lomefloxacin	hsa05016	Huntington's disease	5330_1211_7416_4695_581	5	+	0.0461634532092102	0.849198870067477
7590	lomefloxacin	hsa04740	Olfactory transduction	810_4991_1179_816_390892	5	+	2.64593368793205e-06	0.00021961249609836
7591	lomefloxacin	hsa05012	Parkinson's disease	4695_7416	2	+	0.0179558162098714	0.745166372709663
7592	lomefloxacin	hsa04740	Olfactory transduction	818_5613_26212_5566_4991	5	-	0.00316069935844155	0.256016648033766
7593	lomefloxacin	hsa04710	Circadian rhythm - mammal	9572_5187_8863	3	-	0.0223327227737794	0.904475272338066
7594	famprofazone	hsa05332	Graft-versus-host disease	3553_3126_3113_3127_3111_3125_5551_3123	8	+	0.00444390467804229	0.0773239413979358
7595	famprofazone	hsa05320	Autoimmune thyroid disease	3441_3126_3127_3111_3125_5551_3123_3113	8	+	0.0146776716370339	0.159619679052744
7596	famprofazone	hsa04740	Olfactory transduction	8392_26476_7932_23538_816	5	+	4.40238658745773e-05	0.00191503816554411
7597	famprofazone	hsa04514	Cell adhesion molecules (CAMs)	4684_8174_3383_9369_3123_1272_3126_3127_3111_3125_23308_51208_3113_923_25945_3897_26047_5817	18	+	0.00136514469941195	0.0296918972122099
7598	famprofazone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_9103_8294_8341_8340_3123_3126_3127_3125_8370_8359_554313_121504_3113_3111	23	+	2.33913167700386e-05	0.00191503816554411
7599	famprofazone	hsa05310	Asthma	3123_3126_3127_3111_3125_3113	6	+	0.0108295686557672	0.134596067578821
7600	famprofazone	hsa05330	Allograft rejection	3113_3126_3127_3111_3125_5551_3123	7	+	0.00890538354038763	0.129128061335621
7601	famprofazone	hsa04940	Type I diabetes mellitus	3382_3113_3126_3127_3111_2571_5551_3123_3553_3125	10	+	0.000468599120033784	0.0135893744809797
7602	famprofazone	hsa05332	Graft-versus-host disease	3553_3126_3107_3113_3127_3125_355_5551_3123	9	-	0.00887460270674311	0.179951732598306
7603	famprofazone	hsa04080	Neuroactive ligand-receptor interaction	5618_4157_1081_1813_7067_134_6754_3354_7433_2740	10	-	0.0290299669492919	0.280623013843155
7604	famprofazone	hsa05320	Autoimmune thyroid disease	3451_1081_3113_3107_3126_3127_3125_355_5551_3123	10	-	0.012547450992757	0.179951732598306
7605	famprofazone	hsa04310	Wnt signaling pathway	5566_23236_6934_5578	4	-	0.0259758143842097	0.280623013843155
7606	famprofazone	hsa05016	Huntington's disease	7419_2776_23236	3	-	0.000891920270586204	0.0258656878469999
7607	famprofazone	hsa04740	Olfactory transduction	810_51806_26212_5566_157	5	-	1.00363543018868e-07	4.36581412132076e-06
7608	famprofazone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113_727_720_721	38	-	1.07121191347704e-09	9.31954364725025e-08
7609	famprofazone	hsa05012	Parkinson's disease	2861_7419_7054_5413	4	-	0.046211688218365	0.402041687499775
7610	famprofazone	hsa05330	Allograft rejection	3113_3107_3126_3127_3125_355_5551_3123	8	-	0.0144788750366453	0.179951732598306
7611	famprofazone	hsa04940	Type I diabetes mellitus	3553_3113_3107_3126_3127_3125_355_5551_3123	9	-	0.0113972137453669	0.179951732598306
7612	Prestwick-689	hsa04740	Olfactory transduction	26333_23538	2	+	0.00922799044995205	0.29068169917349
7613	Prestwick-689	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	1.64384544462594e-05	0.00103562263011434
7614	Prestwick-689	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0367216463639312	0.771154573642555
7615	Prestwick-689	hsa04080	Neuroactive ligand-receptor interaction	3953_56288	2	-	0.013714387034456	0.236573176344366
7616	Prestwick-689	hsa04740	Olfactory transduction	5566	1	-	2.53984994896457e-05	0.000876248232392777
7617	Prestwick-689	hsa05322	Systemic lupus erythematosus	8358_85235_8968_3013_8330_8332_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357	18	-	1.14450882666075e-05	0.000789711090395918
7618	Prestwick-689	hsa04060	Cytokine-cytokine receptor interaction	3953_5155	2	-	0.00935570012362533	0.215181102843383
7619	rotenone	hsa05332	Graft-versus-host disease	3812_3824_3125_3107_3126_3127_3558_356_3811_3123_3802	11	+	0.00714125337650736	0.157107574283162
7620	rotenone	hsa05131	Shigellosis	51807_347688_3688_7278_113457_9475_56604_10382_9181_7430_6093_2534	12	+	0.0302393301960993	0.281028648324627
7621	rotenone	hsa05016	Huntington's disease	2902_246721_627_1639_317_7350_5978_7416_6875	9	+	0.0236685493059472	0.281028648324627
7622	rotenone	hsa05130	Pathogenic Escherichia coli infection	51807_347688_3688_7278_113457_9475_56604_10382_9181_7430_6093_2534	12	+	0.0302393301960993	0.281028648324627
7623	rotenone	hsa04740	Olfactory transduction	26211_4993_390892_5137_816_81797	6	+	4.71170096857391e-10	4.14629685234504e-08
7624	rotenone	hsa04510	Focal adhesion	23533_1301_1302_2909_5155_5154_9475_5649_5602_87_3674_2321_5063_3690_2889_3695_93408_1399_29780_55742_1291_29895_8515_1311_331_3908_1950_3725_6093_2335_1284_3688_7148_2318_5579_1282_5599_6655_7422_824_6696_2534	42	+	7.21132146484916e-05	0.00317298144453363
7625	rotenone	hsa04360	Axon guidance	9475_7852_9037_23365_27289_1949_57715_5063_1944_10154_5533_4772_10501_6093_10505_64218_1969_5362_3688_9901_6405_2534	22	+	0.0319350736732531	0.281028648324627
7626	rotenone	hsa04512	ECM-receptor interaction	1284_8515_7148_1302_1311_1282_3690_3908_3695_5649_3688_2335_961_1291_6696_3674_1301	17	+	0.0131051455938834	0.230650562452348
7627	rotenone	hsa05012	Parkinson's disease	9627_7416_6622_317_7054	5	+	0.0174459988650815	0.255874650021195
7628	rotenone	hsa03010	Ribosome	140801_6141	2	+	0.00552166988572273	0.157107574283162
7629	rotenone	hsa05016	Huntington's disease	4899_6648_841_6390_3708_9001_7419_161	8	-	0.0443601495060281	0.767681020265841
7630	rotenone	hsa04740	Olfactory transduction	26529_9635	2	-	8.57966991014288e-12	7.20692272452002e-10
7631	rotenone	hsa05322	Systemic lupus erythematosus	8348_8329_8343_8347_8346_8344_8339_8969_8968_8358_8330_8331_8336_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013_942_3017_3014_720_721	31	-	2.33773508566645e-05	0.000981848735979909
7632	betonicine	hsa04640	Hematopoietic cell lineage	2814_1435_3553_2057_3815_3690_3574_2812_952_920_7850_926_914_933_1378_3589_3676_925_3674_960	20	+	0.00461170228703138	0.136813834515264
7633	betonicine	hsa05010	Alzheimer's disease	4713_3553_2904_54205_509_487_348	7	+	0.00368329275959955	0.136813834515264
7634	betonicine	hsa05016	Huntington's disease	246721_5439_4713_2904_54205_64446_10540_509_548644_291	10	+	0.0212617008987103	0.378458275997043
7635	betonicine	hsa04740	Olfactory transduction	26211_5593_5592_5566_26664_9635_815_1258	8	+	7.58143155998648e-10	6.74747408838797e-08
7636	betonicine	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_2904_8368_6737_8360_8362_8294_8341_8340_8366_8370_8359_554313_121504_8354_83740_3113_3111_729	25	+	0.0357226628079994	0.397414623738993
7637	betonicine	hsa04110	Cell cycle	6502_699_1029_4193_8556	5	+	0.0315766539824693	0.397414623738993
7638	betonicine	hsa03450	Non-homologous end-joining	27343_27434_2547_3981_10111	5	+	0.0323197133889227	0.397414623738993
7639	betonicine	hsa04512	ECM-receptor interaction	8516_2814_1291_1281_22798_1311_2812_3690_3695_3685_7060_5649_1284_7148_960_1277_3676_6696_3674	19	+	0.0066400258503945	0.147740575171278
7640	betonicine	hsa05012	Parkinson's disease	4713_5413_54205_6531_7345_509_291	7	+	0.0467198240750485	0.462007149186591
7641	betonicine	hsa05211	Renal cell carcinoma	2271_208_6655_6513_405_3845_7422_7042_3725_4233	10	-	0.0125594898519884	0.33765785143136
7642	betonicine	hsa05200	Pathways in cancer	8030_4088_9618_5881_10342_5888_8321_7184_3675_6513_5371_405_208_4193_3918_1956_7042_91_3725_4233_1436_2271_6502_6655_7189_355_3845_7422_6257	29	-	0.0319972017914979	0.359287933394523
7643	betonicine	hsa04740	Olfactory transduction	219464	1	-	1.38558781337719e-08	1.1361820069693e-06
7644	betonicine	hsa04514	Cell adhesion molecules (CAMs)	3135_5817	2	-	0.034820237342931	0.359287933394523
7645	betonicine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8367_554313_3017_8359_55766_8337_720_721_121504_8294	19	-	0.00135906525730052	0.0557216755493213
7646	betonicine	hsa04350	TGF-beta signaling pathway	7059_4086_4088_7057_9475_91_7027_653_7042_10637_57154	11	-	0.020588893379961	0.33765785143136
7647	betonicine	hsa05012	Parkinson's disease	2861_7419	2	-	0.0350524813067827	0.359287933394523
7648	betonicine	hsa05210	Colorectal cancer	4088_208_6655_4233_5881_1956_3845_7042_91_3725_8321	11	-	0.0181702240632858	0.33765785143136
7649	BAS-012416453	hsa04080	Neuroactive ligand-receptor interaction	3354	1	+	0.0011580126140762	0.0503735487123147
7650	BAS-012416453	hsa04740	Olfactory transduction	5567	1	+	1.16979404802778e-05	0.00101772082178417
7651	BAS-012416453	hsa05214	Glioma	818_5728_5155_5154_673_5605_1869	7	-	0.0217971142280249	0.25222375035286
7652	BAS-012416453	hsa04080	Neuroactive ligand-receptor interaction	5025_5031	2	-	0.00479259060311773	0.0835214557057366
7653	BAS-012416453	hsa05014	Amyotrophic lateral sclerosis (ALS)	842_572_5630_5606_5534_6300	6	-	0.0332481601095482	0.299233440985934
7654	BAS-012416453	hsa04740	Olfactory transduction	818	1	-	5.53817030050105e-06	0.000224295897170293
7655	BAS-012416453	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_8362_8294_121504_8366_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_83740_3013_3014	29	-	2.2444992027469e-11	1.81804435422499e-09
7656	BAS-012416453	hsa05212	Pancreatic cancer	5728_842_3551_572_4824_5155_5154_673_5605_1869	10	-	0.00515564541393436	0.0835214557057366
7657	BAS-012416453	hsa05215	Prostate cancer	5728_842_3551_572_4824_5155_5154_673_5605_1869	10	-	0.00479665498388312	0.0835214557057366
7658	BAS-012416453	hsa05218	Melanoma	5728_572_5155_5154_673_5605_1869	7	-	0.0321191121173106	0.299233440985934
7659	BAS-012416453	hsa05223	Non-small cell lung cancer	842_6789_572_673_5605_1869_6257	7	-	0.00927611476609693	0.125227549342309
7660	BAS-012416453	hsa03020	RNA polymerase	246721_5439_548644_5434	4	-	0.0382566549173084	0.309878904830198
7661	BAS-012416453	hsa04912	GnRH signaling pathway	4215_115_3709_5598_2776_818_5606_5605_6300	9	-	0.0483888143982501	0.345601940969411
7662	iopanoic acid	hsa05332	Graft-versus-host disease	3107_3119_3811_3802	4	+	0.0416223800195423	0.717986055337105
7663	iopanoic acid	hsa04740	Olfactory transduction	810	1	+	0.000255603592996059	0.00881832395836404
7664	iopanoic acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_718_8368_8366_8359_3119_8294_8367_554313_121504_8341	17	+	3.32188141662011e-06	0.000229209817746788
7665	iopanoic acid	hsa04912	GnRH signaling pathway	8398_3710_6655_3709_1956_5337_810_10746_6714	9	+	0.00624826828562504	0.143710170569376
7666	iopanoic acid	hsa04710	Circadian rhythm - mammal	9572_5187	2	-	0.0373935813470889	1
7667	iopanoic acid	hsa04010	MAPK signaling pathway	57551_4149_3925_5154_5607_5606_5600_7043_5534_7786_8398_4763_408	13	-	0.008754411631624	0.534019109529064
7668	SB-202190	hsa04740	Olfactory transduction	818_219464_8390_56656_157	5	+	0.00168058600624962	0.13276629449372
7669	SB-202190	hsa04912	GnRH signaling pathway	50487_1081_5578_5598_1839_818_5600_3725_6714_5609	10	+	0.0302281773156623	1
7670	SB-202190	hsa04640	Hematopoietic cell lineage	960	1	-	0.0212586757921918	0.369900958784137
7671	SB-202190	hsa04080	Neuroactive ligand-receptor interaction	9568_1241_2908_5025_4886	5	-	0.000159247727024222	0.00461818408370244
7672	SB-202190	hsa04740	Olfactory transduction	818_26212_157	3	-	6.42105956196653e-10	2.79316090945544e-08
7673	SB-202190	hsa04514	Cell adhesion molecules (CAMs)	3135_3106_1365_4267	4	-	0.0467879150867866	0.428850529559301
7674	SB-202190	hsa05322	Systemic lupus erythematosus	55506_8361_8363_8362_8365_8364_8367_8360_8368_8329_8294_121504_8343_8347_8346_8344_8339_8366_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3014_727	40	-	3.48127837295041e-10	2.79316090945544e-08
7675	SB-202190	hsa04010	MAPK signaling pathway	8399_7157_6655_2005_5605_5607_1956_5606_5536_10454_5970_2264	12	-	0.0379824407021978	0.428850529559301
7676	SB-202190	hsa04060	Cytokine-cytokine receptor interaction	3597_23529_7852_1956_9180_8718_93_4233_51330	9	-	0.00653436941606093	0.142122534799325
7677	SB-202190	hsa03010	Ribosome	6234_6165	2	-	0.0348272299021716	0.428850529559301
7678	SB-202190	hsa04020	Calcium signaling pathway	6262_5025_818_3708_1956_7416_5335	7	-	0.049293164317161	0.428850529559301
7679	SB-202190	hsa05213	Endometrial cancer	3611_8503_842_7157_572_6655_5605_1956_324	9	-	0.0428940919002331	0.428850529559301
7680	naftidrofuryl	hsa04740	Olfactory transduction	810_51806_81697_8392_5137	5	+	2.25283519937858e-05	0.00189238156747801
7681	naftidrofuryl	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3117_8368_941_8359_8294_8367_554313_121504_3119	17	+	0.0132833331879238	0.415186226209807
7682	naftidrofuryl	hsa04110	Cell cycle	1017	1	+	0.0148280795074931	0.415186226209807
7683	naftidrofuryl	hsa04130	SNARE interactions in vesicular transport	9570_662_6844	3	-	0.0442670963237931	0.435293113850632
7684	naftidrofuryl	hsa05131	Shigellosis	7278_7280_113457_347733	4	-	0.0284449811948861	0.435293113850632
7685	naftidrofuryl	hsa05130	Pathogenic Escherichia coli infection	7278_7280_113457_347733	4	-	0.0284449811948861	0.435293113850632
7686	naftidrofuryl	hsa05322	Systemic lupus erythematosus	3013_8343_8351_8339_8347_8346_8344	7	-	0.027094970572618	0.435293113850632
7687	naftidrofuryl	hsa03450	Non-homologous end-joining	27343_7518	2	-	0.0373051800847943	0.435293113850632
7688	naftidrofuryl	hsa04540	Gap junction	7278_7280_113457_2776_347733	5	-	0.0410789484152188	0.435293113850632
7689	pentoxyverine	hsa05010	Alzheimer's disease	6390	1	+	0.00761087523036492	0.300629571599414
7690	pentoxyverine	hsa04740	Olfactory transduction	816	1	+	1.13791519568266e-06	8.98953004589301e-05
7691	pentoxyverine	hsa05218	Melanoma	1021_5154_5290_8817_1956_2258_2260	7	+	0.049801887977372	1
7692	pentoxyverine	hsa04080	Neuroactive ligand-receptor interaction	1269_2925_1812	3	-	0.00277832106916355	0.0777929899365794
7693	pentoxyverine	hsa04740	Olfactory transduction	5567_157	2	-	1.39718033015293e-06	5.86815738664231e-05
7694	pentoxyverine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8347_8346_8344_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235	26	-	1.41455818072148e-07	1.18822887180604e-05
7695	pentoxyverine	hsa05221	Acute myeloid leukemia	2475_3551_5371_8503_6932_3845_5914	7	-	0.0383892281698721	0.644939033253851
7696	pentoxyverine	hsa04060	Cytokine-cytokine receptor interaction	23529_5155_8742_8741	4	-	0.00804802795322955	0.169008587017821
7697	clomifene	hsa04740	Olfactory transduction	2979_816_390892	3	+	4.79041264288215e-07	1.94011712036727e-05
7698	clomifene	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8348_8294_121504_8343_8347_8352_8344_8339_8346_8968_8370_8358_8359_8335_8350_8351_7124_8353_8354_8355_8356_8357_2215_3012_3013_8970	36	+	1.60411689217754e-11	1.29933468266381e-09
7699	clomifene	hsa04062	Chemokine signaling pathway	115_5290_5293_4792	4	+	0.0268655435653199	0.544027257197728
7700	clomifene	hsa05012	Parkinson's disease	4698	1	+	0.00742412070784412	0.200451259111791
7701	clomifene	hsa04080	Neuroactive ligand-receptor interaction	4889_5618_4886	3	-	0.00033360267202364	0.0138445108889811
7702	clomifene	hsa04740	Olfactory transduction	157	1	-	4.07005848949882e-09	3.37814854628402e-07
7703	clomifene	hsa03450	Non-homologous end-joining	5591_27343_3981_7518	4	-	0.0168217907864372	0.349052158818572
7704	clomifene	hsa04060	Cytokine-cytokine receptor interaction	5618_2057_8742_8741_6387_4233	6	-	0.0104439363037223	0.288948904402984
7705	clomifene	hsa04020	Calcium signaling pathway	115_7419_5335_2776	4	-	0.0366160890985552	0.607827079036016
7706	zoxazolamine	hsa05332	Graft-versus-host disease	3105_3106_3126_3127_3111_3125_3135_3123_3002_649853	10	+	3.45047562220787e-05	0.000483066587109102
7707	zoxazolamine	hsa05320	Autoimmune thyroid disease	3449_3105_3106_3126_3127_3111_3125_3135_3123_3002_649853	11	+	4.23131571105572e-05	0.000493653499623167
7708	zoxazolamine	hsa04612	Antigen processing and presentation	3449_972_3123_3106_3126_3127_3111_3125_3135_6892_3105_649853	12	+	0.000711867507046804	0.00711867507046804
7709	zoxazolamine	hsa05016	Huntington's disease	64446_7416	2	+	0.0370554572184784	0.235807455026681
7710	zoxazolamine	hsa04740	Olfactory transduction	23538_4991	2	+	2.95861919977306e-05	0.000483066587109102
7711	zoxazolamine	hsa04514	Cell adhesion molecules (CAMs)	8174_3123_3106_3126_3127_3696_3125_3135_3111_3105_7122_649853	12	+	0.0170155190287548	0.132342925779204
7712	zoxazolamine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8290_8294_3123_3126_3127_3125_8370_8359_554313_121504_8354_2215_3111	22	+	7.82939893524359e-07	5.48057925467051e-05
7713	zoxazolamine	hsa05310	Asthma	3123_3126_3127_3111_3125	5	+	0.0123213403777058	0.107811728304926
7714	zoxazolamine	hsa04512	ECM-receptor interaction	1281_1302_3910_3691_3696_1277_3371_3918	8	+	0.0314728147402357	0.22030970318165
7715	zoxazolamine	hsa05012	Parkinson's disease	7416	1	+	0.0458603339482676	0.267518614698228
7716	zoxazolamine	hsa05330	Allograft rejection	3105_3106_3126_3127_3111_3125_3135_3123_3002_649853	10	+	1.64752962380288e-05	0.000384423578887339
7717	zoxazolamine	hsa04940	Type I diabetes mellitus	2572_3105_3106_3126_3127_3111_3125_3135_3123_3002_649853	11	+	9.43297264644258e-06	0.00033015404262549
7718	zoxazolamine	hsa04080	Neuroactive ligand-receptor interaction	7067	1	-	0.00750359501760403	0.273881218142547
7719	zoxazolamine	hsa04740	Olfactory transduction	157	1	-	0.000261394934177306	0.0190818301949433
7720	zoxazolamine	hsa03010	Ribosome	440589_6187_284393_439992_6129_389342_6189	7	-	0.0380402574106284	0.847796512303492
7721	N6-methyladenosine	hsa04740	Olfactory transduction	26476	1	+	5.95646130584261e-05	0.00452691059244038
7722	N6-methyladenosine	hsa04912	GnRH signaling pathway	8399_1081_6655_115_3708_5603_3725_5338_23236	9	+	0.0159079505819345	0.604502122113511
7723	N6-methyladenosine	hsa04730	Long-term depression	8399_2775_5519_3708_4842_23236	6	+	0.0426609562112888	1
7724	N6-methyladenosine	hsa05131	Shigellosis	7278_7280_113457_347733	4	-	0.0117784090347648	0.164136751368885
7725	N6-methyladenosine	hsa05130	Pathogenic Escherichia coli infection	7278_7280_113457_347733	4	-	0.0117784090347648	0.164136751368885
7726	N6-methyladenosine	hsa05322	Systemic lupus erythematosus	85235_3013_8330_3014_8332_8969_8331_8329_8351_8343_8336_8339_8347_8346_8344	15	-	1.13497837548145e-08	4.99390485211838e-07
7727	N6-methyladenosine	hsa04540	Gap junction	7278_7280_113457_2776_347733	5	-	0.0149215228517168	0.164136751368885
7728	chlorprothixene	hsa04740	Olfactory transduction	1179	1	+	1.65156179288403e-06	6.27593481295931e-05
7729	chlorprothixene	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8329_8294_121504_8343_8347_8346_8344_8339_8969_8968_8370_8358_8359_8330_8331_8336_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3012_3013_942_940_8970	42	+	5.99520898357204e-20	4.55635882751475e-18
7730	cefalexin	hsa04662	B cell receptor signaling pathway	3551_5880_5293_8519_4776_7410_4775_3725_4793	9	+	0.00163176883803979	0.041338143897008
7731	cefalexin	hsa05010	Alzheimer's disease	4714	1	+	0.0321274349346442	0.348812150718994
7732	cefalexin	hsa04660	T cell receptor signaling pathway	3551_5293_867_3558_4776_7410_4775_3725_4793	9	+	0.0159210350070232	0.282146655755364
7733	cefalexin	hsa04740	Olfactory transduction	7932	1	+	5.55331539843723e-05	0.0042205197028123
7734	cefalexin	hsa04510	Focal adhesion	3679_22798_93408_5599_3691_2909_5880_5293_3690_7410_1956_3725_3082_2335	14	+	0.0185622799839055	0.282146655755364
7735	cefalexin	hsa05322	Systemic lupus erythematosus	718_3013_3113_8358_8968_8335_8350_8351_8352_8353_8354_8355_8356_8357	14	+	0.000663446535568897	0.0252109683516181
7736	cefalexin	hsa05210	Colorectal cancer	4088_5880_5293_5599_1956_3725_8326	7	+	0.0292035299415723	0.348812150718994
7737	cefalexin	hsa04080	Neuroactive ligand-receptor interaction	1269_4157_1081_1813_64106_2908	6	-	0.0183911447583801	0.754036935093584
7738	cefalexin	hsa04740	Olfactory transduction	4991	1	-	1.39663966856222e-08	1.14524452822102e-06
7739	cefalexin	hsa05012	Parkinson's disease	7419_517	2	-	0.0350918422312719	0.959177020988099
7740	bepridil	hsa05010	Alzheimer's disease	4695_3553_4842_23236	4	+	0.0193139884760702	0.488465594293595
7741	bepridil	hsa04740	Olfactory transduction	26211_8392_390892	3	+	5.02469627739154e-08	4.47197968687847e-06
7742	bepridil	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8290_3013_554313_8366_3111_8359_8294_8367_121504_8368_8351	18	+	0.0205671829204005	0.488465594293595
7743	bepridil	hsa03010	Ribosome	6234	1	+	0.0219535098558919	0.488465594293595
7744	bepridil	hsa04070	Phosphatidylinositol signaling system	3628_5296_8396_3631_8394_8821_23396_810_8526_3705	10	-	0.0143137153196583	0.29700959288291
7745	bepridil	hsa04080	Neuroactive ligand-receptor interaction	64106_2690	2	-	0.000178819052100177	0.00742099066215735
7746	bepridil	hsa04740	Olfactory transduction	810_5567_157	3	-	2.18849259402296e-06	0.000181644885303906
7747	bepridil	hsa04530	Tight junction	5521_5581	2	-	0.0349233556339879	0.483106419603499
7748	bepridil	hsa05310	Asthma	3123_3126_3127_3113_3125	5	-	0.0345267349525765	0.483106419603499
7749	bepridil	hsa04350	TGF-beta signaling pathway	5308_4090_3624_9475_654_655_652_7040_5933_6093_268_6199	12	-	0.00552904529307958	0.152970253108535
7750	bepridil	hsa04940	Type I diabetes mellitus	3126_3113_3127_3125_1363_3123	6	-	0.0456658295131653	0.525952955053763
7751	bezafibrate	hsa04740	Olfactory transduction	816	1	+	0.00249030857659602	0.154399131748953
7752	bezafibrate	hsa04080	Neuroactive ligand-receptor interaction	3953_1081	2	-	0.00159064046941066	0.0652162592458371
7753	bezafibrate	hsa04740	Olfactory transduction	5613_801_808_157_805	5	-	0.0012299570047335	0.0652162592458371
7754	dequalinium chloride	hsa04740	Olfactory transduction	26212_815_3000	3	+	4.21735102723658e-05	0.00341605433206163
7755	dequalinium chloride	hsa05322	Systemic lupus erythematosus	8341	1	+	0.0226543836166797	0.917502536475528
7756	dequalinium chloride	hsa04630	Jak-STAT signaling pathway	6655_59067	2	+	0.0494673291047655	1
7757	dequalinium chloride	hsa05332	Graft-versus-host disease	3119_3105_3106_3135_3134_649853	6	-	0.0373818837307162	0.988081921030725
7758	dequalinium chloride	hsa04612	Antigen processing and presentation	4800_3119_6890_3105_3106_3135_3134_3306_811_3304_821_3303_649853	13	-	0.00239511473477496	0.213165211394971
7759	dequalinium chloride	hsa05330	Allograft rejection	3119_3105_3106_3135_3134_649853	6	-	0.0255685042567317	0.988081921030725
7760	dequalinium chloride	hsa04940	Type I diabetes mellitus	3119_3105_3106_3135_3134_649853	6	-	0.0444081762261	0.988081921030725
7761	xamoterol	hsa04740	Olfactory transduction	5566	1	+	0.00167611688428247	0.0511215649706153
7762	xamoterol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	1.72212601254469e-05	0.00105049686765226
7763	xamoterol	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0371057043389605	0.754482654892197
7764	xamoterol	hsa04010	MAPK signaling pathway	3725_10912_5154	3	-	0.0484363145595233	0.347343816301533
7765	xamoterol	hsa04540	Gap junction	5154_1813	2	-	0.0325158073413366	0.347343816301533
7766	primidone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	1.56870994526924e-05	0.000800042072087312
7767	primidone	hsa04710	Circadian rhythm - mammal	1454_9572	2	-	0.0078249377102088	0.25822294443689
7768	medrysone	hsa05332	Graft-versus-host disease	57292_3119_3804_3126_3127_3125_3123	7	+	0.00442966350729018	0.354373080583214
7769	medrysone	hsa04612	Antigen processing and presentation	57292_3119_3123_3126_3127_3125_6891_3804_3310	9	+	0.0373326700659111	0.426659086467555
7770	medrysone	hsa05016	Huntington's disease	5331_1211	2	+	0.0267560191454203	0.426659086467555
7771	medrysone	hsa04740	Olfactory transduction	51806_8388_8387_135948_8392_26211_81797_81696	8	+	0.021564594810248	0.426659086467555
7772	medrysone	hsa05310	Asthma	3123_3126_3127_3119_3125	5	+	0.0155086074279707	0.426659086467555
7773	medrysone	hsa05012	Parkinson's disease	6622	1	+	0.0316427814952008	0.426659086467555
7774	medrysone	hsa05330	Allograft rejection	3123_3126_3127_3119_3125	5	+	0.0349180707471171	0.426659086467555
7775	medrysone	hsa05010	Alzheimer's disease	842_4137_5331_3708_5534_102	6	-	0.0129778483717027	0.183852851932455
7776	medrysone	hsa04080	Neuroactive ligand-receptor interaction	1909_5618_7442_7433	4	-	7.6521262949133e-06	0.000325215367533815
7777	medrysone	hsa04612	Antigen processing and presentation	3135_4802	2	-	0.0327414060038907	0.347877438791339
7778	medrysone	hsa05016	Huntington's disease	5331_246721_27113_842_3708	5	-	0.00289792488749296	0.0492647230873803
7779	medrysone	hsa04740	Olfactory transduction	818_219464_4991	3	-	5.79182544925187e-11	4.92305163186409e-09
7780	medrysone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3017_3014	27	-	0.000577715093758327	0.0122764457423644
7781	medrysone	hsa05012	Parkinson's disease	842	1	-	0.000207939841202626	0.0058916288340744
7782	medrysone	hsa04060	Cytokine-cytokine receptor interaction	5154_5618_8771_2057_3594_3455_8742_8741_3572_7852_655_4254	12	-	0.0235770558901895	0.28629282152373
7783	demeclocycline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_3119	15	+	5.91206400407432e-07	3.25163520224088e-05
7784	demeclocycline	hsa04080	Neuroactive ligand-receptor interaction	7067_2740_5618_152_1909	5	-	0.00781435139070493	0.312574055628197
7785	demeclocycline	hsa04740	Olfactory transduction	818	1	-	1.36908885209737e-08	1.0952710816779e-06
7786	digoxigenin	hsa05332	Graft-versus-host disease	3569_3553_3119_3821_942_3107_3126_3127_3111_3125_3135_3133_3123	13	+	0.00792045760493938	0.102965948864212
7787	digoxigenin	hsa05010	Alzheimer's disease	3553_3710_6390_5534_9451_5330_509_487_4695_348	10	+	0.00943361346711858	0.107307353188474
7788	digoxigenin	hsa05016	Huntington's disease	1213_4695_6390_55567_6667_5330_7416_509_2033_1387	10	+	0.00412534452551124	0.0921240641069017
7789	digoxigenin	hsa04740	Olfactory transduction	26212_5566_81797	3	+	1.87275356956813e-16	1.704205748307e-14
7790	digoxigenin	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_8335_8349_8362_8329_8294_121504_8343_8342_8341_8347_8346_8345_8344_8339_723790_3123_8366_3126_3127_3125_8969_8968_8370_92815_8358_8359_8330_8331_8336_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_83740_3012_3013_942_3017_3111	57	+	1.25743222980488e-11	5.7213166456122e-10
7791	digoxigenin	hsa04664	Fc epsilon RI signaling pathway	5293_2207	2	+	0.00725508192074376	0.102965948864212
7792	digoxigenin	hsa05012	Parkinson's disease	4695_5413_6390_7345_7416_509	6	+	0.00471601354343355	0.0921240641069017
7793	digoxigenin	hsa04260	Cardiac muscle contraction	782_4635	2	+	0.00506176176411548	0.0921240641069017
7794	digoxigenin	hsa04270	Vascular smooth muscle contraction	59_3710_5566_5330_108_135_6093	7	+	0.0452161714900039	0.36613211646442
7795	digoxigenin	hsa04940	Type I diabetes mellitus	3553_2572_3119_942_3107_3126_3127_3111_3125_3135_3133_3123	12	+	0.0293935955084177	0.297201910140668
7796	digoxigenin	hsa04650	Natural killer cell mediated cytotoxicity	836_6850_6655_5295_355_10451_3845_5336	8	-	0.0319305164045284	0.169043910376915
7797	digoxigenin	hsa03440	Homologous recombination	10714_5888_675_80198_641_7516_5892_5893_25788_10111	10	-	0.00606658195121576	0.0454993646341182
7798	digoxigenin	hsa04640	Hematopoietic cell lineage	3678_2057	2	-	0.00528982097644883	0.0432803534436722
7799	digoxigenin	hsa05010	Alzheimer's disease	836_841_8772_355_3709_7132_23236	7	-	0.000747736786610752	0.00950003585305375
7800	digoxigenin	hsa04080	Neuroactive ligand-receptor interaction	5618_4157_1813_2561_5021_56288_136_7433_2149	9	-	1.32137117157322e-05	0.000546779724705
7801	digoxigenin	hsa05200	Pathways in cancer	5295_5155_5154_5336_5888_8321_8322_1488_4149_3551_652_2260_9134_8772_675_836_9915_841_6502_6655_6777_6772_7188_355_3845_2535	26	-	0.0245914383611344	0.147548630166806
7802	digoxigenin	hsa05320	Autoimmune thyroid disease	355	1	-	0.0267045979727686	0.150213363596823
7803	digoxigenin	hsa04670	Leukocyte transendothelial migration	10451_5336_5295_1500_9080	5	-	0.00904038437586306	0.0625872764482827
7804	digoxigenin	hsa05016	Huntington's disease	246721_836_841_5439_548644_5481_23236	7	-	0.00041514385874992	0.0062271578812488
7805	digoxigenin	hsa04740	Olfactory transduction	818_5613_5616_157	4	-	7.44648451020384e-15	6.70183605918346e-13
7806	digoxigenin	hsa04514	Cell adhesion molecules (CAMs)	5818_214_5792_9080	4	-	0.000844447631382556	0.00950003585305375
7807	digoxigenin	hsa04510	Focal adhesion	6655_5295_5155_3678_5154_10451	6	-	1.82259908235e-05	0.000546779724705
7808	digoxigenin	hsa05322	Systemic lupus erythematosus	55506_718_3021_3020_727_55766_6737	7	-	0.0115638857697359	0.0743392656625879
7809	digoxigenin	hsa04530	Tight junction	5583_5581_9080_51776_56288_3845_9223_27134	8	-	0.0423668149265732	0.200710920856691
7810	digoxigenin	hsa04370	VEGF signaling pathway	5295_3845_5336	3	-	0.0446024268570424	0.200710920856691
7811	digoxigenin	hsa04512	ECM-receptor interaction	3678	1	-	0.00125030314873952	0.0125030314873952
7812	digoxigenin	hsa04810	Regulation of actin cytoskeleton	3678_6655_5295_5155_5154_10451_50649_3845_54434_23365_3984_3985_2260_8396_2149_1445	16	-	0.0436829177383564	0.200710920856691
7813	digoxigenin	hsa05012	Parkinson's disease	836_5481	2	-	4.21847534686248e-05	0.000949156953044058
7814	digoxigenin	hsa04060	Cytokine-cytokine receptor interaction	5618_7132_2057_3594_5155_8742_8741_5154_657_355_27242	11	-	6.82398333491392e-05	0.00122831700028451
7815	digoxigenin	hsa03010	Ribosome	6168_6137_6181	3	-	0.0041748883671096	0.0375739953039864
7816	felbinac	hsa05010	Alzheimer's disease	51806_3553_2905_355_4137_3708_3709_5534_4695_801_348_808_805	13	+	0.0114801875153618	0.170289448144533
7817	felbinac	hsa05016	Huntington's disease	4899_4695_3708	3	+	2.21694003007194e-08	1.63967283631845e-06
7818	felbinac	hsa04740	Olfactory transduction	51806_26212_7932_8390_56656_26211_8386_8385_2774_5616_5593_808_26532_805_81696_801_26189_816_81797	19	+	3.68465805914258e-08	1.63967283631845e-06
7819	felbinac	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8290_8294_121504_959_3108_3126_8968_6738_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2212_3119_3013_3113_3014_941_727	36	+	0.00673566360198828	0.148101299110124
7820	felbinac	hsa04110	Cell cycle	995_993_4088_8881_1028_1032_8243_10744_4616	9	+	0.046201339490069	0.551625406527277
7821	felbinac	hsa05012	Parkinson's disease	4695_5413	2	+	2.21645128244596e-06	6.57547213792301e-05
7822	felbinac	hsa03010	Ribosome	6187_440589_6137_6192_6171	5	+	0.00832029770281597	0.148101299110124
7823	diloxanide	hsa05214	Glioma	10000_208_6655_4193_5925_1956_810_816	8	+	0.0270674132410623	0.766910041830098
7824	diloxanide	hsa04740	Olfactory transduction	157_8388_8387_5566_810_816	6	+	0.000496453438020607	0.0421985422317516
7825	diloxanide	hsa04920	Adipocytokine signaling pathway	6794_51703_10000_948_3953_208_5781_9370_9021	9	+	0.0122785808452898	0.521839685924817
7826	diloxanide	hsa05131	Shigellosis	7278_7454_113457	3	-	0.0216025829604057	0.26643185651167
7827	diloxanide	hsa05016	Huntington's disease	5439_4899_548644_246721_1213	5	-	0.0455738782256726	0.421558373587472
7828	diloxanide	hsa05130	Pathogenic Escherichia coli infection	7278_7454_113457	3	-	0.0216025829604057	0.26643185651167
7829	diloxanide	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00400796245413915	0.148294610803149
7830	2-aminobenzenesulfonamide	hsa04740	Olfactory transduction	5566_26476_816_4991	4	+	0.0199740989292596	0.426114110490871
7831	2-aminobenzenesulfonamide	hsa05322	Systemic lupus erythematosus	3119_3013_8358_8968_8342_8350_8351_8352_8353_8354_8355_8356_8357	13	+	0.000644245178212084	0.0412316914055734
7832	2-aminobenzenesulfonamide	hsa04270	Vascular smooth muscle contraction	9138_3779_3778_5331_3708_72_5320_1909_81579_5566	10	+	0.00405523191620412	0.129767421318532
7833	meclofenoxate	hsa04512	ECM-receptor interaction	3690_3688_1290_3910_22987	5	+	0.0197244607574255	0.650907204995042
7834	meclofenoxate	hsa04540	Gap junction	5593_7082_5598_5331_57369_1902	6	+	0.00770609940468427	0.508602560709162
7835	meclofenoxate	hsa04912	GnRH signaling pathway	5331_5598_776_816_51806	5	+	0.0479771398853618	0.9668268692089
7836	meclofenoxate	hsa04080	Neuroactive ligand-receptor interaction	64106_5618	2	-	0.000538797796627095	0.0220907096617109
7837	meclofenoxate	hsa04740	Olfactory transduction	157	1	-	1.52967427741796e-07	1.25433290748273e-05
7838	meclofenoxate	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	0.0225245331391516	0.615670572470144
7839	levonorgestrel	hsa04740	Olfactory transduction	51806	1	+	0.0156721489551127	0.641044974616329
7840	levonorgestrel	hsa04512	ECM-receptor interaction	1292_960_3908_22798_2812	5	+	0.0197244607574255	0.641044974616329
7841	levonorgestrel	hsa04080	Neuroactive ligand-receptor interaction	7067_5618_1131	3	-	7.82207682699843e-05	0.00328527226733934
7842	levonorgestrel	hsa04612	Antigen processing and presentation	3305	1	-	0.0452349385575318	0.474966854854084
7843	levonorgestrel	hsa04740	Olfactory transduction	818_26212	2	-	6.11769793426312e-09	5.13886626478102e-07
7844	levonorgestrel	hsa04210	Apoptosis	8503_3554_842_841_581_7157_5295_8795_472_8737_8837_651610_9020	13	-	0.0127199007404386	0.265206855205853
7845	levonorgestrel	hsa04115	p53 signaling pathway	27113_842_841_581_7157_4194_4193_472_25898_651610_8795	11	-	0.0166081147255964	0.265206855205853
7846	levonorgestrel	hsa04020	Calcium signaling pathway	818_8912_1131_7419_489	5	-	0.0335582963127083	0.4026995557525
7847	levonorgestrel	hsa05210	Colorectal cancer	8503_6934_581_7157_6655_5295_5599_5881_324_7042_91_842	12	-	0.0189433468004181	0.265206855205853
7848	levonorgestrel	hsa04270	Vascular smooth muscle contraction	5581	1	-	0.00693560378943415	0.194196906104156
7849	tetrandrine	hsa03320	PPAR signaling pathway	4199_2182_2180_4023_6319_5105	6	+	0.0488011157790551	0.346044275524209
7850	tetrandrine	hsa05200	Pathways in cancer	23533_1021_324_868_27006_6655_331_330_1950_1857_4088_11211_2249_5290_5602_91_8324_4233_861_7422	20	+	0.0362764508157535	0.314395907069864
7851	tetrandrine	hsa05016	Huntington's disease	2904	1	+	0.0155041714459522	0.182132847591603
7852	tetrandrine	hsa04740	Olfactory transduction	442194	1	+	2.59097952592214e-05	0.00202096403021927
7853	tetrandrine	hsa04510	Focal adhesion	23533_29895_1302_1311_3690_331_6655_3791_7057_5290_330_88_1950_5602_55742_4233_7422	17	+	0.00238034498942389	0.0618889697250211
7854	tetrandrine	hsa05218	Melanoma	23533_1021_27006_5290_2249_4233_1950	7	+	0.0186802920606772	0.182132847591603
7855	tetrandrine	hsa04012	ErbB signaling pathway	868_23533_6655_5290_1950_5602_3084	7	+	0.0454411533386828	0.346044275524209
7856	tetrandrine	hsa05223	Non-small cell lung cancer	2309_23533_1021_6655_5290_1950	6	+	0.0176516506354497	0.182132847591603
7857	tetrandrine	hsa05213	Endometrial cancer	2309_23533_6655_5290_1950_324	6	+	0.0151166636710962	0.182132847591603
7858	tetrandrine	hsa05210	Colorectal cancer	23533_4088_6655_5290_1857_11211_324_5602_91_8324_4233	11	+	0.000447211362411854	0.0174412431340623
7859	tetrandrine	hsa05220	Chronic myeloid leukemia	23533_1021_868_4088_6655_5290_861_91	8	+	0.0081509648616152	0.158943814801496
7860	tetrandrine	hsa04080	Neuroactive ligand-receptor interaction	7434_2740_56288	3	-	0.01974246077047	0.261408045255216
7861	tetrandrine	hsa05200	Pathways in cancer	4089_5154_1488_1613_2263_2260_2261_3912_998_3918_6932_8453_8554_367_1436_2247_6502_6655_867_2257_5914_7186	22	-	0.0222448521162634	0.261408045255216
7862	tetrandrine	hsa05016	Huntington's disease	5331	1	-	0.0108855946454936	0.261408045255216
7863	tetrandrine	hsa04740	Olfactory transduction	818	1	-	8.09662283683236e-06	0.000319816602054878
7864	tetrandrine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8329_8294_8969_8370_8332_8359_8330_8331_8336_6737_6738_121504_85235_3111	24	-	1.86931109970295e-08	1.47675576876533e-06
7865	tetrandrine	hsa04512	ECM-receptor interaction	960_3912_2812_3691_3693_1289_3918_9672	8	-	0.023162738187171	0.261408045255216
7866	tetrandrine	hsa04810	Regulation of actin cytoskeleton	2261_3984_9138_3691_6655_3693_998_5154_8394_7409_54434_2257_2263_2260_2247_2909_2264	17	-	0.0138739954784788	0.261408045255216
7867	tetrandrine	hsa04010	MAPK signaling pathway	5154_784_9479_1432_6655_27092_998_7186_4137_5607_776_2261_10454_2257_2263_2260_2247_2264	18	-	0.040849128334124	0.403385142299474
7868	tetrandrine	hsa04060	Cytokine-cytokine receptor interaction	1436_5154_3454_3448	4	-	0.0490435782231476	0.430493631069851
7869	ozagrel	hsa05332	Graft-versus-host disease	3123_3107_3126_3127_941_3125	6	+	0.0094349241184239	0.135862907305304
7870	ozagrel	hsa05320	Autoimmune thyroid disease	7253_3123_3107_3126_3127_941_3125	7	+	0.00757823824147848	0.135862907305304
7871	ozagrel	hsa04740	Olfactory transduction	810_26529_4992_2979_4991	5	+	0.00433647417983894	0.135862907305304
7872	ozagrel	hsa04514	Cell adhesion molecules (CAMs)	965_3689_3123_3107_3126_3127_3125_5797_23308_941_5817_1462	12	+	0.0132717911377854	0.159261493653425
7873	ozagrel	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0393524616886236	0.4047681773687
7874	ozagrel	hsa05330	Allograft rejection	3123_3107_3126_3127_941_3125	6	+	0.00616491826917325	0.135862907305304
7875	ozagrel	hsa04940	Type I diabetes mellitus	3382_3123_3107_3126_3127_941_3125	7	+	0.00304402320861622	0.135862907305304
7876	ozagrel	hsa04650	Natural killer cell mediated cytotoxicity	5336	1	-	0.0468014130865665	0.723899765890316
7877	ozagrel	hsa04740	Olfactory transduction	157	1	-	2.44566445481421e-06	0.000205435814204394
7878	ozagrel	hsa05322	Systemic lupus erythematosus	3119	1	-	0.0318465370407523	0.723899765890316
7879	ozagrel	hsa04530	Tight junction	4619	1	-	0.0464091675189432	0.723899765890316
7880	ozagrel	hsa04062	Chemokine signaling pathway	5331_157	2	-	0.0258064428587739	0.723899765890316
7881	pergolide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	3.56082431514584e-10	1.10385553769521e-08
7882	streptozocin	hsa05332	Graft-versus-host disease	57292_3108_3123_3126_3127_3125_3134	7	+	0.00379004099757116	0.0960143719384694
7883	streptozocin	hsa05010	Alzheimer's disease	836	1	+	0.00735607939023908	0.137604184447969
7884	streptozocin	hsa05320	Autoimmune thyroid disease	3108_3123_3126_3127_3125_3134	6	+	0.0345235208557894	0.290041693499051
7885	streptozocin	hsa04740	Olfactory transduction	5566_442194	2	+	2.07469253104918e-05	0.000788383161798688
7886	streptozocin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8347_8346_8344_3108_3123_3126_3127_3125_8969_8370_717_8332_8359_8330_8331_8336_554313_6738_121504_8339_85235	33	+	2.09174364400373e-13	1.58972516944283e-11
7887	streptozocin	hsa05219	Bladder cancer	1029_11186_3576_3845_7057	5	+	0.0438553035446854	0.299222109672243
7888	streptozocin	hsa04115	p53 signaling pathway	836_1029_7057_3486_472_5054_8795	7	+	0.0374402449629794	0.290041693499051
7889	streptozocin	hsa05310	Asthma	3123_3125_3108_3127_3126	5	+	0.0138544517220618	0.175489721812783
7890	streptozocin	hsa04810	Regulation of actin cytoskeleton	6655_3845_2335	3	+	0.0381633807235594	0.290041693499051
7891	streptozocin	hsa05012	Parkinson's disease	836	1	+	0.0472455962640384	0.299222109672243
7892	streptozocin	hsa05330	Allograft rejection	3108_3123_3126_3127_3125_3134	6	+	0.00905290687157691	0.137604184447969
7893	streptozocin	hsa04940	Type I diabetes mellitus	3108_3123_3126_3127_3125_3134	6	+	0.0165693749778323	0.179896071187894
7894	streptozocin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_85235_8364_8370_8366_8368_8365_8330_8332_8359_8969_8331_8329_8336_8367_554313_121504_8294	21	-	8.34758122331482e-13	5.42592779515463e-11
7895	streptozocin	hsa04664	Fc epsilon RI signaling pathway	208_8681_100137049_5600_5578	5	-	0.0157203908040792	0.170304233710858
7896	streptozocin	hsa04370	VEGF signaling pathway	208_8681_100137049_5600_5578	5	-	0.0142841885468594	0.170304233710858
7897	streptozocin	hsa04010	MAPK signaling pathway	1326_5578_5598_1852_208_8681_5600_7042_2257_3725_2260_100137049	12	-	0.00428472473634855	0.0928357026208853
7898	streptozocin	hsa04620	Toll-like receptor signaling pathway	1326_3448_208_148022_5600_3725_9641	7	-	0.00296371703164004	0.0928357026208853
7899	streptozocin	hsa04912	GnRH signaling pathway	5578_5598_8681_5600_3725_100137049	6	-	0.0148227726133444	0.170304233710858
7900	5155877	hsa04080	Neuroactive ligand-receptor interaction	4157_1081_7068_64106_5031_9170	6	+	0.00765456874206806	0.317664602795824
7901	5155877	hsa04740	Olfactory transduction	818_26212_109	3	+	1.53163744565788e-07	1.27125907989604e-05
7902	5155877	hsa03010	Ribosome	6233	1	+	0.031960224094693	0.66317464996488
7903	5155877	hsa04020	Calcium signaling pathway	818_109_3710_5336	4	+	0.0270081172097224	0.66317464996488
7904	5155877	hsa05332	Graft-versus-host disease	3105_3106_3126_3127_3125_3135_3123_649853	8	-	0.000485580961763539	0.00983301447571166
7905	5155877	hsa05320	Autoimmune thyroid disease	3105_3106_3126_3127_3125_3135_3123_649853	8	-	0.00186209683200819	0.0215471204846662
7906	5155877	hsa04612	Antigen processing and presentation	4800_3123_3106_3126_3127_3125_3135_3105_1385_811_649853	11	-	0.00125127623556287	0.0168922291800987
7907	5155877	hsa04740	Olfactory transduction	219464	1	-	7.91468369705668e-06	0.000320544689730796
7908	5155877	hsa04514	Cell adhesion molecules (CAMs)	3123_3106_3126_3127_3685_3125_3135_3105_6693_9080_649853	11	-	0.0239950858653851	0.215955772788466
7909	5155877	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	29	-	8.1666299569442e-12	6.6149702651248e-10
7910	5155877	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.037020907318257	0.299869349277882
7911	5155877	hsa04060	Cytokine-cytokine receptor interaction	5155_2057	2	-	0.0046458601670707	0.0470393341915908
7912	5155877	hsa04020	Calcium signaling pathway	6262_2149	2	-	0.0499260647339289	0.367637385768022
7913	5155877	hsa05330	Allograft rejection	3105_3106_3126_3127_3125_3135_3123_649853	8	-	0.000268930010375464	0.00726111028013753
7914	5155877	hsa04940	Type I diabetes mellitus	3105_3106_3126_3127_3125_3135_3123_649853	8	-	0.000637662290441268	0.0103301291051485
7915	enalapril	hsa04662	B cell receptor signaling pathway	10892_4793_8519	3	+	0.0296556290092785	0.711735096222684
7916	enalapril	hsa04070	Phosphatidylinositol signaling system	8527_51763_64768	3	-	0.0455356852547757	0.873382660979184
7917	methotrexate	hsa04080	Neuroactive ligand-receptor interaction	1241_2911_2692_5030_886	5	+	0.0466616423014075	0.670169368267466
7918	methotrexate	hsa05016	Huntington's disease	5331_4713	2	+	0.0190869278714114	0.537537728926434
7919	methotrexate	hsa04740	Olfactory transduction	26212	1	+	5.0761942602293e-07	4.11171735078573e-05
7920	methotrexate	hsa05322	Systemic lupus erythematosus	8348_3013_3014_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	13	+	0.029970665823966	0.606905982935312
7921	methotrexate	hsa04630	Jak-STAT signaling pathway	867_3976	2	+	0.0496421754272197	0.670169368267466
7922	methotrexate	hsa04810	Regulation of actin cytoskeleton	4638_50649_998	3	+	0.0199088047750531	0.537537728926434
7923	methotrexate	hsa04640	Hematopoietic cell lineage	3554	1	-	0.00652247336129836	0.0810650260618511
7924	methotrexate	hsa04080	Neuroactive ligand-receptor interaction	64106_1131_2908	3	-	2.64725061489607e-07	7.6770267831986e-06
7925	methotrexate	hsa04520	Adherens junction	51701_1387_5594_1457_117178_6932_6885_5792_6934_91_6714_10458_25945_2241_8976	15	-	0.0253651936819284	0.245196872258641
7926	methotrexate	hsa04740	Olfactory transduction	409	1	-	2.13359084991718e-14	1.85622403942795e-12
7927	methotrexate	hsa04514	Cell adhesion molecules (CAMs)	3135_6693_25945_5792	4	-	0.00948412320834622	0.103139839890765
7928	methotrexate	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8343_8342_8347_8346_8345_8344_8339_3021_3020_8969_8968_55766_8370_8358_8359_8330_8331_8336_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3014	44	-	7.24467887257391e-10	3.15143530956965e-08
7929	methotrexate	hsa04110	Cell cycle	890_595_891_983_701_699_9133_1031_995_994_5001_996_991_7027_9700_8243_5591_5347_472_10926_8556_1387_7465	23	-	0.00374815214317723	0.0543482060760698
7930	methotrexate	hsa05012	Parkinson's disease	7327_7419_1327	3	-	0.00340262508342323	0.0543482060760698
7931	methotrexate	hsa04060	Cytokine-cytokine receptor interaction	3554_3454_23529_5154_7852_6387_91_93	8	-	0.000257332728078956	0.00559698683571729
7932	mifepristone	hsa05332	Graft-versus-host disease	3812_3108_3119_3107_3113_3111_3134_355	8	+	0.0048664373124903	0.180072055259575
7933	mifepristone	hsa05320	Autoimmune thyroid disease	3108_3119_3107_3113_3111_3134_355	7	+	0.0412746755075948	0.679948839745223
7934	mifepristone	hsa04740	Olfactory transduction	26539_5593_4992	3	+	1.55540741313213e-06	0.000135320444942495
7935	mifepristone	hsa05330	Allograft rejection	3108_3119_3107_3113_3111_3134_355	7	+	0.00963771218883616	0.209620240107186
7936	mifepristone	hsa04940	Type I diabetes mellitus	3108_3119_3107_3113_3111_3134_355_3382	8	+	0.00620938121584741	0.180072055259575
7937	mifepristone	hsa04650	Natural killer cell mediated cytotoxicity	3455_5295_5290_3135_5534_8795_5777	7	-	0.0202156397996245	0.135289281735949
7938	mifepristone	hsa04640	Hematopoietic cell lineage	3589_966_3675	3	-	0.0233631791229209	0.145185470263866
7939	mifepristone	hsa05010	Alzheimer's disease	4714_5664_2776_6868_488_5534_102_8851	8	-	0.00349233195560711	0.0434046971625455
7940	mifepristone	hsa04080	Neuroactive ligand-receptor interaction	5029_5025_5618_56288_4886	5	-	1.07153958989002e-07	4.66119721602159e-06
7941	mifepristone	hsa05320	Autoimmune thyroid disease	3135	1	-	0.0412903517942957	0.211309447417866
7942	mifepristone	hsa05016	Huntington's disease	5432_4714_4899_27113_6648_581_2776_1385	8	-	0.00141957336164254	0.0247005764925802
7943	mifepristone	hsa04740	Olfactory transduction	219464	1	-	7.68133883943505e-18	6.68276479030849e-16
7944	mifepristone	hsa04514	Cell adhesion molecules (CAMs)	24146_214_3135_9672_6382_5817	6	-	0.0120321117898138	0.10467937257138
7945	mifepristone	hsa04510	Focal adhesion	5295_595_896_596_1729_2324_331_7057_5290_9475_3914_3725_1277_3675	14	-	0.0451707411526257	0.218325248904358
7946	mifepristone	hsa05322	Systemic lupus erythematosus	8347_3014_8343_8970_8339_9555_8346_8344	8	-	0.0324477325842733	0.176434545926986
7947	mifepristone	hsa04530	Tight junction	24146_2037_50855_5519_84612_56288_8573	7	-	0.0201920870751249	0.135289281735949
7948	mifepristone	hsa04720	Long-term potentiation	2776_5534	2	-	0.0151575052634065	0.119882087083306
7949	mifepristone	hsa04062	Chemokine signaling pathway	7852_7454_3579_5295_2788_5290_9475_115_6387_56288_113_408	12	-	0.0284192193142601	0.164831472022709
7950	mifepristone	hsa05012	Parkinson's disease	4714_2861_7327_51465_7332	5	-	0.00349160533257641	0.0434046971625455
7951	mifepristone	hsa04260	Cardiac muscle contraction	6548_488	2	-	0.00742666018242025	0.0717910484300624
7952	mifepristone	hsa04060	Cytokine-cytokine receptor interaction	5618_3579_2324_3589_3455_3601_3572_7852_6387_10913_8718_27242_8795	13	-	0.000675663838130952	0.0167812937764141
7953	mifepristone	hsa03010	Ribosome	6168_6141_6129	3	-	0.00601629625425178	0.0654272217649881
7954	mifepristone	hsa04020	Calcium signaling pathway	5255_5534_5025_2776_115_113_488	7	-	0.000771553736846626	0.0167812937764141
7955	mepyramine	hsa05010	Alzheimer's disease	5533_6390_317_4713	4	+	0.0260597336953895	0.534224540755485
7956	mepyramine	hsa04740	Olfactory transduction	26539_26664	2	+	1.28797300825599e-08	1.05613786676991e-06
7957	mepyramine	hsa04512	ECM-receptor interaction	1278_10319_1291_7148_2335_948_3910_3690_2812_3694_3685_3679_51206	13	+	0.0075448819001479	0.219079839854661
7958	mepyramine	hsa04062	Chemokine signaling pathway	5294_6368_2833_6347_5579	5	+	0.0337394226680405	0.553326531755864
7959	mepyramine	hsa04610	Complement and coagulation cascades	623_5265_5340_2155_720_721_2244_1378_2160_5328_5329	11	+	0.0080151160922437	0.219079839854661
7960	mepyramine	hsa05211	Renal cell carcinoma	112399_2271_5594_5296_2549_5155_405_7423_5781_3725	10	-	0.0135337367028512	0.234382126122174
7961	mepyramine	hsa04080	Neuroactive ligand-receptor interaction	7434_2908_4157_1909	4	-	0.0021164627869055	0.0836002800827673
7962	mepyramine	hsa04740	Olfactory transduction	409	1	-	9.13329898567227e-09	7.21530619868109e-07
7963	mepyramine	hsa04110	Cell cycle	1028	1	-	0.0148343117798844	0.234382126122174
7964	mepyramine	hsa05012	Parkinson's disease	517_509	2	-	0.0354102811869955	0.466235368962107
7965	mepyramine	hsa04060	Cytokine-cytokine receptor interaction	3601_3566_2057_5155_7423_91	6	-	0.0138199236569822	0.234382126122174
7966	desipramine	hsa04610	Complement and coagulation cascades	1378_721_720_1361	4	+	0.0421313716520604	1
7967	desipramine	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	-	0.0259523091827305	0.502916863139585
7968	desipramine	hsa03440	Homologous recombination	7156_8940_7516	3	-	0.0397653936534468	0.502916863139585
7969	desipramine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8347_8346_8344_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235	26	-	5.60601829451231e-14	3.92421280615862e-12
7970	desipramine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0431071596976787	0.502916863139585
7971	desipramine	hsa05330	Allograft rejection	3135_3105_3106_649853	4	-	0.0191998150963856	0.502916863139585
7972	desipramine	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853	4	-	0.0297997739529252	0.502916863139585
7973	mepacrine	hsa04910	Insulin signaling pathway	5140	1	+	0.0456665842431597	0.890498392741614
7974	mepacrine	hsa04740	Olfactory transduction	5593_816	2	+	4.30022173254872e-05	0.003354172951388
7975	mepacrine	hsa05322	Systemic lupus erythematosus	2213_8361_8363_8362_8365_8364_8370_8360_8368_8366_958_8359_8294_8367_554313_121504_3119	17	+	0.000188275455855562	0.00698743737519729
7976	mepacrine	hsa04115	p53 signaling pathway	1647_1026_64393_7161_317_7057_4193_355_5054_8795_9540	11	+	0.000268747591353742	0.00698743737519729
7977	mepacrine	hsa04080	Neuroactive ligand-receptor interaction	3953_2911_5618_2908_1909	5	-	0.0106149939513502	0.297219830637806
7978	mepacrine	hsa04740	Olfactory transduction	810	1	-	3.18739130516173e-08	2.67740869633585e-06
7979	mepacrine	hsa04514	Cell adhesion molecules (CAMs)	6693_214	2	-	0.0494104915381301	0.691746881533821
7980	mepacrine	hsa05012	Parkinson's disease	7327	1	-	0.0104878142443398	0.297219830637806
7981	mepacrine	hsa04620	Toll-like receptor signaling pathway	5600	1	-	0.0444739645203184	0.691746881533821
7982	mepacrine	hsa04060	Cytokine-cytokine receptor interaction	5618_3579_3552_3953_4254_7852	6	-	0.0247752886971534	0.520281062640221
7983	pimozide	hsa05010	Alzheimer's disease	2902_5532_6263_2905_23236	5	+	0.00200798189974351	0.045179592744229
7984	pimozide	hsa05320	Autoimmune thyroid disease	3451_1081_3119_3117_3441_3126_3127_3125_3123_3113_3448	11	+	0.022776838332499	0.256239431240614
7985	pimozide	hsa05016	Huntington's disease	2902_7052_1639_64446_9001_23236	6	+	0.00284126034537181	0.0511426862166926
7986	pimozide	hsa04740	Olfactory transduction	26211_7932_5132_9635_393046	5	+	3.25042338947768e-10	2.92538105052991e-08
7987	pimozide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_9103_88_8348_8294_121504_723790_3123_3126_3127_3125_8968_8370_8358_8359_8337_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3117_3013_3113_8349_720_721_8970	42	+	4.18249914837144e-09	1.88212461676715e-07
7988	pimozide	hsa05310	Asthma	3119_3117_3123_3126_3127_3125_3113	7	+	0.0360148387311373	0.355808668907919
7989	pimozide	hsa04010	MAPK signaling pathway	1326_1649_50487_5155_22808_5602_10000_3164_11221_4616_5319_3551_1850_4791_3725_4214_4776_5532_5536_3310_3727_7048_1647_1848_782_2318_1843_5598_1847_1846_8817_27006_6196_2258_2353_5971_5879	37	+	0.0395342965453243	0.355808668907919
7990	pimozide	hsa05012	Parkinson's disease	6570_6531	2	+	0.000643535282606424	0.0193060584781927
7991	pimozide	hsa04620	Toll-like receptor signaling pathway	7096_10333_3576_1326_3448_3551_7097_3456_10000_3569_3441_2353_148022_3451_4792_5602_6352_5879_9641_3725	20	+	0.00495123391676885	0.0742685087515327
7992	pimozide	hsa03010	Ribosome	284393_389342	2	+	0.00801629024575246	0.10306658887396
7993	pimozide	hsa05016	Huntington's disease	4899_2876_7019	3	-	0.0365501306883046	0.721865081094016
7994	pimozide	hsa04740	Olfactory transduction	818_5567_157	3	-	1.36990737805522e-05	0.00108222682866362
7995	pimozide	hsa04514	Cell adhesion molecules (CAMs)	3123	1	-	0.021994583692132	0.579190703892809
7996	pimozide	hsa05322	Systemic lupus erythematosus	3123	1	-	0.015450216967003	0.579190703892809
7997	fipexide	hsa04080	Neuroactive ligand-receptor interaction	2902_153_1268_886_5030_3001_9038_3361_2740_2688_1442_1395_2917_3953_6869_1910_5618_5340_2890_2893_6755_2798_680	23	+	0.00400401249229989	0.172172537168895
7998	fipexide	hsa04740	Olfactory transduction	81696_81797	2	+	9.73845895261448e-06	0.000837507469924845
7999	fipexide	hsa04514	Cell adhesion molecules (CAMs)	9076_9378_214_965_29851_958_4684_3696_3695_5797_933_5010_26047_5817	14	+	0.00634105519020613	0.181776915452576
8000	fipexide	hsa05322	Systemic lupus erythematosus	958_3013_8358_733_8968_6737_8350_8351_8352_8353_8354_8355_8356_8357	14	+	0.00966236169422779	0.207740776425897
8001	fipexide	hsa04920	Adipocytokine signaling pathway	51703_10000_3551_3953_208_2182_1375_9021	8	+	0.0157114047478505	0.270236161663029
8002	fipexide	hsa05223	Non-small cell lung cancer	23533_10000_208_1029_1950_5915	6	+	0.0450529112891972	0.553507195838709
8003	fipexide	hsa05220	Chronic myeloid leukemia	23533_10000_3551_208_6776_1029_1399_598	8	+	0.0272811460443849	0.391029759969517
8004	fipexide	hsa04080	Neuroactive ligand-receptor interaction	3953_4157	2	-	2.69713714906259e-05	0.00109234054537035
8005	fipexide	hsa04740	Olfactory transduction	810	1	-	1.18797793078161e-09	9.62262123933104e-08
8006	fipexide	hsa05322	Systemic lupus erythematosus	8358_85235_8968_9555_3013_8330_3014_8332_6738_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357	21	-	0.00123382309257574	0.033313223499545
8007	fipexide	hsa04540	Gap junction	5607	1	-	0.0450330605337396	0.590567919032725
8008	fipexide	hsa05012	Parkinson's disease	4714_317	2	-	0.0175391260449415	0.284133841928052
8009	fipexide	hsa05222	Small cell lung cancer	3913_5728_3688_4149_3912_5296_598_317_5290_51588_3914_3655	12	-	0.0159948630388485	0.284133841928052
8010	cinnarizine	hsa05332	Graft-versus-host disease	3812_3118_3117_3107_3113_940	6	+	0.00413751031355507	0.078209223777819
8011	cinnarizine	hsa05320	Autoimmune thyroid disease	1081_3118_3117_3107_3113_940_7253	7	+	0.00297009075808634	0.0762323294575494
8012	cinnarizine	hsa04740	Olfactory transduction	26211_9635	2	+	0.000568088786658756	0.0437428365727242
8013	cinnarizine	hsa04514	Cell adhesion molecules (CAMs)	965_3383_8506_3117_29851_3107_3113_940_3118_23308_5817	11	+	0.00701779100657474	0.0900616512510425
8014	cinnarizine	hsa05330	Allograft rejection	3593_3118_3117_3107_3113_940	6	+	0.00264955836636117	0.0762323294575494
8015	cinnarizine	hsa04940	Type I diabetes mellitus	3593_3118_3117_3107_3113_940	6	+	0.0050785210245337	0.078209223777819
8016	cinnarizine	hsa05010	Alzheimer's disease	517_5664	2	-	0.0182712809628199	0.365425619256398
8017	cinnarizine	hsa04080	Neuroactive ligand-receptor interaction	7434_2911_1131_7442	4	-	0.0106350730242882	0.283601947314352
8018	cinnarizine	hsa05016	Huntington's disease	2876_517_3064	3	-	0.0364711948191133	0.498139852210897
8019	cinnarizine	hsa04740	Olfactory transduction	818_5567	2	-	3.13216317028783e-06	0.000250573053623026
8020	cinnarizine	hsa04062	Chemokine signaling pathway	5567_6654_4793	3	-	0.0373604889158173	0.498139852210897
8021	cinnarizine	hsa04060	Cytokine-cytokine receptor interaction	3570_3572	2	-	0.000539303393948949	0.021572135757958
8022	methylprednisolone	hsa05332	Graft-versus-host disease	3824_3119_3123_3107_3126_3127_3803_3558_3125	9	+	0.00029410855576389	0.0119113965084375
8023	methylprednisolone	hsa05320	Autoimmune thyroid disease	3119_3123_3107_3126_3127_3558_3125	7	+	0.014410048674766	0.166562556851391
8024	methylprednisolone	hsa04612	Antigen processing and presentation	3824_972_3119_3805_3123_3107_3126_3127_3803_3125_6891	11	+	0.00385644479941348	0.052062004792082
8025	methylprednisolone	hsa04740	Olfactory transduction	2978_816	2	+	9.548595867783e-06	0.000773436265290423
8026	methylprednisolone	hsa04514	Cell adhesion molecules (CAMs)	3689_3119_3123_3107_3126_3127_3125_5797_23308_3676_57863_933_25945_26047_5817	15	+	0.00196497582450684	0.0318326083570108
8027	methylprednisolone	hsa05310	Asthma	3123_3126_3127_3119_3125	5	+	0.0164506228989028	0.166562556851391
8028	methylprednisolone	hsa05330	Allograft rejection	3593_3119_3123_3107_3126_3127_3558_3125	8	+	0.000704343557112328	0.0190172760420329
8029	methylprednisolone	hsa04940	Type I diabetes mellitus	3593_3119_3123_3107_3126_3127_3558_3125	8	+	0.00161949557347259	0.0318326083570108
8030	methylprednisolone	hsa04080	Neuroactive ligand-receptor interaction	2911_2149	2	-	0.000371578297260492	0.0146773427417894
8031	methylprednisolone	hsa05016	Huntington's disease	5331_27113_2876	3	-	0.0265351321365872	0.349379239798398
8032	methylprednisolone	hsa04740	Olfactory transduction	5566_157	2	-	9.506766618056e-07	7.51034562826424e-05
8033	methylprednisolone	hsa04540	Gap junction	2911_5598_5566_113457_115_113_112_6714_7278_5331	10	-	0.0341381476966414	0.38527338114781
8034	methylprednisolone	hsa05012	Parkinson's disease	7332	1	-	0.0151336174133733	0.239111155131298
8035	methylprednisolone	hsa04060	Cytokine-cytokine receptor interaction	27242_3554_3552	3	-	0.0013554964086976	0.0356947387623701
8036	methylprednisolone	hsa04912	GnRH signaling pathway	5331_776_8399_5598_5566_2002_115_8681_113_112_3725_6714_100137049	13	-	0.00829867500658458	0.163898831380045
8037	clomipramine	hsa05332	Graft-versus-host disease	3119_3122_3113_3107_3126_3127_3111_3125_355_3123_7124_941	12	+	0.000570634905254978	0.00836931194373968
8038	clomipramine	hsa04120	Ubiquitin mediated proteolysis	8945_9063_5371_330	4	+	0.0250466825594143	0.157436290373461
8039	clomipramine	hsa04640	Hematopoietic cell lineage	3581_1435_2814_3122_3123_4254_3126_3127_3559_3125_3690_1438_1441_1378_7124_3684	16	+	0.00717146593772566	0.0699156039892439
8040	clomipramine	hsa04662	B cell receptor signaling pathway	2213_23533_973_5579_3551_208_5294_5533_2353_4776_4772_11025_3725	13	+	0.0225003118651476	0.157436290373461
8041	clomipramine	hsa05010	Alzheimer's disease	775_51806_4714_2904_5533_355_7124	7	+	0.0489134817098713	0.269024149404292
8042	clomipramine	hsa05320	Autoimmune thyroid disease	3119_3122_3113_3107_3126_3127_3111_3125_355_3123_941	11	+	0.00794495499877772	0.0699156039892439
8043	clomipramine	hsa05016	Huntington's disease	4714_64446_1742_2904	4	+	0.0014032551488988	0.0176409218718706
8044	clomipramine	hsa04740	Olfactory transduction	51806_4991_8383_1179_26716	5	+	1.52714711545591e-08	1.3438894616012e-06
8045	clomipramine	hsa04514	Cell adhesion molecules (CAMs)	9076_9379_3119_3122_3123_29851_3107_3126_3127_3685_3125_7412_4359_941_6693_3111_5010_3684_5788_3113	20	+	0.0195879034559888	0.15670322764791
8046	clomipramine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_2904_8368_8335_9103_8294_3122_3123_8366_3126_3127_3125_8370_8359_8330_554313_121504_7124_8354_2213_3119_3113_3111_941	30	+	1.69257781852942e-05	0.000664901179138759
8047	clomipramine	hsa05310	Asthma	3119_3122_3123_3126_3127_3111_3125_7124_3113	9	+	0.00207600478991574	0.0228360526890731
8048	clomipramine	hsa04540	Gap junction	51807_5579	2	+	0.0477630108923512	0.269024149404292
8049	clomipramine	hsa05012	Parkinson's disease	4714	1	+	0.000469766070827714	0.00826788284656777
8050	clomipramine	hsa03010	Ribosome	6165_6144	2	+	0.0237067996101508	0.157436290373461
8051	clomipramine	hsa05330	Allograft rejection	3593_3119_3122_3126_3107_3113_3127_3111_3125_355_3123_7124_941	13	+	7.68852857792987e-05	0.00169147628714457
8052	clomipramine	hsa04940	Type I diabetes mellitus	3593_3382_3119_3122_3113_3107_3126_3127_3111_2571_355_3123_941_7124_3125	15	+	2.26670856524577e-05	0.000664901179138759
8053	clomipramine	hsa05214	Glioma	6655_5155_673_818_1869_808_810_801_805	9	-	0.00926542593750585	0.178359449296988
8054	clomipramine	hsa04080	Neuroactive ligand-receptor interaction	1131_4157	2	-	0.000564162476713461	0.0264588029179668
8055	clomipramine	hsa04740	Olfactory transduction	818_808_409_810_801_805	6	-	0.000687241634232905	0.0264588029179668
8056	clomipramine	hsa04912	GnRH signaling pathway	115_776_8398_2002_6655_2767_2776_818_808_810_6714_801_805	13	-	0.00810881669510112	0.178359449296988
8057	clomipramine	hsa04270	Vascular smooth muscle contraction	776_8398_9138_2767_2776_673_115_808_810_801_9475_805	12	-	0.0354466607524137	0.545878575587171
8058	etacrynic acid	hsa05332	Graft-versus-host disease	3824_3553_3821_3113_3111_355	6	+	0.0459591212892684	0.413632091603416
8059	etacrynic acid	hsa04650	Natural killer cell mediated cytotoxicity	23533_3824_3822_3821_3805_6655_5293_8795_355_27040_3451_80328_80329_2185_9436_9437_5294_3383	18	+	0.00363571912090962	0.0736233121984198
8060	etacrynic acid	hsa04640	Hematopoietic cell lineage	1436_3554_3553_948_3690_3568_3559_1435_915_1378	10	+	0.0435332586135968	0.413632091603416
8061	etacrynic acid	hsa04612	Antigen processing and presentation	4261_3824_3822_3821_3805_3113_3111_3451_3310_3304_3303	11	+	0.0241940119277006	0.279959280877678
8062	etacrynic acid	hsa05016	Huntington's disease	841_23236	2	+	0.00319718800260357	0.0736233121984198
8063	etacrynic acid	hsa04740	Olfactory transduction	26211_1258	2	+	1.45055905520356e-07	1.17495283471488e-05
8064	etacrynic acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8290_8368_8366_3113_3111_8359_88_8294_8367_554313_121504_6737	19	+	0.00157954466438893	0.0639715589077517
8065	etacrynic acid	hsa04210	Apoptosis	23533_4914_3554_3553_841_598_5294_5293_355_824_843_8795	12	+	0.0123106722204488	0.199432889971271
8066	etacrynic acid	hsa04930	Type II diabetes mellitus	23533_9021_5294_5293_8660_8651_8471	7	+	0.0224972573247337	0.279959280877678
8067	etacrynic acid	hsa05332	Graft-versus-host disease	3553_3126_3127_3123_3125	5	-	0.047069540462242	0.39283179089933
8068	etacrynic acid	hsa03440	Homologous recombination	5890_7156_5888_5425_8438	5	-	0.011735590726506	0.185422333478795
8069	etacrynic acid	hsa04640	Hematopoietic cell lineage	960_3553_3123_3568_3126_3127_3125_3678_3589_3673_4254	11	-	0.00274930481092615	0.0723983600210553
8070	etacrynic acid	hsa04080	Neuroactive ligand-receptor interaction	5029_4157	2	-	0.00237850743086685	0.0723983600210553
8071	etacrynic acid	hsa04740	Olfactory transduction	818_157	2	-	1.39410821544243e-05	0.00110134549019952
8072	etacrynic acid	hsa04664	Fc epsilon RI signaling pathway	8503_1432_8399_5296_5599_5881_8681_7409_5602_100137049	10	-	0.0041900809736502	0.0827540992295915
8073	etacrynic acid	hsa04010	MAPK signaling pathway	4217_9479_3553_8399_5599_9344_5881_9693_4763_8986_8681_2249_5602_1432_2260_2261_100137049_23162_7186_4149	20	-	0.0370347895900965	0.365718547202203
8074	etacrynic acid	hsa05012	Parkinson's disease	517	1	-	0.0316128154762042	0.356773203231447
8075	etacrynic acid	hsa04020	Calcium signaling pathway	818_3707	2	-	0.0256192630769172	0.33732029717941
8076	bupropion	hsa04650	Natural killer cell mediated cytotoxicity	3107_3824_3383_5579_3445_3444_3937_4775_5293_6452_5551_5294_2534	13	+	0.0108862924075895	0.384269442333483
8077	bupropion	hsa05010	Alzheimer's disease	317_23236	2	+	0.0356547358431753	0.438043897501868
8078	bupropion	hsa04080	Neuroactive ligand-receptor interaction	146_6752_2901_1268_2917_2918_4159_148_680_3953_2740_2688_1442_5733_7433_9568_1394_5644_64106	19	+	0.0289034408830768	0.438043897501868
8079	bupropion	hsa04740	Olfactory transduction	26211_26212_135948_8392_26476_26538_1258	7	+	0.0134047479883773	0.384269442333483
8080	bupropion	hsa04510	Focal adhesion	1278_3688_7148_2335_5579_3690_83660_5294_1289_998_5154_2002_1956_23396_2534_5293_1291_2064_3674	19	+	0.00307368008798795	0.264336487566964
8081	bupropion	hsa05322	Systemic lupus erythematosus	8330	1	+	0.0321387041861023	0.438043897501868
8082	bupropion	hsa05012	Parkinson's disease	317	1	+	0.046703988031466	0.502067871338259
8083	bupropion	hsa05213	Endometrial cancer	5294_5293_2002_1956_1496_2064	6	+	0.0309038416882293	0.438043897501868
8084	bupropion	hsa05332	Graft-versus-host disease	3135_3105_3106_3119_649853	5	-	0.0350083659578578	0.537919835011201
8085	bupropion	hsa04080	Neuroactive ligand-receptor interaction	7434_2911_4889_1909	4	-	0.0491760671604432	0.537919835011201
8086	bupropion	hsa04910	Insulin signaling pathway	8835_5170_3551_32_6655_5562_23433_8651_23265_10211_810	11	-	0.0493109059128677	0.537919835011201
8087	bupropion	hsa04740	Olfactory transduction	810_219464	2	-	4.21442027275343e-05	0.00332939201547521
8088	bupropion	hsa03020	RNA polymerase	246721_5439_548644_10622	4	-	0.0379748067548985	0.537919835011201
8089	bupropion	hsa05330	Allograft rejection	3135_3105_3106_3119_649853	5	-	0.0248958866728416	0.537919835011201
8090	bupropion	hsa04940	Type I diabetes mellitus	3135_3105_3106_3119_649853	5	-	0.040891070698803	0.537919835011201
8091	novobiocin	hsa04640	Hematopoietic cell lineage	2815_3581_1435_3553_2057_2812_3690_3123_960_3126_3127_1438_3125_921_915_1378_931_930	18	+	0.00521225701622363	0.226733180205728
8092	novobiocin	hsa04740	Olfactory transduction	26211_5593_56656_109_8392_5137_26532_4992_3000_157_4991_26539_817	13	+	1.2832793602444e-05	0.00111645304341263
8093	novobiocin	hsa04912	GnRH signaling pathway	2185_5595_5594_1081_5578_6655_2767_998_109_30814_5608_1956_5322_4323_5602_3972_3725_8398_2797_817	20	+	0.0111481399402246	0.323296058266513
8094	novobiocin	hsa04730	Long-term depression	2911_10842_8398_5594_5578_3480_5595_2767_5593_5519_5322_2982_30814	13	+	0.049434824233532	0.811322278937063
8095	novobiocin	hsa04640	Hematopoietic cell lineage	2815_3568_3675	3	-	0.0116446288463023	0.132457653126689
8096	novobiocin	hsa05010	Alzheimer's disease	4714_4694_841_4698_22926_102_23236_517_1020	9	-	0.0024024782128761	0.043725103474345
8097	novobiocin	hsa04080	Neuroactive ligand-receptor interaction	152_5733_7068_2847_4886_2147_3354_2742_56288_4987_8484_5644	12	-	6.41816798676913e-05	0.00194684428931997
8098	novobiocin	hsa04742	Taste transduction	5613	1	-	0.0179842612414236	0.136380647747462
8099	novobiocin	hsa04740	Olfactory transduction	5137_5613_409_816	4	-	5.9119538194146e-16	5.37987797566729e-14
8100	novobiocin	hsa04510	Focal adhesion	857_2335_5062_5829_83660_1729_998_7057_5604_6093_4233_55742_5500_3675	14	-	0.0137523654078664	0.136380647747462
8101	novobiocin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_94239_8366_8368_6738_8294_121504_8343_8347_8346_8344_8339_8367_3021_3020_8968_8370_92815_8358_8359_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	36	-	0.000870043761346853	0.0197934955706409
8102	novobiocin	hsa04062	Chemokine signaling pathway	5580_5829_5613_998_6773_5604_6774_56288_6093_4793_2790_409_23236	13	-	0.0151368316041051	0.136380647747462
8103	novobiocin	hsa05012	Parkinson's disease	4714_2861_4694_4698_6531_517_291	7	-	0.0114329279696984	0.132457653126689
8104	novobiocin	hsa04620	Toll-like receptor signaling pathway	841_3441_5605_5604_5606_7187	6	-	0.0488986234981161	0.317841052737755
8105	novobiocin	hsa04260	Cardiac muscle contraction	27092_6548	2	-	0.00344757892189949	0.0522882803154756
8106	novobiocin	hsa04060	Cytokine-cytokine receptor interaction	3601_3561_55540_3441_27242_8741_3572_657_9180_91_4233_3568	12	-	4.79367871487055e-05	0.00194684428931997
8107	novobiocin	hsa03010	Ribosome	6187_9349_440589_6189_439992	5	-	0.021815017123525	0.152705119864675
8108	novobiocin	hsa04020	Calcium signaling pathway	5256_5613_56848_2767_8912_9630_5733_5137_23236_490_816_291	12	-	0.0170723262079597	0.136380647747462
8109	fasudil	hsa04740	Olfactory transduction	26333_4991_26532_26664_56656	5	+	0.0347153684019745	1
8110	fasudil	hsa05210	Colorectal cancer	6655_4233_842_8312	4	-	0.0445533610938917	0.861652626211431
8111	mefenamic acid	hsa05332	Graft-versus-host disease	3812_3804_3106_3135_3105_649853	6	+	0.00191385501790822	0.11865901111031
8112	mefenamic acid	hsa04612	Antigen processing and presentation	3812_3804_3106_3135_6892_3105_649853	7	+	0.0164999532261732	0.255749275005685
8113	mefenamic acid	hsa04740	Olfactory transduction	5132_8392_4991	3	+	0.0104201602400913	0.242845498091966
8114	mefenamic acid	hsa04930	Type II diabetes mellitus	8660_8913_776_8471_5315	5	+	0.0117505886173532	0.242845498091966
8115	mefenamic acid	hsa05330	Allograft rejection	3135_3105_3106_649853	4	+	0.0276971024912213	0.343444070891144
8116	mefenamic acid	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853	4	+	0.0424214069398716	0.438354538378673
8117	mefenamic acid	hsa04080	Neuroactive ligand-receptor interaction	1269	1	-	0.0327354423588147	0.548278959596316
8118	mefenamic acid	hsa05322	Systemic lupus erythematosus	55506_85235_3113_8330_8332_8969_8331_8336_8343_8329_8339_8347_8346_8344	14	-	1.72212601254469e-05	0.00111938190815405
8119	mefenamic acid	hsa04060	Cytokine-cytokine receptor interaction	3552	1	-	0.0337402436674656	0.548278959596316
8120	mefenamic acid	hsa03020	RNA polymerase	246721_5439_548644_661	4	-	0.00676512431164408	0.219866540128433
8121	atracurium besilate	hsa04010	MAPK signaling pathway	776_355_8912_5607_23162_2257_3725	7	+	0.00436604153610159	0.21830207680508
8122	atracurium besilate	hsa04912	GnRH signaling pathway	2778_3725_776	3	+	0.048047551289085	0.675695996780569
8123	atracurium besilate	hsa02010	ABC transporters	20_5826	2	-	0.0364214935002831	0.577329236695731
8124	pirinixic acid	hsa04070	Phosphatidylinositol signaling system	5728_5578_8394_5293_5287_5333_3707	7	+	0.0316570648363587	0.648969829145353
8125	pirinixic acid	hsa04080	Neuroactive ligand-receptor interaction	2901_5733_2905	3	+	0.0273292870417645	0.648969829145353
8126	pirinixic acid	hsa04740	Olfactory transduction	26532_816_4991	3	+	0.000489532518708989	0.0401416665341371
8127	pirinixic acid	hsa04510	Focal adhesion	1278_5728_5170_2318_596_5599_5578_5155_998_859_93408_1292_5293_55742_3675	15	+	0.0178722551978841	0.648969829145353
8128	pirinixic acid	hsa05010	Alzheimer's disease	2903_836_3553_6622_317_322_4698_22926_4023_489_4842_487_824_348_517_4843	16	-	0.0209705230329578	0.325043107010846
8129	pirinixic acid	hsa05016	Huntington's disease	4899_1211_836_7052_4698_5439_317_246721_7350_5978_2033_3066_6875_548644_517	15	-	0.00417100016795823	0.0969757539050288
8130	pirinixic acid	hsa04740	Olfactory transduction	26211_26212_7932_56656_157_8392_23538_135948_5593_1179_2979_4992_81797_4991_5137_817	16	-	2.31017712515128e-11	2.14846472639069e-09
8131	pirinixic acid	hsa05012	Parkinson's disease	836_4698_317_7054_7345_6622_517	7	-	0.000615792233147443	0.0190895592275707
8132	pirinixic acid	hsa04260	Cardiac muscle contraction	6546_7168_782_7171_4625_4635	6	-	0.0459457685861185	0.585446829469422
8133	pirinixic acid	hsa03010	Ribosome	6129	1	-	5.18046384190631e-06	0.000240891568648643
8134	pirinixic acid	hsa03050	Proteasome	5698	1	-	0.0114510618466172	0.21298975034708
8135	cobalt chloride	hsa03320	PPAR signaling pathway	3611_2710_5170_4199_335_51_2173_1375_5467_6319_8309	11	+	0.0478643848465198	0.528875031111578
8136	cobalt chloride	hsa05010	Alzheimer's disease	779	1	+	3.15514212224147e-05	0.00135671111256383
8137	cobalt chloride	hsa04080	Neuroactive ligand-receptor interaction	2859_1129_1132_2570_3062_2743_56288_8698_7433_8001_6869	11	+	0.0422486081608988	0.528875031111578
8138	cobalt chloride	hsa05016	Huntington's disease	7052_7416_1211_6648_3064	5	+	0.00741778704560394	0.159482421480485
8139	cobalt chloride	hsa04740	Olfactory transduction	157_2978_1179_26476_26532_4992	6	+	2.66135190887693e-07	2.28876264163416e-05
8140	cobalt chloride	hsa04810	Regulation of actin cytoskeleton	10093_1129_2335_8394_1132_3684_93408_10787	8	+	0.0270303467726243	0.464921964489138
8141	cobalt chloride	hsa05012	Parkinson's disease	7416	1	+	0.000699723211472819	0.0200587320622208
8142	cobalt chloride	hsa04020	Calcium signaling pathway	1129_490_779_7416_6869_2185_2064	7	+	0.0491976773127049	0.528875031111578
8143	cobalt chloride	hsa04740	Olfactory transduction	5593_23538_2978_81797_26529_815	6	-	2.25744265430155e-06	0.000200912396232838
8144	cobalt chloride	hsa04012	ErbB signaling pathway	2475_27_5062_208_6777_867_673_1956_5747_2065_57144_815	12	-	0.0390741509386705	0.869399858385419
8145	cobalt chloride	hsa05012	Parkinson's disease	27429_842	2	-	0.00871223275990046	0.38769435781557
8146	cobalt chloride	hsa03010	Ribosome	9045	1	-	0.0147694747640239	0.438161084666042
8147	tetraethylenepentamine	hsa05332	Graft-versus-host disease	3812_57292_3811_3804_3111_3802_356_355_5551_3803_3133	11	+	0.000739789052111854	0.0162753591464608
8148	tetraethylenepentamine	hsa04650	Natural killer cell mediated cytotoxicity	57292_3809_3808_3805_3804_3806_3803_3802_5880_3452_3439_3812_3810_3811_3133_4776_5530_5551_2185_5291_8795_5595_3447_356_355_6452_5879	27	+	2.5300290065135e-05	0.00175933834468468
8149	tetraethylenepentamine	hsa04612	Antigen processing and presentation	3812_4801_57292_3811_3809_3808_3439_3805_3804_3447_3806_3810_3803_3802_3452_3111_3133_920_3310_115653	20	+	3.99849623791973e-05	0.00175933834468468
8150	tetraethylenepentamine	hsa05016	Huntington's disease	2904_317_5978_3066_9001_291	6	+	0.0421699820838047	0.742191684674963
8151	tetraethylenepentamine	hsa04740	Olfactory transduction	26211_5593_5568_157_135948_818_5137_26476_26539_8590	10	+	0.000153190751928403	0.00449359538989982
8152	tetraethylenepentamine	hsa05010	Alzheimer's disease	102_22926_6622_841_488	5	-	0.0137578917750275	0.306113091994362
8153	tetraethylenepentamine	hsa04080	Neuroactive ligand-receptor interaction	1081_7068_2847_3362_1241_57105_2742_56288_135_1132_3269	11	-	0.0423689730210116	0.481134352867577
8154	tetraethylenepentamine	hsa04910	Insulin signaling pathway	23433_5604_23265_5602	4	-	0.0341434134505202	0.481134352867577
8155	tetraethylenepentamine	hsa04740	Olfactory transduction	26333_409	2	-	1.08659505839863e-10	9.67069601974781e-09
8156	tetraethylenepentamine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2215_3013	26	-	0.000293569858215876	0.0130638586906065
8157	tetraethylenepentamine	hsa04720	Long-term potentiation	5604	1	-	0.0432480317184339	0.481134352867577
8158	tetraethylenepentamine	hsa05012	Parkinson's disease	2861_6622_291	3	-	0.0131348647412731	0.306113091994362
8159	tetraethylenepentamine	hsa04060	Cytokine-cytokine receptor interaction	3601_3561_3566_3596_3589_7292_8741_657_8718_29949_1896	11	-	0.0334596870289822	0.481134352867577
8160	clozapine	hsa05010	Alzheimer's disease	776_54205_317_3709_6868_351_5534_810_517	9	+	0.0032350908381512	0.097052725144536
8161	clozapine	hsa05016	Huntington's disease	1213_246721_5439_6648_1639_54205_317_6667_3092_548644_161_517	12	+	0.0169475830975508	0.262776311974554
8162	clozapine	hsa04740	Olfactory transduction	810_23538	2	+	8.7738600801355e-18	7.89647407212195e-16
8163	clozapine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8294_121504_8343_8347_8346_8344_8339_8968_8370_718_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	32	+	0.00526490241308479	0.118460304294408
8164	clozapine	hsa04512	ECM-receptor interaction	8516_1284_7059_2811_2335_8515_3910_3690_3693_7057_3685_1277_375790_1282_961_9672_7148_3339_1291_3675	20	+	0.0175184207983036	0.262776311974554
8165	clozapine	hsa05012	Parkinson's disease	6570_54205_317_517	4	+	0.0006055620769696	0.027250293463632
8166	clozapine	hsa04260	Cardiac muscle contraction	776_6262_782	3	+	0.0234881171815751	0.301990078048823
8167	clozapine	hsa03010	Ribosome	6165_6129_6192_439992_6189	5	+	0.0298522398284436	0.335837698069991
8168	clozapine	hsa04080	Neuroactive ligand-receptor interaction	5618_1813_64106_7434_2561_10203_9568	7	-	0.000884785800012601	0.0259537168003696
8169	clozapine	hsa04612	Antigen processing and presentation	3805_3134	2	-	0.0463923400256401	0.680420987042721
8170	clozapine	hsa04740	Olfactory transduction	219464_157_26333_5613_5616_818_2978	7	-	3.18253943885289e-07	2.80063470619054e-05
8171	clozapine	hsa05322	Systemic lupus erythematosus	9555	1	-	0.000213888420130219	0.00941109048572964
8172	clozapine	hsa04060	Cytokine-cytokine receptor interaction	5618_3589_5155_3601_3570_355_4982_91_4254_8795	10	-	0.0104363130694311	0.229598887527484
8173	clozapine	hsa04610	Complement and coagulation cascades	5104	1	-	0.0421936700949216	0.680420987042721
8174	betazole	hsa04310	Wnt signaling pathway	51701_8945_27101_4088_6932_8312_23236	7	-	0.0233199819400304	0.781219394991018
8175	betazole	hsa05322	Systemic lupus erythematosus	8358_85235_8968_3119_3013_8330_8332_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357	19	-	6.99431658825937e-11	4.68619211413378e-09
8176	haloperidol	hsa05010	Alzheimer's disease	5533_1339_6622_6390_317_4137_5663_3708_3709_5534_3553_348	12	+	0.00989535015069802	0.300158954571173
8177	haloperidol	hsa05016	Huntington's disease	4899_1211_1339_581_1639_6390_317_3092_3708_3066_55567_1385	12	+	0.00452572390320047	0.205920437595621
8178	haloperidol	hsa04740	Olfactory transduction	5568_157_442194_5137_393046_409	6	+	1.04089422629504e-15	9.47213745928487e-14
8179	haloperidol	hsa05110	Vibrio cholerae infection	5568_5578	2	+	0.0295515013274698	0.384169517257107
8180	haloperidol	hsa04010	MAPK signaling pathway	5320_9344_1147_3925_50487_22808_6237_4763_8986_5602_3164_5608_11221_3553_27006_6788_8911_5871_1399_2260_2247_100137049_409_4149_4217_8398_9254_2258_9252_5533_1956_7043_5534_5568_3310_5971_784_1848_782_5578_1843_5598_6655_4915_1846_4137_8912_23162_8681_2005_10454_1386_27330_9693_7186	55	+	0.017002551639798	0.37235528562507
8181	haloperidol	hsa05012	Parkinson's disease	2861_1339_5413_6622_6390_317_7345_6531_9627	9	+	0.0215851067397983	0.37235528562507
8182	haloperidol	hsa04940	Type I diabetes mellitus	3553_3109_3117_3123_3126_3127_3111_2571_3134_1363_3133_3125_5798	13	+	0.0245508979533013	0.37235528562507
8183	haloperidol	hsa05010	Alzheimer's disease	5331_836_351_841_4698_1329_1347_5664_102_355_23385_4842_489_488_810_6868_517	17	-	0.0360893457204396	0.28446281232038
8184	haloperidol	hsa04080	Neuroactive ligand-receptor interaction	2569_2901_1081_7068_7434_56288_136_5733_4988_680_5646	11	-	2.10468661011613e-07	9.57632407602839e-06
8185	haloperidol	hsa04742	Taste transduction	2785	1	-	0.00512627804644623	0.0983687218511634
8186	haloperidol	hsa04740	Olfactory transduction	219464_26212_2978_818_26476_4991_810_409	8	-	1.76375060160932e-16	1.60501304746448e-14
8187	haloperidol	hsa05110	Vibrio cholerae infection	9414_5335_4583	3	-	0.0406375446171972	0.28446281232038
8188	haloperidol	hsa04630	Jak-STAT signaling pathway	29949_2057_3455_23529_1154_6655_9655_5291_10379_51561_9180_3589_5781	13	-	0.017933916734702	0.223984357666316
8189	haloperidol	hsa04062	Chemokine signaling pathway	2785_5970_7454_2786_6352_3551_6655_2773_1398_673_5331_5291_3845_8976_5747_56288_2931_409	18	-	0.0207240774367054	0.223984357666316
8190	haloperidol	hsa05012	Parkinson's disease	836_4698_1329_1347_7416_27429_7419_517	8	-	0.00219763154815831	0.0666614902941354
8191	haloperidol	hsa04060	Cytokine-cytokine receptor interaction	29949_5155_5154_8741_9180_2057_970_23495_4982_3605_23529_3589_1956_51561_7042_91_655_93_8795_6352_3455_355_7423_7422	24	-	0.005404874826987	0.0983687218511634
8192	haloperidol	hsa03010	Ribosome	285053_6181_6142_284393_439992_389342_6189	7	-	0.0246136656776171	0.223984357666316
8193	haloperidol	hsa04020	Calcium signaling pathway	5331_5256_5733_5260_56848_818_9630_1956_5335_136_489_488_810_7416_7419_3707_4842	17	-	0.0232496747378997	0.223984357666316
8194	haloperidol	hsa03050	Proteasome	5690	1	-	0.0112560041513335	0.170716062961891
8195	haloperidol	hsa04610	Complement and coagulation cascades	5627_1675_727_5329	4	-	0.0395964740687065	0.28446281232038
8196	sulfadiazine	hsa04740	Olfactory transduction	4991	1	+	0.000177274446048212	0.0122319367773266
8197	sulfadiazine	hsa05131	Shigellosis	7278_7280_113457_347733	4	-	0.0416015253893358	0.489431059482629
8198	sulfadiazine	hsa05130	Pathogenic Escherichia coli infection	7278_7280_113457_347733	4	-	0.0416015253893358	0.489431059482629
8199	sulfadiazine	hsa04740	Olfactory transduction	409	1	-	0.0036721383782321	0.128524843238123
8200	sulfadiazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_55766_8294_8367_554313_8343_121504_8339_8347_8346_8344	20	-	3.86687889581836e-10	2.70681522707285e-08
8201	sulfadiazine	hsa04710	Circadian rhythm - mammal	1454_5187	2	-	0.0412702859214802	0.489431059482629
8202	sulfadiazine	hsa04060	Cytokine-cytokine receptor interaction	5155	1	-	0.0489431059482629	0.489431059482629
8203	sulfadiazine	hsa05222	Small cell lung cancer	598_7186_3913_8554_9618	5	-	0.0485485749915906	0.489431059482629
8204	diprophylline	hsa05332	Graft-versus-host disease	3824_3108_3119_3123_3106_3126_3127_3125	8	+	0.000146643913819808	0.00901915606155574
8205	diprophylline	hsa04650	Natural killer cell mediated cytotoxicity	3824_4276_5578_6464_3106_6654_8743_7410_27040_6452_919_5534_8795	13	+	0.000920030337378602	0.0124036584015496
8206	diprophylline	hsa04640	Hematopoietic cell lineage	1436_1435_3566_2057_960_3690_3123_3126_3127_3125_1378	11	+	0.000240510828308153	0.00901915606155574
8207	diprophylline	hsa05320	Autoimmune thyroid disease	3108_3119_3123_3106_3126_3127_3125	7	+	0.00260284646826656	0.0278876407314274
8208	diprophylline	hsa04612	Antigen processing and presentation	4800_3824_3108_3119_3123_3106_3126_3127_3125	9	+	0.00358403185521533	0.0336002986426437
8209	diprophylline	hsa05310	Asthma	3108_3119_3123_3126_3127_3125	6	+	0.000801566952240003	0.0124036584015496
8210	diprophylline	hsa04630	Jak-STAT signaling pathway	6777_3566_2057_6654_3718_6772_3572_200734_9180_10379_10253	11	+	0.0202719981006233	0.168933317505194
8211	diprophylline	hsa05330	Allograft rejection	3108_3119_3123_3106_3126_3127_3125	7	+	0.000456807649087828	0.0114201912271957
8212	diprophylline	hsa04940	Type I diabetes mellitus	3108_3119_3123_3106_3126_3127_3125	7	+	0.000992292672123966	0.0124036584015496
8213	diprophylline	hsa04740	Olfactory transduction	409	1	-	0.0337156197226511	0.919308141460095
8214	triamterene	hsa04520	Adherens junction	7082_4088_7525_91_5770_8976	6	+	0.00572040975865072	0.383267453829598
8215	triamterene	hsa04210	Apoptosis	10000_5575_5534_317_596	5	+	0.0327673253664167	0.731803599849973
8216	triamterene	hsa05222	Small cell lung cancer	10000_3918_317_2335_596	5	+	0.0290304762488167	0.731803599849973
8217	triamterene	hsa04810	Regulation of actin cytoskeleton	7454_8874_5829_26999_5155_8074_7430_3985	8	-	0.0237476179971846	1
8218	isoxicam	hsa05016	Huntington's disease	5432_1213_246721_1639_5439_317_548644	7	-	0.0142655379872908	0.228248607796653
8219	isoxicam	hsa04360	Axon guidance	3985_5534_3983_7869_2041	5	-	0.0332554324547376	0.399065189456851
8220	isoxicam	hsa04210	Apoptosis	317_472_51135_5534_8837_651610	6	-	0.00152719722922855	0.0366527335014852
8221	isoxicam	hsa03020	RNA polymerase	5432_246721_5439_548644	4	-	0.000864072491957002	0.0366527335014852
8222	sulfacetamide	hsa05131	Shigellosis	7278_113457	2	+	0.00770132545993038	0.0154026509198608
8223	sulfacetamide	hsa05130	Pathogenic Escherichia coli infection	7278_113457	2	+	0.00770132545993038	0.0154026509198608
8224	sulfacetamide	hsa04540	Gap junction	7278_113457	2	+	0.01976158525863	0.02634878034484
8225	noretynodrel	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	1.64469807791762e-06	9.04583942854691e-05
8226	noretynodrel	hsa04512	ECM-receptor interaction	7059_960_2335_1302	4	+	0.0188270327069204	0.345162266293541
8227	noretynodrel	hsa04912	GnRH signaling pathway	5599_5331_776_1432_23236	5	+	0.00989891192252236	0.272220077869365
8228	noretynodrel	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_6714_1432_4067	4	-	0.029792595243605	0.878881559686348
8229	noretynodrel	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0133830126319556	0.78959774528538
8230	trazodone	hsa04360	Axon guidance	3984_2042_57556_2048_6405	5	+	0.0420752418935925	0.899172035691873
8231	trazodone	hsa05212	Pancreatic cancer	367_2950_6934_208	4	+	0.0413331799266516	0.899172035691873
8232	trazodone	hsa05215	Prostate cancer	367_2950_6934_208	4	+	0.0399740809009778	0.899172035691873
8233	trazodone	hsa04080	Neuroactive ligand-receptor interaction	5029	1	-	0.003692090418242	0.131069209847591
8234	trazodone	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_5606_317_834_581	5	-	0.0491307058682175	0.731989168185261
8235	trazodone	hsa04740	Olfactory transduction	801_808_805	3	-	0.00197115273344054	0.131069209847591
8236	trazodone	hsa04062	Chemokine signaling pathway	9475	1	-	0.0227208043986646	0.537725704101729
8237	zidovudine	hsa04740	Olfactory transduction	8392	1	+	0.0327012806720513	0.561478313501698
8238	zidovudine	hsa05322	Systemic lupus erythematosus	718_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	+	5.3864520030741e-06	0.000296254860169075
8239	zidovudine	hsa04512	ECM-receptor interaction	1284_1291_1282_3381	4	+	0.048108245441748	0.561478313501698
8240	zidovudine	hsa04610	Complement and coagulation cascades	2162_7056_2149_718	4	+	0.026782577090656	0.561478313501698
8241	zidovudine	hsa05214	Glioma	6655_5154_808_7039_801_805	6	-	0.00523523666125003	0.180615664813126
8242	zidovudine	hsa05332	Graft-versus-host disease	3135_3105_355_3119	4	-	0.0196973801045358	0.260889448493672
8243	zidovudine	hsa05211	Renal cell carcinoma	7039_5908_2271_6655_643752	5	-	0.0298552868380105	0.28996888258099
8244	zidovudine	hsa05320	Autoimmune thyroid disease	3135_3105_355_3119	4	-	0.0394261304979458	0.28996888258099
8245	zidovudine	hsa05131	Shigellosis	7278_7430_113457_9475	4	-	0.0462269233100129	0.28996888258099
8246	zidovudine	hsa04910	Insulin signaling pathway	2872_6655_808_23265_801_5566_805	7	-	0.0460106047485698	0.28996888258099
8247	zidovudine	hsa05130	Pathogenic Escherichia coli infection	7278_7430_113457_9475	4	-	0.0462269233100129	0.28996888258099
8248	zidovudine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3021_3020_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3119	24	-	3.92161849974922e-13	2.70591676482696e-11
8249	zidovudine	hsa04720	Long-term potentiation	5566_808_5908_801_805_643752	6	-	0.00985555302685576	0.226677719617682
8250	zidovudine	hsa05330	Allograft rejection	3135_3105_355_3119	4	-	0.01448392573693	0.249847718962042
8251	zidovudine	hsa04940	Type I diabetes mellitus	3135_3105_355_3119	4	-	0.0226860389994497	0.260889448493672
8252	butirosin	hsa04740	Olfactory transduction	26211	1	+	0.000373324290726209	0.0139996609022328
8253	butirosin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3111_8359_8294_8367_554313_121504_3119	16	+	8.1636564149124e-06	0.00061227423111843
8254	butirosin	hsa05131	Shigellosis	7278_7454_7430_113457	4	-	0.0444606570556514	0.64912559301251
8255	butirosin	hsa05130	Pathogenic Escherichia coli infection	7278_7454_7430_113457	4	-	0.0444606570556514	0.64912559301251
8256	butirosin	hsa05322	Systemic lupus erythematosus	55506_8361_8363_8362_8365_8364_8370_8360_8368_8366_3111_8359_8294_8367_554313_121504_6737	17	-	1.02065259694929e-07	7.45076395772982e-06
8257	butirosin	hsa04540	Gap junction	2778_5598_7278_113457_112_6714_23236	7	-	0.00691170000343213	0.252277050125273
8258	butirosin	hsa04912	GnRH signaling pathway	2778_1432_5598_112_6714_23236	6	-	0.0419726013268688	0.64912559301251
8259	ketanserin	hsa04740	Olfactory transduction	810_26539	2	+	0.0022865164297535	0.086887624330633
8260	ketanserin	hsa05322	Systemic lupus erythematosus	3013_9103_3111_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	13	+	0.0003758092969377	0.0285615065672652
8261	ketanserin	hsa04062	Chemokine signaling pathway	1236_3579_6347_10850_3576_2788_2931_7410_6352_6093_6367	11	+	0.0281621048133032	0.713439988603681
8262	ketanserin	hsa04130	SNARE interactions in vesicular transport	8773_6804_9570_10228_8675_8417	6	-	0.0355709425732682	0.503435891950849
8263	ketanserin	hsa04080	Neuroactive ligand-receptor interaction	5618_2908_1909	3	-	0.00033100443911875	0.009268124295325
8264	ketanserin	hsa04740	Olfactory transduction	219464_5613	2	-	6.26746104927793e-08	5.26466728139346e-06
8265	ketanserin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_3123_8969_8370_8332_8359_8330_8331_8336_554313_6738_8351_85235_3013_3014	26	-	2.91576359697159e-06	0.000122462071072807
8266	ketanserin	hsa05012	Parkinson's disease	7327_7332	2	-	0.0247560731677205	0.503435891950849
8267	ketanserin	hsa04020	Calcium signaling pathway	5613_6262_2776_1909	4	-	0.0359597065679178	0.503435891950849
8268	ketanserin	hsa05210	Colorectal cancer	8503_5594_5599_572_6655_1856_5881_6934_3725_4233	10	-	0.0425616168024351	0.510739401629221
8269	heliotrine	hsa04740	Olfactory transduction	8387_4991_5568_816_8388	5	+	0.000641249752838812	0.0334531707516061
8270	heliotrine	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8370_83740_8368_8366_8360_8359_8362_8294_8367_554313_121504	17	+	0.000815930993941612	0.0334531707516061
8271	heliotrine	hsa04340	Hedgehog signaling pathway	5568_51384_5727_656_353500_53944_7472	7	+	0.0230751759755966	0.630721476666307
8272	heliotrine	hsa05012	Parkinson's disease	4695	1	+	0.0330389792827607	0.677299075296594
8273	heliotrine	hsa05332	Graft-versus-host disease	3135_3113_3107_3108_5551	5	-	0.0481705045363289	0.463641106162166
8274	heliotrine	hsa05010	Alzheimer's disease	5534_5664	2	-	0.0366790132414174	0.463641106162166
8275	heliotrine	hsa05016	Huntington's disease	7052_246721	2	-	0.026637854607143	0.463641106162166
8276	heliotrine	hsa04740	Olfactory transduction	219464_26212_393046	3	-	8.80593682479387e-05	0.00339028567754564
8277	heliotrine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3108_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3113	23	-	5.80759839966834e-07	4.47185076774462e-05
8278	heliotrine	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_1839_5600_5603_5602_28964_23545	7	-	0.0474891558090075	0.463641106162166
8279	heliotrine	hsa04920	Adipocytokine signaling pathway	6794_5599_208_6513_8660_1375_5602	7	-	0.037290413308588	0.463641106162166
8280	heliotrine	hsa05330	Allograft rejection	3135_3108_3107_3113_5551	5	-	0.03464184956327	0.463641106162166
8281	tolmetin	hsa05131	Shigellosis	7278_113457_7430_2534_6093_8976	6	+	0.00346346224820046	0.0819686065407442
8282	tolmetin	hsa05130	Pathogenic Escherichia coli infection	7278_113457_7430_2534_6093_8976	6	+	0.00346346224820046	0.0819686065407442
8283	tolmetin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_8294_8367_8342_121504	15	+	5.62204350992039e-06	0.000399165089204348
8284	tolmetin	hsa04360	Axon guidance	5362_7852_5532_9037_6093_27289_2534	7	+	0.0467951554266273	0.553742672548423
8285	tolmetin	hsa04540	Gap junction	5593_5598_7278_113457_3709_2977	6	+	0.0306729157336743	0.544444254272719
8286	tolmetin	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0398504951547512	0.553742672548423
8287	tolmetin	hsa04070	Phosphatidylinositol signaling system	8394_8396_5335_23236	4	-	0.047160786627165	1
8288	tolmetin	hsa04650	Natural killer cell mediated cytotoxicity	3383_3107_6452_5335_5781_5534	6	-	0.0361780860848821	1
8289	tolmetin	hsa04740	Olfactory transduction	26212	1	-	0.0154009922987261	1
8290	mestranol	hsa05131	Shigellosis	7278_6093_7430_113457_9181	5	+	0.0476570523671178	0.85782694260812
8291	mestranol	hsa05130	Pathogenic Escherichia coli infection	7278_6093_7430_113457_9181	5	+	0.0476570523671178	0.85782694260812
8292	mestranol	hsa04740	Olfactory transduction	1179	1	+	5.50397570274888e-05	0.00396286250597919
8293	mestranol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_942_8359_8294_8367_554313_121504	15	+	0.000204702557835048	0.00736929208206173
8294	mestranol	hsa05211	Renal cell carcinoma	112399_2271_5594_4233_7042_405_8453_5781_1398_6921	10	-	0.000752579136144572	0.0534331186662646
8295	mestranol	hsa05200	Pathways in cancer	4089_112399_2271_5594_3551_5747_6921_7042_5727_5899_332_6789_405_8453_6934_1398_675_5335_4233_5914	20	-	0.0426875937904999	0.865628389921523
8296	mestranol	hsa04520	Adherens junction	6591_5594_4089_117178_6885_6934_4233	7	-	0.0389877847404688	0.865628389921523
8297	arcaine	hsa04740	Olfactory transduction	5566	1	+	0.0106850639503664	0.379319770238007
8298	arcaine	hsa04062	Chemokine signaling pathway	1234_208_5566_3576_2788_6358_6359_7852_6093_4793	10	+	0.00376062884021711	0.267004647655415
8299	arcaine	hsa04070	Phosphatidylinositol signaling system	5333_3708_5290_3631	4	-	0.00699736044219142	0.377857463878337
8300	arcaine	hsa05211	Renal cell carcinoma	3725_112399_5290	3	-	0.0344000434083385	0.89153331712399
8301	arcaine	hsa05210	Colorectal cancer	3725_1855_5290	3	-	0.0498215804023981	0.89153331712399
8302	azacitidine	hsa04740	Olfactory transduction	9635	1	+	8.20410400770718e-05	0.00557879072524088
8303	azacitidine	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	0.0168964523257843	0.382986252717778
8304	azacitidine	hsa04350	TGF-beta signaling pathway	4091_7057_3624_3400_654_353500_7042_83729	8	+	0.010526200881755	0.35789082997967
8305	azacitidine	hsa05332	Graft-versus-host disease	355_5551_3552	3	-	0.00690215146679167	0.0302379969021349
8306	azacitidine	hsa04650	Natural killer cell mediated cytotoxicity	8503_5295_5290_3460_5881_6452_5335_3454_4772_3459_7410_4277_4276_10725_4775_5894_5291_8795_5578_6655_6654_6464_10451_355_5530_3845_5551	27	-	0.049618639272783	0.169070919003557
8307	azacitidine	hsa04640	Hematopoietic cell lineage	3554_3566_3552_2057_960_4254_3673	7	-	0.000108874269766183	0.000910584801680803
8308	azacitidine	hsa03320	PPAR signaling pathway	11001_5170_1375_1376_6257_6256	6	-	0.000889327556046179	0.00511363344726553
8309	azacitidine	hsa05010	Alzheimer's disease	1327_2776_5663_5664_7132_6622_509_348_8772_2932_5530_3709_488_102_23236_842_841_840_4137_355_808_801_805	23	-	5.70902456609744e-05	0.000583589177867738
8310	azacitidine	hsa04080	Neuroactive ligand-receptor interaction	5029_4889_5618_7442_7068_2690_2908_4886_5030_3354_5026_2150_136_135_7433_56288_5031_9170	18	-	3.71469812503854e-13	1.70876113751773e-11
8311	azacitidine	hsa04742	Taste transduction	5613_5616_112	3	-	0.0006846935807485	0.00419945396192413
8312	azacitidine	hsa05320	Autoimmune thyroid disease	355_5551	2	-	0.000149329649798227	0.00114486064845307
8313	azacitidine	hsa04612	Antigen processing and presentation	4800_4801_3312_5993_3306_1385_3304_3305_3303	9	-	0.000633065274001481	0.00416014322915259
8314	azacitidine	hsa05016	Huntington's disease	246721_1327_64764_2776_23186_6875_6874_6908_5433_5431_1639_5439_2033_509_7419_1213_548644_23236_51164_842_841_5978_1385_1387	24	-	2.20914871013692e-05	0.000290345259046567
8315	azacitidine	hsa04740	Olfactory transduction	5613_5616_818_808_801_805	6	-	8.37583690628546e-36	7.70576995378262e-34
8316	azacitidine	hsa04514	Cell adhesion molecules (CAMs)	965_4685_4897_9080_6385_5819_1364_1365_5792_9672_23705_4950_9019_5817	14	-	2.94536485574281e-05	0.000338716958410423
8317	azacitidine	hsa04510	Focal adhesion	8503_5170_595_10298_6464_2909_5295_5154_5290_9475_5881_5747_3673_81_4659_6714_5728_3911_3693_7057_7410_23396_1399_1398_55742_8515_7414_5063_1793_3480_2932_5894_6093_5291_4233_5578_6655_6654_5602_10451_2002_7423	42	-	0.0264948109885162	0.101563442122645
8318	azacitidine	hsa05322	Systemic lupus erythematosus	6738_6632_8343_81_8347_8346_8345_8344_8339_3021_3020_8968_8358_8337_8350_8351_8352_8353_8354_8355_8356_8357_85236_3013_3017_3014	26	-	0.0167510917945558	0.0670043671782232
8319	azacitidine	hsa05340	Primary immunodeficiency	8517_64421_5993	3	-	0.0310652257414388	0.109923106469707
8320	azacitidine	hsa04512	ECM-receptor interaction	8515_960_3911_3693_1605_7057_6385_9672_3673_3161	10	-	0.00416936332620438	0.0201884961058317
8321	azacitidine	hsa04062	Chemokine signaling pathway	3717_6777_156_6464_112_8503_5290_9475_115_6387_56288_5747_2309_4067_5580_7074_7410_1399_1398_408_8517_5295_2932_5894_6093_5291_4790_23236_7852_3551_5613_6655_6654_5616_10451_3845_5970	37	-	0.013786956707778	0.0576545462325262
8322	azacitidine	hsa05012	Parkinson's disease	2861_7326_1327_7332_51465_509_27429_7419_6622_842	10	-	4.25810879647733e-07	9.79365023189786e-06
8323	azacitidine	hsa04260	Cardiac muscle contraction	1327_6548_4635_488_10479_481	6	-	0.000105919719829189	0.000910584801680803
8324	azacitidine	hsa04060	Cytokine-cytokine receptor interaction	8744_5154_7852_6387_90_7132_27242_3554_3552_3454_3459_3572_657_4982_659_3601_3588_23765_3625_4055_4254_7043_91_655_4233_8795_5618_3566_2057_3460_355_7423_2690	33	-	3.39911623481077e-07	9.79365023189786e-06
8325	azacitidine	hsa03010	Ribosome	6139_9349_6137_6125_6168_6234_6160_6171	8	-	1.91827304962258e-05	0.000290345259046567
8326	azacitidine	hsa04020	Calcium signaling pathway	2776_115_5333_5335_136_135_493_818_808_7419_5026_3709_488_3707_23236_5578_5613_5616_8912_5530_801_2065_805	23	-	1.78391086219558e-05	0.000290345259046567
8327	azacitidine	hsa03050	Proteasome	5717_23198_5718	3	-	0.00219216233729096	0.0118634667665158
8328	azacitidine	hsa05330	Allograft rejection	355_5551	2	-	0.00410068833668121	0.0201884961058317
8329	azacitidine	hsa04950	Maturity onset diabetes of the young	3087	1	-	0.028118487291714	0.103476033233508
8330	azacitidine	hsa04940	Type I diabetes mellitus	355_5551_3552	3	-	0.00472068247399834	0.0217151393803924
8331	azacitidine	hsa04610	Complement and coagulation cascades	5627_5329_4179_5328_7035	5	-	0.000409663967550088	0.00289916038573908
8332	(+/-)-catechin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_941	28	+	4.34448205163809e-13	2.99769261563028e-11
8333	(+/-)-catechin	hsa04130	SNARE interactions in vesicular transport	6843_10228_2054_6844_662	5	-	0.0407230841910309	0.437501051206299
8334	(+/-)-catechin	hsa04080	Neuroactive ligand-receptor interaction	4157	1	-	0.000171458725293725	0.00440077394920561
8335	(+/-)-catechin	hsa04670	Leukocyte transendothelial migration	1535	1	-	0.0453206123966256	0.437501051206299
8336	(+/-)-catechin	hsa04740	Olfactory transduction	818	1	-	5.05017527702196e-07	3.88863496330691e-05
8337	(+/-)-catechin	hsa04514	Cell adhesion molecules (CAMs)	9672	1	-	0.0322145684813906	0.437501051206299
8338	(+/-)-catechin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8336_8294_8367_554313_8343_121504_8339_8347_8346_8344	20	-	3.82918739151469e-05	0.00147423714573316
8339	(+/-)-catechin	hsa04530	Tight junction	5519	1	-	0.0333703750357993	0.437501051206299
8340	(+/-)-catechin	hsa04630	Jak-STAT signaling pathway	6777_3572	2	-	0.0494673291047655	0.437501051206299
8341	chloropyramine	hsa04740	Olfactory transduction	23538	1	+	0.00756946480544443	0.249792338579666
8342	chloropyramine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_8354	15	+	4.90099808601492e-07	3.23465873676985e-05
8343	orciprenaline	hsa05131	Shigellosis	7278_113457_998	3	+	0.0478218507261484	0.892674546888103
8344	orciprenaline	hsa04520	Adherens junction	4088_5770_2260_998	4	+	0.028730274121927	0.892674546888103
8345	orciprenaline	hsa05130	Pathogenic Escherichia coli infection	7278_113457_998	3	+	0.0478218507261484	0.892674546888103
8346	orciprenaline	hsa04130	SNARE interactions in vesicular transport	8773_9570_6844	3	-	0.0345016368542753	0.385268278206074
8347	orciprenaline	hsa04910	Insulin signaling pathway	5613_5575_6654_5616_51422_5605_23265_10211	8	-	0.00406600101184083	0.272422067793336
8348	orciprenaline	hsa04210	Apoptosis	5613_5575_5616_8837_841	5	-	0.0243459899107297	0.385268278206074
8349	orciprenaline	hsa04720	Long-term potentiation	818_5605_5616_5613	4	-	0.049403103974803	0.472858280901686
8350	orciprenaline	hsa04010	MAPK signaling pathway	6416_3925_5613_6654_5616_5605_5607_51776_3306_1386	10	-	0.0331959678268087	0.385268278206074
8351	orciprenaline	hsa04540	Gap junction	5605_5613_5607_6654_5616	5	-	0.0285073062117666	0.385268278206074
8352	orciprenaline	hsa04912	GnRH signaling pathway	5605_6416_5613_6654_5616_818	6	-	0.0148227726133444	0.385268278206074
8353	trimethadione	hsa05010	Alzheimer's disease	4695_6622	2	+	0.0363506779247356	0.975275236904718
8354	trimethadione	hsa04740	Olfactory transduction	26211_26212_8390_5593_26532_2979	6	+	0.00441889835854212	0.326998478532117
8355	cefaclor	hsa04740	Olfactory transduction	5137_5566_26212_816	4	+	0.0487248438986468	1
8356	cefaclor	hsa04340	Hedgehog signaling pathway	656_5566_652_653_353500	5	+	0.0210133832216077	1
8357	cefaclor	hsa04350	TGF-beta signaling pathway	4088_656_652_653_353500_6093	6	+	0.0319960182324512	1
8358	cefaclor	hsa05214	Glioma	2475_3845	2	-	0.0421274226273044	0.258782738996299
8359	cefaclor	hsa05131	Shigellosis	7278_3688_7430_113457	4	-	0.000199070120028864	0.00428000758062058
8360	cefaclor	hsa04670	Leukocyte transendothelial migration	7409_3688_7430	3	-	0.0228499011163527	0.164486358287579
8361	cefaclor	hsa05130	Pathogenic Escherichia coli infection	7278_3688_7430_113457	4	-	0.000199070120028864	0.00428000758062058
8362	cefaclor	hsa05221	Acute myeloid leukemia	5914_2475_3845	3	-	0.00336718948231215	0.0482630492464741
8363	cefaclor	hsa04810	Regulation of actin cytoskeleton	7409_7430_3688_3845	4	-	0.0229515848773366	0.164486358287579
8364	cefaclor	hsa04540	Gap junction	7278_3845_113457	3	-	0.0113327476027895	0.121827036729987
8365	terconazole	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.00627712214662827	0.238530641571874
8366	terconazole	hsa04740	Olfactory transduction	818_219464_393046	3	-	0.00741583917076274	0.511692902782629
8367	tobramycin	hsa04650	Natural killer cell mediated cytotoxicity	1437_3383_3805_5880_5532_6452_919_5879	8	+	0.00287433378383057	0.172460027029834
8368	tobramycin	hsa04360	Axon guidance	7852_5532_5880_9037_5879_3897	6	+	0.0259632316237071	0.451263110952434
8369	tobramycin	hsa04370	VEGF signaling pathway	5532_5879_5880_7422	4	+	0.0448733024432665	0.451263110952434
8370	tobramycin	hsa04080	Neuroactive ligand-receptor interaction	5618_56288_1813	3	-	0.00137177602809198	0.0569287051658172
8371	tobramycin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8348_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_9555	23	-	1.20234235745964e-05	0.000997944156691501
8372	tobramycin	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_528_535_6868_5600_523_3725_4233_5781	9	-	0.0199051314828082	0.286561063974887
8373	tobramycin	hsa04115	p53 signaling pathway	55367_841_581_4194_4193_355_51512_1017_3732	9	-	0.0171048728147143	0.286561063974887
8374	tobramycin	hsa03022	Basal transcription factors	2966_2969_10629_51616_6872_728198	6	-	0.0207152576367388	0.286561063974887
8375	tobramycin	hsa05012	Parkinson's disease	9627	1	-	0.0103737615042186	0.286561063974887
8376	tolazamide	hsa04210	Apoptosis	472_5566_651610_8837	4	+	0.0285630295141301	0.348468960072387
8377	tolazamide	hsa04340	Hedgehog signaling pathway	656_5566_353500_4036	4	+	0.00690430665115638	0.218719570080073
8378	tolazamide	hsa04350	TGF-beta signaling pathway	656_91_4090_353500	4	+	0.0266409153909366	0.348468960072387
8379	tolazamide	hsa04010	MAPK signaling pathway	4149_5566_8911_23162_3725_91_2263_2260	8	+	0.0239345317556632	0.348468960072387
8380	tolazamide	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.00717113344524828	0.218719570080073
8381	tolazamide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8359_8370_8294_554313_121504	14	-	5.20541960644417e-16	5.20541960644417e-15
8382	pyrazinamide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8359_8370_8294_554313_121504	14	+	1.56581604904097e-11	6.57642740597207e-10
8383	pyrazinamide	hsa05218	Melanoma	8817_2260_4286	3	+	0.0201756046154288	0.423687696924005
8384	pyrazinamide	hsa05332	Graft-versus-host disease	3119_3105_3106_3126_3127_3125_3135_3123_649853	9	-	0.000109120113209316	0.00376589805097364
8385	pyrazinamide	hsa04080	Neuroactive ligand-receptor interaction	706_1131_4886	3	-	0.01974246077047	0.166714113172858
8386	pyrazinamide	hsa05320	Autoimmune thyroid disease	3119_3105_3106_3126_3127_3125_3135_3123_649853	9	-	0.000503734931497901	0.00957096369846012
8387	pyrazinamide	hsa04612	Antigen processing and presentation	3119_3123_3106_3126_3127_3125_3135_3105_649853	9	-	0.0118666986819552	0.112733637478574
8388	pyrazinamide	hsa04514	Cell adhesion molecules (CAMs)	3119_3123_3106_3126_3127_3125_3135_1364_3105_9019_649853	11	-	0.0254300234760147	0.193268178417712
8389	pyrazinamide	hsa05310	Asthma	3123_3126_3127_3119_3125	5	-	0.00969985370106205	0.105312697325817
8390	pyrazinamide	hsa04062	Chemokine signaling pathway	8976	1	-	0.007415163048131	0.105312697325817
8391	pyrazinamide	hsa03020	RNA polymerase	10621_246721_5439_548644_661	5	-	0.00857449055106706	0.105312697325817
8392	pyrazinamide	hsa05330	Allograft rejection	3119_3105_3106_3126_3127_3125_3135_3123_649853	9	-	5.58883470997947e-05	0.00376589805097364
8393	pyrazinamide	hsa04940	Type I diabetes mellitus	3119_3105_3106_3126_3127_3125_3135_3123_649853	9	-	0.00014865387043317	0.00376589805097364
8394	tiabendazole	hsa04080	Neuroactive ligand-receptor interaction	2561_2908	2	-	0.026406033544296	0.476148896001446
8395	tiabendazole	hsa04740	Olfactory transduction	818_393046	2	-	0.00079978124955632	0.0559846874689424
8396	tiabendazole	hsa05221	Acute myeloid leukemia	5605_208_5914_5371_11040	5	-	0.0473883814577698	0.555013392660467
8397	tiabendazole	hsa04664	Fc epsilon RI signaling pathway	5581_208_5605_8681_5606_100137049	6	-	0.0475725765137543	0.555013392660467
8398	tiabendazole	hsa04370	VEGF signaling pathway	208_998_5605_8681_5534_6714_100137049	7	-	0.0149968292494274	0.476148896001446
8399	tiabendazole	hsa04912	GnRH signaling pathway	4214_8681_998_818_5606_5605_6714_100137049	8	-	0.0272085083429398	0.476148896001446
8400	propylthiouracil	hsa04662	B cell receptor signaling pathway	971_10725_4776_7410_5880_933	6	+	0.0357209963705018	0.60901976214288
8401	propylthiouracil	hsa04310	Wnt signaling pathway	894_5578_10725_5880_1856_4776_11211_5568_7475_816	10	+	0.0319122845974691	0.60901976214288
8402	propylthiouracil	hsa04740	Olfactory transduction	5593_5568_9635_816	4	+	0.0147902989426256	0.569426509291086
8403	propylthiouracil	hsa04370	VEGF signaling pathway	8398_5578_10725_4776_5880_9047	6	+	0.0395467378014857	0.60901976214288
8404	propylthiouracil	hsa04010	MAPK signaling pathway	4908_3554_5568_782_3925_5578_5880_2122_4776_23162_5871_4791_8398_2260_4342_2251_4915	17	+	0.00826093737410438	0.569426509291086
8405	propylthiouracil	hsa05332	Graft-versus-host disease	3553_3552_3105_3106_3135_355_649853	7	-	0.00427539311969769	0.0833701658341049
8406	propylthiouracil	hsa04080	Neuroactive ligand-receptor interaction	3354_5618_4158_5030	4	-	0.0272393826270423	0.379897860773977
8407	propylthiouracil	hsa04740	Olfactory transduction	26212_109	2	-	1.40713332995297e-05	0.000548781998681658
8408	propylthiouracil	hsa05322	Systemic lupus erythematosus	55506_8361_8363_8362_8365_8364_8367_8360_8368_6738_8294_121504_8343_81_8347_8346_8344_8339_8366_8968_8370_8358_8359_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3014	35	-	1.62584353615641e-14	1.268157958202e-12
8409	propylthiouracil	hsa05012	Parkinson's disease	6390	1	-	0.0316131658488388	0.379897860773977
8410	propylthiouracil	hsa05330	Allograft rejection	3135_3105_3106_355_649853	5	-	0.0340933977617672	0.379897860773977
8411	propylthiouracil	hsa04940	Type I diabetes mellitus	3382_3552_3105_3106_3135_355_3553_649853	8	-	0.00141312466700494	0.0367412413421284
8412	etifenin	hsa05322	Systemic lupus erythematosus	3113_88_8343_8341_8339_8347_8346_8344	8	+	0.00108882275193227	0.0544411375966135
8413	etifenin	hsa04210	Apoptosis	472_5575_651610_8837	4	+	0.0378854728104815	0.631424546841358
8414	etifenin	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.00917324912393908	0.229331228098477
8415	etifenin	hsa03440	Homologous recombination	5890_7516_5892_8940	4	-	0.0254100315388262	0.514553138661231
8416	etifenin	hsa04080	Neuroactive ligand-receptor interaction	3354_1813	2	-	0.00938898100382993	0.253502487103408
8417	etifenin	hsa04740	Olfactory transduction	5566_4991	2	-	0.000195412589791688	0.00791420988656336
8418	etifenin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8370_8332_8359_8330_8331_8336_554313_8351_85235_3013_3111	24	-	4.91270888480738e-09	3.97929419669398e-07
8419	etoposide	hsa04740	Olfactory transduction	810_5613_9635_81797	4	+	6.89163980736797e-07	6.06464303048381e-05
8420	etoposide	hsa04210	Apoptosis	23533_8503_843_841_581_5613_596_11213_355_8837_8794_8795	12	+	0.0205269613586579	0.464096920033221
8421	etoposide	hsa04115	p53 signaling pathway	1647_27113_2810_1643_581_64393_4193_5268_841_355_1026_8795_9540	13	+	0.00121796693375876	0.0535905450853854
8422	etoposide	hsa03010	Ribosome	6192	1	+	0.0210953145469646	0.464096920033221
8423	etoposide	hsa04110	Cell cycle	995_890_5347_991_891_699_701_996_9700_51343_1031_7465	12	-	4.35947030450861e-06	0.000279006099488551
8424	etoposide	hsa04540	Gap junction	2697_23236_3845_2776_5578	5	-	0.0328119842345211	0.699988997003117
8425	etoposide	hsa04730	Long-term depression	10672_5578_3845_2776_23236	5	-	0.0122397207169021	0.391671062940867
8426	carcinine	hsa03320	PPAR signaling pathway	10062_2171_51_6319	4	-	0.028408558372419	0.326698421282819
8427	carcinine	hsa04080	Neuroactive ligand-receptor interaction	4889_7068_706_5025_56288_2150_9170	7	-	4.1912095170931e-10	1.92795637786283e-08
8428	carcinine	hsa04740	Olfactory transduction	5613_801_808_805	4	-	1.26458012378113e-20	1.16341371387864e-18
8429	carcinine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_94239_8366_8368_8329_8294_6632_121504_8343_8347_87_8345_8344_8339_723790_8367_3123_3126_3127_3125_8969_8968_8346_3108_8370_92815_8358_8359_8330_8331_8336_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_85236_3013_3014_9555	52	-	3.40071467356049e-06	0.000104288583322522
8430	carcinine	hsa03430	Mismatch repair	9156_6118_5982_5983_6117_5985_4436_3978_2956	9	-	0.0358143099781259	0.366101835331954
8431	carcinine	hsa04060	Cytokine-cytokine receptor interaction	27242_3597_2057_3460_3588_3459_5155_355_51330_3572_6387_655_7422_7042_90_8795_7048	17	-	3.48529794484602e-05	0.000801618527314585
8432	carcinine	hsa03010	Ribosome	283412_440589_51187_284064_6135_6187_6159	7	-	0.0180621447216678	0.237388187770491
8433	carcinine	hsa04020	Calcium signaling pathway	5256_3710_5578_5613_2767_3709_5331_808_7416_5025_801_7419_805_291	14	-	0.00359411024373295	0.0661316284846863
8434	carcinine	hsa04610	Complement and coagulation cascades	966_4179_7035	3	-	0.010300077985937	0.157934529117701
8435	corticosterone	hsa05320	Autoimmune thyroid disease	3107_3448_3119_3440	4	+	0.0321165275890643	0.653036060977641
8436	corticosterone	hsa04612	Antigen processing and presentation	3806_3448_3119_3107_3440_3310	6	+	0.0152390062959503	0.464789692026484
8437	corticosterone	hsa04740	Olfactory transduction	816	1	+	0.00353202167028442	0.21545332188735
8438	corticosterone	hsa04740	Olfactory transduction	51806	1	-	0.00012557136232562	0.00866442400046778
8439	corticosterone	hsa05221	Acute myeloid leukemia	5914_595_4609_5292_5371	5	-	0.0484165153684533	0.764672048612892
8440	fusaric acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8359_8370_8294_554313_121504	14	+	2.2277643720197e-11	7.57439886486698e-10
8441	fusaric acid	hsa05332	Graft-versus-host disease	3105_3106_3107_3126_3127_3125_3135_3133_3123_649853	10	-	0.0288647595163621	0.402396326238309
8442	fusaric acid	hsa04080	Neuroactive ligand-receptor interaction	1269_7442_7068_706_5025_5031_2150	7	-	1.65991902734817e-05	0.000746963562306676
8443	fusaric acid	hsa04740	Olfactory transduction	818_393046_4991	3	-	1.16123527466203e-13	1.04511174719583e-11
8444	fusaric acid	hsa05322	Systemic lupus erythematosus	8363_8362_3123_3126_3127_3125_6628	7	-	0.0359548658683182	0.402396326238309
8445	fusaric acid	hsa04060	Cytokine-cytokine receptor interaction	3597_3455_3589_3459_5155_4982_7422_7042_93_51330	10	-	0.000333990691607669	0.0100197207482301
8446	fusaric acid	hsa04020	Calcium signaling pathway	776_5256_5025_818_5335_7419_23236	7	-	0.00273490197564089	0.06153529445192
8447	fusaric acid	hsa05330	Allograft rejection	3105_3106_3107_3126_3127_3125_3135_3133_3123_649853	10	-	0.0217387963794476	0.391298334830057
8448	fusaric acid	hsa04940	Type I diabetes mellitus	3105_3106_3107_3126_3127_3125_3135_3133_3123_649853	10	-	0.0343194213843953	0.402396326238309
8449	fusaric acid	hsa05217	Basal cell carcinoma	652	1	-	0.0402396326238309	0.402396326238309
8450	boldine	hsa05332	Graft-versus-host disease	3119_3123_3126_3127_3125_3558	6	+	0.00109497253519068	0.0188882762320392
8451	boldine	hsa04640	Hematopoietic cell lineage	3123_3126_3127_3125_947_933_921	7	+	0.00848560640967981	0.083643834609701
8452	boldine	hsa05320	Autoimmune thyroid disease	3119_3123_3126_3127_3558_3125	6	+	0.00320947878954403	0.0369090060797563
8453	boldine	hsa04612	Antigen processing and presentation	3119_3123_3806_3126_3127_3125	6	+	0.0298740121609408	0.229034093233879
8454	boldine	hsa04740	Olfactory transduction	5593_393046_23538	3	+	0.0279369350850467	0.229034093233879
8455	boldine	hsa04514	Cell adhesion molecules (CAMs)	214_3688_3119_3683_3123_3126_3127_3125_23308_6693_947_933_4684	13	+	6.81003929126271e-05	0.00469892711097127
8456	boldine	hsa05310	Asthma	3123_3126_3127_3119_3125	5	+	0.00155784216606036	0.021498221891633
8457	boldine	hsa05330	Allograft rejection	3119_3123_3126_3127_3558_3125	6	+	0.000683834191857775	0.0157281864127288
8458	boldine	hsa04940	Type I diabetes mellitus	3382_3119_3123_3126_3127_3558_3125	7	+	0.000234816931959061	0.0081011841525876
8459	boldine	hsa05211	Renal cell carcinoma	5296_6513_405_8453_5781_1399_7042_3725_7422	9	-	0.0209889954867131	0.552710214483445
8460	boldine	hsa04740	Olfactory transduction	5613_5566_5616_157	4	-	2.70309569531018e-05	0.00213544559929504
8461	boldine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3012_8368_8335_8359_8294_8367_554313_121504_92815_6737	18	-	0.00161786730628382	0.0639057585982109
8462	boldine	hsa04370	VEGF signaling pathway	9261_5296_56848_5747_5881_5600_5534_81579_7422	9	-	0.0408763977717561	0.741916135663585
8463	yohimbic acid	hsa04070	Phosphatidylinositol signaling system	8394_5335	2	-	0.0438069578184835	0.281325162334652
8464	yohimbic acid	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_5335	2	-	0.0388519094615818	0.281325162334652
8465	yohimbic acid	hsa04664	Fc epsilon RI signaling pathway	1432_5335	2	-	0.0468875270557754	0.281325162334652
8466	yohimbic acid	hsa04370	VEGF signaling pathway	1432_5335	2	-	0.0448250349202749	0.281325162334652
8467	calcium pantothenate	hsa04740	Olfactory transduction	5568	1	+	0.00743417234709774	0.438616168478767
8468	calcium pantothenate	hsa05332	Graft-versus-host disease	3123_3107_3126_3127_3125_3135	6	-	0.0039065903612239	0.0863653650359009
8469	calcium pantothenate	hsa04080	Neuroactive ligand-receptor interaction	3953_5031	2	-	0.0184355760808882	0.221226912970658
8470	calcium pantothenate	hsa05320	Autoimmune thyroid disease	3123_3107_3126_3127_3125_3135	6	-	0.01073204025341	0.154541379649104
8471	calcium pantothenate	hsa05322	Systemic lupus erythematosus	85235_3123_8330_3126_3127_3125_8332_8969_8331_8336_8343_8329_8339_8347_8346_8344	16	-	4.77421165505031e-05	0.00343743239163622
8472	calcium pantothenate	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.0218695407409815	0.224943847621524
8473	calcium pantothenate	hsa05330	Allograft rejection	3123_3107_3126_3127_3125_3135	6	-	0.00249854682401371	0.0863653650359009
8474	calcium pantothenate	hsa04940	Type I diabetes mellitus	3123_3107_3126_3127_3125_3135	6	-	0.00479807583532783	0.0863653650359009
8475	levothyroxine sodium	hsa04740	Olfactory transduction	5566	1	+	0.00743417234709774	0.237893515107128
8476	levothyroxine sodium	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	2.12445745632697e-06	0.000135965277204926
8477	levothyroxine sodium	hsa04512	ECM-receptor interaction	1284_2814_1277_22798_3910	5	+	0.0287866833771408	0.61411591204567
8478	protoveratrine A	hsa05010	Alzheimer's disease	5331_5534_22926_5664	4	-	0.000164098930501855	0.0037332506689172
8479	protoveratrine A	hsa04080	Neuroactive ligand-receptor interaction	3953_1131_4886_64106_1909_9170	6	-	5.18091829992045e-06	0.00023573178264638
8480	protoveratrine A	hsa05016	Huntington's disease	5432_581_5331_5978_161_163	6	-	0.00109957682213329	0.0142944986877328
8481	protoveratrine A	hsa04740	Olfactory transduction	109_157	2	-	1.51405246758461e-14	1.377787745502e-12
8482	protoveratrine A	hsa04514	Cell adhesion molecules (CAMs)	3123_3106_3126_3127_3125_3134	6	-	0.0398233802428595	0.362392760210021
8483	protoveratrine A	hsa04512	ECM-receptor interaction	3909_3912	2	-	0.01575358572678	0.159286255681887
8484	protoveratrine A	hsa04630	Jak-STAT signaling pathway	3953_200734_6654	3	-	0.000278979107908593	0.00507741976393639
8485	protoveratrine A	hsa05012	Parkinson's disease	65018	1	-	4.25565674550082e-05	0.00129088254613525
8486	protoveratrine A	hsa04620	Toll-like receptor signaling pathway	1432_51135	2	-	0.00379584741236301	0.0431777643156292
8487	protoveratrine A	hsa04060	Cytokine-cytokine receptor interaction	3554_3953_23765_5154_8795_657_4982_7422_7042_4233_7048	11	-	0.0010462816519914	0.0142944986877328
8488	protoveratrine A	hsa04020	Calcium signaling pathway	1131_5534_2767_3707_5331_5333_109_5335_1909_56848	10	-	0.0459889942070406	0.380454406621881
8489	gramine	hsa03320	PPAR signaling pathway	10580_2710_5465_5467	4	+	0.0338688540420406	1
8490	gramine	hsa04080	Neuroactive ligand-receptor interaction	7442_4157_64106_5030_4886_135_1909	7	-	0.0230931765103135	0.46186353020627
8491	gramine	hsa04740	Olfactory transduction	157	1	-	1.79938656417506e-09	1.43950925134005e-07
8492	gramine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_727	32	-	9.14343656466199e-09	3.6573746258648e-07
8493	gramine	hsa04060	Cytokine-cytokine receptor interaction	6358_6359_7852_9180_3572_4233	6	-	0.00791196288647337	0.210985676972623
8494	gramine	hsa03010	Ribosome	140801	1	-	0.0318064831927735	0.508903731084376
8495	trimethylcolchicinic acid	hsa05332	Graft-versus-host disease	5551_3126_3127_3123_3125	5	+	0.00688438550452253	0.0991351512651244
8496	trimethylcolchicinic acid	hsa05320	Autoimmune thyroid disease	5551_3126_3127_3123_3125	5	+	0.0163849815392718	0.168531238689653
8497	trimethylcolchicinic acid	hsa04740	Olfactory transduction	26211_5593	2	+	0.00470120887197915	0.0846217596956247
8498	trimethylcolchicinic acid	hsa05322	Systemic lupus erythematosus	3123_3126_3127_3125_8358_88_8968_3013_8350_8351_8352_8353_8354_8355_8356_8357	16	+	3.43542194726497e-06	0.000247350380203078
8499	trimethylcolchicinic acid	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0108179213384683	0.12981505606162
8500	trimethylcolchicinic acid	hsa05330	Allograft rejection	5551_3126_3127_3123_3125	5	+	0.00469430216176503	0.0846217596956247
8501	trimethylcolchicinic acid	hsa04940	Type I diabetes mellitus	3123_3126_3127_2571_5551_3125	6	+	0.0016821039492937	0.0605557421745732
8502	trimethylcolchicinic acid	hsa04080	Neuroactive ligand-receptor interaction	5618_2908_4886_1909	4	-	0.0107655495051767	0.398325331691538
8503	trimethylcolchicinic acid	hsa05016	Huntington's disease	3092_27113_23236	3	-	0.0366889612218593	0.904994376805863
8504	trimethylcolchicinic acid	hsa04740	Olfactory transduction	810_26211	2	-	2.05153538598288e-06	0.000151813618562733
8505	emetine	hsa04916	Melanogenesis	2776_818_54361_6934_1906_2033	6	+	0.00567740852832305	0.0404096265841068
8506	emetine	hsa04120	Ubiquitin mediated proteolysis	25898_5371_23759_6477_330_22954_26272_9820_8651	9	+	0.00285744660508404	0.028891960118072
8507	emetine	hsa05010	Alzheimer's disease	836_842_4713_2776_5533_3708_7124	7	+	3.74854165894607e-06	0.000113705763654697
8508	emetine	hsa04080	Neuroactive ligand-receptor interaction	2550_623_5030_7442_1081_624_2918_1131_2908_799_4887_1241_6915_7067_1909_2151_5733_134_9568_7433	20	+	0.000335914291164339	0.00509470008265914
8509	emetine	hsa04742	Taste transduction	51764	1	+	0.00330702751350432	0.0300939503728893
8510	emetine	hsa04310	Wnt signaling pathway	5533_5526_10725_324_2033_6477_8061_818_4088_54361_6934_5602_3725	13	+	0.0180132860178166	0.0964240604483124
8511	emetine	hsa05131	Shigellosis	3059_7430_347733	3	+	0.0397443187114507	0.140393233489081
8512	emetine	hsa05016	Huntington's disease	1212_5430_836_842_4713_246721_2776_64446_3708_2033_10540_55567_6875_161	14	+	0.00156147544289835	0.0202991807576786
8513	emetine	hsa05130	Pathogenic Escherichia coli infection	3059_7430_347733	3	+	0.0397443187114507	0.140393233489081
8514	emetine	hsa04740	Olfactory transduction	26212_157_5593_818_4991_393046	6	+	3.97787192021176e-19	3.6198634473927e-17
8515	emetine	hsa04510	Focal adhesion	1284_8503_7059_3913_3695_7060_3690_5155_5154_330_5293_8515_4636_3918_5602_7791_3725_56924_4659_3675	20	+	0.0162149812446929	0.0922227058291909
8516	emetine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_9103_8349_8348_8329_8294_121504_8343_8342_8341_8347_8352_8345_8344_958_8339_723790_3109_8346_92815_8969_8968_55766_8370_718_717_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_7124_8353_8354_8355_8356_8357_8332_3018_85235_85236_3012_3013_3017_8970	59	+	4.27443091724531e-08	1.94486606734662e-06
8517	emetine	hsa04710	Circadian rhythm - mammal	8864_5187_8553_406_1408_1453_79365_9572	8	+	0.00621465777500717	0.0404096265841068
8518	emetine	hsa04110	Cell cycle	1647_4088_1028_10912_7042_1032_2033_4999_8556_4616	10	+	0.0310747218614828	0.130846560128528
8519	emetine	hsa04340	Hedgehog signaling pathway	54361_5727_1453	3	+	0.0401123524254518	0.140393233489081
8520	emetine	hsa04530	Tight junction	5010_64398_9080_4619_51776_4624_4636_3059_9863_27134	10	+	0.00621686562832413	0.0404096265841068
8521	emetine	hsa04062	Chemokine signaling pathway	8503_6347_157_5293_6358_6773_51764_6359_2185_10663_2792_2791_4790_4792_4793	15	+	0.00188170317690743	0.021404373637322
8522	emetine	hsa04540	Gap junction	5593_347733_5155_5154_2776_3708_1453	7	+	0.0316332343167871	0.130846560128528
8523	emetine	hsa05012	Parkinson's disease	836_9627_842_4713	4	+	8.63297981506792e-06	0.000196400290792795
8524	emetine	hsa04260	Cardiac muscle contraction	4624_6262_7170_782	4	+	0.00543489182695489	0.0404096265841068
8525	emetine	hsa04060	Cytokine-cytokine receptor interaction	5155_5154_958_53832_268_6347_3459_3572_10663_8718_23765_8771_3976_51561_7042_7124_92_8795_1436_1435_3448_4050_3569_6358_6359_51330	26	+	0.00809284419247592	0.0490965881010206
8526	emetine	hsa03010	Ribosome	6168_6171	2	+	2.94719642692824e-05	0.00053638974970094
8527	emetine	hsa04020	Calcium signaling pathway	623_5336_6262_5733_5261_6915_1131_624_56848_2776_3707_818_7220_3708_5533_2185_1909_491	18	+	0.0254777706749263	0.12202511217991
8528	emetine	hsa03050	Proteasome	5698_23198	2	+	0.0400481693994029	0.140393233489081
8529	emetine	hsa04730	Long-term depression	3708_8398_5593_2776	4	+	0.0204247126352582	0.103258269433805
8530	emetine	hsa04270	Vascular smooth muscle contraction	8398_9138_4660_2776_27094_3708_9826_72_1909_4659	10	+	0.031054739803848	0.130846560128528
8531	emetine	hsa04080	Neuroactive ligand-receptor interaction	7068_64106_706_4886_136_9170	6	-	1.56055971130663e-05	0.000710054668644517
8532	emetine	hsa04740	Olfactory transduction	5613_5567_5616_808_801_805	6	-	4.63460472413173e-10	4.21749029895987e-08
8533	emetine	hsa05322	Systemic lupus erythematosus	6738_9555_3119_94239	4	-	0.00355636523813387	0.0809073091675455
8534	emetine	hsa04110	Cell cycle	5591_890_5001_5111_4172_993_4173_4088_6502_699_4193_51433_9134_898_7027_7534_1017_7531_7533_4085	20	-	0.0361205916274362	0.547828973016116
8535	emetine	hsa05110	Vibrio cholerae infection	375_30001_11015_5567_5616_10945_60_526_5613_523_528_5578	12	-	0.0342284962297134	0.547828973016116
8536	emetine	hsa04060	Cytokine-cytokine receptor interaction	3556_27242_3554_3597_4254_657_6387_355	8	-	9.50732328420438e-05	0.00288388806287533
8537	bicuculline	hsa05200	Pathways in cancer	1284_2247_51384_3576_405_5880_7849_5467_1387	9	+	0.0400497864626077	0.854395444535631
8538	bicuculline	hsa04310	Wnt signaling pathway	5467_51384_5566_5880_5526_1387	6	+	0.0144392432985523	0.854395444535631
8539	bicuculline	hsa04340	Hedgehog signaling pathway	51384_5566_3549	3	+	0.0392864838278059	0.854395444535631
8540	bicuculline	hsa04080	Neuroactive ligand-receptor interaction	5030_4886_4157	3	-	0.0197015409483923	0.453135441813023
8541	bicuculline	hsa04740	Olfactory transduction	393046	1	-	8.02953981878795e-06	0.000554038247496369
8542	bicuculline	hsa05322	Systemic lupus erythematosus	3013_8358_6738_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	-	0.0175409950197793	0.453135441813023
8543	palmatine	hsa04520	Adherens junction	91_6714_25945	3	+	0.0466570301080251	0.788661002008941
8544	palmatine	hsa04120	Ubiquitin mediated proteolysis	10277_996_4281_8945_7332_55294_1642_23759_4193_8881_51588_51619_8453_51433_8454_8450_51343_27338_51465_7327_9040	21	-	0.0267579338579562	0.392449696583358
8545	palmatine	hsa04080	Neuroactive ligand-receptor interaction	2561_5618_5030_4886	4	-	7.8389908548222e-06	0.000344915597612177
8546	palmatine	hsa04740	Olfactory transduction	5613_5616	2	-	3.73104851928623e-12	3.28332269697188e-10
8547	palmatine	hsa04110	Cell cycle	995_5001_5000_2810_4172_4087_4088_983_996_699_8881_4193_8454_8556_51433_8555_51343_1031_1017_7531_7465	21	-	0.0069420910743088	0.152726003634794
8548	palmatine	hsa04512	ECM-receptor interaction	960_6383	2	-	0.0459278353947179	0.512289782558327
8549	palmatine	hsa04540	Gap junction	5605_7280_5594_347733_5613_6655_1453_5616_113457_5331_3709_3265_113_983_7278_3710	16	-	0.0194261338951394	0.341899956554453
8550	palmatine	hsa04060	Cytokine-cytokine receptor interaction	5618_3554_2057_3601_355_7422	6	-	8.87530077744071e-05	0.00260342156138261
8551	palmatine	hsa05222	Small cell lung cancer	51588_1017	2	-	0.0465717984143934	0.512289782558327
8552	diflorasone	hsa05222	Small cell lung cancer	5925_3918_317_22798_330	5	+	0.0263592908278606	1
8553	diflorasone	hsa05200	Pathways in cancer	2335_3551_5599_6655_6777_5371_3909_1857_4088_5335_8312_5914_2260_652671	14	-	0.0202904424077093	0.265521126595565
8554	diflorasone	hsa04310	Wnt signaling pathway	6424_5599_1857_4088_4772_8312_5534_64840	8	-	0.0207438380152785	0.265521126595565
8555	diflorasone	hsa04660	T cell receptor signaling pathway	3551_6655_4772_5600_5534_5335	6	-	0.036985875648453	0.326017153336395
8556	diflorasone	hsa05221	Acute myeloid leukemia	3551_6655_6777_5371_5914_652671	6	-	0.00249177818036963	0.123717665663537
8557	diflorasone	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3551_5599_5335_5600_28964_5781	6	-	0.00579926557797832	0.123717665663537
8558	diflorasone	hsa04920	Adipocytokine signaling pathway	3551_948_5599_8660_1375_5781	6	-	0.00446479760712684	0.123717665663537
8559	diflorasone	hsa05210	Colorectal cancer	4088_5599_6655_8312_1857	5	-	0.0407521441670494	0.326017153336395
8560	diflorasone	hsa05220	Chronic myeloid leukemia	4088_6655_6777_5781_3551	5	-	0.0274432832010449	0.292728354144479
8561	seneciphylline	hsa04740	Olfactory transduction	26212_816	2	+	8.8201741088005e-05	0.00661513058160037
8562	seneciphylline	hsa04010	MAPK signaling pathway	8912_3164_9479_5598_4914_5923_6196_5156_8817_5607_8681_5536_3725_23542_2246_100137049_2260_2250	18	+	0.0268383992613751	0.650704691152695
8563	seneciphylline	hsa02010	ABC transporters	8714_5244_20_5243_1080	5	+	0.0332869940422334	0.650704691152695
8564	seneciphylline	hsa04640	Hematopoietic cell lineage	960_4254_2057	3	-	0.00121609406484869	0.028274187007732
8565	seneciphylline	hsa03320	PPAR signaling pathway	2180_51_9415_6319	4	-	0.0283950715657092	0.264074165561096
8566	seneciphylline	hsa04080	Neuroactive ligand-receptor interaction	4889_5618_7068_3953_1131_2908_5025_4886_7067_2150_5030_1909	12	-	3.02698730244757e-07	1.40754909563812e-05
8567	seneciphylline	hsa04742	Taste transduction	5613_5616	2	-	0.0193468238614723	0.224906827389615
8568	seneciphylline	hsa05320	Autoimmune thyroid disease	3106_3133	2	-	0.0191807098641546	0.224906827389615
8569	seneciphylline	hsa04740	Olfactory transduction	5613_5616_808_109_801_805	6	-	9.72275960167588e-19	9.04216642955857e-17
8570	seneciphylline	hsa04514	Cell adhesion molecules (CAMs)	24146_965_214_4685_3133_3106_4897_6383_23705_50848_9019	11	-	0.0219303588971852	0.226613708604247
8571	seneciphylline	hsa04512	ECM-receptor interaction	7059_960_3912_6383	4	-	0.00801183982646607	0.124183517310224
8572	seneciphylline	hsa04260	Cardiac muscle contraction	7168_7381_1327_1347	4	-	0.00778529094116438	0.124183517310224
8573	seneciphylline	hsa04060	Cytokine-cytokine receptor interaction	3556_5618_3597_2057_3953_3459_27242_4254_7852_6387_1956_90_655_4233_8795	15	-	4.41780400543902e-06	0.00013695192416861
8574	seneciphylline	hsa04020	Calcium signaling pathway	5257_109_5534_5613_1131_3709_5616_2776_808_5331_1956_1909_5025_801_7419_490_805_23236	18	-	0.0318574641923407	0.269340379080699
8575	sulfadoxine	hsa05214	Glioma	1956_5155_5293_5578	4	+	0.0161471659469594	0.36472157087486
8576	sulfadoxine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3113_8359_8294_8367_554313_121504_87	16	+	7.5310062239665e-10	5.19639429453688e-08
8577	sulfadoxine	hsa05212	Pancreatic cancer	1956_5155_5293_3630	4	+	0.042221706252878	0.36472157087486
8578	sulfadoxine	hsa05215	Prostate cancer	1956_5155_5293_3630	4	+	0.0408363164885602	0.36472157087486
8579	sulfadoxine	hsa04012	ErbB signaling pathway	5293_1956_374_5578	4	+	0.0394773081122585	0.36472157087486
8580	sulfadoxine	hsa05223	Non-small cell lung cancer	5915_1956_5293_5578	4	+	0.00891968275523594	0.30772905505564
8581	sulfadoxine	hsa04630	Jak-STAT signaling pathway	3560_3589_5293_3572_9180_10379	6	+	0.026277676131568	0.36472157087486
8582	sulfadoxine	hsa04150	mTOR signaling pathway	6196_5293_3630	3	+	0.0422865589420127	0.36472157087486
8583	sulfadoxine	hsa05010	Alzheimer's disease	22926	1	-	0.0321093301945783	0.60965359085048
8584	sulfadoxine	hsa04080	Neuroactive ligand-receptor interaction	5618	1	-	0.0036300998470898	0.134313694342323
8585	sulfadoxine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_8359_8348_8337_8367_554313_6738_121504_8294	18	-	5.10077217530749e-06	0.000377457140972754
8586	sulfadoxine	hsa04020	Calcium signaling pathway	5257	1	-	0.03295424815408	0.60965359085048
8587	pyrimethamine	hsa04740	Olfactory transduction	818	1	+	0.0036347581295683	0.239894036551508
8588	pyrimethamine	hsa03450	Non-homologous end-joining	5591_3981	2	+	0.0461347342153223	1
8589	pyrimethamine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0112648224362317	0.66462452373767
8590	ticlopidine	hsa04740	Olfactory transduction	7932_135948_8392	3	+	0.00385545481589364	0.140724100780118
8591	ticlopidine	hsa05322	Systemic lupus erythematosus	718_8348_3013_8358_8350_8968_8970_8351_8352_8353_8354_8355_8356_8357	14	+	0.000346038328421566	0.0252607979747743
8592	ticlopidine	hsa03450	Non-homologous end-joining	27343_2547_79840	3	+	0.0140740750991751	0.342469160746594
8593	ticlopidine	hsa04740	Olfactory transduction	818	1	-	0.00167914135823883	0.099069340136091
8594	cinchocaine	hsa04740	Olfactory transduction	26333_135948_816	3	+	0.00140018820391768	0.105014115293826
8595	cinchocaine	hsa04070	Phosphatidylinositol signaling system	8867_3710_8394_8396_5335_3707_23236	7	-	0.00355996118810826	0.277676972672444
8596	cinchocaine	hsa04360	Axon guidance	2050_2041_5533_64221_5534_3984_3985_22885	8	-	0.0179797818620241	0.70121149261894
8597	cinchocaine	hsa04370	VEGF signaling pathway	5829_208_5335_5533_5534	5	-	0.0457088839642967	0.891323237303786
8598	cinchocaine	hsa04720	Long-term potentiation	5533_23236_814_3710_5534	5	-	0.041812794757753	0.891323237303786
8599	amiloride	hsa04662	B cell receptor signaling pathway	11025_10000_3551_10725_4772_5534	6	+	0.0175046135974295	0.425945597537451
8600	amiloride	hsa04740	Olfactory transduction	5137_816	2	+	0.0046714648400799	0.341016933325833
8601	amiloride	hsa05340	Primary immunodeficiency	6891_326_925_57379	4	+	0.017156043942612	0.425945597537451
8602	amiloride	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0477904076886492	0.862219128050109
8603	amiloride	hsa05332	Graft-versus-host disease	3119_3123_3126_3127_3111_3125_5551	7	-	0.0125524346176793	0.129264578041472
8604	amiloride	hsa04080	Neuroactive ligand-receptor interaction	3354_1269_5030_135_4889	5	-	0.010594128925233	0.129264578041472
8605	amiloride	hsa05320	Autoimmune thyroid disease	3119_3123_3126_3127_3111_3125_5551	7	-	0.034764950133264	0.221957390472162
8606	amiloride	hsa04740	Olfactory transduction	818_157	2	-	2.98128535919607e-07	2.56390540890862e-05
8607	amiloride	hsa04514	Cell adhesion molecules (CAMs)	2734_965_3119_3123_4099_3126_3127_3111_3125_999_6693_1365_933_9019_5817	15	-	0.0135276883996889	0.129264578041472
8608	amiloride	hsa05322	Systemic lupus erythematosus	6738_8329_3111_3123_3126_3127_3125_8969_8968_8358_8330_8331_8336_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013_3014	26	-	6.17879295619652e-07	2.6568809711645e-05
8609	amiloride	hsa05218	Melanoma	5296_5155_999_4193_673_2258_1869_2260_4233	9	-	0.0361325984489566	0.221957390472162
8610	amiloride	hsa05310	Asthma	3119_3123_3126_3127_3111_3125	6	-	0.00976242512217664	0.129264578041472
8611	amiloride	hsa03022	Basal transcription factors	2962_2969_6875_51616_6872_728198	6	-	0.0225451327921164	0.161573451676834
8612	amiloride	hsa04060	Cytokine-cytokine receptor interaction	5155_3572_4233_4254_7042	5	-	0.0108960616838714	0.129264578041472
8613	amiloride	hsa03010	Ribosome	140801	1	-	0.0445237439278035	0.255269465186073
8614	amiloride	hsa04020	Calcium signaling pathway	818_5533_135	3	-	0.0191521578232226	0.149735052072468
8615	amiloride	hsa05330	Allograft rejection	3119_3123_3126_3127_3111_3125_5551	7	-	0.00791967846449468	0.129264578041472
8616	amiloride	hsa04940	Type I diabetes mellitus	3119_3123_3126_3127_3111_3125_5551	7	-	0.015484843000148	0.133169649801273
8617	amiloride	hsa05220	Chronic myeloid leukemia	4088_6777_6464_4193_673_5296_1399_1398_1869_7042	10	-	0.0122522000747093	0.129264578041472
8618	levodopa	hsa04740	Olfactory transduction	26211	1	+	0.0110987502387991	0.632628763611549
8619	levodopa	hsa04080	Neuroactive ligand-receptor interaction	135	1	-	0.0462509880955889	1
8620	doxylamine	hsa04340	Hedgehog signaling pathway	656_51384_353500	3	+	0.045638510205115	1
8621	doxylamine	hsa04350	TGF-beta signaling pathway	656_3398_4088_4090_353500	5	+	0.00759127876518063	0.387155217024212
8622	doxylamine	hsa04740	Olfactory transduction	157	1	-	0.000177274446048212	0.0127637601154713
8623	doxylamine	hsa03010	Ribosome	440589_9349_6187_284393_6181_6234_389342	7	-	0.0439872539751131	1
8624	doxylamine	hsa04020	Calcium signaling pathway	146	1	-	0.0465028959730761	1
8625	troleandomycin	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.000756172343925727	0.005158325631182
8626	troleandomycin	hsa04640	Hematopoietic cell lineage	3123_3126_3127_3125	4	+	0.00911020310719867	0.0377422700155374
8627	troleandomycin	hsa05320	Autoimmune thyroid disease	3123_3451_3126_3127_3125	5	+	0.000167843358502821	0.00338382224914324
8628	troleandomycin	hsa04612	Antigen processing and presentation	3123_3451_3126_3127_3125	5	+	0.00155919738782003	0.00753612070779681
8629	troleandomycin	hsa04514	Cell adhesion molecules (CAMs)	3123_3126_3127_3125	4	+	0.0359113847926296	0.130178769873282
8630	troleandomycin	hsa05322	Systemic lupus erythematosus	3123_3126_3127_3125	4	+	0.0445675680918358	0.143606608295915
8631	troleandomycin	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.000233367051665051	0.00338382224914324
8632	troleandomycin	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.000533103268722998	0.00515333159765565
8633	troleandomycin	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	+	0.000889366488134827	0.005158325631182
8634	troleandomycin	hsa05211	Renal cell carcinoma	3725_405_8453_673	4	-	0.0304725656438334	0.552672905560729
8635	troleandomycin	hsa04710	Circadian rhythm - mammal	1454_406	2	-	0.0221050268831601	0.552672905560729
8636	troleandomycin	hsa04810	Regulation of actin cytoskeleton	1793_1730_5154_5881_673_8936_2263_6548	8	-	0.0253641797952186	0.552672905560729
8637	troleandomycin	hsa05210	Colorectal cancer	6932_3725_5881_673	4	-	0.048108245441748	0.552672905560729
8638	naphazoline	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.00848994292839127	0.0984833379693387
8639	naphazoline	hsa04130	SNARE interactions in vesicular transport	6804_9570_6844	3	+	0.0349849399144875	0.289875216434325
8640	naphazoline	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	+	0.0177156314930497	0.171251104432814
8641	naphazoline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504	18	+	4.21950838455617e-10	2.44731486304258e-08
8642	naphazoline	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.00284015748837922	0.0549097114419983
8643	naphazoline	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.00614785732182475	0.0891439311664589
8644	naphazoline	hsa04940	Type I diabetes mellitus	2572_3126_3127_3123_3125	5	+	0.00162103668654777	0.0470100639098853
8645	naphazoline	hsa05322	Systemic lupus erythematosus	85235_3119_8330_8332_8969_8331_8329_8336_9555	9	-	0.00155540577721866	0.0839919119698076
8646	sulpiride	hsa05332	Graft-versus-host disease	3126_3107_3113_3127_3111_3125_3123	7	+	0.00142989337152926	0.0191605711784921
8647	sulpiride	hsa05010	Alzheimer's disease	3709	1	+	0.0223042539982599	0.186798127235427
8648	sulpiride	hsa05320	Autoimmune thyroid disease	3126_3107_3113_3127_3111_3125_3123	7	+	0.00463782863586216	0.0517890864337941
8649	sulpiride	hsa04612	Antigen processing and presentation	3123_3107_3126_3127_3111_3125_3113	7	+	0.0499424097098543	0.304194677323658
8650	sulpiride	hsa04520	Adherens junction	51176_4301_10580_1495_5770_4233_2534	7	+	0.0317789439233927	0.232942500733474
8651	sulpiride	hsa04514	Cell adhesion molecules (CAMs)	9073_5175_3123_3107_3126_3127_3111_3125_3113_1462	10	+	0.0347675374229065	0.232942500733474
8652	sulpiride	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_3123_3126_3127_3125_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3113_3111	38	+	1.45984550158459e-19	9.78096486061675e-18
8653	sulpiride	hsa05310	Asthma	3123_3126_3127_3111_3125_3113	6	+	0.0013785025547107	0.0191605711784921
8654	sulpiride	hsa04062	Chemokine signaling pathway	6355	1	+	0.0157511848364894	0.150761340577827
8655	sulpiride	hsa05330	Allograft rejection	3593_3113_3107_3126_3127_3111_3125_3123	8	+	0.000164387267044759	0.00367131563066628
8656	sulpiride	hsa04940	Type I diabetes mellitus	3593_3382_3113_3107_3126_3127_3111_2571_3123_3125	10	+	1.41740710339253e-05	0.000474831379636498
8657	sulpiride	hsa05211	Renal cell carcinoma	2549_2271_998_6655_673	5	-	0.0167830053533759	0.39719779336323
8658	sulpiride	hsa05131	Shigellosis	7278_7430_113457_998_9181	5	-	0.00647239759805703	0.229770114731025
8659	sulpiride	hsa05130	Pathogenic Escherichia coli infection	7278_7430_113457_998_9181	5	-	0.00647239759805703	0.229770114731025
8660	sulpiride	hsa04810	Regulation of actin cytoskeleton	5829_6655_998_54961_673_8394_7430_2260_2149	9	-	0.0445984732531473	0.527748600162243
8661	sulpiride	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0236505581510582	0.416412282598654
8662	sulpiride	hsa05210	Colorectal cancer	5900_673_6655_1856_581	5	-	0.029324808633708	0.416412282598654
8663	minaprine	hsa04740	Olfactory transduction	26538	1	+	0.010696091633936	0.58828503986648
8664	minaprine	hsa05332	Graft-versus-host disease	3123_3107_3126_3127_3125_3135	6	-	0.0084109272855452	0.13962139294005
8665	minaprine	hsa04080	Neuroactive ligand-receptor interaction	706_5025	2	-	0.00672187387801416	0.13962139294005
8666	minaprine	hsa05320	Autoimmune thyroid disease	3123_3107_3126_3127_3125_3135	6	-	0.021985329417364	0.228097792705151
8667	minaprine	hsa05322	Systemic lupus erythematosus	85235_3123_3126_3127_3125_8332_8969_8331_8336_8970_8329_8330	12	-	0.0162256471702001	0.192389816446658
8668	minaprine	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_3551_10392_5335_5602_3725_6714	7	-	0.0258449137811154	0.23834753820362
8669	minaprine	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.0364505253651339	0.260038055281285
8670	minaprine	hsa04060	Cytokine-cytokine receptor interaction	5155	1	-	0.000793450387346771	0.065856382149782
8671	minaprine	hsa03020	RNA polymerase	5432_246721_5439_548644	4	-	0.0331018648592609	0.260038055281285
8672	minaprine	hsa04930	Type II diabetes mellitus	5296_5581_5290_3551_5602	5	-	0.0375958634141617	0.260038055281285
8673	minaprine	hsa05330	Allograft rejection	3123_3107_3126_3127_3125_3135	6	-	0.00547895935156983	0.13962139294005
8674	minaprine	hsa05210	Colorectal cancer	836_4088_5602_1856_1857_5296_5290_369_3725	9	-	0.00767429563146596	0.13962139294005
8675	minaprine	hsa04940	Type I diabetes mellitus	3123_3107_3126_3127_3125_3135	6	-	0.0102365264039756	0.141605281921662
8676	methylbenzethonium chloride	hsa05010	Alzheimer's disease	4695	1	+	0.000507569711762514	0.0218254976057881
8677	methylbenzethonium chloride	hsa04080	Neuroactive ligand-receptor interaction	623_886_1081_624_59340_5745_134_4829_2563_5724_3363_2151_185_799_719_2917_4986_3355_3350_3269_23566_11255_2692_728	24	+	0.0490883825793924	0.351800075152312
8678	methylbenzethonium chloride	hsa05200	Pathways in cancer	23533_331_5154_9618_5881_5337_4254_3551_3576_1613_1856_2034_2248_2249_324_51384_3480_4193_330_5467_7042_91_3918_26281_1284_3688_861_2253_1029_3685_8817_7422_2353_1387_6257	35	+	0.00277630104060452	0.0676323211710198
8679	methylbenzethonium chloride	hsa04740	Olfactory transduction	26211_2979_393046_816	4	+	2.06546068184649e-06	0.000177629618638798
8680	methylbenzethonium chloride	hsa04510	Focal adhesion	23533_331_5154_5881_3679_2321_3690_3695_93408_1290_3480_330_1277_6714_3918_1284_3688_7148_88_3685_7422_2534	22	+	0.0197192353576171	0.270720532887111
8681	methylbenzethonium chloride	hsa05322	Systemic lupus erythematosus	8358_85235_8968_3013_8330_8969_8332_88_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357	19	+	0.00314568935679162	0.0676323211710198
8682	methylbenzethonium chloride	hsa05218	Melanoma	23533_3480_1029_4193_5154_8817_2248_2249_2253_26281	10	+	0.0251833053848475	0.270720532887111
8683	methylbenzethonium chloride	hsa04920	Adipocytokine signaling pathway	3551_5106_10645_8660_6257_5465_5781_23305_4793	9	+	0.0402005238088081	0.34572450475575
8684	methylbenzethonium chloride	hsa04512	ECM-receptor interaction	1284_3688_7148_2812_3690_3695_3685_1277_3679_1290_3918	11	+	0.0232541855762129	0.270720532887111
8685	methylbenzethonium chloride	hsa04810	Regulation of actin cytoskeleton	623_23533_3688_324_624_3690_2934_5154_3685_3695_8817_93408_5881_3679_2248_2249_88_7430_2253_8976_26281	21	+	0.0485032316008257	0.351800075152312
8686	methylbenzethonium chloride	hsa05012	Parkinson's disease	4695	1	+	0.00485705607837149	0.0835413645479896
8687	methylbenzethonium chloride	hsa03010	Ribosome	6165	1	+	0.0308371114043644	0.29466573119726
8688	methylbenzethonium chloride	hsa04650	Natural killer cell mediated cytotoxicity	3107_6452_5781_5534	4	-	0.00350380118273241	0.0637691815257299
8689	methylbenzethonium chloride	hsa04080	Neuroactive ligand-receptor interaction	5029_2901_1813_3953_1131_4886_5031_3355_7433	9	-	0.000179725422681405	0.00817750673200393
8690	methylbenzethonium chloride	hsa05016	Huntington's disease	5433_4899_1213_7052_3708_7019	6	-	0.00111289395718725	0.0255288914964281
8691	methylbenzethonium chloride	hsa04740	Olfactory transduction	219464_157_818_808_810_801_805	7	-	6.18220554923827e-10	5.62580704980683e-08
8692	methylbenzethonium chloride	hsa05218	Melanoma	208_4193	2	-	0.0444143393621158	0.449078320216949
8693	methylbenzethonium chloride	hsa05110	Vibrio cholerae infection	7082	1	-	0.0421377505817327	0.449078320216949
8694	methylbenzethonium chloride	hsa04810	Regulation of actin cytoskeleton	8516_2261_1131_9138_998_7430_324_5747_3655_6093_10458_2264_10627	13	-	0.040973495500907	0.449078320216949
8695	methylbenzethonium chloride	hsa05012	Parkinson's disease	2861_6622_7332	3	-	0.00112214907676607	0.0255288914964281
8696	methylbenzethonium chloride	hsa04060	Cytokine-cytokine receptor interaction	3556_3953_1271_8742_8741_3572_6359_7423_6358_9180_7042_8718_4254_268	14	-	0.00899378540379134	0.136405745290835
8697	helveticoside	hsa05211	Renal cell carcinoma	5879_10000_10298_208_7042_5293_201163_405_2034_2033_5781_1399_1398_3725_1387_3082	16	+	0.0175313578378331	0.195036355945893
8698	helveticoside	hsa05010	Alzheimer's disease	348_317_3553_9451_5534	5	+	0.000372244031833349	0.00828242970829201
8699	helveticoside	hsa04080	Neuroactive ligand-receptor interaction	11255_886_1081_1813_2558_2908_1812_5030_4887_7067_3953_5737_5724_4987_7068_4142	16	+	0.0232574413684336	0.214798639362031
8700	helveticoside	hsa05016	Huntington's disease	1213_1387_317_6667_2033	5	+	0.000132568302427743	0.00393285963868971
8701	helveticoside	hsa04740	Olfactory transduction	26212_7932_8388_8387_26664_5132_393046	7	+	1.32555087695444e-10	1.17974028048945e-08
8702	helveticoside	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8349_8329_8294_121504_8343_8342_8341_8347_8346_8344_8339_723790_8969_8968_8370_92815_8358_8359_8330_8331_8336_8337_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3012_3013_942_3111	47	+	2.29523246611194e-09	1.02137844741981e-07
8703	helveticoside	hsa05110	Vibrio cholerae infection	4583	1	+	0.02769141220268	0.224048698730775
8704	helveticoside	hsa04540	Gap junction	1812_1813	2	+	0.00533456283241641	0.0791293486808434
8705	helveticoside	hsa05012	Parkinson's disease	317_7318_6531	3	+	0.000800083156271631	0.014241480181635
8706	helveticoside	hsa03010	Ribosome	140801_9045_6192_6144	4	+	0.0321627543383219	0.238540428009221
8707	helveticoside	hsa04912	GnRH signaling pathway	3725_8398_1432_1081	4	+	0.0241346785800035	0.214798639362031
8708	helveticoside	hsa04270	Vascular smooth muscle contraction	8398_6093_3778_4637	4	+	0.00908309577452961	0.115485074847591
8709	helveticoside	hsa04610	Complement and coagulation cascades	1604_2162	2	+	0.0441723489768198	0.302410696841305
8710	helveticoside	hsa05332	Graft-versus-host disease	3553_3119	2	-	0.0167886201690773	0.0918436279837758
8711	helveticoside	hsa04650	Natural killer cell mediated cytotoxicity	3451_836_5534_5578_5296_8794_3455_5881_10451_6452_5335_5336_7409_4772_5295_2534	16	-	0.0143550686786607	0.0834388366947153
8712	helveticoside	hsa05010	Alzheimer's disease	3553_1327_841_8772_5534_8883_4137_3709_22926_488_810_836_7132_517_23236	15	-	0.000120876157315407	0.00140518532879161
8713	helveticoside	hsa04080	Neuroactive ligand-receptor interaction	5029_2911_2901_7442_4157_3953_1131_3360_1269_5031_3355_5021_56288_136_1909_2149	16	-	7.82967253937971e-09	3.64079773081156e-07
8714	helveticoside	hsa05200	Pathways in cancer	10000_596_4088_598_5295_5155_5154_5881_5335_5336_3673_7976_8321_7184_3675_1050_836_4149_3551_5371_5727_1856_5296_5900_652_208_2263_2261_581_8772_675_8322_5888_5467_91_1499_4233_2271_2335_841_5578_861_6502_26060_6772_7188_2257_5914_2064	49	-	0.00960705748628535	0.0612260543363956
8715	helveticoside	hsa04742	Taste transduction	5613_5616	2	-	0.00247907908861007	0.019212862936728
8716	helveticoside	hsa05320	Autoimmune thyroid disease	3451_3119	2	-	0.00384102116997751	0.0274780745236853
8717	helveticoside	hsa04612	Antigen processing and presentation	4801_3451_3119_1508_5994_5993_1514_3304_3305_3303	10	-	0.0470145201925752	0.182181265746229
8718	helveticoside	hsa05016	Huntington's disease	5432_246721_7419_836_1327_841_581_5439_3092_517_6875_548644_5481_23236	14	-	1.03980770478739e-05	0.000193404233090455
8719	helveticoside	hsa04740	Olfactory transduction	157_5613_5616_818_5137_810	6	-	1.25924973915537e-25	1.17110225741449e-23
8720	helveticoside	hsa04514	Cell adhesion molecules (CAMs)	965_214_3119_4099_9080_5797_6693_1365_5792_9672_933	11	-	0.000630827219584691	0.00651854793570847
8721	helveticoside	hsa05322	Systemic lupus erythematosus	55506_3119_6737_3021_3020_55766_720_721_6738	9	-	2.53642283662844e-05	0.000336981891152064
8722	helveticoside	hsa05216	Thyroid cancer	1499	1	-	0.0318613638217983	0.135157064856415
8723	helveticoside	hsa05310	Asthma	3119	1	-	0.0319726389982918	0.135157064856415
8724	helveticoside	hsa04630	Jak-STAT signaling pathway	10000_3717_3451_3566_2057_3455_3953_598_3568_5295_3601_6772_3572_5296_51561_10379_208_8835_6778_10253	20	-	0.0279332450540427	0.129889589501299
8725	helveticoside	hsa04062	Chemokine signaling pathway	3717_10000_5580_3551_5296_5613_5295_5616_7454_6772_9475_157_7074_10451_56288_113_208_7409_10681_23236	20	-	0.000763708168583491	0.00710248596782647
8726	helveticoside	hsa05012	Parkinson's disease	836_1327_7054_5481_7419_517	6	-	2.16916064101031e-06	6.72439798713196e-05
8727	helveticoside	hsa04260	Cardiac muscle contraction	784_9254_1327_4635_488	5	-	0.00176909555507734	0.0149568987838357
8728	helveticoside	hsa04060	Cytokine-cytokine receptor interaction	5155_5154_8741_7132_27242_3554_3553_2057_2324_8794_3572_657_8718_3601_3953_8742_3451_51561_91_4233_1435_3566_3568_3455	24	-	6.95648154665579e-06	0.000161738195959747
8729	helveticoside	hsa03010	Ribosome	6125_6168_6137_9349	4	-	1.85158501524389e-05	0.000286995677362803
8730	helveticoside	hsa03050	Proteasome	5713_23198_5718	3	-	0.0257997399770136	0.126282937782224
8731	helveticoside	hsa05330	Allograft rejection	3119	1	-	0.00987517005425736	0.0612260543363956
8732	helveticoside	hsa04940	Type I diabetes mellitus	3553_3119_2571	3	-	0.0359997611821479	0.145564251736511
8733	helveticoside	hsa04610	Complement and coagulation cascades	7056_7035_720_721_2149_5329	6	-	0.0227831257063013	0.117712816149223
8734	lanatoside C	hsa04662	B cell receptor signaling pathway	11025_5594_5579_695_10725_208_6655_2353_4772_4792_5534_3725_27071_4793	14	+	0.0353755810790559	0.345549297210833
8735	lanatoside C	hsa05010	Alzheimer's disease	4695_5594_4713_9451_3708_5534_7124	7	+	0.0121551196744913	0.194591038657275
8736	lanatoside C	hsa05016	Huntington's disease	4899_4695_4713_1639_6667_246721_3708_2033	8	+	0.0151348585622325	0.194591038657275
8737	lanatoside C	hsa04740	Olfactory transduction	8392_26212_5566_816	4	+	3.04731551927006e-11	2.06006482761989e-09
8738	lanatoside C	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8349_8329_8294_121504_8343_8341_8347_8352_8344_8339_723790_8346_8969_8968_8370_92815_8358_8359_8330_8331_8336_8337_8335_8350_8351_7124_8353_8354_8355_8356_8357_8332_85235_3012_3013_942_3111	47	+	4.57792183915531e-11	2.06006482761989e-09
8739	lanatoside C	hsa05219	Bladder cancer	2277_11186_5594_9252_7057_1613_4193_1871_2261	9	+	0.0411797036187908	0.345549297210833
8740	lanatoside C	hsa04010	MAPK signaling pathway	5534_6722_7850_5494_3164_5609_4342_11221_2002_3554_1850_6788_5566_8823_1399_1398_2261_23118_208_5923_9252_998_7042_3725_7124_3727_782_1432_5594_5579_1843_6655_1649_1846_8817_6789_23162_8649_2353_4763	40	+	0.0149416917105518	0.194591038657275
8741	lanatoside C	hsa05012	Parkinson's disease	4695_4713	2	+	0.000670225029371737	0.0201067508811521
8742	lanatoside C	hsa03010	Ribosome	6234_6192	2	+	0.0080647099827358	0.181455974611556
8743	lanatoside C	hsa05220	Chronic myeloid leukemia	868_5594_861_4089_6655_1871_4193_867_208_5781_1399_1398_7042_4792	14	+	0.0353755810790559	0.345549297210833
8744	lanatoside C	hsa05332	Graft-versus-host disease	355_3553_3119	3	-	0.0159369989148839	0.0604659468135539
8745	lanatoside C	hsa04650	Natural killer cell mediated cytotoxicity	5295_836_3383_3454_5578_5296_6655_3455_5881_5290_5532_10451_6452_3845_5534_7409_4772_8794_355_4775_6850	21	-	0.0178201761076427	0.0644267905430159
8746	lanatoside C	hsa04640	Hematopoietic cell lineage	1436_3554_3553_2057_2812_960_3568_3566_3655_3673	10	-	0.00820193886008661	0.0453518972263613
8747	lanatoside C	hsa05010	Alzheimer's disease	51806_776_3553_1327_841_8772_5534_317_8883_4137_5331_5532_355_3709_489_488_836_7132_517_23236	20	-	8.84126068019439e-05	0.000923420559931414
8748	lanatoside C	hsa04080	Neuroactive ligand-receptor interaction	3355_5618_7442_4157_3953_1131_5031_7434_2150_136_1909_56288_5026_2690	14	-	5.33890934123279e-13	2.50928739037941e-11
8749	lanatoside C	hsa04742	Taste transduction	5613_5566_5616	3	-	0.00169563368626924	0.0122607358853314
8750	lanatoside C	hsa05320	Autoimmune thyroid disease	355_3119	2	-	0.000632580324258082	0.00540568640729634
8751	lanatoside C	hsa04612	Antigen processing and presentation	10197_3312_3119_4801_1508_6890_5993_3304_3305_3303_5994	11	-	0.0131291375046224	0.0536582141493263
8752	lanatoside C	hsa04670	Leukocyte transendothelial migration	6494_4313_3383_5578_5829_5295_1500_27035_4689_5296_10451_1365_7430_5290_7409_9475_9080_5600	18	-	0.0206552408696242	0.0719108385831361
8753	lanatoside C	hsa05016	Huntington's disease	3092_246721_7419_836_1327_841_1639_5439_317_10488_517_3064_5331_548644_5481_23236	16	-	7.66463627274753e-07	1.44095161927654e-05
8754	lanatoside C	hsa04740	Olfactory transduction	51806_157_5613_5566_5616_818_816_5137_409	9	-	1.95392832784743e-28	1.83669262817658e-26
8755	lanatoside C	hsa04514	Cell adhesion molecules (CAMs)	6402_965_214_3383_3119_9080_5797_1365_22871_6693_3655_5817_9019_5792	14	-	0.00032031702631643	0.00301098004737444
8756	lanatoside C	hsa04510	Focal adhesion	596_5296_5295_5155_5154_5290_9475_10451_3655_3673_2324_5829_55742_1277_6714_4233_1290_5578_83660_6655_5881_7424_7409_2064	24	-	3.65959794827743e-05	0.000430002758922598
8757	lanatoside C	hsa05322	Systemic lupus erythematosus	55506_3119_6737_3021_3020_727_55766_720_721	9	-	3.52277820173862e-07	1.03220227888752e-05
8758	lanatoside C	hsa04140	Regulation of autophagy	30849_9474	2	-	0.0229509573563714	0.0743927583275487
8759	lanatoside C	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	7082_836_3551_1445_10392_5600_6714_4233_23545	9	-	0.0371907454872843	0.116531002526824
8760	lanatoside C	hsa04530	Tight junction	5584_7082_5583_5580_5581_5578_8777_50855_9080_4619_51776_1457_3845_1019_56288_6714_2036_9223_27134_1365	20	-	0.0128707167892759	0.0536582141493263
8761	lanatoside C	hsa05310	Asthma	3119	1	-	0.0127309786166396	0.0536582141493263
8762	lanatoside C	hsa04512	ECM-receptor interaction	960_2812_1605_1277_3673_3655_1290_3161	8	-	0.00276138328585569	0.0173046685913623
8763	lanatoside C	hsa04630	Jak-STAT signaling pathway	3717_5296_598_5295_5290_867_10254_2057_3455_3953_51561_4609_6778_5618_3566_3454_3568_6772_6773_10379_8835_6655_2690	23	-	0.00887240129444289	0.0463336512043129
8764	lanatoside C	hsa04062	Chemokine signaling pathway	3717_157_5296_5295_5290_9475_5331_10451_56288_6358_113_6773_7454_5580_5829_5566_3845_409_408_23236_3551_5613_6655_5616_6772_6359_7074_7409	28	-	0.00246544201695742	0.016553682113857
8765	lanatoside C	hsa04810	Regulation of actin cytoskeleton	5296_5295_5155_5154_5290_9475_5881_23365_3655_3673_7454_5829_23191_8396_1445_50649_7430_324_2263_2260_2934_2768_1131_9138_3985_200576_10451_6655_5305_54961_7074_3845_54434_2257_7409	35	-	0.0047930956385554	0.028159436876513
8766	lanatoside C	hsa05012	Parkinson's disease	836_1327_5413_317_51465_5481_7419_517	8	-	4.3923501229256e-07	1.03220227888752e-05
8767	lanatoside C	hsa04260	Cardiac muscle contraction	784_776_1327_27092_4635_488_10479	7	-	0.00150811563026901	0.0118135724371072
8768	lanatoside C	hsa04060	Cytokine-cytokine receptor interaction	5155_5154_8741_7132_8792_27242_3554_3553_2057_2324_8794_657_8718_3953_8742_51561_90_93_268_4233_7048_1436_5618_3566_3454_3568_3455_943_6358_6359_355_7424_2690	33	-	1.61116250882797e-05	0.000216356108328327
8769	lanatoside C	hsa03010	Ribosome	6125_6168_6129_6137_9349	5	-	3.55789187766386e-06	5.57403060834005e-05
8770	lanatoside C	hsa04020	Calcium signaling pathway	51806_5534_5331_7220_5333_136_113_1909_5137_493_5256_5257_5566_818_7419_816_776_1131_5026_5532_3709_489_488_3707_5481_23236_5578_5613_5616_2064_9630	31	-	0.0216629041902543	0.0727254640672823
8771	lanatoside C	hsa03050	Proteasome	5713_10197_23198_5701	4	-	0.016081368833392	0.0604659468135539
8772	lanatoside C	hsa05330	Allograft rejection	355_3119	2	-	0.0101266392921673	0.0501002154454593
8773	lanatoside C	hsa04940	Type I diabetes mellitus	355_3553_3119	3	-	0.0110551919003781	0.0519594019317771
8774	lanatoside C	hsa04610	Complement and coagulation cascades	5265_7056_727_722_7035_720_721_2161_5329	9	-	0.048858109745274	0.146906688462922
8775	PHA-00851261E	hsa05010	Alzheimer's disease	824_6622_4713	3	+	0.0369469808067268	0.568983504423593
8776	PHA-00851261E	hsa04660	T cell receptor signaling pathway	208	1	+	0.0457561026927635	0.587203317890465
8777	PHA-00851261E	hsa04740	Olfactory transduction	7932_816	2	+	6.65812674024092e-07	5.12675758998551e-05
8778	PHA-00851261E	hsa05322	Systemic lupus erythematosus	2215	1	+	0.0110268592280872	0.424534080281357
8779	PHA-00851261E	hsa05219	Bladder cancer	1029_4193_1613_5925_7422_7057	6	+	0.0327548460630686	0.568983504423593
8780	PHA-00851261E	hsa04270	Vascular smooth muscle contraction	4881	1	+	0.0318963952012529	0.568983504423593
8781	PHA-00851261E	hsa04080	Neuroactive ligand-receptor interaction	3355_7067_2901_4158_1812	5	-	0.0458915276090948	0.448717158844482
8782	PHA-00851261E	hsa05016	Huntington's disease	4899_246721	2	-	0.0184440722419748	0.448717158844482
8783	PHA-00851261E	hsa04740	Olfactory transduction	810_5613_5137	3	-	4.08729334322799e-05	0.00359681814204063
8784	PHA-00851261E	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_8294_720_721_121504_8367	16	-	0.0025041013723193	0.110180460382049
8785	PHA-00851261E	hsa04720	Long-term potentiation	5578_5613_673_3709_5534_810_814_107	8	-	0.0291108008098889	0.448717158844482
8786	PHA-00851261E	hsa03450	Non-homologous end-joining	5591_27343_27434	3	-	0.0362964227252233	0.448717158844482
8787	PHA-00851261E	hsa04540	Gap junction	1812_5578_5613_6655_5155_5607_3709_6714_107	9	-	0.0452265510599026	0.448717158844482
8788	PHA-00851261E	hsa05012	Parkinson's disease	2861	1	-	0.0324288996984188	0.448717158844482
8789	PHA-00851261E	hsa04270	Vascular smooth muscle contraction	776_5581_5613_3778_673_3709_810_6093_800_107_5578	11	-	0.0295221954192609	0.448717158844482
8790	metamizole sodium	hsa04740	Olfactory transduction	5137_26476_56656_393046	4	+	1.80063409040719e-05	0.00145851361322982
8791	metamizole sodium	hsa05218	Melanoma	23533_10000_5154_8823_1956_2258_2260_2247_2250	9	+	0.0203174380971655	0.822856242935203
8792	metamizole sodium	hsa05010	Alzheimer's disease	3553_351_841_5534_4698_11261_509_4137_3416_355_22926_489_5664_23236	14	-	0.0212613944779654	0.279435470281831
8793	metamizole sodium	hsa04080	Neuroactive ligand-receptor interaction	1909_146_1269_7068_3953_2908_3360_5618_7067_56288_7433	11	-	2.49502243083982e-06	0.000114771031818632
8794	metamizole sodium	hsa04742	Taste transduction	5566_773	2	-	0.0416876120744749	0.427403080080902
8795	metamizole sodium	hsa05016	Huntington's disease	4899_7419_841_581_4698_6667_246721_3092_509_1385_6875_1387_5481_23236	14	-	0.0103085547902845	0.237096760176544
8796	metamizole sodium	hsa04740	Olfactory transduction	5566_157	2	-	1.61831891808519e-20	1.48885340463837e-18
8797	metamizole sodium	hsa04512	ECM-receptor interaction	3691_8515_960_3918	4	-	0.0155936799934574	0.261963554496796
8798	metamizole sodium	hsa05012	Parkinson's disease	2861_7327_7318_4698_509_7419_5481	7	-	0.00234965950375491	0.0720562247818172
8799	metamizole sodium	hsa04020	Calcium signaling pathway	146_489_773_5578_3360_11261_5534_56848_8912_8911_113_1909_7419_5566_5481_23236	16	-	0.0418111708774796	0.427403080080902
8800	metamizole sodium	hsa03050	Proteasome	9491	1	-	0.0170845796410954	0.261963554496796
8801	citiolone	hsa05010	Alzheimer's disease	4713	1	+	0.0034679903613345	0.142187604814714
8802	citiolone	hsa05016	Huntington's disease	6648_6667_4713	3	+	0.0364523847823094	0.783748383420666
8803	citiolone	hsa04740	Olfactory transduction	8387_4993_8388	3	+	1.9980441926625e-05	0.00163839623798325
8804	citiolone	hsa04514	Cell adhesion molecules (CAMs)	8174_3383_947_3684_23308_10666_51208_923_54413_925_26047_23562	12	+	0.0457602512308861	0.783748383420666
8805	citiolone	hsa05332	Graft-versus-host disease	3119_3105_3106_3107_3113_3135_649853	7	-	0.00458804983184131	0.0798320670740388
8806	citiolone	hsa05320	Autoimmune thyroid disease	3119_3105_3106_3107_3113_3135_649853	7	-	0.0138041655327448	0.2001604002248
8807	citiolone	hsa04740	Olfactory transduction	4991	1	-	1.1284312622552e-06	4.90867599081012e-05
8808	citiolone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8370_8332_8359_8330_8331_8336_8337_554313_8351_85235_3119_3013_3113_720_721	28	-	9.03826947084325e-10	7.86329443963363e-08
8809	citiolone	hsa05330	Allograft rejection	3119_3105_3106_3107_3113_3135_649853	7	-	0.00280734066684463	0.0610596595038707
8810	citiolone	hsa04940	Type I diabetes mellitus	3119_3105_3106_3107_2572_3135_3113_649853	8	-	0.00153429203498506	0.0444944690145667
8811	benfotiamine	hsa05332	Graft-versus-host disease	3123_3126_3127_3119_3125	5	+	0.0178759368512162	0.206850126421216
8812	benfotiamine	hsa04640	Hematopoietic cell lineage	3123_2993_3126_3127_3125_933_931	7	+	0.0335863434534696	0.302277091081226
8813	benfotiamine	hsa05320	Autoimmune thyroid disease	959_3119_3123_3446_3126_3127_3125	7	+	0.00321877479922751	0.0521441517474857
8814	benfotiamine	hsa04612	Antigen processing and presentation	3446_3119_3123_3806_3126_3127_3125_5994	8	+	0.013715477435477	0.18515894537894
8815	benfotiamine	hsa04514	Cell adhesion molecules (CAMs)	959_4684_3688_3119_3123_4099_3126_3127_3125_23308_933_26047_5817	13	+	0.00101630236344574	0.027440163813035
8816	benfotiamine	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_8362_8294_959_3123_8366_3126_3127_3125_8370_8359_554313_121504_3119_83740_720_721	25	+	1.95127557008284e-10	1.5805332117671e-08
8817	benfotiamine	hsa04360	Axon guidance	8482_3688_10505_998_219699_4772_6093_4233_9423	9	+	0.0488088823701284	0.39535194719804
8818	benfotiamine	hsa05310	Asthma	959_3119_2207_3123_3126_3127_3125	7	+	0.000162818560312487	0.00659415169265572
8819	benfotiamine	hsa05330	Allograft rejection	959_3119_3123_3126_3127_3125	6	+	0.00284772732493017	0.0521441517474857
8820	benfotiamine	hsa04940	Type I diabetes mellitus	3123_3126_3127_3119_3125	5	+	0.0210876047709545	0.213511998305914
8821	benfotiamine	hsa05010	Alzheimer's disease	810_6390_842_517_5534	5	-	0.0186141906458657	0.395551551224646
8822	benfotiamine	hsa04080	Neuroactive ligand-receptor interaction	146_3355_2901_2561_2925_7434_2798_56288_134	9	-	0.0147821092405969	0.395551551224646
8823	benfotiamine	hsa05016	Huntington's disease	4899_842_581_6390_517_163	6	-	0.0235456350871644	0.400275796481795
8824	benfotiamine	hsa04740	Olfactory transduction	818_810_157	3	-	2.12261618261328e-09	1.80422375522129e-07
8825	benfotiamine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8329_8294_8343_8347_8346_8344_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235_3119_3113	29	-	1.39752280498407e-05	0.00059394719211823
8826	benfotiamine	hsa05012	Parkinson's disease	2861_6390_842_517	4	-	0.046211688218365	0.654665583093504
8827	acacetin	hsa05010	Alzheimer's disease	779_54205_348_489_3709	5	+	0.0136055554156503	0.385490736776758
8828	acacetin	hsa05016	Huntington's disease	1211_7052_1639_54205_6667_7416_163	7	+	0.049383989027159	0.699606511218086
8829	acacetin	hsa04740	Olfactory transduction	5593_5568_393046_8392	4	+	1.08721177273764e-08	9.24130006826994e-07
8830	acacetin	hsa04110	Cell cycle	5925	1	+	0.00216075308656143	0.0918320061788608
8831	acacetin	hsa05012	Parkinson's disease	5071_54205_7416	3	+	0.0189758318413347	0.403236426628362
8832	acacetin	hsa05330	Allograft rejection	3113_3107_3126_3127_3558_3123_3125	7	+	0.0406025335135601	0.690243069730522
8833	acacetin	hsa05010	Alzheimer's disease	3708_6622_842_489_23236	5	-	0.0248684458023287	0.422763578639588
8834	acacetin	hsa04080	Neuroactive ligand-receptor interaction	2901_2740_3953_2908_3354_56288	6	-	0.00165527241404652	0.0703490775969771
8835	acacetin	hsa05016	Huntington's disease	3708_1213_246721_842_23236	5	-	0.0191864169728482	0.407711360673024
8836	acacetin	hsa04740	Olfactory transduction	5566	1	-	6.96427596247563e-11	5.91963456810428e-09
8837	acacetin	hsa05322	Systemic lupus erythematosus	8337_720_721	3	-	0.0188762198668376	0.407711360673024
8838	acacetin	hsa04912	GnRH signaling pathway	2002_4313_8399_6655_1839_998_115_3708_1956_5600_3725_6714_5566_23236	14	-	0.0448761498884842	0.635745456753526
8839	latamoxef	hsa04080	Neuroactive ligand-receptor interaction	886_2917_3953_799_2566_1241_2561_3269_1395_2892_2357	11	+	0.0288089628611362	0.777841997250677
8840	latamoxef	hsa04740	Olfactory transduction	26659_442194	2	+	0.0182776174228042	0.777841997250677
8841	latamoxef	hsa03440	Homologous recombination	7156_8940_6742	3	-	0.0101337106055352	0.547220372698901
8842	0317956-0000	hsa05010	Alzheimer's disease	2902_776_3710_317_5533_487_824	7	+	0.0215566657373904	0.474246646222589
8843	0317956-0000	hsa05016	Huntington's disease	2902_6648_1213_1639_317_6667	6	+	0.00531259360055418	0.155836078949589
8844	0317956-0000	hsa04740	Olfactory transduction	8387_5566_7932_816_8388	5	+	1.57913728643883e-09	1.38964081206617e-07
8845	0317956-0000	hsa05012	Parkinson's disease	9627_317_5413	3	+	0.00469516202278957	0.155836078949589
8846	0317956-0000	hsa03010	Ribosome	6165_6192_6224	3	+	0.0472772910461537	0.776701209816689
8847	0317956-0000	hsa04740	Olfactory transduction	818_5137_4991	3	-	0.000350591321388981	0.0140236528555592
8848	0317956-0000	hsa04510	Focal adhesion	8516_5578_331_998_3918_93408_1956_7422_1399_3725_1499_6093_55742_3675	14	-	0.0499747088092333	0.750880934038307
8849	0317956-0000	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_3014_8359_8294_720_721_121504_8367	17	-	0.000129621815277788	0.010369745222223
8850	0317956-0000	hsa04010	MAPK signaling pathway	4214_3553_3551_5578_5534_50487_1847_998_1846_355_4763_1956_5536_1399_3725_1432_2260_3164_10125	19	-	0.0194461706909948	0.388923413819896
8851	0317956-0000	hsa04912	GnRH signaling pathway	4214_1432_5578_50487_998_3709_3708_818_2798_1956_3725_23236	12	-	0.00199125559815008	0.0531001492840021
8852	proglumide	hsa05332	Graft-versus-host disease	3811_3109_3123_3126_3127_3125_3802	7	+	0.00532355993581432	0.220927737336294
8853	proglumide	hsa04640	Hematopoietic cell lineage	2814_2811_3123_3126_3127_3125_1440_920_3684_925	10	+	0.0102137768387151	0.236472933003832
8854	proglumide	hsa04662	B cell receptor signaling pathway	11025_973_208_6655_8519_5881_5291_4793	8	+	0.0294236399248026	0.279119463407679
8855	proglumide	hsa04742	Taste transduction	5568_3710_40_5330_51764_50834	6	+	0.0477944080936642	0.305148913213394
8856	proglumide	hsa04612	Antigen processing and presentation	3811_3109_3123_3126_3127_3125_920_3802_925	9	+	0.040354621215568	0.279119463407679
8857	proglumide	hsa04740	Olfactory transduction	5568_4992	2	+	6.44874819722254e-06	0.000535246100369471
8858	proglumide	hsa04514	Cell adhesion molecules (CAMs)	3383_3123_3126_3127_3125_23308_5817_920_3109_3684_925_1462	12	+	0.0380027119628114	0.279119463407679
8859	proglumide	hsa05310	Asthma	3123_3126_3127_3109_3125	5	+	0.0177155671591863	0.245065345702077
8860	proglumide	hsa05223	Non-small cell lung cancer	2309_208_6655_1029_5291_5925_6257	7	+	0.017239065896272	0.245065345702077
8861	proglumide	hsa04912	GnRH signaling pathway	776_1432_3710_5599_6655_5330_2185_5337_5568_4323	10	+	0.0400000099050009	0.279119463407679
8862	proglumide	hsa05330	Allograft rejection	3127_3126_3109_3123_3125	5	+	0.0395192042727585	0.279119463407679
8863	proglumide	hsa04940	Type I diabetes mellitus	3382_3109_3123_3126_3127_3125	6	+	0.0218209848412293	0.258734534546005
8864	proglumide	hsa05220	Chronic myeloid leukemia	861_208_6655_1029_5291_5925_5781_7042_91	9	+	0.0113962859278955	0.236472933003832
8865	proglumide	hsa05131	Shigellosis	1499_7278_7430_113457_9181	5	-	0.0308651532974298	0.385814416217872
8866	proglumide	hsa05130	Pathogenic Escherichia coli infection	1499_7278_7430_113457_9181	5	-	0.0308651532974298	0.385814416217872
8867	proglumide	hsa04740	Olfactory transduction	810_5566	2	-	0.00163447331876244	0.0612927494535915
8868	proglumide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_6738_121504	15	-	5.39514332304933e-05	0.004046357492287
8869	proglumide	hsa04360	Axon guidance	1949_57715_80031_2041_6405_1944_5534_4233_27289	9	-	0.0199660001195856	0.385814416217872
8870	proglumide	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	5599_534_5335_3725_4233_23545	6	-	0.0234702076425684	0.385814416217872
8871	propoxycaine	hsa05016	Huntington's disease	5432_246721_27113_1339_3708	5	+	0.00752783464732925	0.331224724482487
8872	propoxycaine	hsa04740	Olfactory transduction	810_5137_816_390892	4	+	4.97069786432668e-09	4.37421412060748e-07
8873	propoxycaine	hsa05012	Parkinson's disease	9627_6622_1339	3	+	0.0131756852016535	0.386486765915169
8874	propoxycaine	hsa05211	Renal cell carcinoma	2271_5155_5290_405_8453_3725	6	-	0.0255383797189678	0.784203018159049
8875	propoxycaine	hsa04080	Neuroactive ligand-receptor interaction	5618_2908	2	-	0.0364726216563714	0.784203018159049
8876	propoxycaine	hsa04210	Apoptosis	5576_317_5290_472_355_8837_651610	7	-	0.0214458988384598	0.784203018159049
8877	propoxycaine	hsa04062	Chemokine signaling pathway	5290	1	-	0.047527455646003	0.784203018159049
8878	norethisterone	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8336_3108	8	+	0.0128317055744013	0.782734040038479
8879	norethisterone	hsa04740	Olfactory transduction	818_109_157	3	-	0.0148541900106194	0.519896650371679
8880	norethisterone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_727_8368_8366_8359_8294_8367_554313_8970_121504	16	-	5.99037530455114e-06	0.00041932627131858
8881	Prestwick-920	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.0347677220064127	0.339631688790594
8882	Prestwick-920	hsa04640	Hematopoietic cell lineage	1437_960_3123_3126_3127_3125	6	+	0.039444837098958	0.339631688790594
8883	Prestwick-920	hsa05320	Autoimmune thyroid disease	3123_7253_3126_3127_3125	5	+	0.0196576618983927	0.339631688790594
8884	Prestwick-920	hsa04612	Antigen processing and presentation	3123_3126_3127_3125_6892_3305	6	+	0.0430519042128922	0.339631688790594
8885	Prestwick-920	hsa04740	Olfactory transduction	816	1	+	0.000567522982187063	0.0402941317352815
8886	Prestwick-920	hsa05322	Systemic lupus erythematosus	3123_3126_3127_3125_8343_8339_8347_8346_8344	9	+	0.0226044623975099	0.339631688790594
8887	Prestwick-920	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0126805688669293	0.339631688790594
8888	Prestwick-920	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.0259065148774311	0.339631688790594
8889	Prestwick-920	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	+	0.0397803417517661	0.339631688790594
8890	Prestwick-920	hsa04070	Phosphatidylinositol signaling system	8871_5578_8396_3707_808_801_8527_8526_805	9	-	0.0013366794301337	0.104260995550429
8891	Prestwick-920	hsa04740	Olfactory transduction	801_808_805	3	-	0.00272475966583136	0.106265626967423
8892	Prestwick-920	hsa04912	GnRH signaling pathway	1081_5578_50487_808_1956_5606_3725_801_805	9	-	0.0112375109383042	0.292175284395909
8893	octopamine	hsa05332	Graft-versus-host disease	3812_3108_3123_3126_3127_3125	6	+	0.0039065903612239	0.0859818839792105
8894	octopamine	hsa05320	Autoimmune thyroid disease	3126_3108_3127_3123_3125	5	+	0.0364360914176381	0.337033845613152
8895	octopamine	hsa04612	Antigen processing and presentation	3812_3108_3805_3123_3126_3127_3125	7	+	0.0328326776150716	0.337033845613152
8896	octopamine	hsa04740	Olfactory transduction	26529_8390	2	+	0.000550856349552911	0.0203816849334577
8897	octopamine	hsa04514	Cell adhesion molecules (CAMs)	8174_3383_3123_3126_3127_3125_3108_923_1000	9	+	0.0480326771814191	0.39493534571389
8898	octopamine	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8366_8368_8360_8362_8294_3108_3123_3126_3127_3125_8370_8359_554313_121504_83740	22	+	1.23421490806643e-08	9.13319031969158e-07
8899	octopamine	hsa05310	Asthma	3123_3125_3108_3127_3126	5	+	0.00464766940428165	0.0859818839792105
8900	octopamine	hsa05330	Allograft rejection	3126_3108_3127_3123_3125	5	+	0.0112164349644569	0.166003237473962
8901	octopamine	hsa04940	Type I diabetes mellitus	3126_3108_3127_3123_3125	5	+	0.0190579369846034	0.235047889476775
8902	octopamine	hsa05214	Glioma	6464_6654_5155_808_1956_801_805	7	-	0.0155344274988031	0.403895114968881
8903	octopamine	hsa04080	Neuroactive ligand-receptor interaction	5618_152	2	-	0.00655483240543392	0.255638463811923
8904	octopamine	hsa04740	Olfactory transduction	801_808_5566_805	4	-	0.00217807476271882	0.169889831492068
8905	octopamine	hsa04010	MAPK signaling pathway	784_9261_3925_6788_11261_6654_5155_4217_1845_4137_4763_1956_10912_2005_5566_2260_7048_4616	18	-	0.0253980854270706	0.495262665827877
8906	ceftazidime	hsa05332	Graft-versus-host disease	3135_3123_3811_3119_3802	5	+	0.0114382501795204	0.417496131552495
8907	ceftazidime	hsa04612	Antigen processing and presentation	4261_3811_3119_3805_3123_3802_3135	7	+	0.021785302725541	0.530109032988164
8908	ceftazidime	hsa04740	Olfactory transduction	9635	1	+	0.000271484815484303	0.0198183915303541
8909	ceftazidime	hsa05322	Systemic lupus erythematosus	85235_3119_3123_8330_8332_8969_8331_8329_8336	9	+	0.0452972932722481	0.826675602218528
8910	ceftazidime	hsa04080	Neuroactive ligand-receptor interaction	7442	1	-	0.00751109263387568	0.315465890622779
8911	ceftazidime	hsa04520	Adherens junction	6591_7082_5594_999_5792_6934	6	-	0.0381682718416551	0.534355805783171
8912	ceftazidime	hsa04740	Olfactory transduction	818_157	2	-	0.00164772571920418	0.138408960413151
8913	ceftazidime	hsa05221	Acute myeloid leukemia	861_5970_5594_6934_673	5	-	0.0373688220874999	0.534355805783171
8914	ceftazidime	hsa05216	Thyroid cancer	999_5594_6934_673	4	-	0.0145225980053854	0.406632744150791
8915	ceftazidime	hsa05220	Chronic myeloid leukemia	2122_5594_861_6464_673_5970	6	-	0.0296425560909189	0.534355805783171
8916	adrenosterone	hsa04070	Phosphatidylinositol signaling system	23533_8396_5335_3708_23236	5	+	0.0400762617033482	0.830622771854022
8917	adrenosterone	hsa04740	Olfactory transduction	7932	1	+	0.00167624308094183	0.122365744908754
8918	adrenosterone	hsa05223	Non-small cell lung cancer	1029_23533_5915_5335	4	+	0.0455135765399464	0.830622771854022
8919	adrenosterone	hsa04512	ECM-receptor interaction	8516_7148_2335_2812_3918_1290	6	+	0.0182301127161528	0.665399114139577
8920	adrenosterone	hsa05332	Graft-versus-host disease	3135_3123_3126_3127_3125	5	-	0.0201657294134484	0.359397916746158
8921	adrenosterone	hsa04640	Hematopoietic cell lineage	960_3123_3126_3570_3125_3655_3127	7	-	0.0387334787479307	0.359397916746158
8922	adrenosterone	hsa05320	Autoimmune thyroid disease	3135_3123_3126_3127_3125	5	-	0.0448151536930389	0.359397916746158
8923	adrenosterone	hsa04612	Antigen processing and presentation	4802_3123_3126_3127_3125_3135_6890	7	-	0.0426526805846747	0.359397916746158
8924	adrenosterone	hsa05219	Bladder cancer	4318_1613_4193_1956_7422_1869	6	-	0.00516185673474736	0.359397916746158
8925	adrenosterone	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.0263277403383222	0.359397916746158
8926	adrenosterone	hsa05330	Allograft rejection	3135_3123_3126_3127_3125	5	-	0.0141031368064021	0.359397916746158
8927	adrenosterone	hsa04940	Type I diabetes mellitus	3135_3123_3126_3127_3125	5	-	0.023750225706105	0.359397916746158
8928	oxyphenbutazone	hsa04640	Hematopoietic cell lineage	2323_3553_2057_3570_1604_933_3655	7	+	0.0443645225891051	0.850522839574516
8929	oxyphenbutazone	hsa04740	Olfactory transduction	818	1	+	2.55578024943862e-05	0.000958417593539482
8930	oxyphenbutazone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_3113_8359_8294_720_721_121504_3119_8367	18	+	1.23177555448368e-05	0.00092383166586276
8931	oxyphenbutazone	hsa03440	Homologous recombination	7517_5425_5888	3	-	0.0246480326908599	0.278010212046299
8932	oxyphenbutazone	hsa05131	Shigellosis	7100_7278_7430_113457	4	-	0.0336610318143406	0.278010212046299
8933	oxyphenbutazone	hsa05130	Pathogenic Escherichia coli infection	7100_7278_7430_113457	4	-	0.0336610318143406	0.278010212046299
8934	oxyphenbutazone	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8336	7	-	0.0347512765057874	0.278010212046299
8935	oxyphenbutazone	hsa04060	Cytokine-cytokine receptor interaction	91	1	-	0.046239440675775	0.3082629378385
8936	oxyphenbutazone	hsa03020	RNA polymerase	246721_5439_548644_10622	4	-	0.00431317786694867	0.172527114677947
8937	nomegestrol	hsa04910	Insulin signaling pathway	32	1	+	0.0457995126192552	0.602339128385789
8938	nomegestrol	hsa05016	Huntington's disease	6390_7416	2	+	0.0361664917402727	0.602339128385789
8939	nomegestrol	hsa04740	Olfactory transduction	26212_7932	2	+	4.44877859334904e-05	0.00320312058721131
8940	nomegestrol	hsa05322	Systemic lupus erythematosus	3013_8358_88_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	+	0.0339654444667079	0.602339128385789
8941	nomegestrol	hsa04512	ECM-receptor interaction	1291_1301_3910_1289_1277_5649_51206_3674_2335	9	+	0.0109816531487725	0.39533951335581
8942	nomegestrol	hsa05214	Glioma	5594_5296_808_3845_801_805	6	-	0.00614084841471718	0.0933848927300044
8943	nomegestrol	hsa04070	Phosphatidylinositol signaling system	5296_808_8394_8821_801_805	6	-	0.0121606821496224	0.0933848927300044
8944	nomegestrol	hsa05211	Renal cell carcinoma	2271_5594_5296_1398_405_3845_7042	7	-	0.00240402584421373	0.0933848927300044
8945	nomegestrol	hsa05010	Alzheimer's disease	1339_5594_642502_11261_6391_5663_808_102_801_805	10	-	0.0122874858855269	0.0933848927300044
8946	nomegestrol	hsa05200	Pathways in cancer	4089_2271_5594_6789_6502_7042_1398_6772_1613_5296_405_3845_3655_5899_1017	15	-	0.018326969515038	0.126622698467535
8947	nomegestrol	hsa04910	Insulin signaling pathway	5594_5577_8660_5296_808_3845_1398_801_805	9	-	0.00748890951299103	0.0933848927300044
8948	nomegestrol	hsa04740	Olfactory transduction	801_808_805	3	-	0.0375092976915245	0.230845555749813
8949	nomegestrol	hsa05322	Systemic lupus erythematosus	85235_3113_8330_8332_8969_8331_8329_6738_8336	9	-	0.00962101829927632	0.0933848927300044
8950	nomegestrol	hsa04370	VEGF signaling pathway	5296_11261_3845_56848_5594	5	-	0.0425241813223339	0.230845555749813
8951	nomegestrol	hsa04720	Long-term potentiation	5594_11261_808_3845_801_805	6	-	0.0114883903808456	0.0933848927300044
8952	nomegestrol	hsa05223	Non-small cell lung cancer	2309_6789_5296_3845_5594	5	-	0.0119510893027879	0.0933848927300044
8953	nomegestrol	hsa05213	Endometrial cancer	2309_5296_3845_5594	4	-	0.0413383985428065	0.230845555749813
8954	nomegestrol	hsa04912	GnRH signaling pathway	5594_5598_4323_6416_808_3845_801_805	8	-	0.00572131030280299	0.0933848927300044
8955	nomegestrol	hsa05220	Chronic myeloid leukemia	5594_5296_4089_1398_3845_7042	6	-	0.0114883903808456	0.0933848927300044
8956	ifenprodil	hsa05332	Graft-versus-host disease	3824_3804_3126_3127_3111_3125_3123	7	+	0.00351942084392813	0.131978281647305
8957	ifenprodil	hsa05010	Alzheimer's disease	6390_4842	2	+	0.0356532418425543	0.331785354795293
8958	ifenprodil	hsa05320	Autoimmune thyroid disease	7252_3123_3126_3127_3111_3125	6	+	0.032637983768406	0.331785354795293
8959	ifenprodil	hsa04740	Olfactory transduction	5568	1	+	2.48218722737907e-06	0.00018616404205343
8960	ifenprodil	hsa05322	Systemic lupus erythematosus	85235_718_3123_3126_3127_3111_3125_8332_8969_8331_8336_2209_8329_8330	14	+	0.00655009199079171	0.163752299769793
8961	ifenprodil	hsa04360	Axon guidance	1949	1	+	0.0454300643954567	0.331785354795293
8962	ifenprodil	hsa04530	Tight junction	4625	1	+	0.0468840864996165	0.331785354795293
8963	ifenprodil	hsa05310	Asthma	3123_3126_3127_3111_3125	5	+	0.0131320324026307	0.246225607549326
8964	ifenprodil	hsa05012	Parkinson's disease	6390	1	+	0.0464715094371324	0.331785354795293
8965	ifenprodil	hsa05330	Allograft rejection	3123_3126_3127_3111_3125	5	+	0.0298964128715439	0.331785354795293
8966	ifenprodil	hsa04940	Type I diabetes mellitus	3123_3126_3127_3111_3125	5	+	0.048661852036643	0.331785354795293
8967	ifenprodil	hsa05010	Alzheimer's disease	836_5664	2	-	0.0184121027051692	0.252464630064074
8968	ifenprodil	hsa04080	Neuroactive ligand-receptor interaction	5618_7442_2150_7068	4	-	0.0106831216930442	0.210991653437623
8969	ifenprodil	hsa04740	Olfactory transduction	818_5613	2	-	2.04550179247412e-06	8.07973208027277e-05
8970	ifenprodil	hsa04514	Cell adhesion molecules (CAMs)	3655	1	-	0.021994583692132	0.252464630064074
8971	ifenprodil	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6738_88_8294_121504_3021_3020_8968_8370_8358_8359_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_727_8970	32	-	2.65330666202314e-11	2.09611226299828e-09
8972	ifenprodil	hsa05012	Parkinson's disease	836	1	-	0.0223702836765635	0.252464630064074
8973	ifenprodil	hsa04060	Cytokine-cytokine receptor interaction	5618	1	-	8.04978412604346e-05	0.00211977648652478
8974	scopoletin	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8343_8336_8339_8347_8346_8344	12	+	6.10582041389022e-08	1.83174612416707e-06
8975	scopoletin	hsa05211	Renal cell carcinoma	3725_405_5155_5594	4	-	0.0287006019119947	0.387906289294375
8976	scopoletin	hsa04520	Adherens junction	1956_10458_2260_5594	4	-	0.0393580620454088	0.387906289294375
8977	scopoletin	hsa05219	Bladder cancer	1956_9252_1613_5594	4	-	0.00517867857235004	0.336614107202753
8978	scopoletin	hsa05218	Melanoma	2260_1956_5155_5594	4	-	0.0275063546816006	0.387906289294375
8979	scopoletin	hsa04912	GnRH signaling pathway	5331_3725_6416_1956_5594	5	-	0.0292518349828937	0.387906289294375
8980	cefepime	hsa04740	Olfactory transduction	810_1179	2	+	0.000568088786658756	0.0227235514663502
8981	cefepime	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8329_8294_8969_8370_717_8332_8359_8330_8331_8336_554313_121504_85235	23	+	3.34871679650813e-09	2.6789734372065e-07
8982	cefepime	hsa04150	mTOR signaling pathway	5296_6794_10000_6196_5562	5	+	0.0356516339648092	0.872562279199045
8983	aminoglutethimide	hsa03440	Homologous recombination	7156_8940	2	+	0.0446281109289747	0.990833137897596
8984	Prestwick-1085	hsa05131	Shigellosis	7278_347733_113457_9181	4	+	0.0480311745917996	0.92660205955268
8985	Prestwick-1085	hsa05130	Pathogenic Escherichia coli infection	7278_347733_113457_9181	4	+	0.0480311745917996	0.92660205955268
8986	Prestwick-1085	hsa04540	Gap junction	2778_1812_347733_7278_113457_23236	6	+	0.0257853328377282	0.92660205955268
8987	Prestwick-1085	hsa04120	Ubiquitin mediated proteolysis	89910	1	-	0.0468412316564917	0.68093914163471
8988	Prestwick-1085	hsa04080	Neuroactive ligand-receptor interaction	7442_2908	2	-	0.00329912764038961	0.230938934827273
8989	Prestwick-1085	hsa04514	Cell adhesion molecules (CAMs)	3655	1	-	0.0455367544665179	0.68093914163471
8990	Prestwick-1085	hsa05012	Parkinson's disease	2861	1	-	0.0458603339482676	0.68093914163471
8991	denatonium benzoate	hsa04740	Olfactory transduction	9635_4991	2	+	0.00344261284437124	0.247868124794729
8992	denatonium benzoate	hsa04012	ErbB signaling pathway	10298_6655_6777_5605_5335_1950	6	+	0.0405902840531518	1
8993	denatonium benzoate	hsa05332	Graft-versus-host disease	3126_3106_3113_3127_3125_3123	6	-	0.0028460960144633	0.0618872014808073
8994	denatonium benzoate	hsa04080	Neuroactive ligand-receptor interaction	2901	1	-	0.00779740146448578	0.092871947642688
8995	denatonium benzoate	hsa05320	Autoimmune thyroid disease	3126_3106_3113_3127_3125_3123	6	-	0.00796045265508754	0.092871947642688
8996	denatonium benzoate	hsa05016	Huntington's disease	27113	1	-	0.0474684595338489	0.369199129707714
8997	denatonium benzoate	hsa04514	Cell adhesion molecules (CAMs)	3123_3106_3126_3127_3125_9672_6693_923_3113_5817	10	-	0.0108525533384557	0.108525533384557
8998	denatonium benzoate	hsa05310	Asthma	3123_3126_3127_3113_3125	5	-	0.00353641151318899	0.0618872014808073
8999	denatonium benzoate	hsa04020	Calcium signaling pathway	115	1	-	0.0465028959730761	0.369199129707714
9000	denatonium benzoate	hsa05330	Allograft rejection	3113_3106_3126_3127_3125_3123	6	-	0.00180828838025769	0.0618872014808073
9001	denatonium benzoate	hsa04940	Type I diabetes mellitus	3126_3106_3113_3127_3125_3123	6	-	0.00350709819450354	0.0618872014808073
9002	diethylcarbamazine	hsa05211	Renal cell carcinoma	10000_208_5295_998_4233_405_2033_5781_7043_7042_8453_6921	12	+	0.0165953645968751	0.243247905322422
9003	diethylcarbamazine	hsa05010	Alzheimer's disease	5533_6868_3710_23236	4	+	0.00756557785781164	0.160768529478497
9004	diethylcarbamazine	hsa04080	Neuroactive ligand-receptor interaction	5028_5618_1812_7253_2561_5540_4886_3363_7067_3350	10	+	0.0290383183105879	0.308532132049996
9005	diethylcarbamazine	hsa05016	Huntington's disease	6667_2033_9001_3064_10126_23236	6	+	0.0235725660844522	0.286238302454062
9006	diethylcarbamazine	hsa04740	Olfactory transduction	818_157_816	3	+	2.11460091176223e-09	1.7974107749979e-07
9007	diethylcarbamazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	30	+	6.76200812456452e-06	0.000287385345293992
9008	diethylcarbamazine	hsa04810	Regulation of actin cytoskeleton	3985_5295_998_7409_3673_2245_3676	7	+	0.0171704403757004	0.243247905322422
9009	diethylcarbamazine	hsa05012	Parkinson's disease	7318	1	+	0.00106942361652475	0.0303003358015346
9010	diethylcarbamazine	hsa04080	Neuroactive ligand-receptor interaction	5025	1	-	0.0159380154080759	0.805478334198488
9011	diethylcarbamazine	hsa04010	MAPK signaling pathway	9261_23162_3552_11261_4763_1845_5607_8986_3725_2263_1386_4616_776_9064	14	-	0.023690539241132	0.805478334198488
9012	cyclopentolate	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_718_8368_8366_8359_8348_8294_8367_554313_121504	16	+	0.000133612428849248	0.00988731973484435
9013	cyclopentolate	hsa04360	Axon guidance	1630_9353_6585_6405_1946_56924_1944_4776_6093_27289_2534	11	+	0.0167923579644495	0.621317244684632
9014	cyclopentolate	hsa04664	Fc epsilon RI signaling pathway	5163_3596_6655_5290_27040_5320_2534	7	+	0.0293363680232696	0.72363041124065
9015	cyclopentolate	hsa04080	Neuroactive ligand-receptor interaction	3953_5618	2	-	0.00661338472597906	0.178561387601435
9016	cyclopentolate	hsa04740	Olfactory transduction	109_157	2	-	8.8545834043893e-05	0.00717221255755533
9017	cyclopentolate	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	0.00209781149993718	0.0849613657474558
9018	cyclopentolate	hsa05212	Pancreatic cancer	5170_842_3551_5296_6934_369_1869_367	8	-	0.0266007290178661	0.430931810089431
9019	cyclopentolate	hsa05215	Prostate cancer	5170_842_3551_5296_6934_369_1869_367	8	-	0.0251838197454885	0.430931810089431
9020	alfaxalone	hsa04740	Olfactory transduction	26476_393046_8590	3	+	0.01026508438854	0.171940163508045
9021	alfaxalone	hsa04510	Focal adhesion	10298_596_3690_3908_3910_1289_88_1277_7410_1956_3918_6714_1291	13	+	0.00885667379491579	0.171940163508045
9022	alfaxalone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_718_8368_8366_8359_88_8294_8367_554313_121504_8341	17	+	1.58089204466323e-06	0.000105919766992436
9023	alfaxalone	hsa04512	ECM-receptor interaction	1291_960_3910_3690_1289_3908_1277_3918	8	+	0.00338375211667412	0.113355695908583
9024	alfaxalone	hsa05222	Small cell lung cancer	4149_3910_596_3908_3918_1869	6	+	0.0382638888905543	0.512736111133428
9025	alfaxalone	hsa04070	Phosphatidylinositol signaling system	5331_8394_51763_27124_3631	5	-	0.0307401617882496	0.868422857316495
9026	alfaxalone	hsa04640	Hematopoietic cell lineage	3655_3568_960_3552_2057	5	-	0.0489252313981124	0.868422857316495
9027	alfaxalone	hsa04080	Neuroactive ligand-receptor interaction	2740	1	-	0.0469392719776771	0.868422857316495
9028	alfaxalone	hsa04912	GnRH signaling pathway	1432_4323_5331_3845_112_5338	6	-	0.0370450949383108	0.868422857316495
9029	fenoterol	hsa05218	Melanoma	2246_1956_5155_4193	4	+	0.0189783973393896	0.531395125502909
9030	fenoterol	hsa04540	Gap junction	347688_56604_1956_5155_3709	5	+	0.0107466446798519	0.531395125502909
9031	fenoterol	hsa05322	Systemic lupus erythematosus	8348_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	-	1.5936438244361e-05	0.000812758350462411
9032	fenoterol	hsa04350	TGF-beta signaling pathway	656_91_1874_7059_353500	5	-	0.0214888569876109	0.547965853184078
9033	pimethixene	hsa05322	Systemic lupus erythematosus	85235_8348_8330_8332_8969_8331_8329_8336	8	+	0.023855864493048	1
9034	proxymetacaine	hsa03440	Homologous recombination	8940_5893_10111	3	+	0.0453438969093417	0.742550669737007
9035	proxymetacaine	hsa04360	Axon guidance	5362_2047_1949_2041_2048_9475_3984_6093	8	+	0.028032283672807	0.742550669737007
9036	proxymetacaine	hsa04340	Hedgehog signaling pathway	7482_8643_653_2619_7475	5	+	0.0219229261818644	0.742550669737007
9037	proxymetacaine	hsa04270	Vascular smooth muscle contraction	9475_3708_8681_10242_6093_800_100137049	7	+	0.0437131025381636	0.742550669737007
9038	proxymetacaine	hsa05332	Graft-versus-host disease	3135_3123_3126_3127_3125	5	-	0.00764884296153833	0.181022616756407
9039	proxymetacaine	hsa05320	Autoimmune thyroid disease	3135_3123_3126_3127_3125	5	-	0.0180988794182369	0.257004087738964
9040	proxymetacaine	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.0117975945093175	0.209407302540386
9041	proxymetacaine	hsa05330	Allograft rejection	3135_3123_3126_3127_3125	5	-	0.00522674829295479	0.181022616756407
9042	proxymetacaine	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125_3135_1363	6	-	0.00191431071982736	0.135916061107743
9043	AG-012559	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013	33	+	3.80054932720474e-24	2.50836255595513e-22
9044	AG-012559	hsa04310	Wnt signaling pathway	5467_1856_8061_818_5526_1488	6	-	0.0416495156065269	1
9045	AG-012559	hsa04740	Olfactory transduction	818	1	-	0.0221646098749858	1
9046	debrisoquine	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.0117109956226701	0.142327730902629
9047	debrisoquine	hsa04640	Hematopoietic cell lineage	3123_3568_3126_4254_3127_3125	6	+	0.00914323283288419	0.142327730902629
9048	debrisoquine	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	+	0.0240840803515254	0.216756723163729
9049	debrisoquine	hsa04740	Olfactory transduction	51806	1	+	0.00743417234709774	0.142327730902629
9050	debrisoquine	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.00398145547980923	0.142327730902629
9051	debrisoquine	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.0085258164216448	0.142327730902629
9052	debrisoquine	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	+	0.0135550219907266	0.142327730902629
9053	debrisoquine	hsa05016	Huntington's disease	1213_246721_6391_6648_841_642502_5439_3092_548644_163	10	-	0.029222834521861	0.716628333567003
9054	debrisoquine	hsa05322	Systemic lupus erythematosus	85235_8330_8332_6738_8969_8331_8329_8970_8336	9	-	0.011711510454876	0.716628333567003
9055	debrisoquine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0410568601681311	0.716628333567003
9056	S-propranolol	hsa05010	Alzheimer's disease	489	1	+	0.00170677817057692	0.0455140845487179
9057	S-propranolol	hsa04520	Adherens junction	7082_4088_4089_5818_10580_88_1496_2260_25945_6714	10	+	0.0264517772444519	0.352690363259359
9058	S-propranolol	hsa05016	Huntington's disease	64446_4899_246721	3	+	0.0197377305265633	0.315803688425013
9059	S-propranolol	hsa04740	Olfactory transduction	26212	1	+	3.18739130516173e-08	2.54991304412938e-06
9060	S-propranolol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8329_8294_8341_8969_8370_718_8332_8359_8330_8331_8336_554313_121504_85235	24	+	6.40291641743715e-06	0.000256116656697486
9061	S-propranolol	hsa05012	Parkinson's disease	5413	1	+	0.0104878142443398	0.209756284886796
9062	netilmicin	hsa05010	Alzheimer's disease	5532_6868	2	+	0.0357820711581879	0.942261207165615
9063	netilmicin	hsa04740	Olfactory transduction	26211_5566_393046	3	+	0.000126234766033804	0.00997254651667051
9064	netilmicin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	0.00717599166626273	0.283451670817378
9065	netilmicin	hsa03440	Homologous recombination	5890_7516_5888	3	-	0.046170169986559	0.298028845127956
9066	netilmicin	hsa04662	B cell receptor signaling pathway	5296_6655_5291_5533_3725_4793	6	-	0.018983837779343	0.273367264022539
9067	netilmicin	hsa04660	T cell receptor signaling pathway	5296_6655_5291_5533_5600_3725_4793	7	-	0.0333686082499752	0.298028845127956
9068	netilmicin	hsa04740	Olfactory transduction	818_5613_219464_5616	4	-	0.0495151406228226	0.298028845127956
9069	netilmicin	hsa05212	Pancreatic cancer	842_5296_6655_5291_1385_7184	6	-	0.0377521103518283	0.298028845127956
9070	netilmicin	hsa05215	Prostate cancer	842_5296_6655_5291_1385_7184	6	-	0.036124548591264	0.298028845127956
9071	netilmicin	hsa04210	Apoptosis	472_842_5296_5613_5616_5291_5533_355_8837_651610	10	-	0.000250165020284936	0.0180118814605154
9072	netilmicin	hsa05223	Non-small cell lung cancer	6789_5296_6655_842_5291	5	-	0.0185657484331951	0.273367264022539
9073	netilmicin	hsa04010	MAPK signaling pathway	4149_6789_5613_6655_27092_5616_7042_5533_355_4763_5600_6788_7786_3725_23542_3164	16	-	0.00418106899528871	0.150518483830394
9074	netilmicin	hsa04912	GnRH signaling pathway	5331_5613_6655_5616_818_5600_3725	7	-	0.0307796439563629	0.298028845127956
9075	netilmicin	hsa05210	Colorectal cancer	842_5296_6655_5291_5900_7042_3725	7	-	0.00957765086559407	0.229863620774258
9076	phensuximide	hsa04740	Olfactory transduction	7932_393046_390892	3	+	0.000120310437112075	0.0091435932205177
9077	phensuximide	hsa04340	Hedgehog signaling pathway	8945_3549_656_654_7480_353500_6608	7	+	0.0152831336346185	0.580759078115503
9078	phensuximide	hsa03440	Homologous recombination	5890_7156_5893_5888	4	-	0.0400325073202098	0.580893867964155
9079	phensuximide	hsa04080	Neuroactive ligand-receptor interaction	7067_4889_2908	3	-	0.0102610738518241	0.192395134721702
9080	phensuximide	hsa04740	Olfactory transduction	801_808_805	3	-	0.000119898607124608	0.0089923955343456
9081	phensuximide	hsa04062	Chemokine signaling pathway	156	1	-	0.00514996858071383	0.128749214517846
9082	phensuximide	hsa05012	Parkinson's disease	4712	1	-	0.0464715094371324	0.580893867964155
9083	phensuximide	hsa04060	Cytokine-cytokine receptor interaction	3552_2057	2	-	0.00232032595836905	0.0870122234388394
9084	imidurea	hsa05332	Graft-versus-host disease	3119_3123_3126_3127_3125_356	6	+	0.0135699006162576	0.15890194521633
9085	imidurea	hsa04640	Hematopoietic cell lineage	1436_2812_3690_3123_3126_3570_3127_3589_915_3125_290	11	+	0.00231824633240581	0.0625926509749569
9086	imidurea	hsa05320	Autoimmune thyroid disease	3119_3123_3126_3127_3125_356	6	+	0.0342045825168608	0.346321397983216
9087	imidurea	hsa04740	Olfactory transduction	5593_393046	2	+	2.0518637413373e-05	0.000831004815241607
9088	imidurea	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013	30	+	2.03113773619149e-11	1.64522156631511e-09
9089	imidurea	hsa05310	Asthma	3123_3126_3127_3119_3125	5	+	0.013732266870547	0.15890194521633
9090	imidurea	hsa05330	Allograft rejection	3119_3123_3126_3127_3125_356	6	+	0.00895921928009228	0.145139352337495
9091	imidurea	hsa04940	Type I diabetes mellitus	3382_3119_3123_3126_3127_3125_356	7	+	0.00470185052736052	0.0952124731790505
9092	imidurea	hsa05010	Alzheimer's disease	355_489	2	-	0.049800556034615	0.766928562933071
9093	imidurea	hsa04080	Neuroactive ligand-receptor interaction	2561_5618	2	-	0.00466006989509773	0.119608460640842
9094	imidurea	hsa04740	Olfactory transduction	818	1	-	5.35600390849962e-06	0.000412412300954471
9095	imidurea	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8348_8294_8367_554313_121504_3119	16	-	0.000433193854042301	0.0166779633806286
9096	imidurea	hsa04062	Chemokine signaling pathway	3579_2931	2	-	0.0362134350511554	0.697108624734741
9097	etomidate	hsa04740	Olfactory transduction	26211	1	+	1.78019840726783e-06	0.000137075277359623
9098	etomidate	hsa05322	Systemic lupus erythematosus	474382_474381_85235_83740_8330_8969_8332_88_8331_8329_720_721_8336_8341_8340	15	+	0.00399219611963782	0.153699550606056
9099	etomidate	hsa04080	Neuroactive ligand-receptor interaction	1131_2908	2	-	0.0259730059793434	0.441541101648838
9100	etomidate	hsa04740	Olfactory transduction	818_157	2	-	0.000783410305594005	0.0266359503901962
9101	etomidate	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_8359_8294_8367_554313_121504_9555	16	-	2.86261054694338e-05	0.0019465751719215
9102	etomidate	hsa04664	Fc epsilon RI signaling pathway	8398_4067_5581_6654_8681_1432_100137049	7	-	0.0156541958916652	0.354828440211078
9103	etomidate	hsa04010	MAPK signaling pathway	51295_1432_8681_6654_5155_5154_1846_6722_5607_23162_8398_3725_100137049_7186_4149	15	-	0.0365450499312421	0.497012679064893
9104	moracizine	hsa04740	Olfactory transduction	2978	1	+	5.49505155592137e-05	0.00211559484902973
9105	moracizine	hsa04514	Cell adhesion molecules (CAMs)	9076_965_5175_3676_3106_3135_23308_9672_3105_5817_25945_649853	12	+	0.00271469541189242	0.0696771822385721
9106	moracizine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013	33	+	1.50801546457768e-16	1.16117190772481e-14
9107	moracizine	hsa04010	MAPK signaling pathway	782_9479_1432_5579_3551_5598_9254_4915_1649_4137_8817_4208_1956_8681_7042_100137049	16	+	0.0398720772200147	0.517426536048624
9108	moracizine	hsa04912	GnRH signaling pathway	1432_5579_5598_1956_8681_6714_100137049_23236	8	+	0.0341524430710164	0.517426536048624
9109	moracizine	hsa05330	Allograft rejection	3135_3105_3106_649853	4	+	0.04579137123247	0.517426536048624
9110	moracizine	hsa05200	Pathways in cancer	1436_4149_3551_4088_208_8074_3909_405_2263_1869_367_2260_3675	13	-	0.0275084382130933	0.244137389141203
9111	moracizine	hsa04740	Olfactory transduction	5613	1	-	0.00780899247073287	0.13687449983521
9112	moracizine	hsa05212	Pancreatic cancer	3551_208_367_1869_2263_2260	6	-	0.0115668591410037	0.13687449983521
9113	moracizine	hsa05215	Prostate cancer	3551_208_367_1869_2263_2260	6	-	0.0110134911956198	0.13687449983521
9114	moracizine	hsa04210	Apoptosis	3554_3551_5613_5575_208_5534	6	-	0.0115668591410037	0.13687449983521
9115	moracizine	hsa04010	MAPK signaling pathway	4217_3554_4149_3551_3925_5613_208_8074_2002_5607_5534_2263_2260_8398_3164	15	-	0.000628235367287061	0.0446047110773813
9116	moracizine	hsa05222	Small cell lung cancer	4149_3551_208_3909_1869_3675	6	-	0.00996347819836698	0.13687449983521
9117	moracizine	hsa02010	ABC transporters	5244_215_20_5243	4	-	0.0149586023006377	0.151722966192182
9118	rimexolone	hsa05332	Graft-versus-host disease	3105_3126_3127_3125_356_3123_3558	7	+	0.0372423374553499	0.54792735396779
9119	rimexolone	hsa04614	Renin-angiotensin system	183_59272_2028_186	4	+	0.0433162468828566	0.54792735396779
9120	rimexolone	hsa04740	Olfactory transduction	810	1	+	1.51465978859636e-10	1.25716762453498e-08
9121	rimexolone	hsa04012	ErbB signaling pathway	6655	1	+	0.0455087223925895	0.54792735396779
9122	rimexolone	hsa05330	Allograft rejection	3593_3105_3126_3127_3558_356_3123_3125	8	+	0.00869052160756007	0.240437764475829
9123	rimexolone	hsa04940	Type I diabetes mellitus	3593_2572_3105_3126_3127_3558_356_3123_3125	9	+	0.00648213540855733	0.240437764475829
9124	rimexolone	hsa05214	Glioma	5578_3480_4193_808_1956_5335_1869_801_805	9	-	0.0106214934081908	0.117095518604021
9125	rimexolone	hsa04070	Phosphatidylinositol signaling system	8871_5298_5578_8394_808_5335_4952_801_3707_805	10	-	0.00990152919027721	0.117095518604021
9126	rimexolone	hsa04080	Neuroactive ligand-receptor interaction	2561_2150	2	-	0.000378531708720947	0.0149520024944774
9127	rimexolone	hsa05131	Shigellosis	7280_7277_347733_7278_5578_113457_9475_8440	8	-	0.0133399957903315	0.117095518604021
9128	rimexolone	hsa05016	Huntington's disease	5432_4712_163	3	-	0.0268846453373147	0.176990581803988
9129	rimexolone	hsa05130	Pathogenic Escherichia coli infection	7280_7277_347733_7278_5578_113457_9475_8440	8	-	0.0133399957903315	0.117095518604021
9130	rimexolone	hsa04740	Olfactory transduction	801_808_157_805	4	-	3.82862801122539e-05	0.00302461612886806
9131	rimexolone	hsa05322	Systemic lupus erythematosus	8353_94239_8344_8347_8346_8358_8343_8968_3013_8350_8351_8352_8339_8354_8355_8356_8357	17	-	0.00286858430082541	0.0755393865884025
9132	rimexolone	hsa04370	VEGF signaling pathway	5533_8398_5578_5829_11261_7867_8681_5335_5600_5603_100137049	11	-	0.00403660039113978	0.0797228577250107
9133	rimexolone	hsa04010	MAPK signaling pathway	4763_8681_5600_5603_4616_4149_3552_6789_6788_11261_5922_10746_2260_100137049_8398_7867_1956_3725_3727_5533_5578_5607_6195_23162_2005	25	-	0.0095242693163153	0.117095518604021
9134	rimexolone	hsa05012	Parkinson's disease	4712	1	-	0.0153756562610242	0.121467684462091
9135	rimexolone	hsa04060	Cytokine-cytokine receptor interaction	1435_3552_3455_4254_1956_8795	6	-	0.0323622467083945	0.19666288384332
9136	rimexolone	hsa04912	GnRH signaling pathway	8398_5578_808_1956_8681_5600_5603_3725_10746_801_100137049_805	12	-	0.0179661163990228	0.129029381411164
9137	torasemide	hsa05010	Alzheimer's disease	5331	1	+	0.0050546673719965	0.194604693821865
9138	torasemide	hsa04740	Olfactory transduction	393046_4991	2	+	6.40942454890952e-06	0.000493525690266033
9139	torasemide	hsa04080	Neuroactive ligand-receptor interaction	64106_2561_2149	3	-	0.00739612552300877	0.194764638772564
9140	torasemide	hsa04740	Olfactory transduction	818_219464	2	-	1.46052615352272e-05	0.000576907830641474
9141	torasemide	hsa05322	Systemic lupus erythematosus	8358_85235_8968_3013_8351_8330_8332_8969_8331_8329_8337_720_721_8350_8336_8352_8353_8354_8355_8356_8357	21	-	6.69537668747063e-06	0.00052893475831018
9142	torasemide	hsa05012	Parkinson's disease	27429	1	-	0.0316427814952008	0.624944934530216
9143	lymecycline	hsa05010	Alzheimer's disease	776	1	+	0.0337939783830531	0.443014254832729
9144	lymecycline	hsa05320	Autoimmune thyroid disease	942_3113_3119_1081_7253	5	+	0.0484574513590921	0.443014254832729
9145	lymecycline	hsa04740	Olfactory transduction	26211_5593_816	3	+	0.000978771100104198	0.0337676029535948
9146	lymecycline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_717_8368_3113_9103_3014_8359_8294_8367_554313_121504_3119_942	20	+	8.23174567597065e-07	5.67990451641975e-05
9147	lymecycline	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3576_998_5600_5879_528_23545	6	+	0.0487575465450144	0.443014254832729
9148	lymecycline	hsa04630	Jak-STAT signaling pathway	3589	1	+	0.0458693607762691	0.443014254832729
9149	lymecycline	hsa04940	Type I diabetes mellitus	3382_942_3113_3119_2571	5	+	0.0258147073281632	0.443014254832729
9150	lymecycline	hsa05211	Renal cell carcinoma	208_6655_201163_3725_7042	5	-	0.0485519061928447	0.246227524263712
9151	lymecycline	hsa04662	B cell receptor signaling pathway	208_11261_4775_5534_3725_6655	6	-	0.0180865548199994	0.160043954868269
9152	lymecycline	hsa05200	Pathways in cancer	3688_4149_3912_4088_598_6655_6777_331_1855_1856_208_6934_7042_2263_2260_5888_3725_3675	18	-	0.00516727947965186	0.0917192107638205
9153	lymecycline	hsa04310	Wnt signaling pathway	8945_4041_27101_4088_11261_1855_1856_9475_4775_6934_5534_3725_23236	13	-	0.000340353530334632	0.0241651006537589
9154	lymecycline	hsa04660	T cell receptor signaling pathway	208_11261_4775_5600_5534_3725_6655	7	-	0.0317130367096933	0.187635467199019
9155	lymecycline	hsa05014	Amyotrophic lateral sclerosis (ALS)	598_11261_5600_834_5534	5	-	0.0202872618847101	0.160043954868269
9156	lymecycline	hsa04740	Olfactory transduction	157	1	-	0.000815804059158409	0.0289610441001235
9157	lymecycline	hsa04510	Focal adhesion	3688_3912_208_6655_331_9475_2002_3725_83660_2909_3675	11	-	0.0283670287459024	0.183096276450825
9158	lymecycline	hsa04210	Apoptosis	5534_598_11261_8717_331_51135_208	7	-	0.0119602707229961	0.141529870222121
9159	lymecycline	hsa05221	Acute myeloid leukemia	208_6655_6777_5292_6934	5	-	0.0244436310735996	0.173549780622557
9160	lymecycline	hsa04330	Notch signaling pathway	23220_1855_1856_9541	4	-	0.0421044250842737	0.229954936998726
9161	lymecycline	hsa05210	Colorectal cancer	4088_208_6655_1855_1856_6934_7042_3725	8	-	0.00254166097160074	0.0601526429945508
9162	lymecycline	hsa05222	Small cell lung cancer	3688_4149_3912_598_331_208_3675	7	-	0.0101419885504251	0.141529870222121
9163	lymecycline	hsa05220	Chronic myeloid leukemia	4088_208_6655_6777_598_7042	6	-	0.0180865548199994	0.160043954868269
9164	talampicillin	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	2.68481252598592e-06	0.000115446938617395
9165	talampicillin	hsa04070	Phosphatidylinositol signaling system	8867_5298_64768_56623_808_23396_51763_801_805	9	-	0.0128939889074542	0.251432783695357
9166	talampicillin	hsa04740	Olfactory transduction	818_801_808_805	4	-	0.000218683396056784	0.0170573048924292
9167	talampicillin	hsa04062	Chemokine signaling pathway	10451	1	-	0.00240102095809268	0.0936398173656145
9168	talampicillin	hsa04060	Cytokine-cytokine receptor interaction	8744_1956_8795	3	-	0.00377681634821974	0.0981972250537132
9169	talampicillin	hsa05213	Endometrial cancer	324_2002_1956_6934_2064_842	6	-	0.0429657334476067	0.558554534818887
9170	talampicillin	hsa04912	GnRH signaling pathway	2002_2767_2776_808_818_1956_5600_5338_801_805	10	-	0.0415160574926221	0.558554534818887
9171	ribavirin	hsa05010	Alzheimer's disease	355_54205_779_351	4	+	0.0481429784333196	0.818430633366433
9172	ribavirin	hsa05016	Huntington's disease	246721_54205	2	+	0.00218104672935903	0.0617963239985058
9173	ribavirin	hsa04740	Olfactory transduction	5593_26529_9635	3	+	7.41808139933807e-07	6.30536918943736e-05
9174	ribavirin	hsa05322	Systemic lupus erythematosus	474382_474381_8350_8329_8969_8968_8358_8330_8331_8336_6737_6738_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_83740_3013	24	+	2.04424329716679e-05	0.000868803401295886
9175	ribavirin	hsa04210	Apoptosis	23533_843_3551_598_54205_331_472_355_51135_8837_651610_8794	12	+	0.0134623852219345	0.286075685966108
9176	ribavirin	hsa04070	Phosphatidylinositol signaling system	3707_8503_3710_5290_3631	5	-	0.0105805521741985	0.232772147832367
9177	ribavirin	hsa05211	Renal cell carcinoma	8503_7424_2271_5290_7042	5	-	0.00859564335915139	0.232772147832367
9178	ribavirin	hsa04662	B cell receptor signaling pathway	8503_4067_5290_4793	4	-	0.040803708973087	0.506685242948642
9179	ribavirin	hsa04910	Insulin signaling pathway	2308_8503_5290_2002_23265_8835	6	-	0.0313007566437813	0.506685242948642
9180	ribavirin	hsa04664	Fc epsilon RI signaling pathway	8503_5606_4067_5290	4	-	0.0474917617611197	0.506685242948642
9181	ribavirin	hsa04930	Type II diabetes mellitus	8835_8503_776_5290	4	-	0.00837625386766978	0.232772147832367
9182	AH-23848	hsa05211	Renal cell carcinoma	23533_2271_208_6655_998_8453_7422	7	+	0.0341097725543744	0.447091760347295
9183	AH-23848	hsa04080	Neuroactive ligand-receptor interaction	7067_6915_7442	3	+	0.0141977920763172	0.447091760347295
9184	AH-23848	hsa04310	Wnt signaling pathway	80319	1	+	0.0323539700231972	0.447091760347295
9185	AH-23848	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_85235_8364_8370_8366_8368_8365_8330_8332_8359_8969_8331_8329_8336_8367_554313_121504_8294	21	+	1.67663827923625e-06	0.000124071232663483
9186	AH-23848	hsa05223	Non-small cell lung cancer	23533_5170_6789_208_6655_5335	6	+	0.0288718880127665	0.447091760347295
9187	AH-23848	hsa04060	Cytokine-cytokine receptor interaction	1436_5154_2057_7422	4	+	0.0362506832714023	0.447091760347295
9188	AH-23848	hsa04080	Neuroactive ligand-receptor interaction	5618_7068_5025_2901_56288_1909_9170	7	-	9.13106213639472e-05	0.00406332265069565
9189	AH-23848	hsa04740	Olfactory transduction	5137_5613_26212_5616	4	-	2.92557759707517e-11	2.6037640613969e-09
9190	AH-23848	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_81_3108_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_85236	24	-	0.0181404066950338	0.322899239171602
9191	AH-23848	hsa04110	Cell cycle	5591_4174_5001_5347_51343_4173_7157_699_4193_472_4176_996_7040_8243_7534_1017_7531_4999_4616	19	-	0.0469986792215754	0.518322650797895
9192	AH-23848	hsa05216	Thyroid cancer	5594_7157_999_5605_7849_6934_10342_6257	8	-	0.013131274993005	0.292170868594361
9193	AH-23848	hsa04630	Jak-STAT signaling pathway	3601_3597_5618_2057_6774_3717_5296	7	-	0.048333514609272	0.518322650797895
9194	AH-23848	hsa04060	Cytokine-cytokine receptor interaction	5618_3597_2057_2324_3601_4982_7040_655_51330	9	-	0.000648411532629738	0.0192362088013489
9195	AH-23848	hsa04610	Complement and coagulation cascades	5329	1	-	0.0300303769750616	0.445450591796747
9196	isotretinoin	hsa04740	Olfactory transduction	219464	1	+	1.18482122813766e-05	0.000876767708821868
9197	isotretinoin	hsa05010	Alzheimer's disease	23236	1	-	0.0465000860539645	1
9198	isotretinoin	hsa04510	Focal adhesion	596_3691_2324_858_6464_3678_4636_208_7791_6714_6093_2534	12	-	0.0467996299194517	1
9199	isotretinoin	hsa04730	Long-term depression	2911_4067_50487_2767_5515_23236	6	-	0.0319478893580622	1
9200	chlorpropamide	hsa04740	Olfactory transduction	818_26476_157_816	4	+	3.55737993942534e-08	3.20164194548281e-06
9201	chlorpropamide	hsa04512	ECM-receptor interaction	960_2335_3910_3690_3694_3696_1277_3918_6383_1290_51206_3675	12	+	0.0411264202175257	0.740275563915463
9202	chlorpropamide	hsa04630	Jak-STAT signaling pathway	208_3717_3561_3441	4	+	0.0259306768014382	0.669195660731357
9203	chlorpropamide	hsa05012	Parkinson's disease	27429_513_317	3	+	0.0183524246458305	0.669195660731357
9204	chlorpropamide	hsa04260	Cardiac muscle contraction	6548	1	+	0.0297420293658381	0.669195660731357
9205	chlorpropamide	hsa04120	Ubiquitin mediated proteolysis	51343_51433_23291_7329	4	-	0.0475169532052881	0.583779710807825
9206	chlorpropamide	hsa04080	Neuroactive ligand-receptor interaction	5618_2918_2925_3362_3354_3351_7067_7433	8	-	0.00522511573049635	0.224679976411343
9207	chlorpropamide	hsa04740	Olfactory transduction	219464_4992_409	3	-	1.42286211914652e-09	1.22366142246601e-07
9208	chlorpropamide	hsa04710	Circadian rhythm - mammal	1454_79365_9572_1453	4	-	0.0293959523618145	0.505610380623209
9209	chlorpropamide	hsa05012	Parkinson's disease	642502_6391_1329_842	4	-	0.0463258404346765	0.583779710807825
9210	chlorpropamide	hsa04020	Calcium signaling pathway	8911_2925_3362_2776_23236	5	-	0.010078122847715	0.288906188301163
9211	chlorpropamide	hsa05210	Colorectal cancer	23533_842_581_4088_6655_6654_332_6932_5880_6934_7855_3725_4233	13	-	0.0267603340057086	0.505610380623209
9212	0297417-0002B	hsa04740	Olfactory transduction	26476_157	2	+	9.506766618056e-07	3.85024048031268e-05
9213	0297417-0002B	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8348_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013	34	+	4.70386183583571e-12	3.81012808702693e-10
9214	0297417-0002B	hsa04530	Tight junction	56288	1	+	0.0152291944487519	0.308391187587226
9215	0297417-0002B	hsa05012	Parkinson's disease	4713	1	+	0.0151336174133733	0.308391187587226
9216	0297417-0002B	hsa04060	Cytokine-cytokine receptor interaction	5618_3572_2688_2689_93_6366	6	+	0.0428623274936114	0.511646149230754
9217	0297417-0002B	hsa04940	Type I diabetes mellitus	3119_3105_3106_2571_3135_649853	6	+	0.0337812813779168	0.511646149230754
9218	0297417-0002B	hsa03440	Homologous recombination	5890_5888_8438_5424_7517_7516_5893_10714_675_5889_25788	11	-	0.0173852756752747	0.0999653351328295
9219	0297417-0002B	hsa04640	Hematopoietic cell lineage	3554_960_2057	3	-	0.00182522460274045	0.0239886662074459
9220	0297417-0002B	hsa04080	Neuroactive ligand-receptor interaction	5029_1269_7068_5021_5724_136_1909_2690_9170	9	-	1.35774931415582e-08	4.16376456341118e-07
9221	0297417-0002B	hsa05016	Huntington's disease	5432_246721_6391_5434_841_581_4700_5441_54205_1175_642502_7419_548644_5481_842	15	-	0.00544030317142092	0.0455007174337022
9222	0297417-0002B	hsa04740	Olfactory transduction	157_5613_5616_808_816_801_805	7	-	2.14638575675233e-17	1.97467489621214e-15
9223	0297417-0002B	hsa04514	Cell adhesion molecules (CAMs)	4685_999_3106_4897_3685_9080_3134_1365_5792_6383_9019	11	-	0.0286452303499937	0.14640895512219
9224	0297417-0002B	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_94239_8366_8368_8329_8294_121504_81_6632_8367_8969_8968_8370_718_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3014_727	38	-	0.0090956940966587	0.064369527453277
9225	0297417-0002B	hsa04360	Axon guidance	5594_2041_5062_5881_1944_2049_5532_6405_4775_3984_10507	11	-	0.036786566651411	0.178124427996306
9226	0297417-0002B	hsa04110	Cell cycle	595_983_11200_23594_5111_2810_896_699_8881_1017_890_4174_996_990_993_9134_898_4193_9088_7027_7040_8555_1869_8318_5591_4175_4176_5347_4171_4172_4173_6502_5933_4998	34	-	0.00447817175423511	0.0455007174337022
9227	0297417-0002B	hsa03030	DNA replication	4174_23649_4176_246243_5111_4171_4172_4175_5982_5983_4173_5426_2237_5985_10714_5557_5424_5427	18	-	0.0002239172393112	0.0051500965041576
9228	0297417-0002B	hsa04512	ECM-receptor interaction	3685_960_3912_6383	4	-	0.00780212207477441	0.0598162692399371
9229	0297417-0002B	hsa04630	Jak-STAT signaling pathway	10401_9063_595_896_2057_2885_6772_2690	8	-	0.000342237297403675	0.00629716627222762
9230	0297417-0002B	hsa04062	Chemokine signaling pathway	2309_5594_157_2885_5613_156_5616_6464_6772_115_7410_4067_4793_1398_10681_107_408	17	-	0.0116916501202404	0.0768308436472941
9231	0297417-0002B	hsa04810	Regulation of actin cytoskeleton	2909_60_5881_10109_81_7410_23396_1398_2261_10152_5062_8394_8396_22800_10787_4628_23191_10093_5605_5594_26999_3685_3984	23	-	0.0481147879263235	0.220053963197295
9232	0297417-0002B	hsa05012	Parkinson's disease	54205_842_4700_642502_6391_7054_7327_7419_5481	9	-	0.00510915216621486	0.0455007174337022
9233	0297417-0002B	hsa03430	Mismatch repair	9156_5111_5395_5982_5983_27030_5985_10714_5424_2956	10	-	0.0186751353952479	0.101065438609577
9234	0297417-0002B	hsa04260	Cardiac muscle contraction	784_27092_488	3	-	0.00254729810710766	0.0292939282317381
9235	0297417-0002B	hsa04060	Cytokine-cytokine receptor interaction	3556_3554_2057_355_7422_51330_7040_2690	8	-	1.20520629472893e-09	5.54394895575308e-08
9236	0297417-0002B	hsa03010	Ribosome	6142_285053_6234_9349	4	-	0.00100000775317362	0.0153334522153288
9237	0297417-0002B	hsa04610	Complement and coagulation cascades	727_5329_718	3	-	0.0150991394012543	0.0926080549943597
9238	skimmianine	hsa04070	Phosphatidylinositol signaling system	5578_3635_23396_3633_3631	5	+	0.0495810977112577	1
9239	skimmianine	hsa04740	Olfactory transduction	818_1179	2	+	0.00665562736315498	0.419304523878764
9240	skimmianine	hsa05010	Alzheimer's disease	5534	1	-	0.0159575036622217	0.430852598879986
9241	skimmianine	hsa05016	Huntington's disease	581	1	-	0.0111546072820422	0.430852598879986
9242	skimmianine	hsa05222	Small cell lung cancer	5728_3688_3551_6502_3909_3918_8554_208_3675	9	-	0.0106911356187199	0.430852598879986
9243	suxibuzone	hsa05332	Graft-versus-host disease	3812_57292_3811_3804_3107_3803_3802	7	+	0.000128749122646956	0.00231748420764521
9244	suxibuzone	hsa04650	Natural killer cell mediated cytotoxicity	3812_57292_3811_3809_3808_3804_3806_3810_3803_3802_3107	11	+	0.000723677931859499	0.00976965208010324
9245	suxibuzone	hsa04612	Antigen processing and presentation	3812_57292_3811_3809_3808_3804_3806_3810_3803_3802_115653_3107	12	+	3.76990281912742e-06	0.00010178737611644
9246	suxibuzone	hsa04740	Olfactory transduction	26212_8390	2	+	0.00926369505738651	0.100047906619774
9247	suxibuzone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_2904_2209_8366_8359_8294_8367_554313_8368_121504	16	+	9.608689470397e-07	5.18869231401438e-05
9248	suxibuzone	hsa04070	Phosphatidylinositol signaling system	64768_8394_8760_5335_51763_5336_3705	7	-	0.0173618156085864	0.248879706207375
9249	suxibuzone	hsa04662	B cell receptor signaling pathway	208_11261_5336_5533_5534_933_4793	7	-	0.0163329940622341	0.248879706207375
9250	suxibuzone	hsa05014	Amyotrophic lateral sclerosis (ALS)	5533_11261_1432_834_5534	5	-	0.0462095147699379	0.53471009948071
9251	suxibuzone	hsa04740	Olfactory transduction	816_4991	2	-	0.000574465474219716	0.046531703411797
9252	suxibuzone	hsa05322	Systemic lupus erythematosus	85235_3123_8330_8332_8969_8331_8336_8343_8329_8339_8347_8346_8344	13	-	0.00167197035419676	0.0677147993449688
9253	suxibuzone	hsa04370	VEGF signaling pathway	1432_208_11261_5336_5533_5335_5534	7	-	0.0184355337931389	0.248879706207375
9254	suxibuzone	hsa04010	MAPK signaling pathway	7046_9479_1432_208_11261_5534_1846_51347_5533_5607_23162_5598_7040_10454_4149_2247_4616	17	-	0.0166281720695992	0.248879706207375
9255	SB-203580	hsa03440	Homologous recombination	4361_7156_7516_5893_6742_5888_29935_10111	8	+	0.0272893709716492	0.184621502885403
9256	SB-203580	hsa05010	Alzheimer's disease	776_842_317_355_6868_351	6	+	0.000538012541166867	0.00676358623181204
9257	SB-203580	hsa04080	Neuroactive ligand-receptor interaction	2550_4889_5618_1813_5021_4886_7067_1909	8	+	1.26136355991687e-05	0.000554999966363423
9258	SB-203580	hsa05016	Huntington's disease	1385_317_6648_842_246721	5	+	6.47393960105792e-05	0.00189902228297699
9259	SB-203580	hsa04740	Olfactory transduction	818_26212_393046_157	4	+	6.06627171206827e-14	5.33831910662008e-12
9260	SB-203580	hsa04530	Tight junction	8189_5578_8777_10207_50848_10627	6	+	0.0120816512449645	0.0885987757964063
9261	SB-203580	hsa04920	Adipocytokine signaling pathway	5563	1	+	0.00866360239316558	0.0762397010598571
9262	SB-203580	hsa04630	Jak-STAT signaling pathway	5618_3566_3594_1154_8554_8651	6	+	0.00365921569319291	0.040251372625122
9263	SB-203580	hsa04062	Chemokine signaling pathway	157_156_5829_7852_113_107	6	+	0.00021161918136913	0.00465436276994603
9264	SB-203580	hsa05012	Parkinson's disease	317_842_7054	3	+	0.000365650951866798	0.0053628806273797
9265	SB-203580	hsa04260	Cardiac muscle contraction	776_4635	2	+	0.0108810659792594	0.0870485278340752
9266	SB-203580	hsa04060	Cytokine-cytokine receptor interaction	5618_1435_3566_3552_3594_5155_8741_7852_355_655_10913_7043_8718_7046_8795	15	+	0.00487511682334951	0.0476678089394174
9267	SB-203580	hsa03010	Ribosome	6165	1	+	0.00026445243011057	0.00465436276994603
9268	SB-203580	hsa04020	Calcium signaling pathway	776_5256_5578_5021_818_7220_5333_113_1909_9630_107	11	+	0.0314695743554664	0.184621502885403
9269	SB-203580	hsa04610	Complement and coagulation cascades	5104_5329	2	+	0.0308133213150925	0.184621502885403
9270	SB-203580	hsa04080	Neuroactive ligand-receptor interaction	1269_9170	2	-	0.0372032229986422	1
9271	SB-203580	hsa04740	Olfactory transduction	157	1	-	0.000174046633882013	0.013227544175033
9272	pivmecillinam	hsa05332	Graft-versus-host disease	3135_3123_3126_3127_3125	5	+	0.0214906758146658	0.318939681233714
9273	pivmecillinam	hsa05320	Autoimmune thyroid disease	3135_3123_3126_3127_3125	5	+	0.0475312689042712	0.372112592674325
9274	pivmecillinam	hsa04740	Olfactory transduction	219464_51806_8388_8387_26211_810	6	+	0.0327117621778168	0.318939681233714
9275	pivmecillinam	hsa04514	Cell adhesion molecules (CAMs)	9076_965_9074_3123_3126_3127_3125_3135_23308_926	10	+	0.0322767207089051	0.318939681233714
9276	pivmecillinam	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_718_3123_8366_3126_3127_3125_8359_8294_8367_554313_8368_121504	19	+	2.84666000881573e-06	0.000222039480687627
9277	pivmecillinam	hsa04710	Circadian rhythm - mammal	4862_8553_5187	3	+	0.0159356716493614	0.310745597162547
9278	pivmecillinam	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	7082_3551_1839_5335_5602_3725	6	+	0.0477067426505545	0.372112592674325
9279	pivmecillinam	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.027761594030544	0.318939681233714
9280	pivmecillinam	hsa05330	Allograft rejection	3135_3123_3126_3127_3125	5	+	0.0150564794204345	0.310745597162547
9281	pivmecillinam	hsa04940	Type I diabetes mellitus	3382_3123_3126_3127_3125_3135	6	+	0.00683749194789083	0.266662185967742
9282	pivmecillinam	hsa04740	Olfactory transduction	5566	1	-	0.0162930012040895	1
9283	naftifine	hsa04740	Olfactory transduction	26539	1	+	3.78066533106063e-05	0.00279769234498487
9284	naftifine	hsa05322	Systemic lupus erythematosus	8348_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	+	0.00648703509214442	0.240020298409344
9285	naftifine	hsa04710	Circadian rhythm - mammal	406_5187_9572	3	+	0.0153602358453379	0.378885817518335
9286	naftifine	hsa04010	MAPK signaling pathway	1647_2122_3551_5578_1649_5155_1846_8817_5607_6196_8681_1399_5534_5971_100137049_4791_11221	17	+	0.0294125029304773	0.54413130421383
9287	naftifine	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8336	7	-	0.0181286330235324	0.543858990705972
9288	naftifine	hsa04370	VEGF signaling pathway	5296_5533_9261_50487_5600	5	-	0.0152403685159972	0.543858990705972
9289	bethanechol	hsa05332	Graft-versus-host disease	3811_3123_3126_3112_3127_3135_3125	7	+	0.00750257064533195	0.177305738873741
9290	bethanechol	hsa04740	Olfactory transduction	810_5137_5568_393046	4	+	7.3995676336771e-05	0.0028118357007973
9291	bethanechol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_2215_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504_3112_9555_8364	21	+	2.9379645608208e-05	0.00223285306622381
9292	bethanechol	hsa05310	Asthma	3123_3112_3126_3127_3125	5	+	0.0227167139787796	0.287745043731208
9293	bethanechol	hsa05330	Allograft rejection	3123_3126_3112_3127_3135_3125	6	+	0.0161606981549675	0.245642611955506
9294	bethanechol	hsa04940	Type I diabetes mellitus	3126_2572_3112_3127_3135_3123_3125	7	+	0.0093318809933548	0.177305738873741
9295	bethanechol	hsa04080	Neuroactive ligand-receptor interaction	2561	1	-	0.0157518051329657	0.519809569387868
9296	bethanechol	hsa04210	Apoptosis	3554_836_5576_5575_472_9941_5534_651610_7186	9	-	0.00101830604170125	0.0672081987522825
9297	bethanechol	hsa04115	p53 signaling pathway	472_651610_836_7057_7249	5	-	0.0437669684546513	0.751404857063106
9298	Prestwick-1083	hsa05332	Graft-versus-host disease	3107_3811_3802	3	+	0.0430830704437129	0.613933753822909
9299	Prestwick-1083	hsa05200	Pathways in cancer	1488	1	+	0.0320794372022492	0.609509306842735
9300	Prestwick-1083	hsa04740	Olfactory transduction	26211	1	+	0.0155732280236746	0.443836998674726
9301	Prestwick-1083	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_8294_720_721_121504_8367	16	+	1.63609777286393e-08	9.3257573053244e-07
9302	Prestwick-1083	hsa02010	ABC transporters	19_20_89845	3	-	0.00943312215872516	0.349025519872831
9303	Prestwick-1103	hsa05016	Huntington's disease	6390_509	2	+	0.00157547683547267	0.0435881924480772
9304	Prestwick-1103	hsa04740	Olfactory transduction	26333_26212_157_1179	4	+	9.92439454201973e-07	4.11862373493819e-05
9305	Prestwick-1103	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_6737_88_8362_8294_121504_8366_8968_8370_8358_8359_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_83740_3013_3113_720_721	35	+	2.86907784131361e-10	2.3813346082903e-08
9306	Prestwick-1103	hsa04350	TGF-beta signaling pathway	6093_7059_6667_1874	4	-	0.0429242597428571	1
9307	cefadroxil	hsa05332	Graft-versus-host disease	3811_3122_3123_3126_3127_3125_3802	7	+	0.000763137179673058	0.0270913698783936
9308	cefadroxil	hsa04640	Hematopoietic cell lineage	2814_2811_3122_3123_3126_3127_3125	7	+	0.0277152224658346	0.218642310563806
9309	cefadroxil	hsa05320	Autoimmune thyroid disease	3448_7252_3122_3123_3126_3127_3125	7	+	0.0025594958412659	0.0452733941208343
9310	cefadroxil	hsa04612	Antigen processing and presentation	3811_3448_3122_3123_3806_3126_3127_3125_3802	9	+	0.00351386353225799	0.0452733941208343
9311	cefadroxil	hsa05016	Huntington's disease	4695	1	+	0.0324346734339151	0.230286181380797
9312	cefadroxil	hsa04740	Olfactory transduction	26211_4992_26664	3	+	0.00272160056593352	0.0452733941208343
9313	cefadroxil	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_9103_8294_8341_3122_3123_3126_3127_3125_8370_8359_554313_121504_3018	23	+	2.00246554082997e-09	1.42175053398928e-07
9314	cefadroxil	hsa05310	Asthma	3122_3123_3126_3127_3125	5	+	0.004363490778123	0.0452733941208343
9315	cefadroxil	hsa05330	Allograft rejection	3122_3123_3126_3127_3125	5	+	0.010562565526254	0.0937427690455042
9316	cefadroxil	hsa04940	Type I diabetes mellitus	3382_3122_3123_3126_3127_3125	6	+	0.00446357406825127	0.0452733941208343
9317	cefadroxil	hsa04740	Olfactory transduction	26212	1	-	0.00168483118488983	0.107829195832949
9318	cefadroxil	hsa04710	Circadian rhythm - mammal	8553_8863_79365	3	-	0.00568039866434458	0.181772757259027
9319	cefadroxil	hsa04210	Apoptosis	3556_3553_5575_472_651610_8794	6	-	0.0239811462421497	0.383698339874395
9320	cefadroxil	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_6714_5600_5781_5602	5	-	0.0326477771751018	0.417891547841303
9321	cefadroxil	hsa04912	GnRH signaling pathway	776_4323_5600_5602_3725_6714_107	7	-	0.0183730366072656	0.383698339874395
9322	prednicarbate	hsa05332	Graft-versus-host disease	3105_3106_3107_942_3135_3133_649853	7	+	0.0133486837091565	0.164463459935363
9323	prednicarbate	hsa05320	Autoimmune thyroid disease	7253_3105_3106_3107_942_3135_3133_649853	8	+	0.0138704122837053	0.164463459935363
9324	prednicarbate	hsa05016	Huntington's disease	7802_842_23236	3	+	0.0199491627639235	0.206972563675706
9325	prednicarbate	hsa04740	Olfactory transduction	81697_26211_442194_4991	4	+	1.28744744158805e-05	0.00106858137651808
9326	prednicarbate	hsa04514	Cell adhesion molecules (CAMs)	5010_3383_9672_3105_3106_3107_942_3135_23308_57502_3133_1462_25945_1002_26047_649853	16	+	0.0080988786631581	0.164463459935363
9327	prednicarbate	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_942_8359_8294_8367_554313_121504	15	+	0.0286712043400928	0.264412217803078
9328	prednicarbate	hsa05012	Parkinson's disease	842	1	+	0.0105567225685334	0.164463459935363
9329	prednicarbate	hsa05330	Allograft rejection	3105_3106_3107_942_3135_3133_649853	7	+	0.00844003846644563	0.164463459935363
9330	prednicarbate	hsa04940	Type I diabetes mellitus	3382_3105_3106_3107_942_3135_3133_649853	8	+	0.00534357818599633	0.164463459935363
9331	prednicarbate	hsa04010	MAPK signaling pathway	2122_2005_3551_3925_6788_6416_5881_5533_5607_3725_23542_4763	12	-	0.0222096045484818	1
9332	prednicarbate	hsa04060	Cytokine-cytokine receptor interaction	3572	1	-	0.0479376417565444	1
9333	levopropoxyphene	hsa04640	Hematopoietic cell lineage	960_3566_947_3690_3123_3570_3684_290_1378_3553_3589_3674	12	+	0.00342563587117143	0.0993434402639715
9334	levopropoxyphene	hsa04740	Olfactory transduction	393046_8392_4991	3	+	6.68333019860111e-06	0.000290724863639148
9335	levopropoxyphene	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_6738_8294_121504_8343_8347_8346_8344_8339_3123_8968_55766_8370_8358_8359_8335_8350_8351_8352_8353_8354_8355_8356_8357_3013	34	+	6.7440890594641e-12	5.86735748173377e-10
9336	levopropoxyphene	hsa04664	Fc epsilon RI signaling pathway	8399_5580_5581_8681_3845_5602_5335_100137049_2534_4067	10	+	0.0121767089917677	0.211874736456758
9337	levopropoxyphene	hsa04370	VEGF signaling pathway	8399_5829_8681_3845_7422_5534_5335_6714_100137049	9	+	0.0383231616394407	0.476302151804477
9338	levopropoxyphene	hsa04912	GnRH signaling pathway	8399_5580_4323_1839_2776_3708_8681_3845_5602_5338_6714_100137049_23236	13	+	0.00879114202133729	0.191207338964086
9339	levopropoxyphene	hsa04730	Long-term depression	8399_2776_673_3708_8681_3845_23236_100137049_4067	9	+	0.016818784988074	0.243872382327073
9340	levopropoxyphene	hsa05322	Systemic lupus erythematosus	85235_8969_88_8332_8330_8331_8329_8336	8	-	0.00032905281696969	0.0128330598618179
9341	meprylcaine	hsa05332	Graft-versus-host disease	3811_3553_3119_3802	4	+	0.0321478940074595	0.658132259663601
9342	meprylcaine	hsa04080	Neuroactive ligand-receptor interaction	2911_1816_2913_5733_2846_2563_5030_6915_2688_2689_135_2918_1442	13	+	0.0313622127108521	0.658132259663601
9343	meprylcaine	hsa04740	Olfactory transduction	56656_1258	2	+	0.00324867978194885	0.227407584736419
9344	meprylcaine	hsa04020	Calcium signaling pathway	2911_1816_776_5733_5532_6915_7416_135_5335_2066	10	+	0.0376075576950629	0.658132259663601
9345	meprylcaine	hsa04080	Neuroactive ligand-receptor interaction	1131_2908_1081	3	-	0.0273292870417645	0.710561463085877
9346	meprylcaine	hsa04740	Olfactory transduction	818	1	-	1.16921779339678e-05	0.000911989878849488
9347	meprylcaine	hsa04370	VEGF signaling pathway	9261_1432_10725_11261_5881_7422_5603_5534	8	-	0.0122101211882963	0.476194726343556
9348	cyproterone	hsa04916	Melanogenesis	51176	1	+	0.00690223527384255	0.0698851321476558
9349	cyproterone	hsa05332	Graft-versus-host disease	3824_3553_3119_3113_3107_3126_3127_3125_356_3123_3558	11	+	0.00128973342471327	0.0393079372275277
9350	cyproterone	hsa05010	Alzheimer's disease	3553_6390_4035_4023_6622_517	6	+	0.0310074510937671	0.209300294882928
9351	cyproterone	hsa05320	Autoimmune thyroid disease	3119_7253_3445_3113_3107_3126_3127_3558_356_3123_3125	11	+	0.00605960880366755	0.0698851321476558
9352	cyproterone	hsa04310	Wnt signaling pathway	51176_4772	2	+	0.00145584952694547	0.0393079372275277
9353	cyproterone	hsa05016	Huntington's disease	6390_7416_161_517	4	+	0.00283081691339628	0.0573240424962747
9354	cyproterone	hsa04740	Olfactory transduction	26539_9635_1258_4991	4	+	7.30558192638109e-09	5.91752136036868e-07
9355	cyproterone	hsa04110	Cell cycle	51343_4193	2	+	0.012250712790893	0.110256415118037
9356	cyproterone	hsa04012	ErbB signaling pathway	6714	1	+	0.0208884853586406	0.153815210368172
9357	cyproterone	hsa05310	Asthma	2206_3119_3123_3126_3127_3125_3113	7	+	0.0159568660333926	0.12925061487048
9358	cyproterone	hsa05330	Allograft rejection	3119_3113_3107_3126_3127_3558_356_3123_3125	9	+	0.00612239883546574	0.0698851321476558
9359	cyproterone	hsa04270	Vascular smooth muscle contraction	800_148_185	3	+	0.0345303753048766	0.215150799976539
9360	cyproterone	hsa04940	Type I diabetes mellitus	3553_3119_3113_3107_3126_3127_3558_356_3123_3125	10	+	0.00506599888230497	0.0698851321476558
9361	cyproterone	hsa04080	Neuroactive ligand-receptor interaction	3953_3354_5618_7442_136	5	-	5.49089345485255e-05	0.00155575314554156
9362	cyproterone	hsa04910	Insulin signaling pathway	2002_5584_23265_5257_3551_2319_1977_5575_5562_5291_23433_8835_6720_51763_5290_5602_8651_805_801_31_808	21	-	0.0154564917962013	0.262760360535422
9363	cyproterone	hsa05016	Huntington's disease	1639_513_5978_842_841	5	-	0.00393905225602646	0.0837048604405623
9364	cyproterone	hsa04740	Olfactory transduction	157_801_808_805_409	5	-	1.06819999930038e-08	9.07969999405323e-07
9365	cyproterone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6738_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3014_727	33	-	2.25089834445988e-06	9.56631796395449e-05
9366	cyproterone	hsa05012	Parkinson's disease	7314_513_842_65018	4	-	0.0249468554993811	0.353413786241232
9367	cefoperazone	hsa04740	Olfactory transduction	810	1	+	0.00180505677094514	0.0604694018266622
9368	cefoperazone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_2215_8370_2214_8368_8367_554313_8366_941_8359_8294_720_721_121504_8364	19	+	1.2288049712132e-08	8.23299330712844e-07
9369	cefoperazone	hsa04710	Circadian rhythm - mammal	1454_1408	2	-	0.0104683904688061	0.198899418907316
9370	cefoperazone	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00445999014957349	0.169479625683793
9371	7-aminocephalosporanic acid	hsa04080	Neuroactive ligand-receptor interaction	146_7067_706_4157	4	-	0.0106632900895741	0.215931624313876
9372	7-aminocephalosporanic acid	hsa04612	Antigen processing and presentation	4802_3123_3126_3127_3125_3133_1385_3306_811	9	-	0.0482398352290047	0.563936285179306
9373	7-aminocephalosporanic acid	hsa04740	Olfactory transduction	5613_5616	2	-	3.21906986728639e-06	0.000260744659250198
9374	7-aminocephalosporanic acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_727_3123_8366_3126_3127_3125_8359_8294_8367_554313_8970_121504_8368	20	-	7.69812893786699e-05	0.00311774221983613
9375	7-aminocephalosporanic acid	hsa05012	Parkinson's disease	4694	1	-	0.0223137344919516	0.361482498769616
9376	7-aminocephalosporanic acid	hsa04060	Cytokine-cytokine receptor interaction	5155_8795_2057_3572	4	-	0.00775826724298407	0.20947321556057
9377	7-aminocephalosporanic acid	hsa05330	Allograft rejection	3123_3126_3127_3133_3125	5	-	0.0487352345216684	0.563936285179306
9378	chrysin	hsa04740	Olfactory transduction	26532_5132_1179_4991	4	+	0.00300652124508271	0.234508657116451
9379	chrysin	hsa05322	Systemic lupus erythematosus	3013_8358_88_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	+	0.012586486354381	0.490872967820859
9380	chrysin	hsa05010	Alzheimer's disease	836_842_4712_840_11261_5534_5663_5532_23385_5664_102_8851_4728	13	-	0.0493344797553857	0.374119804811675
9381	chrysin	hsa04080	Neuroactive ligand-receptor interaction	4889_5618_152_64106_5025_5031_2561_136_9170	9	-	4.74845031662291e-06	0.000216054489406342
9382	chrysin	hsa05016	Huntington's disease	5430_836_6648_842_4712_1639_161_3092_4728_1385_163_10126_291	13	-	0.024629012235285	0.320177159058705
9383	chrysin	hsa04740	Olfactory transduction	157	1	-	1.96397099452817e-19	1.78721360502063e-17
9384	chrysin	hsa04530	Tight junction	998_9080_1364_3845_4636_9223_27134	7	-	0.0112822756959284	0.171114514721581
9385	chrysin	hsa04630	Jak-STAT signaling pathway	868_3717_6777_3566_3455_23529_6654_5618_6772_5291	10	-	0.0343797306606199	0.346234516177419
9386	chrysin	hsa05012	Parkinson's disease	836_842_4712_51465_27429_291_4728	7	-	0.0111727411769787	0.171114514721581
9387	chrysin	hsa04260	Cardiac muscle contraction	9254_27092_481_6548	4	-	0.0418525239335341	0.346234516177419
9388	chrysin	hsa04060	Cytokine-cytokine receptor interaction	5618_3554_3566_2324_23529_23765_3455_7852_1956_4982_7042_91	12	-	6.54133651889585e-05	0.00198420541073174
9389	chrysin	hsa03010	Ribosome	6129	1	-	0.000115763510346694	0.00263361986038729
9390	chrysin	hsa03050	Proteasome	23198	1	-	0.0390042657513278	0.346234516177419
9391	chrysin	hsa05210	Colorectal cancer	836_1956_2535_8312_6654_7042_673_4437_4436_3845_6934_324_91_8324_2956_5291_8321_3725_842	19	-	0.0285134311220493	0.324340279013311
9392	acemetacin	hsa05211	Renal cell carcinoma	208_2889_405_5781_4233_3082	6	+	0.0221410181250094	0.698915079332385
9393	acemetacin	hsa05014	Amyotrophic lateral sclerosis (ALS)	5533_2902_317_2890_1432	5	+	0.0279566031732954	0.698915079332385
9394	acemetacin	hsa03450	Non-homologous end-joining	27343_27434_7518	3	+	0.0111354903931327	0.698915079332385
9395	acemetacin	hsa05210	Colorectal cancer	324_4088_208_8312_5602_4233	6	+	0.0407788728609465	0.764603866142747
9396	acemetacin	hsa04916	Melanogenesis	801_23236_808_805_112	5	-	0.0335785774443853	0.240646471684761
9397	acemetacin	hsa04070	Phosphatidylinositol signaling system	56623_808_8821_801_805_23236	6	-	0.00224421122238652	0.096384108897917
9398	acemetacin	hsa04910	Insulin signaling pathway	5576_5315_808_801_3643_805	6	-	0.0313007566437813	0.240646471684761
9399	acemetacin	hsa04720	Long-term potentiation	801_808_805_23236	4	-	0.040803708973087	0.250651355120392
9400	acemetacin	hsa04540	Gap junction	7278_5607_23236_113457_112	5	-	0.0224933931362199	0.240646471684761
9401	acemetacin	hsa04912	GnRH signaling pathway	4323_808_112_801_805_23236	6	-	0.0111435403662025	0.159724078582236
9402	acemetacin	hsa04270	Vascular smooth muscle contraction	808_9826_72_112_801_805_23236	7	-	0.00448298180920544	0.096384108897917
9403	lysergol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	7.83475119017468e-09	3.83902808318559e-07
9404	lysergol	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	-	0.0387154474277209	0.27576079503453
9405	lysergol	hsa04640	Hematopoietic cell lineage	3566_2057_3123_3126_3127_3125	6	-	0.0453783586765682	0.27576079503453
9406	lysergol	hsa04080	Neuroactive ligand-receptor interaction	7067	1	-	0.0110332186257724	0.174324854287204
9407	lysergol	hsa04910	Insulin signaling pathway	5296_5613_5616_5140_23265_51763_5290_5509_572	9	-	0.0218723369384073	0.215989327266772
9408	lysergol	hsa04740	Olfactory transduction	5613_5616_157	3	-	0.0107300944930118	0.174324854287204
9409	lysergol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504_81	19	-	1.28534008952294e-07	1.01541867072312e-05
9410	lysergol	hsa04210	Apoptosis	5296_5613_5534_5616_5290_572_8837	7	-	0.0176527717785624	0.199224138643776
9411	lysergol	hsa04370	VEGF signaling pathway	5829_572_5290_5296_8681_5534_6714_100137049	8	-	0.00249436203255181	0.0985273002857965
9412	lysergol	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.0142425007182266	0.18752625945665
9413	lysergol	hsa04010	MAPK signaling pathway	5534_5613_8681_2005_5616_6196_51776_5606_7042_1386_4616_100137049_9693_27092	14	-	0.0422612415971283	0.27576079503453
9414	lysergol	hsa05330	Allograft rejection	3123_3126_3127_3125	4	-	0.0289301705087286	0.25394260779884
9415	lysergol	hsa05210	Colorectal cancer	4088_572_1856_5296_5900_5290_8312_7042	8	-	0.00408227715930115	0.10749996519493
9416	lysergol	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	-	0.0442348362392566	0.27576079503453
9417	3-nitropropionic acid	hsa04740	Olfactory transduction	7932_5566_23538_26716_2978_81797_26538_393046_816	9	+	5.04840062489941e-08	4.19017251866651e-06
9418	3-nitropropionic acid	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_88_8362_8294_121504_8366_8370_717_8359_554313_8351_3119_83740_3013_3113	23	+	0.0400516816314017	0.664857915081268
9419	3-nitropropionic acid	hsa04530	Tight junction	10000_9071_84612_88_7525_5865	6	+	0.0393203081266753	0.664857915081268
9420	3-nitropropionic acid	hsa04512	ECM-receptor interaction	1278_2814_8515_7148_22798_3381_3690_3691_3685_7057_3371_3918_5649_3688_3696_51206	16	+	0.0214596142165438	0.593715993324378
9421	3-nitropropionic acid	hsa05012	Parkinson's disease	6392_6622_836_651820_7318	5	+	0.0174188641748769	0.593715993324378
9422	3-nitropropionic acid	hsa04120	Ubiquitin mediated proteolysis	7337_4281_7320_8916_55294_7189_331_8065_5371_4193_22888_996_8453_8452_55236_11060_8651_10075_9021_652671	20	-	0.0331238837577636	0.254602469017104
9423	3-nitropropionic acid	hsa05010	Alzheimer's disease	775_3553_6263_2904_351_2081_4137_5532_3708_3709_805_56901_5534_810_4695_801_6622_808_517_4843	20	-	0.00092256694454532	0.0142997876404525
9424	3-nitropropionic acid	hsa04742	Taste transduction	50838_50832_2914_773_112	5	-	0.0442878502359151	0.288518812066549
9425	3-nitropropionic acid	hsa05016	Huntington's disease	4899_7802_4695_9001_2904_7052_1639_581_6667_161_3708_5978_7416_1742_56901_9586_1385_1387_10126_517_5430	21	-	0.000490625353066117	0.0114070394587872
9426	3-nitropropionic acid	hsa04740	Olfactory transduction	219464_26211_26212_7932_56656_23538_5137_808_805_390892_810_801_26529_9635_816_81797	16	-	1.25015085023308e-19	1.16264029071676e-17
9427	3-nitropropionic acid	hsa05322	Systemic lupus erythematosus	55506_8361_8363_8362_8365_8364_8367_2904_8368_8360_88_8329_8294_3109_121504_8341_8370_3123_8366_3126_3127_3125_8969_8968_55766_940_3586_717_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_3018_85235_3119_3013_3115_3113_3111_941	51	-	0.0165039920882317	0.173371934860147
9428	3-nitropropionic acid	hsa04110	Cell cycle	995_8243_5000_5111_993_4088_699_4193_472_996_8556_1870_7042_1031_1387_8555	16	-	0.0355895924432511	0.254602469017104
9429	3-nitropropionic acid	hsa04115	p53 signaling pathway	581_4194_4193_7249_472_5054_3732	7	-	0.0272613098698726	0.253530181789815
9430	3-nitropropionic acid	hsa05110	Vibrio cholerae infection	525_534_4583_23545_5578	5	-	0.0167779291800142	0.173371934860147
9431	3-nitropropionic acid	hsa04062	Chemokine signaling pathway	3717_9475_7852_5880_2829_10235_112_4283_3579_4067_3576_2788_25759_6369_6363_26230_6360_1230_2919_998_2931_2833_4793_6357_6655_6464_6773_3845_2792_5879_10803	31	-	0.0479829146378672	0.288518812066549
9432	3-nitropropionic acid	hsa05012	Parkinson's disease	2861_4695_5413_7416_56901_6622_517	7	-	1.52056128419717e-06	4.71373998101123e-05
9433	3-nitropropionic acid	hsa03010	Ribosome	6165	1	-	1.61271552634388e-08	7.49912719749904e-07
9434	3-nitropropionic acid	hsa03020	RNA polymerase	5430	1	-	0.0322930063754562	0.254602469017104
9435	3-nitropropionic acid	hsa03050	Proteasome	23198	1	-	0.000738940525712472	0.013744293778252
9436	3-nitropropionic acid	hsa04940	Type I diabetes mellitus	3593_2572_940_941_3382_3109_3123_3107_3126_3127_3125_5551_3553_3119_3115_3113_3111_2571_1363_3105_5799_5798	22	-	0.00669155625441776	0.0889021045229788
9437	artemisinin	hsa05322	Systemic lupus erythematosus	85235_3012_8330_3014_8332_8969_8331_8329_8335_8336	10	-	0.000363687939641305	0.0236397160766848
9438	artemisinin	hsa04710	Circadian rhythm - mammal	1454_406	2	-	0.0275027547599472	0.893839529698284
9439	tiletamine	hsa05010	Alzheimer's disease	6392_651820_23236	3	+	0.0138870147331868	0.411981437084542
9440	tiletamine	hsa04740	Olfactory transduction	8390_816	2	+	4.20721062127986e-08	3.74441745293908e-06
9441	tiletamine	hsa04530	Tight junction	3996_5578	2	+	0.0251223950938689	0.447178632670866
9442	tiletamine	hsa04512	ECM-receptor interaction	960_22798_1311_3910_3690_3691_2812_3695_1288_5649_3679_1291	12	+	0.0117689023273415	0.411981437084542
9443	tiletamine	hsa04060	Cytokine-cytokine receptor interaction	6354_10850_3953_4254_2688_2689_7040	7	+	0.0228790041554055	0.447178632670866
9444	tiletamine	hsa04310	Wnt signaling pathway	4040_7157_5613_6477_5616_5602_8945_6093_23236	9	-	0.046514108560092	0.347736532389545
9445	tiletamine	hsa04910	Insulin signaling pathway	2002_5792_5613_5575_5602_5616_5315_8660_208_23265_3845_51763_1398_8835_5105	15	-	2.33640309416377e-05	0.00168221022779791
9446	tiletamine	hsa04740	Olfactory transduction	5613_5616	2	-	0.00234802350074119	0.0845288460266828
9447	tiletamine	hsa04210	Apoptosis	7157_5613_5575_5616_208_598	6	-	0.0494549437757236	0.347736532389545
9448	tiletamine	hsa04920	Adipocytokine signaling pathway	208_8660_1375_5602_4793_5105	6	-	0.0159752316702685	0.287554170064833
9449	tiletamine	hsa04060	Cytokine-cytokine receptor interaction	1436	1	-	0.011554793740963	0.277315049783112
9450	tiletamine	hsa04930	Type II diabetes mellitus	8660_8835_5315_5602	4	-	0.0471514291904047	0.347736532389545
9451	tiletamine	hsa04912	GnRH signaling pathway	5613_5616_2002_3845_5600_5602_23236	7	-	0.0417904817188738	0.347736532389545
9452	clemastine	hsa04080	Neuroactive ligand-receptor interaction	5724	1	+	0.0331976976654081	1
9453	clemastine	hsa04740	Olfactory transduction	26212	1	+	0.00168483118488983	0.111198858202729
9454	clemastine	hsa04540	Gap junction	7278_6714_113457	3	-	0.0239941890652801	0.46443476779531
9455	ginkgolide A	hsa04512	ECM-receptor interaction	3339_3679_7148_2812	4	+	0.0233066287154528	1
9456	ginkgolide A	hsa04080	Neuroactive ligand-receptor interaction	5618_3953_4886_3354_2150_64106	6	-	5.76524768130998e-07	2.62318769499604e-05
9457	ginkgolide A	hsa04740	Olfactory transduction	818_109	2	-	3.03313840499697e-16	2.76015594854724e-14
9458	ginkgolide A	hsa04110	Cell cycle	890_699_4088_983_651610_7157_51343_51433_4089_7534_1017_7531_995_5001_993_9134_4193_10393_7027_8555_1869_5591_4173_1022_472_7465_4999	27	-	0.00245162843705762	0.0557745469430609
9459	ginkgolide A	hsa05012	Parkinson's disease	4714_7327_642502_6391_51465_7385	6	-	0.0120477067947806	0.219268263665007
9460	ginkgolide A	hsa03010	Ribosome	6160_51187	2	-	0.00177339659248146	0.0537930299719376
9461	chenodeoxycholic acid	hsa04740	Olfactory transduction	816_4991	2	+	0.00676250366967799	0.419275227520035
9462	chenodeoxycholic acid	hsa04662	B cell receptor signaling pathway	10892_7410_4775_3845	4	-	0.0246603445782762	1
9463	cortisone	hsa04910	Insulin signaling pathway	5584_5256_5599_208_867_5296	6	+	0.0222495235012161	0.447704652286887
9464	cortisone	hsa04012	ErbB signaling pathway	5599_208_6777_867_5296_6714	6	+	0.00284462562404852	0.156454409322669
9465	cortisone	hsa05220	Chronic myeloid leukemia	5296_208_6777_867	4	+	0.0318208850365318	0.447704652286887
9466	cortisone	hsa05214	Glioma	1869_5578_5155_5336	4	-	0.0415443252087035	0.6612804986721
9467	cortisone	hsa04664	Fc epsilon RI signaling pathway	9846_8399_5578_5608_5336	5	-	0.0213972780346546	0.6612804986721
9468	nimodipine	hsa05010	Alzheimer's disease	6392_651820_3553_4842	4	+	0.0260035582841507	0.646413158342059
9469	nimodipine	hsa05016	Huntington's disease	7052_6392_651820_1213_64446	5	+	0.0449631597910161	0.708328597179749
9470	nimodipine	hsa04740	Olfactory transduction	26211_818_5137_4991_26539_9635	6	+	1.80250741024842e-05	0.00151410622460867
9471	nimodipine	hsa05012	Parkinson's disease	6392_651820	2	+	0.0175254614172016	0.646413158342059
9472	nimodipine	hsa04940	Type I diabetes mellitus	3553_3117_3113_3630_3558_356_5551	7	+	0.0307815789686695	0.646413158342059
9473	salbutamol	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.0109374500510871	0.144405397147556
9474	salbutamol	hsa04640	Hematopoietic cell lineage	3690_3123_3126_3127_3125_7850_915_931	8	+	0.000425354566621468	0.0242452102974237
9475	salbutamol	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	+	0.0225657874464626	0.183749983492624
9476	salbutamol	hsa04612	Antigen processing and presentation	3123_3126_3127_972_3125	5	+	0.0327673253664167	0.233467193235719
9477	salbutamol	hsa04514	Cell adhesion molecules (CAMs)	965_3123_3126_3127_3125_26285_5817	7	+	0.0176281792676423	0.167467703042602
9478	salbutamol	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.00370519273161166	0.105597992850932
9479	salbutamol	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.00795323177364811	0.144405397147556
9480	salbutamol	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	+	0.0126671401006628	0.144405397147556
9481	salbutamol	hsa05200	Pathways in cancer	367_9063_6934_841_581_8554_6777_5155_1613_5290_1857_7043_5914_91_3655_2260_2263_3725	18	-	0.0257153433297005	0.475733851599459
9482	salbutamol	hsa04740	Olfactory transduction	26211_157_409	3	-	0.0038143365401303	0.141130451984821
9483	salbutamol	hsa05322	Systemic lupus erythematosus	3013_8358_8968_720_721_8350_8351_8352_8353_8354_8355_8356_8357	13	-	0.000972092841226022	0.0719348702507256
9484	salbutamol	hsa05210	Colorectal cancer	6934_581_5290_1857_7043_91_3725	7	-	0.0204517771783139	0.475733851599459
9485	pentolonium	hsa05200	Pathways in cancer	2271_2335_5578_861_5371_5155_4254_998_51384_2260_6257_2251	12	+	0.0142018207385492	0.608830750160642
9486	pentolonium	hsa04740	Olfactory transduction	51806	1	+	0.0224968487047365	0.608830750160642
9487	pentolonium	hsa03450	Non-homologous end-joining	2547_10111	2	+	0.0276741250073019	0.608830750160642
9488	pentolonium	hsa04740	Olfactory transduction	219464_5566	2	-	4.54372625797698e-06	0.000386216731928043
9489	pentolonium	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8367_554313_8359_8337_720_721_121504_8294	17	-	0.00154903026402314	0.0658337862209834
9490	pentolonium	hsa04630	Jak-STAT signaling pathway	8554	1	-	0.0105809722867453	0.299794214791117
9491	pentolonium	hsa04062	Chemokine signaling pathway	5331_5566_7409	3	-	0.0365608829178807	0.621535009603972
9492	pentolonium	hsa04060	Cytokine-cytokine receptor interaction	8744_7042_5155_8795_2324	5	-	0.0352452193081526	0.621535009603972
9493	mephenesin	hsa05332	Graft-versus-host disease	3123_3458_942_3127_3111_3126_3125	7	+	0.000116172914720499	0.00212015569364911
9494	mephenesin	hsa04640	Hematopoietic cell lineage	3690_3123_3126_3127_3125_915_914_4254	8	+	0.0014956673997067	0.015597674311227
9495	mephenesin	hsa05320	Autoimmune thyroid disease	3448_3126_942_3127_3111_3125_3123	7	+	0.000421679279669517	0.00615651748317495
9496	mephenesin	hsa04612	Antigen processing and presentation	3448_3123_3126_3127_3111_3125_5994	7	+	0.00649374146504705	0.0592553908685543
9497	mephenesin	hsa04514	Cell adhesion molecules (CAMs)	3123_3126_3127_3111_3125_57863_914_942	8	+	0.0165565796716607	0.134292257336803
9498	mephenesin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_3458_3126_3127_3111_3125_8359_8294_8367_554313_8368_121504_942	21	+	1.59781866586298e-10	1.16640762607998e-08
9499	mephenesin	hsa05310	Asthma	3123_3126_3127_3111_3125	5	+	0.00113094447088521	0.0137598243957701
9500	mephenesin	hsa05330	Allograft rejection	3123_3458_942_3127_3111_3126_3125	7	+	6.63502399656599e-05	0.00161452250583106
9501	mephenesin	hsa04940	Type I diabetes mellitus	3123_3458_3126_3127_3111_3125_942_5799	8	+	2.15739230671002e-05	0.000787448191949157
9502	mephenesin	hsa04740	Olfactory transduction	5568	1	-	2.44818437039473e-06	0.000193406565261184
9503	mephenesin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8370_94239_8366_8364_8368_6737_3014_8359_8337_8367_554313_121504_8294	18	-	9.29528638547756e-05	0.00367163812226364
9504	mephenesin	hsa04710	Circadian rhythm - mammal	1408_5187_8863	3	-	0.0247729051180836	0.391411900865721
9505	mephenesin	hsa05221	Acute myeloid leukemia	2475_5292_5371_5290_11040_5914_652671	7	-	0.0167145928184272	0.330113208163937
9506	mephenesin	hsa04060	Cytokine-cytokine receptor interaction	8792_4982_3455	3	-	0.0104000068576302	0.273866847250929
9507	nitrofurantoin	hsa05322	Systemic lupus erythematosus	942_720_721_8343_8339_8347_8346_8344	8	+	0.00754614540211149	0.347739449486122
9508	nitrofurantoin	hsa04610	Complement and coagulation cascades	2155_721_7056_720_1378	5	+	0.0122013841924955	0.347739449486122
9509	nitrofurantoin	hsa04810	Regulation of actin cytoskeleton	5829_2934_5155_54961_8394_7430_324_2263_2260_4638_8396_3675	12	-	0.037726249581818	0.780279097816686
9510	nitrofurantoin	hsa04060	Cytokine-cytokine receptor interaction	8792_5155	2	-	0.0361135259445193	0.780279097816686
9511	ofloxacin	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.0299963009279617	0.395419883570611
9512	ofloxacin	hsa04640	Hematopoietic cell lineage	960_3690_3123_3568_3126_3127_3125	7	+	0.0105227836662301	0.248812190784771
9513	ofloxacin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_721_3126_3127_3125_8359_8294_720_554313_8368_121504_8367	20	+	6.93532089185108e-09	4.78537141537725e-07
9514	ofloxacin	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0108179213384683	0.248812190784771
9515	ofloxacin	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.0222683035457838	0.384128236164771
9516	ofloxacin	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	+	0.0343843377017923	0.395419883570611
9517	ofloxacin	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	-	0.0135761521560388	0.188317210350176
9518	ofloxacin	hsa04070	Phosphatidylinositol signaling system	8503_5578_8394_3633_8760_23236	6	-	0.00616674750823317	0.178379830528054
9519	ofloxacin	hsa04650	Natural killer cell mediated cytotoxicity	8503_3383_5578_3105_6655_3135_7409_3106	8	-	0.00943580568770239	0.178379830528054
9520	ofloxacin	hsa05320	Autoimmune thyroid disease	3135_3105_3106_649853	4	-	0.0277190432989178	0.24947138969026
9521	ofloxacin	hsa04612	Antigen processing and presentation	3135_3105_3106_6892_649853	5	-	0.0413561719350206	0.330849375480165
9522	ofloxacin	hsa04740	Olfactory transduction	818_5568	2	-	0.0257045878584627	0.24947138969026
9523	ofloxacin	hsa04540	Gap junction	5568_5578_7278_113457_5607_6655_23236	7	-	0.00404691148191705	0.178379830528054
9524	ofloxacin	hsa05330	Allograft rejection	3135_3105_3106_649853	4	-	0.00990999058489191	0.178379830528054
9525	ofloxacin	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853	4	-	0.0156931008625147	0.188317210350176
9526	clemizole	hsa02010	ABC transporters	6891_26154_10347	3	+	0.0258839882020161	1
9527	clemizole	hsa05010	Alzheimer's disease	3708_489_23236	3	-	0.019084235353758	0.316798306872383
9528	clemizole	hsa04080	Neuroactive ligand-receptor interaction	5021_5618_2149_2917	4	-	0.00211351212409973	0.0877107531501388
9529	clemizole	hsa04740	Olfactory transduction	109_157	2	-	1.36502988869434e-07	1.1329748076163e-05
9530	clemizole	hsa05322	Systemic lupus erythematosus	85235_3123_8330_3126_3127_3125_8332_727_8969_8331_8336_8337_8343_8329_8339_8347_8346_8344	18	-	0.00406852599296231	0.112562552471957
9531	clemizole	hsa04530	Tight junction	27134	1	-	0.0071245416383225	0.147834238995192
9532	mebendazole	hsa04740	Olfactory transduction	5593	1	+	0.000261394934177306	0.0190818301949433
9533	mebendazole	hsa04514	Cell adhesion molecules (CAMs)	9076_4684_3383_3119_3111_23308_940_1003_5817	9	+	0.0225697530777649	0.823795987338419
9534	mebendazole	hsa04940	Type I diabetes mellitus	940_3382_3119_3111	4	+	0.0489522246225092	1
9535	mebendazole	hsa05332	Graft-versus-host disease	3552_3123_3106_3126_3127_3125_5551	7	-	0.0467647370182853	0.601216666565662
9536	mebendazole	hsa04080	Neuroactive ligand-receptor interaction	4889_5618_1081_2917_3953_5031_3354_7067_2740_2690	10	-	0.0475662346837006	0.601216666565662
9537	mebendazole	hsa04740	Olfactory transduction	5613_5616	2	-	8.24109034098234e-10	7.33457040347428e-08
9538	mebendazole	hsa05012	Parkinson's disease	509_65018	2	-	0.00601679779828154	0.178498334682352
9539	mebendazole	hsa04060	Cytokine-cytokine receptor interaction	5618_3552_2057_3953_6387_8792_2690	7	-	0.00304259107656203	0.13539530290701
9540	mebendazole	hsa03010	Ribosome	6205	1	-	0.00983719748871166	0.218877644123834
9541	mebendazole	hsa04940	Type I diabetes mellitus	3552_3123_3106_3126_3127_2571_5551_3125	8	-	0.0233501729109057	0.415633077814122
9542	kawain	hsa04740	Olfactory transduction	8387_816_8388	3	+	0.036825562734066	1
9543	kawain	hsa04080	Neuroactive ligand-receptor interaction	2901_4157_1081_2918_2908_3953	6	-	0.0430307494992151	0.501652187225165
9544	kawain	hsa04740	Olfactory transduction	818_5568	2	-	6.47678786241026e-07	5.69957331892103e-05
9545	kawain	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_6738_121504	15	-	0.0161837315230874	0.474722791343897
9546	kawain	hsa05012	Parkinson's disease	7332	1	-	0.0156459484185018	0.474722791343897
9547	kawain	hsa04060	Cytokine-cytokine receptor interaction	3953_3572_4982_7042_91_4233	6	-	0.0324406657100716	0.501652187225165
9548	kawain	hsa03020	RNA polymerase	5432_246721_5439_548644_84172	5	-	0.0259947783444182	0.501652187225165
9549	sulfadimidine	hsa05211	Renal cell carcinoma	23533_2549_5155_7042_5879_4233	6	+	0.0308445059255046	0.488472279514121
9550	sulfadimidine	hsa04662	B cell receptor signaling pathway	23533_8519_5881_5534_5879_4793	6	+	0.0361831318158608	0.488472279514121
9551	sulfadimidine	hsa05010	Alzheimer's disease	5534	1	+	0.0461044334915349	0.500458665658571
9552	sulfadimidine	hsa04740	Olfactory transduction	5566_26212_8392	3	+	0.0038143365401303	0.288297447250916
9553	sulfadimidine	hsa04360	Axon guidance	55558_57715_57556_6585_5881_9037_5534_6093_5879_4233	10	+	0.0106776832315154	0.288297447250916
9554	sulfadimidine	hsa04210	Apoptosis	23533_581_5566_330_472_5534_8837_5575	8	+	0.00917499764329316	0.288297447250916
9555	sulfadimidine	hsa05218	Melanoma	23533_27006_5155_5925_1950_4233	6	+	0.0291866570109206	0.488472279514121
9556	sulfadimidine	hsa04740	Olfactory transduction	26212	1	-	1.16921779339678e-05	0.000444302761490776
9557	sulfadimidine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_85235_8364_8370_8366_8368_8365_8330_8332_8359_8969_8331_8329_8336_8367_554313_121504_8294	21	-	5.727563194951e-07	4.35294802816276e-05
9558	ethoxyquin	hsa05214	Glioma	208_6655_5154_5293_818_5925	6	+	0.00843218864987576	0.119560689573673
9559	ethoxyquin	hsa05211	Renal cell carcinoma	10298_208_6655_5293_7422_5781	6	+	0.0131007100962756	0.119560689573673
9560	ethoxyquin	hsa04640	Hematopoietic cell lineage	3581_960_3552_3690_4254_1438	6	+	0.0286386377646164	0.127267233488099
9561	ethoxyquin	hsa05200	Pathways in cancer	1613_861_208_6655_862_331_5154_1438_4254_5925_7422_5602_5293_2064_2251_2249	16	+	0.0205710016958984	0.127267233488099
9562	ethoxyquin	hsa04740	Olfactory transduction	818	1	+	0.00121196596094889	0.0770602001828468
9563	ethoxyquin	hsa04510	Focal adhesion	10298_3690_208_6655_331_5154_1277_88_7422_5602_5293_6093_2064	13	+	0.00335044348621073	0.0770602001828468
9564	ethoxyquin	hsa05212	Pancreatic cancer	208_6655_5154_5293_5925_2064	6	+	0.0313556952072127	0.127267233488099
9565	ethoxyquin	hsa05215	Prostate cancer	208_6655_5154_5293_5925_2064	6	+	0.0299769603479611	0.127267233488099
9566	ethoxyquin	hsa05221	Acute myeloid leukemia	861_208_6655_862_5293	5	+	0.0214981720976079	0.127267233488099
9567	ethoxyquin	hsa05219	Bladder cancer	5925_2064_1613_7422	4	+	0.0272620256474809	0.127267233488099
9568	ethoxyquin	hsa05218	Melanoma	208_5293_5154_5925_2249_2251	6	+	0.0123430468813957	0.119560689573673
9569	ethoxyquin	hsa04012	ErbB signaling pathway	10298_208_6655_5293_818_5602_2064	7	+	0.00900990654222658	0.119560689573673
9570	ethoxyquin	hsa05223	Non-small cell lung cancer	208_6655_2064_5293_5925	5	+	0.0155948725530878	0.119560689573673
9571	ethoxyquin	hsa04630	Jak-STAT signaling pathway	3581_5618_3561_208_6655_5293_1438_3572_3451_5781_1489	11	+	0.00295064323299736	0.0770602001828468
9572	ethoxyquin	hsa04060	Cytokine-cytokine receptor interaction	3581_5618_3561_3552_6357_5154_1438_3572_3451_7422_4254_83729_1489	13	+	0.0276650119008973	0.127267233488099
9573	ethoxyquin	hsa04912	GnRH signaling pathway	1432_6655_2798_818_108_5602_4323	7	+	0.0249294466257896	0.127267233488099
9574	ethoxyquin	hsa05220	Chronic myeloid leukemia	861_208_6655_5293_5925_5781	6	+	0.0155682952498662	0.119560689573673
9575	ethoxyquin	hsa04662	B cell receptor signaling pathway	3725_6655_4793_27071_5534	5	-	0.00383084931634373	0.107263780857624
9576	ethoxyquin	hsa05322	Systemic lupus erythematosus	85235_8969_8332_8330_8331_8329_720_721_8336	9	-	0.000168541011694811	0.00943829665490942
9577	ethoxyquin	hsa05221	Acute myeloid leukemia	6932_6655_5371	3	-	0.0468696557811671	0.715840738325068
9578	piperacillin	hsa05332	Graft-versus-host disease	3123_3126_3127_3111_3125	5	+	0.048912689389978	0.420649128753811
9579	piperacillin	hsa04640	Hematopoietic cell lineage	3581_3815_3690_3123_2993_3126_3127_3125_921_1378_4254_3684_925	13	+	0.000315012458940506	0.0270910714688835
9580	piperacillin	hsa05010	Alzheimer's disease	3708_317	2	+	0.036932652520056	0.37445388308969
9581	piperacillin	hsa05320	Autoimmune thyroid disease	3444_3126_3127_3111_3125_3123	6	+	0.039187034276828	0.37445388308969
9582	piperacillin	hsa04740	Olfactory transduction	8387_8388_5568_816_26716	5	+	0.00124173199604789	0.0533944758300593
9583	piperacillin	hsa04514	Cell adhesion molecules (CAMs)	8174_3383_3123_3126_3127_3111_3125_23308_3684_3897_6693_923_925_5817	14	+	0.00580913494646499	0.124896401348997
9584	piperacillin	hsa05310	Asthma	3123_3126_3127_3111_3125	5	+	0.0156409612150278	0.269024532898478
9585	piperacillin	hsa05012	Parkinson's disease	317	1	+	0.0316621542107996	0.37445388308969
9586	piperacillin	hsa05330	Allograft rejection	3123_3126_3127_3111_3125	5	+	0.035195623303488	0.37445388308969
9587	piperacillin	hsa04940	Type I diabetes mellitus	3382_3123_3126_3127_3111_3125_5799	7	+	0.00561561581726081	0.124896401348997
9588	piperacillin	hsa04740	Olfactory transduction	5137	1	-	0.000371330881796415	0.0116969227765871
9589	piperacillin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_720_721	23	-	1.29228359068039e-10	8.14138662128646e-09
9590	spiramycin	hsa04740	Olfactory transduction	5566_8392_1258_4991	4	+	0.00418898730951529	0.163370505071096
9591	spiramycin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_717_8368_3113_9103_8359_8294_8367_554313_121504	17	+	3.88861493731545e-05	0.00303311965110605
9592	spiramycin	hsa04080	Neuroactive ligand-receptor interaction	2901_3360_1812	3	-	0.019613604298542	0.454698384459618
9593	spiramycin	hsa04520	Adherens junction	7082_25945_6932_88_7046_2064_8976	7	-	0.0441716101022505	0.689077117595108
9594	spiramycin	hsa04740	Olfactory transduction	5137_219464_26212	3	-	0.000345338413610747	0.0134681981308191
9595	spiramycin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3013_554313_8330_8359_88_8294_8367_8351_8368_121504	18	-	3.47275431984407e-05	0.00270874836947837
9596	spiramycin	hsa04115	p53 signaling pathway	55367_25898_581_5268_3486_472_651610	7	-	0.023317865869724	0.454698384459618
9597	mephentermine	hsa04512	ECM-receptor interaction	961_3339_3912_1282	4	+	0.0355584624613818	0.589653821110626
9598	mephentermine	hsa04912	GnRH signaling pathway	5599_5331_6655_1956_5600	5	+	0.0216624984151512	0.589653821110626
9599	mephentermine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0187805315042843	0.807562854684225
9600	fenbufen	hsa05010	Alzheimer's disease	6622_348_3710	3	+	0.00503694782278958	0.107035141234279
9601	fenbufen	hsa04740	Olfactory transduction	5593_26333_5566_442194_818_8392_816	7	+	2.01881646421513e-05	0.00171599399458286
9602	fenbufen	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8370_83740_3117_8368_8366_8360_8359_8362_8294_8367_554313_121504_3119_81_729	21	+	0.00205387218478223	0.0641371514655777
9603	fenbufen	hsa04110	Cell cycle	699_7042	2	+	0.0243019530838103	0.413133202424775
9604	fenbufen	hsa04630	Jak-STAT signaling pathway	3717_3446_200734_867	4	+	0.0475030780551074	0.672960272447355
9605	fenbufen	hsa05012	Parkinson's disease	6622	1	+	0.00226366416937333	0.0641371514655777
9606	fenbufen	hsa04080	Neuroactive ligand-receptor interaction	1131_7433	2	-	0.00114501822674585	0.0282437829263976
9607	fenbufen	hsa04740	Olfactory transduction	219464	1	-	5.26258584084046e-07	3.89431352222194e-05
9608	fenbufen	hsa04514	Cell adhesion molecules (CAMs)	26047	1	-	0.0329705430010584	0.406636697013054
9609	fenbufen	hsa05322	Systemic lupus erythematosus	55506_8361_8363_8362_8365_8364_8370_8360_8368_8366_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	20	-	4.81731685631449e-05	0.00178240723683636
9610	fenbufen	hsa04210	Apoptosis	651610_841_5575_5534_331_472_8717_8837_1677	9	-	0.0432422941742579	0.457132824127869
9611	fenbufen	hsa04062	Chemokine signaling pathway	6655_1399	2	-	0.0132020642425157	0.24423818848654
9612	fenbufen	hsa05012	Parkinson's disease	7419	1	-	0.0218711894234331	0.32369360346681
9613	trimethoprim	hsa04740	Olfactory transduction	5566_5568_157	3	-	5.84458444109862e-05	0.00473411339728988
9614	trimethoprim	hsa05322	Systemic lupus erythematosus	727	1	-	0.0219866634645818	0.890459870315563
9615	trimethoprim	hsa04920	Adipocytokine signaling pathway	8517_3953_208_5562_2182_1375_1374	7	-	0.0384075109900098	1
9616	hydroxyzine	hsa05131	Shigellosis	7278_6093_7430_113457	4	+	0.00651312949961022	0.172597931739671
9617	hydroxyzine	hsa05130	Pathogenic Escherichia coli infection	7278_6093_7430_113457	4	+	0.00651312949961022	0.172597931739671
9618	hydroxyzine	hsa04130	SNARE interactions in vesicular transport	8773_8417_6844	3	-	0.023948950307044	1
9619	chlorhexidine	hsa04740	Olfactory transduction	816	1	+	8.72043599175699e-05	0.0031829591369913
9620	chlorhexidine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_958_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3113	23	+	3.54161952712459e-09	2.58538225480095e-07
9621	chlorhexidine	hsa05322	Systemic lupus erythematosus	8353_8344_8347_8346_8358_8343_8968_3013_8350_8351_8352_8339_8354_8355_8356_8357	16	-	6.30227570600476e-08	3.08811509594233e-06
9622	ciprofloxacin	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	0.000532594753041708	0.0319556851825025
9623	ciprofloxacin	hsa04310	Wnt signaling pathway	5331_4040_51701_10725_818_1454_5332_5534_8945_3725	10	-	0.00269749244155168	0.0784017654545346
9624	ciprofloxacin	hsa04740	Olfactory transduction	818	1	-	0.00360324432158554	0.0784017654545346
9625	ciprofloxacin	hsa04370	VEGF signaling pathway	10725_8681_5600_5534_100137049_7422	6	-	0.00904091951693623	0.146914942150214
9626	ciprofloxacin	hsa04010	MAPK signaling pathway	51701_23162_51776_1956_8681_5600_5534_5494_3725_100137049_4791_11221	12	-	0.0344750483187299	0.448175628143489
9627	ciprofloxacin	hsa04912	GnRH signaling pathway	5331_818_1956_5332_8681_5600_3725_100137049	8	-	0.00361854302097852	0.0784017654545346
9628	dehydrocholic acid	hsa05332	Graft-versus-host disease	3812_3824_3108_3804_3107_3126_3127_3125_5551_3123_3553	11	+	5.69114408882164e-05	0.00161249082516613
9629	dehydrocholic acid	hsa04650	Natural killer cell mediated cytotoxicity	3812_23533_3824_3449_2215_3804_3107_5293_27040_5551_80329_5534_8794_2534	14	+	0.0371337551517904	0.263030765658515
9630	dehydrocholic acid	hsa05320	Autoimmune thyroid disease	3108_3123_3107_3126_3127_3125_5551_7038_3449	9	+	0.00384093459331957	0.0652958880864327
9631	dehydrocholic acid	hsa04612	Antigen processing and presentation	3812_3824_3449_3123_3107_3126_3127_3125_3804_3108	10	+	0.0340381518383035	0.263022082386891
9632	dehydrocholic acid	hsa04740	Olfactory transduction	26707_442194	2	+	6.91737757125794e-07	5.87977093556925e-05
9633	dehydrocholic acid	hsa04514	Cell adhesion molecules (CAMs)	965_3108_3123_4099_3107_3126_3127_3125_3676_57863_933_923_25945_26047	14	+	0.0220254680771112	0.263022082386891
9634	dehydrocholic acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8341_3108_3123_3126_3127_3125_8370_8359_554313_6738_121504_2215	22	+	3.3156814442034e-05	0.00140916461378645
9635	dehydrocholic acid	hsa04110	Cell cycle	51343	1	+	0.0325610532046194	0.263022082386891
9636	dehydrocholic acid	hsa04530	Tight junction	6714_4622	2	+	0.0492719536777308	0.29915114732908
9637	dehydrocholic acid	hsa05310	Asthma	3123_3125_3108_3127_3126	5	+	0.0305198306182683	0.263022082386891
9638	dehydrocholic acid	hsa04512	ECM-receptor interaction	1278_7148_3690_1289_3371_1277_1290_3676_3339_3674	10	+	0.0279068478373705	0.263022082386891
9639	dehydrocholic acid	hsa04930	Type II diabetes mellitus	775_23533_776_5293_9021_3651	6	+	0.0433430915249374	0.283397136893821
9640	dehydrocholic acid	hsa05330	Allograft rejection	3108_3123_3107_3126_3127_3125_5551	7	+	0.00708242799425951	0.100334396585343
9641	dehydrocholic acid	hsa04940	Type I diabetes mellitus	3108_2572_3107_3126_3127_3125_5551_3123_3553	9	+	0.00125712523822071	0.0267139113121901
9642	dehydrocholic acid	hsa04080	Neuroactive ligand-receptor interaction	7434	1	-	8.22585264351846e-05	0.00341372884706016
9643	dehydrocholic acid	hsa04740	Olfactory transduction	818_810_409	3	-	9.56689293925422e-06	0.0007940521139581
9644	azacyclonol	hsa04070	Phosphatidylinositol signaling system	23533	1	+	0.0202336486029253	0.203365868383147
9645	azacyclonol	hsa03320	PPAR signaling pathway	2710	1	+	0.0288661524200525	0.204083374210941
9646	azacyclonol	hsa05010	Alzheimer's disease	2902_836_317_9451_6868_5534_7124	7	+	0.0215328566523332	0.203365868383147
9647	azacyclonol	hsa05016	Huntington's disease	836_2902_6875_2033_317	5	+	0.00147499756352417	0.0313436982248886
9648	azacyclonol	hsa04740	Olfactory transduction	4991_817	2	+	1.64173064926758e-12	6.97735525938721e-11
9649	azacyclonol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_8349_8348_8329_8294_121504_8343_8341_8347_8352_8345_8344_8339_723790_8346_8969_8968_55766_8370_92815_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_7124_8353_8354_8355_8356_8357_8332_3018_85235_85236_3012_3013_3017_8970	53	+	5.40676947505291e-15	4.59575405379497e-13
9650	azacyclonol	hsa04710	Circadian rhythm - mammal	8553_8864_9572_5187_79365	5	+	0.0135472042595288	0.164501766008564
9651	azacyclonol	hsa05212	Pancreatic cancer	2308_1026_468_23533_4790_4824_5155_4193_5925_2033_7039_5970_2950_7184_4792	15	+	0.0312127513499086	0.204083374210941
9652	azacyclonol	hsa05215	Prostate cancer	2308_1026_468_23533_4790_4824_5155_4193_5925_2033_7039_5970_2950_7184_4792	15	+	0.0297821720627936	0.204083374210941
9653	azacyclonol	hsa04530	Tight junction	6709_24146_5584_1364	4	+	0.0132341348833971	0.164501766008564
9654	azacyclonol	hsa04810	Regulation of actin cytoskeleton	23533_1131_5155_3684_7430_2264_7414_3985_10458_2251	10	+	0.028565330653393	0.204083374210941
9655	azacyclonol	hsa05012	Parkinson's disease	836_317	2	+	0.000942573193089041	0.0267062404708562
9656	azacyclonol	hsa03010	Ribosome	6129_6144	2	+	0.0115484997228871	0.164501766008564
9657	azacyclonol	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8336	7	-	0.0162609059772748	0.910610734727389
9658	cyproheptadine	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	+	0.00318624100038684	0.0508713233759585
9659	cyproheptadine	hsa05320	Autoimmune thyroid disease	3135_3105_3106_649853	4	+	0.00689325190586788	0.0706558320351458
9660	cyproheptadine	hsa04612	Antigen processing and presentation	3135_3105_3106_649853	4	+	0.035411462860373	0.222674791328228
9661	cyproheptadine	hsa04514	Cell adhesion molecules (CAMs)	3135_3105_3106_5817_649853	5	+	0.0380176472999414	0.222674791328228
9662	cyproheptadine	hsa04710	Circadian rhythm - mammal	8553_9572	2	+	0.0165087278462059	0.135371568338888
9663	cyproheptadine	hsa05330	Allograft rejection	3135_3105_3106_649853	4	+	0.00227687423481183	0.0508713233759585
9664	cyproheptadine	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853	4	+	0.00372229195433843	0.0508713233759585
9665	oleandomycin	hsa05332	Graft-versus-host disease	3135_3105_3106_942_649853	5	+	0.0314566789136558	0.403694046058583
9666	oleandomycin	hsa05320	Autoimmune thyroid disease	3105_3106_3441_3135_942_649853	6	+	0.0234478501348479	0.387057817702149
9667	oleandomycin	hsa04740	Olfactory transduction	7932_1179	2	+	6.09045163559817e-05	0.00468964775941059
9668	oleandomycin	hsa04514	Cell adhesion molecules (CAMs)	6402_24146_8174_1462_3106_942_3135_6383_3105_923_649853	11	+	0.0251336245261136	0.387057817702149
9669	oleandomycin	hsa05330	Allograft rejection	3135_3105_3106_942_649853	5	+	0.022292340762543	0.387057817702149
9670	oleandomycin	hsa04940	Type I diabetes mellitus	3105_3106_942_2571_3135_649853	6	+	0.010962079804096	0.387057817702149
9671	oleandomycin	hsa04080	Neuroactive ligand-receptor interaction	7434_146_1812	3	-	0.00738298358596369	0.575872719705168
9672	edrophonium chloride	hsa05332	Graft-versus-host disease	57292_3123_3126_3127_3125_3558	6	+	0.00123199470368838	0.0830127564878371
9673	edrophonium chloride	hsa05320	Autoimmune thyroid disease	3449_3123_3126_3127_3558_3125	6	+	0.00359219900335636	0.0830127564878371
9674	edrophonium chloride	hsa04612	Antigen processing and presentation	57292_3449_3123_3126_3127_3125	6	+	0.0328839725494275	0.338235146222683
9675	edrophonium chloride	hsa04740	Olfactory transduction	9635_816	2	+	0.00461181980487984	0.0830127564878371
9676	edrophonium chloride	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0101509305162457	0.121811166194948
9677	edrophonium chloride	hsa05330	Allograft rejection	3123_3558_3126_3127_3125	5	+	0.00433817317759251	0.0830127564878371
9678	edrophonium chloride	hsa04940	Type I diabetes mellitus	3123_3558_3126_3127_3125	5	+	0.00760530219701878	0.10951635163707
9679	edrophonium chloride	hsa04740	Olfactory transduction	818_157	2	-	0.0360231891259302	0.459363382767417
9680	edrophonium chloride	hsa04920	Adipocytokine signaling pathway	5599_2180_7186_3551_4793	5	-	0.0123377829671812	0.434781163737357
9681	edrophonium chloride	hsa04010	MAPK signaling pathway	836_3551_5599_4763_2002_6789_5607_2005_5494_6300_7186_4616	12	-	0.0126023525720973	0.434781163737357
9682	Prestwick-860	hsa04740	Olfactory transduction	81696_5568_4992_81797_390892	5	+	0.00123526173880991	0.0975856773659829
9683	Prestwick-860	hsa05322	Systemic lupus erythematosus	3013_3458_3014_8358_88_8968_8350_8351_8352_8353_8354_8355_8356_8357	14	+	0.00847994790637562	0.334957942301837
9684	Prestwick-860	hsa05218	Melanoma	23533_8817_1956_2249_2260_2251_3082	7	+	0.0479462111713006	0.820554805241412
9685	Prestwick-860	hsa04512	ECM-receptor interaction	1278_3910_2812_3695_3371_7057_5649_3918_3674	9	+	0.0173355287104967	0.45650225604308
9686	Prestwick-860	hsa04080	Neuroactive ligand-receptor interaction	9568_7434_56288_7067_7068	5	-	0.000620334804050013	0.0285354009863006
9687	Prestwick-860	hsa04670	Leukocyte transendothelial migration	5829_50848_5603	3	-	0.0478757220100437	0.734094404154003
9688	Prestwick-860	hsa04740	Olfactory transduction	157_5566_808_409_810_801_805	7	-	7.62146159541228e-06	0.00070117446677793
9689	Prestwick-860	hsa04510	Focal adhesion	5829_6655_7422_3675	4	-	0.00202149112100523	0.0619923943774937
9690	Prestwick-860	hsa04012	ErbB signaling pathway	6655	1	-	0.0302311550659102	0.556253253212748
9691	Prestwick-860	hsa05012	Parkinson's disease	4712_7054_517	3	-	0.0255730514215023	0.556253253212748
9692	luteolin	hsa04740	Olfactory transduction	2979	1	+	0.0161038528923037	0.442855954538352
9693	luteolin	hsa05322	Systemic lupus erythematosus	8353_2215_8344_8348_8347_3017_8346_8358_8343_8968_8334_3013_8350_8351_8352_8339_8354_8355_8356_8357	20	+	9.20984566487172e-12	5.06541511567945e-10
9694	luteolin	hsa04080	Neuroactive ligand-receptor interaction	152_1081_64106_5031_2561_136_2690_2149_9170	9	-	7.02196300243042e-05	0.00323010298111799
9695	luteolin	hsa05016	Huntington's disease	4714_5430_836_842_6667_3092_2033_1385_1387	9	-	0.00805362605485435	0.125587629988052
9696	luteolin	hsa04740	Olfactory transduction	5613_157	2	-	1.13610270877396e-15	1.04521449207204e-13
9697	luteolin	hsa05322	Systemic lupus erythematosus	718_3123_3126_3127_3014_3125_6738	7	-	0.0204875944248212	0.269265526726222
9698	luteolin	hsa04330	Notch signaling pathway	2648_182_4854_1856_5663_2033_5664_113878_23220_1387_8850	11	-	0.0440049969362408	0.471790110632246
9699	luteolin	hsa04512	ECM-receptor interaction	1289_7059_1605	3	-	0.0461533803879371	0.471790110632246
9700	luteolin	hsa05012	Parkinson's disease	4714_2861_836_51465_842	5	-	0.00681599193023647	0.125587629988052
9701	luteolin	hsa04060	Cytokine-cytokine receptor interaction	3554_3566_3552_3454_3455_23529_8771_3625_4254_8741_2057_7042_8718_4233_2690	15	-	0.00819049760791645	0.125587629988052
9702	luteolin	hsa03010	Ribosome	6125	1	-	0.000402323804733556	0.0123379300118291
9703	profenamine	hsa04740	Olfactory transduction	26476	1	+	0.0109000558948094	0.374111120697518
9704	profenamine	hsa04514	Cell adhesion molecules (CAMs)	8516_4099_5797_23308_933_923_25945	7	+	0.0159196221573412	0.374111120697518
9705	profenamine	hsa05131	Shigellosis	7278_7454_113457	3	-	0.031339049311662	0.344729542428282
9706	profenamine	hsa05016	Huntington's disease	5432_246721_581_1639_5439_9001_548644	7	-	0.00773723301054579	0.170219126232007
9707	profenamine	hsa05130	Pathogenic Escherichia coli infection	7278_7454_113457	3	-	0.031339049311662	0.344729542428282
9708	profenamine	hsa04810	Regulation of actin cytoskeleton	7454_8394_8396_3693_2245_2260	6	-	0.0477887611990288	0.420541098551453
9709	profenamine	hsa03020	RNA polymerase	5432_246721_5439_548644	4	-	0.000553917136493837	0.0243723540057288
9710	equilin	hsa04740	Olfactory transduction	7932	1	+	5.49452380751087e-05	0.00240767208147667
9711	equilin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_718_8368_8366_8359_8294_8367_554313_121504_3119	16	+	6.09537235816879e-05	0.00240767208147667
9712	equilin	hsa04510	Focal adhesion	7424	1	-	0.0322578403729541	1
9713	equilin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	19	-	1.35551561717063e-07	9.21750619676028e-06
9714	equilin	hsa04062	Chemokine signaling pathway	8976	1	-	0.0462519561762898	1
9715	3-acetylcoumarin	hsa04740	Olfactory transduction	26476_56656_26212	3	+	0.0196168897490016	0.766787526501961
9716	3-acetylcoumarin	hsa04664	Fc epsilon RI signaling pathway	23533_5319_5579_2207_5320_5609	6	+	0.0196612186282554	0.766787526501961
9717	3-acetylcoumarin	hsa04730	Long-term depression	2911_5319_5579_3708_5320	5	+	0.0416397341365514	1
9718	3-acetylcoumarin	hsa04740	Olfactory transduction	5566	1	-	8.14787051303021e-05	0.00513315842320903
9719	3-acetylcoumarin	hsa04115	p53 signaling pathway	55367_27113_5366_7057_3732_8795_4616	7	-	0.0100917921808286	0.317891453696101
9720	3-acetylcoumarin	hsa04512	ECM-receptor interaction	7059_960_1302_3693_7057_9672_3675	7	-	0.0250923673611126	0.526939714583365
9721	3-acetylcoumarin	hsa04540	Gap junction	1813_7278_5155_113457_5607_6714_5566	7	-	0.0391497815326004	0.616609059138456
9722	hymecromone	hsa05332	Graft-versus-host disease	3811_3553_3123_3126_3127_3125_3802	7	+	0.0078941344057182	0.153057313538415
9723	hymecromone	hsa04640	Hematopoietic cell lineage	3581_3566_3123_3126_3127_3125_3574_3553_925	9	+	0.0473053804824483	0.409979964181219
9724	hymecromone	hsa04310	Wnt signaling pathway	7855_5534	2	+	0.0352613803616647	0.384607377306944
9725	hymecromone	hsa04910	Insulin signaling pathway	208	1	+	0.0151069055603085	0.19638977228401
9726	hymecromone	hsa05016	Huntington's disease	7052_3708	2	+	0.00907642214610259	0.153057313538415
9727	hymecromone	hsa04740	Olfactory transduction	26659_5592_4995_8590_442186	5	+	0.000237526985276061	0.0100027502309074
9728	hymecromone	hsa05322	Systemic lupus erythematosus	2903_8361_8363_8362_8365_8364_8370_8360_3123_8366_3126_3127_3125_8359_8294_8367_554313_8368_121504	19	+	0.000256480775151473	0.0100027502309074
9729	hymecromone	hsa05340	Primary immunodeficiency	23495_29851_5788_925_5896	5	+	0.0394469104930199	0.384607377306944
9730	hymecromone	hsa04940	Type I diabetes mellitus	3553_3126_2572_3127_2571_3123_3125	7	+	0.00981136625246247	0.153057313538415
9731	hymecromone	hsa04080	Neuroactive ligand-receptor interaction	64106_2561	2	-	0.0261980179881082	0.491212837277029
9732	hymecromone	hsa04740	Olfactory transduction	810_109	2	-	0.00078985576061552	0.059239182046164
9733	hymecromone	hsa04010	MAPK signaling pathway	4217_9479_4149_6788_5534_1649_4763_8074_5607_2122_5600_10454_2263_2260_4616_776_408	17	-	0.00923130302667045	0.346173863500142
9734	hymecromone	hsa04060	Cytokine-cytokine receptor interaction	268_2057	2	-	0.0184350019871029	0.460875049677572
9735	midecamycin	hsa05014	Amyotrophic lateral sclerosis (ALS)	7133_5600_5534	3	+	0.0414230311177255	0.813727311402164
9736	midecamycin	hsa04010	MAPK signaling pathway	782_1846_8822_4763_5600_5534_3725_5971_4791	9	+	0.0113585702676333	0.567928513381665
9737	midecamycin	hsa05210	Colorectal cancer	5599_3725_4233_8322	4	-	0.0403225188875528	1
9738	moroxydine	hsa04010	MAPK signaling pathway	4214_57551_3554_1844_5534_5971_5609	7	+	0.0419243103692358	1
9739	moroxydine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00309579621395973	0.0773949053489933
9740	pempidine	hsa05010	Alzheimer's disease	54205_6622_5534	3	+	0.0137790643623457	0.585610235399692
9741	pempidine	hsa04670	Leukocyte transendothelial migration	5010_1432_2909_998_27035_5293_7852_93408_7410_7430_51208_2185_6093_3676	14	+	0.036609763742053	1
9742	pempidine	hsa04740	Olfactory transduction	817_8392_390892	3	+	4.8922711456346e-07	4.15843047378941e-05
9743	pempidine	hsa05010	Alzheimer's disease	51806_836_841_2081_3708_351_5534_810_517	9	-	0.0303399543766233	0.300028437724386
9744	pempidine	hsa04080	Neuroactive ligand-receptor interaction	5029_146_2555_64106_1131_2908	6	-	7.54254877831518e-06	0.000335643420635026
9745	pempidine	hsa04612	Antigen processing and presentation	3305_3107_3119	3	-	0.0456995554515524	0.369750948653469
9746	pempidine	hsa05016	Huntington's disease	1213_4899_6648_841_3092_3708_836_517	8	-	0.00872328651966079	0.0970465625312263
9747	pempidine	hsa04740	Olfactory transduction	810_51806	2	-	2.35133061644476e-14	2.09268424863584e-12
9748	pempidine	hsa04514	Cell adhesion molecules (CAMs)	3688_3107_3119_5817	4	-	0.00485054977991207	0.0731405989547681
9749	pempidine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_8337_554313_6738_121504_85235_3119_3014_720_721	27	-	0.00740463579415695	0.0941446550971384
9750	pempidine	hsa04110	Cell cycle	5001_8556_51433_993_8555	5	-	0.0421223253507185	0.369750948653469
9751	pempidine	hsa05012	Parkinson's disease	836_51465_7054_517	4	-	0.00493082689582706	0.0731405989547681
9752	pempidine	hsa04260	Cardiac muscle contraction	4635	1	-	0.00419741266662754	0.0731405989547681
9753	pempidine	hsa03010	Ribosome	9045	1	-	0.000927744572887749	0.0275230889956699
9754	eldeline	hsa05332	Graft-versus-host disease	3109_3105_3106_3107_3135_649853	6	+	0.00558962812340212	0.129912347009926
9755	eldeline	hsa05320	Autoimmune thyroid disease	3109_3105_3106_3107_3135_649853	6	+	0.0150207054796258	0.20086767970016
9756	eldeline	hsa04740	Olfactory transduction	81697	1	+	3.99693686251026e-05	0.0030376720155078
9757	eldeline	hsa04350	TGF-beta signaling pathway	6667_1634_7057_3626_10637_1387_83729_10468	8	+	0.0158579747131705	0.20086767970016
9758	eldeline	hsa05330	Allograft rejection	3109_3105_3106_3107_3135_649853	6	+	0.00360413597261946	0.129912347009926
9759	eldeline	hsa04940	Type I diabetes mellitus	3109_3105_3106_3107_3135_649853	6	+	0.00683749194789083	0.129912347009926
9760	eldeline	hsa04740	Olfactory transduction	818_26212	2	-	6.73242077216911e-07	5.06067856092877e-05
9761	eldeline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8370_8332_8359_8330_8331_8336_554313_8351_85235_3013_720_721	25	-	1.21944061709127e-06	5.06067856092877e-05
9762	eldeline	hsa04062	Chemokine signaling pathway	6655_1399_6773	3	-	0.0196002462916603	0.542273480735935
9763	eldeline	hsa05012	Parkinson's disease	4698_517	2	-	0.0489777755887249	1
9764	atovaquone	hsa05332	Graft-versus-host disease	3119_3123_3107_3126_3127_3111_3125	7	+	0.00719966824670917	0.0746965580596076
9765	atovaquone	hsa04640	Hematopoietic cell lineage	1435_2811_2812_3123_3568_3126_3127_3125_947	9	+	0.0446755611951428	0.337097416290623
9766	atovaquone	hsa05010	Alzheimer's disease	4713	1	+	0.00348557965357896	0.0482171852078423
9767	atovaquone	hsa05320	Autoimmune thyroid disease	958_3119_3123_3107_3126_3127_3111_3125	8	+	0.0070524201797535	0.0746965580596076
9768	atovaquone	hsa05016	Huntington's disease	55567_4713	2	+	0.0133165620367677	0.110527464905172
9769	atovaquone	hsa04740	Olfactory transduction	26211_2978_5568_1258	4	+	7.36801677141426e-05	0.00611545392027384
9770	atovaquone	hsa04514	Cell adhesion molecules (CAMs)	8516_958_3384_3695_3119_3123_3107_3126_3127_3111_3125_5818_947_1462	14	+	0.00996540423412181	0.0919031723813456
9771	atovaquone	hsa05322	Systemic lupus erythematosus	958_3119_3123_3013_3126_3127_3111_3125_8358_8968_8341_8350_8351_8352_8353_8354_8355_8356_8357	19	+	0.000205538914525041	0.0085298649527892
9772	atovaquone	hsa05310	Asthma	958_3119_3123_3126_3127_3111_3125	7	+	0.00139552693658859	0.0289571839342132
9773	atovaquone	hsa05330	Allograft rejection	958_3119_3123_3107_3126_3127_3111_3125	8	+	0.00114916174349149	0.0289571839342132
9774	atovaquone	hsa04940	Type I diabetes mellitus	3119_3123_3107_3126_3127_3111_3125_3630	8	+	0.0025955544859447	0.043086204466682
9775	atovaquone	hsa04640	Hematopoietic cell lineage	928_3554_960_3552_1604	5	-	0.020880332226966	0.172737293877628
9776	atovaquone	hsa04080	Neuroactive ligand-receptor interaction	5618_3953_2908_4886_2150_2690	6	-	2.25669066648848e-10	1.02679425325226e-08
9777	atovaquone	hsa04742	Taste transduction	5567	1	-	0.00509290852171595	0.0662078107823073
9778	atovaquone	hsa05320	Autoimmune thyroid disease	3135_355	2	-	0.0282971020554093	0.214586357253521
9779	atovaquone	hsa04740	Olfactory transduction	801_808_5567_805	4	-	4.9919647577544e-20	4.5426879295565e-18
9780	atovaquone	hsa04514	Cell adhesion molecules (CAMs)	965_4685_3685_3135_9019_1001	6	-	0.000441709497281189	0.00803911285051764
9781	atovaquone	hsa05322	Systemic lupus erythematosus	6738_6632_55766_8357	4	-	9.49006473131933e-06	0.000215898972637515
9782	atovaquone	hsa04110	Cell cycle	4089_4085_983_9184_1871_7157_545_7534_1017_7531_7533_9133_5001_5000_990_10393_7027_7042_8243_5591_1027_1031_1022_472_5934_10926_8556_1387_7465	29	-	0.0404128318508319	0.282889822955823
9783	atovaquone	hsa04260	Cardiac muscle contraction	9167_7168_7381_488	4	-	0.0111348801853161	0.112586010762641
9784	atovaquone	hsa04060	Cytokine-cytokine receptor interaction	3556_5618_3554_3597_3552_3953_3459_355_3572_6387_7422_7042_90_2690	14	-	4.71734790189439e-06	0.000143092886357463
9785	atovaquone	hsa03010	Ribosome	51187_6125_6168_6160_28998_6171	6	-	0.0106905950382312	0.112586010762641
9786	atovaquone	hsa04020	Calcium signaling pathway	5257_5567_808_7220_5530_7416_805_488_5332_801_7419_5481_23236	13	-	0.00227435795355553	0.0344944289622589
9787	atovaquone	hsa02010	ABC transporters	20	1	-	0.0165633352804932	0.150726351052488
9788	strophanthidin	hsa04640	Hematopoietic cell lineage	948_3123_3569_3126_3127_3125_920_3655_1604	9	+	0.0435979431567499	0.469042575116582
9789	strophanthidin	hsa04080	Neuroactive ligand-receptor interaction	2846_7067_2908_1812	4	+	0.010621332806307	0.287078988456951
9790	strophanthidin	hsa04740	Olfactory transduction	26212_56656	2	+	3.04256849592389e-06	0.000124745308332879
9791	strophanthidin	hsa04514	Cell adhesion molecules (CAMs)	9076_3123_3126_3127_3125_5817_57863_5792_920_3655_9080_1000	12	+	0.0457602512308861	0.469042575116582
9792	strophanthidin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6738_8349_8294_121504_8343_8347_8346_8344_8339_723790_3123_3126_3127_3125_8968_8370_8358_8359_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	38	+	2.19855743853454e-15	1.80281709959832e-13
9793	strophanthidin	hsa05310	Asthma	3123_3125_3126_3596_3127	5	+	0.0213914714512434	0.350820131800392
9794	strophanthidin	hsa04350	TGF-beta signaling pathway	4092_1311_3397_3399_3398_7057_3400_7042_6093_92	10	+	0.014003853095461	0.287078988456951
9795	strophanthidin	hsa04620	Toll-like receptor signaling pathway	8503_5599_3569_3441_5600_2353_3725_5609_4792_7187	10	+	0.0391760367672099	0.469042575116582
9796	strophanthidin	hsa04650	Natural killer cell mediated cytotoxicity	6655_5295_7409_7410_355_10451_6452_5335_5058_5534_5551	11	-	0.0478435776832013	0.171132797097605
9797	strophanthidin	hsa04640	Hematopoietic cell lineage	960_3566_3570_2057_2812	5	-	0.0282738804214875	0.138393204168334
9798	strophanthidin	hsa05010	Alzheimer's disease	842_841_8772_317_355_5534_8851_7132_23236	9	-	0.000365065749870746	0.00377234608199771
9799	strophanthidin	hsa04080	Neuroactive ligand-receptor interaction	4157_2561_1131_7434_5021_136	6	-	1.7550702847345e-09	8.16107682401543e-08
9800	strophanthidin	hsa05320	Autoimmune thyroid disease	355_5551	2	-	0.0411853006045735	0.166531867661971
9801	strophanthidin	hsa04670	Leukocyte transendothelial migration	5295_7410_1500_9475_10451_7409_5600_5335	8	-	0.0174825809337876	0.0903266681579026
9802	strophanthidin	hsa05016	Huntington's disease	842_841_1639_317_5468_7419_5481_23236	8	-	5.41624774948124e-05	0.000839518401169592
9803	strophanthidin	hsa04740	Olfactory transduction	5613_109_5616_157	4	-	1.91737737688657e-18	1.78316096050451e-16
9804	strophanthidin	hsa04514	Cell adhesion molecules (CAMs)	214_1272	2	-	2.16604024248757e-06	5.81065110813571e-05
9805	strophanthidin	hsa04510	Focal adhesion	5295_2324_1793_208_6655_3693_5155_5154_9475_2002_10451_23396_5058_7410_7409_4233	16	-	0.00837347291525829	0.0519155320746014
9806	strophanthidin	hsa05322	Systemic lupus erythematosus	55506_55766_3021_3020	4	-	3.17029843817274e-05	0.00058967550950013
9807	strophanthidin	hsa03410	Base excision repair	55247_143_5427_4968_5423_7515_8930_10038_4595_27343_3980	11	-	0.045619997837177	0.171132797097605
9808	strophanthidin	hsa04530	Tight junction	9223_208_8189_27134_5581	5	-	0.00021227561946844	0.00246770407632062
9809	strophanthidin	hsa05219	Bladder cancer	4609	1	-	0.0372436408079886	0.164936123578235
9810	strophanthidin	hsa04720	Long-term potentiation	5613_23236_5616_5534	4	-	0.0410154393030862	0.166531867661971
9811	strophanthidin	hsa04512	ECM-receptor interaction	3339_3693_960_2812	4	-	0.0156114262954181	0.0903266681579026
9812	strophanthidin	hsa04630	Jak-STAT signaling pathway	3717_6778_2057_598_6655_5295_3570_6772_208_10379_4609_8835_3566	13	-	0.047782718134304	0.171132797097605
9813	strophanthidin	hsa04062	Chemokine signaling pathway	2785_3717_157_3551_5613_6655_5295_5616_7410_6772_9475_10451_109_7409_208_5058_23236	17	-	0.0370910946062012	0.164936123578235
9814	strophanthidin	hsa05012	Parkinson's disease	7419_317_842_5481_5413	5	-	0.000212182092342863	0.00246770407632062
9815	strophanthidin	hsa04260	Cardiac muscle contraction	10479_4635	2	-	0.00160239417252131	0.0135475143676802
9816	strophanthidin	hsa04060	Cytokine-cytokine receptor interaction	27242_3566_2057_2324_5155_5154_3570_657_355_90_7132_4233	12	-	2.49920477769278e-06	5.81065110813571e-05
9817	strophanthidin	hsa03010	Ribosome	6125_6168_284393_389342_9349	5	-	0.00832723640611204	0.0519155320746014
9818	strophanthidin	hsa04020	Calcium signaling pathway	5021_5613_1131_5616_7220_109_5335_136_5534_7419_3707_5481_23236	13	-	0.00693210363951056	0.0495912029595755
9819	strophanthidin	hsa03050	Proteasome	23198	1	-	0.0170912393075328	0.0903266681579026
9820	strophanthidin	hsa04730	Long-term depression	23236	1	-	0.00111745147971006	0.0103922987613036
9821	strophanthidin	hsa04610	Complement and coagulation cascades	7056_5329	2	-	0.00680371189094116	0.0495912029595755
9822	suramin sodium	hsa04120	Ubiquitin mediated proteolysis	89910_4214	2	+	0.0491765115801639	0.656034865043572
9823	suramin sodium	hsa05010	Alzheimer's disease	1329_56901_5664	3	+	0.036428561939959	0.656034865043572
9824	suramin sodium	hsa04080	Neuroactive ligand-receptor interaction	6915_7068_2740_56288_1813	5	+	0.0197370607621039	0.53947966083084
9825	suramin sodium	hsa04740	Olfactory transduction	818	1	+	6.88033223892746e-08	2.82093621796026e-06
9826	suramin sodium	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_8362_8329_8294_121504_8366_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_83740_3013_940	37	+	1.06887530072018e-13	8.76477746590548e-12
9827	suramin sodium	hsa05012	Parkinson's disease	1329_56901	2	+	0.0489478699930636	0.656034865043572
9828	suramin sodium	hsa05214	Glioma	51806_2475_5578_6655_5295_5155_4193_808_5335_7039_801_805	12	-	0.013092477016394	0.290854759176078
9829	suramin sodium	hsa04740	Olfactory transduction	51806_26716_808_4991_801_805	6	-	1.87042903774235e-07	1.64597755321327e-05
9830	suramin sodium	hsa05322	Systemic lupus erythematosus	2903_8361_8363_8362_8365_8364_8367_8360_8368_554313_8329_8294_8342_3108_6737_8366_8969_8370_8332_8359_8330_8331_8336_8335_121504_8354_85235_3012_8970	29	-	2.62400493155188e-05	0.00115456216988283
9831	suramin sodium	hsa05012	Parkinson's disease	642502_6391_7416	3	-	0.0132206708716399	0.290854759176078
9832	caffeic acid	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8336_8329	7	+	1.01008640866897e-08	4.04034563467588e-08
9833	caffeic acid	hsa04650	Natural killer cell mediated cytotoxicity	3455_3107_5336	3	-	0.0362437110478001	0.464968669897581
9834	caffeic acid	hsa05223	Non-small cell lung cancer	11186_5336	2	-	0.0338407529540894	0.464968669897581
9835	desoxycortone	hsa04062	Chemokine signaling pathway	8976	1	-	0.0462184469517304	1
9836	desoxycortone	hsa04060	Cytokine-cytokine receptor interaction	5618_7040	2	-	0.036128038080735	1
9837	rolipram	hsa05320	Autoimmune thyroid disease	3451_3107_3111_7253	4	+	0.0119992351606711	0.383975525141475
9838	rolipram	hsa05322	Systemic lupus erythematosus	3013_3111_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	+	5.74414790132111e-06	0.000367625465684551
9839	rolipram	hsa05210	Colorectal cancer	91_208_5900_3725	4	+	0.0490205259932409	0.93056734864392
9840	rolipram	hsa04080	Neuroactive ligand-receptor interaction	5618	1	-	0.00527775454804701	0.197915795551763
9841	rolipram	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_958_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235	22	-	7.96385095571984e-09	5.97288821678988e-07
9842	rolipram	hsa04020	Calcium signaling pathway	5331	1	-	0.048772510771545	1
9843	idazoxan	hsa04662	B cell receptor signaling pathway	11025_974_4772_4793	4	+	0.035124364816477	0.95461448827725
9844	idazoxan	hsa04310	Wnt signaling pathway	5578_4088_4772_5602_5528_816	6	+	0.0376779643463043	0.95461448827725
9845	idazoxan	hsa05200	Pathways in cancer	1869_3845	2	-	0.0184034051165758	1
9846	(-)-atenolol	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8336	7	+	0.0402969042114527	0.779073481421419
9847	(-)-atenolol	hsa04010	MAPK signaling pathway	8913	1	+	0.0322693842099533	0.779073481421419
9848	(-)-atenolol	hsa05217	Basal cell carcinoma	83439_11211_8321_81029	4	+	0.0353260000973448	0.779073481421419
9849	(-)-atenolol	hsa05211	Renal cell carcinoma	8453_7042_2271_10298_5293	5	-	0.0454581576046267	1
9850	(-)-atenolol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_958_8359_8294_8367_554313_121504	15	-	1.18782518599446e-05	0.000867112385775956
9851	betamethasone	hsa05322	Systemic lupus erythematosus	720_721	2	+	0.0306669202466917	0.222301661078669
9852	betamethasone	hsa04610	Complement and coagulation cascades	720_721	2	+	0.00783253921143698	0.125320627382992
9853	betamethasone	hsa04740	Olfactory transduction	5566	1	-	0.0318206650307395	0.779606293253118
9854	betamethasone	hsa05322	Systemic lupus erythematosus	3013_8343_8351_8339_8347_8346_8344	7	-	0.00728034952380141	0.356737126666269
9855	dexibuprofen	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_2209_8359_8294_8367_554313_8368_121504_3119	16	+	1.3937612389206e-08	9.89570479633626e-07
9856	dexibuprofen	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0287892258044374	1
9857	promethazine	hsa05332	Graft-versus-host disease	3135_3105_3106_5551_649853	5	+	0.00240806034298386	0.041155236924774
9858	promethazine	hsa04650	Natural killer cell mediated cytotoxicity	5605_3383_3105_3106_3135_27040_5551	7	+	0.0268857527520474	0.190888844539537
9859	promethazine	hsa05200	Pathways in cancer	5605_4088_4149_5337_3551_861_331_6776_5371_867_1857_8822_7479_405_3918_2260_1387	17	+	0.000660384657254821	0.041155236924774
9860	promethazine	hsa05320	Autoimmune thyroid disease	3135_3105_3106_5551_649853	5	+	0.00602335046227053	0.0610939832601725
9861	promethazine	hsa04740	Olfactory transduction	5593_9635	2	+	0.0256440793243306	0.190888844539537
9862	promethazine	hsa04510	Focal adhesion	7059_7148_1301_3691_331_3918_1281_55742_1277	9	+	0.0416127407806092	0.268591326856659
9863	promethazine	hsa05221	Acute myeloid leukemia	5605_861_6776_5371_3551	5	+	0.00910155350518242	0.080776287358494
9864	promethazine	hsa04512	ECM-receptor interaction	7059_1281_1301_3691_3918_7148_1277	7	+	0.0023184966196554	0.041155236924774
9865	promethazine	hsa05330	Allograft rejection	3135_3105_3106_5551_649853	5	+	0.00161227153053433	0.041155236924774
9866	promethazine	hsa04940	Type I diabetes mellitus	3135_3105_3106_5551_649853	5	+	0.00289825612146296	0.041155236924774
9867	promethazine	hsa05220	Chronic myeloid leukemia	3551_4088_6776_867_5605_861	6	+	0.00567951568475236	0.0610939832601725
9868	promethazine	hsa05200	Pathways in cancer	3655_367	2	-	0.018589053227057	0.887638529995374
9869	urapidil	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.00483789808292157	0.0552457679457323
9870	urapidil	hsa04640	Hematopoietic cell lineage	3123_3126_3127_3125_7850_947_924	7	+	0.00050621997200347	0.02480477862817
9871	urapidil	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	+	0.0103203923767226	0.0842832044099012
9872	urapidil	hsa04514	Cell adhesion molecules (CAMs)	3123_3126_3127_3125_947_23562	6	+	0.0185815706777033	0.130070994743923
9873	urapidil	hsa05322	Systemic lupus erythematosus	3123_3126_3127_3125_8341_8340	6	+	0.0251109267217339	0.15380442617062
9874	urapidil	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.00157935880593914	0.0386942907455089
9875	urapidil	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.00347500448965308	0.0552457679457323
9876	urapidil	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	+	0.0056373232597686	0.0552457679457323
9877	urapidil	hsa04360	Axon guidance	1949_10298_998_1944_9475_5534_5998	7	-	0.0493312954670551	1
9878	urapidil	hsa04060	Cytokine-cytokine receptor interaction	2057	1	-	0.0227623134722793	1
9879	dizocilpine	hsa05332	Graft-versus-host disease	57292_3553_3123_3107_3126_3127_3125	7	+	0.00254534115973224	0.0888594337799342
9880	dizocilpine	hsa04640	Hematopoietic cell lineage	1436_3553_3123_3126_3127_1438_3125_3570_920	9	+	0.0115780973503802	0.236387152748718
9881	dizocilpine	hsa05010	Alzheimer's disease	3553	1	+	0.0160261878076356	0.236387152748718
9882	dizocilpine	hsa04612	Antigen processing and presentation	57292_3123_3107_3126_3127_3125_5994_920	8	+	0.0333674403718449	0.276949755086313
9883	dizocilpine	hsa04520	Adherens junction	7454_7082_5881_10580_5795_1956_91_3643	8	+	0.0199362658944702	0.236387152748718
9884	dizocilpine	hsa04740	Olfactory transduction	157	1	+	5.36052581078401e-06	0.000444923642295073
9885	dizocilpine	hsa05322	Systemic lupus erythematosus	85235_3123_3126_3127_3125_8332_8969_8331_8336_8337_8329_8330	12	+	0.0195222056859972	0.236387152748718
9886	dizocilpine	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0405482261223165	0.305954797104752
9887	dizocilpine	hsa04350	TGF-beta signaling pathway	4090_656_3400_654_353500_91_6093_268	8	+	0.0299621810592695	0.276317891991041
9888	dizocilpine	hsa05330	Allograft rejection	3123_3107_3126_3127_3125	5	+	0.0240077606502642	0.249080516746491
9889	dizocilpine	hsa04940	Type I diabetes mellitus	3553_3126_3107_2572_3127_3125_3123	7	+	0.00321178676313015	0.0888594337799342
9890	dizocilpine	hsa04130	SNARE interactions in vesicular transport	9570_8417_2054_8675_6809	5	-	0.0172653492286683	0.34313924262538
9891	dizocilpine	hsa04080	Neuroactive ligand-receptor interaction	2561	1	-	0.00170136297021252	0.137810400587214
9892	dizocilpine	hsa05200	Pathways in cancer	1436_868_2737_4149_5594_9134_8074_331_999_4193_2335_1613_405_5291_2271_6934_5899_3725_1017_3675	20	-	0.037966232484036	0.390558654388317
9893	dizocilpine	hsa05131	Shigellosis	7280_347733_999_60_7534_2017	6	-	0.0219382674339038	0.34313924262538
9894	dizocilpine	hsa04660	T cell receptor signaling pathway	1739_868_5594_11261_5291_6885_3725_6300_4793	9	-	0.0385736942605745	0.390558654388317
9895	dizocilpine	hsa05130	Pathogenic Escherichia coli infection	7280_347733_999_60_7534_2017	6	-	0.0219382674339038	0.34313924262538
9896	dizocilpine	hsa04110	Cell cycle	995_9134_4173_699_4193_51433_472_7534_1017_7531	10	-	0.0254177216759541	0.34313924262538
9897	dizocilpine	hsa05219	Bladder cancer	5594_4193_999_1613_7057	5	-	0.0245491622895959	0.34313924262538
9898	dizocilpine	hsa05222	Small cell lung cancer	4149_2335_9134_331_5291_1017_3675	7	-	0.046483434204511	0.414119606334455
9899	mianserin	hsa05332	Graft-versus-host disease	3135_3105_3106_3108_649853	5	+	0.0129928250955661	0.240065807481842
9900	mianserin	hsa05320	Autoimmune thyroid disease	3108_3105_3106_3446_3135_649853	6	+	0.00832110641894418	0.233587130159997
9901	mianserin	hsa04740	Olfactory transduction	7932	1	+	0.000183438351176054	0.0143081913917322
9902	mianserin	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	7082_1839_998_10392_5603_23545	6	+	0.0280523293551174	0.364680281616526
9903	mianserin	hsa05330	Allograft rejection	3135_3105_3106_3108_649853	5	+	0.00898412039076912	0.233587130159997
9904	mianserin	hsa04940	Type I diabetes mellitus	3135_3105_3106_3108_649853	5	+	0.0153888338129386	0.240065807481842
9905	mianserin	hsa04740	Olfactory transduction	109	1	-	0.010723060181307	0.300245685076596
9906	mianserin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	1.08305301233164e-06	6.06509686905718e-05
9907	fluticasone	hsa05016	Huntington's disease	2776	1	+	0.0223671112428054	0.861133782848008
9908	fluticasone	hsa04740	Olfactory transduction	5566	1	+	5.55331539843723e-05	0.00427605285679667
9909	fluticasone	hsa03022	Basal transcription factors	2957_51616	2	-	0.0381423713732074	0.922166294762137
9910	valproic acid	hsa04120	Ubiquitin mediated proteolysis	23327_10277_7328_23759_330_9246_23221_652671_6923_4281_7320_55294_51343_5371_7329_389898_326_26232_4193_8651_8453_9820_8554_8450_868_7322_6502_11060_57154_7428	30	+	0.0385033847640527	0.255772484504064
9911	valproic acid	hsa05010	Alzheimer's disease	2902_3710_317_9451_2776_5330_6622_3553_4698_11261_23621_348_4842_776_54205_5532_6868_489_5534_1020_4714_842_841_840_6390_4137_351_823	28	+	0.000153045730830194	0.00355831324180201
9912	valproic acid	hsa04080	Neuroactive ligand-receptor interaction	1129_2901_1268_887_2902_64106_3360_2908_2925_153_553_3062_55879_134_9038_1902_5646_1812_1813_5645_3953_3362_1133_2150_7433_9568_186_1394_5023_5028_2914_719_2917_2918_1132_1131_3355_6915_3351_10203_5733_3269_23566_57105_2550_5618_4157_4158_4160_2893_680_1241_2740_2798_728_2692_2149_8698	58	+	0.009685794622802	0.0818889909018715
9913	valproic acid	hsa05016	Huntington's disease	2902_55081_317_246721_2776_5330_5430_6648_7052_1639_6667_7416_2033_581_54205_9001_163_4714_27019_842_841_6390_5440_3092_5978_4698_9519	27	+	1.38751828142245e-05	0.00043013066724096
9914	valproic acid	hsa04740	Olfactory transduction	26211_26333_5566_5567_2979_2978_1179_818_5137_26476_26532_4992_409_26539_81797_26529_393046_816_3000	19	+	1.3347943337805e-27	1.24135873041587e-25
9915	valproic acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8294_8341_3586_3123_3458_3126_3127_3125_8370_717_8359_554313_121504_3109_2212_3119_3113_3017_940_8970_729	31	+	0.0337836104448465	0.241682751643902
9916	valproic acid	hsa04110	Cell cycle	51343_5111_4616_699_5925_10912_1032_2033_1017_995_5000_2810_993_898_4193_8556_7040_8555_1021_1022_6502_1029_1028_7465	24	+	0.0312668082826954	0.241682751643902
9917	valproic acid	hsa04530	Tight junction	5590_4301_5583_5581_50848_5578_5584_50855_998_4633_93408_84612_51776_3845_208_5865_26285_9223_6714_10627	20	+	0.000353429567265652	0.00657378995114113
9918	valproic acid	hsa03030	DNA replication	5111_5558	2	+	0.00380130319971249	0.0441901496966577
9919	valproic acid	hsa04062	Chemokine signaling pathway	3717_5567_3718_5290_5291_7852_5604_10235_112_6359_2785_4283_2786_3551_7074_5566_3576_2788_7410_5293_409_208_998_3627_2931_108_2185_107_4793_5590_5330_6774_6655_6358_6773_51764_3845_6370_8976	39	+	0.00546848759142816	0.0522634109031591
9920	valproic acid	hsa05012	Parkinson's disease	4714_2861_842_7314_6390_54205_317_9246_4698_7345_7416_65018_27429_6622	14	+	2.2678000267593e-06	0.000105452701244307
9921	valproic acid	hsa04260	Cardiac muscle contraction	784_7168_776_6262_781_782_9254_786_6548_7139_4635_27092	12	+	0.00561972160249022	0.0522634109031591
9922	valproic acid	hsa03010	Ribosome	6138_285053_6181_6233_6125_6142_6139_9045_439992_6144_6160_6129_6173_6189_6171	15	+	0.00235157425128232	0.0312423436241794
9923	valproic acid	hsa03050	Proteasome	3458_5699_5698	3	+	0.000878896790052219	0.0136229002458094
9924	valproic acid	hsa04640	Hematopoietic cell lineage	3581_966_3554_2057_3575_3123_3126_3127_3125_921_3655_3589_3675	13	-	0.0287542417548641	0.228851665105877
9925	valproic acid	hsa03320	PPAR signaling pathway	2712_2710_5170_7350_6258_1375_1376_8310_6319_28965	10	-	0.0416103158265111	0.300874591360926
9926	valproic acid	hsa05010	Alzheimer's disease	55851_2902_1329_4712_2776_5663_7385_4695_4698_810_4842_776_6868_5534_102_836_8851_1020_4714_5594_841_642502_6391_1537_51107_355_808_23385_805_351_22926_801_517	33	-	0.028609713903224	0.228851665105877
9927	valproic acid	hsa04080	Neuroactive ligand-receptor interaction	2902_64106_5031_56288_136_5645_5644_5646_799_7434_2742_9568_5029_140_5025_3269_2550_5618_7067_4158_6754_8484	22	-	2.81986237218535e-10	1.32533531492711e-08
9928	valproic acid	hsa04742	Taste transduction	5613_5567	2	-	0.000254567322168703	0.00398822138064301
9929	valproic acid	hsa04740	Olfactory transduction	157_5613_23538_5567_26716_818_26532_805_810_801_808_409	12	-	3.42068353059795e-28	3.21544251876207e-26
9930	valproic acid	hsa05012	Parkinson's disease	4714_2861_6391_4695_4712_642502_1329_1537_4698_7327_65018_836_7419_517_7385	15	-	0.000149139049811367	0.0028038141364537
9931	valproic acid	hsa04260	Cardiac muscle contraction	7168_776_782_1329_6548_1537_4625_481_4635_27092_7137_7385	12	-	0.0250774138175704	0.228851665105877
9932	valproic acid	hsa04060	Cytokine-cytokine receptor interaction	3576_3597_3596_5155_5154_8741_7852_9180_3459_3439_27242_3554_2057_3455_3575_3458_5196_4982_8718_6367_6366_658_3581_3601_3556_23529_3589_3625_6363_1956_7042_91_93_5618_3447_6358_6359_355_7422_51330	40	-	0.000104845663955985	0.0028038141364537
9933	valproic acid	hsa03010	Ribosome	283412_440589_6181_9349_284064_6187_284393_439992_6203_6234_6159_389342_6189_6171	14	-	0.00915320477487431	0.122914464119741
9934	valproic acid	hsa04020	Calcium signaling pathway	2902_2776_115_5333_136_5567_107_818_810_7419_4842_776_2767_56848_5025_1956_5534_3269_3707_5578_5613_808_801_805	24	-	0.000130361195102804	0.0028038141364537
9935	valproic acid	hsa03050	Proteasome	5717_9491_3458_5690_5702	5	-	0.029215106183729	0.228851665105877
9936	valproic acid	hsa02010	ABC transporters	215_10347_23457_5826	4	-	0.0218405124917231	0.228851665105877
9937	nomifensine	hsa04740	Olfactory transduction	26211	1	+	0.00115509301354673	0.0820116039618178
9938	nomifensine	hsa04514	Cell adhesion molecules (CAMs)	24146	1	-	0.0456331390608387	0.843838065154902
9939	nomifensine	hsa05213	Endometrial cancer	6934_842_673_2002_8312_2064	6	-	0.0291805352651611	0.843838065154902
9940	nomifensine	hsa05210	Colorectal cancer	6934_1856_673_5881_8312_3725_8321_842	8	-	0.0325890405177328	0.843838065154902
9941	acetylsalicylsalicylic acid	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	5.56951007685521e-05	0.00289614523996471
9942	acetylsalicylsalicylic acid	hsa04130	SNARE interactions in vesicular transport	9570_8417_2054_6844	4	-	0.0161838411615143	0.550250599491486
9943	acetylsalicylsalicylic acid	hsa03440	Homologous recombination	7517_7156_25788_5425	4	-	0.00622984392139295	0.423629386654721
9944	acetylsalicylsalicylic acid	hsa04664	Fc epsilon RI signaling pathway	100137049_6655_8681_5335_5163	5	-	0.0463775046511464	0.751205239160964
9945	acetylsalicylsalicylic acid	hsa04370	VEGF signaling pathway	100137049_9261_8681_5335_5534	5	-	0.0425241813223339	0.751205239160964
9946	spironolactone	hsa04510	Focal adhesion	596_3691_1282_5154_3696_1277_93408_3685	8	+	0.0271739057765028	0.49890034584925
9947	spironolactone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3111_8359_8294_8367_554313_121504	15	+	6.03087233131395e-08	3.67883212210151e-06
9948	spironolactone	hsa04530	Tight junction	4301_5521_93408_84612_4624_3996	6	+	0.032714776777	0.49890034584925
9949	spironolactone	hsa04512	ECM-receptor interaction	3691_1282_3685_3696_1277	5	+	0.0165465315640166	0.49890034584925
9950	nalbuphine	hsa04740	Olfactory transduction	5568_816_390892	3	+	0.00071116896900542	0.0568935175204336
9951	nalbuphine	hsa04012	ErbB signaling pathway	2475_5579_208_1839_56924_1956_3084_816	8	+	0.0211037562061479	0.844150248245916
9952	nalbuphine	hsa05016	Huntington's disease	10126	1	-	0.0225593001421302	1
9953	canrenoic acid	hsa04020	Calcium signaling pathway	775_8913_5023_5578_3708_6915_5333_489	8	+	0.0152399035092036	0.961352045995431
9954	canrenoic acid	hsa04912	GnRH signaling pathway	775_5598_3708_1839_5578	5	+	0.0408269255090028	0.961352045995431
9955	canrenoic acid	hsa04070	Phosphatidylinositol signaling system	8394_3633_5290_5331_23396_23236	6	-	0.0256106062495601	0.473796215616862
9956	canrenoic acid	hsa04080	Neuroactive ligand-receptor interaction	5618	1	-	0.0109097785483299	0.403661806288206
9957	canrenoic acid	hsa04740	Olfactory transduction	109	1	-	0.000375299642527819	0.0277721735470586
9958	canrenoic acid	hsa04540	Gap junction	5598_7278_113457_5331_5607_109_23236	7	-	0.0205569011776836	0.473796215616862
9959	terfenadine	hsa04660	T cell receptor signaling pathway	1432_56924_5588_3558_27040_2534_2353_4794_3725_7124_5609_4792	12	+	0.0151962869223376	0.173671850541001
9960	terfenadine	hsa04740	Olfactory transduction	26211_1179	2	+	2.07266346197528e-06	8.29065384790112e-05
9961	terfenadine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_8349_8348_8329_8294_121504_8343_8342_8341_8347_8352_8344_8339_723790_8346_8969_8968_8370_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_7124_8353_8354_8355_8356_8357_8332_85235_3012_3013_3111_8970_729	50	+	7.42508033536177e-24	5.94006426828942e-22
9962	terfenadine	hsa04710	Circadian rhythm - mammal	8553_8864_5187	3	+	0.0371132274123804	0.247421516082536
9963	terfenadine	hsa04664	Fc epsilon RI signaling pathway	1432_5609_50487_27040_8681_5602_7124_100137049_2534	9	+	0.0366703896854129	0.247421516082536
9964	terfenadine	hsa05219	Bladder cancer	11186_3576_5925_1956_7422_4609	6	+	0.0246362967598345	0.218989304531862
9965	terfenadine	hsa04920	Adipocytokine signaling pathway	5106_5588_8660_181_5602_4794_7124_9021_4792	9	+	0.00931758272493893	0.173671850541001
9966	terfenadine	hsa04012	ErbB signaling pathway	1839_56924_4609_1956_5602_7039_5609_374_3725	9	+	0.0466964531355169	0.266836875060097
9967	terfenadine	hsa04512	ECM-receptor interaction	1284_1291_2811_3690_3695_1277_3679_3918_3676	9	+	0.0421483336790793	0.259374361102026
9968	terfenadine	hsa04010	MAPK signaling pathway	1649_50487_5156_8681_5602_3164_5609_7124_11221_4616_1850_100137049_468_1647_1956_4609_3725_3310_3727_786_1848_1432_1843_5598_4915_1847_1846_8817_2353_5971	30	+	0.000145362791786911	0.00387634111431763
9969	terfenadine	hsa04620	Toll-like receptor signaling pathway	7097_1432_3448_3576_2353_4792_5602_3456_7124_5609_3725	11	+	0.0217695112167824	0.217695112167824
9970	terfenadine	hsa04020	Calcium signaling pathway	624_1956_5156	3	+	0.0363938057878418	0.247421516082536
9971	terfenadine	hsa04912	GnRH signaling pathway	50487_1432_468_1081_100137049_5598_1839_1956_8681_5602_3725_5609	12	+	0.0140052610676598	0.173671850541001
9972	terfenadine	hsa05210	Colorectal cancer	2353_4088_4089_5602_5156_4609_1956_11211_8324_3725	10	+	0.0130710502962358	0.173671850541001
9973	terfenadine	hsa04080	Neuroactive ligand-receptor interaction	2561_5618	2	-	0.000127606214820939	0.00561467345212132
9974	terfenadine	hsa04520	Adherens junction	1457_117178_998_1956_6934_7525_2260_4233_2241_8976	10	-	0.0308379886845137	0.678435751059301
9975	terfenadine	hsa04740	Olfactory transduction	818_5613_5616_816	4	-	6.31535701018139e-06	0.000555751416895962
9976	terfenadine	hsa04210	Apoptosis	3554_3552_841_5613_5575_5295_5616_5291_472_355_23052_5576_3551_8794	14	-	0.00137908701723054	0.0404532191720958
9977	ursolic acid	hsa04080	Neuroactive ligand-receptor interaction	5618	1	+	0.0016922065706661	0.0643038496853118
9978	ursolic acid	hsa05200	Pathways in cancer	22798_330_6772_7170_5602_3655_1488_836_1612_1399_998_4254_1956_7849_7042_91_3725_4233_4791_2122_5599_867_861_2353	24	+	0.00289808937042631	0.0734182640507998
9979	ursolic acid	hsa04740	Olfactory transduction	818_5137	2	+	0.000190729604440037	0.0144954499374428
9980	ursolic acid	hsa04510	Focal adhesion	22798_5599_2909_5602_998_330_1956_1399_3725_3655_6093_1277_4233_55742	14	+	0.0383290655719344	0.291300898346701
9981	ursolic acid	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	836_5599_1839_998_1956_5602_3725_4233	8	+	0.00646724332441097	0.0983020985310468
9982	ursolic acid	hsa04012	ErbB signaling pathway	5599_1839_867_818_1956_1399_5602_3725	8	+	0.0186117787664241	0.235749197708039
9983	ursolic acid	hsa04010	MAPK signaling pathway	2353_2122_836_9693_5599_7042_1649_998_1846_1956_1399_5602_91_3725_3164_1844_4791	17	+	0.0349772617181916	0.291300898346701
9984	ursolic acid	hsa04912	GnRH signaling pathway	115_5599_1839_998_818_5330_1956_5602_3725	9	+	0.0221839302850884	0.23908048290579
9985	ursolic acid	hsa05210	Colorectal cancer	836_5599_7042_2353_1956_5602_91_3725_4233	9	+	0.00536159629471538	0.0983020985310468
9986	ursolic acid	hsa05220	Chronic myeloid leukemia	2122_861_867_1399_7042_91_1488	7	+	0.0251663666216621	0.23908048290579
9987	ursolic acid	hsa05200	Pathways in cancer	898	1	-	0.0228849404511497	0.915397618045988
9988	neomycin	hsa04740	Olfactory transduction	5566_4991	2	+	0.0130540623212433	0.960785163673504
9989	neomycin	hsa04080	Neuroactive ligand-receptor interaction	2561_4889_152	3	-	0.0144542769016355	0.375811199442523
9990	neomycin	hsa04740	Olfactory transduction	219464	1	-	3.67519453549063e-06	0.000286665173768269
9991	neomycin	hsa04060	Cytokine-cytokine receptor interaction	7852_1436_8795_9180	4	-	0.0368703682399578	0.70138613690871
9992	neomycin	hsa05210	Colorectal cancer	836_324_596_4088_3480_1856_6934_3725_8321	9	-	0.0116220061031024	0.375811199442523
9993	isradipine	hsa05322	Systemic lupus erythematosus	6738	1	+	0.0465735804592215	1
9994	isradipine	hsa04080	Neuroactive ligand-receptor interaction	2740	1	-	0.0226931992911724	1
9995	dimenhydrinate	hsa04740	Olfactory transduction	5137	1	+	0.00249030857659602	0.166850674631933
9996	dimenhydrinate	hsa04530	Tight junction	9076_5010_5584_5578_8777_5865_6714_9223	8	+	0.0173339799703219	0.580688329005784
9997	dimenhydrinate	hsa04370	VEGF signaling pathway	5296_6714_8681_100137049_5578	5	+	0.0382942363953235	0.855237946162225
9998	dimenhydrinate	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	-	9.3709168973362e-08	5.71625930737508e-06
9999	dimenhydrinate	hsa04350	TGF-beta signaling pathway	656_4091_4052_353500	4	-	0.0474613200572403	1
10000	terguride	hsa05332	Graft-versus-host disease	3824_3119_3105_3106_3107_3126_3127_3111_3802_3135_3811_5551_3123_941_3125_3113_649853	17	+	5.99832438871336e-06	0.000129917061130723
10001	terguride	hsa04650	Natural killer cell mediated cytotoxicity	4776_5533_3824_3448_3454_2207_3105_4068_6654_3446_3107_3443_3802_3135_3811_5551_4772_5879_8794_3106_2534	21	+	0.045471738748175	0.260704635489537
10002	terguride	hsa05010	Alzheimer's disease	5331_1339_6392_651820_5533_3708_3709_23236	8	+	0.033817507157072	0.242358801292349
10003	terguride	hsa05320	Autoimmune thyroid disease	959_649853_3107_1081_3119_3105_3106_3446_3126_3127_3443_3125_3135_5551_3111_3123_941_3113_3448	19	+	7.19922328117519e-06	0.000129917061130723
10004	terguride	hsa04612	Antigen processing and presentation	4049_3824_3448_3119_3123_3106_3446_3126_3127_3443_3125_3135_3811_3111_3105_3802_3107_3113_649853	19	+	0.00269792487443014	0.0257801710223324
10005	terguride	hsa04670	Leukocyte transendothelial migration	6494_399_5879_7122	4	+	0.0244098613882615	0.190840734490044
10006	terguride	hsa05016	Huntington's disease	1339_6392_651820_5331_3708_7416_23236	7	+	0.00935541357559225	0.0804565567500933
10007	terguride	hsa04740	Olfactory transduction	81697_8390_26664_4991	4	+	4.34814891803923e-11	3.73940806951374e-09
10008	terguride	hsa04514	Cell adhesion molecules (CAMs)	6402_6403_959_3119_965_3123_3106_3107_3126_3127_3111_3125_3135_3105_941_947_7122_649853_5133_3113_1462	21	+	0.0416581285418869	0.255899932471591
10009	terguride	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8369_8368_8335_8294_8341_959_3123_3126_3127_3125_8370_8359_554313_121504_2213_3119_3113_3111_941_1511	28	+	0.00090335112505183	0.0129480327924096
10010	terguride	hsa05310	Asthma	959_6356_3119_2207_3123_3126_3127_3111_3125_3113	10	+	0.00167953941949715	0.0206343414395364
10011	terguride	hsa03010	Ribosome	6192	1	+	0.00211360003733076	0.0227212004013057
10012	terguride	hsa05330	Allograft rejection	3593_959_3126_3119_3105_3106_3107_3113_3127_3111_3125_3135_5551_3123_941_649853	16	+	7.55331750760018e-06	0.000129917061130723
10013	terguride	hsa04950	Maturity onset diabetes of the young	4825_4760_5078_3170_6927_3172	6	+	0.0400955809667232	0.255899932471591
10014	terguride	hsa04940	Type I diabetes mellitus	3593_4049_3382_3119_3105_3106_3107_3126_3127_3111_3125_3135_5551_3123_941_3113_5799_649853	18	+	2.84357343625981e-06	0.000122273657759172
10015	terguride	hsa04080	Neuroactive ligand-receptor interaction	5028_5618_1081_3953_2908_2925_2692	7	-	0.000250307231034862	0.0110135181655339
10016	terguride	hsa05016	Huntington's disease	27113_836_842_317_3092_161_23236	7	-	0.0123667710053536	0.231912408636547
10017	terguride	hsa04740	Olfactory transduction	5566_157	2	-	1.65589815397089e-12	1.45719037549438e-10
10018	terguride	hsa05322	Systemic lupus erythematosus	6738_8329_8343_8347_8346_8344_8339_8969_8968_8358_8330_8331_8336_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013_3113_727	27	-	0.00113569360771519	0.0333136791596456
10019	terguride	hsa05012	Parkinson's disease	836_317_842_7054	4	-	0.0131768413998038	0.231912408636547
10020	terguride	hsa04260	Cardiac muscle contraction	6262_783	2	-	0.0461653428966453	0.677091695817464
10021	tolfenamic acid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_717_8368_8335_8359_8294_8367_554313_121504_3119	17	+	2.91682747604131e-08	2.10011578274974e-06
10022	tolfenamic acid	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	-	0.000117794182965378	0.00683206261199192
10023	doxorubicin	hsa04740	Olfactory transduction	81797	1	+	0.00740148004105896	0.362672522011889
10024	doxorubicin	hsa05332	Graft-versus-host disease	355_3113_3552	3	-	0.00445363018327251	0.0149514727581291
10025	doxorubicin	hsa04650	Natural killer cell mediated cytotoxicity	8503_3459_836_5578_10725_8794_6655_6654_6464_355_673_5533_5532_10451_4775_3845_5534_4772_5291_5295_8795	21	-	0.00100079727250716	0.00477829013928931
10026	doxorubicin	hsa04640	Hematopoietic cell lineage	3554_960_3552_2057_4254_3673	6	-	1.34450891704591e-05	0.000126383838202316
10027	doxorubicin	hsa03320	PPAR signaling pathway	79966_5170_7316_2181_1375_5467_6256	7	-	0.00116962262204368	0.00477829013928931
10028	doxorubicin	hsa05010	Alzheimer's disease	4698_5533_776_836_1327_841_8772_317_5534_2932_9451_5663_5532_355_6868_351_509_8851_7132	19	-	3.1415392697801e-07	4.92174485598882e-06
10029	doxorubicin	hsa04080	Neuroactive ligand-receptor interaction	5029_4889_5618_7442_7068_7067_1131_2908_4886_5031_3354_2150_136_1909_56288_2690_9170	17	-	4.51354544350453e-15	2.12136635844713e-13
10030	doxorubicin	hsa04742	Taste transduction	5613_112	2	-	5.64147393898111e-05	0.00037878467876016
10031	doxorubicin	hsa05320	Autoimmune thyroid disease	355_3113	2	-	9.0721115573528e-05	0.000568518990927442
10032	doxorubicin	hsa04612	Antigen processing and presentation	4800_4801_4802_3113_3308_1385_811_3304_3305_3303	10	-	0.00055694355899878	0.00307957026740502
10033	doxorubicin	hsa04670	Leukocyte transendothelial migration	1364_8503_5295_1432_5578_2909_394_10451_9475_7852_6387_1365_7430_5600_5747_6093_5291	17	-	0.000636474776542755	0.0033238127219455
10034	doxorubicin	hsa05016	Huntington's disease	4899_1327_317_246721_23186_6875_6874_6908_5432_5433_6648_4698_5439_2033_509_1213_836_548644_27113_841_1385_1387_9519	23	-	1.35967287114558e-06	1.59761562359606e-05
10035	doxorubicin	hsa04740	Olfactory transduction	5613_157	2	-	7.48852309135235e-44	7.03921170587121e-42
10036	doxorubicin	hsa04514	Cell adhesion molecules (CAMs)	965_4685_3113_4897_23308_1364_1365_5792_6693_9019_5817	11	-	3.79964434899701e-07	5.10237955436741e-06
10037	doxorubicin	hsa04510	Focal adhesion	8503_5170_595_596_2909_5747_5155_5154_9475_10451_394_3673_4659_6093_5501_5728_2324_3693_7057_1399_1398_329_8515_3480_2932_673_3725_6714_5291_4233_5228_5578_5599_6655_6654_6464_7422_5295	38	-	0.0014355965237576	0.00539784292932858
10038	doxorubicin	hsa05340	Primary immunodeficiency	8517_64421	2	-	0.00589688906816101	0.0184769190802378
10039	doxorubicin	hsa04530	Tight junction	6709_50855_5520_64398_56288_55870_9223_5728_5581_84612_1365_2017_55844_10207_8777_5519_22800_6714_5590_7082_8189_5578_1364_1457_3845_7525_1459	27	-	0.021369192264417	0.0573915449387199
10040	doxorubicin	hsa04720	Long-term potentiation	468_5578_5613_673_5533_5532_2033_5534_3845_1387_4659_5501	12	-	0.0232465089282108	0.0606992177569949
10041	doxorubicin	hsa05110	Vibrio cholerae infection	5613_7082_528_23545_5578	5	-	0.00111887943728835	0.00477829013928931
10042	doxorubicin	hsa05310	Asthma	3113	1	-	0.00484674709501157	0.0157101457562444
10043	doxorubicin	hsa04512	ECM-receptor interaction	3673_3693_960_7057_8515	5	-	5.0686193198591e-06	5.29389128963062e-05
10044	doxorubicin	hsa04062	Chemokine signaling pathway	3717_6777_157_5747_8503_9475_7852_6387_56288_112_2309_3551_7074_1399_1398_8517_5295_2932_673_6093_5291_4792_5590_5613_6655_6654_6464_10451_6772_3845_5970_8976	32	-	0.000284062274038594	0.00166886585997674
10045	doxorubicin	hsa04810	Regulation of actin cytoskeleton	8503_10672_2909_5295_5155_5154_9475_10451_8515_5747_3673_10458_4659_5501_7074_1730_3693_7430_1399_1398_2263_2260_10152_2768_324_8394_1131_673_22800_6093_5291_200576_8874_6655_6654_5305_3845_54434_3984_3985_8976	41	-	0.00121998897173344	0.00477829013928931
10046	doxorubicin	hsa04540	Gap junction	7082_5578_5598_6655_6654_5155_5154_5607_3845_5613_1453_6714_112	13	-	0.00293476781409822	0.0102173397972308
10047	doxorubicin	hsa05012	Parkinson's disease	2861_7326_836_1327_7314_317_4698_509_27429	9	-	2.11811906455098e-08	4.9775798016948e-07
10048	doxorubicin	hsa04260	Cardiac muscle contraction	784_776_1327_4635_10479_481	6	-	2.8583387393524e-05	0.000244258037726478
10049	doxorubicin	hsa04060	Cytokine-cytokine receptor interaction	5155_5154_8741_7852_6387_9180_7132_27242_3554_3552_2057_2324_8794_3459_3572_657_4982_10913_3601_23529_3625_4254_8742_91_90_92_4233_7048_5618_355_7422_8795_51330_2690	34	-	5.96047612061552e-08	1.12056951067572e-06
10050	doxorubicin	hsa03010	Ribosome	6139_6181_6205_9349_6137_6125_6168_6141_284393_6233_439992_6234_6158_6160_389342_6189_6171	17	-	0.0127298075052698	0.03739380954673
10051	doxorubicin	hsa04020	Calcium signaling pathway	776_5578_5613_1131_5534_3707_5533_7220_5532_136_1909_490_56848	13	-	1.20070503235925e-10	3.76220910139232e-09
10052	doxorubicin	hsa03050	Proteasome	23198	1	-	3.35081623894875e-05	0.000262480605384319
10053	doxorubicin	hsa04912	GnRH signaling pathway	4215_4214_6654_1432_468_5578_5599_5598_6655_1839_112_4216_3845_5600_5613_3725_6714_5608_776	19	-	0.0160032259567401	0.0455849466646536
10054	doxorubicin	hsa05330	Allograft rejection	355_3113	2	-	0.00253205948518834	0.00915436890798861
10055	doxorubicin	hsa04730	Long-term depression	2768_5578_10672_673_5519_3845_3480	7	-	0.00121378610999224	0.00477829013928931
10056	doxorubicin	hsa04270	Vascular smooth muscle contraction	1909_2768_5581_5613_5578_673_10672_27094_9826_4637_136_112_6093_9475_4659_776_5501	17	-	0.0011259960339615	0.00477829013928931
10057	doxorubicin	hsa04940	Type I diabetes mellitus	3113_355_3382_3552	4	-	0.0100248464516974	0.0303979214986953
10058	doxorubicin	hsa02010	ABC transporters	19_89845_5826_1244_9619	5	-	0.0191992605313146	0.0530803085277521
10059	doxorubicin	hsa04610	Complement and coagulation cascades	7056_7035_2152_5329	4	-	4.54347337033716e-05	0.000328528074470533
10060	velnacrine	hsa05131	Shigellosis	7278_7430_113457_8976	4	+	0.00488458206322777	0.0732687309484166
10061	velnacrine	hsa05130	Pathogenic Escherichia coli infection	7278_7430_113457_8976	4	+	0.00488458206322777	0.0732687309484166
10062	velnacrine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3113_8359_8294_8367_554313_121504	15	+	3.18332036169158e-10	1.43249416276121e-08
10063	velnacrine	hsa04740	Olfactory transduction	157	1	-	0.0154966916135747	0.945298188428057
10064	protriptyline	hsa05016	Huntington's disease	3708_1339	2	+	0.0181930290155388	0.359312323056891
10065	protriptyline	hsa04740	Olfactory transduction	26539_5568_26664	3	+	6.00975383346607e-05	0.0047477055284382
10066	protriptyline	hsa04510	Focal adhesion	1284_7059_10298_1311_596_3690_857_1289_3695_5156_88_1956_3918_3725_6714_1277_55742_3674	18	+	0.0114535496246375	0.301610140115454
10067	protriptyline	hsa04512	ECM-receptor interaction	1284_7059_960_1311_2812_3690_1289_3695_1277_3918_3674	11	+	0.00262045357914987	0.10350791637642
10068	protriptyline	hsa04912	GnRH signaling pathway	5568_1081_50487_3709_3708_1956_5600_5337_3725_6714	10	+	0.0371659572653322	0.587222124792249
10069	protriptyline	hsa05332	Graft-versus-host disease	3135_3123_3126_3127_3125	5	-	0.0224042074740609	0.409561164052721
10070	protriptyline	hsa05320	Autoimmune thyroid disease	3135_3123_3126_3127_3125	5	-	0.049394040336287	0.515109277792707
10071	protriptyline	hsa04514	Cell adhesion molecules (CAMs)	3123_3126_3127_3125_3135_5792_9672_6693_9019_5817	10	-	0.0336625614289908	0.409561164052721
10072	protriptyline	hsa05322	Systemic lupus erythematosus	6738_8343_8347_8346_8344_8339_3123_3126_3127_3125_8968_8358_8336_8350_8351_8352_8353_8354_8355_8356_8357_3013_727	23	-	1.34184707677536e-08	9.79548366046013e-07
10073	protriptyline	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.0287423643647445	0.409561164052721
10074	protriptyline	hsa05330	Allograft rejection	3135_3123_3126_3127_3125	5	-	0.0157150690757635	0.409561164052721
10075	protriptyline	hsa04940	Type I diabetes mellitus	3135_3123_3126_3127_3125	5	-	0.0263478829114363	0.409561164052721
10076	remoxipride	hsa04740	Olfactory transduction	818_5613_26212_7932_5616	5	+	0.00317123676532053	0.0887946294289748
10077	remoxipride	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_718_8368_3458_8366_3111_8359_8294_8367_554313_121504_8354	18	+	6.31750425983851e-05	0.00530670357826435
10078	remoxipride	hsa04540	Gap junction	5613_7278_5616_113457_2776_3708_5331_5607_10382_112_57369_6714	12	+	0.000807574556344211	0.0339181313664569
10079	remoxipride	hsa05012	Parkinson's disease	7345	1	+	0.0455433170812947	0.688557128791827
10080	remoxipride	hsa04020	Calcium signaling pathway	5331_776_2925_5613_5616_5333_2776_818_6915_3708_683_487_3706_4842	14	+	0.0383171883546836	0.688557128791827
10081	remoxipride	hsa04912	GnRH signaling pathway	5331_776_5613_5616_2776_818_3708_112_6714	9	+	0.0491826520565591	0.688557128791827
10082	remoxipride	hsa04130	SNARE interactions in vesicular transport	8773_9570_10228_2054_6844	5	-	0.0150564794204345	0.416562597298688
10083	remoxipride	hsa04740	Olfactory transduction	157	1	-	3.99693686251026e-05	0.00165872879794176
10084	remoxipride	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3113	22	-	4.67413582064161e-08	3.87953273113254e-06
10085	progesterone	hsa04740	Olfactory transduction	81696_81797	2	+	0.00113042986895443	0.0412606902168367
10086	progesterone	hsa05322	Systemic lupus erythematosus	3013_8358_8968_720_721_8350_8351_8352_8353_8354_8355_8356_8357	13	+	0.000794119643752929	0.0412606902168367
10087	progesterone	hsa04610	Complement and coagulation cascades	719_624_720_721_10747_2243_2162	7	+	0.00720957553057523	0.175433004577331
10088	progesterone	hsa04080	Neuroactive ligand-receptor interaction	64106_7067_1131_9170	4	-	0.0271588512930088	0.549966738683428
10089	progesterone	hsa04740	Olfactory transduction	5613_5616	2	-	1.39410821544243e-05	0.00112922765450837
10090	progesterone	hsa04540	Gap junction	3710_5613_6654_5616_5154_5331_5607_3845_112_10746	10	-	0.0115530437540314	0.467898272038272
10091	progesterone	hsa04912	GnRH signaling pathway	2002_4313_3710_5613_6654_5616_5331_5606_3845_112_10746	11	-	0.0174893336816498	0.472212009404545
10092	butoconazole	hsa04740	Olfactory transduction	8387_26212_8388	3	+	8.4087506598431e-05	0.00655882551467762
10093	butoconazole	hsa05322	Systemic lupus erythematosus	3013_8358_8968_720_721_8350_8351_8352_8353_8354_8355_8356_8357	13	+	0.0238416280366183	0.929823493428114
10094	butoconazole	hsa04360	Axon guidance	9353	1	+	0.0459126144670031	1
10095	butoconazole	hsa04810	Regulation of actin cytoskeleton	10093_10627_8394_2934_5290_6548_7410_7430_10458_28964_26999_8976_3675	13	-	0.0270256253326959	0.865342721482928
10096	butoconazole	hsa04060	Cytokine-cytokine receptor interaction	7852_91	2	-	0.0258455045323185	0.865342721482928
10097	biotin	hsa04640	Hematopoietic cell lineage	2322_960_2812_3568_3815_3676	6	+	0.0361311638946503	0.893477478384872
10098	biotin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_2215_8370_2214_8368_8366_8359_3119_8294_8367_554313_121504_8341_3109_8364	19	+	5.30494044339567e-08	3.5543100970751e-06
10099	biotin	hsa04080	Neuroactive ligand-receptor interaction	1081	1	-	0.0229704645981359	0.83842195783196
10100	biotin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3012_8368_8335_8359_8294_8367_554313_6738_121504	17	-	4.89107840430862e-07	3.57048723514529e-05
10101	biotin	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0443609953041692	1
10102	cephaeline	hsa04916	Melanogenesis	7306_54361_112_1857_818_5332_2033_6934_8324_1906_1385_1387_816_7477	14	+	0.0210668173163766	0.0692195426109517
10103	cephaeline	hsa04120	Ubiquitin mediated proteolysis	23327_4214_29882_25898_51366_22888_7328_23759_6477_330_83737_10393_9820_8651_8945_23221_9021_7189_51343_57154	20	+	0.0129554171447865	0.0567784015405122
10104	cephaeline	hsa03320	PPAR signaling pathway	10062_2710_51703_2170_5465_51129_1375_6257	8	+	0.0237374742452011	0.0727949210186167
10105	cephaeline	hsa05010	Alzheimer's disease	776_836_842_6392_317_651820_5533_8772_3708_3709_6868_5332_7124_348	14	+	7.6006276398045e-07	1.39851548572403e-05
10106	cephaeline	hsa04080	Neuroactive ligand-receptor interaction	1269_624_2908_5030_5724_1909_2569_799_2740_3973_7433_1395_5029_5021_1131_5025_6915_3269_2550_7442_5734_7067_5617_1241_8484_728	26	+	4.29641458805106e-07	1.31756714033566e-05
10107	cephaeline	hsa04742	Taste transduction	51764_6337_112	3	+	0.00255342533020978	0.0195762608649416
10108	cephaeline	hsa05320	Autoimmune thyroid disease	3135_3134_3111_3133_3119	5	+	0.0220691521473648	0.0700124826743987
10109	cephaeline	hsa04310	Wnt signaling pathway	57680_4088_5332_5526_5602_8324_8945_6477_1857_818_2033_324_816_7477_10725_8061_5533_4775_54361_6934_3725_4772_1387	23	+	0.0176924184532944	0.0626039422193494
10110	cephaeline	hsa05131	Shigellosis	7100_7278_113457_8976_347733	5	+	0.015956891825964	0.0604142119944836
10111	cephaeline	hsa04670	Leukocyte transendothelial migration	1364_8503_3383_2185_5336_7070_5293_9080_7852_7410_5335_4636_7414_394_7409_399_3684	17	+	0.0146734023704261	0.0604142119944836
10112	cephaeline	hsa04910	Insulin signaling pathway	2308_5584_5261_3551_5564_32_6464_8503_7249_673_8660_8651_8789_6720_8835_5602_9322_5507_9021_5293	20	+	0.0129602873081604	0.0567784015405122
10113	cephaeline	hsa05016	Huntington's disease	4899_836_51164_842_6392_317_651820_161_3708_5978_2033_55567_5332_1385_6875_1387_10126_6908	18	+	7.06711978744197e-06	0.000108362503407444
10114	cephaeline	hsa05130	Pathogenic Escherichia coli infection	7100_7278_113457_8976_347733	5	+	0.015956891825964	0.0604142119944836
10115	cephaeline	hsa04740	Olfactory transduction	818_26476_26212_816_157	5	+	7.27028895442489e-32	6.6886658380709e-30
10116	cephaeline	hsa04514	Cell adhesion molecules (CAMs)	6402_6385_1364_8174_3383_3119_8506_23308_3695_3111_9080_3135_3134_5817_3684_3133_920_1000_925_1013	20	+	0.0204339894508197	0.0692195426109517
10117	cephaeline	hsa04510	Focal adhesion	8503_10298_6464_5602_5155_5154_3678_4636_394_4659_3674_3675_3691_3695_7410_7414_5293_55742_3913_3912_3911_3910_330_1956_3725_3918_4233_1284_2277_1281_1289_7060_7424_7409_7422_673	36	+	0.0357316290710357	0.102728433579228
10118	cephaeline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_8349_8348_8329_8294_121504_8343_8342_8341_8347_8352_8345_8344_8353_723790_3021_3020_92815_8969_8968_8346_55766_8370_718_717_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_7124_8339_8354_8355_8356_8357_8332_3018_85235_3119_85236_3012_3013_3017_3111_8970_729	61	+	0.00118538911105774	0.0112545970657414
10119	cephaeline	hsa04710	Circadian rhythm - mammal	8864_5187_8553_406_1408_1453_79365_9572_8863	9	+	0.0291365908919694	0.086469882647135
10120	cephaeline	hsa04340	Hedgehog signaling pathway	8945_1453_54361_5727_7477	5	+	0.0164169054332836	0.0604142119944836
10121	cephaeline	hsa04530	Tight junction	5584_64398_9080_4619_1364_4636_93643_27134	8	+	6.76970256977707e-07	1.39851548572403e-05
10122	cephaeline	hsa03030	DNA replication	10714	1	+	0.00360038552537641	0.0254796514103561
10123	cephaeline	hsa05110	Vibrio cholerae infection	525_5335_55176_5336	4	+	0.00412467800093982	0.0271050268633188
10124	cephaeline	hsa04062	Chemokine signaling pathway	3717_157_2921_5293_7852_5332_112_8503_2309_3551_3576_7410_6363_1230_673_2185_4790_4792_4793_6347_6774_6464_51764_7409_5970_8976	26	+	0.00122332576801537	0.0112545970657414
10125	cephaeline	hsa04810	Regulation of actin cytoskeleton	8503_6548_10298_624_5155_5154_3678_4636_10458_4659_3674_3675_3691_3695_7410_7414_5293_2261_10152_324_8394_8395_1131_9138_673_1956_9459_8874_54961_3684_8817_7409_2258_3985_8976	35	+	0.00734296348226103	0.0410178213271727
10126	cephaeline	hsa04540	Gap junction	347733_7278_1453_5155_5154_3709_113457_3708_1956_112_5332	11	+	0.0101082010308526	0.0507903782026887
10127	cephaeline	hsa05012	Parkinson's disease	836_842_6392_651820_317_9627	6	+	4.49544481664938e-08	2.06790461565871e-06
10128	cephaeline	hsa04260	Cardiac muscle contraction	786_776_7170_6548	4	+	4.45534312906145e-05	0.000585559382676648
10129	cephaeline	hsa04060	Cytokine-cytokine receptor interaction	3459_29949_2921_5155_5154_7852_92_6347_3576_3572_3976_8718_4050_3581_1230_23495_3589_8771_6363_1956_51561_7042_7124_268_4233_8795_2277_1435_3460_3569_5617_7424_7422_51330	34	+	5.47267701213184e-05	0.000629357856395162
10130	cephaeline	hsa04020	Calcium signaling pathway	624_1909_7220_5333_5332_5335_5336_9630_5724_818_3973_56848_816_776_5021_1131_5025_5533_6915_3708_1956_2185_3269_7125_8877_5261_8912_3709	28	+	0.00757938002784713	0.0410178213271727
10131	cephaeline	hsa03050	Proteasome	5698_23198	2	+	0.00220486222567711	0.0184406658874813
10132	cephaeline	hsa04950	Maturity onset diabetes of the young	3280	1	+	0.0442932727029403	0.123484275414258
10133	cephaeline	hsa04730	Long-term depression	8398_3709_673_3708_5332_8681_100137049	7	+	0.0104893172375118	0.0507903782026887
10134	cephaeline	hsa04270	Vascular smooth muscle contraction	9138_8398_100137049_1909_4660_3709_673_27094_3708_5332_8681_112_4659_776	14	+	0.00443526435938489	0.0272029547375607
10135	cephaeline	hsa04650	Natural killer cell mediated cytotoxicity	5296_355	2	-	0.0362999614513967	0.267299716142103
10136	cephaeline	hsa04080	Neuroactive ligand-receptor interaction	64106_3354_2925_4886_1813	5	-	0.00803880379827047	0.162785776914977
10137	cephaeline	hsa04670	Leukocyte transendothelial migration	5296	1	-	0.0149869052011461	0.173419903041833
10138	cephaeline	hsa05016	Huntington's disease	7416_317	2	-	0.00318653411200362	0.129054631536147
10139	cephaeline	hsa04740	Olfactory transduction	5613_5616_818_808_801_805	6	-	9.74015723339494e-05	0.0078895273590499
10140	cephaeline	hsa05322	Systemic lupus erythematosus	6738_94239	2	-	0.0254856827898335	0.229371145108501
10141	cephaeline	hsa04630	Jak-STAT signaling pathway	5296_8027	2	-	0.0125657443743524	0.173419903041833
10142	cephaeline	hsa05012	Parkinson's disease	7416_317	2	-	0.0354770339123628	0.267299716142103
10143	cephaeline	hsa04620	Toll-like receptor signaling pathway	5296	1	-	0.0456827155460802	0.308358329936041
10144	cephaeline	hsa04060	Cytokine-cytokine receptor interaction	3556_3552_4254_355_7046_8792	6	-	0.0138254611185654	0.173419903041833
10145	cephaeline	hsa03010	Ribosome	6139_6181_9349_6137_6125_6168_6141_284393_439992_6234_6160_6129_389342_6189	14	-	0.0057073390669222	0.154098154806899
10146	cephaeline	hsa05222	Small cell lung cancer	9134_4149_596_5296_6502_1871_317_898_3655_3673_1017	11	-	0.0208128634447463	0.210730242378056
10147	digoxin	hsa05016	Huntington's disease	4713_1387_509	3	+	0.00512553511954212	0.143514983347179
10148	digoxin	hsa04740	Olfactory transduction	26212	1	+	1.2292623616916e-09	5.16290191910472e-08
10149	digoxin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_88_8348_8329_8294_121504_8343_8341_8347_8346_8344_8339_723790_8969_8968_8370_92815_8358_8359_8330_8331_8336_8337_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3012_3013_8349	46	+	1.48610750010273e-16	1.24833030008629e-14
10150	digoxin	hsa04350	TGF-beta signaling pathway	4092_4088_92_3397_3399_3398_7057_3400_7042_6093_1387	11	+	0.0496250340121942	0.694750476170719
10151	digoxin	hsa05012	Parkinson's disease	2861_4713_509	3	+	0.0485543057351825	0.694750476170719
10152	digoxin	hsa04020	Calcium signaling pathway	3709_51196_2065_1812_5534	5	+	0.0447515376208765	0.694750476170719
10153	digoxin	hsa04916	Melanogenesis	5613_8321_5616_4157_113	5	-	0.00598016103773906	0.0436332788948098
10154	digoxin	hsa05332	Graft-versus-host disease	355	1	-	0.0374150579571472	0.0990398592983308
10155	digoxin	hsa05211	Renal cell carcinoma	9915_5295_2271_112399	4	-	0.0401221867581012	0.101815851643904
10156	digoxin	hsa04650	Natural killer cell mediated cytotoxicity	6850_5295_10451_355_4772_2534_5336_5777	8	-	0.00415293345332423	0.0415293345332423
10157	digoxin	hsa03440	Homologous recombination	8940_4683_5424_80198_10714_7516_5892_25788_10111	9	-	0.0490313044853985	0.119265335234753
10158	digoxin	hsa04640	Hematopoietic cell lineage	933_3655_960_2057_3673	5	-	0.02827141451571	0.0847251607994222
10159	digoxin	hsa05010	Alzheimer's disease	4729_1327_841_8772_317_8883_4137_355_3709_509_4712_7132_842	13	-	0.00873454321889086	0.0462416993941281
10160	digoxin	hsa04080	Neuroactive ligand-receptor interaction	7442_4157_5021_1131_5031_136	6	-	1.12942150253587e-09	5.08239676141141e-08
10161	digoxin	hsa05200	Pathways in cancer	5467_4088_598_5747_5154_5336_3655_8321_1050_4149_9134_1613_5900_652_1019_2263_112399_581_8772_355_8312_4609_9915_2271_842_841_26060_6502_6772_7188_5979_3673_5295_7187	34	-	0.0326003363643243	0.088910008266339
10162	digoxin	hsa04742	Taste transduction	5613_5616	2	-	0.0285456218921366	0.0847251607994222
10163	digoxin	hsa05320	Autoimmune thyroid disease	355	1	-	0.00776830675586408	0.0462416993941281
10164	digoxin	hsa04310	Wnt signaling pathway	8312_27101_4088_5613_5616_1454_6885_4772_5467_4609_5528_8321	12	-	0.0261645115860623	0.0847251607994222
10165	digoxin	hsa04670	Leukocyte transendothelial migration	5295_5747_9080_10451_7430_5600_5336_10627	8	-	0.0174944946739439	0.0684567182893457
10166	digoxin	hsa05016	Huntington's disease	1213_246721_7419_4729_1327_841_581_5439_317_509_4712_55567_548644_10126_5481_842	16	-	0.0268133001339023	0.0847251607994222
10167	digoxin	hsa04740	Olfactory transduction	5613_5616_157_409	4	-	1.20299386884686e-18	1.08269448196217e-16
10168	digoxin	hsa04514	Cell adhesion molecules (CAMs)	214_4099_9080_5792_6382_933_3655	7	-	0.00231975230004385	0.0283889633714897
10169	digoxin	hsa04510	Focal adhesion	857_2317_5747_1289_5154_10451_3655_3673_3691_5295_83660_2534_10627	13	-	0.00105224674342236	0.0157837011513354
10170	digoxin	hsa05322	Systemic lupus erythematosus	55766_3021_3020	3	-	5.16305550739969e-06	0.000116168748916493
10171	digoxin	hsa05212	Pancreatic cancer	2263_9134_5295_5154_842	5	-	0.0291831109420232	0.0847251607994222
10172	digoxin	hsa05215	Prostate cancer	2263_9134_5295_5154_842	5	-	0.0285982157189529	0.0847251607994222
10173	digoxin	hsa03410	Base excision repair	55247_10357_143_5424_5427_4913_10714_7515_27301_10038_3146_4595_8930_100130561_23583_3980	16	-	0.000630817339829682	0.0113547121169343
10174	digoxin	hsa04530	Tight junction	5580_5581_50855_9080_10207_51776_1019_27134_10627	9	-	0.0124802928695724	0.0561613179130758
10175	digoxin	hsa05218	Melanoma	5295_5154_1019	3	-	0.0220523215640238	0.0793883576304857
10176	digoxin	hsa04720	Long-term potentiation	5613_3709_5616	3	-	0.010728129243119	0.0534941372120703
10177	digoxin	hsa04012	ErbB signaling pathway	4609_5336_5295_5747	4	-	0.0112932067447704	0.0534941372120703
10178	digoxin	hsa04630	Jak-STAT signaling pathway	3717_6778_2057_598_5295_6772_10379_4609_8835_5777	10	-	0.00499113776146341	0.0436332788948098
10179	digoxin	hsa04150	mTOR signaling pathway	1977_5295	2	-	0.0407263406575616	0.101815851643904
10180	digoxin	hsa04062	Chemokine signaling pathway	3717_157_5580_5613_5295_5616_6772_6359_10451_6358_113_5747_10681_409	14	-	0.00630258472925031	0.0436332788948098
10181	digoxin	hsa04810	Regulation of actin cytoskeleton	5295_1445_3985_26999_2934_5747_5154_54961_23191_8396_10451_7430_54434_2263_3655_3673_200576_3691_1131_10627	20	-	0.0319495008161695	0.088910008266339
10182	digoxin	hsa05012	Parkinson's disease	4729_1327_4712_317_509_7419_5481_842	8	-	0.00562738944059814	0.0436332788948098
10183	digoxin	hsa04260	Cardiac muscle contraction	784_9254_1327_27092	4	-	0.0155038535637727	0.066445086701883
10184	digoxin	hsa04060	Cytokine-cytokine receptor interaction	27242_2057_23765_5154_6358_6359_355_90_7132	9	-	6.55996954327173e-08	1.96799086298152e-06
10185	digoxin	hsa03010	Ribosome	6125_6168_6189_439992_9349	5	-	0.00843812371030435	0.0462416993941281
10186	digoxin	hsa04020	Calcium signaling pathway	5257_5021_5613_1131_5616_3709_136_113_5336_7419_3707_5481	12	-	0.00252346341079908	0.0283889633714897
10187	digoxin	hsa03050	Proteasome	23198	1	-	0.017144324267182	0.0684567182893457
10188	digoxin	hsa04730	Long-term depression	8681_3709_100137049	3	-	0.0220523215640238	0.0793883576304857
10189	digoxin	hsa04610	Complement and coagulation cascades	7056_5329	2	-	0.0068526834044263	0.0440529647427405
10190	hydrocortisone	hsa04910	Insulin signaling pathway	5599_32_10211	3	+	0.04363405204053	0.453021366537497
10191	hydrocortisone	hsa04080	Neuroactive ligand-receptor interaction	2150_4886	2	-	0.0132044771751013	0.312505959810731
10192	hydrocortisone	hsa04740	Olfactory transduction	5567	1	-	3.78066533106063e-05	0.00268427238505305
10193	hydrocortisone	hsa03020	RNA polymerase	246721_5439_548644_5430	4	-	0.024058675426854	0.427041488826659
10194	hydrocortisone	hsa05213	Endometrial cancer	3611_5728_2002_572_6932_6934	6	-	0.0130406388236677	0.312505959810731
10195	meclozine	hsa05016	Huntington's disease	1639	1	+	0.0474684595338489	0.996053930839344
10196	meclozine	hsa04740	Olfactory transduction	8387_8388	2	+	0.0011366500936167	0.0807021566467857
10197	meclozine	hsa05218	Melanoma	56034_1029_26291_2246_2250_3082	6	+	0.0269471150708635	0.956622585015654
10198	meclozine	hsa05332	Graft-versus-host disease	3553_3123_3126_3127_3125_355	6	-	0.00489019580673507	0.157768125557014
10199	meclozine	hsa05320	Autoimmune thyroid disease	3123_355_3126_3127_3125	5	-	0.0430564074434268	0.566909364671786
10200	meclozine	hsa04740	Olfactory transduction	816	1	-	5.95646130584261e-05	0.00470560443161566
10201	meclozine	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.0253966438059415	0.401266972133876
10202	meclozine	hsa05330	Allograft rejection	3123_355_3126_3127_3125	5	-	0.0134903147193475	0.266433715707113
10203	meclozine	hsa04940	Type I diabetes mellitus	3553_3123_3126_3127_3125_355	6	-	0.00599119464140558	0.157768125557014
10204	naringin	hsa05332	Graft-versus-host disease	3553_3126_3127_3123_3125	5	+	0.00450689167278662	0.113157004928351
10205	naringin	hsa04640	Hematopoietic cell lineage	3553_3123_3126_3127_3125_3589	6	+	0.0210855961855305	0.137113660908508
10206	naringin	hsa05320	Autoimmune thyroid disease	3448_3123_3126_3127_3125	5	+	0.0109623693389344	0.113157004928351
10207	naringin	hsa04740	Olfactory transduction	135948_442194	2	+	0.009240709890108	0.113157004928351
10208	naringin	hsa04514	Cell adhesion molecules (CAMs)	965_6401_3123_3126_3127_3685_3125_6693_25945	9	+	0.00612073018042903	0.113157004928351
10209	naringin	hsa04510	Focal adhesion	5170_10298_56034_5294_5578_1288_3685_1956_3371_824_1291	11	+	0.0182477530108178	0.137113660908508
10210	naringin	hsa04710	Circadian rhythm - mammal	4862_1408	2	+	0.0463104769679282	0.228716024130133
10211	naringin	hsa05212	Pancreatic cancer	5170_56034_5294_1956_9586_2260	6	+	0.023149059633904	0.137113660908508
10212	naringin	hsa05215	Prostate cancer	5170_56034_5294_1956_9586_2260	6	+	0.0221010680502591	0.137113660908508
10213	naringin	hsa05218	Melanoma	56034_5294_1029_1956_2260_2246	6	+	0.00888924523851045	0.113157004928351
10214	naringin	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.00763877180061193	0.113157004928351
10215	naringin	hsa05223	Non-small cell lung cancer	5294_5170_1029_1956_5578	5	+	0.0117565719406079	0.113157004928351
10216	naringin	hsa04540	Gap junction	1813_7278_5578_113457_1956_56034	6	+	0.0276740203886831	0.152207112137757
10217	naringin	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.0159649131438257	0.13658870134162
10218	naringin	hsa04940	Type I diabetes mellitus	3123_3553_3126_3127_3125	5	+	0.00539666397922626	0.113157004928351
10219	naringin	hsa04740	Olfactory transduction	157	1	-	8.58486772527606e-05	0.00643865079395704
10220	naringin	hsa05322	Systemic lupus erythematosus	8348_3013_3113_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	13	-	0.0016291626257626	0.0610935984660975
10221	naringin	hsa05330	Allograft rejection	3135_355_3113_3133	4	-	0.0449848356281538	0.811778551280137
10222	naproxen	hsa04740	Olfactory transduction	5137_26211_442194	3	+	3.13079988159464e-06	0.00026298719005395
10223	naproxen	hsa05322	Systemic lupus erythematosus	718_8335	2	+	0.0353033945434174	1
10224	naproxen	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	-	0.00438745608033504	0.293959557382448
10225	dapsone	hsa05200	Pathways in cancer	7175_1488_1284_4791_613_6777_5371_355_6772_1613_5605_405_1956_3845_324_2260_1017_652671	18	+	0.0122006485451645	0.237912646630708
10226	dapsone	hsa04740	Olfactory transduction	5137_1179	2	+	0.00236972180634803	0.184838300895146
10227	dapsone	hsa05221	Acute myeloid leukemia	6777_5371_5605_3845_11040_652671	6	+	0.00946216341824356	0.237912646630708
10228	dapsone	hsa04370	VEGF signaling pathway	1432_5605_3845_5534_8398_6714	6	+	0.0285984849663563	0.318668832482256
10229	dapsone	hsa05219	Bladder cancer	5605_1956_3845_1613	4	+	0.0391234919456266	0.381454046469859
10230	dapsone	hsa04012	ErbB signaling pathway	6777_1839_5605_1956_3845_6714	6	+	0.0460001955733632	0.398668361635814
10231	dapsone	hsa04010	MAPK signaling pathway	1432_783_4763_5605_355_7850_1956_3845_5534_5494_10746_2260_8398_4791_2264	15	+	0.0178717626556434	0.276193822640121
10232	dapsone	hsa05213	Endometrial cancer	5605_2309_1956_3845_324	5	+	0.0212456786646247	0.276193822640121
10233	dapsone	hsa04912	GnRH signaling pathway	1432_1839_5605_1956_3845_112_10746_6714_8398	9	+	0.00549708418415675	0.214386283182113
10234	dapsone	hsa03440	Homologous recombination	5425_7156	2	-	0.0239828321300978	0.279799708184474
10235	dapsone	hsa05131	Shigellosis	7278_7430_113457	3	-	0.0117623827469104	0.205841698070932
10236	dapsone	hsa05130	Pathogenic Escherichia coli infection	7278_7430_113457	3	-	0.0117623827469104	0.205841698070932
10237	dapsone	hsa04512	ECM-receptor interaction	3655_3914_1302	3	-	0.0327059049618303	0.286176668416015
10238	thiamphenicol	hsa04740	Olfactory transduction	810	1	+	0.010723060181307	0.675552791422341
10239	thiamphenicol	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8336_8329	7	-	1.6627415294293e-05	0.000349175721180153
10240	heptaminol	hsa05131	Shigellosis	6093_7430_9181	3	-	0.0406553127282041	0.619132007106911
10241	heptaminol	hsa05130	Pathogenic Escherichia coli infection	6093_7430_9181	3	-	0.0406553127282041	0.619132007106911
10242	heptaminol	hsa05220	Chronic myeloid leukemia	4088_7157_1029_598	4	-	0.0190339716445281	0.619132007106911
10243	naltrexone	hsa04120	Ubiquitin mediated proteolysis	25898_10075_51343_867_22888_8916_8450	7	+	0.0259383271711023	0.937555308427457
10244	naltrexone	hsa04740	Olfactory transduction	26476_816	2	+	0.0375022123370983	0.937555308427457
10245	naltrexone	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0248849431528665	0.937555308427457
10246	naltrexone	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	-	3.81051726579641e-05	0.00171473276960838
10247	naltrexone	hsa05222	Small cell lung cancer	3655_51588_9134_3909_3675	5	-	0.0153581912188118	0.345559302423265
10248	adiphenine	hsa04740	Olfactory transduction	109	1	+	0.0161038528923037	0.450907880984504
10249	adiphenine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	7.83960951511326e-07	4.39018132846343e-05
10250	adiphenine	hsa04520	Adherens junction	3480_117178_998_1457_5792_8976	6	-	0.00040599440267759	0.0114403269848939
10251	adiphenine	hsa05322	Systemic lupus erythematosus	85235_8969_8332_8330_8331_8329_8336	7	-	0.00156125374376466	0.0244596419856463
10252	adiphenine	hsa03010	Ribosome	6142_285053_6189_439992_6168	5	-	0.0071188055694091	0.0836459654405569
10253	adiphenine	hsa03020	RNA polymerase	5432_246721_5439_548644	4	-	0.000486822424889103	0.0114403269848939
10254	diphenhydramine	hsa04740	Olfactory transduction	818	1	+	0.00116602335056337	0.0734594710854923
10255	diphenhydramine	hsa05322	Systemic lupus erythematosus	85235_3119_3113_8330_8332_8969_8331_8329_8336	9	+	0.0131786454598033	0.415127331983804
10256	diphenhydramine	hsa04810	Regulation of actin cytoskeleton	324	1	+	0.0462901713390783	0.71464214837676
10257	diphenhydramine	hsa04662	B cell receptor signaling pathway	3725_8503_5534_7409_8519	5	-	0.00359160692449896	0.193946773922944
10258	diphenhydramine	hsa04210	Apoptosis	472_8503_651610_5534	4	-	0.0315007871106766	0.567014167992179
10259	diphenhydramine	hsa04810	Regulation of actin cytoskeleton	8503_8394_54961_7409_1399_8826_7430	7	-	0.0262772022320543	0.567014167992179
10260	acetohexamide	hsa05131	Shigellosis	7100_7278_113457_9181	4	+	0.0427324649183213	0.683719438693141
10261	acetohexamide	hsa05130	Pathogenic Escherichia coli infection	7100_7278_113457_9181	4	+	0.0427324649183213	0.683719438693141
10262	acetohexamide	hsa04540	Gap junction	7278_113457_5331_3708_1956_6714_23236	7	+	0.00645216777061639	0.412938737319449
10263	acetohexamide	hsa04912	GnRH signaling pathway	50487_5331_3708_1956_3725_6714_23236	7	+	0.0134174260009528	0.42935763203049
10264	acetohexamide	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.000842440837425646	0.0219034617730668
10265	flucloxacillin	hsa04740	Olfactory transduction	26539	1	+	0.000261394934177306	0.0201274099316526
10266	flucloxacillin	hsa04370	VEGF signaling pathway	5319_9261_998_5605_8681_5534_6714_100137049	8	+	0.00306165360541067	0.117873663808311
10267	flucloxacillin	hsa04912	GnRH signaling pathway	5319_998_2776_5605_8681_5337_6714_100137049	8	+	0.0188792408241267	0.45060403962374
10268	flucloxacillin	hsa04730	Long-term depression	5319_2776_5605_8681_100137049_2977	6	+	0.0234702076425684	0.45060403962374
10269	flucloxacillin	hsa04270	Vascular smooth muscle contraction	5319_3778_9138_2776_5605_8681_100137049_2977	8	+	0.0292600025729701	0.45060403962374
10270	flucloxacillin	hsa05016	Huntington's disease	1339	1	-	0.0461752068317341	0.765616965935398
10271	flucloxacillin	hsa04740	Olfactory transduction	219464_5613_5616	3	-	0.0075023668527058	0.45355380784096
10272	flucloxacillin	hsa05322	Systemic lupus erythematosus	85235_3013_3113_8330_8332_8969_8331_8329_8351_8336	10	-	0.0128259623835176	0.45355380784096
10273	flucloxacillin	hsa04912	GnRH signaling pathway	1432_5594_5613_4323_5616_1956_5598_10746	8	-	0.0179034397831958	0.45355380784096
10274	canavanine	hsa04080	Neuroactive ligand-receptor interaction	146_136	2	-	0.000124511518383323	0.00491820497614126
10275	canavanine	hsa04740	Olfactory transduction	810	1	-	1.42743508055367e-08	1.1276737136374e-06
10276	canavanine	hsa04514	Cell adhesion molecules (CAMs)	965	1	-	0.0109228974309121	0.287636299014019
10277	canavanine	hsa04110	Cell cycle	5591_4085_4173_983_6500_4089_51433_472_11200_10393_545_7534_1017	13	-	0.0321394368143443	0.466958842085708
10278	canavanine	hsa04530	Tight junction	8573_10627	2	-	0.0354652285128386	0.466958842085708
10279	canavanine	hsa04720	Long-term potentiation	5604_6196_5332_5906_810_5908_4659_5500_643752	9	-	0.0469086327728923	0.529397427008356
10280	canavanine	hsa05012	Parkinson's disease	6392_4698	2	-	0.0351823319944206	0.466958842085708
10281	astemizole	hsa04740	Olfactory transduction	5137_26211_5132	3	+	6.56270807844254e-06	0.000255945615059259
10282	astemizole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8349_8348_8294_121504_8343_8341_8347_8346_8344_8339_723790_8968_8370_8358_8359_8337_8334_8335_8350_8351_8352_8353_8354_8355_8356_8357_3012_3013_8970	39	+	3.03690280092662e-15	2.36878418472276e-13
10283	astemizole	hsa04710	Circadian rhythm - mammal	8553_9572_5187_79365	4	+	0.00812943283185053	0.158523940221085
10284	astemizole	hsa05219	Bladder cancer	1026_11186_9252_3576_1612_7422	6	+	0.0287352441743389	0.373558174266406
10285	astemizole	hsa04010	MAPK signaling pathway	9479_1326_1649_50487_4208_3310_3164_11221_4616_5319_836_5923_4214_468_9252_3725_3727_1647_1848_781_782_1843_5598_1847_1846_8817_6196_2258_2353_5971	30	+	0.000214859795302881	0.00558635467787491
10286	astemizole	hsa05012	Parkinson's disease	836	1	+	0.0151704867284226	0.236659592963393
10287	astemizole	hsa04740	Olfactory transduction	818	1	-	0.000372008978563745	0.0249246015637709
10288	mefloquine	hsa05010	Alzheimer's disease	7124_1339	2	+	0.00215378554724577	0.0579504584201191
10289	mefloquine	hsa05016	Huntington's disease	64446_5430_1339_6648_5978	5	+	0.0448475308017004	0.459687190717429
10290	mefloquine	hsa04740	Olfactory transduction	816	1	+	1.82367396699593e-09	7.47706326468331e-08
10291	mefloquine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_8349_8348_8329_8294_121504_8343_8341_8347_8352_8345_8344_8339_723790_8346_8969_8968_55766_8370_718_92815_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_7124_8353_8354_8355_8356_8357_8332_85235_85236_3012_3013_3017_8970	53	+	1.48976132405529e-21	1.22160428572534e-19
10292	mefloquine	hsa04710	Circadian rhythm - mammal	8553_9572_5187_79365	4	+	0.0155816349322659	0.182527723492258
10293	mefloquine	hsa05219	Bladder cancer	2277_1026_11186_4193_5925_7422_4609_2261	8	+	0.00850255052321363	0.138520740726036
10294	mefloquine	hsa04010	MAPK signaling pathway	1326_1649_4609_5602_3725_3164_3303_11221_4616_3554_2261_2264_1647_7042_3310_7124_3727_4791_786_1848_782_2318_1843_3304_1847_1846_8817_7189_5598_2353_5971	31	+	0.00282685163024971	0.0579504584201191
10295	mefloquine	hsa04270	Vascular smooth muscle contraction	1909	1	+	0.0101356639555636	0.138520740726036
10296	mefloquine	hsa04740	Olfactory transduction	5567	1	-	0.000264270578457621	0.0206131051196944
10297	pirenperone	hsa05010	Alzheimer's disease	487_6622_3708_3709_1339	5	+	0.00732263468745711	0.333179878279299
10298	pirenperone	hsa04740	Olfactory transduction	56656_1179_2978_3000_26539_5132_816	7	+	3.19495503636623e-07	2.90740908309327e-05
10299	pirenperone	hsa05012	Parkinson's disease	9627_7416_6622_1339	4	+	0.0351187114381345	1
10300	pirenperone	hsa05016	Huntington's disease	23236	1	-	0.0323141970344672	0.53764160770332
10301	pirenperone	hsa04740	Olfactory transduction	26212	1	-	0.00012557136232562	0.00489728313069918
10302	pirenperone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_718_8368_8366_8359_8336_8294_8367_554313_121504	16	-	3.71141096519525e-05	0.00289490055285229
10303	pirenperone	hsa04810	Regulation of actin cytoskeleton	10152_8503_5829_10672_3693_5155_5154_8394_7430_3984_28964_2264_3675	13	-	0.0344642056220077	0.53764160770332
10304	pirenperone	hsa05220	Chronic myeloid leukemia	8503_3551_4088_6777_4193_7046_5781	7	-	0.0136696211044107	0.355410148714678
10305	sodium phenylbutyrate	hsa04070	Phosphatidylinositol signaling system	5333_5335_5291	3	+	0.0437384062097609	0.49752437063603
10306	sodium phenylbutyrate	hsa05010	Alzheimer's disease	836_5594_840_317_355_5530_22926_489_7381_23621	10	+	0.0162892310429199	0.349553059291859
10307	sodium phenylbutyrate	hsa04742	Taste transduction	5566	1	+	0.0268886968686045	0.349553059291859
10308	sodium phenylbutyrate	hsa05016	Huntington's disease	4899_836_6648_7052_5441_317_55081_246721_3066_9001_7019_1385_7381	13	+	0.0499785281701698	0.505338451498384
10309	sodium phenylbutyrate	hsa04740	Olfactory transduction	26211_56656_157_5566_2979_8392_818_26532_8590_409	10	+	7.5890196262939e-10	6.90600785992745e-08
10310	sodium phenylbutyrate	hsa05322	Systemic lupus erythematosus	723790_717_3017_727_8337_720_721_8357	8	+	0.0245630890406359	0.349553059291859
10311	sodium phenylbutyrate	hsa04062	Chemokine signaling pathway	5594_157_156_6655_3627_5291_5906_409_5747_6362_5566_8976	12	+	0.0219887500799704	0.349553059291859
10312	sodium phenylbutyrate	hsa05012	Parkinson's disease	836_7314_7381_317_2861	5	+	0.00355392688978813	0.16170367348536
10313	sodium phenylbutyrate	hsa04260	Cardiac muscle contraction	7381_782_4635	3	+	0.0227885886742184	0.349553059291859
10314	sodium phenylbutyrate	hsa05016	Huntington's disease	55567	1	-	0.0485448345774707	1
10315	sodium phenylbutyrate	hsa04740	Olfactory transduction	5137	1	-	0.00011844946906033	0.00840991230328343
10316	azathioprine	hsa05332	Graft-versus-host disease	3553_3552_3123_3107_3126_3127_3125	7	+	0.00575400970600962	0.14369387584213
10317	azathioprine	hsa04640	Hematopoietic cell lineage	2815_3553_3552_2812_3123_3568_3126_3127_3125_3589_925_926	12	+	0.00148935563476845	0.059574225390738
10318	azathioprine	hsa05320	Autoimmune thyroid disease	7252_3123_3107_3126_3127_3125	6	+	0.0472733286085968	0.540266612669678
10319	azathioprine	hsa04740	Olfactory transduction	1179	1	+	5.05509633004014e-07	4.04407706403211e-05
10320	azathioprine	hsa04514	Cell adhesion molecules (CAMs)	3123_1272_3107_3126_3127_3125_5797_51208_9672_3897_925_926_1462	13	+	0.0235685538473458	0.377096861557533
10321	azathioprine	hsa05330	Allograft rejection	3123_3107_3126_3127_3125	5	+	0.0416401056145944	0.540266612669678
10322	azathioprine	hsa04940	Type I diabetes mellitus	3553_3552_3123_3107_3126_3127_3125	7	+	0.0071846937921065	0.14369387584213
10323	azathioprine	hsa05332	Graft-versus-host disease	3812_3811_3553_3118_3117_3106_3569_942_940_3802_3134_355_356_5551	14	-	0.0144280386781163	0.305927884117697
10324	azathioprine	hsa05010	Alzheimer's disease	776_3553_4712_841_1329_317_355_51107_3708_5534_810_23621_517_23236	14	-	0.0166265154411792	0.305927884117697
10325	azathioprine	hsa05016	Huntington's disease	8218_246721_5439_6648_4712_841_1329_317_64446_3708_2033_7419_548644_517_23236	15	-	0.0149830659917247	0.305927884117697
10326	azathioprine	hsa04740	Olfactory transduction	219464_5566_8390_23538_26716_5137_8392_810_393046	9	-	3.60730287989661e-14	3.31871864950488e-12
10327	azathioprine	hsa04530	Tight junction	5584_10000_5581_998_8777_4633_84612_51776_5728_5865_3996	11	-	0.0477295147010197	0.65752441732089
10328	azathioprine	hsa05012	Parkinson's disease	2861_7419_4712_1329_317_5071_517	7	-	0.00236859971993505	0.108955587117012
10329	nifedipine	hsa05010	Alzheimer's disease	322_3708_3709_22926_56901	5	+	0.0451055688037018	0.754333431064601
10330	nifedipine	hsa04910	Insulin signaling pathway	5599_23265	2	+	0.00865067819781272	0.250869667736569
10331	nifedipine	hsa04520	Adherens junction	7454_5879_4088_3480_5795_1956_56288_91_2260_10458_2241	11	+	0.0475302975730591	0.754333431064601
10332	nifedipine	hsa04740	Olfactory transduction	26211_135948_442194_442186_4995_81797_5137_81696_816_817	10	+	0.00050732552834013	0.0441373209655913
10333	nifedipine	hsa05012	Parkinson's disease	56901	1	+	0.00227693996559307	0.0990468885032985
10334	nifedipine	hsa04120	Ubiquitin mediated proteolysis	10277_51343_4281_8916	4	-	0.013251336890378	0.401957219008133
10335	nifedipine	hsa04080	Neuroactive ligand-receptor interaction	2555_2905_6752_2563_2908_3360_3354_7067_186_10203_7433_3269	12	-	0.0233676810137702	0.425291794450618
10336	nifedipine	hsa04740	Olfactory transduction	810_8390_393046_157	4	-	3.29506957928669e-10	2.99851331715089e-08
10337	nifedipine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8347_8346_8344_87_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235_3119_3118_3117_942	31	-	3.49023720916025e-05	0.00158805793016791
10338	nifedipine	hsa04710	Circadian rhythm - mammal	1454_4862_1407_9572	4	-	0.0445504255934781	0.532360973794697
10339	nifedipine	hsa05012	Parkinson's disease	4712_842_517_65018	4	-	0.0184156479177209	0.41895599012815
10340	nifedipine	hsa04260	Cardiac muscle contraction	477_781	2	-	0.0458277415704928	0.532360973794697
10341	nifedipine	hsa03010	Ribosome	6142_285053_6165	3	-	0.0468009647292041	0.532360973794697
10342	mercaptopurine	hsa05332	Graft-versus-host disease	3804_355_3107_5551_3119	5	+	0.00118500922752052	0.0402903137356977
10343	mercaptopurine	hsa05320	Autoimmune thyroid disease	355_3107_5551_3119	4	+	0.0161552872578859	0.156937076219463
10344	mercaptopurine	hsa04740	Olfactory transduction	815	1	+	0.015410601018595	0.156937076219463
10345	mercaptopurine	hsa05322	Systemic lupus erythematosus	3119_3017_8337_8343_8339_8347_8346_8344	8	+	0.00453216587820236	0.0947800310469331
10346	mercaptopurine	hsa04115	p53 signaling pathway	1026_1029_3486_355_5054_8795_4616	7	+	0.000307233561856944	0.0208918822062722
10347	mercaptopurine	hsa05330	Allograft rejection	355_3107_5551_3119	4	+	0.00557529594393724	0.0947800310469331
10348	mercaptopurine	hsa04940	Type I diabetes mellitus	355_3107_5551_3119	4	+	0.00895536670996941	0.121792987255584
10349	mercaptopurine	hsa05010	Alzheimer's disease	1329_779	2	-	0.0180667705637762	0.599545084424803
10350	mercaptopurine	hsa04080	Neuroactive ligand-receptor interaction	5029_4159_3360_799_2893	5	-	0.0346136436697624	0.645468474993683
10351	mercaptopurine	hsa04740	Olfactory transduction	10798	1	-	3.41033084749509e-07	2.79647129494597e-05
10352	mercaptopurine	hsa05012	Parkinson's disease	1329	1	-	0.021934576259444	0.599545084424803
10353	felodipine	hsa05016	Huntington's disease	5432_4899_5430	3	+	0.0270925251999095	0.361233669332127
10354	felodipine	hsa04740	Olfactory transduction	81696_81797	2	+	6.45717409711484e-07	2.58286963884594e-05
10355	felodipine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_8349_8348_8329_8294_121504_8343_8341_8347_7124_8344_8339_723790_87_8969_8968_8346_8370_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3012_3013_3014_8970	49	+	4.86071097790706e-22	3.88856878232565e-20
10356	felodipine	hsa04710	Circadian rhythm - mammal	406_9572_5187_8553	4	+	0.00866473918363012	0.138635826938082
10357	felodipine	hsa04920	Adipocytokine signaling pathway	3953_208_10645_8660_1375_7186_4794_7124_9021_4792	10	+	0.00473274381410527	0.0946548762821054
10358	felodipine	hsa04010	MAPK signaling pathway	1326_5607_3310_3164_11221_4616_1850_1399_2263_777_773_208_5778_5534_3725_7124_3727_4791_1647_782_1843_6655_1649_1846_2353_5971_7186	27	+	0.00276940876295419	0.0738509003454451
10359	felodipine	hsa05332	Graft-versus-host disease	3812_3118_3117_3804_3106_3126_3127_940_3125_3135_355_3123_3105_942_649853	15	-	8.62191514643549e-05	0.00244287595815672
10360	felodipine	hsa04080	Neuroactive ligand-receptor interaction	2905_4158_2908_4886_7434_3354_9568_2563	8	-	0.000248529177523342	0.00528124502237102
10361	felodipine	hsa05320	Autoimmune thyroid disease	3118_3117_3105_3106_3126_3127_940_3125_3135_355_3123_942_649853	13	-	0.00667559551089123	0.0709282023032193
10362	felodipine	hsa04740	Olfactory transduction	219464_157_8390_818_109_810	6	-	9.8188714916067e-10	8.3460407678657e-08
10363	felodipine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_94239_8366_8368_8329_8294_8342_8367_3123_3126_3127_3125_8969_55766_8370_8332_8359_8330_8331_8336_554313_121504_85235_3118_3117_942_940_727	33	-	3.85366134103992e-05	0.00163780606994197
10364	felodipine	hsa04530	Tight junction	79784_55844_50855	3	-	0.00232340947250713	0.0282128293090151
10365	felodipine	hsa05310	Asthma	3118_3117_3123_3126_3127_3125_6037	7	-	0.0400907272059762	0.340771181250798
10366	felodipine	hsa03010	Ribosome	6204_6165_6181	3	-	0.0240789244069124	0.227412063843062
10367	felodipine	hsa05330	Allograft rejection	3118_3117_3105_3106_3126_3127_940_3125_3135_355_3123_942_649853	13	-	0.000355657316401884	0.00556709871821794
10368	felodipine	hsa04940	Type I diabetes mellitus	3118_3117_3105_3106_3126_3127_940_3125_3135_355_3123_649853_942_5798	14	-	0.000392971674227149	0.00556709871821794
10369	nitrendipine	hsa04910	Insulin signaling pathway	51806_5584_6655_5140_5562_9021_5575	7	+	0.0468645901630356	0.532691154105597
10370	nitrendipine	hsa04740	Olfactory transduction	51806_7932_135948_815_818_81797_4991_81696_9635_1258_817	11	+	8.71469321052093e-08	7.66893002525842e-06
10371	nitrendipine	hsa05110	Vibrio cholerae infection	23545	1	+	0.0275897629644972	0.532691154105597
10372	nitrendipine	hsa04512	ECM-receptor interaction	2815_2814_1281_22798_1302_3690_948_1280_1277_63923_50509_2335_960_9672_51206_3676_1301	17	+	0.0254916262975514	0.532691154105597
10373	nitrendipine	hsa05012	Parkinson's disease	1339_6390_6622_317_56901	5	+	0.00929514692726778	0.408986464799782
10374	nitrendipine	hsa03010	Ribosome	140801_6192_439992_6189	4	+	0.0448846861770888	0.532691154105597
10375	nitrendipine	hsa04120	Ubiquitin mediated proteolysis	4214_23759_4281_6923	4	-	0.0341684195393493	0.655772019337702
10376	nitrendipine	hsa04080	Neuroactive ligand-receptor interaction	5618_3269_2563_2925_3354_3001_4987_4986_9568	9	-	0.0113096696878092	0.316670751258658
10377	nitrendipine	hsa04740	Olfactory transduction	810_2978_8390_157	4	-	7.31602591296832e-09	6.14546176689339e-07
10378	nitrendipine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_6738_121504_85235_3119_3113	24	-	0.00134898654220813	0.0566574347727415
10379	nitrendipine	hsa04664	Fc epsilon RI signaling pathway	5163_8398_6850_5578_6655_7410_27040_9846_5603_5602_30814_5594	12	-	0.0396027845370493	0.655772019337702
10380	nitrendipine	hsa05012	Parkinson's disease	2861_1329_317_4712	4	-	0.0468408585241216	0.655772019337702
10381	arachidonyltrifluoromethane	hsa04080	Neuroactive ligand-receptor interaction	3360_2893	2	+	0.0131034828208615	0.904140314639443
10382	arachidonyltrifluoromethane	hsa05332	Graft-versus-host disease	3804_57292_3811_355_3133	5	-	0.0195234833847855	0.741892368621849
10383	arachidonyltrifluoromethane	hsa04740	Olfactory transduction	26529	1	-	3.73706157461262e-05	0.00284016679670559
10384	sirolimus	hsa04650	Natural killer cell mediated cytotoxicity	4776_3383_5532_3445_8743_5293_5290_3135_80328_27040_6452_3845_5781_5534_7535_5335_4772_8794_8795_2534_6850	21	+	0.0226321694364598	0.177285327252268
10385	sirolimus	hsa04120	Ubiquitin mediated proteolysis	10277_23759_7322_4281_7320_55294_51343_5371_51619_326_26232_10075_4193_8651_9820_8450_55284_868_25898_7318_867_7428	22	+	0.0304143571731898	0.219919198021526
10386	sirolimus	hsa05010	Alzheimer's disease	317_2776_5331_5664_6622_4695_4694_348_776_54205_5532_3709_6868_5534_5663_842_841_4713_642502_6391_4137_22926	22	+	0.000520266150686722	0.012226254541138
10387	sirolimus	hsa04080	Neuroactive ligand-receptor interaction	151_2901_886_4889_64106_2908_2925_5030_552_3062_56288_135_1909_6755_2568_1812_2740_2563_3363_7434_3953_2688_2689_1442_146_2911_719_2918_1131_4886_4887_3355_5733_4157_5618_7442_2555_7068_7067_2570_2892_1241_2692_728	44	+	0.00919793732306503	0.105005540278241
10388	sirolimus	hsa05016	Huntington's disease	8218_4899_317_246721_2776_5331_6875_5432_6648_4694_7052_6667_7416_1213_54205_9001_5468_161_27113_842_841_4713_642502_6391_3092_7157_4695_1385_1387	29	+	0.00663693801896696	0.0979563132196706
10389	sirolimus	hsa03420	Nucleotide excision repair	2074_29935_8450	3	+	0.0111708021572597	0.105005540278241
10390	sirolimus	hsa04740	Olfactory transduction	26212_157_5613_5566_442194_5137_26539	7	+	5.93445325690182e-30	5.57838606148771e-28
10391	sirolimus	hsa03030	DNA replication	4173_29935_5558	3	+	0.0467313838477655	0.306185832051687
10392	sirolimus	hsa04062	Chemokine signaling pathway	10000_157_156_5293_5290_9475_115_56288_2309_7454_2786_10850_5829_5566_3576_6368_1398_6360_408_2785_6093_10681_5331_6357_5613_6777_6772_51764_3845_8976	30	+	0.00729461906954994	0.0979563132196706
10393	sirolimus	hsa05012	Parkinson's disease	2861_54205_4695_7318_4713_642502_6391_317_7345_7416_65018_4694_6622_842	14	+	0.000329351024081442	0.0103196654212185
10394	sirolimus	hsa04260	Cardiac muscle contraction	776_6262_782_4635	4	+	4.45334770702082e-05	0.00209307342229979
10395	sirolimus	hsa04060	Cytokine-cytokine receptor interaction	3597_55540_5155_5154_8741_7850_6368_8792_2323_27242_3552_2057_10850_3574_3576_3953_4982_2688_2689_3976_8718_6360_3082_3581_3626_23529_3589_8771_3624_8742_1435_8743_7042_90_93_268_8794_8795_6357_5618_3561_3566_1271_3445_8995_7423_7422	47	+	0.0185056168050407	0.158138907243075
10396	sirolimus	hsa03010	Ribosome	6204_440589_6139_6181_6138_6187_284393_439992_6144_6160_6129_389342_6189	13	+	0.0107451802189491	0.105005540278241
10397	sirolimus	hsa03050	Proteasome	5717_5689	2	+	0.00140618931147095	0.0264363590556539
10398	sirolimus	hsa04610	Complement and coagulation cascades	5265_719_5627_2_3075_1361_1675_728_7035	9	+	0.0488594412848436	0.306185832051687
10399	sirolimus	hsa04120	Ubiquitin mediated proteolysis	5371_7329_652671_7327_7322_51343_6477_51433_26091_83737_51619_26232_23291_997_996_8065_8454_8453_8450_7337_4734_6502_867_22888_27338_51465	26	-	0.047423800828637	0.247657626549549
10400	sirolimus	hsa04640	Hematopoietic cell lineage	1436_3581_966_960_2057_3123_3126_3127_3125_914_3678_3673_3655_3589	14	-	0.0412333492086204	0.242245926600645
10401	sirolimus	hsa05010	Alzheimer's disease	51806_2597_3710_572_2776_5332_5664_6622_1327_836_4701_11261_651820_776_5533_5532_3709_5534_487_8851_23236_4713_6392_642502_6391_4137_355_808_823_351_805_801_517	33	-	0.0235094694405024	0.169991548262094
10402	sirolimus	hsa04080	Neuroactive ligand-receptor interaction	1269_1081_4889_2908_2901_553_5031_56288_5644_1813_3362_2742_2150_7433_5029_2911_3953_1131_148_3354_5732_9170_5618_7442_2555_6915_7068_2690	28	-	4.64321585568735e-08	2.18231145217305e-06
10403	sirolimus	hsa04742	Taste transduction	5568_3710_5613_5567_5616_50831_346562	7	-	0.0442495544634126	0.244674007032987
10404	sirolimus	hsa05016	Huntington's disease	4899_1327_246721_2776_5332_3064_10126_5432_5433_6648_5434_7052_651820_64446_2033_1212_1211_581_836_161_23236_27113_4701_4713_6392_642502_6391_7157_1385_1387_517	31	-	0.00307029297938952	0.0360759425078269
10405	sirolimus	hsa04740	Olfactory transduction	808_51806_5568_5613_5567_5616_393046_818_2978_109_409_4991_805_801_26529_9635_816	17	-	1.5739352044408e-24	1.47949909217435e-22
10406	sirolimus	hsa05340	Primary immunodeficiency	6890_64421	2	-	0.00943734404039069	0.0824577165922583
10407	sirolimus	hsa03410	Base excision repair	3980_4968	2	-	0.00964930726079619	0.0824577165922583
10408	sirolimus	hsa04140	Regulation of autophagy	115201_23192	2	-	0.00943734404039069	0.0824577165922583
10409	sirolimus	hsa04512	ECM-receptor interaction	960_3912_3910_3693_1605_1288_3678_6383_6382_3673_3655_9672_961	13	-	0.0367097091892971	0.230047510919595
10410	sirolimus	hsa04630	Jak-STAT signaling pathway	3717_10000_3594_5295_5293_5291_9180_9655_10253_30837_10254_2057_3455_3572_2033_5781_3976_3581_896_3953_3589_10379_5618_3460_6655_6777_867_1387_2690	29	-	0.0321524441133106	0.215880696189371
10411	sirolimus	hsa05012	Parkinson's disease	2861_7327_836_1327_4701_4713_6392_642502_6391_651820_51465_6531_6622_517	14	-	4.329161845441e-05	0.00135647071157151
10412	sirolimus	hsa04260	Cardiac muscle contraction	776_6262_1327_6548_10368_27092_481	7	-	0.000487049325240667	0.00915652731452454
10413	sirolimus	hsa04060	Cytokine-cytokine receptor interaction	3594_5155_5154_8741_7852_6387_9180_1896_27242_2057_2324_3576_3572_657_4982_10913_3976_8718_6367_6366_3082_3581_7293_3953_3589_23765_2277_655_4233_8795_1436_5618_3460_3455_943_6358_6359_355_7422_51330_2690	41	-	0.000147879455066234	0.0034751671940565
10414	sirolimus	hsa03010	Ribosome	9349_6138_6129_6203_6204_6141_284393_439992_6144_6165_389342_6189	12	-	0.00147213081052242	0.0197686137413011
10415	sirolimus	hsa03050	Proteasome	5717_10197_5699_23198_5719	5	-	0.0206308919972314	0.161608653978313
10416	sirolimus	hsa04610	Complement and coagulation cascades	966_2160_7056_5265_5329	5	-	0.000622456316289381	0.00975181562186697
10417	diclofenac	hsa05332	Graft-versus-host disease	3804_3119_3133_3111_3134	5	+	0.0445580883115501	0.696848761670462
10418	diclofenac	hsa05010	Alzheimer's disease	322_4695	2	+	0.0358286477348547	0.696848761670462
10419	diclofenac	hsa04740	Olfactory transduction	26212_23538_157_1179_4991	5	+	0.00170551885514765	0.13814702726696
10420	diclofenac	hsa04530	Tight junction	5581	1	+	0.0481446320464827	0.696848761670462
10421	diclofenac	hsa05010	Alzheimer's disease	1329_489_841_5534	4	-	0.0190687101371688	0.297471878139833
10422	diclofenac	hsa04080	Neuroactive ligand-receptor interaction	1132_5618	2	-	1.85680905083522e-05	0.000724155529825736
10423	diclofenac	hsa05016	Huntington's disease	5430_1329_90993_841_5978	5	-	0.0336791863647913	0.382854740001131
10424	diclofenac	hsa04740	Olfactory transduction	157_409	2	-	8.96085055325358e-09	6.98946343153779e-07
10425	diclofenac	hsa05012	Parkinson's disease	1329	1	-	0.00343312580506502	0.0892612709316905
10426	diclofenac	hsa04020	Calcium signaling pathway	5335_2767_489_5534	4	-	0.0140072969095132	0.273142289735507
10427	diclofenac	hsa04270	Vascular smooth muscle contraction	5605_2767	2	-	0.0343587587180502	0.382854740001131
10428	trichostatin A	hsa04120	Ubiquitin mediated proteolysis	23327_10277_29882_10273_8554_7328_23759_331_330_9246_7332_7322_11059_9039_6921_652671_4281_51366_7321_55294_22888_5371_51433_26091_8925_8924_26272_55236_8651_326_329_23291_4214_996_89910_9354_8065_4193_672_23221_26232_10393_8453_7329_8450_8945_7320_9021_55284_7337_868_25898_7319_7318_11060_6500_867_3093_51588_27338_9690_8916_7189_57154_63893_7428	66	+	0.00280440954595319	0.0239649543017818
10429	trichostatin A	hsa05010	Alzheimer's disease	2902_2081_3710_2904_572_1329_317_9451_2776_5663_5330_4023_5664_7381_6622_836_3553_4694_4697_4698_11261_651820_4709_322_808_522_509_810_23621_348_4842_775_776_1339_5534_54205_5530_5533_5532_3708_3709_6868_489_1020_102_4695_23236_5331_5594_841_4712_6392_642502_6390_6391_4719_4137_842_805_351_4713_22926_801_517	64	+	3.50557201019157e-07	1.09841256319336e-05
10430	trichostatin A	hsa04080	Neuroactive ligand-receptor interaction	1268_2846_5745_135_134_2488_9287_624_4142_3972_2150_2151_4987_9568_2859_2911_2912_2913_2914_719_2917_2918_5032_4887_6915_10203_23566_2550_5618_7442_2554_2555_2557_5617_2798_10800_2149_2902_2901_1081_2904_2908_3274_6754_6755_799_7434_1133_7433_1395_1394_3953_1132_1131_9002_3269_4543_2832_2570_2692_1241_2563_6869_623_9127_64106_5732_2925_2862_56288_1909_887_9038_3363_1902_154_2568_8001_4829_2561_5540_3360_3361_3362_2566_57105_2688_2689_185_186_5028_5021_10316_1910_2898_6752_2897_2893_2892_2696_2357_728_151_153_155_886_554_59340_3062_55879_5645_5644_5646_1816_4161_1813_5724_2741_2740_3973_2742_1442_146_147_148_3355_5734_3356_3351_3350_5733_3352_6865_5739_3358_1812_7068_7067_4158_11255_8484_680	142	+	0.00648471974232897	0.0468895119829941
10431	trichostatin A	hsa05200	Pathways in cancer	3716_1147_10297_1613_91_5899_10342_2323_51176_4149_7479_5228_5371_405_650_2249_2247_8900_23604_11186_3480_54205_999_998_673_1956_1495_5467_7042_4233_7048_2261_5594_83439_6655_5599_3845_7476_2259_2258_5915_5914_2254_2253_2251_2250_5159_2475_22798_596_7855_5155_5154_5156_5605_5604_4313_5601_867_3655_8324_8326_3674_3675_2308_4286_6789_3815_3479_1856_1857_51384_1399_1398_367_2260_1017_112399_581_4193_6932_2257_11211_8453_1436_2277_1387_2271_842_5579_5578_6774_6776_6777_1438_8817_51588_3091_7423_7422_7428_8503_8554_2735_572_331_330_5337_5336_6921_652671_613_2885_27006_4824_5900_5296_652_2263_7040_3082_10319_6513_9134_8322_1950_5293_2122_54361_7480_7482_5898_3725_2950_26281_868_1026_1021_841_26060_861_862_1029_3685_2353_10928_23533_2736_10000_4088_4089_5602_8074_5290_7175_5881_5880_7170_7039_26291_5888_7046_8823_1050_5728_7189_1612_5727_5925_2034_324_7471_7472_329_7474_7475_4842_3914_3912_3910_1496_898_208_3688_4254_3918_1870_9618_6772_836_4791_1284_1286_2335_1282_1288_356_354_3576_7849_7184_8643_2535	203	+	0.0367107120283368	0.199124041372344
10432	trichostatin A	hsa04742	Taste transduction	2778_3710_114_112_5136_2785_2784_5568_5566_5567_50833_40_2914_773_6340_100134077_3745_5330_51764_50832_50835_50839_6338	23	+	0.0278784794116522	0.187184076049665
10433	trichostatin A	hsa04310	Wnt signaling pathway	56998_23236_11197_4088_1454_10297_7855_6885_9475_5331_5330_5881_5880_5601_5526_5602_5528_8324_8326_3725_8322_51176_7482_4776_4040_7476_27101_7474_51701_11261_5567_1856_1857_818_7479_5527_324_4089_7471_7472_64840_59343_7475_23291_5568_894_4316_6425_10725_5663_896_5530_23500_5519_5532_11211_54361_7480_5467_5534_8945_6093_5515_5516_6424_6932_64321_5579_5578_83439_80319_51384_6500_1459_23002_5599_4775_5533_816_1452_4772_1387_5566_2535	84	+	0.0339340551172014	0.199124041372344
10434	trichostatin A	hsa05016	Huntington's disease	2902_4899_5440_627_2904_64764_1329_317_55081_2776_4719_5331_5330_1211_23186_4697_7019_6875_7381_10126_5432_5433_5430_836_6648_4694_5434_7052_1639_5439_651820_4709_10488_64446_7416_522_509_3064_7419_90993_1212_1213_1175_7802_1339_2876_581_54205_7350_163_10540_9001_4712_5436_55567_548644_161_23236_27113_27019_842_841_4713_6392_642502_6390_6391_8218_3708_246721_3092_4695_4698_1387_9519_5441_517_291	78	+	1.09908096900838e-05	0.000206627222173575
10435	trichostatin A	hsa03420	Nucleotide excision repair	1069_57804_6117_2966_5111_1022_5425_5981_2968_4331_2068_5887_902_8450_2072_7508_29935_2067	18	+	0.038772034390645	0.199124041372344
10436	trichostatin A	hsa04740	Olfactory transduction	7932_157_23538_5137_26476_26532_390892_26539_9635_26211_26212_5568_26333_5566_5567_442194_5132_818_810_409_4993_26692_1179_2978_2979_81797_81697_26189_5593_5592_442186_808_816_4991_801_393046_805_1258	38	+	1.07400612633372e-53	1.0095657587537e-51
10437	trichostatin A	hsa04110	Cell cycle	4089_29882_5111_4085_4088_983_8555_11200_996_23594_23595_1870_651610_4616_10971_699_51433_5925_10912_545_1032_1017_7531_8900_995_902_5001_5000_894_990_896_9134_898_4193_10393_8556_7040_7042_9700_8243_5591_1647_1026_1021_1022_6500_1029_1028_472_5934_5933_1387	52	+	0.00138496273441934	0.0130186497035418
10438	trichostatin A	hsa03410	Base excision repair	57804_55247_5111_5425_5423_10039_4968_8930	8	+	0.00108815529410625	0.0113651775162208
10439	trichostatin A	hsa04530	Tight junction	9076_5010_9074_10000_9073_9071_2770_2771_93643_2773_4301_50855_6709_10398_88_89_56288_4636_22808_3059_9223_9863_24146_2037_5584_5583_5581_10686_8573_93408_2035_5588_4626_2036_84612_51776_51208_4633_3996_2017_23562_50848_10627_29895_10207_208_103910_998_60_5519_5865_4624_1495_1496_4627_4628_4629_26285_5515_5516_5590_7082_8189_5579_5578_22989_79784_5728_3845_7525_5521_6237_1459_27134_4625	75	+	0.0423668173132647	0.199124041372344
10440	trichostatin A	hsa03030	DNA replication	57804_6117_5111_5425_5981_5558_29935	7	+	0.000505302160098049	0.00642213514542892
10441	trichostatin A	hsa04062	Chemokine signaling pathway	3717_5567_1147_3718_9475_7454_5829_5906_10663_5908_409_408_2919_998_673_729230_6093_10681_5590_5594_6655_51764_3845_2792_2790_2791_8976_2770_2771_2773_115_5604_2829_10235_112_2309_2784_2786_3579_5566_3576_2788_1524_25759_1399_1398_1234_1236_1237_1230_1233_2931_9844_2833_107_5579_6774_2885_6772_6773_6372_6373_6374_6376_8503_7852_5330_56288_4067_10850_7410_6369_6363_6362_26230_6360_6366_2185_6361_23236_6356_6357_6354_6355_6352_114_6358_6359_643752_23533_6777_10000_113_157_156_5296_5293_5290_5880_5058_6347_7074_5197_2785_208_100134077_5568_3055_5331_4793	110	+	0.0345913372098099	0.199124041372344
10442	trichostatin A	hsa05012	Parkinson's disease	2861_1329_317_9246_7345_7054_6531_7381_6622_836_4695_4694_4697_5413_4698_651820_4709_7416_522_509_7419_642502_1339_54205_7332_27429_9627_842_7318_4712_4713_6392_7314_6390_6391_4719_65018_517_291	39	+	3.08039150768892e-08	1.44778400861379e-06
10443	trichostatin A	hsa03430	Mismatch repair	57804_5981_5111_5395_5425_6117_29935	7	+	0.0410062344550136	0.199124041372344
10444	trichostatin A	hsa04260	Cardiac muscle contraction	1329_7139_7170_4635_4634_7381_10479_7137_6262_775_776_1339_785_9254_786_4624_4625_70_483_482_481_6546_7168_7169_781_782_783_6548_477_478	30	+	0.000546564693227993	0.00642213514542892
10445	trichostatin A	hsa04060	Cytokine-cytokine receptor interaction	56034_2323_3556_2321_3554_3553_3552_3594_3791_3559_3558_4982_10663_8718_2919_23765_5618_1956_1950_7042_6352_268_4233_7048_3560_3567_3565_3568_5617_5159_5155_5154_5156_2829_7133_1233_53832_3579_3576_3570_3572_1524_23495_1234_3581_1236_1237_1230_3586_3815_3588_3589_4254_55801_2833_4352_1436_1437_2277_1435_2057_11009_970_1438_1439_50615_9966_50616_7423_7422_6372_6373_6374_6376_3593_3590_3596_3595_64109_55540_8744_8743_7852_7850_60401_3455_27242_58985_3454_10850_3459_6369_655_2688_10913_650_6363_6362_6361_6360_6366_7040_2689_7292_3600_3606_3604_8771_91_92_6356_6357_6354_6355_3449_3448_3447_3446_3440_6358_6359_3082_7293_9180_1896_51561_3439_6347_5197_3977_958_1271_3624_4804_8792_8793_8794_8795_3587_3953_943_356_7046_83729_729230	145	+	0.0052270073863625	0.0409448911931729
10446	trichostatin A	hsa03010	Ribosome	285053_140801_9349_6125_6142_6141_284393_6123_6144_6165_28998_6204_6129_439992_6187_6205_6202_6203_389342_6189_440589_6224_6181_9045_6171_6139_51187_6194_6192_6234_6233	31	+	5.44911625261853e-06	0.000128054231936535
10447	trichostatin A	hsa03050	Proteasome	10197_5718_5706_5721_5710_5690_5689_7979_5698_23198	10	+	7.97675083928379e-05	0.00124969096482113
10448	trichostatin A	hsa04640	Hematopoietic cell lineage	3570_3678_3655_3673_3675_2323_3554_3553_3575_3123_3126_3127_3125_933_3581_3815_3589_4254_915_960_1437_1435_3566_3568_3569_3690_920_925_926	29	-	0.00506839755969838	0.0366484131239729
10449	trichostatin A	hsa03320	PPAR signaling pathway	10062_3611_2710_335_79966_1962_2173_1375_1374_1376_28965_4199_2180_1593_5468_11001_7316_51_9415_6319_6257_6256	22	-	0.00669039533900883	0.0419264774577887
10450	trichostatin A	hsa05010	Alzheimer's disease	55851_2597_3710_51806_572_1329_4712_2776_5663_5330_5332_5664_4694_7132_6622_1327_7381_3553_4728_4700_4698_11261_8883_509_810_7385_348_4842_22926_776_1339_637_8772_5530_5533_5532_3708_3709_6868_489_5534_102_836_487_8851_23236_4714_5331_5594_841_4713_642502_6390_6391_1537_355_842_23385_517_351_824_513_823	63	-	0.000210693484494011	0.00330086459040617
10451	trichostatin A	hsa04080	Neuroactive ligand-receptor interaction	2570_1269_152_155_4889_64106_2847_706_2908_2925_2901_5030_5031_55879_56288_136_134_5645_5644_5646_5021_2741_3354_5029_2488_1813_2561_3360_3361_799_7434_3953_2150_2689_4987_7068_9568_2688_1395_1442_2859_2911_6754_2917_2918_1131_4157_5025_4886_5026_6915_3362_146_148_1812_552_9170_5618_7442_2555_9294_7253_7067_2559_6751_2893_2692_2740_2798_1909_2149_2690	72	-	1.05576995112174e-09	4.96211877027218e-08
10452	trichostatin A	hsa04742	Taste transduction	2785_6340_5568_3710_2782_5613_5566_5616_5330_51764_6337_112_6338	13	-	0.00215477014826376	0.0202548393936793
10453	trichostatin A	hsa05131	Shigellosis	9076_25_4950_7280_347733_7278_3688_999_113457_998_9475_60_203068_7430_9181_7534_2017_6093_8976_5578	20	-	0.043689270779192	0.157953517432463
10454	trichostatin A	hsa05016	Huntington's disease	4899_627_1327_1329_4712_246721_2776_5331_5330_5332_3064_6875_7381_7385_5432_1537_5430_6874_6648_4694_5434_4700_7052_1639_5438_5439_6667_836_7416_509_2033_7419_1212_1213_1175_1211_1339_2876_581_55567_163_9001_5468_548644_161_5481_23236_4714_27113_51164_842_841_4713_642502_6390_6391_3708_3092_7157_5978_4728_4698_1385_513_1387_293_517	67	-	0.000147102702251227	0.00276553080232307
10455	trichostatin A	hsa05130	Pathogenic Escherichia coli infection	9076_25_4950_7280_347733_7278_3688_999_113457_998_9475_60_203068_7430_9181_7534_2017_6093_8976_5578	20	-	0.043689270779192	0.157953517432463
10456	trichostatin A	hsa04740	Olfactory transduction	219464_26531_26212_7932_5568_157_51806_5613_5566_5616_442194_818_26211_109_23538_4991_810_9635_816	19	-	2.83383277684602e-56	2.66380281023526e-54
10457	trichostatin A	hsa04514	Cell adhesion molecules (CAMs)	9076_2734_214_3107_8174_5175_8506_942_4897_23308_57863_22871_6382_3655_9019_24146_5818_3383_3123_3106_4267_3126_3127_3696_3125_933_4099_1272_26047_29851_999_9080_3135_6693_3688_4359_965_4684_4685_3119_1366_3113_3111_5797_1364_1365_5792_920_4950_923_925_926_5817	53	-	0.00963320695255279	0.0565950908462476
10458	trichostatin A	hsa04360	Axon guidance	10298_2773_9475_7852_6387_5880_23365_5747_10512_5364_29984_25_1949_57715_6585_1942_10505_11261_1946_27289_64218_5365_5361_8829_54910_5921_23654_5063_5062_10725_3688_998_4776_5532_4775_3265_5534_6093_6092_4233_5998_7869_80031_5362_5533_2043_2042_5594_10371_2041_6405_5881_2048_5530_3845_3984_1969_2050	58	-	0.04966475339032	0.172269953119121
10459	trichostatin A	hsa04340	Hedgehog signaling pathway	51715_2737_5568_5613_5566_5616_1454_1455_1456_655_1452_1453_53944_8945_7473_7475_7477	17	-	0.0109894396295935	0.0588684566659284
10460	trichostatin A	hsa04140	Regulation of autophagy	3451_3448_3446_9474_5563_8408_10533_5562_9706	9	-	0.0189998889660239	0.0776517201220107
10461	trichostatin A	hsa04530	Tight junction	9076_4301_8777_2773_4619_50855_6709_93408_88_89_56288_4636_55870_9223_87_22800_24146_5584_1365_5583_5580_5581_93643_2035_2036_84612_51776_5865_2017_10627_29895_55844_10207_208_998_9080_5519_5518_3265_1495_8573_8531_6714_5515_60_7082_8189_5579_5578_5728_1366_1364_1457_3845_7525_4624_4950_27134_4625	59	-	0.0312645384601329	0.122452775635521
10462	trichostatin A	hsa04512	ECM-receptor interaction	375790_1302_1289_3908_3909_3678_6382_3655_3675_7059_3690_3691_3693_7057_3696_1290_1278_3913_3911_3910_1277_7148_3339_3918_3688_960_961_1605_3371_3673	30	-	0.0148785210089394	0.0665990940400145
10463	trichostatin A	hsa04630	Jak-STAT signaling pathway	2690_3717_6654_595_3595_10401_5296_598_5294_5295_3718_5290_5291_6772_6777_9180_9655_3597_8503_30837_10253_1442_53832_3451_3454_3575_208_3459_3446_3570_3572_23529_2688_5781_3589_2033_81848_2689_3581_9063_3953_1154_3976_3560_200734_4609_6778_9021_1437_5618_3566_3448_3460_3568_3569_867_10254_51588_50616_8835_1387_3601_6655_6776	64	-	0.011272683191348	0.0588684566659284
10464	trichostatin A	hsa04062	Chemokine signaling pathway	3717_6777_113_157_156_5296_6464_5294_2773_3718_5290_9475_115_5330_10451_5332_56288_6358_10235_5747_8503_6359_2309_2786_5568_4067_3551_2782_5829_4790_5566_3576_112_2788_2931_7410_1399_1398_7409_4793_5291_408_2785_5295_208_5580_998_673_108_109_3265_6093_10681_2833_107_4792_23236_7852_5594_5579_5613_6655_6654_5616_6387_6772_2783_51764_5880_3845_5894_6372_5970_8976_5331	75	-	0.000924517034231805	0.0108630751522237
10465	trichostatin A	hsa04810	Regulation of actin cytoskeleton	10298_9475_10451_10109_23365_5747_3655_10458_5500_5829_50649_2249_2245_2247_5063_5062_1793_369_998_673_1956_6093_5962_8874_5594_6655_6654_3845_2257_8976_2250_2909_5155_5154_5605_3678_89_5499_3673_4659_87_3675_7430_1399_1398_2263_2260_2261_2264_1131_10787_1729_26999_2149_3265_8503_60_10552_4636_3690_3691_3693_3696_8823_7410_10627_10152_29895_9138_22800_5894_10093_3688_10094_88_54961_7409_5296_10672_5294_5295_8074_5290_5291_5881_5880_26291_93408_1445_324_54434_8394_8396_3984	94	-	0.00553120157895853	0.0371380677444358
10466	trichostatin A	hsa05012	Parkinson's disease	1327_1329_7381_6622_7385_7327_836_4694_4700_4698_7054_7416_509_7419_1339_7332_51465_9627_5481_4728_4714_842_4712_4713_7314_6390_6391_1537_642502_513_293_517	32	-	2.14818783347012e-07	5.04824140865478e-06
10467	trichostatin A	hsa04260	Cardiac muscle contraction	1327_1329_7139_7171_10368_4635_4634_7381_7385_6262_776_1339_786_4624_4625_784_7168_7169_781_782_783_1537_27092	23	-	0.000568248787997843	0.00763076943882818
10468	trichostatin A	hsa04060	Cytokine-cytokine receptor interaction	7046_3459_3597_9180_3595_8794_8600_5155_5154_8741_7852_6387_8742_60401_90_8764_2277_4254_7132_3953_2323_53832_3554_3553_3454_2324_3575_64806_3576_3446_3570_3572_657_4982_2688_2689_7424_8718_27242_55540_659_3581_3601_8771_3815_23529_3589_23765_2833_3625_3560_3624_3451_1956_3976_7043_7042_91_655_93_268_4233_8795_1437_5618_1435_3566_3448_3460_3568_3569_943_6358_6359_356_355_50616_7423_7422_51330_8995_6372_83729_4055_2690	85	-	2.13489873622798e-07	5.04824140865478e-06
10469	trichostatin A	hsa03010	Ribosome	3921_140801_9349_6122_6125_6168_6141_285053_6144_6160_6165_6129_6187_6205_6227_439992_6203_389342_6189_440589_6181_284064_6159_9045_6138_6139_6142_51187_6137_283412_284393_6192_6234_6233	34	-	0.0023795629096918	0.0203344466828208
10470	trichostatin A	hsa04020	Calcium signaling pathway	51806_155_3710_2925_2776_552_115_7220_5532_5332_5335_136_113_1909_9630_8911_493_5568_1812_5255_11261_3360_3361_3362_3707_818_6262_7416_810_7419_814_56848_816_146_2911_2769_776_5021_1131_5025_5530_5026_5533_6915_3708_1956_487_148_489_5534_5330_5256_107_5481_23236_5331_5579_8877_5578_5613_3709_5616_108_293_8912_109_4842_5566_2064_2065_2149	71	-	0.00109048224061762	0.011389481179784
10471	trichostatin A	hsa03050	Proteasome	10197_5709_5719_5718_5717_5706_5713_5702_5710_5690_23198_5688_5689_5682	14	-	0.017290304453588	0.0738767553926033
10472	trichostatin A	hsa05217	Basal cell carcinoma	6934_2737_324_7157_1855_1856_1857_7473_11211_8312_8325_8324_7976_8321_7475_8323_7477	17	-	0.0143954721808825	0.0665990940400145
10473	trichostatin A	hsa02010	ABC transporters	6833_26154_20_11194_1080_10058_6891_215_8714_23457_368_10257	12	-	0.0124333083466563	0.0615121570834575
10474	trichostatin A	hsa04610	Complement and coagulation cascades	5345_5265_729_10747_5627_629_727_7056_4179_2155_5327_2_7035_720_721_717_2162_2161_2149_5328_5329	21	-	0.00446477396589584	0.0349740627328507
10475	trimetazidine	hsa05332	Graft-versus-host disease	3135_3824_3107	3	+	0.0248506085443738	0.410035040982168
10476	trimetazidine	hsa05320	Autoimmune thyroid disease	3135_958_3107	3	+	0.0434816589145327	0.570239479278315
10477	trimetazidine	hsa04514	Cell adhesion molecules (CAMs)	5797_958_3107_3135_23308_57502	6	+	0.0137602636852011	0.410035040982168
10478	trimetazidine	hsa05221	Acute myeloid leukemia	861_23533_5371_652671	4	+	0.0115913948837558	0.410035040982168
10479	trimetazidine	hsa05330	Allograft rejection	3135_958_3107	3	+	0.0194358206581049	0.410035040982168
10480	trimetazidine	hsa04080	Neuroactive ligand-receptor interaction	64106_2561_7442_2149	4	-	0.00408339905288883	0.110251774427998
10481	trimetazidine	hsa05016	Huntington's disease	1385_27113_4712_517	4	-	0.0478826736698023	0.542987191992451
10482	trimetazidine	hsa04740	Olfactory transduction	219464_5613	2	-	4.50653942592549e-07	3.65029693499965e-05
10483	trimetazidine	hsa05322	Systemic lupus erythematosus	8358_85235_8968_727_3013_8330_8969_8332_8350_88_8331_8336_8351_8970_8329_8352_8353_8354_8355_8356_8357	21	-	0.000110502320710011	0.00447534398875545
10484	trimetazidine	hsa05012	Parkinson's disease	4712_517	2	-	0.04951032988674	0.542987191992451
10485	trimetazidine	hsa04020	Calcium signaling pathway	5613_2149	2	-	0.0064705701524466	0.131029045587044
10486	thiocolchicoside	hsa04740	Olfactory transduction	5613_7932_816	3	+	0.0269026142509669	0.981945420160292
10487	thiocolchicoside	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_3111_8359_8294_8367_8342_121504	16	+	1.25674473260657e-06	9.17423654802796e-05
10488	thiocolchicoside	hsa04070	Phosphatidylinositol signaling system	8394_8396_3633_5287_3631_3708_5335_4952	8	-	0.00380562086016726	0.142241113845017
10489	thiocolchicoside	hsa04910	Insulin signaling pathway	5584_5257_5599_5576_6655_673_5211_8651_6009	9	-	0.0449640825924141	0.833381195178869
10490	thiocolchicoside	hsa04740	Olfactory transduction	109	1	-	0.00011844946906033	0.00959440699388673
10491	thiocolchicoside	hsa04060	Cytokine-cytokine receptor interaction	3572	1	-	0.00526818940166728	0.142241113845017
10492	mesoridazine	hsa04080	Neuroactive ligand-receptor interaction	3953	1	-	0.000845252076372259	0.0329648309785181
10493	mesoridazine	hsa04740	Olfactory transduction	5566	1	-	5.77576347188257e-06	0.00045050955080684
10494	mesoridazine	hsa05322	Systemic lupus erythematosus	718_3013_8358_8350_8968_8970_8351_8352_8353_8354_8355_8356_8357	13	-	0.0106491190993172	0.276877096582247
10495	mesoridazine	hsa05219	Bladder cancer	23604_5925_1956_11186_5595	5	-	0.0362440118322628	0.472614151464081
10496	mesoridazine	hsa04920	Adipocytokine signaling pathway	2475_3953_6513_8660_1375_1374_4793	7	-	0.0257948832768155	0.472614151464081
10497	mesoridazine	hsa05012	Parkinson's disease	7054	1	-	0.0455393144787829	0.483479871501595
10498	mesoridazine	hsa04060	Cytokine-cytokine receptor interaction	3953_1956_8795_2324	4	-	0.0363549347280062	0.472614151464081
10499	mesoridazine	hsa04912	GnRH signaling pathway	1432_5566_5331_3708_1956_5600_5603_3725_5595	9	-	0.0495876791283687	0.483479871501595
10500	imatinib	hsa05332	Graft-versus-host disease	3135_3123_3126_3127_3125	5	+	0.00709714838096043	0.0828000644445383
10501	imatinib	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125_3135_7038	6	+	0.00408002980520406	0.0677928262269741
10502	imatinib	hsa04612	Antigen processing and presentation	3123_3126_3127_3125_3135_3308	6	+	0.0366332795972168	0.320541196475647
10503	imatinib	hsa04740	Olfactory transduction	219464	1	+	0.000824873011382486	0.0407436318875404
10504	imatinib	hsa04514	Cell adhesion molecules (CAMs)	24146_3383_5175_3123_3126_3127_3125_3135_923_3897_5817	11	+	0.00135510502549721	0.0407436318875404
10505	imatinib	hsa04115	p53 signaling pathway	1021_5728_545_1029_4616	5	+	0.0426379189645751	0.331628258613362
10506	imatinib	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.011092332285671	0.11092332285671
10507	imatinib	hsa05330	Allograft rejection	3135_3123_3126_3127_3125	5	+	0.00484234473049815	0.0677928262269741
10508	imatinib	hsa04940	Type I diabetes mellitus	3382_3123_3126_3127_3125_3135	6	+	0.00174615565232316	0.0407436318875404
10509	imatinib	hsa05016	Huntington's disease	4899_5978	2	-	0.00105844429678174	0.0296364403098887
10510	imatinib	hsa04740	Olfactory transduction	7932_23538_26664_81797_816_817	6	-	1.27995843837666e-05	0.00107516508823639
10511	imatinib	hsa05322	Systemic lupus erythematosus	55506_8343_81_8347_8346_8344_8339_8968_8358_8335_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_940_720_721	23	-	0.000213121472378777	0.00895110183990863
10512	imatinib	hsa05012	Parkinson's disease	6570_7054	2	-	0.017831108811382	0.374453285039022
10513	imatinib	hsa04020	Calcium signaling pathway	115_6546_1956_816_817	5	-	0.0447958405856143	0.75257012183832
10514	bromperidol	hsa04070	Phosphatidylinositol signaling system	8871_3612_5298_64768_8394_8396_5295_5287_5291_5333_8821_23396_51763_5336_3709_3707	16	-	0.0412267194527061	0.262084145092203
10515	bromperidol	hsa05010	Alzheimer's disease	776_836_1327_351_11261_355_3709_6868_489_8851	10	-	0.0160983004304831	0.166022481833676
10516	bromperidol	hsa04080	Neuroactive ligand-receptor interaction	3354_5618_2150_4886_7068	5	-	6.92695015945496e-08	3.08249282095746e-06
10517	bromperidol	hsa05016	Huntington's disease	5441_836_6667_1327	4	-	8.6565018140486e-06	0.000256809553816775
10518	bromperidol	hsa04740	Olfactory transduction	109_409	2	-	1.31491472649511e-16	1.17027410658065e-14
10519	bromperidol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_81_3108_3123_3126_3127_3125_8969_8370_8332_8359_8330_8331_8336_554313_6738_121504_85235	28	-	0.0237537648125093	0.192189551664848
10520	bromperidol	hsa05215	Prostate cancer	2475_5170_595_3551_9134_898_6655_5295_5154_4193_5925_5291_6934_7039_1869_2263_2260_1017	18	-	0.0392779709127031	0.262084145092203
10521	bromperidol	hsa04720	Long-term potentiation	11261_3709	2	-	0.0151229293706675	0.166022481833676
10522	bromperidol	hsa04062	Chemokine signaling pathway	5295_3551_5580_6655_6777_5291_115_109_409_4793	10	-	0.00551880808769125	0.0818623199674202
10523	bromperidol	hsa05012	Parkinson's disease	836_1327	2	-	4.07905226807246e-05	0.000907589129646122
10524	bromperidol	hsa04260	Cardiac muscle contraction	776_1327_481	3	-	0.0326629198455205	0.242249988854277
10525	bromperidol	hsa04060	Cytokine-cytokine receptor interaction	5618_3554_2057_2324_5154_3572_657_355_93_4233_8795	11	-	9.25318576678187e-05	0.00164706706648717
10526	bromperidol	hsa03010	Ribosome	6187_140801_440589_6129	4	-	0.0167887902977875	0.166022481833676
10527	bromperidol	hsa04020	Calcium signaling pathway	776_11261_3709_115_7220_5333_109_489_5336_490_3707	11	-	0.0188774674248072	0.168009460080784
10528	propafenone	hsa05131	Shigellosis	929_7278_113457_998	4	+	0.0404875570966734	0.599215845030766
10529	propafenone	hsa04520	Adherens junction	998_5818_88_91_5770_10458	6	+	0.010679427641139	0.395138822722143
10530	propafenone	hsa05130	Pathogenic Escherichia coli infection	929_7278_113457_998	4	+	0.0404875570966734	0.599215845030766
10531	propafenone	hsa04740	Olfactory transduction	26212_26529	2	+	0.0187247833201441	0.461877988563554
10532	propafenone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_88_8294_8367_554313_121504	15	+	1.6986589262959e-06	0.000125700760545897
10533	propafenone	hsa04080	Neuroactive ligand-receptor interaction	146_136	2	-	0.00471503411840346	0.174456262380928
10534	propafenone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	30	-	3.96787312845829e-12	2.93622611505913e-10
10535	gliclazide	hsa05332	Graft-versus-host disease	3119_3804_3106_3135_3105_649853	6	+	0.000659128818872366	0.0214216866133519
10536	gliclazide	hsa05320	Autoimmune thyroid disease	3439_3119_3105_3106_3135_3447_649853	7	+	0.000361992984522101	0.0214216866133519
10537	gliclazide	hsa04612	Antigen processing and presentation	3439_3119_3804_3447_3135_3105_3106_649853	8	+	0.00145705197200229	0.031569459393383
10538	gliclazide	hsa04740	Olfactory transduction	810	1	+	0.00244495123572715	0.0336771579207562
10539	gliclazide	hsa04514	Cell adhesion molecules (CAMs)	3119_3105_3106_3135_923_26047_649853	7	+	0.0390310654502323	0.362431322037871
10540	gliclazide	hsa05330	Allograft rejection	3135_3105_3106_3119_649853	5	+	0.00259055060928894	0.0336771579207562
10541	gliclazide	hsa04940	Type I diabetes mellitus	3135_3105_3106_3119_649853	5	+	0.00460493962677094	0.0498868459566852
10542	gliclazide	hsa04080	Neuroactive ligand-receptor interaction	1131_2908_56288_1909	4	-	4.69937050072721e-05	0.00195023875780179
10543	gliclazide	hsa05016	Huntington's disease	1213_836_4712_5331_509_6648	6	-	0.0236084322359617	0.558645266302883
10544	gliclazide	hsa04740	Olfactory transduction	157	1	-	1.28769097130467e-11	1.06878350618288e-09
10545	gliclazide	hsa05012	Parkinson's disease	836_4712_7054_509	4	-	0.0462994399380141	0.640475585809195
10546	gliclazide	hsa04620	Toll-like receptor signaling pathway	8503_3454	2	-	0.0336533292953544	0.558645266302883
10547	gliclazide	hsa04260	Cardiac muscle contraction	488	1	-	0.0303284949759028	0.558645266302883
10548	chloroquine	hsa05214	Glioma	6464_6655_5155_5154_4193	5	-	0.0371561994247798	0.169525159875558
10549	chloroquine	hsa05332	Graft-versus-host disease	3135_3105_3106_3552_649853	5	-	0.00764884296153833	0.0797665051703283
10550	chloroquine	hsa05211	Renal cell carcinoma	6655_5155_998_201163_405_7422_1399_3725	8	-	0.00118715819973866	0.0288875161936407
10551	chloroquine	hsa03440	Homologous recombination	5425_7516_5888	3	-	0.0474231693799765	0.203640668514017
10552	chloroquine	hsa04662	B cell receptor signaling pathway	10725_10892_6655_8519_3725_4793	6	-	0.0199107120325691	0.124544464400951
10553	chloroquine	hsa05200	Pathways in cancer	11186_3912_4088_1613_6655_5155_998_5154_405_1399_324_3725_2260_5888_4193_7422	16	-	0.0265506889657645	0.129213352966721
10554	chloroquine	hsa04612	Antigen processing and presentation	4800_3105_3106_3135_3308_811_649853	7	-	0.0133594628136982	0.108360087266663
10555	chloroquine	hsa04660	T cell receptor signaling pathway	5163_1432_10725_10892_6655_998_5603_3725_4793	9	-	0.00418676861243756	0.0611268217415884
10556	chloroquine	hsa04740	Olfactory transduction	409	1	-	0.000542952328494051	0.0198177599900329
10557	chloroquine	hsa04510	Focal adhesion	5154_3912_2324_6464_6655_5155_7057_998_23396_7422_1399_3725_6714_83660	14	-	0.00207428250917355	0.0378556557924173
10558	chloroquine	hsa05322	Systemic lupus erythematosus	8358_85235_8968_3013_8330_8332_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357	18	-	2.50155375758066e-07	1.82613424303388e-05
10559	chloroquine	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_998_6868_5603_3725_6714	6	-	0.0158585971233061	0.115767759000135
10560	chloroquine	hsa04370	VEGF signaling pathway	1432_10725_998_7422_5603_6714	6	-	0.0221791511946899	0.124544464400951
10561	chloroquine	hsa05219	Bladder cancer	4193_7422_11186_1613_7057	5	-	0.00764884296153833	0.0797665051703283
10562	chloroquine	hsa04810	Regulation of actin cytoskeleton	324_6655_5155_998_5154_7430_8976_1399_23396_2260_2934_2149	12	-	0.0214024566220941	0.124544464400951
10563	chloroquine	hsa05330	Allograft rejection	3135_3105_3106_649853	4	-	0.0241864503181172	0.12611506237304
10564	chloroquine	hsa04940	Type I diabetes mellitus	3135_3105_3106_3552_649853	5	-	0.00911279249131991	0.0831542314832942
10565	iobenguane	hsa04740	Olfactory transduction	810_5566_7932_26212_4991	5	+	0.0195354425032361	0.416756106735703
10566	iobenguane	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_717_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	26	+	4.13967307649916e-11	2.64939076895946e-09
10567	iobenguane	hsa05221	Acute myeloid leukemia	3815_861_5371_5467_5914_652671	6	+	0.0191224307924624	0.416756106735703
10568	iobenguane	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_727	22	-	5.24847612098286e-11	3.46399423984869e-09
10569	iobenguane	hsa04060	Cytokine-cytokine receptor interaction	5618	1	-	0.0225642743043968	0.744621052045094
10570	Prestwick-559	hsa04080	Neuroactive ligand-receptor interaction	2908	1	-	0.000380664797338998	0.0300725189897808
10571	Prestwick-559	hsa04062	Chemokine signaling pathway	208_6772	2	-	0.018188939865982	0.718463124706289
10572	chlorcyclizine	hsa04120	Ubiquitin mediated proteolysis	5371_8452	2	+	0.0365882710037878	0.384176845539772
10573	chlorcyclizine	hsa05010	Alzheimer's disease	6622_348	2	+	0.0044340656167691	0.186230755904302
10574	chlorcyclizine	hsa04910	Insulin signaling pathway	8660_23265	2	+	0.0360976885474992	0.384176845539772
10575	chlorcyclizine	hsa05016	Huntington's disease	1213_1387_7350	3	+	0.014329890280367	0.240742156710166
10576	chlorcyclizine	hsa04740	Olfactory transduction	26211_56656_135948_1179_4992_8392_26529_393046	8	+	0.00095488383569887	0.0802102421987051
10577	chlorcyclizine	hsa04514	Cell adhesion molecules (CAMs)	5010_8516_214_3383_965_3123_1272_3126_3127_3125_5797_51208_6614_6402_3684_5817	16	+	0.00972684838134374	0.204263816008219
10578	chlorcyclizine	hsa05322	Systemic lupus erythematosus	3123_6737_3126_3127_3125_8358_8968_3013_8350_8351_8352_8353_8354_8355_8356_8357	16	+	0.0202048277880458	0.282867589032641
10579	chlorcyclizine	hsa05012	Parkinson's disease	6622	1	+	0.00711903929623818	0.199333100294669
10580	chlorcyclizine	hsa04070	Phosphatidylinositol signaling system	8871_5578_8396_3633_808_5333_3709_801_3705_8526_805_23236	12	-	0.0104500980594621	0.296086111684759
10581	chlorcyclizine	hsa04650	Natural killer cell mediated cytotoxicity	4776_3454_5578	3	-	0.0486812530670663	0.689651085116773
10582	chlorcyclizine	hsa04740	Olfactory transduction	219464_157_5613_808_818_109_801_393046_805	9	-	0.000517971753258809	0.0227950462468313
10583	chlorcyclizine	hsa05012	Parkinson's disease	4698_7416	2	-	0.0176661985267795	0.358455930190877
10584	chlorcyclizine	hsa03010	Ribosome	9349	1	-	0.0210856429524045	0.358455930190877
10585	chlorcyclizine	hsa04912	GnRH signaling pathway	4214_1432_1081_5578_5613_3709_808_818_109_8681_8398_5603_3725_6714_100137049_801_805_23236	18	-	0.000536354029337207	0.0227950462468313
10586	monobenzone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8347_8346_8344_8969_8370_718_92815_8332_8359_8330_8331_8336_8334_554313_121504_8339_85235_3017	30	-	1.10490942681325e-18	7.0714203316048e-17
10587	monobenzone	hsa04110	Cell cycle	995_9133_5347_991_891_4088_983_699_996_7042	10	-	0.000603772535984056	0.0128804807676599
10588	monobenzone	hsa04115	p53 signaling pathway	9133_983_4194_51512_891	5	-	0.0244715282333163	0.391544451733061
10589	monobenzone	hsa03450	Non-homologous end-joining	7518_27434_64421_10111	4	-	0.000575475813943345	0.0128804807676599
10590	pramocaine	hsa04910	Insulin signaling pathway	3991	1	+	0.0332013468937741	0.841100787975611
10591	pramocaine	hsa04740	Olfactory transduction	5593_23538_816	3	+	4.08729334322799e-05	0.00310634294085327
10592	pramocaine	hsa04512	ECM-receptor interaction	3688_960_1301_961_3908_1277_9672_7148_3674_1280	10	+	0.00813425717176332	0.309101772527006
10593	pramocaine	hsa04080	Neuroactive ligand-receptor interaction	2561_146_2901_2925_1081	5	-	0.0108179139036784	0.181740953581797
10594	pramocaine	hsa04740	Olfactory transduction	818_219464_109	3	-	1.4867685393988e-06	0.000115982648743685
10595	pramocaine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013	25	-	2.7614916367544e-06	0.000115982648743685
10596	pramocaine	hsa04370	VEGF signaling pathway	1432_10725_208_56848_5533_8681_3845_5600_4772_8398_100137049	11	-	0.0065406345402183	0.137353325344584
10597	pramocaine	hsa04060	Cytokine-cytokine receptor interaction	1436_1271_8744_3572_9180_4233	6	-	0.0184282846700141	0.257995985380197
10598	pramocaine	hsa04912	GnRH signaling pathway	4214_8681_1432_1081_5599_6655_1839_818_109_3845_5600_5338_8398_100137049_23236	15	-	0.00328171867651188	0.0918881229423326
10599	spiradoline	hsa05010	Alzheimer's disease	5532_6622_351_2776_23236	5	+	0.0333783746358007	0.47842336977981
10600	spiradoline	hsa04612	Antigen processing and presentation	3119	1	+	0.0301116780985917	0.47842336977981
10601	spiradoline	hsa05016	Huntington's disease	1387_627_581_2776_23236	5	+	0.0255172629674616	0.47842336977981
10602	spiradoline	hsa04740	Olfactory transduction	5568_9635_56656	3	+	2.27944763760764e-08	1.96032496834257e-06
10603	spiradoline	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8370_83740_8368_554313_8366_8360_8359_8362_8294_720_721_121504_3119_8354_8367	21	+	0.00343685928448665	0.0985232994886173
10604	spiradoline	hsa05012	Parkinson's disease	6622	1	+	0.00235685405883347	0.0985232994886173
10605	spiradoline	hsa02010	ABC transporters	8714_10347_23457	3	-	0.0319526304154972	1
10606	cefalotin	hsa05332	Graft-versus-host disease	3811_3553_3119_3117_3123_3107_3126_3127_3125_3802	10	+	0.000947764015154737	0.0327417176284556
10607	cefalotin	hsa04640	Hematopoietic cell lineage	2322_960_3553_948_3581_3690_3123_2993_3126_3127_3125_2811_931_3684_926	15	+	0.00114215294052752	0.0327417176284556
10608	cefalotin	hsa04080	Neuroactive ligand-receptor interaction	623_1129_2862_2902_2925_3001_9038_5644_5646_2488_4829_9340_4986_9248_5028_2912_2918_6915_8698_4161_5618_2554_2555_6755_2798_8811_728	27	+	0.0161362069857484	0.168536168720651
10609	cefalotin	hsa05320	Autoimmune thyroid disease	3451_3449_3119_3117_3123_3107_3126_3127_3125	9	+	0.0116135350775612	0.166460669445044
10610	cefalotin	hsa04612	Antigen processing and presentation	3811_3449_3119_3805_3123_3107_3126_3127_3125_3117_3451_3802_926	13	+	0.00993322194747056	0.166460669445044
10611	cefalotin	hsa05016	Huntington's disease	7052_2902_246721_1339_317	5	+	0.045442178750042	0.355275215682147
10612	cefalotin	hsa04740	Olfactory transduction	26539_23538_1258	3	+	1.04246492744175e-07	8.96519837599905e-06
10613	cefalotin	hsa05310	Asthma	3119_3117_3123_3126_3127_3125	6	+	0.0195972289210059	0.168536168720651
10614	cefalotin	hsa05012	Parkinson's disease	1339_317	2	+	0.0176948885315838	0.168536168720651
10615	cefalotin	hsa05330	Allograft rejection	3119_3117_3123_3107_3126_3127_3125	7	+	0.0173733741937713	0.168536168720651
10616	cefalotin	hsa04940	Type I diabetes mellitus	3553_3119_3117_3123_3107_3126_3127_3125_5799	9	+	0.00410416707869079	0.088239592191852
10617	esculin	hsa03320	PPAR signaling pathway	2710_51703_2173_2170_5465_2169	6	+	0.0427827415438356	0.616071478231233
10618	esculin	hsa05010	Alzheimer's disease	5331	1	+	0.0328257296390426	0.616071478231233
10619	esculin	hsa04740	Olfactory transduction	5568_1179	2	+	0.000265395420858885	0.0191084703018397
10620	esculin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	0.000897600285855515	0.0323136102907985
10621	esculin	hsa04270	Vascular smooth muscle contraction	5568_5739_5331_8681_5320_8398_6093_800_100137049	9	+	0.0402237602839491	0.616071478231233
10622	esculin	hsa03440	Homologous recombination	5425_5893_5888	3	-	0.0320859154187562	0.393646285071097
10623	esculin	hsa05131	Shigellosis	7278_7454_6093_113457_9475	5	-	0.0119822865300865	0.30754535427222
10624	esculin	hsa04910	Insulin signaling pathway	51806_6655_5140_5290_2002_867_5562	7	-	0.0460106047485698	0.393646285071097
10625	esculin	hsa04520	Adherens junction	5818_7454_6714_2260_2241	5	-	0.0429794847014867	0.393646285071097
10626	esculin	hsa05130	Pathogenic Escherichia coli infection	7278_7454_6093_113457_9475	5	-	0.0119822865300865	0.30754535427222
10627	esculin	hsa04740	Olfactory transduction	51806	1	-	0.00247112864017181	0.190276905293229
10628	esculin	hsa04810	Regulation of actin cytoskeleton	7454_2909_5290_9475_8396_6655_324_6093_2260_3675	10	-	0.039953623103418	0.393646285071097
10629	esculin	hsa04060	Cytokine-cytokine receptor interaction	7424	1	-	0.0326701717097326	0.393646285071097
10630	esculin	hsa05213	Endometrial cancer	2002_6655_324_5290	4	-	0.0372955633398989	0.393646285071097
10631	fenbendazole	hsa04640	Hematopoietic cell lineage	3690_3673_3569_3676_960	5	+	0.0344092108145157	0.408981761067284
10632	fenbendazole	hsa05322	Systemic lupus erythematosus	717_3013_8341_8358_8968_720_721_8350_8351_8352_8353_8354_8355_8356_8357	15	+	4.90099808601492e-07	2.9896088324691e-05
10633	fenbendazole	hsa04720	Long-term potentiation	2911_6196_1387_816_5534	5	+	0.0202542606214419	0.408981761067284
10634	fenbendazole	hsa04512	ECM-receptor interaction	3690_960_3676_3673_1277	5	+	0.0304198216180154	0.408981761067284
10635	fenbendazole	hsa04630	Jak-STAT signaling pathway	3448_3569_50615_51561_3976_1387_30837	7	+	0.0402277142033394	0.408981761067284
10636	fenbendazole	hsa04610	Complement and coagulation cascades	624_717_629_2_722_7035_720_721_2160_5328	10	+	2.9805054793522e-06	9.09054171202421e-05
10637	fenbendazole	hsa04080	Neuroactive ligand-receptor interaction	4889	1	-	0.00120932765310742	0.0489777699508505
10638	fenbendazole	hsa05200	Pathways in cancer	1488_2271_5594_841_9134_6789_6257_999_208_6772_5291_6932_7157_51588_324_6502_91_2263_4254_1017_4233	21	-	0.032449863630753	0.175229263606066
10639	fenbendazole	hsa05131	Shigellosis	7280_7277_347733_999_203068_8976	6	-	0.0282377642354569	0.168415812505732
10640	fenbendazole	hsa05130	Pathogenic Escherichia coli infection	7280_7277_347733_999_203068_8976	6	-	0.0282377642354569	0.168415812505732
10641	fenbendazole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8347_958_8368_8359_8294_8367_554313_8343_121504_8339_8342_8346_8344	21	-	8.98354702918994e-07	7.27667309364385e-05
10642	fenbendazole	hsa05212	Pancreatic cancer	5594_9134_7157_208_5291_6932_2263_1017	8	-	0.0291089058651882	0.168415812505732
10643	fenbendazole	hsa05215	Prostate cancer	5594_9134_7157_208_5291_6932_2263_1017	8	-	0.0275731479558701	0.168415812505732
10644	fenbendazole	hsa04210	Apoptosis	651610_841_7157_208_5291_472_8837_1677	8	-	0.0291089058651882	0.168415812505732
10645	fenbendazole	hsa05216	Thyroid cancer	7157_6932_6257_999_5594	5	-	0.00823524652865528	0.133410993764216
10646	fenbendazole	hsa04115	p53 signaling pathway	55367_1017_841_9134_7157_472_651610_3732	8	-	0.00804779798859213	0.133410993764216
10647	fenbendazole	hsa03450	Non-homologous end-joining	5591_27434_3981	3	-	0.0241247269026852	0.168415812505732
10648	fenbendazole	hsa05223	Non-small cell lung cancer	5594_6789_208_5291_7157_6257	6	-	0.0244629279204779	0.168415812505732
10649	fenbendazole	hsa05213	Endometrial cancer	5594_7157_208_999_5291_6932_324	7	-	0.00631207347246526	0.133410993764216
10650	fenbendazole	hsa05210	Colorectal cancer	5594_7157_208_5291_6932_324_91_4233	8	-	0.0219916774049012	0.168415812505732
10651	fenbendazole	hsa05222	Small cell lung cancer	9134_7157_6502_5291_51588_208_1017_6257	8	-	0.0246720260595253	0.168415812505732
10652	2,6-dimethylpiperidine	hsa05332	Graft-versus-host disease	3812_3824_3119_3126_3113_3127_3125_356_3123	9	+	0.000381619169864657	0.0152647667945863
10653	2,6-dimethylpiperidine	hsa04640	Hematopoietic cell lineage	2322_960_3815_3690_3123_3126_3127_3125_920_931	10	+	0.0113788808060965	0.113788808060965
10654	2,6-dimethylpiperidine	hsa05320	Autoimmune thyroid disease	3119_3126_3113_3127_3125_356_3123	7	+	0.0171943776629677	0.137555021303742
10655	2,6-dimethylpiperidine	hsa04612	Antigen processing and presentation	3812_3824_3119_3123_3126_3127_3125_6892_920_3113	10	+	0.0130287644966834	0.115811239970519
10656	2,6-dimethylpiperidine	hsa05016	Huntington's disease	5330_1339	2	+	0.0190869278714114	0.138814020882992
10657	2,6-dimethylpiperidine	hsa04740	Olfactory transduction	8392_26476_2979_390892_26539_5132	6	+	0.00173993839135856	0.0404756801964366
10658	2,6-dimethylpiperidine	hsa04514	Cell adhesion molecules (CAMs)	8174_3383_3119_3123_1272_3126_3127_3125_23308_6693_920_923_3113_5817	14	+	0.00762291417396059	0.0871190191309782
10659	2,6-dimethylpiperidine	hsa05322	Systemic lupus erythematosus	3119_3123_3126_3127_3014_3125_8358_8290_8968_3113_3013_8350_8351_8352_8353_8354_8355_8356_8357	19	+	0.000122728084824204	0.00981824678593632
10660	2,6-dimethylpiperidine	hsa04110	Cell cycle	1021	1	+	0.0451100555831172	0.277600342049952
10661	2,6-dimethylpiperidine	hsa05310	Asthma	3119_3123_3113_3127_3126_3125	6	+	0.00485276200883698	0.0647034934511597
10662	2,6-dimethylpiperidine	hsa05012	Parkinson's disease	1339	1	+	0.0334070451361858	0.222713634241239
10663	2,6-dimethylpiperidine	hsa05330	Allograft rejection	3119_3113_3126_3127_3125_356_3123	7	+	0.00358313020372625	0.05733008325962
10664	2,6-dimethylpiperidine	hsa04940	Type I diabetes mellitus	3119_3126_3113_3127_2571_356_3123_3125	8	+	0.00202378400982183	0.0404756801964366
10665	2,6-dimethylpiperidine	hsa05214	Glioma	51806_8503_1021_208_6655_5295_5155_4193_818_5925_808_810_801_805	14	-	0.00458271692473046	0.114122754985237
10666	2,6-dimethylpiperidine	hsa04070	Phosphatidylinositol signaling system	8871_51806_8503_5298_5295_3632_3633_3631_3708_808_810_801_3707_805_23236	15	-	0.0050721224437883	0.114122754985237
10667	2,6-dimethylpiperidine	hsa05211	Renal cell carcinoma	8503_2271_208_6655_5295_5155_56924_405_8453_5781_1399_4233_7040	13	-	0.0223710334862899	0.271439357451068
10668	2,6-dimethylpiperidine	hsa04080	Neuroactive ligand-receptor interaction	2911_5618_7068_64106_2908_4886_7433_5644	8	-	0.00160680895259704	0.0723064028668668
10669	2,6-dimethylpiperidine	hsa04740	Olfactory transduction	51806_818_808_4991_810_801_805	7	-	1.5561141451009e-07	1.40050273059081e-05
10670	2,6-dimethylpiperidine	hsa04514	Cell adhesion molecules (CAMs)	50848_3105_3107_3113	4	-	0.0248696207371292	0.271439357451068
10671	2,6-dimethylpiperidine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8342_8347_8346_8344_8370_8359_8330_554313_121504_8339_3113	22	-	0.0129654293935536	0.233377729083965
10672	2,6-dimethylpiperidine	hsa04010	MAPK signaling pathway	9261_9479_1326_3925_5155_6722_5607_8986_5600_3164_3305_836_1616_6788_8911_1399_2260_4214_776_208_5533_5536_91_81579_4791_1432_5599_6655_4763_2002_23162_2257_9693_7040	34	-	0.0398072309388055	0.358265078449249
10673	2,6-dimethylpiperidine	hsa04912	GnRH signaling pathway	4214_776_1432_2002_51806_5599_6655_818_3708_808_5600_810_801_81579_107_805_23236	17	-	0.0271439357451068	0.271439357451068
10674	2,6-dimethylpiperidine	hsa05220	Chronic myeloid leukemia	8503_1021_208_6655_5295_4193_5925_5781_1399_91_1488_1027_7040	13	-	0.0253606377934864	0.271439357451068
10675	ciclacillin	hsa05332	Graft-versus-host disease	3123_3126_3127_941_356_3125	6	+	0.00489019580673507	0.0782431329077611
10676	ciclacillin	hsa04640	Hematopoietic cell lineage	3123_3126_3127_3125_933_931_3674	7	+	0.0368064069724257	0.294451255779406
10677	ciclacillin	hsa05010	Alzheimer's disease	317	1	+	0.0323831358224878	0.287850096199892
10678	ciclacillin	hsa05320	Autoimmune thyroid disease	3451_3123_3126_3127_941_356_3125	7	+	0.00359300113140705	0.071860022628141
10679	ciclacillin	hsa04740	Olfactory transduction	5137_26539_26529	3	+	0.00138019905353052	0.0552079621412208
10680	ciclacillin	hsa05322	Systemic lupus erythematosus	3123_941_3013_3126_3127_3125_8358_8290_8968_720_721_8350_8351_8352_8353_8354_8355_8356_8357	19	+	1.89016939308197e-06	0.000151213551446558
10681	ciclacillin	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0253966438059415	0.253966438059415
10682	ciclacillin	hsa04810	Regulation of actin cytoskeleton	29895_2261_10298_5063_56034_8394_10297_3694_5290_7414_2263_2245_324_10458_3674	15	+	0.0145598314499532	0.166398073713751
10683	ciclacillin	hsa05330	Allograft rejection	3123_3126_3127_941_356_3125	6	+	0.00314333612531394	0.071860022628141
10684	ciclacillin	hsa04940	Type I diabetes mellitus	3123_3126_3127_941_356_3125	6	+	0.00599119464140558	0.0798825952187411
10685	ciclacillin	hsa04080	Neuroactive ligand-receptor interaction	2550_2901	2	-	0.0134748328536113	0.242546991365003
10686	ciclacillin	hsa04740	Olfactory transduction	818_4991	2	-	0.000274922039607054	0.00989719342585394
10687	ciclacillin	hsa05322	Systemic lupus erythematosus	55506_8361_8363_8362_8365_8364_8367_8360_8368_8329_8294_121504_8342_8366_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013	34	-	1.32837468748871e-16	9.56429774991871e-15
10688	ciclacillin	hsa04330	Notch signaling pathway	113878_182_5986_4851_1857	5	-	0.0317483508376045	0.380980210051254
10689	ciclacillin	hsa04540	Gap junction	7082_5598_6655_113457_3708_113_112_7278_23236	9	-	0.00807543065096091	0.193810335623062
10690	ciclacillin	hsa04912	GnRH signaling pathway	4214_1432_5598_6655_818_3708_113_112_23236	9	-	0.018710154365163	0.269426222858347
10691	flutamide	hsa05016	Huntington's disease	317_581	2	+	0.0357906031070359	0.671073808256923
10692	flutamide	hsa04740	Olfactory transduction	3000	1	+	5.36146570996372e-06	0.000402109928247279
10693	flutamide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_3119	15	+	0.00115828142450402	0.0434355534189007
10694	flutamide	hsa05219	Bladder cancer	5925_2064_3576_1612_1950	5	+	0.0332034923250004	0.671073808256923
10695	flutamide	hsa05211	Renal cell carcinoma	2271_208_6655_5295_998_5291_5058_5781_7042_3845	10	-	0.0101777813093621	0.166398694697452
10696	flutamide	hsa04662	B cell receptor signaling pathway	208_6655_5295_5291_5881_4772_3845_27071_4793	9	-	0.0417004340478909	0.269716748801919
10697	flutamide	hsa04080	Neuroactive ligand-receptor interaction	1241_3354_2561	3	-	0.000963621405474151	0.0375812348134919
10698	flutamide	hsa05200	Pathways in cancer	595_5295_5154_9618_5291_7175_5881_1487_6789_5371_1613_5900_324_208_4842_7477_3480_998_6934_7042_91_4791_2271_5599_6655_3845_5914_6257	28	-	0.039228316913247	0.269716748801919
10699	flutamide	hsa05221	Acute myeloid leukemia	595_208_6655_5295_5371_5291_3845_6934_5914	9	-	0.00860041269535896	0.166398694697452
10700	flutamide	hsa04370	VEGF signaling pathway	1432_208_56848_5295_998_5291_5881_3845_4772	9	-	0.0449527914669865	0.269716748801919
10701	flutamide	hsa05216	Thyroid cancer	7175_3845_6257_595_6934	5	-	0.0304850819874368	0.264204043891119
10702	flutamide	hsa05223	Non-small cell lung cancer	595_6789_208_6655_5295_5291_3845_6257	8	-	0.014933216190797	0.166398694697452
10703	flutamide	hsa04810	Regulation of actin cytoskeleton	79784_3985_1729_8394_3691_6655_5295_998_5154_5881_7430_5058_324_8826_4628_3845_5291_4659_8976_54434	20	-	0.0378424381226295	0.269716748801919
10704	flutamide	hsa05213	Endometrial cancer	595_324_208_6655_5295_5291_3845_6934	8	-	0.0123717752826596	0.166398694697452
10705	flutamide	hsa05210	Colorectal cancer	595_6934_5599_3480_6655_5295_5881_5291_5900_3845_324_208_91_7042	14	-	0.000546902635221284	0.0375812348134919
10706	flutamide	hsa04270	Vascular smooth muscle contraction	4659	1	-	0.021531120893677	0.209928428713351
10707	flutamide	hsa05220	Chronic myeloid leukemia	595_208_6655_5295_5291_1487_5781_7042_91_3845	10	-	0.0129585330008588	0.166398694697452
10708	ethotoin	hsa04310	Wnt signaling pathway	6424_7474_5534	3	+	0.0370741659568314	0.578675110076941
10709	ethotoin	hsa05016	Huntington's disease	1211_54205_7416_581	4	+	0.0194398478123366	0.578675110076941
10710	ethotoin	hsa04740	Olfactory transduction	23538_7932_9635_390892	4	+	9.90187724129548e-07	8.11953933786229e-05
10711	ethotoin	hsa04110	Cell cycle	1017_1028	2	+	0.0493990947626657	0.578675110076941
10712	ethotoin	hsa04512	ECM-receptor interaction	375790_1281_22798_3910_3690_3680_1282_960_2335_3674_3675	11	+	0.0276525939151039	0.578675110076941
10713	ethotoin	hsa04062	Chemokine signaling pathway	7410_3576_5293_3551_6773	5	+	0.0460963289050139	0.578675110076941
10714	ethotoin	hsa05222	Small cell lung cancer	22798_3551_3910_54205_5293_1282_2335_1017_7185_3674_3675	11	+	0.0468298362101441	0.578675110076941
10715	ethotoin	hsa04080	Neuroactive ligand-receptor interaction	2550_5618_2690_4157_1081_7068_3953_1131_2908_5025_4886_5031_1241_3354_7433_9568_5026_2149_9170	19	-	0.00237950830698718	0.0793652642877276
10716	ethotoin	hsa05016	Huntington's disease	5433_4899_6648_842_841_581_5441_5435_1175_3092_3708_7416_4712_1387	14	-	0.0103298874860258	0.183332413750882
10717	ethotoin	hsa03420	Nucleotide excision repair	8450	1	-	0.0388746442351255	0.318065271014663
10718	ethotoin	hsa04740	Olfactory transduction	219464_51806_157_5613_5566_4991_810_393046	8	-	1.76943371537872e-14	1.59249034384085e-12
10719	ethotoin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8343_8347_8346_8344_3123_3126_3127_3125_8969_8370_718_8332_8359_8330_8331_8336_554313_8351_8339_85235_3119_3013	34	-	0.0122221609167255	0.183332413750882
10720	ethotoin	hsa04062	Chemokine signaling pathway	2788_8503_157_156_5829_5613_6655_998_6772_9475_115_3845_7409_5566_8976_4793	16	-	0.0270313678048136	0.248670971812289
10721	ethotoin	hsa05012	Parkinson's disease	2861_7327_842_4712_7054_7416_65018	7	-	0.00325986096687589	0.0793652642877276
10722	ethotoin	hsa04260	Cardiac muscle contraction	7168_10479_4635_27092	4	-	0.0219294700971353	0.246706538592772
10723	ethotoin	hsa04060	Cytokine-cytokine receptor interaction	5618_3554_3455_3953_1271_3568_5155_5154_8741_8742_657_355_1435_7422_7042_655_4254_4233_8792_2690	20	-	0.00352734507945456	0.0793652642877276
10724	ethotoin	hsa03010	Ribosome	140801_9349_6204_6168_6234_6165	6	-	0.0276301079791432	0.248670971812289
10725	ethotoin	hsa03050	Proteasome	23198	1	-	0.0171346439654849	0.22030256527052
10726	eticlopride	hsa05332	Graft-versus-host disease	3811_3109_3123_3107_3126_3127_3125_941_3802	9	+	0.042639232407227	0.293767225736681
10727	eticlopride	hsa05010	Alzheimer's disease	348_2905_23236	3	+	9.61091947243327e-05	0.0027551302487642
10728	eticlopride	hsa04310	Wnt signaling pathway	6424_5599_4776_3725_7471_23236	6	+	0.0229558019391975	0.230000247173637
10729	eticlopride	hsa05016	Huntington's disease	7350_4899_23236	3	+	4.85123877335955e-05	0.00208603267254461
10730	eticlopride	hsa04740	Olfactory transduction	8387_26211_8388_8392_390892	5	+	1.53598256021866e-10	1.32094500178805e-08
10731	eticlopride	hsa04514	Cell adhesion molecules (CAMs)	214_8174_3127_23308_57863_3676_3383_3123_3107_3126_3695_3125_25945_8516_920_3109_6402_965_4684_941_6693_5817	22	+	0.0318965673242637	0.274310478988668
10732	eticlopride	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8341_3109_3123_3126_3127_3125_8370_716_8359_8337_554313_6738_121504_8354_2213_2215_2214_941	28	+	0.00163819088948426	0.0352211041239116
10733	eticlopride	hsa04210	Apoptosis	3556_5293	2	+	0.0238454521786455	0.230000247173637
10734	eticlopride	hsa04530	Tight junction	23136_84612_9863_998	4	+	0.00684421770042744	0.0981004537061266
10735	eticlopride	hsa05110	Vibrio cholerae infection	534	1	+	0.0409315391772229	0.293767225736681
10736	eticlopride	hsa05012	Parkinson's disease	2861_9627_5413	3	+	0.00232367459940534	0.0399672031097718
10737	eticlopride	hsa03010	Ribosome	6189_439992_6144	3	+	0.024069793308869	0.230000247173637
10738	eticlopride	hsa04916	Melanogenesis	5605_5613_5616_4254_6932_3845_810_7475	8	-	0.0205060747530268	0.118642289642512
10739	eticlopride	hsa05214	Glioma	5296_5154_5290_5605_3845_810	6	-	0.0204664093022252	0.118642289642512
10740	eticlopride	hsa05332	Graft-versus-host disease	3119_3123_3126_3127_3125_3135	6	-	0.00312412333798834	0.0599482124210183
10741	eticlopride	hsa04070	Phosphatidylinositol signaling system	5296_5290_8394_8821_810_3707	6	-	0.0380864001631945	0.133399172521509
10742	eticlopride	hsa04662	B cell receptor signaling pathway	3551_5296_10892_5290_5605_3845	6	-	0.0361831318158608	0.13321971259476
10743	eticlopride	hsa05010	Alzheimer's disease	810	1	-	0.0461044334915349	0.143633042800551
10744	eticlopride	hsa04080	Neuroactive ligand-receptor interaction	2561	1	-	0.00518070971539664	0.0599482124210183
10745	eticlopride	hsa05200	Pathways in cancer	5605_4313_4149_2335_3551_5296_7475_5371_5154_5290_3909_6932_5900_3845_652_4254_5914_2260_1488_652671	20	-	0.00651420471034361	0.065956322692229
10746	eticlopride	hsa05320	Autoimmune thyroid disease	3119_3123_3126_3127_3125_3135	6	-	0.00869321715242073	0.0675613462824314
10747	eticlopride	hsa04612	Antigen processing and presentation	3119_3123_3126_3127_3125_3135_1520	7	-	0.02653690561672	0.131339956549143
10748	eticlopride	hsa04910	Insulin signaling pathway	3551_5296_5613_5616_5290_5605_23265_3845_810_10211	10	-	0.0146503413631315	0.0988898042011376
10749	eticlopride	hsa04740	Olfactory transduction	810_5613_5616_157_409	5	-	0.0347162540954165	0.13321971259476
10750	eticlopride	hsa04514	Cell adhesion molecules (CAMs)	9076_3119_3123_3126_3127_3125_3135_9672_9019	9	-	0.0418525667481522	0.135602316264013
10751	eticlopride	hsa05212	Pancreatic cancer	6932_3551_5296_5154_5290_5605_3845_2260	8	-	0.00917499764329316	0.0675613462824314
10752	eticlopride	hsa05215	Prostate cancer	6932_3551_5296_5154_5290_5605_3845_2260	8	-	0.00863895245714963	0.0675613462824314
10753	eticlopride	hsa04210	Apoptosis	3554_3551_5296_5613_5616_5290_51135	7	-	0.02653690561672	0.131339956549143
10754	eticlopride	hsa05221	Acute myeloid leukemia	6932_3551_5296_5371_5290_5605_3845_5914_652671	9	-	0.000198588579713096	0.0160856749567608
10755	eticlopride	hsa04340	Hedgehog signaling pathway	8945_5613_652_7475_5616	5	-	0.0395256807471137	0.133399172521509
10756	eticlopride	hsa05218	Melanoma	5296_5154_5290_5605_3845_2260	6	-	0.0291866570109206	0.131339956549143
10757	eticlopride	hsa04720	Long-term potentiation	5613_5616_5605_6196_3845_810	6	-	0.0361831318158608	0.13321971259476
10758	eticlopride	hsa05310	Asthma	3123_3126_3127_3119_3125	5	-	0.00383222381571162	0.0599482124210183
10759	eticlopride	hsa04010	MAPK signaling pathway	3554_4149_9064_3551_5613_5616_5154_4763_1844_5605_6196_3845_6788_10912_2260_51347_9693_409	18	-	0.00448618706130255	0.0599482124210183
10760	eticlopride	hsa05213	Endometrial cancer	5605_5296_3845_6932_5290	5	-	0.0288600365604025	0.131339956549143
10761	eticlopride	hsa05330	Allograft rejection	3119_3123_3126_3127_3125_3135	6	-	0.00198869728122409	0.0599482124210183
10762	eticlopride	hsa04940	Type I diabetes mellitus	3119_3123_3126_3127_3125_3135	6	-	0.00384607005726122	0.0599482124210183
10763	eticlopride	hsa05220	Chronic myeloid leukemia	3551_5296_5290_5605_3845_1488	6	-	0.0361831318158608	0.13321971259476
10764	beta-escin	hsa04740	Olfactory transduction	7932_393046_1179	3	+	4.82498455957544e-08	4.05298703004337e-06
10765	beta-escin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8370_3586_8366_8368_8335_8359_88_8294_8367_554313_121504_8364	17	+	0.031209335461796	0.655396044697716
10766	beta-escin	hsa04512	ECM-receptor interaction	3688_9672_9900_3910_3690_3695_3685_6383_1293_1290_1291	11	+	0.0498545065223924	0.837555709576192
10767	beta-escin	hsa05012	Parkinson's disease	6390_517	2	+	0.0123104613161239	0.517039375277204
10768	beta-escin	hsa03010	Ribosome	6192	1	+	0.0216092525523443	0.60505907146564
10769	beta-escin	hsa04740	Olfactory transduction	816	1	-	1.532298155356e-07	1.25648448739192e-05
10770	beta-escin	hsa04062	Chemokine signaling pathway	23236	1	-	0.00168557161633539	0.069108436269751
10771	beta-escin	hsa05012	Parkinson's disease	5413	1	-	0.0228609573863006	0.624866168558883
10772	lycorine	hsa05010	Alzheimer's disease	3553_3710_2905_6392_651820_3708_5534	7	+	0.00268792435702609	0.0302049206952355
10773	lycorine	hsa04080	Neuroactive ligand-receptor interaction	4161_2905_624_2895_5540_2908_1812_799_4887_2358_3356_2150_5724_3351_1395_23566_8484	17	+	0.0398483424184782	0.264830475146269
10774	lycorine	hsa04310	Wnt signaling pathway	8945_4088_8061_2033_5526_5534_3725_1387	8	+	0.0327163884921896	0.264830475146269
10775	lycorine	hsa05016	Huntington's disease	1213_246721_6392_651820_3708_5978_2033_1387	8	+	0.00356881434085702	0.0341020037015226
10776	lycorine	hsa04740	Olfactory transduction	26212_2979_3000	3	+	2.15081845618713e-14	1.84970387232093e-12
10777	lycorine	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_6738_8349_8362_8329_8294_121504_8343_8347_8346_8344_8353_723790_3123_8366_3126_3127_3125_92815_8969_8968_8370_717_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_8352_8339_8354_8355_8356_8357_8332_85235_3119_85236_3013_83740_8970	54	+	2.54139542146488e-12	1.0928000312299e-10
10778	lycorine	hsa04530	Tight junction	9076_4301_8189_5588_1495_3996_93643	7	+	0.035600006902286	0.264830475146269
10779	lycorine	hsa04062	Chemokine signaling pathway	1234_2785_3576_5293_7409_9844_4792_4793	8	+	0.00268371175963563	0.0302049206952355
10780	lycorine	hsa04810	Regulation of actin cytoskeleton	624_8394_5155_3694_5293_3684_7409_7414_2261_4659	10	+	0.00246078015246619	0.0302049206952355
10781	lycorine	hsa05012	Parkinson's disease	6392_7345_651820	3	+	0.000533180765127986	0.0114633864502517
10782	lycorine	hsa04260	Cardiac muscle contraction	7168	1	+	0.00280976006467307	0.0302049206952355
10783	lycorine	hsa03010	Ribosome	6129	1	+	0.000399823916875397	0.011461618950428
10784	lycorine	hsa04020	Calcium signaling pathway	3710_2905_624_5534_8877_5724_8911_3708_3356_1812_490	11	+	0.0400325136849011	0.264830475146269
10785	lycorine	hsa04916	Melanogenesis	2778_115_5578_5613_5616_818_808_113_2535_8324_801_23236_107_805_8322	15	-	0.0156773477495026	0.213319837704305
10786	lycorine	hsa05332	Graft-versus-host disease	3552_3126_3107_3113_3127_3125_355_3123	8	-	0.0173632426038388	0.213319837704305
10787	lycorine	hsa04080	Neuroactive ligand-receptor interaction	64106_2901_2925_5644_1813	5	-	0.000609904982570839	0.0262259142505461
10788	lycorine	hsa04612	Antigen processing and presentation	3312_3123_3107_3126_3127_3125_5994_3306_3304_3305_3303_3113	12	-	0.0449304910212359	0.322001852318857
10789	lycorine	hsa04660	T cell receptor signaling pathway	208_6655	2	-	0.0343409512668073	0.295332180894543
10790	lycorine	hsa05016	Huntington's disease	5432_4899_7052_317_246721_23236	6	-	0.0414927072213915	0.322001852318857
10791	lycorine	hsa04740	Olfactory transduction	5613_5616_818_808_801_805	6	-	1.58019595711641e-06	0.000135896852312011
10792	lycorine	hsa04540	Gap junction	2778_7082_7278_5578_5613_6655_1813_5616_113457_5154_115_203068_113_107_23236	15	-	0.00609169864243019	0.130971520812249
10793	lycorine	hsa05012	Parkinson's disease	317_7054	2	-	0.00891252249414998	0.15329538689938
10794	lycorine	hsa04912	GnRH signaling pathway	2778_115_4313_8399_5580_5578_5613_6655_50487_5616_107_818_808_113_5338_801_4323_805_23236	19	-	0.0009274991107627	0.0265883078418641
10795	lycorine	hsa05330	Allograft rejection	3113_3107_3126_3127_3125_355_3123	7	-	0.0291353835922572	0.278404776548235
10796	lycorine	hsa04940	Type I diabetes mellitus	3552_3126_3107_3113_3127_3125_355_3123	8	-	0.0216503455309097	0.232741214457279
10797	wortmannin	hsa04916	Melanogenesis	818_810_2535_816_8324	5	+	0.0115807370789104	0.115807370789104
10798	wortmannin	hsa05010	Alzheimer's disease	836_348_317_4137_355_3709_6868_5534_810_6622_4842	11	+	0.00641702914226391	0.0962554371339586
10799	wortmannin	hsa04080	Neuroactive ligand-receptor interaction	623_624_64106_2908_1909_5644_3361_799_2741_2688_1442_7433_9568_1394_2689_4886_4887_5733_5618_7442_2555_728	22	+	0.0316855378837398	0.249298937793303
10800	wortmannin	hsa05016	Huntington's disease	246721_1211_836_1639_317_27113	6	+	1.15267336343711e-05	0.000390596586450252
10801	wortmannin	hsa04740	Olfactory transduction	157_393046_818_810_9635_816	6	+	3.70159134450148e-15	3.33143221005133e-13
10802	wortmannin	hsa04514	Cell adhesion molecules (CAMs)	3119_942_1272_3113_6693_22871_9672_933_925	9	+	0.0281961183206068	0.249298937793303
10803	wortmannin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8349_8348_8329_8294_121504_8342_8341_8969_8968_55766_8370_92815_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_2215_2214_3013_3113_8970_942	44	+	1.30198862150084e-05	0.000390596586450252
10804	wortmannin	hsa04530	Tight junction	8189_4619_10207_51776_9223_1459	6	+	0.00176361569417071	0.0317450824950728
10805	wortmannin	hsa05110	Vibrio cholerae infection	534	1	+	0.00832056496290942	0.106978692380264
10806	wortmannin	hsa05012	Parkinson's disease	836_6622_5413_317_65018	5	+	0.000624136377638312	0.014043068496862
10807	wortmannin	hsa04260	Cardiac muscle contraction	785_6262_27092	3	+	0.0114727611344258	0.115807370789104
10808	wortmannin	hsa03010	Ribosome	440589_439992_6187_6181_6144_6189	6	+	0.0366553618223298	0.253767889539206
10809	wortmannin	hsa04020	Calcium signaling pathway	623_8912_2769_5256_624_5534_3361_818_3709_4842_5733_1909_810_6262_816	15	+	0.0478526285866492	0.307624040914173
10810	wortmannin	hsa05210	Colorectal cancer	2353_836_596_4088_3480_6655_5295_5602_5290_673_5599_5900_4609_324_3725_91_8324_5291_4233_2535	20	+	0.0332398583724404	0.249298937793303
10811	wortmannin	hsa04910	Insulin signaling pathway	1977_5575_6464_5140_808_2002_23265_5315_801_805	10	-	0.0400183291110186	0.960439898664446
10812	wortmannin	hsa04740	Olfactory transduction	801_808_157_805	4	-	0.00300592775628018	0.216426798452173
10813	wortmannin	hsa04060	Cytokine-cytokine receptor interaction	55540_2057	2	-	0.00960561215146946	0.345802037452901
10814	5182598	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	0.000117794182965378	0.00624309169716503
10815	5182598	hsa04360	Axon guidance	1948_1944_9475_7852_54910_2534_10507_3983	8	-	0.033672005401776	1
10816	ionomycin	hsa05010	Alzheimer's disease	4713_9451_3708_22926_488_348	6	+	0.017428083495376	0.357933905016149
10817	ionomycin	hsa05016	Huntington's disease	4713_64764_64446_3708_90993_55567_7419	7	+	0.0292476662732087	0.359328471356564
10818	ionomycin	hsa04740	Olfactory transduction	26211_22802_81285_815_26707	5	+	1.10055794655525e-08	9.46479834037515e-07
10819	ionomycin	hsa04514	Cell adhesion molecules (CAMs)	9076_9379_24146_3383_5175_3106_3683_3105_29851_3126_1013_3685_3695_3135_3688_57863_920_923_1002_649853	20	+	0.0215828815301889	0.357933905016149
10820	ionomycin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8341_3126_8969_8370_8332_8359_8330_8331_8336_554313_121504_8354_3018_85235	25	+	0.00193352390067676	0.0831415277291007
10821	ionomycin	hsa04062	Chemokine signaling pathway	208_2931_1524_5880_729230_6366_4793	7	+	0.0221737793678527	0.357933905016149
10822	ionomycin	hsa05012	Parkinson's disease	51465_7419_9627_4713	4	+	0.0249721329081034	0.357933905016149
10823	ionomycin	hsa04120	Ubiquitin mediated proteolysis	10277_29882_23759_51433_11059_64682_6921_7326_9039_51366_7321_7322_7189_9817_7328_8881_22954_83737_51619_55236_89910_7327_23291_8065_64750_4193_672_8454_8453_8452_8554_8450_8945_7320_7332_7337_7334_7319_4734_1643_55120_6502_6500_3093_51588_51465_9690	47	-	0.029433544360074	0.180525738741787
10824	ionomycin	hsa04640	Hematopoietic cell lineage	3554_3123_3126_3127_3125_3673	6	-	0.00119907270622673	0.0183857814954765
10825	ionomycin	hsa05010	Alzheimer's disease	3710_2776_5663_7381_4702_11261_4708_808_23236_5532_5530_5534_8851_5331_1020_3416_5594_4712_6392_642502_6391_355_3709_805_351_801_539	27	-	0.0378388807540648	0.193398723854109
10826	ionomycin	hsa04080	Neuroactive ligand-receptor interaction	5021_3354_706_4886_4889	5	-	1.37710414080511e-17	6.33467904770351e-16
10827	ionomycin	hsa05016	Huntington's disease	4899_5440_246721_2776_5331_23186_7019_7381_5433_6874_4702_5434_5435_5439_4708_7419_1212_548644_23236_4712_6392_642502_6391_1385_1387_9519_539	27	-	0.0172209503735002	0.121871341104771
10828	ionomycin	hsa04740	Olfactory transduction	5613_5566_5567_5616_808_109_805_801_409	9	-	8.69680793445942e-25	8.00106329970267e-23
10829	ionomycin	hsa04514	Cell adhesion molecules (CAMs)	4897_4267_3123_3126_3127_4756_3125_3134_3105_5792_9672_6382_23705_9019_5819	15	-	0.00427955181921926	0.0393718767368172
10830	ionomycin	hsa04510	Focal adhesion	595_596_5295_5154_5290_9475_5881_5601_5747_3673_4659_6093_5500_5501_5728_3911_858_1499_1398_3915_3912_207_5062_998_673_3725_6714_5594_5578_5599_2317_6654_2002	33	-	0.0448777402877296	0.217302742445849
10831	ionomycin	hsa04110	Cell cycle	890_29882_595_4085_4087_4088_983_701_51433_1869_1871_5111_64682_8243_699_8881_5925_5934_4089_7534_1017_7531_7533_995_4174_5000_993_9134_4193_8454_7027_7040_9700_1031_5591_4175_4176_5347_4171_4172_4173_6502_6500_8317_5933_4998_1387_7465	48	-	0.00187484150775039	0.0215606773391295
10832	ionomycin	hsa03030	DNA replication	4174_23649_4176_4173_5111_4171_4172_4175_5982_5983_5427_5426_6117_2237_5985_5557_6118_5422_5558	19	-	0.00519300768813166	0.0434324279371011
10833	ionomycin	hsa04512	ECM-receptor interaction	3915_375790_3912_3911_1605_9672_6382_3673_3161	9	-	0.02287225629773	0.15030339852794
10834	ionomycin	hsa04630	Jak-STAT signaling pathway	3455_3717_6777_595_8554_207_3460_6654_51588_5290_10254_6772_200734_5781_9180_9655_3597_1387_5295_8027	20	-	0.0110168812993827	0.0844627566286007
10835	ionomycin	hsa05012	Parkinson's disease	2861_7326_7419_4702_4712_6392_642502_6391_7054_4708_7327_51465_7381_539_7332	15	-	0.00327943243393735	0.0335230871024707
10836	ionomycin	hsa04260	Cardiac muscle contraction	7168_7381_10479_27092	4	-	0.000161626944505392	0.00297393577889921
10837	ionomycin	hsa04060	Cytokine-cytokine receptor interaction	3556_27242_3554_3597_3460_55540_3455_3625_5154_8741_8742_7852_657_6387_4982_7040_9180_91_93_355_659	21	-	5.3471327030592e-08	1.63978736227149e-06
10838	ionomycin	hsa03010	Ribosome	6125_6158_6160_6204_6171	5	-	2.99170649506294e-05	0.000688092493864476
10839	ionomycin	hsa04020	Calcium signaling pathway	3710_2776_5331_5335_493_5256_11261_5567_3707_7419_5021_2767_5530_5532_109_5534_107_23236_115_8877_5578_5613_3709_5616_808_801_5566_805	28	-	0.0333970472690215	0.180736961691175
10840	ionomycin	hsa04912	GnRH signaling pathway	6416_3710_2776_115_5601_5603_112_5605_5608_5580_5566_5567_808_6300_4215_4216_8399_2767_998_109_3725_6714_81579_107_23236_5331_1432_5594_5578_5599_5613_6654_5616_2002_3709_3845_801_805	38	-	0.0326501866809694	0.180736961691175
10841	ionomycin	hsa04610	Complement and coagulation cascades	2155_2161_7035_727	4	-	0.00148583574007067	0.0195281268695002
10842	pyrvinium	hsa04662	B cell receptor signaling pathway	23533_973_971_3551_7410_4772_2353_4794_3725_29760_4792_4793	12	+	0.0421321318648261	0.603893890062507
10843	pyrvinium	hsa05010	Alzheimer's disease	810_355_7124_348_4023	5	+	0.00731753692555063	0.157327043899339
10844	pyrvinium	hsa05016	Huntington's disease	1212_27113_9001	3	+	0.000301247621337504	0.00863576514500845
10845	pyrvinium	hsa04740	Olfactory transduction	810_9635	2	+	2.0373810291729e-11	1.75214768508869e-09
10846	pyrvinium	hsa04710	Circadian rhythm - mammal	406_8864_5187_8553	4	+	0.0373875367156492	0.603893890062507
10847	pyrvinium	hsa04115	p53 signaling pathway	55367_1647_27113_5366_1643_64393_7161_6477_7057_4193_355_25898_1026_5268_8795_9540_4616	17	+	0.000261497940931403	0.00863576514500845
10848	pyrvinium	hsa03440	Homologous recombination	5890_5888_6118_675_641_7517_5892_10714_25788_10111	10	-	0.00709922736350991	0.0922899557256288
10849	pyrvinium	hsa04080	Neuroactive ligand-receptor interaction	152_1131_5031_56288_2150_2690	6	-	1.29460187929985e-07	3.92695903387621e-06
10850	pyrvinium	hsa04742	Taste transduction	112	1	-	0.0278587761902685	0.211262386109536
10851	pyrvinium	hsa05016	Huntington's disease	246721_836_4713_581_5439_2776_3092_7019_513_548644_517_23236	12	-	0.0169129238803139	0.153907607310857
10852	pyrvinium	hsa04740	Olfactory transduction	801_109_157_805_808	5	-	1.92634847275668e-14	1.75297711020858e-12
10853	pyrvinium	hsa04510	Focal adhesion	5295_596_3691_2324_9475_2002_93408_4636_3655_5291_4233_83660_5578	13	-	0.01205617846576	0.13713903004802
10854	pyrvinium	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_6738_8348_8329_8294_121504_8343_3125_8347_8346_8345_8344_8339_3123_3126_3127_3021_3020_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3012_3013_3017_3014	51	-	2.95623330694526e-09	1.34508615466009e-07
10855	pyrvinium	hsa04110	Cell cycle	701_9700_651610_51433_1031_7531_890_891_991_990_993_9134_898_8379_8317_1869_8318_5347_4171_4173_6502_472_5933_10926_4998	25	-	0.0224343054999656	0.185592890954261
10856	pyrvinium	hsa04630	Jak-STAT signaling pathway	3717_3455_1154_5295_5291_8554_2690	7	-	0.00347024959865685	0.0526321189129622
10857	pyrvinium	hsa05012	Parkinson's disease	836_4713_7054_65018_27429_513_517	7	-	0.0151098961599625	0.152777838950732
10858	pyrvinium	hsa04060	Cytokine-cytokine receptor interaction	3556_3579_2324_23765_3455_8741_7852_6387_4982_4233_55540_2690	12	-	0.000124648800756603	0.00226860817377017
10859	pyrvinium	hsa03010	Ribosome	6137	1	-	0.000113228291258223	0.00226860817377017
10860	oxaprozin	hsa05332	Graft-versus-host disease	3123_3126_3127_3119_3125	5	+	0.00871499467245322	0.0958649413969854
10861	oxaprozin	hsa04640	Hematopoietic cell lineage	2814_3123_3126_3127_3125_7066_3674	7	+	0.0140839117495355	0.132791167924192
10862	oxaprozin	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3119_3125	5	+	0.0204686151292847	0.168866074816599
10863	oxaprozin	hsa04612	Antigen processing and presentation	3119_3123_3126_3127_3125_6892_3310_3305	8	+	0.00487986574786515	0.06441422787182
10864	oxaprozin	hsa04740	Olfactory transduction	8387_7932_3000_8388	4	+	0.0370214225463034	0.244341388805602
10865	oxaprozin	hsa05322	Systemic lupus erythematosus	3119_9103_3123_3126_3127_3125_8358_8968_3013_8350_8351_8352_8353_8354_8355_8356_8357	17	+	1.74003064888835e-06	0.000114842022826631
10866	oxaprozin	hsa05310	Asthma	3119_3123_3126_3127_3125_8288	6	+	0.000378735119616439	0.00941383062491168
10867	oxaprozin	hsa04512	ECM-receptor interaction	2814_22798_1282_5649_1284_3674	6	+	0.0359348401561064	0.244341388805602
10868	oxaprozin	hsa05330	Allograft rejection	3593_3119_3123_3126_3127_3125	6	+	0.00114393030051738	0.0188748499585368
10869	oxaprozin	hsa04940	Type I diabetes mellitus	3593_3119_3126_2572_3127_3125_3123	7	+	0.00042790139204144	0.00941383062491168
10870	oxaprozin	hsa04662	B cell receptor signaling pathway	6655_5295_5533_4772_5534_3845_29760_4793	8	-	0.0209974807196849	0.425198984573619
10871	oxaprozin	hsa04740	Olfactory transduction	157	1	-	2.63901556282138e-06	0.000213760260588532
10872	oxaprozin	hsa04360	Axon guidance	1949_57556_6405_1944_5533_64221_3845_23365_5534_4772_6093_22885	12	-	0.0175702857334467	0.425198984573619
10873	oxaprozin	hsa04370	VEGF signaling pathway	5829_5295_5533_8681_3845_7422_5534_4772_100137049	9	-	0.00888963074294182	0.360030045089144
10874	5230742	hsa04130	SNARE interactions in vesicular transport	8773_23673_9570_6809	4	-	0.00233804656326263	0.130930607542707
10875	5230742	hsa05014	Amyotrophic lateral sclerosis (ALS)	11261_1432_5603	3	-	0.0445656291556509	0.623918808179113
10876	5230742	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	4233_10312_1432_5603	4	-	0.0180993619715019	0.337854756801369
10877	5230742	hsa03022	Basal transcription factors	51616_2969_728198	3	-	0.0162567262019984	0.337854756801369
10878	ikarugamycin	hsa05131	Shigellosis	9076_7278_3688_113457	4	+	0.0372475973168917	0.572996143869339
10879	ikarugamycin	hsa05130	Pathogenic Escherichia coli infection	9076_7278_3688_113457	4	+	0.0372475973168917	0.572996143869339
10880	ikarugamycin	hsa04740	Olfactory transduction	81285	1	+	0.00353478575855988	0.173204502169434
10881	ikarugamycin	hsa04060	Cytokine-cytokine receptor interaction	23529	1	+	0.0467751954179052	0.572996143869339
10882	quinostatin	hsa04130	SNARE interactions in vesicular transport	8773_9570_662_8675_6809	5	-	0.045753858480635	0.401617202218907
10883	quinostatin	hsa04080	Neuroactive ligand-receptor interaction	4889_2690_7068_5031	4	-	0.0149755539798791	0.295767191102612
10884	quinostatin	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_581_11261_5868_5534_1432_5608	7	-	0.0247013266618935	0.31175139415062
10885	quinostatin	hsa04740	Olfactory transduction	801_808_805	3	-	1.97235727878532e-05	0.0015581622502404
10886	quinostatin	hsa04510	Focal adhesion	3655_7057_7422	3	-	0.0276235412538524	0.31175139415062
10887	quinostatin	hsa05322	Systemic lupus erythematosus	85235_3012_8330_3021_3020_8332_8969_8331_8329_3014_8335_8336_6632	13	-	0.0335690478941472	0.331494347954704
10888	quinostatin	hsa04115	p53 signaling pathway	836_841_9134_898_581_7057_5366_1017	8	-	0.0244097155242649	0.31175139415062
10889	quinostatin	hsa04062	Chemokine signaling pathway	7852_6772	2	-	0.0090996330781665	0.282913053418512
10890	quinostatin	hsa04060	Cytokine-cytokine receptor interaction	7852_55540_7422_2690	4	-	0.0107435336741207	0.282913053418512
10891	pentetic acid	hsa04640	Hematopoietic cell lineage	3690_3589_2993_915_920_914_925	7	+	0.0254250116709504	0.63562529177376
10892	pentetic acid	hsa04740	Olfactory transduction	8387_26212_8388	3	+	0.00387760651613778	0.145410244355167
10893	pentetic acid	hsa05340	Primary immunodeficiency	3561_3718_6891_920_915_925	6	+	0.00145599089200645	0.109199316900484
10894	docosahexaenoic acid ethyl ester	hsa04070	Phosphatidylinositol signaling system	5293_3633	2	+	0.0401901174838861	0.396141460570829
10895	docosahexaenoic acid ethyl ester	hsa04662	B cell receptor signaling pathway	5293_4793	2	+	0.0392592966410746	0.396141460570829
10896	docosahexaenoic acid ethyl ester	hsa04660	T cell receptor signaling pathway	925_5293_4793	3	+	0.0108445867663841	0.396141460570829
10897	docosahexaenoic acid ethyl ester	hsa04062	Chemokine signaling pathway	3576_5293_4793	3	+	0.0454075943229937	0.396141460570829
10898	docosahexaenoic acid ethyl ester	hsa05200	Pathways in cancer	4318_2263_5599_8453_6934	5	-	0.00663829238181586	0.162641366435593
10899	docosahexaenoic acid ethyl ester	hsa04310	Wnt signaling pathway	5599_4041_6934	3	-	0.0177739732187211	0.162641366435593
10900	docosahexaenoic acid ethyl ester	hsa04520	Adherens junction	3643_6934	2	-	0.0347258019959339	0.162641366435593
10901	docosahexaenoic acid ethyl ester	hsa05212	Pancreatic cancer	2263_6934	2	-	0.0419719655317659	0.162641366435593
10902	docosahexaenoic acid ethyl ester	hsa05215	Prostate cancer	2263_6934	2	-	0.0411406598957652	0.162641366435593
10903	docosahexaenoic acid ethyl ester	hsa04920	Adipocytokine signaling pathway	5599_3717	2	-	0.0252509646621312	0.162641366435593
10904	docosahexaenoic acid ethyl ester	hsa04930	Type II diabetes mellitus	5599_3643	2	-	0.0122215469192563	0.162641366435593
10905	docosahexaenoic acid ethyl ester	hsa05210	Colorectal cancer	5599_6934	2	-	0.0378801484473608	0.162641366435593
10906	depudecin	hsa05332	Graft-versus-host disease	3135_3105_3106_3133_649853	5	+	0.00118500922752052	0.0250807977265456
10907	depudecin	hsa04650	Natural killer cell mediated cytotoxicity	3383_3105_3106_5293_3135_3133	6	+	0.0370352785966159	0.259246950176311
10908	depudecin	hsa05320	Autoimmune thyroid disease	3135_3105_3106_3133_649853	5	+	0.00304406375156346	0.0414274427814309
10909	depudecin	hsa04612	Antigen processing and presentation	3135_3105_3106_3133_649853	5	+	0.0223619917882053	0.173926602797152
10910	depudecin	hsa04910	Insulin signaling pathway	2308_2872_5575_5293_5562_23433_5792_8835	8	+	0.00355092366697979	0.0414274427814309
10911	depudecin	hsa04520	Adherens junction	4088_3480_5787_4233_5792	5	+	0.015089897215025	0.134842758912706
10912	depudecin	hsa04740	Olfactory transduction	26211	1	+	0.015410601018595	0.134842758912706
10913	depudecin	hsa04514	Cell adhesion molecules (CAMs)	9076_3383_5792_3105_3106_3135_22871_3133_649853	9	+	0.000762954837909561	0.0250807977265456
10914	depudecin	hsa05330	Allograft rejection	3135_3105_3106_3133_649853	5	+	0.000785696927737687	0.0250807977265456
10915	depudecin	hsa04940	Type I diabetes mellitus	3135_3105_3106_3133_649853	5	+	0.00143318844151689	0.0250807977265456
10916	propofol	hsa04650	Natural killer cell mediated cytotoxicity	3811_3383_962_2207_3802_5335_5534_4772	8	+	0.0270123194378338	0.444887721938329
10917	propofol	hsa04662	B cell receptor signaling pathway	11025_5534_8519_4772_2353_3725	6	+	0.014278729216012	0.401281802158802
10918	propofol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8348_8294_121504_8343_8347_8346_8344_8339_6737_8968_8370_8358_8359_8335_8350_8351_8352_8353_8354_8355_8356_8357_3012_3013_720_721_8970	37	+	3.85707883463474e-24	2.69995518424432e-22
10919	propofol	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3725_1839_1432_5335_6352	5	+	0.0383144036278913	0.444887721938329
10920	propofol	hsa04010	MAPK signaling pathway	9344_1843_1649_2353_11221_1432_5534_3553_3310_2261_8398_3164_3725_4616	14	+	0.0171977915210915	0.401281802158802
10921	propofol	hsa04620	Toll-like receptor signaling pathway	3665_6352_1432_3725_2353_3553	6	+	0.0492001697354241	0.444887721938329
10922	propofol	hsa03020	RNA polymerase	5432_246721_5439_548644	4	-	0.00189751644528306	0.0929783058188699
10923	IC-86621	hsa04080	Neuroactive ligand-receptor interaction	2740_1131_7442_56288_9170	5	+	0.0258786770148501	0.426829330826206
10924	IC-86621	hsa04910	Insulin signaling pathway	23433	1	+	0.0151152712348228	0.403073899595275
10925	IC-86621	hsa04740	Olfactory transduction	219464_4991	2	+	2.07266346197528e-06	0.000165813076958022
10926	IC-86621	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_718_8368_8366_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	20	+	9.02957058702523e-05	0.00361182823481009
10927	IC-86621	hsa04060	Cytokine-cytokine receptor interaction	8718_3581_3601_5154_8795	5	+	0.0266768331766379	0.426829330826206
10928	IC-86621	hsa04080	Neuroactive ligand-receptor interaction	624_3953_1131_3355_6915_7067	6	-	0.00418537766509003	0.179971239598871
10929	IC-86621	hsa04740	Olfactory transduction	51806_409	2	-	5.7970817686153e-09	4.98549032100916e-07
10930	IC-86621	hsa05012	Parkinson's disease	836_6622_5413	3	-	0.0493014213887567	1
10931	ramifenazone	hsa04650	Natural killer cell mediated cytotoxicity	3439_2215_5296_3804_6655_3107_3447_4775_9436_9437_5879_4068_2534	13	+	0.0334388184721999	0.521426070111054
10932	ramifenazone	hsa05010	Alzheimer's disease	841	1	+	0.00364180152705828	0.101970442757632
10933	ramifenazone	hsa05016	Huntington's disease	7350_9001_841	3	+	0.0372447192936467	0.521426070111054
10934	ramifenazone	hsa04740	Olfactory transduction	26212_9635_390892	3	+	1.44740287332086e-05	0.000607909206794761
10935	ramifenazone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8294_121504_958_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2215_3013_720_721	30	+	6.92597712115996e-10	5.81782078177437e-08
10936	ramifenazone	hsa05012	Parkinson's disease	5413	1	+	0.0231220820060745	0.485563722127564
10937	ramifenazone	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	-	0.0464285211671429	0.617331284240832
10938	ramifenazone	hsa05320	Autoimmune thyroid disease	3135_3105_3106_3448_649853	5	-	0.0280690764887484	0.610232247024423
10939	ramifenazone	hsa04740	Olfactory transduction	219464_157	2	-	0.00112579465264191	0.0788056256849337
10940	ramifenazone	hsa04010	MAPK signaling pathway	3554_8398_5534_1850_5598_6655_2005_5533_5607_9479_10454_7786_2263_7186_27092	15	-	0.0320637199344898	0.610232247024423
10941	ramifenazone	hsa05330	Allograft rejection	3135_3105_3106_649853	4	-	0.0348704141156813	0.610232247024423
10942	bemegride	hsa04740	Olfactory transduction	816	1	+	0.0154424938207073	0.494159802262634
10943	bemegride	hsa04540	Gap junction	7278_113457_3709_6714_2977_23236	6	+	0.00712141077474494	0.455770289583676
10944	bemegride	hsa04912	GnRH signaling pathway	6714_3709_5603_816_23236	5	+	0.0452154336706621	0.745763425002385
10945	bemegride	hsa05200	Pathways in cancer	4233_5154_1613_324_5336_6257	6	-	0.0396355834841986	0.384443604567775
10946	bemegride	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	50617_4233_5336	3	-	0.0176070897917964	0.384443604567775
10947	bemegride	hsa04540	Gap junction	5607_5154_1813	3	-	0.0345805547517935	0.384443604567775
10948	valdecoxib	hsa04650	Natural killer cell mediated cytotoxicity	3107_4772_3383	3	+	0.035327349988325	0.462716344707442
10949	valdecoxib	hsa05010	Alzheimer's disease	3709_4035	2	+	0.00153613274778041	0.0629814426589968
10950	valdecoxib	hsa04910	Insulin signaling pathway	10580_5602	2	+	0.0125985359077703	0.258269986109291
10951	valdecoxib	hsa05016	Huntington's disease	1212_4899_161	3	+	0.00368705336428245	0.10077945862372
10952	valdecoxib	hsa04740	Olfactory transduction	26211_135948_26476_81797_390892_81696_5132	7	+	2.83761199513932e-05	0.00232684183601424
10953	valdecoxib	hsa05212	Pancreatic cancer	51176	1	+	0.0451504855406236	0.462716344707442
10954	valdecoxib	hsa05215	Prostate cancer	51176	1	+	0.044499740037181	0.462716344707442
10955	valdecoxib	hsa04012	ErbB signaling pathway	5602	1	+	0.0440087453798842	0.462716344707442
10956	valdecoxib	hsa04120	Ubiquitin mediated proteolysis	22888_10075_51343_26272_8452	5	-	0.0130303905194874	0.197627589545559
10957	valdecoxib	hsa05010	Alzheimer's disease	4695_4713_6390_4137_351_4843	6	-	0.00281560548209288	0.085406699623484
10958	valdecoxib	hsa05016	Huntington's disease	5430_4695_4713_6390_246721_6648_161	7	-	0.00382000345288049	0.0869050785530311
10959	valdecoxib	hsa04740	Olfactory transduction	23538_8390_818_81797_5137_816	6	-	2.18419915090059e-10	1.98762122731954e-08
10960	valdecoxib	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8290_88_8294_121504_8342_3586_8968_8370_717_8358_8359_8330_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3115_3111_720_721	35	-	2.09988183914214e-05	0.000955446236809674
10961	valdecoxib	hsa05110	Vibrio cholerae infection	534	1	-	0.0412791186829511	0.417377755572061
10962	valdecoxib	hsa04630	Jak-STAT signaling pathway	3590_3586_3589_6655_5292_3600_10252	7	-	0.0279479834886287	0.317908312183151
10963	valdecoxib	hsa04062	Chemokine signaling pathway	4283_3579_6357_6655_3576_998_2931_25759_10235_6363	10	-	0.0276529688790515	0.317908312183151
10964	valdecoxib	hsa05012	Parkinson's disease	27429_6390_4695_4713	4	-	0.00489221839802496	0.0890383748440543
10965	crotamiton	hsa05332	Graft-versus-host disease	3812_3824_3553_3109_3821_3804_3107_3113_941	9	+	0.00521712714150778	0.113472515327794
10966	crotamiton	hsa04120	Ubiquitin mediated proteolysis	26272	1	+	0.00154296885242674	0.0447460967203755
10967	crotamiton	hsa04740	Olfactory transduction	26539_5137_157_390892	4	+	1.62907653093753e-07	1.41729658191565e-05
10968	crotamiton	hsa04530	Tight junction	93643	1	+	0.00152418421100235	0.0447460967203755
10969	crotamiton	hsa05012	Parkinson's disease	6622_1339_5413	3	+	0.035749930087168	0.518373986263936
10970	crotamiton	hsa03010	Ribosome	6125	1	+	0.0145103441914874	0.252479988931881
10971	crotamiton	hsa04080	Neuroactive ligand-receptor interaction	7068_2150_4157_5031	4	-	3.38986030129227e-05	0.00294917846212428
10972	crotamiton	hsa05200	Pathways in cancer	4089_4088_598_5295_331_5290_5899_10342_1488_652671_4149_3551_7157_4824_5371_1613_405_324_1398_2263_2260_1017_9063_581_999_4193_4254_6934_7042_3725_4233_3688_2271_5594_841_7184_6655_6772_51588_6257	40	-	0.0200930568981935	0.288121971573249
10973	crotamiton	hsa04210	Apoptosis	3551_841_581_7157_598_5575_5295_331_5290_472_5534_5576_8837_651610	14	-	0.0231822275978476	0.288121971573249
10974	crotamiton	hsa05216	Thyroid cancer	5594_7157_999_6934_10342_6257	6	-	0.0423244038491416	0.409135903875035
10975	crotamiton	hsa05012	Parkinson's disease	2861_7327_4712	3	-	0.0133476117256641	0.242853199786456
10976	crotamiton	hsa04060	Cytokine-cytokine receptor interaction	2057_23529_8742_8741_4254_7852_9180_7042_4233_51330	10	-	0.0135411128158102	0.242853199786456
10977	crotamiton	hsa04020	Calcium signaling pathway	5534_814_489_2776_23236	5	-	0.00738964537817573	0.242853199786456
10978	crotamiton	hsa05210	Colorectal cancer	324_581_4088_4089_6655_5295_5290_7157_6934_7042_3725_4233_5594	13	-	0.0318924806319089	0.346830726872009
10979	crotamiton	hsa05220	Chronic myeloid leukemia	5594_3551_4088_4089_6655_5295_4193_5290_7157_1398_598_7042_1488	13	-	0.0139570804474975	0.242853199786456
10980	flunisolide	hsa05332	Graft-versus-host disease	3812_3553_3126_3113_3127_3111_3125_3123_942	9	+	0.00178712716845149	0.0611055675681332
10981	flunisolide	hsa04650	Natural killer cell mediated cytotoxicity	3812_23533_3383_5579_2207_7410_962_27040_5880_5335_5781_5293_51744_5058_2534_3448	16	+	0.0189464262935597	0.114344642751449
10982	flunisolide	hsa05010	Alzheimer's disease	2903_779_3553_4712	4	+	0.0478734432720975	0.236551131462129
10983	flunisolide	hsa05200	Pathways in cancer	23533_5154_5880_5335_5337_8325_5371_3479_7048_8823_405_2249_5293_2260_2261_3082_51384_4254_330_11211_1950_5467_91_2246_1284_2335_5579_862_8817_5915_2353	31	+	0.0188597365978659	0.114344642751449
10984	flunisolide	hsa05320	Autoimmune thyroid disease	3448_942_3113_3127_3111_3126_3123_3125	8	+	0.0190574404585749	0.114344642751449
10985	flunisolide	hsa05016	Huntington's disease	4712_163	2	+	0.0021823416988619	0.0611055675681332
10986	flunisolide	hsa04740	Olfactory transduction	23538_9635_816	3	+	7.11690982223045e-07	5.97820425067358e-05
10987	flunisolide	hsa04514	Cell adhesion molecules (CAMs)	3383_942_3123_3126_3127_3111_3125_23308_5817_57863_6693_3684_3113_1462	14	+	0.0455417830527176	0.236551131462129
10988	flunisolide	hsa04510	Focal adhesion	23533_7148_2335_5579_1284_1281_5154_859_3479_93408_7410_5880_330_1950_7414_5293_5058_1290_1277_2534_3082	21	+	0.0189670292466155	0.114344642751449
10989	flunisolide	hsa04110	Cell cycle	699	1	+	0.0148463408277448	0.114344642751449
10990	flunisolide	hsa04664	Fc epsilon RI signaling pathway	23533_5579_2207_7410_5880_5293_27040_8681_5335_100137049_2534	11	+	0.0166588223327632	0.114344642751449
10991	flunisolide	hsa05218	Melanoma	5154_23533_3479_5293_8817_8823_2249_2246_3082_2260_1950	11	+	0.00551017481635223	0.0771424474289312
10992	flunisolide	hsa05310	Asthma	2207_3123_3126_3127_3111_3125_3113	7	+	0.00379971437887487	0.0765989813756462
10993	flunisolide	hsa04010	MAPK signaling pathway	9344_5154_5801_5880_5058_10368_3164_3553_7048_8823_8911_2249_2260_2261_100137049_11184_779_1950_91_2246_5579_782_4915_8817_8913_23162_8681_2353_27330	29	+	0.0045594631771218	0.0765989813756462
10994	flunisolide	hsa04020	Calcium signaling pathway	2903_1139_5579_8913_779_148_2925_1816_553_6915_108_8911_5335_5724_3269_1910_3358_816	18	+	0.0430584869136143	0.236551131462129
10995	flunisolide	hsa05330	Allograft rejection	3126_942_3127_3111_3125_3123_3113	7	+	0.0114183640230001	0.114344642751449
10996	flunisolide	hsa04940	Type I diabetes mellitus	3553_3113_3126_3127_3111_3125_3123_942	8	+	0.00752193243724719	0.0902631892469663
10997	flunisolide	hsa04080	Neuroactive ligand-receptor interaction	2901_1813_3953_6754_2740_56288_134	7	-	0.0232206776188714	0.450003603399229
10998	flunisolide	hsa04740	Olfactory transduction	810_5613_5616_816	4	-	9.89698714556802e-07	4.35467434404993e-05
10999	flunisolide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6738_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013_3113_3014	36	-	7.15609013458587e-11	6.29735931843557e-09
11000	flunisolide	hsa04210	Apoptosis	5970_3553_841_3551_5613_5616_472_836_208_8737_8837_651610	12	-	0.017914929271863	0.450003603399229
11001	flunisolide	hsa04115	p53 signaling pathway	55367_27113_836_841_5268_3486_472_51512_25898_651610	10	-	0.0255683865567744	0.450003603399229
11002	flunisolide	hsa04330	Notch signaling pathway	196403_1856_1857_6868_22938_1488_9541	7	-	0.0388265211784492	0.569455643950588
11003	ipratropium bromide	hsa05340	Primary immunodeficiency	6891_973	2	+	0.027843810074161	0.667660233341735
11004	ipratropium bromide	hsa02010	ABC transporters	6891_8714	2	+	0.0415581387421443	0.667660233341735
11005	ipratropium bromide	hsa04070	Phosphatidylinositol signaling system	5331_8526_3633_8396_3631	5	-	0.0400762617033482	0.422901869292567
11006	ipratropium bromide	hsa04650	Natural killer cell mediated cytotoxicity	5533_4276_10725_3106_3135_6452_3845_80328	8	-	0.0205671253480843	0.344499349580412
11007	ipratropium bromide	hsa04080	Neuroactive ligand-receptor interaction	64106	1	-	0.0328713783888333	0.422901869292567
11008	ipratropium bromide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_85235_8364_8370_8366_8368_8365_8330_8332_8359_8969_8331_8329_8336_8367_554313_121504_8294	21	-	2.01479952309471e-10	1.34991568047346e-08
11009	ipratropium bromide	hsa04664	Fc epsilon RI signaling pathway	1432_50487_3845_5600_5608	5	-	0.0457073281457915	0.422901869292567
11010	ipratropium bromide	hsa04370	VEGF signaling pathway	1432_10725_50487_5533_3845_5600	6	-	0.0126228481468806	0.344499349580412
11011	ipratropium bromide	hsa04912	GnRH signaling pathway	1432_50487_5331_3845_5600_113_5608	7	-	0.0176482237515239	0.344499349580412
11012	atropine	hsa04080	Neuroactive ligand-receptor interaction	64106_4889	2	-	0.0130941969929277	0.34061899024069
11013	atropine	hsa04310	Wnt signaling pathway	8312_5613_5566_5616_8061_1454_6934_5534_3725_1488_2535	11	-	0.0239872528338514	0.34061899024069
11014	atropine	hsa05016	Huntington's disease	10126	1	-	0.0224699332800612	0.34061899024069
11015	atropine	hsa04740	Olfactory transduction	5613_5566_5616	3	-	0.00138019905353052	0.0979941328006669
11016	atropine	hsa04340	Hedgehog signaling pathway	5613_5566_5616_1454_655_652	6	-	0.0179063532384367	0.34061899024069
11017	disopyramide	hsa04080	Neuroactive ligand-receptor interaction	1269	1	+	0.0238829695483966	0.549308299613122
11018	disopyramide	hsa04310	Wnt signaling pathway	4040_4041_894_5331_5467_5534_8324_8321_3725	9	+	0.0217554697394253	0.549308299613122
11019	disopyramide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_3108	15	+	1.24212067565886e-05	0.000857063266204614
11020	disopyramide	hsa04810	Regulation of actin cytoskeleton	2251	1	+	0.0472684180970148	0.815380212173505
11021	disopyramide	hsa05214	Glioma	5594_7157_5295_4193_5605_808_801_805	8	-	0.00281915998505611	0.0693761928068649
11022	disopyramide	hsa05332	Graft-versus-host disease	3135_3123_3126_3127_3125	5	-	0.0193123765764582	0.0861065982262815
11023	disopyramide	hsa04070	Phosphatidylinositol signaling system	8394_8396_5295_808_23396_801_805	7	-	0.0202603760532427	0.0861065982262815
11024	disopyramide	hsa05211	Renal cell carcinoma	2271_5594_5295_5605_7422_1398_3725	7	-	0.0158148791213618	0.0832570323980685
11025	disopyramide	hsa04080	Neuroactive ligand-receptor interaction	5618_2150	2	-	0.0130941969929277	0.0832570323980685
11026	disopyramide	hsa05200	Pathways in cancer	4149_5594_4318_598_324_5295_999_4193_5899_1613_5605_7157_5881_842_2271_7422_1398_3725_1017_7184_8030	21	-	0.00939341835940096	0.0832570323980685
11027	disopyramide	hsa05320	Autoimmune thyroid disease	3135_3123_3126_3127_3125	5	-	0.0430564074434268	0.135547949358936
11028	disopyramide	hsa04612	Antigen processing and presentation	4800_3123_3126_3127_3125_3135_3308	7	-	0.0405548737628631	0.135547949358936
11029	disopyramide	hsa05014	Amyotrophic lateral sclerosis (ALS)	4217_1432_842_7157_598_5868	6	-	0.0166514064796137	0.0832570323980685
11030	disopyramide	hsa04740	Olfactory transduction	801_808_157_805	4	-	0.0057339977120398	0.0727502206456392
11031	disopyramide	hsa05212	Pancreatic cancer	5594_7157_5295_4193_5605_1017_7184_842	8	-	0.015301058071588	0.0832570323980685
11032	disopyramide	hsa05215	Prostate cancer	5594_7157_5295_4193_5605_1017_7184_842	8	-	0.014442362088543	0.0832570323980685
11033	disopyramide	hsa04370	VEGF signaling pathway	1432_5594_5829_5295_5605_10725_5881_7422_842	9	-	0.00216210006113449	0.0693761928068649
11034	disopyramide	hsa05219	Bladder cancer	5594_7157_999_1613_4193_5605_4318_7422	8	-	0.000218293595174801	0.0185549555898581
11035	disopyramide	hsa05218	Melanoma	5594_7157_5295_999_4193_5605	6	-	0.0426609562112888	0.135547949358936
11036	disopyramide	hsa05216	Thyroid cancer	5605_7157_999_8030_5594	5	-	0.00497053414196037	0.0727502206456392
11037	disopyramide	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.0253966438059415	0.102795939214525
11038	disopyramide	hsa05223	Non-small cell lung cancer	5605_7157_5295_842_5594	5	-	0.0458160055250065	0.139084302486627
11039	disopyramide	hsa03022	Basal transcription factors	10629_6884_51616_2969_728198	5	-	0.0122462357483607	0.0832570323980685
11040	disopyramide	hsa04810	Regulation of actin cytoskeleton	10093_60_5594_5829_10672_8396_5295_9475_5605_8394_5881_23396_324_1398_5962	15	-	0.0145598314499532	0.0832570323980685
11041	disopyramide	hsa04060	Cytokine-cytokine receptor interaction	5618_7422_8795	3	-	0.037004741425774	0.135547949358936
11042	disopyramide	hsa05213	Endometrial cancer	5594_7157_5295_999_5605_324_842	7	-	0.0032647620144407	0.0693761928068649
11043	disopyramide	hsa04912	GnRH signaling pathway	1432_5594_2776_5605_808_3725_10746_801_805	9	-	0.0159079505819345	0.0832570323980685
11044	disopyramide	hsa05330	Allograft rejection	3135_3123_3126_3127_3125	5	-	0.0134903147193475	0.0832570323980685
11045	disopyramide	hsa05210	Colorectal cancer	5594_7157_5295_5881_324_3725_842	7	-	0.031624790428609	0.122186690292353
11046	disopyramide	hsa04270	Vascular smooth muscle contraction	5594_10672_2776_9475_5605_808_801_805_5583	9	-	0.0389332495795202	0.135547949358936
11047	disopyramide	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125_3135_1363	6	-	0.00599119464140558	0.0727502206456392
11048	disopyramide	hsa05220	Chronic myeloid leukemia	5594_7157_598_5295_4193_5605_1398	7	-	0.019075914657386	0.0861065982262815
11049	imipenem	hsa04740	Olfactory transduction	4991	1	+	0.00535851714415014	0.136642187175829
11050	imipenem	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_958_8359_8294_8367_554313_121504	15	+	1.07780113556666e-06	5.49678579138997e-05
11051	imipenem	hsa04650	Natural killer cell mediated cytotoxicity	10725	1	-	0.0462462677858138	0.656697002558556
11052	imipenem	hsa04080	Neuroactive ligand-receptor interaction	4886	1	-	0.000545858926636651	0.0129186612637341
11053	imipenem	hsa04740	Olfactory transduction	219464	1	-	3.74513311188125e-06	0.000132952225471784
11054	imipenem	hsa04514	Cell adhesion molecules (CAMs)	26047	1	-	0.0455042240198137	0.656697002558556
11055	imipenem	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013	32	-	3.98429372127957e-13	2.8288485421085e-11
11056	dorzolamide	hsa05322	Systemic lupus erythematosus	2215_3013_3113_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	13	+	0.00204886875123424	0.161860631347505
11057	dorzolamide	hsa04080	Neuroactive ligand-receptor interaction	64106_5618	2	-	0.0190373556187987	0.55108484088506
11058	dorzolamide	hsa04740	Olfactory transduction	219464_109	2	-	0.000381890712786446	0.0290236941717699
11059	dorzolamide	hsa03020	RNA polymerase	246721_5439_548644_10622	4	-	0.021753348982305	0.55108484088506
11060	meropenem	hsa05200	Pathways in cancer	841_596_861_598_4193_1613_51384_1956_3918_1488_8321_3674	12	+	0.0417792418175524	0.643933977520458
11061	meropenem	hsa04740	Olfactory transduction	810_8390	2	+	0.0359033542161109	0.643933977520458
11062	meropenem	hsa05322	Systemic lupus erythematosus	718_3013_3113_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	13	+	9.36616509382173e-06	0.000664997721661343
11063	meropenem	hsa04920	Adipocytokine signaling pathway	6794_51703_1375_5781	4	+	0.0467903854777949	0.643933977520458
11064	meropenem	hsa05220	Chronic myeloid leukemia	861_598_1488_5781_4193	5	+	0.0184007388488509	0.643933977520458
11065	glafenine	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	-	0.0186227116663299	0.167872617254385
11066	glafenine	hsa04070	Phosphatidylinositol signaling system	8394_8396_808_801_805	5	-	0.0338627708027825	0.240425672699756
11067	glafenine	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	-	0.0373930270914206	0.241354993044624
11068	glafenine	hsa05014	Amyotrophic lateral sclerosis (ALS)	834_581_572_5533_5606_5608	6	-	0.00243980493824009	0.153884455380262
11069	glafenine	hsa04210	Apoptosis	472_581_572_5533_8717_8837	6	-	0.0189152244793673	0.167872617254385
11070	glafenine	hsa04720	Long-term potentiation	5533_801_808_805_2776	5	-	0.0323344444181902	0.240425672699756
11071	glafenine	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.00650216008648994	0.153884455380262
11072	glafenine	hsa04350	TGF-beta signaling pathway	3397_3398_3400_5934_5933_57154	6	-	0.0172002082044222	0.167872617254385
11073	glafenine	hsa04912	GnRH signaling pathway	2776_808_5606_10746_801_5608_805	7	-	0.0140157539243805	0.167872617254385
11074	glafenine	hsa05330	Allograft rejection	3123_3126_3127_3125	4	-	0.013677737209834	0.167872617254385
11075	glafenine	hsa04940	Type I diabetes mellitus	3123_1363_3126_3127_3125	5	-	0.00444081203845596	0.153884455380262
11076	dyclonine	hsa04520	Adherens junction	91_2260_1956_3643	4	+	0.028730274121927	0.775121165129734
11077	dyclonine	hsa04916	Melanogenesis	5566_808_801_805	4	-	0.0326436605750094	0.170472449669494
11078	dyclonine	hsa05214	Glioma	801_808_805	3	-	0.0403145802011118	0.189478526945225
11079	dyclonine	hsa04070	Phosphatidylinositol signaling system	801_808_23396_805	4	-	0.0121936671335452	0.0955170592127707
11080	dyclonine	hsa05010	Alzheimer's disease	1327_4712_808_801_805_842	6	-	0.0165936374454944	0.11141442284832
11081	dyclonine	hsa04910	Insulin signaling pathway	801_5566_808_5575_805	5	-	0.0219076428715457	0.128707401870331
11082	dyclonine	hsa05016	Huntington's disease	5432_246721_1327_4712_5439_3064_548644_842	8	-	0.00155514407155186	0.0365458856814687
11083	dyclonine	hsa04720	Long-term potentiation	801_808_5566_805	4	-	0.0116824013606742	0.0955170592127707
11084	dyclonine	hsa03020	RNA polymerase	5432_246721_5439_548644	4	-	0.000470993904721526	0.0221367135219117
11085	dyclonine	hsa04912	GnRH signaling pathway	801_5566_808_8399_805	5	-	0.00860158295438117	0.0955170592127707
11086	dyclonine	hsa04270	Vascular smooth muscle contraction	801_5566_808_8399_805	5	-	0.0121332829722357	0.0955170592127707
11087	DL-thiorphan	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.000820007742192834	0.00799507548638013
11088	DL-thiorphan	hsa04640	Hematopoietic cell lineage	3123_3126_3127_3125	4	+	0.00981165044215164	0.0515338168154633
11089	DL-thiorphan	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	+	0.00183769965334308	0.014334057296076
11090	DL-thiorphan	hsa04612	Antigen processing and presentation	3123_3126_3127_3125	4	+	0.0105710393467617	0.0515338168154633
11091	DL-thiorphan	hsa04514	Cell adhesion molecules (CAMs)	3123_3126_3127_3685_3125	5	+	0.00909957954849924	0.0515338168154633
11092	DL-thiorphan	hsa05322	Systemic lupus erythematosus	3123_3126_3127_3125	4	+	0.0475976902347947	0.20625665768411
11093	DL-thiorphan	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.000253539799017842	0.00494402608084792
11094	DL-thiorphan	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.000578465816617325	0.00752005561602523
11095	DL-thiorphan	hsa04940	Type I diabetes mellitus	3123_3126_3127_5799_3125	5	+	8.25222923375692e-05	0.0032183694011652
11096	DL-thiorphan	hsa04916	Melanogenesis	2771	1	-	0.0307615642065856	0.396993265963005
11097	DL-thiorphan	hsa05010	Alzheimer's disease	355_1020_4708	3	-	0.0195055242067277	0.319890596990334
11098	DL-thiorphan	hsa04080	Neuroactive ligand-receptor interaction	5029_5618_56288_2690	4	-	0.00216008776367245	0.128116118329161
11099	DL-thiorphan	hsa04310	Wnt signaling pathway	5519_3725_1457	3	-	0.049354672632254	0.396993265963005
11100	DL-thiorphan	hsa04530	Tight junction	24146_6709_79784_5583_5581_2771_998_5519_10207_1457_56288_4636_6714_50848	14	-	0.0484269056404543	0.396993265963005
11101	DL-thiorphan	hsa05012	Parkinson's disease	4708	1	-	0.00720639886091331	0.196974902198297
11102	DL-thiorphan	hsa04060	Cytokine-cytokine receptor interaction	5618_23765_3572_355_8795_2690	6	-	0.0139420980915809	0.285813010877408
11103	DL-thiorphan	hsa03010	Ribosome	6168	1	-	0.0462903214533366	0.396993265963005
11104	DL-thiorphan	hsa03020	RNA polymerase	64425_246721_5439_548644_5430	5	-	0.037389716544412	0.396993265963005
11105	DL-thiorphan	hsa04020	Calcium signaling pathway	2767_8877	2	-	0.00312478337388197	0.128116118329161
11106	pyridoxine	hsa03420	Nucleotide excision repair	2068_2072	2	+	0.0344402108286707	0.189421159557689
11107	pyridoxine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8359_8370_8294_554313_121504	14	+	7.51831042685059e-13	8.27014146953565e-12
11108	pyridoxine	hsa04510	Focal adhesion	7409_9475	2	-	0.00453106276368494	0.34889183280374
11109	pyridoxine	hsa04060	Cytokine-cytokine receptor interaction	7852_655_23765_50616_7040	5	-	0.0265713941376212	0.934272777424992
11110	pyridoxine	hsa04020	Calcium signaling pathway	5335_490_3707	3	-	0.0364002380814932	0.934272777424992
11111	dacarbazine	hsa04940	Type I diabetes mellitus	3107_3382_3109	3	+	0.0226562451341821	1
11112	dacarbazine	hsa05010	Alzheimer's disease	22926	1	-	0.00512741128553742	0.389683257700844
11113	dacarbazine	hsa04080	Neuroactive ligand-receptor interaction	64106_7067_5618_1909	4	-	0.0145202125651576	0.551768077475989
11114	dacarbazine	hsa04514	Cell adhesion molecules (CAMs)	5792	1	-	0.032464106019839	0.822424019169255
11115	syrosingopine	hsa04650	Natural killer cell mediated cytotoxicity	4277_3383_5578_6655_5293_8795_6452_80328_4772_7124_3106_2534_4276	13	+	0.0110253837680282	0.183021370549268
11116	syrosingopine	hsa04120	Ubiquitin mediated proteolysis	4281	1	+	0.0316814956581608	0.375652019946764
11117	syrosingopine	hsa04080	Neuroactive ligand-receptor interaction	5732_7433	2	+	0.00227426931543946	0.0629214510604917
11118	syrosingopine	hsa05016	Huntington's disease	161_509	2	+	0.0255821233981619	0.35388604034124
11119	syrosingopine	hsa04740	Olfactory transduction	393046	1	+	2.56075493565553e-06	0.000106271329829704
11120	syrosingopine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8349_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_7124_85235_3119_88_8970	26	+	5.96067978829544e-09	4.94736422428521e-07
11121	syrosingopine	hsa05012	Parkinson's disease	509	1	+	0.0468298222690974	0.485859406041885
11122	syrosingopine	hsa04020	Calcium signaling pathway	5578	1	+	0.00756662714520436	0.15700751326299
11123	syrosingopine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_3014_8359_8294_8367_554313_8368_121504	16	-	4.55528145629129e-06	0.000350756672134429
11124	syrosingopine	hsa04110	Cell cycle	595_9134_4089_472_7027_7042_651610	7	-	0.0483287839458874	0.55981558439222
11125	syrosingopine	hsa04210	Apoptosis	596_5296_5576_5575_472_8837_651610_9020	8	-	0.00394660262636562	0.0759721005575382
11126	syrosingopine	hsa03020	RNA polymerase	246721_5439_9533_548644_84172	5	-	0.0018029063761576	0.0694118954820676
11127	syrosingopine	hsa05213	Endometrial cancer	5296_2002_595_6934_324	5	-	0.0166552635504962	0.256491058677641
11128	syrosingopine	hsa05210	Colorectal cancer	595_6934_596_5296_4089_324_7042_4233	8	-	0.00284363551846434	0.0729866449739181
11129	ellipticine	hsa04916	Melanogenesis	23236_4286_2535_5578_5613_4254_1856_1857_6932_2033_6934_112_1385_7976_8322	15	-	0.00595100763209911	0.0195533107911828
11130	ellipticine	hsa05332	Graft-versus-host disease	3105_355	2	-	0.00181863344598352	0.00697142820960349
11131	ellipticine	hsa04650	Natural killer cell mediated cytotoxicity	5296_5295_5291_10451_6452_5335_836_3454_3455_3105_3459_4277_4276_10725_5533_5534_8795_5578_6655_6464_355_7409	22	-	0.00572039656684082	0.0194917216351613
11132	ellipticine	hsa04640	Hematopoietic cell lineage	3554_3566_2057_4254_7037_3673	6	-	3.2924349189552e-05	0.000216360008959913
11133	ellipticine	hsa03320	PPAR signaling pathway	5170_7316_1962_2181_1375_5467_8310_6257_6256	9	-	0.0147667067288575	0.0377371394181914
11134	ellipticine	hsa05010	Alzheimer's disease	776_836_1327_841_4700_8772_9451_4137_5533_355_6868_5534_7132_23236	14	-	1.53860805826726e-08	2.83103882721176e-07
11135	ellipticine	hsa04080	Neuroactive ligand-receptor interaction	5029_4889_5618_64106_5025_4886_5031_136_2690_9170	10	-	3.40984435031688e-18	1.56852840114576e-16
11136	ellipticine	hsa04742	Taste transduction	5613_6337_112	3	-	0.000684451092994783	0.00299854764550095
11137	ellipticine	hsa05320	Autoimmune thyroid disease	3105_355	2	-	0.000149403015394618	0.000763615412016936
11138	ellipticine	hsa04612	Antigen processing and presentation	4800_4801_3105_5993_3306_1385_3304_3312_3303	9	-	0.000633261705488005	0.00291300384524482
11139	ellipticine	hsa04670	Leukocyte transendothelial migration	9076_1364_81_1432_5578_5296_5295_7409_6387_9475_4318_10451_1365_7430_5603_5747_5335_1500_50848_5291	20	-	0.0116743708585143	0.0325467308782823
11140	ellipticine	hsa05016	Huntington's disease	4899_1327_246721_23186_3064_6874_5433_836_4700_7052_5438_5439_6667_2033_1213_581_548644_161_23236_27113_841_3092_5978_1385	24	-	2.20941859382471e-05	0.00015635885433221
11141	ellipticine	hsa04740	Olfactory transduction	5613_157	2	-	5.03532319165751e-41	4.63249733632491e-39
11142	ellipticine	hsa04514	Cell adhesion molecules (CAMs)	9076_965_4685_3105_1364_1365_5792_50848_9019_5817	10	-	6.09914276923561e-07	7.01401418462095e-06
11143	ellipticine	hsa04510	Focal adhesion	5170_595_5296_5295_5154_9475_10451_5747_3673_81_7094_7057_1399_1398_3480_6714_5291_4233_5228_5578_6655_6464_7409_7422_2064	25	-	3.58709286965534e-06	3.30012544008291e-05
11144	ellipticine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_94239_8366_8368_8294_121504_8343_81_8347_8346_8344_6632_8367_8370_8359_554313_8351_8339_3013_3014	25	-	0.0123997039392327	0.033552140070865
11145	ellipticine	hsa04360	Axon guidance	23654_9475_6387_5747_25_1948_1942_1945_5921_54910_4690_10725_5533_5534_6092_4233_5998_10507_2049_23380_3985_2050_3983	23	-	0.0199829917122187	0.0496874388520033
11146	ellipticine	hsa04340	Hedgehog signaling pathway	8945_5613_655_652_1453_23291	6	-	0.00987543995494177	0.0283918898704576
11147	ellipticine	hsa04530	Tight junction	9076_50855_6709_64398_55870_81_9223_5584_5581_93643_84612_51776_2017_50848_55844_8777_5519_10207_6714_5515_4619_7082_5578_1364_1457_1365	26	-	0.0383388994233698	0.0904404806910262
11148	ellipticine	hsa05218	Melanoma	1026_595_5296_3480_5295_5154_5291_4286_2260_4233	10	-	0.0234455230278237	0.0567628452252574
11149	ellipticine	hsa04720	Long-term potentiation	468_5578_5613_5533_2033_5534_23236	7	-	0.00131294872739994	0.00525179490959976
11150	ellipticine	hsa05110	Vibrio cholerae infection	7082_5578_5613_535_526_5335_55176_23545	8	-	0.0395844103907046	0.0910441438986206
11151	ellipticine	hsa04512	ECM-receptor interaction	3673_7057_3161	3	-	9.73565094629346e-07	9.95199874509998e-06
11152	ellipticine	hsa04630	Jak-STAT signaling pathway	3717_595_5296_598_5295_5291_9655_10254_3454_3455_3459_2033_10401_9063_1154_200734_8554_4609_8027_5618_3566_2057_6655_6772_51588_10379_8835_2690	28	-	0.0129600466775447	0.0340664084095461
11153	ellipticine	hsa04062	Chemokine signaling pathway	3717_1147_157_5296_5747_5291_6387_112_3551_7074_1399_1398_8517_5295_9475_4792_23236_5613_6655_6464_10451_6772_7409_5970	24	-	1.26925441478323e-05	9.7309505133381e-05
11154	ellipticine	hsa04810	Regulation of actin cytoskeleton	5296_5295_5154_9475_10451_5747_3673_81_7074_1730_23191_1445_7430_1399_1398_2263_2260_200576_324_8394_8396_10787_5291_5962_8874_6655_5305_54961_7409_54434_3985_26999	32	-	7.00297902669222e-05	0.000402671294034803
11155	ellipticine	hsa04540	Gap junction	7082_5578_5613_6655_112_2767_5154_5607_983_2697_1453_6714_23236	13	-	0.00736959206344456	0.0218710474140935
11156	ellipticine	hsa05012	Parkinson's disease	7326_7327_836_1327_4700_7314_51465_27429	8	-	3.3062415891341e-08	5.06957043667229e-07
11157	ellipticine	hsa04260	Cardiac muscle contraction	776_1327	2	-	1.54959240617449e-07	2.03660716240076e-06
11158	ellipticine	hsa04060	Cytokine-cytokine receptor interaction	5154_6387_7132_27242_3554_2057_3455_4233_3459_8795_657_4982_23765_4055_4254_91_90_93_92_655_7048_5618_3566_3454_355_7422_51330_2690	28	-	6.44628825569546e-09	1.97686173174661e-07
11159	ellipticine	hsa03010	Ribosome	3921_9349_6137_6125_6168_6139_6234_6160_6233	9	-	5.86402837313182e-05	0.000359660406885418
11160	ellipticine	hsa04020	Calcium signaling pathway	776_5256_5578_5613_56848_2767_5533_7220_5335_136_5534_5025_23236_2064_493	15	-	1.15061219241965e-08	2.6464080425652e-07
11161	ellipticine	hsa03050	Proteasome	23198	1	-	9.89488920534381e-05	0.000535488121700959
11162	ellipticine	hsa04912	GnRH signaling pathway	4216_1432_468_5578_8399_5613_6655_50487_2767_5606_5603_112_6714_6416_776_23236	16	-	0.00694467261473179	0.0212969960185108
11163	ellipticine	hsa05330	Allograft rejection	3105_355	2	-	0.00410199890256695	0.0150953559614464
11164	ellipticine	hsa04730	Long-term depression	8399_5578_3480_50487_2767_5519_5515_23236	8	-	0.00655855639854166	0.0208064547815804
11165	ellipticine	hsa04270	Vascular smooth muscle contraction	776_8399_5581_5613_50487_2767_9475_9826_4637_136_112_23236_4660_5578	14	-	0.000509742293185712	0.00246822584068871
11166	ellipticine	hsa04940	Type I diabetes mellitus	3105_355	2	-	0.0012089298982793	0.00505552502916798
11167	ellipticine	hsa02010	ABC transporters	23461_89845_5826	3	-	0.00472119159641204	0.0167057548796118
11168	ellipticine	hsa04610	Complement and coagulation cascades	2161_5329	2	-	5.30290417614693e-06	4.43515622005016e-05
11169	piperlongumine	hsa05211	Renal cell carcinoma	3725_2277_5228_7422	4	+	0.0361643036469063	0.497259175144962
11170	piperlongumine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8348_8294_121504_3021_3020_8968_8370_8358_8359_8330_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_8970	30	+	1.23486885807392e-22	6.79177871940656e-21
11171	piperlongumine	hsa05219	Bladder cancer	2277_5228_4193_7422	4	+	0.00670057072886694	0.122843796695894
11172	piperlongumine	hsa04010	MAPK signaling pathway	2353_3164_5578_1843_1847_1649_1647_3303_4791_3725_3310_9175_3305_3304	14	+	0.000266002378387687	0.00731506540566139
11173	piperlongumine	hsa05332	Graft-versus-host disease	355_3119	2	-	0.037891186358581	0.195771129519335
11174	piperlongumine	hsa04640	Hematopoietic cell lineage	928_3655_960_4254_2057	5	-	0.00261938763643988	0.0304503812736136
11175	piperlongumine	hsa05010	Alzheimer's disease	776_842_841_8772_351_5534_4137_5532_355_5530_23385_489_509_6868_7132	15	-	0.000742964360877751	0.0115159475936051
11176	piperlongumine	hsa04080	Neuroactive ligand-receptor interaction	5029_4889_5618_152_706_4886_5031_136_2149_2690	10	-	1.33147972263883e-10	6.19138071027056e-09
11177	piperlongumine	hsa05320	Autoimmune thyroid disease	355_3119	2	-	0.00892079066774111	0.0754212301909021
11178	piperlongumine	hsa04612	Antigen processing and presentation	4800_10197_3119_4801_5993_1385	6	-	0.00509213434706101	0.0473568494276674
11179	piperlongumine	hsa05016	Huntington's disease	5433_246721_6874_6648_842_841_581_7052_5439_6667_1213_5440_3092_1387_509_1385_548644_10126	18	-	0.00219133851368522	0.0291134973961036
11180	piperlongumine	hsa04740	Olfactory transduction	818_5613_5566_109_5616	5	-	8.59679436030302e-24	7.99501875508181e-22
11181	piperlongumine	hsa04514	Cell adhesion molecules (CAMs)	965_4685_3119_4897_3685_9080_1366_1364_1365_5792_3655_50848_5817	13	-	0.0128996929393464	0.0856908173828011
11182	piperlongumine	hsa04210	Apoptosis	1147_596_598_5295_5291_651610_4615_7132_3551_5566_8717_1677_207_581_8772_23052_5532_5530_5534_4790_4792_842_841_5577_5613_5616_472_355_8837_7186	30	-	0.0120204832841025	0.0856908173828011
11183	piperlongumine	hsa05310	Asthma	3119	1	-	0.0495414926595255	0.206252630574598
11184	piperlongumine	hsa04512	ECM-receptor interaction	375790_960_3911_1289_1605_7057_3685_3655	8	-	0.0470444039081611	0.206252630574598
11185	piperlongumine	hsa05012	Parkinson's disease	2861_27429_7327_842_509	5	-	2.91316100287251e-06	9.03079910890478e-05
11186	piperlongumine	hsa04260	Cardiac muscle contraction	776_481	2	-	8.2803897083287e-05	0.00154015248574914
11187	piperlongumine	hsa04060	Cytokine-cytokine receptor interaction	5618_7132_355_9180_2057_3460_3588_3455_3625_5154_4254_657_6387_655_7043_91_90_27242_4233_7048_2690	21	-	1.31626735811777e-05	0.000306032160762382
11188	piperlongumine	hsa03010	Ribosome	6187_440589_9349_6138_6137_6125_6168_6203_6160	9	-	0.0191840786113125	0.118941287390138
11189	piperlongumine	hsa04020	Calcium signaling pathway	115_136_113_5336_490_493_5257_5566_818_776_2767_5532_5530_489_5534_3707_5578_5613_5616_109_2064_2065_2149	23	-	0.045568609226296	0.206252630574598
11190	piperlongumine	hsa03050	Proteasome	10197	1	-	0.00299505566184225	0.0309489085057033
11191	piperlongumine	hsa05210	Colorectal cancer	595_7043_596_4088_4089_5295_5291_4437_7976_8322_1855_1857_5900_324_207_581_3480_6932_6934_4609_91_4233_7048_842_26060_6655_5881_3845_2535	29	-	0.0100044205618523	0.0775342593543553
11192	piperlongumine	hsa04940	Type I diabetes mellitus	355_3119	2	-	0.0258840925624619	0.15045128801931
11193	piperlongumine	hsa05220	Chronic myeloid leukemia	595_1147_4088_4089_5295_5291_1869_1487_1488_25_3551_5781_598_207_613_7043_4609_91_4790_7048_4792_6655_6777_6464_3845	25	-	0.028248116907574	0.154533816023787
11194	riboflavin	hsa04670	Leukocyte transendothelial migration	93408_6093_1495_3684	4	+	0.0384968371964766	0.615385532439505
11195	riboflavin	hsa04510	Focal adhesion	596_208_3918_93408_824_6093	6	+	0.0202533282406728	0.567093190738838
11196	riboflavin	hsa04210	Apoptosis	824_208_8794_596	4	+	0.014413654637358	0.567093190738838
11197	riboflavin	hsa04740	Olfactory transduction	5566_816	2	-	0.00461160868747326	0.299754564685762
11198	riboflavin	hsa04912	GnRH signaling pathway	1432_8399_5566_5331_5603_10746_816	7	-	0.0258473175726223	0.840037821110225
11199	cytisine	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8336	7	+	0.00108314636560306	0.0454921473553285
11200	cytisine	hsa04810	Regulation of actin cytoskeleton	2335_5829_2909_6654_8394_7410_7409_2245_2260	9	-	0.0232492457771943	0.750636430526595
11201	etodolac	hsa04740	Olfactory transduction	51806_409	2	-	0.00482660545408497	0.371648619964543
11202	etodolac	hsa03020	RNA polymerase	246721_5439_548644_84172	4	-	0.0101120478790936	0.389313843345104
11203	pentetrazol	hsa05016	Huntington's disease	6667	1	+	0.032231783324602	1
11204	pentetrazol	hsa04740	Olfactory transduction	157	1	-	0.000254042314138003	0.0182910466179362
11205	pentetrazol	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	-	0.00461193040016507	0.166029494405943
11206	pentetrazol	hsa03020	RNA polymerase	5432_246721_5439_548644	4	-	0.0135898991840073	0.326157580416175
11207	alimemazine	hsa04514	Cell adhesion molecules (CAMs)	5010_8516_3119_3107_4359_933_923_1003_5817	9	+	0.0418525667481522	1
11208	alimemazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8329_8294_121504_8341_8969_8968_8370_8358_8359_8330_8331_8336_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013	35	+	4.53720634246768e-19	3.40290475685076e-17
11209	alimemazine	hsa03450	Non-homologous end-joining	2547_3981_7518	3	+	0.01372840441448	0.514815165543
11210	alimemazine	hsa05322	Systemic lupus erythematosus	85235_8969_8332_8330_8331_8329_8336	7	-	0.00417282012128376	0.20029536582162
11211	gentamicin	hsa05332	Graft-versus-host disease	3553_3123_3126_3127_3125_5551	6	+	0.0303496058635434	0.714155527409839
11212	gentamicin	hsa04640	Hematopoietic cell lineage	2814_3553_2812_3123_3126_3127_3125_920_960_4254	10	+	0.0287730385482529	0.714155527409839
11213	gentamicin	hsa04740	Olfactory transduction	26212_7932_81797_4991_26529_815_816	7	+	0.00129518551764067	0.111385954517098
11214	gentamicin	hsa04940	Type I diabetes mellitus	3553_3123_3126_3127_3125_5551	6	+	0.0362003687829688	0.714155527409839
11215	isoniazid	hsa04120	Ubiquitin mediated proteolysis	996_6477_7329_8881_26091_9039	6	+	0.016578609477861	0.305046414392642
11216	isoniazid	hsa04740	Olfactory transduction	818_2774_219464_135948_816	5	+	2.8646634110819e-12	2.63549033819535e-10
11217	isoniazid	hsa04514	Cell adhesion molecules (CAMs)	958_22871_6383_3655_26285_923	6	+	0.0219854478996601	0.337110201128122
11218	isoniazid	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8341_8347_8346_8344_958_8339_8968_55766_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2213_3013_720_721	36	+	4.17914672766745e-05	0.00192240749472703
11219	isoniazid	hsa05012	Parkinson's disease	7419_842_509	3	+	0.000533180765127986	0.0163508767972582
11220	isoniazid	hsa04260	Cardiac muscle contraction	7168	1	+	0.00280976006467307	0.0646244814874806
11221	isoniazid	hsa04020	Calcium signaling pathway	2778_2911_5578_2774_5724_818_1956_136_1910_7419_816	11	+	0.0400325136849011	0.526141608430129
11222	isoniazid	hsa04120	Ubiquitin mediated proteolysis	10277_8065_11060_51343_5371_4193_672_22888_9820_89910_55958	11	-	0.00934623806884153	0.172905404273568
11223	isoniazid	hsa05200	Pathways in cancer	4149_8312_6789_5371_999_3909_4193_6932_7157_405_1956_7422_6934_324_91_3725_4254_4233_7184_5293	20	-	0.0132640721638304	0.182904459114644
11224	isoniazid	hsa04520	Adherens junction	999_6932_1956_6934_91_4233_8976	7	-	0.0222451369193486	0.182904459114644
11225	isoniazid	hsa05322	Systemic lupus erythematosus	8353_8344_8347_8346_8358_8343_8968_3013_8350_8351_8352_8339_8354_8355_8356_8357	16	-	5.88894794799804e-05	0.00435782148151855
11226	isoniazid	hsa05212	Pancreatic cancer	7157_4193_5293_6932_1956_6934_7184	7	-	0.0356043789815563	0.216078383355675
11227	isoniazid	hsa05215	Prostate cancer	7157_4193_5293_6932_1956_6934_7184	7	-	0.0339073111115533	0.216078383355675
11228	isoniazid	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_10392_1956_6868_3725_4233	6	-	0.0379597159949158	0.216078383355675
11229	isoniazid	hsa05219	Bladder cancer	7157_1956_999_4193_7422	5	-	0.0172822577180623	0.182904459114644
11230	isoniazid	hsa05218	Melanoma	7157_999_5293_4193_1956_4233	6	-	0.0379597159949158	0.216078383355675
11231	isoniazid	hsa05216	Thyroid cancer	7157_6932_999_6934	4	-	0.020949400554339	0.182904459114644
11232	isoniazid	hsa05213	Endometrial cancer	6934_7157_999_8312_5293_6932_1956_324	8	-	0.000646546929624038	0.0217987239418494
11233	isoniazid	hsa05330	Allograft rejection	3135_3105_3106_649853	4	-	0.04579137123247	0.225904098080185
11234	isoniazid	hsa05210	Colorectal cancer	324_7157_8312_5293_6932_1956_6934_91_3725_4233	10	-	0.000883732051696597	0.0217987239418494
11235	isoniazid	hsa04940	Type I diabetes mellitus	3135_3105_3106_3382_649853	5	-	0.020396313195151	0.182904459114644
11236	isoniazid	hsa05217	Basal cell carcinoma	7157_6932_324_8312_6934	5	-	0.0439761745925905	0.225904098080185
11237	tranexamic acid	hsa04740	Olfactory transduction	816	1	+	0.000375299642527819	0.0288980724746421
11238	ampyrone	hsa04740	Olfactory transduction	26211_4991	2	+	0.000183455307058397	0.0126584161870294
11239	ampyrone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_8354	15	+	0.000394956994306302	0.0136260163035674
11240	ampyrone	hsa04060	Cytokine-cytokine receptor interaction	8718_3556_5618	3	+	0.0381535926557296	0.877532631081781
11241	ampyrone	hsa04130	SNARE interactions in vesicular transport	6804_9570_6844	3	-	0.0080680273268832	0.250108847133379
11242	midodrine	hsa04740	Olfactory transduction	26211_5566	2	+	0.0046714648400799	0.170508466662916
11243	midodrine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_958_3014_8359_8294_8367_554313_121504	16	+	3.27488458409312e-06	0.000239066574638798
11244	midodrine	hsa05340	Primary immunodeficiency	23495_958_326_29760	4	+	0.017156043942612	0.417463735936892
11245	midodrine	hsa04916	Melanogenesis	5613_5616_6934_5578	4	-	0.033551204006254	0.154851710798095
11246	midodrine	hsa04310	Wnt signaling pathway	5578_5613_11261_5616_6934_5534	6	-	0.00882855220177762	0.0882855220177762
11247	midodrine	hsa05131	Shigellosis	7278_113457_5578	3	-	0.028724241178117	0.154851710798095
11248	midodrine	hsa04660	T cell receptor signaling pathway	11261_5603_3551_5534	4	-	0.039714779983618	0.158859119934472
11249	midodrine	hsa04910	Insulin signaling pathway	5613_10211_5562_3551_5616	5	-	0.0226517401168787	0.154851710798095
11250	midodrine	hsa05130	Pathogenic Escherichia coli infection	7278_113457_5578	3	-	0.028724241178117	0.154851710798095
11251	midodrine	hsa05014	Amyotrophic lateral sclerosis (ALS)	11261_5603_5534	3	-	0.028724241178117	0.154851710798095
11252	midodrine	hsa04210	Apoptosis	3551_5613_11261_5616_5534_8837	6	-	0.000691460163414079	0.0414876098048447
11253	midodrine	hsa04340	Hedgehog signaling pathway	5613_654_5616_4036	4	-	0.00487579253905711	0.0590934550381396
11254	midodrine	hsa04370	VEGF signaling pathway	11261_5578_5603_5534	4	-	0.0130986710730265	0.112274323483084
11255	midodrine	hsa04720	Long-term potentiation	5613_11261_5578_5616_5534	5	-	0.00204518813793841	0.0590934550381396
11256	midodrine	hsa05110	Vibrio cholerae infection	5613_5616_5578	3	-	0.032621845159156	0.154851710798095
11257	midodrine	hsa04010	MAPK signaling pathway	3551_5578_5613_11261_2005_5616_10912_5603_5534	9	-	0.0045148276430959	0.0590934550381396
11258	midodrine	hsa04540	Gap junction	5613_7278_5616_113457_5578	5	-	0.00492445458651163	0.0590934550381396
11259	midodrine	hsa04912	GnRH signaling pathway	5613_5616_5603_5578	4	-	0.0375930990169002	0.158859119934472
11260	midodrine	hsa04270	Vascular smooth muscle contraction	5613_27094_5616_5578	4	-	0.0488741622622906	0.18327810848359
11261	ranitidine	hsa04740	Olfactory transduction	818_8387_5568_8388	4	+	0.00217085023534748	0.0781506084725093
11262	ranitidine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3126_9103_8359_8294_8367_554313_121504	16	+	0.000222719031534235	0.0160357702704649
11263	ranitidine	hsa04912	GnRH signaling pathway	5319_776_5568_8399_5598_6655_1839_818_3708	9	+	0.0390857187639462	0.938057250334709
11264	ranitidine	hsa04740	Olfactory transduction	51806	1	-	1.663650367338e-06	7.2368790979203e-05
11265	ranitidine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3119_3014	23	-	4.27539972627613e-07	3.71959776186023e-05
11266	ranitidine	hsa04010	MAPK signaling pathway	5608_3164_4149_6789_9254_4915_4763_1844_6195_5607_23162_8398_6655_7786_10746_2260_355_27330_11261_408	20	-	0.0360070419640027	1
11267	piroxicam	hsa05214	Glioma	801_808_6464_805	4	-	0.0365323375558533	0.416468648136728
11268	piroxicam	hsa04070	Phosphatidylinositol signaling system	8394_1606_808_801_3631_805	6	-	0.00370029706095343	0.210916932474346
11269	piroxicam	hsa04910	Insulin signaling pathway	9470_6464_867_808_23265_801_805	7	-	0.0164882445662618	0.283169522181112
11270	piroxicam	hsa04720	Long-term potentiation	11261_808_801_805_5534	5	-	0.0150344974686523	0.283169522181112
11271	piroxicam	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0198715454162184	0.283169522181112
11272	norfloxacin	hsa05214	Glioma	2475_10000_5154_5293_5925_816	6	+	0.00406450498897423	0.094838449742732
11273	norfloxacin	hsa05332	Graft-versus-host disease	3824_3113_3811_3802	4	+	0.01658331664773	0.290208041335275
11274	norfloxacin	hsa04740	Olfactory transduction	816	1	+	0.00355761273421362	0.094838449742732
11275	norfloxacin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3113_8359_8294_8367_554313_121504_8341	16	+	3.03831157962804e-07	2.12681810573963e-05
11276	norfloxacin	hsa05215	Prostate cancer	5925_2475_10000_5154_5293	5	+	0.0492692138503531	0.344445609909562
11277	norfloxacin	hsa05221	Acute myeloid leukemia	5371_2475_10000_5293	4	+	0.045823282583095	0.344445609909562
11278	norfloxacin	hsa05218	Melanoma	5925_2249_10000_5154_5293	5	+	0.0233431474713113	0.326804064598358
11279	norfloxacin	hsa04012	ErbB signaling pathway	2475_10000_56924_816_5293	5	+	0.0474107779404671	0.344445609909562
11280	norfloxacin	hsa04210	Apoptosis	3552_3551_472_51135_8837_651610_7186	7	-	0.0224751229959667	1
11281	viomycin	hsa04080	Neuroactive ligand-receptor interaction	5028_3972_5646	3	+	0.0147173519307221	0.387556934175682
11282	viomycin	hsa04740	Olfactory transduction	393046_816_4991	3	+	0.000175161497189275	0.00691887913897636
11283	viomycin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_6738_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	20	+	9.0342318053748e-06	0.000713704312624609
11284	viomycin	hsa04916	Melanogenesis	801_808_4254_805	4	-	0.0413336522836085	0.323444992288024
11285	viomycin	hsa05214	Glioma	1869_801_808_805	4	-	0.00950672956522951	0.192661859271093
11286	viomycin	hsa04130	SNARE interactions in vesicular transport	8773_6844_8675	3	-	0.0130512419932264	0.192661859271093
11287	viomycin	hsa04070	Phosphatidylinositol signaling system	8394_801_808_805	4	-	0.0157274987160076	0.192661859271093
11288	viomycin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8348_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235	22	-	3.01696787978568e-17	1.47831426109498e-15
11289	viomycin	hsa05223	Non-small cell lung cancer	6789_1869_11186	3	-	0.0311993016847533	0.305753156510582
11290	viomycin	hsa04912	GnRH signaling pathway	3725_801_808_805	4	-	0.0462064274697177	0.323444992288024
11291	hexylcaine	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.001270495136999	0.03811485410997
11292	hexylcaine	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	-	0.00656377026042109	0.145014410305805
11293	hexylcaine	hsa05320	Autoimmune thyroid disease	3135_3105_3106_649853	4	-	0.0138421805526558	0.197251072875345
11294	hexylcaine	hsa04740	Olfactory transduction	157	1	-	0.0223673526725664	0.254987820467257
11295	hexylcaine	hsa05330	Allograft rejection	3135_3105_3106_649853	4	-	0.00473459359253102	0.145014410305805
11296	hexylcaine	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853	4	-	0.00763233738451606	0.145014410305805
11297	benzethonium chloride	hsa04740	Olfactory transduction	8387_5593_8388	3	+	0.000491074566743429	0.018906370819622
11298	benzethonium chloride	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8341_958_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113	28	+	2.42949899947964e-11	1.87071422959932e-09
11299	benzethonium chloride	hsa04080	Neuroactive ligand-receptor interaction	1269_5618_2690	3	-	0.000161823172769345	0.00687748484269716
11300	benzethonium chloride	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8329_8294_81_3021_3020_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3111	26	-	7.51605427195304e-06	0.000638864613116008
11301	benzethonium chloride	hsa04060	Cytokine-cytokine receptor interaction	3556_5618_5155_6387_50616_2690	6	-	0.00568965339996353	0.1612068463323
11302	benzethonium chloride	hsa04020	Calcium signaling pathway	5533_5534_3707_493	4	-	0.019181883239156	0.407615018832065
11303	proadifen	hsa04115	p53 signaling pathway	5366_1647_836_4616	4	+	0.0128529444315414	0.175656907231066
11304	proadifen	hsa04010	MAPK signaling pathway	1647_836_1843_2353_7042_91_3725_3164_11221_4616	10	+	0.00275586835635122	0.101908091846414
11305	proadifen	hsa05210	Colorectal cancer	91_3725_7042_836_2353	5	+	0.00497112643153237	0.101908091846414
11306	proadifen	hsa05332	Graft-versus-host disease	3135_3105_3106_649853_3123	5	-	0.00137438966810864	0.0387487328710615
11307	proadifen	hsa04650	Natural killer cell mediated cytotoxicity	5533_3105_3106_5291_3135_2534	6	-	0.0424483179232323	0.371422781828283
11308	proadifen	hsa04120	Ubiquitin mediated proteolysis	10277_8945_7332_7328_6477_51619_8453	7	-	0.0149205267880674	0.149205267880674
11309	proadifen	hsa05320	Autoimmune thyroid disease	3135_3105_3106_649853_3123	5	-	0.00351230922005852	0.0513892617446621
11310	proadifen	hsa04612	Antigen processing and presentation	3123_3106_3135_3105_3306_649853	6	-	0.00666698576562853	0.0777815005989995
11311	proadifen	hsa04514	Cell adhesion molecules (CAMs)	4685_3123_3106_3135_3105_6693_3655_649853	8	-	0.00367066155319015	0.0513892617446621
11312	proadifen	hsa05330	Allograft rejection	3135_3105_3106_649853_3123	5	-	0.000912992033883621	0.0387487328710615
11313	proadifen	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853_3123	5	-	0.00166065998018835	0.0387487328710615
11314	sulfanilamide	hsa04740	Olfactory transduction	8390	1	+	0.0233250572769127	0.653101603753556
11315	sulfanilamide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	3.96608786363022e-07	2.22100920363292e-05
11316	sulfanilamide	hsa05332	Graft-versus-host disease	3119_3105_3106_3126_3127_3125_3135_3134_3123_649853	10	-	8.02234485548769e-09	2.47871473915561e-07
11317	sulfanilamide	hsa04640	Hematopoietic cell lineage	3123_3566_3126_3127_3125	5	-	0.0164193505068012	0.114935453547608
11318	sulfanilamide	hsa05320	Autoimmune thyroid disease	3119_3105_3106_3126_3127_3125_3135_3134_3123_649853	10	-	5.56444019247872e-08	8.76399330315398e-07
11319	sulfanilamide	hsa04612	Antigen processing and presentation	3119_3123_3106_3126_3127_3125_3135_3134_3105_649853	10	-	4.12019114612071e-06	5.19144084411209e-05
11320	sulfanilamide	hsa04520	Adherens junction	4088_2260_1956_2241	4	-	0.0466637565235757	0.226139743152713
11321	sulfanilamide	hsa04740	Olfactory transduction	219464	1	-	0.0222012338605892	0.139867773321712
11322	sulfanilamide	hsa04514	Cell adhesion molecules (CAMs)	3119_3123_3106_3126_3127_3125_3135_3134_3105_649853	10	-	0.000108993459156516	0.00114443132114342
11323	sulfanilamide	hsa05322	Systemic lupus erythematosus	3119_3123_3126_3127_3125_8348	6	-	0.0344665941349098	0.180949619208276
11324	sulfanilamide	hsa04710	Circadian rhythm - mammal	1454_8553_5187	3	-	0.00197911952416235	0.0155855662527785
11325	sulfanilamide	hsa05218	Melanoma	2257_8503_1956_2260	4	-	0.0328023302997871	0.180949619208276
11326	sulfanilamide	hsa05310	Asthma	3123_3126_3127_3119_3125	5	-	0.000225787231725267	0.0020320850855274
11327	sulfanilamide	hsa05330	Allograft rejection	3119_3105_3106_3126_3127_3125_3135_3134_3123_649853	10	-	3.50596324787485e-09	2.20875684616116e-07
11328	sulfanilamide	hsa04940	Type I diabetes mellitus	3119_3105_3106_3126_3127_3125_3135_3134_3123_649853	10	-	1.18034035197886e-08	2.47871473915561e-07
11329	securinine	hsa04662	B cell receptor signaling pathway	10725_4772_27071_3551_5534	5	+	0.0166616881583249	0.161929006547381
11330	securinine	hsa05200	Pathways in cancer	3551_581_4088_3480_4193_5925_355_11211_2249_8324_2950_7422	12	+	0.0381642158969912	0.185369048642529
11331	securinine	hsa04612	Antigen processing and presentation	4800_3310_3304_3305_3303	5	+	0.0309570159575876	0.161929006547381
11332	securinine	hsa04310	Wnt signaling pathway	10725_8061_5519_4088_11211_4772_5534_8324	8	+	0.0101342284143362	0.161929006547381
11333	securinine	hsa05131	Shigellosis	9076_7278_2017_113457	4	+	0.0253914210786039	0.161929006547381
11334	securinine	hsa05130	Pathogenic Escherichia coli infection	9076_7278_2017_113457	4	+	0.0253914210786039	0.161929006547381
11335	securinine	hsa05014	Amyotrophic lateral sclerosis (ALS)	10452_5534_1432_581	4	+	0.0253914210786039	0.161929006547381
11336	securinine	hsa05212	Pancreatic cancer	3480_2950_4193_3551_5925	5	+	0.0309570159575876	0.161929006547381
11337	securinine	hsa05215	Prostate cancer	3480_2950_4193_3551_5925	5	+	0.0297436626093492	0.161929006547381
11338	securinine	hsa04210	Apoptosis	824_355_5534_3551_581	5	+	0.0309570159575876	0.161929006547381
11339	securinine	hsa04370	VEGF signaling pathway	10725_4772_1432_7422_5534	5	+	0.0183605141140869	0.161929006547381
11340	securinine	hsa04115	p53 signaling pathway	355_4194_5366_4193_581	5	+	0.0122013841924955	0.161929006547381
11341	securinine	hsa04010	MAPK signaling pathway	1432_3551_1846_6722_355_2249_5534_3310_3304_3305_3303	11	+	0.0217528491258566	0.161929006547381
11342	securinine	hsa05210	Colorectal cancer	4088_8324_581_11211_3480	5	+	0.025193319671748	0.161929006547381
11343	securinine	hsa04710	Circadian rhythm - mammal	1454_9572_1408_5187	4	-	0.00178805802882244	0.132316294132861
11344	securinine	hsa04330	Notch signaling pathway	182_3714_23220_1856_5664	5	-	0.0251597086563955	0.620606146857756
11345	securinine	hsa03020	RNA polymerase	246721_5439_548644_84172	4	-	0.0205542594452598	0.620606146857756
11346	butacaine	hsa05322	Systemic lupus erythematosus	85235_8969_8332_8330_8331_8329_8336	7	+	0.00102547980961328	0.032815353907625
11347	butacaine	hsa05014	Amyotrophic lateral sclerosis (ALS)	836_6300_581	3	-	0.0326912276741088	0.498541222030159
11348	butacaine	hsa04210	Apoptosis	5576_836_8795_581	4	-	0.0244720342973195	0.497598030712163
11349	butacaine	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	8992_3725_836_6300	4	-	0.0119714074186462	0.497598030712163
11350	butacaine	hsa05210	Colorectal cancer	3725_836_6934_581	4	-	0.0204386375130877	0.497598030712163
11351	azlocillin	hsa05214	Glioma	810_1956_5155_673	4	+	0.0209728852486814	0.30410683610588
11352	azlocillin	hsa04210	Apoptosis	5613_8837_5534_5616_581	5	+	0.0143668257884237	0.277758631909525
11353	azlocillin	hsa04720	Long-term potentiation	810_5613_5534_5616_673	5	+	0.00745046419850638	0.277758631909525
11354	azlocillin	hsa04010	MAPK signaling pathway	5155_9064_5613_5616_998_673_4763_1956_5534_5971	10	+	0.0114024340459089	0.277758631909525
11355	azlocillin	hsa04912	GnRH signaling pathway	810_5613_1956_5616_998	5	+	0.0292518349828937	0.339321285801567
11356	azlocillin	hsa04070	Phosphatidylinositol signaling system	8394_801_808_805	4	-	0.0305138202870673	0.974201824059408
11357	dienestrol	hsa04740	Olfactory transduction	7932_157	2	+	0.0358198618628112	0.573117789804979
11358	dienestrol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8343_8347_8346_8344_8339_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013	38	+	2.3553833727017e-29	1.13058401889682e-27
11359	dienestrol	hsa05340	Primary immunodeficiency	920_5994_3561	3	+	0.0351609811370585	0.573117789804979
11360	dienestrol	hsa04910	Insulin signaling pathway	5584_5613_5616_2002_10211_5792_8835	7	-	0.00566095659387055	0.261143946293819
11361	dienestrol	hsa04210	Apoptosis	5613_3554_5616_5534_581	5	-	0.0126359974013138	0.261143946293819
11362	dienestrol	hsa04340	Hedgehog signaling pathway	1454_5613_5616_5727	4	-	0.0124634571962998	0.261143946293819
11363	dienestrol	hsa04270	Vascular smooth muscle contraction	5613_9826_5616_27345_27094	5	-	0.0355388156297066	0.550851642260452
11364	carbinoxamine	hsa04662	B cell receptor signaling pathway	208_4775_27071_8519	4	+	0.0172051731257166	0.303958058554327
11365	carbinoxamine	hsa05200	Pathways in cancer	3688_2271_208_6777_5371_8817_7170_5888_7186	9	+	0.0400497864626077	0.376758420807244
11366	carbinoxamine	hsa05221	Acute myeloid leukemia	208_6777_5371	3	+	0.0426518966951597	0.376758420807244
11367	carbinoxamine	hsa04920	Adipocytokine signaling pathway	208_3717_1375_4852_7186	5	+	0.00204982358222996	0.108640649858188
11368	carbinoxamine	hsa04512	ECM-receptor interaction	3690_3691_3688_1291	4	+	0.0245182071485758	0.324866244718629
11369	carbinoxamine	hsa04630	Jak-STAT signaling pathway	3717_3448_64109_208_6777_3570_10379	7	+	0.0042315039794392	0.112134855455139
11370	carbinoxamine	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8336	7	-	0.00567022073231764	0.249489712221976
11371	amrinone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_8354	15	+	2.621936256419e-06	0.000175669729180073
11372	amrinone	hsa04810	Regulation of actin cytoskeleton	2335_3690_8817_8394_7430_1399_3984_2263_6093_4342	10	+	0.0384994806952469	0.953816513008284
11373	amrinone	hsa04912	GnRH signaling pathway	5319_1432_2488_5598_108_5609	6	+	0.0427082020749978	0.953816513008284
11374	amrinone	hsa04740	Olfactory transduction	818	1	-	0.0322369934570227	0.757569346240033
11375	amrinone	hsa04360	Axon guidance	5364_6405_2041_64218_6092_10507	6	-	0.0189044707056106	0.757569346240033
11376	cicloheximide	hsa05010	Alzheimer's disease	5533_5534_9451_23236	4	+	0.000686364099066046	0.0115309168643096
11377	cicloheximide	hsa04080	Neuroactive ligand-receptor interaction	2550_7442_7067_1131_2908_1241_7433_1909	8	+	0.0004759499093561	0.0099949480964781
11378	cicloheximide	hsa04612	Antigen processing and presentation	4801_6890	2	+	0.022921934091312	0.192544246367021
11379	cicloheximide	hsa05016	Huntington's disease	5430_2033_23186_3064_161_23236	6	+	0.00394647042622979	0.0414379394754128
11380	cicloheximide	hsa04740	Olfactory transduction	818_26212	2	+	7.24899094418812e-13	3.04457619655901e-11
11381	cicloheximide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_8349_8348_8329_8294_121504_8343_8342_8347_8346_8345_8344_8339_723790_8969_8968_55766_8370_92815_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_85236_3012_3013_3017_8970	51	+	1.7635170613652e-13	1.48135433154677e-11
11382	cicloheximide	hsa04710	Circadian rhythm - mammal	8864_5187_8553_406_1408_9572_79365	7	+	0.000937422251380388	0.0131239115193254
11383	cicloheximide	hsa04062	Chemokine signaling pathway	2309_7454_6347_6774_8503_3845_112_4792_23236	9	+	0.0406782289350738	0.284747602545517
11384	cicloheximide	hsa05012	Parkinson's disease	2861	1	+	0.000145952053457126	0.00408665749679953
11385	cicloheximide	hsa04260	Cardiac muscle contraction	481_6548	2	+	0.047615072445357	0.307666621954614
11386	cicloheximide	hsa04060	Cytokine-cytokine receptor interaction	1435_6347_4050_23529_3589_23765_3569_7422_9180_7042_8744_3459_51330	13	+	0.0211053553990611	0.192544246367021
11387	cicloheximide	hsa03010	Ribosome	6129	1	+	0.00207450482431459	0.0248940578917751
11388	cicloheximide	hsa04020	Calcium signaling pathway	5533_5261_1131_5534_818_7220_1909_23236	8	+	0.0260942857333046	0.19926545469069
11389	cicloheximide	hsa04080	Neuroactive ligand-receptor interaction	2690_4886_5031	3	-	0.00527893386495724	0.302600609422504
11390	cicloheximide	hsa04740	Olfactory transduction	5613_5616_808_109_805_801_409	7	-	0.00767870505137109	0.302600609422504
11391	cicloheximide	hsa05322	Systemic lupus erythematosus	94239	1	-	0.0221646341641112	0.448254280565014
11392	cicloheximide	hsa04210	Apoptosis	3554_3551_596_5613_5295_317_5291_5616_355_7132	10	-	0.0109373714249098	0.302600609422504
11393	cicloheximide	hsa04530	Tight junction	2017	1	-	0.0324039238962661	0.448254280565014
11394	cicloheximide	hsa04010	MAPK signaling pathway	2872_3554_7132_3551_9448_5613_9693_5616_355_4137_7867_51347_5881_51701_1386_27092_3306_3304_3312_3303_409	21	-	0.0280109589735113	0.448254280565014
11395	cinoxacin	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.0024905017713979	0.0488008807449337
11396	cinoxacin	hsa04640	Hematopoietic cell lineage	3123_3126_3127_3125	4	+	0.0266409153909366	0.198180829763433
11397	cinoxacin	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	+	0.00542858252155992	0.0727430057889029
11398	cinoxacin	hsa04612	Antigen processing and presentation	3123_3126_3127_3125	4	+	0.0285630295141301	0.198180829763433
11399	cinoxacin	hsa04514	Cell adhesion molecules (CAMs)	3123_3125_3126_3127_9071	5	+	0.0295792283229005	0.198180829763433
11400	cinoxacin	hsa05221	Acute myeloid leukemia	5605_861_11040	3	+	0.0418320434119912	0.254795173509401
11401	cinoxacin	hsa04664	Fc epsilon RI signaling pathway	5605_8398_5603_5581	4	+	0.0197470065398486	0.189007062595694
11402	cinoxacin	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.000793926769272596	0.0488008807449337
11403	cinoxacin	hsa04912	GnRH signaling pathway	5605_2002_8398_5603_112	5	+	0.013292433439274	0.148432173405226
11404	cinoxacin	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.00177482523250911	0.0488008807449337
11405	cinoxacin	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	+	0.00291348541760798	0.0488008807449337
11406	econazole	hsa04640	Hematopoietic cell lineage	3566_2812_3565_3684_915_933	6	+	0.043544018814762	0.364681157573632
11407	econazole	hsa05320	Autoimmune thyroid disease	3449_1081_3119_3565_356_3133	6	+	0.0055558481838223	0.124080609438698
11408	econazole	hsa04660	T cell receptor signaling pathway	3565_6655_5293_2353_915_3725_2534	7	+	0.0431568335444042	0.364681157573632
11409	econazole	hsa04740	Olfactory transduction	4991	1	+	0.000375299642527819	0.0125725380246819
11410	econazole	hsa04514	Cell adhesion molecules (CAMs)	3383_3119_4099_3684_3133_933_26285_923_25945	9	+	0.0175565829568023	0.235258211621151
11411	econazole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_8970	27	+	1.40634204907749e-13	9.42249172881918e-12
11412	econazole	hsa04010	MAPK signaling pathway	4214_1647_9479_1843_6655_1649_1846_2353_356_5607_10454_3310_3164_4791_3725_4616	16	+	0.0089971762115396	0.150702701543288
11413	econazole	hsa05330	Allograft rejection	356_3119_3133_3565	4	+	0.0280024140650049	0.312693623725888
11414	econazole	hsa05200	Pathways in cancer	2737_4149_581_6502_998_91_3845_7042_1869_2260_8322	11	-	0.0272645262764057	0.308997964465931
11415	econazole	hsa04740	Olfactory transduction	5613	1	-	0.0222688169775154	0.302855910894209
11416	econazole	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8336	7	-	0.0114745820052103	0.28573840669765
11417	econazole	hsa04350	TGF-beta signaling pathway	91_6093_655_4052_7042	5	-	0.01680814157045	0.28573840669765
11418	econazole	hsa04010	MAPK signaling pathway	4149_9064_5613_8399_998_2002_3845_7042_91_2260_3552	11	-	0.00654608934258107	0.28573840669765
11419	econazole	hsa04912	GnRH signaling pathway	2002_5613_3845_998_8399	5	-	0.0367051048004893	0.334376516088994
11420	econazole	hsa05210	Colorectal cancer	91_7042_581_3845_8322	5	-	0.0147429161692818	0.28573840669765
11421	econazole	hsa05220	Chronic myeloid leukemia	1869_91_3845_7042	4	-	0.0393384136575287	0.334376516088994
11422	calcium folinate	hsa05200	Pathways in cancer	4254_6934	2	+	0.0191582344077874	0.655695010837938
11423	calcium folinate	hsa03022	Basal transcription factors	51616_6875_2969_728198	4	+	0.0195729853981474	0.655695010837938
11424	calcium folinate	hsa03440	Homologous recombination	5425_8940	2	-	0.0207908263682282	0.614545556901715
11425	calcium folinate	hsa03030	DNA replication	5425_5558	2	-	0.0323445029948271	0.614545556901715
11426	clidinium bromide	hsa05014	Amyotrophic lateral sclerosis (ALS)	10452_1432_581	3	+	0.0478218507261484	0.756149668081104
11427	clidinium bromide	hsa04740	Olfactory transduction	818	1	-	0.048057729121989	0.865039124195802
11428	clidinium bromide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8970_121504	15	-	1.13497837548145e-08	6.12888322759983e-07
11429	clidinium bromide	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0114673001034204	0.309617102792351
11430	gabapentin	hsa05214	Glioma	801_1956_805_816_808	5	+	0.0149495983140329	0.172284067251952
11431	gabapentin	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.0149174472845007	0.172284067251952
11432	gabapentin	hsa04640	Hematopoietic cell lineage	2057_3123_2993_3126_3127_3125	6	+	0.0127320475900498	0.172284067251952
11433	gabapentin	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	+	0.0303120187154459	0.199003129763925
11434	gabapentin	hsa04210	Apoptosis	472_8837_1677_317_651610	5	+	0.0457326426926645	0.24625269142204
11435	gabapentin	hsa04720	Long-term potentiation	801_808_805_816_23236	5	+	0.0251837538345232	0.199003129763925
11436	gabapentin	hsa05310	Asthma	3123_3125_3126_3127_2207	5	+	0.000718819991112768	0.0503173993778938
11437	gabapentin	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0281176343032377	0.199003129763925
11438	gabapentin	hsa04912	GnRH signaling pathway	808_1956_816_801_805_23236	6	+	0.031271920391474	0.199003129763925
11439	gabapentin	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.0109083225659096	0.172284067251952
11440	gabapentin	hsa04270	Vascular smooth muscle contraction	4882_9138_808_801_805_23236	6	+	0.0442964214874641	0.24625269142204
11441	gabapentin	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	+	0.0172284067251952	0.172284067251952
11442	gabapentin	hsa02010	ABC transporters	8714_215_10347_23457	4	+	0.0172284067251952	0.172284067251952
11443	sulfadimethoxine	hsa04080	Neuroactive ligand-receptor interaction	5618	1	+	0.0469392719776771	0.891846167575865
11444	sulfadimethoxine	hsa04740	Olfactory transduction	219464	1	+	0.00360324432158554	0.102692463165188
11445	sulfadimethoxine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	20	+	3.30300187261817e-10	1.88271106739236e-08
11446	sulfadimethoxine	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	8992_3725_28964	3	-	0.0251365307513625	0.55361319350259
11447	sulfadimethoxine	hsa04010	MAPK signaling pathway	5568_3925_1846_4763_10454_3725	6	-	0.0316350396287194	0.55361319350259
11448	vidarabine	hsa04010	MAPK signaling pathway	785_5568_51347_22808_2263_3305_4791	7	+	0.0180333776024234	0.730800250087025
11449	vidarabine	hsa04020	Calcium signaling pathway	2778_3274_5568_489_2149	5	+	0.03527417715818	0.730800250087025
11450	vidarabine	hsa04740	Olfactory transduction	818_5613	2	-	0.000400049381450362	0.0152018764951138
11451	vidarabine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3014	26	-	6.05052121117511e-11	4.59839612049308e-09
11452	vidarabine	hsa04010	MAPK signaling pathway	9261_2768_9344_1843_5613_5534_1846_4137_2002_6722_4763_5600_6788_5494_5970_6300	16	-	0.0437142410979544	0.916630423081088
11453	vidarabine	hsa05330	Allograft rejection	3135_3105_3106_649853	4	-	0.0499418285692583	0.916630423081088
11454	ursodeoxycholic acid	hsa04740	Olfactory transduction	109	1	-	0.0327012806720513	0.675826467222394
11455	ursodeoxycholic acid	hsa04510	Focal adhesion	3693_5829_2909_6654_5155_5154_3909_3655	8	-	0.0185589767546936	0.675826467222394
11456	ursodeoxycholic acid	hsa04810	Regulation of actin cytoskeleton	3693_8874_5829_2909_6654_5155_5154_3655	8	-	0.0253641797952186	0.675826467222394
11457	ribostamycin	hsa04210	Apoptosis	10000_5613_5616_3553_8837_7186	6	+	0.00600059062202408	0.0951969068720129
11458	ribostamycin	hsa05221	Acute myeloid leukemia	5371_6777_10000_11040	4	+	0.0233604954952467	0.216918886741577
11459	ribostamycin	hsa04920	Adipocytokine signaling pathway	3717_10000_3953_5599_1375_7186	6	+	0.00160430960259535	0.0951969068720129
11460	ribostamycin	hsa04012	ErbB signaling pathway	5599_3725_6777_10000_1950	5	+	0.0214888569876109	0.216918886741577
11461	ribostamycin	hsa04630	Jak-STAT signaling pathway	3717_10000_3953_3589_6777_3558_23529_10379	8	+	0.00732283899015484	0.0951969068720129
11462	ribostamycin	hsa04010	MAPK signaling pathway	1848_3553_9064_5599_5598_10000_5616_1950_5613_3725_4791_7186	12	+	0.00391903261956538	0.0951969068720129
11463	ribostamycin	hsa04540	Gap junction	5598_7278_5616_113457_1950_5613	6	+	0.00731263707104047	0.0951969068720129
11464	ribostamycin	hsa04620	Toll-like receptor signaling pathway	5599_9641_10000_3553_3725	5	+	0.0378863205880531	0.307826354777931
11465	ribostamycin	hsa04912	GnRH signaling pathway	5599_5598_5616_3725_5613	5	+	0.0461252704362909	0.33312695315099
11466	ribostamycin	hsa05322	Systemic lupus erythematosus	85235_8969_8332_8330_8331_8329_8336	7	-	0.00487859975463617	0.209779789449355
11467	flunarizine	hsa05332	Graft-versus-host disease	3135_3105_3106_355_649853	5	-	0.00324699027568716	0.0818759879755375
11468	flunarizine	hsa05320	Autoimmune thyroid disease	3135_3105_3106_355_649853	5	-	0.00801882774409827	0.126296536969548
11469	flunarizine	hsa04612	Antigen processing and presentation	4800_3105_3106_3135_3306_649853	6	-	0.0165133444647532	0.20806814025589
11470	flunarizine	hsa05330	Allograft rejection	3135_3105_3106_355_649853	5	-	0.00218416500017094	0.0818759879755375
11471	flunarizine	hsa04940	Type I diabetes mellitus	3135_3105_3106_355_649853	5	-	0.00389885657026369	0.0818759879755375
11472	etanidazole	hsa05131	Shigellosis	7278_3688_7430_113457_9181	5	-	0.0452589952478404	0.62357870007407
11473	etanidazole	hsa05130	Pathogenic Escherichia coli infection	7278_3688_7430_113457_9181	5	-	0.0452589952478404	0.62357870007407
11474	etanidazole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_8337	15	-	0.000174743156283448	0.0129309935649752
11475	etanidazole	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	535_10392_5335_5781_5603_9020	6	-	0.0366158873161849	0.62357870007407
11476	etanidazole	hsa04512	ECM-receptor interaction	3688_2335_2812_9672_1289_6383_3655_3339	8	-	0.00919543362876369	0.340231044264257
11477	bacitracin	hsa04740	Olfactory transduction	7932	1	+	0.00243567370349329	0.153447443320077
11478	bacitracin	hsa04070	Phosphatidylinositol signaling system	8394_8821_3707_3631	4	-	0.0401572345301124	0.82991618028899
11479	bacitracin	hsa03420	Nucleotide excision repair	2072_7507_2067	3	-	0.0398745510667066	0.82991618028899
11480	bacitracin	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8336	7	-	0.011127887993668	0.689929055607416
11481	mepenzolate bromide	hsa05200	Pathways in cancer	1436_1612_1613_5337_2260_7474	6	+	0.0249319421888717	0.623298554721793
11482	mepenzolate bromide	hsa04740	Olfactory transduction	8387_26529_5568_8388	4	+	0.000601009458262148	0.0450757093696611
11483	mepenzolate bromide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_3109	15	+	0.00351979254790439	0.131992220546415
11484	mepenzolate bromide	hsa05012	Parkinson's disease	4695	1	+	0.0469620409763645	0.880538268306834
11485	mepenzolate bromide	hsa05214	Glioma	51806_5296_208_673_818_3845_810	7	-	0.0489871621312417	0.482033994172654
11486	mepenzolate bromide	hsa05211	Renal cell carcinoma	5296_208_673_405_7424_3845_7042_3725	8	-	0.0317580946848326	0.482033994172654
11487	mepenzolate bromide	hsa04080	Neuroactive ligand-receptor interaction	64106_7442_2908_1909_7433	5	-	0.0351490252375325	0.482033994172654
11488	mepenzolate bromide	hsa04670	Leukocyte transendothelial migration	5296	1	-	0.0473433546926413	0.482033994172654
11489	mepenzolate bromide	hsa05016	Huntington's disease	3708_23236	2	-	0.0132128444356338	0.369959644197746
11490	mepenzolate bromide	hsa04740	Olfactory transduction	818_810_157_51806	4	-	0.000108716043918514	0.00456607384457759
11491	mepenzolate bromide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3119_3113_727	24	-	8.23467693879133e-07	6.91712862858472e-05
11492	mepenzolate bromide	hsa04810	Regulation of actin cytoskeleton	5296_3845_324_673	4	-	0.0359230769589249	0.482033994172654
11493	epitiostanol	hsa04740	Olfactory transduction	5568	1	+	0.0107660088990159	0.333746275869493
11494	epitiostanol	hsa04920	Adipocytokine signaling pathway	8660_2182_3717_5465_6794	5	+	0.0102496357017066	0.333746275869493
11495	epitiostanol	hsa03440	Homologous recombination	7517_7156_10111	3	-	0.0290529548563654	0.504937507297501
11496	epitiostanol	hsa04740	Olfactory transduction	219464	1	-	0.0036347581295683	0.116312260146186
11497	epitiostanol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8970_121504	15	-	1.79536075309955e-06	0.000114903088198371
11498	epitiostanol	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0315585942060938	0.504937507297501
11499	deptropine	hsa05332	Graft-versus-host disease	3812_57292_3108_3119_3107_941_356	7	+	0.0327741999121867	0.69277336275415
11500	deptropine	hsa04740	Olfactory transduction	5613_23538_4991_26539_390892_810_9635_409	8	+	7.96233457837801e-05	0.00660873770005375
11501	deptropine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8290_88_8294_8341_8340_3108_8370_717_715_8359_554313_121504_3119_941	23	+	0.000336643121645389	0.0139706895482836
11502	deptropine	hsa04930	Type II diabetes mellitus	776_3551_9370_5315_8660_5602_9021	7	+	0.0434683329173546	0.69277336275415
11503	deptropine	hsa04940	Type I diabetes mellitus	3108_3119_3107_2572_941_356_3382	7	+	0.0396830670073495	0.69277336275415
11504	deptropine	hsa04080	Neuroactive ligand-receptor interaction	5618_2149	2	-	0.00324537759244423	0.134683170086436
11505	deptropine	hsa05322	Systemic lupus erythematosus	8353_8344_3123_727_3126_3127_3125_8358_8343_8968_8346_8347_3013_8350_8351_8352_8339_8354_8355_8356_8357	21	-	1.94916297869383e-06	0.000161780527231588
11506	deptropine	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.0433116386090737	0.985939658203095
11507	ricinine	hsa05332	Graft-versus-host disease	3123_3107_3126_3127_3125	5	+	0.00343693785489743	0.0349422015247905
11508	ricinine	hsa04640	Hematopoietic cell lineage	2323_2814_3690_3123_3126_3127_3125_915_924	9	+	0.000237936674008714	0.00725706855726578
11509	ricinine	hsa05320	Autoimmune thyroid disease	3448_3123_3107_3126_3127_3125	6	+	0.00172999146586912	0.0263823698545041
11510	ricinine	hsa04612	Antigen processing and presentation	3448_3805_3123_3107_3126_3127_3125	7	+	0.00493234879252745	0.0429818966205964
11511	ricinine	hsa04740	Olfactory transduction	5137_5593	2	+	0.0190378111418069	0.129034053294469
11512	ricinine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8348_8329_8294_3123_3126_3127_3125_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235	26	+	3.11114337053907e-15	1.89779745602883e-13
11513	ricinine	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.00611812351495329	0.0466506918015188
11514	ricinine	hsa05330	Allograft rejection	3123_3107_3126_3127_3125	5	+	0.00231409689983514	0.0282319821779887
11515	ricinine	hsa04940	Type I diabetes mellitus	3123_3107_3126_3127_2571_3125	6	+	0.000717888661101729	0.0145970694424018
11516	ricinine	hsa05211	Renal cell carcinoma	208_6655_5290_405_3725_4233	6	-	0.0277326643357859	0.365146747087848
11517	ricinine	hsa04650	Natural killer cell mediated cytotoxicity	3107_3383_3455_6655_3806_5290_8795_6452_7409_3106	10	-	0.012467003014293	0.328297746043049
11518	ricinine	hsa05200	Pathways in cancer	5914_3913_841_4088_208_6655_6789_1855_5290_1613_7188_5925_405_6934_3725_1869_3673_4233	18	-	0.022798343174113	0.360213822150985
11519	ricinine	hsa05221	Acute myeloid leukemia	208_6655_6934_5290_5914	5	-	0.040551591823694	0.375279497978683
11520	ricinine	hsa05223	Non-small cell lung cancer	6789_208_6655_5290_5925_1869	6	-	0.00837707182417182	0.328297746043049
11521	ricinine	hsa04620	Toll-like receptor signaling pathway	3663_841_3455_208_5290_51135_3725	7	-	0.042753360529217	0.375279497978683
11522	ricinine	hsa05210	Colorectal cancer	4088_208_6655_1855_5290_6934_3725_4233	8	-	0.00580500518666156	0.328297746043049
11523	ricinine	hsa05222	Small cell lung cancer	3913_208_5290_7188_5925_1869_3673	7	-	0.0201461987344161	0.360213822150985
11524	ricinine	hsa05220	Chronic myeloid leukemia	4088_208_6655_5290_5925_1869	6	-	0.032590955100023	0.367812207557402
11525	fenofibrate	hsa04070	Phosphatidylinositol signaling system	5333_23236_3710_3709_3631	5	+	0.0193164360733194	0.275259214044801
11526	fenofibrate	hsa04740	Olfactory transduction	157	1	+	0.00740105119142981	0.140619972637166
11527	fenofibrate	hsa04630	Jak-STAT signaling pathway	3581_3601_3566_3589_5292_867_30837	7	+	0.035921004614425	0.292499609003175
11528	fenofibrate	hsa04020	Calcium signaling pathway	3710_2925_8911_8912_7220_5333_3709_23236	8	+	0.0311263006823815	0.292499609003175
11529	fenofibrate	hsa04912	GnRH signaling pathway	8398_3710_3709_8681_5600_100137049_23236	7	+	0.00648194054131428	0.140619972637166
11530	fenofibrate	hsa04730	Long-term depression	8398_3710_3709_8681_100137049_23236	6	+	0.00348641396219131	0.140619972637166
11531	fenofibrate	hsa04270	Vascular smooth muscle contraction	8398_3710_3709_8681_100137049_23236	6	+	0.0316099839634346	0.292499609003175
11532	fenofibrate	hsa04310	Wnt signaling pathway	4088_3725_1855_1454	4	-	0.0395372749532866	0.528662338369296
11533	fenofibrate	hsa05210	Colorectal cancer	4088_3725_1855	3	-	0.034777324504506	0.528662338369296
11534	pipemidic acid	hsa04740	Olfactory transduction	816	1	+	0.0106850639503664	0.282924237806399
11535	pipemidic acid	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6714_528_23545_5602	4	+	0.0465380812553428	0.438787623264661
11536	pipemidic acid	hsa04720	Long-term potentiation	2911_3708_3709_6196_816	5	+	0.0147222389540692	0.282924237806399
11537	pipemidic acid	hsa04540	Gap junction	2911_7278_113457_3708_3709_112_57369_6714	8	+	0.000470773027028967	0.0310710197839118
11538	pipemidic acid	hsa04020	Calcium signaling pathway	2911_8911_6915_3708_3709_5733_1910_816	8	+	0.0231606293014684	0.305720306779383
11539	pipemidic acid	hsa04912	GnRH signaling pathway	112_3708_3709_5602_6714_816	6	+	0.0171469235034181	0.282924237806399
11540	pipemidic acid	hsa04730	Long-term depression	2911_3708_3709_2781	4	+	0.0465380812553428	0.438787623264661
11541	pipemidic acid	hsa04350	TGF-beta signaling pathway	91_268_7059_653_9475	5	-	0.00323099124466524	0.126008658541944
11542	kinetin	hsa04740	Olfactory transduction	56656	1	+	0.000261394934177306	0.0185590403265887
11543	kinetin	hsa04510	Focal adhesion	1284_2335_1302_1282_3690_208_5880_93408_1956_1290_5063_3082	12	+	0.0361649346789265	0.751116714453517
11544	kinetin	hsa05221	Acute myeloid leukemia	861_208_5371_652671_5914	5	+	0.0369269040046108	0.751116714453517
11545	kinetin	hsa04512	ECM-receptor interaction	1284_2335_1302_1282_3690_1290	6	+	0.0454105516735403	0.751116714453517
11546	kinetin	hsa05010	Alzheimer's disease	6390	1	-	0.0464091791093862	0.759881470318851
11547	kinetin	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1839_535_5600_5603_6714_5781	6	-	0.031543545618483	0.759881470318851
11548	kinetin	hsa04370	VEGF signaling pathway	8503_10725_9261_5600_5603_6714	6	-	0.0431713402058352	0.759881470318851
11549	meglumine	hsa04520	Adherens junction	51176_4301_4088_10580_1956_56288	6	+	0.0446202793590386	0.740375632807835
11550	meglumine	hsa05016	Huntington's disease	10540	1	+	0.048076071799172	0.740375632807835
11551	meglumine	hsa04740	Olfactory transduction	818_81697_5593_5566	4	+	0.014685618781605	0.55805351370099
11552	meglumine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_727	26	+	6.23606814804135e-12	4.73941179251143e-10
11553	meglumine	hsa05219	Bladder cancer	1956_1029_4193_7422	4	+	0.0487089232110418	0.740375632807835
11554	meglumine	hsa04662	B cell receptor signaling pathway	3725_7409_27071_4793	4	-	0.0131240863531654	0.350348590446588
11555	meglumine	hsa04660	T cell receptor signaling pathway	915_3725_7409_4793	4	-	0.0429846048179183	0.429846048179183
11556	meglumine	hsa04510	Focal adhesion	7059_3688_7409_3725_3655_55742	6	-	0.0362441164768101	0.429846048179183
11557	meglumine	hsa04350	TGF-beta signaling pathway	9372_7059_1874_653	4	-	0.0210209154267953	0.350348590446588
11558	meglumine	hsa04512	ECM-receptor interaction	3655_7059_1605_3688	4	-	0.0188270327069204	0.350348590446588
11559	MG-262	hsa04080	Neuroactive ligand-receptor interaction	5618_1812_3360_2901_3355_56288_136_2150	8	+	4.40165349174801e-06	0.00019807440712866
11560	MG-262	hsa05016	Huntington's disease	1213_4899_27113_51164_1639_5439_246721_548644_10126_517_23236	11	+	0.014654098017631	0.188409831655256
11561	MG-262	hsa04740	Olfactory transduction	818_157	2	+	8.11658206220875e-17	7.30492385598788e-15
11562	MG-262	hsa05322	Systemic lupus erythematosus	3108_3119_718_3123_3126_3127_3125	7	+	0.0114015196827852	0.171022795241778
11563	MG-262	hsa04530	Tight junction	79784_7082_5578_6709_56288_7525_5865_1459	8	+	0.0417451793801445	0.313088845351084
11564	MG-262	hsa04810	Regulation of actin cytoskeleton	23533_8503_26999_6654_5293_79784_3678_2257_3673_2260_10458_4659	12	+	0.00484360842713647	0.108981189610571
11565	MG-262	hsa05012	Parkinson's disease	7314_6622_7054_517	4	+	0.000852708587410368	0.025581257622311
11566	MG-262	hsa04260	Cardiac muscle contraction	70_4635_488	3	+	0.0329943062402551	0.28926956416534
11567	MG-262	hsa04060	Cytokine-cytokine receptor interaction	5618_1435_3566_3552_3459_3576_3570_355_655_7422_8744_3449_83729_27242_3601_8795_8794	17	+	0.010392428364782	0.171022795241778
11568	MG-262	hsa03010	Ribosome	6204_6168_6233_6205	4	+	0.0168318761014202	0.189358606140977
11569	MG-262	hsa04020	Calcium signaling pathway	5533_1812_5578_3360_818_136_113_488_9630_23236_4842_493	12	+	0.0353551689535416	0.28926956416534
11570	MG-262	hsa04610	Complement and coagulation cascades	1604_718	2	+	0.0313492528747664	0.28926956416534
11571	MG-262	hsa04080	Neuroactive ligand-receptor interaction	3953_4886	2	-	0.00933325107522105	0.184331708735616
11572	MG-262	hsa04740	Olfactory transduction	801_808_805	3	-	0.00102480796457278	0.0319915225063983
11573	MG-262	hsa05322	Systemic lupus erythematosus	8329_8343_8347_8346_8345_8344_3123_3126_3127_3125_8969_8332_8330_8331_8336_8334_8335_8339_8357_85235_85236_3012_3017_3014	24	-	4.42658451398533e-09	3.49700176604841e-07
11574	MG-262	hsa04110	Cell cycle	890_5111_9134_983_7027_7465_6502_9700_1031_9232	10	-	0.0251237061388429	0.396954556993718
11575	MG-262	hsa04330	Notch signaling pathway	3714_3280_22938_1487_5664	5	-	0.0354043127048648	0.399562957669188
11576	MG-262	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.0305067015753869	0.399562957669188
11577	MG-262	hsa04010	MAPK signaling pathway	27092	1	-	0.00121486794328095	0.0319915225063983
11578	erastin	hsa04120	Ubiquitin mediated proteolysis	23327_51343_5371	3	+	0.000781213088838006	0.0139055929813165
11579	erastin	hsa05010	Alzheimer's disease	5330_6622_351	3	+	3.05920171722205e-05	0.00136134476416381
11580	erastin	hsa05016	Huntington's disease	5330_90993_1742_1639	4	+	8.61310468693566e-05	0.00255522105712425
11581	erastin	hsa04740	Olfactory transduction	393046_8392	2	+	1.57876909603426e-14	1.40510449547049e-12
11582	erastin	hsa04110	Cell cycle	51343_7040_1028	3	+	0.0045208312049499	0.0670589962067569
11583	erastin	hsa04115	p53 signaling pathway	7057	1	+	0.0130646392247735	0.145344111375605
11584	erastin	hsa04512	ECM-receptor interaction	1278_3688_22798_3381_3690_9899_3910_3695_7060_2812_3679_1282_1288_1293_1290_1277_7057_961	18	+	0.00956900945821597	0.12166312025446
11585	erastin	hsa05012	Parkinson's disease	6622_5413	2	+	0.000200921355707494	0.00447050016449174
11586	erastin	hsa03010	Ribosome	6165_6129_6144	3	+	0.0174812629369995	0.172870266821439
11587	erastin	hsa04120	Ubiquitin mediated proteolysis	7337_51343_10075_7318_11060_23759_5371_4193_7329_8925_8916_8452_57154_9021_652671_63893_9820	17	-	0.0159844388745023	0.132234903416337
11588	erastin	hsa04640	Hematopoietic cell lineage	3590_2814_3570_7850_3674_3553_2057_2056_2208_3123_2812_3126_3127_3559_3125_933_3581_3815_3589_4254_1437_1435_960_948_7066_3568_1438_929_3574_924	30	-	0.0409754862995728	0.266340660947223
11589	erastin	hsa05010	Alzheimer's disease	775_51806_776_3553_5534_5664_2776_4137_5533_5532_3709_489_488_810_4695_801_4843_6622_808_805_23236	21	-	0.0038896888530566	0.0630745175807162
11590	erastin	hsa05016	Huntington's disease	1212_5430_6648_246721_2776_9586_9001_4695_1387_1742_23236	11	-	2.23764670037824e-07	7.03685517768703e-06
11591	erastin	hsa03420	Nucleotide excision repair	5111	1	-	0.00283925910387727	0.0630745175807162
11592	erastin	hsa04740	Olfactory transduction	51806_7932_26211_5613_8390_9635_808_805_4991_810_801_815_816	13	-	3.06105201716709e-20	2.78555733562205e-18
11593	erastin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_9103_88_8329_8294_121504_3020_6737_3123_3126_3127_3021_3125_8969_8968_940_8370_717_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_2215_2214_3013_3113_3111_941	49	-	0.0141332754452695	0.128612806551952
11594	erastin	hsa03410	Base excision repair	5111	1	-	0.00925772523109371	0.105306624503691
11595	erastin	hsa04530	Tight junction	9076_5728_10000_5578_23136_84612_5588_10207_88_56288_7525_5865_55870_8735_7122_23562	16	-	0.0110727576604277	0.111957883010991
11596	erastin	hsa03022	Basal transcription factors	10629_6872	2	-	0.0353355714544683	0.247349000181278
11597	erastin	hsa05012	Parkinson's disease	4695_7345_6622_7318_6531	5	-	2.31984236627045e-07	7.03685517768703e-06
11598	erastin	hsa04260	Cardiac muscle contraction	775_785_776_781_782_7170_488_482	8	-	0.0195278368031244	0.148086095757027
11599	erastin	hsa03010	Ribosome	440589_285053_439992_6187_6142_9045_6181_6144_6189	9	-	0.00415875940092634	0.0630745175807162
11600	erastin	hsa03050	Proteasome	23198_5689	2	-	0.00525063377903284	0.0682582391274269
11601	nystatin	hsa04740	Olfactory transduction	8390_393046	2	+	0.0130056262596363	0.819354454357087
11602	nystatin	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0112648224362317	0.619565233992744
11603	cyclopenthiazide	hsa04080	Neuroactive ligand-receptor interaction	56288	1	-	0.000795546330082021	0.0628481600764797
11604	cyclopenthiazide	hsa04110	Cell cycle	5591_472_5001_4087_4173_699_1111_7027_7042_8556_1017	11	-	0.0172582034633631	0.403630643125849
11605	cyclopenthiazide	hsa03450	Non-homologous end-joining	5591_7518_10111	3	-	0.0255462432358132	0.403630643125849
11606	cyclopenthiazide	hsa03022	Basal transcription factors	10629_2967_2969_6884_6880	5	-	0.0214847125962087	0.403630643125849
11607	cyclopenthiazide	hsa04060	Cytokine-cytokine receptor interaction	657_3459_3597_7042	4	-	0.0497206812592388	0.572693617225445
11608	cyclopenthiazide	hsa05210	Colorectal cancer	842_4087_6654_5291_6934_7042_2956_7976	8	-	0.0246865908240694	0.403630643125849
11609	articaine	hsa04070	Phosphatidylinositol signaling system	8871_8867_3708_23236_3631	5	+	0.013304552001124	0.284336059130834
11610	articaine	hsa04912	GnRH signaling pathway	8398_5599_818_3708_5320_23236	6	+	0.014457765718517	0.284336059130834
11611	articaine	hsa04730	Long-term depression	3708_8398_5320_23236	4	+	0.0414216723977497	0.610969667866808
11612	articaine	hsa04270	Vascular smooth muscle contraction	8398_3779_3708_5320_1909_6093_800_23236	8	+	0.00157051661921451	0.0926604805336561
11613	articaine	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	-	0.0010341280582856	0.0157921377399336
11614	articaine	hsa04640	Hematopoietic cell lineage	3123_3568_3126_3127_3125	5	-	0.00205113512369487	0.0199837170531307
11615	articaine	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	-	0.00230581350613047	0.0199837170531307
11616	articaine	hsa04612	Antigen processing and presentation	3123_3126_3127_3125	4	-	0.0130484025672873	0.0969309904998485
11617	articaine	hsa04514	Cell adhesion molecules (CAMs)	3123_3126_3127_3125	4	-	0.0464775008652056	0.302103755623836
11618	articaine	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.000321534136403293	0.0157921377399336
11619	articaine	hsa05330	Allograft rejection	3123_3126_3127_3125	4	-	0.000730870263135997	0.0157921377399336
11620	articaine	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	-	0.00121477982614874	0.0157921377399336
11621	CP-863187	hsa04080	Neuroactive ligand-receptor interaction	5029_4889_5618_7442_64106_56288	6	+	1.27668097750831e-07	5.7450643987874e-06
11622	CP-863187	hsa04740	Olfactory transduction	5613_5567_5616_808_801_805	6	+	2.44630811817265e-13	2.20167730635539e-11
11623	CP-863187	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_6632_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013_3017_3014_727_9555	38	+	0.000108017424763234	0.00324052274289702
11624	CP-863187	hsa04260	Cardiac muscle contraction	488	1	+	0.00126127132976831	0.028378604919787
11625	CP-863187	hsa04060	Cytokine-cytokine receptor interaction	5618_3459_2324_23495_8771_3455_5155_5154_8741_3572_91_355_8742_7422_9180_8718_1896	17	+	0.00501276176153166	0.0902297117075699
11626	CP-863187	hsa03010	Ribosome	6125_140801_6234_9349	4	+	0.0120496299617122	0.180744449425683
11627	CP-863187	hsa05010	Alzheimer's disease	6622_489	2	-	0.0498209440217736	0.727385782717895
11628	CP-863187	hsa05016	Huntington's disease	27113	1	-	0.011100882496435	0.270121474079918
11629	CP-863187	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8970_121504	15	-	0.00115828142450402	0.0845545439887935
11630	CP-863187	hsa04370	VEGF signaling pathway	8681_5335_5600_5603_6714_100137049_7422	7	-	0.0420108877673257	0.727385782717895
11631	CP-863187	hsa04062	Chemokine signaling pathway	113	1	-	0.00741841014019604	0.270121474079918
11632	nifurtimox	hsa04740	Olfactory transduction	219464	1	-	0.00118491970760599	0.0426571094738156
11633	nifurtimox	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8970_121504_3119_8339_8347_8346_8343_8344	21	-	6.5418674261857e-10	4.7101445468537e-08
11634	nifurtimox	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	3551_6868_5781_102_3725_6714_28964	7	-	0.00311608562625539	0.0747860550301294
11635	nifurtimox	hsa04330	Notch signaling pathway	22938_6868_23385_8650	4	-	0.0370512871059387	0.444615445271264
11636	nifurtimox	hsa04060	Cytokine-cytokine receptor interaction	7422	1	-	0.0237112020740731	0.341441309866653
11637	nifurtimox	hsa05220	Chronic myeloid leukemia	3551_4088_598_4193_867_5781	6	-	0.0150432599427492	0.270778678969486
11638	anabasine	hsa04710	Circadian rhythm - mammal	9572_8863	2	+	0.0396377592553298	1
11639	anabasine	hsa04910	Insulin signaling pathway	5584_5170_32_6655_8503_5562_8660_51763_208_5575	10	-	0.0404924591809429	0.5576845748594
11640	anabasine	hsa04740	Olfactory transduction	157	1	-	2.68134386809313e-05	0.00219870197183637
11641	anabasine	hsa04710	Circadian rhythm - mammal	8553_1408_8863	3	-	0.0171216200264461	0.473233228741826
11642	anabasine	hsa05215	Prostate cancer	8503_5170_208_6655_5925_2263_2260	7	-	0.0493728394771692	0.5576845748594
11643	anabasine	hsa04920	Adipocytokine signaling pathway	208_5562_8660_1375_32_4793	6	-	0.0427482623946703	0.5576845748594
11644	anabasine	hsa05222	Small cell lung cancer	8503_3688_4149_6502_3918_5925_208_7187	8	-	0.0173134108076278	0.473233228741826
11645	antazoline	hsa05332	Graft-versus-host disease	3123_3106_3126_3127_3125	5	+	0.0428134306452796	0.569562727640179
11646	antazoline	hsa05320	Autoimmune thyroid disease	3448_3123_3106_3126_3127_3125	6	+	0.0335723323931129	0.537157318289806
11647	antazoline	hsa04740	Olfactory transduction	8387_26211_8388	3	+	0.000121619987259411	0.00486479949037644
11648	antazoline	hsa05322	Systemic lupus erythematosus	1991_3123_3013_3126_3127_3125_8358_6738_8330_8968_2209_8350_8351_8352_8353_8354_8355_8356_8357	19	+	3.92596660271962e-05	0.0031407732821757
11649	antazoline	hsa05310	Asthma	3123_3126_3127_3125_5553_8288	6	+	0.00319015447480499	0.0850707859947997
11650	antazoline	hsa05330	Allograft rejection	3123_3106_3126_3127_3125	5	+	0.0306576404928107	0.537157318289806
11651	antazoline	hsa04940	Type I diabetes mellitus	3123_3106_3126_3127_3125	5	+	0.0498367386685157	0.569562727640179
11652	antazoline	hsa04080	Neuroactive ligand-receptor interaction	2846	1	-	0.0051843013226196	0.127879432624617
11653	antazoline	hsa05131	Shigellosis	7278_6093_3688_113457_8976	5	-	0.0376470671995604	0.464313828794578
11654	antazoline	hsa05016	Huntington's disease	161	1	-	0.032193001651412	0.464313828794578
11655	antazoline	hsa05130	Pathogenic Escherichia coli infection	7278_6093_3688_113457_8976	5	-	0.0376470671995604	0.464313828794578
11656	antazoline	hsa04740	Olfactory transduction	810	1	-	0.000118503192630595	0.00876923625466403
11657	antazoline	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8343_8336_8339_8347_8346_8344	12	-	0.00287968574764803	0.106548372662977
11658	vinpocetine	hsa05332	Graft-versus-host disease	3824_3119_3804_3107_3126_3127_3125_3123	8	+	0.00104058805806173	0.0426641103805309
11659	vinpocetine	hsa05320	Autoimmune thyroid disease	3449_1081_3119_3123_3107_3126_3127_3125	8	+	0.00381701624421954	0.0625990664052005
11660	vinpocetine	hsa04612	Antigen processing and presentation	3824_3449_3119_3123_3107_3126_3127_3125_6892_3804_926	11	+	0.00311779399966207	0.0625990664052005
11661	vinpocetine	hsa04740	Olfactory transduction	109	1	+	1.70636359949844e-06	0.000139921815158872
11662	vinpocetine	hsa04514	Cell adhesion molecules (CAMs)	965_4684_3119_3123_3107_3126_3127_3685_3125_5797_23308_9672_926	13	+	0.0107024510729394	0.125371569711576
11663	vinpocetine	hsa05310	Asthma	2205_3119_3123_3126_3127_3125	6	+	0.00355891145277974	0.0625990664052005
11664	vinpocetine	hsa05330	Allograft rejection	3119_3123_3107_3126_3127_3125	6	+	0.00972813095032168	0.125371569711576
11665	vinpocetine	hsa04940	Type I diabetes mellitus	3119_3123_3107_3126_3127_3125	6	+	0.0177488375257063	0.18192558463849
11666	vinpocetine	hsa04080	Neuroactive ligand-receptor interaction	2908	1	-	1.64102812596931e-05	0.000459487875271407
11667	vinpocetine	hsa05016	Huntington's disease	4899_246721_2776_2876	4	-	0.049150222876287	0.688103120268018
11668	vinpocetine	hsa04740	Olfactory transduction	818_157_409	3	-	1.49282843336452e-06	0.00012539758840262
11669	vinpocetine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8370_8332_8359_8330_8331_8336_554313_8351_85235_3119_3013_3014	25	-	3.21062495831991e-06	0.000134846248249436
11670	vinpocetine	hsa04530	Tight junction	2036_8573	2	-	0.0349940537952401	0.688103120268018
11671	vinpocetine	hsa04020	Calcium signaling pathway	818_115_113_2776	4	-	0.0479424292277134	0.688103120268018
11672	dimethadione	hsa05332	Graft-versus-host disease	3135_3105_3106_3553_649853	5	+	0.0219444022650341	0.541295255870841
11673	dimethadione	hsa05320	Autoimmune thyroid disease	3135_3105_3106_3451_649853	5	+	0.0484574513590921	0.640473648348316
11674	dimethadione	hsa04740	Olfactory transduction	26539_5593_8390_816	4	+	0.00417303856372844	0.259610611186233
11675	dimethadione	hsa04514	Cell adhesion molecules (CAMs)	9076_3384_3105_3106_3135_51208_6383_923_25945_649853	10	+	0.0329571764016984	0.60970776343142
11676	dimethadione	hsa04940	Type I diabetes mellitus	3553_3105_3106_2571_3135_649853	6	+	0.00701650300503332	0.259610611186233
11677	dimethadione	hsa05010	Alzheimer's disease	841	1	-	0.0466023907079165	0.568549166636581
11678	dimethadione	hsa04080	Neuroactive ligand-receptor interaction	7434_3354	2	-	0.0266604424971321	0.406571748081265
11679	dimethadione	hsa04740	Olfactory transduction	157	1	-	0.00012557136232562	0.00382992655093141
11680	dimethadione	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013	32	-	3.10772175003177e-16	1.89571026751938e-14
11681	dimethadione	hsa04060	Cytokine-cytokine receptor interaction	8794	1	-	0.00357286130118763	0.0726481797908151
11682	diclofenamide	hsa03440	Homologous recombination	5888_10111	2	+	0.048884396242859	0.672160448339311
11683	diclofenamide	hsa04520	Adherens junction	6932_91_5881_25945	4	+	0.0175287321696222	0.45228408427954
11684	diclofenamide	hsa03420	Nucleotide excision repair	2068_2967_5111	3	+	0.0180522308428572	0.45228408427954
11685	diclofenamide	hsa04514	Cell adhesion molecules (CAMs)	933_23308_4099_25945_3119	5	+	0.0246700409607022	0.45228408427954
11686	diclofenamide	hsa05131	Shigellosis	999_7278_7430_113457_8976	5	-	0.0132422826005915	0.48334331492159
11687	diclofenamide	hsa05016	Huntington's disease	1213_246721_6648_841_7157_5439_3092_3064_548644	9	-	0.0490889276939161	0.597248620275979
11688	diclofenamide	hsa05130	Pathogenic Escherichia coli infection	999_7278_7430_113457_8976	5	-	0.0132422826005915	0.48334331492159
11689	diclofenamide	hsa04210	Apoptosis	841_7157_472_5534_8837_651610	6	-	0.0227403117721825	0.514988384109883
11690	diclofenamide	hsa04115	p53 signaling pathway	7157_472_651610_25898_841	5	-	0.0282185415950621	0.514988384109883
11691	diclofenamide	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0371057043389605	0.541743283348823
11692	sulconazole	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.011514448427854	0.130756054959503
11693	sulconazole	hsa04640	Hematopoietic cell lineage	3690_3123_3126_3127_3125	5	+	0.0319886671463454	0.170543415108034
11694	sulconazole	hsa04662	B cell receptor signaling pathway	11025_208_7410_2353_3725	5	+	0.0187622054563995	0.150097643651196
11695	sulconazole	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	+	0.0236989247921029	0.151673118669459
11696	sulconazole	hsa04612	Antigen processing and presentation	3123_3310_3126_3127_3125	5	+	0.0346416311938195	0.170543415108034
11697	sulconazole	hsa04740	Olfactory transduction	23538	1	+	0.00741193668938959	0.130756054959503
11698	sulconazole	hsa04510	Focal adhesion	5599_208_3694_330_3690_7410_3725_2064_2534	9	+	0.0229950830426847	0.151673118669459
11699	sulconazole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_9103_8348_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_8970	32	+	1.2034636958032e-22	7.70216765314048e-21
11700	sulconazole	hsa04012	ErbB signaling pathway	5599_3725_1839_2064_208	5	+	0.0319886671463454	0.170543415108034
11701	sulconazole	hsa05310	Asthma	3123_3126_3127_8288_3125	5	+	0.000506614929722386	0.0162116777511164
11702	sulconazole	hsa04930	Type II diabetes mellitus	8651_5590_5599_8660	4	+	0.0143014435111956	0.130756054959503
11703	sulconazole	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.00838024538757506	0.130756054959503
11704	sulconazole	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	+	0.013329489605322	0.130756054959503
11705	sulconazole	hsa04080	Neuroactive ligand-receptor interaction	152_4157_64106_2908_4886_7434_9170	7	-	0.0173115332114431	0.252166386542987
11706	sulconazole	hsa04740	Olfactory transduction	51806	1	-	1.19771570802309e-09	1.03003550889986e-07
11707	sulconazole	hsa05322	Systemic lupus erythematosus	3119	1	-	0.002289673880673	0.098455976868939
11708	sulconazole	hsa05012	Parkinson's disease	2861_4701	2	-	0.0175930037123014	0.252166386542987
11709	sulconazole	hsa04060	Cytokine-cytokine receptor interaction	27242_2057_5154_3572_91_4233	6	-	0.00574924862633476	0.15738473037326
11710	sulconazole	hsa04020	Calcium signaling pathway	51806_56848_5534	3	-	0.00732022001736093	0.15738473037326
11711	carbenoxolone	hsa05332	Graft-versus-host disease	3126_3107_3113_3127_3125_3123	6	+	0.0130284472758918	0.17532326123354
11712	carbenoxolone	hsa05010	Alzheimer's disease	51806	1	+	0.0111652871340371	0.17532326123354
11713	carbenoxolone	hsa05320	Autoimmune thyroid disease	3126_3107_3113_3127_3125_3123	6	+	0.0329475667157543	0.276759560412336
11714	carbenoxolone	hsa04612	Antigen processing and presentation	4261_3107_3123_3806_3126_3127_3125_8302_3113	9	+	0.0187845521199907	0.17532326123354
11715	carbenoxolone	hsa05016	Huntington's disease	7052	1	+	0.00788145302989144	0.17532326123354
11716	carbenoxolone	hsa04740	Olfactory transduction	51806_5566_7932_9635_26211	5	+	0.00168139177121147	0.141236908781763
11717	carbenoxolone	hsa04514	Cell adhesion molecules (CAMs)	6402_965_3383_3123_3107_3126_3127_3125_23308_3684_3113_1000	12	+	0.018784635132165	0.17532326123354
11718	carbenoxolone	hsa04530	Tight junction	5521	1	+	0.0470190512444155	0.359054573139173
11719	carbenoxolone	hsa05310	Asthma	3123_3126_3127_3113_3125	5	+	0.0132506593381385	0.17532326123354
11720	carbenoxolone	hsa05330	Allograft rejection	3113_3107_3126_3127_3125_3123	6	+	0.00859130036804031	0.17532326123354
11721	carbenoxolone	hsa04940	Type I diabetes mellitus	3126_3107_3113_3127_3125_3123	6	+	0.0157602474947445	0.17532326123354
11722	carbenoxolone	hsa04740	Olfactory transduction	26212	1	-	0.00756946480544443	0.227083944163333
11723	carbenoxolone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_3119	15	-	4.90099808601492e-07	2.94059885160895e-05
11724	phthalylsulfathiazole	hsa05332	Graft-versus-host disease	3123_942_3127_3111_3126_3125	6	+	0.00774272446651515	0.0997244940402249
11725	phthalylsulfathiazole	hsa04640	Hematopoietic cell lineage	3123_3126_3127_3125_947_933_1378_4254	8	+	0.0228894201048433	0.211727135969801
11726	phthalylsulfathiazole	hsa04080	Neuroactive ligand-receptor interaction	2911_2555_6915_2917_2846_9294_3352_2925_2892_7434_2918_3274_55879_134_9568_1395_4161	17	+	0.0317182868410171	0.260794802915029
11727	phthalylsulfathiazole	hsa05320	Autoimmune thyroid disease	3126_942_3127_3111_3125_3123_7038	7	+	0.00605713097800918	0.0997244940402249
11728	phthalylsulfathiazole	hsa04740	Olfactory transduction	816	1	+	1.172192334685e-05	0.0008674223276669
11729	phthalylsulfathiazole	hsa04514	Cell adhesion molecules (CAMs)	5175_3123_4099_3126_3127_3111_3125_22871_9672_947_933_923_942	13	+	0.00284809764911175	0.0997244940402249
11730	phthalylsulfathiazole	hsa05310	Asthma	3123_3126_3127_3111_3125	5	+	0.00841113791847392	0.0997244940402249
11731	phthalylsulfathiazole	hsa05330	Allograft rejection	3123_942_3127_3111_3126_3125	6	+	0.00503281613439598	0.0997244940402249
11732	phthalylsulfathiazole	hsa04940	Type I diabetes mellitus	3123_3126_3127_3111_3125_942	6	+	0.00943339808488614	0.0997244940402249
11733	phthalylsulfathiazole	hsa04640	Hematopoietic cell lineage	966_4254_3675	3	-	0.0465509663043222	0.470681992632591
11734	phthalylsulfathiazole	hsa05010	Alzheimer's disease	4714_4728_841_4698_355_6868_489_23236_5594	9	-	0.0237341383380749	0.308543798394974
11735	phthalylsulfathiazole	hsa04080	Neuroactive ligand-receptor interaction	5618_1813_3953_1131_2908_3354_7433_9568_64106_9170	10	-	0.000328460558259098	0.014944955400789
11736	phthalylsulfathiazole	hsa04742	Taste transduction	112	1	-	0.0400267239666112	0.455303985120202
11737	phthalylsulfathiazole	hsa04740	Olfactory transduction	818_26212_157	3	-	5.01171657781658e-14	4.56066208581309e-12
11738	phthalylsulfathiazole	hsa05012	Parkinson's disease	4714_7327_7332_4698_293_4728	6	-	0.0219932227402801	0.308543798394974
11739	phthalylsulfathiazole	hsa04260	Cardiac muscle contraction	27092	1	-	0.00281020991543709	0.0852430341015917
11740	phthalylsulfathiazole	hsa04020	Calcium signaling pathway	8877_1131_3707_818_489_814_293_23236	8	-	0.00644402897967665	0.146601659287644
11741	phthalylsulfathiazole	hsa04270	Vascular smooth muscle contraction	23236_5594_23365_112	4	-	0.012877402543009	0.234368726282764
11742	fluvastatin	hsa04662	B cell receptor signaling pathway	11025_29760_8519	3	+	0.0370047326965863	0.634555826144045
11743	fluvastatin	hsa04020	Calcium signaling pathway	135_6262_816_2149_5724	5	+	0.0326839341935689	0.634555826144045
11744	fluvastatin	hsa04662	B cell receptor signaling pathway	3725_27071_3551_4793	4	-	0.040803708973087	0.64265841632612
11745	fluvastatin	hsa04920	Adipocytokine signaling pathway	6257_1375_3551_4793	4	-	0.0291469558455418	0.64265841632612
11746	fluvastatin	hsa05210	Colorectal cancer	4088_3725_7042_4233_581	5	-	0.0154478448558094	0.64265841632612
11747	fluvastatin	hsa05220	Chronic myeloid leukemia	4088_598_3551_7042	4	-	0.040803708973087	0.64265841632612
11748	glibenclamide	hsa05200	Pathways in cancer	10319_3910_5578_861_4914_3576_998_3479_8823_1284_7849_2251_650_2257_7471_2950_3674	17	+	0.0358700031482449	0.925042354904817
11749	glibenclamide	hsa05016	Huntington's disease	6390	1	+	0.0468375875901173	0.925042354904817
11750	glibenclamide	hsa04740	Olfactory transduction	81285_8390	2	+	0.00112123119871375	0.0885772646983863
11751	glibenclamide	hsa05340	Primary immunodeficiency	6891_326_920_973	4	+	0.0268808551098307	0.925042354904817
11752	glibenclamide	hsa04080	Neuroactive ligand-receptor interaction	2846_5618	2	-	2.75126627670736e-05	0.00118304449898416
11753	glibenclamide	hsa04740	Olfactory transduction	818_157	2	-	1.29587422077478e-08	1.11445182986631e-06
11754	glibenclamide	hsa05012	Parkinson's disease	7332_4712	2	-	0.0177257243835288	0.381103074245869
11755	glibenclamide	hsa04060	Cytokine-cytokine receptor interaction	5618_2057_3568_7852_7042_4233_23765	7	-	0.0131536738846495	0.377071984693286
11756	glibenclamide	hsa04020	Calcium signaling pathway	818_115_5534_113_5331	5	-	0.0447525489416685	0.769743841796698
11757	albendazole	hsa05010	Alzheimer's disease	775_836_351_23236	4	+	0.0141794600909407	0.256551201571732
11758	albendazole	hsa05016	Huntington's disease	1211_836_27113_23236	4	+	0.00745274933313021	0.253252211508275
11759	albendazole	hsa04740	Olfactory transduction	7932_26333_8390_4992_815_816	6	+	3.27561288182188e-06	0.000288253933600325
11760	albendazole	hsa05012	Parkinson's disease	836_7318	2	+	0.00863359811960027	0.253252211508275
11761	albendazole	hsa03010	Ribosome	6129	1	+	0.0145767728165757	0.256551201571732
11762	albendazole	hsa04080	Neuroactive ligand-receptor interaction	3953_1131_2908_2149	4	-	6.76704913836859e-05	0.00280832539242297
11763	albendazole	hsa05131	Shigellosis	7280_7278_113457_998_9475_203068_7430_10381_8976	9	-	0.0466995748609662	0.430673857051133
11764	albendazole	hsa05130	Pathogenic Escherichia coli infection	7280_7278_113457_998_9475_203068_7430_10381_8976	9	-	0.0466995748609662	0.430673857051133
11765	albendazole	hsa05014	Amyotrophic lateral sclerosis (ALS)	4217_836_2876_581_598_11261_5533_5603_572_842	10	-	0.0246466525280081	0.340945359970779
11766	albendazole	hsa04740	Olfactory transduction	818_810_109	3	-	2.11392614485009e-09	1.75455870022557e-07
11767	albendazole	hsa05322	Systemic lupus erythematosus	474382_474381_8329_8343_8342_8347_8346_8344_3123_3126_3127_3125_8969_55766_8332_8330_8331_8336_8351_8339_85235_83740_3013_3014	24	-	0.00112360272933901	0.0233147566337845
11768	albendazole	hsa04210	Apoptosis	472_3553_842_581_598_11261_5290_5533_572_836_8837_651610_5575_7186	14	-	0.0178956988367534	0.297068600690106
11769	albendazole	hsa05012	Parkinson's disease	4714_836_1327_842	4	-	0.0462241973448801	0.430673857051133
11770	albendazole	hsa04060	Cytokine-cytokine receptor interaction	3953_23765_3553_8742_8741	5	-	0.000228786127943643	0.00632974953977412
11771	labetalol	hsa04740	Olfactory transduction	51806_5593_7932_26211_442194_81797_815	7	+	0.00177159424166591	0.0717495667874694
11772	labetalol	hsa05322	Systemic lupus erythematosus	2903_8361_8363_8362_8365_8364_8370_718_8368_8335_8366_3111_8360_8359_8294_8367_554313_121504_3119_3109	20	+	0.00015048588681948	0.0121893568323779
11773	labetalol	hsa04710	Circadian rhythm - mammal	4862_79365_8864	3	+	0.0408267778202845	0.472424143349006
11774	labetalol	hsa04110	Cell cycle	4193	1	+	0.0313616155943938	0.423381810524316
11775	labetalol	hsa04512	ECM-receptor interaction	10319_960_961_3690_3371_7148_1290_1291_6696	9	+	0.0475034110162366	0.480972036539396
11776	labetalol	hsa04062	Chemokine signaling pathway	208_4793_2931	3	+	0.0276285843732493	0.423381810524316
11777	labetalol	hsa05330	Allograft rejection	3593_3109_3119_3111_355_3002	6	+	0.0196137069159697	0.397177565048386
11778	labetalol	hsa04940	Type I diabetes mellitus	3593_3382_3109_3119_3111_355_3002	7	+	0.0116844985929825	0.315481462010528
11779	labetalol	hsa04650	Natural killer cell mediated cytotoxicity	6655	1	-	0.0071263656195216	0.156239502414433
11780	labetalol	hsa04080	Neuroactive ligand-receptor interaction	2846_5029_5618_2908	4	-	0.0029422323471638	0.11621817771297
11781	labetalol	hsa04740	Olfactory transduction	818_157	2	-	2.01593470977962e-07	1.5925884207259e-05
11782	labetalol	hsa04540	Gap junction	5331_5598_6655_2767_113457_5154_115_5607_113_112_7278	11	-	0.0250393966931093	0.395622467751127
11783	labetalol	hsa04060	Cytokine-cytokine receptor interaction	3579_5618_3553_5154_3589	5	-	0.00791086088174342	0.156239502414433
11784	labetalol	hsa03010	Ribosome	6137	1	-	0.0445671551120873	0.586800875642483
11785	oxybutynin	hsa05010	Alzheimer's disease	775_6622_4023_351_23236	5	+	0.0455389390931511	0.532472710074907
11786	oxybutynin	hsa05016	Huntington's disease	1639_9001_23236	3	+	0.00256580467320925	0.103915089264975
11787	oxybutynin	hsa04740	Olfactory transduction	26211_5593_3000_816	4	+	1.53831710998432e-07	1.2460368590873e-05
11788	oxybutynin	hsa05212	Pancreatic cancer	354	1	+	0.0300895167035844	0.487450170598067
11789	oxybutynin	hsa05215	Prostate cancer	354	1	+	0.0460161601299302	0.532472710074907
11790	oxybutynin	hsa04512	ECM-receptor interaction	3688_2811_2335_1302_3690_3693_3695_3696_3918_7148_1292_1281_1291	13	+	0.0106768263626286	0.259752629398369
11791	oxybutynin	hsa05012	Parkinson's disease	6622_6531	2	+	0.0128272903406602	0.259752629398369
11792	oxybutynin	hsa05010	Alzheimer's disease	5534_5664	2	-	0.00652987332033091	0.180659828529155
11793	oxybutynin	hsa04080	Neuroactive ligand-receptor interaction	2911_5618_2908	3	-	0.000679898896986867	0.028215804224955
11794	oxybutynin	hsa05016	Huntington's disease	2876_10126_581	3	-	0.0140277970229426	0.291076788226059
11795	oxybutynin	hsa04740	Olfactory transduction	109_157	2	-	1.36754706449711e-07	1.1350640635326e-05
11796	oxybutynin	hsa04530	Tight junction	9223_3845	2	-	0.035228970595685	0.487334093240309
11797	oxybutynin	hsa05012	Parkinson's disease	7327_7332	2	-	0.0350170481893892	0.487334093240309
11798	oxybutynin	hsa04020	Calcium signaling pathway	2911_109_3707_5534	4	-	0.0483377559033069	0.5698180469813
11799	benzydamine	hsa05211	Renal cell carcinoma	2271_5296_6513_56924_5290_8453_7042_3725	8	+	0.0161436717266332	0.285053351384904
11800	benzydamine	hsa04080	Neuroactive ligand-receptor interaction	2740_1395_8698_799	4	+	0.0369623609974841	0.365003314850156
11801	benzydamine	hsa04740	Olfactory transduction	26333_26707_816	3	+	0.000119898607124608	0.00473599498142202
11802	benzydamine	hsa04514	Cell adhesion molecules (CAMs)	6402_958_6401_3383_5175_3119_4099_3113_941_57863_933_923	12	+	0.018551101768852	0.285053351384904
11803	benzydamine	hsa04510	Focal adhesion	2321_7148_1301_2324_5296_3910_56924_5290_5156_93408_1281_5602_1292_3725_1291_2534	16	+	0.0247000774159559	0.285053351384904
11804	benzydamine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_958_3113_941_8359_8294_8367_554313_121504_3119	18	+	0.000107329765835546	0.00473599498142202
11805	benzydamine	hsa05310	Asthma	958_3113_3119_2207	4	+	0.0484726911609043	0.397062127556588
11806	benzydamine	hsa04620	Toll-like receptor signaling pathway	958_5296_3576_5602_5290_941_3725_2353_9641_7187	10	+	0.0252578918948649	0.285053351384904
11807	benzydamine	hsa05210	Colorectal cancer	2353_836_5296_7042_5290_5156_11211_5602_91_3725	10	+	0.00491694197802503	0.129479472087992
11808	benzydamine	hsa05332	Graft-versus-host disease	3553_3105_3106_3135_3134_649853	6	-	0.016985618341391	0.331518370647356
11809	benzydamine	hsa04080	Neuroactive ligand-receptor interaction	2911_5618_7442	3	-	0.00765855728571025	0.310171570071265
11810	benzydamine	hsa04740	Olfactory transduction	810	1	-	7.50334674043958e-07	6.07771085975606e-05
11811	benzydamine	hsa04530	Tight junction	7525	1	-	0.032241433305086	0.433512824357632
11812	benzydamine	hsa04810	Regulation of actin cytoskeleton	8394_7454_5881	3	-	0.0194588640198237	0.331518370647356
11813	benzydamine	hsa05330	Allograft rejection	3135_3105_3106_649853_3134	5	-	0.037464071240783	0.433512824357632
11814	benzydamine	hsa04940	Type I diabetes mellitus	3553_3105_3106_3135_3134_649853	6	-	0.0204640969535405	0.331518370647356
11815	oxytetracycline	hsa05332	Graft-versus-host disease	3811_3119_3126_3113_3802_3134	6	+	0.00551661532329883	0.119526665338141
11816	oxytetracycline	hsa05200	Pathways in cancer	8817_4312_2271_1288_3082	5	+	0.0461821257851957	0.583311372272007
11817	oxytetracycline	hsa04612	Antigen processing and presentation	3811_3119_3113_3806_3126_3802_3134_3310	8	+	0.0175275352230305	0.284822447374246
11818	oxytetracycline	hsa04740	Olfactory transduction	7932_135948	2	+	0.000272199014155816	0.0111143396222777
11819	oxytetracycline	hsa05322	Systemic lupus erythematosus	3119_3113_3013_3126_8358_8968_8335_8350_8351_8352_8353_8354_8355_8356_8357	15	+	0.000341979680685469	0.0111143396222777
11820	oxytetracycline	hsa04080	Neuroactive ligand-receptor interaction	2911	1	-	0.000117569561534315	0.00446764333830397
11821	oxytetracycline	hsa05016	Huntington's disease	4899_27113_842	3	-	0.0364523847823094	0.461730207242586
11822	oxytetracycline	hsa04740	Olfactory transduction	219464_157	2	-	3.04256849592389e-06	0.000231235205690216
11823	oxytetracycline	hsa04514	Cell adhesion molecules (CAMs)	3134	1	-	0.0218611314725815	0.335643191459916
11824	oxytetracycline	hsa04062	Chemokine signaling pathway	6654_157	2	-	0.0091047014806366	0.230652437509461
11825	oxytetracycline	hsa05012	Parkinson's disease	842	1	-	0.0220817889118366	0.335643191459916
11826	guanethidine	hsa05332	Graft-versus-host disease	3824_3119_356_3123_3126_3127_3111_3125_3134	9	+	0.00165281353604631	0.0306634479069919
11827	guanethidine	hsa04120	Ubiquitin mediated proteolysis	23327	1	+	0.00746758902977675	0.0681417498967128
11828	guanethidine	hsa04640	Hematopoietic cell lineage	1435_2812_3123_3126_3127_3125_920_3684_924_925_290	11	+	0.0222845063880999	0.125136074333176
11829	guanethidine	hsa05200	Pathways in cancer	861_6776_3685_3918_8817_356_2249_7042_2353	9	+	0.0152158970794026	0.100978226072399
11830	guanethidine	hsa05320	Autoimmune thyroid disease	3451_3119_356_3123_3126_3127_3111_3125_3134_7038	10	+	0.00213714722752906	0.0306634479069919
11831	guanethidine	hsa04612	Antigen processing and presentation	3824_3119_3123_3126_3127_3111_3125_6891_3134_3451_920_925	12	+	0.0124727636042168	0.100978226072399
11832	guanethidine	hsa04310	Wnt signaling pathway	63928_5526_5330	3	+	0.0492166177990365	0.211341947019392
11833	guanethidine	hsa04910	Insulin signaling pathway	10580_5563	2	+	0.0248247060239064	0.129443109981798
11834	guanethidine	hsa04740	Olfactory transduction	26659_5593	2	+	9.23781325707295e-08	6.74360367766325e-06
11835	guanethidine	hsa04514	Cell adhesion molecules (CAMs)	9073_5175_3123_3695_3126_3127_3685_3125_3134_3111_6383_920_3119_3684_925	15	+	0.0269150472721773	0.130986563391263
11836	guanethidine	hsa05322	Systemic lupus erythematosus	3119_3123_3013_3126_3127_3111_3125_8358_8330_8968_716_8350_8351_8352_8353_8354_8355_8356_8357	19	+	0.00252028338961577	0.0306634479069919
11837	guanethidine	hsa04110	Cell cycle	7042	1	+	0.0148136648104005	0.100978226072399
11838	guanethidine	hsa04530	Tight junction	9863_9073	2	+	0.036127928184271	0.164833672340736
11839	guanethidine	hsa05310	Asthma	3119_2206_2207_3123_3126_3127_3111_3125	8	+	0.000899014916227221	0.0306634479069919
11840	guanethidine	hsa04512	ECM-receptor interaction	1302_2812_3691_3693_3694_3695_3685_1277_6383_3918_9899	11	+	0.0194324484970516	0.118214061690397
11841	guanethidine	hsa05330	Allograft rejection	3119_356_3123_3126_3127_3111_3125_3134	8	+	0.00325789898632726	0.0339752322859843
11842	guanethidine	hsa04940	Type I diabetes mellitus	3382_3119_356_3123_3126_3127_3111_3125_3134	9	+	0.00218348703051435	0.0306634479069919
11843	guanethidine	hsa04520	Adherens junction	4088_5795_7525_6714_10458_4233_2260_8976	8	-	0.0186861737513268	0.710074602550418
11844	guanethidine	hsa04740	Olfactory transduction	157	1	-	8.27878022493393e-06	0.000629187297094979
11845	clonidine	hsa04740	Olfactory transduction	26211_26212	2	+	0.000405137868222432	0.0320058915895721
11846	clonidine	hsa04080	Neuroactive ligand-receptor interaction	5618_1909	2	-	0.00966951880812847	0.352937436496689
11847	clonidine	hsa04740	Olfactory transduction	810_157	2	-	0.000128757169434723	0.00939927336873478
11848	Prestwick-857	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	0.000970631410380718	0.0737679871889346
11849	Prestwick-857	hsa05216	Thyroid cancer	10342_4914_6257	3	+	0.0374917824283215	1
11850	SC-19220	hsa05010	Alzheimer's disease	351_4712_4842_5534	4	+	0.0195917041265508	0.274184581529603
11851	SC-19220	hsa05016	Huntington's disease	1211_5978_4712_581	4	+	0.0103129616856225	0.217927977081001
11852	SC-19220	hsa04740	Olfactory transduction	26333_5568_393046_157_4991	5	+	1.30262879960174e-06	0.00011202607676575
11853	SC-19220	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_88_8329_8294_3108_8969_8370_8332_8359_8330_8331_8336_8335_121504_85235_720_721_9555	27	+	9.72319790965059e-06	0.000418097510114975
11854	SC-19220	hsa04530	Tight junction	88_8189	2	+	0.0126702312256396	0.217927977081001
11855	SC-19220	hsa05012	Parkinson's disease	4712	1	+	0.00225681547635671	0.0646953769888924
11856	SC-19220	hsa03010	Ribosome	6234	1	+	0.0223173496593863	0.274184581529603
11857	SC-19220	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	-	0.0194252523350036	0.228233788790427
11858	SC-19220	hsa05200	Pathways in cancer	7175_5914	2	-	0.0364663367018576	0.247044975935144
11859	SC-19220	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3125	4	-	0.0389121359780456	0.247044975935144
11860	SC-19220	hsa04740	Olfactory transduction	219464	1	-	0.00245602118195807	0.125257080279862
11861	SC-19220	hsa04710	Circadian rhythm - mammal	9572_5187	2	-	0.043596172223849	0.247044975935144
11862	SC-19220	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.00680032952734707	0.17340840294735
11863	SC-19220	hsa04060	Cytokine-cytokine receptor interaction	3601	1	-	0.0325585142740777	0.247044975935144
11864	SC-19220	hsa05330	Allograft rejection	3123_3126_3127_3125	4	-	0.0142796630949984	0.228233788790427
11865	SC-19220	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	-	0.0223758616461203	0.228233788790427
11866	perphenazine	hsa05016	Huntington's disease	7052_4899_2904_9001_23236	5	+	0.0139585323205975	0.572299825144498
11867	perphenazine	hsa04740	Olfactory transduction	390892	1	+	2.88751333657526e-11	2.36776093599171e-09
11868	perphenazine	hsa04010	MAPK signaling pathway	10000_1649_57551_4208_5602_1326_3164_5609_3725_2002_9344_5923_2247_4217_1956_8912_5534_3310_9175_3727_9020_1647_1848_781_5579_1847_1846_8817_2258_27330_4763	31	+	0.0287626153748884	0.786178153580283
11869	danazol	hsa04120	Ubiquitin mediated proteolysis	6502_9063_8065_331_8554	5	-	0.0490726516544465	0.577837258449518
11870	danazol	hsa05322	Systemic lupus erythematosus	85235_8969_8332_8330_8331_8329_8336	7	-	0.00487859975463617	0.258565786995717
11871	danazol	hsa05219	Bladder cancer	9252_1956_11186	3	-	0.0239659022297864	0.577837258449518
11872	danazol	hsa05222	Small cell lung cancer	6502_9063_331_8554	4	-	0.035742215637693	0.577837258449518
11873	lynestrenol	hsa04660	T cell receptor signaling pathway	5163_5335_5600_2353_3725_5609_4792	7	+	0.0196101751538828	0.640139141856579
11874	lynestrenol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8348_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_8330_8335_8350_8351_8352_8353_8354_8355_8356_8357_3012_3013_720_721_8970	37	+	6.69024511540705e-25	4.41556177616865e-23
11875	lynestrenol	hsa04664	Fc epsilon RI signaling pathway	5609_5163_5335_5600_9846	5	+	0.0463775046511464	0.765228826743916
11876	lynestrenol	hsa04115	p53 signaling pathway	1647_3486_5366_842_4616	5	+	0.0290972337207536	0.640139141856579
11877	lynestrenol	hsa04130	SNARE interactions in vesicular transport	6843_8417_8675	3	-	0.0316744744196174	0.996335042760269
11878	baclofen	hsa04740	Olfactory transduction	26212	1	+	0.000377942953289968	0.0257001208237178
11879	baclofen	hsa05220	Chronic myeloid leukemia	2122_861_4193_5290_5925_7048	6	+	0.0246381796729976	0.837698108881918
11880	baclofen	hsa04360	Axon guidance	9353_6093_5364_64218_6405	5	-	0.0400059426078578	0.72010696694144
11881	baclofen	hsa04710	Circadian rhythm - mammal	1454_5187	2	-	0.0176671150983081	0.647079360204233
11882	baclofen	hsa05219	Bladder cancer	7423_9252_1613	3	-	0.0239659022297864	0.647079360204233
11883	josamycin	hsa05010	Alzheimer's disease	23236	1	+	0.00117028560898296	0.030427425833557
11884	josamycin	hsa05320	Autoimmune thyroid disease	3441_3107_3126_941_3134_7038_3113	7	+	0.0438212479586366	0.488293905824808
11885	josamycin	hsa05016	Huntington's disease	7350_5978_10540_23236	4	+	0.0356349339664411	0.47846839387275
11886	josamycin	hsa04740	Olfactory transduction	1179_816_390892	3	+	1.03406615983117e-06	4.03285802334156e-05
11887	josamycin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8341_2209_3126_8969_8370_8332_8359_8330_8331_8336_8337_554313_121504_85235_2215_3113_941	28	+	1.69904924410089e-07	1.32525841039869e-05
11888	josamycin	hsa04512	ECM-receptor interaction	1281_22798_948_3690_3695_1277_1288_7148_1290_1291	10	+	0.0368052610671346	0.47846839387275
11889	josamycin	hsa04940	Type I diabetes mellitus	3382_3126_3107_2572_2571_3134_941_3113	8	+	0.00671198043815919	0.130883618544104
11890	josamycin	hsa04080	Neuroactive ligand-receptor interaction	3354	1	-	0.0156515174747402	0.571280387828017
11891	josamycin	hsa04740	Olfactory transduction	5613_5616	2	-	0.00473695289228348	0.345797561136694
11892	loperamide	hsa05016	Huntington's disease	5330_3708_317	3	+	0.0266396391943714	0.680882260615441
11893	loperamide	hsa04740	Olfactory transduction	810_26212_8383	3	+	6.58215050211152e-06	0.000546318491675256
11894	loperamide	hsa05322	Systemic lupus erythematosus	3119_3013_942_8358_8350_8968_8970_8351_8352_8353_8354_8355_8356_8357	14	+	0.0377773494640164	0.680882260615441
11895	loperamide	hsa04710	Circadian rhythm - mammal	8553_5187_79365	3	+	0.0410170036515326	0.680882260615441
11896	loperamide	hsa05012	Parkinson's disease	317	1	+	0.0152170194370189	0.631506306636284
11897	loperamide	hsa04662	B cell receptor signaling pathway	10725_10892_11261_5881_5533_7410_5534	7	-	0.00823407891805264	0.189383815115211
11898	loperamide	hsa04310	Wnt signaling pathway	1454_4040_10725_11261_5331_5881_1457_5533_5534	9	-	0.0480783903955719	0.362503947105879
11899	loperamide	hsa04740	Olfactory transduction	109	1	-	0.000401513531624439	0.0277044336820863
11900	loperamide	hsa04360	Axon guidance	55558_57556_10725_11261_5533_5881_5534_22885_10507	9	-	0.0174501407321949	0.253791349665265
11901	loperamide	hsa04210	Apoptosis	3556_3553_842_11261_5534_5533_8717	7	-	0.0185534231448026	0.253791349665265
11902	loperamide	hsa04370	VEGF signaling pathway	842_10725_11261_5533_5881_5534	6	-	0.0294250840191612	0.253791349665265
11903	loperamide	hsa04010	MAPK signaling pathway	7046_3553_6788_11261_5534_5155_4763_5881_4137_5533_5607_8986_10454_1844_408	15	-	0.0272974091674665	0.253791349665265
11904	loperamide	hsa04540	Gap junction	2778_5331_1812_5155_115_5607_109	7	-	0.0226832726280082	0.253791349665265
11905	loperamide	hsa04020	Calcium signaling pathway	2778_5331_6262_1812_11261_5534_115_109_5533_488_9630_7419_493	13	-	0.00381071256737253	0.131469583574352
11906	diltiazem	hsa05322	Systemic lupus erythematosus	85235_8969_8332_8330_8331_8329_8336	7	+	0.000571037363026955	0.0182731956168626
11907	diltiazem	hsa04662	B cell receptor signaling pathway	10725_3725_4067_4793	4	-	0.0230379468778312	1
11908	hesperetin	hsa04080	Neuroactive ligand-receptor interaction	64106_2690	2	-	0.00228841646827343	0.0972576999016208
11909	hesperetin	hsa04740	Olfactory transduction	157	1	-	1.65026890261817e-06	0.000140272856722544
11910	hesperetin	hsa04370	VEGF signaling pathway	9261_5595_5829_4775_8681_5600_5747_100137049	8	-	0.0244360564231858	0.388157014558513
11911	hesperetin	hsa04630	Jak-STAT signaling pathway	2690	1	-	0.022984074717958	0.388157014558513
11912	hesperetin	hsa04060	Cytokine-cytokine receptor interaction	27242_655_355_2690	4	-	0.0273993186747186	0.388157014558513
11913	hesperetin	hsa04020	Calcium signaling pathway	2767_5481	2	-	0.0254963238315381	0.388157014558513
11914	ampicillin	hsa05016	Huntington's disease	23236	1	+	0.0107203238107756	0.2197666381209
11915	ampicillin	hsa04740	Olfactory transduction	818_816	2	+	8.96488152500427e-05	0.00367560142525175
11916	ampicillin	hsa05322	Systemic lupus erythematosus	8361_8360_3018_8362_8365_8364_8370_8366_8368_3458_6737_942_8363_3111_9103_8359_8294_8367_554313_121504_3119	21	+	7.33762691988649e-07	6.01685407430692e-05
11917	ampicillin	hsa04620	Toll-like receptor signaling pathway	7097_3451_3456_5599_3576_942_148022_5603_3725	9	+	0.0219451268906716	0.359900081007014
11918	ampicillin	hsa04912	GnRH signaling pathway	1081_5599_5598_3709_818_8681_5603_3725_100137049_816_23236	11	+	0.00460276606540743	0.125808939121136
11919	ampicillin	hsa04130	SNARE interactions in vesicular transport	8773_8417_6844	3	-	0.0349849399144875	1
11920	ampicillin	hsa04912	GnRH signaling pathway	818_2002_6714_8681_100137049	5	-	0.0489191816667645	1
11921	famotidine	hsa04740	Olfactory transduction	5137_816	2	+	0.00112123119871375	0.040364323153695
11922	famotidine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8341_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_720_721	28	+	1.07363175653475e-13	7.7301486470502e-12
11923	famotidine	hsa03440	Homologous recombination	7517_8940_5892	3	-	0.0141868036000713	0.865395019604349
11924	famotidine	hsa05219	Bladder cancer	4318_7423_7422	3	-	0.0379049862334812	1
11925	oxamniquine	hsa05211	Renal cell carcinoma	6655_405_1399_7042_3725_4233	6	-	0.00123223901886599	0.0763988191696914
11926	oxamniquine	hsa05200	Pathways in cancer	324_596_7184_6655_7042_5371_4193_405_1399_2258_3725_4233	12	-	0.00670208798590238	0.101166326048768
11927	oxamniquine	hsa04740	Olfactory transduction	109	1	-	0.0322369934570227	0.237755004113021
11928	oxamniquine	hsa04510	Focal adhesion	596_6655_7409_1399_3725_6093_4233	7	-	0.0459153533932488	0.256056628962918
11929	oxamniquine	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	4233_3725_10392_1432_102	5	-	0.0061707680842483	0.101166326048768
11930	oxamniquine	hsa04062	Chemokine signaling pathway	6655_7852_109_7409_1399_6093_23236	7	-	0.0345128231776966	0.237755004113021
11931	oxamniquine	hsa04540	Gap junction	6655_109_7280_23236_347733	5	-	0.017363637689689	0.179424256126786
11932	oxamniquine	hsa04912	GnRH signaling pathway	4214_1432_6655_109_3725_23236	6	-	0.00815857468135226	0.101166326048768
11933	oxamniquine	hsa05210	Colorectal cancer	596_6655_324_7042_3725_4233	6	-	0.00256975688579538	0.0796624634596568
11934	oxamniquine	hsa04270	Vascular smooth muscle contraction	6093_109_5583_135_23236	5	-	0.0408921837364267	0.253531539165846
11935	oxamniquine	hsa05220	Chronic myeloid leukemia	6655_4193_1399_7042	4	-	0.0331195891243053	0.237755004113021
11936	Prestwick-685	hsa03320	PPAR signaling pathway	10580_2167_4973_4023_2182	5	+	0.0471332956407295	0.911294020678632
11937	Prestwick-685	hsa04740	Olfactory transduction	5593_26212	2	+	0.00324867978194885	0.224158904954471
11938	Prestwick-685	hsa04512	ECM-receptor interaction	1286_7148_22798_1605_7057_2335	6	+	0.0310002709043695	0.911294020678632
11939	Prestwick-685	hsa04080	Neuroactive ligand-receptor interaction	146_2911_1813	3	-	0.00761649401158083	0.21072300098707
11940	Prestwick-685	hsa04740	Olfactory transduction	219464_26211_5568	3	-	6.00975383346607e-05	0.00249404784088842
11941	Prestwick-685	hsa05322	Systemic lupus erythematosus	8329_8969_8968_8358_8330_8331_8336_6737_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3113_720_721	22	-	2.71138044641665e-06	0.000225044577052582
11942	Prestwick-685	hsa04330	Notch signaling pathway	3714_1857_182_5664_4853_9541	6	-	0.0263004009513689	0.545733319740905
11943	0175029-0000	hsa04740	Olfactory transduction	51806_26212	2	+	0.00331297633894781	0.0728854794568518
11944	0175029-0000	hsa05322	Systemic lupus erythematosus	8349_8348_8329_8343_8347_8346_8345_8344_8339_8969_8968_8358_8330_8331_8336_8334_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_85236_3012_3013_3017	31	+	2.72196641507533e-17	1.79649783394972e-15
11945	0175029-0000	hsa04115	p53 signaling pathway	1647_1026_5366_64393_4193_5268_355_8795	8	+	0.00101148102907597	0.033378873959507
11946	0175029-0000	hsa05332	Graft-versus-host disease	355_3107_3552	3	-	0.00454717097269863	0.0147783056612705
11947	0175029-0000	hsa04650	Natural killer cell mediated cytotoxicity	8503_3459_355_5578_10725_6655_6654_7410_5290_8795_5533_5532_10451_6452_7409_5336_4772_5295_3107	19	-	0.000417092933123483	0.00246827150227139
11948	0175029-0000	hsa04640	Hematopoietic cell lineage	960_3552_2057_3570_1604_3566_3675	7	-	7.10793209734087e-05	0.000539018184048349
11949	0175029-0000	hsa03320	PPAR signaling pathway	11001_5170_7316_2181_1375_5467_1376_6256	8	-	0.00450153950391403	0.0147783056612705
11950	0175029-0000	hsa05010	Alzheimer's disease	4714_5533_776_1327_841_840_8772_4698_509_317_9451_4137_5663_5532_355_3709_489_488_8851_7132	20	-	1.69861765190749e-06	2.20820294747974e-05
11951	0175029-0000	hsa04080	Neuroactive ligand-receptor interaction	5029_4889_7442_4157_3953_2908_146_4886_5031_7067_2150_136_7433_56288_9170	15	-	1.11857251385831e-15	5.08950493805531e-14
11952	0175029-0000	hsa04742	Taste transduction	5613_5568_5616_112	4	-	0.00159473698302234	0.00691052692643014
11953	0175029-0000	hsa05320	Autoimmune thyroid disease	355_3107	2	-	9.17395397782828e-05	0.00064217677844798
11954	0175029-0000	hsa04612	Antigen processing and presentation	4800_4801_4802_3107_6890_3306_1385_3304_3305_3303	10	-	0.00115110462579243	0.00551318531300585
11955	0175029-0000	hsa04670	Leukocyte transendothelial migration	1364_8503_5295_1432_5578_4318_2909_5336_10451_5290_9475_7852_6387_1365_7430_7410_5747_7409_6093_9080	20	-	0.0069668518472704	0.0218615006241933
11956	0175029-0000	hsa05016	Huntington's disease	4899_1327_64764_317_246721_23186_6874_6908_5433_5430_4698_5439_2033_509_1213_548644_4714_27113_841_3092_1385_1387_9519	23	-	3.69170754655156e-06	4.1993173342024e-05
11957	0175029-0000	hsa04740	Olfactory transduction	26211_109_5616_5568_5613	5	-	2.60486936368876e-38	2.37043112095677e-36
11958	0175029-0000	hsa04514	Cell adhesion molecules (CAMs)	965_4685_3107_9080_1364_1365_5792_923_9019_5817	10	-	1.75732345997834e-07	3.19832869716058e-06
11959	0175029-0000	hsa04510	Focal adhesion	8503_5170_595_596_2909_5295_5155_5154_5290_9475_10451_5747_7791_4638_4659_3675_2324_7410_23396_1399_29780_329_896_1793_3480_3725_6093_4233_5228_5578_6655_6654_2002_7409_7422	35	-	0.000698139747226474	0.00373710099985936
11960	0175029-0000	hsa05322	Systemic lupus erythematosus	6738_8348_3013_3014_8358_727_8968_8337_8350_8351_8352_8353_8354_8355_8356_8357	16	-	1.34746916716911e-05	0.000136244104680432
11961	0175029-0000	hsa05340	Primary immunodeficiency	6890_64421_8517	3	-	0.0206086476638315	0.0625128979136222
11962	0175029-0000	hsa04530	Tight junction	5590_5520_55844_5583_10207_5581_6709_5578_8777_64398_9080_5519_22800_1364_7082_56288_2017_2036_9223_27134_1365	21	-	0.00173690540272822	0.00712920312528649
11963	0175029-0000	hsa04720	Long-term potentiation	5568_5578_5613_5616_3709_5533_5532_6197_2033_1387_4659_107	12	-	0.0309178380780264	0.0879226020343876
11964	0175029-0000	hsa05110	Vibrio cholerae infection	7082_5568_5578_5613_5616_115_109_5336_23545	9	-	0.04486436495342	0.123716885174582
11965	0175029-0000	hsa04512	ECM-receptor interaction	3675_960_3161	3	-	3.60645106674474e-07	5.46978411789619e-06
11966	0175029-0000	hsa04062	Chemokine signaling pathway	8503_6777_1147_112_5290_9475_115_6387_56288_5747_2309_7454_5568_4067_3551_7074_7410_1399_8517_5295_109_6093_107_4793_5590_5613_6655_6654_5616_10451_7409_5970_7852	33	-	0.00111942457387851	0.00551318531300585
11967	0175029-0000	hsa04810	Regulation of actin cytoskeleton	8503_2909_5295_5155_5154_5290_9475_10451_5747_4638_4659_3675_7454_10458_7074_1445_8394_7410_50649_7430_1399_2263_2260_2261_10152_324_1793_8396_22800_6093_200576_8874_23396_6655_6654_54961_6548_7409_54434_3985	40	-	0.00180188650419329	0.00712920312528649
11968	0175029-0000	hsa05012	Parkinson's disease	4714_2861_7326_1327_7314_317_4698_51465_509_27429	10	-	1.20460364411598e-07	2.74047329036385e-06
11969	0175029-0000	hsa04260	Cardiac muscle contraction	784_776_6262_1327_27092_6548_488_481	8	-	0.000433981802597167	0.00246827150227139
11970	0175029-0000	hsa04060	Cytokine-cytokine receptor interaction	55540_5155_5154_7852_6387_9180_7132_8792_27242_3552_2057_2324_3459_3570_3572_657_655_3601_3953_23765_3625_7042_91_90_93_92_4233_8795_3566_355_7422_51330	32	-	4.122356361622e-08	1.25044809635867e-06
11971	0175029-0000	hsa03010	Ribosome	6139_9349_6125_6168_6181_6158_6234_6233_6171	9	-	3.89856913529355e-05	0.000354769791311713
11972	0175029-0000	hsa04020	Calcium signaling pathway	115_7220_5256_136_5336_4638_493_5568_3707_146_776_56848_2767_5533_5532_109_489_488_6262_107_8877_5578_5613_5616_8912_3709	26	-	5.33537314095634e-05	0.000441380868933661
11973	0175029-0000	hsa03050	Proteasome	23198_5689	2	-	0.000326805904642428	0.00212423838017578
11974	0175029-0000	hsa05330	Allograft rejection	355_3107	2	-	0.00413746311008136	0.0144811208852848
11975	0175029-0000	hsa04730	Long-term depression	4067_5578_3480_50487_2767_5519_3709	7	-	0.00122279967738413	0.00556373853209779
11976	0175029-0000	hsa04940	Type I diabetes mellitus	355_3107_3552	3	-	0.00307852557255578	0.011205833084103
11977	0175029-0000	hsa02010	ABC transporters	6890_215_23457_10257_9619	5	-	0.0273259035506308	0.0802147491324969
11978	0175029-0000	hsa04610	Complement and coagulation cascades	727_7056_1604_5327_7035_2161_5329	7	-	0.00248599110817711	0.00942604961850487
11979	0173570-0000	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_958_8359_8294_8367_554313_121504	15	+	0.000158649266597012	0.0104708515954028
11980	0173570-0000	hsa04060	Cytokine-cytokine receptor interaction	3556_27242_8793_3606_958_3589_3576_8743_6358_6366_7852_1956_7040_6359_6846_6375	16	+	0.0219314766261004	0.723738728661313
11981	0173570-0000	hsa05214	Glioma	208_5155_5154_5578	4	-	0.0448620405888932	0.353911653534602
11982	0173570-0000	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	-	0.0119096623630618	0.322798171894133
11983	0173570-0000	hsa05320	Autoimmune thyroid disease	3135_3105_3106_649853	4	-	0.0244729675208265	0.322798171894133
11984	0173570-0000	hsa04612	Antigen processing and presentation	3135_811_3106_3105_649853	5	-	0.0359269186764321	0.322798171894133
11985	0173570-0000	hsa04740	Olfactory transduction	219464_5568	2	-	0.0363716250021558	0.322798171894133
11986	0173570-0000	hsa04350	TGF-beta signaling pathway	4088_3400_6093_5933_7042	5	-	0.0331853258390174	0.322798171894133
11987	0173570-0000	hsa04010	MAPK signaling pathway	5568_5578_6788_208_2005_5155_5154_2002_4763_7042_2261	11	-	0.0261782373200097	0.322798171894133
11988	0173570-0000	hsa05330	Allograft rejection	3135_3105_3106_649853	4	-	0.00867301526022985	0.322798171894133
11989	0173570-0000	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853	4	-	0.013782941580456	0.322798171894133
11990	fludroxycortide	hsa05332	Graft-versus-host disease	3804_3126_3127_3125_3123_3113	6	+	0.00850961040232583	0.129346078115353
11991	fludroxycortide	hsa04640	Hematopoietic cell lineage	3690_3123_3126_3127_3125_7850_920_924	8	+	0.0254301629647153	0.214743598368707
11992	fludroxycortide	hsa05320	Autoimmune thyroid disease	958_3126_3113_3127_3125_3123	6	+	0.0222247561373904	0.214743598368707
11993	fludroxycortide	hsa04612	Antigen processing and presentation	3123_3126_3127_3125_6892_3804_920_3310_3113	9	+	0.0108463278416255	0.137386819327256
11994	fludroxycortide	hsa04740	Olfactory transduction	26212	1	+	7.92319515438566e-06	0.00060216283173331
11995	fludroxycortide	hsa04514	Cell adhesion molecules (CAMs)	958_9369_3123_3126_3127_3125_23308_9672_920_3113_1000	11	+	0.0237221457763908	0.214743598368707
11996	fludroxycortide	hsa05322	Systemic lupus erythematosus	958_85235_3123_8330_3126_3127_3125_8332_8969_8331_8336_8329_3113	13	+	0.00833112133392002	0.129346078115353
11997	fludroxycortide	hsa05310	Asthma	958_3113_3126_3127_3125_3123	6	+	0.00196559073138623	0.0746924477926767
11998	fludroxycortide	hsa04020	Calcium signaling pathway	2902_8911	2	+	0.0498996914454082	0.344761504531911
11999	fludroxycortide	hsa05330	Allograft rejection	958_3113_3126_3127_3125_3123	6	+	0.00554494890122718	0.129346078115353
12000	fludroxycortide	hsa04940	Type I diabetes mellitus	3113_3126_3127_3123_3125	5	+	0.03517983682555	0.26736675987418
12001	fludroxycortide	hsa05010	Alzheimer's disease	842	1	-	0.0328257296390426	1
12002	fludroxycortide	hsa05322	Systemic lupus erythematosus	85235_3123_8330_8332_8969_8331_8329_720_721_8336	10	-	0.0404048694245438	1
12003	fludroxycortide	hsa03020	RNA polymerase	246721_5439_548644_10622	4	-	0.024058675426854	1
12004	3-acetamidocoumarin	hsa05214	Glioma	2475_5578_5296_208_6655_1029_4193_1950	8	+	0.00568145324643105	0.142354559057134
12005	3-acetamidocoumarin	hsa04650	Natural killer cell mediated cytotoxicity	3812_1437_3456_962_5578_5296_6655_3107_27040_6452_5551_4772	12	+	0.0135857228251415	0.142354559057134
12006	3-acetamidocoumarin	hsa04640	Hematopoietic cell lineage	1436_1437_2811_3690_947_925_3674_3675	8	+	0.0254301629647153	0.171686388011577
12007	3-acetamidocoumarin	hsa05200	Pathways in cancer	2475_5296_3674_3675_3551_2246_4842_23604_11186_208_4193_1950_3725_1436_3688_5578_6502_6655_1029_5914_7184_1495	22	+	0.0209656056667231	0.171686388011577
12008	3-acetamidocoumarin	hsa04660	T cell receptor signaling pathway	1437_3551_5296_208_6655_27040_4772_3725_5609_925	10	+	0.0142354559057134	0.142354559057134
12009	3-acetamidocoumarin	hsa04740	Olfactory transduction	8387_219464_4991_9635_8388	5	+	0.0059626766877716	0.142354559057134
12010	3-acetamidocoumarin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_8294_8367_8342_121504	15	+	0.000882933211110843	0.0706346568888674
12011	3-acetamidocoumarin	hsa05212	Pancreatic cancer	2475_3551_5296_208_6655_4193_1950_7184	8	+	0.0283764959002665	0.171686388011577
12012	3-acetamidocoumarin	hsa05215	Prostate cancer	2475_3551_5296_208_6655_4193_1950_7184	8	+	0.0268752755796899	0.171686388011577
12013	3-acetamidocoumarin	hsa05221	Acute myeloid leukemia	2475_3551_5296_208_6655_5914	6	+	0.033881271332899	0.180700113775461
12014	3-acetamidocoumarin	hsa04664	Fc epsilon RI signaling pathway	1437_5578_5296_208_6655_27040_5609	7	+	0.041437357879279	0.207186789396395
12015	3-acetamidocoumarin	hsa05219	Bladder cancer	23604_1029_11186_4193_1950	5	+	0.030045117902026	0.171686388011577
12016	3-acetamidocoumarin	hsa04012	ErbB signaling pathway	2475_5578_5296_208_6655_1950_3725_5609	8	+	0.0254301629647153	0.171686388011577
12017	3-acetamidocoumarin	hsa05223	Non-small cell lung cancer	11186_5578_5296_208_6655_1029_1950	7	+	0.00737812207743787	0.142354559057134
12018	3-acetamidocoumarin	hsa04930	Type II diabetes mellitus	2475_776_3551_5296_9370_8660	6	+	0.0113769377368029	0.142354559057134
12019	3-acetamidocoumarin	hsa05222	Small cell lung cancer	3688_3551_5296_6502_317_4842_208_3674_3675	9	+	0.00892456570805491	0.142354559057134
12020	3-acetamidocoumarin	hsa04660	T cell receptor signaling pathway	10725_3725_867_5534	4	-	0.033613339015157	0.377651790530657
12021	3-acetamidocoumarin	hsa04210	Apoptosis	472_651610_5534_581	4	-	0.0174055272785948	0.365516072850491
12022	3-acetamidocoumarin	hsa04115	p53 signaling pathway	472_651610_581	3	-	0.0416000852967093	0.377651790530657
12023	3-acetamidocoumarin	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00469701594463385	0.197274669674622
12024	Prestwick-665	hsa05332	Graft-versus-host disease	3812_57292_3811_3552_3804_3115_3107_3126_3127_3111_3802_3803_3123_940_3125	15	+	3.08883772026094e-07	1.26642346530699e-05
12025	Prestwick-665	hsa04120	Ubiquitin mediated proteolysis	26232	1	+	0.00487720242449388	0.0499913248510623
12026	Prestwick-665	hsa04640	Hematopoietic cell lineage	3554_960_3552_2208_3123_4254_3126_3127_3125_3690_920_931_916_917_3675	15	+	0.000479940900063105	0.00787103076103492
12027	Prestwick-665	hsa05010	Alzheimer's disease	54205_4035_4023_2081	4	+	0.0478213960750562	0.297958294154919
12028	Prestwick-665	hsa05320	Autoimmune thyroid disease	3107_3123_3115_3446_3126_3127_940_3125_3111	9	+	0.00686175037546632	0.062518170087582
12029	Prestwick-665	hsa04612	Antigen processing and presentation	57292_3809_3808_3804_3806_3803_3802_6892_3123_3107_3126_3127_3125_3812_3810_3811_3310_3115_3446_3111_920_115653	22	+	1.46006247202122e-07	1.1972512270574e-05
12030	Prestwick-665	hsa04310	Wnt signaling pathway	7471_6093_6422	3	+	0.0495411226906002	0.297958294154919
12031	Prestwick-665	hsa04740	Olfactory transduction	26211_81797_9635_442194_81696	5	+	2.27188551743442e-05	0.000620982041432075
12032	Prestwick-665	hsa05322	Systemic lupus erythematosus	474382_474381_83740_717_3123_3115_3126_3127_3111_3125_940_8335_8343_8339_8347_8346_8344	17	+	0.0133396327952546	0.109384988921088
12033	Prestwick-665	hsa05310	Asthma	2205_3123_3115_3126_3127_3111_3125_8288	8	+	0.000957753248414768	0.0130892943950018
12034	Prestwick-665	hsa05012	Parkinson's disease	54205_7416	2	+	0.0362529594374318	0.270249333988128
12035	Prestwick-665	hsa05330	Allograft rejection	3123_3115_3107_3126_3127_3111_3125_940	8	+	0.00345760075573925	0.0405033231386598
12036	Prestwick-665	hsa04940	Type I diabetes mellitus	3552_3123_3115_3107_3126_3127_3111_3125_3630_940_5798	11	+	0.000180381192952729	0.00369781445553094
12037	Prestwick-665	hsa04120	Ubiquitin mediated proteolysis	1161_5371_23759_331_7329_9039_6921_55958_23221_51366_22888_6477_8881_26091_83737_51619_55236_9063_996_4193_10393_8453_8451_8945_7337_25898_6502_3093_11060_57154	30	-	0.0219490238425409	0.201931019351376
12038	Prestwick-665	hsa05010	Alzheimer's disease	4712_11261_841_2776_5534	5	-	1.4017464019137e-05	0.000429868896586868
12039	Prestwick-665	hsa04080	Neuroactive ligand-receptor interaction	2901_4157_1813_2918_1131_2908_3953_2150_56288_2690_2561	11	-	1.31228505401525e-05	0.000429868896586868
12040	Prestwick-665	hsa04742	Taste transduction	5568	1	-	0.0185234211804718	0.189350527622601
12041	Prestwick-665	hsa05016	Huntington's disease	246721_548644_4712_841_5441_5439_2776_3064_7419_1387	10	-	0.00171395126555747	0.0262805860718812
12042	Prestwick-665	hsa04740	Olfactory transduction	818_219464_5568_157_4991	5	-	1.56197903090816e-15	1.43702070843551e-13
12043	Prestwick-665	hsa04062	Chemokine signaling pathway	3717_5568_157_156_6654_6772_9475_115_6359_3845_6358_5290_56288_5970_5291	15	-	0.0388060640959426	0.324559808802429
12044	Prestwick-665	hsa05012	Parkinson's disease	7419_4712_7054	3	-	5.30149379761537e-05	0.00121934357345154
12045	Prestwick-665	hsa04260	Cardiac muscle contraction	4635	1	-	0.000526253311354361	0.00968306092892024
12046	Prestwick-665	hsa04060	Cytokine-cytokine receptor interaction	1436_1435_2057_3588_1271_3459_5155_5154_8741_3572_3953_8742_6358_7042_8718_6359_4233_8795_7040_2690	20	-	0.0113738617536909	0.130799410167445
12047	Prestwick-665	hsa04020	Calcium signaling pathway	115_7419_5568_11261_2767_2776_818_8911_5534_4638_1131	11	-	0.00491296364601276	0.0645703793475963
12048	halcinonide	hsa04740	Olfactory transduction	2978_157_442194	3	+	0.00382384006747114	0.26766880472298
12049	halcinonide	hsa05214	Glioma	10000_5578_5296_6655_4193_810	6	-	0.0348515617704865	0.71420708917838
12050	halcinonide	hsa04740	Olfactory transduction	810	1	-	2.53894243126937e-05	0.00092671398741332
12051	halcinonide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8347_8346_8344_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235_720_721	28	-	5.05245840240596e-12	3.68829463375635e-10
12052	clobetasol	hsa04740	Olfactory transduction	26659	1	+	2.50334864603717e-06	0.000215287983559197
12053	clobetasol	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_3111_8359_8294_8367_554313_121504	15	+	0.00342844711108152	0.147423225776505
12054	clobetasol	hsa04340	Hedgehog signaling pathway	4036_3549_656_353500_7482_7474	6	+	0.0434292469110281	1
12055	clobetasol	hsa05211	Renal cell carcinoma	5228_2271_5594_6654_5291_3845_5781_1399_3725_201163_4233	11	-	0.018809956002855	0.217076705645343
12056	clobetasol	hsa04640	Hematopoietic cell lineage	4254	1	-	0.0439679412968472	0.331239120143649
12057	clobetasol	hsa04080	Neuroactive ligand-receptor interaction	7067_4889_2740	3	-	7.81009974180743e-05	0.00359264588123142
12058	clobetasol	hsa05014	Amyotrophic lateral sclerosis (ALS)	4217_1432_7157_598_11261_5630_5533_5868_5534	9	-	0.0195958693598197	0.217076705645343
12059	clobetasol	hsa04740	Olfactory transduction	5567_816	2	-	5.97186118097483e-09	5.49411228649684e-07
12060	clobetasol	hsa04360	Axon guidance	3688_5594_5364_6405_11261_9475_5533_3984_4775_3845_10507_5534_10512_3985_6092_4233_54910	17	-	0.015240327210759	0.217076705645343
12061	clobetasol	hsa04110	Cell cycle	995_5591_9134_1017_472_4173_7157_6502_699_51433_5925_4088_5000_7534_651610_7531	16	-	0.011909703686928	0.217076705645343
12062	clobetasol	hsa04210	Apoptosis	472_7157_598_11261_5567_5291_5533_355_5534_8837_651610_5575_8795	13	-	0.012497693931375	0.217076705645343
12063	clobetasol	hsa05219	Bladder cancer	5228_5594_7157_999_1613_5925_3845	7	-	0.032135670085921	0.26877105890043
12064	clobetasol	hsa05216	Thyroid cancer	7175_5594_7157_999_6932_3845	6	-	0.0204159939380222	0.217076705645343
12065	clobetasol	hsa05012	Parkinson's disease	7419_6391_642502	3	-	0.0497570090706287	0.331239120143649
12066	clobetasol	hsa04060	Cytokine-cytokine receptor interaction	3597_4254_3572_355_4982_9180_4233_8795	8	-	0.0212357646826966	0.217076705645343
12067	clobetasol	hsa04912	GnRH signaling pathway	2778_6654_1432_5594_1839_2776_5567_3845_112_3725_6714_6416_816_23236	14	-	0.0238120066362412	0.219070461053419
12068	zalcitabine	hsa04070	Phosphatidylinositol signaling system	8867_8503_3633_3709_3708_5333_8821_200576_23236	9	+	0.0481025350048024	1
12069	zalcitabine	hsa04080	Neuroactive ligand-receptor interaction	3360_2150_886_2149_7068	5	+	0.00784467368412767	0.682486610519107
12070	zalcitabine	hsa04662	B cell receptor signaling pathway	10000_27071_4793	3	-	0.0305279644296694	0.383311024017569
12071	zalcitabine	hsa05221	Acute myeloid leukemia	6777_10000_11040	3	-	0.0167551437275005	0.383311024017569
12072	zalcitabine	hsa04512	ECM-receptor interaction	3909_9672_3675	3	-	0.0402425576837004	0.383311024017569
12073	zalcitabine	hsa04010	MAPK signaling pathway	10000_3925_6789_50487_4763_3164	6	-	0.034831294641601	0.383311024017569
12074	zalcitabine	hsa05222	Small cell lung cancer	10000_3909_3675	3	-	0.0425901137797299	0.383311024017569
12075	butamben	hsa05332	Graft-versus-host disease	3123_3115_3126_3127_3125	5	+	0.0217167806619499	0.408811001672381
12076	butamben	hsa04640	Hematopoietic cell lineage	2814_3123_3126_3127_3125_3589_915	7	+	0.042260199630138	0.482304044041571
12077	butamben	hsa05320	Autoimmune thyroid disease	3123_3115_3126_3127_3125	5	+	0.047993059289896	0.482304044041571
12078	butamben	hsa05310	Asthma	3123_3115_3126_3127_3125	5	+	0.00640979082007911	0.408811001672381
12079	butamben	hsa04062	Chemokine signaling pathway	6772	1	+	0.0155535030288537	0.408811001672381
12080	butamben	hsa05330	Allograft rejection	3123_3115_3126_3127_3125	5	+	0.0152193891442262	0.408811001672381
12081	butamben	hsa04730	Long-term depression	5578_6261_2892_5605_4842_5516	6	+	0.0482304044041571	0.482304044041571
12082	butamben	hsa04940	Type I diabetes mellitus	3123_3115_3126_3127_3125	5	+	0.0255506876045238	0.408811001672381
12083	butamben	hsa05332	Graft-versus-host disease	3123_3126_3127_3111_3125	5	-	0.003840367057097	0.0547933015128228
12084	butamben	hsa04640	Hematopoietic cell lineage	1436_3566_3123_3126_3127_3125_3675	7	-	0.00505784321656826	0.0547933015128228
12085	butamben	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3111_3125	5	-	0.00941228292718113	0.0873997700381105
12086	butamben	hsa04612	Antigen processing and presentation	3123_3126_3127_3111_3125_6891	6	-	0.0196426100924099	0.15959620700083
12087	butamben	hsa04740	Olfactory transduction	4991	1	-	0.00244495123572715	0.0547933015128228
12088	butamben	hsa04514	Cell adhesion molecules (CAMs)	2734_3123_3126_3127_3111_3125_5817	7	-	0.0390310654502323	0.281891028251678
12089	butamben	hsa05310	Asthma	3123_3126_3127_3111_3125	5	-	0.00100997132078408	0.0547933015128228
12090	butamben	hsa05330	Allograft rejection	3123_3126_3127_3111_3125	5	-	0.00259055060928894	0.0547933015128228
12091	butamben	hsa04940	Type I diabetes mellitus	3123_3126_3127_3111_3125	5	-	0.00460493962677094	0.0547933015128228
12092	lisinopril	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	+	0.0231445299149731	0.281306703081062
12093	lisinopril	hsa05320	Autoimmune thyroid disease	3123_3126_3127_7252_3125	5	+	0.0118939106734258	0.281306703081062
12094	lisinopril	hsa04740	Olfactory transduction	56656	1	+	0.0017188876247026	0.127197684227992
12095	lisinopril	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.00819542619784541	0.281306703081062
12096	lisinopril	hsa05330	Allograft rejection	3123_3126_3127_3125	4	+	0.0170781122771591	0.281306703081062
12097	lisinopril	hsa05210	Colorectal cancer	23533_842_4088_5900_8326_4233	6	+	0.0199352042939815	0.281306703081062
12098	lisinopril	hsa04940	Type I diabetes mellitus	3123_3126_3127_3125	4	+	0.0266100935346951	0.281306703081062
12099	lisinopril	hsa04740	Olfactory transduction	818	1	-	1.76031284281045e-05	0.00062491105919771
12100	lisinopril	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8370_8332_8359_8330_8331_8336_554313_8351_85235_3013	23	-	2.68354744230168e-08	1.90531868403419e-06
12101	lisinopril	hsa04630	Jak-STAT signaling pathway	10254	1	-	0.0467992453785325	0.879373514551178
12102	isosorbide	hsa04070	Phosphatidylinositol signaling system	8871_64768_5578_8394_8396_27124_5331_23396_810_8526_23236	11	-	0.0225361471924839	0.534569050875774
12103	isosorbide	hsa04080	Neuroactive ligand-receptor interaction	1131_7442_56288_1813_7433	5	-	0.00163181460562666	0.0685362134363197
12104	isosorbide	hsa04740	Olfactory transduction	810	1	-	5.39744537063993e-10	4.53385411133754e-08
12105	isosorbide	hsa04110	Cell cycle	5001_5000_8243_7157_51343_4193_4088_996_10912_8555_1032_8556_1031_4616	14	-	0.0464710460279093	0.596116806098101
12106	isosorbide	hsa04115	p53 signaling pathway	25898_5366_842_7157_317_4193_355_10912_3732_4616	10	-	0.0304720135930439	0.534569050875774
12107	isosorbide	hsa05213	Endometrial cancer	6934_7157_6655_3845_8312_324_2064_842	8	-	0.0318195863616532	0.534569050875774
12108	isosorbide	hsa05210	Colorectal cancer	6934_596_4088_6655_8312_1856_7157_3845_324_4233_842	11	-	0.0496764005081751	0.596116806098101
12109	tacrine	hsa04650	Natural killer cell mediated cytotoxicity	3439_2215_3447_3107_3441_5293_5290_6452_9436	9	+	0.0145109557927758	0.676686938238293
12110	tacrine	hsa05218	Melanoma	8817_8823_2260_5293_5290	5	+	0.0475526481552301	0.676686938238293
12111	tacrine	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	-	0.0113200134188617	0.256586970827532
12112	tacrine	hsa05320	Autoimmune thyroid disease	3135_3105_3106_649853	4	-	0.0233174949177593	0.396397413601908
12113	tacrine	hsa05330	Allograft rejection	3135_3105_3106_649853	4	-	0.00823629545528692	0.256586970827532
12114	tacrine	hsa04940	Type I diabetes mellitus	3135_3105_3106_3382_649853	5	-	0.00234328301304968	0.159343244887378
12115	altizide	hsa04640	Hematopoietic cell lineage	2323_1436_1435_2811_3815_3690_3589_3570_7850_1378_931	11	+	0.0213311224346413	0.358362856901974
12116	altizide	hsa05016	Huntington's disease	2902_54205_317	3	+	0.014278009246232	0.299838194170872
12117	altizide	hsa04740	Olfactory transduction	26476_5568_2978_157	4	+	6.22192947890617e-06	0.000522642076228118
12118	altizide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_716_3113_3014_8359_8294_8367_554313_8368_121504_3119_3109	19	+	0.00147708907821718	0.0620377412851216
12119	altizide	hsa04512	ECM-receptor interaction	1278_7059_2811_1311_3910_3690_3695_3918_5649_63923_1290_1291	12	+	0.00576085671518338	0.161303988025135
12120	altizide	hsa04740	Olfactory transduction	818	1	-	0.000791533991799135	0.0261206217293715
12121	altizide	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013	32	-	6.87593239810433e-19	4.53811538274886e-17
12122	gabexate	hsa05332	Graft-versus-host disease	3119_3804_3113_3127_3111_3126_3134_355_5551_3123_3125	11	+	0.00537439160970204	0.139467495362728
12123	gabexate	hsa04080	Neuroactive ligand-receptor interaction	5028_5618_1081_4889_2918_7068_2901_4886_2150_5733_1910	11	+	0.00422164101173697	0.139467495362728
12124	gabexate	hsa05320	Autoimmune thyroid disease	1081_3119_3126_3113_3127_3111_3125_3134_355_5551_3123	11	+	0.0246300679772382	0.323709464843702
12125	gabexate	hsa04740	Olfactory transduction	26211_816	2	+	3.05910886162734e-13	2.81438015269715e-11
12126	gabexate	hsa05310	Asthma	3119_3123_3113_3127_3111_3126_3125	7	+	0.0387012693322505	0.445064597320881
12127	gabexate	hsa04260	Cardiac muscle contraction	4635	1	+	0.00979778147940406	0.150232649350862
12128	gabexate	hsa05330	Allograft rejection	3119_3113_3126_3127_3111_3125_3134_355_5551_3123	10	+	0.00757975518275696	0.139467495362728
12129	gabexate	hsa04940	Type I diabetes mellitus	3382_3119_3113_3126_3127_3111_3125_3134_355_5551_3123	11	+	0.00718794692267728	0.139467495362728
12130	gabexate	hsa05016	Huntington's disease	4714_246721_27113_5439_6667_2776_10126_548644_161	9	-	0.00101511327382055	0.049740550417207
12131	gabexate	hsa03450	Non-homologous end-joining	3981_7518	2	-	0.017686049339354	0.288872139209449
12132	gabexate	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.00797033452479778	0.195273195857546
12133	trimipramine	hsa05332	Graft-versus-host disease	3126_3113_3112_3127_3123_3125	6	+	0.0282843929361876	0.176233525217784
12134	trimipramine	hsa04640	Hematopoietic cell lineage	2323_2057_3690_3123_3126_3127_3125_929_920_926	10	+	0.0272674568833885	0.176233525217784
12135	trimipramine	hsa05010	Alzheimer's disease	317	1	+	0.00238139833745235	0.0368967610832361
12136	trimipramine	hsa05320	Autoimmune thyroid disease	958_3448_3445_3113_3126_3127_3112_3123_3125	9	+	0.00294519493445183	0.0368967610832361
12137	trimipramine	hsa04612	Antigen processing and presentation	3448_3445_3123_3806_3126_3127_3125_920_3310_3112_3113_926	12	+	0.00364412455143073	0.0368967610832361
12138	trimipramine	hsa05016	Huntington's disease	1387_317_27113	3	+	0.0265351321365872	0.176233525217784
12139	trimipramine	hsa04740	Olfactory transduction	135948_157	2	+	9.506766618056e-07	3.85024048031268e-05
12140	trimipramine	hsa04514	Cell adhesion molecules (CAMs)	6403_4684_958_3123_3126_3127_3125_23308_6693_920_3112_10686_3113_926	14	+	0.0183090199477858	0.148303061577065
12141	trimipramine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_958_3123_3126_3127_3125_8968_8370_717_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113_3112_8970_729	35	+	1.10694820250108e-12	8.96628044025875e-11
12142	trimipramine	hsa05310	Asthma	958_3113_3126_3127_3125_3123_3112	7	+	0.00181542859810554	0.0367624291116372
12143	trimipramine	hsa05012	Parkinson's disease	317	1	+	0.0151336174133733	0.13620255672036
12144	trimipramine	hsa05330	Allograft rejection	3593_958_3113_3126_3127_3125_3123_3112	8	+	0.00153978534636367	0.0367624291116372
12145	trimipramine	hsa04940	Type I diabetes mellitus	3593_3126_3113_3127_2571_3112_3123_3125	8	+	0.00343814213222175	0.0368967610832361
12146	trimipramine	hsa05010	Alzheimer's disease	489_5534	2	-	0.0183143334303477	0.296807620600264
12147	trimipramine	hsa05016	Huntington's disease	6875_581	2	-	0.0133165620367677	0.296807620600264
12148	trimipramine	hsa05322	Systemic lupus erythematosus	958_85235_3123_3126_3127_3125_8332_727_8969_8331_8336_8329_9555_8330	14	-	0.0200820283922047	0.296807620600264
12149	trimipramine	hsa05310	Asthma	958_3125_3126_3127_3123	5	-	0.0220477637556522	0.296807620600264
12150	trimipramine	hsa03022	Basal transcription factors	11037_2969_10629_6875_51616_728198	6	-	0.0140123243834546	0.296807620600264
12151	trimipramine	hsa05012	Parkinson's disease	7345	1	-	0.0222605715450198	0.296807620600264
12152	trimipramine	hsa05330	Allograft rejection	958_3126_3127_3123_3125	5	-	0.0483985801917107	0.553126630762408
12153	suprofen	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	2.78572790068376e-08	1.17000571828718e-06
12154	suprofen	hsa04710	Circadian rhythm - mammal	1408_5187	2	+	0.0171997869595292	0.361195526150113
12155	suprofen	hsa04210	Apoptosis	843_5575_317_5532	4	+	0.0378854728104815	0.530396619346741
12156	suprofen	hsa04740	Olfactory transduction	219464_5613_5616	3	-	0.0141991314551726	0.369177417834488
12157	suprofen	hsa05322	Systemic lupus erythematosus	3013_3113_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	12	-	0.000732985843591734	0.0571728958001553
12158	suprofen	hsa04210	Apoptosis	5613_5575_5616_5290_472_651610_8795	7	-	0.0121858376458732	0.369177417834488
12159	simvastatin	hsa04740	Olfactory transduction	26211_1179	2	+	0.049795156899398	1
12160	simvastatin	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	0.000102066642907553	0.00561366535991541
12161	simvastatin	hsa05211	Renal cell carcinoma	2271_5290_405_7424_8453_7042	6	-	0.0320670926675688	1
12162	simvastatin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_720_721	23	-	1.32493718354093e-09	9.00957284807832e-08
12163	oxantel	hsa04740	Olfactory transduction	81696_81797_816	3	+	0.000123589255530098	0.0100107296979379
12164	oxantel	hsa04360	Axon guidance	3985	1	+	0.045525846039659	1
12165	oxantel	hsa04340	Hedgehog signaling pathway	51384_656_653_353500_7474_7475	6	+	0.045033546182057	1
12166	oxantel	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_8343_8336_8339_8347_8346_8344	12	-	8.75979205494013e-05	0.00630705027955689
12167	oxantel	hsa04664	Fc epsilon RI signaling pathway	5296_5163_5335_5600_4067	5	-	0.0292579640432025	1
12168	oxantel	hsa03450	Non-homologous end-joining	27343_7518	2	-	0.0418106608322499	1
12169	tetroquinone	hsa04512	ECM-receptor interaction	1281_22798_9900_3381_3691_3674	6	+	0.0224979803739316	1
12170	tetroquinone	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0422811075859936	1
12171	tetroquinone	hsa04640	Hematopoietic cell lineage	3655_3552	2	-	0.00755944611310534	0.171977399073146
12172	tetroquinone	hsa04080	Neuroactive ligand-receptor interaction	3354_706_1081_2149_9170	5	-	2.21620453370522e-07	1.00837306283588e-05
12173	tetroquinone	hsa05016	Huntington's disease	1213_246721_548644_4700_7052_2776_3708_2033_7419_23236	10	-	0.0124985624556657	0.227473836693116
12174	tetroquinone	hsa04740	Olfactory transduction	51806_26212	2	-	7.310854281732e-16	6.65287739637612e-14
12175	tetroquinone	hsa04514	Cell adhesion molecules (CAMs)	4685_3107_3135_5792_3655_923_50848	7	-	0.0353900547265864	0.463034446214155
12176	tetroquinone	hsa04630	Jak-STAT signaling pathway	9063_3597_6655_867_6772_200734_2033_5781_10254	9	-	0.0496480159223951	0.564746181117244
12177	tetroquinone	hsa05012	Parkinson's disease	2861_4700_7054_51465_27429_7419_9627	7	-	0.0356180343241658	0.463034446214155
12178	tetroquinone	hsa04060	Cytokine-cytokine receptor interaction	3556_3597_3552_6358_6359_7852_657_655_7423_7042	10	-	9.56891530270314e-05	0.00290257097515329
12179	amiprilose	hsa04510	Focal adhesion	10298_5578_3690_3691_93408_63923_208_3675	8	+	0.0211773257028976	0.556540695004387
12180	amiprilose	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	2.05550971395935e-07	1.39774660549236e-05
12181	amiprilose	hsa04810	Regulation of actin cytoskeleton	10298_3690_3691_93408_7430_9459_2247_3675	8	+	0.0288231256267048	0.556540695004387
12182	amiprilose	hsa04270	Vascular smooth muscle contraction	4881_4882_5578_3710_5581	5	+	0.0467039018591899	0.556540695004387
12183	amiprilose	hsa04310	Wnt signaling pathway	8945_1855_1856_1857_8324_6093_64840_23236	8	-	0.0331553818354028	0.448149742086153
12184	amiprilose	hsa04740	Olfactory transduction	409	1	-	0.00167624308094183	0.059506629373435
12185	amiprilose	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_6738_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344	20	-	1.1952489160642e-09	8.48626730405582e-08
12186	amiprilose	hsa04330	Notch signaling pathway	8650_6868_1855_1856_1857	5	-	0.00695400936304904	0.164578221592161
12187	amiprilose	hsa05210	Colorectal cancer	5296_1855_1856_1857_1956_8324	6	-	0.0182301127161528	0.323584500711712
12188	amiprilose	hsa05217	Basal cell carcinoma	8324_1855_1856_1857	4	-	0.0479686314198982	0.448149742086153
12189	fosfosal	hsa05332	Graft-versus-host disease	355_3811_3802	3	+	0.0401653189364656	0.662727762451682
12190	fosfosal	hsa03410	Base excision repair	10039_5111_3980	3	+	0.0278240917073554	0.642425827157433
12191	fosfosal	hsa03450	Non-homologous end-joining	3981_10111	2	+	0.0292011739617015	0.642425827157433
12192	fosfosal	hsa04512	ECM-receptor interaction	3655_1277_3696_1302_3691	5	+	0.0173068844484398	0.642425827157433
12193	fosfosal	hsa03020	RNA polymerase	5432_246721_5439_548644	4	-	0.00376047739136298	0.188023869568149
12194	trichlormethiazide	hsa04740	Olfactory transduction	1179	1	+	0.000801931692988083	0.0236569849431485
12195	trichlormethiazide	hsa05322	Systemic lupus erythematosus	3013_942_8358_8968_8341_8350_8351_8352_8353_8354_8355_8356_8357	13	+	0.000194195254630509	0.0114575200232
12196	trichlormethiazide	hsa04060	Cytokine-cytokine receptor interaction	3624	1	+	0.0158221910627452	0.311169757567322
12197	trichlormethiazide	hsa03020	RNA polymerase	246721_5439_548644	3	+	0.0477904076886492	0.704908513407576
12198	trichlormethiazide	hsa04916	Melanogenesis	1857_109_3845_112_810_23236	6	-	0.0375225573284229	0.684786671243718
12199	trichlormethiazide	hsa04080	Neuroactive ligand-receptor interaction	1909	1	-	0.0322941315527081	0.684786671243718
12200	trichlormethiazide	hsa04740	Olfactory transduction	810_109	2	-	0.0131629935709006	0.480449265337872
12201	trichlormethiazide	hsa04540	Gap junction	7280_347733_5154_109_3845_112_23236	7	-	0.00723116432538104	0.480449265337872
12202	estropipate	hsa05332	Graft-versus-host disease	3553_3123_3126_3127_3111_3125	6	+	0.000892743529571699	0.0202799444191854
12203	estropipate	hsa04640	Hematopoietic cell lineage	2323_3553_3123_3126_3127_3125_931	7	+	0.00689807628177002	0.0712801215782902
12204	estropipate	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3111_3125	5	+	0.0118939106734258	0.0921778077190499
12205	estropipate	hsa04740	Olfactory transduction	26211_393046	2	+	0.00946716560949046	0.0838520382554869
12206	estropipate	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_3123_3126_3127_3125_8370_8359_554313_121504_8354_3111_720_721	22	+	4.85038821233855e-11	3.0072406916499e-09
12207	estropipate	hsa05310	Asthma	3123_3126_3127_3111_3125	5	+	0.00130838351091519	0.0202799444191854
12208	estropipate	hsa05330	Allograft rejection	3123_3126_3127_3111_3125	5	+	0.00332677624724893	0.0412520254658867
12209	estropipate	hsa04940	Type I diabetes mellitus	3553_3123_3126_3127_3111_3125	6	+	0.00111132812624678	0.0202799444191854
12210	estropipate	hsa05320	Autoimmune thyroid disease	3111_3107_3448_3133	4	-	0.0281417464015295	0.548853790229122
12211	estropipate	hsa05212	Pancreatic cancer	5925_2263_8503_5154_842	5	-	0.0420674025199269	0.548853790229122
12212	estropipate	hsa05215	Prostate cancer	5925_2263_8503_5154_842	5	-	0.0404692602179418	0.548853790229122
12213	estropipate	hsa05218	Melanoma	2257_5925_8503_2247_5154	5	-	0.0188870192175214	0.548853790229122
12214	estropipate	hsa04010	MAPK signaling pathway	3554_5599_5154_9479_5536_10454_2257_2263_3164_2247_9693_11221	12	-	0.0159851841403731	0.548853790229122
12215	estropipate	hsa05330	Allograft rejection	3107_3133_3111	3	-	0.0498910425011844	0.548853790229122
12216	zardaverine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_6738_121504_3109	16	+	9.41572760234936e-05	0.0073442675298325
12217	zardaverine	hsa04010	MAPK signaling pathway	9448_51347_3306_10912_5600_91_3725_3164_3305	9	-	0.038115304816878	1
12218	delsoline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	0.000682345443063686	0.0491288719005854
12219	delsoline	hsa04080	Neuroactive ligand-receptor interaction	7434_2561_56288_7067_3360	5	-	0.0145680514740896	0.412761458432539
12220	delsoline	hsa04520	Adherens junction	51701_4088_117178_6932_56288_91_6714_10458_2534	9	-	0.0471813670636391	0.628520322973404
12221	delsoline	hsa04740	Olfactory transduction	157_816	2	-	4.41097577922775e-07	3.74932941234359e-05
12222	delsoline	hsa04710	Circadian rhythm - mammal	9572_1407_8863	3	-	0.0455100124410367	0.628520322973404
12223	delsoline	hsa04010	MAPK signaling pathway	9261_9479_5534_7786_5607_5606_10454_5608_11221_836_1850_1852_8491_2247_57551_6789_7042_91_9020_51701_5578_5598_4296_4763_1616_8911_2005_9693	28	-	0.00205558642764562	0.0873624231749389
12224	oxolamine	hsa04670	Leukocyte transendothelial migration	1432_7070_7852_7430_5335_26285	6	+	0.0230139648515754	0.506307226734659
12225	oxolamine	hsa04340	Hedgehog signaling pathway	5566_652_653_650	4	+	0.0206323685006161	0.506307226734659
12226	oxolamine	hsa05219	Bladder cancer	5925_1029_7423	3	+	0.0419037263098875	0.691411484113144
12227	oxolamine	hsa04350	TGF-beta signaling pathway	3624_3400_652_653_650_91	6	+	0.00526923633931965	0.347769598395097
12228	indoprofen	hsa05332	Graft-versus-host disease	3109_3123_3126_3127_3111_3125	6	+	0.00146145409955956	0.0208257209187237
12229	indoprofen	hsa04640	Hematopoietic cell lineage	3123_2993_3126_3570_3127_3125	6	+	0.0345428268996046	0.268983786256777
12230	indoprofen	hsa05200	Pathways in cancer	324	1	+	0.00247542159023616	0.0282198061286922
12231	indoprofen	hsa05320	Autoimmune thyroid disease	3109_3123_3126_3127_3111_3125	6	+	0.00422791405275394	0.0401651835011624
12232	indoprofen	hsa04612	Antigen processing and presentation	3109_3123_3126_3127_3111_3125	6	+	0.0377521103518283	0.268983786256777
12233	indoprofen	hsa05310	Asthma	3109_3123_3126_3127_3111_3125	6	+	0.00030130479066012	0.0094245880432907
12234	indoprofen	hsa05330	Allograft rejection	3109_3123_3126_3127_3111_3125	6	+	0.000917107735748299	0.0174250469792177
12235	indoprofen	hsa04940	Type I diabetes mellitus	3109_3123_3126_3127_3111_2571_3125	7	+	0.000330687299764586	0.0094245880432907
12236	indoprofen	hsa04070	Phosphatidylinositol signaling system	8394_8527_5335	3	-	0.0477459315686797	0.571219100805093
12237	indoprofen	hsa05131	Shigellosis	7100_7278_7454_113457	4	-	0.00332025746464471	0.0879868228130848
12238	indoprofen	hsa05130	Pathogenic Escherichia coli infection	7100_7278_7454_113457	4	-	0.00332025746464471	0.0879868228130848
12239	yohimbine	hsa04740	Olfactory transduction	26211	1	+	0.0221646098749858	0.620609076499602
12240	yohimbine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_718_8368_8366_8359_8294_8367_554313_121504	15	+	3.45939179244977e-08	1.93725940377187e-06
12241	yohimbine	hsa04020	Calcium signaling pathway	155_2925_8911_6915_3708_1956_107	7	+	0.0340767344527611	0.636099043118207
12242	yohimbine	hsa04920	Adipocytokine signaling pathway	1375_3551_5562_4793	4	-	0.0308105523202589	0.741295380148818
12243	yohimbine	hsa04062	Chemokine signaling pathway	7454_3551_6655_115_56288_1399_408_4793	8	-	0.0195346628481997	0.741295380148818
12244	yohimbine	hsa05220	Chronic myeloid leukemia	6655_3551_1399_4193	4	-	0.043058425978199	0.741295380148818
12245	BW-B70C	hsa04115	p53 signaling pathway	1647_5366_8795_842	4	+	0.00863813824129745	0.185719972187895
12246	BW-B70C	hsa04010	MAPK signaling pathway	2872_1647_1843_1649_1846_2353_3725_3164_4791	9	+	0.00402083281907681	0.172895811220303
12247	BW-B70C	hsa05210	Colorectal cancer	4088_3725_842_2353	4	+	0.016320017377858	0.233920249082631
12248	cytochalasin B	hsa04510	Focal adhesion	7791_10451_7414	3	+	0.0440279210318738	0.325991634877775
12249	cytochalasin B	hsa04012	ErbB signaling pathway	868_374	2	+	0.0444647428109884	0.325991634877775
12250	phentolamine	hsa04650	Natural killer cell mediated cytotoxicity	4772_5881_8793_8794	4	+	0.0463135046987668	0.751703293370115
12251	phentolamine	hsa05010	Alzheimer's disease	810_56901_4713	3	+	0.00176939332708472	0.0751992164011006
12252	phentolamine	hsa04740	Olfactory transduction	1179_5137_81797_810_81696_816	6	+	7.94039057076916e-07	6.74933198515379e-05
12253	phentolamine	hsa04740	Olfactory transduction	818	1	-	1.74630222583385e-05	0.000699912711512737
12254	phentolamine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_8294_720_721_6738_121504_3119_8367	18	-	1.89165597706145e-05	0.000699912711512737
12255	phentolamine	hsa04270	Vascular smooth muscle contraction	5578_5581_3778_673_27094_8681_4637_100137049_23236	9	-	0.0478345466710453	0.983748734864978
12256	minocycline	hsa04740	Olfactory transduction	5568_10798_393046	3	+	0.0204931453279219	0.707013513813305
12257	minocycline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504	14	+	5.74216297738397e-05	0.00396209245439494
12258	minocycline	hsa04740	Olfactory transduction	219464_5613	2	-	0.0256109666738276	0.792637957456606
12259	minocycline	hsa04810	Regulation of actin cytoskeleton	1793_1730_5155_6548_8394_88_7430_4636_3985_3675	10	-	0.0259881297526756	0.792637957456606
12260	tyrphostin AG-1478	hsa04130	SNARE interactions in vesicular transport	6811_9570_10282_2054	4	+	0.0399347253733744	0.439281979107118
12261	tyrphostin AG-1478	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8349_8329_8294_121504_8345_723790_8969_8968_55766_8370_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013	38	+	2.0846396642059e-21	1.14655181531325e-19
12262	tyrphostin AG-1478	hsa04115	p53 signaling pathway	1647_5366_472_836_8795_4616	6	+	0.0281782008631839	0.387450261868779
12263	tyrphostin AG-1478	hsa04810	Regulation of actin cytoskeleton	10627	1	+	0.0159626519648839	0.33784609632811
12264	tyrphostin AG-1478	hsa04060	Cytokine-cytokine receptor interaction	7422_8795	2	+	0.0184279688906242	0.33784609632811
12265	MG-132	hsa04115	p53 signaling pathway	1647_1026_5366_6477_4193_8493_355_8795	8	+	0.000422919017471708	0.0232605459609439
12266	MG-132	hsa05332	Graft-versus-host disease	3123_3126_3127_3125	4	-	0.045979608872321	0.491696606095258
12267	MG-132	hsa04080	Neuroactive ligand-receptor interaction	5029_4886	2	-	0.0372032229986422	0.491696606095258
12268	MG-132	hsa04740	Olfactory transduction	801_808_805	3	-	0.00536003045437588	0.214401218175035
12269	MG-132	hsa04514	Cell adhesion molecules (CAMs)	3385_3123_3126_3127_3125_6385_1365_5792_6382	9	-	0.0390512855388439	0.491696606095258
12270	MG-132	hsa05322	Systemic lupus erythematosus	3014_3017_3020_85236_3123_3126_3127_3021_3125_8344_8349_8337_8334_8343_723790_8339_8347_8346_8345_8357	20	-	6.99400181423464e-08	5.59520145138771e-06
12271	MG-132	hsa05310	Asthma	3123_3126_3127_3125	4	-	0.0171627013954873	0.457672037212995
12272	MG-132	hsa05330	Allograft rejection	3123_3126_3127_3125	4	-	0.0345235561092373	0.491696606095258
12273	cimetidine	hsa05131	Shigellosis	7278_6093_7430_113457	4	+	0.0404875570966734	0.627557134998438
12274	cimetidine	hsa05130	Pathogenic Escherichia coli infection	7278_6093_7430_113457	4	+	0.0404875570966734	0.627557134998438
12275	cimetidine	hsa04740	Olfactory transduction	816	1	+	0.00360324432158554	0.223401147938303
12276	cimetidine	hsa04630	Jak-STAT signaling pathway	3448_3953_6772_23529_10379_1489_30837_4352	8	+	0.0251450235099405	0.627557134998438
12277	cimetidine	hsa04070	Phosphatidylinositol signaling system	5296_8867_5333_8394_5290	5	-	0.0185747254645282	0.454685803107424
12278	cimetidine	hsa05322	Systemic lupus erythematosus	85235_8330_8332_8969_8331_8329_720_721_8336	9	-	0.00248470911729793	0.173929638210855
12279	cimetidine	hsa04370	VEGF signaling pathway	5829_5296_9261_4772_5290	5	-	0.0194865344188896	0.454685803107424
12280	sulfathiazole	hsa04540	Gap junction	5159_7278_113457_3708_10382_6655	6	+	0.0202399771734251	0.859307886445378
12281	sulfathiazole	hsa04080	Neuroactive ligand-receptor interaction	706_136	2	-	0.00327471294199763	0.132625874150904
12282	sulfathiazole	hsa04740	Olfactory transduction	810_26211	2	-	2.91551208989889e-05	0.0023615647928181
12283	sulfathiazole	hsa05212	Pancreatic cancer	5595_842_3551_5296_5605_1385_1869_2263_1017	9	-	0.0164419506158038	0.221966333313351
12284	sulfathiazole	hsa05215	Prostate cancer	5595_842_3551_5296_5605_1385_1869_2263_1017	9	-	0.0154583335099492	0.221966333313351
12285	sulfathiazole	hsa05223	Non-small cell lung cancer	5595_842_5296_5605_1869_11186	6	-	0.0321830549625109	0.372403921709055
12286	sulfathiazole	hsa04060	Cytokine-cytokine receptor interaction	3597_9180_8741	3	-	0.0102908171673841	0.221966333313351
12287	sulfathiazole	hsa03020	RNA polymerase	246721_5439_548644_5434	4	-	0.0414341722006489	0.41952099353157
12288	sulfathiazole	hsa05222	Small cell lung cancer	4149_842_3551_5296_6502_3909_9618_1869_1017	9	-	0.0136219005857821	0.221966333313351
12289	STOCK1N-35215	hsa04740	Olfactory transduction	26532	1	+	0.00740105119142981	0.451464122677218
12290	STOCK1N-35215	hsa04070	Phosphatidylinositol signaling system	23533_3628_3710_51806_5296_56623_3709_3633_5290_3631_8394_3708_5332_23396_51763_5291_8760	17	-	0.0442159476647649	0.335304269791134
12291	STOCK1N-35215	hsa04640	Hematopoietic cell lineage	1436_2812_2057_7037	4	-	0.0425827885602784	0.335304269791134
12292	STOCK1N-35215	hsa05010	Alzheimer's disease	51806_1339_3710_4698_317_3709_3708_5332_22926_489_5534_6622	12	-	0.0350418106069963	0.335304269791134
12293	STOCK1N-35215	hsa04080	Neuroactive ligand-receptor interaction	4889_7067_4158_799_5026_2798_56288_4886_5644_728_2690	11	-	6.72168062929393e-05	0.0027065422244273
12294	STOCK1N-35215	hsa05016	Huntington's disease	1339_581_7052_4698_5440_317_3708_5332_6648	9	-	0.00183718450550251	0.0417959475001821
12295	STOCK1N-35215	hsa04740	Olfactory transduction	51806_26476_109_26212_157	5	-	1.91768571782092e-14	1.74509400321704e-12
12296	STOCK1N-35215	hsa04010	MAPK signaling pathway	3925_5154_8681_5600_5603_10125_1616_5921_1399_2263_2261_100137049_4217_4216_8398_998_5534_1432_2317_1844_6237_7186	22	-	0.047987383449613	0.335911684147291
12297	STOCK1N-35215	hsa05012	Parkinson's disease	1339_5413_4698_317_7054_51465_6622	7	-	0.0151227605420761	0.229361868221488
12298	STOCK1N-35215	hsa03430	Mismatch repair	27030_5983_5981_4437_5424_2956_29935	7	-	0.0426165373194344	0.335304269791134
12299	STOCK1N-35215	hsa04260	Cardiac muscle contraction	7168_1339	2	-	0.00506056452932156	0.0921022744336524
12300	STOCK1N-35215	hsa04060	Cytokine-cytokine receptor interaction	1436_3556_2057_2324_23765_3455_5154_8200_6387_9180_8794_2690	12	-	8.92266667393616e-05	0.0027065422244273
12301	STOCK1N-35215	hsa03010	Ribosome	6125_6168_284393_6165_389342	5	-	0.0297855231095278	0.335304269791134
12302	STOCK1N-35215	hsa04020	Calcium signaling pathway	51806_3710_2767_3709_5026_115_3708_109_489_5534_5332_107_493	13	-	0.039476414555783	0.335304269791134
12303	PF-00539758-00	hsa04740	Olfactory transduction	7932_1179_4995	3	+	4.85673069249583e-07	4.22535570247137e-05
12304	PF-00539758-00	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_718_8368_8366_9103_3111_958_8359_8294_8367_554313_121504_8341_8342	20	+	0.00101310251670779	0.0440699594767889
12305	PF-00539758-00	hsa04512	ECM-receptor interaction	51206_1281_961_1311_2812_3371_7060_1292_1290_1277	10	+	0.0435110200738522	0.810458859063528
12306	PF-00539758-00	hsa05016	Huntington's disease	64446_246721_317_7416	4	-	0.000708890889666634	0.0207941327635546
12307	PF-00539758-00	hsa04740	Olfactory transduction	51806_56656_5566_818_26476_109_4991_815_816	9	-	1.1654768923141e-06	0.000102561966523641
12308	PF-00539758-00	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_8330_554313_8350_8351_8352_8353_8354_8355_8356_8357_2215_2214_3013_3113_940_8970	31	-	3.10982050627614e-05	0.0013683210227615
12309	PF-00539758-00	hsa05012	Parkinson's disease	7416_6622_317_7318_6531	5	-	0.042943677245779	0.539863371089793
12310	PF-00539758-00	hsa03010	Ribosome	6141_9045	2	-	0.0169326549492458	0.298014727106726
12311	PF-00539758-00	hsa04020	Calcium signaling pathway	623_51806_5733_624_3709_7220_1909_5256_5566_51196_3360_818_7416_815_4842_4843_146_1131_148_6915_109_489_3269_5532_8913_1956_816_2066	28	-	0.0102567042815938	0.225647494195064
12312	PF-00539758-00	hsa04270	Vascular smooth muscle contraction	146_51806_8398_3709_109_5581_3779_3778_5588_8681_148_23365_1909_6093_800_100137049_5566_10203	18	-	0.0377177805627415	0.539863371089793
12313	sulfafurazole	hsa05131	Shigellosis	347688_7278_113457_7430_9181_56604	6	+	0.0188298657961974	0.420764183010713
12314	sulfafurazole	hsa05130	Pathogenic Escherichia coli infection	347688_7278_113457_7430_9181_56604	6	+	0.0188298657961974	0.420764183010713
12315	sulfafurazole	hsa04740	Olfactory transduction	390892	1	+	3.99693686251026e-05	0.0030376720155078
12316	sulfafurazole	hsa04540	Gap junction	347688_2911_5579_7278_113457_5330_3357_56604	8	+	0.0221454833163533	0.420764183010713
12317	sulfafurazole	hsa04080	Neuroactive ligand-receptor interaction	2555_1813_2908_2925_7434_7433	6	-	0.0245607541855185	0.48507489516399
12318	sulfafurazole	hsa04740	Olfactory transduction	26212_393046	2	-	2.01729224397269e-07	1.59366087273843e-05
12319	sulfafurazole	hsa04630	Jak-STAT signaling pathway	6655_5781	2	-	0.0180330465918021	0.474870226917455
12320	sulfafurazole	hsa04060	Cytokine-cytokine receptor interaction	7046_4254_8795	3	-	0.000698260104893029	0.0275812741432746
12321	sulfafurazole	hsa04940	Type I diabetes mellitus	3382_3123_3106_3126_3127_3125	6	-	0.0479182933651458	0.698961278147094
12322	phenylpropanolamine	hsa05332	Graft-versus-host disease	3824_3118_3117_3123_3106_3126_3127_3125	8	+	1.13834757727267e-05	0.000426880341477251
12323	phenylpropanolamine	hsa04650	Natural killer cell mediated cytotoxicity	3689_3824_4276_7305_3683_3106_5293_5880_9436	9	+	0.00499975714899646	0.0374981786174734
12324	phenylpropanolamine	hsa04640	Hematopoietic cell lineage	3123_3126_3127_3125_2209_920	6	+	0.0162319685738749	0.110672513003692
12325	phenylpropanolamine	hsa05320	Autoimmune thyroid disease	3118_3117_3123_3106_3126_3127_3125	7	+	0.000317573086529555	0.00361005659025566
12326	phenylpropanolamine	hsa04612	Antigen processing and presentation	3824_3118_3117_3123_3106_3126_3127_3125_920	9	+	0.00028729873678112	0.00361005659025566
12327	phenylpropanolamine	hsa04670	Leukocyte transendothelial migration	3689_3683_5293_4688_4689_7852_4478_5880_7430	9	+	0.00231842703184189	0.0217352534235177
12328	phenylpropanolamine	hsa04740	Olfactory transduction	1179	1	+	0.00371544187378938	0.0309620156149115
12329	phenylpropanolamine	hsa04514	Cell adhesion molecules (CAMs)	965_3689_3118_3683_3123_3106_3126_3127_3125_3117_920	11	+	0.000336938615090528	0.00361005659025566
12330	phenylpropanolamine	hsa05322	Systemic lupus erythematosus	1991_3118_3117_3123_3126_3127_3125_2209	8	+	0.0185981738223262	0.116238586389539
12331	phenylpropanolamine	hsa05310	Asthma	3118_3117_3123_3126_3127_3125_5553_6037	8	+	1.3002479901124e-06	9.751859925843e-05
12332	phenylpropanolamine	hsa04810	Regulation of actin cytoskeleton	3689_9459_3683_8394_5293_4478_5880_7430_2261_2335	10	+	0.0351628408128696	0.202862543151171
12333	phenylpropanolamine	hsa05330	Allograft rejection	3118_3117_3123_3106_3126_3127_3125	7	+	4.92900054124005e-05	0.00123225013531001
12334	phenylpropanolamine	hsa04940	Type I diabetes mellitus	3118_3117_3123_3106_3126_3127_3125	7	+	0.000112487508263604	0.00210914077994257
12335	phenylpropanolamine	hsa04912	GnRH signaling pathway	5599_6655_2002_8681_113_6714_100137049	7	-	0.00996363849895975	0.607781948436545
12336	C-75	hsa04130	SNARE interactions in vesicular transport	9570	1	+	0.0357186640920444	0.260084313602767
12337	C-75	hsa04640	Hematopoietic cell lineage	3590_2814_3570_7850_3673_2323_2322_3690_3123_3126_3127_3125_4311_914_3581_2811_2812_3589_960_948_1380_3568_2993_1438_7066_2209_924	27	+	0.00604893365274415	0.0777720041067105
12338	C-75	hsa05010	Alzheimer's disease	2903_4311_776_2081_836_5534_6622_54205_4137_5330_3709_5664_348_517	14	+	0.00596817983665309	0.0777720041067105
12339	C-75	hsa05016	Huntington's disease	1213_4899_1211_627_54205_246721_5330_9586_9001_55567_836_1387_161_517	14	+	0.00206829193234379	0.0465365684777353
12340	C-75	hsa04740	Olfactory transduction	5568_1179_26716_390892_5137_26529_9635_817	8	+	7.5025201022363e-17	6.75226809201267e-15
12341	C-75	hsa05322	Systemic lupus erythematosus	2903_474382_8363_474381_8365_8364_8367_8360_8368_8335_9103_8362_8294_121504_8341_958_8370_3123_8366_3126_3127_3125_8968_3586_718_716_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_83740_3013_3112_8361_2209_8970	43	+	0.000888229981622988	0.0266468994486896
12342	C-75	hsa04360	Axon guidance	2044_9723_6585_4917_223117_219699_2048_5534_10505_57556	10	+	0.0142919925693321	0.160784916404986
12343	C-75	hsa04110	Cell cycle	10744_9134_4089_1029_4193_1028_996_7042_1032_1387	10	+	0.0404575598937638	0.260084313602767
12344	C-75	hsa04530	Tight junction	9074_5581_23136_5578_5588_22808_3059_7525_4629_9223_5516	11	+	0.0169558211453205	0.169558211453205
12345	C-75	hsa04512	ECM-receptor interaction	22798_3908_7148_3673_3690_3696_1293_51206_1278_2814_2811_2812_3918_1281_3339_2335_1284_960_961_948_1282_1288_3371	23	+	0.034492837003128	0.260084313602767
12346	C-75	hsa04810	Regulation of actin cytoskeleton	56034_5293_5156_3673_4342_7454_3690_3696_2248_324_2260_2247_8395_1956_1950_22808_2335_6655_3687_8817_2251_2254_8976	23	+	0.0395136244708716	0.260084313602767
12347	C-75	hsa05012	Parkinson's disease	836_7318_5413_54205_7345_6622_517	7	+	0.000616348411815637	0.0266468994486896
12348	C-75	hsa04260	Cardiac muscle contraction	776_6262_782_783_9254_4635	6	+	0.0459699790842105	0.275819874505263
12349	C-75	hsa03010	Ribosome	140801_6234_6165_6192_6123	5	+	0.00296680467201509	0.0534024840962716
12350	C-75	hsa03050	Proteasome	5689_5710	2	+	0.0395714123872407	0.260084313602767
12351	C-75	hsa05010	Alzheimer's disease	775_55851_1339_842_841_2902_572_317_51806_5532_3708_3709_6868_4023_489_5534_348_4842	18	-	0.00158816770435212	0.0271700646700239
12352	C-75	hsa04080	Neuroactive ligand-receptor interaction	9340_2902_2901_9248_2908_5030_5031_3062_135_134_5646_2741_1813_2561_5029_3973_2742_4986_2859_2911_3953_185_6915_3356_146_3350_3269_5618_7442_2898_4158_2570_2798_2359_1909_728	36	-	0.0229402755680918	0.213344562783254
12353	C-75	hsa04742	Taste transduction	2778_6337_50836	3	-	0.0129084314832046	0.150060515992253
12354	C-75	hsa05016	Huntington's disease	1212_2902_4899_1211_51164_842_841_581_1339_317_246721_1213_64446_3708_1385_161_163	17	-	0.000258707568573987	0.0080199346257936
12355	C-75	hsa04740	Olfactory transduction	51806_26212_157_8388_8387_1179_26476_4991_5132_816	10	-	5.70809010473944e-21	5.30852379740768e-19
12356	C-75	hsa04110	Cell cycle	995_51343_1028_4088_6502_699_4193_8317_51433_996_8556_8555_1032_8697	14	-	0.0376340272561553	0.318178594074768
12357	C-75	hsa05110	Vibrio cholerae infection	2778_50617_534_4583	4	-	0.0184277108272693	0.190419678548449
12358	C-75	hsa05012	Parkinson's disease	1339_7318_5413_7332_317_65018_842	7	-	1.09839150722158e-05	0.000510752050858035
12359	C-75	hsa04260	Cardiac muscle contraction	775_7168_1339_477_781	5	-	0.00175290739806606	0.0271700646700239
12360	C-75	hsa04060	Cytokine-cytokine receptor interaction	7852_9180_1896_59067_3579_2057_970_8794_3577_4982_10913_3976_8718_6362_3953_2919_8771_4254_8200_1956_1950_91_4233_5618_1435_3566_3448_9966_7424_6374_51561	31	-	0.00132321113895504	0.0271700646700239
12361	C-75	hsa03010	Ribosome	440589_6202_439992_6187_6168_6224_6160_6129_6189	9	-	0.00776953673434587	0.103223845184881
12362	5707885	hsa05332	Graft-versus-host disease	3812_57292_3811_3119_3821_3117_3804_3107_3126_3127_3803_3802_3135_3123_3125	15	+	0.00265000994025544	0.061612731110939
12363	5707885	hsa04612	Antigen processing and presentation	57292_3809_3822_3821_3804_3806_3803_3802_6892_3808_3123_3107_3126_3127_3125_3812_3810_3811_3135_3310_3119_3117_115653_1385_925	25	+	0.00177383340549469	0.0549888355703354
12364	5707885	hsa04310	Wnt signaling pathway	324_5579_5578_5599_5566_6477_83439_5526_23236_7157	10	+	0.026015343011033	0.302441211717673
12365	5707885	hsa04740	Olfactory transduction	8390_5566_135948_442194_26476_8392_810_9635	8	+	6.89082623146202e-13	6.40846839525968e-11
12366	5707885	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_2904_8369_8368_8335_9103_6738_8348_8329_8294_121504_8343_8342_8347_8346_8344_8353_3123_8366_3126_3127_3125_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8339_8354_8355_8356_8357_8332_85235_3119_3012_3013_3017_3117_720_721	54	+	1.70238154344738e-09	7.91607417703032e-08
12367	5707885	hsa05012	Parkinson's disease	6391_6392_642502_6390_54205_651820_6531_6622_517	9	+	0.0369243118059607	0.381551221994927
12368	5707885	hsa04260	Cardiac muscle contraction	776_10368_4635	3	+	0.0112770142620709	0.174793721062099
12369	5707885	hsa03010	Ribosome	284393_6129_389342_6123	4	+	0.00885389728873206	0.164682489570416
12370	5707885	hsa03050	Proteasome	5689	1	+	0.0260164483197998	0.302441211717673
12371	5707885	hsa05010	Alzheimer's disease	51806_4713_808_3709_22926_801_4137_805	8	-	0.00256204303035201	0.0514991100377641
12372	5707885	hsa05016	Huntington's disease	246721_1387_4713_6667_581	5	-	4.65801319326185e-05	0.00142845737926697
12373	5707885	hsa04740	Olfactory transduction	51806_5592_26211_5566_135948_2978_808_805_801_816	10	-	7.42555869530796e-10	6.83151399968332e-08
12374	5707885	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8329_8294_81_959_3123_3126_3127_3125_8969_8370_8332_8359_8330_8331_8336_554313_121504_8354_85235_3119_3113_3112	32	-	0.00279886467596544	0.0514991100377641
12375	5707885	hsa05012	Parkinson's disease	4713_5413	2	-	4.06637421988072e-05	0.00142845737926697
12376	5707885	hsa03010	Ribosome	6165_6129_6192	3	-	0.0060934637964022	0.0934331115448337
12377	F0447-0125	hsa05010	Alzheimer's disease	3709_348_351_5664	4	+	0.0352782923498827	0.476256946723416
12378	F0447-0125	hsa04740	Olfactory transduction	8392_2978_23538_1179	4	+	2.06180265195029e-06	8.35030074039867e-05
12379	F0447-0125	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_715_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_941_720_721	29	+	1.43256961467965e-07	1.16038138789052e-05
12380	F0447-0125	hsa04530	Tight junction	3996	1	+	0.00487425533191091	0.131604893961595
12381	F0447-0125	hsa05012	Parkinson's disease	7419_7345	2	+	0.0249201025451067	0.476256946723416
12382	F0447-0125	hsa03010	Ribosome	6192	1	+	0.0307870357467574	0.476256946723416
12383	F0447-0125	hsa04916	Melanogenesis	5331_5579_51806_7475_6932_3845_1385_7473_107_816_7477	11	-	0.0434857542949817	0.333390782928193
12384	F0447-0125	hsa05010	Alzheimer's disease	51806_3710_5331_4023_6622_3553_651820_348_4842_1339_54205_5532_3708_3709_5534_102_4695_23621_4714_6392_6390_824	22	-	0.0277299904353559	0.30268192297015
12385	F0447-0125	hsa05131	Shigellosis	9076_6093_998_8976	4	-	0.036190229920344	0.30268192297015
12386	F0447-0125	hsa05016	Huntington's disease	5432_1213_246721_1339_4714_64446_7052_6390_54205_651820_581_5331_6392_3708_7019_1385_4695	17	-	0.000623401413661037	0.0131861920099623
12387	F0447-0125	hsa05130	Pathogenic Escherichia coli infection	9076_6093_998_8976	4	-	0.036190229920344	0.30268192297015
12388	F0447-0125	hsa04740	Olfactory transduction	51806_26212_7932_157_8388_8387_1179_26476_4991_26539_5132_816	12	-	2.0089862104969e-18	1.84826731365715e-16
12389	F0447-0125	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_6738_88_8362_8329_8294_121504_3108_3123_8366_3126_3127_3125_8969_8968_55766_8370_718_717_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_2215_2214_3013_83740	48	-	0.00329366087671814	0.0505028001096781
12390	F0447-0125	hsa04110	Cell cycle	5001_51343_9134_6502_699_472_996_8556_8243_651610_7465_5934	12	-	0.0180849107723267	0.237687398722008
12391	F0447-0125	hsa04810	Regulation of actin cytoskeleton	8503_10297_5295_5155_5293_88_3679_4638_3676_3674_1730_1399_369_2263_2247_8396_10152_79784_324_8394_1131_998_10787_6093_10451_54961_3845_8976_2149	29	-	0.0314066181857233	0.30268192297015
12392	F0447-0125	hsa05012	Parkinson's disease	4714_2861_1339_5413_6392_6390_54205_651820_4695_6622	10	-	0.000716640870106645	0.0131861920099623
12393	F0447-0125	hsa04260	Cardiac muscle contraction	1339_782_4635	3	-	0.00022870711695575	0.0105205273799645
12394	F0447-0125	hsa03010	Ribosome	439992_6125_6168_6224_6160_6189	6	-	0.000687735528788266	0.0131861920099623
12395	atropine methonitrate	hsa05322	Systemic lupus erythematosus	3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	11	+	4.25593619115188e-05	0.0020428493717529
12396	atropine methonitrate	hsa04080	Neuroactive ligand-receptor interaction	5618	1	-	0.0225351086956117	0.503284094201995
12397	atropine methonitrate	hsa04740	Olfactory transduction	157	1	-	0.00115256682377699	0.0772219771930583
12398	atropine methonitrate	hsa05322	Systemic lupus erythematosus	3013_3113_3014_8343_8351_8339_8347_8346_8344	9	-	0.0122830303085309	0.411481515335785
12399	Prestwick-1080	hsa05214	Glioma	25759_6464_5293_1950	4	+	0.0265882526908552	0.432059106226397
12400	Prestwick-1080	hsa04670	Leukocyte transendothelial migration	5293_4689_1495_6093_399_23562	6	+	0.0188190218514031	0.427857273766633
12401	Prestwick-1080	hsa05221	Acute myeloid leukemia	861_5914_5371_5293	4	+	0.0197472587892292	0.427857273766633
12402	Prestwick-1080	hsa04664	Fc epsilon RI signaling pathway	5599_27040_5293_2207	4	+	0.0474917617611197	0.514494085745464
12403	Prestwick-1080	hsa04012	ErbB signaling pathway	5599_6464_5293_25759_1950_3084	6	+	0.00421530589678874	0.273994883291268
12404	Prestwick-1080	hsa05220	Chronic myeloid leukemia	861_25759_6464_5293	4	+	0.040803708973087	0.514494085745464
12405	Prestwick-1080	hsa04080	Neuroactive ligand-receptor interaction	5618_2561_706_2150_7433_5644_9170	7	-	3.2008632609934e-07	1.5044057326669e-05
12406	Prestwick-1080	hsa04740	Olfactory transduction	818_109	2	-	5.65841729360942e-18	5.31891225599285e-16
12407	Prestwick-1080	hsa05322	Systemic lupus erythematosus	8970_3119_3014	3	-	5.86924365306755e-05	0.00183902967796117
12408	Prestwick-1080	hsa03410	Base excision repair	3980_10357_5425_5424_10039_3146_23583_100130561_4350_27343	10	-	0.0346236385281579	0.406827752705855
12409	Prestwick-1080	hsa04370	VEGF signaling pathway	7867_9261_1432_8399_207_5829_208_56848_5291_5605_5296_5881_5335_7422_5603_3265_4772_8398	18	-	0.0323999211138804	0.406827752705855
12410	Prestwick-1080	hsa04260	Cardiac muscle contraction	7168_7384_4635_488	4	-	0.0418821805968389	0.437436108455873
12411	Prestwick-1080	hsa04060	Cytokine-cytokine receptor interaction	1436_5618_3597_2057_3594_3589_23765_2324_4055_4254_7852_1271_50616_7422_3976_8718_655_4233_51330_8794	20	-	0.0220127520809032	0.344866449267483
12412	Prestwick-1080	hsa03010	Ribosome	284393_389342_6137_6203	4	-	0.00859713016562241	0.161626047113701
12413	Prestwick-1080	hsa04020	Calcium signaling pathway	2778_56848_2767_818_109_5335_489_488_493_2064_291	11	-	0.00852450906367586	0.161626047113701
12414	tetryzoline	hsa05332	Graft-versus-host disease	3812_3126_3569_3113_3127_3111_3125_3123	8	+	0.00902985667018778	0.230913552279862
12415	tetryzoline	hsa05016	Huntington's disease	64446_6390_7802_4713_5330	5	+	0.0450027923424801	0.505367997229246
12416	tetryzoline	hsa04740	Olfactory transduction	26212_2774_81697_4991_26539_1258	6	+	1.80276686939296e-05	0.0014602411642083
12417	tetryzoline	hsa04514	Cell adhesion molecules (CAMs)	947_3123_3126_3127_3111_3125_23308_5817_57863_4359_6614_920_923_25945_3113_1013	16	+	0.0224790049636188	0.303466567008854
12418	tetryzoline	hsa04110	Cell cycle	51343_699	2	+	0.0499128886152342	0.505367997229246
12419	tetryzoline	hsa05310	Asthma	3123_3126_3127_3111_3125_6037_3113	7	+	0.00565043704297689	0.228842700240564
12420	tetryzoline	hsa05330	Allograft rejection	3593_3113_3126_3127_3111_3125_3123	7	+	0.0165011730623635	0.267319003610289
12421	tetryzoline	hsa04940	Type I diabetes mellitus	3593_3382_3113_3126_3127_3111_3125_3123	8	+	0.0114031383841907	0.230913552279862
12422	tetryzoline	hsa05332	Graft-versus-host disease	3105_3106_3107_3135_5551_649853	6	-	0.0135699006162576	0.255923349506529
12423	tetryzoline	hsa04070	Phosphatidylinositol signaling system	3628_5298_8394_3633_3631_8821_3707_3705	8	-	0.0224027198690107	0.291235358297139
12424	tetryzoline	hsa04080	Neuroactive ligand-receptor interaction	7434_1131_4157_2692	4	-	0.0268183158938578	0.298832662817273
12425	tetryzoline	hsa05320	Autoimmune thyroid disease	3105_3106_3107_3135_5551_649853	6	-	0.0342045825168608	0.333494679539393
12426	tetryzoline	hsa04740	Olfactory transduction	5613_5616_157	3	-	0.000123589255530098	0.00481998096567382
12427	tetryzoline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_85235_8364_8370_8366_8368_8365_8330_8332_8359_8969_8331_8329_8336_8367_554313_121504_8294	21	-	4.15839605407687e-06	0.000324354892217996
12428	tetryzoline	hsa05012	Parkinson's disease	6622	1	-	0.0471006352314301	0.408205505339061
12429	tetryzoline	hsa05330	Allograft rejection	3105_3106_3107_3135_5551_649853	6	-	0.00895921928009228	0.232939701282399
12430	tetryzoline	hsa04940	Type I diabetes mellitus	3105_3106_3107_3135_5551_649853	6	-	0.0164053429170852	0.255923349506529
12431	lactobionic acid	hsa05131	Shigellosis	7100_7430_9475	3	+	0.0205216591907766	0.448184737113565
12432	lactobionic acid	hsa05130	Pathogenic Escherichia coli infection	7100_7430_9475	3	+	0.0205216591907766	0.448184737113565
12433	lactobionic acid	hsa04920	Adipocytokine signaling pathway	6513_6257_5781	3	+	0.0319805574406582	0.448184737113565
12434	lactobionic acid	hsa05332	Graft-versus-host disease	3123_3126_3127_3119_3125	5	-	0.00569974861891035	0.085810576996089
12435	lactobionic acid	hsa04662	B cell receptor signaling pathway	8519_5533_5881_3725_27071_4793	6	-	0.0145305248107775	0.130774723296997
12436	lactobionic acid	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3119_3125	5	-	0.0137019707851203	0.130774723296997
12437	lactobionic acid	hsa04740	Olfactory transduction	818_157	2	-	0.00661456239414458	0.085810576996089
12438	lactobionic acid	hsa05310	Asthma	3123_3126_3127_3119_3125	5	-	0.00153145203836645	0.085810576996089
12439	lactobionic acid	hsa05330	Allograft rejection	3123_3126_3127_3119_3125	5	-	0.00387223413963482	0.085810576996089
12440	lactobionic acid	hsa04940	Type I diabetes mellitus	3123_3126_3127_3119_3125	5	-	0.00681036325365786	0.085810576996089
12441	flupentixol	hsa05214	Glioma	5159_810_6655_1956_4193	5	+	0.0246567332966368	0.426257814760632
12442	flupentixol	hsa04740	Olfactory transduction	810	1	+	0.0017046777088385	0.119327439618695
12443	flupentixol	hsa04010	MAPK signaling pathway	5159_4149_782_6655_50487_1649_2002_355_1956_2263_3725_5971_2261_27330	14	+	0.00915041411699844	0.213509662729964
12444	flupentixol	hsa04912	GnRH signaling pathway	1081_6655_50487_2002_3708_1956_810_3725	8	+	0.00614652829641162	0.213509662729964
12445	flupentixol	hsa04610	Complement and coagulation cascades	5328_5265_7035_2152_718	5	+	0.0304469867686166	0.426257814760632
12446	flupentixol	hsa04210	Apoptosis	472_651610_5295_5534	4	-	0.0487385199411381	0.777488850491888
12447	flupentixol	hsa04350	TGF-beta signaling pathway	57154_9372_652_9475	4	-	0.0456161061349696	0.777488850491888
12448	flupentixol	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0114673001034204	0.699505306308644
12449	cefixime	hsa05332	Graft-versus-host disease	3123_3126_3127_3111_3125	5	+	0.00356788561364799	0.0488017769885227
12450	cefixime	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3111_3125	5	+	0.00877408147576724	0.0833537740197888
12451	cefixime	hsa04740	Olfactory transduction	5137	1	+	0.00376473012532381	0.0488017769885227
12452	cefixime	hsa04514	Cell adhesion molecules (CAMs)	5175_3683_3123_3126_3127_3111_3125_1462	8	+	0.013109171235038	0.106746108628167
12453	cefixime	hsa05310	Asthma	2205_3123_3126_3127_3111_3125	6	+	0.000119035562983097	0.00678502709003653
12454	cefixime	hsa05330	Allograft rejection	3123_3126_3127_3111_3125	5	+	0.00240375836339354	0.0488017769885227
12455	cefixime	hsa04940	Type I diabetes mellitus	3123_3126_3127_3111_3125	5	+	0.00428085763057217	0.0488017769885227
12456	cefixime	hsa04080	Neuroactive ligand-receptor interaction	9568_56288_5644_4886_1909	5	-	0.000837075052158979	0.0368313022949951
12457	cefixime	hsa05016	Huntington's disease	5433_246721_7381_6648_7419	5	-	0.0253650743627453	0.558031635980397
12458	cefixime	hsa04740	Olfactory transduction	5566_816	2	-	2.64819650974113e-09	2.33041292857219e-07
12459	cefixime	hsa04360	Axon guidance	6092_2042_5530	3	-	0.0491154851017871	0.720360448159544
12460	cefixime	hsa05012	Parkinson's disease	7419_7381	2	-	0.00863683629989142	0.253347198130148
12461	cefixime	hsa04260	Cardiac muscle contraction	7381	1	-	0.0433886969743432	0.720360448159544
12462	ioversol	hsa04514	Cell adhesion molecules (CAMs)	933_4099_25945_26285	4	+	0.0133098339847937	0.654620802790381
12463	ioversol	hsa04020	Calcium signaling pathway	818_3269_2185_135	4	+	0.0363072628509668	0.654620802790381
12464	ioversol	hsa04310	Wnt signaling pathway	5519_4041_6932_8061_818_6934_324	7	-	0.0337223412936853	0.35970497379931
12465	ioversol	hsa04740	Olfactory transduction	818	1	-	0.00741193668938959	0.191907306363214
12466	ioversol	hsa05322	Systemic lupus erythematosus	85235_8330_8332_727_8969_8331_8329_8336	8	-	0.00899565498577565	0.191907306363214
12467	ioversol	hsa05216	Thyroid cancer	6932_6257_6934	3	-	0.0230459838886665	0.35970497379931
12468	ioversol	hsa04920	Adipocytokine signaling pathway	2180_6257_5781_51422	4	-	0.0475081480300993	0.434360210560908
12469	ioversol	hsa04350	TGF-beta signaling pathway	5519_655_9372_653_7042	5	-	0.0319886671463454	0.35970497379931
12470	ioversol	hsa05222	Small cell lung cancer	317_3918_7189_5747_6257_7187	6	-	0.00848872830902431	0.191907306363214
12471	promazine	hsa05010	Alzheimer's disease	3710_4713	2	+	0.0090061913151703	0.412009975020547
12472	promazine	hsa04740	Olfactory transduction	5593_7932_56656_26692_8388_8387_23538_8390_8392_3000_816	11	+	0.0343913545292739	0.67922925195316
12473	promazine	hsa05322	Systemic lupus erythematosus	941	1	+	0.0108517629378092	0.412009975020547
12474	promazine	hsa04530	Tight junction	5521_93643	2	+	0.0489854063360604	0.693494977008219
12475	promazine	hsa05012	Parkinson's disease	4713	1	+	0.0156459484185018	0.412009975020547
12476	promazine	hsa05211	Renal cell carcinoma	8503_2271_208_2549_405_5781_1399_7042_3725_7422	10	-	0.0412377762079421	0.595458831798147
12477	promazine	hsa04080	Neuroactive ligand-receptor interaction	3355_1269_3953_5618_5030_7434_2740_56288_7433	9	-	0.0415436394277777	0.595458831798147
12478	promazine	hsa05016	Huntington's disease	7052_7419_841_2776	4	-	0.0105517680971671	0.274932186152155
12479	promazine	hsa04740	Olfactory transduction	810_51806_26529_219464_816	5	-	8.98622621672884e-07	3.8640772731934e-05
12480	promazine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_3113_720_721	30	-	6.0896719356878e-07	3.8640772731934e-05
12481	promazine	hsa05012	Parkinson's disease	7419_5413	2	-	0.0127875435419607	0.274932186152155
12482	bisoprolol	hsa04740	Olfactory transduction	8392_816	2	+	2.03244455960976e-05	0.00166660453888
12483	bisoprolol	hsa04510	Focal adhesion	8516_10319_3910_3381_3690_3480_2909_3693_3791_3695_3685_7422_3691_3725_55742_1291_2534	17	+	0.0152351637404914	0.416427808906765
12484	bisoprolol	hsa04512	ECM-receptor interaction	8516_10319_2811_3910_3381_3690_3691_3693_3695_3685_960_1291	12	+	0.000558287764588007	0.0228897983481083
12485	bisoprolol	hsa05012	Parkinson's disease	4698	1	+	0.0469620409763645	0.962721840015472
12486	bisoprolol	hsa03450	Non-homologous end-joining	27343_7518	2	-	0.0390154191476985	1
12487	Prestwick-981	hsa04740	Olfactory transduction	815_816	2	+	0.0257924695029325	1
12488	Prestwick-981	hsa04012	ErbB signaling pathway	5605_6714_867_815_816	5	+	0.0389086869575918	1
12489	Prestwick-981	hsa05330	Allograft rejection	958_355_3107	3	+	0.0498910425011844	1
12490	Prestwick-981	hsa05214	Glioma	6655_5155_5154_5336	4	-	0.0276024456715908	0.82098529444002
12491	N-phenylanthranilic acid	hsa04740	Olfactory transduction	2979_26716	2	+	0.00488060564817282	0.38068724055748
12492	N-phenylanthranilic acid	hsa04060	Cytokine-cytokine receptor interaction	3452_6357_3566_970_3589_3568_3576_8741_6359_6370_6358_8718_7124	13	+	0.0336320696960501	1
12493	N-phenylanthranilic acid	hsa05332	Graft-versus-host disease	3811_3105_3106_3126_3127_3125_3135_3123_942_649853	10	-	1.04472477036483e-05	0.000417889908145932
12494	N-phenylanthranilic acid	hsa04640	Hematopoietic cell lineage	1435_2057_3123_3568_952_3126_3127_3125_926	9	-	0.00637573206759036	0.0623095765629097
12495	N-phenylanthranilic acid	hsa05320	Autoimmune thyroid disease	3105_3106_3126_3127_3125_3135_3123_942_649853	9	-	0.000282296210111088	0.00451673936177741
12496	N-phenylanthranilic acid	hsa04612	Antigen processing and presentation	3811_3123_3106_3806_3126_3127_3125_3135_3105_926_649853	11	-	0.000726107775508605	0.0082983745772412
12497	N-phenylanthranilic acid	hsa04740	Olfactory transduction	810_5568	2	-	0.000187229404022681	0.00374458808045362
12498	N-phenylanthranilic acid	hsa04514	Cell adhesion molecules (CAMs)	3383_942_3123_4099_3126_3127_3125_3135_1000_3105_923_3106_926_649853	14	-	0.000680281088354488	0.0082983745772412
12499	N-phenylanthranilic acid	hsa05310	Asthma	3123_3126_3127_8288_3125	5	-	0.00700982736332734	0.0623095765629097
12500	N-phenylanthranilic acid	hsa05330	Allograft rejection	3105_3106_3126_3127_3125_3135_3123_942_649853	9	-	3.01260339724228e-05	0.000803360905931275
12501	N-phenylanthranilic acid	hsa04940	Type I diabetes mellitus	3105_3106_3126_3127_3125_3135_1363_3123_942_5799_649853	11	-	2.50796967957461e-06	0.000200637574365969
12502	monorden	hsa05010	Alzheimer's disease	776_3553_840_4713_355_3708_3709_351_5664_4843	10	+	0.00938401765035599	0.249778539351285
12503	monorden	hsa04080	Neuroactive ligand-receptor interaction	5028_5618_3953_887_1812_3354_2846_3360_1131_2908_1133_799_7434_6915_5030_1909_3269_624_5724	19	+	0.0249907950431015	0.444836151767207
12504	monorden	hsa04660	T cell receptor signaling pathway	1326_998_5293_3725_2534_4793	6	+	0.0373353864064572	0.553808231695782
12505	monorden	hsa04910	Insulin signaling pathway	2872_6464_5293_7249_6009_10580_8651	7	+	0.0112260017685971	0.249778539351285
12506	monorden	hsa05016	Huntington's disease	1212_1213_4713_7052_64446_3708_7416_161_5481	9	+	0.00184227735148221	0.0819813421409583
12507	monorden	hsa04740	Olfactory transduction	219464_1179_816	3	+	1.84597863639751e-16	1.64292098639378e-14
12508	monorden	hsa03320	PPAR signaling pathway	11001_7316_8310_1374_1375_28965	6	-	0.0317592178518975	0.369200907528308
12509	monorden	hsa04080	Neuroactive ligand-receptor interaction	5029_4889_2901_2917_3953_2847_1132_7068_4886_552_3062_6915_117_2359_7067_135_7433_9568_1395_1902_2690	21	-	6.84344718430831e-06	0.000318220294070336
12510	monorden	hsa03420	Nucleotide excision repair	5887	1	-	0.00437489377075761	0.101716280170114
12511	monorden	hsa04740	Olfactory transduction	157_5613_5616_808_109_805_4991_801_9635_816	10	-	3.42831966757121e-20	3.18833729084123e-18
12512	monorden	hsa05012	Parkinson's disease	509_7327_836_1327_7314_6390_6391_6531_7416_65018_27429_7419_517_642502	14	-	0.0112926032181429	0.175035349881215
12513	monorden	hsa04260	Cardiac muscle contraction	784_27092_1327_482	4	-	0.00082033497828332	0.0254303843267829
12514	monorden	hsa04060	Cytokine-cytokine receptor interaction	3446_3597_55540_5155_8742_8741_6387_2323_958_3554_3553_3454_10850_3576_3953_4982_7040_3082_3605_23495_51561_7042_91_655_93_4233_8795_6356_944_970_3441_6358_6359_7423_2690	35	-	0.0182892021844946	0.242985114736857
12515	monorden	hsa03010	Ribosome	6187_440589_285053_9349_6125_6142_6234_6160_6233	9	-	0.0105436811590961	0.175035349881215
12516	monorden	hsa05210	Colorectal cancer	8503_10000_4088_572_5295_8322_836_7157_1855_1856_1857_5900_324_581_673_6932_7040_8312_4609_91_3725_2956_4233_6655_6654_7042_2535	27	-	0.0412198128092418	0.425938065695499
12517	acetylsalicylic acid	hsa05332	Graft-versus-host disease	3812_3105_3106_3126_3127_3125_3135_3123_3113_649853	10	+	0.00353783487368733	0.0615583268021595
12518	acetylsalicylic acid	hsa05010	Alzheimer's disease	4714_6390_776_1339_4023	5	+	0.0136055554156503	0.146114282428923
12519	acetylsalicylic acid	hsa05320	Autoimmune thyroid disease	3439_3586_3105_3106_3126_3127_3125_3135_3447_3123_3113_649853	12	+	0.0020945020916368	0.0455554204931004
12520	acetylsalicylic acid	hsa05016	Huntington's disease	4714_1639_6390_1339_55567	5	+	0.00742685264928009	0.107689363414561
12521	acetylsalicylic acid	hsa04740	Olfactory transduction	818_7932_9635_442194_81797	5	+	7.00373317622382e-08	6.09324786331472e-06
12522	acetylsalicylic acid	hsa05322	Systemic lupus erythematosus	8329_8341_3123_3126_3127_3125_8969_8968_3586_717_8358_8330_8331_8336_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3113	26	+	0.000240579567821257	0.0104652112002247
12523	acetylsalicylic acid	hsa05310	Asthma	3586_3123_3126_3127_3125_3113_8288	7	+	0.0151152705960955	0.146114282428923
12524	acetylsalicylic acid	hsa04062	Chemokine signaling pathway	1234_5879_3551_3576_6358_6359_6360	7	+	0.0378840552252172	0.299628436781263
12525	acetylsalicylic acid	hsa05012	Parkinson's disease	4714_6390_1339_5413	4	+	0.046509002412958	0.336179363036573
12526	acetylsalicylic acid	hsa03010	Ribosome	9045_6192	2	+	0.0338194142819343	0.294228904252828
12527	acetylsalicylic acid	hsa05330	Allograft rejection	3586_3105_3106_3126_3127_3125_3135_3123_3113_649853	10	+	0.00189895517605982	0.0455554204931004
12528	acetylsalicylic acid	hsa04940	Type I diabetes mellitus	3105_3106_3126_3127_3125_3135_3123_3113_649853	9	+	0.0126411719042794	0.146114282428923
12529	acetylsalicylic acid	hsa04080	Neuroactive ligand-receptor interaction	2902_2912_155_886_64106_1132_2908_5618_4887_57105_7067_4987_9568_5645_2901_2149_5646	17	-	8.40390798282349e-05	0.00386579767209881
12530	acetylsalicylic acid	hsa04740	Olfactory transduction	219464_5568_157_5613_5566_808_109_10798_805_810_801_409	12	-	1.51193434445234e-13	1.39097959689615e-11
12531	acetylsalicylic acid	hsa04710	Circadian rhythm - mammal	8864_8863_9572_1454_406_1408	6	-	0.038510180414806	0.442867074770269
12532	acetylsalicylic acid	hsa05012	Parkinson's disease	836_4712_1329_65018_7054_6531_7419_517_291	9	-	0.00510915216621486	0.117510499822942
12533	acetylsalicylic acid	hsa04260	Cardiac muscle contraction	1329_27092	2	-	0.000710779124912003	0.0217972264973014
12534	acetylsalicylic acid	hsa04060	Cytokine-cytokine receptor interaction	3576_3596_958_27242_3554_2057_6348_5196_3572_657_655_659_3581_3587_3588_23765_4254_7040_7042_91_8792_7048_5618_3566_355_7422_8795	27	-	0.024660134104573	0.324104619660102
12535	acetylsalicylic acid	hsa03010	Ribosome	6204_284393_6181_6203_389342_6171	6	-	0.0109235719695095	0.172810009860418
12536	acetylsalicylic acid	hsa03050	Proteasome	5717	1	-	0.0112702180343751	0.172810009860418
12537	flufenamic acid	hsa05010	Alzheimer's disease	5330_3708_779_56901_2776	5	+	0.0100712726054265	0.214014542865313
12538	flufenamic acid	hsa04740	Olfactory transduction	8386_8385_8390_9635_2978_815_816	7	+	4.56217951141698e-07	1.93892629235222e-05
12539	flufenamic acid	hsa05322	Systemic lupus erythematosus	474382_8361_8363_474381_8365_8364_8367_8360_8368_8335_8362_8294_121504_8343_8347_8346_8344_8339_3123_8366_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2213_83740_3013_942_9555	41	+	2.25018742561988e-10	1.9126593117769e-08
12540	flufenamic acid	hsa05012	Parkinson's disease	7318_56901	2	+	0.00294462214184541	0.0834309606856199
12541	flufenamic acid	hsa04740	Olfactory transduction	810_26539_5568	3	-	2.2459140601474e-07	1.95394523232824e-05
12542	flufenamic acid	hsa05322	Systemic lupus erythematosus	55506_2903_85235_3119_3123_3126_3127_3014_3125_8332_8969_8331_8336_720_721_8970_8329_8330	18	-	0.00961447514773805	0.418229668926605
12543	flufenamic acid	hsa05310	Asthma	3123_3126_3127_3119_3125	5	-	0.0499866688432239	0.740756917415092
12544	flufenamic acid	hsa05012	Parkinson's disease	1329_4712	2	-	0.0254414264421326	0.737801366821845
12545	flufenamic acid	hsa03020	RNA polymerase	5432_246721_5439_548644_661	5	-	0.0449044387226398	0.740756917415092
12546	staurosporine	hsa04740	Olfactory transduction	26476	1	+	2.82139254412078e-09	2.42639758794387e-07
12547	staurosporine	hsa04640	Hematopoietic cell lineage	3581_3566_3552_2057_921_3690_947_3568_7037_3570_3684_3678_4254_1378_915_3655_931_1604	18	-	0.0155815636446745	0.0658675190433967
12548	staurosporine	hsa03320	PPAR signaling pathway	79966_2710_5170_10998_11001_6256_2181_5465_1376_6319_23305_28965	12	-	0.00635099774331881	0.0329674047803276
12549	staurosporine	hsa05010	Alzheimer's disease	4714_776_1327_841_840_8772_6622_509_317_9451_2905_51107_355_3709_22926_5534_488_7132_842_23236	20	-	1.68269525234465e-09	5.21635528226842e-08
12550	staurosporine	hsa04080	Neuroactive ligand-receptor interaction	1129_152_887_2905_64106_2847_2908_5030_3062_117_55879_56288_136_5746_134_4142_1902_5644_5646_2569_3354_4161_2561_5645_3360_799_2566_5029_57105_2742_2150_4987_9568_2859_4889_140_1132_4886_4887_6915_3362_5733_3269_9170_5618_7442_2557_7067_2897_7068_2570_2692_1241_22953_2798_3356_1909_2357_2690	59	-	0.000267580062569857	0.00355499225985667
12551	staurosporine	hsa04742	Taste transduction	5136_5566_50834_50833_112	5	-	0.000390336848918737	0.00453766586868032
12552	staurosporine	hsa05320	Autoimmune thyroid disease	3449_3448_3586_3446_3441_3442_3135_355_5551	9	-	0.0218929927695727	0.0848353469820942
12553	staurosporine	hsa05016	Huntington's disease	4899_1327_317_246721_23186_6875_6874_10126_6908_5433_5430_7052_1639_6667_2033_509_1213_9001_23236_4714_27113_27019_842_841_1385_1387_9519	27	-	1.22949921927102e-07	2.2868685478441e-06
12554	staurosporine	hsa04740	Olfactory transduction	157_26692_5566_8390_26664_26716_109_10798_81797_23538_816	11	-	8.74023801435686e-41	8.12842135335188e-39
12555	staurosporine	hsa04514	Cell adhesion molecules (CAMs)	2734_9073_5175_8506_57863_3655_9019_25945_999_9080_3135_4359_23705_965_3689_4685_3683_50848_3684_1364_1365_5792_947_6693_923_1001_5817	27	-	0.00136963960969623	0.0106147069751458
12556	staurosporine	hsa05322	Systemic lupus erythematosus	8363_8362_88_8348_8329_8343_8347_8346_8344_8339_3021_3020_8969_8968_55766_3586_717_715_8358_8330_8331_8336_8334_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_2215_3013_3017_3014	37	-	0.0294673260023023	0.109618452728565
12557	staurosporine	hsa05340	Primary immunodeficiency	915_4261_973_64421_5993	5	-	0.0328165649648265	0.116128657989831
12558	staurosporine	hsa04530	Tight junction	9073_5520_5521_88_56288_9223_5583_5581_93643_2037_1365_3996_2017_50848_64398_208_998_9080_5519_22800_4625_5515_7082_8189_5579_5578_1364_1457_3845	29	-	0.00286794948051231	0.0190513786919746
12559	staurosporine	hsa04720	Long-term potentiation	5579_1387_10411_2905_5578_814_5566_3709_2033_5534_3845_23236_4659_107_816_468	16	-	0.033714771674467	0.116128657989831
12560	staurosporine	hsa05110	Vibrio cholerae infection	7082_5579_5578_5566_51382_115_109_5335_4583	9	-	0.00623952665606651	0.0329674047803276
12561	staurosporine	hsa04512	ECM-receptor interaction	1284_7058_7148_22798_3911_961_3690_284217_1280_3909_7057_5649_3678_50509_1288_3655_1291_6696_3161	19	-	0.0356259125815343	0.118328923931525
12562	staurosporine	hsa04062	Chemokine signaling pathway	3717_6777_157_156_5295_8503_5290_9475_115_10451_5880_56288_112_2309_7454_2786_3551_5829_5566_2788_7410_1399_1398_4793_5291_1237_208_998_2931_108_109_729230_6093_3055_107_23236_7852_5579_6655_6654_6464_7074_3845_6376_5970_8976	46	-	0.00274268020170425	0.0190513786919746
12563	staurosporine	hsa05012	Parkinson's disease	4714_2861_7326_7327_842_317_509_27429_6622_1327	10	-	2.95729759582943e-10	1.37514338206069e-08
12564	staurosporine	hsa04260	Cardiac muscle contraction	6546_776_1327_782_783_27092_6548_10369_4625_4635_488_482_481	13	-	0.00124916035771445	0.0105610830243131
12565	staurosporine	hsa04060	Cytokine-cytokine receptor interaction	3596_64109_3441_8744_5155_5154_7852_9180_90_1896_1439_27242_7132_3552_3454_4055_3459_3570_8795_657_655_8718_658_3082_3581_3601_1237_3586_3604_3588_1271_23765_3625_2277_4254_1956_729230_7042_91_3566_4233_7048_3587_3448_23529_5618_3449_2057_3568_3446_7292_3442_355_7424_7422_51330_6376_2690	58	-	6.51148097877916e-05	0.00100927955171077
12566	staurosporine	hsa03010	Ribosome	6139_9349_6137_6125_6168_6160_6165	7	-	3.29181172481029e-08	7.65346226018392e-07
12567	staurosporine	hsa04020	Calcium signaling pathway	1129_887_2905_5534_3709_115_7220_5335_136_1909_5136_490_22953_5566_3360_3362_57105_8911_814_816_2769_776_56848_2767_6915_108_109_5733_488_3269_7125_107_3356_23236_6546_5579_8877_5578_1956_2064	40	-	0.000675977293424202	0.00628658882884508
12568	staurosporine	hsa03050	Proteasome	5690_5707_23198_5718	4	-	0.00052391668640866	0.00541380575955615
12569	staurosporine	hsa05330	Allograft rejection	3135_355_5551_3586	4	-	0.00845697151057622	0.0396457111164017
12570	staurosporine	hsa04730	Long-term depression	2768_5579_5578_10672_2767_5519_3709_3845_5320_3480_5515_23236	12	-	0.00638078802199888	0.0329674047803276
12571	staurosporine	hsa04270	Vascular smooth muscle contraction	10672_3778_3709_9475_115_776_4637_136_23365_112_4659_5583_5581_5566_1909_2768_2767_108_109_5320_6093_107_23236_59_5579_5578_27094_9826	28	-	0.0200108538217265	0.0809134524095898
12572	staurosporine	hsa04940	Type I diabetes mellitus	3135_5551_355_2572_3552	5	-	0.00576769136374394	0.0329674047803276
12573	staurosporine	hsa02010	ABC transporters	20_4363_5826_10057_9619_8647	6	-	0.0109054516129417	0.0482955714287418
12574	staurosporine	hsa04610	Complement and coagulation cascades	717_715_2153_7056_1604_2155_7035_1361_1378_2162_5328_5329	12	-	0.00852595937987134	0.0396457111164017
12575	NU-1025	hsa05332	Graft-versus-host disease	3824_3117_3123_3126_3127_3125	6	+	0.0278381375760744	0.535884148339432
12576	NU-1025	hsa05010	Alzheimer's disease	351_4842	2	+	0.0128709630372315	0.495532076933413
12577	NU-1025	hsa04740	Olfactory transduction	219464_26532_4992_409	4	+	5.47181020464906e-05	0.00421329385757978
12578	NU-1025	hsa05310	Asthma	3117_3123_3126_3127_3125	5	+	0.0258853222786239	0.535884148339432
12579	NU-1025	hsa05332	Graft-versus-host disease	3824_3804_3569_3126_3127_3125_3135_3811_3123_3802_942	11	-	0.0144026707878838	0.218440506949571
12580	NU-1025	hsa05010	Alzheimer's disease	322_810_6390_2903_4843	5	-	0.000736235693762854	0.0133994896264839
12581	NU-1025	hsa05016	Huntington's disease	27019_6390_6648_9001	4	-	8.27413685150043e-05	0.0025098215116218
12582	NU-1025	hsa04740	Olfactory transduction	26211_26333_23538_8390_26716_26539_81797_810	8	-	3.38029072065753e-09	3.07606455579835e-07
12583	NU-1025	hsa05322	Systemic lupus erythematosus	55506_2903_8363_8362_8365_8364_8367_8360_8368_8348_8294_121504_8341_8340_3123_8366_3126_3127_3125_8968_8370_717_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_942_3017_8361_720_721	39	-	1.01462055731626e-06	4.61652353578898e-05
12584	NU-1025	hsa04010	MAPK signaling pathway	4215_4776_5603_5579_6196_1844_8817_5607_26291_5536_5320_27092_773_2263_3551_782_4616	17	-	0.0404397335852885	0.496197549285691
12585	NU-1025	hsa05012	Parkinson's disease	6390_6531	2	-	0.000308939095078	0.0070283644130245
12586	fulvestrant	hsa04120	Ubiquitin mediated proteolysis	10277_23759_331_5071_652671_6923_4281_8945_22888_51343_5371_89910_23291_996_4193_8651_9820_8450_867_7189_8916_57154_7428	23	+	0.0208493818268492	0.279977413103404
12587	fulvestrant	hsa05016	Huntington's disease	2902_4899_2904_8218_246721_2776_5331_5332_6648_4701_7052_1639_6667_7419_1175_1339_55567_4695_161_23236_51164_842_4712_642502_6390_6391_5978_4698_1385_1387_9519_291	32	+	0.0101508658027559	0.190836277091811
12588	fulvestrant	hsa04740	Olfactory transduction	26212_5568_56656_5566_5616_1179_818_808_10798_805_390892_5137_801_4993_816_4995	16	+	5.5237899807393e-24	5.19236258189494e-22
12589	fulvestrant	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_2904_8368_8335_9103_6738_88_8329_8294_8351_8343_8341_8347_8346_8344_8353_3108_3109_6737_3123_8366_3126_3127_3125_8969_8968_940_8370_8358_8359_8330_8331_8336_8337_554313_8350_121504_8352_8339_8354_8355_8356_8357_8332_85235_3012_3013_3113_3111_720_721_8970	58	+	0.0154036191707686	0.241323367008708
12590	fulvestrant	hsa03410	Base excision repair	10039_57804_5111	3	+	0.0319150455116467	0.345053518878184
12591	fulvestrant	hsa05012	Parkinson's disease	2861_7419_1339_842_4701_642502_6390_6391_4712_4698_6531_4695_5071_6622_291	15	+	0.000209796560553382	0.00986043834600895
12592	fulvestrant	hsa04260	Cardiac muscle contraction	784_7168_776_1339_782_9254_786_6548_4635_6262_23439_7137	12	+	0.0330370390415283	0.345053518878184
12593	fulvestrant	hsa03010	Ribosome	9349_285053_6181_6205_6129_6142_6192_6144_6165_6171	10	+	0.000699832982418661	0.0205988237914089
12594	fulvestrant	hsa03020	RNA polymerase	246721_10622	2	+	0.0463541216135955	0.435728743167798
12595	fulvestrant	hsa03050	Proteasome	5699_5710	2	+	0.000876545693251442	0.0205988237914089
12596	fulvestrant	hsa03320	PPAR signaling pathway	79966_2710_5170_2173_9370_51_11001_1962_10580_2181_2171_1375_1374_1376_2182_5465_23305_8309	18	-	0.00888647713770729	0.0835328850944485
12597	fulvestrant	hsa05010	Alzheimer's disease	55851_2597_3710_51806_5534_317_2776_5663_5330_5332_5664_6622_56901_836_3553_11261_808_509_810_4842_776_8772_779_5533_5532_3708_3709_6868_489_488_102_4695_4714_805_5595_5594_841_840_642502_6390_6391_4137_51107_355_5530_823_351_4713_22926_801_517	51	-	0.000227050580244247	0.00237141717143991
12598	fulvestrant	hsa04080	Neuroactive ligand-receptor interaction	1129_1269_4159_155_1081_147_2847_1909_2925_2901_5030_552_56288_5745_134_5645_5644_6870_1816_4889_1813_2561_9287_3360_799_2740_2150_4987_7068_4988_5646_2642_146_2911_5724_140_3953_1131_5025_4886_4887_6915_3350_5733_553_3269_1910_5026_8001_9170_2550_5618_7442_5340_4161_7252_3354_7067_2897_4829_2570_1241_5732_8484_728_1511_2692_2149_10203	69	-	9.74382863828831e-07	3.05306630666367e-05
12599	fulvestrant	hsa04742	Taste transduction	6340_3745_3710_5613_5566_5567_5616_50831_5330_51764_6337_50835_346562_6338	14	-	0.0277937241179767	0.200970005160755
12600	fulvestrant	hsa05016	Huntington's disease	8218_55081_3064_317_246721_2776_5330_5332_23186_3065_7019_6875_5433_4695_5434_7052_1639_5439_6667_509_7419_1213_1175_7802_581_1211_3708_56901_836_548644_161_163_4714_841_4713_642502_6390_6391_3092_7157_5978_55567_1385_5441_517_291	46	-	2.55064918886693e-06	5.99402559383729e-05
12601	fulvestrant	hsa03420	Nucleotide excision repair	2967_6118_1161_5425_5983_5981_2068_5887_5424_2073_2072	11	-	0.0322013235564726	0.216208886736316
12602	fulvestrant	hsa04740	Olfactory transduction	51806_157_26539_5137_26211_5566_5567_818_810_816_817_1179_2978_109_8392_26529_5593_5613_5616_808_4992_4991_801_805	24	-	1.41527124856432e-42	1.33035497365046e-40
12603	fulvestrant	hsa04630	Jak-STAT signaling pathway	23533_3717_3446_3597_3596_5296_598_5295_5292_3718_5290_5291_6777_9180_9655_595_10254_3452_3439_1271_3451_3454_3455_3570_3572_1270_5781_3977_3589_81848_3581_3601_3587_3953_1154_208_8554_4609_9021_3448_868_5618_3566_2057_3460_6774_6775_3447_6654_3441_6772_3442_51588_50616_6776	55	-	0.0225162158772665	0.176377024371921
12604	fulvestrant	hsa04062	Chemokine signaling pathway	23533_3717_3576_1147_157_156_5296_6464_5295_3718_113_9475_115_5330_6387_5332_56288_6358_6777_5747_6359_2309_4283_2786_4067_3551_5829_5566_5567_2788_25759_5906_1399_1398_6363_7409_6357_6367_5291_8517_1233_208_998_2931_108_109_729230_5290_6093_3055_107_4793_7852_6355_5595_5594_5579_6774_5613_6654_5616_6772_2783_7074_51764_3845_5058_5879_8976	69	-	0.0121009886869414	0.103408448779317
12605	fulvestrant	hsa05012	Parkinson's disease	2861_317_7345_27429_6622_6570_7327_4695_5413_7054_509_7419_51465_56901_836_7332_4714_7318_4713_642502_6390_6391_517_291	24	-	1.24927533779219e-07	5.87159408762329e-06
12606	fulvestrant	hsa04260	Cardiac muscle contraction	784_6546_7168_776_6262_782_9254_27092_779_786_481_4635_488_7137_7170	15	-	5.93903501772715e-05	0.000724013785415826
12607	fulvestrant	hsa04060	Cytokine-cytokine receptor interaction	6355_7046_3446_3597_3596_3441_55540_5155_5154_3815_7852_3439_6387_9180_6359_8794_3452_4283_2321_3451_3553_3454_2324_959_3455_3576_3953_3570_3572_1270_4982_3977_1271_8718_27242_6367_659_3604_3581_3601_7293_3626_3605_1233_23495_3589_23765_8771_3625_3624_4254_6363_1956_729230_7042_91_655_93_92_4233_8795_3587_3448_1436_6357_5618_1435_3566_2057_3460_3447_970_7292_6358_3442_356_355_50616_7422_51330	80	-	3.73906558938427e-05	0.000702944330804243
12608	fulvestrant	hsa03010	Ribosome	6234_440589_285053_6168_140801_9349_6203_6139_6137_6187_6142_6141_284393_439992_6144_6158_6160_6129_389342_6189_6171	21	-	4.97461592159839e-05	0.000724013785415826
12609	fulvestrant	hsa03050	Proteasome	10197_5698_23198_5701_5702	5	-	6.16181945034746e-05	0.000724013785415826
12610	monastrol	hsa04080	Neuroactive ligand-receptor interaction	2859_2550_1269_7442_2688_150_2905_2911_2847_3360_5617_2566_117_3351_1442_1909_56288_1394_1902	19	+	0.0466559299862881	0.849137925750443
12611	monastrol	hsa05016	Huntington's disease	8218_4899_1211_842_841_7052_7350_5332	8	+	0.00142331307596219	0.0431738299708531
12612	monastrol	hsa04740	Olfactory transduction	2979_1179_5137_26532_4992_816_810_409	8	+	5.43650896888742e-11	4.94722316168755e-09
12613	monastrol	hsa05012	Parkinson's disease	842	1	+	7.82132925905059e-06	0.000355870481286802
12614	monastrol	hsa04260	Cardiac muscle contraction	6546_779_4635	3	+	0.0325210404281457	0.739853669740315
12615	monastrol	hsa04120	Ubiquitin mediated proteolysis	10277_8945_6502_23759_8554_8450_8651_9021_6923	9	-	0.0217410951074083	0.186846326407189
12616	monastrol	hsa05010	Alzheimer's disease	810_2903_4843_4023_2904	5	-	9.57996180769034e-06	0.00028739885423071
12617	monastrol	hsa05016	Huntington's disease	1212_246721_5439_27019_581_7052_5441_2904_7416_9001_3064_548644	12	-	0.00591624408128473	0.115691436069999
12618	monastrol	hsa04740	Olfactory transduction	5593_56656_157_26716_5137_810_9635	7	-	2.97278542694702e-14	2.67550688425232e-12
12619	monastrol	hsa05212	Pancreatic cancer	6932_1869_3551_596	4	-	0.0159644403210262	0.186846326407189
12620	monastrol	hsa05215	Prostate cancer	6932_1869_3551_596	4	-	0.0228367732275453	0.186846326407189
12621	monastrol	hsa04210	Apoptosis	5577_581_3551_596	4	-	0.0159644403210262	0.186846326407189
12622	monastrol	hsa04062	Chemokine signaling pathway	2784_5879_2786_157_3551_6774_3576_6376_729230_4793_10663_6370_3055_8976_10803	15	-	0.0310720375001623	0.233040281251217
12623	monastrol	hsa04010	MAPK signaling pathway	4776_5879_781_5320_3551_5599_2005_1844_8817_1850_10369_773_5603_7042_91_3310_2246_4616_9693_27006_2250	21	-	0.00642730200388886	0.115691436069999
12624	monastrol	hsa05012	Parkinson's disease	2861_7416	2	-	5.17562125561054e-06	0.000232902956502474
12625	monastrol	hsa05213	Endometrial cancer	6932	1	-	0.0178776751499451	0.186846326407189
12626	monastrol	hsa04912	GnRH signaling pathway	2778_5320_5599_5603_5337_810	6	-	0.0204472978949209	0.186846326407189
12627	sulindac sulfide	hsa05214	Glioma	8503_808_801_805	4	+	0.00316106466673522	0.0853487460018509
12628	sulindac sulfide	hsa04070	Phosphatidylinositol signaling system	801_5333_808_8503_805	5	+	0.000721535356909943	0.0389629092731369
12629	sulindac sulfide	hsa05010	Alzheimer's disease	805_801_808_1020_4701	5	+	0.0222135988927653	0.329782451150685
12630	sulindac sulfide	hsa04910	Insulin signaling pathway	8503_808_801_805	4	+	0.0366424945722983	0.329782451150685
12631	sulindac sulfide	hsa04720	Long-term potentiation	801_808_805	3	+	0.0314135972108401	0.329782451150685
12632	sulindac sulfide	hsa04020	Calcium signaling pathway	5333_808_3360_801_805	5	+	0.0256368520824942	0.329782451150685
12633	sulindac sulfide	hsa04740	Olfactory transduction	7932_1179	2	-	0.000281632972856193	0.0216857389099269
12634	exisulind	hsa05332	Graft-versus-host disease	3553_3123_3107_3126_3127_3125_7124_3112	8	+	0.00150145658778015	0.0519270289291405
12635	exisulind	hsa04640	Hematopoietic cell lineage	3553_2057_3123_3126_3127_3125_3678_960_7124_3675	10	+	0.0109308740743707	0.145744987658276
12636	exisulind	hsa05320	Autoimmune thyroid disease	3123_3107_3126_3127_3112_3125	6	+	0.0464995683886291	0.464995683886291
12637	exisulind	hsa04740	Olfactory transduction	815_393046	2	+	6.73689167011724e-06	0.000538951333609379
12638	exisulind	hsa05310	Asthma	3123_3126_3112_3127_7124_3125	6	+	0.00471001585326575	0.075360253652252
12639	exisulind	hsa05012	Parkinson's disease	6570	1	+	0.0330389792827607	0.377588334660122
12640	exisulind	hsa05330	Allograft rejection	3123_3107_3126_3112_3127_7124_3125	7	+	0.00346344728461659	0.0692689456923318
12641	exisulind	hsa04940	Type I diabetes mellitus	3553_3123_3107_3126_3112_3127_7124_3125	8	+	0.00194726358484277	0.0519270289291405
12642	exisulind	hsa05010	Alzheimer's disease	6622_5595	2	-	0.00325223640419333	0.144724519986603
12643	exisulind	hsa05016	Huntington's disease	27019_64764_6648_246721_1639	5	-	0.0448873722677468	0.798995226365893
12644	exisulind	hsa04740	Olfactory transduction	7932	1	-	1.7895364084057e-09	1.59268740348107e-07
12645	exisulind	hsa04062	Chemokine signaling pathway	2793_5595_107_6362	4	-	0.0141119003605311	0.313989783021817
12646	exisulind	hsa05012	Parkinson's disease	6622	1	-	0.0050223474155697	0.148996306661901
12647	pizotifen	hsa04740	Olfactory transduction	5137_26664_157	3	+	0.000987209167996471	0.06713022342376
12648	pizotifen	hsa04912	GnRH signaling pathway	5337_6654_2776_2798_5320_5603_3725_6714_23236	9	+	0.0205525718663397	0.69878744345555
12649	pizotifen	hsa04720	Long-term potentiation	5613_801_808_107_805	5	-	0.049399976157289	0.986364110506583
12650	pizotifen	hsa04912	GnRH signaling pathway	6654_1432_5613_4323_6416_808_801_107_805	9	-	0.00258624518706177	0.178450917907262
12651	pizotifen	hsa04270	Vascular smooth muscle contraction	5613_27094_808_4637_801_107_805	7	-	0.0369139606181095	0.986364110506583
12652	carbarsone	hsa05221	Acute myeloid leukemia	861_208_5371	3	+	0.0177743301399815	0.750003925651714
12653	carbarsone	hsa04530	Tight junction	5010_5865_84612_208	4	+	0.0371071962748928	0.750003925651714
12654	carbarsone	hsa04512	ECM-receptor interaction	3679_22798_1277	3	+	0.0425420171576391	0.750003925651714
12655	carbarsone	hsa04070	Phosphatidylinositol signaling system	8871_3710_64768_3636_8396_3633_5287_3631_8394_3708_808_23396_5298_801_1606_4952_805	17	-	0.00218476291343745	0.049703356280702
12656	carbarsone	hsa04080	Neuroactive ligand-receptor interaction	5618_1081_3953_2908_5030_7067_2150_56288	8	-	0.000468984150432797	0.0142258525631282
12657	carbarsone	hsa04740	Olfactory transduction	801_808_805	3	-	1.2005989611678e-11	1.0925450546627e-09
12658	carbarsone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6738_8348_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_9555	29	-	0.000452640787612693	0.0142258525631282
12659	carbarsone	hsa05012	Parkinson's disease	4698_513_4713_517_9246	5	-	0.0320577133827628	0.364656489728927
12660	carbarsone	hsa04260	Cardiac muscle contraction	784	1	-	0.00936050838345946	0.170361252578962
12661	carbarsone	hsa03010	Ribosome	6203_6171	2	-	0.0118011379251986	0.178983925198845
12662	carbarsone	hsa04020	Calcium signaling pathway	3710_3708_808_805_489_801_2064_4842	8	-	0.0260537604460078	0.338698885798101
12663	perhexiline	hsa04916	Melanogenesis	7306	1	+	0.021370075816009	0.221714536591093
12664	perhexiline	hsa05332	Graft-versus-host disease	3108_3821_3804_3106_3569_942_3135_3105_649853	9	+	0.00316777016501526	0.0876416412320889
12665	perhexiline	hsa05320	Autoimmune thyroid disease	3439_3108_1081_3105_3106_942_3442_3135_3447_649853	10	+	0.00425719087940697	0.0883367107476946
12666	perhexiline	hsa04612	Antigen processing and presentation	3439_3108_3822_3821_3804_3447_3442_3135_3105_3309_3310_3106_649853	13	+	0.0100142307701183	0.13853019231997
12667	perhexiline	hsa05016	Huntington's disease	3708_1639_246721_836_10126	5	+	0.0455280070598855	0.336042865877613
12668	perhexiline	hsa04740	Olfactory transduction	5593_1179	2	+	1.29587422077478e-08	5.37787801621534e-07
12669	perhexiline	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_8349_8348_8329_8294_121504_8343_8347_8346_8344_8339_723790_8969_8968_55766_3108_8370_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3012_3013_942_8970	48	+	8.75062454329206e-18	7.26301837093241e-16
12670	perhexiline	hsa04530	Tight junction	4619_4625_5581	3	+	0.0485845107292935	0.336042865877613
12671	perhexiline	hsa04010	MAPK signaling pathway	4763_3725_3164_11221_4616_836_7048_2246_5923_2260_2247_4214_468_9252_5533_5778_7786_3310_9020_1647_1848_783_1843_5598_1649_1846_8817_2353_5971_2251	30	+	0.00691510335751194	0.114790715734698
12672	perhexiline	hsa05012	Parkinson's disease	836_6622_5413	3	+	0.0485303189865108	0.336042865877613
12673	perhexiline	hsa05330	Allograft rejection	3593_3108_3105_3106_942_3135_649853	7	+	0.0175005217984985	0.207506187039339
12674	perhexiline	hsa04940	Type I diabetes mellitus	3593_3108_3105_3106_942_3135_649853	7	+	0.0327582438085258	0.30210380401196
12675	perhexiline	hsa04740	Olfactory transduction	157	1	-	0.000127500127425662	0.00892500891979634
12676	perhexiline	hsa04060	Cytokine-cytokine receptor interaction	3588_23765	2	-	0.0184856391833317	0.646997371416609
12677	perhexiline	hsa05330	Allograft rejection	3135_3105_3106_649853	4	-	0.0410704827677321	0.767381355976956
12678	pirlindole	hsa04120	Ubiquitin mediated proteolysis	26091	1	+	0.0219335625405094	0.533821082713208
12679	pirlindole	hsa05010	Alzheimer's disease	2902	1	+	0.00505665252659051	0.204794427326916
12680	pirlindole	hsa04740	Olfactory transduction	818_5593_393046	3	+	4.08729334322799e-05	0.00331070760801467
12681	pirlindole	hsa04370	VEGF signaling pathway	1432_5579_208_998_5605_5600_5603_7422	8	+	0.0329519186860005	0.533821082713208
12682	pirlindole	hsa05012	Parkinson's disease	6571	1	+	0.0324288996984188	0.533821082713208
12683	pirlindole	hsa04740	Olfactory transduction	109	1	-	0.00245602118195807	0.0896447731414696
12684	pirlindole	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3113_3014	23	-	2.49527946314649e-12	1.82155400809694e-10
12685	estradiol	hsa03320	PPAR signaling pathway	2712_2710_51703_2173_5465_9415_1593_6257	8	+	0.0237072329696439	0.18373105551474
12686	estradiol	hsa05010	Alzheimer's disease	2902_3710_2904_2776_5331_5664_6622_3553_651820_4842_776_5532_6868_5534_23236_5594_841_6392_2081_4137_355_517	22	+	0.000520999258730884	0.0161509770206574
12687	estradiol	hsa04080	Neuroactive ligand-receptor interaction	2902_2901_886_2904_64106_2908_2925_3001_5745_1812_1813_3360_3361_2566_2740_2688_1442_4987_4986_9568_4988_1394_4889_3953_1131_7433_4886_3355_6915_9002_5733_3352_3269_2550_5618_7253_6752_7068_2570_2692_1241_7067_10800_2357_728	45	+	0.0139956262927196	0.13957724832707
12688	estradiol	hsa04742	Taste transduction	2778_50834_6338_3710_112	5	+	0.0223820914765758	0.18373105551474
12689	estradiol	hsa05016	Huntington's disease	2902_4899_627_8218_64764_246721_2776_5331_6875_7052_1639_2904_651820_64446_2033_23236_1175_581_10540_163_27113_841_6392_3092_55567_517	26	+	0.00152844555429685	0.0284290873099214
12690	estradiol	hsa03420	Nucleotide excision repair	2068_5983_5111_2067	4	+	0.0319628741058525	0.228657483988022
12691	estradiol	hsa04740	Olfactory transduction	7932_1179_26716_5137_3000_4991_26539_26529_5132_816	10	+	3.52586202417416e-27	3.27905168248197e-25
12692	estradiol	hsa03410	Base excision repair	3980_27343_5111	3	+	0.0467180332709652	0.305872673481628
12693	estradiol	hsa04530	Tight junction	5010_4301_2773_9223_5584_5581_93643_93408_84612_5865_10627_79784_64398_998_6714_10686_7082_8189_5728_2036_3845_7525_27134	23	+	0.0493343021744562	0.305872673481628
12694	estradiol	hsa03030	DNA replication	5983_5111	2	+	0.015008306271728	0.13957724832707
12695	estradiol	hsa05110	Vibrio cholerae infection	2778_115_7082_5335_523	5	+	0.00807433602796755	0.0938641563251228
12696	estradiol	hsa05012	Parkinson's disease	5413_6392_651820_7054_7345_6531_6622_517	8	+	6.67117962740581e-07	3.1020985267437e-05
12697	estradiol	hsa04260	Cardiac muscle contraction	776_6262_782_477_4635_4634_7170	7	+	0.00149265831632391	0.0284290873099214
12698	estradiol	hsa03010	Ribosome	6192_140801_9349_6125_6205_284393_6181_439992_6144_389342_6189	11	+	0.00320961556896536	0.0497490413189631
12699	estradiol	hsa03050	Proteasome	5717_10197_5710	3	+	0.00807201177451712	0.0938641563251228
12700	estradiol	hsa03320	PPAR signaling pathway	5360_10998_9370_2173_1375_6257_5105	7	-	0.0278167367338029	0.319892472438733
12701	estradiol	hsa05010	Alzheimer's disease	1329_5664_3553_322_348_775_776_5533_3708_3709_22926_5534_842_5594_841_642502_6391_4137_355_808_805_351_801_517	24	-	0.0084575984599068	0.155619811662285
12702	estradiol	hsa04080	Neuroactive ligand-receptor interaction	155_154_2908_553_5031_55879_1909_887_2740_2561_3360_3362_3953_2688_2689_4986_9568_1442_2859_2911_2912_1133_7433_148_3354_3350_5733_3352_3269_23566_5618_2555_9294_6915_7067_2559_4159_6755_2696_2692_2149_2690	42	-	0.0251367746178207	0.319892472438733
12703	estradiol	hsa05016	Huntington's disease	8218_4899_1329_10126_5432_6648_7052_64446_1212_1175_7802_3708_9001_161_27113_842_841_642502_5441_6391_5978_1387_517	23	-	0.00142985518082697	0.0438488922120271
12704	estradiol	hsa03420	Nucleotide excision repair	2067_5887_2074	3	-	0.0243720542244187	0.319892472438733
12705	estradiol	hsa04740	Olfactory transduction	26531_157_26211_5613_23538_5567_5616_1179_808_818_26476_2979_805_4991_801_9635_816	17	-	5.25466414679415e-19	4.83429101505062e-17
12706	estradiol	hsa04110	Cell cycle	995_1647_51343_993_8243_4088_699_4193_51433_5934_10912_8555_7042_1031_1387_5933	16	-	0.0356653151376038	0.364578776962172
12707	estradiol	hsa05218	Melanoma	8503_5594_27006_5155_4193_26291_2247_2251	8	-	0.0436146867787597	0.364777380331445
12708	estradiol	hsa04150	mTOR signaling pathway	8503_6196_5594_7249_7422	5	-	0.043451724976755	0.364777380331445
12709	estradiol	hsa05012	Parkinson's disease	2861_1329_842_642502_6391_7345_65018_517_7332	9	-	1.57444613525651e-05	0.000724245222217995
12710	estradiol	hsa03050	Proteasome	5717_23198	2	-	0.00339790536192718	0.0781518233243251
12711	isometheptene	hsa05332	Graft-versus-host disease	3123_355_3126_3127_3125	5	+	0.0337986508796747	0.480786109736038
12712	isometheptene	hsa05320	Autoimmune thyroid disease	3445_3123_3126_3127_3125_355	6	+	0.0254958297104945	0.480786109736038
12713	isometheptene	hsa04740	Olfactory transduction	818_5593_26529	3	+	0.000242850164036666	0.0201565636150433
12714	isometheptene	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.0405482261223165	0.480786109736038
12715	isometheptene	hsa04062	Chemokine signaling pathway	6093	1	+	0.00743806661248522	0.308679764418137
12716	isometheptene	hsa05330	Allograft rejection	3123_355_3126_3127_3125	5	+	0.0240077606502642	0.480786109736038
12717	isometheptene	hsa04940	Type I diabetes mellitus	3123_355_3126_3127_3125	5	+	0.0395007598138265	0.480786109736038
12718	isometheptene	hsa04740	Olfactory transduction	5566	1	-	0.00780899247073287	0.265505744004918
12719	isometheptene	hsa03450	Non-homologous end-joining	79840_7518	2	-	0.0393608954430751	0.892180296709702
12720	isometheptene	hsa03020	RNA polymerase	5432_246721_5439_548644	4	-	0.00396180406053005	0.265505744004918
12721	adipiodone	hsa05332	Graft-versus-host disease	3811_3105_3106_3802_3135_649853	6	+	0.00558962812340212	0.231103255950847
12722	adipiodone	hsa05320	Autoimmune thyroid disease	3135_3105_3106_3448_649853	5	+	0.0475312689042712	0.669544773510447
12723	adipiodone	hsa04612	Antigen processing and presentation	6891_3811_3448_3105_3106_3802_3135_6892_649853	9	+	0.00624603394461748	0.231103255950847
12724	adipiodone	hsa04740	Olfactory transduction	818_81696_81797_1179_4991	5	+	0.0147776946710167	0.364516468551745
12725	adipiodone	hsa04514	Cell adhesion molecules (CAMs)	9076_3383_3105_3106_3685_9080_3135_23308_6693_649853	10	+	0.0322767207089051	0.597119333114744
12726	adipiodone	hsa04080	Neuroactive ligand-receptor interaction	3953_7067	2	-	0.000257020555933582	0.00762494315936293
12727	adipiodone	hsa04740	Olfactory transduction	219464_109	2	-	6.54470721019383e-07	5.82478941707251e-05
12728	adipiodone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_55766_8370_8332_8359_8330_8331_8336_554313_121504_85235_3113	23	-	1.01079461008339e-05	0.000449803601487109
12729	adipiodone	hsa05216	Thyroid cancer	7175_3845_999_5594_6934	5	-	0.0263521084455449	0.469067530330699
12730	adipiodone	hsa04060	Cytokine-cytokine receptor interaction	3953_657_4982_3572	4	-	0.00409389269923429	0.091089112557963
12731	carisoprodol	hsa05214	Glioma	5295_4193_5291_808_801_805	6	-	0.0289148680150479	0.58552607730472
12732	carisoprodol	hsa04070	Phosphatidylinositol signaling system	5298_8394_8396_5295_1606_5333_3709_801_5291_808_805	11	-	0.000123730182387049	0.010022144773351
12733	carisoprodol	hsa04740	Olfactory transduction	801_808_805	3	-	0.00198421971666041	0.0803608985247466
12734	carisoprodol	hsa04710	Circadian rhythm - mammal	1454_8553_9572	3	-	0.0143538940570548	0.38755513954048
12735	carisoprodol	hsa05330	Allograft rejection	3135_3123_3119_3133	4	-	0.0482581359755708	0.680852477460479
12736	nisoxetine	hsa05332	Graft-versus-host disease	3812_3553_3123_3126_3127_3111_3125_3135	8	+	0.000176026460789783	0.0137300639416031
12737	nisoxetine	hsa04640	Hematopoietic cell lineage	3553_3123_3126_3127_3125_929_3589_3684	8	+	0.0114309245166228	0.111932143657474
12738	nisoxetine	hsa05320	Autoimmune thyroid disease	3123_3126_3127_3111_3125_3135	6	+	0.011480219862305	0.111932143657474
12739	nisoxetine	hsa04612	Antigen processing and presentation	3812_972_3123_3126_3127_3111_3125_3135_6892	9	+	0.00426580174437995	0.0642797883163407
12740	nisoxetine	hsa04740	Olfactory transduction	4991_81797_390892	3	+	0.00194033736143765	0.0504487713973789
12741	nisoxetine	hsa04360	Axon guidance	2042_10154_2041_64221_2048_9475_5532_219699_3985_6093	10	+	0.0252755184603988	0.212806246216529
12742	nisoxetine	hsa05310	Asthma	3123_3126_3127_3111_3125	5	+	0.00494459910125698	0.0642797883163407
12743	nisoxetine	hsa05330	Allograft rejection	3123_3126_3127_3111_3125_3135	6	+	0.00268834703596739	0.0524227672013641
12744	nisoxetine	hsa05210	Colorectal cancer	10000_842_4088_5156_5900_11211_1857	7	+	0.0272828520790422	0.212806246216529
12745	nisoxetine	hsa04940	Type I diabetes mellitus	3553_3123_3126_3127_3111_3125_3135	7	+	0.00115831269816347	0.0451741952283753
12746	nisoxetine	hsa04080	Neuroactive ligand-receptor interaction	64106_1269	2	-	0.00469421518058584	0.199504145174898
12747	nisoxetine	hsa05016	Huntington's disease	5978_1339	2	-	0.0357760774352485	1
12748	nisoxetine	hsa04740	Olfactory transduction	818_5566	2	-	4.18881819303832e-05	0.00356049546408257
12749	bufexamac	hsa04740	Olfactory transduction	5613	1	+	0.000381262961436168	0.0282134591462764
12750	bufexamac	hsa04514	Cell adhesion molecules (CAMs)	9076_5010_5175_947_3111_23308_5817_923_26047_1462	10	+	0.00685589314813132	0.253668046480859
12751	bufexamac	hsa04930	Type II diabetes mellitus	5599_8660_5293_3551	4	+	0.0466672388240489	0.836424295708109
12752	bufexamac	hsa05332	Graft-versus-host disease	3113_3126_3127_3123_3125	5	-	0.0407739437315823	0.386885745466328
12753	bufexamac	hsa04080	Neuroactive ligand-receptor interaction	5021_2908_152	3	-	0.0102409967194146	0.349330536568639
12754	bufexamac	hsa05131	Shigellosis	7278_113457_998_7430_6093_9475	6	-	0.0391560571260043	0.386885745466328
12755	bufexamac	hsa05130	Pathogenic Escherichia coli infection	7278_113457_998_7430_6093_9475	6	-	0.0391560571260043	0.386885745466328
12756	bufexamac	hsa05322	Systemic lupus erythematosus	85235_3123_8330_3126_3127_3014_3125_8332_8969_8331_8336_8343_8329_8339_8347_8346_3113_8344	18	-	9.8487012587246e-05	0.00807593503215417
12757	bufexamac	hsa05310	Asthma	3123_3126_3127_3113_3125	5	-	0.0127803854842185	0.349330536568639
12758	bufexamac	hsa03020	RNA polymerase	246721_5439_548644_84172	4	-	0.0432268994960135	0.386885745466328
12759	bufexamac	hsa04020	Calcium signaling pathway	5021_1956	2	-	0.0363676220699621	0.386885745466328
12760	bufexamac	hsa05330	Allograft rejection	3126_3113_3127_3123_3125	5	-	0.0291469801345677	0.386885745466328
12761	bufexamac	hsa04940	Type I diabetes mellitus	3113_3126_3127_3123_3125	5	-	0.0475031622341216	0.386885745466328
12762	11-deoxy-16,16-dimethylprostaglandin E2	hsa04740	Olfactory transduction	5137_51806_4991_135948_26211	5	+	1.62386107036813e-05	0.00134780468840555
12763	11-deoxy-16,16-dimethylprostaglandin E2	hsa04062	Chemokine signaling pathway	23533_6655_10000_2788	4	+	0.0192939742732732	0.686125651123028
12764	11-deoxy-16,16-dimethylprostaglandin E2	hsa05012	Parkinson's disease	317_842	2	+	0.024799722329748	0.686125651123028
12765	11-deoxy-16,16-dimethylprostaglandin E2	hsa05010	Alzheimer's disease	776_836_3710_4713_348_317_355_3708_56901_4698_779_6622_4842_5594	14	-	0.000617885667838639	0.0165160963515018
12766	11-deoxy-16,16-dimethylprostaglandin E2	hsa05016	Huntington's disease	8218_4899_7419_6648_4713_4698_317_246721_161_3708_56901_3064_836_1387_10126	15	-	0.000437150210508986	0.0165160963515018
12767	11-deoxy-16,16-dimethylprostaglandin E2	hsa04740	Olfactory transduction	26212_157_8383_5593_8392_4992_4991_9635_816	9	-	3.62044034035612e-19	3.33080511312763e-17
12768	11-deoxy-16,16-dimethylprostaglandin E2	hsa03410	Base excision repair	3980	1	-	0.0227436693020665	0.348736262631686
12769	11-deoxy-16,16-dimethylprostaglandin E2	hsa04664	Fc epsilon RI signaling pathway	23533_8503_3596_5296_5605_27040_8681_5335_5600_5603_5609_5608_6850_4067_5581_100137049_6300_5320_1432_5594_5579_5578_6655_6654_7409	25	-	0.0296073163199994	0.389124728777135
12770	11-deoxy-16,16-dimethylprostaglandin E2	hsa04010	MAPK signaling pathway	1326_5155_57551_5906_5605_4208_8986_5600_5603_10454_9344_3164_3305_5609_5608_4616_5579_836_4149_3551_51776_2248_5921_2263_2260_23118_6300_4214_4217_776_9064_51701_9252_9254_27092_779_8074_4776_1956_5536_5320_7042_91_3725_4791_782_1848_1432_5594_2318_5578_100137049_6655_6654_5607_2122_2002_356_355_23162_8681_2005_2257_4763_2253_9693_2251	67	-	0.0498546461818176	0.523579756166027
12771	11-deoxy-16,16-dimethylprostaglandin E2	hsa05012	Parkinson's disease	2861_6570_836_5413_4698_4713_317_7054_56901_7419_6622	11	-	0.00414706389157731	0.0763059756050225
12772	11-deoxy-16,16-dimethylprostaglandin E2	hsa03010	Ribosome	283412_6159_284064_6123_6203	5	-	0.00071809114571747	0.0165160963515018
12773	CP-645525-01	hsa05332	Graft-versus-host disease	3119_3105_3106_3113_3135_355_649853	7	+	0.0149207707055368	0.295646317306298
12774	CP-645525-01	hsa05320	Autoimmune thyroid disease	3119_3105_3106_3113_3135_355_649853	7	+	0.0406530931772451	0.363156366852103
12775	CP-645525-01	hsa04612	Antigen processing and presentation	4800_3119_3105_3106_3113_3135_3308_1385_811_10437_649853	11	+	0.0218997272078739	0.295646317306298
12776	CP-645525-01	hsa04670	Leukocyte transendothelial migration	3688	1	+	0.0148677392555131	0.295646317306298
12777	CP-645525-01	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8348_8294_121504_8968_8370_8358_8359_8336_8335_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_3113	30	+	1.09200640261093e-08	8.84525186114853e-07
12778	CP-645525-01	hsa04530	Tight junction	56288_5581	2	+	0.0350935518329442	0.35532221230856
12779	CP-645525-01	hsa05012	Parkinson's disease	642502_6391	2	+	0.0349343565681612	0.35532221230856
12780	CP-645525-01	hsa03010	Ribosome	6224	1	+	0.0448341193644572	0.363156366852103
12781	CP-645525-01	hsa05330	Allograft rejection	3119_3105_3106_3113_3135_355_649853	7	+	0.0094713614443484	0.295646317306298
12782	CP-645525-01	hsa04940	Type I diabetes mellitus	3119_3105_3106_3113_3135_355_649853	7	+	0.0183510132883417	0.295646317306298
12783	CP-645525-01	hsa04650	Natural killer cell mediated cytotoxicity	5296_8503_3455_4772_259197	5	-	0.0324350381921267	0.27148413469107
12784	CP-645525-01	hsa05010	Alzheimer's disease	2903_572_317_4842_23236	5	-	0.00280086684503685	0.0410793803938738
12785	CP-645525-01	hsa04080	Neuroactive ligand-receptor interaction	2903_4889_2901_4157_2740_4158_5732_1241_6915_135_134_5644_728	13	-	0.0339355168363837	0.27148413469107
12786	CP-645525-01	hsa05016	Huntington's disease	7052_64446_317_23236	4	-	0.000347819455173806	0.0153040560276475
12787	CP-645525-01	hsa04740	Olfactory transduction	26529_109_157_26716	4	-	9.76774515794176e-11	8.59561573898875e-09
12788	CP-645525-01	hsa05322	Systemic lupus erythematosus	2903_8361_8363_8362_8365_8364_8367_8360_8368_554313_8294_8342_3108_3123_8366_3126_3127_3125_8370_8359_8335_6738_121504_8354_3012_727_8970	27	-	0.0013054362936422	0.0229756787681027
12789	CP-645525-01	hsa05221	Acute myeloid leukemia	2475_3551_5296_572_6777_5371_8503_6932_652346_5914_652671	11	-	0.0471620019424401	0.345854680911227
12790	CP-645525-01	hsa04530	Tight junction	6714_84612	2	-	0.000987042981347144	0.0217149455896372
12791	CP-645525-01	hsa05012	Parkinson's disease	317_5413	2	-	0.000962439634573725	0.0217149455896372
12792	CP-645525-01	hsa04260	Cardiac muscle contraction	4635	1	-	0.00933365900435887	0.117337427483369
12793	CP-645525-01	hsa04060	Cytokine-cytokine receptor interaction	3581_3601_2057_3455_3588_8744_608_4254_3604_1956_6361_3082	12	-	0.0111181246867195	0.122299371553915
12794	CP-645525-01	hsa04270	Vascular smooth muscle contraction	6093_109_135_23236	4	-	0.0331983669210007	0.27148413469107
12795	abamectin	hsa05332	Graft-versus-host disease	5551_3126_3127_3123_3125	5	+	0.00709714838096043	0.100779507009638
12796	abamectin	hsa04640	Hematopoietic cell lineage	2323_960_2812_3123_3126_3127_3125_917	8	+	0.00317722930427894	0.0859516189663422
12797	abamectin	hsa05320	Autoimmune thyroid disease	5551_3126_3127_3123_3125	5	+	0.0168632964780945	0.171042007134959
12798	abamectin	hsa04740	Olfactory transduction	26333_3000	2	+	0.00477873709700603	0.0859516189663422
12799	abamectin	hsa05310	Asthma	3123_3126_3127_3125	4	+	0.011092332285671	0.13125926538044
12800	abamectin	hsa04512	ECM-receptor interaction	3688_960_2812_3695_1293_1291	6	+	0.029156040484233	0.258759859297568
12801	abamectin	hsa05330	Allograft rejection	5551_3126_3127_3123_3125	5	+	0.00484234473049815	0.0859516189663422
12802	abamectin	hsa04940	Type I diabetes mellitus	3382_3123_3126_3127_3125_5551	6	+	0.00174615565232316	0.0859516189663422
12803	abamectin	hsa04080	Neuroactive ligand-receptor interaction	2690	1	-	3.60963330162696e-05	0.00151604598668332
12804	abamectin	hsa04740	Olfactory transduction	816	1	-	4.60086719989204e-08	3.86472844790931e-06
12805	abamectin	hsa05322	Systemic lupus erythematosus	6738_3111	2	-	0.0350982846692596	0.491375985369634
12806	abamectin	hsa04210	Apoptosis	842_208_5575_5290_472_355_51135_5534_8837_651610	10	-	0.0333044691642779	0.491375985369634
12807	abamectin	hsa05223	Non-small cell lung cancer	11186_842_208_5290_5925_1869_6256	7	-	0.0332679065808292	0.491375985369634
12808	abamectin	hsa04062	Chemokine signaling pathway	208_4067_5290_4793	4	-	0.0479767113204996	0.575720535845995
12809	abamectin	hsa04020	Calcium signaling pathway	8911_816_5534	3	-	0.0267325758624439	0.491375985369634
12810	GW-8510	hsa04740	Olfactory transduction	818_26211_26529	3	+	0.014251982382119	0.577205286475819
12811	GW-8510	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3108_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3119_9555	24	+	9.93856472133378e-12	8.05023742428036e-10
12812	GW-8510	hsa04916	Melanogenesis	7976_2535_5613_7855_5616_115_3845_6934_112_8324_1385_1387_8321_2033_8322	15	-	0.0179965402100735	0.0486965205684342
12813	GW-8510	hsa05332	Graft-versus-host disease	355	1	-	0.000602938636914771	0.00308168636645327
12814	GW-8510	hsa04650	Natural killer cell mediated cytotoxicity	8503_5295_5290_5291_10451_6452_836_3459_7410_7409_673_5533_4775_4772_5534_8795_5777_6655_6654_6464_355_3845_2534	23	-	0.0259618984337536	0.0663470737751481
12815	GW-8510	hsa04640	Hematopoietic cell lineage	3655_960_3566_2057_3673	5	-	3.27443427490147e-05	0.000251039961075779
12816	GW-8510	hsa03320	PPAR signaling pathway	10062_11001_7316_1962_5467_6257_6256	7	-	0.0052388144518164	0.0178507751691522
12817	GW-8510	hsa05010	Alzheimer's disease	4714_5533_776_836_1327_841_8772_5534_9451_5663_355_489_509_8851_7132	15	-	4.87095339773139e-07	8.96255425182576e-06
12818	GW-8510	hsa04080	Neuroactive ligand-receptor interaction	5029_4889_5618_7442_5021_2908_5025_4886_5031_7067_2150_136_2690_56288_5026_9170	16	-	8.69435365280475e-13	2.66626845352679e-11
12819	GW-8510	hsa04742	Taste transduction	5613_5616_112	3	-	0.00109472854616366	0.00503575131235284
12820	GW-8510	hsa05320	Autoimmune thyroid disease	355	1	-	4.45916306297782e-05	0.000315571539841507
12821	GW-8510	hsa04612	Antigen processing and presentation	4800_4801_4802_3308_3306_1385_3304_3305_3303	9	-	0.00184302754032846	0.00752621711386273
12822	GW-8510	hsa04670	Leukocyte transendothelial migration	1364_8503_5295_1432_394_6387_5290_9475_7852_10451_1365_7430_7410_5747_7409_6093_9080_5291	18	-	0.0126006214490686	0.0373953926875584
12823	GW-8510	hsa05016	Huntington's disease	4714_1213_4899_1387_51164_1327_841_6667_246721_836_2033_23186_509_1385_6875_6874_161_5481_6908	19	-	3.20053007326079e-06	3.2716529637777e-05
12824	GW-8510	hsa04740	Olfactory transduction	5613_5616	2	-	2.83166166905188e-38	2.60512873552773e-36
12825	GW-8510	hsa04514	Cell adhesion molecules (CAMs)	965_4685_9080_1364_1365_5792_23705_3655_25945_9019	10	-	3.05831758624657e-06	3.2716529637777e-05
12826	GW-8510	hsa04510	Focal adhesion	8503_596_5295_5154_5290_9475_10451_394_3673_4659_6093_7057_7410_1399_1398_329_3911_5747_3480_673_3655_3725_6714_5291_4233_6655_6654_6464_7409_7422_2534	31	-	0.00102009766897882	0.00493942029189744
12827	GW-8510	hsa05322	Systemic lupus erythematosus	55766_3014	2	-	5.9002098537049e-13	2.66626845352679e-11
12828	GW-8510	hsa05340	Primary immunodeficiency	64421	1	-	0.00348175814890924	0.012812869987986
12829	GW-8510	hsa04530	Tight junction	5520_64398_56288_55870_9223_5583_5581_51776_2017_55844_8777_9080_10207_6714_5515_6709_7082_8189_1364_1457_3845_27134_1365	23	-	0.0258361228258253	0.0663470737751481
12830	GW-8510	hsa05218	Melanoma	8503_3480_5295_5154_5290_5291_3845_1871_673_4233	10	-	0.0421964103229469	0.102159730255556
12831	GW-8510	hsa04720	Long-term potentiation	5613_5616_673_5533_2033_5534_3845_1387_4659	9	-	0.0156773548498011	0.0450723951931782
12832	GW-8510	hsa05110	Vibrio cholerae infection	115_5613_526_7082_5616	5	-	0.00550623427843308	0.0180919126291373
12833	GW-8510	hsa04512	ECM-receptor interaction	960_3911_7057_3655_3673_3161	6	-	0.000244350698605814	0.00140501651698343
12834	GW-8510	hsa04062	Chemokine signaling pathway	3717_6464_112_8503_5290_9475_7852_6387_56288_5747_2309_3551_7074_7410_1399_1398_7409_5295_673_6093_5291_115_5613_6655_6654_5616_10451_6772_3845_5970_8976	31	-	0.00398363887282751	0.0140959529346204
12835	GW-8510	hsa04810	Regulation of actin cytoskeleton	8503_10672_5295_5154_5290_9475_10451_5747_3673_10458_4659_3985_7074_7410_7430_1399_1398_2263_200576_324_8394_673_10787_2245_6093_5291_8874_6655_6654_54961_3845_54434_3655_7409_8976	35	-	0.0019608195916634	0.00752621711386273
12836	GW-8510	hsa04540	Gap junction	7082_5598_6655_6654_5616_5154_115_5607_3845_5613_1453_6714_112	13	-	0.0174985110181234	0.0486965205684342
12837	GW-8510	hsa05012	Parkinson's disease	4714_2861_7326_836_1327_7314_509_27429_5481	9	-	6.59213792881927e-07	1.01079448241895e-05
12838	GW-8510	hsa04260	Cardiac muscle contraction	784_776_1327_481	4	-	1.81438120472433e-05	0.000151748246213308
12839	GW-8510	hsa04060	Cytokine-cytokine receptor interaction	5154_7852_6387_7132_2057_4233_3459_3572_657_4982_23765_3625_91_90_93_92_655_7048_5618_3566_355_7422_8795_2690	24	-	2.42098164558896e-09	5.56825778485461e-08
12840	GW-8510	hsa03010	Ribosome	6204_6139_6125_6168_6158_6233	6	-	8.76565433697022e-06	8.0644019900126e-05
12841	GW-8510	hsa04020	Calcium signaling pathway	5533_776_5021_5613_56848_5616_5026_115_7220_136_489_5534_5025_490_3707_5481_493	17	-	9.25609334375531e-07	1.21651512517927e-05
12842	GW-8510	hsa03050	Proteasome	5706	1	-	0.000164246438650063	0.00100737815705372
12843	GW-8510	hsa04912	GnRH signaling pathway	4215_776_4216_1432_5598_6655_6654_5616_115_5606_3845_5613_5338_6714_112_6416_3725	17	-	0.028679053449179	0.0713100788466072
12844	GW-8510	hsa05330	Allograft rejection	355	1	-	0.0014294561008354	0.00626237910842175
12845	GW-8510	hsa04730	Long-term depression	2781_10672_673_3845_3480_5515	6	-	0.00196336098622506	0.00752621711386273
12846	GW-8510	hsa04270	Vascular smooth muscle contraction	776_5583_10672_5581_5613_5616_673_115_27094_9826_136_27345_112_6093_9475_4659	16	-	0.00572837469397854	0.0181727748912423
12847	GW-8510	hsa04940	Type I diabetes mellitus	355	1	-	0.000391096234772684	0.00211652079994629
12848	GW-8510	hsa02010	ABC transporters	23461_10257_9619	3	-	0.00738446987223075	0.0226457076081743
12849	GW-8510	hsa04610	Complement and coagulation cascades	7056_2152_5104	3	-	6.90743128631718e-05	0.000453916913100843
12850	trapidil	hsa05332	Graft-versus-host disease	3123_3112_3126_3127_3125	5	+	0.0134852975909855	0.199562041698414
12851	trapidil	hsa05320	Autoimmune thyroid disease	3127_3126_3112_3123_3125	5	+	0.0308272232777193	0.289005218228618
12852	trapidil	hsa04612	Antigen processing and presentation	3123_3806_3126_3127_3125_6892_3112	7	+	0.02653690561672	0.284323988750571
12853	trapidil	hsa04740	Olfactory transduction	815	1	+	0.000118370754810919	0.00443890330540946
12854	trapidil	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504_3112	19	+	4.75274382231423e-07	3.56455786673567e-05
12855	trapidil	hsa05310	Asthma	3123_3112_3126_3127_3125	5	+	0.00383222381571162	0.0958055953927905
12856	trapidil	hsa05330	Allograft rejection	3123_3112_3126_3127_3125	5	+	0.00933306725238976	0.174995010982308
12857	trapidil	hsa04940	Type I diabetes mellitus	3123_3112_3126_3127_3125	5	+	0.0159649633358731	0.199562041698414
12858	alclometasone	hsa05010	Alzheimer's disease	775	1	+	0.0154490110176722	0.563888902145035
12859	alclometasone	hsa04740	Olfactory transduction	5132_393046	2	+	8.90276280290637e-05	0.00649901684612165
12860	alclometasone	hsa04662	B cell receptor signaling pathway	5533_10892_7409_3725_5534	5	-	0.0293397776382877	1
12861	alclometasone	hsa04660	T cell receptor signaling pathway	10892_5533_7409_5603_5534_3725	6	-	0.0398036522079027	1
12862	fluorometholone	hsa04740	Olfactory transduction	51806_26212	2	+	0.000833548585142833	0.0316748462354277
12863	fluorometholone	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_8335_3126_8359_8294_8367_554313_121504	16	+	3.99141736024693e-05	0.00303347719378767
12864	fluorometholone	hsa04662	B cell receptor signaling pathway	6655_10451_5534_3725_27071_4793	6	-	0.0272576315378475	0.577149404898151
12865	fluorometholone	hsa04660	T cell receptor signaling pathway	1432_6655_5534_10451_8440_3725_1326_4793	8	-	0.0189575708405313	0.577149404898151
12866	fluorometholone	hsa05016	Huntington's disease	161	1	-	0.0461719523918521	0.577149404898151
12867	fluorometholone	hsa04740	Olfactory transduction	409	1	-	0.000254042314138003	0.0190531735603502
12868	fluorometholone	hsa04060	Cytokine-cytokine receptor interaction	5155_7042	2	-	0.036477858590723	0.577149404898151
12869	fluorometholone	hsa04912	GnRH signaling pathway	4313_1432_5598_6655_1839_3725_5338	7	-	0.0450580161117718	0.577149404898151
12870	salsolidin	hsa04740	Olfactory transduction	7932_1179_816	3	+	0.00278682934393456	0.105899515069513
12871	salsolidin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_3111_8359_8294_720_721_121504_8367	17	+	1.41338892636822e-05	0.00107417558403985
12872	salsolidin	hsa04012	ErbB signaling pathway	5063_5599_1839_1950_5602_9542_816	7	+	0.0301398482973496	0.572657117649642
12873	salsolidin	hsa04930	Type II diabetes mellitus	5599_5581_773_3551_5602	5	+	0.0208780232311048	0.528909921854655
12874	salsolidin	hsa04080	Neuroactive ligand-receptor interaction	5025_4886_1909	3	-	8.02587828458767e-12	3.73203340233327e-10
12875	salsolidin	hsa04740	Olfactory transduction	818_801_808_805_409	5	-	7.62801135309344e-17	7.0940505583769e-15
12876	salsolidin	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8343_8347_8346_8344_8339_723790_3123_3126_3127_3125_8969_8968_8370_8358_8359_8330_8331_8336_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_85236_3013_3014_6741_9555	48	-	2.47124274426456e-06	5.7456393804151e-05
12877	salsolidin	hsa05110	Vibrio cholerae infection	375_523	2	-	0.0302067199042084	0.401317850155912
12878	salsolidin	hsa04062	Chemokine signaling pathway	2786_5829_6654_6772_673_6774_3845_6777_5290_1398_7409_6093_409	13	-	0.00408158961561305	0.0759175668504027
12879	salsolidin	hsa03430	Mismatch repair	6118_5395_5982_5983_27030_5985_3978_2956	8	-	0.0494015792402442	0.53434346819772
12880	salsolidin	hsa04060	Cytokine-cytokine receptor interaction	3556_3597_2057_3588_3459_5155_3572_655_93_51330	10	-	6.20834277936267e-07	1.92458626160243e-05
12881	salsolidin	hsa04020	Calcium signaling pathway	8877_5025_11261_2767_3709_818_808_7416_489_1909_801_7419_490_805	14	-	0.0168955642635735	0.261881246085389
12882	thiostrepton	hsa05332	Graft-versus-host disease	3122_355_3107_3811_3111	5	+	0.0284038654669405	0.37398422864805
12883	thiostrepton	hsa04650	Natural killer cell mediated cytotoxicity	2207_3811_3383_2215_2214_3107_8743_5293_355_6452_80328_80329_2534	13	+	0.00375277011612626	0.148234419586987
12884	thiostrepton	hsa04612	Antigen processing and presentation	3811_3122_3107_3111_3310_3304_3305_3303	8	+	0.0262549600935765	0.37398422864805
12885	thiostrepton	hsa04740	Olfactory transduction	26664	1	+	1.18482122813766e-05	0.000936008770228751
12886	thiostrepton	hsa04115	p53 signaling pathway	1647_1026_5366_317_4193_5268_355_10912	8	+	0.00716902067874328	0.188784211206906
12887	thiostrepton	hsa04940	Type I diabetes mellitus	3122_3107_2572_3111_2571_355	6	+	0.00965816904911231	0.190748838719968
12888	thiostrepton	hsa05010	Alzheimer's disease	8851_3709_23621	3	-	0.00254049107783094	0.043188348323126
12889	thiostrepton	hsa04080	Neuroactive ligand-receptor interaction	5618_7442_2908_4886_3354_1909	6	-	0.00120193973471187	0.026984479411097
12890	thiostrepton	hsa05016	Huntington's disease	3092_7419_581	3	-	0.00126985785463986	0.026984479411097
12891	thiostrepton	hsa04740	Olfactory transduction	219464_5613_5566_5616	4	-	3.38620921164048e-08	2.87827782989441e-06
12892	thiostrepton	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8329_8294_8342_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3014_720_721	26	-	9.63455677539946e-05	0.00409468662954477
12893	thiostrepton	hsa05221	Acute myeloid leukemia	2475_6777_595_6655_5295_5371_6934_11040_5914	9	-	0.0497083744886109	0.469467981281325
12894	thiostrepton	hsa05012	Parkinson's disease	27429_7419_2861	3	-	0.0260537950601849	0.276821572514465
12895	thiostrepton	hsa04060	Cytokine-cytokine receptor interaction	5618_2057_3568_4254_6387_7424_7042_4233	8	-	0.00698911775433275	0.099012501519714
12896	thiostrepton	hsa05210	Colorectal cancer	595_596_4088_6655_5295_1855_1856_6934_7042_3725_7976_4233_581	13	-	0.022991794209336	0.276821572514465
12897	benzocaine	hsa04916	Melanogenesis	2778_51806_5566	3	+	0.0246589240589473	0.369883860884209
12898	benzocaine	hsa05016	Huntington's disease	2902_4899_6648_64446	4	+	0.000170230257512892	0.00510690772538676
12899	benzocaine	hsa04740	Olfactory transduction	51806_5593_5566_4991	4	+	1.30510637820321e-11	1.17459574038289e-09
12900	benzocaine	hsa05322	Systemic lupus erythematosus	474382_474381_88_8342_958_3122_3123_3126_3127_3125_8968_718_8358_8350_8351_8352_8353_8354_8355_8356_8357_83740_3013_720_721	25	+	0.0132929348934354	0.299091035102297
12901	benzocaine	hsa05012	Parkinson's disease	6622	1	+	6.09205874029203e-05	0.00274142643313141
12902	benzocaine	hsa04260	Cardiac muscle contraction	9254_4635	2	+	0.0328156216105914	0.421915134993318
12903	benzocaine	hsa04060	Cytokine-cytokine receptor interaction	958_5618_3554_2057_3594_3953_8771_3576_27242_7293_6372_4233_1896_4352	14	+	0.0239038570179047	0.369883860884209
12904	benzocaine	hsa05322	Systemic lupus erythematosus	8343_8339_8347_8346_8344	5	-	0.0125753005333897	0.440135518668639
12905	succinylsulfathiazole	hsa04740	Olfactory transduction	8390_1179	2	+	2.88525314803322e-05	0.00239476011286757
12906	succinylsulfathiazole	hsa04630	Jak-STAT signaling pathway	4352	1	+	0.0221173429020866	0.917869730436594
12907	succinylsulfathiazole	hsa04120	Ubiquitin mediated proteolysis	8945_6477_5371_8881_51433_89910_51588_8651_57154_55958	10	-	0.0114950649336952	0.436812467480418
12908	succinylsulfathiazole	hsa04080	Neuroactive ligand-receptor interaction	1131_2150	2	-	0.0364726216563714	0.595617514392534
12909	succinylsulfathiazole	hsa04740	Olfactory transduction	5613_409	2	-	0.00166325472997203	0.126407359477874
12910	succinylsulfathiazole	hsa04060	Cytokine-cytokine receptor interaction	355_2324	2	-	0.0376463590412348	0.595617514392534
12911	succinylsulfathiazole	hsa03010	Ribosome	440589_140801_9349_6187_284393_6203_389342	7	-	0.0391853627889825	0.595617514392534
12912	Prestwick-692	hsa04740	Olfactory transduction	8387_5137_26476_5566_8388	5	+	0.000123487002586794	0.0101259342121171
12913	Prestwick-692	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_717_8368_8359_8294_8367_554313_6738_121504	16	+	0.00879510220846795	0.360599190547186
12914	Prestwick-692	hsa05012	Parkinson's disease	1339	1	+	0.0155948322038864	0.426258746906228
12915	Prestwick-692	hsa04662	B cell receptor signaling pathway	3725_4793_5534	3	-	0.0279509654954838	0.530170331910058
12916	Prestwick-692	hsa05210	Colorectal cancer	4088_91_3725	3	-	0.0369145069894205	0.530170331910058
12917	Prestwick-682	hsa04740	Olfactory transduction	818_9635_393046	3	+	0.0102963316084407	0.782521202241493
12918	Prestwick-682	hsa04070	Phosphatidylinositol signaling system	5331_8867_3708_8394	4	-	0.00699736044219142	0.185430051718073
12919	Prestwick-682	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	4233_528_1432_28964	4	-	0.00557427284751582	0.185430051718073
12920	canadine	hsa05332	Graft-versus-host disease	3824_3553_3123_3126_3127_3125_356	7	+	0.0298641549993234	0.779013395898171
12921	canadine	hsa04740	Olfactory transduction	219464_26211_56656_23538_8390_10798_3000	7	+	3.95378430077637e-05	0.00170012724933384
12922	canadine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8329_8294_8341_8340_3123_3126_3127_3125_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_2215	29	+	7.47892689036767e-07	6.4318771257162e-05
12923	canadine	hsa04940	Type I diabetes mellitus	3382_3123_3126_3127_3125_356_3553	7	+	0.0362331812045661	0.779013395898171
12924	canadine	hsa05131	Shigellosis	6093_7430_8976	3	-	0.0174610231968708	0.20953227836245
12925	canadine	hsa05130	Pathogenic Escherichia coli infection	6093_7430_8976	3	-	0.0174610231968708	0.20953227836245
12926	canadine	hsa04110	Cell cycle	472_651610_10912_7042	4	-	0.0276454574281086	0.211630142702661
12927	canadine	hsa04115	p53 signaling pathway	472_651610_10912	3	-	0.0293930753753696	0.211630142702661
12928	canadine	hsa03020	RNA polymerase	246721_5439_548644	3	-	0.0031901188668247	0.114844279205689
12929	gelsemine	hsa04740	Olfactory transduction	26211_26212_7932_26333_5566_5137_816	7	+	0.00583730154795128	0.242248014239978
12930	gelsemine	hsa04510	Focal adhesion	2064_859_596	3	+	0.0268630469179145	0.595284379897812
12931	gelsemine	hsa05322	Systemic lupus erythematosus	2903_8361_8363_8362_8365_8364_8367_8360_8368_8329_8294_8366_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3119	23	+	1.54481135749267e-06	0.000128219342671892
12932	gelsemine	hsa04810	Regulation of actin cytoskeleton	8817_79784_2251_2250	4	+	0.0485084560630277	0.595284379897812
12933	gelsemine	hsa04912	GnRH signaling pathway	3710_2488_108_100137049_5566_1081_2798_8681_5609_816	10	+	0.0439146300747808	0.595284379897812
12934	picrotoxinin	hsa04120	Ubiquitin mediated proteolysis	5371_7329_22888_10393_8651_652671	6	+	0.0476228586293569	0.579855638304389
12935	picrotoxinin	hsa05320	Autoimmune thyroid disease	3451_5551_3448_1081	4	+	0.0193657497544516	0.504906690801966
12936	picrotoxinin	hsa04740	Olfactory transduction	5593	1	+	0.0106850639503664	0.504906690801966
12937	picrotoxinin	hsa04630	Jak-STAT signaling pathway	3581_3451_3566_3448_3953_51561_8651	7	+	0.0275403649528345	0.504906690801966
12938	picrotoxinin	hsa04070	Phosphatidylinositol signaling system	8394_5305_3633_5331_3631_3707	6	-	0.0128545621740899	0.426975829427341
12939	picrotoxinin	hsa04740	Olfactory transduction	5613_5616	2	-	0.00939949087850042	0.426975829427341
12940	picrotoxinin	hsa04370	VEGF signaling pathway	10725_6714_4775_81579_8399	5	-	0.0444186353023933	0.59520971305207
12941	picrotoxinin	hsa04540	Gap junction	5613_6655_5616_5331_5607_6714	6	-	0.0296509628654993	0.496653627997113
12942	picrotoxinin	hsa04912	GnRH signaling pathway	8399_5613_6655_5616_5331_6714_81579	7	-	0.0191183207206272	0.426975829427341
12943	Prestwick-642	hsa04740	Olfactory transduction	5566_393046	2	+	0.00236972180634803	0.172989691863406
12944	Prestwick-642	hsa05322	Systemic lupus erythematosus	3013_6737_8358_8968_720_721_8350_8351_8352_8353_8354_8355_8356_8357	14	-	6.17574818643431e-08	2.7173292020311e-06
12945	Prestwick-642	hsa03010	Ribosome	6205_284393_389342_439992_6189	5	-	0.019484936539592	0.312225245644394
12946	Prestwick-642	hsa04610	Complement and coagulation cascades	2_7035_720_721	4	-	0.0212880849302996	0.312225245644394
12947	solasodine	hsa05016	Huntington's disease	90993_4695_6667_10540	4	+	0.047903151679153	0.666284458387333
12948	solasodine	hsa04740	Olfactory transduction	26539_5566	2	+	2.97548090156828e-07	2.38038472125462e-05
12949	solasodine	hsa05322	Systemic lupus erythematosus	2213_2903_8363_8362_8365_8364_8370_8360_8368_8335_8366_9103_8359_8361_8294_8367_554313_121504	18	+	0.00202104849409077	0.0808419397636308
12950	solasodine	hsa04350	TGF-beta signaling pathway	1634_9372_6667_7057_5519_91_6093_3626_10468_5516	10	+	0.0342962608923051	0.666284458387333
12951	solasodine	hsa04512	ECM-receptor interaction	10319_1281_22798_9900_2814_7057_1277_2335_1290_1291_1280	11	+	0.0161908091023104	0.431754909394944
12952	solasodine	hsa05012	Parkinson's disease	7345_4695	2	+	0.04997133437905	0.666284458387333
12953	solasodine	hsa04080	Neuroactive ligand-receptor interaction	4889_1269_5618_3953_5025_2908_2925_2901_4886_7434_64106_2150_56288	13	-	1.03738453901528e-07	4.72009965251952e-06
12954	solasodine	hsa04742	Taste transduction	5613_5566	2	-	0.01333797531334	0.17339367907342
12955	solasodine	hsa05016	Huntington's disease	5432_1212_4899_1387_836_842_841_5435_642502_6391_246721_4698_3708_27113_517_7019_7419_7381_5481_23236	20	-	0.0243860408235449	0.246569968326954
12956	solasodine	hsa04740	Olfactory transduction	219464_26212_5613_5566_818_808_810_801_805	9	-	5.13930310937823e-18	4.67676582953419e-16
12957	solasodine	hsa05340	Primary immunodeficiency	8625	1	-	0.0345108649335521	0.24698779848884
12958	solasodine	hsa03410	Base excision repair	8930	1	-	0.0352839712126914	0.24698779848884
12959	solasodine	hsa04140	Regulation of autophagy	3451	1	-	0.0345108649335521	0.24698779848884
12960	solasodine	hsa04062	Chemokine signaling pathway	3717_5295_208_5829_5613_6655_6777_998_6358_6359_115_5296_6387_56288_1399_5747_5566_4793_107_23236	20	-	0.0157541304968462	0.179203234401626
12961	solasodine	hsa05012	Parkinson's disease	7419_836_842_642502_6391_5481_4698_27429_7381_517_7332	11	-	0.00736278825595668	0.140541856129959
12962	solasodine	hsa04260	Cardiac muscle contraction	784_7168_7381_10479_27092	5	-	0.0103719390261283	0.157307741896279
12963	solasodine	hsa04060	Cytokine-cytokine receptor interaction	3597_55540_8742_8741_6387_3556_3451_2057_3455_3572_4982_8718_3601_3953_1271_5154_51561_7042_8795_1436_5618_943_6358_6359_355_50616_7423_7422	28	-	0.00772208000714058	0.140541856129959
12964	solasodine	hsa03010	Ribosome	6138_140801_6137_6125_6168_6234_6165	7	-	0.00713117891090757	0.140541856129959
12965	solasodine	hsa05217	Basal cell carcinoma	7976_6934_324	3	-	0.0277575752218263	0.24698779848884
12966	0225151-0000	hsa05200	Pathways in cancer	10297_331_5293_7855_7039_5728_356_2034_2249_2261_1495_23604_4193_1950_4233_3688_841_5599_862_1029_867_83439_5915_7428_6257_2250	26	+	0.0196669728008426	0.444175169253741
12967	0225151-0000	hsa04740	Olfactory transduction	26659_23538	2	+	2.9958880160714e-06	0.000242666929301783
12968	0225151-0000	hsa05322	Systemic lupus erythematosus	8358_8342_85235_8968_2904_8348_3013_8330_8332_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357	21	+	2.01183864699126e-05	0.00081479465203146
12969	0225151-0000	hsa05218	Melanoma	5728_1029_4193_5293_1950_2250_4233_2249	8	+	0.0276919332142161	0.448609318070301
12970	0225151-0000	hsa04512	ECM-receptor interaction	3688_1281_948_3690_3680_1277_3679_1292_1291	9	+	0.0388084495623304	0.52391406909146
12971	0225151-0000	hsa05012	Parkinson's disease	6390	1	+	0.021934576259444	0.444175169253741
12972	0225151-0000	hsa05213	Endometrial cancer	5728_83439_10297_5293_1950_1495	6	+	0.0485744353690257	0.562075609270155
12973	0225151-0000	hsa05332	Graft-versus-host disease	3811_3109_3119_3569_3113_3112_3111_3802_3134_3552	10	-	0.0241680477938301	0.303826886551007
12974	0225151-0000	hsa05010	Alzheimer's disease	776_3710_2904_3709_6622_4842	6	-	0.00389289363423382	0.112834938785145
12975	0225151-0000	hsa05016	Huntington's disease	1212_64446_10126_9001_2904	5	-	0.000541748707401914	0.0238369431256842
12976	0225151-0000	hsa04740	Olfactory transduction	26211_2978_5592_135948_393046	5	-	6.89051175501966e-11	6.0636503444173e-09
12977	0225151-0000	hsa04110	Cell cycle	472_51343_1028_4616	4	-	0.0175995087969867	0.258126129022472
12978	0225151-0000	hsa04630	Jak-STAT signaling pathway	10252_1271_3569_10000_23533	5	-	0.00512886085387021	0.112834938785145
12979	0225151-0000	hsa05012	Parkinson's disease	2861_6622_9627_5413	4	-	0.00695036212992997	0.122326373486767
12980	quinisocaine	hsa05131	Shigellosis	6093_7454_7430_113457_7278	5	+	0.0466891258218951	0.690999062164047
12981	quinisocaine	hsa05130	Pathogenic Escherichia coli infection	6093_7454_7430_113457_7278	5	+	0.0466891258218951	0.690999062164047
12982	quinisocaine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_2904_8368_8348_8294_121504_8366_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_942_8970	29	+	2.00375916229712e-13	1.48278178009987e-11
12983	quinisocaine	hsa04020	Calcium signaling pathway	3708	1	+	0.0327318302801563	0.690999062164047
12984	quinisocaine	hsa05210	Colorectal cancer	6654_6934_54205_324_2353_3725_7042	7	+	0.0276600040855584	0.690999062164047
12985	quinisocaine	hsa04080	Neuroactive ligand-receptor interaction	56288_7068	2	-	0.00026585291109882	0.00700079332560226
12986	quinisocaine	hsa05200	Pathways in cancer	5728_3912_581_5900_4254_405_5335_5914	8	-	0.0167552712057807	0.264733285051335
12987	quinisocaine	hsa04740	Olfactory transduction	810_5613_109	3	-	3.16640873706813e-06	0.000125073145114191
12988	quinisocaine	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3123_3126_3127_3125_8969_8370_8332_8359_8330_8331_8336_554313_6738_121504_85235_3014	27	-	1.62536693355872e-07	1.28403987751139e-05
12989	quinisocaine	hsa04630	Jak-STAT signaling pathway	3717_10379	2	-	0.026150839222935	0.344319383101977
12990	quinisocaine	hsa05012	Parkinson's disease	4712_291	2	-	0.0494336405711274	0.496627197035236
12991	quinisocaine	hsa04060	Cytokine-cytokine receptor interaction	7852_6387_8792_4254	4	-	0.00294513128366249	0.0581663428523342
12992	solanine	hsa05332	Graft-versus-host disease	3122_3123_3126_3127_3125	5	+	0.0337986508796747	0.333761677436788
12993	solanine	hsa04650	Natural killer cell mediated cytotoxicity	3448	1	+	0.045593166043232	0.360186011741533
12994	solanine	hsa04640	Hematopoietic cell lineage	3122_3123_3126_3570_3127_7850_915_3125	8	+	0.0299621810592695	0.333761677436788
12995	solanine	hsa05320	Autoimmune thyroid disease	958_3448_1081_3122_3123_3126_3127_3125	8	+	0.00223633482464975	0.0607525097961613
12996	solanine	hsa04740	Olfactory transduction	5566_26532_26692	3	+	0.000242850164036666	0.0191851629588966
12997	solanine	hsa05218	Melanoma	5925_3480_2250_8823_80310_2254_3082	7	+	0.0303796281236714	0.333761677436788
12998	solanine	hsa05310	Asthma	958_3122_3123_3126_3127_3125	6	+	0.00230705733403144	0.0607525097961613
12999	solanine	hsa05330	Allograft rejection	958_3122_3123_3126_3127_3125	6	+	0.00645584869570818	0.127503011740237
13000	solanine	hsa04270	Vascular smooth muscle contraction	800_8398_5581_2983_5566_23365_10242_6093_4638_2977	10	+	0.0323341673404725	0.333761677436788
13001	solanine	hsa04940	Type I diabetes mellitus	3122_3123_3126_3127_3125	5	+	0.0395007598138265	0.346728891699144
13002	solanine	hsa04120	Ubiquitin mediated proteolysis	23327_10277_25898_51366_7321_868_6502_6477_4193_867_26091_7337_8925_51619_9820_8451_26232_7320_7334	19	-	0.0288010520871287	0.309611309936634
13003	solanine	hsa04080	Neuroactive ligand-receptor interaction	5618_7068_1131_4886_3355_56288_7433_2690	8	-	0.0052950387676542	0.143724566742897
13004	solanine	hsa04740	Olfactory transduction	409	1	-	8.37529391972381e-12	7.20275277096248e-10
13005	solanine	hsa04115	p53 signaling pathway	472_5728_25898_5366_842_581_898_6477_4193_1111_651610	11	-	0.0462421346880269	0.441869287018924
13006	solanine	hsa04060	Cytokine-cytokine receptor interaction	5618_2057_27242_3572_7046_7042_91_90_2690	9	-	0.00863756892049012	0.14772876488692
13007	solanine	hsa03010	Ribosome	6125	1	-	0.00668486356943707	0.143724566742897
13008	solanine	hsa05210	Colorectal cancer	8503_842_581_6655_6654_7042_6932_4437_7046_5602_91_3725_2956_8321_8323	15	-	0.00550037804093795	0.143724566742897
13009	solanine	hsa04270	Vascular smooth muscle contraction	81579_5332	2	-	0.0120244343512609	0.14772876488692
13010	solanine	hsa05220	Chronic myeloid leukemia	868_8503_6777_3551_598_6655_6654_4193_867_5925_7046_7042_91	13	-	0.0118245071407594	0.14772876488692
13011	harmaline	hsa04664	Fc epsilon RI signaling pathway	5319_5609_7410	3	+	0.0452793237729428	0.579037264544452
13012	harmaline	hsa04610	Complement and coagulation cascades	722_720_721	3	+	0.0326579092960192	0.579037264544452
13013	harmaline	hsa04080	Neuroactive ligand-receptor interaction	4889_5618_7068_2561_5025_5030_2150_4886	8	-	2.5014654653669e-05	0.00113816678674194
13014	harmaline	hsa04742	Taste transduction	5567	1	-	0.040019558106037	0.455222473456171
13015	harmaline	hsa05131	Shigellosis	9076_4690_7280_347733_7278_999_113457_998_9475_60_7430_7534_8976	13	-	0.0237323564856645	0.308520634313639
13016	harmaline	hsa05130	Pathogenic Escherichia coli infection	9076_4690_7280_347733_7278_999_113457_998_9475_60_7430_7534_8976	13	-	0.0237323564856645	0.308520634313639
13017	harmaline	hsa04740	Olfactory transduction	157_801_808_5567_805	5	-	1.80551733246704e-12	1.64302077254501e-10
13018	harmaline	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	1432_528_5058_5602_998_51382_535_1956_6868_5781_523_102_5335_6714_50848_4233	16	-	0.0173684078210716	0.308520634313639
13019	harmaline	hsa05012	Parkinson's disease	7314_6391_7416_7327_642502	5	-	0.00674370795710947	0.15341935602424
13020	harmaline	hsa04060	Cytokine-cytokine receptor interaction	5618_3597_2057_3454_4254_3572_355_1956_4982_7422_9180_4233_51330	13	-	0.0020840084382394	0.0632149226265951
13021	harmaline	hsa05220	Chronic myeloid leukemia	868_6777_5594_4088_613_6655_5295_6464_4193_5291_7157_5781_1399_1398_598	15	-	0.0490244017437327	0.495691173186631
13022	harman	hsa04650	Natural killer cell mediated cytotoxicity	3383_3683_3107_5532_27040_2185_8794	7	+	0.037099339227705	0.754353230963335
13023	harman	hsa04514	Cell adhesion molecules (CAMs)	6402_3383_3683_3107_5818_6693_923	7	+	0.032598569086252	0.754353230963335
13024	harman	hsa05322	Systemic lupus erythematosus	729_717_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357	13	+	3.29985582657706e-05	0.00201291205421201
13025	harman	hsa05211	Renal cell carcinoma	2271_6655_998_5781_1399_3725_4233_7422	8	-	0.0104944409611775	0.36829471742664
13026	harman	hsa04740	Olfactory transduction	157_409	2	-	6.09045163559817e-05	0.00487236130847854
13027	harman	hsa04010	MAPK signaling pathway	2872_9479_1844_6655_50487_998_4137_5606_8681_11221_1399_2258_3725_2260_2261_100137049_3164_409_27092	19	-	0.0188912555207009	0.377825110414018
13028	harman	hsa04912	GnRH signaling pathway	4313_6655_50487_2767_998_5331_5606_8681_3725_100137049	10	-	0.013811051903499	0.36829471742664
13029	dydrogesterone	hsa04080	Neuroactive ligand-receptor interaction	2561	1	-	0.0016922065706661	0.0383769898600667
13030	dydrogesterone	hsa05016	Huntington's disease	4714	1	-	0.0155363349688268	0.224156239705793
13031	dydrogesterone	hsa04740	Olfactory transduction	818_109	2	-	0.000190729604440037	0.0123974242886024
13032	dydrogesterone	hsa04710	Circadian rhythm - mammal	1408_8863_9575	3	-	0.0172427876696764	0.224156239705793
13033	dydrogesterone	hsa04664	Fc epsilon RI signaling pathway	8399_50487_5881_5290_7410_5606_5600	7	-	0.031617974440442	0.293595476946961
13034	dydrogesterone	hsa04370	VEGF signaling pathway	9261_8399_50487_5290_5881_5600_6714	7	-	0.0282675149668427	0.293595476946961
13035	dydrogesterone	hsa04060	Cytokine-cytokine receptor interaction	55540	1	-	0.00177124568584923	0.0383769898600667
13036	hydroxyachillin	hsa04740	Olfactory transduction	26539_4991	2	+	0.00324867978194885	0.194920786916931
13037	hydroxyachillin	hsa04514	Cell adhesion molecules (CAMs)	3119_3113_6693_23308_57863_920_26285_25945_925	9	+	0.0131163009492003	0.393489028476009
13038	hydroxyachillin	hsa04080	Neuroactive ligand-receptor interaction	5618_4157_7068_2908_5030_56288_4886_2150	8	-	3.51141640429261e-12	1.63280862799606e-10
13039	hydroxyachillin	hsa05016	Huntington's disease	1212_1213_246721_6874_6648_5439_581_4728_1639_6391_5331_5978_1387_642502_7019_5332_1385_4714_548644_161_23236	21	-	0.00848478961045989	0.078908543377277
13040	hydroxyachillin	hsa04740	Olfactory transduction	26211_5613_5616_808_818_109_810_801_805	9	-	1.56734417579717e-20	1.45763008349137e-18
13041	hydroxyachillin	hsa04514	Cell adhesion molecules (CAMs)	965_3123_3126_3127_3125_5792_9672_3105_50848_9019_1001_5817	12	-	0.00483544197688859	0.0499662337611821
13042	hydroxyachillin	hsa05340	Primary immunodeficiency	5993	1	-	0.0224314474829838	0.151604485430099
13043	hydroxyachillin	hsa04140	Regulation of autophagy	9474	1	-	0.0224314474829838	0.151604485430099
13044	hydroxyachillin	hsa04062	Chemokine signaling pathway	3717_5296_5295_5331_5332_56288_112_5580_2782_1399_1398_2773_109_6093_23236_5594_5613_6655_2885_5616_6772_3845	22	-	0.00947804770219864	0.0801325851185885
13045	hydroxyachillin	hsa05012	Parkinson's disease	4714_642502_6391_4728	4	-	4.63344097111828e-07	1.077275025785e-05
13046	hydroxyachillin	hsa04260	Cardiac muscle contraction	776_10479_481_27092	4	-	0.00121712504454427	0.0161703755918024
13047	hydroxyachillin	hsa04060	Cytokine-cytokine receptor interaction	5618_3566_3455_55540_3459_3625_4254_3572_657_355_4982_7422_7042_3597_8795_7040	16	-	5.12334714039338e-08	1.58823761352195e-06
13048	hydroxyachillin	hsa03010	Ribosome	6142_6138_285053_6234_6203	5	-	0.000334493511787382	0.00622157931924531
13049	hydroxyachillin	hsa04020	Calcium signaling pathway	5331_7220_5332_490_493_5257_5255_818_808_810_776_5532_109_489_3707_23236_5578_5613_5616_3709_801_805	22	-	0.0228221806023805	0.151604485430099
13050	hydroxyachillin	hsa03050	Proteasome	9491_5707_23198	3	-	0.0372453463500751	0.230921147370466
13051	hydroxyachillin	hsa02010	ABC transporters	26154	1	-	0.00440865658430894	0.0499662337611821
13052	hydroxyachillin	hsa04610	Complement and coagulation cascades	7035_1604	2	-	0.000578410128134594	0.00896535698608621
13053	glimepiride	hsa04740	Olfactory transduction	393046	1	+	0.00115509301354673	0.0421608949944556
13054	glimepiride	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_8370_8366_3122_8368_8359_8294_8367_554313_121504	15	+	7.49827543733238e-06	0.000547374106925264
13055	glimepiride	hsa04360	Axon guidance	55558_5361_5534_1944_9475_5747	6	-	0.0330252644326352	0.588530839246724
13056	glimepiride	hsa04810	Regulation of actin cytoskeleton	3693_8394_1131_4627_54961_9475_7074_5747_2260_28964	10	-	0.00692534058425494	0.387819072718277
13057	glimepiride	hsa04540	Gap junction	7278_6714_113_113457_5607	5	-	0.0285073062117666	0.588530839246724
13058	vitexin	hsa05332	Graft-versus-host disease	3122_3134_3107_3111	4	+	0.0328843583351616	0.586367080971469
13059	vitexin	hsa04612	Antigen processing and presentation	3806_3122_3107_3111_3134_925	6	+	0.0400538308687129	0.586367080971469
13060	vitexin	hsa05330	Allograft rejection	3122_3134_3107_3111	4	+	0.0244682463496642	0.586367080971469
13061	vitexin	hsa04940	Type I diabetes mellitus	3122_3134_3107_3111	4	+	0.0376520777022647	0.586367080971469
13062	vitexin	hsa04070	Phosphatidylinositol signaling system	1609_8394_5333_5335_51763_3707	6	-	0.0371229742377679	0.903325706452352
13063	vitexin	hsa04740	Olfactory transduction	5566	1	-	0.000186170689714814	0.0135904603491814
13064	vitexin	hsa04330	Notch signaling pathway	113878_182_171558_4854_5664	5	-	0.0197457701897171	0.720720611924674
13065	Prestwick-691	hsa05010	Alzheimer's disease	2903_6392_4698_651820_3708_488_810_6622	8	+	0.0338147702902534	0.512857349402177
13066	Prestwick-691	hsa04310	Wnt signaling pathway	324_5613_5566_6477_5526_6093	6	+	0.0303433266475066	0.512857349402177
13067	Prestwick-691	hsa05016	Huntington's disease	4899_6392_4698_651820_246721_3708	6	+	0.00394647042622979	0.11970960292897
13068	Prestwick-691	hsa04740	Olfactory transduction	26211_7932_5613_5566_8390_23538_2979_810_26189	9	+	3.00761810078128e-07	2.73693247171096e-05
13069	Prestwick-691	hsa05012	Parkinson's disease	6392_6622_651820_4698	4	+	0.013619132919321	0.309835273914553
13070	Prestwick-691	hsa03010	Ribosome	6165	1	+	0.00207450482431459	0.0943899695063139
13071	sulfabenzamide	hsa04350	TGF-beta signaling pathway	91_4088_6093_3624	4	+	0.0253225240557822	0.737462676435242
13072	sulfabenzamide	hsa05332	Graft-versus-host disease	3135_3105_3106_649853	4	-	0.0111276831422784	0.222275846689559
13073	sulfabenzamide	hsa04130	SNARE interactions in vesicular transport	8417_9570_10228	3	-	0.0426442312117115	0.454203730884393
13074	sulfabenzamide	hsa05320	Autoimmune thyroid disease	3135_3105_3106_649853	4	-	0.022939784588118	0.316569027316028
13075	sulfabenzamide	hsa05322	Systemic lupus erythematosus	85235_8348_8330_8332_8969_8331_8329_8336	8	-	0.00849131664852345	0.222275846689559
13076	sulfabenzamide	hsa04920	Adipocytokine signaling pathway	8660_3717_4793_5602	4	-	0.0460786393650833	0.454203730884393
13077	sulfabenzamide	hsa05330	Allograft rejection	3135_3105_3106_649853	4	-	0.00809395985972208	0.222275846689559
13078	sulfabenzamide	hsa04940	Type I diabetes mellitus	3135_3105_3106_649853	4	-	0.0128855563298295	0.222275846689559
13079	BCB000039	hsa04740	Olfactory transduction	816	1	+	0.00376473012532381	0.0865887928824476
13080	BCB000039	hsa04514	Cell adhesion molecules (CAMs)	9076_214_3383_3119_5797_26285_925_5817	8	+	0.013109171235038	0.185160478813149
13081	BCB000039	hsa05322	Systemic lupus erythematosus	85235_3119_8330_8332_8969_8331_8329_8336	8	+	0.0190385838228507	0.218943713962783
13082	BCB000039	hsa04370	VEGF signaling pathway	572_8681_50487_100137049_8398	5	+	0.0343294326691587	0.338390122024564
13083	BCB000039	hsa04912	GnRH signaling pathway	8398_50487_1956_8681_112_100137049_816	7	+	0.0134174260009528	0.185160478813149
13084	BCB000039	hsa04730	Long-term depression	8398_2983_10672_50487_8681_1394_100137049	7	+	0.00159743019673178	0.0665943899531289
13085	BCB000039	hsa04270	Vascular smooth muscle contraction	8398_2983_10672_50487_27094_8681_135_112_100137049	9	+	0.00193027217255446	0.0665943899531289
13086	BCB000039	hsa05016	Huntington's disease	8218_246721_27113_6648_9001_581_7052_1639_4713_317_3708_56901_4695_10126	14	-	0.0348590411102917	0.468768646730153
13087	BCB000039	hsa04740	Olfactory transduction	5593_5566_4991_8383_8392_4992_390892_5137_9635_816	10	-	2.50280719893572e-11	2.22749840705279e-09
13088	BCB000039	hsa05322	Systemic lupus erythematosus	8361_8360_8363_8362_8365_8364_94239_8366_8368_6738_8294_121504_959_8367_8968_8370_717_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_3113_3111_1511	33	-	0.00607143902173541	0.246274295200126
13089	BCB000039	hsa04340	Hedgehog signaling pathway	51715_5566	2	-	0.0421365075712497	0.468768646730153
13090	BCB000039	hsa04530	Tight junction	5579_1364_5519_84612_56288_9223_23562	7	-	0.00830138073708291	0.246274295200126
13091	BCB000039	hsa04664	Fc epsilon RI signaling pathway	5320_9846_5295_1432_3596_5579_5599_6655_6654_7410_27040_5335_5600_5603_7409_5609_6300_6850	18	-	0.0382090382665587	0.468768646730153
13092	BCB000039	hsa05012	Parkinson's disease	2861_6570_4695_5413_4713_317_7054_56901_6622	9	-	0.036993959963442	0.468768646730153
13093	BCB000039	hsa05217	Basal cell carcinoma	6932	1	-	0.0186408324637377	0.414758522318164
